PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pei, Q; Zhang, DD; Lee, HF; Li, GD				Pei, Qing; Zhang, David D.; Lee, Harry F.; Li, Guodong			Climate Change and Macro-Economic Cycles in Pre-Industrial Europe	PLOS ONE			English	Article							ECONOMIC-GROWTH; GRAIN MARKETS; POPULATION; INTERVENTION; CAUSALITY; PRICES	Climate change has been proven to be the ultimate cause of social crisis in pre-industrial Europe at a large scale. However, detailed analyses on climate change and macro-economic cycles in the pre-industrial era remain lacking, especially within different temporal scales. Therefore, fine-grained, paleo-climate, and economic data were employed with statistical methods to quantitatively assess the relations between climate change and agrarian economy in Europe during AD 1500 to 1800. In the study, the Butterworth filter was adopted to filter the data series into a long-term trend (low-frequency) and short-term fluctuations (high-frequency). Granger Causality Analysis was conducted to scrutinize the associations between climate change and macro-economic cycle at different frequency bands. Based on quantitative results, climate change can only show significant effects on the macro-economic cycle within the long-term. In terms of the short-term effects, society can relieve the influences from climate variations by social adaptation methods and self-adjustment mechanism. On a large spatial scale, temperature holds higher importance for the European agrarian economy than precipitation. By examining the supply-demand mechanism in the grain market, population during the study period acted as the producer in the long term, whereas as the consumer in the short term. These findings merely reflect the general interactions between climate change and macro-economic cycles at the large spatial region with a long-term study period. The findings neither illustrate individual incidents that can temporarily distort the agrarian economy nor explain some specific cases. In the study, the scale thinking in the analysis is raised as an essential methodological issue for the first time to interpret the associations between climatic impact and macro-economy in the past agrarian society within different temporal scales.	[Pei, Qing; Zhang, David D.; Lee, Harry F.] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Pei, Qing; Zhang, David D.; Lee, Harry F.] Univ Hong Kong, Int Ctr China Dev Study, Hong Kong, Hong Kong, Peoples R China; [Li, Guodong] Univ Hong Kong, Dept Stat & Actuarial Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Pei, Q (corresponding author), Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China.	peiqing@hku.hk	Lee, Harry F./M-9979-2019; Li, Guodong/A-2741-2010	Lee, Harry F./0000-0001-5415-7845; Li, Guodong/0000-0003-3137-8471; Pei, Qing/0000-0002-9699-2950	Research Grants Council of the Government of the Hong Kong SAR	Research Grants Council of the Government of the Hong Kong SAR	The research grants generously are provided by Prestigious Fellowship of Research Grants Council of the Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen R.C., 2005, LIVING STANDARDS NEW; Allen RC, 2001, EXPLOR ECON HIST, V38, P411, DOI 10.1006/exeh.2001.0775; Allen RC, 2000, EUR REV ECON HIST, V4, P1, DOI 10.1017/S1361491600000125; Arnold L.G., 2002, BUSINESS CYCLE THEOR; Assenmacher-Wesche K, 2008, J ECON DYN CONTROL, V32, P411, DOI 10.1016/j.jedc.2007.02.002; Aston T., 1996, CRISIS EUROPE 1560 1; BRANDON PF, 1972, ECON HIST REV, V25, P403; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Bunge MA, 2009, CAUSALITY MODERN SCI; Burroughs W., 2001, CLIMATE CHANGE MULTI; Butlin RA, 1993, HIST GROGRAPHY GATES; Campbell B.M.S., 2000, ENGLISH SEIGNIORIAL; Campbell BMS, 2010, ECON HIST REV, V63, P281, DOI 10.1111/j.1468-0289.2009.00492.x; CAMPBELL Bruce M. S., 2009, AGRARHISTORIA PA MAN, P23; Casty C, 2007, CLIM DYNAM, V29, P791, DOI 10.1007/s00382-007-0257-6; Chilosi D, 2013, EXPLOR ECON HIST, V50, P46, DOI 10.1016/j.eeh.2012.09.002; Clark G, 2006, LONG MARCH HIST FARM; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Ewert UC, 2007, HIST SOC RES, V32, P122; FAN SG, 1991, AM J AGR ECON, V73, P266, DOI 10.2307/1242711; Fischer D.H., 1996, GREAT WAVE PRICE REV; Fulbrook Mary., 2004, CONCISE HIST GERMANY; GALLOWAY PR, 1986, POPUL DEV REV, V12, P1, DOI 10.2307/1973349; Goldstein JS, 2003, OXFORD ENCY EC HIST; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hartmann HT, 1981, PLANT SCI GROWTH DEV; HINSCH B, 1988, J ASIAN HIST, V22, P131; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Hubbard R.G., 2009, ECONOMICS; IPCC, 2007, CONTRIBUTION WORKING; JONES PD, 1992, CLIMATE AD 1500; Jones PD, 1995, CLIMATE AD 1500, P649; Karl G. P., 1999, GRAIN MARKETS EUROPE; Kong X, 2010, J NANJING AGR U SOCI, V10, P135; Macdonald KI, 1998, COMP STUD SOC HIST, V40, P287; Mackie J., 1974, CEMENT UNIVERSE STUD; MACKIE JL, 1965, AM PHILOS QUART, V2, P245; Maland D., 1983, EUROPE 17 CENTURY; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mathias RJ, 1990, WHEAT, V35; McConnell CR, 2002, EC PRINCIPLES PROBLE; McEvedy C., 1978, ATLAS WORLD POPULATI; Orlove B, 2005, ENVIRON SCI POLICY, V8, P589, DOI 10.1016/j.envsci.2005.06.009; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; OSullivan A., 2003, EC PRINCIPLES ACTION, P157; Ozmucur S., 2007, NEW COMP EC HIST ESS, P59; Pei Q, 2013, CLIM RES, V56, P169, DOI 10.3354/cr01145; Pennington D.H., 1989, EUROPE 17 CENTURY; Persson KG, 1996, ECON HIST REV, V49, P692; Petersen W., 1975, POPULATION; Pollock DSG, 2000, J ECONOMETRICS, V99, P317, DOI 10.1016/S0304-4076(00)00028-2; Poulsen TM, 1997, CONT EUROPE GEOGRAPH, P41; Rich DZ, 1997, CRISIS THEORY; Russo F., 2009, CAUSALITY CAUSAL MOD; SAUNDERS PJ, 1988, AM J AGR ECON, V70, P588, DOI 10.2307/1241497; Stone D, 2001, POLISH LITHUANIAN ST; Stove D, 1986, RATIONALITY INDUCTIO; Symons L, 1979, AGR GROGRAPHY; Thornton J, 2001, SOUTHERN ECON J, V68, P464, DOI 10.2307/1061606; Turchin P, 2003, HIST DYNAMICS; van Bath B. H. Slicher, 1966, AGRARIAN CONDITIONS, P24; van Bath BHS, 1963, YIELD RATIOS 810 182; van Zanden JL, 1999, EUROPE INT EC 1500 2; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108; Zhang DD, 2011, GLOBAL ECOL BIOGEOGR, V20, P520, DOI 10.1111/j.1466-8238.2010.00625.x	70	36	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88155	10.1371/journal.pone.0088155	http://dx.doi.org/10.1371/journal.pone.0088155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516601	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400036
J	Zhang, WQ; Liu, H; Jiang, XL; Wu, DM; Tian, YL				Zhang, Weiqing; Liu, Hui; Jiang, Xiaolian; Wu, Dongmei; Tian, Yali			A Longitudinal Study of Posttraumatic Stress Disorder Symptoms and Its Relationship with Coping Skill and Locus of Control in Adolescents after an Earthquake in China	PLOS ONE			English	Article							MAGNITUDE EARTHQUAKE; DEPRESSIVE REACTIONS; PTSD; SURVIVORS; ACCIDENT; SEQUELAE; CHILDREN; VICTIMS; TAIWAN; TRAUMA	Background/Objectives: Post-traumatic stress disorder is a common psychological maladaptation among adolescents after undergoing an earthquake. Knowledge about the prevalence and maintenance of post-traumatic stress disorder symptoms and the changes of its predictors over time can help medical providers assist adolescent survivors with mitigating long-term impacts. This study examined the changes in posttraumatic stress disorder symptoms and its relationship with coping skill and locus of control among adolescent earthquake survivors in China. Methodology/Findings: The study used an observational longitudinal design. A total of 1420 adolescents were evaluated twice after the earthquake by using the Post-traumatic stress disorder Checklist-Civilian Version, The Internality, Powerful others and Chance scale and the Coping Styles Scale. The results indicated that the mean scores of posttraumatic stress disorder symptoms were decreased significantly and the positive rates of posttraumatic stress disorder symptoms also declined remarkably at 17 months compared to the 3 months post-earthquake. Internality locus of control and problem solving coping skill were effective resilient factors for the development and maintenance of posttraumatic stress disorder symptoms, while chance locus of control was a powerful risk factor of posttraumatic stress disorder symptoms as well as being female, being injured and property loss. Conclusions/Significance: Continuous screening is recommended to identify adolescent earthquake survivors with posttraumatic stress disorder symptoms. More attention should be paid to adolescent survivors who are prone to adopt passive coping strategies responding to trauma events and who own external causal attribution.	[Zhang, Weiqing; Jiang, Xiaolian; Wu, Dongmei; Tian, Yali] Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu 610064, Sichuan Provinc, Peoples R China; [Zhang, Weiqing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Liu, Hui] Sichuan Univ, West China Hosp 2, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University; Shanghai Jiao Tong University; Sichuan University	Jiang, XL (corresponding author), Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu 610064, Sichuan Provinc, Peoples R China.	jiang_xiaolian@126.com			Post-disaster Reconstruction Support & Research Center of Sichuan University; Hong Kong Polytechnic University	Post-disaster Reconstruction Support & Research Center of Sichuan University; Hong Kong Polytechnic University(Hong Kong Polytechnic University)	The data reported in this paper was part of a research project supported by The Post-disaster Reconstruction Support & Research Center of Sichuan University and The Hong Kong Polytechnic University. The authors would like to thank all the principals and teachers of the study recruited secondary schools in the earthquake epicenter for their substantial assistance with data collection and all the adolescents for their participation.	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Ahmed AS, 2007, ADV PSYCHIAT TREATME, V13, P369, DOI [DOI 10.1192/APT.BP.106.003236, 10.1192/apt.bp.106.003236]; Aldwin C.M., 2004, COPING HLTH COMP STR; Amaya-Jackson, 1995, Adolesc Med, V6, P251; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004; Carr VJ, 1997, PSYCHOL MED, V27, P167, DOI 10.1017/S0033291796004278; Chang CM, 2005, J NERV MENT DIS, V193, P40, DOI 10.1097/01.nmd.0000149217.67211.ab; Dell'Osso L, 2011, J AFFECT DISORDERS, V134, P59, DOI 10.1016/j.jad.2011.06.025; Eksi A, 2007, INT J PSYCHIAT CLIN, V11, P190, DOI 10.1080/13651500601017548; Eksi A, 2009, EUR CHILD ADOLES PSY, V18, P384, DOI 10.1007/s00787-009-0745-9; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Goenjian AK, 2005, AM J PSYCHIAT, V162, P2302, DOI 10.1176/appi.ajp.162.12.2302; GOENJIAN AK, 1994, AM J PSYCHIAT, V151, P895; Goenjian AK, 2011, J AFFECT DISORDERS, V133, P509, DOI 10.1016/j.jad.2011.04.053; HARDIN SB, 1994, J TRAUMA STRESS, V7, P427, DOI 10.1007/BF02102787; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; Huang X., 2000, PSYCHOL SCI, V23, P1, DOI DOI 10.3969/j.issn.1671-6981.2000.01.001; Karakaya Isil, 2004, Turk Psikiyatri Derg, V15, P257; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; LEVENSON H, 1976, J PERS SOC PSYCHOL, V33, P199, DOI 10.1037/0022-3514.33.2.199; Maeda M, 2009, PSYCHIAT CLIN NEUROS, V63, P747, DOI 10.1111/j.1440-1819.2009.02031.x; March JS, 1997, J AM ACAD CHILD PSY, V36, P1080, DOI 10.1097/00004583-199708000-00015; MARTINI DR, 1990, J AM ACAD CHILD PSY, V29, P70, DOI 10.1097/00004583-199001000-00012; Matsuoka T, 2000, PUBLIC HEALTH, V114, P249, DOI 10.1016/S0033-3506(00)00339-5; North C S, 2001, Ann Clin Psychiatry, V13, P81, DOI 10.3109/10401230109148952; Olff M, 2005, PSYCHONEUROENDOCRINO, V30, P974, DOI 10.1016/j.psyneuen.2005.04.009; PYNOOS RS, 1987, ARCH GEN PSYCHIAT, V44, P1057; Salcioglu E, 2003, J NERV MENT DIS, V191, P154, DOI 10.1097/00005053-200303000-00003; Shi T., 2005, CLIN REHABIL, V9, P44, DOI DOI 10.3321/J.ISSN:1673-8225.2005.40.019; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260; Xiao L., 1989, CHINESE J APPL PSYCH, P22; Yang X., 2007, CHINA J HLTH PSYCHOL, V15, P6, DOI [DOI 10.1097/TA.0000000000000749, 10.13342/j.cmki.cjhp.2007.01.003, DOI 10.13342/J.CMKI.CJHP.2007.01.003]; Zhang WQ, 2011, J CLIN NURS, V20, P3057, DOI 10.1111/j.1365-2702.2011.03825.x	36	45	49	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88263	10.1371/journal.pone.0088263	http://dx.doi.org/10.1371/journal.pone.0088263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516622	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400047
J	Hailu, D; Berhe, H				Hailu, Desta; Berhe, Hailemariam			Knowledge about Obstetric Danger Signs and Associated Factors among Mothers in Tsegedie District, Tigray Region, Ethiopia 2013: Community Based Cross-Sectional Study	PLOS ONE			English	Article							WOMEN; AWARENESS; BIRTH; CARE	Background: In many developing countries including Ethiopia, maternal morbidity and mortality still pose a substantial burden and thus progress towards the fifth Millennium Development Goal (MDG) remains slow. Raising awareness of women about the danger signs of pregnancy and childbirth is the first essential step in accepting appropriate and timely referral to obstetric care. However, in Ethiopia little is known about the knowledge level of mothers about obstetric danger signs. The objective of this study was to assess the status of knowledge of danger signs of pregnancy and childbirth among mothers who gave birth in the past two years prior to the survey in Tsegedie district, Tigray regional state, Ethiopia. Methods: A Community based cross-sectional study was conducted from November 20, 2012 to June 30, 2013 on a randomly selected sample of 485 women who had at least one delivery in the past two years. Multistage sampling technique was employed to select the study participants. A pre-tested structured questionnaire was used to collect quantitative data. Focus group discussion and in-depth interviews were utilized to supplement the Quantitative data. Bivariate and multivariate data analysis was performed using SPSS version 17.0 software. Result: Four hundred eighty five mothers participated in the study making a response rate of 100%. Vaginal bleeding was the most commonly mentioned danger signs of pregnancy (49.1%) and childbirth (52.8%). Two hundred eighty five (58.8%) and 299 (61.6%) of respondents mentioned at least two danger signs of pregnancy and childbirth respectively. One hundred seventy (35.1%) and 154 (31.8%) of respondents didn't know any danger signs of pregnancy and childbirth respectively. Educational status of the mother, place of delivery and having functional radio were found to be independent predictors of knowledge of women about the danger signs of pregnancy and childbirth. Conclusion: Educational status of the mother, place of delivery and having functional radio were independently associated with knowledge of women about obstetric danger signs. Thus, provision of information, education and communication targeting women, family and the general community on danger signs of pregnancy and childbirth and associated factors was recommended.	[Hailu, Desta] Arba Minch Univ, Dept Nursing, Coll Med & Hlth Sci, Arba Minch, Ethiopia; [Berhe, Hailemariam] Mekelle Univ, Dept Nursing, Coll Med & Hlth Sci, Mekelle, Ethiopia	Arba Minch University; Mekelle University	Berhe, H (corresponding author), Mekelle Univ, Dept Nursing, Coll Med & Hlth Sci, Mekelle, Ethiopia.	aidhbk@gmail.com			Addis Ababa University College of Health Sciences	Addis Ababa University College of Health Sciences	This research work was funded by Addis Ababa University College of Health Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, J HLTH POPUL NUTR, V28; [Anonymous], 2011, MILL DEV GOALS REP; Baya B, 2004, MEASURING EFFECTS BE; Becker F, 2004, MEASURING EFFECTS BE; Central Statistical Agency, 2005, ETH DEM HLTH SURV 20; Central Statistical Agency Ethiopia, 2007, POP HOUS CENS ET STA; Central Statistical Agency Ethiopia, 2011, ETH DEM HLTH SURV 20; Department of community medicine medical college Rewa MP, 2009, STUD ASS BIRTH PREP; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, HLTH SECT DEV PROGR; Federal Democratic Republic of Ethiopia MOH, 2011, HLTH HLTH REL IND PO; Hailu M, 2010, ETHIOP J HEALTH SCI, V20, P25; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; Hiluf M, 2008, J HLTH DEV, V22, P1; Hoque M, 2011, ASIA-PAC J PUBLIC HE, V23, P946, DOI 10.1177/1010539511428698; Iliyasu Zubairu, 2010, Afr J Reprod Health, V14, P21; JHPIEGO, 2004, TOOLS IND MAT NEWB H; Kabakyenga JK, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-33; Making pregnancy and childbirth safer, 1997, POLICY BRIEF; Okour A, 2012, INT J GYNECOL OBSTET, V118, P11, DOI 10.1016/j.ijgo.2012.01.020; Pembe AB, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-35; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Rai RK, 2012, WOMEN HEALTH ISS, V22, pE407, DOI 10.1016/j.whi.2012.05.001; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; The Maternal Mortality Estimation Inter-Agency Group USA, 2010, WHO UNICEF UNFPA WOR; Tsegedie District Health Office, 2011, REP DISTR HLTH DEP; UNICEF, 2010, SAV LIV WORLD WOM NE; Wafaa A., 2010, J AM SCI, V6; WHO, 2005, MAK EV MOTH CHILD CO	28	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e83459	10.1371/journal.pone.0083459	http://dx.doi.org/10.1371/journal.pone.0083459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516516	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700001
J	Liu, FC; Enanoria, WTA; Ray, KJ; Coffee, MP; Gordon, A; Aragon, TJ; Yu, GW; Cowling, BJ; Porco, TC				Liu, Fengchen; Enanoria, Wayne T. A.; Ray, Kathryn J.; Coffee, Megan P.; Gordon, Aubree; Aragon, Tomas J.; Yu, Guowei; Cowling, Benjamin J.; Porco, Travis C.			Effect of the One-Child Policy on Influenza Transmission in China: A Stochastic Transmission Model	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; PANDEMIC INFLUENZA; HOUSEHOLD TRANSMISSION; SEASONAL INFLUENZA; FAMILY POLICY; DISEASE; STRATEGIES; EPIDEMIOLOGY; INFECTIONS; PARAMETERS	Background: China's one-child-per-couple policy, introduced in 1979, led to profound demographic changes for nearly a quarter of the world's population. Several decades later, the consequences include decreased fertility rates, population aging, decreased household sizes, changes in family structure, and imbalanced sex ratios. The epidemiology of communicable diseases may have been affected by these changes since the transmission dynamics of infectious diseases depend on demographic characteristics of the population. Of particular interest is influenza because China and Southeast Asia lie at the center of a global transmission network of influenza. Moreover, changes in household structure may affect influenza transmission. Is it possible that the pronounced demographic changes that have occurred in China have affected influenza transmission? Methods and Findings: To address this question, we developed a continuous-time, stochastic, individual-based simulation model for influenza transmission. With this model, we simulated 30 years of influenza transmission and compared influenza transmission rates in populations with and without the one-child policy control. We found that the average annual attack rate is reduced by 6.08% (SD 2.21%) in the presence of the one-child policy compared to a population in which no demographic changes occurred. There was no discernible difference in the secondary attack rate, -0.15% (SD 1.85%), between the populations with and without a one-child policy. We also forecasted influenza transmission over a ten-year time period in a population with a two-child policy under a hypothesis that a two-child-per-couple policy will be carried out in 2015, and found a negligible difference in the average annual attack rate compared to the population with the one-child policy. Conclusions: This study found that the average annual attack rate is slightly lowered in a population with a one-child policy, which may have resulted from a decrease in household size and the proportion of children in the population.	[Liu, Fengchen; Enanoria, Wayne T. A.; Ray, Kathryn J.; Coffee, Megan P.; Porco, Travis C.] Univ Calif San Francisco, FI Proctor Fdn, San Francisco, CA 94143 USA; [Liu, Fengchen; Enanoria, Wayne T. A.; Coffee, Megan P.; Aragon, Tomas J.; Porco, Travis C.] Univ Calif Berkeley, Sch Publ Hlth, Ctr Infect Dis & Emergency Readiness, Berkeley, CA 94720 USA; [Enanoria, Wayne T. A.; Gordon, Aubree; Aragon, Tomas J.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Yu, Guowei] Northwest Univ Nationalities, West China Inst Environm Hlth, Lanzhou, Gansu, Peoples R China; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Northwest Minzu University; University of Hong Kong; University of California System; University of California San Francisco	Porco, TC (corresponding author), Univ Calif San Francisco, FI Proctor Fdn, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu	Cowling, Benjamin John/C-4263-2009; Coffee, Megan/AAY-6752-2020; Gordon, Aubree/X-1113-2019; coffee, megan/AAD-9793-2022	Cowling, Benjamin John/0000-0002-6297-7154; Coffee, Megan/0000-0002-4581-111X; Gordon, Aubree/0000-0002-9352-7877; Aragon, Tomas/0000-0002-2058-0423	Models of Infectious Disease Agent Study (MIDAS); National Institute of General Medical Sciences at the National Institutes of Health [RFA RFA-GM-11-002, 1-U01-GM087728-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER	Models of Infectious Disease Agent Study (MIDAS); National Institute of General Medical Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health (RFA RFA-GM-11-002) to the University of California San Francisco (1-U01-GM087728-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditama TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029971; [Anonymous], 2010, SCIENCE, V329, P1460; [Anonymous], ABM FRAMEW; [Anonymous], 2011, P CSEE, V31, P19; [Anonymous], 1991, CHINAS CHANGING POPU; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Barrett C, 2011, EPIDEMICS-NETH, V3, P19, DOI 10.1016/j.epidem.2010.11.002; Beaumont MA, 2002, GENETICS, V162, P2025; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Brown S.J., 2011, BMC PUBLIC HLTH, V11; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Carcione D, 2011, EURO SURVEILL, V16; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chambers JM, 2008, STAT COMPUT SER, P1; Chao DL, 2010, J INFECT DIS, V202, P877, DOI 10.1086/655810; China NBoSo, 1992, CHIN STAT YB 1992; China NBoSo, 1995, CHIN STAT YB 1995; China NBoSo, 2002, CHIN STAT YB 202; China NBoSo, 2009, CHIN STAT YB 2009; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Fraser C, 2011, AM J EPIDEMIOL, V174, P505, DOI 10.1093/aje/kwr122; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Hvistendahl M, 2010, SCIENCE, V329, P1458, DOI [10.1126/science.329.5998.1458, 10.1126/science.329.5998.1460]; Jain R, 2009, PEDIATR EMERG CARE, V25, P791, DOI 10.1097/PEC.0b013e3181c3c8f8; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kwok KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022089; Lau LLH, 2012, EPIDEMIOLOGY, V23, P531, DOI 10.1097/EDE.0b013e31825588b8; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Marathe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022461; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Miller RR, 2010, CHEST, V137, P752, DOI 10.1378/chest.09-2517; Minayev P, 2009, J R SOC INTERFACE, V6, P989, DOI 10.1098/rsif.2008.0467; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nukiwa-Souma N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033046; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Pellis L, 2011, J MATH BIOL, V63, P691, DOI 10.1007/s00285-010-0386-0; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; Shaban N, 2009, BIOMETRICAL J, V51, P408, DOI 10.1002/bimj.200800172; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shi P, 2010, EPIDEMIOL INFECT, V138, P1472, DOI 10.1017/S0950268810000300; Shim E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S4; Shu YL, 2010, EMERG INFECT DIS, V16, P725, DOI 10.3201/eid1604.091578; SONG J, 1988, MATH COMPUT MODEL, V11, P11, DOI 10.1016/0895-7177(88)90443-8; Song J., 1988, POPULATION SYSTEM CO; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Truscott J, 2012, J R SOC INTERFACE, V9, P304, DOI 10.1098/rsif.2011.0309; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Uddin M, 2010, J EPIDEMIOL COMMUN H, V64, P808, DOI 10.1136/jech.2009.090852; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wu JT, 2006, PLOS MED, V3, P1532, DOI 10.1371/journal.pmed.0030361; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yang Z, 1996, CHIN HIST POP DAT RE; Yu D, 2006, HLTH ED, V24, P114; ZENG Y, 1986, POPUL DEV REV, V12, P675	85	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e84961	10.1371/journal.pone.0084961	http://dx.doi.org/10.1371/journal.pone.0084961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516519	Green Published, gold			2022-12-27	WOS:000330830700002
J	De Franco, M; Peters, LC; Correa, MA; Galvan, A; Canhamero, T; Borrego, A; Jensen, JR; Goncalves, J; Cabrera, WHK; Starobinas, N; Ribeiro, OG; Dragani, T; Ibanez, OM				De Franco, Marcelo; Peters, Luciana C.; Correa, Mara A.; Galvan, Antonella; Canhamero, Tatiane; Borrego, Andrea; Jensen, Jose R.; Goncalves, Jussara; Cabrera, Wafa H. K.; Starobinas, Nancy; Ribeiro, Orlando G.; Dragani, Tommaso; Ibanez, Olga M.			Pristane-Induced Arthritis Loci Interact with the Slc11a1 Gene to Determine Susceptibility in Mice Selected for High Inflammation	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; MOUSE LINES; SALMONELLA INFECTION; NATURAL-RESISTANCE; NRAMP1 GENE; EXPRESSION; RESPONSIVENESS; IDENTIFICATION	AIRmax (maximal inflammation) and AIRmin (minimal inflammation) mice show distinct susceptibilities to pristane-induced arthritis (PIA). The Slc11a1 gene, which regulates macrophage and neutrophil activity, is involved in this infirmity. AIRmax(SS) mice homozygous for the non-functional Slc11a1 S (gly169asp) allele obtained by genotype-assisted crosses from AIRmax and AIRmin mice are more susceptible than mice homozygous for the Slc11a1 resistant (R) allele. The present work sought to identify the quantitative trait loci (QTL) regulating PIA and to examine the interactions of these QTL with Slc11a1 alleles in modulating PIA. Mice were given two ip injections of 0.5 mL pristane at 60 day intervals, and the incidence and severity of PIA was scored up to 160 days. Genome-wide linkage studies were performed to search for arthritis QTL in an F2 (AIRmax x AIRmin, n = 290) population. Significant arthritis QTL (LODscore>4) were detected on chromosomes 5 and 8, and suggestive QTL on chromosomes 7, 17 and 19. Global gene expression analyses performed on Affymetrix mouse 1.0 ST bioarrays (27k genes) using RNA from arthritic or control mice paws showed 419 differentially expressed genes between AIRmax and AIRmin mice and demonstrated significantly (P<0.001) over-represented genes related to inflammatory responses and chemotaxis. Up-regulation of the chemokine genes Cxcl1, Cxcl9, Cxcl5, Cxcl13 on chromosome 5 was higher in AIRmax(SS) than in the other lines. Macrophage scavenger receptor 1 and hemeoxigenase (decycling) 1 genes on chromosome 8 were also expressed at higher levels in AIRmax(SS) mice. Our results show that the gene expression profiles of the two arthritis QTL (on chromosomes 5 and 8) correlate with Slc11a1 alleles, resulting in enhanced AIRmax(SS) mice susceptibility to PIA.	[De Franco, Marcelo; Peters, Luciana C.; Correa, Mara A.; Canhamero, Tatiane; Borrego, Andrea; Jensen, Jose R.; Goncalves, Jussara; Cabrera, Wafa H. K.; Starobinas, Nancy; Ribeiro, Orlando G.] Inst Butantan, Immunogenet Lab, Sao Paulo, Brazil; [Galvan, Antonella; Dragani, Tommaso; Ibanez, Olga M.] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy	Instituto Butantan; Fondazione IRCCS Istituto Nazionale Tumori Milan	De Franco, M (corresponding author), Inst Butantan, Immunogenet Lab, Sao Paulo, Brazil.	marcelo.franco@butantan.gov.br	Ibañez, Olga CM/B-9627-2015; Ribeiro, Orlando Garcia/AAY-9424-2020; Jensen, José R/F-2927-2017; Starobinas, Nancy/B-9178-2015; DE FRANCO, MARCELO/S-5870-2019; Cabrera, Wafa HK/F-7189-2016; Ribeiro, Orlando Garcia/B-5241-2016; Borrego, Andrea/E-2234-2012; Dragani, Tommaso A./K-4493-2016; Correa, Mara/B-3451-2016	Ibañez, Olga CM/0000-0002-2672-4758; Ribeiro, Orlando Garcia/0000-0003-2117-2402; Jensen, José R/0000-0001-6228-2988; Starobinas, Nancy/0000-0001-5716-3394; DE FRANCO, MARCELO/0000-0002-0417-8215; Borrego, Andrea/0000-0001-6454-9279; Dragani, Tommaso A./0000-0001-5915-4598; Correa, Mara/0000-0003-4985-3330	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo LMM, 1998, EUR J IMMUNOL, V28, P2913, DOI 10.1002/(SICI)1521-4141(199809)28:09&lt;2913::AID-IMMU2913&gt;3.0.CO;2-3; Biozzi G, 1998, CARCINOGENESIS, V19, P337, DOI 10.1093/carcin/19.2.337; Borrego A, 2006, MICROBES INFECT, V8, P2766, DOI 10.1016/j.micinf.2006.08.005; Canonne-Hergaux F, 1999, P ASSOC AM PHYSICIAN, V111, P283, DOI 10.1046/j.1525-1381.1999.99236.x; Carneiro PD, 2009, IMMUNOLOGY, V128, pe562, DOI 10.1111/j.1365-2567.2008.03032.x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; De Franco M, 2007, MAMM GENOME, V18, P263, DOI 10.1007/s00335-007-9012-x; De Franco M, 2010, CANCER LETT, V294, P187, DOI 10.1016/j.canlet.2010.01.038; Di Pace RF, 2006, CARCINOGENESIS, V27, P1517, DOI 10.1093/carcin/bgl080; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Filer A, 2008, FRONT BIOSCI-LANDMRK, V13, P2674, DOI 10.2741/2874; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Galvan A, 2011, GENES IMMUN, V12, P390, DOI 10.1038/gene.2011.10; Glant TT, 2004, AM J MED SCI, V327, P188, DOI 10.1097/00000441-200404000-00004; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Hashizume M, 2012, EUR J PHARMACOL, V689, P249, DOI 10.1016/j.ejphar.2012.05.035; Hernandez-Sanchez J, 2009, BIOINFORMATICS, V25, P1377, DOI 10.1093/bioinformatics/btp171; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; IBANEZ OM, 1992, EUR J IMMUNOL, V22, P2555, DOI 10.1002/eji.1830221014; Ibrahim SM, 2002, J AUTOIMMUN, V18, P159, DOI 10.1006/jaut.2001.0580; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Immenschuh S, 2010, CURR DRUG TARGETS, V11, P1541, DOI 10.2174/1389450111009011541; JAWAHEER D, 1994, ARTHRITIS RHEUM, V37, P681, DOI 10.1002/art.1780370511; Jensen JR, 2006, GENES IMMUN, V7, P44, DOI 10.1038/sj.gene.6364271; John S, 1997, J RHEUMATOL, V24, P452; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Lalmanach AC, 2001, MICROBES INFECT, V3, P639, DOI 10.1016/S1286-4579(01)01419-8; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2009, INFECT IMMUN, V77, P3302, DOI 10.1128/IAI.00396-09; Maria DA, 2003, ONCOGENE, V22, P426, DOI 10.1038/sj.onc.1206157; Peters LC, 2007, GENES IMMUN, V8, P51, DOI 10.1038/sj.gene.6364358; POTTER M, 1981, J IMMUNOL, V127, P1591; Ribeiro OG, 2003, J LEUKOCYTE BIOL, V74, P497, DOI 10.1189/jlb.0103039; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Shaw MA, 1997, J RHEUMATOL, V24, P212; Soe-Lin S, 2008, EXP HEMATOL, V36, P929, DOI 10.1016/j.exphem.2008.02.013; Stasiuk LM, 1997, IMMUNOLOGY, V90, P81, DOI 10.1046/j.1365-2567.1997.00121.x; THOMPSON SJ, 1992, CLIN EXP IMMUNOL, V89, P434; THOMPSON SJ, 1990, EUR J IMMUNOL, V20, P2479, DOI 10.1002/eji.1830201118; THOMPSON SJ, 1993, IMMUNOLOGY, V79, P152; Thompson SJ, 1998, J IMMUNOL, V160, P4628; THOMPSON SJ, 1993, IMMUNOL LETT, V36, P227, DOI 10.1016/0165-2478(93)90057-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VIDAL SM, 1992, GENOMICS, V14, P32, DOI 10.1016/S0888-7543(05)80279-4; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vigar ND, 2000, EUR J IMMUNOL, V30, P431; Vorraro F, 2010, J IMMUNOL, V185, P1616, DOI 10.4049/jimmunol.1000358; Weis JJ, 1999, J IMMUNOL, V162, P948; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Wooley PH, 1998, ARTHRITIS RHEUM, V41, P2022, DOI 10.1002/1529-0131(199811)41:11<2022::AID-ART18>3.0.CO;2-P; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88302	10.1371/journal.pone.0088302	http://dx.doi.org/10.1371/journal.pone.0088302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505471	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200172
J	Fingelkurts, AA; Fingelkurts, AA				Fingelkurts, Alexander A.; Fingelkurts, Andrew A.			EEG Oscillatory States: Universality, Uniqueness and Specificity across Healthy-Normal, Altered and Pathological Brain Conditions	PLOS ONE			English	Article							NEURAL MASS MODEL; SPACE-ORIENTED SEGMENTATION; PHYSIOLOGICAL ADAPTATION; TEMPORAL CHARACTERISTICS; ADAPTIVE SEGMENTATION; FREQUENCY-ANALYSIS; INTERICTAL EEG; THETA-BAND; MAP SERIES; GAMMA	For the first time the dynamic repertoires and oscillatory types of local EEG states in 13 diverse conditions (examined over 9 studies) that covered healthy-normal, altered and pathological brain states were quantified within the same methodological and conceptual framework. EEG oscillatory states were assessed by the probability-classification analysis of short-term EEG spectral patterns. The results demonstrated that brain activity consists of a limited repertoire of local EEG states in any of the examined conditions. The size of the state repertoires was associated with changes in cognition and vigilance or neuropsychopathologic conditions. Additionally universal, optional and unique EEG states across 13 diverse conditions were observed. It was demonstrated also that EEG oscillations which constituted EEG states were characteristic for different groups of conditions in accordance to oscillations' functional significance. The results suggested that (a) there is a limit in the number of local states available to the cortex and many ways in which these local states can rearrange themselves and still produce the same global state and (b) EEG individuality is determined by varying proportions of universal, optional and unique oscillatory states. The results enriched our understanding about dynamic microstructure of EEG-signal.	[Fingelkurts, Alexander A.; Fingelkurts, Andrew A.] BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland		Fingelkurts, AA (corresponding author), BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland.	alexander.fingelkurts@bm-science.com						Aftanas LI, 2003, INT J PSYCHOPHYSIOL, V50, P205, DOI 10.1016/S0167-8760(03)00156-9; Alkire MT, 2008, NEUROLOGY CONSCIOUSN, V1; Allefeld C, 2009, CHAOS, V19, DOI 10.1063/1.3072788; Anokhin AP, 2001, BEHAV GENET, V31, P545, DOI 10.1023/A:1013341310865; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ashby W.R., 1960, DESIGN BRAIN ORIGIN, V2nd ed.; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Balazs S, 2006, J NEUROL SCI, V246, P65, DOI 10.1016/j.jns.2006.02.007; Ball T, 2008, NEUROIMAGE, V41, P302, DOI 10.1016/j.neuroimage.2008.02.032; BARLOW JS, 1985, J CLIN NEUROPHYSIOL, V2, P267, DOI 10.1097/00004691-198507000-00005; Basar E, 1999, IEEE ENG MED BIOL, V18, P56, DOI 10.1109/51.765190; Basar E, 2004, INT J BIFURCAT CHAOS, V14, P453, DOI 10.1142/S0218127404009272; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P197, DOI 10.1016/S0167-8760(00)00141-0; Begleiter H, 2006, INT J PSYCHOPHYSIOL, V60, P162, DOI 10.1016/j.ijpsycho.2005.12.013; BODENSTEIN G, 1977, P IEEE, V65, P642, DOI 10.1109/PROC.1977.10543; Bodunov M.V., 1988, INDIVIDUAL PSYCHOL D, P56; BODUNOV MV, 1985, ZH VYSSH NERV DEYAT+, V35, P1045; Bodunov MV, 1985, J PSYCHOL, V6, P125; Bodunov MV, 1987, J PSYCHOL, V8, P48; Bonnet MH, 2001, PHYSIOL BEHAV, V74, P291, DOI 10.1016/S0031-9384(01)00581-9; Breakspear M, 2002, NEUROIMAGE, V16, P822, DOI 10.1006/nimg.2002.1106; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; Brodsky BE, 1999, COMPUT METH PROG BIO, V60, P93, DOI 10.1016/S0169-2607(98)00079-0; Bullock TH, 2003, NEUROSCIENCE, V121, P233, DOI 10.1016/S0306-4522(03)00208-2; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; CREUTZFELDT OD, 1985, ELECTROEN CLIN NEURO, V60, P373, DOI 10.1016/0013-4694(85)91012-0; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; DUMERMUTH G, 1987, NEUROPSYCHOBIOLOGY, V17, P85, DOI 10.1159/000118345; Fell J, 2000, ACTA NEUROBIOL EXP, V60, P87; Ferrer R, 2011, CRIT CARE CLIN, V27, P229, DOI 10.1016/j.ccc.2010.12.008; Fingelkurts AA, 2006, CLIN NEUROPHYSIOL, V117, P789, DOI 10.1016/j.clinph.2005.12.011; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Fingelkurts AA, 2004, CLIN NEUROPHYSIOL, V115, P674, DOI 10.1016/j.clinph.2003.10.025; Fingelkurts AA, 2006, INT J PSYCHOPHYSIOL, V59, P116, DOI 10.1016/j.ijpsycho.2005.03.014; Fingelkurts AA, 2003, INT J PSYCHOPHYSIOL, V47, P23, DOI 10.1016/S0167-8760(02)00089-2; Fingelkurts AA, 2006, CLIN NEUROPHYSIOL, V117, P208, DOI 10.1016/j.clinph.2005.09.011; Fingelkurts AA, 2003, INT J NEUROSCI, V113, P1447, DOI 10.1080/00207450390231347; Fingelkurts AA, 2002, CLIN NEUROPHYSIOL, V113, P826, DOI 10.1016/S1388-2457(02)00058-5; Fingelkurts AA, 2007, CONT HYPNOSIS, V24, P3, DOI DOI 10.1002/CH.327; FINGELKURTS AA, 2000, VESTNIK MOSKOVSKOGO, V4, P3; Fingelkurts Al A, 2010, Open Neuroimag J, V4, P130, DOI 10.2174/1874440001004010130; Fingelkurts A, 2008, J PSYCHOPHARMACOL, V22, P270, DOI 10.1177/0269881108089810; Fingelkurts AA, 2006, NEUROSCI RES, V56, P133, DOI 10.1016/j.neures.2006.06.006; Fingelkurts AA, 2006, PROG NEURO-PSYCHOPH, V30, P1453, DOI 10.1016/j.pnpbp.2006.06.005; Fingelkurts AA, 2010, NEUROSCI RES, V68, P207, DOI 10.1016/j.neures.2010.07.2031; Fingelkurts Andrew A, 2006, Cogn Process, V7, P135, DOI 10.1007/s10339-006-0035-0; Fingelkurts AA, 2010, PHYS LIFE REV, V7, P195, DOI 10.1016/j.plrev.2010.04.001; Fingelkurts AA, 2010, INT J PSYCHOPHYSIOL, V76, P93, DOI 10.1016/j.ijpsycho.2010.02.009; Fingelkurts AA, 2006, FOCUS ON BRAIN MAPPING RESEARCH, P59; Fingelkurts Andrew A, 2008, Open Neuroimag J, V2, P73, DOI 10.2174/1874440000802010073; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Freeman W. J., 1992, International Journal of Bifurcation and Chaos in Applied Sciences and Engineering, V2, P451, DOI 10.1142/S0218127492000653; Freeman WJ, 2007, NEURAL NETWORKS, V20, P1021, DOI 10.1016/j.neunet.2007.09.004; Freeman Walter J, 2003, J Integr Neurosci, V2, P3, DOI 10.1142/S0219635203000214; Freeman WJ, 2005, ELECTROMAGN BIOL MED, V24, P233, DOI 10.1080/15368370500379608; Freeman WJ, 2005, NEURAL NETWORKS, V18, P497, DOI 10.1016/j.neunet.2005.06.014; Freeman WJ, 2003, CHAOS, V13, P1067, DOI 10.1063/1.1596553; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Gazzaniga M.S., 2002, COGNITIVE NEUROSCIEN, V2nd ed.; GEVINS AS, 1984, IEEE T BIO-MED ENG, V31, P833, DOI 10.1109/TBME.1984.325246; Gevins AS, 1986, EXPT TECHNIQUES HUMA, P419; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Gohberg I.C., 1969, INTRO THEORY LINEAR, P1; GRINDEL OM, 1973, CLIN ELECTROENCEPHAL, P213; Gutkin BS, 2001, J COMPUT NEUROSCI, V11, P121, DOI 10.1023/A:1012837415096; Harmony T, 1996, INT J PSYCHOPHYSIOL, V24, P161, DOI 10.1016/S0167-8760(96)00053-0; Heinen K, 2003, NEUROSCIENCE, V122, P699, DOI 10.1016/S0306-4522(03)00477-9; Herscovitch P., 1994, FUNCTIONAL NEUROIMAG, P29; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Imas OA, 2005, ANESTHESIOLOGY, V102, P937, DOI 10.1097/00000542-200505000-00012; Inouye T, 1995, COGNITIVE BRAIN RES, V3, P33, DOI 10.1016/0926-6410(95)00016-X; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Jacobs B, 1997, J COMP NEUROL, V386, P661; JANSEN BH, 1988, INT J BIOMED COMPUT, V23, P221, DOI 10.1016/0020-7101(88)90016-5; JANSEN BH, 1981, COMPUT BIOMED RES, V14, P168, DOI 10.1016/0010-4809(81)90034-3; John ER, 1997, CONSCIOUS COGN, V6, P3, DOI 10.1006/ccog.1996.0287; Kaplan A. Ya, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P35; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Kelso J.A.S., 1995, DYNAMICS PATTERNS SE; KINOSHITA T, 1995, PHARMACOPSYCHIATRY, V28, P51, DOI 10.1055/s-2007-979588; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; Knyazev G.G., 2006, NETH J PSYCHOL, V62, P78, DOI [10.1007/BF03061054, DOI 10.1007/BF03061054]; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazeva MG, 1986, HUMAN PHYSL, V12, P387; Koenig T, 1999, EUR ARCH PSY CLIN N, V249, P205, DOI 10.1007/s004060050088; KOOI KA, 1971, FUNDAMENTALS ELECTRO; Kropotov, 2009, QUANTITATIVE EEG EVE; Lantz G, 2001, CLIN NEUROPHYSIOL, V112, P688, DOI 10.1016/S1388-2457(01)00479-5; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; LEHMANN D, 1990, MACHINERY OF THE MIND, P209; Lehmann D, 1998, INT J PSYCHOPHYSIOL, V29, P1, DOI 10.1016/S0167-8760(97)00098-6; LEHMANN D, 1993, PSYCHIAT RES-NEUROIM, V50, P275, DOI 10.1016/0925-4927(93)90005-3; Lehmann D., 2009, SCHOLARPEDIA, V4, P7632, DOI DOI 10.4249/SCHOLARPEDIA.7632; LEVY WJ, 1987, ANESTHESIOLOGY, V66, P489, DOI 10.1097/00000542-198704000-00007; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; MCEWEN JA, 1975, IEEE T BIO-MED ENG, V22, P361, DOI 10.1109/TBME.1975.324504; MESHKOVA TA, 1988, ROLE ENV HEREDITY FO; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Muller TJ, 2005, J NEURAL TRANSM, V112, P565, DOI 10.1007/s00702-004-0194-z; Muller UA, 1993, 19930618 OLS ASS; Norris PR, 2009, ANN SURG, V250, P524, DOI [10.1097/SLA.0b013e181b8fb1f, 10.1097/SLA.0b013e3181b8fb1f]; Nunez P.L, 1981, ELECT FIELDS BRAIN N; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; NUWER MR, 1988, J CLIN NEUROPHYSIOL, V5, P1, DOI 10.1097/00004691-198801000-00001; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; PASCUALMARQUI RD, 1995, IEEE T BIO-MED ENG, V42, P658, DOI 10.1109/10.391164; Pereda E, 1999, NEUROSCI LETT, V263, P37, DOI 10.1016/S0304-3940(99)00104-4; PHILLIPS RL, 1994, NEUROPSYCHOPHARMACOL, V10, P171, DOI 10.1038/npp.1994.19; Porjesz B, 2002, P NATL ACAD SCI USA, V99, P3729, DOI 10.1073/pnas.052716399; PULVERMULLER F, 1995, NEUROREPORT, V6, P2059, DOI 10.1097/00001756-199510010-00025; Quiroga RQ, 2001, BIOL CYBERN, V84, P291, DOI 10.1007/s004220000212; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ray W. J., 1990, PRINCIPLES PSYCHOPHY, P385; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Robinson PA, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021903; Robinson TE, 2000, ADDICTION, V95, pS91; Sachs G, 2004, PSYCHIAT RES-NEUROIM, V131, P237, DOI 10.1016/j.pscychresns.2003.08.007; Sampson T, 2002, THESIS U WAIKATO; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; SCHACTER DL, 1977, BIOL PSYCHOL, V5, P47, DOI 10.1016/0301-0511(77)90028-X; SCHUTT A, 1992, COMP BIOCHEM PHYS C, V102, P159, DOI 10.1016/0742-8413(92)90058-F; Shaw J.C., 2003, BRAINS ALPHA RHYTHMS; SIMON O, 1977, ELEKTROENZEPHALOGRAR; Smit DJA, 2005, PSYCHOPHYSIOLOGY, V42, P691, DOI 10.1111/j.1469-8986.2005.00352.x; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Stam C. J., 2006, NONLINEAR BRAIN DYNA; Steriade M, 1996, J NEUROSCI, V16, P392, DOI 10.1523/jneurosci.16-01-00392.1996; Steyn-Ross ML, 2004, PROG BIOPHYS MOL BIO, V85, P369, DOI 10.1016/j.pbiomolbio.2004.02.001; STRIK WK, 1993, ELECTROEN CLIN NEURO, V87, P169, DOI 10.1016/0013-4694(93)90016-O; STRIK WK, 1995, J NEURAL TRANSM-GEN, V99, P213, DOI 10.1007/BF01271480; Sullivan EV, 2004, NEUROBIOL AGING, V25, P185, DOI 10.1016/S0197-4580(03)00044-7; Thatcher R.W., 2003, J NEUROTHER, V7, P87, DOI [10.1300/j184v07n03_05, DOI 10.1300/J184V07N03_05]; Thatcher Robert W., 1977, FUNCTIONAL NEUROSCIE, V1; Thatcher RW., 2001, J NEUROTHER, V3, P1; Tirsch W., 1988, PROGR COMPUTER ASSIS, P109; Tirsch WS, 2000, BIOL CYBERN, V82, P1, DOI 10.1007/PL00007957; Tones JL, 1996, BR HOMEOPATH J, V85, P134; Triesch J, 2001, NEURAL COMPUT, V13, P2049, DOI 10.1162/089976601750399308; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Vaitl D, 2005, PSYCHOL BULL, V131, P98, DOI 10.1037/0033-2909.131.1.98; van Beijsterveldt CEM, 2002, BIOL PSYCHOL, V61, P111, DOI 10.1016/S0301-0511(02)00055-8; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; Van der Werf YD, 2001, COGNITIVE BRAIN RES, V11, P377, DOI 10.1016/S0926-6410(01)00010-6; van Vugt MK, 2007, J NEUROSCI METH, V162, P49, DOI 10.1016/j.jneumeth.2006.12.004; vanBeijsterveldt CEM, 1996, AM J HUM GENET, V58, P562; VOLAVKA J, 1970, NEUROPHARMACOLOGY, V9, P587, DOI 10.1016/0028-3908(70)90009-2; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; WACKERMANN J, 1993, INT J PSYCHOPHYSIOL, V14, P269, DOI 10.1016/0167-8760(93)90041-M; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; WRIGHT JJ, 1985, BIOL CYBERN, V53, P11, DOI 10.1007/BF00355686; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zavaglia M, 2006, J NEUROSCI METH, V157, P317, DOI 10.1016/j.jneumeth.2006.04.022; Zhai YR, 2004, COMPUT METH PROG BIO, V76, P229, DOI 10.1016/j.cmpb.2004.07.002; [No title captured]; [No title captured]	170	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87507	10.1371/journal.pone.0087507	http://dx.doi.org/10.1371/journal.pone.0087507			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505292	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200051
J	George, SM; Alfano, CM; Groves, J; Karabulut, Z; Haman, KL; Murphy, BA; Matthews, CE				George, Stephanie M.; Alfano, Catherine M.; Groves, Jay; Karabulut, Zafer; Haman, Kirsten L.; Murphy, Barbara A.; Matthews, Charles E.			Objectively Measured Sedentary Time Is Related to Quality of Life among Cancer Survivors	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH; INTERVENTION; POSTURE; SF-36; MOVE	Purpose: While exercise has been shown to be beneficial in improving health-related quality of life (HRQOL) among cancer survivors, evidence is limited on the independent role of sedentary behavior. We examined how objectively measured sedentary time was associated with HRQOL among long-term cancer survivors. Methods: This cross-sectional study included 54 cancer survivors, on average 3.4 years postdiagnosis, who were enrolled into an exercise trial designed to improve cognitive function. At baseline, we measured sedentary time and moderate-vigorous intensity physical activity with the ActivPal, cardiorespiratory fitness with treadmill testing, and self-reported HRQOL with an established scale (SF-36). In multivariate models, we regressed HRQOL on sedentary time (percent of waking time spent sitting and lying). Results: Survivors with higher sedentary time had significantly poorer physical functioning (beta = -0.50, p = 0.028), general health (beta = -0.75, ptrend = 0.004), and physical summary scores (beta = -0.34, p = 0.003). We did not observe associations between sedentary time and role-physical (p = 0.342), bodily-pain (p = 0.117), vitality (p = 0.095), social functioning (p = 0.407), role-emotional (p = 0.509), mental health (p = 0.494), or mental summary scores (p = 0.527). Conclusion: In this cross-sectional study of cancer survivors, we observed deleterious associations between sedentary time and aspects of physical HRQOL. Future prospective studies of sedentary time and HRQOL are needed to establish temporality and to facilitate the design of effective health promotion interventions for cancer survivors.	[George, Stephanie M.] NCI, Div Canc Control & Populat Sci, Appl Res Program, Bethesda, MD 20892 USA; [Alfano, Catherine M.] NCI, Off Canc Survivorship, Bethesda, MD 20892 USA; [Groves, Jay; Karabulut, Zafer] Vanderbilt Univ, Med Ctr, Vanderbilt Dayani Ctr Hlth & Wellness, Nashville, TN USA; [Haman, Kirsten L.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Murphy, Barbara A.] Vanderbilt Univ, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Nutr Epidemiol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	George, SM (corresponding author), NCI, Div Canc Control & Populat Sci, Appl Res Program, Bethesda, MD 20892 USA.	Stephanie.george@nih.gov	matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103; Murphy, Barbara/0000-0003-2163-7927	Lance Armstrong Foundation; NATIONAL CANCER INSTITUTE [ZIACP010197] Funding Source: NIH RePORTER	Lance Armstrong Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Lance Armstrong Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSM, 2000, AM COLL SPORTS MED G, P92; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Demark-Wahnefried W, 2009, J AM GERIATR SOC, V57, pS262, DOI 10.1111/j.1532-5415.2009.02507.x; EU Working Group, 2008, EU PHYS ACT GUID; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; George SM, 2012, J PHYS ACT HLTH; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; GUYATT G, 1987, J CHRON DIS, V40, P171, DOI 10.1016/0021-9681(87)90069-5; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hays Ron D, 2005, COPD, V2, P63; Hewitt M, 2003, J GERONTOL A-BIOL, V58, P82; Jacobsen PB, 2011, CANCER EPIDEM BIOMAR, V20, P2035, DOI 10.1158/1055-9965.EPI-11-0563; Kim RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057598; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; Kotler DP, 1996, AM J CLIN NUTR, V64, P489; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lynch BM, 2011, EUR J CANCER CARE, V20, P514, DOI 10.1111/j.1365-2354.2010.01205.x; Lynch BM, 2011, CANCER CAUSE CONTROL, V22, P1111, DOI 10.1007/s10552-011-9786-8; Lynch BM, 2010, CANCER CAUSE CONTROL, V21, P283, DOI 10.1007/s10552-009-9460-6; Matthews CE, 2013, MED SCI SPO IN PRESS; Michael YL, 2000, CANCER-AM CANCER SOC, V89, P2176, DOI 10.1002/1097-0142(20001201)89:11<2176::AID-CNCR5>3.0.CO;2-6; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Reich KA, 2010, J APPL PHYSIOL, V109, P1404, DOI 10.1152/japplphysiol.00444.2010; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Seguin R, 2012, J AGING RES, V2012, DOI [10.1155/2012/271589, DOI 10.1155/2012/271589]; Short CE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-124; Short CE, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-172; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sweeney C, 2006, JNCI-J NATL CANCER I, V98, P521, DOI 10.1093/jnci/djj130; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Ware DL, 1996, QUALITY LIFE PHARMAC, P337; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Westerterp KR, 2001, NATURE, V410, P539, DOI 10.1038/35069142; Yost KJ, 2005, QUAL LIFE RES, V14, P1251, DOI 10.1007/s11136-004-6673-8	38	47	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87937	10.1371/journal.pone.0087937	http://dx.doi.org/10.1371/journal.pone.0087937			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505335	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200087
J	Hoonhorst, SJM; ten Hacken, NHT; Vonk, JM; Timens, W; Hiemstra, PS; Lapperre, TS; Sterk, PJ; Postma, DS				Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Vonk, Judith M.; Timens, Wim; Hiemstra, Pieter S.; Lapperre, Therese S.; Sterk, Peter J.; Postma, Dirkje S.			Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; AIRWAY INFLAMMATION; SALMETEROL/FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE; SMOKING-CESSATION; CIGARETTE-SMOKING; LUNG-FUNCTION; DOUBLE-BLIND; MILD ASTHMA	Background: Inhaled corticosteroids (ICS) reduce exacerbation rates and improve health status but can increase the risk of pneumonia in COPD. The GLUCOLD study, investigating patients with mild-to-moderate COPD, has shown that long-term (2.5-year) ICS therapy induces anti-inflammatory effects. The literature suggests that cigarette smoking causes ICS insensitivity. The aim of this study is to compare anti-inflammatory effects of ICS in persistent smokers and persistent ex-smokers in a post-hoc analysis of the GLUCOLD study. Methods: Persistent smokers (n = 41) and persistent ex-smokers (n = 31) from the GLUCOLD cohort were investigated. Effects of ICS treatment compared with placebo were estimated by analysing changes in lung function, hyperresponsiveness, and inflammatory cells in sputum and bronchial biopsies during short-term (0-6 months) and long-term (6-30 months) treatment using multiple regression analyses. Results: Bronchial mast cells were reduced by short-term and long-term ICS treatment in both smokers and ex-smokers. In contrast, CD3(+), CD4(+), and CD8(+) cells were reduced by short-term ICS treatment in smokers only. In addition, sputum neutrophils and lymphocytes, and bronchial CD8(+) cells were reduced after long-term treatment in ex-smokers only. No significant interactions existed between smoking and ICS treatment. Conclusion: Even in the presence of smoking, long-term ICS treatment may lead to anti-inflammatory effects in the lung. Some anti-inflammatory ICS effects are comparable in smokers and ex-smokers with COPD, other effects are cell-specific. The clinical relevance of these findings, however, are uncertain.	[Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands; [Hoonhorst, Susan J. M.; ten Hacken, Nick H. T.; Vonk, Judith M.; Timens, Wim; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Hiemstra, Pieter S.; Lapperre, Therese S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Sterk, Peter J.] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Pulm Dis, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Postma, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands.	d.s.postma@umcg.nl	Vonk, Judith/K-8477-2019; Hiemstra, Pieter S/K-8587-2018; Vonk, Judith M/ABA-3009-2020; Timens, Wim/K-5570-2013; Sterk, P.J./AAK-8175-2020; /V-8478-2019	Vonk, Judith/0000-0001-7531-4547; Hiemstra, Pieter S/0000-0002-0238-5982; Vonk, Judith M/0000-0001-7531-4547; Timens, Wim/0000-0002-4146-6363; Lapperre, Therese/0000-0002-5176-0101	Netherlands Organization for Scientific Research (NWO) [940-35-033]; Netherlands Asthma Foundation (NAF) [3.4.93.96.3]; GlaxoSmithKline of The Netherlands; University Medical Center Groningen; Leiden University Medical Center	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Foundation (NAF); GlaxoSmithKline of The Netherlands(GlaxoSmithKline); University Medical Center Groningen; Leiden University Medical Center	This work was supported by the Netherlands Organization for Scientific Research (NWO, 940-35-033), the Netherlands Asthma Foundation (NAF, 3.4.93.96.3), GlaxoSmithKline of The Netherlands, University Medical Center Groningen, and Leiden University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Bourbeau J, 2007, THORAX, V62, P938, DOI 10.1136/thx.2006.071068; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chalmers GW, 2002, THORAX, V57, P226, DOI 10.1136/thorax.57.3.226; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Culpitt SV, 1999, AM J RESP CRIT CARE, V160, P1635, DOI 10.1164/ajrccm.160.5.9811058; Gizycki MJ, 2002, THORAX, V57, P799, DOI 10.1136/thorax.57.9.799; Global Initiative for Chronic Obstructive Lung Disease, 2010, GLOB STRAT DIAGN MAN; Hattotuwa KL, 2002, AM J RESP CRIT CARE, V165, P1592, DOI 10.1164/rccm.2105025; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Kaur M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-20; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; Van Overveld FJ, 2006, J PHYSIOL PHARMACOL, V57, P273; Willemse BWM, 2005, EUR RESPIR J, V26, P835, DOI 10.1183/09031936.05.00108904; Yang YW, 2008, J ALLERGY CLIN IMMUN, V121, P1393, DOI 10.1016/j.jaci.2008.02.031	22	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87443	10.1371/journal.pone.0087443	http://dx.doi.org/10.1371/journal.pone.0087443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505290	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200049
J	Kan, ASY; Lau, ET; Tang, WF; Chan, SSY; Ding, SCK; Chan, KYK; Lee, CP; Hui, PW; Chung, BHY; Leung, KY; Ma, T; Leung, WC; Tang, MHY				Kan, Anita S. Y.; Lau, Elizabeth T.; Tang, W. F.; Chan, Sario S. Y.; Ding, Simon C. K.; Chan, Kelvin Y. K.; Lee, C. P.; Hui, Pui Wah; Chung, Brian H. Y.; Leung, K. Y.; Ma, Teresa; Leung, Wing C.; Tang, Mary H. Y.			Whole-Genome Array CGH Evaluation for Replacing Prenatal Karyotyping in Hong Kong	PLOS ONE			English	Article							CHROMOSOMAL MICROARRAY; QF-PCR; 1ST-LINE TEST; DIAGNOSIS; HYBRIDIZATION; SAMPLES; ISSUES	Objective: To evaluate the effectiveness of whole-genome array comparative genomic hybridization (aCGH) in prenatal diagnosis in Hong Kong. Methods: Array CGH was performed on 220 samples recruited prospectively as the first-tier test study. In addition 150 prenatal samples with abnormal fetal ultrasound findings found to have normal karyotypes were analyzed as a 'further-test' study using NimbleGen CGX-135K oligonucleotide arrays. Results: Array CGH findings were concordant with conventional cytogenetic results with the exception of one case of triploidy. It was found in the first-tier test study that aCGH detected 20% (44/220) clinically significant copy number variants (CNV), of which 21 were common aneuploidies and 23 had other chromosomal imbalances. There were 3.2% (7/220) samples with CNVs detected by aCGH but not by conventional cytogenetics. In the 'further-test' study, the additional diagnostic yield of detecting chromosome imbalance was 6% (9/150). The overall detection for CNVs of unclear clinical significance was 2.7% (10/370) with 0.9% found to be de novo. Eleven loci of common CNVs were found in the local population. Conclusion: Whole-genome aCGH offered a higher resolution diagnostic capacity than conventional karyotyping for prenatal diagnosis either as a first-tier test or as a 'further-test' for pregnancies with fetal ultrasound anomalies. We propose replacing conventional cytogenetics with aCGH for all pregnancies undergoing invasive diagnostic procedures after excluding common aneuploidies and triploidies by quantitative fluorescent PCR. Conventional cytogenetics can be reserved for visualization of clinically significant CNVs.	[Kan, Anita S. Y.; Lau, Elizabeth T.; Tang, W. F.; Chan, Kelvin Y. K.; Lee, C. P.; Hui, Pui Wah; Tang, Mary H. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Kan, Anita S. Y.; Lau, Elizabeth T.; Chan, Sario S. Y.; Ding, Simon C. K.; Chan, Kelvin Y. K.; Lee, C. P.; Hui, Pui Wah; Chung, Brian H. Y.; Tang, Mary H. Y.] Queen Mary Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Chung, Brian H. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Leung, K. Y.; Ma, Teresa] Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Leung, Wing C.] Kwong Wah Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Kwong Wah Hospital	Kan, ASY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	kansya@hku.hk	Leung, Kwok-yin/T-8503-2018; Chan, Kelvin/HGA-3097-2022	Leung, Kwok-yin/0000-0002-9289-6857; Hui, Pui Wah/0000-0001-7376-7307	Hospital Authority of Hong Kong; S. K. Yee Medical Research Fund	Hospital Authority of Hong Kong; S. K. Yee Medical Research Fund	The authors would like to acknowledge the Hospital Authority of Hong Kong and also S. K. Yee Medical Research Fund for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists Committee on Genetics, 2013, Obstet Gynecol, V122, P1374, DOI 10.1097/01.AOG.0000438962.16108.d1; Battaglia A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-30; Callaway JLA, 2013, PRENATAL DIAG, V33, P1119, DOI 10.1002/pd.4209; Chong SS, 2000, BLOOD, V95, P360; de Wit MC, 2013, ULTRASOUND OBST GYN, DOI [10.1002/uog.12575, DOI 10.1002/U0G.12575]; Fiorentino F, 2013, EUR J HUM GENET, V21, P725, DOI 10.1038/ejhg.2012.253; Hillman SC, 2013, ULTRASOUND OBST GYN, V41, P610, DOI 10.1002/uog.12464; Hillman SC, 2011, ULTRASOUND OBST GYN, V37, P6, DOI 10.1002/uog.7754; Hills A, 2010, PRENATAL DIAG, V30, P509, DOI 10.1002/pd.2503; Hogart A, 2009, J MED GENET, V46, P86, DOI 10.1136/jmg.2008.061580; Kirchhoff M, 2001, J MED GENET, V38, P740, DOI 10.1136/jmg.38.11.740; Kou KO, 2013, FETAL DIAGN THER, DOI [10.1159/00354808, DOI 10.1159/00354808]; Lamb AN, 2012, GENET MED, V14, P914, DOI 10.1038/gim.2012.77; Langlois S, 2011, J OBSTET GYNAECOL CA, V33, P955, DOI 10.1016/S1701-2163(16)35022-8; Lau ET, 2009, PRENATAL DIAG, V29, P151, DOI 10.1002/pd.2194; Mann K, 2012, PRENATAL DIAG, V32, P309, DOI 10.1002/pd.2945; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; McGillivray G, 2012, PRENATAL DIAG, V32, P389, DOI 10.1002/pd.3849; Mignon-Ravix C, 2007, EUR J HUM GENET, V15, P432, DOI 10.1038/sj.ejhg.5201775; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Novelli A, 2012, ULTRASOUND OBST GYN, V39, P384, DOI 10.1002/uog.11092; Scott F, 2013, ULTRASOUND OBST GYN, V41, P500, DOI 10.1002/uog.12429; Shek NWM, 2013, CASE REP PERINAT MED, V2, P39, DOI 10.1515/crpm-2012-0032; Vetro A, 2012, HUM MUTAT, V33, P923, DOI 10.1002/humu.22050; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Wapner RJ, 2012, PRENATAL DIAG, V32, P396, DOI 10.1002/pd.3863	26	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87988	10.1371/journal.pone.0087988	http://dx.doi.org/10.1371/journal.pone.0087988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505343	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200093
J	Mekenkamp, LJM; Haan, JC; Israeli, D; van Essen, HFB; Dijkstra, JR; van Cleef, P; Punt, CJA; Meijer, GA; Nagtegaal, ID; Ylstra, B				Mekenkamp, Leonie J. M.; Haan, Josien C.; Israeli, Danielle; van Essen, Hendrik F. B.; Dijkstra, Jeroen R.; van Cleef, Patricia; Punt, Cornelis J. A.; Meijer, Gerrit A.; Nagtegaal, Iris D.; Ylstra, Bauke			Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent	PLOS ONE			English	Article							LIVER METASTASES; GENOMIC ANALYSIS; BREAST-CANCER; TUMORS; PROGRESSION; CHEMOTHERAPY; CARCINOMAS; EXPRESSION; SIGNATURE; EVOLUTION	The metastatic process is complex and remains a major obstacle in the management of colorectal cancer. To gain a better insight into the pathology of metastasis, we investigated genomic aberrations in a large cohort of matched colorectal cancer primaries and distant metastases from various sites by high resolution array comparative genomic hybridization. In total, 62 primary colorectal cancers, and 68 matched metastases (22 liver, 11 lung, 12 ovary, 12 omentum, and 11 distant lymph nodes) were analyzed. Public datasets were used for validation purposes. Metastases resemble their matched primary tumors in the majority of the patients. This validates the significant overlap in chromosomal aberrations between primary tumors and corresponding metastases observed previously. We observed 15 statistically significant different regions between the primary tumors and their matched metastases, of which only one recurrent event in metastases was observed. We conclude, based on detailed analysis and large independent datasets, that chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts, and differences are typically non-recurrent.	[Mekenkamp, Leonie J. M.; Dijkstra, Jeroen R.; van Cleef, Patricia; Nagtegaal, Iris D.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Haan, Josien C.; Israeli, Danielle; van Essen, Hendrik F. B.; Meijer, Gerrit A.; Ylstra, Bauke] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands	Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Ylstra, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands.	B.Ylstra@vumc.nl	Ylstra, Bauke/D-2906-2012; Dijkstra, Jeroen R/N-4383-2015; Nagtegaal, Iris D/A-2448-2014	Ylstra, Bauke/0000-0001-9479-3010; Nagtegaal, Iris D/0000-0003-0887-4127; Meijer, Gerrit/0000-0003-0330-3130	Dutch Cancer Society [KWF-2007-3832]; Stichting Sacha Swarttouw-Hijmans; Dutch Colorectal Cancer Group; DeCoDe project [03O-101]	Dutch Cancer Society(KWF Kankerbestrijding); Stichting Sacha Swarttouw-Hijmans; Dutch Colorectal Cancer Group; DeCoDe project	This research was financially supported by the Dutch Cancer Society (KWF-2007-3832), the 'Stichting Sacha Swarttouw-Hijmans', the Dutch Colorectal Cancer Group and performed within the framework of Center for Translational Molecular Medicine; DeCoDe project, Contract grant number: 03O-101. These funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Borger ME, 2007, J PATHOL, V212, P278, DOI 10.1002/path.2181; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Buffart TE, 2008, GENE CHROMOSOME CANC, V47, P994, DOI 10.1002/gcc.20605; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Diep CB, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-6; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Habermann JK, 2007, GENE CHROMOSOME CANC, V46, P10, DOI 10.1002/gcc.20382; Hamilton SR, 2000, WHO CLASSIFICATION T; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Koopman M, 2009, BRIT J CANCER, V100, P266, DOI 10.1038/sj.bjc.6604867; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Krijgsman O, 2013, CELL ONCOL, V36, P27, DOI 10.1007/s13402-012-0108-2; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Scheinin I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-331; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Stange DE, 2010, GUT, V59, P1236, DOI 10.1136/gut.2009.195701; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vermaat JS, 2012, CLIN CANCER RES, V18, P688, DOI 10.1158/1078-0432.CCR-11-1965; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358	38	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86833	10.1371/journal.pone.0086833	http://dx.doi.org/10.1371/journal.pone.0086833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505270	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200029
J	Ohshima, N; Kubota-Koketsu, R; Iba, Y; Okuno, Y; Kurosawa, Y				Ohshima, Nobuko; Kubota-Koketsu, Ritsuko; Iba, Yoshitaka; Okuno, Yoshinobu; Kurosawa, Yoshikazu			Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; MONOCLONAL-ANTIBODIES; HEMAGGLUTININ; STRAINS; EPITOPE; EXPRESSION; HUMANS; SYSTEM; CELLS; H2	Many people have a history of catching the flu several times during childhood but no additional flu in adulthood, even without vaccination. We analyzed the total repertoire of antibodies (Abs) against influenza A group 1 viruses induced in such a flu-resistant person after vaccination with 2009 H1N1 pandemic influenza virus. They were classified into two types, with no exceptions. The first type, the products of B cells newly induced through vaccination, binds near the sialic acid-binding pocket. The second type, the products of long-lived memory B cells established before vaccination, utilizes the 1-69 V-H gene, binds to the stem of HA, and neutralizes both H1N1 and H5N1 viruses with few exceptions. These observations indicate that the sialic acid-binding pocket and its surrounding region are immunogenically very potent and majority of the B cells whose growth is newly induced by vaccination produce Abs that recognize these regions. However, they play a role in protection against influenza virus infection for a short period since variant viruses that have acquired resistance to these Abs become dominant. On the other hand, although the stem of HA is immunogenically not potent, the second type of B cells eventually becomes dominant. Thus, a selection system should function in forming the repertoire of long-lived memory B cells and the stability of the epitope would greatly affect the fate of the memory cells. Acquisition of the ability to produce Abs that bind to the stable epitope could be a major factor of flu resistance.	[Ohshima, Nobuko; Iba, Yoshitaka; Kurosawa, Yoshikazu] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Antibody Project, Toyoake, Aichi, Japan; [Kubota-Koketsu, Ritsuko] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan; [Okuno, Yoshinobu] Osaka Univ, Res Fdn Microbial Dis, Kanonji, Kagawa, Japan	Fujita Health University; Osaka University; Osaka University	Kurosawa, Y (corresponding author), Fujita Hlth Univ, Inst Comprehens Med Sci, Div Antibody Project, Toyoake, Aichi, Japan.	kurosawa@fujita-hu.ac.jp			Ministry of Health, Labor, and Welfare of Japan; Research Foundation for Microbial Disease, Osaka University	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Foundation for Microbial Disease, Osaka University	This work was supported in part by a grant for Research on Pharmaceutical and Medical Safety from the Ministry of Health, Labor, and Welfare of Japan, and a grant from the Research Foundation for Microbial Disease, Osaka University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Iba Y, 1997, GENE, V194, P35, DOI 10.1016/S0378-1119(97)00101-7; ITO W, 1993, J BIOL CHEM, V268, P20668; Knossow M, 2002, VIROLOGY, V302, P294, DOI 10.1006/viro.2002.1625; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Morino K, 2001, J IMMUNOL METHODS, V257, P175, DOI 10.1016/S0022-1759(01)00462-8; Ohshima N, 2011, J VIROL, V85, P11048, DOI 10.1128/JVI.05397-11; Okada J, 2011, J GEN VIROL, V92, P326, DOI 10.1099/vir.0.026419-0; Okada J, 2010, VIROLOGY, V397, P322, DOI 10.1016/j.virol.2009.11.025; OKUNO Y, 1990, J CLIN MICROBIOL, V28, P1308, DOI 10.1128/JCM.28.6.1308-1313.1990; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; UNDERWOOD PA, 1982, J GEN VIROL, V62, P153, DOI 10.1099/0022-1317-62-1-153; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87305	10.1371/journal.pone.0087305	http://dx.doi.org/10.1371/journal.pone.0087305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505283	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200042
J	Perazzolli, M; Malacarne, G; Baldo, A; Righetti, L; Bailey, A; Fontana, P; Velasco, R; Malnoy, M				Perazzolli, Michele; Malacarne, Giulia; Baldo, Angela; Righetti, Laura; Bailey, Aubrey; Fontana, Paolo; Velasco, Riccardo; Malnoy, Mickael			Characterization of Resistance Gene Analogues (RGAs) in Apple (Malus x domestica Borkh.) and Their Evolutionary History of the Rosaceae Family	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE IDENTIFICATION; FIRE BLIGHT RESISTANCE; RICH REPEAT GENES; DISEASE-RESISTANCE; SCAB RESISTANCE; APHID RESISTANCE; BROAD-SPECTRUM; POWDERY MILDEW; QTL ANALYSIS	The family of resistance gene analogues (RGAs) with a nucleotide-binding site (NBS) domain accounts for the largest number of disease resistance genes and is one of the largest gene families in plants. We have identified 868 RGAs in the genome of the apple (Malus x domestica Borkh.) cultivar 'Golden Delicious'. This represents 1.51% of the total number of predicted genes for this cultivar. Several evolutionary features are pronounced in M. domestica, including a high fraction (80%) of RGAs occurring in clusters. This suggests frequent tandem duplication and ectopic translocation events. Of the identified RGAs, 56% are located preferentially on six chromosomes (Chr 2, 7, 8, 10, 11, and 15), and 25% are located on Chr 2. TIR-NBS and non-TIR-NBS classes of RGAs are primarily exclusive of different chromosomes, and 99% of non-TIR-NBS RGAs are located on Chr 11. A phylogenetic reconstruction was conducted to study the evolution of RGAs in the Rosaceae family. More than 1400 RGAs were identified in six species based on their NBS domain, and a neighbor-joining analysis was used to reconstruct the phylogenetic relationships among the protein sequences. Specific phylogenetic clades were found for RGAs of Malus, Fragaria, and Rosa, indicating genus-specific evolution of resistance genes. However, strikingly similar RGAs were shared in Malus, Pyrus, and Prunus, indicating high conservation of specific RGAs and suggesting a monophyletic origin of these three genera.	[Perazzolli, Michele; Malacarne, Giulia; Righetti, Laura; Fontana, Paolo; Velasco, Riccardo; Malnoy, Mickael] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Baldo, Angela; Bailey, Aubrey] USDA ARS, Plant Genet Resources Unit, Geneva, NY USA	Fondazione Edmund Mach; United States Department of Agriculture (USDA)	Malnoy, M (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	mickael.malnoy@fmach.it	Perazzolli, Michele/B-3636-2012; malnoy, mickael/C-5007-2012; Malnoy, Mickael/AAO-5431-2021; Malacarne, Giulia/N-4244-2015	Perazzolli, Michele/0000-0001-7218-9963; malnoy, mickael/0000-0002-5158-534X; Malnoy, Mickael/0000-0002-5158-534X; Malacarne, Giulia/0000-0003-1439-5958; Bailey, Aubrey/0000-0002-0712-217X; Velasco, Riccardo/0000-0002-8760-5031; Righetti, Laura/0000-0002-5421-7630	Provincia Autonoma di Trento	Provincia Autonoma di Trento(Autonomous Province of Trento)	The research was supported by the Provincia Autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Andolfo G, 2013, NEW PHYTOL, V197, P223, DOI 10.1111/j.1469-8137.2012.04380.x; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bus VGM, 2008, TREE GENET GENOMES, V4, P223, DOI 10.1007/s11295-007-0103-3; Bus VGM, 2011, ANNU REV PHYTOPATHOL, V49, P391, DOI 10.1146/annurev-phyto-072910-095339; Calenge F, 2006, MOL BREEDING, V17, P329, DOI 10.1007/s11032-006-9004-7; Calenge F, 2005, THEOR APPL GENET, V110, P660, DOI 10.1007/s00122-004-1891-6; Calenge F, 2004, PHYTOPATHOLOGY, V94, P370, DOI 10.1094/PHYTO.2004.94.4.370; Cevik V, 2002, THEOR APPL GENET, V105, P346, DOI 10.1007/s00122-002-0904-6; Chen QH, 2010, J MOL EVOL, V70, P137, DOI 10.1007/s00239-009-9316-4; Cheng Y, 2012, FEBS J, V279, P2431, DOI 10.1111/j.1742-4658.2012.08621.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Ding J, 2007, MOL GENET GENOMICS, V277, P619, DOI 10.1007/s00438-007-0213-5; Dunemann F, 2007, PLANT BREEDING, V126, P476, DOI 10.1111/j.1439-0523.2007.01415.x; Durbin R., 1998, BIOL SEQUENCE ANAL P; Evans RC, 2000, MOL PHYLOGENET EVOL, V17, P388, DOI 10.1006/mpev.2000.0828; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Galli P, 2010, MOL PLANT MICROBE IN, V23, P608, DOI 10.1094/MPMI-23-5-0608; Gardiner SE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-25; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Le Roux PMF, 2010, GENOME, V53, P710, DOI [10.1139/G10-047, 10.1139/g10-047]; Lee SY, 2003, MOL GENET GENOMICS, V269, P101, DOI 10.1007/s00438-003-0816-4; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Leister D, 1996, NAT GENET, V14, P421, DOI 10.1038/ng1296-421; Li J, 2010, MOL GENET GENOMICS, V283, P427, DOI 10.1007/s00438-010-0527-6; LI WH, 1991, FUNDAMENTALS MOL EVO; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Malacarne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029762; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Monosi B, 2004, THEOR APPL GENET, V109, P1434, DOI 10.1007/s00122-004-1758-x; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Murat F, 2012, GENOME BIOL EVOL, V4, P917, DOI 10.1093/gbe/evs066; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Plocik A, 2004, MOL PHYLOGENET EVOL, V31, P153, DOI 10.1016/S1055-7903(03)00274-4; Porter BW, 2009, MOL GENET GENOMICS, V281, P609, DOI 10.1007/s00438-009-0434-x; Potter D, 2002, PLANT SYST EVOL, V231, P77, DOI 10.1007/s006060200012; Prachumwat A, 2008, GENOME RES, V18, P221, DOI 10.1101/gr.7046608; Pushker R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r27; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Sanzol J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-87; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Soriano JM, 2009, TREE GENET GENOMES, V5, P475, DOI 10.1007/s11295-009-0201-5; Soufflet-Freslon V, 2008, GENOME, V51, P657, DOI 10.1139/G08-046; Stoeckli S, 2009, TREE GENET GENOMES, V5, P257, DOI 10.1007/s11295-008-0186-5; Stoeckli S, 2008, TREE GENET GENOMES, V4, P833, DOI 10.1007/s11295-008-0156-y; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yu YG, 1996, P NATL ACAD SCI USA, V93, P11751, DOI 10.1073/pnas.93.21.11751; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	80	44	47	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e83844	10.1371/journal.pone.0083844	http://dx.doi.org/10.1371/journal.pone.0083844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505246	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200006
J	Jung, HW; Kim, SW; Ahn, S; Lim, JY; Han, JW; Kim, TH; Kim, KW; Kim, KI; Kim, CH				Jung, Hee-Won; Kim, Sun-Wook; Ahn, Soyeon; Lim, Jae-Young; Han, Ji-Won; Kim, Tae-Hui; Kim, Ki-Woong; Kim, Kwang-il; Kim, Cheol-Ho			Prevalence and Outcomes of Frailty in Korean Elderly Population: Comparisons of a Multidimensional Frailty Index with Two Phenotype Models	PLOS ONE			English	Article							OLDER-ADULTS; HEALTH; PREDICTION; DISABILITY; MORTALITY; DEATH	Background: Frailty is related to adverse outcomes in the elderly. However, current status and clinical significance of frailty have not been evaluated for the Korean elderly population. We aimed to investigate the usefulness of established frailty criteria for community-dwelling Korean elderly. We also tried to develop and validate a new frailty index based on a multidimensional model. Methods: We studied 693 participants of the Korean Longitudinal Study on Health and Aging (KLoSHA). We developed a new frailty index (KLoSHA Frailty Index, KFI) and compared predictability of it with the established frailty indexes from the Cardiovascular Health Study (CHS) and Study of Osteoporotic Fracture (SOF). Mortality, hospitalization, and functional decline were evaluated. Results: The prevalence of frailty was 9.2% (SOF index), 13.2% (CHS index), and 15.6% (KFI). The criteria from CHS and KFI correlated with each other, but SOF did not correlate with KFI. During the follow-up period (5.6 +/- 0.9 years), 97 participants (14.0%) died. Frailty defined by KFI predicted mortality better than CHS index (c-index: 0.713 and 0.596, respectively; p<0.001, better for KFI). In contrast, frailty by SOF index was not related to mortality. The KFI showed better predictability for following functional decline than CHS index (area under the receiver-operating characteristic curve was 0.937 for KFI and 0.704 for CHS index, p = 0.001). However, the SOF index could not predict subsequent functional decline. Frailty by the KFI (OR = 2.13, 95% CI 1.04-4.35) and CHS index (OR = 2.24, 95% CI 1.05-4.76) were associated with hospitalization. In contrast, frailty by the SOF index was not correlated with hospitalization (OR = 1.43, 95% CI 0.68-3.01). Conclusion: Prevalence of frailty was higher in Korea compared to previous studies in other countries. A novel frailty index (KFI), which includes domains of comprehensive geriatric assessment, is a valid criterion for the evaluation and prediction of frailty in the Korean elderly population.	[Jung, Hee-Won; Kim, Sun-Wook; Kim, Kwang-il; Kim, Cheol-Ho] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Lim, Jae-Young] Seoul Natl Univ, Bundang Hosp, Dept Rehabil, Songnam, South Korea; [Han, Ji-Won; Kim, Tae-Hui; Kim, Ki-Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Songnam, South Korea; [Jung, Hee-Won; Kim, Sun-Wook; Lim, Jae-Young; Han, Ji-Won; Kim, Tae-Hui; Kim, Ki-Woong; Kim, Kwang-il; Kim, Cheol-Ho] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kim, Ki-Woong] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, KI (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kikim907@snu.ac.kr	Kim, Tae Hui/AAR-9213-2020; Kim, Kwang-il/AAP-7315-2021; Lim, Jae-Young/J-5622-2012; Jung, Hee-Won/B-4269-2015; Kim, Kwang-il/D-8024-2012; Kim, Ki Woong/D-5801-2012	Kim, Kwang-il/0000-0002-6658-047X; Lim, Jae-Young/0000-0002-9454-0344; Jung, Hee-Won/0000-0002-2583-3354; Kim, Kwang-il/0000-0002-6658-047X; Kim, Ki Woong/0000-0002-1103-3858; Kim, Tae Hui/0000-0003-0133-5227	Korean Health Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [A092077]	Korean Health Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This study was supported by the grant of the Korean Health Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (Grant No. A092077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Dupre ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1175; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Harrell FE, 2001, REGRESSION MODELING, Vxxii; Hwang HS, 2010, ANN GERIATR MED RES, V14, P191, DOI 10.4235/jkgs.2010.14.4.191; Imuta H, 2001, AGING CLIN EXP RES, V13, P443; Jung IK, 1997, J KOREAN NEUROPSYCHI, V1, P61; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Kim KI, 2008, HYPERTENS RES, V31, P97, DOI 10.1291/hypres.31.97; Kulminski AM, 2007, J AM GERIATR SOC, V55, P935, DOI 10.1111/j.1532-5415.2007.01155.x; MCGANDY RB, 1966, J GERONTOL, V21, P581, DOI 10.1093/geronj/21.4.581; Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2; OECD, 2012, OECD EC SURV KOR 201; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; Pilotto A, 2008, REJUV RES, V11, P151, DOI 10.1089/rej.2007.0569; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x	21	94	95	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87958	10.1371/journal.pone.0087958	http://dx.doi.org/10.1371/journal.pone.0087958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6GY	24505338	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300024
J	Liu, XZ; Meng, W; Liang, GH; Li, K; Xu, WQ; Huang, LJ; Yan, JH				Liu, Xingzhao; Meng, Wei; Liang, Guohua; Li, Kun; Xu, Weiqiang; Huang, Liujing; Yan, Junhua			Available Phosphorus in Forest Soil Increases with Soil Nitrogen but Not Total Phosphorus: Evidence from Subtropical Forests and a Pot Experiment	PLOS ONE			English	Article							OLD-GROWTH FORESTS; SOUTHERN CHINA; TROPICAL FORESTS; ORGANIC-MATTER; CARBON; LIMITATION; ECOSYSTEM; EXCHANGE; PLANT; ACQUISITION	This paper aims to establish evidence for available phosphorous (AP) binding with total nitrogen (N) in subtropical forest soils. Soil organic carbon (SOC), total N, total phosphorous (P) and AP concentration were measured for three contrasting forest types in southern China: Masson pine forest (MPF), coniferous and broadleaved mixed forest (CBMF) and monsoon evergreen broadleaved forest (MEBF). A pot experiment with N addition was conducted to confirm the dominant factor to affect on soil AP concentration. The results showed that mean soil total N concentration in 0-10 cm soil layer was 440 +/- 50 for MPF, 840 +/- 80 for CBMF and 1020 +/- 50 mg kg(-1) for MEBF, respectively. The mean soil AP concentration in 0-10 cm soil layer was 2.67 +/- 0.87 for MPF, 2.65 +/- 0.58 for CBMF, 4.10 +/- 0.29 mg kg(-1) for MEBF, respectively. The soil total N concentration could explain about 70% of the variations in soil AP concentration in the top 20 cm soil layers in the three forest types. A pot experiment with N addition also showed an increase of AP concentration from 2.56 to 5.63 mg kg(-1), when N addition increased from 5 g to 17 g NH4NO3. Our results therefore suggested that N addition significantly increased soil AP concentration, which might be beneficial for stabilizing the net primary production of subtropical forests that were limited by soil AP. This finding may provide a theory basis for tropical and subtropical forests management.	[Liu, Xingzhao; Li, Kun; Xu, Weiqiang; Yan, Junhua] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Meng, Wei] China Forestry Adm, Paulownia Res & Dev Ctr, Zhengzhou, Peoples R China; [Liang, Guohua] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Huang, Liujing] Guangdong Prov Acad Environm Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Forestry; Paulownia R&D Center of State Administration of Forestry & Grassland, CAF; South China Agricultural University	Yan, JH (corresponding author), Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	jhyan@scib.ac.cn	Liu, Xingzhao/GRO-2429-2022		National Natural Science Foundation of China [30872012, 41301058]; National Basic Research Program of China [2011CB403202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (No. 30872012 and 41301058) and National Basic Research Program of China (2011CB403202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ACTA ECOL SIN, DOI DOI 10.3321/J.ISSN:1000-0933.2001.12.006; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Ding MM, 2001, 2TF17 USDA FOR SERV; Dinkelaker B, 1989, PLANT CELL ENVIRON, V12, P265; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; GARDNER WK, 1983, PLANT SOIL, V70, P107, DOI 10.1007/BF02374754; Gress SE, 2007, ECOLOGY, V88, P119, DOI 10.1890/0012-9658(2007)88[119:NLISED]2.0.CO;2; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Hocking PJ, 2001, ADV AGRON, V74, P63, DOI 10.1016/S0065-2113(01)74031-X; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Huang WJ, 2011, ACTA OECOLOGICA INT, DOI DOI 10.1016/J.ACTA0; Huang YH, 2011, FOREST ECOL MANAG, V261, P1170, DOI 10.1016/j.foreco.2010.12.030; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Li YL, 2012, ASIA-PAC J ATMOS SCI, V48, P1, DOI 10.1007/s13143-012-0001-y; Liu G., 1996, SOIL PHYS CHEM ANAL; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu Xing-Zhao, 2010, Chinese Journal of Plant Ecology, V34, P64, DOI 10.3773/j.issn.1005-264x.2010.01.010; Lloyd J, 2001, GLOBAL BIOGEOCHEMICA, P96; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; MCGILL WB, 1981, GEODERMA, V26, P267, DOI 10.1016/0016-7061(81)90024-0; Mo Jiang-ming, 2000, Journal of Tropical and Subtropical Botany, V8, P198; [莫江明 Mo Jiangming], 2004, [生态学报, Acta Ecologica Sinica], V24, P1413; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng Shao-Lin, 1995, Chinese Journal of Botany, V7, P75; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Tang XL, 2011, PLANT ECOL, V212, P1385, DOI 10.1007/s11258-011-9914-2; TAYLOR SR, 1964, GEOCHIM COSMOCHIM AC, V28, P1273, DOI 10.1016/0016-7037(64)90129-2; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Walker TW, GEODERMA, V15, P1; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Wu H., 1982, TROP SUBTROP ECOSYS, V1, P1; Yan JH, 2006, GLOBAL CHANGE BIOL, V12, P810, DOI 10.1111/j.1365-2486.2006.01141.x; Yan JH, 2007, PEDOSPHERE, V17, P397, DOI 10.1016/S1002-0160(07)60048-4; Yan JH, 2013, AGR FOREST METEOROL, V182, P257, DOI 10.1016/j.agrformet.2013.03.002; Zhang C, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002296; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168; ZHOU LX, 2002, TROPICAL SUBTROPICAL, V9, P169	46	19	20	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88070	10.1371/journal.pone.0088070	http://dx.doi.org/10.1371/journal.pone.0088070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505379	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300048
J	Itesako, T; Seki, N; Yoshino, H; Chiyomaru, T; Yamasaki, T; Hidaka, H; Yonezawa, T; Nohata, N; Kinoshita, T; Nakagawa, M; Enokida, H				Itesako, Toshihiko; Seki, Naohiko; Yoshino, Hirofumi; Chiyomaru, Takeshi; Yamasaki, Takeshi; Hidaka, Hideo; Yonezawa, Tomokazu; Nohata, Nijiro; Kinoshita, Takashi; Nakagawa, Masayuki; Enokida, Hideki			The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster	PLOS ONE			English	Article							CELL-CYCLE ARREST; TUMOR SUPPRESSORS; ONCOGENIC FUNCTION; CARCINOMA-CELLS; PROSTATE-CANCER; T24 CELLS; APOPTOSIS; MIR-133A; TUMORIGENICITY; IDENTIFICATION	Current genome-wide microRNA (miRNA) expression signature analysis using deep sequencing technologies can drive the discovery of novel cancer pathways regulated by oncogenic and/or tumor suppressive miRNAs. We determined the genome-wide miRNA expression signature in bladder cancer (BC) by deep sequencing technology. A total of ten small RNA libraries were sequenced (five BCs and five samples of histologically normal bladder epithelia (NBE)), and 13,190,619 to 18,559,060 clean small RNA reads were obtained. A total of 933 known miRNAs and 17 new miRNA candidates were detected in this analysis. Among the known miRNAs, a total of 60 miRNAs were significantly downregulated in BC compared with NBE. We also found that several miRNAs, such as miR-1/133a, miR-206/133b, let-7c/miR-99a, miR-143/145 and miR-195/497, were located close together at five distinct loci and constituted clustered miRNAs. Among these clustered miRNAs, we focused on the miR-195/497 cluster because this clustered miRNA had not been analyzed in BC. Transfection of mature miR-195 or miR-497 in two BC cell lines (BOY and T24) significantly inhibited cancer cell proliferation, migration and invasion, suggesting that the miR-195/497 cluster functioned as tumor suppressors in BC. Regarding the genes targeted by the miR195/497 cluster, the TargetScan algorithm showed that 6,730 genes were putative miR-195/497 targets, and 113 significantly enriched signaling pathways were identified in this analysis. The "Pathways in cancer'' category was the most enriched, involving 104 candidate target genes. Gene expression data revealed that 27 of 104 candidate target genes were actually upregulated in BC clinical specimens. Luciferase reporter assays and Western blotting demonstrated that BIRC5 and WNT7A were directly targeted by miR-195/497. In conclusion, aberrant expression of clustered miRNAs was identified by deep sequencing, and downregulation of miR-195/497 contributed to BC progression and metastasis. Tumor suppressive miRNA-mediated cancer pathways provide new insights into the potential mechanisms of BC oncogenesis.	[Itesako, Toshihiko; Yoshino, Hirofumi; Chiyomaru, Takeshi; Yamasaki, Takeshi; Hidaka, Hideo; Yonezawa, Tomokazu; Nakagawa, Masayuki; Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan; [Seki, Naohiko; Nohata, Nijiro; Kinoshita, Takashi] Chiba Univ, Grad Sch Med, Dept Funct Genom, Chiba, Japan	Kagoshima University; Chiba University	Enokida, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan.	enokida@m.kufm.kagoshima-u.ac.jp	Nohata, Nijiro/H-5190-2011	Nohata, Nijiro/0000-0002-6816-2984	Ministry of Education, Science, Sports and Culture [23501298, 23592340]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by the Ministry of Education, Science, Sports and Culture Grants-in-Aid for Scientific Research ( C), 23501298 and 23592340, 2011. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen YH, 2013, UROL ONCOL-SEMIN ORI, V31, P219, DOI 10.1016/j.urolonc.2010.11.007; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chiyomaru T, 2010, BRIT J CANCER, V102, P883, DOI 10.1038/sj.bjc.6605570; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fei X, 2012, FEBS LETT, V586, P392, DOI 10.1016/j.febslet.2012.01.006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Haga CL, 2012, J BIOL CHEM, V287, P42695, DOI 10.1074/jbc.M112.387761; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Kanwar JR, 2013, MED RES REV, V33, P765, DOI 10.1002/med.21264; Kawakami K, 2012, EUR J CANCER, V48, P827, DOI 10.1016/j.ejca.2011.06.030; Kojima S, 2012, BRIT J CANCER, V106, P405, DOI 10.1038/bjc.2011.462; Ku JH, 2012, BJU INT, V110, P630, DOI 10.1111/j.1464-410X.2011.10884.x; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Lin YW, 2012, FEBS LETT, V586, P442, DOI 10.1016/j.febslet.2012.01.027; Liu L, 2010, BIOCHEM BIOPH RES CO, V400, P236, DOI 10.1016/j.bbrc.2010.08.046; Luke C, 2010, INTERN MED J, V40, P357, DOI 10.1111/j.1445-5994.2009.01980.x; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Meeks JJ, 2012, EUR UROL, V62, P523, DOI 10.1016/j.eururo.2012.05.048; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Noguchi S, 2013, CANCER LETT, V328, P353, DOI 10.1016/j.canlet.2012.10.017; Noguchi S, 2011, CANCER LETT, V307, P211, DOI 10.1016/j.canlet.2011.04.005; Nohata N, 2012, ONCOTARGET, V3, P9; Nohata N, 2011, INT J ONCOL, V39, P1099, DOI 10.3892/ijo.2011.1096; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shen L, 2012, EXP THER MED, V3, P475, DOI 10.3892/etm.2011.428; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh R, 2012, J CELL SCI, V125, P1568, DOI 10.1242/jcs.095976; SOBIN LH, 2002, TNM CLASSIFICATION M, P199; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Tatarano S, 2011, INT J ONCOL, V39, P13, DOI 10.3892/ijo.2011.1012; Uchida Y, 2013, UROL ONCOL-SEMIN ORI, V31, P115, DOI 10.1016/j.urolonc.2010.09.017; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yamasaki T, 2012, INT J ONCOL, V40, P1821, DOI 10.3892/ijo.2012.1391; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Yoshino H, 2012, BIOCHEM BIOPH RES CO, V417, P588, DOI 10.1016/j.bbrc.2011.12.011; Zhou Y, 2012, SCAND J URO IN PRESS; Zhu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028223; Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4; Zuiverloon TCM, 2012, EUR UROL, V61, P128, DOI 10.1016/j.eururo.2011.09.026	53	134	137	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e84311	10.1371/journal.pone.0084311	http://dx.doi.org/10.1371/journal.pone.0084311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520312	Green Published, gold, Green Submitted			2022-12-27	WOS:000331254600002
J	Gao, GL; Ding, GD; Wu, B; Zhang, YQ; Qin, SG; Zhao, YY; Bao, YF; Liu, YD; Wan, L; Deng, JF				Gao, Guang-Lei; Ding, Guo-Dong; Wu, Bin; Zhang, Yu-Qing; Qin, Shu-Gao; Zhao, Yuan-Yuan; Bao, Yan-Feng; Liu, Yun-Dong; Wan, Li; Deng, Ji-Feng			Fractal Scaling of Particle Size Distribution and Relationships with Topsoil Properties Affected by Biological Soil Crusts	PLOS ONE			English	Article							MICROBIOTIC CRUSTS; TENGGER-DESERT; ENVIRONMENTAL-FACTORS; GURBANTUNGGUT DESERT; SPATIAL-DISTRIBUTION; SUCCESSIONAL STAGES; NITROGEN-FIXATION; INNER-MONGOLIA; NEGEV DESERT; SANDY SOILS	Background: Biological soil crusts are common components of desert ecosystem; they cover ground surface and interact with topsoil that contribute to desertification control and degraded land restoration in arid and semiarid regions. Methodology/Principal Findings: To distinguish the changes in topsoil affected by biological soil crusts, we compared topsoil properties across three types of successional biological soil crusts (algae, lichens, and mosses crust), as well as the referenced sandland in the Mu Us Desert, Northern China. Relationships between fractal dimensions of soil particle size distribution and selected soil properties were discussed as well. The results indicated that biological soil crusts had significant positive effects on soil physical structure (P<0.05); and soil organic carbon and nutrients showed an upward trend across the successional stages of biological soil crusts. Fractal dimensions ranged from 2.1477 to 2.3032, and significantly linear correlated with selected soil properties (R-2 = 0.494-0.955, P<0.01). Conclusions/Significance: Biological soil crusts cause an important increase in soil fertility, and are beneficial to sand fixation, although the process is rather slow. Fractal dimension proves to be a sensitive and useful index for quantifying changes in soil properties that additionally implies desertification. This study will be essential to provide a firm basis for future policy-making on optimal solutions regarding desertification control and assessment, as well as degraded ecosystem restoration in arid and semiarid regions.	[Gao, Guang-Lei; Ding, Guo-Dong; Wu, Bin; Zhang, Yu-Qing; Qin, Shu-Gao; Zhao, Yuan-Yuan; Bao, Yan-Feng; Liu, Yun-Dong; Wan, Li; Deng, Ji-Feng] Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China; [Ding, Guo-Dong; Wu, Bin; Zhang, Yu-Qing; Qin, Shu-Gao; Zhao, Yuan-Yuan] Yanchi Res Stn, Yanchi, Peoples R China	Beijing Forestry University	Ding, GD (corresponding author), Beijing Forestry Univ, Coll Soil & Water Conservat, Beijing, Peoples R China.	dingguodong@bjfu.edu.cn	GAO, Guang-Lei/X-7720-2019; ZHAO, YUAN/HCI-5831-2022; Deng, Jifeng/J-6725-2019	Deng, Jifeng/0000-0001-5496-5009	National Technology & Science Support Program of P. R. China [2012BAD16B02]; National Basic Research Program of P. R. China (973 Program) [2013CB429900]	National Technology & Science Support Program of P. R. China; National Basic Research Program of P. R. China (973 Program)(National Basic Research Program of China)	This work was finacial supported by the National Technology & Science Support Program of P. R. China (2012BAD16B02) and the National Basic Research Program of P. R. China (973 Program, 2013CB429900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2005, SOIL AGR CHEM ANAL, P1; Bao YF, 2013, J FOOD AGRIC ENVIRON, V11, P1449; Belnap J, 2005, ECOLOGY, V86, P298, DOI 10.1890/03-0567; Belnap J, 2004, OECOLOGIA, V141, P306, DOI 10.1007/s00442-003-1438-6; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Belnap J., 2001, BIOL SOIL CRUSTS STR; Belnap J, 2006, HYDROL PROCESS, V20, P3159, DOI 10.1002/hyp.6325; Bhatnagar A, 2008, J ARID ENVIRON, V72, P73, DOI 10.1016/j.jaridenv.2007.05.007; Billings SA, 2003, SOIL BIOL BIOCHEM, V35, P643, DOI 10.1016/S0038-0717(03)00011-7; Bowker MA, 2008, SOIL BIOL BIOCHEM, V40, P2309, DOI 10.1016/j.soilbio.2008.05.008; Bowker MA, 2007, RESTOR ECOL, V15, P13, DOI 10.1111/j.1526-100X.2006.00185.x; BRASHER BR, 1966, SOIL SCI, V101, P108, DOI 10.1097/00010694-196602000-00006; Burgheimer J, 2006, J ARID ENVIRON, V64, P651, DOI 10.1016/j.jaridenv.2005.06.025; Castillo-Monroy AP, 2011, REV CHIL HIST NAT, V84, P1, DOI 10.4067/S0716-078X2011000100001; Chen L, 2006, J ARID ENVIRON, V67, P521, DOI 10.1016/j.jaridenv.2006.02.018; Chen XH, 2009, ENVIRON GEOL, V57, P975, DOI 10.1007/s00254-008-1382-1; Chen YN, 2007, ENVIRON GEOL, V52, P691, DOI 10.1007/s00254-006-0505-9; Delgado-Baquerizo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059807; Dhaliwal AK, 2006, COMMUN SOIL SCI PLAN, V37, P827, DOI 10.1080/00103620600564174; Dumanski J, 2000, AGR ECOSYST ENVIRON, V81, P93, DOI 10.1016/S0167-8809(00)00183-3; Elbert W, 2009, BIOGEOSCIENCES, V6, P6983, DOI [DOI 10.5194/BGD-6-6983-2009, 10.5194/bgd-6-6983-2009]; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; Gao SQ, 2010, J PLANT ECOL, V3, P279, DOI 10.1093/jpe/rtq015; Garcia-Pichel F, 2011, APPL ENVIRON MICROB, V67, P1902; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; George DB, 2003, ARID LAND RES MANAG, V17, P113, DOI 10.1080/15324980301588; Graef F, 2000, SOIL TILL RES, V55, P213, DOI 10.1016/S0167-1987(00)00117-3; Gui DW, 2010, MATH COMPUT MODEL, V51, P1306, DOI 10.1016/j.mcm.2009.10.035; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Housman DC, 2006, J ARID ENVIRON, V66, P620, DOI 10.1016/j.jaridenv.2005.11.014; Institute of Soil Science Chinese Academy of Sciences, 1978, SOIL PHYS CHEM AN, P524; Jia RL, 2008, SOIL BIOL BIOCHEM, V40, P2827, DOI 10.1016/j.soilbio.2008.07.029; Kidron GJ, 2010, CATENA, V82, P92, DOI 10.1016/j.catena.2010.05.006; Lalley JS, 2006, J ARID ENVIRON, V67, P579, DOI 10.1016/j.jaridenv.2006.03.017; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2011, APPL SOIL ECOL, V47, P59, DOI 10.1016/j.apsoil.2010.10.010; Li XR, 2005, PLANT SOIL, V277, P375, DOI 10.1007/s11104-005-8162-4; Liu LC, 2006, J HYDROL, V328, P331, DOI 10.1016/j.jhydrol.2005.12.004; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; Maestre FT, 2011, J ARID ENVIRON, V75, P1282, DOI 10.1016/j.jaridenv.2010.12.008; Mager DM, 2011, J ARID ENVIRON, V75, P91, DOI 10.1016/j.jaridenv.2010.10.001; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; PACHEPSKY YA, 1995, SOIL SCI SOC AM J, V59, P68, DOI 10.2136/sssaj1995.03615995005900010010x; [彭新华 Peng Xinhua], 2003, [土壤通报, Journal of Soil Science], V34, P19; Perfect E, 1997, ENG GEOL, V48, P185, DOI 10.1016/S0013-7952(97)00040-9; Pietrasiak N, 2011, SOIL BIOL BIOCHEM, V43, P967, DOI 10.1016/j.soilbio.2011.01.012; Rajot JL, 2003, CATENA, V53, P1, DOI 10.1016/S0341-8162(02)00201-1; Schlesinger WH, 2003, ECOLOGY, V84, P3222, DOI 10.1890/02-0549; Su YG, 2007, PLANT ECOL, V191, P11, DOI 10.1007/s11258-006-9210-8; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Tirkey J, 2005, CURR SCI INDIA, V89, P515; VERRECCHIA E, 1995, J ARID ENVIRON, V29, P427, DOI 10.1016/S0140-1963(95)80015-8; Wang GuoLiang, 2005, Acta Pedologica Sinica, V42, P545; Wang XD, 2006, GEODERMA, V134, P56, DOI 10.1016/j.geoderma.2005.08.014; Watkins NW, 2008, SCIENCE, V320, P323, DOI 10.1126/science.1151611; Williams JD, 1999, ARID SOIL RES REHAB, V13, P145, DOI 10.1080/089030699263384; Wu N, 2009, J ARID ENVIRON, V73, P828, DOI 10.1016/j.jaridenv.2009.04.002; Zhang YM, 2007, J ARID ENVIRON, V68, P599, DOI 10.1016/j.jaridenv.2006.06.012; Zhang Z, 2008, J ARID ENVIRON, V72, P710, DOI 10.1016/j.jaridenv.2007.09.001	60	36	47	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88559	10.1371/journal.pone.0088559	http://dx.doi.org/10.1371/journal.pone.0088559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516668	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400076
J	Harrabi, H; Aubin, MJ; Zunzunegui, MV; Haddad, S; Freeman, EE				Harrabi, Hanen; Aubin, Marie-Josee; Zunzunegui, Maria Victoria; Haddad, Slim; Freeman, Ellen E.			Visual Difficulty and Employment Status in the World	PLOS ONE			English	Article							LENS OPACITIES; EYE DISEASES; UNEMPLOYMENT; IMPAIRMENT; HEALTH; AGE; MORTALITY; EXPOSURE; VISION; ADULTS	Purpose: Using a world-wide, population-based dataset, we sought to examine the relationship between visual difficulty and employment status. Methods: The World Health Survey was conducted in 70 countries throughout the world in 2003 using a random, multi-stage, stratified, cluster sampling design. Far vision was assessed by asking about the level of difficulty in seeing and recognizing a person you know across the road (i.e. from a distance of about 20 meters). Responses included none, mild, moderate, severe, or extreme/unable. Participants were asked about their current job, and if they were not working, the reason why (unable to find job, ill health, homemaker, studies, unpaid work, other). The occupation in the last 12 months was obtained. Multinomial regression was used accounting for the complex survey design. Results: Of those who wanted to work, 79% of those with severe visual difficulty and 64% of those with extreme visual difficulty were actually working. People who had moderate, severe, or extreme visual difficulty had a higher odds of not working due to an inability to find a job and of not working due to ill health after adjusting for demographic and health factors (P<0.05). Conclusions: As the major causes of visual impairment in the world are uncorrected refractive error and cataract, countries are losing a great deal of labor productivity by failing to provide for the vision health needs of their citizens and failing to help them integrate into the workforce.	[Harrabi, Hanen; Aubin, Marie-Josee; Freeman, Ellen E.] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Aubin, Marie-Josee; Freeman, Ellen E.] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Zunzunegui, Maria Victoria; Haddad, Slim] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Freeman, EE (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	eefreeman@gmail.com	Aubin, Marie-Josée/AAI-9745-2020	Zunzunegui, Maria-Victoria/0000-0003-0827-2804; Freeman, Ellen/0000-0002-1403-8427	Canadian Institutes of Health Research MOP [106533]	Canadian Institutes of Health Research MOP(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research MOP 106533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro DV, 2005, AM J OPHTHALMOL, V139, P488, DOI 10.1016/j.ajo.2004.10.011; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P364; Clemons TE, 2006, ARCH OPHTHALMOL-CHIC, V124, P537; Cohen F, 2007, PSYCHOSOM MED, V69, P225, DOI 10.1097/PSY.0b013e31803139a6; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Dupre ME, 2012, ARCH INTERN MED, V172, P1731, DOI 10.1001/2013.jamainternmed.447; EVANS TG, 1995, B WORLD HEALTH ORGAN, V73, P495; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; Garcy AM, 2012, SOC SCI MED, V74, P1911, DOI 10.1016/j.socscimed.2012.01.034; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042843; Karger H, 2010, J SOC WORK DISABIL R, V9, P73, DOI 10.1080/1536710X.2010.493468; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Limb M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7608; Loerbroks A, 2012, INT J EPIDEMIOL, V41, P1436, DOI 10.1093/ije/dys123; McCarty CA, 1999, AUST NZ J OPHTHALMOL, V27, P190, DOI 10.1046/j.1440-1606.1999.00194.x; Mojon-Azzi SM, 2010, OPHTHALMOLOGICA, V224, P381, DOI 10.1159/000316688; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Popescu ML, 2012, INVEST OPHTH VIS SCI, V53, P2308, DOI 10.1167/iovs.11-9330; Rahi JS, 2009, OPHTHALMOLOGY, V116, P1866, DOI 10.1016/j.ophtha.2009.03.007; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Ryskulova A, 2008, AM J PUBLIC HEALTH, V98, P454, DOI 10.2105/AJPH.2006.098202; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; Stewart L, 2012, J EPIDEMIOL COMMUN H, V66, P641, DOI 10.1136/jech.2010.110718; Szlyk JP, 1998, RETINA-J RET VIT DIS, V18, P360; Vela C, 2012, BMC OPHTHALMOLOGY, V12; Virtanen P, 2013, PUBLIC HEALTH, V127, P46, DOI 10.1016/j.puhe.2012.10.016; Wesseling C, 2001, Int J Occup Environ Health, V7, P1; West SK, 1998, JAMA-J AM MED ASSOC, V280, P714, DOI 10.1001/jama.280.8.714	31	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88306	10.1371/journal.pone.0088306	http://dx.doi.org/10.1371/journal.pone.0088306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516632	gold, Green Published			2022-12-27	WOS:000330834400055
J	Qi, M; Yang, XQ; Zhang, F; Lin, T; Sun, XB; Li, YJ; Yuan, HQ; Ren, YB; Zhang, J; Qin, XM; Han, B				Qi, Mei; Yang, Xiaoqing; Zhang, Fan; Lin, Tao; Sun, Xiubin; Li, Yanjiang; Yuan, Huiqing; Ren, Yubo; Zhang, Juan; Qin, Xiaomin; Han, Bo			ERG Rearrangement Is Associated with Prostate Cancer-Related Death in Chinese Prostate Cancer Patients	PLOS ONE			English	Article							IN-SITU-HYBRIDIZATION; TMPRSS2-ERG GENE FUSION; RADICAL PROSTATECTOMY; ANDROGEN-INDEPENDENCE; FAVORABLE PROGNOSIS; EXPRESSION; PROGRESSION; PTEN; OUTCOMES; RECURRENCE	Recently, ETS-related gene (ERG) gene rearrangements, phosphatase tensin homologue (PTEN) deletions and EGFR family aberrations were characterized as potential biomarkers for prostate cancer (PCa) patient management. Although ERG gene rearrangement has been identified in approximately 50% of localized prostate cancers in western countries, the prognostic significance of this critical molecular event remains unknown in Chinese patients. Using fluorescence in situ hybridization (FISH) and immunohistochemistry, we evaluated ERG, PTEN and EGFR family aberrations in a cohort of 224 Chinese prostate cancer patients diagnosed in transurethral resection of the prostate (TUR-P). Overall, ERG rearrangement was detected in 23.2% (44/190) cases, of which 54.5% (24/44) showed deletion of the 5'end of ERG. PTEN deletion was identified in 10.8% (19/176) cases. Amplification of EGFR and HER2 genes was present in 1.1% (2/178) and 5.8% (10/173) of cases, respectively. Significant correlation between ERG rearrangement and PTEN deletion was identified in this cohort. EGFR and HER2 aberrations occurred more frequently in PCas without ERG rearrangement than in those with ERG rearrangement, although this did not reach statistical significance. Overall, ERG rearrangement was associated with pre-operative PSA values (P = 0.038) and cancer-related death (P = 0.02), but not with the age, clinical T stage, Gleason score, or Ki-67 labeling index (LI). Notably, multivariate analysis including known prognostic markers revealed ERG rearrangement was an independent prognostic factor (P = 0.022). Additionally, ERG rearrangement status was helpful to identify patients with poor prognosis from PCa group with low Ki-67 LI. In summary, we reported that ERG rearrangement was associated with cancer-related death in Chinese PCa patients. Determination of ERG rearrangement status allows stratification of PCa patients into different survival categories.	[Qi, Mei; Yang, Xiaoqing; Han, Bo] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China; [Zhang, Fan] Shandong Univ, Sch Stomatol, Dept Orthodont, Jinan 250100, Peoples R China; [Lin, Tao] Cent Hosp Jinan, Dept Surg, Jinan, Peoples R China; [Sun, Xiubin] Shandong Univ, Sch Publ Hlth, Dept Stat, Jinan 250100, Peoples R China; [Li, Yanjiang] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Urol, Qingdao 266071, Peoples R China; [Yuan, Huiqing] Shandong Univ, Sch Med, Dept Biochem, Jinan 250100, Peoples R China; [Ren, Yubo] Liaocheng Gen Hosp, Dept Pathol, Liaocheng, Peoples R China; [Zhang, Juan; Qin, Xiaomin; Han, Bo] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Qingdao University; Shandong University; Shandong University	Han, B (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China.	boh@sdu.edu.cn			National Natural Science Foundation of China [81072110, 81171951]; Research Foundation of Health Department of Shandong [2011HZ037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Health Department of Shandong	This research was supported by the National Natural Science Foundation of China (grant numbers 81072110 and 81171951); Research Foundation of Health Department of Shandong (grant number 2011HZ037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 1998, JAMA-J AM MED ASSOC, V280, P975, DOI 10.1001/jama.280.11.975; Antonarakis ES, 2012, CANCER-AM CANCER SOC, V118, P6063, DOI 10.1002/cncr.27689; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Baek KH, 2012, CANCER RES TREAT, V44, P50, DOI 10.4143/crt.2012.44.1.50; Barry MJ, 2001, CANCER-AM CANCER SOC, V91, P2302, DOI 10.1002/1097-0142(20010615)91:12<2302::AID-CNCR1262>3.0.CO;2-P; Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411; Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Boormans JL, 2011, EUR UROL, V60, P183, DOI 10.1016/j.eururo.2011.03.028; Braun M, 2011, HISTOPATHOLOGY, V58, P1028, DOI 10.1111/j.1365-2559.2011.03862.x; Bubendorf L, 1996, J PATHOL, V178, P437, DOI 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Falzarano SM, 2010, MODERN PATHOL, V23, P1499, DOI 10.1038/modpathol.2010.150; FitzGerald LM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-230; Gopalan A, 2009, CANCER RES, V69, P1400, DOI 10.1158/0008-5472.CAN-08-2467; Guo CC, 2009, MODERN PATHOL, V22, P866, DOI 10.1038/modpathol.2009.57; Han B, 2008, CANCER RES, V68, P7629, DOI 10.1158/0008-5472.CAN-08-2014; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Hermans KG, 2009, CLIN CANCER RES, V15, P6398, DOI 10.1158/1078-0432.CCR-09-1176; Kimura T, 2012, PATHOL INT, V62, P742, DOI 10.1111/pin.12006; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Korshunov A, 2005, MODERN PATHOL, V18, P1258, DOI 10.1038/modpathol.3800415; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Lee K, 2010, UROLOGY, V76, p[1268, e1267]; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; Magi-Galluzzi C, 2011, PROSTATE, V71, P489, DOI 10.1002/pros.21265; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Miyagi Y, 2010, MODERN PATHOL, V23, P1492, DOI 10.1038/modpathol.2010.149; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Nam RK, 2007, BRIT J CANCER, V97, P1690, DOI 10.1038/sj.bjc.6604054; Pathmanathan N, 2013, J CLIN PATHOL, V66, P512, DOI 10.1136/jclinpath-2012-201085; Perner S, 2010, PATHOLOGE, V31, P121, DOI 10.1007/s00292-010-1345-7; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Saramaki OR, 2008, CLIN CANCER RES, V14, P3395, DOI 10.1158/1078-0432.CCR-07-2051; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Ward JF, 2003, J UROLOGY, V170, P1872, DOI 10.1097/01.ju.0000091876.13656.2e; Winnes M, 2007, ONCOL REP, V17, P1033; Yoshimoto M, 2008, MODERN PATHOL, V21, P1451, DOI 10.1038/modpathol.2008.96; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	51	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e84959	10.1371/journal.pone.0084959	http://dx.doi.org/10.1371/journal.pone.0084959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516518	gold, Green Submitted, Green Published			2022-12-27	WOS:000330834400002
J	Torrecilla, E; Delicado, TL; Holguin, A				Torrecilla, Esther; Llacer Delicado, Teresa; Holguin, Africa			New Findings in Cleavage Sites Variability across Groups, Subtypes and Recombinants of Human Immunodeficiency Virus Type 1	PLOS ONE			English	Article							HIV-1 PROTEASE; VIRAL FITNESS; PROCESSING SITES; GAG; RESISTANCE; MUTATIONS; P6; POLYMORPHISMS; SPECIFICITY; VARIANTS	Background: Polymorphisms at cleavage sites (CS) can influence Gag and Pol proteins processing by the viral protease (PR), restore viral fitness and influence the virological outcome of specific antiretroviral drugs. However, data of HIV-1 variant-associated CS variability is scarce. Methods: In this descriptive research, we examine the effect of HIV-1 variants on CS conservation using all 9,028 gag and 3,906 pol HIV-1 sequences deposited in GenBank, focusing on the 110 residues (10 per site) involved at 11 CS: P17/P24, P24/P2, P2/P7, P7/P1, P1/P6(gag), NC/TFP, TFP/P6(pol), P6(pol)/PR, PR/RTp51, RTp51/RTp66 and RTp66/IN. CS consensus amino acid sequences across HIV-1 groups (M, O, N, P), group M 9 subtypes and 51 circulating recombinant forms (CRF) were inferred from our alignments and compared to the HIV-1 consensus-of-consensuses sequence provided by GenBank. Results: In all HIV-1 variants, the most conserved CS were PR/RTp51, RTp51/RTp66, P24/P2 and RTp66/IN and the least P2/P7 and P6(pol)/PR. Conservation was significantly lower in subtypes vs. recombinants in P2/P7 and TFP/P6(pol) and higher in P17/P24. We found a significantly higher conservation rate among Group M vs. non-M Groups HIV-1. The late processing sites at Gag (P7/P1) and GagPol precursors (PR/RTp51) presented a significantly higher conservation vs. the first CS (P2/P7) in the 4 HIV-1 groups. Here we show 52 highly conserved residues across HIV-1 variants in 11 CS and the amino acid consensus sequence in each HIV-1 group and HIV-1 group M variant for each 11 CS. Conclusions: This is the first study to describe the CS conservation level across all HIV-1 variants and 11 sites in one of the largest available sequence HIV-1 dataset. These results could help other researchers for the future design of both novel antiretroviral agents acting as maturation inhibitors as well as for vaccine targeting CS.	[Holguin, Africa] Hosp Ramon & Cajal, IRYCIS, Dept Microbiol, HIV 1 Mol Epidemiol Lab, E-28034 Madrid, Spain; CIBERESP, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Holguin, A (corresponding author), Hosp Ramon & Cajal, IRYCIS, Dept Microbiol, HIV 1 Mol Epidemiol Lab, E-28034 Madrid, Spain.	africa.holguin@salud.madrid.org	Holguín, Africa/AAF-9001-2021	Holguín, Africa/0000-0002-1330-8050	Ministry of Health and Social Policy through "Independent clinical project" [EC11-131]; FIS by Instituto de Salud Carlos III [PI12/00240]	Ministry of Health and Social Policy through "Independent clinical project"; FIS by Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This study was supported by Ministry of Health and Social Policy through the grant of an "Independent clinical project" (EC11-131) and by research project FIS awarded by Instituto de Salud Carlos III (PI12/00240). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CS, 2008, DRUG DISCOV TODAY, V13, P424, DOI 10.1016/j.drudis.2008.02.003; Adamson CS, 2012, MOL BIOL INT, V604261, P1; Bally F, 2000, AIDS RES HUM RETROV, V16, P1209, DOI 10.1089/08892220050116970; Banke S, 2009, J VIROL, V83, P8916, DOI 10.1128/JVI.00003-09; Barrie KA, 1996, VIROLOGY, V219, P407, DOI 10.1006/viro.1996.0266; Dahirel V, 2011, P NATL ACAD SCI USA, V108, P11530, DOI 10.1073/pnas.1105315108; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; de Oliveira T, 2003, J VIROL, V77, P9422, DOI 10.1128/JVI.77.17.9422-9430.2003; Doherty RS, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-18; Doyon L, 1998, J VIROL, V72, P6146, DOI 10.1128/JVI.72.7.6146-6150.1998; Fun A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-63; Gao Y, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-5; Ghosn J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024798; Goodenow MM, 2002, VIROLOGY, V292, P137, DOI 10.1006/viro.2001.1184; Holguin A, 2006, AIDS, V20, P624, DOI 10.1097/01.aids.0000210619.75707.21; Holguin A, 2006, J CLIN VIROL, V36, P264, DOI 10.1016/j.jcv.2006.05.001; KAPLAN AH, 1994, J VIROL, V68, P6782, DOI 10.1128/JVI.68.10.6782-6786.1994; Sadiq SK, 2012, P NATL ACAD SCI USA, V109, P20449, DOI 10.1073/pnas.1210983109; Kozisek M, 2012, ANTIMICROB AGENTS CH, V56, P4320, DOI 10.1128/AAC.00465-12; Lee SK, 2012, J BIOL CHEM, V287, P13279, DOI 10.1074/jbc.M112.339374; Liegeois F, 2013, AIDS RES HUM RETROV, V29, P1179, DOI [10.1089/aid.2013.0024, 10.1089/AID.2013.0024]; Luo M, 2013, VACCINE, V31, P3000, DOI 10.1016/j.vaccine.2013.04.057; Maguire MF, 2002, J VIROL, V76, P7398, DOI 10.1128/JVI.76.15.7398-7406.2002; Malet I, 2007, J INFECTION, V54, P367, DOI 10.1016/j.jinf.2006.06.012; Muller B, 2002, J VIROL, V76, P1015, DOI 10.1128/JVI.76.3.1015-1024.2002; Myint L, 2004, ANTIMICROB AGENTS CH, V48, P444, DOI 10.1128/AAC.48.2.444-452.2004; Nijhuis M, 2005, ANTIVIR THER, V10, pS117; Nijhuis M, 2007, PLOS MED, V4, P152, DOI 10.1371/journal.pmed.0040036; Peeters M., 2000, THEORETICAL BIOL BIO, P39; Pettit SC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-66; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; Rossi AH, 2013, AIDS RES HUM RETROV, V29, P1056, DOI [10.1089/aid.2012.0311, 10.1089/AID.2012.0311]; Shehu-Xhilaga M, 2001, J VIROL, V75, P9156, DOI 10.1128/JVI.75.19.9156-9164.2001; Snoeck J, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-87; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Swanstrom R., 1997, P263; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; TOMASSELLI AG, 1994, METHOD ENZYMOL, V241, P279; van der Kuyl AC, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-92; Verheyen J, 2009, J INFECTION, V58, P61, DOI 10.1016/j.jinf.2008.11.009; Waheed AA, 2012, AIDS RES HUM RETROV, V28, P54, DOI [10.1089/aid.2011.0230, 10.1089/AID.2011.0230]; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Zhang M, 2011, RETROVIROLOGY, V7, P25; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	47	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88099	10.1371/journal.pone.0088099	http://dx.doi.org/10.1371/journal.pone.0088099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516589	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400030
J	Katz, G; Benkarroum, Y; Wei, H; Rice, WJ; Bucher, D; Alimova, A; Katz, A; Klukowska, J; Herman, GT; Gottlieb, P				Katz, Garrett; Benkarroum, Younes; Wei, Hui; Rice, William J.; Bucher, Doris; Alimova, Alexandra; Katz, Al; Klukowska, Joanna; Herman, Gabor T.; Gottlieb, Paul			Morphology of Influenza B/Lee/40 Determined by Cryo-Electron Microscopy	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; A VIRUS; 3D RECONSTRUCTION; CRYSTAL-STRUCTURE; VISUALIZATION; NEURAMINIDASE; GLYCOPROTEIN; ORGANIZATION; COMPLEXES; ORIGIN	Cryo-electron microscopy projection image analysis and tomography is used to describe the overall architecture of influenza B/Lee/40. Algebraic reconstruction techniques with utilization of volume elements (blobs) are employed to reconstruct tomograms of this pleomorphic virus and distinguish viral surface spikes. The purpose of this research is to examine the architecture of influenza type B virions by cryo-electron tomography and projection image analysis. The aims are to explore the degree of ribonucleoprotein disorder in irregular shaped virions; and to quantify the number and distribution of glycoprotein surface spikes (hemagglutinin and neuraminidase) on influenza B. Projection image analysis of virion morphology shows that the majority (similar to 83%) of virions are spherical with an average diameter of 134 +/- 19 nm. The aspherical virions are larger (average diameter = 155 +/- 47 nm), exhibit disruption of the ribonucleoproteins, and show a partial loss of surface protein spikes. A count of glycoprotein spikes indicates that a typical 130 nm diameter type B virion contains similar to 460 surface spikes. Configuration of the ribonucleoproteins and surface glycoprotein spikes are visualized in tomogram reconstructions and EM densities visualize extensions of the spikes into the matrix. The importance of the viral matrix in organization of virus structure through interaction with the ribonucleoproteins and the anchoring of the glycoprotein spikes to the matrix is demonstrated.	[Katz, Garrett; Wei, Hui; Alimova, Alexandra; Gottlieb, Paul] CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Microbiol & Immunol, New York, NY 10031 USA; [Benkarroum, Younes; Klukowska, Joanna; Herman, Gabor T.] CUNY, Grad Ctr, Dept Comp Sci, New York, NY USA; [Rice, William J.] New York Struct Biol Ctr, New York, NY USA; [Bucher, Doris] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Katz, Al] CUNY City Coll, Dept Phys, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; City University of New York (CUNY) System; New York Medical College; City University of New York (CUNY) System; City College of New York (CUNY)	Gottlieb, P (corresponding author), CUNY City Coll, Sophie Davis Sch Biomed Educ, Dept Microbiol & Immunol, New York, NY 10031 USA.	PGottl@med.cuny.edu	Katz, Garrett/S-8037-2019	Rice, William/0000-0002-5187-255X	CUNY; National Institutes of Health (NIH) Research Centers in Minority Institutions/CCNY [G12-RR03060]; New York State Foundation for Science, Technology and Innovation (NYSTAR) [C000087]; National Science Foundation (NSF) [DMS-1114901]; National Institute of General Medical Science [SC1-GM092781]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM092781] Funding Source: NIH RePORTER	CUNY; National Institutes of Health (NIH) Research Centers in Minority Institutions/CCNY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Foundation for Science, Technology and Innovation (NYSTAR); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by CUNY Collaborative Incentive Research Grant; National Institutes of Health (NIH) Research Centers in Minority Institutions/CCNY Grant G12-RR03060; New York State Foundation for Science, Technology and Innovation (NYSTAR) Grant C000087; National Science Foundation (NSF) grant DMS-1114901; and National Institute of General Medical Science Grant SC1-GM092781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; BOOY FP, 1985, J MOL BIOL, V184, P667, DOI 10.1016/0022-2836(85)90312-2; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Giocondi MC, 2010, J GEN VIROL, V91, P329, DOI 10.1099/vir.0.015156-0; GORDON R, 1970, J THEOR BIOL, V29, P471, DOI 10.1016/0022-5193(70)90109-8; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Kaczmarz S., 1937, B INT ACAD POL SCI L, V35, P355; KHARITONENKOV IG, 1978, FEBS LETT, V96, P120, DOI 10.1016/0014-5793(78)81075-8; KILBOURNE ED, 1960, J EXP MED, V111, P387, DOI 10.1084/jem.111.3.387; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Marabini R, 1998, ULTRAMICROSCOPY, V72, P53, DOI 10.1016/S0304-3991(97)00127-7; Marabini R, 1997, J STRUCT BIOL, V120, P363, DOI 10.1006/jsbi.1997.3923; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Onodera S, 2011, INFLUENZA OTHER RESP, V5, P392; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; RUIGROK RWH, 1985, VIRUS RES, V3, P69, DOI 10.1016/0168-1702(85)90042-5; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sorzano COS, 2001, J STRUCT BIOL, V133, P108, DOI 10.1006/jsbi.2001.4338; Szretter K J., 2006, CURRENT PROTOCOLS MI; Taylor NR, 1998, J MED CHEM, V41, P798, DOI 10.1021/jm9703754; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Wang Q, 2010, INFLUENZA: MOLECULAR VIROLOGY, P1; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; Wang QH, 2007, P NATL ACAD SCI USA, V104, P16874, DOI 10.1073/pnas.0708363104; Wasilewski S, 2012, VACCINE, V30, P7368, DOI 10.1016/j.vaccine.2012.09.082; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007	37	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88288	10.1371/journal.pone.0088288	http://dx.doi.org/10.1371/journal.pone.0088288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516628	gold, Green Published			2022-12-27	WOS:000330830700060
J	Kim, BF; Poulsen, MN; Margulies, JD; Dix, KL; Palmer, AM; Nachman, KE				Kim, Brent F.; Poulsen, Melissa N.; Margulies, Jared D.; Dix, Katie L.; Palmer, Anne M.; Nachman, Keeve E.			Urban Community Gardeners' Knowledge and Perceptions of Soil Contaminant Risks	PLOS ONE			English	Article							INNER-CITY; SPATIAL-DISTRIBUTION; LEAD; ENVIRONMENT; HEALTH; REMEDIATION; ATTENTION; DEMENTIA; FRUIT	Although urban community gardening can offer health, social, environmental, and economic benefits, these benefits must be weighed against the potential health risks stemming from exposure to contaminants such as heavy metals and organic chemicals that may be present in urban soils. Individuals who garden at or eat food grown in contaminated urban garden sites may be at risk of exposure to such contaminants. Gardeners may be unaware of these risks and how to manage them. We used a mixed quantitative/qualitative research approach to characterize urban community gardeners' knowledge and perceptions of risks related to soil contaminant exposure. We conducted surveys with 70 gardeners from 15 community gardens in Baltimore, Maryland, and semi-structured interviews with 18 key informants knowledgeable about community gardening and soil contamination in Baltimore. We identified a range of factors, challenges, and needs related to Baltimore community gardeners' perceptions of risk related to soil contamination, including low levels of concern and inconsistent levels of knowledge about heavy metal and organic chemical contaminants, barriers to investigating a garden site's history and conducting soil tests, limited knowledge of best practices for reducing exposure, and a need for clear and concise information on how best to prevent and manage soil contamination. Key informants discussed various strategies for developing and disseminating educational materials to gardeners. For some challenges, such as barriers to conducting site history and soil tests, some informants recommended city-wide interventions that bypass the need for gardener knowledge altogether.	[Kim, Brent F.; Margulies, Jared D.; Palmer, Anne M.; Nachman, Keeve E.] Johns Hopkins Ctr Livable Future, Baltimore, MD USA; [Poulsen, Melissa N.] Johns Hopkins Ctr Livable Future, CLF, Baltimore, MD USA; [Kim, Brent F.; Margulies, Jared D.; Palmer, Anne M.; Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Poulsen, Melissa N.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Margulies, Jared D.] Univ Maryland, Dept Geog & Environm Syst, Baltimore, MD 21201 USA; [Dix, Katie L.] Pk & People Fdn, Community Greening Resource Network, Baltimore, MD USA; [Palmer, Anne M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Nachman, Keeve E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nachman, KE (corresponding author), Johns Hopkins Ctr Livable Future, Baltimore, MD USA.	knachman@jhsph.edu		Margulies, Jared/0000-0003-2029-4424; Kim, Brent/0000-0002-3942-0569; Nachman, Keeve/0000-0003-4925-4151	Faculty-Community grant from the Johns Hopkins Urban Health Institute; GRACE Communications Foundation	Faculty-Community grant from the Johns Hopkins Urban Health Institute; GRACE Communications Foundation	This work was funded by a Faculty-Community grant from the Johns Hopkins Urban Health Institute (http://www.urbanhealth.jhu.edu/). The Johns Hopkins Center for a Livable Future is supported by a grant from the GRACE Communications Foundation (but did not provide funding specific to this project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaimo K, 2008, J NUTR EDUC BEHAV, V40, P94, DOI 10.1016/j.jneb.2006.12.003; Andersson E, 2007, ECOL APPL, V17, P1267, DOI 10.1890/06-1116.1; [Anonymous], 2011, BROWNF URB AGR INT G; Armstrong D, 2000, HEALTH PLACE, V6, P319, DOI 10.1016/S1353-8292(00)00013-7; Been V, 2006, REAL ESTATE ECON, V36, P241; BLAIR D, 1991, J NUTR EDUC, V23, P161; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Brown KH, 2000, J PUBLIC HEALTH POL, V21, P20, DOI 10.2307/3343472; CASPERSEN CJ, 1991, AM J EPIDEMIOL, V133, P1078, DOI 10.1093/oxfordjournals.aje.a115821; CHANEY RL, 1984, P S HEAV MET URB GAR, P37; City of Baltimore Health Department, 2010, DAT WATCH MAR DEP EN; Clark HF, 2008, ENVIRON RES, V107, P312, DOI 10.1016/j.envres.2008.03.003; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; Finster ME, 2004, SCI TOTAL ENVIRON, V320, P245, DOI 10.1016/j.scitotenv.2003.08.009; HAGHIRI F, 1973, Journal of Environmental Quality, V2, P93, DOI 10.2134/jeq1973.00472425000200010012x; Harms A.M.R., 2013, J EXT, V51, p1FEA10; Harms AMR, 2011, THESIS KANSAS STATE; Heiger-Bernays W, 2009, INT J SOIL SEDIMENT, V2, P1; Hettiarachchi GM, 2004, ENVIRON PROG, V23, P78, DOI 10.1002/ep.10004; Hughner S. R., 2007, J CONSUM BEHAV, V6, P6, DOI DOI 10.1002/CB; KAPLAN R, 1973, ENVIRON BEHAV, V5, P145, DOI 10.1177/001391657300500202; Kessler R, 2013, ENVIRON HEALTH PERSP, V121, pA326, DOI 10.1289/ehp.121-A326; Kuo FE, 2001, ENVIRON BEHAV, V33, P5, DOI 10.1177/00139160121972846; Kuo FE, 2004, AM J PUBLIC HEALTH, V94, P1580, DOI 10.2105/AJPH.94.9.1580; Kuo FE, 2001, ENVIRON BEHAV, V33, P343, DOI 10.1177/00139160121973025; Kuo FE, 1998, AM J COMMUN PSYCHOL, V26, P823, DOI 10.1023/A:1022294028903; Litt JS, 2011, AM J PUBLIC HEALTH, V101, P1466, DOI 10.2105/AJPH.2010.300111; MAGNUS K, 1979, AM J EPIDEMIOL, V110, P724, DOI 10.1093/oxfordjournals.aje.a112853; Maryland Department of the Environment, 2000, MD ENV, V4; McCormack LA, 2010, J AM DIET ASSOC, V110, P399, DOI 10.1016/j.jada.2009.11.023; Meuser H, 2012, SOIL REMEDIATION REH, P128; Meuser H, 2010, ENVIRON POLLUT SER, V18, P29, DOI 10.1007/978-90-481-9328-8_3; MIELKE HW, 1983, AM J PUBLIC HEALTH, V73, P1366, DOI 10.2105/AJPH.73.12.1366; Morgan R., 2013, SOIL HEAVY METALS HU, P59; Patel I.C., 1991, J EXT, V29; Pouyat RV, 2007, SOIL SCI SOC AM J, V71, P1010, DOI 10.2136/sssaj2006.0164; Ramirez-Andreotta MD, 2013, SCI TOTAL ENVIRON, V443, P299, DOI 10.1016/j.scitotenv.2012.10.095; Scheckel KG, 2013, J TOXICOL ENV HEAL B, V16, P337, DOI 10.1080/10937404.2013.825216; Schwarz K, 2012, ENVIRON POLLUT, V163, P32, DOI 10.1016/j.envpol.2011.12.003; Simons LA, 2006, MED J AUSTRALIA, V184, P68, DOI 10.5694/j.1326-5377.2006.tb00120.x; Twiss J, 2003, AM J PUBLIC HEALTH, V93, P1435, DOI 10.2105/AJPH.93.9.1435; U.S. Census Bureau, 2013, BALT CIT; Wakefield S, 2007, HEALTH PROMOT INT, V22, P92, DOI 10.1093/heapro/dam001; Wells NM, 2000, ENVIRON BEHAV, V32, P775, DOI 10.1177/00139160021972793; Yesilonis ID, 2008, ENVIRON POLLUT, V156, P723, DOI 10.1016/j.envpol.2008.06.010	45	63	64	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87913	10.1371/journal.pone.0087913	http://dx.doi.org/10.1371/journal.pone.0087913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516570	Green Published, Green Accepted, gold			2022-12-27	WOS:000330830700033
J	Laureano, MR; Onishi, ET; Bressan, RA; Castiglioni, MLV; Batista, IR; Reis, MA; Garcia, MV; de Andrade, AN; de Almeida, RR; Garrido, GJ; Jackowski, AP				Laureano, Maura Regina; Onishi, Ektor Tsuneo; Bressan, Rodrigo Affonseca; Vieira Castiglioni, Mario Luiz; Batista, Ilza Rosa; Reis, Marilia Alves; Garcia, Michele Vargas; de Andrade, Adriana Neves; de Almeida, Roberta Ribeiro; Garrido, Griselda J.; Jackowski, Andrea Parolin			Memory Networks in Tinnitus: A Functional Brain Image Study	PLOS ONE			English	Article							HEARING-LOSS; SPECT; NEUROSCIENCE; GENERATION; RESPONSES; PERFUSION; MRI	Tinnitus is characterized by the perception of sound in the absence of an external auditory stimulus. The network connectivity of auditory and non-auditory brain structures associated with emotion, memory and attention are functionally altered in debilitating tinnitus. Current studies suggest that tinnitus results from neuroplastic changes in the frontal and limbic temporal regions. The objective of this study was to use Single-Photon Emission Computed Tomography (SPECT) to evaluate changes in the cerebral blood flow in tinnitus patients with normal hearing compared with healthy controls. Methods: Twenty tinnitus patients with normal hearing and 17 healthy controls, matched for sex, age and years of education, were subjected to Single Photon Emission Computed Tomography using the radiotracer ethylenedicysteine diethyl ester, labeled with Technetium 99 m (99 mTc-ECD SPECT). The severity of tinnitus was assessed using the "Tinnitus Handicap Inventory" (THI). The images were processed and analyzed using "Statistical Parametric Mapping" (SPM8). Results: A significant increase in cerebral perfusion in the left parahippocampal gyrus (pFWE<0.05) was observed in patients with tinnitus compared with healthy controls. The average total THI score was 50.8+18.24, classified as moderate tinnitus. Conclusion: It was possible to identify significant changes in the limbic system of the brain perfusion in tinnitus patients with normal hearing, suggesting that central mechanisms, not specific to the auditory pathway, are involved in the pathophysiology of symptoms, even in the absence of clinically diagnosed peripheral changes.	[Laureano, Maura Regina; Bressan, Rodrigo Affonseca; Batista, Ilza Rosa; Reis, Marilia Alves; de Almeida, Roberta Ribeiro; Jackowski, Andrea Parolin] Univ Fed Sao Paulo, Dept Psiquiatria, LiNC, Sao Paulo, Brazil; [Onishi, Ektor Tsuneo] Univ Fed Sao Paulo, Dept Otorrinolaringol & Cirurgia Cabeca & Pescoco, Sao Paulo, Brazil; [Vieira Castiglioni, Mario Luiz] Univ Fed Sao Paulo, Dept Radiol, Secao Med Nucl, Sao Paulo, Brazil; [Bressan, Rodrigo Affonseca; Batista, Ilza Rosa; Reis, Marilia Alves] Hosp Israelita Albert Einstein, Inst Cerebro, Sao Paulo, Brazil; [Garcia, Michele Vargas; de Andrade, Adriana Neves] Univ Fed Sao Paulo, Dept Fonoaudiol, Sao Paulo, Brazil; [Garrido, Griselda J.] Univ Western Australia, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA 6009, Australia	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade Federal de Sao Paulo (UNIFESP); University of Western Australia	Onishi, ET (corresponding author), Univ Fed Sao Paulo, Dept Otorrinolaringol & Cirurgia Cabeca & Pescoco, Sao Paulo, Brazil.	ektor_onishi@yahoo.com.br	Onishi, Ektor/C-6071-2012; Andrade, Adriana N/B-3934-2013; Onishi, Ektor Tsuneo/R-2193-2019; Bressan, Rodrigo A/E-9178-2010; Jackowski, Andrea P/D-8616-2012	Onishi, Ektor/0000-0003-1501-8409; Andrade, Adriana N/0000-0003-0634-4069; Onishi, Ektor Tsuneo/0000-0003-1501-8409; Bressan, Rodrigo A/0000-0002-0868-4449; Jackowski, Andrea P/0000-0001-8842-5406; Batista, Ilza Rosa/0000-0002-4206-5289; Laureano Rocha, Maura Regina/0000-0002-2342-7555	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP-2010/14804-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support was received from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-2010/14804-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2012, JARO-J ASSOC RES OTO, V13, P715, DOI 10.1007/s10162-012-0340-5; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baizer JS, 2012, BRAIN RES, V1485, P1, DOI 10.1016/j.brainres.2012.10.033; Balkenhol T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053180; De Ridder D., 2013, NEUROSCI BIOBEHAV RE; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Farhadi M, 2010, J CEREBR BLOOD F MET, V30, P864, DOI 10.1038/jcbfm.2009.254; FERREIRA PA, 2005, PRO-FONO REV ATUAL C, V17, P277; Gardner A, 2002, NUCL MED COMMUN, V23, P429, DOI 10.1097/00006231-200205000-00002; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Joos K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040544; Langguth B, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00015; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Mahmoudian S, 2012, J RES MED SCI, V17, P242; Marcondes RA, 2010, EUR J NEUROL, V17, P38, DOI 10.1111/j.1468-1331.2009.02730.x; Maudoux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036222; McCombe A, 2001, CLIN OTOLARYNGOL, V26, P388, DOI 10.1046/j.1365-2273.2001.00490.x; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Morbelli S, 2008, Q J NUCL MED MOL IM, V52, P89; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Norena AJ, 2013, HEARING RES, V295, P161, DOI 10.1016/j.heares.2012.09.010; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Sataloff RT, 1996, AM J OTOL, V17, P909; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Shulman, 1995, Int Tinnitus J, V1, P13; Shulman A, 2000, Int Tinnitus J, V6, P98; Shulman Abraham, 2002, Int Tinnitus J, V8, P30; Shulman Abraham, 2007, Int Tinnitus J, V13, P118; Shulman Abraham, 2006, Int Tinnitus J, V12, P75; Staffen W, 1999, AUDIOLOGY, V38, P53; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Weisz N, 2007, PROG BRAIN RES, V166, P61, DOI 10.1016/S0079-6123(07)66006-3	40	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87839	10.1371/journal.pone.0087839	http://dx.doi.org/10.1371/journal.pone.0087839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516567	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700031
J	Li, C; Su, HH; Qiu, YW; Lv, XF; Shen, S; Zhan, WF; Tian, JZ; Jiang, GH				Li, Cheng; Su, Huan-Huan; Qiu, Ying-Wei; Lv, Xiao-Fei; Shen, Sheng; Zhan, Wen-Feng; Tian, Jun-Zhang; Jiang, Gui-Hua			Regional Homogeneity Changes in Hemodialysis Patients with End Stage Renal Disease: In Vivo Resting-State Functional MRI Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MILD COGNITIVE IMPAIRMENT; PARAMETRIC MAPPING ANALYSIS; ALZHEIMERS-DISEASE; HUMAN BRAIN; NEUROLOGICAL COMPLICATIONS; DEFAULT MODE; FMRI; FAILURE; ABNORMALITIES	Objective: To prospectively investigate and detect early cerebral regional homogeneity (ReHo) changes in neurologically asymptomatic patients with end stage renal disease (ESRD) using in vivo resting-state functional MR imaging (Rs-fMRI). Methods: We enrolled 20 patients (15 men, 5 women; meanage, 37.1 years; range, 19-49 years) with ESRD and 20 healthy controls (15 men, 5 women; mean age, 38.3 years; range, 28-49 years). The mean duration of hemodialysis for the patient group was 10.7 +/- 6.4 monthes. There was no significant sex or age difference between the ESRD and control groups. Rs-fMRI was performed using a gradient-echo echo-planar imaging sequence. ReHo was calculated using software (DPARSF). Voxel-based analysis of the ReHo maps between ESRD and control groups was performed with a two-samples t test. Statistical maps were set at P value less than 0.05 and were corrected for multiple comparisons. The Mini-Mental State Examination (MMSE) was administered to all participants at imaging. Results: ReHo values were increased in the bilateral superior temporal gyrus and left medial frontal gyrus in the ERSD group compared with controls, but a significantly decreased ReHo value was found in the right middle temporal gyrus. There was no significant correlation between ReHo values and the duration of hemodialysis in the ESRD group. Both the patients and control subjects had normal MMSE scores (>= 28). Conclusions: Our finding revealed that abnormal brain activity was distributed mainly in the memory and cognition related cotices in patients with ESRD. The abnormal spontaneous neuronal activity in those areas provide information on the neural mechanisms underlying cognitive impairment in patients with ESRD, and demonstrate that Rs-fMRI with ReHo analysis is a useful non-invasive imaging tool for the detection of early cerebral ReHo changes in hemodialysis patients with ESRD.	[Li, Cheng; Shen, Sheng] Guangdong 2 Prov Peoples Hosp, Dept Renal Transplantat, Guangzhou, Guangdong, Peoples R China; [Su, Huan-Huan; Qiu, Ying-Wei; Zhan, Wen-Feng; Tian, Jun-Zhang; Jiang, Gui-Hua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Lv, Xiao-Fei] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Lv, Xiao-Fei] Sun Yat Sen Univ, Dept Med Imaging & Intervent Radiol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Jiang, GH (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	112662748@qq.com		Tian, Junzhang/0000-0002-6212-1882	Guangdong Provincial Science and Technology [2012B031800170]	Guangdong Provincial Science and Technology	This work was supported by the Guangdong Provincial Science and Technology (Grant number: 2012B031800170). The funders had role in data collection and analysis, decision to publish and preparation of the manuscript.	Agildere AM, 2001, EUR RADIOL, V11, P1063; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chiu ML, 2010, EUR RADIOL, V20, P1502, DOI 10.1007/s00330-009-1673-2; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; DEDEYN PP, 1992, ACTA NEUROL BELG, V92, P191; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; FAZEKAS G, 1995, J NEUROL SCI, V134, P83, DOI 10.1016/0022-510X(95)00226-7; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Glaser G H, 1974, Res Publ Assoc Res Nerv Ment Dis, V53, P173; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Kamata T, 2000, AM J NEPHROL, V20, P27, DOI 10.1159/000013551; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kim CD, 2007, AM J KIDNEY DIS, V50, P98, DOI 10.1053/j.ajkd.2007.03.019; Kim SJ, 2008, ANN NUCL MED, V22, P201, DOI 10.1007/s12149-007-0108-x; Kimmel PL, 1998, AM J MED, V105, P214, DOI 10.1016/S0002-9343(98)00245-9; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Liang PP, 2011, CLIN NEUROPHYSIOL, V122, P121, DOI 10.1016/j.clinph.2010.05.026; Liang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071507; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Pereira Arema A, 2007, Hemodial Int, V11, P309, DOI 10.1111/j.1542-4758.2007.00185.x; Post JB, 2010, NEPHRON CLIN PRACT, V116, pC247, DOI 10.1159/000317206; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Savazzi GM, 2001, NEPHRON, V89, P31, DOI 10.1159/000046040; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P41, DOI 10.1016/S0272-6386(97)90563-1; Song SH, 2008, PSYCHIAT CLIN NEUROS, V62, P554, DOI 10.1111/j.1440-1819.2008.01849.x; Song SH, 2009, PSYCHIAT RES-NEUROIM, V173, P243, DOI 10.1016/j.pscychresns.2008.08.007; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Suzuki M, 1997, STROKE, V28, P2528, DOI 10.1161/01.STR.28.12.2528; Tzamaloukas A H, 2004, Niger J Med, V13, P98; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wu T, 2007, NEUROSCI LETT, V423, P189, DOI 10.1016/j.neulet.2007.06.057; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	46	16	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87114	10.1371/journal.pone.0087114	http://dx.doi.org/10.1371/journal.pone.0087114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516545	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700020
J	Mapstone, GM				Mapstone, Gillian M.			Global Diversity and Review of Siphonophorae (Cnidaria: Hydrozoa)	PLOS ONE			English	Review							SPHAERONECTID CALYCOPHORAN SIPHONOPHORE; APOLEMIA-UVARIA LESUEUR; DEEP-SEA SIPHONOPHORE; LIFE-CYCLE STRATEGY; PHYSONECT SIPHONOPHORE; PRAYINE SIPHONOPHORE; RE-DESCRIPTION; EPIPELAGIC SIPHONOPHORES; GELATINOUS ZOOPLANKTON; WEDDELL SEA	In this review the history of discovery of siphonophores, from the first formal description by Carl Linnaeus in 1785 to the present, is summarized, and species richness together with a summary of world-wide distribution of this pelagic group within the clade Hydrozoa discussed. Siphonophores exhibit three basic body plans which are briefly explained and figured, whilst other atypical body plans are also noted. Currently, 175 valid siphonophore species are recognized in the latest WoRMS world list, including 16 families and 65 genera. Much new information since the last review in 1987 is revealed from the first molecular analysis of the group, enabling identification of some new morphological characters diagnostic for physonect siphonophores. Ten types of nematocysts (stinging cells) are identified in siphonophores, more than in any other cnidarian; these are incorporated into batteries in the side branches of the tentacles in most species (here termed tentilla), and tentilla are reviewed in the last section of this paper. Their discharge mechanisms are explained and also how the tentilla of several physonect siphonophores are modified into lures. Of particular interest is the recent discovery of a previously unknown red fluorescent lure in the tentilla of the deep sea physonect Erenna, the first described example of emission of red light by an invertebrate to attract prey.	Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Natural History Museum London	Mapstone, GM (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	g.mapstone@nhm.ac.uk						Alvarino A, 1971, B SCRIPPS I OCEANOGR, V16; ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; [Anonymous], 2005, SYST BIODIVERS, DOI [DOI 10.1017/S1477200004001513, 10.1017/S1477200004001513]; [Anonymous], 2005, SYSTEMATICS BIODIVER; Bamstedt U, 1998, SARSIA, V83, P79, DOI 10.1080/00364827.1998.10413673; Bardi J, 2007, IHERINGIA SER ZOOL, V97, P425, DOI 10.1590/S0073-47212007000400011; Bedot M., 1904, RESULTATS CAMPAGNES, V27, P1; BIDIGARE RR, 1980, COMP BIOCHEM PHYS A, V66, P467, DOI 10.1016/0300-9629(80)90193-0; Bigelow H. B., 1918, Bulletin of the Museum of Comparative Zoology, V62; Bigelow H. B., 1911, Transactions of the Linnean Society London, V10; BIGELOW HB, 1911, MEM MUS COMP ZOOL, V38, P173; BIGELOW HENRY B., 1931, ZOOLOGICA [NEW YORK], V8, P525; BIGGS D C, 1978, Beaufortia, V27, P207; BIGGS DC, 1978, B MAR SCI, V28, P537; BIGGS DC, 1977, MAR BEHAV PHYSIOL, V4, P261, DOI 10.1080/10236247709386958; Bouillon J, 2004, SCI MAR, V68, P5, DOI 10.3989/scimar.2004.68s25; CARRE C, 1979, ANN I OCEANOGR PARIS, V55, P27; CARRE C, 1991, PHILOS T ROY SOC B, V334, P27, DOI 10.1098/rstb.1991.0095; CARRE C, 1973, EXP CELL RES, V81, P237, DOI 10.1016/0014-4827(73)90130-4; Carre C, 1969, CAH BIOL MAR, V10, P71; Carre C, 1969, BEAUFORTIA, V214, P109; Carre C, 1968, BEAUFORTIA, V16, P79; Carre C, 1969, MILIEU PARIS, V20, P30; CARRE D, 1969, CAH BIOL MAR, V10, P325; CARRE D, 1971, CAH BIOL MAR, V12, P77; CARRE D, 1967, CAH BIOL MAR, V8, P233; CARRE D, 1974, Annales d'Embryologie et de Morphogenese, V7, P205; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Chun C, 1891, ABH SENCKENB NAT, V16, P553; Chun C., 1897, SIPHONOPHOREN PLANKT; Chun C., 1892, ABH SENCKENB NAT, V18, P57; Chun C., 1888, ANN MAGAZINE NATURAL, V3, P214, DOI [10.1080/00222938909460321, DOI 10.1080/00222938909460321]; Chun C, 1886, SITZUNGSBER PREUSS A, V1886, P681; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Collins Allen G., 2009, Smithsonian Contributions to the Marine Sciences, P139; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dunn CW, 2006, DEV GENES EVOL, V216, P743, DOI 10.1007/s00427-006-0101-8; Dunn CW, 2005, SYST BIOL, V54, P916, DOI 10.1080/10635150500354837; Dunn CW, 2005, DEV DYNAM, V234, P835, DOI 10.1002/dvdy.20483; Dunn CW, 2005, B MAR SCI, V76, P699; Eschscholtz F, 1829, SYSTEM ACALEPHEN AUS; Fautin DG, 2009, TOXICON, V54, P1054, DOI 10.1016/j.toxicon.2009.02.024; Fewkes J.W., 1881, B MUS COMP ZOOL HARV, V8, P141; Fewkes JW, 1888, B MUS COMP ZOOL HARV, V13, P209; GARSTANG W, 1946, Q J MICROSC SCI, V87, P103; Gibbons MJ, 2010, J BIOGEOGR, V37, P606, DOI 10.1111/j.1365-2699.2009.02237.x; Gibbons MJ, 2010, J BIOGEOGR, V37, P441, DOI 10.1111/j.1365-2699.2009.02226.x; Grossmann MM, 2013, SYST BIODIVERS, V11, P381, DOI 10.1080/14772000.2013.825658; Grossmann MM, 2013, J OCEANOGR, V69, P395, DOI 10.1007/s10872-013-0181-9; Grossmann MM, 2013, MAR ECOL-EVOL PERSP, V34, P63, DOI 10.1111/maec.12026; Grossmann MM, 2012, POLAR SCI, V6, P196, DOI 10.1016/j.polar.2011.11.001; Haddock SH., 2006, PHOTOPROTEIN BIONALA, P25; Haddock SHD, 2005, J MAR BIOL ASSOC UK, V85, P695, DOI 10.1017/S0025315405011616; Haddock SHD, 2005, SCIENCE, V309, P263, DOI 10.1126/science.1110441; Haddock SHD, ANGLER JELLYFISH BIO; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Haeckel E, 1888, REPORT SIPHONOPHORAE, V28; Hessinger D.A., 1988, P75; Hiscock K, 2010, MARINE BIODIVERSITY, V3, P1; Hissmann K, 1995, OCEANOL ACTA, V18, P671; Huxley T.H., 1859, OCEANIC HYDROZOA DES; ICZN, 2006, B ZOOL NOMENCLATURE, V63, P207; Kawamura T, 1911, ZOOL MAG TOKYO, V23, P359; Kawamura T, 1911, ZOOL MAG TOKYO, V23, P309; Kawamura T., 1910, ZOOL MAG TOKYO DOBUT, V22, P445; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Keferstein W, 1860, NACHR GES WISS GOTT, V23, P254; Keferstein W., 1861, ZOOLOGISCHE BEITRAGE; Kirkpatrick P.A., 1984, SYNOPSES BRIT FAUNA, V29; Kolliker A, 1853, SCHWIMMPOLYPEN ODER; Kramp P, 1942, MEDD GRONLAND, V80, P3; Leloup E., 1929, Archives de Biologie Liege, V39, P397; Lens A. D., 1908, SIBOGA EXPED, V9, P1, DOI [10.5962/bhl.title.16085, DOI 10.5962/BHL.TITLE.16085]; Lindsay D.J., 2009, KAIYO MONTHLY, V41, P417; Lindsay Dhugal J., 2011, Plankton & Benthos Research, V6, P101; Linnaeus C, 1758, SYSTEMA NATURAE; MACKIE G. O., 1959, TRANS ROY SOC CANADA SECT 5 SER 3, V53, P7; MACKIE GO, 1964, PROC R SOC SER B-BIO, V159, P366, DOI 10.1098/rspb.1964.0008; MACKIE GO, 1988, ZOOMORPHOLOGY, V108, P85, DOI 10.1007/BF00539784; Mackie GO, 1999, MAR FRESHW BEHAV PHY, V32, P113, DOI 10.1080/10236249909379043; MACKIE GO, 1987, ADV MAR BIOL, V24, P97; Mackie GO., 1960, DISCOVERY REPORTS, V30, P371; Mapstone G.M., 1998, Zoologische Verhandelingen (Leiden), V323, P141; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI; Mapstone Gilian M., 2003, Systematics and Biodiversity, V1, P181, DOI 10.1017/S1477200003001166; Mapstone Gillian M., 2004, Bulletin of Zoological Nomenclature, V61, P149; Mapstone GM, 2013, MAR ECOL-EVOL PERSP, V34, P96, DOI 10.1111/maec.12029; Mapstone GM, 2004, HYDROBIOLOGIA, V530, P231, DOI 10.1007/s10750-004-2677-1; Mapstone GM, 2005, J MAR BIOL ASSOC UK, V85, P709, DOI 10.1017/S0025315405011628; MARGULIS RY, 1993, ZOOL ZH, V72, P14; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Mills CE, 1996, SCI MAR, V60, P145; MOSER F., 1925, ZOOLOGIE, V9, P1; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Ortman BD, 2010, DEEP-SEA RES PT II, V57, P2148, DOI 10.1016/j.dsr2.2010.09.017; Ostman C, 2000, SCI MAR, V64, P31; Pages F, 1996, MAR ECOL PROG SER, V141, P139, DOI 10.3354/meps141139; PAGES F, 1994, POLAR BIOL, V14, P243; Pages F, 1996, J MARINE SYST, V9, P231, DOI 10.1016/S0924-7963(96)00047-4; PAGES F, 1994, J MAR BIOL ASSOC UK, V74, P873, DOI 10.1017/S0025315400090111; PAGES F, 1989, Scientia Marina, V53, P53; Pages F, 2002, ACTA ZOOL-STOCKHOLM, V83, P329, DOI 10.1046/j.1463-6395.2002.00124.x; Pages Frances, 1992, Scientia Marina, V56, P65; Pages Frances, 1992, Scientia Marina, V56, P1; Pages F, 2006, SCI MAR, V70, P363, DOI 10.3989/scimar.2006.70n3363; Peterson KJ, 2008, PHILOS T R SOC B, V363, P1435, DOI 10.1098/rstb.2007.2233; PICKWELL GV, 1964, SCIENCE, V144, P860, DOI 10.1126/science.144.3620.860; Plachetzki DC, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-17; Pugh PR, 2006, ZOOTAXA, P1; Pugh PR, 2006, J MAR BIOL ASSOC UK, V86, P997, DOI 10.1017/S002531540601397X; Pugh P.R., 1999, Bulletin of the Natural History Museum Zoology Series, V65, P51; Pugh P.R., 2001, Bulletin of the Natural History Museum Zoology Series, V67, P169; Pugh PR, 2010, J MAR BIOL ASSOC UK, V90, P1119, DOI 10.1017/S0025315409990543; Pugh PR, 2009, ZOOTAXA, P1; Pugh P.R., 1989, Progress in Underwater Science, V14, P67; Pugh Phil R., 1999, P467; PUGH PR, 1993, J MAR BIOL ASSOC UK, V73, P595, DOI 10.1017/S0025315400033130; Pugh PR, 1997, SCI MAR, V61, P153; PUGH PR, 1992, J MAR BIOL ASSOC UK, V72, P895, DOI 10.1017/S0025315400060136; PUGH PR, 1992, PHILOS T ROY SOC B, V335, P281, DOI 10.1098/rstb.1992.0023; PUGH PR, 1988, J MAR BIOL ASSOC UK, V68, P1, DOI 10.1017/S0025315400050050; PUGH PR, 1986, J MAR BIOL ASSOC UK, V66, P695, DOI 10.1017/S0025315400042296; PUGH PR, 1995, B MAR SCI, V57, P453; PUGH PR, 1992, B MAR SCI, V50, P89; Pugh PR, 1998, SCI MAR, V62, P233; Pugh PR, 2003, J NAT HIST, V37, P1281, DOI 10.1080/00222930110120638; PUGH PR, 1988, J PLANKTON RES, V10, P637, DOI 10.1093/plankt/10.4.637; PUGH PR, 1987, B MAR SCI, V41, P68; PUGH PR, 1995, SCI MAR, V59, P181; PUGH PR, 1991, HYDROBIOLOGIA, V216, P327, DOI 10.1007/BF00026482; PUGH PR, 1983, PHILOS T ROY SOC B, V301, P165, DOI 10.1098/rstb.1983.0025; PURCELL JE, 1980, SCIENCE, V209, P1045, DOI 10.1126/science.209.4460.1045; PURCELL JE, 1981, MAR BIOL, V65, P83, DOI 10.1007/BF00397071; PURCELL JE, 1981, LIMNOL OCEANOGR, V26, P424, DOI 10.4319/lo.1981.26.3.0424; PURCELL JE, 1984, BIOL BULL, V166, P310, DOI 10.2307/1541219; Quoy J., 1833, ZOOLOGIE, V4, P1; Quoy JRC, 1827, VOYAGE COUVERTES LAS, V10, P172; Quoy JRC, 1827, VOYAGE COUVERTES LAS, V10, P1; Richter Walter, 1907, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V86; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; Robson EA, 1973, NATURE, V244, P187; RUSSELL F. S., 1939, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V23, P347; SEARS M., 1953, BULL MUS COMP ZOOL, V109, P1; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Siebert S, 2013, ZOOTAXA, V3702, P201, DOI 10.11646/zootaxa.3702.3.1; Siebert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022953; Skaer R.J., 1988, P165; Steele RE, 2011, TRENDS GENET, V27, P7, DOI 10.1016/j.tig.2010.10.002; Stepanjants S. D., 1967, OPREDELITELI FAUNE S, V96, P1; Thibault-Botha D, 2005, AFR J MAR SCI, V27, P129, DOI 10.2989/18142320509504073; Totton A. K., 1932, Scientific Reports Great Barrier Reef Expedition, V4, P317; Totton A. K., 1960, Discovery Reports, V30, P301; Totton A. K., 1954, Discovery Reports, V27, P1; TOTTON A. K., 1955, DEEP SEA RES, V3, P239; Totton AK, 1965, SYNOPSIS SIPHONOPHOR; VOGT C, 1854, MEMOIRES I NATL GENE, V1, P1; WEILL ROBERT, 1934, TRAV STAT ZOOL WIMEREUX, V10, P1; WERNER B, 1965, HELGOLAND WISS MEER, V12, P1, DOI 10.1007/BF01612091; Will L, 1909, SITZB ABHAND NATURFO, V1, P33; Winsor MP, 1971, P ROY SOC EDINB B, V73, P315; Wrobel D, PHYSOPHORA HYDROSTAT	162	72	75	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87737	10.1371/journal.pone.0087737	http://dx.doi.org/10.1371/journal.pone.0087737			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516560	Green Published, gold			2022-12-27	WOS:000330830700028
J	Memish, ZA; Fagbo, SF; Ali, AO; AlHakeem, R; Elnagi, FM; Bamgboye, EA				Memish, Ziad A.; Fagbo, Shamsudeen F.; Ali, Ahmed Osman; AlHakeem, Rafat; Elnagi, Fathelrhman M.; Bamgboye, Elijah A.			Is the Epidemiology of Alkhurma Hemorrhagic Fever Changing? : A Three-Year Overview in Saudi Arabia	PLOS ONE			English	Article							VIRUS; INFECTION; EVOLUTION; HUMANS; NAJRAN; EGYPT	Background: The epidemiology of Alkhurma hemorrhagic fever disease is yet to be fully understood since the virus was isolated in 1994 in the Kingdom of Saudi Arabia. Setting: Preventive Medicine department, Ministry of Health, Kingdom of Saudi Arabia. Design: Retrospective analysis of all laboratory confirmed cases of Alkhurma hemorrhagic fever disease collected through active and passive surveillance from 1st-January 2009 to December, 31, 2011. Results: Alkhurma hemorrhagic fever (AHFV) disease increased from 59 cases in 2009 to 93 cases in 2011. Cases are being discovered outside of the region where it was initially diagnosed in Saudi Arabia. About a third of cases had no direct contact with animals or its products. Almost all cases had gastro-intestinal symptoms. Case fatality rate was less than 1%. Conclusions: Findings in this study showed the mode of transmission of AHFV virus may not be limited to direct contact with animals or its products. Gastro-intestinal symptoms were not previously documented. Observed low case fatality rate contradicted earlier reports. Close monitoring of the epidemiology of AHFV is recommended to aid appropriate diagnosis. Housewives are advised to wear gloves when handling animals and animal products as a preventive measure.	[Memish, Ziad A.; Fagbo, Shamsudeen F.; Ali, Ahmed Osman; AlHakeem, Rafat; Bamgboye, Elijah A.] Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia; [Elnagi, Fathelrhman M.] Minist Hlth, Najran, Saudi Arabia; [Memish, Ziad A.] Al Faisal Univ, Coll Med, Riyadh, Saudi Arabia; [Bamgboye, Elijah A.] Univ Ibadan, Dept Med Stat & Epidemiol, Ibadan, Nigeria	Ministry of Health - Saudi Arabia; Alfaisal University; University of Ibadan	Memish, ZA (corresponding author), Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022; Fagbo, Shamsudeen/GYE-1971-2022	Memish, Ziad Ahmed/0000-0002-5099-0714; Fagbo, Shamsudeen/0000-0003-3448-6136				Alzahrani AG, 2010, EMERG INFECT DIS, V16, P1882, DOI 10.3201/eid1612.100417; [Anonymous], 1968, IBM STAT PACK SOC SC; Carletti F, 2010, EMERG INFECT DIS, V16, P1979, DOI 10.3201/eid1612.101092; Charrel RN, 2007, EMERG INFECT DIS, V13, P153, DOI 10.3201/eid1301.061094; Charrel RN, 2011, EMERG INFECT DIS, V17, P1573, DOI 10.3201/eid1708.101858; Charrel Remi N., 2008, P179, DOI 10.1007/978-0-387-75722-3_11; Charrel RN, 2005, EMERG INFECT DIS, V11, P683, DOI 10.3201/eid1105.041298; Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610; Dodd KA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001352; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Hoogstraal H., 1981, Fauna of Saudi Arabia, V3, P25; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Madani TA, 2005, J INFECTION, V51, P91, DOI 10.1016/j.jinf.2004.11.012; Madani TA, 2010, J INFECTION, P1; Madani TA, 2012, ARCH VIROL, V157, P819, DOI 10.1007/s00705-012-1237-7; Madani TA, 2012, T ROY SOC TROP MED H, V106, P180, DOI 10.1016/j.trstmh.2011.11.003; Mahdi M, 2011, EMERG INFECT DIS, V17, P945, DOI 10.3201/eid1705.101824; Memish ZA, 2005, BRIT J BIOMED SCI, V62, P37, DOI 10.1080/09674845.2005.11978070; Memish ZA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001604; Memish ZA, 2011, EMERG INFECT DIS, V17, P2316, DOI 10.3201/eid1712.110658; Memish ZA, 2010, INT J ANTIMICROB AG, V36, pS53, DOI 10.1016/j.ijantimicag.2010.06.022; Venturi G, 2009, J MED VIROL, V81, P665, DOI 10.1002/jmv.21431; Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7	24	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e85564	10.1371/journal.pone.0085564	http://dx.doi.org/10.1371/journal.pone.0085564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516520	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700003
J	Selao, TT; Zhang, LF; Arioz, C; Wieslander, A; Norling, B				Selao, Tiago Toscano; Zhang, Lifang; Arioz, Candan; Wieslander, Ake; Norling, Birgitta			Subcellular Localization of Monoglucosyldiacylglycerol Synthase in Synechocystis sp PCC6803 and Its Unique Regulation by Lipid Environment	PLOS ONE			English	Article							ACHOLEPLASMA-LAIDLAWII; SULFOQUINOVOSYL DIACYLGLYCEROL; MEMBRANE-LIPIDS; PHOSPHORUS LIMITATION; GLUCOLIPID SYNTHESIS; PLASMA-MEMBRANE; PHOTOSYSTEM-II; CYANOBACTERIUM; BIOSYNTHESIS; ENZYME	Synthesis of monogalactosyldiacylglycerol (GalDAG) and digalactosyldiacylglycerol (GalGalDAG), the major membrane lipids in cyanobacteria, begins with production of the intermediate precursor monoglucosyldiacylglycerol (GlcDAG), by monoglucosyldiacylglycerol synthase (MGS). In Synechocystis sp. PCC6803 (Synechocystis) this activity is catalyzed by an integral membrane protein, Sll1377 or MgdA. In silico sequence analysis revealed that cyanobacterial homologues of MgdA are highly conserved and comprise a distinct group of lipid glycosyltransferases. Global regulation of lipid synthesis in Synechocystis and, more specifically, the influence of the lipid environment on MgdA activity have not yet been fully elucidated. Therefore, we purified membrane subfractions from this organism and assayed MGS activity in vitro, with and without different lipids and other potential effectors. Sulfoquinovosyldiacylglycerol (SQDAG) potently stimulates MgdA activity, in contrast to other enzymes of a similar nature, which are activated by phosphatidylglycerol instead. Moreover, the final products of galactolipid synthesis, GalDAG and GalGalDAG, inhibited this activity. Western blotting revealed the presence of MgdA both in plasma and thylakoid membranes, with a high specific level of the MgdA protein in the plasma membrane but highest MGS activity in the thylakoid membrane. This discrepancy in the subcellular localization of enzyme activity and protein may indicate the presence of either an unknown regulator and/or an as yet unidentified MGS-type enzyme. Furthermore, the stimulation of MgdA activity by SQDAG observed here provides a new insight into regulation of the biogenesis of both sulfolipids and galactolipids in cyanobacteria.	[Selao, Tiago Toscano; Zhang, Lifang; Norling, Birgitta] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Arioz, Candan; Wieslander, Ake] Stockholm Univ, Arrhenius Labs, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stockholm University	Norling, B (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ibnorling@ntu.edu.sg	Selao, Tiago/AAX-4709-2021		NTU (Singapore) [M4080306]; Swedish Foundation for Strategic Research (SSF)	NTU (Singapore)(Nanyang Technological University); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	The authors acknowledge financing by grant M4080306 from NTU (Singapore, www.ntu.edu.sg) to BN, and by the Swedish Foundation for Strategic Research (SSF, www.stratresearch.com) to the Center for Biomembrane Research (CBR, www.cbr.su.se), on behalf of AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz LD, 2008, P NATL ACAD SCI USA, V105, P5803, DOI 10.1073/pnas.0800981105; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Andersson MX, 2001, PLANT PHYSIOL, V127, P184, DOI 10.1104/pp.127.1.184; Andres E, 2011, J BIOL CHEM, V286, P35367, DOI 10.1074/jbc.M110.214148; Aoki M, 2004, EUR J BIOCHEM, V271, P685, DOI 10.1111/j.1432-1033.2003.03970.x; Aoki Motohide, 2012, BMC Res Notes, V5, P98, DOI 10.1186/1756-0500-5-98; Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Awai K, 2007, PLANT CELL PHYSIOL, V48, P1517, DOI 10.1093/pcp/pcm134; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogos B, 2010, PHOTOSYNTH RES, V103, P19, DOI 10.1007/s11120-009-9497-0; DAHLQVIST A, 1992, BIOCHIM BIOPHYS ACTA, V1105, P131, DOI 10.1016/0005-2736(92)90171-H; DAHLQVIST A, 1995, BIOCHEMISTRY-US, V34, P13381, DOI 10.1021/bi00041a015; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Elkehal R, 2012, BBA-MOL CELL RES, V1823, P1033, DOI 10.1016/j.bbamcr.2012.02.020; Frentzen M, 2004, CURR OPIN PLANT BIOL, V7, P270, DOI 10.1016/j.pbi.2004.03.001; Furukawa Tomoyuki, 2006, J Oleo Sci, V56, P43; Geske T, 2012, GLYCOBIOLOGY; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Horvath I, 2012, PROG LIPID RES, V51, P208, DOI 10.1016/j.plipres.2012.02.002; Huang F, 2002, MOL CELL PROTEOMICS, V1, P956, DOI 10.1074/mcp.M200043-MCP200; Juntarajumnong W, 2007, ARCH MICROBIOL, V188, P389, DOI 10.1007/s00203-007-0259-0; KARLSSON OP, 1994, J BIOL CHEM, V269, P23484; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; LINDBLOM G, 1986, BIOCHEMISTRY-US, V25, P7502, DOI 10.1021/bi00371a037; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Mizushina Y, 2008, BIOCHIMIE, V90, P947, DOI 10.1016/j.biochi.2008.02.018; Nilsson L, 2010, PHYSIOL PLANTARUM, V139, P129, DOI 10.1111/j.1399-3054.2010.01356.x; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; OMATA T, 1986, PLANT CELL PHYSIOL, V27, P485; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pisareva T, 2011, J PROTEOME RES, V10, P3617, DOI 10.1021/pr200268r; Rengstl B, 2012, PLANTA; SATO N, 1982, PLANT CELL PHYSIOL, V23, P1115; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P1697, DOI 10.1016/j.biortech.2010.08.007; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; Shimojima M, 2009, FEBS LETT, V583, P2372, DOI 10.1016/j.febslet.2009.06.033; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Stengel A, 2012, PLANT CELL, V24, P660, DOI 10.1105/tpc.111.093914; Suzuki S, 2004, J BIOL CHEM, V279, P13234, DOI 10.1074/jbc.M313358200; van de Meene AML, 2006, ARCH MICROBIOL, V184, P259, DOI 10.1007/s00203-005-0027-y; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Vikstrom S, 2000, J BIOL CHEM, V275, P9296, DOI 10.1074/jbc.275.13.9296; Westphal S, 2001, FEBS LETT, V506, P257, DOI 10.1016/S0014-5793(01)02931-3; Zulkifli L, 2010, J BACTERIOL, V192, P5063, DOI 10.1128/JB.00569-10	55	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88153	10.1371/journal.pone.0088153	http://dx.doi.org/10.1371/journal.pone.0088153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516600	Green Published, gold			2022-12-27	WOS:000330830700049
J	Cumming, K; Hoyle, GE; Hutchison, JD; Soiza, RL				Cumming, Kirsten; Hoyle, Graeme E.; Hutchison, James D.; Soiza, Roy L.			Prevalence, Incidence and Etiology of Hyponatremia in Elderly Patients with Fragility Fractures	PLOS ONE			English	Article							PROGNOSTIC IMPLICATIONS; HIP FRACTURE; ELECTROLYTE; ASSOCIATION; ENCEPHALOPATHY; MANAGEMENT; PEOPLE; RISK	Introduction: Hyponatremia (serum sodium <135 mMol/L) is the commonest electrolyte imbalance encountered in clinical practice. It is associated with multiple poor clinical outcomes including increased mortality, longer hospital stay, falls and fractures. Prevalence is higher in frail patient groups, and elderly patients with fragility fractures (EPFF) are particularly susceptible. Euvolemic hyponatremia due to syndrome of inappropriate anti-diuretic hormone (SIADH) is widely assumed to be the commonest cause. However, little is known about the epidemiology and etiology of hyponatremia in EPFF. This study established prevalence, incidence and etiology of hyponatremia in EPFF. Methods: Prospective observational study of consenting adults aged >= 65 years admitted with a fragility fracture to a university hospital between 7th January and 4th April 2013. Prevalence of hyponatremia on admission and incidence of cases developing in hospital were reported. Etiology of cases of hyponatremia was determined by consensus of an expert panel using pre-specified data collected daily. Results: 127/212 (60%) EPFF were recruited (mean age 79 yrs, 78% female). Two participants withdrew mid-study. Of those not recruited, 66 had incapacity to consent and 19 refused participation. Point prevalence of hyponatremia on admission was 13.4% and a further 12.6% developed hyponatremia during admission. Hypovolemic hyponatremia was predominant (70%). 73% of cases were multi-factorial in etiology. The commonest potentially causative factors in cases of hyponatremia were thiazide diuretics (76%), dehydration (70%), proton pump inhibitors (70%), SIADH (27%) and mirtazapine (15%). Conclusion: Hyponatremia is highly prevalent in EPFF, seen in 26% of cases. Dehydration and prescription of thiazide diuretics and proton pump inhibitors were the commonest potentially causative factors, not SIADH.	[Cumming, Kirsten; Hoyle, Graeme E.; Soiza, Roy L.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Hutchison, James D.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Soiza, RL (corresponding author), Aberdeen Royal Infirm, Aberdeen, Scotland.	roy.soiza@nhs.net	, roysoiza/Q-3525-2019	, roysoiza/0000-0002-1397-4272	NRS Research Fellowship	NRS Research Fellowship	Dr Soiza is funded by an NRS Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYUS JC, 1987, NEW ENGL J MED, V317, P1190, DOI 10.1056/NEJM198711053171905; Ayus JC, 2000, ANN INTERN MED, V132, P711, DOI 10.7326/0003-4819-132-9-200005020-00005; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Ayus JC, 2010, CLIN J AM SOC NEPHRO, V5, P167, DOI 10.2215/CJN.09281209; Barsony J, 2013, AGE, V35, P271, DOI 10.1007/s11357-011-9347-9; Beloosesky Y, 2011, ARCH GERONTOL GERIAT, V53, P179, DOI 10.1016/j.archger.2010.10.014; Boscoe Audra, 2006, Cost Eff Resour Alloc, V4, P10, DOI 10.1186/1478-7547-4-10; Ayus JC, 2012, NEPHROL DIAL TRANSPL, V27, P3725, DOI 10.1093/ndt/gfs412; Chua M, 2007, ARCH GERONTOL GERIAT, V45, P253, DOI 10.1016/j.archger.2006.11.002; Chung HM, 1986, SURV ANESTHESIOL, V30, P292; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; Clayton JA, 2006, BRIT J CLIN PHARMACO, V61, P87, DOI 10.1111/j.1365-2125.2005.02531.x; DURST RY, 1994, AM J MED, V97, P400, DOI 10.1016/0002-9343(94)90313-1; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; Gosch M, 2012, GERONTOLOGY, V58, P430, DOI 10.1159/000339100; Hamzat H, 2012, DRUG AGING, V29, P681, DOI 10.2165/11632700-000000000-00000; Hoorn EJ, 2011, J BONE MINER RES, V26, P1822, DOI 10.1002/jbmr.380; Hoyle GE, 2011, QJM-INT J MED, V104, P35, DOI 10.1093/qjmed/hcq157; INCALZI RA, 1993, AGE AGEING, V22, P325, DOI 10.1093/ageing/22.5.325; Kengne FG, 2008, QJM-INT J MED, V101, P583, DOI 10.1093/qjmed/hcn061; Kinsella S, 2010, CLIN J AM SOC NEPHRO, V5, P275, DOI 10.2215/CJN.06120809; Mann SJ, 2008, J CLIN HYPERTENS, V10, P477, DOI 10.1111/j.1751-7176.2008.08126.x; McPherson E, 2002, SCOT MED J, V47, P115, DOI 10.1177/003693300204700506; Movig KLL, 2002, BRIT J CLIN PHARMACO, V53, P363, DOI 10.1046/j.1365-2125.2002.01550.x; Renneboog B., 2006, AM J MED, V119, p71.E1, DOI 10.1016/j.amjmed.2005.09.026; Rosholm JU, 2002, DRUG AGING, V19, P685, DOI 10.2165/00002512-200219090-00005; Saeed BO, 2002, J CLIN PATHOL, V55, P893, DOI 10.1136/jcp.55.12.893; Sandhu HS, 2009, INT UROL NEPHROL, V41, P733, DOI 10.1007/s11255-009-9585-2; Shapiro DS, 2010, INTERN MED J, V40, P574, DOI 10.1111/j.1445-5994.2010.02217.x; Soiza RL, 2011, INTERN MED J, V41, P295, DOI 10.1111/j.1445-5994.2010.02388.x; Soiza RL, 2008, REV CLIN GERONTOL, V18, P143, DOI 10.1017/S0959259809002822; Soiza RL, 2011, THER ADV DRUG SAF, V2, P9, DOI 10.1177/2042098610394233; Tambe AA, 2003, INJURY, V34, P253, DOI 10.1016/S0020-1383(02)00256-5; Tolouian R, 2012, J NEPHROL, V25, P789, DOI 10.5301/jn.5000064; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513; Wilkinson TJ, 1999, BRIT J CLIN PHARMACO, V47, P211, DOI 10.1046/j.1365-2125.1999.00872.x	41	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88272	10.1371/journal.pone.0088272	http://dx.doi.org/10.1371/journal.pone.0088272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505459	Green Published, gold			2022-12-27	WOS:000330829200161
J	Ellam, T; Fotheringham, J; Wilkie, ME; Francis, SE; Chico, TJA				Ellam, Timothy; Fotheringham, James; Wilkie, Martin E.; Francis, Sheila E.; Chico, Timothy J. A.			Bone Mineral Metabolism Parameters and Urinary Albumin Excretion in a Representative US Population Sample	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; PARATHYROID-HORMONE LEVELS; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; SURVEY NHANES-III; CARDIOVASCULAR-DISEASE; PRIMARY HYPERPARATHYROIDISM; GENERAL-POPULATION; ALKALINE-PHOSPHATASE; SERUM PHOSPHORUS	Background and Hypothesis: Even within accepted normal ranges, higher serum phosphorus, dietary phosphorus density, parathyroid hormone (PTH) and alkaline phosphatase (ALP) are independent predictors of cardiovascular mortality. Lower serum 25-hydroxy vitamin D (25(OH)D) also predicts adverse cardiovascular outcomes. We hypothesized that vascular dysfunction accompanying subtle disturbances of these bone metabolism parameters would result in associations with increased low grade albuminuria. Study Population and Measures: We examined participants in the National Health and Nutrition Examination Surveys 1999-2010 (N = 19,383) with estimated glomerular filtration rate (eGFR) >= 60 ml/min/1.73 m(2) and without severe albuminuria (urine albumin: creatinine ratio (ACR) <300 mg/g). Albuminuria was quantified as ACR and fractional albumin excretion (FEalb). Results: Increasing quintiles of dietary phosphorus density, serum phosphorus and ALP were not associated with higher ACR or FEalb. The lowest versus highest quintile of 25(OH)D was associated with greater albuminuria, but not after adjustment for other covariates including cardiovascular risk factors. An association between the highest versus lowest quintile of bone-specific ALP and greater ACR persisted after covariate adjustment, but was not accompanied by an independent association with FEalb. Increasing quintiles of PTH demonstrated associations with both higher ACR and FEalb that were not abolished by adjusting for covariates including age, gender, race, body mass index, diabetes, blood pressure, history of cardiovascular disease, smoking, eGFR, 25(OH)D, season of measurement, lipids, hemoglobin and C-reactive protein. Adjusted increases in ACR and FEalb associated with the highest versus lowest quintile of PTH were 19% (95% confidence interval 7-28% p<0.001) and 17% (8-31% p = 0.001) respectively. Conclusion: In this population, of the bone mineral parameters associated with cardiovascular outcomes, only PTH is independently associated with ACR and FEalb.	[Ellam, Timothy; Francis, Sheila E.; Chico, Timothy J. A.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Ellam, Timothy; Fotheringham, James; Wilkie, Martin E.] Sheffield Kidney Inst, Sheffield, S Yorkshire, England; [Fotheringham, James] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Ellam, T (corresponding author), Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England.	T.Ellam@sheffield.ac.uk		Francis, Sheila/0000-0001-6552-0339; Chico, Timothy/0000-0002-7458-5481	British Heart Foundation [TE FS/11/74/29015]; British Heart Foundation [FS/11/74/29015] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a British Heart Foundation (www.bhf.org.uk) Clinical Research Training Fellowship to TE FS/11/74/29015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz M, CLIN J AM SOC NEPHRO, V5, P1064; Andersson P, 2004, EUR HEART J, V25, P1776, DOI 10.1016/j.ehj.2004.07.010; Calvo MS, 2013, AM J CLIN NUTR, V98, P6, DOI 10.3945/ajcn.112.053934; Centers for Disease Control and Prevention, 2010, NHANES AN GUID; Chang A, 2013, AM J KIDNEY DIS, V62, P900, DOI 10.1053/j.ajkd.2013.04.022; Chang AR, 2013, AM J CLIN NUTR; de Boer IH, 2007, AM J KIDNEY DIS, V50, P69, DOI 10.1053/j.ajkd.2007.04.015; de Boer IH, 2009, AM J KIDNEY DIS, V53, P399, DOI 10.1053/j.ajkd.2008.07.036; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Drechsler C, 2011, CLIN J AM SOC NEPHRO, V6, P1752, DOI 10.2215/CJN.10091110; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Ellam TJ, 2011, NEPHRON CLIN PRACT, V118, pC217, DOI 10.1159/000321687; Filipowicz R, 2013, CLIN J AM SOC NEPHRO, V8, P26, DOI 10.2215/CJN.12031111; Forman JP, 2012, CIRCULATION, V125, P3108, DOI 10.1161/CIRCULATIONAHA.112.096115; Fotheringham J, 2013, AM J KIDNEY DIS, DOI 101053/jajkd201308009; Fraser A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013882; Fuleihan GE-H, 1997, J CLIN ENDOCR METAB, V82, P281, DOI [DOI 10.1210/JC.82.1.281), DOI 10.1210/JC.82.1.281]; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hocher B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040242; Isakova T, 2011, NEPHROL DIAL TRANSPL, V26, P1258, DOI 10.1093/ndt/gfr026; Ix JH, 2011, CLIN J AM SOC NEPHRO, V6, P184, DOI 10.2215/CJN.05030610; Jablonski KL, 2011, HYPERTENSION, V57, P63, DOI 10.1161/HYPERTENSIONAHA.110.160929; Karp HJ, 2007, CALCIFIED TISSUE INT, V80, P251, DOI 10.1007/s00223-007-9011-7; Kayaniyil S, 2011, J CLIN ENDOCR METAB, V96, P168, DOI 10.1210/jc.2010-1439; Kim HW, 2013, CLIN ENDOCRINOL OXF; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Kosch M, 2000, CARDIOVASC RES, V47, P813, DOI 10.1016/S0008-6363(00)00130-9; Lee H, 2012, NEPHROL DIAL TRANSPL, V27, P2799, DOI 10.1093/ndt/gfr762; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin JL, 2010, AM J CLIN NUTR, V92, P897, DOI 10.3945/ajcn.2010.29479; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Nilsson IL, 1999, SURGERY, V126, P1049, DOI 10.1067/msy.2099.101422; Osto E, 2012, CIRCULATION, V126, P1031, DOI 10.1161/CIRCULATIONAHA.111.081307; Paik JM, 2012, OSTEOPOROSIS INT, V23, P1727, DOI 10.1007/s00198-011-1776-x; Park W, 2009, DIABETES RES CLIN PR, V83, P119, DOI 10.1016/j.diabres.2008.08.018; Pilz S, EUR HEART J, V31, P1591; POCOCK SJ, 1989, J CLIN PATHOL, V42, P172, DOI 10.1136/jcp.42.2.172; Rashid G, 2007, AM J PHYSIOL-RENAL, V292, pF1215, DOI 10.1152/ajprenal.00406.2006; Reis JP, 2008, EUR J ENDOCRINOL, V159, P41, DOI 10.1530/EJE-08-0072; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Salmon AHJ, 2012, J AM SOC NEPHROL, V23, P1339, DOI 10.1681/ASN.2012010017; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Selvin E, 2013, AM J KIDNEY DIS, V61, P716, DOI 10.1053/j.ajkd.2012.11.048; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Talmor Y, 2008, EUR J CLIN INVEST, V38, P548, DOI 10.1111/j.1365-2362.2008.01977.x; Thakore P, 2011, BRIT J PHARMACOL, V162, P749, DOI 10.1111/j.1476-5381.2010.01079.x; Tomaschitz A, 2012, CARDIOVASC RES, V94, P10, DOI 10.1093/cvr/cvs092; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; TUTTLE KR, 1992, KIDNEY INT, V42, P167, DOI 10.1038/ki.1992.274; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; van Ballegooijen AJ, 2013, AM HEART J, V165, P655, DOI 10.1016/j.ahj.2013.02.014; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Vita JA, 2011, CIRCULATION, V124, pE906, DOI 10.1161/CIRCULATIONAHA.111.078824; Wannamethee SG, 2013, ARTERIOSCL THROM VAS, V33, P1070, DOI 10.1161/ATVBAHA.112.300826	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88388	10.1371/journal.pone.0088388	http://dx.doi.org/10.1371/journal.pone.0088388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505486	Green Published, gold, Green Accepted			2022-12-27	WOS:000330829200187
J	Goesaert, E; Van Baelen, M; Spileers, W; Wagemans, J; Op de Beeck, HP				Goesaert, Elfi; Van Baelen, Marc; Spileers, Werner; Wagemans, Johan; Op de Beeck, Hans P.			Visual Space and Object Space in the Cerebral Cortex of Retinal Disease Patients	PLOS ONE			English	Article							FUSIFORM FACE AREA; MACULAR DEGENERATION; NEGATIVE BOLD; CORTICAL MAPS; REORGANIZATION; ORGANIZATION; SPECIFICITY; RECOGNITION; DEPRIVATION; DYNAMICS	The lower areas of the hierarchically organized visual cortex are strongly retinotopically organized, with strong responses to specific retinotopic stimuli, and no response to other stimuli outside these preferred regions. Higher areas in the ventral occipitotemporal cortex show a weak eccentricity bias, and are mainly sensitive for object category (e. g., faces versus buildings). This study investigated how the mapping of eccentricity and category sensitivity using functional magnetic resonance imaging is affected by a retinal lesion in two very different low vision patients: a patient with a large central scotoma, affecting central input to the retina (juvenile macular degeneration), and a patient where input to the peripheral retina is lost (retinitis pigmentosa). From the retinal degeneration, we can predict specific losses of retinotopic activation. These predictions were confirmed when comparing stimulus activations with a no-stimulus fixation baseline. At the same time, however, seemingly contradictory patterns of activation, unexpected given the retinal degeneration, were observed when different stimulus conditions were directly compared. These unexpected activations were due to position-specific deactivations, indicating the importance of investigating absolute activation (relative to a no-stimulus baseline) rather than relative activation (comparing different stimulus conditions). Data from two controls, with simulated scotomas that matched the lesions in the two patients also showed that retinotopic mapping results could be explained by a combination of activations at the stimulated locations and deactivations at unstimulated locations. Category sensitivity was preserved in the two patients. In sum, when we take into account the full pattern of activations and deactivations elicited in retinotopic cortex and throughout the ventral object vision pathway in low vision patients, the pattern of (de) activation is consistent with the retinal loss.	[Goesaert, Elfi; Op de Beeck, Hans P.] Univ Leuven KU Leuven, Lab Biol Psychol, Louvain, Belgium; [Van Baelen, Marc; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium; [Spileers, Werner] Univ Leuven KU Leuven, Div Ophthalmol, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Op de Beeck, HP (corresponding author), Univ Leuven KU Leuven, Lab Biol Psychol, Louvain, Belgium.	hans.opdebeeck@ppw.kuleuven.be	Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541; Op de Beeck, Hans/0000-0002-2250-212X	Methusalem program [METH/08/02]; ERC [ERC-2011-Stg-284101]; Human Frontier Science Program [CDA 0040/2008]; FWO; FWO [G.0562.10];  [IUAP/PAI P6/29];  [IUAP/PAI P7/11]	Methusalem program; ERC(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program); FWO(FWO); FWO(FWO); ; 	This work was supported by IUAP/PAI P6/29 and IUAP/PAI P7/11 (http://www.belspo.be/belspo/iap/index_en.stm); Methusalem program (METH/08/02) to JW (http://www.kuleuven.be/research/keydomains/methusalem); ERC grant (ERC-2011-Stg-284101) to HOdB (http://erc.europa.eu/); Human Frontier Science Program, project CDA 0040/2008 to HODB (http://www.hfsp.org/); FWO, doctoral fellowship to MVB (http://www.fwo.be/Default.aspx?L = en); and FWO, research project to HOdB G.0562.10 (http://www.fwo.be/Default.aspx?L = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2011, NAT NEUROSCI, V14, P649, DOI 10.1038/nn.2793; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chalupa L.M., 2004, VISUAL NEUROSCIENCES; Cheung SH, 2005, VISUAL NEUROSCI, V22, P187, DOI 10.1017/S0952523805222071; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dumoulin SO, 2008, NEUROIMAGE, V39, P647, DOI 10.1016/j.neuroimage.2007.09.034; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Fine I, 2003, NAT NEUROSCI, V6, P915, DOI 10.1038/nn1102; Giannikopoulos DV, 2006, P NATL ACAD SCI USA, V103, P10805, DOI 10.1073/pnas.0604539103; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Goesaert E, 2010, NEUROIMAGE, V49, P3248, DOI 10.1016/j.neuroimage.2009.11.036; Golarai G, 2010, J NEUROSCI, V30, P6700, DOI 10.1523/JNEUROSCI.4268-09.2010; Grover S, 1998, OPHTHALMOLOGY, V105, P1069, DOI 10.1016/S0161-6420(98)96009-2; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; He CX, 2013, NEUROIMAGE, V79, P1, DOI 10.1016/j.neuroimage.2013.04.051; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kandel E., 2000, PRINCIPLES NEURAL SC; Kanski JJ, 1999, CLIN OPHTALMOLOGY SY; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lerner Y, 2003, NEURON, V40, P1023, DOI 10.1016/S0896-6273(03)00720-7; Levin N, 2010, NEURON, V65, P21, DOI 10.1016/j.neuron.2009.12.006; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Masuda Y, 2010, INVEST OPHTH VIS SCI, V51, P5356, DOI 10.1167/iovs.09-4775; Op de Beeck HP, 2010, NEUROIMAGE, V49, P3414, DOI 10.1016/j.neuroimage.2009.11.022; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Smith AT, 2000, NEUROREPORT, V11, P271, DOI 10.1097/00001756-200002070-00010; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Tootell RBH, 1998, TRENDS COGN SCI, V2, P174, DOI 10.1016/S1364-6613(98)01171-1; Tootell RBH, 1997, INVEST OPHTH VIS SCI, V38, P2273; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wandell BA, 2003, NEUROL CLIN, V21, P417, DOI 10.1016/S0733-8619(03)00003-3; Wandell BA, 2009, NAT REV NEUROSCI, V10, P873, DOI 10.1038/nrn2741	50	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88248	10.1371/journal.pone.0088248	http://dx.doi.org/10.1371/journal.pone.0088248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505449	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200153
J	Kamin, D; Revelo, NH; Rizzoli, SO				Kamin, Dirk; Revelo, Natalia H.; Rizzoli, Silvio O.			FM Dye Photo-Oxidation as a Tool for Monitoring Membrane Recycling in Inner Hair Cells	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; SYNAPTIC VESICLE POOLS; RETINAL BIPOLAR CELLS; RIBBON SYNAPSE; NEUROMUSCULAR-JUNCTION; MAMMALIAN COCHLEA; ENDOCYTOSIS; REPLENISHMENT; LOCALIZATION; RETRIEVAL	Styryl (FM) dyes have been used for more than two decades to investigate exo- and endocytosis in conventional synapses. However, they are difficult to use in the inner hair cells of the auditory pathway (IHCs), as FM dyes appear to penetrate through mechanotransducer channels into the cytosol of IHCs, masking endocytotic uptake. To solve this problem we applied to IHCs the FM dye photo-oxidation technique, which renders the dyes into electron microscopy markers. Photo-oxidation allowed the unambiguous identification of labeled organelles, despite the presence of FM dye in the cytosol. This enabled us to describe the morphologies of several organelles that take up membrane in IHCs, both at rest and during stimulation. At rest, endosome-like organelles were detected in the region of the cuticular plate. Larger tubulo-cisternal organelles dominated the top and nuclear regions. Finally, the basal region, where the IHC active zones are located, contained few labeled organelles. Stimulation increased significantly membrane trafficking in the basal region, inducing the appearance of labeled vesicles and cistern-like organelles. The latter were replaced by small, synaptic-like vesicles during recovery after stimulation. In contrast, no changes in membrane trafficking were induced by stimulation in the cuticular plate region or in the top and nuclear regions. We conclude that synaptic vesicle recycling takes place mostly in the basal region of the IHCs. Other organelles participate in abundant constitutive membrane trafficking throughout the rest of the IHC volume.	[Kamin, Dirk; Revelo, Natalia H.; Rizzoli, Silvio O.] Univ Med Ctr Gottingen, Dept Neuro & Sensory Physiol, Gottingen, Germany; [Kamin, Dirk; Revelo, Natalia H.] European Neurosci Inst, STED Microscopy Synapt Funct, Gottingen, Germany; [Revelo, Natalia H.] Int Max Planck Res Sch Neurosci, Gottingen, Germany; [Revelo, Natalia H.; Rizzoli, Silvio O.] Univ Gottingen, Collaborat Res Ctr 889, D-37073 Gottingen, Germany; [Rizzoli, Silvio O.] Univ Gottingen, D-37073 Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen; University of Gottingen	Kamin, D (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany.	dirk.kamin@mpibpc.mpg.de; srizzol@gwdg.de	Rizzoli, Silvio/ABG-2227-2020; Revelo, Natalia Hasel H/A-5773-2016; 889, CRC/L-1607-2018; Revelo, Natalia Hasel/AAM-7483-2021	Revelo, Natalia Hasel H/0000-0003-2492-1317; 889, CRC/0000-0002-6678-3138; Revelo, Natalia Hasel/0000-0003-2492-1317; Rizzoli, Silvio/0000-0002-1667-7839	Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center [889]; Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain; Starting Grant from the European Research Council	Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center(German Research Foundation (DFG)); Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain; Starting Grant from the European Research Council	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center 889 'Cellular Mechanisms of Sensory Processing' (to SOR), by the Cluster of Excellence Nanoscale Microscopy and Molecular Physiology of the Brain (to SOR) and by a Starting Grant from the European Research Council, Program FP7 (NANOMAP, to SOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Clayton EL, 2009, J NEUROCHEM, V111, P901, DOI 10.1111/j.1471-4159.2009.06384.x; Cousin MA, 2009, MOL NEUROBIOL, V39, P185, DOI 10.1007/s12035-009-8062-3; Crumling MA, 2009, NEUROSCIENCE, V161, P1144, DOI 10.1016/j.neuroscience.2009.02.076; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Denker A, 2011, P NATL ACAD SCI USA, V108, P17177, DOI 10.1073/pnas.1112688108; Denker A, 2009, J PHYSIOL-LONDON, V587, P2919, DOI 10.1113/jphysiol.2009.170985; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Grabenbauer M, 2005, NAT METHODS, V2, P857, DOI 10.1038/nmeth806; Griesinger CB, 2004, EUR J NEUROSCI, V20, P41, DOI 10.1111/j.0953-816X.2004.03452.x; Griesinger CB, 2005, NATURE, V435, P212, DOI 10.1038/nature03567; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Meyers JR, 2003, J NEUROSCI, V23, P4054; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Opazo F, 2010, J VIS EXP, pe1970, DOI [10.3791/1790.doi:10.3791/1790, DOI 10.3791/1790.D0I:10.3791/1790]; Paillart C, 2003, J NEUROSCI, V23, P4092; Pangrsic T, 2012, TRENDS NEUROSCI, V35, P671, DOI 10.1016/j.tins.2012.08.002; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Reid B, 1999, J NEUROSCI, V19, P2511; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Sendin G, 2007, J NEUROSCI, V27, P3163, DOI 10.1523/JNEUROSCI.3974-06.2007; SIEGEL JH, 1986, J NEUROCYTOL, V15, P311, DOI 10.1007/BF01611434; Spicer SS, 2007, HEARING RES, V233, P40, DOI 10.1016/j.heares.2007.07.005; Spicer SS, 1999, J COMP NEUROL, V409, P424; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412	41	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88353	10.1371/journal.pone.0088353	http://dx.doi.org/10.1371/journal.pone.0088353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505482	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200183
J	Knudsen, S; Jensen, T; Hansen, A; Mazin, W; Lindemann, J; Kuter, I; Laing, N; Anderson, E				Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor; Lindemann, Justin; Kuter, Irene; Laing, Naomi; Anderson, Elizabeth			Development and Validation of a Gene Expression Score That Predicts Response to Fulvestrant in Breast Cancer Patients	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; PROTEIN EXPRESSION; CELLS; APOPTOSIS; CHEMOSENSITIVITY; INHIBITOR; MUTATIONS; TRIAL; PLUS	Fulvestrant is a selective estrogen receptor antagonist. Based on the measured growth inhibition of 60 human cancer cell lines (NCI60) in the presence of fulvestrant, as well as the baseline gene expression of the 60 cell lines, a gene expression score that predicts response to fulvestrant was developed. The score is based on 414 genes, 103 of which show increased expression in sensitive cell lines, while 311 show increased expression in the non-responding cell lines. The sensitivity genes primarily sense signaling through estrogen receptor alpha, whereas the resistance genes modulate the PI3K signaling pathway. The latter genes suggest that resistance to fulvestrant can be overcome by drugs targeting the PI3K pathway. The level of this gene expression score and its correlation with fulvestrant response was measured in a panel of 20 breast cancer cell lines. The predicted sensitivity matched the measured sensitivity well (CC = -0.63, P = 0.003). The predictor was applied to tumor biopies obtained from a Phase II clinical trial. The sensitivity of each patient to treatment with fulvestrant was predicted based on the RNA profile of the biopsy taken before neoadjuvant treatment and without knowledge of the subsequent response. The prediction was then compared to clinical response to show that the responders had a significantly higher sensitivity prediction than the non-responders (P = 0.01). When clinical covariates, tumor grade and estrogen receptor H-score, were included in the prediction, the difference in predicted senstivity between responders and non-responders improved (P = 0.003). Using a pre-defined cutoff to separate patients into predicted sensitive and predicted resistant yielded a positive predictive value of 88% and a negative predictive value of 100% when compared to clinical data. We conclude that pre-screening patients with the new gene expression predictor has the potential to identify those postmenopausal women with locally advanced, estrogen-receptor-positive breast cancer most likely to respond to fulvestrant.	[Knudsen, Steen; Jensen, Thomas; Hansen, Anker; Mazin, Wiktor] Med Prognosis Inst, Horsholm, Denmark; [Lindemann, Justin; Anderson, Elizabeth] Astrazeneca UK Ltd, Oncol iMED, Alderley Pk, Cheshire, England; [Laing, Naomi] Astrazeneca R&D Boston, Waltham, MA USA; [Kuter, Irene] Massachusetts Gen Hosp, Boston, MA 02114 USA	AstraZeneca; AstraZeneca; Harvard University; Massachusetts General Hospital	Knudsen, S (corresponding author), Med Prognosis Inst, Horsholm, Denmark.	steen@medical-prognosis.com		Lindemann, Justin/0000-0003-1531-9754	Astrazeneca; Medical Prognosis Institute	Astrazeneca(AstraZeneca); Medical Prognosis Institute	The work has been funded entirely by Astrazeneca and Medical Prognosis Institute. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Caglayan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013608; Chen JJ, 2012, MOL CANCER THER, V11, P34, DOI 10.1158/1535-7163.MCT-11-0620; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Di Leo A, 2012, CANCER RES S, V72; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Fox EM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3449; Fox EM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00145; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang Shoulei, 2010, Hormones & Cancer, V1, P11, DOI 10.1007/s12672-010-0006-x; Ju JH, 2011, CARCINOGENESIS, V32, P1474, DOI 10.1093/carcin/bgr173; Kuter I, 2012, BREAST CANCER RES TR, V133, P237, DOI 10.1007/s10549-011-1947-7; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021112; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Pierga JY, 2010, CANCER RES, V70, DOI 10.1158/0008-5472.SABCS10-S6-6; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Robertson JFR, 2004, CLIN PHARMACOKINET, V43, P529, DOI 10.2165/00003088-200443080-00003; Robertson JFR, 2009, J CLIN ONCOL, V27, P4530, DOI 10.1200/JCO.2008.21.1136; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Smith IE, 2007, J CLIN ONCOL, V25, P3816, DOI 10.1200/JCO.2006.09.6578; Smolnikar K, 2000, BREAST CANCER RES TR, V63, P249, DOI 10.1023/A:1006490416408; Stemmer-Rachamimov AO, 2001, AM J PATHOL, V158, P57, DOI 10.1016/S0002-9440(10)63944-2; Sunohara JR, 2001, J NEUROCHEM, V78, P664, DOI 10.1046/j.1471-4159.2001.00458.x; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Treon SP, 1998, BLOOD, V92, P1749, DOI 10.1182/blood.V92.5.1749.417k38_1749_1757; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Wang WT, 2013, JNCI-J NATL CANCER I, V105, P1284, DOI 10.1093/jnci/djt202; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117	41	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87415	10.1371/journal.pone.0087415	http://dx.doi.org/10.1371/journal.pone.0087415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505287	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200046
J	Lee, H; Park, HJ; Park, CS; Oh, ET; Choi, BH; Williams, B; Lee, CK; Song, CW				Lee, Hyemi; Park, Heon Joo; Park, Chang-Shin; Oh, Eun-Taex; Choi, Bo-Hwa; Williams, Brent; Lee, Chung K.; Song, Chang W.			Response of Breast Cancer Cells and Cancer Stem Cells to Metformin and Hyperthermia Alone or Combined	PLOS ONE			English	Article							ANTIDIABETIC DRUG; IONIZING-RADIATION; PANCREATIC-CANCER; DIABETIC-PATIENTS; INITIATING CELLS; THERMAL THERAPY; IN-VITRO; GROWTH; CHEMOTHERAPY; KINASE	Metformin, the most widely prescribed drug for treatment of type 2 diabetes, has been shown to exert significant anticancer effects. Hyperthermia has been known to kill cancer cells and enhance the efficacy of various anti-cancer drugs and radiotherapy. We investigated the combined effects of metformin and hyperthermia against MCF-7 and MDA-MB-231 human breast cancer cell, and MIA PaCa-2 human pancreatic cancer cells. Incubation of breast cancer cells with 0.5-10 mM metformin for 48 h caused significant clonogenic cell death. Culturing breast cancer cells with 30 mM metformin, clinically relevant plasma concentration of metformin, significantly reduced the survival of cancer cells. Importantly, metformin was preferentially cytotoxic to CD44(high)/CD24(low) cells of MCF-7 cells and, CD44(high)/CD24(high) cells of MIA PaCa-2 cells, which are known to be cancer stem cells (CSCs) of MCF-7 cells and MIA PaCa-2 cells, respectively. Heating at 42 degrees C for 1 h was slightly toxic to both cancer cells and CSCs, and it markedly enhanced the efficacy of metformin to kill cancer cells and CSCs. Metformin has been reported to activate AMPK, thereby suppressing mTOR, which plays an important role for protein synthesis, cell cycle progression, and cell survival. For the first time, we show that hyperthermia activates AMPK and inactivates mTOR and its downstream effector S6K. Furthermore, hyperthermia potentiated the effect of metformin to activate AMPK and inactivate mTOR and S6K. Cell proliferation was markedly suppressed by metformin or combination of metformin and hyperthermia, which could be attributed to activation of AMPK leading to inactivation of mTOR. It is conclude that the effects of metformin against cancer cells including CSCs can be markedly enhanced by hyperthermia.	[Lee, Hyemi; Park, Heon Joo; Oh, Eun-Taex; Choi, Bo-Hwa] Inha Univ, Coll Med, Dept Microbiol, Inchon, South Korea; [Park, Chang-Shin] Inha Univ, Coll Med, Dept Pharmacol, Inchon, South Korea; [Williams, Brent; Lee, Chung K.; Song, Chang W.] Univ Minnesota, Sch Med, Dept Therapeut Radiol Radiat Oncol, Minneapolis, MN 55455 USA	Inha University; Inha University; University of Minnesota System; University of Minnesota Twin Cities	Park, HJ (corresponding author), Inha Univ, Coll Med, Dept Microbiol, Inchon, South Korea.	park001@inha.ac.kr; parkshin@inha.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0015230, NRF-2013M2A2A7043703]; Komen for Cure from the University of Minnesota Cancer Center	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Komen for Cure from the University of Minnesota Cancer Center	This work was supported by grants from the R&D Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015230 and NRF-2013M2A2A7043703), and the Komen for Cure from the University of Minnesota Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Atkinson RL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001447; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Bao Qi, 2010, Cancers (Basel), V2, P1629, DOI 10.3390/cancers2031629; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Bull JMC, 2008, INT J HYPERTHER, V24, P649, DOI 10.1080/02656730802104740; Burke AR, 2012, BIOMATERIALS, V33, P2961, DOI 10.1016/j.biomaterials.2011.12.052; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Park HJ, 2005, CLIN CANCER RES, V11, P8866, DOI 10.1158/1078-0432.CCR-05-0818; Pelicci PG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2847; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rattan R, 2012, J ONCOL, V2012, DOI 10.1155/2012/928127; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Sugahara T, 2008, INT J HYPERTHER, V24, P123, DOI 10.1080/02656730701883675; Tomimoto A, 2008, CANCER SCI, V99, P2136, DOI 10.1111/j.1349-7006.2008.00933.x; Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zakikhani M, 2008, CANCER PREV RES, V1, P369, DOI 10.1158/1940-6207.CAPR-08-0081; Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	50	50	54	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87979	10.1371/journal.pone.0087979	http://dx.doi.org/10.1371/journal.pone.0087979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505341	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200092
J	Ozpinar, A; Kelestimur, F; Songur, Y; Can, O; Valentin, L; Caldwell, K; Arikan, E; Unsal, I; Serteser, M; Inal, T; Erdemgil, Y; Coskun, A; Bakirci, N; Sezgin, O; Blount, B				Ozpinar, Aysel; Kelestimur, Fahrettin; Songur, Yildiran; Can, Ozge; Valentin, Liza; Caldwell, Kathleen; Arikan, Ender; Unsal, Ibrahim; Serteser, Mustafa; Inal, Tamer; Erdemgil, Yigit; Coskun, Abdurrahman; Bakirci, Nadi; Sezgin, Ozlem; Blount, Ben			Iodine Status in Turkish Populations and Exposure to Iodide Uptake Inhibitors	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; UNITED-STATES; NATIONAL-HEALTH; URINARY IODINE; PREGNANT-WOMEN; DEFICIENCY DISORDERS; PERCHLORATE EXPOSURE; MASS-SPECTROMETRY; GOITER PREVALENCE; WATER	Perchlorate, nitrate, and thiocyanate are competitive inhibitors of the sodium iodide symporter of the thyroid membrane. These inhibitors can decrease iodine uptake by the symporter into the thyroid gland and may disrupt thyroid function. This study assesses iodine status and exposure to iodide uptake inhibitors of non-pregnant and non-lactating adult women living in three different cities in Turkey (Istanbul, Isparta and Kayseri). We measured iodine and iodide uptake inhibitors in 24-hr urines collected from study participants (N = 255). All three study populations were mildly iodine deficient, with median urinary iodine (UI) levels of 77.5 mu g/L in Istanbul, 58.8 mu g/L in Isparta, and 69.8 mu g/L in Kayseri. Perchlorate doses were higher in the study population (median 0.13 mu g/kg/day), compared with a reference population (median 0.059 mu g/kg/day), but lower than the U. S. EPA reference dose (0.7 mu g/kg/day). Urinary thiocyanate levels increased with increasing exposure to tobacco smoke, with non-smokers (268 mu g/L) significantly lower than light smokers (1110 mu g/L), who were significantly lower than heavy smokers (2410 mu g/L). This pilot study provides novel data indicating that study participants were moderately iodine deficient and had higher intakes of the iodide uptake inhibitor perchlorate compared with a reference population. Further investigation is needed to characterize the thyroid impact resulting from iodine deficiency coupled with exposure to iodide uptake inhibitors such as perchlorate, thiocyanate and nitrate.	[Ozpinar, Aysel; Can, Ozge; Unsal, Ibrahim; Serteser, Mustafa; Inal, Tamer; Erdemgil, Yigit; Coskun, Abdurrahman; Bakirci, Nadi; Sezgin, Ozlem] Acibadem Univ, Sch Med, Dept Med Biochem, Istanbul, Turkey; [Kelestimur, Fahrettin] Erciyes Univ, Sch Med, Kayseri, Turkey; [Songur, Yildiran] Suleyman Demirel Univ, Sch Med, TR-32200 Isparta, Turkey; [Arikan, Ender; Sezgin, Ozlem] Acibadem Hosp, Istanbul, Turkey; [Valentin, Liza; Caldwell, Kathleen; Blount, Ben] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA 30333 USA	Acibadem University; Erciyes University; Suleyman Demirel University; Acibadem Hastaneleri; Acibadem Hospitals Group; Centers for Disease Control & Prevention - USA	Blount, B (corresponding author), Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA 30333 USA.	bkb3@cdc.gov	Serteser, Mustafa/F-9130-2015; Ozpinar, Aysel/D-5150-2016; kelestimur, f/ABE-9873-2021; İNAL, TAMER/G-3661-2018; Can, Ozge/G-9355-2015; Coskun, Abdurrahman/C-3906-2015	Serteser, Mustafa/0000-0001-7868-7613; Ozpinar, Aysel/0000-0002-7399-4929; Coskun, Abdurrahman/0000-0002-1273-0604; Erdemgil, Yigit/0000-0001-7732-5960	Acibadem University; Erciyes University; Suleyman Demirel University; CDC	Acibadem University(Acibadem University); Erciyes University(Erciyes University); Suleyman Demirel University(Suleyman Demirel University); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by funds from Acibadem University, Erciyes University, Suleyman Demirel University, and CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2005, B WORLD HEALTH ORGAN, V83, P518; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2007, ASS IOD DEF DIS MON; Asami M, 2009, J HEALTH SCI, V55, P549, DOI 10.1248/jhs.55.549; Becker DV, 2006, THYROID, V16, P949, DOI 10.1089/thy.2006.16.949; Bilir N, 2009, TOBACCO CONTROL TURK; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Blount BC, 2010, ENVIRON SCI TECHNOL, V44, P9564, DOI 10.1021/es1025195; Blount BC, 2008, J AGR FOOD CHEM, V56, P10709, DOI 10.1021/jf8018326; Brandhuber P, 2009, J AM WATER WORKS ASS, V101, P63; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Caldwell KL, 2005, THYROID, V15, P692, DOI 10.1089/thy.2005.15.692; Caldwell KL, 2003, CLIN CHEM, V49, P1019, DOI 10.1373/49.6.1019; Cetin H, 2006, J ENDOCRINOL INVEST, V29, P714, DOI 10.1007/BF03344181; Erdogan G. E. M., 2003, 2002 YILI 20 BOLGE T; Erdogan MF, 2009, J ENDOCRINOL INVEST, V32, P617, DOI 10.3275/6379; Erdogan MF, 2007, ENDOKRINOLOJIDE DIVA, V4, P211; Gatseva P, 2007, BIOL TRACE ELEM RES, V116, P273, DOI 10.1007/BF02698011; Greer MA, 2002, ENVIRON HEALTH PERSP, V110, P927, DOI 10.1289/ehp.02110927; Gultepe M, 2005, CLIN CHEM LAB MED, V43, P280, DOI 10.1515/CCLM.2005.047; Gur E, 2003, J TROP PEDIATRICS, V49, P168, DOI 10.1093/tropej/49.3.168; Gurkan R, 2004, TURK J CHEM, V28, P181; Guruge KS, 2011, J ENVIRON MONITOR, V13, P2312, DOI 10.1039/c1em10327j; Ha W, 2011, ENV SCI TECHNOLOGY; Hacettepe University Institute of Population Studies, 2009, TURK DEM HLTH SURV 2; Her N, 2010, CHEMOSPHERE, V81, P732, DOI 10.1016/j.chemosphere.2010.07.031; HETZEL BS, 1983, LANCET, V2, P1126; Huber DR, 2011, J EXPO SCI ENV EPID, V21, P395, DOI 10.1038/jes.2010.31; Junge W, 2004, CLIN CHIM ACTA, V344, P137, DOI 10.1016/j.cccn.2004.02.007; KASKI, 2012, ICM KULL SUYU AN RAP; Kirk AB, 2005, ENVIRON SCI TECHNOL, V39, P2011, DOI 10.1021/es048118t; Knudsen N, 2002, ARCH INTERN MED, V162, P439, DOI 10.1001/archinte.162.4.439; Kucharzyk KH, 2009, J ENVIRON MANAGE, V91, P303, DOI 10.1016/j.jenvman.2009.09.023; Kurtoglu S, 2004, TURKISH J PEDIATR, V46, P11; Kut A, 2010, J ENDOCRINOL INVEST, V33, P461, DOI [10.3275/6767, 10.1007/BF03346625]; Kutlu AO, 2012, CLIN ENDOCRINOL, V77, P615, DOI 10.1111/j.1365-2265.2012.04440.x; Lau FK, 2013, J EXPO SCI ENV EPID, V23, P207, DOI 10.1038/jes.2012.108; Laurberg P, 2000, THYROID, V10, P951, DOI 10.1089/thy.2000.10.951; Mage DT, 2004, J EXPO ANAL ENV EPID, V14, P457, DOI 10.1038/sj.jea.7500343; McLaughlin CL, 2011, WATER ENVIRON J, V25, P456, DOI 10.1111/j.1747-6593.2010.00237.x; NAS, 2005, HLTH IMPL PERCHL ING; Oh S-H, 2011, ENV HLTH TOXICOL, V26; Sanchez CA, 2006, ANAL CHIM ACTA, V567, P33, DOI 10.1016/j.aca.2006.02.013; Shi YL, 2007, ENVIRON INT, V33, P955, DOI 10.1016/j.envint.2007.05.007; Stanbury JB, 1998, THYROID, V8, P83, DOI 10.1089/thy.1998.8.83; Steinmaus C, 2007, ENVIRON HEALTH PERSP, V115, P1333, DOI 10.1289/ehp.10300; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; Urbansky ET, 2002, ENVIRON SCI POLLUT R, V9, P187, DOI 10.1007/BF02987487; US EPA, 2008, EPA822R08025; Valentin-Blasini L, 2007, J CHROMATOGR A, V1155, P40, DOI 10.1016/j.chroma.2007.04.014; van Grinsven Hans J M, 2006, Environ Health, V5, P26, DOI 10.1186/1476-069X-5-26; Wang H, 2001, Environ Health Prev Med, V6, P88, DOI 10.1007/BF02897951; World Health Organization, 1995, PHYS STAT US INT ANT; Yang M, 2011, J AGR FOOD CHEM, V59, P7490, DOI 10.1021/jf2009638; Yu LL, 2012, ANAL BIOANAL CHEM, V404, P1877, DOI 10.1007/s00216-012-6263-5; Zewdie T, 2010, ENVIRON HEALTH PERSP, V118, P42, DOI 10.1289/ehp.0900635	57	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88206	10.1371/journal.pone.0088206	http://dx.doi.org/10.1371/journal.pone.0088206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505430	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200136
J	Guo, JJ; Wu, GS; Bao, JL; Hao, WH; Lu, JJ; Chen, XP				Guo, Jiajie; Wu, Guosheng; Bao, Jiaolin; Hao, Wenhui; Lu, Jinjian; Chen, Xiuping			Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CONSTITUTIVE ACTIVATION; CHECKPOINT CONTROL; SIGNAL TRANSDUCER; MOLECULAR TARGETS; INHIBITS GROWTH; TRANSCRIPTION 3; CANCER-CELLS; APOPTOSIS; RESPONSES	Cucurbitacins are a class of triterpenoids widely distributed in plant kingdom with potent anti-cancer activities both in vitro and in vivo by inducing cycle arrest, autophagy, and apoptosis. Cucurbitacin B (Cuc B), could induce S or G2/M cell cycle arrest in cancer cells while the detailed mechanisms remain to be clear. This study was designed to precisely dissect the signaling pathway(s) responsible for Cuc B induced cell cycle arrest in human lung adenocarcinoma epithelial A549 cells. We demonstrated that low concentrations of Cuc B dramatically induced G2/M phase arrest in A549 cells. Cuc B treatment caused DNA double-strand breaks (DSBs) without affecting the signal transducer and activator of transcription 3 (STAT3), the potential molecular target for Cuc B. Cuc B triggers ATM-activated Chk1-Cdc25C-Cdk1, which could be reversed by both ATM siRNA and Chk1 siRNA. Cuc B also triggers ATM-activated p53-14-3-3-sigma pathways, which could be reversed by ATM siRNA. Cuc B treatment also led to increased intracellular reactive oxygen species (ROS) formation, which was inhibited by N-acetyl-l-cysteine (NAC) pretreatment. Furthermore, NAC pretreatment inhibited Cuc B induced DNA damage and G2/M phase arrest. Taken together, these results suggested that Cuc B induces DNA damage in A549 cells mediated by increasing intracellular ROS formation, which lead to G2/M cell phase arrest through ATM-activated Chk1-Cdc25C-Cdk1 and p53-14-3-3-sigma parallel branches. These observations provide novel mechanisms and potential targets for better understanding of the anti-cancer mechanisms of cucurbitacins.	[Guo, Jiajie; Wu, Guosheng; Bao, Jiaolin; Hao, Wenhui; Lu, Jinjian; Chen, Xiuping] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China	University of Macau	Chen, XP (corresponding author), Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China.	xpchen@umac.mo	Chen, Xiuping/AAG-3086-2020; Lu, Jinjian/X-2083-2019; Chen, Xiuping/O-8927-2017; Lu, Jinjian/R-6207-2019; Bao, Jiaolin/GRJ-8416-2022	Lu, Jinjian/0000-0001-6703-3120; Chen, Xiuping/0000-0003-2675-7645; Bao, Jiaolin/0000-0003-0630-071X	University of Macau [MYRG118(Y1-L4)-ICMS13-CXP, MRG007/CXP/2013/ICMS]; Science and Technology Development Fund of Macau Special Administrative Region [045/2011/A, 021/2012/A1]	University of Macau; Science and Technology Development Fund of Macau Special Administrative Region	The present study was supported by the Research Fund of the University of Macau (Nos. MYRG118(Y1-L4)-ICMS13-CXP, MRG007/CXP/2013/ICMS) and the grants from Science and Technology Development Fund of Macau Special Administrative Region (Nos. 045/2011/A, 021/2012/A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Blaskovich MA, 2003, CANCER RES, V63, P1270; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Buettner R, 2002, CLIN CANCER RES, V8, P945; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Chan KT, 2010, CANCER LETT, V289, P46, DOI 10.1016/j.canlet.2009.07.015; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chen JC, 2005, NAT PROD REP, V22, P386, DOI 10.1039/b418841c; Chen WK, 2010, INT J ONCOL, V37, P737, DOI 10.3892/ijo_00000723; Chen XP, 2012, ANTI-CANCER DRUG, V23, P777, DOI 10.1097/CAD.0b013e3283541384; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gerlitz G, 2009, CELL CYCLE, V8, P1641, DOI 10.4161/cc.8.11.8569; Guachalla LM, 2010, CELL CYCLE, V9, P4058, DOI 10.4161/cc.9.20.13577; Haritunians T, 2008, LEUKEMIA RES, V32, P1366, DOI 10.1016/j.leukres.2008.01.019; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Indovina P, 2010, CANCER BIOL THER, V9, P523, DOI 10.4161/cbt.9.7.11276; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kausar H, 2013, CANC LETT; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lam MH, 2004, CELL CYCLE, V3, P1355, DOI 10.4161/cc.3.11.1225; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MEIJER L, 1991, EMBO J, V10, P1545, DOI 10.1002/j.1460-2075.1991.tb07674.x; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; RIME H, 1992, DEV BIOL, V151, P105, DOI 10.1016/0012-1606(92)90217-5; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shi XZ, 2006, BRIT J HAEMATOL, V135, P26, DOI 10.1111/j.1365-2141.2006.06259.x; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; Wu GS, 2012, FITOTERAPIA, V83, P408, DOI 10.1016/j.fitote.2011.12.004; Yasuda S, 2010, MOL NUTR FOOD RES, V54, P559, DOI 10.1002/mnfr.200900165; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang MX, 2010, PANCREAS, V39, P923, DOI 10.1097/MPA.0b013e3181ce719e; Zhang MX, 2009, CANCER CHEMOTH PHARM, V63, P635, DOI 10.1007/s00280-008-0780-0; Zhang T, 2012, AUTOPHAGY, V8, P559, DOI 10.4161/auto.18867; Zhang YT, 2011, ACTA BIOCH BIOPH SIN, V43, P556, DOI 10.1093/abbs/gmr042; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	53	54	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88140	10.1371/journal.pone.0088140	http://dx.doi.org/10.1371/journal.pone.0088140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505404	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300058
J	Krasniqi, B; Lee, JS				Krasniqi, Besnik; Lee, Jeremy S.			RNase A Does Not Translocate the Alpha-Hemolysin Pore	PLOS ONE			English	Article							SOLID-STATE NANOPORES; BOVINE PANCREATIC RIBONUCLEASE; SINGLE-MOLECULE; PROTEIN TRANSLOCATION; DNA; SPECTROSCOPY; COMPLEXES; PEPTIDES; KINETICS; BINDING	The application of nanopore sensing utilizing the alpha-hemolysin pore to probe proteins at single-molecule resolution has expanded rapidly. In some studies protein translocation through the alpha-hemolysin has been reported. However, there is no direct evidence, as yet, that proteins can translocate the alpha-hemolysin pore. The biggest challenge to obtaining direct evidence is the lack of a highly sensitive assay to detect very low numbers of protein molecules. Furthermore, if an activity based assay is applied then the proteins translocating by unfolding should refold back to an active confirmation for the assay technique to work. To overcome these challenges we selected a model enzyme, ribonuclease A, that readily refolds to an active conformation even after unfolding it with denaturants. In addition we have developed a highly sensitive reverse transcription polymerase chain reaction based activity assay for ribonuclease A. Initially, ribonuclease A, a protein with a positive net charge and dimensions larger than the smallest diameter of the pore, was subjected to nanopore analysis under different experimental conditions. Surprisingly, although the protein was added to the cis chamber (grounded) and a positive potential was applied, the interaction of ribonuclease A with alpha-hemolysin pore induced small and large blockade events in the presence and the absence of a reducing and/or denaturing agent. Upon measuring the zeta potential, it was found that the protein undergoes a charge reversal under the experimental conditions used for nanopore sensing. From the investigation of the effect of voltage on the interaction of ribonuclease A with the alpha-hemolysin pore, it was impossible to conclude if the events observed were translocations. However, upon testing for ribonuclease A activity on the trans chamber it was found that ribonuclease A does not translocate the alpha-hemolysin pore.	[Krasniqi, Besnik; Lee, Jeremy S.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Lee, JS (corresponding author), Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada.	jeremy.lee@usask.ca			NSERC [RGPIN 203084-2013]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by NSERC (RGPIN 203084-2013) (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2001, BIOPHYS J, V81, P1580, DOI 10.1016/S0006-3495(01)75812-2; Bahrami A, 2012, BIOCHEM SOC T, V40, P624, DOI 10.1042/BST20120121; Baran C, 2010, BIOCHEM BIOPH RES CO, V391, P224, DOI 10.1016/j.bbrc.2009.11.036; Bastings MMC, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-76; Cao A, 2001, BIOCHEMISTRY-US, V40, P8536, DOI 10.1021/bi010692j; Christensen C, 2011, J PEPT SCI, V17, P726, DOI 10.1002/psc.1393; Fennouri A, 2013, ANAL CHEM, V85, P8488, DOI 10.1021/ac4020929; Fennouri A, 2012, ACS NANO, V6, P9672, DOI 10.1021/nn3031047; Firnkes M, 2010, NANO LETT, V10, P2162, DOI 10.1021/nl100861c; Hall AR, 2009, NANO LETT, V9, P4441, DOI 10.1021/nl9027318; Hornblower B, 2007, NAT METHODS, V4, P315, DOI 10.1038/NMETH1021; Ivankin A, 2013, J AM CHEM SOC, V135, P15350, DOI 10.1021/ja408354s; Japrung D, 2013, ANAL CHEM, V85, P2449, DOI 10.1021/ac3035025; Jetha NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054982; JosephMcCarthy D, 1996, PROTEIN ENG, V9, P773, DOI 10.1093/protein/9.9.773; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kowalczyk SW, 2010, NANO LETT, V10, P324, DOI 10.1021/nl903631m; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krasniqi B, 2012, METALLOMICS, V4, P539, DOI 10.1039/c2mt20050c; Kukwikila M, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454103; Ma L, 2010, CHEMBIOCHEM, V11, P25, DOI 10.1002/cbic.200900526; Madampage C, 2012, PRION, V6, P116, DOI 10.4161/pri.18665; Madampage CA, 2013, PRION, V7, P301, DOI 10.4161/pri.25148; Madampage CA, 2010, ANAL BIOCHEM, V396, P36, DOI 10.1016/j.ab.2009.08.028; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Marino T, 2012, DALTON T, V41, P1816, DOI 10.1039/c1dt11028d; Meng H, 2010, J PEPT SCI, V16, P701, DOI 10.1002/psc.1289; Merstorf C, 2012, ACS CHEM BIOL, V7, P652, DOI 10.1021/cb2004737; Miles BN, 2013, CHEM SOC REV, V42, P15, DOI 10.1039/c2cs35286a; Miyamoto T, 2009, BIOTECHNOL PROGR, V25, P1678, DOI 10.1002/btpr.267; Mohammad MM, 2008, EUR BIOPHYS J BIOPHY, V37, P913, DOI 10.1007/s00249-008-0309-9; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Mohammad MM, 2012, J AM CHEM SOC, V134, P9521, DOI 10.1021/ja3043646; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Neira JL, 1997, FOLD DES, V2, pR1, DOI 10.1016/S1359-0278(97)00001-1; Niedzwiecki DJ, 2013, ACS NANO, V7, P3341, DOI 10.1021/nn400125c; Nivala J, 2013, NAT BIOTECHNOL, V31, P247, DOI 10.1038/nbt.2503; Oukhaled A, 2012, ACS CHEM BIOL, V7, P1935, DOI 10.1021/cb300449t; Oukhaled A, 2011, ACS NANO, V5, P3628, DOI 10.1021/nn1034795; Oukhaled G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158101; Pastoriza-Gallego M, 2011, J AM CHEM SOC, V133, P2923, DOI 10.1021/ja1073245; Payet L, 2012, ANAL CHEM, V84, P4071, DOI 10.1021/ac300129e; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Reinstadler D, 1996, BIOCHEMISTRY-US, V35, P15822, DOI 10.1021/bi961810j; Rodriguez-Larrea D, 2013, NAT NANOTECHNOL, V8, P288, DOI [10.1038/nnano.2013.22, 10.1038/NNANO.2013.22]; Safarian S, 2000, J PROTEIN CHEM, V19, P335, DOI 10.1023/A:1026414928279; SELA M, 1957, BIOCHIM BIOPHYS ACTA, V24, P229, DOI 10.1016/0006-3002(57)90186-5; Smeets RMM, 2009, NANO LETT, V9, P3089, DOI 10.1021/nl803189k; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Soni GV, 2012, NANO LETT, V12, P3180, DOI 10.1021/nl301163m; Stefureac R, 2008, SMALL, V4, P59, DOI 10.1002/smll.200700402; Stefureac RI, 2008, SMALL, V4, P1646, DOI 10.1002/smll.200800585; Stefureac RI, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454133; Stefureac RI, 2010, BIOCHEM CELL BIOL, V88, P347, DOI [10.1139/O09-176, 10.1139/o09-176]; TAKAHASH.T, 1969, J BIOCHEM-TOKYO, V65, P55; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b; Tavassoly O, 2012, FEBS LETT, V586, P3222, DOI 10.1016/j.febslet.2012.06.040; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Zhao QT, 2009, J AM CHEM SOC, V131, P6324, DOI 10.1021/ja9004893	60	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88004	10.1371/journal.pone.0088004	http://dx.doi.org/10.1371/journal.pone.0088004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505349	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300031
J	Daly, A; Pollard, CM; Phillips, M; Binns, CW				Daly, Alison; Pollard, Christina Mary; Phillips, Michael; Binns, Colin William			Benefits, Barriers and Enablers of Breastfeeding: Factor Analysis of Population Perceptions in Western Australia	PLOS ONE			English	Article							LIFE; ATTITUDES; DURATION; PERTH; RISK	Objective: The objective of this study was to investigate knowledge and community perceptions of breastfeeding in Western Australia using a factor analysis approach. Methods: Data were pooled from five Nutrition Monitoring Survey Series which included information on breastfeeding from 4,802 Western Australian adults aged 18-64 years. Tetrachoric factor analysis was conducted for data reduction and significant associations identified using logistic, ordinal and poisson regression analyses. Results: Four factors were derived for benefits (it's natural, good nutrition, good for the baby, and convenience), barriers (breastfeeding problems, poor community acceptability, having to go back to work, and inconvenience) and for enablers (breastfeeding education, community support, family support and not having to work). As assessed by standardized odds ratios the most important covariates across benefit factors were: importance of breastfeeding (ORs range from 1.22-1.44), female gender (ORs range from 0.80 to 1.46), being able to give a time for how long a baby should be breastfed (ORs range from 0.96 to 1.27) and education (less than high school to university completion) (ORs range from 0.95 to 1.23); the most important covariate across barrier factors was being able to give a time for how long a baby should be breastfed (ORs range from 0.89 to 1.93); and the most important covariates across all enabling factors were education (ORs range from 1.14 to 1.32) and being able to give a time for how long a baby should be breastfed (ORs range from 1.17 to 1.42). Conclusions: Being female, rating breastfeeding as important, believing that babies should be breastfed for a period of time and education accounted for most of the statistically significant associations. The differences between male and female perceptions require investigation particularly in relation to returning to work.	[Daly, Alison; Pollard, Christina Mary; Binns, Colin William] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia; [Pollard, Christina Mary] Dept Hlth, Perth, WA, Australia; [Phillips, Michael] Univ Western Australia, Harry Perkins Inst Med Res, Perth, WA 6009, Australia	Curtin University; Harry Perkins Institute of Medical Research; University of Western Australia	Pollard, CM (corresponding author), Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia.	C.Pollard@curtin.edu.au	Pollard, Christina/M-9539-2019; Binns, Colin/A-6012-2008	Pollard, Christina/0000-0003-4261-4601; Phillips, Michael/0000-0002-0252-9085; Binns, Colin/0000-0002-6220-3933	Healthway; Western Australian Health Promotion Foundation; Healthway [19986] Funding Source: researchfish	Healthway; Western Australian Health Promotion Foundation; Healthway	Curtin University received funding from Healthway, the Western Australian Health Promotion Foundation, to assist the translation of research into practice through the "Food Law, Policy and Communications to Improve Public Health Project". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2006, ARCH DIS CHILD, V91, P39, DOI 10.1136/adc.2005.082016; Anderson Joy, 2009, Breastfeed Rev, V17, P23; Australian Bureau of Statistics, 2010, POP AG SEX AUSTR STA; [Australian Government Department of Human Services Centrelink], 2013, BUS EMPL AUSTR GOV D; Australian Institute of Health and Welfare, 2011, 2010 AUSTR NAT INF F; Becker G, 2011, COCHRANE DB SYST REV, P12; Benazzi F, 2008, PROG NEURO-PSYCHOPH, V32, P186, DOI 10.1016/j.pnpbp.2007.08.005; Bonett DG, 2005, J EDUC BEHAV STAT, V30, P213, DOI 10.3102/10769986030002213; Boyer K, 2011, HEALTH PLACE, V17, P430, DOI 10.1016/j.healthplace.2010.06.013; Brodribb W, 2011, ACTA PAEDIATR, V100, P486, DOI 10.1111/j.1651-2227.2010.02108.x; BUTTE NF, 2001, NUTR ADEQUACY EXCLUS; Cardenas RA, 2005, J BUS PSYCHOL, V20, P31, DOI 10.1007/s10869-005-6982-0; Cattaneo A, 2005, PUBLIC HEALTH NUTR, V8, P39, DOI 10.1079/PHN2005660; Cooklin AR, 2008, ACTA PAEDIATR, V97, P620, DOI 10.1111/j.1651-2227.2008.00740.x; Dykes F, 2010, EARLY HUM DEV, V86, P733, DOI 10.1016/j.earlhumdev.2010.08.004; Fairbrother N, 2010, J HUM LACT, V26, P157, DOI 10.1177/0890334409352853; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; HOLM S, 1979, SCAND J STAT, V6, P65; Horta BL, 2007, EVIDENCE LONG TERM E; IP S, 2007, EVID REP TECHNOL ASS, V153, P1; Jansson M, 2009, WOMEN STUD INT FORUM, V32, P240, DOI 10.1016/j.wsif.2009.05.011; Kramer M S, 2002, Cochrane Database Syst Rev, pCD003517, DOI 10.1002/14651858.CD003517; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; McQueen D.V., 2003, GLOBAL BEHAV RISK FA; Moore ER, 2009, COCHRANE DATABASE SY; National Health and Medical Research Council, 2012, INF FEED GUID; National Health and Medical Research Council, 2012, LIT REV INF FEED GUI LIT REV INF FEED GUI; O'Brien M, 2009, ANN AM ACAD POLIT SS, V624, P190, DOI 10.1177/0002716209334349; Oddy WH, 2009, ADV EXP MED BIOL, V639, P237, DOI 10.1007/978-1-4020-8749-3_17; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Owen CG, 2008, AM J CLIN NUTR, V88, P305, DOI 10.1093/ajcn/88.2.305; Scott JA, 1997, J NUTR EDUC, V29, P244, DOI 10.1016/S0022-3182(97)70213-9; Scott JA, 2001, J PAEDIATR CHILD H, V37, P254, DOI 10.1046/j.1440-1754.2001.00646.x; Scott JA, 1999, ACTA PAEDIATR, V88, P416, DOI 10.1080/08035259950169800; Skafida V, 2012, MATERN CHILD HLTH J, V16, P519, DOI 10.1007/s10995-011-0743-7; U.S. Department of Health and Human Services, 2011, SURG GEN CALL ACTION; Weber D, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-19; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Cancer Research Fund/American Institute for Cancer Research, 2009, POL ACT CANC PREV FO; World Health Organization, 2008, 2008 2013 ACT PLAN G	40	18	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88204	10.1371/journal.pone.0088204	http://dx.doi.org/10.1371/journal.pone.0088204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516612	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400041
J	Gill, SE; Taneja, R; Rohan, M; Wang, LF; Mehta, S				Gill, Sean E.; Taneja, Ravi; Rohan, Marta; Wang, Lefeng; Mehta, Sanjay			Pulmonary Microvascular Albumin Leak Is Associated with Endothelial Cell Death in Murine Sepsis-Induced Lung Injury In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MICROCIRCULATORY ALTERATIONS; NADPH OXIDASE; PROTEIN LEAK; TNF-ALPHA; APOPTOSIS; PATHOPHYSIOLOGY; CYTOTOXICITY; DYSFUNCTION; GENERATION	Sepsis is a systemic inflammatory response that targets multiple components of the cardiovascular system including the microvasculature. Microvascular endothelial cells (MVEC) are central to normal microvascular function, including maintenance of the microvascular permeability barrier. Microvascular/MVEC dysfunction during sepsis is associated with barrier dysfunction, resulting in the leak of protein-rich edema fluid into organs, especially the lung. The specific role of MVEC apoptosis in septic microvascular/MVEC dysfunction in vivo remains to be determined. To examine pulmonary MVEC death in vivo under septic conditions, we used a murine cecal ligation/perforation (CLP) model of sepsis and identified non-viable pulmonary cells with propidium iodide (PI) by intravital videomicroscopy (IVVM), and confirmed this by histology. Septic pulmonary microvascular Evans blue (EB)-labeled albumin leak was associated with an increased number of PI-positive cells, which were confirmed to be predominantly MVEC based on specific labeling with three markers, anti-CD31 (PECAM), anti-CD34, and lectin binding. Furthermore, this septic death of pulmonary MVEC was markedly attenuated by cyclophosphamide-mediated depletion of neutrophils (PMN) or use of an anti-CD18 antibody developed for immunohistochemistry but shown to block CD18-dependent signaling. Additionally, septic pulmonary MVEC death was iNOS-dependent as mice lacking iNOS had markedly fewer PI-positive MVEC. Septic PI-positive pulmonary cell death was confirmed to be due to apoptosis by three independent markers: caspase activation by FLIVO, translocation of phosphatidylserine to the cell surface by Annexin V binding, and DNA fragmentation by TUNEL. Collectively, these findings indicate that septic pulmonary MVEC death, putatively apoptosis, is a result of leukocyte activation and iNOS-dependent signaling, and in turn, may contribute to pulmonary microvascular barrier dysfunction and albumin hyper-permeability during sepsis.	[Gill, Sean E.; Taneja, Ravi; Rohan, Marta; Wang, Lefeng; Mehta, Sanjay] London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, PIIRL, London, ON, Canada; [Gill, Sean E.; Mehta, Sanjay] Univ Western Ontario, Dept Med, Div Respirol, Schulich Sch Med & Dent, London, ON, Canada; [Gill, Sean E.] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada; [Taneja, Ravi] Univ Western Ontario, Dept Crit Care Med, Schulich Sch Med & Dent, London, ON, Canada; [Taneja, Ravi] Univ Western Ontario, Dept Anesthesia & Perioperat Med, Schulich Sch Med & Dent, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Mehta, S (corresponding author), London Hlth Sci Ctr, Lawson Hlth Res Inst, Ctr Crit Illness Res, PIIRL, London, ON, Canada.	Sanjay.Mehta@lhsc.on.ca	Mehta, Sanjay/G-3332-2011; Gill, Sean E/G-4057-2012	Mehta, Sanjay/0000-0002-7707-1056; 	Heart & Stroke Foundation of Ontario/Canada [T6461]; Ontario Thoracic Society; Lawson Health Research Institute; Parker B. Francis Fellowship	Heart & Stroke Foundation of Ontario/Canada; Ontario Thoracic Society; Lawson Health Research Institute; Parker B. Francis Fellowship	This work was supported by Heart & Stroke Foundation of Ontario/Canada grant #T6461 (www.heartandstroke.ca/); Ontario Thoracic Society (http://www.on.lung.ca/page.aspx?pid=421); Lawson Health Research Institute (https://www.lawsonresearch.com); and Parker B. Francis Fellowship (http://www.francisfellowships.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; BRATT J, 1995, ARTHRITIS RHEUM, V38, P768, DOI 10.1002/art.1780380609; Choi KB, 1998, J BIOL CHEM, V273, P20185, DOI 10.1074/jbc.273.32.20185; Cines DB, 1998, BLOOD, V91, P3527; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-27; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Driessens MHE, 1996, J LEUKOCYTE BIOL, V60, P758, DOI 10.1002/jlb.60.6.758; Ferrer R, 2009, AM J RESP CRIT CARE, V180, P861, DOI 10.1164/rccm.200812-1912OC; Fujita M, 1998, INT ARCH ALLERGY IMM, V117, P202, DOI 10.1159/000024011; Gao XP, 2002, J IMMUNOL, V168, P3974, DOI 10.4049/jimmunol.168.8.3974; Glauser MP, 2000, CRIT CARE MED, V28, pS4, DOI 10.1097/00003246-200009001-00002; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; Hemmer CJ, 2011, TROP MED INT HEALTH, V16, P906, DOI 10.1111/j.1365-3156.2011.02788.x; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hu HX, 2009, MICROVASC RES, V78, P33, DOI 10.1016/j.mvr.2009.04.005; Husak Liudmila, 2010, Healthc Q, V13 Spec No, P35; Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kuckleburg CJ, 2008, THROMB HAEMOSTASIS, V99, P363, DOI 10.1160/TH07-07-0474; LAM C, 1994, J CLIN INVEST, V94, P2077, DOI 10.1172/JCI117562; Matsuda N, 2007, CARDIOVASC RES, V76, P132, DOI 10.1016/j.cardiores.2007.05.024; Matsuda N, 2010, AM J PHYSIOL-HEART C, V298, pH92, DOI 10.1152/ajpheart.00069.2009; McCormack DG, 2000, MICROVASC RES, V60, P131, DOI 10.1006/mvre.2000.2261; Mehta S, 2005, VASC PHARMACOL, V43, P390, DOI 10.1016/j.vph.2005.08.013; Mehta S, 1999, CRIT CARE MED, V27, P385, DOI 10.1097/00003246-199902000-00047; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Razavi HM, 2005, CRIT CARE MED, V33, P1333, DOI 10.1097/01.CCM.0000165445.48350.4F; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Razavi HM, 2002, CRIT CARE MED, V30, P868, DOI 10.1097/00003246-200204000-00026; Reinhart K, 2002, CRIT CARE MED, V30, pS302, DOI 10.1097/00003246-200205001-00021; Rudkowski JC, 2004, AM J PHYSIOL-LUNG C, V286, pL793, DOI 10.1152/ajplung.00266.2003; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Sandrock CE, 2010, SEMIN RESP CRIT CARE, V31, P66, DOI 10.1055/s-0029-1246290; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Schmidt EP, 2011, PHYSIOLOGY, V26, P334, DOI 10.1152/physiol.00011.2011; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Shelton JL, 2008, MICROVASC RES, V76, P80, DOI 10.1016/j.mvr.2008.06.001; Shelton JL, 2007, MICROVASC RES, V74, P23, DOI 10.1016/j.mvr.2007.02.008; Shelton JL, 2006, MICROVASC RES, V71, P40, DOI 10.1016/j.mvr.2005.11.003; Trzeciak S, 2007, ANN EMERG MED, V49, P88, DOI 10.1016/j.annemergmed.2006.08.021; Vallet B, 2002, CRIT CARE MED, V30, pS229, DOI 10.1097/00003246-200205001-00010; Vincent JL, 2002, CRIT CARE MED, V30, pS313, DOI 10.1097/00003246-200205001-00022; Wagner JG, 1999, J LEUKOCYTE BIOL, V66, P10, DOI 10.1002/jlb.66.1.10; Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a; Wang LF, 2010, BIOCHEM BIOPH RES CO, V401, P207, DOI 10.1016/j.bbrc.2010.09.029; Wang LF, 2002, AM J RESP CRIT CARE, V165, P1634, DOI 10.1164/rccm.2110017; Wang LF, 2001, BIOCHEM BIOPH RES CO, V283, P694, DOI 10.1006/bbrc.2001.4842; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wu DF, 2001, MOL PHARMACOL, V59, P795, DOI 10.1124/mol.59.4.795; Yamaoka J, 2002, BIOCHEM BIOPH RES CO, V291, P780, DOI 10.1006/bbrc.2002.6487; Yang JJ, 2001, AM J PATHOL, V158, P581, DOI 10.1016/S0002-9440(10)64000-X; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yang SL, 2002, SHOCK, V17, P55, DOI 10.1097/00024382-200201000-00010; ZAHALKA MA, 1993, J IMMUNOL, V150, P4466; Zhou M, 2004, ANN SURG, V240, P321, DOI 10.1097/01.sla.0000133253.45591.5b	61	62	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88501	10.1371/journal.pone.0088501	http://dx.doi.org/10.1371/journal.pone.0088501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516666	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400074
J	Bao, ZM; Stodghill, PV; Myers, CR; Lam, H; Wei, HL; Chakravarthy, S; Kvitko, BH; Collmer, A; Cartinhour, SW; Schweitzer, P; Swingle, B				Bao, Zhongmeng; Stodghill, Paul V.; Myers, Christopher R.; Lam, Hanh; Wei, Hai-Lei; Chakravarthy, Suma; Kvitko, Brian H.; Collmer, Alan; Cartinhour, Samuel W.; Schweitzer, Peter; Swingle, Bryan			Genomic Plasticity Enables Phenotypic Variation of Pseudomonas syringae pv. tomato DC3000	PLOS ONE			English	Article							SECRETION SYSTEM EFFECTORS; GENE DUPLICATION; III EFFECTORS; ESCHERICHIA-COLI; AVIRULENCE GENES; REGULON MEMBERS; EVOLUTION; PATHOGEN; BACTERIA; IDENTIFICATION	Whole genome sequencing revealed the presence of a genomic anomaly in the region of 4.7 to 4.9 Mb of the Pseudomonas syringae pv. tomato (Pst) DC3000 genome. The average read depth coverage of Pst DC3000 whole genome sequencing results suggested that a 165 kb segment of the chromosome had doubled in copy number. Further analysis confirmed the 165 kb duplication and that the two copies were arranged as a direct tandem repeat. Examination of the corresponding locus in Pst NCPPB1106, the parent strain of Pst DC3000, suggested that the 165 kb duplication most likely formed after the two strains diverged via transposition of an ISPsy5 insertion sequence (IS) followed by unequal crossing over between ISPsy5 elements at each end of the duplicated region. Deletion of one copy of the 165 kb region demonstrated that the duplication facilitated enhanced growth in some culture conditions, but did not affect pathogenic growth in host tomato plants. These types of chromosomal structures are predicted to be unstable and we have observed resolution of the 165 kb duplication to single copy and its subsequent re-duplication. These data demonstrate the role of IS elements in recombination events that facilitate genomic reorganization in P. syringae.	[Bao, Zhongmeng; Lam, Hanh; Wei, Hai-Lei; Chakravarthy, Suma; Collmer, Alan; Cartinhour, Samuel W.; Swingle, Bryan] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Stodghill, Paul V.; Cartinhour, Samuel W.; Swingle, Bryan] ARS, USDA, Ithaca, NY USA; [Myers, Christopher R.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Kvitko, Brian H.] Michigan State Univ, MSU DOE Plant Res Lab, E Lansing, MI 48824 USA; [Schweitzer, Peter] Cornell Univ, Biotechnol Resource Ctr, Ithaca, NY USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Michigan State University; United States Department of Energy (DOE); Cornell University	Swingle, B (corresponding author), Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA.	Bryan.Swingle@ars.usda.gov	Lam, Hanh/AAV-9060-2020; Myers, Christopher R/I-8516-2017; Swingle, Bryan/AAX-6102-2021; Wei, Hailei/AAD-8664-2020; Wei, Hai-Lei/N-9495-2013	Lam, Hanh/0000-0002-6323-2146; Wei, Hailei/0000-0001-6554-009X; Chakravarthy, Suma/0000-0001-8245-998X	USDA-ARS; National Science Foundation [IOS-1025642]; ARS [ARS-0423000] Funding Source: Federal RePORTER	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Science Foundation(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by the USDA-ARS. This work was partially supported by National Science Foundation Plant Genome Research Program Grant IOS-1025642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; ANDERSON RP, 1979, COLD SPRING HARB SYM, V43, P1083, DOI 10.1101/SQB.1979.043.01.120; ANDERSON RP, 1977, ANNU REV MICROBIOL, V31, P473, DOI 10.1146/annurev.mi.31.100177.002353; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Bao ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050617; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025773; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Brigulla M, 2010, APPL MICROBIOL BIOT, V86, P1027, DOI 10.1007/s00253-010-2489-3; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CAIRNS J, 1991, GENETICS, V128, P695; Cunnac S, 2011, P NATL ACAD SCI USA, V108, P2975, DOI 10.1073/pnas.1013031108; CUPPELS DA, 1986, APPL ENVIRON MICROB, V51, P323, DOI 10.1128/AEM.51.2.323-327.1986; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Filiatrault MJ, 2010, J BACTERIOL, V192, P2359, DOI 10.1128/JB.01445-09; Garcia-Gonzalez A, 2013, GENE, V528, P295, DOI 10.1016/j.gene.2013.05.082; Gardan L, 1999, INT J SYST BACTERIOL, V49, P469, DOI 10.1099/00207713-49-2-469; Greenberg JT, 2003, CURR OPIN MICROBIOL, V6, P20, DOI 10.1016/S1369-5274(02)00004-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim JF, 1998, MOL PLANT MICROBE IN, V11, P1247, DOI 10.1094/MPMI.1998.11.12.1247; KING EO, 1954, J LAB CLIN MED, V44, P301; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kugelberg E, 2010, GENETICS, V185, P65, DOI 10.1534/genetics.110.114074; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Kvitko BH, 2011, METHODS MOL BIOL, V712, P109, DOI 10.1007/978-1-61737-998-7_10; Landgraf A, 2006, MOL PLANT PATHOL, V7, P355, DOI 10.1111/j.1364-3703.2006.00343.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence Jeffrey G., 2009, V532, P29, DOI 10.1007/978-1-60327-853-9_3; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Luria SE, 1943, GENETICS, V28, P491; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mansfield JW, 2009, MOL PLANT PATHOL, V10, P721, DOI 10.1111/j.1364-3703.2009.00576.x; Markel E, 2013, APPL ENVIRON MICROB, V79, P725, DOI 10.1128/AEM.02801-12; Markel E, 2011, J BACTERIOL, V193, P5775, DOI 10.1128/JB.05114-11; Marsin S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000146; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Monteil CL, 2013, NEW PHYTOL, V199, P800, DOI 10.1111/nph.12316; O'Brien HE, 2011, ANNU REV PHYTOPATHOL, V49, P269, DOI 10.1146/annurev-phyto-072910-095242; Oldfield NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069746; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pettersson ME, 2005, GENETICS, V169, P1105, DOI 10.1534/genetics.104.030338; Pitman AR, 2005, CURR BIOL, V15, P2230, DOI 10.1016/j.cub.2005.10.074; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Skovgaard O, 2011, GENOME RES, V21, P1388, DOI 10.1101/gr.117416.110; STASKAWICZ BJ, 1984, P NATL ACAD SCI-BIOL, V81, P6024, DOI 10.1073/pnas.81.19.6024; Stavrinides J, 2006, PLOS PATHOG, V2, P913, DOI 10.1371/journal.ppat.0020104; Swingle B, 2008, MOL MICROBIOL, V68, P871, DOI 10.1111/j.1365-2958.2008.06209.x; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Zhou K, 2013, FEMS MICROBIOL REVS; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	64	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86628	10.1371/journal.pone.0086628	http://dx.doi.org/10.1371/journal.pone.0086628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516535	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700010
J	Benitez-Quiroz, CF; Gokgoz, K; Wilbur, RB; Martinez, AM				Benitez-Quiroz, C. Fabian; Goekgoez, Kadir; Wilbur, Ronnie B.; Martinez, Aleix M.			Discriminant Features and Temporal Structure of Nonmanuals in American Sign Language	PLOS ONE			English	Article							SYNTAX	To fully define the grammar of American Sign Language (ASL), a linguistic model of its nonmanuals needs to be constructed. While significant progress has been made to understand the features defining ASL manuals, after years of research, much still needs to be done to uncover the discriminant nonmanual components. The major barrier to achieving this goal is the difficulty in correlating facial features and linguistic features, especially since these correlations may be temporally defined. For example, a facial feature (e.g., head moves down) occurring at the end of the movement of another facial feature (e.g., brows moves up), may specify a Hypothetical conditional, but only if this time relationship is maintained. In other instances, the single occurrence of a movement (e.g., brows move up) can be indicative of the same grammatical construction. In the present paper, we introduce a linguistic-computational approach to efficiently carry out this analysis. First, a linguistic model of the face is used to manually annotate a very large set of 2,347 videos of ASL nonmanuals (including tens of thousands of frames). Second, a computational approach is used to determine which features of the linguistic model are more informative of the grammatical rules under study. We used the proposed approach to study five types of sentences - Hypothetical conditionals, Yes/no questions, Wh-questions, Wh-questions postposed, and Assertions - plus their polarities - positive and negative. Our results verify several components of the standard model of ASL nonmanuals and, most importantly, identify several previously unreported features and their temporal relationship. Notably, our results uncovered a complex interaction between head position and mouth shape. These findings define some temporal structures of ASL nonmanuals not previously detected by other approaches.	[Benitez-Quiroz, C. Fabian; Martinez, Aleix M.] Ohio State Univ, Columbus, OH 43210 USA; [Goekgoez, Kadir; Wilbur, Ronnie B.] Purdue Univ, W Lafayette, IN 47907 USA	University System of Ohio; Ohio State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Martinez, AM (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	martinez.158@osu.edu	Gökgöz, Kadir/AAL-7544-2021	Gökgöz, Kadir/0000-0003-2777-7656	National Institutes of Health [R21 DC011081, R01 EY 020834]; NATIONAL EYE INSTITUTE [R01EY020834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by National Institutes of Health grants R21 DC011081 and R01 EY 020834. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons D, 1992, NORD J LINGUIST, V15; Aarons D, 1994, THESIS BOSTON U BOST; Abner N, 2010, P 28 W COAST C FORM, P24; ALLEN JF, 1984, ARTIF INTELL, V23, P123, DOI 10.1016/0004-3702(84)90008-0; Anderson D, 1998, SIGN LANGUAGE LINGUI, V2, P117, DOI DOI 10.1075/SLL.1.2.03AND; Bahan B, 1996, THESIS BOSTON U BOST; Baker C., 1978, UNDERSTING LANGUA, P27; Baker-Shenk Charlotte Lee, 1983, THESIS U CALIFORNIA; Barbera G., 2012, THESIS U POMPEU FABR; Battison R., 1978, LEXICAL BORROWING AM; Berwick RC, 2011, COGNITIVE SCI, V35, P1207, DOI 10.1111/j.1551-6709.2011.01189.x; Boyes Braem P., 2001, HANDS ARE HEAD MOUTH; Brentari D., 2002, SIGN LANG LINGUIST, V5, P105, DOI [10.1075/sll.5.2.03bre, DOI 10.1075/SLL.5.2.03BRE]; Brentari Diane, 1998, PROSODIC MODEL SIGN; Brugman H., 2004, P LREC 2004 4 INT C; Chomsky N., 1986, KNOWLEDGE LANGUAGE I; Churng S, 2009, THESIS U WASHINGTON; Churng S, 2006, P 25 W COAST C FORM, P114; Churng S, 2011, SIGN LANG LINGUIST, V14, P9, DOI 10.1075/sll.14.1.03chu; Coulter G, 1978, P 2 NAT S SIGN LANG; Dachkovsky S, 2008, SIGNS TIME; de Vos C, 2009, LANG SPEECH, V52, P315, DOI 10.1177/0023830909103177; Ding LY, 2010, IEEE T PATTERN ANAL, V32, P2022, DOI 10.1109/TPAMI.2010.28; Fitch WT, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P137; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Geraci C., 2006, P N E LINGUISTIC SOC, P217; Gokgoz K, 2012, P FORM EXPT ADV SIGN; Gokgoz K, 2011, SIGN LANG LINGUIST, V14, P49, DOI 10.1075/sll.14.1.04gok; Gotardo PFU, 2011, IEEE T PATTERN ANAL, V33, P2051, DOI 10.1109/TPAMI.2011.50; Hrastinski I, 2010, THESIS PURDUE U W LA; Kelly D., 2009, PROC INT C MULTIMODA, P351; Lackner A, 2012, CODING MODALITY AUST; Liddell S.K., 1980, AM SIGN LANGUAGE SYN, DOI 10.1515/9783112418260; Liddell Scott K, 1986, SIGN LANG STUD, V52, P244; Lillo-Martin D, 1992, P 5 THEOR ISS SIGN L; Loeding BL, 2004, LECT NOTES COMPUT SC, V3118, P1079; Makaroglu B, 2012, THESIS ANKARA U; Martinez AM, 2005, IEEE T PATTERN ANAL, V27, P1934, DOI 10.1109/TPAMI.2005.250; Messing LS, 1999, GESTURE SPEECH SIGN; Nadolske MA, 2007, TRENDS LINGUIST-STUD, V188, P35; Neidle C., 2000, SYNTAX AM SIGN LANGU; Neidle C, 2002, FUNCTIONAL STRUCTURE, V1, P195; Neth D, 2010, VISION RES, V50, P1693, DOI 10.1016/j.visres.2010.05.024; Neth D, 2009, J VISION, V9, DOI 10.1167/9.1.5; Patschke C., 1999, SIGN LANGUAGE LINGUI, V2, P3, DOI [DOI 10.1075/SLL.2.1.03WIL, 10.1075/sll.2.1.03wil]; Pfau R., 2002, RIV GRAMM GEN, V27, P73; Pfau R., 2010, SIGNLANGUAGES, P381, DOI [DOI 10.1017/CBO9780511712203.018, 10.1017/CBO9780511712203.018]; Pitsikalis V, 2011, CVPRW, P1, DOI DOI 10.1109/CVPRW.2011.5981681; Porikli F, 2004, P COMP VIS PATT REC; Romero M, 2004, LINGUIST PHILOS, V27, P609, DOI 10.1023/B:LING.0000033850.15705.94; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Sandler W., 1989, PHONOLOGICAL REPRESE; Stokoe W., 1960, STUD LINGUISTICS, V8, P7; Stokoe W. C., 1965, DICT AM SIGN LANGUAG; Veinberg SC, 1990, SIGN LANGUAGE STUDIE, V68, P217, DOI DOI 10.1353/SLS.1990.0013; Watson K, 2010, THESIS PURDUE U W LA; Weast T, 2008, THESIS U TEXAS ARLIN; Wilbur R. B., 1994, SIGN LANGUAGE STUDY, V84, P221, DOI DOI 10.1353/SLS.1994.0019; Wilbur RB, 2000, SIGNS OF LANGUAGE REVISITED, P215; Wilbur RB, 1998, J PRAGMATICS, V30, P275, DOI 10.1016/S0378-2166(98)00003-4; Wilbur RB, 2011, P WORKSH SIGN LANG C; Wilbur RB, 2009, LANG SPEECH, V52; Wilbur RB, 2011, SIGN LANG LINGUIST, V14, P148, DOI 10.1075/sll.14.1.08wil; Zeshan U., 2004, LINGUIST TYPOL, V8, P1, DOI [10.1515/lity.2004.003, DOI 10.1515/LITY.2004.003]; Zhu ML, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-280	65	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86268	10.1371/journal.pone.0086268	http://dx.doi.org/10.1371/journal.pone.0086268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516528	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700007
J	Kanyas, S; Aydin, D; Kizilel, R; Demirel, AL; Kizilel, S				Kanyas, Selin; Aydin, Derya; Kizilel, Riza; Demirel, A. Levent; Kizilel, Seda			Nanoparticle and Gelation Stabilized Functional Composites of an Ionic Salt in a Hydrophobic Polymer Matrix	PLOS ONE			English	Article							MACROPOROUS CERAMICS; SILICA; PARTICLES; EMULSIONS; FOAMS	Polymer composites consisted of small hydrophilic pockets homogeneously dispersed in a hydrophobic polymer matrix are important in many applications where controlled release of the functional agent from the hydrophilic phase is needed. As an example, a release of biomolecules or drugs from therapeutic formulations or release of salt in anti-icing application can be mentioned. Here, we report a method for preparation of such a composite material consisted of small KCOOH salt pockets distributed in the styrene-butadiene-styrene (SBS) polymer matrix and demonstrate its effectiveness in anti-icing coatings. The mixtures of the aqueous KCOOH and SBS-cyclohexane solutions were firstly stabilized by adding silica nanoparticles to the emulsions and, even more, by gelation of the aqueous phase by agarose. The emulsions were observed in optical microscope to check its stability in time and characterized by rheological measurements. The dry composite materials were obtained via casting the emulsions onto the glass substrates and evaporations of the organic solvent. Composite polymer films were characterized by water contact angle (WCA) measurements. The release of KCOOH salt into water and the freezing delay experiments of water droplets on dry composite films demonstrated their anti-icing properties. It has been concluded that hydrophobic and thermoplastic SBS polymer allows incorporation of the hydrophilic pockets/phases through our technique that opens the possibility for controlled delivering of anti-icing agents from the composite.	[Kanyas, Selin; Demirel, A. Levent; Kizilel, Seda] Koc Univ, Istanbul, Turkey; [Aydin, Derya; Kizilel, Seda] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey; [Kizilel, Riza] Koc Univ, TUPRAS Energy Ctr KUTEM, Istanbul, Turkey; [Demirel, A. Levent] Koc Univ, Dept Chem, Istanbul, Turkey	Koc University; Koc University; Koc University; Tupras; Koc University	Kizilel, S (corresponding author), Koc Univ, Istanbul, Turkey.	skizilel@ku.edu.tr	Kizilel, Seda/P-3959-2014	Kizilel, Seda/0000-0001-9092-2698	Turkish Petroleum Oil Refineries (TUPRAS) Company	Turkish Petroleum Oil Refineries (TUPRAS) Company	This research was supported by Turkish Petroleum Oil Refineries (TUPRAS) Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akartuna I, 2008, LANGMUIR, V24, P7161, DOI 10.1021/la800478g; Akartuna I, 2009, LANGMUIR, V25, P12419, DOI 10.1021/la901916q; Akartuna I, 2009, POLYMER, V50, P3645, DOI 10.1016/j.polymer.2009.05.023; Akartuna I, 2008, ADV MATER, V20, P4714, DOI 10.1002/adma.200801888; Aranberri I, 2009, J POROUS MAT, V16, P429, DOI 10.1007/s10934-008-9215-x; Binks BP, 2002, ADV MATER, V14, P1824, DOI 10.1002/adma.200290010; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Busby W, 2002, POLYM INT, V51, P871, DOI 10.1002/pi.934; Cayre OJ, 2004, J MATER CHEM, V14, P3351, DOI 10.1039/b411359d; Dai LL, 2005, LANGMUIR, V21, P2641, DOI 10.1021/la047256t; Dickinson E, 1997, J COLLOID INTERF SCI, V191, P166, DOI 10.1006/jcis.1997.4939; Duan HW, 2005, NANO LETT, V5, P949, DOI 10.1021/nl0505391; Dubois R, 1984, PROCESS PREVENTING F; French HK, 2001, J CONTAM HYDROL, V49, P23, DOI 10.1016/S0169-7722(00)00187-X; Haibach K, 2006, POLYMER, V47, P4513, DOI 10.1016/j.polymer.2006.03.114; Hellsten PP, 2005, ENVIRON SCI TECHNOL, V39, P5095, DOI 10.1021/es0482738; Ikem VO, 2010, ADV MATER, V22, P3588, DOI 10.1002/adma.201000729; Imhof A, 1998, CHEM ENG TECHNOL, V21, P682, DOI 10.1002/(SICI)1521-4125(199808)21:8<682::AID-CEAT682>3.0.CO;2-U; Imhof A, 1997, NATURE, V389, P948, DOI 10.1038/40105; Lee MN, 2012, LANGMUIR, V28, P3085, DOI 10.1021/la203384f; Lin Y, 2005, LANGMUIR, V21, P191, DOI 10.1021/la048000q; Locke C.E., 1987, TRANSP RES REC, V1113, P30; Melle S, 2005, LANGMUIR, V21, P2158, DOI 10.1021/la047691n; Menner A, 2006, POLYMER, V47, P7628, DOI 10.1016/j.polymer.2006.09.022; Pickering E C, 1907, Science, V25, P435, DOI 10.1126/science.25.637.435; Pulko I, 2008, CHEM COMMUN, P4481, DOI 10.1039/b807095d; Pulko I, 2010, CHEM-EUR J, V16, P2350, DOI 10.1002/chem.200903043; Qiao XY, 2012, COLLOID SURFACE A, V412, P20, DOI 10.1016/j.colsurfa.2012.06.026; Ramsden W, 1903, P R SOC, V72; Robidoux PY, 2001, ECOTOX ENVIRON SAFE, V48, P128, DOI 10.1006/eesa.2000.2035; RUCKENSTEIN E, 1991, J APPL POLYM SCI, V42, P2429, DOI 10.1002/app.1991.070420908; Velikov KP, 2007, COLLOID STABILITY AP; Wei ZX, 2002, ADV MATER, V14, P1314, DOI 10.1002/1521-4095(20020916)14:18<1314::AID-ADMA1314>3.0.CO;2-9; Zoldesi CI, 2005, ADV MATER, V17, P924, DOI 10.1002/adma.200401183	34	10	12	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88125	10.1371/journal.pone.0088125	http://dx.doi.org/10.1371/journal.pone.0088125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516593	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700045
J	Makela, MR; Sietio, OM; de Vries, RP; Timonen, S; Hilden, K				Makela, Miia R.; Sietio, Outi-Maaria; de Vries, Ronald P.; Timonen, Sari; Hilden, Kristiina			Oxalate-Metabolising Genes of the White-Rot Fungus Dichomitus squalens Are Differentially Induced on Wood and at High Proton Concentration	PLOS ONE			English	Article							DEPENDENT FORMATE DEHYDROGENASE; CERIPORIOPSIS-SUBVERMISPORA; BROWN-ROT; PHANEROCHAETE-CHRYSOSPORIUM; MANGANESE PEROXIDASE; ORGANIC-ACIDS; EXPRESSION ANALYSIS; POSTIA-PLACENTA; PHLEBIA-RADIATA; DECARBOXYLASE	Oxalic acid is a prevalent fungal metabolite with versatile roles in growth and nutrition, including degradation of plant biomass. However, the toxicity of oxalic acid makes regulation of its intra-and extracellular concentration crucial. To increase the knowledge of fungal oxalate metabolism, a transcriptional level study on oxalate-catabolising genes was performed with an effective lignin-degrading white-rot fungus Dichomitus squalens, which has demonstrated particular abilities in production and degradation of oxalic acid. The expression of oxalic-acid decomposing oxalate decarboxylase (ODC) and formic-acid decomposing formate dehydrogenase (FDH) encoding genes was followed during the growth of D. squalens on its natural spruce wood substrate. The effect of high proton concentration on the regulation of the oxalate-catabolising genes was determined after addition of organic acid (oxalic acid) and inorganic acid (hydrochloric acid) to the liquid cultures of D. squalens. In order to evaluate the co-expression of oxalate-catabolising and manganese peroxidase (MnP) encoding genes, the expression of one MnP encoding gene, mnp1, of D. squalens was also surveyed in the solid state and liquid cultures. Sequential action of ODC and FDH encoding genes was detected in the studied cultivations. The odc1, fdh2 and fdh3 genes of D. squalens showed constitutive expression, whereas ODC2 and FHD1 most likely are the main responsible enzymes for detoxification of high concentrations of oxalic and formic acids. The results also confirmed the central role of ODC1 when D. squalens grows on coniferous wood. Phylogenetic analysis revealed that fungal ODCs have evolved from at least two gene copies whereas FDHs have a single ancestral gene. As a conclusion, the multiplicity of oxalate-catabolising genes and their differential regulation on wood and in acid-amended cultures of D. squalens point to divergent physiological roles for the corresponding enzymes.	[Makela, Miia R.; Sietio, Outi-Maaria; Timonen, Sari; Hilden, Kristiina] Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Helsinki, Finland; [de Vries, Ronald P.] CBS KNAW, Fungal Biodivers Ctr, Utrecht, Netherlands	University of Helsinki; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Makela, MR (corresponding author), Univ Helsinki, Div Microbiol & Biotechnol, Dept Food & Environm Sci, Viikki Bioctr 1, Helsinki, Finland.	miia.r.makela@helsinki.fi	Mäkelä, Miia R./F-2181-2011; de Vries, Ronald P./F-8125-2011; Hildén, Kristiina/B-7766-2009	Mäkelä, Miia R./0000-0003-0771-2329; de Vries, Ronald P./0000-0002-4363-1123; Hildén, Kristiina/0000-0002-0126-8186; Timonen, Sari/0000-0001-9039-5648; Sietio, Outi-Maaria/0000-0003-0127-9368	Academy of Finland [1133022, 1131819]; EC Marie Curie action [PERG08-GA-2010-276794]; The University of Helsinki Research Foundation	Academy of Finland(Academy of Finland); EC Marie Curie action(European Commission); The University of Helsinki Research Foundation	Financial support from the Academy of Finland (grant nos. 1133022 and 1131819), the EC Marie Curie action PERG08-GA-2010-276794 and The University of Helsinki Research Foundation grant are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 1999, ARCH BIOCHEM BIOPHYS, V366, P275, DOI 10.1006/abbi.1999.1216; Azam M, 2002, BIOCHEM J, V367, P67, DOI 10.1042/BJ20011573; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; DUTTON MV, 1994, FEMS MICROBIOL LETT, V116, P321, DOI 10.1016/0378-1097(94)90054-X; DUTTON MV, 1993, APPL MICROBIOL BIOT, V39, P5, DOI 10.1007/BF00166839; Fackler K, 2006, ENZYME MICROB TECH, V39, P1476, DOI 10.1016/j.enzmictec.2006.03.043; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Galkin S, 1998, BIOTECHNOL TECH, V12, P267, DOI 10.1023/A:1008842012539; Graz M, 2011, WORLD J MICROB BIOT, V27, P1885, DOI 10.1007/s11274-010-0647-5; Graz M, 2009, BIOMETALS, V22, P401, DOI 10.1007/s10534-008-9176-1; Hakala TK, 2004, ENZYME MICROB TECH, V34, P255, DOI 10.1016/j.enzmictec.2003.10.014; Hilden K, 2005, FUNGAL GENET BIOL, V42, P403, DOI 10.1016/j.fgb.2005.01.008; Hofrichter M, 1998, FEBS LETT, V434, P362, DOI 10.1016/S0014-5793(98)01023-0; Hofrichter M, 1999, APPL ENVIRON MICROB, V65, P1864; Kathiara M, 2000, MYCOL RES, V104, P345, DOI 10.1017/S095375629900129X; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KUAN IC, 1993, P NATL ACAD SCI USA, V90, P1242, DOI 10.1073/pnas.90.4.1242; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Makela M, 2002, ENZYME MICROB TECH, V30, P542, DOI 10.1016/S0141-0229(02)00012-1; Makela MR, 2006, CURR GENET, V50, P323, DOI 10.1007/s00294-006-0090-1; Makela MR, 2010, APPL MICROBIOL BIOT, V87, P801, DOI 10.1007/s00253-010-2650-z; Makela MR, 2009, MICROBIOL-SGM, V155, P2726, DOI 10.1099/mic.0.028860-0; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; MEHTA A, 1991, J BIOL CHEM, V266, P23548; Micales JA, 1997, INT BIODETER BIODEGR, V39, P125, DOI 10.1016/S0964-8305(97)00009-7; Munir E, 2001, J WOOD SCI, V47, P368, DOI 10.1007/BF00766787; NICHOLLS P, 1975, BIOCHEM BIOPH RES CO, V67, P610, DOI 10.1016/0006-291X(75)90856-6; POPOV VO, 1994, BIOCHEM J, V301, P625, DOI 10.1042/bj3010625; Sato S, 2007, MICROBIOL-SGM, V153, P3023, DOI 10.1099/mic.0.2006/000513-0; SHIMADA M, 1994, FEMS MICROBIOL REV, V13, P285, DOI 10.1111/j.1574-6976.1994.tb00049.x; Suzuki MR, 2006, ENVIRON MICROBIOL, V8, P2214, DOI 10.1111/j.1462-2920.2006.01160.x; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang JD, 2013, APPL ENVIRON MICROB, V79, P1523, DOI 10.1128/AEM.02916-12; Tanner A, 2000, J BACTERIOL, V182, P5271, DOI 10.1128/JB.182.18.5271-5273.2000; Urzua U, 1998, APPL ENVIRON MICROB, V64, P68; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Varela E, 2003, APPL ENVIRON MICROB, V69, P6025, DOI 10.1128/AEM.69.10.6025-6031.2003; Watanabe T, 2005, ENZYME MICROB TECH, V37, P68, DOI 10.1016/j.enzmictec.2005.01.032; Watanabe T, 2008, FEMS MICROBIOL LETT, V279, P64, DOI 10.1111/j.1574-6968.2007.01022.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Zhu CX, 2010, APPL BIOCHEM BIOTECH, V160, P655, DOI 10.1007/s12010-009-8571-6	49	23	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87959	10.1371/journal.pone.0087959	http://dx.doi.org/10.1371/journal.pone.0087959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505339	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200091
J	Numata, R; Okumura, N; Nakahara, M; Ueno, M; Kinoshita, S; Kanematsu, D; Kanemura, Y; Sasai, Y; Koizumi, N				Numata, Ryohei; Okumura, Naoki; Nakahara, Makiko; Ueno, Morio; Kinoshita, Shigeru; Kanematsu, Daisuke; Kanemura, Yonehiro; Sasai, Yoshiki; Koizumi, Noriko			Cultivation of Corneal Endothelial Cells on a Pericellular Matrix Prepared from Human Decidua-Derived Mesenchymal Cells	PLOS ONE			English	Article							ROCK INHIBITOR; RABBIT MODEL; KERATOPLASTY; TRANSPLANTATION; MEMBRANE; SHEET; CULTURE; GROWTH; MONKEY; ACID	The barrier and pump functions of the corneal endothelium are essential for the maintenance of corneal transparency. Although corneal transplantation is the only current therapy for treating corneal endothelial dysfunction, the potential of tissue-engineering techniques to provide highly efficient and less invasive therapy in comparison to corneal transplantation has been highly anticipated. However, culturing human corneal endothelial cells (HCECs) is technically difficult, and there is no established culture protocol. The aim of this study was to investigate the feasibility of using a pericellular matrix prepared from human decidua-derived mesenchymal cells (PCM-DM) as an animal-free substrate for HCEC culture for future clinical applications. PCM-DM enhanced the adhesion of monkey CECs (MCECs) via integrin, promoted cell proliferation, and suppressed apoptosis. The HCECs cultured on the PCM-DM showed a hexagonal morphology and a staining profile characteristic of Na+/K+-ATPase and ZO-1 at the plasma membrane in vivo, whereas the control HCECs showed a fibroblastic phenotype. The cell density of the cultured HCECs on the PCM-DM was significantly higher than that of the control cells. These results indicate that PCM-DM provides a feasible xeno-free matrix substrate and that it offers a viable in vitro expansion protocol for HCECs while maintaining cellular functions for use as a subsequent clinical intervention for tissue-engineered based therapy of corneal endothelial dysfunction.	[Numata, Ryohei; Okumura, Naoki; Nakahara, Makiko; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Okumura, Naoki; Ueno, Morio; Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kanematsu, Daisuke; Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Inst Clin Res, Div Regenerat Med, Osaka, Japan; [Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Sayo, Hyogo, Japan	Doshisha University; Kyoto Prefectural University of Medicine; Osaka National Hospital; RIKEN	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Cabinet Office in Japan [LS117]; Grants-in-Aid for Scientific Research [23390404] Funding Source: KAKEN	Cabinet Office in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the Funding Program for Next Generation World-Leading Researchers from the Cabinet Office in Japan (Koizumi: LS117); http://www.jsps.go.jp/english/e-jisedai/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshu A, 2012, SURV OPHTHALMOL, V57, P236, DOI 10.1016/j.survophthal.2011.10.005; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; BOURNE WM, 1998, T AM OPHTHAL SOC, V96, P239; Fukusumi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055226; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2005, EXP EYE RES, V81, P629, DOI 10.1016/j.exer.2005.06.012; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kanematsu D, 2011, DIFFERENTIATION, V82, P77, DOI 10.1016/j.diff.2011.05.010; KAUFMAN HE, 1977, INVEST OPHTH VIS SCI, V16, P265; Kinoshita S, 2004, EXP EYE RES, V78, P483, DOI 10.1016/j.exer.2003.09.004; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; MATSUBARA M, 1982, JPN J OPHTHALMOL, V26, P264; MATSUBARA M, 1983, JPN J OPHTHALMOL, V27, P444; Mehta JS, 2008, CORNEA, V27, P722, DOI 10.1097/QAI.0b013e31815e92ac; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Mimura T, 2005, INVEST OPHTH VIS SCI, V46, P3128, DOI 10.1167/iovs.05-0251; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Nagase T, 2009, DEV DYNAM, V238, P1118, DOI 10.1002/dvdy.21944; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069009; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shima N, 2011, INVEST OPHTH VIS SCI, V52, P8711, DOI 10.1167/iovs.11-7592; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Terry MA, 2008, OPHTHALMOLOGY, V115, P488, DOI 10.1016/j.ophtha.2007.10.035; Tourtas T, 2012, AM J OPHTHALMOL, V153, P1082, DOI 10.1016/j.ajo.2011.12.012; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yanaga H, 2004, AESTHET PLAST SURG, V28, P212, DOI 10.1007/s00266-004-3092-8; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814	40	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88169	10.1371/journal.pone.0088169	http://dx.doi.org/10.1371/journal.pone.0088169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505413	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200127
J	Sasanguie, D; Reynvoet, B				Sasanguie, Delphine; Reynvoet, Bert			Adults' Arithmetic Builds on Fast and Automatic Processing of Arabic Digits: Evidence from an Audiovisual Matching Paradigm	PLOS ONE			English	Article							MATHEMATICS ACHIEVEMENT; MAGNITUDE REPRESENTATIONS; INDIVIDUAL-DIFFERENCES; NUMBER-SENSE; DYSCALCULIA; ASSOCIATION; SYMBOLS; SKILLS	Several studies have shown that performance on symbolic number tasks is related to individual differences in arithmetic. However, it is not clear which process is responsible for this association, i.e. fast, automatic processing of symbols per se or access to the underlying non-symbolic representation of the symbols. To dissociate between both options, adult participants performed an audiovisual matching paradigm. Auditory presented number words needed to be matched with either Arabic digits or dot patterns. The results revealed that a distance effect was present in the dots-number word matching task and absent in the digit-number word matching task. Crucially, only performance in the digit task contributed to the variance in arithmetical abilities. This led us to conclude that adults' arithmetic builds on the ability to quickly and automatically process Arabic digits, without the underlying non-symbolic magnitude representation being activated.	[Sasanguie, Delphine; Reynvoet, Bert] Katholieke Univ Leuven, Louvain, Belgium; [Sasanguie, Delphine; Reynvoet, Bert] Fac Psychol & Educ Sci Kulak, Kortrijk, Belgium	KU Leuven	Sasanguie, D (corresponding author), Katholieke Univ Leuven, Louvain, Belgium.	Delphine.Sasanguie@kuleuven-kulak.be		Sasanguie, Delphine/0000-0002-3356-5097; Reynvoet, Bert/0000-0002-4898-2475	Research Fund KU Leuven	Research Fund KU Leuven(KU Leuven)	Delphine Sasanguie is a postdoctoral research fellow of the Research Fund Flanders (www.fwo.be). This research was also supported by the Research Fund KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari, 2013, NUMERACY, V6, P1, DOI [10.5038/1936-4660.6.1.2, DOI 10.5038/1936-4660.6.1.2]; Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Carey S., 2009, ORIGIN CONCEPTS; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Castronovo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033832; Cirino PT, 2011, J EXP CHILD PSYCHOL, V108, P713, DOI 10.1016/j.jecp.2010.11.004; Cohen DJ, 2013, COGNITIVE PSYCHOL, V66, P355, DOI 10.1016/j.cogpsych.2013.03.001; De Smedt B, 2013, TRENDS NEUR IN PRESS; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; De Vos T., 1992, TEMPOTEST REKENEN TT; Defever E, 2013, J EXP CHILD IN PRESS; Defever E, 2012, ACTA PSYCHOL, V140, P35, DOI 10.1016/j.actpsy.2012.02.005; Dehaene S., 1997, NUMBER SENSE; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; He LX, 2014, CEREB CORTEX, V24, P2199, DOI 10.1093/cercor/bht074; Holloway ID, 2010, NEUROIMAGE, V49, P1006, DOI 10.1016/j.neuroimage.2009.07.071; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; Kolkman ME, 2013, LEARN INSTR, V25, P95, DOI 10.1016/j.learninstruc.2012.12.001; Lyons IM, 2012, J EXP PSYCHOL GEN, V141, P635, DOI 10.1037/a0027248; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Noel MP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00165; Noel MP, 2008, BEHAV BRAIN SCI, V31, P664, DOI 10.1017/S0140525X08005815; Raven J., 1962, ADV PROGR MATRICES S; Reigosa-Crespo V, 2012, DEV PSYCHOL, V48, P123, DOI 10.1037/a0025356; Restle F., 1970, J EXP PSYCHOL, V91, P191; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Sasanguie D, 2014, Q J EXP PSYCHOL, V67, P271, DOI 10.1080/17470218.2013.803581; Sasanguie D, 2013, NEUROPSYCHOLOGIA, V51, P1528, DOI 10.1016/j.neuropsychologia.2013.05.001; Sasanguie D, 2013, J EXP CHILD PSYCHOL, V114, P418, DOI 10.1016/j.jecp.2012.10.012; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87739	10.1371/journal.pone.0087739	http://dx.doi.org/10.1371/journal.pone.0087739			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505308	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200067
J	Xu, Q; Xia, P; Li, X; Wang, W; Liu, ZQ; Gao, X				Xu, Qiong; Xia, Pu; Li, Xi; Wang, Wei; Liu, Zhenqi; Gao, Xin			Tetramethylpyrazine Ameliorates High Glucose-Induced Endothelial Dysfunction by Increasing Mitochondrial Biogenesis	PLOS ONE			English	Article							HUO YI HAO; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; SUPEROXIDE-PRODUCTION; NITRIC-OXIDE; PGC-1-ALPHA; PREVENTION; ATHEROSCLEROSIS; EXPRESSION; HEALTH	Tetramethylpyrazine (TMP) is an active compound isolated from a Chinese herbal prescription that is widely used in traditional Chinese medicine for the treatment of inflammatory and cardiovascular diseases. We have previously reported that TMP acts as a potent antioxidant protecting endothelial cells against high glucose-induced damages. However, the molecular mechanism responsible for the antioxidant effect of TMP remains to be elucidated. In this study, we show that TMP increases nitric oxide production in endothelial cells and promotes endothelium-dependent relaxation in rate aortic rings. The antioxidant effect of TMP appears attributable to its ability to activate the mitochondrial biogenesis, as reflected in an up-regulation of complex III and amelioration of mitochondrial membrane potential. Furthermore, TMP is able to reverse high glucose-induced suppression of SIRT1 and the biogenesis-related factors, including PGC-1 alpha, NRF1 and TFAM, suggesting a new molecular mechanism underlying the protective effect of TMP on the endothelium.	[Xu, Qiong; Xia, Pu; Wang, Wei; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Li, Xi] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200433, Peoples R China; [Liu, Zhenqi] Univ Virginia Hlth Syst, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22908 USA	Fudan University; Fudan University; University of Virginia	Liu, ZQ (corresponding author), Univ Virginia Hlth Syst, Dept Med, Div Endocrinol & Metab, Charlottesville, VA 22908 USA.	zl3e@virginia.edu; zhongshan_endo@126.com	Xia, Pu/G-3090-2010; Stefanadis, Christodoulos/ABH-2232-2020	Xia, Pu/0000-0003-4705-8878; Stefanadis, Christodoulos/0000-0001-5974-6454; Gao, Xin/0000-0003-1864-7796	National Basic Research Program of China [2012CB524906, 2011CB504004]; National Natural Science Foundation of China [30871196]; National Ministry of Education Program [985 III-YFX0302]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Ministry of Education Program	This work was supported by: 1. Grants from the National Basic Research Program of China (2012CB524906 and 2011CB504004 to XG) (www.973.gov.cn); 2. The National Natural Science Foundation of China (No. 30871196 to XG) (www.nsfc.gov.cn); 3. The National Ministry of Education Program (985 III-YFX0302 to XG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin S, 2011, FREE RADICAL BIO MED, V51, P2243, DOI 10.1016/j.freeradbiomed.2011.08.036; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; DEMOURA RS, 1983, BRIT J PHARMACOL, V78, P449; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Gao X, 2011, LIFE SCI, V88, P803, DOI 10.1016/j.lfs.2011.02.025; Gao YJ, 2001, BRIT J PHARMACOL, V134, P1639, DOI 10.1038/sj.bjp.0704420; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gori T, 2011, ANN MED; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kang YX, 2009, LIFE SCI, V84, P428, DOI 10.1016/j.lfs.2009.01.003; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250; Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Sheikh-Ali M, 2011, AM J THER, V18, P266, DOI 10.1097/MJT.0b013e3181b7badf; Srinivasan S, 2004, DIABETOLOGIA, V47, P1727, DOI 10.1007/s00125-004-1525-1; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Tsioufis C, 2004, AM J HYPERTENS, V17, P470, DOI 10.1016/j.amjhyper.2004.02.008; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330; Victor VM, 2009, CURR MED CHEM, V16, P4654, DOI 10.2174/092986709789878265; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Xu Q, 2012, ACTA PHARMACOL SIN, V33, P496, DOI 10.1038/aps.2011.191; [余丹箐 Yu Danqing], 2004, [上海医学, Shanghai medical journal], V27, P466; Zoungas S, 2006, J AM COLL CARDIOL, V47, P1108, DOI 10.1016/j.jacc.2005.10.064	41	27	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88243	10.1371/journal.pone.0088243	http://dx.doi.org/10.1371/journal.pone.0088243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505445	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200149
J	Zuckerman, M; Silberman, J; Pham, H; Zahn, I				Zuckerman, Miron; Silberman, Jordan; Hoang Pham; Zahn, Ista			Unpriming or Strategizing?: A Critique of Sparrow and Wegner	PLOS ONE			English	Article								When asked to randomly select answer choices on easy multiple choice questions, people select more correct answers than expected by chance. Sparrow and Wegner showed that this tendency was eliminated if participants answered questions correctly before answering randomly. They argued that answering a question correctly unprimes the tendency to choose the correct answer, thereby reducing the correct response rate close to the chance level of. 5. An alternative explanation, consistent with these results, is that answering questions correctly provides a baseline, which allows participants to strategize, i.e., to match and mismatch equal numbers of their purportedly random responses to the baseline response. Three studies showed that the presence of a baseline, even when unpriming is not feasible, led to lower correct response rates than those obtained in a condition in which no baseline was available. Furthermore, the presence of a baseline led to more nonrandom sequences of correct and incorrect responses. One specific sequence-alternating correct and incorrect answers-mediated the relation between the presence of a baseline and lower correct response rate. These findings suggest that strategizing, not unpriming, accounts for Sparrow and Wegner's results.	[Zuckerman, Miron; Silberman, Jordan] Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA; [Hoang Pham] Univ Rochester, Warner Sch Educ, Rochester, NY USA; [Zahn, Ista] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	University of Rochester; University of Rochester; Harvard University	Zuckerman, M (corresponding author), Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA.	miron@psych.rochester.edu	Silberman, Jordan/GXN-3223-2022					Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Custers R, 2005, J PERS SOC PSYCHOL, V89, P129, DOI 10.1037/0022-3514.89.2.129; Dijksterhuis A, 2009, SOCIAL PSYCHOL UNCON, P51; Jarvis B. G., 2006, MEDIA LAB VERSION 20; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Oskarsson AT, 2009, PSYCHOL BULL, V135, P262, DOI 10.1037/a0014821; Sparrow B, 2006, J PERS SOC PSYCHOL, V91, P1009, DOI 10.1037/0022-3514.91.6.1009; Wegner DM, 2003, J PERS SOC PSYCHOL, V85, P5, DOI 10.1037/0022-3514.85.1.5	8	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87512	10.1371/journal.pone.0087512	http://dx.doi.org/10.1371/journal.pone.0087512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505293	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200052
J	Guzman, R; Nardecchia, S; Gutierrez, MC; Ferrer, ML; Ramos, V; del Monte, F; Abarrategi, A; Lopez-Lacomba, JL				Guzman, Rodrigo; Nardecchia, Stefania; Gutierrez, Maria C.; Luisa Ferrer, Maria; Ramos, Viviana; del Monte, Francisco; Abarrategi, Ander; Luis Lopez-Lacomba, Jose			Chitosan Scaffolds Containing Calcium Phosphate Salts and rhBMP-2: In Vitro and In Vivo Testing for Bone Tissue Regeneration	PLOS ONE			English	Article							CARBON NANOTUBE SCAFFOLDS; FAMILY-MEMBERS; DRUG-DELIVERY; GROWTH-FACTOR; HYDROXYAPATITE; PRECIPITATION; NANOPARTICLES; COMPOSITES; HYDROGELS; PURPOSES	Numerous strategies that are currently used to regenerate bone depend on employing biocompatible materials exhibiting a scaffold structure. These scaffolds can be manufactured containing particular active compounds, such as hydroxyapatite precursors and/or different growth factors to enhance bone regeneration process. Herein, we have immobilized calcium phosphate salts (CPS) and bone morphogenetic protein 2 (BMP-2) - combined or alone - into chitosan scaffolds using ISISA process. We have analyzed whether the immobilized bone morphogenetic protein preserved its osteoinductive capability after manufacturing process as well as BMP-2 in vitro release kinetic. We have also studied both the in vitro and in vivo biocompatibility of the resulting scaffolds using a rabbit model. Results indicated that rhBMP-2 remained active in the scaffolds after the manufacturing process and that its release kinetic was different depending on the presence of CPS. In vitro and in vivo findings showed that cells grew more in scaffolds with both CPS and rhBMP-2 and that these scaffolds induced more bone formation in rabbit tibia. Thus chitosan scaffolds containing both CPS and rhBMP-2 were more osteoinductive than their counterparts alone indicating that could be useful for bone regeneration purposes, such as some applications in dentistry.	[Guzman, Rodrigo; Abarrategi, Ander; Luis Lopez-Lacomba, Jose] Univ Complutense Madrid, Inst Estudios Biofunc, Madrid, Spain; [Nardecchia, Stefania; Gutierrez, Maria C.; Luisa Ferrer, Maria; del Monte, Francisco] CSIC, ICMM, Madrid, Spain; [Ramos, Viviana] Parque Cient Madrid, Dept I D, Noricum Inc, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	del Monte, F (corresponding author), CSIC, ICMM, Campus Cantoblanco, Madrid, Spain.	delmonte@icmm.csic.es; anderabarrategi@gmail.com; lacomba@yahoo.com	Abarrategi, Ander/ABF-2373-2020; Guzmán Martínez, Rodrigo/A-8388-2015; del Monte, Francisco FdM/A-5643-2011; Ferrer, Maria Luisa/C-5463-2011; Nardecchia, Stefania/B-2655-2019; GUTIERREZ, MARIA CONCEPCION/B-5386-2013	Abarrategi, Ander/0000-0002-6510-2337; Guzmán Martínez, Rodrigo/0000-0002-7344-218X; del Monte, Francisco FdM/0000-0002-2868-0023; Ferrer, Maria Luisa/0000-0003-2284-8259; Nardecchia, Stefania/0000-0002-8033-8073; GUTIERREZ, MARIA CONCEPCION/0000-0001-8612-7974	Spanish Ministry of Economy and Competitiveness (MINECO) (CONSOLIDER project) [CSD2009-00088]; Ministerio de Ciencia e Innovacion [MAT2009-10214, MAT2011-25329, MAT2012-34811, SAF2011-27863]; Seventh Framework Programme of the European Commission (EuroNanomed ERA-NET initiative, REBONE project) [PI10/02985FIS]	Spanish Ministry of Economy and Competitiveness (MINECO) (CONSOLIDER project); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Seventh Framework Programme of the European Commission (EuroNanomed ERA-NET initiative, REBONE project)	This work was supported by Spanish Ministry of Economy and Competitiveness (MINECO) (CONSOLIDER project CSD2009-00088), Ministerio de Ciencia e Innovacion (MAT2009-10214, MAT2011-25329, MAT2012-34811, SAF2011-27863) and Seventh Framework Programme of the European Commission (EuroNanomed ERA-NET initiative, REBONE project; PI10/02985FIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229; Abarrategi A, 2008, BIOMACROMOLECULES, V9, P711, DOI 10.1021/bm701049g; Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021; Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912; Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z; Gutierrez MC, 2008, CHEM MATER, V20, P11, DOI 10.1021/cm7020164; Hortiguela MJ, 2011, BIOMACROMOLECULES, V12, P179, DOI 10.1021/bm1010883; Hortiguela MJ, 2008, J MATER CHEM, V18, P5933, DOI 10.1039/b815401e; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Lopez-Lacomba JL, 2006, BIOMACROMOLECULES, V7, P792, DOI 10.1021/bm050859e; MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0; Nardecchia S, 2012, LANGMUIR, V28, P15937, DOI 10.1021/la3033435; Nardecchia S, 2012, ADV FUNCT MATER, V22, P4411, DOI 10.1002/adfm.201200684; Okay O, 2002, POLYMER, V43, P1215, DOI 10.1016/S0032-3861(01)00723-6; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Skrtic D, 2000, J BIOMED MATER RES, V53, P381, DOI 10.1002/1097-4636(2000)53:4<381::AID-JBM12>3.0.CO;2-H; Sondi I, 2003, CHEM MATER, V15, P1322, DOI 10.1021/cm020852t; Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624; Tsiridis E, 2006, INJURY, V37, pS25, DOI 10.1016/j.injury.2006.08.021; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yao SH, 2005, KEY ENG MATER, V288-289, P661, DOI 10.4028/www.scientific.net/KEM.288-289.661; Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487	34	27	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87149	10.1371/journal.pone.0087149	http://dx.doi.org/10.1371/journal.pone.0087149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504411	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800017
J	Lezama-Ochoa, A; Irigoien, X; Chaigneau, A; Quiroz, Z; Lebourges-Dhaussy, A; Bertrand, A				Lezama-Ochoa, Ainhoa; Irigoien, Xabier; Chaigneau, Alexis; Quiroz, Zaida; Lebourges-Dhaussy, Anne; Bertrand, Arnaud			Acoustics Reveals the Presence of a Macrozooplankton Biocline in the Bay of Biscay in Response to Hydrological Conditions and Predator-Prey Relationships	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ZOOPLANKTON DISTRIBUTION; PLANKTON PATCHINESS; PHYSICAL PROCESSES; SPATIAL-PATTERNS; SIZE; SHELF; ZONE; FISH; PROPOSALS	Bifrequency acoustic data, hydrological measurements and satellite data were used to study the vertical distribution of macrozooplankton in the Bay of Biscay in relation to the hydrological conditions and fish distribution during spring 2009. The most noticeable result was the observation of a 'biocline' during the day i.e., the interface where zooplankton biomass changes more rapidly with depth than it does in the layers above or below. The biocline separated the surface layer, almost devoid of macrozooplankton, from the macrozooplankton-rich deeper layers. It is a specific vertical feature which ties in with the classic diel vertical migration pattern. Spatiotemporal correlations between macrozooplankton and environmental variables (photic depth, thermohaline vertical structure, stratification index and chlorophyll-a) indicate that no single factor explains the macrozooplankton vertical distribution. Rather a set of factors, the respective influence of which varies from region to region depending on the habitat characteristics and the progress of the spring stratification, jointly influence the distribution. In this context, the macrozooplankton biocline is potentially a biophysical response to the search for a particular depth range where light attenuation, thermohaline vertical structure and stratification conditions together provide a suitable alternative to the need for expending energy in reaching deeper water without the risk of being eaten.	[Lezama-Ochoa, Ainhoa; Irigoien, Xabier] AZTI Tecnalia, Marine Res Unit, Pasaia, Basque Country, Spain; [Lezama-Ochoa, Ainhoa; Bertrand, Arnaud] UM2, IRD, IFREMER, UMR212,EME, Sete, France; [Chaigneau, Alexis] UPS, CNRS, UMR5566, IRD,LEGOS,CNES, Toulouse, France; [Quiroz, Zaida] Inst Mar Peru IMARPE, Callao, Peru; [Lebourges-Dhaussy, Anne] UBO, IRD, UMR, LEMAR,CNRS, Plouzane, France	AZTI; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Instituto del Mar del Peru; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale	Lezama-Ochoa, A (corresponding author), UM2, IRD, IFREMER, UMR212,EME, Sete, France.	ainhoa.lezama-ochoa@ird.fr	Bertrand, Arnaud/E-4251-2010; Quiroz, Zaida/AFR-3924-2022; Irigoien, Xabier/B-8171-2009; Chaigneau, Alexis/E-4324-2010	Bertrand, Arnaud/0000-0003-4723-179X; Irigoien, Xabier/0000-0002-5411-6741; chaigneau, alexis/0000-0001-6770-0114; Quiroz Cornejo, Zaida/0000-0003-3821-0815	ECOANCHOA project - Department of Agriculture and Fisheries of the Basque Government; Ministry of Agriculture, Fishery and Food (MAPA), of the Spanish Government	ECOANCHOA project - Department of Agriculture and Fisheries of the Basque Government; Ministry of Agriculture, Fishery and Food (MAPA), of the Spanish Government(Spanish Government)	This work was supported by the ECOANCHOA project funded by the Department of Agriculture and Fisheries of the Basque Government and the Ministry of Agriculture, Fishery and Food (MAPA), of the Spanish Government and a grant to AL-O (Technological Centre Foundation). This work has also benefited from the cooperation agreement between the Institut de Recherche pour le Developpement and the Instituto del Mar del Peru and from the International Joint Laboratory Dynamics of the Humboldt Current System (LMI DISCOH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2009, LIMNOL OCEANOGR, V54, P1272, DOI 10.4319/lo.2009.54.4.1272; Albaina A, 2004, MAR ECOL PROG SER, V284, P65, DOI 10.3354/meps284065; Albaina A, 2007, J PLANKTON RES, V29, P851, DOI 10.1093/plankt/fbm064; Ayata SD, 2011, J PLANKTON RES, V33, P1193, DOI 10.1093/plankt/fbr030; Ballon M, 2011, PROG OCEANOGR, V91, P360, DOI 10.1016/j.pocean.2011.03.001; Beaudouin J., 1979, Revue des Travaux de l'Institut des Peches Maritimes, V43, P367; Beaudouin J., 1975, Revue Trav Inst Peches Marit, V39, P121; Borja A, 2004, OCEANOGRAPHY MARINE, P335; Cantin A, 2011, CAN J FISH AQUAT SCI, V68, P260, DOI 10.1139/F10-138; Carlotti F, 2010, PROG OCEANOGR, V84, P20, DOI 10.1016/j.pocean.2009.09.003; CASSIE R. MORRISON, 1963, NEW ZEALAND JOUR SCI, V6, P36; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Dale MRT, 2002, J AGR BIOL ENVIR ST, V14, P188; De Robertis A, 2002, LIMNOL OCEANOGR, V47, P925, DOI 10.4319/lo.2002.47.4.0925; De Robertis A, 2000, LIMNOL OCEANOGR, V45, P1838, DOI 10.4319/lo.2000.45.8.1838; DENMAN KL, 1984, OCEANOGR MAR BIOL, V22, P125; Dupont N, 2012, J PLANKTON RES, V34, P263, DOI 10.1093/plankt/fbr096; Evans GT, 1978, MAR SCI PLENUM, V3, P157; Fernandes P. G., 2006, Q5RS200102054 EC; Fiksen O, 1998, SARSIA, V83, P129; Fofonoff N. P., 1983, UNESCO TECH PAP MAR, V44, P53; Foote K.G., 1987, ICES COOPERATIVE RES, V144, P1, DOI DOI 10.1121/1.396131; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; HAMRIN SF, 1986, CAN J FISH AQUAT SCI, V43, P1617, DOI 10.1139/f86-200; Haury L.R., 1978, NATO Conference Series IV Marine Sciences, V3, P277; Hays GC, 2001, LIMNOL OCEANOGR, V46, P2050, DOI 10.4319/lo.2001.46.8.2050; Huskin I, 2003, J MARINE SYST, V42, P1, DOI 10.1016/S0924-7963(03)00061-7; Ianson D, 2004, LIMNOL OCEANOGR, V49, P2297, DOI 10.4319/lo.2004.49.6.2297; ICES, 2009, 2009LRC20 ICES CM; Irigoien X, 2011, J PLANKTON RES, V33, P1182, DOI 10.1093/plankt/fbr026; Irigoien X, 2009, J PLANKTON RES, V31, P1, DOI 10.1093/plankt/fbn096; Kaartvedt S, 2005, MAR ECOL PROG SER, V299, P1, DOI 10.3354/meps299001; Kloser RJ, 2002, CAN J FISH AQUAT SCI, V59, P1065, DOI 10.1139/F02-076; Korneliussen RJ, 2000, ICES J MAR SCI, V57, P1204, DOI 10.1006/jmsc.2000.0806; Korneliussen RJ, 2008, ICES J MAR SCI, V65, P982, DOI 10.1093/icesjms/fsn052; Koslow JA, 2009, ICES J MAR SCI, V66, P966, DOI 10.1093/icesjms/fsp082; Koutsikopoulos C, 1996, SCI MAR, V60, P9; Kullenberg G., 1978, SPATIAL PATTERN PLAN, P43; Lampert Winfried, 1993, Advances in Limnology, V39, P79; Lawson GL, 2008, DEEP-SEA RES PT II, V55, P432, DOI 10.1016/j.dsr2.2007.11.014; LEIBOLD MA, 1990, LIMNOL OCEANOGR, V35, P938, DOI 10.4319/lo.1990.35.4.0938; Lezama-Ochoa A, 2011, MAR ECOL PROG SER, V439, P151, DOI 10.3354/meps09318; Mackas DL, 2010, J MARINE SYST, V79, P286, DOI 10.1016/j.jmarsys.2008.11.030; MACKAS DL, 1985, B MAR SCI, V37, P652; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Maycas ER, 1999, DEEP-SEA RES PT II, V46, P2081, DOI 10.1016/S0967-0645(99)00056-9; MCLAREN IA, 1963, J FISH RES BOARD CAN, V20, P685, DOI 10.1139/f63-046; Mitson RB, 1996, ICES J MAR SCI, V53, P209, DOI 10.1006/jmsc.1996.0024; Motos L, 1996, SCI MAR, V60, P117; ONA E, 1990, J MAR BIOL ASSOC UK, V70, P107, DOI 10.1017/S002531540003424X; Ritz DA, 2011, ADV MAR BIOL, V60, P161, DOI 10.1016/B978-0-12-385529-9.00004-4; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; Simmonds J, 2005, FISHERIES ACOUSTICS, V2; Sourisseau M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003063; Stanton TK, 1996, ICES J MAR SCI, V53, P289, DOI 10.1006/jmsc.1996.0037; Tarling G, 2000, CAN J FISH AQUAT SCI, V57, P38, DOI 10.1139/cjfas-57-S3-38; Trenkel VM, 2011, MAR ECOL PROG SER, V442, P285, DOI 10.3354/meps09425; Urick R.J., 1986, AMBIENT NOISE SEA; WIEBE PH, 1992, DEEP-SEA RES, V39, pS247, DOI 10.1016/S0198-0149(11)80015-4; WIEBE PH, 1968, LIMNOL OCEANOGR, V13, P315, DOI 10.4319/lo.1968.13.2.0315; Woillez M, 2007, ICES J MAR SCI, V64, P537, DOI 10.1093/icesjms/fsm025; Yacobi YZ, 2006, J PLANKTON RES, V28, P725, DOI 10.1093/plankt/fbl004; Zarauz L, 2008, J PLANKTON RES, V30, P857, DOI 10.1093/plankt/fbn049	63	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88054	10.1371/journal.pone.0088054	http://dx.doi.org/10.1371/journal.pone.0088054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505374	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300045
J	McAdams, NM; Gollnick, P				McAdams, Natalie M.; Gollnick, Paul			The Bacillus subtilis TRAP Protein Can Induce Transcription Termination in the Leader Region of the Tryptophan Biosynthetic (trp) Operon Independent of the trp Attenuator RNA	PLOS ONE			English	Article							ESCHERICHIA-COLI; TRPEDCFBA OPERON; IN-VITRO; INTRINSIC TERMINATOR; GLYQS GENE; BINDING; MECHANISM; PREDICTION; SITES; ANTITERMINATION	In Bacillus subtilis, transcription of the tryptophan biosynthetic operon is regulated by an attenuation mechanism. When intracellular tryptophan levels are high, the TRAP protein binds to the 5'leader region of the nascent trp mRNA and induces transcription termination prior to the structural genes. In limiting tryptophan, TRAP does not bind and the operon is transcribed. Two competing RNA secondary structures termed the antiterminator and terminator (attenuator) can form in the leader region RNA. In prior attenuation models, the only role of TRAP binding was to alter the RNA secondary structure to allow formation of the attenuator, which has been thought function as an intrinsic transcription terminator. However, recent studies have shown that the attenuator is not an effective intrinsic terminator. From these studies it was not clear whether TRAP functions independently or requires the presence of the attenuator RNA structure. Hence we have further examined the role of the attenuator RNA in TRAP-mediated transcription termination. TRAP was found to cause efficient transcription termination in the trp leader region in vivo when the attenuator was mutated or deleted. However, TRAP failed to induce transcription termination at these mutant attenuators in a minimal in vitro transcription system with B. subtilis RNA polymerase. Further studies using this system showed that NusA as well as the timing of TRAP binding to RNA play a role in the observed differences in vivo and in vitro.	[McAdams, Natalie M.; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gollnick, P (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	gollnick@buffalo.edu			National Science Foundation [MCB 1019969]; Direct For Biological Sciences [1019960] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Grant MCB 1019969 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; ANTSON AA, 1994, J MOL BIOL, V244, P1, DOI 10.1006/jmbi.1994.1698; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; Babitzke P, 2003, METHOD ENZYMOL, V371, P392; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; Barbolina MV, 2007, J MOL BIOL, V370, P925, DOI 10.1016/j.jmb.2007.05.027; Baumann C, 1996, J BIOL CHEM, V271, P12269, DOI 10.1074/jbc.271.21.12269; CARAFA YD, 1990, J MOL BIOL, V216, P835, DOI 10.1016/S0022-2836(99)80005-9; CARLTON BC, 1969, GENETICS, V62, P445; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Du H, 2000, J BACTERIOL, V182, P1819, DOI 10.1128/JB.182.7.1819-1827.2000; Ermolaeva MD, 2000, J MOL BIOL, V301, P27, DOI 10.1006/jmbi.2000.3836; GOLLNICK P, 1994, MOL MICROBIOL, V11, P991, DOI 10.1111/j.1365-2958.1994.tb00377.x; GOLLNICK P, 1990, P NATL ACAD SCI USA, V87, P8726, DOI 10.1073/pnas.87.22.8726; Grundy FJ, 2005, J MOL BIOL, V346, P73, DOI 10.1016/j.jmb.2004.11.051; Grundy FJ, 2004, J BACTERIOL, V186, P5392, DOI 10.1128/JB.186.16.5392-5399.2004; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; KURODA MI, 1988, J BACTERIOL, V170, P3080, DOI 10.1128/jb.170.7.3080-3088.1988; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Miller J.H., 1972, EXPT MOL GENETICS; Mitra A, 2009, GENOMICS, V94, P110, DOI 10.1016/j.ygeno.2009.04.004; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Potter KD, 2011, NUCLEIC ACIDS RES, V39, P2092, DOI 10.1093/nar/gkq965; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Schaak JE, 2003, RNA, V9, P1502, DOI 10.1261/rna.5149603; SHIMOTSU H, 1986, GENE, V43, P85; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Szigeti R, 2004, J BACTERIOL, V186, P818, DOI 10.1128/JB.186.3.818-828.2004; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Washio T, 1998, NUCLEIC ACIDS RES, V26, P5456, DOI 10.1093/nar/26.23.5456; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; WU AM, 1981, P NATL ACAD SCI-BIOL, V78, P2913, DOI 10.1073/pnas.78.5.2913; Yakhnin AV, 2006, MOL CELL, V24, P547, DOI 10.1016/j.molcel.2006.09.018; Yakhnin AV, 2010, MOL MICROBIOL, V76, P690, DOI 10.1111/j.1365-2958.2010.07126.x; Yakhnin AV, 2002, P NATL ACAD SCI USA, V99, P11067, DOI 10.1073/pnas.162373299; YANG M, 1995, J BACTERIOL, V177, P4272, DOI 10.1128/jb.177.15.4272-4278.1995; Yang M, 1997, J MOL BIOL, V270, P696, DOI 10.1006/jmbi.1997.1149; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88097	10.1371/journal.pone.0088097	http://dx.doi.org/10.1371/journal.pone.0088097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505391	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300054
J	Noack, A; Noack, S; Hoffmann, A; Maalouf, K; Buettner, M; Couraud, PO; Romero, IA; Weksler, B; Alms, D; Romermann, K; Naim, HY; Loscher, W				Noack, Andreas; Noack, Sandra; Hoffmann, Andrea; Maalouf, Katia; Buettner, Manuela; Couraud, Pierre-Olivier; Romero, Ignacio A.; Weksler, Babette; Alms, Dana; Roemermann, Kerstin; Naim, Hassan Y.; Loescher, Wolfgang			Drug-Induced Trafficking of P-Glycoprotein in Human Brain Capillary Endothelial Cells as Demonstrated by Exposure to Mitomycin C	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTERS; INTRACELLULAR TRAFFICKING; MULTIDRUG-RESISTANCE; ANTIEPILEPTIC DRUGS; EFFLUX TRANSPORTERS; ABC TRANSPORTERS; EXPRESSION; BARRIER; HCMEC/D3; LINE	P-glycoprotein (Pgp; ABCB1/MDR1) is a major efflux transporter at the blood-brain barrier (BBB), restricting the penetration of various compounds. In other tissues, trafficking of Pgp from subcellular stores to the cell surface has been demonstrated and may constitute a rapid way of the cell to respond to toxic compounds by functional membrane insertion of the transporter. It is not known whether drug-induced Pgp trafficking also occurs in brain capillary endothelial cells that form the BBB. In this study, trafficking of Pgp was investigated in human brain capillary endothelial cells (hCMEC/D3) that were stably transfected with a doxycycline-inducible MDR1-EGFP fusion plasmid. In the presence of doxycycline, these cells exhibited a 15-fold increase in Pgp-EGFP fusion protein expression, which was associated with an increased efflux of the Pgp substrate rhodamine 123 (Rho123). The chemotherapeutic agent mitomycin C (MMC) was used to study drug-induced trafficking of Pgp. Confocal fluorescence microscopy of single hCMEC/D3-MDR1-EGFP cells revealed that Pgp redistribution from intracellular pools to the cell surface occurred within 2 h of MMC exposure. Pgp-EGFP exhibited a punctuate pattern at the cell surface compatible with concentrated regions of the fusion protein in membrane microdomains, i.e., lipid rafts, which was confirmed by Western blot analysis of biotinylated cell surface proteins in Lubrol-resistant membranes. MMC exposure also increased the functionality of Pgp as assessed in three functional assays with Pgp substrates (Rho123, eFluxx-ID Gold, calcein-AM). However, this increase occurred with some delay after the increased Pgp expression and coincided with the release of Pgp from the Lubrol-resistant membrane complexes. Disrupting rafts by depleting the membrane of cholesterol increased the functionality of Pgp. Our data present the first direct evidence of drug-induced Pgp trafficking at the human BBB and indicate that Pgp has to be released from lipid rafts to gain its full functionality.	[Noack, Andreas; Alms, Dana; Roemermann, Kerstin; Loescher, Wolfgang] Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany; [Noack, Sandra; Hoffmann, Andrea] Hannover Med Sch, Dept Trauma Surg, Hannover, Germany; [Maalouf, Katia; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [Buettner, Manuela] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany; [Couraud, Pierre-Olivier] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France; [Romero, Ignacio A.] Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; [Weksler, Babette] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Loescher, Wolfgang] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Open University - UK; Cornell University	Loscher, W (corresponding author), Univ Vet Med Hannover, Dept Pharmacol Toxicol & Pharm, Hannover, Germany.	wolfgang.loescher@tiho-hannover.de	Hoffmann, Andrea/AAG-4488-2020; Löscher, Wolfgang/G-9824-2016	Hoffmann, Andrea/0000-0003-2318-8985; Löscher, Wolfgang/0000-0002-9648-8973; Romero, Ignacio/0000-0002-0322-9180	Braukmann-Wittenberg-Herz-Stiftung (Burgwedel, Germany); Deutsche Forschungsgemeinschaft (Bonn, Germany)	Braukmann-Wittenberg-Herz-Stiftung (Burgwedel, Germany); Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG))	The authors would like to acknowledge the assistance of the Cell Sorting Core Facility of the Hannover Medical School supported in part by the Braukmann-Wittenberg-Herz-Stiftung (Burgwedel, Germany) and the Deutsche Forschungsgemeinschaft (Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroziak K, 2010, EUR J PHARMACOL, V628, P57, DOI 10.1016/j.ejphar.2009.11.051; Bauer B, 2003, PHARM RES-DORDR, V20, P1170, DOI 10.1023/A:1025040712857; Dauchy S, 2009, BIOCHEM PHARMACOL, V77, P897, DOI 10.1016/j.bcp.2008.11.001; EFFERTH T, 1989, ANTICANCER RES, V9, P1633; Fu D, 2004, INT J CANCER, V109, P174, DOI 10.1002/ijc.11659; Fu D, 2012, INT J BIOCHEM CELL B, V44, P461, DOI 10.1016/j.biocel.2011.12.009; Hartz AMS, 2004, MOL PHARMACOL, V66, P387, DOI 10.1124/mol.104.001503; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; Huber O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044776; Ihnat MA, 1999, ONCOL RES, V11, P303; Kim RB, 2001, CLIN PHARMACOL THER, V70, P189, DOI 10.1067/mcp.2001.117412; Kipp H, 2000, SEMIN LIVER DIS, V20, P339, DOI 10.1055/s-2000-9388; Kipp H, 2002, ANNU REV PHYSIOL, V64, P595, DOI 10.1146/annurev.physiol.64.081501.155793; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lee CA, 2010, EXPERT OPIN DRUG MET, V6, P603, DOI 10.1517/17425251003610640; Loscher W, 2011, CURR PHARM DESIGN, V17, P2808, DOI 10.2174/138161211797440212; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; Maitra R, 2001, BIOCHEM J, V355, P617, DOI 10.1042/bj3550617; McCaffrey G, 2012, J NEUROCHEM, V122, P962, DOI 10.1111/j.1471-4159.2012.07831.x; Mealey KL, 2002, ANTIMICROB AGENTS CH, V46, P755, DOI 10.1128/AAC.46.3.755-761.2002; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Ott M, 2010, PHARM RES-DORDR, V27, P811, DOI 10.1007/s11095-010-0074-1; Petriz Jordi, 2004, Current Drug Delivery, V1, P43, DOI 10.2174/1567201043480072; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Porcelli L, 2009, CURR TOP MED CHEM, V9, P197, DOI 10.2174/156802609787521562; Sai Y, 1999, J CELL SCI, V112, P4535; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Szakacs G, 1998, Pathol Oncol Res, V4, P251; Tai LM, 2009, BRAIN RES, V1292, P14, DOI 10.1016/j.brainres.2009.07.039; Urquhart BL, 2007, J CLIN PHARMACOL, V47, P566, DOI 10.1177/0091270007299930; Vogel M, 2008, J ANTIMICROB CHEMOTH, V61, P541, DOI 10.1093/jac/dkm513; Vutskits GV, 2006, BREAST CANCER RES TR, V99, P143, DOI 10.1007/s10549-006-9195-y; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhao ZZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-1	37	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88154	10.1371/journal.pone.0088154	http://dx.doi.org/10.1371/journal.pone.0088154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505408	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000336971300060
J	Pakrashi, S; Jain, N; Dalai, S; Jayakumar, J; Chandrasekaran, PT; Raichur, AM; Chandrasekaran, N; Mukherjee, A				Pakrashi, Sunandan; Jain, Nitin; Dalai, Swayamprava; Jayakumar, Jerobin; Chandrasekaran, Prathna Thanjavur; Raichur, Ashok M.; Chandrasekaran, Natarajan; Mukherjee, Amitava			In Vivo Genotoxicity Assessment of Titanium Dioxide Nanoparticles by Allium cepa Root Tip Assay at High Exposure Concentrations	PLOS ONE			English	Article							SILVER NANOPARTICLES; CYTOTOXICITY; RELEASE; PLANTS; VITRO; CELLS	The industrial production and commercial applications of titanium dioxide nanoparticles have increased considerably in recent times, which has increased the probability of environmental contamination with these agents and their adverse effects on living systems. This study was designed to assess the genotoxicity potential of TiO2 NPs at high exposure concentrations, its bio-uptake, and the oxidative stress it generated, a recognised cause of genotoxicity. Allium cepa root tips were treated with TiO2 NP dispersions at four different concentrations (12.5, 25, 50, 100 mu g/mL). A dose dependant decrease in the mitotic index (69 to 21) and an increase in the number of distinctive chromosomal aberrations were observed. Optical, fluorescence and confocal laser scanning microscopy revealed chromosomal aberrations, including chromosomal breaks and sticky, multipolar, and laggard chromosomes, and micronucleus formation. The chromosomal aberrations and DNA damage were also validated by the comet assay. The bio-uptake of TiO2 in particulate form was the key cause of reactive oxygen species generation, which in turn was probably the cause of the DNA aberrations and genotoxicity observed in this study.	[Pakrashi, Sunandan; Jain, Nitin; Dalai, Swayamprava; Jayakumar, Jerobin; Chandrasekaran, Natarajan; Mukherjee, Amitava] VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India; [Chandrasekaran, Prathna Thanjavur; Raichur, Ashok M.] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India; [Raichur, Ashok M.] Univ Johannesburg, Dept Chem Technol, Johannesburg, South Africa	Vellore Institute of Technology; Indian Institute of Science (IISC) - Bangalore; University of Johannesburg	Mukherjee, A (corresponding author), VIT Univ, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	amit.mookerjea@gmail.com	Raichur, Ashok M/J-8100-2012; Dalai, Swayamprava/AAD-8677-2021; Chandrasekaran, Natarajan/F-2312-2018; Raichur, Ashok/N-6842-2019; Mukherjee, Amitava/H-5560-2011	Raichur, Ashok M/0000-0001-5042-3122; Chandrasekaran, Natarajan/0000-0002-0586-134X; Mukherjee, Amitava/0000-0001-8682-4278; Dalai, Swayamprava/0000-0001-5311-4763	VIT University; Council of Scientific & Industrial Research (CSIR), India	VIT University; Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	We profoundly thank VIT University management for funding the research. SP and SD acknowledge fellowship support from Council of Scientific & Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achary VMM, 2010, MUTAGENESIS, V25, P201, DOI 10.1093/mutage/gep063; Afaq F, 1998, J APPL TOXICOL, V18, P307, DOI 10.1002/(SICI)1099-1263(1998090)18:5<307::AID-JAT508>3.0.CO;2-K; Bakare AA, 2000, J ENVIRON BIOL, V21, P263; Borboa L, 1996, NEW PHYTOL, V134, P481, DOI 10.1111/j.1469-8137.1996.tb04365.x; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; Fiskesjo G, 1997, PLANTS ENV STUDIES; Ghosh M, 2012, MUTAT RES-GEN TOX EN, V749, P60, DOI 10.1016/j.mrgentox.2012.08.007; Ghosh M, 2010, CHEMOSPHERE, V81, P1253, DOI 10.1016/j.chemosphere.2010.09.022; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; GRANT WF, 1994, MUTAT RES-FUND MOL M, V310, P175, DOI 10.1016/0027-5107(94)90112-0; Jadhav SB, 2011, INT BIODETER BIODEGR, V65, P733, DOI 10.1016/j.ibiod.2011.04.003; Kaegi R, 2010, ENVIRON POLLUT, V158, P2900, DOI 10.1016/j.envpol.2010.06.009; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Klancnik K, 2011, ECOTOX ENVIRON SAFE, V74, P85, DOI 10.1016/j.ecoenv.2010.09.001; Kumari M, 2011, J HAZARD MATER, V190, P613, DOI 10.1016/j.jhazmat.2011.03.095; Kumari M, 2009, SCI TOTAL ENVIRON, V407, P5243, DOI 10.1016/j.scitotenv.2009.06.024; Leme DM, 2009, MUTAT RES-REV MUTAT, V682, P71, DOI 10.1016/j.mrrev.2009.06.002; Liman ST, 2003, EUR J CARDIO-THORAC, V23, P374, DOI 10.1016/S1010-7940(02)00813-8; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Panda KK, 2011, TOXICOL IN VITRO, V25, P1097, DOI 10.1016/j.tiv.2011.03.008; Phugare SS, 2011, J HAZARD MATER, V186, P713, DOI 10.1016/j.jhazmat.2010.11.049; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Sun W, 2009, J LUMIN, V129, P778, DOI 10.1016/j.jlumin.2009.02.010; Xi Zhu-ge, 2004, Huanjing Kexue, V25, P102	24	103	106	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87789	10.1371/journal.pone.0087789	http://dx.doi.org/10.1371/journal.pone.0087789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504252	Green Submitted, gold, Green Published			2022-12-27	WOS:000330631800072
J	Shih, KC; Lee, CC; Tsai, CN; Lin, YS; Tang, CY				Shih, Kuei-Chung; Lee, Chi-Ching; Tsai, Chi-Neu; Lin, Yu-Shan; Tang, Chuan-Yi			Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors	PLOS ONE			English	Article							ACID AMIDE DERIVATIVES; DHODH INHIBITORS; PHARMACOPHORE; 3D-QSAR; SERIES; BREQUINAR; DISCOVERY; VALIDATION; MECHANISM; DATABASE	Human dihydroorotate dehydrogenase (hDHODH) is a class-2 dihydroorotate dehydrogenase. Because it is extensively used by proliferating cells, its inhibition in autoimmune and inflammatory diseases, cancers, and multiple sclerosis is of substantial clinical importance. In this study, we had two aims. The first was to develop an hDHODH pharma-similarity index approach (PhSIA) using integrated molecular dynamics calculations, pharmacophore hypothesis, and comparative molecular similarity index analysis (CoMSIA) contour information techniques. The approach, for the discovery and design of novel inhibitors, was based on 25 diverse known hDHODH inhibitors. Three statistical methods were used to verify the performance of hDHODH PhSIA. Fischer's cross-validation test provided a 98% confidence level and the goodness of hit (GH) test score was 0.61. The q(2), r(2), and predictive r(2) values were 0.55, 0.97, and 0.92, respectively, for a partial least squares validation method. In our approach, each diverse inhibitor structure could easily be aligned with contour information, and common substructures were unnecessary. For our second aim, we used the proposed approach to design 13 novel hDHODH inhibitors using a scaffold-hopping strategy. Chemical features of the approach were divided into two groups, and the Vitas-M Laboratory fragment was used to create de novo inhibitors. This approach provides a useful tool for the discovery and design of potential inhibitors of hDHODH, and does not require docking analysis; thus, our method can assist medicinal chemists in their efforts to identify novel inhibitors.	[Shih, Kuei-Chung; Lin, Yu-Shan; Tang, Chuan-Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Lee, Chi-Ching] Chang Gung Univ, Bioinformat Ctr, Taoyuan, Taiwan; [Tsai, Chi-Neu] Chang Gung Univ, Grad Inst Chang Gung Med Sci, Taoyuan, Taiwan; [Tang, Chuan-Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan	National Tsing Hua University; Chang Gung University; Chang Gung University; Providence University - Taiwan	Shih, KC (corresponding author), Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan.	kcshih0307@gmail.com; cytang@pu.edu.tw	Tsai, Chi-Neu/AAZ-2558-2020; Tsai, Chi neu/C-3373-2011	Tsai, Chi-Neu/0000-0002-5940-0696; Tsai, Chi neu/0000-0002-5940-0696	National Science Council in Taiwan [NSC100-2221-E-126-010-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the National Science Council in Taiwan (Grant number:NSC100-2221-E-126-010-MY3, http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldred A, 2001, Expert Opin Pharmacother, V2, P125, DOI 10.1517/14656566.2.1.125; Baumann P, 2009, MOL CANCER THER, V8, P366, DOI 10.1158/1535-7163.MCT-08-0664; Baumgartner R, 2006, J MED CHEM, V49, P1239, DOI 10.1021/jm0506975; Bjornberg O, 1997, BIOCHEMISTRY-US, V36, P16197, DOI 10.1021/bi971628y; Boppana K, 2009, EUR J MED CHEM, V44, P3584, DOI 10.1016/j.ejmech.2009.02.031; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cheleski J, 2010, EUR J MED CHEM, V45, P5899, DOI 10.1016/j.ejmech.2010.09.055; CHEN SF, 1986, CANCER RES, V46, P5014; CRAMER RD, 1988, QUANT STRUCT-ACT REL, V7, P18, DOI 10.1002/qsar.19880070105; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Hurt DE, 2006, BIOORG MED CHEM LETT, V16, P1610, DOI 10.1016/j.bmcl.2005.12.029; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S28; KLEBE G, 1994, J MED CHEM, V37, P4130, DOI 10.1021/jm00050a010; Knecht W, 2000, CHEM-BIOL INTERACT, V124, P61, DOI 10.1016/S0009-2797(99)00144-1; Kuo EA, 1996, J MED CHEM, V39, P4608, DOI 10.1021/jm9604437; Leban J, 2004, BIOORG MED CHEM LETT, V14, P55, DOI 10.1016/j.bmcl.2003.10.021; Li SL, 2011, INT J MOL SCI, V12, P2982, DOI 10.3390/ijms12052982; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Loffler M, 2002, INSECT BIOCHEM MOLEC, V32, P1159, DOI 10.1016/S0965-1748(02)00052-8; Madhavan T, 2012, CHEM BIOL DRUG DES, V79, P53, DOI 10.1111/j.1747-0285.2011.01168.x; MINET M, 1992, GENE, V121, P393, DOI 10.1016/0378-1119(92)90150-N; Mu L, 2011, BIOORG MED CHEM LETT, V21, P66, DOI 10.1016/j.bmcl.2010.11.071; Norager S, 2002, STRUCTURE, V10, P1211, DOI 10.1016/S0969-2126(02)00831-6; Ojha PK, 2010, EUR J MED CHEM, V45, P4645, DOI 10.1016/j.ejmech.2010.07.034; Osman FGD, 2000, PHAMACOPHORE PERCEPT, P2193; Pally C, 1998, TOXICOLOGY, V127, P207, DOI 10.1016/S0300-483X(98)00026-2; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; Rawls J, 2000, EUR J BIOCHEM, V267, P2079, DOI 10.1046/j.1432-1327.2000.01213.x; Sakkiah S, 2012, J MOL MODEL; Shih KC, 2011, BIOORG MED CHEM LETT, V21, P4490, DOI 10.1016/j.bmcl.2011.06.003; Shih KC, 2011, J CHEM INF MODEL, V51, P398, DOI 10.1021/ci100351s; Singh KD, 2011, J MOL GRAPH MODEL, V30, P186, DOI 10.1016/j.jmgm.2011.07.004; Sprague PW, 1995, PERSPECT DRUG DISCOV, V3, P1, DOI 10.1007/BF02174464; Thangapandian S, 2011, CHEM BIOL DRUG DES, V78, P289, DOI 10.1111/j.1747-0285.2011.01127.x; Vyas VK, 2013, MED CHEM, V9, P222; Vyas VK, 2012, CURR COMPUT-AID DRUG, V8, P271; Warnke C, 2009, NEUROPSYCH DIS TREAT, V5, P333; Zameitat E, 2007, APPL ENVIRON MICROB, V73, P3371, DOI 10.1128/AEM.02569-06; Zeng HH, 2011, CHEM BIOL DRUG DES, V78, P333, DOI 10.1111/j.1747-0285.2011.01139.x; Zhao WX, 2011, J CHEM INF MODEL, V51, P2147, DOI 10.1021/ci100511v	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87960	10.1371/journal.pone.0087960	http://dx.doi.org/10.1371/journal.pone.0087960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504131	Green Submitted, gold, Green Published			2022-12-27	WOS:000336971300025
J	Toseeb, U; Bryant, EJ; Keeble, DRT				Toseeb, Umar; Bryant, Eleanor J.; Keeble, David R. T.			The Muslim Headscarf and Face Perception: "They All Look the Same, Don't They?''	PLOS ONE			English	Article							EXTERNAL FEATURES; UNFAMILIAR FACES; EYE-MOVEMENTS; RECOGNITION; INVERSION; OWN; MEMORY; IDENTIFICATION; FAMILIARITY; INFORMATION	The headscarf conceals hair and other external features of a head (such as the ears). It therefore may have implications for the way in which such faces are perceived. Images of faces with hair (H) or alternatively, covered by a headscarf (HS) were used in three experiments. In Experiment 1 participants saw both H and HS faces in a yes/no recognition task in which the external features either remained the same between learning and test (Same) or switched (Switch). Performance was similar for H and HS faces in both the Same and Switch condition, but in the Switch condition it dropped substantially compared to the Same condition. This implies that the mere presence of the headscarf does not reduce performance, rather, the change between the type of external feature (hair or headscarf) causes the drop in performance. In Experiment 2, which used eye-tracking methodology, it was found that almost all fixations were to internal regions, and that there was no difference in the proportion of fixations to external features between the Same and Switch conditions, implying that the headscarf influenced processing by virtue of extrafoveal viewing. In Experiment 3, similarity ratings of the internal features of pairs of HS faces were higher than pairs of H faces, confirming that the internal and external features of a face are perceived as a whole rather than as separate components.	[Toseeb, Umar; Keeble, David R. T.] Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England; [Toseeb, Umar; Bryant, Eleanor J.; Keeble, David R. T.] Univ Bradford, Div Psychol, Bradford BD7 1DP, W Yorkshire, England	University of Bradford; University of Bradford	Keeble, DRT (corresponding author), Univ Bradford, Bradford Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	d.r.t.keeble@bradford.ac.uk		Keeble, David/0000-0002-8829-6090; Toseeb, Umar/0000-0002-7536-2722	Educational Charity of the Federation of Ophthalmic and Dispensing Opticians	Educational Charity of the Federation of Ophthalmic and Dispensing Opticians	This work is supported by a studentship from the Educational Charity of the Federation of Ophthalmic and Dispensing Opticians which was provided to UT. The Educational Charity of the Federation of Ophthalmic and Dispensing Opticians is non-profit organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Andrews TJ, 2010, J NEUROSCI, V30, P3544, DOI 10.1523/JNEUROSCI.4863-09.2010; Axelrod V, 2010, NEUROIMAGE, V52, P720, DOI 10.1016/j.neuroimage.2010.04.027; Barkdull C, 2011, AFFILIA J WOM SOC WO, V26, P139, DOI 10.1177/0886109911405491; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Betts LR, 2010, J COGNITIVE NEUROSCI, V22, P2276, DOI 10.1162/jocn.2009.21346; Bombari D, 2009, PERCEPTION, V38, P1508, DOI 10.1068/p6117; Braun A, 2011, J VISION, V11; Buttle H, 2010, PERCEPTION, V39, P1672, DOI 10.1068/p6790; Chan JPK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00087; Donovan G, 2003, NATL CATHOLIC REPORT; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Fischer AH, 2012, SOC PSYCHOL PERS SCI, V3, P266, DOI 10.1177/1948550611418534; GOLDSTEIN AG, 1978, J PSYCHOL, V98, P185, DOI 10.1080/00223980.1978.9915960; Green DM, 1966, SIGNAL DETECTION THE; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; HOLE GJ, 1994, PERCEPTION, V23, P65, DOI 10.1068/p230065; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kret ME, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00110; Lickson J, 1974, D CHARLES STORY QUIN; Loven J, 2012, MEMORY, V20, P321, DOI 10.1080/09658211.2012.658064; Mahmud Y, 2010, BODY IMAGE, V7, P90, DOI 10.1016/j.bodyim.2009.09.003; Maple S, 2007, YOU PRINT C T; McKone E, 2004, J EXP PSYCHOL LEARN, V30, P181, DOI 10.1037/0278-7393.30.1.181; McKone E, 2001, J EXP PSYCHOL HUMAN, V27, P573, DOI 10.1037/0096-1523.27.3.573; Megreya AM, 2009, PERCEPTION, V38, P1831, DOI 10.1068/p6385; Megreya AM, 2011, APPL COGNITIVE PSYCH; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; PATTERSON KE, 1977, J EXP PSYCHOL-HUM L, V3, P406, DOI 10.1037/0278-7393.3.4.406; Popivanov ID, 2011, CR ACAD BULG SCI, V64, P425; Rossion B, 2008, ACTA PSYCHOL, V128, P274, DOI 10.1016/j.actpsy.2008.02.003; Rossion B, 2009, ACTA PSYCHOL, V132, P300, DOI 10.1016/j.actpsy.2009.08.002; Schneider W., 2002, E PRIME USERS GUIDE; Sekiguchi T, 2011, ACTA PSYCHOL, V137, P1, DOI 10.1016/j.actpsy.2011.01.014; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Stacey PC, 2005, BRIT J PSYCHOL, V96, P407, DOI 10.1348/000712605X47422; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Toseeb U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034144; Ueda S, 2010, PERCEPTION, V39, P260, DOI 10.1068/p6634; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	47	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e84754	10.1371/journal.pone.0084754	http://dx.doi.org/10.1371/journal.pone.0084754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA7CL	24520313	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600003
J	Brekke, HK; Bertz, F; Rasmussen, KM; Bosaeus, I; Ellegard, L; Winkvist, A				Brekke, Hilde K.; Bertz, Fredrik; Rasmussen, Kathleen M.; Bosaeus, Ingvar; Ellegard, Lars; Winkvist, Anna			Diet and Exercise Interventions among Overweight and Obese Lactating Women: Randomized Trial of Effects on Cardiovascular Risk Factors	PLOS ONE			English	Article							WEIGHT-LOSS; POSTPARTUM BREAST; AEROBIC EXERCISE; HEART-DISEASE; LIPIDS; LIPOPROTEINS; INFLAMMATION; METABOLISM; PREGNANCY; PARITY	Objective: To examine the effects of Diet (D) and Exercise (E) interventions on cardiovascular fitness, waist circumference, blood lipids, glucose metabolism, inflammation markers, insulin-like growth factor 1 (IGF-1) and blood pressure in overweight and obese lactating women. Methods: At 10-14 wk postpartum, 68 Swedish women with a self-reported pre-pregnancy BMI of 25-35 kg/m(2) were randomized to a 12-wk behavior modification treatment with D, E, both or control using a 262 factorial design. The goal of D treatment was to reduce body weight by 0.5 kg/wk, accomplished by decreasing energy intake by 500 kcal/d and monitoring weight loss through self-weighing. The goal of E treatment was to perform 4 45-min walks per wk at 60-70% of max heart-rate using a heart-rate monitor. Effects were measured 12 wk and 1 y after randomization. General Linear Modeling was used to study main and interaction effects adjusted for baseline values of dependent variable. Results: There was a significant main effect of the D treatment, decreasing waist circumference (P = 0.001), total cholesterol (P = 0.007), LDL-cholesterol (P = 0.003) and fasting insulin (P = 0.042), at the end of the 12-wk treatment. The decreased waist circumference (P, 0.001) and insulin (P = 0.024) was sustained and HDL-cholesterol increased (P = 0.005) at the 1-y follow-up. No effects from the E treatment or any interaction effects were observed. Conclusions: Dietary behavior modification that produced sustained weight loss among overweight and obese lactating women also improved risk factors for cardiovascular disease and type 2 diabetes. This intervention may not only reduce weight-related risks with future pregnancies but also long-term risk for metabolic disease.	[Brekke, Hilde K.; Bertz, Fredrik; Ellegard, Lars; Winkvist, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Rasmussen, Kathleen M.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bosaeus, Ingvar] Sahlgrens Univ Hosp, Dept Clin Nutr, Gothenburg, Sweden	University of Gothenburg; Cornell University; Sahlgrenska University Hospital	Brekke, HK (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.	hilde.brekke@nutrition.gu.se	Ellegard, Lars H/E-6191-2016; Winkvist, Anna/AAC-6178-2021	Ellegard, Lars H/0000-0002-2787-4336; Winkvist, Anna/0000-0001-9122-7240	Swedish Research Council [K2009-21091-01-3]; Swedish Council for Working Life and Social Research [2006-0339, 2007-1958]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by The Swedish Research Council, www.vr.se (Project grant: K2009-21091-01-3. PI Anna Winkvist), and the Swedish Council for Working Life and Social Research, www.forte.se (Project grant: 2006-0339, PI Anna Winkvist; Project grant: 2007-1958, PI Cecilia Bjorkelund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian LA, 2010, WOMEN HEALTH ISS, V20, P133, DOI 10.1016/j.whi.2009.11.005; Bertz Fredrik, 2015, Matern Child Nutr, V11, P631, DOI 10.1111/mcn.12103; Bertz F, 2012, AM J CLIN NUTR, V96, P698, DOI 10.3945/ajcn.112.040196; DARMADY JM, 1982, BRIT J OBSTET GYNAEC, V89, P211, DOI 10.1111/j.1471-0528.1982.tb03616.x; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; DEWEY KG, 1994, NEW ENGL J MED, V330, P449, DOI 10.1056/NEJM199402173300701; FAHRAEUS L, 1985, OBSTET GYNECOL, V66, P468; Forsythe LKS, 2008, NUTR RES REV, V21, P117, DOI 10.1017/S0954422408138732; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Groer MW, 2005, AM J REPROD IMMUNOL, V54, P222, DOI 10.1111/j.1600-0897.2005.00301.x; Gunderson EP, 2004, AM J EPIDEMIOL, V159, P1028, DOI 10.1093/aje/kwh146; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; Gunderson EP, 2009, OBSTET GYN CLIN N AM, V36, P317, DOI 10.1016/j.ogc.2009.04.001; HealthyPeople.gov, 2020, NUTR PHYS ACT; KNOPP RH, 1985, J CLIN ENDOCR METAB, V60, P542, DOI 10.1210/jcem-60-3-542; Koski-Rahikkala H, 2006, J EPIDEMIOL COMMUN H, V60, P968, DOI 10.1136/jech.2005.044735; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LOVELADY CA, 1995, MED SCI SPORT EXER, V27, P22; Lovelady CA, 2000, NEW ENGL J MED, V342, P449, DOI 10.1056/NEJM200002173420701; McCrory MA, 1999, AM J CLIN NUTR, V69, P959; Norberg M, 2012, SCAND J PUBLIC HEALT, V40, P135, DOI 10.1177/1403494812459471; Schenck-Gustafsson K, 2009, MATURITAS, V63, P186, DOI 10.1016/j.maturitas.2009.02.014; Stendell-Hollis NR, 2013, J WOMENS HEALTH, V22, P48, DOI 10.1089/jwh.2012.3707; Tiikkainen M, 2004, AM J CLIN NUTR, V79, P22; Winkvist A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063629, 10.1371/journal.p]; World Health Organization, 2008, WHO STEPWISE APPR SU; Zhang XL, 2009, STROKE, V40, P2680, DOI 10.1161/STROKEAHA.109.547554	28	21	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88250	10.1371/journal.pone.0088250	http://dx.doi.org/10.1371/journal.pone.0088250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516621	gold, Green Submitted, Green Published			2022-12-27	WOS:000330834400046
J	Shao, QS; Wang, HZ; Guo, HP; Zhou, AC; Huang, YQ; Sun, YL; Li, MY				Shao, Qingsong; Wang, Hongzhen; Guo, Haipeng; Zhou, Aicun; Huang, Yuqiu; Sun, Yulu; Li, Mingyan			Effects of Shade Treatments on Photosynthetic Characteristics, Chloroplast Ultrastructure, and Physiology of Anoectochilus roxburghii	PLOS ONE			English	Article							MULTI PETAL JASMINE; CHLOROPHYLL FLUORESCENCE; DIFFERENTIAL RESPONSES; LEAF; YIELD; MORPHOLOGY; EFFICIENCY; ANATOMY; STRESS	Anoectochilus roxburghii was grown under different shade treatments-50%, 30%, 20%, and 5% of natural irradiance-to evaluate its photosynthetic characteristics, chloroplast ultrastructure, and physiology. The highest net photosynthetic rates and stomatal conductance were observed under 30% irradiance, followed in descending order by 20%, 5%, and 50% treatments. As irradiance decreased from 50% to 30%, electron transport rate and photochemical quenching increased, while non-photochemical quenching indexes declined. Reductions in irradiance significantly increased Chl a and Chl b contents and decreased Chl a/b ratios. Chloroplast ultrastructure generally displayed the best development in leaves subjected to 30% irradiance. Under 50% irradiance, leaf protein content remained relatively stable during the first 20 days of treatment, and then increased rapidly. The highest peroxidase and superoxide dismutase levels, and the lowest catalase activities, were observed in plants subjected to the 50% irradiance treatment. Soluble sugar and malondialdehyde contents were positively correlated with irradiance levels. Modulation of chloroplast development, accomplished by increasing the number of thylakoids and grana containing photosynthetic pigments, is an important shade tolerance mechanism in A. roxburghii.	[Shao, Qingsong; Wang, Hongzhen; Zhou, Aicun; Huang, Yuqiu; Sun, Yulu] Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Guo, Haipeng] Zhejiang Univ, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Mingyan] Zhejiang Shouxiangu Rare Bot Inst, Wuyi, Peoples R China	Zhejiang A&F University; Zhejiang University	Shao, QS (corresponding author), Zhejiang A&F Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	sqszjfc@126.com			National Natural Science Foundation of China [81303167]; Zhejiang Provincial Natural Science Foundation [LY13H280010]; National College Students' innovation and entrepreneurship training program [201310341020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); National College Students' innovation and entrepreneurship training program	This work was supported by the National Natural Science Foundation of China (Grant No. 81303167), the Zhejiang Provincial Natural Science Foundation (Grant No. LY13H280010) and the National College Students' innovation and entrepreneurship training program (Grant No. 201310341020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argandona VH, 2001, J CHEM ECOL, V27, P53, DOI 10.1023/A:1005615932694; Bertamini M, 2006, ENVIRON EXP BOT, V57, P25, DOI 10.1016/j.envexpbot.2005.04.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Dai YJ, 2009, ENVIRON EXP BOT, V65, P177, DOI 10.1016/j.envexpbot.2008.12.008; Deng YM, 2012, SCI HORTIC-AMSTERDAM, V144, P19, DOI 10.1016/j.scienta.2012.06.031; Deng YM, 2012, PLANT PHYSIOL BIOCH, V55, P93, DOI 10.1016/j.plaphy.2012.03.006; Deng YM, 2011, PLANT CELL REP, V30, P2177, DOI 10.1007/s00299-011-1123-x; Dong CJ, 2011, SCI HORTIC-AMSTERDAM, V129, P629, DOI 10.1016/j.scienta.2011.05.005; Du XM, 2008, J NAT MED, V62, P132, DOI 10.1007/s11418-007-0169-0; Favaretto VF, 2011, ENVIRON EXP BOT, V70, P20, DOI 10.1016/j.envexpbot.2010.06.003; Flowers MD, 2007, ENVIRON EXP BOT, V61, P190, DOI 10.1016/j.envexpbot.2007.05.009; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Ghosh PK, 2004, BIORESOURCE TECHNOL, V95, P85, DOI 10.1016/j.biortech.2004.02.012; Guo HX, 2006, PHOTOSYNTHETICA, V44, P140, DOI 10.1007/s11099-005-0170-3; [何春年 He Chunnian], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P81; He JP, 2011, J PLANT PHYSIOL, V168, P687, DOI 10.1016/j.jplph.2010.10.009; Helle G, 2004, PLANT CELL ENVIRON, V27, P367, DOI 10.1111/j.0016-8025.2003.01159.x; Lei TT, 1996, PHYSIOL PLANTARUM, V96, P411, DOI 10.1111/j.1399-3054.1996.tb00452.x; Li H.S., 2000, PRINCIPLES TECHNIQUE, P194; Liu YB, 2012, PLANT PHYSIOL BIOCH, V51, P159, DOI 10.1016/j.plaphy.2011.11.002; Mao LZ, 2007, PHOTOSYNTHETICA, V45, P601, DOI 10.1007/s11099-007-0103-4; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NAIDU RA, 1984, PHYSIOL PLANT PATHOL, V25, P191, DOI 10.1016/0048-4059(84)90057-2; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rascher U, 2000, PLANT CELL ENVIRON, V23, P1397, DOI 10.1046/j.1365-3040.2000.00650.x; Raveh E, 1998, SCI HORTIC-AMSTERDAM, V73, P151, DOI 10.1016/S0304-4238(97)00134-9; Schapendonk AHCM, 1997, GLOBAL CHANGE BIOL, V3, P207, DOI 10.1046/j.1365-2486.1997.00099.x; Schiefthaler U, 1999, AUST J PLANT PHYSIOL, V26, P485, DOI 10.1071/PP98102; Schreiber U, 1997, PLANT CELL PHYSIOL, V38, P945, DOI 10.1093/oxfordjournals.pcp.a029256; Schreiber U., 1995, ECOL STUD, P49, DOI DOI 10.1007/978-3-642-79354-7_3; SESTAK Z, 1966, BIOL PLANTARUM, V8, P336, DOI 10.1007/BF02930670; Sharma P, 2007, PLANT CELL REP, V26, P2027, DOI 10.1007/s00299-007-0416-6; Tezara W, 2003, ANN BOT-LONDON, V92, P757, DOI 10.1093/aob/mcg199; Veres S, 2006, PHOTOSYNTHETICA, V44, P255, DOI 10.1007/s11099-006-0016-7; Wittmann C, 2001, BASIC APPL ECOL, V2, P145, DOI 10.1078/1439-1791-00047; Yin DM, 2010, ENVIRON EXP BOT, V68, P122, DOI 10.1016/j.envexpbot.2009.11.008; Zhang HY, 2009, STRAIT PHARM J, V29, P82; Zhang YH, 2007, J ETHNOPHARMACOL, V114, P141, DOI 10.1016/j.jep.2007.05.022	40	82	90	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e85996	10.1371/journal.pone.0085996	http://dx.doi.org/10.1371/journal.pone.0085996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516523	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400004
J	Zhang, FB; Wang, ZL; Yang, MY				Zhang, Feng-Bao; Wang, Zhan-Li; Yang, Ming-Yi			Validating and Improving Interrill Erosion Equations	PLOS ONE			English	Article							SOIL-EROSION; SEDIMENT TRANSPORT; MODEL-EQUATIONS; SLOPE LENGTH; FLOW DEPTH; RAINFALL; RUNOFF; ERODIBILITIES; INTENSITY	Existing interrill erosion equations based on mini-plot experiments have largely ignored the effects of slope length and plot size on interrill erosion rate. This paper describes a series of simulated rainfall experiments which were conducted according to a randomized factorial design for five slope lengths (0.4, 0.8, 1.2, 1.6, and 2 m) at a width of 0.4 m, five slope gradients (17%, 27%, 36%, 47%, and 58%), and five rainfall intensities (48, 62.4, 102, 149, and 170 mm h(-1)) to perform a systematic validation of existing interrill erosion equations based on mini-plots. The results indicated that the existing interrill erosion equations do not adequately describe the relationships between interrill erosion rate and its influencing factors with increasing slope length and rainfall intensity. Univariate analysis of variance showed that runoff rate, rainfall intensity, slope gradient, and slope length had significant effects on interrill erosion rate and that their interactions were significant at p = 0.01. An improved interrill erosion equation was constructed by analyzing the relationships of sediment concentration with rainfall intensity, slope length, and slope gradient. In the improved interrill erosion equation, the runoff rate and slope factor are the same as in the interrill erosion equation in the Water Erosion Prediction Project (WEPP), with the weight of rainfall intensity adjusted by an exponent of 0.22 and a slope length term added with an exponent of -0.25. Using experimental data from WEPP cropland soil field interrill erodibility experiments, it has been shown that the improved interrill erosion equation describes the relationship between interrill erosion rate and runoff rate, rainfall intensity, slope gradient, and slope length reasonably well and better than existing interrill erosion equations.	[Zhang, Feng-Bao; Wang, Zhan-Li; Yang, Ming-Yi] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Zhang, Feng-Bao; Wang, Zhan-Li; Yang, Ming-Yi] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Zhang, Feng-Bao; Wang, Zhan-Li; Yang, Ming-Yi] Minist Water Resources, Yangling, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Wang, ZL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	zwang@ms.iswc.ac.cn			National Natural Science Foundation of China [41171227, 40901127, 40971172]; Natural Science Foundation of Shannxi Province [S2012JC6612]; Northwest AF University [QN2011072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shannxi Province(Natural Science Foundation of Shanxi Province); Northwest AF University	Financial support for this research was provided by the National Natural Science Foundation of China (41171227, 40901127, 40971172), Natural Science Foundation of Shannxi Province (S2012JC6612), and the special funds of Northwest A&F University for the operational costs of basic scientific research (QN2011072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascough JC, 1997, T ASAE, V40, P921, DOI 10.13031/2013.21343; Chaplot VAM, 2003, SOIL SCI SOC AM J, V67, P844, DOI 10.2136/sssaj2003.0844; DeRoo APJ, 1996, HYDROL PROCESS, V10, P1107, DOI 10.1002/(SICI)1099-1085(199608)10:8&lt;1107::AID-HYP415&gt;3.0.CO;2-4; Elliot W.J., 1989, 3 NSERL USDAARS PURD; Elliot WJ, 1989, T ASAE; Flanagan D.C., 1995, NSERL REP; FOSTER GR, 1977, T ASAE, V20, P678; Foster GR, 1982, ASAE MONOGRAPH, V5, P297; Gabriels D, 1999, GEOMORPHOLOGY, V28, P169, DOI 10.1016/S0169-555X(98)00107-X; GILLEY JE, 1985, T ASAE, V28, P154; GILLEY JE, 1985, T ASAE, V28, P147; GUY BT, 1987, T ASAE, V30, P1378; KINNELL PIA, 1993, T ASAE, V36, P1099; Kinnell PIA, 2000, SOIL SCI SOC AM J, V64, P1004, DOI 10.2136/sssaj2000.6431004x; KINNELL PIA, 1993, AUST J SOIL RES, V31, P333, DOI 10.1071/SR9930333; KINNELL PIA, 1994, AUST J SOIL RES, V32, P127, DOI 10.1071/SR9940127; KINNELL PIA, 1991, T ASAE, V34, P161, DOI 10.13031/2013.31639; MCCOOL DK, 1987, T ASAE, V30, P1387; Meyer L.D., 1975, ARSS40, P177; MEYER LD, 1989, T ASAE, V32, P639; MEYER LD, 1984, SOIL SCI SOC AM J, V48, P1152, DOI 10.2136/sssaj1984.03615995004800050040x; MEYER LD, 1981, T ASAE, V24, P1472, DOI 10.13031/2013.34475; MONKE EJ, 1977, T ASAE, V20, P58, DOI 10.13031/2013.35492; Morgan RPC, 1998, EARTH SURF PROC LAND, V23, P527, DOI 10.1002/(SICI)1096-9837(199806)23:6&lt;527::AID-ESP868&gt;3.0.CO;2-5; NEAL J. H., 1938, Proceedings. Soil Science Society of America, V2, P525; Nord G, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003690; Renard K.G., 1997, PREDICTING SOIL EROS; TRUMAN CC, 1995, SOIL SCI SOC AM J, V59, P519, DOI 10.2136/sssaj1995.03615995005900020035x; Valmis S, 2005, SOIL TILL RES, V80, P139, DOI 10.1016/j.still.2004.03.007; Watson D. A., 1986, Transactions of the ASAE, V29, P98, DOI 10.13031/2013.30109; Wei H, 2009, SOIL SCI SOC AM J, V73, P1754, DOI 10.2136/sssaj2008.0061er; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; Yan FL, 2008, SOIL TILL RES, V100, P34, DOI 10.1016/j.still.2008.04.006; YOUNG RA, 1973, WATER RESOUR RES, V9, P1629, DOI 10.1029/WR009i006p01629; Zhang XC, 1998, SOIL SCI SOC AM J, V62, P438, DOI 10.2136/sssaj1998.03615995006200020021x	35	10	11	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88275	10.1371/journal.pone.0088275	http://dx.doi.org/10.1371/journal.pone.0088275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516624	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700059
J	Berg, A; Patel, S; Aukrust, P; David, C; Gonca, M; Berg, ES; Dalen, I; Langeland, N				Berg, Aase; Patel, Sam; Aukrust, Pal; David, Catarina; Gonca, Miguel; Berg, Einar S.; Dalen, Ingvild; Langeland, Nina			Increased Severity and Mortality in Adults Co-Infected with Malaria and HIV in Maputo, Mozambique: A Prospective Cross-Sectional Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; HOSPITALIZED ADULTS; RURAL AREA; PREVALENCE; DIAGNOSIS; CHILDREN; RISK; BLOOD	Background: Co-infection with falciparum malaria and HIV-1 increases the severity and mortality of both infections in unstable malaria-transmission areas. In contrast, in stable transmission areas, HIV co-infection increases the severity of both infections but has not been found to influence malaria mortality. Methods: In a prospective cross-sectional study, clinical and laboratory data were consecutively collected for all adults admitted with fever and/or suspected malaria to the medical department of the Central Hospital of Maputo, Mozambique, during two malaria seasons from January 2011. Malaria and HIV PCRs were performed, and risk factors for fatal outcomes were analysed. The impact of HIV on the clinical presentation and mortality of malaria was assessed. Findings: A total of 212 non-pregnant adults with fever and/or suspected malaria and 56 healthy controls were included in the study. Of the 131 patients with confirmed falciparum malaria, 70 were co-infected with HIV-1. The in-hospital mortality of the co-infected patients was 13.0% (9/69) compared with 1.7% (1/59) in the patients without HIV (p = 0.018). Malaria severity (p = 0.016) and co-infection with HIV (p = 0.064) were independent risk factors for death although the association with HIV did not reach statistical significance. The co-infected patients had significantly more frequent respiratory distress, bleeding disturbances, hypoglycaemia, liver and renal failure and high malaria parasitemia compared with the patients with malaria alone. Interpretations: HIV co-infection is associated with increased disease severity in and mortality from malaria in an area of stable malaria transmission. This finding was not observed earlier and should motivate doctors working in malaria-endemic areas to consider early HIV testing and a closer follow-up of patients with malaria and HIV co-infection.	[Berg, Aase] Stavanger Univ Hosp, Dept Med, Stavanger, Norway; [Berg, Aase; Patel, Sam; David, Catarina; Gonca, Miguel] Cent Hosp Maputo, Dept Med, Maputo, Mozambique; [Berg, Aase; Langeland, Nina] Univ Bergen, Fac Med, Bergen, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, Sect Clin Immunol & Infect Dis, Oslo, Norway; [Berg, Einar S.] Norwegian Inst Publ Hlth, Dept Virol, Oslo, Norway; [Dalen, Ingvild] Stavanger Univ Hosp, Dept Res, Stavanger, Norway	Stavanger University Hospital; University of Bergen; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH); Stavanger University Hospital	Berg, A (corresponding author), Stavanger Univ Hosp, Dept Med, Stavanger, Norway.	beaa@sus.no	Berg, Aase/AAS-7666-2020	Berg, Aase/0000-0002-6937-3580	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Norwegian Medical Association for Infectious Diseases	Western Norway Regional Health Authority; National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway; Norwegian Medical Association for Infectious Diseases	Funding was provided by the Western Norway Regional Health Authority to AB. Economical support was also received from the National Center for Tropical Medicine and Imported Infectious Diseases in Bergen, Norway, and The Norwegian Medical Association for Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-252; Brentlinger PE, 2007, ARCH INTERN MED, V167, P1827, DOI 10.1001/archinte.167.17.1827; Chalwe V, 2009, EMERG INFECT DIS, V15, P749, DOI 10.3201/eid1505.081009; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Diallo A H, 2004, Med Trop (Mars), V64, P345; Erhabor O, 2012, AFR HEALTH SCI, V12, P98, DOI 10.4314/ahs.v12i2.4; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Francesconi P, 2001, AIDS, V15, P2445, DOI 10.1097/00002030-200112070-00013; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Funk-Bauman M, 2001, GEOGRAPHIC DISTRIBUT, p76 p; Gudo ES, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-244; Haanshuus CG, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-26; Hendriksen ICE, 2012, CLIN INFECT DIS, V55, P1144, DOI 10.1093/cid/cis590; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; LEAVER RJ, 1990, T ROY SOC TROP MED H, V84, P201, DOI 10.1016/0035-9203(90)90253-B; Mabunda S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-216; Mayor A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-3; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NIYONGABO T, 1994, ACTA TROP, V56, P299, DOI 10.1016/0001-706X(94)90101-5; Noormahomed EV, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-252; Puri S K, 1982, Prog Drug Res, V26, P167; Saracino A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-241; Soumare M, 2008, Bull Soc Pathol Exot, V101, P20; Stevens W, 2008, J CLIN MICROBIOL, V46, P3941, DOI 10.1128/JCM.00754-08; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Tiago AD, 2011, NORMAS TRATAMENTO MA, P16; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; UNAIDS, 2010, GLOB AIDS RESP REP 2; WHO, 2007, HIV AIDS PROGR; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization, 2011, GUID TREATM MAL	33	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88257	10.1371/journal.pone.0088257	http://dx.doi.org/10.1371/journal.pone.0088257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505451	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200154
J	Cai, XX; Chen, Z; Pan, XK; Xia, L; Chen, P; Yang, Y; Hu, H; Zhang, J; Li, KJ; Ge, J; Yu, KM; Zhuang, J				Cai, Xiaoxiao; Chen, Zhao; Pan, Xueke; Xia, Lei; Chen, Pei; Yang, Ying; Hu, Huan; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Zhuang, Jing			Inhibition of Angiogenesis, Fibrosis and Thrombosis by Tetramethylpyrazine: Mechanisms Contributing to the SDF-1/CXCR4 Axis	PLOS ONE			English	Article							CIRCULATING FIBROCYTES; CHEMOKINE RECEPTOR; GLIOMA-CELLS; CXCR4; ACTIVATION; PROMOTES	Background: Tetramethylpyrazine (TMP) is one of the active ingredients extracted from the Chinese herb Chuanxiong, which has been used to treat cerebrovascular and cardiovascular diseases, pulmonary diseases and cancer. However, the molecular mechanisms underlying the actions of TMP have not been fully elucidated. In a previous study we showed that TMP-mediated glioma suppression and neural protection involves the inhibition of CXCR4 expression. The SDF-1/CXCR4 axis plays a fundamental role in many physiological and pathological processes. In this study, we further investigated whether the regulation of the SDF-1/CXCR4 pathway is also involved in the TMP-mediated inhibition of neovascularization or fibrosis and improvement of microcirculation. Methodology/Principal Findings: Using a scratch-wound assay, we demonstrated that TMP significantly suppressed the migration and tubule formation of the human umbilical vein endothelial cell line ECV304 in vitro. The expression of CXCR4 in ECV304 cells is notably down-regulated after TMP treatment. In addition, TMP significantly suppresses corneal neovascularization in a rat model of corneal alkali burn injury. The expression of CXCR4 on days 1, 3 and 7 post-injury was determined through RT-PCR analysis. Consistent with our hypotheses, the expression of CXCR4 in the rat cornea is significantly increased with alkali burn and dramatically down-regulated with TMP treatment. Moreover, TMP treatment significantly attenuates bleomycin-induced rat pulmonary fibrosis, while immunofluorescence shows a notably decreased amount of CXCR4-positive cells in the TMP-treated group. Furthermore, TMP significantly down-regulates the expression of CXCR4 in platelets, lymphocytes and red blood cells. Whole-blood viscosity and platelet aggregation in rats are significantly decreased by TMP treatment. Conclusions: These results show that TMP exerts potent effects in inhibiting neovascularization, fibrosis and thrombosis under pathological conditions; thus, the underlying mechanism of TMP might partially contribute to the down-regulation of CXCR4.	[Cai, Xiaoxiao; Chen, Zhao; Pan, Xueke; Xia, Lei; Chen, Pei; Yang, Ying; Hu, Huan; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Zhuang, Jing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuang, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuangj@mail.sysu.edu.cn			National Natural Science Foundation [81370987, 30970923, 30872811]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	All the studies were funded by grants from the National Natural Science Foundation (Project: 81370987; 30970923; 30872811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Chen Z, 2012, NEW MED, V6, P376; Chen Z, 2013, CANCER LETT, V336, P281, DOI 10.1016/j.canlet.2013.03.015; de Nigris F, 2010, P NATL ACAD SCI USA, V107, P14484, DOI 10.1073/pnas.1008256107; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Fu YS, 2008, NEURO-ONCOLOGY, V10, P139, DOI 10.1215/15228517-2007-051; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hu JZ, 2006, J CENTRAL S U MED SC, V16, P57; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Li M, 2001, THROMB RES, V104, P15, DOI 10.1016/S0049-3848(01)00343-7; Liang XL, 2012, INVEST OPHTH VIS SCI, V4, P2057; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liu GQ, 2011, MOL VIS, V17, P2129; Liu M, 2004, CHIN J CLIN REHAB, V8, P1299; Liu Y, 2005, CHIN J MED PHYS, V22, P680; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Moser B, 1998, Int Rev Immunol, V16, P323, DOI 10.3109/08830189809043000; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pang PKT, 1996, PLANTA MED, V62, P431, DOI 10.1055/s-2006-957933; Panicot-Dubois L, 2007, J CLIN INVEST, V117, P3708, DOI 10.1172/JCI32655; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Ru FQ, 2003, J CLIN PULMONARY MED, V8, P335; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Tan Y, 2009, CARDIOVASC RES, V82, P513, DOI 10.1093/cvr/cvp044; Tang Ze-yao, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P114, DOI 10.3867/j.issn.1000-3002.2011.01.023; Unoki N, 2010, INVEST OPHTH VIS SCI, V51, P3362, DOI 10.1167/iovs.09-4978; Wang JD, 2010, THROMB RES, V126, P311, DOI 10.1016/j.thromres.2010.06.023; Wang Xin, 2003, Zhongguo Zhong Yao Za Zhi, V28, P295; Yang XG, 2010, CHINESE MED J-PEKING, V123, P3206, DOI 10.3760/cma.j.issn.0366-6999.2010.22.006; Yang ZK, 2008, NEUROCHEM INT, V52, P1176, DOI 10.1016/j.neuint.2007.12.008; You JM, 2010, CHIN MED, V28, P2666; Yu KM, 2007, BIOCHEM BIOPH RES CO, V358, P990, DOI 10.1016/j.bbrc.2007.05.004; Yu KM, 2012, ONCOL REP, V28, P955, DOI 10.3892/or.2012.1866; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zhu AZ, 2010, J MED CHEM, V53, P8556, DOI 10.1021/jm100786g; Zhu JX, 2005, EUR J PHARMACOL, V510, P187, DOI 10.1016/j.ejphar.2005.01.026	43	50	57	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88176	10.1371/journal.pone.0088176	http://dx.doi.org/10.1371/journal.pone.0088176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505417	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200129
J	Dolrenry, S; Stenglein, J; Hazzah, L; Lutz, RS; Frank, L				Dolrenry, Stephanie; Stenglein, Jennifer; Hazzah, Leela; Lutz, R. Scott; Frank, Laurence			A Metapopulation Approach to African Lion (Panthera leo) Conservation	PLOS ONE			English	Article							HUMAN DENSITIES; DYNAMICS; POPULATION; HABITAT; DISPERSAL; CONNECTIVITY; AREA; FRAGMENTATION; PREDATORS; MIGRATION	Due to anthropogenic pressures, African lion (Panthera leo) populations in Kenya and Tanzania are increasingly limited to fragmented populations. Lions living on isolated habitat patches exist in a matrix of less-preferred habitat. A framework of habitat patches within a less-suitable matrix describes a metapopulation. Metapopulation analysis can provide insight into the dynamics of each population patch in reference to the system as a whole, and these analyses often guide conservation planning. We present the first metapopulation analysis of African lions. We use a spatially-realistic model to investigate how sex-biased dispersal abilities of lions affect patch occupancy and also examine whether human densities surrounding the remaining lion populations affect the metapopulation as a whole. Our results indicate that male lion dispersal ability strongly contributes to population connectivity while the lesser dispersal ability of females could be a limiting factor. When populations go extinct, recolonization will not occur if distances between patches exceed female dispersal ability or if females are not able to survive moving across the matrix. This has profound implications for the overall metapopulation; the female models showed an intrinsic extinction rate from five-fold to a hundred-fold higher than the male models. Patch isolation is a consideration for even the largest lion populations. As lion populations continue to decline and with local extinctions occurring, female dispersal ability and the proximity to the nearest lion population are serious considerations for the recolonization of individual populations and for broader conservation efforts.	[Dolrenry, Stephanie; Hazzah, Leela] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Dolrenry, Stephanie; Hazzah, Leela; Frank, Laurence] Mpala Res Ctr, Nanyuki, Kenya; [Stenglein, Jennifer; Lutz, R. Scott] Univ Wisconsin, Madison, WI USA; [Frank, Laurence] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley	Dolrenry, S (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.	stephanie@lionguardians.org			National Science Foundation [2008058924]; Panthera Kaplan Awards	National Science Foundation(National Science Foundation (NSF)); Panthera Kaplan Awards	The research was funded by National Science Foundation Fellowship Grant No. 2008058924 and Panthera Kaplan Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf TD, 2012, CONSERV BIOL, V26, P953, DOI 10.1111/j.1523-1739.2012.01919.x; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H., 2008, IUCN RED LIST THREAT; Bauer H., 2008, MANAGEMENT CONSERVAT, P13; Becker MS, 2012, J WILDLIFE MANAGEMEN; Beier P, 1993, COUGAR SANTA ANA MOU; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Carpenter Len H., 2000, Human Dimensions of Wildlife, V5, P5; Chardonnet P., 2002, CONSERVATION AFRICAN; Conservation DL, 2007, DISP EXP; Creel S, 2013, ECOLOGY LETT; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; DECKER DJ, 1988, WILDLIFE SOC B, V16, P53; Dolrenry S, 2013, THESIS U WISCONSIN M; Driscoll DA, 2007, CAN J ZOOL, V85, P1031, DOI 10.1139/Z07-096; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Force KsNLCT, 2008, CONS MAN STRAT LIONS; Funston PJ, 2011, S AFR J WILDL RES, V41, P1, DOI 10.3957/056.041.0108; Gilpin Michael, 1996, P11; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; HANSKI I, 1994, TRENDS ECOL EVOL, V9, P131, DOI 10.1016/0169-5347(94)90177-5; HANSKI I, 1992, AM NAT, V139, P657, DOI 10.1086/285349; HANSKI I, 1993, J THEOR BIOL, V163, P491, DOI 10.1006/jtbi.1993.1134; Hanski I., 1999, METAPOPULATION ECOLO; HANSKI I, 1997, METAPOPULATION BIOL; Hanski Ilkka, 1997, P5, DOI 10.1016/B978-012323445-2/50003-1; Hanski Ilkka, 1997, Monographs in Population Biology, V30, P21; Hazzah L, PARTICIPATI IN PRESS; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Hellgren EC, 2005, BIOL CONSERV, V122, P131, DOI 10.1016/j.biocon.2004.07.007; Ikanda Dennis, 2008, Endangered Species Research, V6, P67, DOI 10.3354/esr00120; Iucn Cat Specialist Group, 2006, REG CONS STRAT LION; Jackson P., 1996, BIOL CONSERVATION; Jules ES, 2003, J VEG SCI, V14, P459, DOI 10.1111/j.1654-1103.2003.tb02172.x; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; [KNBS Statistics KNBo], 2009, POP HOUS DENS; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Loveridge A, 2003, LION CONS RES WORKSH, P1; Loveridge A., 2009, AFRICAN LION DISTRIB; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCollough D, 1996, METAPOPULATIONS WILD; Mesochina P, 2010, CONSERVATION STATUS; Mills LS, 1996, CONSERV BIOL, V10, P1509, DOI 10.1046/j.1523-1739.1996.10061509.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.2307/3071919; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Oksanen J., 2004, INCIDENCE FUNCTION M; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PACKER C, 1991, CONSERV BIOL, V5, P219, DOI 10.1111/j.1523-1739.1991.tb00127.x; Packer C, 2013, ECOLOGY LETT; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; R Development Core Team, 2021, R PROJECT STAT COMPU; Ray J.C., 2005, 24 WILDL CONS SOC; Ray J. C., 2005, LARGE CARNIVORES CON; Reed JM, 2005, ECOL MODEL, V183, P411, DOI 10.1016/j.ecolmodel.2004.02.025; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Riggio J, 2011, THESIS DUKE U; Riggio J, 2012, BIODIVERS CONSERV, P1; Schaller G. B., 1972, SERENGETI LION STUDY; Stacey PB, 1997, METAPOPULATION BIOL, P215; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 1999, J HUM EVOL, V36, P275, DOI 10.1006/jhev.1998.0268; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Vandermeer J, 2001, AM NAT, V158, P211, DOI 10.1086/321318; VERNER J, 1992, CONDOR, V94, P301, DOI 10.2307/1368825; Wiens John A., 1996, P53; Wood C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001220; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066	83	44	46	0	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88081	10.1371/journal.pone.0088081	http://dx.doi.org/10.1371/journal.pone.0088081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505385	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200112
J	Herath, S; Benlahrech, A; Papagatsias, T; Athanasopoulos, T; Bouzeboudjen, Z; Hervouet, C; Klavinskis, L; Meiser, A; Kelleher, P; Dickson, G; Patterson, S				Herath, Shanthi; Benlahrech, Adel; Papagatsias, Timos; Athanasopoulos, Takis; Bouzeboudjen, Zineb; Hervouet, Catherine; Klavinskis, Linda; Meiser, Andrea; Kelleher, Peter; Dickson, George; Patterson, Steven			Fusion of Ubiquitin to HIV Gag Impairs Human Monocyte-Derived Dendritic Cell Maturation and Reduces Ability to Induce Gag T Cell Responses	PLOS ONE			English	Article							MHC CLASS-I; ANTIGEN PRESENTATION; ANTIVIRAL PROTECTION; DNA IMMUNIZATION; VACCINE; PROTEIN; EXPANSION; DEGRADATION; EXPRESSION; SEQUENCE	The efficient induction of CD8 T cell immunity is dependent on the processing and presentation of antigen on MHC class I molecules by professional antigen presenting cells (APC). To develop an improved T cell vaccine for HIV we investigated whether fusing the ubiquitin gene to the N terminus of the HIV gag gene enhanced targeting to the proteasome resulting in better CD8 T cell responses. Human monocyte derived dendritic cells (moDC), transduced with adenovirus vectors carrying either ubiquitinated or non-ubiquitinated gag transgene constructs, were co-cultured with autologous naive T cells and T cell responses were measured after several weekly cycles of stimulation. Despite targeting of the ubiquitin gag transgene protein to the proteasome, ubiquitination did not increase CD8 T cell immune responses and in some cases diminished responses to gag peptides. There were no marked differences in cytokines produced from ubiquitinated and non-ubiquitinated gag stimulated cultures or in the expression of inhibitory molecules on expanded T cells. However, the ability of moDC transduced with ubiquitinated gag gene to upregulate co-stimulatory molecules was reduced, whilst no difference in moDC maturation was observed with a control ubiquitinated and non-ubiquitinated MART gene. Furthermore moDC transduced with ubiquitinated gag produced more IL-10 than transduction with unmodified gag. Thus failure of gag ubiquitination to enhance CD8 responses may be caused by suppression of moDC maturation. These results indicate that when designing a successful vaccine strategy to target a particular cell population, attention must also be given to the effect of the vaccine on APCs.	[Herath, Shanthi; Benlahrech, Adel; Papagatsias, Timos; Bouzeboudjen, Zineb; Meiser, Andrea; Kelleher, Peter; Patterson, Steven] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England; [Athanasopoulos, Takis; Dickson, George] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Hervouet, Catherine; Klavinskis, Linda] Kings Coll London, Guys Hosp, Peter Gorer Dept Immunobiol, London, England	Imperial College London; University of London; Royal Holloway University London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Patterson, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Immunol, London, England.	s.patterson@imperial.ac.uk		Patterson, Steven/0000-0003-0652-7797; Klavinskis, Linda S./0000-0001-5828-6978	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding provided by the Bill and Melinda Gates Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2000, J EXP MED, V192, P63, DOI 10.1084/jem.192.1.63; Bachy V, 2013, P NATL ACAD SCI USA, V110, P3041, DOI 10.1073/pnas.1214449110; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Benlahrech A, 2009, P NATL ACAD SCI USA, V106, P19940, DOI 10.1073/pnas.0907898106; Butterfield LH, 2008, J IMMUNOTHER, V31, P294, DOI 10.1097/CJI.0b013e31816a8910; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Dalod M, 1999, J VIROL, V73, P7108, DOI 10.1128/JVI.73.9.7108-7116.1999; Day CL, 2007, J VIROL, V81, P434, DOI 10.1128/JVI.01754-06; Dobano C, 2007, IMMUNOL LETT, V111, P92, DOI 10.1016/j.imlet.2007.05.007; ECKER DJ, 1989, J BIOL CHEM, V264, P7715; Elahi S, 2011, NAT MED, V17, P989, DOI 10.1038/nm.2422; Fu TM, 1998, J VIROL, V72, P1469, DOI 10.1128/JVI.72.2.1469-1481.1998; Gamble LJ, 2010, DRUG DES DEV THER, V5, P9, DOI 10.2147/DDDT.S6959; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldwich A, 2008, J IMMUNOL, V180, P372, DOI 10.4049/jimmunol.180.1.372; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Huang L, 2011, J IMMUNOL, V186, P1904, DOI 10.4049/jimmunol.1003411; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE, pxxiii; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kloetzel PM, 2004, BBA-MOL CELL RES, V1695, P225, DOI 10.1016/j.bbamcr.2004.10.004; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lu W, 2003, NAT MED, V9, P27, DOI 10.1038/nm806; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Rodriguez F, 1998, J VIROL, V72, P5174, DOI 10.1128/JVI.72.6.5174-5181.1998; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; Rouard H, 2003, HUM GENE THER, V14, P1319, DOI 10.1089/104303403322319408; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Tobery TW, 1997, J EXP MED, V185, P909, DOI 10.1084/jem.185.5.909; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Van Gulck ER, 2008, J VIROL, V82, P3561, DOI 10.1128/JVI.02080-07; Verkoczy L, 2011, CURR OPIN IMMUNOL, V23, P383, DOI 10.1016/j.coi.2011.04.003; Vidalin O, 1999, DNA CELL BIOL, V18, P611, DOI 10.1089/104454999315024; Wilson JDK, 1998, J EXP MED, V188, P785, DOI 10.1084/jem.188.4.785; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	47	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88327	10.1371/journal.pone.0088327	http://dx.doi.org/10.1371/journal.pone.0088327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505475	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200176
J	Ouyang, YL; Pleyer, U; Shao, Q; Keane, PA; Stubiger, N; Joussen, AM; Sadda, SR; Heussen, FM				Ouyang, Yanling; Pleyer, Uwe; Shao, Qing; Keane, Pearse A.; Stuebiger, Nicole; Joussen, Antonia M.; Sadda, Srinivas R.; Heussen, Florian M.			Evaluation of Cystoid Change Phenotypes in Ocular Toxoplasmosis Using Optical Coherence Tomography	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; MACULAR DEGENERATION; RETINOCHOROIDITIS; PATHOGENESIS; FEATURES; GONDII	Purpose: To present unique cystoid changes occurring in patients with ocular toxoplasmosis observed in spectral domain optical coherence tomography (OCT). Methods: Forty-six patients (80 eyes) with a diagnosis of ocular toxoplasmosis, who underwent volume OCT examination between January 2005 and October 2012, were retrospectively collected. Review of clinical examination findings, fundus photographs, fluorescein angiograms (FA) and OCT image sets obtained at initial visits and follow-up. Qualitative and quantitative analyses of cystoid space phenotypes visualized using OCT. Results: Of the 80 eyes included, 17 eyes (15 patients) demonstrated cystoid changes in the macula on OCT. Six eyes (7.5%) had cystoid macular edema (CME), 2 eyes (2.5%) had huge outer retinal cystoid space (HORC), 12 eyes (15%) had cystoid degeneration and additional 3 eyes (3.75%) had outer retinal tubulation due to age related macular degeneration. In one eye with HORC, the lesion was seen in the photoreceptor outer segment, accompanied by photoreceptor elongation and splitting. Three eyes presented with paravascular cystoid degeneration in the inner retina without other macular OCT abnormality. Conclusions: In this study, different phenotypes of cystoid spaces seen in eyes with ocular toxoplasmosis using spectral domain OCT (SD-OCT) were demonstrated. CME presented as an uncommon feature, consistently with previous findings. Identification of rare morphological cystoid features (HORC with/without photoreceptor enlongation or splitting) on clinical examination had provided evidence to previous experimental models, which may also expand the clinical spectrum of the disease. Cystoid degeneration in the inner retina next to the retinal vessels in otherwise "normal" looking macula was observed, which may suggest more often clinical evaluation for those patients. Further studies are needed to verify the relevance of cystoid features seen on SD-OCT in assisting with the diagnosis and management of ocular toxoplasmosis.	[Ouyang, Yanling; Pleyer, Uwe; Shao, Qing; Stuebiger, Nicole; Joussen, Antonia M.; Heussen, Florian M.] Univ Med Berlin, Charite, Dept Ophthalmol, Berlin, Germany; [Keane, Pearse A.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr Ophthalmol, London, England; [Keane, Pearse A.] UCL Inst Ophthalmol, London, England; [Sadda, Srinivas R.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Sadda, Srinivas R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Doheny Eye Institute; University of Southern California; University of Southern California	Heussen, FM (corresponding author), Univ Med Berlin, Charite, Dept Ophthalmol, Berlin, Germany.	florian.heussen@gmail.com	Joussen, Antonia/AAA-6901-2022; Keane, Pearse/AAE-5709-2019	Keane, Pearse/0000-0002-9239-745X; Heussen, Florian Moritz/0000-0003-0536-9870	Department of Health's NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Allergan European Retina Panel; Novartis; Allergan Inc.; Bayer AG; federal ministry of education and research of Germany (BMBF) through the Toxonet 02 research collaboration; Carl Zeiss Meditec; Optos; Optovue, Inc.; Academy of Medical Sciences (AMS) [AMS-SGCL6-Keane] Funding Source: researchfish; National Institute for Health Research [CL-2010-18-004] Funding Source: researchfish	Department of Health's NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital; UCL Institute of Ophthalmology; Allergan European Retina Panel; Novartis(Novartis); Allergan Inc.(AbbVieAllergan); Bayer AG(Bayer AG); federal ministry of education and research of Germany (BMBF) through the Toxonet 02 research collaboration; Carl Zeiss Meditec; Optos; Optovue, Inc.; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. Keane has received a proportion of his funding from the Department of Health's NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology. The views expressed in the publication are those of the author and not necessarily those of the Department of Health. Drs. Keane and Heussen have received travel grants from the Allergan European Retina Panel. Dr. Joussen received financial compensation for lectures from Novartis, Allergan Inc. and Bayer AG. Dr. Pleyer received funding from the federal ministry of education and research of Germany (BMBF) through the Toxonet 02 research collaboration and has been the Principal Investigator/Consultant for Abbott, Alcon, Allergan, Amgen, Bausch and Lomb, Bayer/Schering, Centocor, Esba Tech, Novartis but no commercial interests or financial relationships to any agent, device, or technique. Dr. Sadda is a co-inventor of Doheny intellectual property related to optical coherence tomography that has been licensed by Topcon Medical Systems, and is a member of the scientific advisory board for Heidelberg Engineering. Dr Sadda also receives research support from Carl Zeiss Meditec, Optos, and Optovue, Inc. The authors have no commercial interests for the manuscript. This work was partially supported by the funding from the federal ministry of education and research of Germany (BMBF) through the Toxonet 02 research collaboration and the Department of Health's NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P129, DOI 10.1080/08820530500231961; Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; CASSADY J V, 1960, Trans Am Ophthalmol Soc, V58, P392; Diniz B, 2011, CLIN OPHTHALMOL, V5, P645, DOI 10.2147/OPTH.S20033; Dodds EM, 2008, AM J OPHTHALMOL, V146, P856, DOI 10.1016/j.ajo.2008.09.006; FRENKEL J K, 1961, Surv Ophthalmol, V6, P799; Gallagher MJ, 2007, BRIT J OPHTHALMOL, V91, P1680, DOI 10.1136/bjo.2007.124099; Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; GROSSNIKLAUS HE, 1990, OPHTHALMOLOGY, V97, P1342, DOI 10.1016/S0161-6420(90)32412-0; Heussen FM, 2011, INVEST OPHTH VIS SCI, V52, P7792, DOI 10.1167/iovs.11-8023; Holland GN, 1999, AM J OPHTHALMOL, V128, P502, DOI 10.1016/S0002-9394(99)00263-9; Ishihara K, 2009, OPHTHALMOLOGY, V116, P1799, DOI 10.1016/j.ophtha.2009.04.002; Keane PA, 2012, SURV OPHTHALMOL, V57, P389, DOI 10.1016/j.survophthal.2012.01.006; Kianersi F, 2012, INT OPHTHALMOLOGY; Kovacevic-Pavicevic D, 2012, EYE, V26, P723, DOI 10.1038/eye.2012.20; Ouyang Y, 2013, RETINA PHILADELPHIA; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P1460, DOI 10.1167/iovs.12-10727; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; Ouyang YL, 2010, INVEST OPHTH VIS SCI, V51, P5213, DOI 10.1167/iovs.09-4635; Remington JSDG, 1976, TOXOPLASMOSIS INFECT, P191; Roberts F, 1999, PARASITOL TODAY, V15, P51, DOI 10.1016/S0169-4758(98)01377-5; ROBERTS T, 1990, J AM VET MED ASSOC, V196, P249; Saxena Sandeep, 2010, J Ocul Biol Dis Infor, V3, P109, DOI 10.1007/s12177-011-9062-x; SCHLAEGEL TF, 1984, ARCH OPHTHALMOL-CHIC, V102, P697, DOI 10.1001/archopht.1984.01040030553014; Tedesco RC, 2004, PARASITOL RES, V92, P467, DOI 10.1007/s00436-003-1031-2; Zweifel SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1596, DOI 10.1001/archophthalmol.2009.326	27	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86626	10.1371/journal.pone.0086626	http://dx.doi.org/10.1371/journal.pone.0086626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505261	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200021
J	Versluis, B; Nelemans, PJ; Brans, R; Wildberger, JE; Schurink, GW; Leiner, T; Backes, WH				Versluis, Bas; Nelemans, Patty J.; Brans, Rutger; Wildberger, Joachim E.; Schurink, Geert-Willem; Leiner, Tim; Backes, Walter H.			Functional MRI in Peripheral Arterial Disease: Arterial Peak Flow versus Ankle-Brachial Index	PLOS ONE			English	Article							LOWER-EXTREMITY; PRESSURE INDEX; ALL-CAUSE; SENSITIVITY; ANGIOGRAPHY; QUANTIFICATION; CALCIFICATION; SPECIFICITY; GUIDELINES; MANAGEMENT	Objectives: The purpose of this study was to compare the success rate of successful arterial peak flow (APF) and ankle-brachial index (ABI) measurements in patients with suspected or known peripheral arterial disease (PAD). Materials and Methods: 183 patients with varying degrees of PAD were included. All subjects underwent ABI measurements and MR imaging of the popliteal artery to determine APF. Proportions of patients with successful APF and ABI measurements were compared and the discriminative capability was evaluated. Results: APF was successfully measured in 91% of the patients, whereas the ABI could be determined in 71% of the patients (p<0.01). Success rates of APF and ABI were significantly higher in patients with intermittent claudication (95% and 80%, respectively) than in patients with critical ischemia (87% and 62%, respectively). Conclusions: Compared to the assessment of PAD severity with ABI, the success rate of MRI-based APF measurements in patients with a clinical indication for MRA is 20% higher, with similar discriminatory capacity for disease severity. Therefore, APF is an especially convenient and valuable measure to assess severity in PAD patients scheduled to undergo MR angiography to obtain additional functional information concerning the vascular status.	[Versluis, Bas; Brans, Rutger; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Schurink, Geert-Willem] Maastricht Univ, Med Ctr, Dept Surg, Maastricht, Netherlands; [Nelemans, Patty J.] Maastricht Univ, Med Ctr, Dept Epidemiol, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim E.; Leiner, Tim; Backes, Walter H.] Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University	Backes, WH (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	w.backes@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854				Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Allen J, 1996, ANGIOLOGY, V47, P225, DOI 10.1177/000331979604700302; Andersen CA, 2010, J VASC SURG, V52, p76S, DOI 10.1016/j.jvs.2010.06.012; Aslam F, 2009, SOUTH MED J, V102, P1141, DOI 10.1097/SMJ.0b013e3181bb9ab8; Begelman Susan M, 2006, Cleve Clin J Med, V73 Suppl 4, pS22; Bishara RA, 2004, INT ANGIOL, V23, P368; Brooks B, 2001, DIABETIC MED, V18, P528, DOI 10.1046/j.1464-5491.2001.00493.x; Creager M A, 1997, Vasc Med, V2, P231; de Vries M, 2005, INVEST RADIOL, V40, P495, DOI 10.1097/01.rli.0000163004.65460.8b; de Vries M, 2005, J MAGN RESON IMAGING, V21, P37, DOI 10.1002/jmri.20240; Doobay AV, 2005, ARTERIOSCL THROM VAS, V25, P1463, DOI 10.1161/01.ATV.0000168911.78624.b7; Gerhard-Herman M, 2006, VASC MED, V11, P183, DOI 10.1177/1358863x06070516; Giachelli CM, 2004, J AM SOC NEPHROL, V15, P2959, DOI 10.1097/01.ASN.0000145894.57533.C4; GOSS DE, 1989, DIABETIC MED, V6, P576; Guo X, 2008, CIRC J, V72, P605; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Leiner T, 2005, RADIOLOGY, V235, P699, DOI 10.1148/radiol.2352040089; Leiner T, 2004, J MAGN RESON IMAGING, V20, P417, DOI 10.1002/jmri.20129; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; McDermott MM, 2004, J VASC SURG, V39, P523, DOI 10.1016/j.jvs.2003.08.038; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Mohajer K, 2006, J MAGN RESON IMAGING, V23, P355, DOI 10.1002/jmri.20514; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Potier L, 2010, EUR J VASC ENDOVASC; Prakash A, 2006, J MAGN RESON IMAGING, V24, P676, DOI 10.1002/jmri.20654; RAINES JK, 1976, SURGERY, V79, P21; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Stein R, 2006, VASC MED, V11, P29, DOI 10.1191/1358863x06vm663oa; van Langen H, 2009, VASC MED, V14, P221, DOI 10.1177/1358863X08101017; Versluis B, 2011, INVEST RADIOL, V46, P11, DOI 10.1097/RLI.0b013e3181f2bfb8; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376	32	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88471	10.1371/journal.pone.0088471	http://dx.doi.org/10.1371/journal.pone.0088471			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505494	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200194
J	Wang, HQ; Wu, YH; Fu, R; Qu, W; Ruan, EB; Wang, GJ; Liu, H; Song, J; Xing, LM; Guan, J; Li, LJ; Liu, CY; Shao, ZH				Wang, Huaquan; Wu, Yuhong; Fu, Rong; Qu, Wen; Ruan, Erbao; Wang, Guojin; Liu, Hong; Song, Jia; Xing, Limin; Guan, Jing; Li, Lijuan; Liu, Chunyan; Shao, Zonghong			Granulocyte Transfusion Combined with Granulocyte Colony Stimulating Factor in Severe Infection Patients with Severe Aplastic Anemia: A Single Center Experience from China	PLOS ONE			English	Article							ANTITHYMOCYTE GLOBULIN; IMMUNOSUPPRESSIVE THERAPY; MARROW-TRANSPLANTATION; NEUTROPENIC PATIENTS; FOLLOW-UP; CYCLOSPORINE; CANCER	Objective: To investigate the efficacy and safety of granulocyte transfusion combined with granulocyte colony stimulating factor (G-CSF) in severe infection patients with severe aplastic anemia (SAA). Methods: Fifty-six patients in severe infections with SAA who had received granulocyte transfusions combined with G-CSF from 2006 to 2012 in our department were analyzed. A retrospective analysis was undertaken to investigate the survival rates (at 30 days, 90 days and 180 days), the responses to treatment (at 7 days and 30 days, including microbiological, radiographic and clinical responses), the neutrophil count and adverse events after transfusion. Results: All SAA patients with severe infections were treated with granulocyte transfusions combined with G-CSF. Forty-seven patients had received antithymocyte globulin/antilymphocyte globulin and cyclosporine A as immunosuppressive therapy. The median number of granulocyte components transfused was 18 (range, 3-75). The survival at 30 days, 90 days and 180 days were 50(89%), 39(70%) and 37(66%) respectively. Among 31 patients who had invasive fungal infections, the survival at 30 days, 90 days and 180 days were 27(87%), 18(58%) and 16(52%) respectively. Among the 25 patients who had refractory severe bacterial infections, the survival at 30 days, 90 days and 180 days were 23(92%), 21(84%) and 21(84%) respectively. Survival rate was correlated with hematopoietic recovery. Responses of patients at 7 and 30 days were correlated with survival rate. Common adverse effects of granulocyte transfusion included mild to moderate fever, chills, allergy and dyspnea. Conclusion: Granulocyte transfusions combined with G-CSF could be an adjunctive therapy for treating severe infections of patients with SAA.	[Wang, Huaquan; Wu, Yuhong; Fu, Rong; Qu, Wen; Ruan, Erbao; Wang, Guojin; Liu, Hong; Song, Jia; Xing, Limin; Guan, Jing; Li, Lijuan; Liu, Chunyan; Shao, Zonghong] Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China	Tianjin Medical University	Shao, ZH (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Hematol, Tianjin, Peoples R China.	shaozonghong@sina.com	LI, LI QING/GRR-8855-2022; Li, Li/AEM-3636-2022; li, li/AAT-2097-2020; Wang, Huaquan/AAN-6917-2021; li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022		Natural Science Foundation of China [30971286, 30971285, 81170472]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is partly supported by Natural Science Foundation of China (No. 30971286, 30971285, 81170472) http://isisn.nsfc.gov.cn/egrantweb/. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; Bacigalupo Andrea, 2007, Hematology Am Soc Hematol Educ Program, P23; Brodsky RA, 2010, BLOOD, V115, P2136, DOI 10.1182/blood-2009-06-225375; CAMITTA BM, 1976, BLOOD, V48, P63; Chinese Invasive Fungal Infection Working Group, 2010, ZHONGHUA NEI KE ZA Z, V49, P451; Drewniak A, 2009, BLOOD, V113, P5979, DOI 10.1182/blood-2008-10-182147; Gluckman E, 2002, BRIT J HAEMATOL, V119, P1075, DOI 10.1046/j.1365-2141.2002.03947.x; Kojima S, 2000, BLOOD, V96, P2049; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; Ofran Y, 2007, VOX SANG, V93, P363, DOI 10.1111/j.1423-0410.2007.00971.x; Peters C, 2009, VOX SANG, V96, P275, DOI 10.1111/j.1423-0410.2008.01159.x; Quillen K, 2009, HAEMATOL-HEMATOL J, V94, P1661, DOI 10.3324/haematol.2009.010231; Risitano AM, 2010, BRIT J HAEMATOL, V148, P791, DOI 10.1111/j.1365-2141.2009.08027.x; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; Safdar A, 2004, CANCER, V101, P2859, DOI 10.1002/cncr.20710; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Shao ZH, 1998, AM J HEMATOL, V59, P185, DOI 10.1002/(SICI)1096-8652(199811)59:3<185::AID-AJH2>3.0.CO;2-3; Teramura M, 2007, BLOOD, V110, P1756, DOI 10.1182/blood-2006-11-050526; Tichelli A, 2011, BLOOD, V117, P4434, DOI 10.1182/blood-2010-08-304071; Torres HA, 2003, CANCER, V98, P86, DOI 10.1002/cncr.11478; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Wu YH, 2005, ZHONGHUA YI YUAN GAN, V15, P866; Wu Yu-hong, 2003, Zhonghua Xue Ye Xue Za Zhi, V24, P530; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	24	15	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88148	10.1371/journal.pone.0088148	http://dx.doi.org/10.1371/journal.pone.0088148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505406	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200124
J	Yoon, JH; Ahn, YS				Yoon, Jin-Ha; Ahn, Yeon-Soon			Cause-Specific Mortality Due to Malignant and Non-Malignant Disease in Korean Foundry Workers	PLOS ONE			English	Article							BRAZILIAN STEEL WORKERS; SWEDISH IRON FOUNDRIES; NESTED CASE-CONTROL; GASTRIC-CANCER; OCCUPATIONAL EXPOSURES; STOMACH-CANCER; DUST EXPOSURE; RISK; LUNG; SUICIDE	Background: Foundry work is associated with serious occupational hazards. Although several studies have investigated the health risks associated with foundry work, the results of these studies have been inconsistent with the exception of an increased lung cancer risk. The current study evaluated the mortality of Korean foundry workers due to malignant and nonmalignant diseases. Methods: This study is part of an ongoing investigation of Korean foundry workers. To date, we have observed more than 150,000 person-years in male foundry production workers. In the current study, we stratified mortality ratios by the following job categories: melting-pouring, molding-coremaking, fettling, and uncategorized production work. We calculated standard mortality ratios (SMR) of foundry workers compare to general Korean men and relative risk (RR) of mortality of foundry production workers reference to non-production worker, respectively. Results: Korean foundry production workers had a significantly higher risk of mortality due to malignant disease, including stomach (RR: 3.96; 95% CI: 1.41-11.06) and lung cancer (RR: 2.08; 95% CI: 1.01-4.30), compared with non-production workers. High mortality ratios were also observed for non-malignant diseases, including diseases of the circulatory (RR: 1.92; 95% CI: 1.18-3.14), respiratory (RR: 1.71; 95% CI: 1.52-21.42 for uncategorized production worker), and digestive (RR: 2.27; 95% CI: 1.22-4.24) systems, as well as for injuries (RR: 2.36; 95% CI: 1.52-3.66) including suicide (RR: 3.64; 95% CI: 1.32-10.01). Conclusion: This study suggests that foundry production work significantly increases the risk of mortality due to some kinds of malignant and non-malignant diseases compared with non-production work.	[Yoon, Jin-Ha] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Yoon, Jin-Ha] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju, South Korea; [Ahn, Yeon-Soon] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Dongguk University; NHIS Ilsan Hospital	Ahn, YS (corresponding author), Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea.	ysahn@dongguk.ac.kr		Yoon, Jin-Ha/0000-0003-4198-2955				Adzersen KH, 2003, AM J IND MED, V43, P295, DOI 10.1002/ajim.10187; Ager E, 2007, PSYCHOL MED, V37, P1131, DOI 10.1017/S0033291707000487; Ahn YS, 2006, AM J IND MED, V49, P647, DOI 10.1002/ajim.20337; Ahn YS, 2010, J KOREAN MED SCI, V25, P1733, DOI 10.3346/jkms.2010.25.12.1733; Ahn YS, 1997, J OCCUPATIONAL ENV M, V9, P589; Ahn YS, 2000, KOREAN J PREV MED, V33, P299; Ahn YS, 2005, RESP DIS FOUNDRY WOR, P171; Andersson L, 2012, J OCCUP ENVIRON HYG, V9, P110, DOI 10.1080/15459624.2011.645397; Andersson L, 2009, J OCCUP ENVIRON HYG, V6, P9, DOI 10.1080/15459620802523943; Barreto SM, 1996, OCCUP ENVIRON MED, V53, P343, DOI 10.1136/oem.53.5.343; Barreto SM, 1997, OCCUP ENVIRON MED, V54, P599, DOI 10.1136/oem.54.8.599; Choi JK, 1994, KOREAN J PREVENTIVE, V27, P274; Cocco P, 1996, EPIDEMIOL REV, V18, P218, DOI 10.1093/oxfordjournals.epirev.a017927; DUCOS P, 1988, ENVIRON RES, V47, P72, DOI 10.1016/S0013-9351(88)80022-7; Dungan RS, 2005, J ENVIRON SCI HEAL A, V40, P1557, DOI 10.1081/ESE-200060630; Ekstrom AM, 1999, CANCER RES, V59, P5932; Gaertner RRW, 2002, OCCUP ENVIRON MED, V59, P655, DOI 10.1136/oem.59.10.655; Gomes J, 2001, OCCUP ENVIRON MED, V58, P656, DOI 10.1136/oem.58.10.656; HANSEN ES, 1991, AM J IND MED, V20, P401, DOI 10.1002/ajim.4700200312; Horng CJ, 2003, ARCH ENVIRON HEALTH, V58, P104, DOI 10.3200/AEOH.58.2.104-110; IARC, 1987, OV EV CARC UPD IARC, V1-42, P224; Kim H, 1998, J KOREAN SOC OCCUP E, V8, P50; 박용선, 2003, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V13, P90; 김세영, 2011, Annals of Occupational and Environmental Medicine, V23, P317; 김민기, 2008, Annals of Occupational and Environmental Medicine, V20, P46; Koo JW, 2000, J OCCUP HEALTH, V42, P251, DOI 10.1539/joh.42.251; Korea National Statistical Office, CAUS DEATH STAT 2011; Koskela Riitta-Sisko, 1997, Scandinavian Journal of Work Environment and Health, V23, P1; Koskela RS, 2000, AM J EPIDEMIOL, V152, P628, DOI 10.1093/aje/152.7.628; KOSKELA RS, 1983, SCAND J WORK ENV HEA, V9, P155, DOI 10.5271/sjweh.2430; Krstev S, 2005, OCCUP ENVIRON MED, V62, P318, DOI 10.1136/oem.2004.015883; Kuo HW, 1999, OCCUP MED-OXFORD, V49, P499, DOI 10.1093/occmed/49.8.499; Maris RW, 2002, LANCET, V360, P319, DOI 10.1016/S0140-6736(02)09556-9; Palda VA, 2003, OCCUP MED-OXFORD, V53, P179, DOI 10.1093/occmed/kqg052; Parent ME, 1998, EPIDEMIOLOGY, V9, P48, DOI 10.1097/00001648-199801000-00011; Park RM, 2005, AM J IND MED, V48, P194, DOI 10.1002/ajim.20197; Park RM, 2001, J OCCUP ENVIRON MED, V43, P483, DOI 10.1097/00043764-200105000-00009; Parks CG, 1999, ENVIRON HEALTH PERSP, V107, P793, DOI 10.2307/3434342; Phee YG, 1997, J KOREAN SOC OCCUP E, V7, P196; Porru S, 2001, INT J CANCER, V94, P878, DOI 10.1002/ijc.1538; Raj A, 2003, POSTGRAD MED J, V79, P252, DOI 10.1136/pmj.79.931.252; Scott CS, 2011, INT J ENV RES PUB HE, V8, P4238, DOI 10.3390/ijerph8114238; SHERSON D, 1991, ARCH ENVIRON HEALTH, V46, P75, DOI 10.1080/00039896.1991.9937432; Skegg K, 2010, AUST NZ J PSYCHIAT, V44, P429, DOI 10.3109/00048670903487191; SORAHAN T, 1994, OCCUP ENVIRON MED, V51, P316, DOI 10.1136/oem.51.5.316; Steenland K, 1996, AM J IND MED, V30, P495, DOI 10.1002/(SICI)1097-0274(199610)30:4<495::AID-AJIM16>3.3.CO;2-I; Sullivan, 2000, Ann Epidemiol, V10, P480, DOI 10.1016/S1047-2797(00)00120-4; Taeger D, 2000, EPIDEMIOLOGY, V11, P607, DOI 10.1097/00001648-200009000-00019; Tossavainen A, 1990, IARC Sci Publ, P363; Xu ZY, 1996, AM J IND MED, V30, P7; 오도석, 2006, [Journal of Korean Society of Occupational and Environmental Hygiene, 한국산업보건학회지], V16, P27; 안연순, 2007, Annals of Occupational and Environmental Medicine, V19, P81	52	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88264	10.1371/journal.pone.0088264	http://dx.doi.org/10.1371/journal.pone.0088264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505454	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200157
J	Mehic, E; Xu, JM; Caler, CJ; Coulson, NK; Moritz, CT; Mourad, PD				Mehic, Edin; Xu, Julia M.; Caler, Connor J.; Coulson, Nathaniel K.; Moritz, Chet T.; Mourad, Pierre D.			Increased Anatomical Specificity of Neuromodulation via Modulated Focused Ultrasound	PLOS ONE			English	Article							VIBRO-ACOUSTOGRAPHY; BRAIN-STEM; STIMULATION; NERVE; PARAMETERS; POTENTIALS; ANESTHESIA; CELLS	Transcranial ultrasound can alter brain function transiently and nondestructively, offering a new tool to study brain function now and inform future therapies. Previous research on neuromodulation implemented pulsed low-frequency (250-700 kHz) ultrasound with spatial peak temporal average intensities (I-SPTA) of 0.1-10 W/cm(2). That work used transducers that either insonified relatively large volumes of mouse brain (several mL) with relatively low-frequency ultrasound and produced bilateral motor responses, or relatively small volumes of brain (on the order of 0.06 mL) with relatively high-frequency ultrasound that produced unilateral motor responses. This study seeks to increase anatomical specificity to neuromodulation with modulated focused ultrasound (mFU). Here, 'modulated' means modifying a focused 2-MHz carrier signal dynamically with a 500-kHz signal as in vibro-acoustography, thereby creating a low-frequency but small volume (approximately 0.015 mL) source of neuromodulation. Application of transcranial mFU to lightly anesthetized mice produced various motor movements with high spatial selectivity (on the order of 1 mm) that scaled with the temporal average ultrasound intensity. Alone, mFU and focused ultrasound (FUS) each induced motor activity, including unilateral motions, though anatomical location and type of motion varied. Future work should include larger animal models to determine the relative efficacy of mFU versus FUS. Other studies should determine the biophysical processes through which they act. Also of interest is exploration of the potential research and clinical applications for targeted, transcranial neuromodulation created by modulated focused ultrasound, especially mFU's ability to produce compact sources of ultrasound at the very low frequencies (10-100s of Hertz) that are commensurate with the natural frequencies of the brain.	[Mehic, Edin; Caler, Connor J.; Coulson, Nathaniel K.; Mourad, Pierre D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Xu, Julia M.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA; [Moritz, Chet T.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Moritz, Chet T.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Appl Phys Lab, Seattle, WA 98105 USA; [Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Dept Engn & Math, Bothell, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Bothell	Mourad, PD (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	pierre@apl.washington.edu			Mary Gates Foundation of the University of Washington; NASA Summer Undergraduate Research Program at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Mary Gates Foundation of the University of Washington; NASA Summer Undergraduate Research Program at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work has been funded by the Mary Gates Foundation of the University of Washington and the NASA Summer Undergraduate Research Program at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bystritsky A, 2011, BRAIN STIMUL, V4, P125, DOI 10.1016/j.brs.2011.03.007; Fatemi M, 1999, P NATL ACAD SCI USA, V96, P6603, DOI 10.1073/pnas.96.12.6603; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; GORMAN PH, 1983, IEEE T BIO-MED ENG, V30, P407, DOI 10.1109/TBME.1983.325041; GOSSSAMPSON MA, 1991, LAB ANIM, V25, P360, DOI 10.1258/002367791780810074; GUSTAFSSON B, 1976, J PHYSIOL-LONDON, V258, P33, DOI 10.1113/jphysiol.1976.sp011405; Haghighi SS, 1998, NEUROL RES, V20, P555; Jay J, 2009, NEUROSURGERY, V64, P201; Kim H, 2012, ULTRASOUND MED BIOL, V38, P1568, DOI 10.1016/j.ultrasmedbio.2012.04.023; King RL, 2013, ULTRASOUND MED BIOL, V39, P312, DOI 10.1016/j.ultrasmedbio.2012.09.009; Lucas TH, 2013, J NEUROSCI, V33, P5261, DOI 10.1523/JNEUROSCI.4683-12.2013; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Monteith S, 2013, J NEUROSURG, V118, P215, DOI 10.3171/2012.10.JNS12449; Pollak TA, 2014, J NEUROL NEUROSUR PS, V85, P191, DOI 10.1136/jnnp-2012-304181; PREUSS TM, 1987, J COMP NEUROL, V257, P269, DOI 10.1002/cne.902570211; Prochazka A, 2001, J PHYSIOL-LONDON, V533, P99, DOI 10.1111/j.1469-7793.2001.0099b.x; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Tufail Y, 2011, NAT PROTOC, V6, P1453, DOI 10.1038/nprot.2011.371; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2010, NAT REV NEUROL, V6, P13, DOI 10.1038/nrneurol.2009.211; Urban MW, 2011, CURR MED IMAGING, V7, P350; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058	24	100	105	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e86939	10.1371/journal.pone.0086939	http://dx.doi.org/10.1371/journal.pone.0086939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504255	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800016
J	Negrao-Correa, D; Fittipaldi, JF; Lambertucci, JR; Teixeira, MM; Antunes, CMD; Carneiro, M				Negrao-Correa, Deborah; Fittipaldi, Juliana F.; Lambertucci, Jose Roberto; Teixeira, Mauro Martins; de Figueiredo Antunes, Carlos Mauricio; Carneiro, Mariangela			Association of Schistosoma mansoni-Specific IgG and IgE Antibody Production and Clinical Schistosomiasis Status in a Rural Area of Minas Gerais, Brazil	PLOS ONE			English	Article							MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; ADULT WORM ANTIGENS; HEPATIC-FIBROSIS; PERIPORTAL FIBROSIS; IMMUNOGLOBULIN-E; ENDEMIC AREA; GRANULOMATOUS INFLAMMATION; ISOTYPE RESPONSES; LIVER PATHOLOGY; DOWN-REGULATION	Background: Studies in murine models and human populations have indicated that the collagen-rich granulomatous response against parasite eggs trapped in the liver is associated with the development of severe hepatosplenic schistosomiasis, characterized by periportal fibrosis and portal hypertension. The role of the humoral response in parasite susceptibility has been well established, but its participation in disease severity remains poorly understood. In this work, we evaluated the relationship between parasite-reactive IgE and IgG levels and schistosomiasis morbidity in infected patients with similar parasite burdens. Methodology/Principal Findings: Ninety-seven Schistosoma mansoni-infected individuals were subjected to clinical examination and abdominal ultrasound analysis. IgG reactivity and IgE concentration against Schistosoma mansoni soluble egg antigens (SEA) and adult worm antigen preparation (SWAP) were evaluated by ELISA assay. Multivariable linear regression models were used to evaluate the relationship between parasite-reactive antibodies and the co-variables investigated. The study population showed low parasite burden (median 30 eggs/g feces), constant re-infection, and signs of fibrosis was detected in more than 30% of individuals. Most infected individuals showed IgG reactivity, and the median concentrations of IgE anti-SEA and anti-SWAP antibodies were 1,870 and 1,375 ng/mL, respectively. There was no association between parasite burden and antibody response or any parameter of disease severity. However, IgG anti-SWAP level was positively associated with morbidity parameters, such as spleen size and thickness of portal vein at the entrance and secondary branch. In contrast, the data also revealed independent inverse correlations between concentration of parasite-reactive IgE and gallbladder wall thickness, a marker of fibrosis in schistosomiasis. Conclusions/Significance: The data indicate that IgG anti-SWAP is positively associated with severe schistosomiasis, independently of parasite burden, while high production of parasite-specific IgE is associated with mild disease in the human population. Antibody profiles are good correlates for schistosomiasis severity and could be tested as biomarkers of disease severity.	[Negrao-Correa, Deborah; Fittipaldi, Juliana F.; Carneiro, Mariangela] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil; [Teixeira, Mauro Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Lambertucci, Jose Roberto; Carneiro, Mariangela] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [de Figueiredo Antunes, Carlos Mauricio] Santa Casa Belo Horizonte, Inst Ensino & Pesquisa, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Negrao-Correa, D (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Programa Posgrad Parasitol, Belo Horizonte, MG, Brazil.	denegrao@icb.ufmg.br	Teixeira, Mauro M/A-4587-2008	Teixeira, Mauro M/0000-0002-6944-3008	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas Gerais State Foundation for Scientifical Research); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas Gerais State Foundation for Scientifical Research); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development	The experimental work was partially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG (Minas Gerais State Foundation for Scientifical Research) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (National Council for the Scientific and Technological Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Abath FGC, 2006, TRENDS PARASITOL, V22, P85, DOI 10.1016/j.pt.2005.12.004; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003; Bina José Carlos, 2003, Rev. Soc. Bras. Med. Trop., V36, P211, DOI 10.1590/S0037-86822003000200003; Black CL, 2010, J INFECT DIS, V202, P399, DOI 10.1086/653828; Bonnard P, 2004, AM J TROP MED HYG, V71, P202, DOI 10.4269/ajtmh.2004.71.202; Booth M, 2004, J IMMUNOL, V172, P1295, DOI 10.4049/jimmunol.172.2.1295; CHEEVER AW, 1967, T ROY SOC TROP MED H, V61, P626, DOI 10.1016/0035-9203(67)90125-3; CHEEVER AW, 1992, MEM I OSWALDO CRUZ, V87, P337, DOI 10.1590/S0074-02761992000800054; Cheever AW, 1998, MEM I OSWALDO CRUZ, V93, P25, DOI 10.1590/S0074-02761998000700004; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Coutinho HM, 2007, J INFECT DIS, V195, P288, DOI 10.1086/510313; de Jesus AR, 2004, INFECT IMMUN, V72, P3391, DOI 10.1128/IAI.72.6.3391-3397.2004; DUNNE DW, 1992, EUR J IMMUNOL, V22, P1483, DOI 10.1002/eji.1830220622; DUNNE DW, 1992, MEM I OSWALDO CRUZ, V87, P99, DOI 10.1590/S0074-02761992000800014; Fairfax KC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002490; Falcao PL, 2002, J INFECT DIS, V186, P1696, DOI 10.1086/345370; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Figueiredo JP, 2012, PARASITE IMMUNOL, V34, P604, DOI 10.1111/pim.12001; Grogan JL, 1996, J INFECT DIS, V173, P1242, DOI 10.1093/infdis/173.5.1242; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; HAGAN P, 1991, NATURE, V349, P243, DOI 10.1038/349243a0; Henri S, 2002, J IMMUNOL, V169, P929, DOI 10.4049/jimmunol.169.2.929; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; HOMEIDA M, 1988, AM J TROP MED HYG, V39, P196, DOI 10.4269/ajtmh.1988.39.196; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jankovic D, 1999, J IMMUNOL, V163, P337; Jankovic D, 1997, J IMMUNOL, V159, P1868; Jankovic D, 1998, J EXP MED, V187, P619, DOI 10.1084/jem.187.4.619; Jiz M, 2009, INFECT IMMUN, V77, P2051, DOI 10.1128/IAI.00012-09; Kabatereine NB, 1999, PARASITOLOGY, V118, P101, DOI 10.1017/S0031182098003576; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CL, 1997, J IMMUNOL, V158, P294; Lambertucci JR, 2001, MEM I OSWALDO CRUZ, V96, P147, DOI 10.1590/S0074-02762001000900022; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; Meiler F, 2008, ALLERGY, V63, P1455, DOI 10.1111/j.1398-9995.2008.01774.x; Mohamed-Ali Q, 1999, J INFECT DIS, V180, P1298, DOI 10.1086/314999; Naus CWA, 1999, INFECT IMMUN, V67, P3444, DOI 10.1128/IAI.67.7.3444-3451.1999; Naus CWA, 2003, TROP MED INT HEALTH, V8, P561, DOI 10.1046/j.1365-3156.2003.01056.x; Negrao-Correa D, 1999, PARASITE IMMUNOL, V21, P287, DOI 10.1046/j.1365-3024.1999.00219.x; Oliveira LFA, 2006, INFECT IMMUN, V74, P1215, DOI 10.1128/IAI.74.2.1215-1221.2006; Oliveira RR, 2012, AM J TROP MED HYG, V86, P296, DOI 10.4269/ajtmh.2012.11-0204; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Pellegrino J., 1956, REV BRAS MALARIOL DO, V8, P585; Polman K, 2002, ANN TROP MED PARASIT, V96, P679, DOI 10.1179/000349802125001708; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Rezende SA, 1997, MEM I OSWALDO CRUZ, V92, P683, DOI 10.1590/S0074-02761997000500023; Richter J, 2001, MEM I OSWALDO CRUZ, V96, P151, DOI 10.1590/S0074-02762001000900023; Richter J., 2000, WHOTDRSTRSCH001; RIHET P, 1991, EUR J IMMUNOL, V21, P2679, DOI 10.1002/eji.1830211106; RIHET P, 1992, EUR J IMMUNOL, V22, P2063, DOI 10.1002/eji.1830220816; Satoguina JS, 2005, J IMMUNOL, V174, P4718, DOI 10.4049/jimmunol.174.8.4718; Silveira AMS, 2002, AM J TROP MED HYG, V66, P542; Souza ALS, 2005, INFECT IMMUN, V73, P2515, DOI 10.1128/IAI.73.4.2515-2523.2005; Stavitsky AB, 2004, INFECT IMMUN, V72, P1, DOI 10.1128/IAI.72.1.1-12.2004; Tawfeek Gihan M., 2003, Journal of the Egyptian Society of Parasitology, V33, P597; Vennervald BJ, 2004, CURR OPIN INFECT DIS, V17, P439, DOI 10.1097/00001432-200410000-00009; Walter K, 2006, J IMMUNOL, V177, P5490, DOI 10.4049/jimmunol.177.8.5490; Webster M, 1997, PARASITE IMMUNOL, V19, P333, DOI 10.1046/j.1365-3024.1997.d01-211.x; WEINSTOCK JV, 1983, J IMMUNOL, V130, P423; Wilson MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002171; Wynn TA, 1998, J IMMUNOL, V160, P4473; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354	68	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88042	10.1371/journal.pone.0088042	http://dx.doi.org/10.1371/journal.pone.0088042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505371	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300043
J	Meysman, P; Collado-Vides, J; Morett, E; Viola, R; Engelen, K; Laukens, K				Meysman, Pieter; Collado-Vides, Julio; Morett, Enrique; Viola, Roberto; Engelen, Kristof; Laukens, Kris			Structural Properties of Prokaryotic Promoter Regions Correlate with Functional Features	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TRANSCRIPTIONAL START SITES; ESCHERICHIA-COLI; DNA-STRUCTURE; BINDING-SITES; CORE PROMOTER; E. COLI; B-DNA; SEQUENCE; PREDICTION	The structural properties of the DNA molecule are known to play a critical role in transcription. In this paper, the structural profiles of promoter regions were studied within the context of their diversity and their function for eleven prokaryotic species; Escherichia coli, Klebsiella pneumoniae, Salmonella Typhimurium, Pseudomonas auroginosa, Geobacter sulfurreducens Helicobacter pylori, Chlamydophila pneumoniae, Synechocystis sp., Synechoccocus elongates, Bacillus anthracis, and the archaea Sulfolobus solfataricus. The main anchor point for these promoter regions were transcription start sites identified through high-throughput experiments or collected within large curated databases. Prokaryotic promoter regions were found to be less stable and less flexible than the genomic mean across all studied species. However, direct comparison between species revealed differences in their structural profiles that can not solely be explained by the difference in genomic GC content. In addition, comparison with functional data revealed that there are patterns in the promoter structural profiles that can be linked to specific functional loci, such as sigma factor regulation or transcription factor binding. Interestingly, a novel structural element clearly visible near the transcription start site was found in genes associated with essential cellular functions and growth in several species. Our analyses reveals the great diversity in promoter structural profiles both between and within prokaryotic species. We observed relationships between structural diversity and functional features that are interesting prospects for further research to yet uncharacterized functional loci defined by DNA structural properties.	[Meysman, Pieter; Laukens, Kris] Univ Antwerp, Dept Math & Comp Sci, B-2020 Antwerp, Belgium; [Meysman, Pieter; Laukens, Kris] Univ Antwerp, Univ Antwerp Hosp, Biomed Informat Res Ctr Antwerp Biomina, Edegem, Belgium; [Collado-Vides, Julio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62191, Morelos, Mexico; [Morett, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Morett, Enrique] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Viola, Roberto; Engelen, Kristof] Fdn Edmund Mach, Dept Computat Biol, Trento, Italy	University of Antwerp; University of Antwerp; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Fondazione Edmund Mach	Engelen, K (corresponding author), Fdn Edmund Mach, Dept Computat Biol, Trento, Italy.	kristof.engelen@fmach.it; kris.laukens@uantwerpen.be	Laukens, Kris/V-1121-2018; Meysman, Pieter/I-1891-2019; Viola, Roberto/F-3657-2014	Laukens, Kris/0000-0002-8217-2564; Meysman, Pieter/0000-0001-5903-633X; Morett, Enrique/0000-0001-5723-0032; Collado-Vides, Julio/0000-0001-8780-7664; Engelen, Kristof/0000-0001-6215-1689; Viola, Roberto/0000-0002-8202-8503	Fund for Scientific Research - Flanders (FWO-Vlaanderen project "Evolving graphs") [G.0903.13N]	Fund for Scientific Research - Flanders (FWO-Vlaanderen project "Evolving graphs")	This work was supported by the Fund for Scientific Research - Flanders (FWO-Vlaanderen project "Evolving graphs'': G.0903.13N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2008, BIOINFORMATICS, V24, pI24, DOI 10.1093/bioinformatics/btn172; Albrecht M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r98; Askary A, 2009, GENES GENET SYST, V84, P425, DOI 10.1266/ggs.84.425; Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Baisnee PF, 2001, BIOINFORMATICS, V17, P237, DOI 10.1093/bioinformatics/17.3.237; Baldi P, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P35; Baldi P, 2000, BIOINFORMATICS, V16, P865, DOI 10.1093/bioinformatics/16.10.865; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BRUKNER I, 1995, EMBO J, V14, P1812, DOI 10.1002/j.1460-2075.1995.tb07169.x; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Conilione PC, 2005, ADV SOFT COMP, P51; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELCOURT SG, 1991, J BIOL CHEM, V266, P15160; Engelen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020938; Evguenieva-Hackenberg E, 2011, CURR OPIN MICROBIOL, V14, P587, DOI 10.1016/j.mib.2011.07.025; Fernandez Michael, 2009, Genome Inform, V23, P13; Florquin K, 2005, NUCLEIC ACIDS RES, V33, P4255, DOI 10.1093/nar/gki737; Friedel M, 2009, NUCLEIC ACIDS RES, V37, pD37, DOI 10.1093/nar/gkn597; Gabrielian A, 1999, COMPUT CHEM, V23, P263, DOI 10.1016/S0097-8485(99)00007-8; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gan YL, 2009, BIOINFORMATICS, V25, P2006, DOI 10.1093/bioinformatics/btp359; Geurts AM, 2006, NUCLEIC ACIDS RES, V34, P2803, DOI 10.1093/nar/gkl301; Goni JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r263; GOODSELL DS, 1994, NUCLEIC ACIDS RES, V22, P5497, DOI 10.1093/nar/22.24.5497; GORIN AA, 1995, J MOL BIOL, V247, P34, DOI 10.1006/jmbi.1994.0120; Hershberg R, 2001, NUCLEIC ACIDS RES, V29, P277, DOI 10.1093/nar/29.1.277; HO PS, 1986, EMBO J, V5, P2737, DOI 10.1002/j.1460-2075.1986.tb04558.x; Kallipolitis BH, 1997, CELL, V89, P1101, DOI 10.1016/S0092-8674(00)80297-4; Kalodimos CG, 2004, CHEM REV, V104, P3567, DOI 10.1021/cr0304065; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Kanhere A, 2005, NUCLEIC ACIDS RES, V33, P3165, DOI 10.1093/nar/gki627; Kim D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002867; Klaiman TN, 2009, COMPUT BIOL CHEM, V33, P275, DOI 10.1016/j.compbiolchem.2009.06.007; Kroger C, 2012, P NATL ACAD SCI USA, V109, pE1277, DOI 10.1073/pnas.1201061109; Mallios RR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-271; Mendoza-Vargas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007526; Meysman P, 2014, NUCLEIC ACIDS RES, V42, pD649, DOI 10.1093/nar/gkt1086; Meysman P, 2013, CURR BIOINFORM, V8, P483, DOI 10.2174/1574893611308040010; Meysman P, 2013, MOL BIOL EVOL, V30, P1302, DOI 10.1093/molbev/mst029; Meysman P, 2012, BIOINFORM BIOL INSIG, V6, P155, DOI 10.4137/BBI.S9426; Meysman P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1071; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Morey C, 2011, PLANT PHYSIOL, V156, P1300, DOI 10.1104/pp.110.167809; Ohler U, 2001, Bioinformatics, V17 Suppl 1, pS199; Olivares-Zavaleta N, 2006, GENOMICS, V87, P329, DOI 10.1016/j.ygeno.2005.11.023; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; ORNSTEIN RL, 1978, BIOPOLYMERS, V17, P2341, DOI 10.1002/bip.1978.360171005; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; Parbhane RV, 2000, COMPUT CHEM, V24, P699, DOI 10.1016/S0097-8485(00)00072-3; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pedersen AG, 2000, J MOL BIOL, V299, P907, DOI 10.1006/jmbi.2000.3787; Prosseda G, 2004, MOL MICROBIOL, V51, P523, DOI 10.1046/j.1365-2958.2003.03848.x; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Rangannan V, 2009, MOL BIOSYST, V5, P1758, DOI [10.1039/B906535K, 10.1039/b906535k]; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Spronk CAEM, 1999, EMBO J, V18, P6472, DOI 10.1093/emboj/18.22.6472; Vijayan V, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r47; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	63	18	19	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88717	10.1371/journal.pone.0088717	http://dx.doi.org/10.1371/journal.pone.0088717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516674	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400078
J	Ribeiro, AM; Lloyd, P; Dean, WRJ; Brown, M; Bowie, RCK				Ribeiro, Angela M.; Lloyd, Penn; Dean, W. Richard J.; Brown, Mark; Bowie, Rauri C. K.			The Ecological and Geographic Context of Morphological and Genetic Divergence in an Understorey-Dwelling Bird	PLOS ONE			English	Article							BODY-SIZE; HAPLOTYPE RECONSTRUCTION; POPULATION-STRUCTURE; STATISTICAL-METHOD; FOREST; BIOGEOGRAPHY; SELECTION; CONSERVATISM; SPECIATION; DISPERSAL	Advances in understanding the process of species formation require an integrated perspective that includes the evaluation of spatial, ecological and genetic components. One approach is to focus on multiple stages of divergence within the same species. Species that comprise phenotypically different populations segregated in apparently distinct habitats, in which range is presently continuous but was putatively geographically isolated provide an interesting system to study the mechanisms of population divergence. Here, we attempt to elucidate the role of ecology and geography in explaining observed morphological and genetic variation in an understorey-dwelling bird endemic to southeastern Africa, where two subspecies are recognized according to phenotype and habitat affinity. We carried out a range-wide analysis of climatic requirements, morphological and genetic variation across southeast Africa to test the hypothesis that the extent of gene flow among populations of the brown scrub-robin are influenced by their distinct climatic niches. We recovered two distinct trends depending on whether our analyses were hierarchically structured at the subspecies or at the within subspecies level. Between subspecies we found pronounced morphological differentiation associated with strong reproductive isolation (no gene flow) between populations occupying divergent climatic niches characterized by changes in the temperature of the warmest and wettest month. In contrast, within subspecies, we recovered continuous morphological variation with extensive gene flow among populations inhabiting the temperate and sub-tropical forests of southern Africa, despite divergence along the climate axis that is mainly determined by minimum temperature and precipitation of the coldest months. Our results highlight the role of niche divergence as a diversifying force that can promote reproductive isolation in vertebrates.	[Ribeiro, Angela M.; Lloyd, Penn; Dean, W. Richard J.; Bowie, Rauri C. K.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7925 Cape Town, South Africa; [Ribeiro, Angela M.; Bowie, Rauri C. K.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ribeiro, Angela M.; Bowie, Rauri C. K.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Brown, Mark] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	National Research Foundation - South Africa; University of Cape Town; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Kwazulu Natal	Ribeiro, AM (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res CIIMA, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ribeiro.angela@gmail.com	Brown, Mark/A-5588-2010; Bowie, Rauri/H-9165-2019; Ribeiro, Ângela M./AAI-1223-2019	Brown, Mark/0000-0002-0253-9363; Bowie, Rauri/0000-0001-8328-6021; Ribeiro, Ângela M./0000-0003-0666-3449	FCT (Portugal) [SFRH/BD/27739/2006]; NSF [DEB 0613668, 1120356]; NRF (South Africa); Centre of Excellence grant from the Department of Science and Technology (South Africa); Leverhulme Trust, London; Global Biodiversity Information Facility, Denmark; Direct For Biological Sciences [1120356] Funding Source: National Science Foundation	FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); NSF(National Science Foundation (NSF)); NRF (South Africa)(National Research Foundation - South Africa); Centre of Excellence grant from the Department of Science and Technology (South Africa); Leverhulme Trust, London(Leverhulme Trust); Global Biodiversity Information Facility, Denmark; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by FCT (Portugal; Ph.D fellowship SFRH/BD/27739/2006 awarded to A.M.R), NSF (DEB 0613668, 1120356), NRF (South Africa) and a Centre of Excellence grant from the Department of Science and Technology (South Africa). The compilation of the database from which occurrence data were extracted by WRJD was partly funded by The Leverhulme Trust, London and the Global Biodiversity Information Facility, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Burnham K. P., 2002, MODEL SELECTION MIXE; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Coyne J.A., 2004, SPECIATION; de Queiroz K, 1998, ENDLESS FORMS, P57; Dobzhansky T., 1951, COPEIA; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Eberhard JR, 2004, AUK, V121, P318, DOI 10.1642/0004-8038(2004)121[0318:PABOTA]2.0.CO;2; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; Ellegren H, 2007, CYTOGENET GENOME RES, V117, P120, DOI 10.1159/000103172; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 1997, MOL ECOL, V6, P1047, DOI 10.1046/j.1365-294X.1997.00277.x; Fuchs J, 2004, MOL PHYLOGENET EVOL, V33, P428, DOI 10.1016/j.ympev.2004.06.014; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Goodwin GH, 1997, GENE, V184, P27, DOI 10.1016/S0378-1119(96)00569-0; GRANT BR, 1983, OIKOS, V41, P530, DOI 10.2307/3544112; Grinnell J, 1914, AM NAT, V48, P248, DOI 10.1086/279402; Harrigan RJ, 2008, MOL ECOL RESOUR, V8, P1239, DOI 10.1111/j.1755-0998.2008.02241.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUDSON RR, 1992, GENETICS, V132, P583; Hughes M, 2008, MOL ECOL, V17, P2643, DOI 10.1111/j.1365-294X.2008.03788.x; Hughes M, 2005, MOL ECOL, V14, P4415, DOI 10.1111/j.1365-294X.2005.02756.x; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kekkonen J, 2012, IBIS, V154, P846, DOI 10.1111/j.1474-919X.2012.01252.x; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; Mittermeier RA, 2004, HOTSPOTS REVISTIED E; Nei M., 1987, MOL EVOLUTIONARY GEN; Oatley T., 1998, ROBINS AFRICA; Oatley TB, 1989, ECOSYSTEMS PROGRAMME, V45, P48; Oatley TB, 2005, ROBERTS BIRDS SO AFR, P942; Olson VA, 2009, ECOL LETT, V12, P249, DOI 10.1111/j.1461-0248.2009.01281.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POYNTON JC, 1961, NATURE, V189, P801, DOI 10.1038/189801a0; Price T, 2008, SPECIATION BIRDS; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ribeiro AM, 2012, MOL ECOL, V21, P662, DOI 10.1111/j.1365-294X.2011.05236.x; Rosenblum EB, 2006, AM NAT, V167, P1, DOI 10.1086/498397; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schemske, 2000, EVOLUTION, V54, P1069, DOI DOI 10.1111/J.0014-3820.2000.TB00111.X; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; VanWyk AE, 1996, BIODIVERSITY OF AFRICAN PLANTS, P198; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Wakeley John, 1998, P157; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x	72	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e85903	10.1371/journal.pone.0085903	http://dx.doi.org/10.1371/journal.pone.0085903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516521	Green Published, gold			2022-12-27	WOS:000330834400003
J	Santos, X; Mateos, E; Bros, V; Brotons, L; De Mas, E; Herraiz, JA; Herrando, S; Mino, A; Olmo-Vidal, JM; Quesada, J; Ribes, J; Sabate, S; Sauras-Yera, T; Serra, A; Vallejo, VR; Vinolas, A				Santos, Xavier; Mateos, Eduardo; Bros, Vicenc; Brotons, Lluis; De Mas, Eva; Herraiz, Joan A.; Herrando, Sergi; Mino, Angel; Olmo-Vidal, Josep M.; Quesada, Javier; Ribes, Jordi; Sabate, Santiago; Sauras-Yera, Teresa; Serra, Antoni; Vallejo, V. Ramon; Vinolas, Amador			Is Response to Fire Influenced by Dietary Specialization and Mobility? A Comparative Study with Multiple Animal Assemblages	PLOS ONE			English	Article							SPECIES-DIVERSITY; PRESCRIBED FIRE; GROUND BEETLES; BIODIVERSITY; COMMUNITIES; RESILIENCE; MANAGEMENT; HABITAT; SUCCESSION; BIRDS	Fire is a major agent involved in landscape transformation and an indirect cause of changes in species composition. Responses to fire may vary greatly depending on life histories and functional traits of species. We have examined the taxonomic and functional responses to fire of eight taxonomic animal groups displaying a gradient of dietary and mobility patterns: Gastropoda, Heteroptera, Formicidae, Coleoptera, Araneae, Orthoptera, Reptilia and Aves. The fieldwork was conducted in a Mediterranean protected area on 3 sites (one unburnt and two burnt with different postfire management practices) with five replicates per site. We collected information from 4606 specimens from 274 animal species. Similarity in species composition and abundance between areas was measured by the Bray-Curtis index and ANOSIM, and comparisons between animal and plant responses by Mantel tests. We analyze whether groups with the highest percentage of omnivorous species, these species being more generalist in their dietary habits, show weak responses to fire (i.e. more similarity between burnt and unburnt areas), and independent responses to changes in vegetation. We also explore how mobility, i.e. dispersal ability, influences responses to fire. Our results demonstrate that differences in species composition and abundance between burnt and unburnt areas differed among groups. We found a tendency towards presenting lower differences between areas for groups with higher percentages of omnivorous species. Moreover, taxa with a higher percentage of omnivorous species had significantly more independent responses of changes in vegetation. High- (e.g. Aves) and low-mobility (e.g. Gastropoda) groups had the strongest responses to fire (higher R scores of the ANOSIM); however, we failed to find a significant general pattern with all the groups according to their mobility. Our results partially support the idea that functional traits underlie the response of organisms to environmental changes caused by fire.	[Santos, Xavier] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Mateos, Eduardo; Serra, Antoni] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Bros, Vicenc; Mino, Angel] Diputacio Barcelona, Oficina Tecn Parcs Nat, Barcelona, Spain; [Brotons, Lluis; Herrando, Sergi] CEMFOR, CTFC, Grp Ecol Paisatge, Solsona, Spain; [Brotons, Lluis; Sabate, Santiago] Univ Autonoma Barcelona, CREAF, Bellaterra, Spain; [De Mas, Eva] CSIC, Dept Ecol Evolut Conducta & Conservac Estn Expt Z, Almeria, Spain; [Herraiz, Joan A.] Univ Girona, Fac Ciencies, AIM, Girona, Spain; [Herrando, Sergi; Quesada, Javier] Museu Ciencies Nat Barcelona, ICO, Barcelona, Spain; [Olmo-Vidal, Josep M.] Direccio Gen Medi Nat & Biodiversitat, Serv Biodiversitat & Proteccio Anim, Barcelona, Spain; [Quesada, Javier; Ribes, Jordi] Museu Ciencies Nat Barcelona, Barcelona, Spain; [Sabate, Santiago] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Sauras-Yera, Teresa; Vallejo, V. Ramon] Univ Barcelona, Dept Biol Vegetal, Barcelona, Spain; [Vallejo, V. Ramon] Fdn CEAM, Paterna, Spain	Universidade do Porto; University of Barcelona; Centre Tecnologic Forestal de Catalunya (CTFC); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de Girona; Museu de Ciencies Naturals de Barcelona; Museu de Ciencies Naturals de Barcelona; University of Barcelona; University of Barcelona	Santos, X (corresponding author), Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal.	xsantossantiro@gmail.com	Quesada, Javier/GQQ-1272-2022; Vallejo, V. Ramon/L-8688-2014; Sabaté, Santiago/I-3395-2016; Brotons, Lluís/D-1570-2009; Bros, Vicenç/V-7423-2019; Quesada, Javier/V-8506-2019; Mateos, Eduardo/B-9327-2013; De Mas, Eva/H-9172-2015; Santos, Xavier/O-4397-2019	Quesada, Javier/0000-0002-6010-8473; Sabaté, Santiago/0000-0003-1854-0761; Brotons, Lluís/0000-0002-4826-4457; Bros, Vicenç/0000-0003-0364-8200; Quesada, Javier/0000-0002-6010-8473; Mateos, Eduardo/0000-0001-9741-5744; De Mas, Eva/0000-0001-8225-5805; Santos, Xavier/0000-0002-4330-4261; Vallejo, V. Ramon/0000-0002-6559-9451; Mino, Angel/0000-0002-8132-4765; Herrando, Sergi/0000-0002-5153-7970	Conveni de Collaboracio per al desenvolupament del Pla de gestio integral per a la conservacio dels sistemes naturals de la Xarxa de Parcs Naturals; Obra Social La Caixa; Diputacio de Barcelona; Spanish Ministry of Education and Science (MEC) [CGL2011-29539, CSD2008-00040]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [SFRH/BPD/73176/2010]	Conveni de Collaboracio per al desenvolupament del Pla de gestio integral per a la conservacio dels sistemes naturals de la Xarxa de Parcs Naturals; Obra Social La Caixa(La Caixa Foundation); Diputacio de Barcelona; Spanish Ministry of Education and Science (MEC)(Spanish Government); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology)	This study was partially supported by the "Conveni de Collaboracio per al desenvolupament del Pla de gestio integral per a la conservacio dels sistemes naturals de la Xarxa de Parcs Naturals" signed by Obra Social La Caixa and the Diputacio de Barcelona, and by the projects CGL2011-29539 and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC). Xavier Santos is supported by a post-doctoral Grant (SFRH/BPD/73176/2010) from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apigian KO, 2006, FOREST ECOL MANAG, V221, P110, DOI 10.1016/j.foreco.2005.09.009; Arnan X, 2006, J BIOGEOGR, V33, P1246, DOI 10.1111/j.1365-2699.2006.01506.x; Arnan X, 2013, ECOGRAPHY, V36, P1182, DOI 10.1111/j.1600-0587.2013.00155.x; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Bengtsson J, 2002, EUR J SOIL BIOL, V38, P119, DOI 10.1016/S1164-5563(02)01133-0; Blondel J, 2010, BIOL BIODIVERSITY SP; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bradstock RA, 2005, WILDLIFE RES, V32, P409, DOI 10.1071/WR02114; Briani DC, 2004, BIODIVERS CONSERV, V13, P1023, DOI 10.1023/B:BIOC.0000014467.27138.0b; Bros V, 2011, FOREST ECOL MANAG, V261, P611, DOI 10.1016/j.foreco.2010.11.014; Brotons L, 2005, J BIOGEOGR, V32, P789, DOI 10.1111/j.1365-2699.2004.01195.x; Brotons L, 2008, J APPL ECOL, V45, P1059, DOI 10.1111/j.1365-2664.2008.01467.x; Buddle CM, 2000, ECOGRAPHY, V23, P424, DOI 10.1034/j.1600-0587.2000.230405.x; Castro J, 2010, CONSERV BIOL, V24, P810, DOI 10.1111/j.1523-1739.2009.01382.x; Caturla RN, 2000, ACTA OECOL, V21, P1, DOI 10.1016/S1146-609X(00)00114-4; Clavero M, 2011, J ANIM ECOL, V80, P128, DOI 10.1111/j.1365-2656.2010.01748.x; Driscoll DA, 2008, BIOL CONSERV, V141, P460, DOI 10.1016/j.biocon.2007.10.016; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Driscoll DA, 2010, CONSERV LETT, V3, P215, DOI 10.1111/j.1755-263X.2010.00115.x; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Estrada J., 2004, ATLES DELS OCELLS NI; FOX BJ, 1982, ECOLOGY, V63, P1332, DOI 10.2307/1938861; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gaines WL, 2011, FOREST ECOL MANAG, V261, P1460, DOI 10.1016/j.foreco.2011.01.034; Gil-Tena A, 2009, GLOBAL CHANGE BIOL, V15, P474, DOI 10.1111/j.1365-2486.2008.01730.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Herrando S, 2003, IBIS, V145, P307, DOI 10.1046/j.1474-919X.2003.00155.x; IPCC, 2007, CLIM CHANG 2007 WORK; Isaac JL, 2009, DIVERS DISTRIB, V15, P280, DOI 10.1111/j.1472-4642.2008.00531.x; IUCN, 2014, IUCN RED LIST THREAT; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Krebs C.J., 1999, ECOLOGICAL METHODOLO; LEVINS RICHARD, 1968; Lindenmayer DB, 2006, CONSERV BIOL, V20, P949, DOI 10.1111/j.1523-1739.2006.00497.x; Lindenmayer DB, 2008, OIKOS, V117, P1086, DOI 10.1111/j.0030-1299.2008.16683.x; Madden EM, 1999, CAN FIELD NAT, V113, P627; Mateos E, 2011, ENVIRON MANAGE, V48, P1000, DOI 10.1007/s00267-011-9750-0; Moreira F, 2001, LANDSCAPE ECOL, V16, P175, DOI 10.1023/A:1011169614489; Moretti M, 2004, ECOGRAPHY, V27, P173, DOI 10.1111/j.0906-7590.2004.03660.x; Moretti M, 2008, ECOGRAPHY, V31, P1; Moretti M, 2009, J ANIM ECOL, V78, P98, DOI 10.1111/j.1365-2656.2008.01462.x; Moretti M, 2006, OECOLOGIA, V149, P312, DOI 10.1007/s00442-006-0450-z; Niwa CG, 2002, ENVIRON ENTOMOL, V31, P785, DOI 10.1603/0046-225X-31.5.785; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Orgeas J, 2001, J APPL ECOL, V38, P49, DOI 10.1046/j.1365-2664.2001.00575.x; PAUSAS JG, 2005, OIKOS, V109, P196; Pausas JG, 2008, ECOLOGY, V89, P2181, DOI 10.1890/07-1737.1; Pearce JL, 2006, ECOL INDIC, V6, P780, DOI 10.1016/j.ecolind.2005.03.005; PECBMS, 2022, SPEC TRENDS; Peix i Massip J, 1999, FOC VERD 2 PROGRAMA; Pons P, 2003, BIODIVERS CONSERV, V12, P1843, DOI 10.1023/A:1024191814560; PRIMER-E, 2001, PRIM 5 WIND VERS 5 2; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Richmond CE, 2005, ECOL MODEL, V188, P279, DOI 10.1016/j.ecolmodel.2005.03.002; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; Rost J, 2012, J APPL ECOL, V49, P644, DOI 10.1111/j.1365-2664.2012.02127.x; Sackmann P, 2006, ECOSCIENCE, V13, P360, DOI 10.2980/i1195-6860-13-3-360.1; Santos X, 2013, BIOL CONSERV, V168, P90, DOI 10.1016/j.biocon.2013.09.008; Santos X, 2012, CONTRIB ZOOL, V81, P167, DOI 10.1163/18759866-08103004; Santos X, 2010, EUR J WILDLIFE RES, V56, P895, DOI 10.1007/s10344-010-0387-8; Santos X, 2009, BIODIVERS CONSERV, V18, P3153, DOI 10.1007/s10531-009-9634-2; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Sileshi G, 2006, BIODIVERS CONSERV, V15, P3153, DOI 10.1007/s10531-005-5411-z; ter Braak CJF., 1997, CANOCO WINDOWS VERSI; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Valentine LE, 2009, CONSERV BIOL, V23, P103, DOI 10.1111/j.1523-1739.2008.01074.x; Van Swaay CAM, 2012, VS2012019 VLIND; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Westgate MJ, 2012, OIKOS, V121, P1516, DOI 10.1111/j.1600-0706.2011.19863.x	70	26	26	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88224	10.1371/journal.pone.0088224	http://dx.doi.org/10.1371/journal.pone.0088224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516616	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400042
J	Sargsyan, O				Sargsyan, Ori			A Framework Including Recombination for Analyzing the Dynamics of Within-Host HIV Genetic Diversity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRAL ALLELE MODEL; SEGREGATING SITES; DEMOGRAPHIC HISTORY; EVOLUTIONARY RATES; POPULATION HISTORY; GENERATION TIME; DNA-SEQUENCES; MUTATION-RATE; INFERENCE	This paper presents a novel population genetic model and a computationally and statistically tractable framework for analyzing within-host HIV diversity based on serial samples of HIV DNA sequences. This model considers within-host HIV evolution during the chronic phase of infection and assumes that the HIV population is homogeneous at the beginning, corresponding to the time of seroconversion, and evolves according to the Wright-Fisher reproduction model with recombination and variable mutation rate across nucleotide sites. In addition, the population size and generation time vary over time as piecewise constant functions of time. Under this model I approximate the genealogical and mutational processes for serial samples of DNA sequences by a continuous coalescent-recombination process and an inhomogeneous Poisson process, respectively. Based on these derivations, an efficient algorithm is described for generating polymorphisms in serial samples of DNA sequences under the model including various substitution models. Extensions of the algorithm are also described for other demographic scenarios that can be more suitable for analyzing the dynamics of genetic diversity of other pathogens in vitro and in vivo. For the case of the infinite-sites model, I derive analytical formulas for the expected number of polymorphic sites in sample of DNA sequences, and apply the developed simulation and analytical methods to explore the fit of the model to HIV genetic diversity based on serial samples of HIV DNA sequences from 9 HIV-infected individuals. The results particularly show that the estimates of the ratio of recombination rate over mutation rate can vary over time between very high and low values, which can be considered as a consequence of the impact of selection forces.				orisargsyan@yahoo.com			U.S. Department of Energy through the LANL/LDRD Program; National Institute of Health (NIH) [5R01AI08752002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087520] Funding Source: NIH RePORTER	U.S. Department of Energy through the LANL/LDRD Program(United States Department of Energy (DOE)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the author, and in the early stage of this study the author was supported by the U.S. Department of Energy through the LANL/LDRD Program and by the National Institute of Health (NIH) [grant number 5R01AI08752002] when he was affiliated with Los Alamos National Laboratory. The U.S. Department of Energy and NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Anisimova M, 2003, GENETICS, V164, P1229; ARIYOSHI K, 1992, LANCET, V340, P1257, DOI 10.1016/0140-6736(92)92953-D; Batorsky R, 2011, P NATL ACAD SCI USA, V108, P5661, DOI 10.1073/pnas.1102036108; BONHOEFFER S, 1995, NATURE, V376, P125, DOI 10.1038/376125a0; Burke DS, 1997, EMERG INFECT DIS, V3, P253, DOI 10.3201/eid0303.970301; Drummond A, 2001, MOL BIOL EVOL, V18, P1365, DOI 10.1093/oxfordjournals.molbev.a003920; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Edwards CTT, 2006, GENETICS, V174, P1441, DOI 10.1534/genetics.105.052019; Excoffier L, 2000, J HERED, V91, P506, DOI 10.1093/jhered/91.6.506; Fu YX, 2001, MOL BIOL EVOL, V18, P620, DOI 10.1093/oxfordjournals.molbev.a003842; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; GRIFFITHS RC, 1981, J APPL PROBAB, V18, P42, DOI 10.2307/3213165; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HEDRICK PW, 1987, GENETICS, V117, P331; HOLMES EC, 1992, P NATL ACAD SCI USA, V89, P4835, DOI 10.1073/pnas.89.11.4835; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.1111/j.1558-5646.1983.tb05528.x; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hudson RR, 1991, OXF SURV EVOL BIOL, V7, P1; Jakobsson M, 2009, BIOINFORMATICS, V25, P2845, DOI 10.1093/bioinformatics/btp534; JUKES T H, 1969, P21; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kingman J.F.C., 1982, EXCHANGEABILITY PROB, P97; Kuhner MK, 2000, GENETICS, V156, P1393; Lemey P, 2006, AIDS REV, V8, P125; LEWONTIN RC, 1964, GENETICS, V49, P49; McVean G, 2002, GENETICS, V160, P1231; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Nielsen R, 1998, GENETICS, V148, P929; Nordborg M., 2001, HDB STAT GENETICS; Opgen-Rhein R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-6; Perlitz M, 1997, J MATH BIOL, V36, P1, DOI 10.1007/s002850050087; Pybus OG, 2000, GENETICS, V155, P1429; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rodrigo AG, 1999, EVOLUTION OF HIV, P233; Rodrigo AG, 1999, P NATL ACAD SCI USA, V96, P2187, DOI 10.1073/pnas.96.5.2187; Rodrigo AG, 2003, MOL BIOL EVOL, V20, P2010, DOI 10.1093/molbev/msg215; Sargsyan O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037588; Schierup MH, 2000, GENETICS, V156, P879; Seo TK, 2002, GENETICS, V160, P1283; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shriner D, 2004, GENETICS, V167, P1573, DOI 10.1534/genetics.103.023382; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; TAJIMA F, 1989, GENETICS, V123, P597; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1983, GENETICS, V105, P437; Tavare S, 1997, GENETICS, V145, P505; Wakeley J, 2008, INTRO COALESCENT THE; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber J, 2001, BRIT MED BULL, V58, P61, DOI 10.1093/bmb/58.1.61; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Yang ZH, 1996, GENETICS, V144, P1941	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87655	10.1371/journal.pone.0087655	http://dx.doi.org/10.1371/journal.pone.0087655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516557	Green Published, gold			2022-12-27	WOS:000330834400017
J	Shen, Y; Dai, LB; Li, XJ; Liang, R; Guan, GX; Zhang, Z; Cao, WJ; Liu, ZH; Mei, S; Liang, WG; Qin, SZN; Xu, JK; Chen, HH				Shen, Yan; Dai, Libing; Li, Xiaojian; Liang, Rong; Guan, Guangxiong; Zhang, Zhi; Cao, Wenjuan; Liu, Zhihe; Mei, Shirley; Liang, Weiguo; Qin, Shennan; Xu, Jiake; Chen, Honghui			Epidermal Stem Cells Cultured on Collagen-Modified Chitin Membrane Induce In Situ Tissue Regeneration of Full-Thickness Skin Defects in Mice	PLOS ONE			English	Article							HAIR FOLLICLE BULGE; CHITOSAN; EXPRESSION; RECONSTRUCTION; NICHE; SCAR; KERATINOCYTES; FIBROBLASTS; SUBSTITUTES; FABRICATION	A Large scale of full-thickness skin defects is lack of auto-grafts and which requires the engineered skin substitutes for repair and regeneration. One major obstacle in skin tissue engineering is to expand epidermal stem cells (ESCs) and develop functional substitutes. The other one is the scaffold of the ESCs. Here, we applied type I collagen-modified chitin membrane to form collagen-chitin biomimetic membrane (C-CBM), which has been proved to have a great biocompatibility and degraded totally when it was subcutaneously transplanted into rat skin. ESCs were cultured, and the resulting biofilm was used to cover full-thickness skin defects in nude mice. The transplantation of ESCs- collagen- chitn biomimetic membrane (ESCs-C-CBM) has achieved in situ skin regeneration. In nude mice, compared to controls with collagen-chitin biomimetic membrane (C-CBM) only, the ESCs-C-CBM group had significantly more dermatoglyphs on the skin wound 10 w after surgery, and the new skin was relatively thick, red and elastic. In vivo experiments showed obvious hair follicle cell proliferation in the full-thickness skin defect. Stem cell markers examination showed active ESCs in repair and regeneration of skin. The results indicate that the collagen-modified chitin membrane carry with ESCs has successfully regenerated the whole skin with all the skin appendages and function.	[Shen, Yan; Dai, Libing; Li, Xiaojian; Liang, Rong; Zhang, Zhi; Cao, Wenjuan; Liu, Zhihe; Liang, Weiguo; Qin, Shennan; Chen, Honghui] Jinan Univ, Guangzhou Red Cross Hosp, Coll Med, Guangzhou Inst Traumat Surg, Guangzhou, Guangdong, Peoples R China; [Guan, Guangxiong] Guangzhou Med Univ, Affiliated Hosp 2, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Mei, Shirley] Sophie Davis Sch Biomed Educ, New York, NY USA	Jinan University; Guangzhou Medical University; University of Western Australia; City University of New York (CUNY) System; Sophie Davis School of Biomedical Education	Li, XJ (corresponding author), Jinan Univ, Guangzhou Red Cross Hosp, Coll Med, Guangzhou Inst Traumat Surg, Guangzhou, Guangdong, Peoples R China.	lixj64@163.com		Xu, Jiake/0000-0003-2021-8309	Guangdong Science and Technology Project [2011B031300026: RMB, 2012B031800338: RMB]; Guangzhou Applied Basic Research Project [2013J4100100: RMB, 2008J1-C121: RMB]; Guangdong Natural Science Foundation Project [9152800001000009 RMB]; National Natural Science Foundation Project [30973118 RMB]; Guangdong Health Department Project [2012A011046 RMB]	Guangdong Science and Technology Project; Guangzhou Applied Basic Research Project; Guangdong Natural Science Foundation Project; National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Guangdong Health Department Project	The sources of funding from: Guangdong Science and Technology Project: 2011B031300026: RMB: 30 thousand (amount to USA $:Five thousand), PI: YS, 2012B031800338: RMB: 10 thousand (amount to USA $: One thousand and Six hundred), PI:LD; Guangzhou Applied Basic Research Project 2013J4100100: RMB: 80 thousand (amount to USA $: Thirteen thousand), PI: YS, 2008J1-C121: RMB: 100 thousand (amount to USA $: 16 thousand), PI: YS; Guangdong Natural Science Foundation Project 9152800001000009 RMB: 30 thousand (amount to USA $: Five thousand), PI: RL; National Natural Science Foundation Project 30973118 RMB: 30 thousand (amount to USA $: Five thousand), PI: ZZ; Guangdong Health Department Project 2012A011046 RMB: 1 thousand (amount to USA $: One hundred and sixty), PI: LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amidi M, 2010, ADV DRUG DELIVER REV, V62, P1, DOI 10.1016/j.addr.2009.12.006; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Aranaz I., 2009, CURR CHEM BIOL, V3, P203, DOI [10.2174/187231309788166415, DOI 10.2174/187231309788166415]; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chou TD, 2001, PLAST RECONSTR SURG, V108, P378, DOI 10.1097/00006534-200108000-00015; Christiano AM, 2004, CELL, V118, P530, DOI 10.1016/j.cell.2004.08.024; Coruh A, 2012, J BURN CARE RES, V33, pE94, DOI 10.1097/BCR.0b013e31823499e9; Cotsarelis G, 2006, J CLIN INVEST, V116, P19, DOI 10.1172/JCI27490; Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009; Cronin H, 2013, DERMATOL SURG, V39, P30, DOI 10.1111/j.1524-4725.2012.02561.x; De Felice B, 2007, DNA CELL BIOL, V26, P541, DOI 10.1089/dna.2007.0591; Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651; Faulhaber J, 2010, J EUR ACAD DERMATOL, V24, P572, DOI 10.1111/j.1468-3083.2009.03473.x; Figus A, 2007, J BURN CARE RES, V28, P913, DOI 10.1097/BCR.0b013e318159eb8c; Franco RA, 2013, J BIOMATER APPL, V27, P605, DOI 10.1177/0885328211416527; Gharzi A, 2003, EXP DERMATOL, V12, P126, DOI 10.1034/j.1600-0625.2003.00106.x; Haik J, 2012, J DRUGS DERMATOL, V11, P866; Haslik W, 2010, J PLAST RECONSTR AES, V63, P360, DOI 10.1016/j.bjps.2008.09.026; Hodgkinson VC, 2012, J PROTEOMICS, V75, P1276, DOI 10.1016/j.jprot.2011.11.005; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595; Kuroyanagi Yoshimitsu, 2006, Nihon Ronen Igakkai Zasshi, V43, P326; Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016; Lei XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026603; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liu X, 2013, BIOMATERIALS, V34, P2038, DOI 10.1016/j.biomaterials.2012.11.062; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Michel M, 1997, J CELL PHYSIOL, V171, P179, DOI 10.1002/(SICI)1097-4652(199705)171:2<179::AID-JCP8>3.0.CO;2-L; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Rennekampff HO, 2009, UNFALLCHIRURG, V112, P543, DOI 10.1007/s00113-009-1655-5; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Shen Yan, 2009, Zhonghua Shao Shang Za Zhi, V25, P197; Spiekstra SW, 2007, WOUND REPAIR REGEN, V15, P708, DOI 10.1111/j.1524-475X.2007.00280.x; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Thibault M, 2011, BIOMATERIALS, V32, P4639, DOI 10.1016/j.biomaterials.2011.03.010; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang TW, 2006, BIOMATERIALS, V27, P5689, DOI 10.1016/j.biomaterials.2006.07.024; Windsor ML, 2009, AUSTRALAS J DERMATOL, V50, P29, DOI 10.1111/j.1440-0960.2008.00512.x; Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yla-Herttuala S, 2009, BIOCHEM SOC T, V37, P1198, DOI 10.1042/BST0371198; Zhang SJ, 2009, AAPS PHARMSCITECH, V10, P900, DOI 10.1208/s12249-009-9279-1	47	15	18	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87557	10.1371/journal.pone.0087557	http://dx.doi.org/10.1371/journal.pone.0087557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516553	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400014
J	Wen, JZ; Liao, JY; Zheng, LL; Xu, H; Yang, JH; Guan, DG; Zhang, SM; Zhou, H; Qu, LH				Wen, Jun-Zhi; Liao, Jian-You; Zheng, Ling-Ling; Xu, Hui; Yang, Jian-Hua; Guan, Dao-Gang; Zhang, Si-Min; Zhou, Hui; Qu, Liang-Hu			A Contig-Based Strategy for the Genome-Wide Discovery of MicroRNAs without Complete Genome Resources	PLOS ONE			English	Article							ALGA CHLAMYDOMONAS-REINHARDTII; EXPRESSED SEQUENCE TAGS; SMALL RNAS; TRANSCRIPTOME ANALYSIS; TRYPANOSOMA-BRUCEI; MOUSE DEVELOPMENT; PLANT MICRORNAS; GENE-EXPRESSION; NONCODING RNAS; EST ANALYSIS	MicroRNAs (miRNAs) are important regulators of many cellular processes and exist in a wide range of eukaryotes. High-throughput sequencing is a mainstream method of miRNA identification through which it is possible to obtain the complete small RNA profile of an organism. Currently, most approaches to miRNA identification rely on a reference genome for the prediction of hairpin structures. However, many species of economic and phylogenetic importance are non-model organisms without complete genome sequences, and this limits miRNA discovery. Here, to overcome this limitation, we have developed a contig-based miRNA identification strategy. We applied this method to a triploid species of edible banana (GCTCV-119, Musa spp. AAA group) and identified 180 pre-miRNAs and 314 mature miRNAs, which is three times more than those were predicted by the available dataset-based methods (represented by EST+GSS). Based on the recently published miRNA data set of Musa acuminate, the recall rate and precision of our strategy are estimated to be 70.6% and 92.2%, respectively, significantly better than those of EST+GSS-based strategy (10.2% and 50.0%, respectively). Our novel, efficient and cost-effective strategy facilitates the study of the functional and evolutionary role of miRNAs, as well as miRNA-based molecular breeding, in non-model species of economic or evolutionary interest.	[Wen, Jun-Zhi; Zheng, Ling-Ling; Xu, Hui; Yang, Jian-Hua; Guan, Dao-Gang; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Key Lab Gene Engn, State Key Lab Biocontrol, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Jun-Zhi; Zheng, Ling-Ling; Xu, Hui; Yang, Jian-Hua; Guan, Dao-Gang; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Jian-You; Zhang, Si-Min] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qu, LH (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, State Key Lab Biocontrol, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	zheng, lingling/Q-7227-2016	Qu, Liang-Hu/0000-0003-3657-2863; Guan, Daogang/0000-0003-1414-0189; Yang, Jian-Hua/0000-0003-3863-2786; Zhou, Hui/0000-0001-9157-3792; Xu, Hui/0000-0003-3424-1219	National Basic Research Program ("973" program) [2011CB811300]; Natural Science Foundation of China [31230042, 31200593, 31370791]; Foundation of China Postdoctoral Science [2012T50738]; State Key Laboratory of Biocontrol	National Basic Research Program ("973" program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of China Postdoctoral Science; State Key Laboratory of Biocontrol	This work was supported by Grant 2011CB811300 from the National Basic Research Program ("973" program), Natural Science Foundation of China (31230042, 31200593, 31370791), the Foundation of China Postdoctoral Science (No. 2012T50738), and Open Project of the State Key Laboratory of Biocontrol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Catalano D, 2012, BMC BIOINFORMATICS, V13; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dolgin E, 2012, NATURE, V486, P460, DOI 10.1038/486460a; Dong QF, 2005, METHOD ENZYMOL, V395, P400; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gebelin V, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-18; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guan DG, 2011, RNA BIOL, V8, P1, DOI [10.4161/rna.8.5, 10.4161/rna.8.5.16026]; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Olson D.L., 2008, ADV DATA MINING TECH, DOI DOI 10.1007/978-3-540-76917-0; Pelaez P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-83; Rudd S, 2003, TRENDS PLANT SCI, V8, P321, DOI 10.1016/S1360-1385(03)00131-6; Song C, 2010, PLANT BIOLOGY, V12, P927, DOI 10.1111/j.1438-8677.2009.00300.x; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-122; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang M, 2012, PLOS ONE, V7; Wen YZ, 2011, P NATL ACAD SCI USA, V108, P8345, DOI 10.1073/pnas.1103894108; Willmann MR, 2007, CURR OPIN PLANT BIOL, V10, P503, DOI 10.1016/j.pbi.2007.07.004; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Ying SY, 2005, BIOCHEM BIOPH RES CO, V326, P515, DOI 10.1016/j.bbrc.2004.10.215; Ying SY, 2004, GENE, V342, P25, DOI 10.1016/j.gene.2004.07.025; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zheng LL, 2013, RNA, V19, P863, DOI 10.1261/rna.035683.112; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107	45	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88179	10.1371/journal.pone.0088179	http://dx.doi.org/10.1371/journal.pone.0088179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516608	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400040
J	Xu, QS; Wu, P; Feng, YP; Ye, K; Tong, Y; Zhou, YQ				Xu, Qingsheng; Wu, Pan; Feng, Yiping; Ye, Ke; Tong, Ying; Zhou, Yongqing			Gamma Knife Surgery for Brain Metastasis from Hepatocellular Carcinoma	PLOS ONE			English	Article							NERVOUS-SYSTEM INVOLVEMENT; PROGNOSTIC-FACTORS; CLINICAL-FEATURES; RADIOSURGERY	Objectives: The authors evaluated the results of Gamma knife surgery (GKS) for the treatment of metastatic brain tumors from hepatocellular carcinoma (HCC). Methods and Results: The authors conducted a retrospective review of the clinical characteristics and treatment outcomes in 14 patients with metastatic brain tumors from HCC who underwent GKS. Twelve (85.7%) patients were male. The mean age of the patients was 53 +/- 12 years. There were totally 22 brain metastases in 14 patients and 8 patients (57.1%) presented with a single brain lesion. Intracranial hemorrhages occurred in 13 (59.1%) of the 22 lesions. The mean KPS score was 81 +/- 14 (range 50-100). Eleven (78.6%) patients were classified as RTOG RPA Class 2. The mean tumor volume was 8.16 +/- 8.15 cm(3) (range 0.59-27.0 cm(3)). The mean marginal dose prescribed was 18.7 +/- 3.2 Gy (range 10.0-22.0 Gy). The mean number of shots administered was 10 +/- 9 (range 1-27). The median overall survival time after GKS was 5.0 +/- 0.93 months (95% CI 3.2-6.8). No complications related to the radiosurgical treatment were identified. Multivariate analysis showed that the total volume of brain metastases, the RTOG RPA class and serum AFP level were significantly correlated with patients' survival time. Conclusions: Although survival was extremely poor in patients with brain metastasis (BM) from HCC, GKS was shown to lead to prolongation of the survival time. Accordingly, GKS can be considered as a valuable treatment option for proper patients with HCC BM.	[Xu, Qingsheng; Wu, Pan; Feng, Yiping; Ye, Ke; Tong, Ying; Zhou, Yongqing] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Xu, QS (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China.	qsxu10@126.com			Health Bureau of Zhejiang Province, China [2010KYA070]	Health Bureau of Zhejiang Province, China	This work was financially supported by funds from the Health Bureau of Zhejiang Province, China (2010KYA070). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI Y, 1991, HEPATOLOGY, V14, P262, DOI 10.1016/0270-9139(91)91413-U; Chang L, 2004, SURG NEUROL, V62, P172, DOI 10.1016/j.surneu.2003.10.002; Chen SF, 2007, EUR J NEUROL, V14, P408, DOI 10.1111/j.1468-1331.2007.01681.x; Choi HJ, 2009, J NEURO-ONCOL, V91, P307, DOI 10.1007/s11060-008-9713-3; Del Ben M, 2003, J EXP CLIN CANC RES, V22, P641; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Han JH, 2013, J NEURO-ONCOL, V115, P45, DOI 10.1007/s11060-013-1192-5; Han JH, 2012, INT J RADIAT ONCOL, V83, P113, DOI 10.1016/j.ijrobp.2011.06.1965; Han JH, 2012, J NEURO-ONCOL, V106, P161, DOI 10.1007/s11060-011-0653-y; Hiraoka A, 2008, INTERNAL MED, V47, P1993, DOI 10.2169/internalmedicine.47.1373; Jiang XB, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-49; Kim M, 1998, J NEURO-ONCOL, V36, P85, DOI 10.1023/A:1005716408970; Kim WH, 2012, INT J RADIAT ONCOL, V82, P1749, DOI 10.1016/j.ijrobp.2011.03.044; Mathieu D, 2007, NEUROSURGERY, V60, P471, DOI 10.1227/01.NEU.0000255342.10780.52; Murakami K, 1996, NEURORADIOLOGY S1, V38, P31; NOMURA F, 1989, CANCER, V64, P1700, DOI 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z; Patchell RA, 1998, JAMA-J AM MED ASSOC, V280, P1485, DOI 10.1001/jama.280.17.1485; Seinfeld J, 2006, J NEURO-ONCOL, V76, P93, DOI 10.1007/s11060-005-4175-3; Shaw E, 2000, INT J RADIAT ONCOL, V47, P291, DOI 10.1016/S0360-3016(99)00507-6	19	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88317	10.1371/journal.pone.0088317	http://dx.doi.org/10.1371/journal.pone.0088317			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516635	gold, Green Submitted, Green Published			2022-12-27	WOS:000330834400058
J	Choe, Y; Zarbalis, KS; Pleasure, SJ				Choe, Youngshik; Zarbalis, Konstantinos S.; Pleasure, Samuel J.			Neural Crest-Derived Mesenchymal Cells Require Wnt Signaling for Their Development and Drive Invagination of the Telencephalic Midline	PLOS ONE			English	Article							BETA-CATENIN GENE; STEM-CELLS; RETINOIC ACID; MOUSE; SPECIFICATION; TRANSITION; EXPRESSION; MIGRATION; FATE; MICE	Embryonic neural crest cells contribute to the development of the craniofacial mesenchyme, forebrain meninges and perivascular cells. In this study, we investigated the function of beta-catenin signaling in neural crest cells abutting the dorsal forebrain during development. In the absence of beta-catenin signaling, neural crest cells failed to expand in the interhemispheric region and produced ectopic smooth muscle cells instead of generating dermal and calvarial mesenchyme. In contrast, constitutive expression of stabilized beta-catenin in neural crest cells increased the number of mesenchymal lineage precursors suggesting that beta-catenin signaling is necessary for the expansion of neural crest-derived mesenchymal cells. Interestingly, the loss of neural crest-derived mesenchymal stem cells (MSCs) leads to failure of telencephalic midline invagination and causes ventricular system defects. This study shows that beta-catenin signaling is required for the switch of neural crest cells to MSCs and mediates the expansion of MSCs to drive the formation of mesenchymal structures of the head. Furthermore, loss of these structures causes striking defects in forebrain morphogenesis.	[Choe, Youngshik; Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Pleasure, Samuel J.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Pleasure, Samuel J.] Univ Calif San Francisco, Program Dev Stem Cell Biol, San Francisco, CA 94143 USA; [Pleasure, Samuel J.] Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA USA; [Pleasure, Samuel J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Zarbalis, Konstantinos S.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Zarbalis, Konstantinos S.] Shriners Hosp Children, Inst Pediat Regenerat Med, Sacramento, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	sam.pleasure@ucsf.edu			NIDA [R01 DA017627]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017627] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by NIDA R01 DA017627. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2005, J HISTOCHEM CYTOCHEM, V53, P653, DOI 10.1369/jhc.4A6518.2005; Ahlstrom Jon D, 2009, Commun Integr Biol, V2, P489; Ahlstrom JD, 2009, DEVELOPMENT, V136, P1801, DOI 10.1242/dev.034785; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Brault V, 2001, DEVELOPMENT, V128, P1253; Campos VE, 2004, BIOCHEM BIOPH RES CO, V320, P606, DOI 10.1016/j.bbrc.2004.05.204; Chai Y, 2000, DEVELOPMENT, V127, P1671; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Choe Y, 2013, J NEUROSCI, V33, P6766, DOI 10.1523/JNEUROSCI.0128-13.2013; Choe Y, 2012, NEURON, V73, P698, DOI 10.1016/j.neuron.2011.11.036; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dupe V, 2009, DEV DYNAM, V238, P2701, DOI 10.1002/dvdy.22087; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Farlie Peter G, 2004, Birth Defects Res C Embryo Today, V72, P173, DOI 10.1002/bdrc.20013; Fuchs S, 2007, NEURODEGENER DIS, V4, P6, DOI 10.1159/000100354; Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003; Grove EA, 1998, DEVELOPMENT, V125, P2315; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hayashi H, 2008, BIOCHEM BIOPH RES CO, V367, P584, DOI 10.1016/j.bbrc.2007.12.183; Huang X, 2007, HUM MOL GENET, V16, P1454, DOI 10.1093/hmg/ddm096; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Junghans D, 2005, DEV DYNAM, V233, P528, DOI 10.1002/dvdy.20365; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Muller SM, 2008, J IMMUNOL, V180, P5344, DOI 10.4049/jimmunol.180.8.5344; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Paek H, 2011, DEV CELL, V20, P689, DOI 10.1016/j.devcel.2011.04.010; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Shinozaki K, 2004, MECH DEVELOP, V121, P475, DOI 10.1016/j.mod.2004.03.013; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tamada M, 2012, DEV CELL, V22, P309, DOI 10.1016/j.devcel.2011.12.025; Theil T, 1999, DEVELOPMENT, V126, P3561; Theveneau E., 2012, DEV BIOL; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	48	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86025	10.1371/journal.pone.0086025	http://dx.doi.org/10.1371/journal.pone.0086025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516524	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700005
J	Hu, SS; Ghabril, M; Amet, T; Hu, NJ; Byrd, D; Yang, K; Vuppalanchi, R; Saxena, R; Desai, M; Lan, J; Johnson, R; Gupta, S; Chalasani, N; Yu, QG				Hu, Sishun; Ghabril, Marwan; Amet, Tohti; Hu, Ningjie; Byrd, Daniel; Yang, Kai; Vuppalanchi, Raj; Saxena, Romil; Desai, Mona; Lan, Jie; Johnson, Raymond; Gupta, Samir; Chalasani, Naga; Yu, Qigui			HIV-1 Coinfection Profoundly Alters Intrahepatic Chemokine but Not Inflammatory Cytokine Profiles in HCV-Infected Subjects	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTION-DRUG USERS; HCV/HIV COINFECTION; LIVER FIBROSIS; EXPRESSION; DISEASES; CXCL10; CELLS	The pathogenesis of accelerated liver damage in subjects coinfected with hepatitis C virus (HCV) and human immunodeficiency virus type 1 (HIV-1) remains largely unknown. Recent studies suggest that ongoing chronic liver inflammation is responsible for the liver injury in HCV-infected patients. We aimed to determine whether HIV-1 coinfection altered intrahepatic inflammatory profiles in HCV infection, thereby hastening liver damage. We used a real-time RT-PCR-based array to comparatively analyze intrahepatic inflammation gene profiles in liver biopsy specimens from HCV-infected (n = 16), HCV/HIV-1-coinfected (n = 8) and uninfected (n = 8) individuals. We then used human hepatocytes to study the molecular mechanisms underlying alternations of the inflammatory profiles. Compared with uninfected individuals, HCV infection and HCV/HIV-1 coinfection markedly altered expression of 59.5% and 50.0% of 84 inflammation-related genes tested, respectively. Among these genes affected, HCV infection up-regulated the expression of 24 genes and downregulated the expression of 26 genes, whereas HCV/HIV-1 coinfection up-regulated the expression of 21 genes and downregulated the expression of 21 genes. Compared with HCV infection, HCV/HIV-1 coinfection did not dramatically affect intrahepatic gene expression profiles of cytokines and their receptors, but profoundly altered expression of several chemokine genes including up-regulation of the CXCR3-associated chemokines. Human hepatocytes produced these chemokines in response to virus-related microbial translocation, viral protein stimulation, and antiviral immune responses. Conclusions: HIV-1 coinfection profoundly alters intrahepatic chemokine but not cytokine profiles in HCV-infected subjects. The altered chemokines may orchestrate the tissue-specific and cell-selective trafficking of immune cells and autoimmunity to accelerate liver disease in HCV/HIV-1 coinfection.	[Hu, Sishun; Amet, Tohti; Byrd, Daniel; Desai, Mona; Lan, Jie; Yu, Qigui] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Ghabril, Marwan; Vuppalanchi, Raj; Chalasani, Naga] Indiana Univ Sch Med, Dept Med, Div Gastroenterol Hepatol, Indianapolis, IN 46202 USA; [Saxena, Romil] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Desai, Mona; Johnson, Raymond; Gupta, Samir; Yu, Qigui] Indiana Univ Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Yu, Qigui] Indiana Univ Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [Hu, Sishun] Huazhong Agr Univ, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Hu, Ningjie; Yang, Kai] Wenzhou Med Coll, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Zhejiang, Peoples R China	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Huazhong Agricultural University; Wenzhou Medical University	Hu, SS (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	husi@iupui.edu; andyu@iupui.edu	Vuppalanchi, Raj/AAI-2482-2021; Ghabril, Marwan/AAF-8661-2020; Vuppalanchi, Raj/AAI-2481-2021	Vuppalanchi, Raj/0000-0003-0637-1577; Ghabril, Marwan/0000-0002-4784-3246; Vuppalanchi, Raj/0000-0003-0637-1577	Grand Challenges Explorations (GCE) through the Bill & Melinda Gates Foundation [OPP1035237]; Showalter Research Trust Fund; NIH [R21AI104268, T32 AI060519]; National Natural Science Foundation of Zhejiang Province [Y2110608, T32 AI07637]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007637, R21AI104268, T32AI060519] Funding Source: NIH RePORTER	Grand Challenges Explorations (GCE) through the Bill & Melinda Gates Foundation; Showalter Research Trust Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of Zhejiang Province; Research Facilities Improvement Program from the National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Grand Challenges Explorations (GCE) Phase II grant through the Bill & Melinda Gates Foundation (OPP1035237 to QY), Showalter Research Trust Fund (QY), NIH R21AI104268 (QY), NIH T32 AI060519 (DB), the National Natural Science Foundation of Zhejiang Province (Y2110608 to NH), T32 AI07637 (MD), and the Research Facilities Improvement Program Grant Number C06 RR015481-01 from the National Center for Research Resources, NIH to Indiana University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate I, 2004, AIDS, V18, P691, DOI 10.1097/00002030-200403050-00015; Amet T, 2012, HEPATOLOGY, V55, P354, DOI 10.1002/hep.24686; [Anonymous], 2011, HEP C; Backmund M, 2001, HEPATOLOGY, V34, P188, DOI 10.1053/jhep.2001.25882; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blackard JT, 2006, J MED VIROL, V78, P202, DOI 10.1002/jmv.20528; Bradford ST, 2011, AM J PHYSIOL-HEART C, V300, pH1518, DOI 10.1152/ajpheart.00928.2010; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Fainboim L, 2007, CYTOKINE GROWTH F R, V18, P143, DOI 10.1016/j.cytogfr.2007.01.017; Gonzalez SA, 2008, J VIRAL HEPATITIS, V15, P331, DOI 10.1111/j.1365-2893.2007.00949.x; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; Hu WG, 2010, J IMMUNOL, V184, P359, DOI 10.4049/jimmunol.0902278; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Koziel MJ, 1999, SEMIN LIVER DIS, V19, P157, DOI 10.1055/s-2007-1007107; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Qu J, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-15; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; UN AIDS, 2010, 2010 AIDS EP UPD; Vali B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003454; Williams RP, 2009, IBM J RES DEV, V53, P1, DOI 10.1147/JRD.2009.5429026; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	30	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86964	10.1371/journal.pone.0086964	http://dx.doi.org/10.1371/journal.pone.0086964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516541	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700016
J	Klinker, H; Mueller-Planitz, F; Yang, RL; Forne, I; Liu, CF; Nordenskiold, L; Becker, PB				Klinker, Henrike; Mueller-Planitz, Felix; Yang, Renliang; Forne, Ignasi; Liu, Chuan-Fa; Nordenskioeld, Lars; Becker, Peter B.			ISWI Remodelling of Physiological Chromatin Fibres Acetylated at Lysine 16 of Histone H4	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; NUCLEOSOME MOBILITY; H4-K16 ACETYLATION; H4K16 ACETYLATION; LINKER HISTONES; DNA; ACF; PROTEIN; COMPLEX; TAIL	ISWI is the catalytic subunit of several ATP-dependent chromatin remodelling factors that catalyse the sliding of nucleosomes along DNA and thereby endow chromatin with structural flexibility. Full activity of ISWI requires residues of a basic patch of amino acids in the N-terminal 'tail' of histone H4. Previous studies employing oligopeptides and mononucleosomes suggested that acetylation of the H4 tail at lysine 16 (H4K16) within the basic patch may inhibit the activity of ISWI. On the other hand, the acetylation of H4K16 is known to decompact chromatin fibres. Conceivably, decompaction may enhance the accessibility of nucleosomal DNA and the H4 tail for ISWI interactions. Such an effect can only be evaluated at the level of nucleosome arrays. We probed the influence of H4K16 acetylation on the ATPase and nucleosome sliding activity of Drosophila ISWI in the context of defined, in vitro reconstituted chromatin fibres with physiological nucleosome spacing and linker histone content. Contrary to widespread expectations, the acetylation did not inhibit ISWI activity, but rather stimulated ISWI remodelling under certain conditions. Therefore, the effect of H4K16 acetylation on ISWI remodelling depends on the precise nature of the substrate.	[Klinker, Henrike; Mueller-Planitz, Felix; Becker, Peter B.] Univ Munich, Adolf Butenandt Inst, Dept Mol Biol, Munich, Germany; [Klinker, Henrike; Forne, Ignasi; Becker, Peter B.] Ctr Integrated Prot Sci Munich, Munich, Germany; [Yang, Renliang; Liu, Chuan-Fa; Nordenskioeld, Lars] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Forne, Ignasi] Univ Munich, Adolf Butenandt Inst, Prot Anal Unit, Munich, Germany	University of Munich; University of Munich; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Munich	Becker, PB (corresponding author), Univ Munich, Adolf Butenandt Inst, Dept Mol Biol, Munich, Germany.	pbecker@med.uni-muenchen.de	Liu, Chuan Fa/A-2190-2011; Mueller-Planitz, Felix/P-8461-2014; Forne, Ignasi/B-3837-2016; NORDENSKIÖLD, LARS/ABD-4725-2020	Liu, Chuan Fa/0000-0001-7433-2081; Mueller-Planitz, Felix/0000-0001-8273-6473; NORDENSKIÖLD, LARS/0000-0002-3681-209X; Becker, Peter/0000-0001-7186-0372	Deutsche Forschungsgemeinschaft [SFB 594 TPA6, BE 1140/6]; Center for Integrated Protein Science, Munich; Singapore Agency for Science Technology and Research (A*STAR) through Biomedical Research Council (BMRC) [10/1/22/19/666, 08/1/22/19/588]; Elite Network of Bavaria	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science, Munich; Singapore Agency for Science Technology and Research (A*STAR) through Biomedical Research Council (BMRC); Elite Network of Bavaria	This work was supported by grants of the Deutsche Forschungsgemeinschaft to PBB (SFB 594 TPA6 and the Gottfried Wilhelm Leibniz Programme BE 1140/6), the Center for Integrated Protein Science, Munich, and the Singapore Agency for Science Technology and Research (A*STAR) through Biomedical Research Council (BMRC) grants to LN (10/1/22/19/666) and CFL (08/1/22/19/588). HK acknowledges support by the Elite Network of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdi A, 2011, NUCLEIC ACIDS RES, V39, P1680, DOI 10.1093/nar/gkq900; Becker P.B., 2013, COLD SPRING HARB PER, V5; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Corona DFV, 2004, BBA-GENE STRUCT EXPR, V1677, P113, DOI 10.1016/j.bbaexp.2003.09.018; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; CROSTON GE, 1991, SCIENCE, V251, P643, DOI 10.1126/science.1899487; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Faye G, 2005, J BIOL CHEM, V280, P33701, DOI 10.1074/jbc.M507048200; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Forne I, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012088; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Georgel PT, 1997, EMBO J, V16, P4717, DOI 10.1093/emboj/16.15.4717; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kan PY, 2009, MOL CELL BIOL, V29, P538, DOI 10.1128/MCB.01343-08; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Ludwigsen J, 2013, EMBO REP; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Maier VK, 2008, EMBO J, V27, P817, DOI 10.1038/sj.emboj.7601902; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P1026, DOI 10.1038/nsmb.2648; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; NELSON PP, 1979, J BIOL CHEM, V254, P1751; NER SS, 1994, EMBO J, V13, P1817, DOI 10.1002/j.1460-2075.1994.tb06450.x; Nightingale KP, 2007, NUCLEIC ACIDS RES, V35, P6311, DOI 10.1093/nar/gkm650; Nightingale KP, 1996, J BIOL CHEM, V271, P7090, DOI 10.1074/jbc.271.12.7090; Oppikofer M, 2011, EMBO J, V30, P2610, DOI 10.1038/emboj.2011.170; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Pepenella S, 2013, CHROMOSOMA; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Robinson PJJ, 2008, J MOL BIOL, V381, P816, DOI 10.1016/j.jmb.2008.04.050; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Routh A, 2009, IN VITRO RECONSTITUT; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Shia WJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-217; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; TAL M, 1985, J BIOL CHEM, V260, P9976; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; URA K, 1995, EMBO J, V14, P3752, DOI 10.1002/j.1460-2075.1995.tb00045.x; van Holde KE., 1989, SPRINGER SERIES MOL; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Villar-Garea A, 2008, CURR PROTOC PROTEIN; Wang XD, 2008, MOL CELL BIOL, V28, P227, DOI 10.1128/MCB.01245-07; Yadon AN, 2011, CELL, V144, P454, DOI 10.1016/j.cell.2011.01.019; Yamada K, 2011, NATURE, V472, P448, DOI 10.1038/nature09947; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	79	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88411	10.1371/journal.pone.0088411	http://dx.doi.org/10.1371/journal.pone.0088411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516652	Green Published, gold			2022-12-27	WOS:000330830700070
J	Qiao, LP; Sun, YJ; Chen, RR; Fu, Y; Zhang, WJ; Li, X; Chen, JC; Shen, Y; Ye, XQ				Qiao, Liping; Sun, Yujing; Chen, Rongrong; Fu, Yu; Zhang, Wenjuan; Li, Xin; Chen, Jianchu; Shen, Yan; Ye, Xingqian			Sonochemical Effects on 14 Flavonoids Common in Citrus: Relation to Stability	PLOS ONE			English	Article							ULTRASOUND-ASSISTED EXTRACTION; MOLECULAR-STRUCTURE; PHENOLIC-COMPOUNDS; PULSED ULTRASOUND; MODEL SYSTEM; QUERCETIN; OXIDATION; RUTIN; ACIDS; PEEL	The sonochemical effects of ultrasound (US) treatment on 14 flavonoids representing the main flavonoids in citrus fruit were investigated in a standard mixture by stability evaluation of a model system. Degradation products were further tentatively identified by Fourier transform infrared spectroscopy and high-performance liquid chromatography-ultraviolet detection-electrospray ionization tandem mass spectrometry. Thirteen flavonoids (i.e., eriocitrin, narirutin, neohesperidin, quercitrin, eridictyol, didymin, naringenin, luteolin, sinensetin, nobiletin, tangeretin, naringin, and hesperidin) were fairly stable whereas quercetin was degraded significantly by US treatment. The types of solvent and temperature used were important factors that determined the resulting degradation reactions. The degradation rate of quercetin was highest in 80% ethanol aqueous solution and decreased with increasing temperature. Longer US durations caused increases in the extent of quercetin degradation. Liquid height, ultrasonic intensity, pulse length, and duty cycle of US affected degradation rates but did not change the nature of degradation of the flavonoids. Four types of reactions occurred simultaneously for quercetin under US treatment: oxidation, addition, polymerization, and decomposition. Eight degradation products were tentatively identified as dimer, alcohol addition, oxidation, and decomposition products.	[Qiao, Liping; Chen, Rongrong; Fu, Yu; Zhang, Wenjuan; Li, Xin; Chen, Jianchu; Shen, Yan; Ye, Xingqian] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Zhejiang Key Lab Agrofood Proc, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Yujing] Zhejiang Univ Technol, Dept Food Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University of Technology	Ye, XQ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Zhejiang Key Lab Agrofood Proc, Fuli Inst Food Sci,Zhejiang R&D Ctr Food Technol, Hangzhou 310003, Zhejiang, Peoples R China.	psu@zju.edu.cn			National Natural Science Foundation of China [31071635]; National Key Technology RD Program [2012BAD31B06, 2012BAD31B02]; Postdoctoral Foundation of China [316000 - X91102, 316000-X91204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); Postdoctoral Foundation of China(China Postdoctoral Science Foundation)	This project was supported by National Natural Science Foundation of China (31071635), National Key Technology R&D Program (2012BAD31B06, 2012BAD31B02) and Postdoctoral Foundation of China (316000 - X91102; 316000-X91204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesaga M, 2013, FOOD CHEM, V136, P46, DOI 10.1016/j.foodchem.2012.07.095; Biesaga M, 2011, J CHROMATOGR A, V1218, P2505, DOI 10.1016/j.chroma.2011.02.059; Buchner N, 2006, RAPID COMMUN MASS SP, V20, P3229, DOI 10.1002/rcm.2720; Cao DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021071; Cherviakovsky EM, 2006, BIOCHEM BIOPH RES CO, V342, P459, DOI 10.1016/j.bbrc.2006.02.001; Elhamirad AH, 2012, EUR J LIPID SCI TECH, V114, P602, DOI 10.1002/ejlt.201100240; Entezari MH, 2004, ULTRASON SONOCHEM, V11, P379, DOI 10.1016/j.ultsonch.2003.10.005; Fahlman BM, 2009, J PHOTOCH PHOTOBIO B, V97, P123, DOI 10.1016/j.jphotobiol.2009.08.009; Grotewold Erich, 2006, P1; Gulsen A, 2007, FOOD RES INT, V40, P7, DOI 10.1016/j.foodres.2006.07.009; GUTIERREZ M, 1990, J PHYS CHEM-US, V94, P3625, DOI 10.1021/j100372a048; Hemwimol S, 2006, ULTRASON SONOCHEM, V13, P543, DOI 10.1016/j.ultsonch.2005.09.009; Iida Y, 2008, INNOV FOOD SCI EMERG, V9, P140, DOI 10.1016/j.ifset.2007.03.029; Ioannou I, 2012, J FOOD ENG, V111, P208, DOI 10.1016/j.jfoodeng.2012.02.006; Kanthale PM, 2003, ULTRASON SONOCHEM, V10, P331, DOI 10.1016/S1350-4177(03)00104-4; Khan MK, 2010, FOOD CHEM, V119, P851, DOI 10.1016/j.foodchem.2009.08.046; Kiani H, 2012, ULTRASON SONOCHEM, V19, P1238, DOI 10.1016/j.ultsonch.2012.04.009; Krishnamachari V, 2002, J AGR FOOD CHEM, V50, P4357, DOI 10.1021/jf020045e; Londono-Londono J, 2010, FOOD CHEM, V119, P81, DOI 10.1016/j.foodchem.2009.05.075; Luque-Garcia JL, 2004, J CHROMATOGR A, V1034, P237, DOI 10.1016/j.chroma.2004.02.020; Ma YQ, 2008, J AGR FOOD CHEM, V56, P5682, DOI 10.1021/jf072474o; Ma YQ, 2008, ULTRASON SONOCHEM, V15, P227, DOI 10.1016/j.ultsonch.2007.03.006; Maini S, 2012, J AGR FOOD CHEM, V60, P6966, DOI 10.1021/jf3016128; Mason TJ, 2002, APPL SONOCHEMISTRY, P57; Mendoza-Wilson AM, 2004, J MOL STRUC-THEOCHEM, V681, P71, DOI 10.1016/j.theochem.2004.04.054; Paniwnyk L, 2001, ULTRASON SONOCHEM, V8, P299, DOI 10.1016/S1350-4177(00)00075-4; Qiao LP, 2013, ULTRASON SONOCHEM, V20, P1017, DOI 10.1016/j.ultsonch.2012.12.007; Ramos FA, 2006, J AGR FOOD CHEM, V54, P3551, DOI 10.1021/jf060251c; Raso J, 1999, ULTRASON SONOCHEM, V5, P157, DOI 10.1016/S1350-4177(98)00042-X; ROBAK J, 1991, Polish Journal of Pharmacology and Pharmacy, V43, P145; ROMDHANE M, 1995, ULTRASONICS, V33, P221, DOI 10.1016/0041-624X(94)00023-I; Sun YJ, 2013, MOLECULES, V18, P4858, DOI 10.3390/molecules18054858; Sun YJ, 2013, MOLECULES, V18, P561, DOI 10.3390/molecules18010561; Sun YJ, 2010, ULTRASON SONOCHEM, V17, P654, DOI 10.1016/j.ultsonch.2009.12.005; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Vilkhu K, 2008, INNOV FOOD SCI EMERG, V9, P161, DOI 10.1016/j.ifset.2007.04.014; Xu GH, 2007, J AGR FOOD CHEM, V55, P330, DOI 10.1021/jf062517l; Zhang YuanMei, 2012, Scientia Agricultura Sinica, V45, P3558; Zhou AL, 2008, J AGR FOOD CHEM, V56, P12081, DOI 10.1021/jf802413v; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068392	40	32	34	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87766	10.1371/journal.pone.0087766	http://dx.doi.org/10.1371/journal.pone.0087766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516562	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700030
J	Wirtz, AL; Pretorius, C; Beyrer, C; Baral, S; Decker, MR; Sherman, SG; Sweat, M; Poteat, T; Butler, J; Oelrichs, R; Semini, I; Kerrigan, D				Wirtz, Andrea L.; Pretorius, Carel; Beyrer, Chris; Baral, Stefan; Decker, Michele R.; Sherman, Susan G.; Sweat, Michael; Poteat, Tonia; Butler, Jennifer; Oelrichs, Robert; Semini, Iris; Kerrigan, Deanna			Epidemic Impacts of a Community Empowerment Intervention for HIV Prevention among Female Sex Workers in Generalized and Concentrated Epidemics	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; MIDDLE-INCOME COUNTRIES; CONDOM USE; HIGH-RISK; REPRODUCTIVE HEALTH; BEHAVIOR; KENYA; POPULATION; MOMBASA; TRANSMISSION	Introduction: Sex workers have endured a high burden of HIV infection in and across HIV epidemics. A comprehensive, community empowerment-based HIV prevention intervention emphasizes sex worker organization and mobilization to address HIV risk and often includes community-led peer education, condom distribution, and other activities. Meta-analysis of such interventions suggests a potential 51% reduction in inconsistent condom use. Mathematical modeling exercises provide theoretical insight into potential impacts of the intervention on HIV incidence and burden in settings where interventions have not yet been implemented. Methods: We used a deterministic model, Goals, to project the impact on HIV infections when the community empowerment interventions were scaled up among female sex workers in Kenya, Thailand, Brazil, and Ukraine. Modeling scenarios included expansion of the comprehensive community empowerment-based HIV prevention intervention from baseline coverage over a 5-year period (5-65% in Kenya and Ukraine; 10-70% in Thailand and Brazil), while other interventions were held at baseline levels. A second exercise increased the intervention coverage simultaneously with equitable access to ART for sex workers. Impacts on HIV outcomes among sex workers and adults are observed from 20122016 and, compared to status quo when all interventions are held constant. Results: Optimistic but feasible coverage (65%-70%) of the intervention demonstrated a range of impacts on HIV: 220 infections averted over 5 yrs. among sex workers in Thailand, 1,830 in Brazil, 2,220 in Ukraine, and 10,800 infections in Kenya. Impacts of the intervention for female sex workers extend to the adult population, cumulatively averting 730 infections in Thailand to 20,700 adult infections in Kenya. Impacts vary by country, influenced by HIV prevalence in risk groups, risk behaviors, intervention use, and population size. Discussion: A community empowerment approach to HIV prevention and access to universal ART for female sex workers is a promising human rights-based solution to overcoming the persistent burden of HIV among female sex workers across epidemic settings.	[Wirtz, Andrea L.; Beyrer, Chris; Baral, Stefan; Decker, Michele R.; Sherman, Susan G.; Poteat, Tonia; Kerrigan, Deanna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Wirtz, Andrea L.] Johns Hopkins Med Inst, Dept Emergency Med, Baltimore, MD 21205 USA; [Pretorius, Carel] Futures Inst, Glastonbury, CT USA; [Decker, Michele R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Sweat, Michael] Med Univ S Carolina, Charleston, SC 29425 USA; [Butler, Jennifer] United Nations Populat Fund, New York, NY USA; [Oelrichs, Robert; Semini, Iris] World Bank, Human Dev Network, Washington, DC 20433 USA; [Kerrigan, Deanna] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Medical University of South Carolina; United Nations Population Fund; The World Bank; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wirtz, AL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	awirtz@jhsph.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Poteat, Tonia/0000-0001-6541-3787; Decker, Michele/0000-0002-7085-7080	UNAIDS under the UBW Trust Fund; World Bank	UNAIDS under the UBW Trust Fund; World Bank(The World Bank India)	The authors thank the World Bank for their support of the parent project, "The Global Epidemics of HIV in Sex Workers." Support from UNAIDS under the UBW Trust Fund is gratefully acknowledged. The funders had no role in the modeling analysis, decision to publish, or interpretation of results.	AIDS Alliance Ukraine, 2012, AN REP BEH MON HIV P; AIDS Alliance Ukraine, 2010, AN REP BAS SOC STUD; Akarasewi P, 2010, OVERVIEW HIV EPIDEMI; Baeten JM, 2009, SEX TRANSM INFECT, V85, P348, DOI 10.1136/sti.2008.035451; Balakireva O, 2007, MONITORING BEHAV FEM; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Brazilian Ministry of Health, 2012, PROGR REP BRAZ RESP; Brazilian Ministry of Health, 2012, MON; Bruce RD, 2007, INT J DRUG POLICY, V18, P326, DOI 10.1016/j.drugpo.2006.12.011; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Cheluget B, 2006, SEX TRANSM INFECT, V82, pI21, DOI 10.1136/sti.2005.015990; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2013, PRIORITY INTERVENTIO; Davida, 2010, HUMAN RIGHTS FEMALE; Decker MR, 2011, J EPIDEMIOL COMMUN H, V65, P334, DOI 10.1136/jech.2009.096834; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Decker MR, 2012, AM J REPROD IMMUNOL; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Family Health International Bureau of AIDS TB and STIs Department of Disease Control MOPH Thailand, 2008, AS EP MOD AEM PROJ H; Ferguson AG, 2007, HEALTH PLACE, V13, P504, DOI 10.1016/j.healthplace.2006.05.009; Ford K, 2007, AIDS BEHAV, V11, P905, DOI 10.1007/s10461-007-9207-x; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Gruskin S, 2009, REPROD HEALTH MATTER, V17, P108, DOI 10.1016/S0968-8080(09)34483-3; Guest P, 2007, 2007 SURVEY SEXUAL R; Hawken MP, 2002, JAIDS-J ACQ IMM DEF, V31, P529, DOI 10.1097/00126334-200212150-00011; Hirbod T, 2008, AIDS, V22, P727, DOI 10.1097/QAD.0b013e3282f56b64; Kalanda B, 2010, MALAWI MED J, V22, P10; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; Kerrigan D, 2013, DIR DEV, P1, DOI 10.1596/978-0-8213-9774-9; Kerrigan D, 2008, HEALTH EDUC RES, V23, P137, DOI 10.1093/her/cym011; Kerrigan DL, 2013, AIDS BEHAV, V17, P1926, DOI 10.1007/s10461-013-0458-4; Kyrychenko P, 2005, SEX TRANSM INFECT, V81, P187, DOI 10.1136/sti.2004.011890; Lacap PA, 2008, AIDS, V22, P1029, DOI 10.1097/QAD.0b013e3282ffb3db; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Lazarus L, 2012, CULT HEALTH SEX, V14, P139, DOI 10.1080/13691058.2011.628411; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; Malta M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-317; McClelland RS, 2011, SEX TRANSM DIS, V38, P429, DOI 10.1097/OLQ.0b013e31820369f6; Mimiaga MJ, 2010, AIDS CARE, V22, P1305, DOI 10.1080/09540121003758515; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Morris CN, 2009, AIDS BEHAV, V13, P860, DOI 10.1007/s10461-008-9431-z; Mukenge-Tshibaka L, 2002, SEX TRANSM DIS, V29, P324, DOI 10.1097/00007435-200206000-00003; Murray LR, 2010, CULT HEALTH SEX, V12, P293, DOI 10.1080/13691050903450122; Nagot N, 2004, SEX TRANSM INFECT, V80, P124, DOI 10.1136/sti.2002.004150; NASCOP, 2009, KEN NAT AIDS STRAT P; NASCOP, 2007, HIV AIDS FACTS FIG; NASCOP, 2012, MOST AT RISK POP UNV; National AIDS Control Council, 2010, UNGASS 2010 COUNTR R; National Aids Control Council OotPK World B Unaids, 2009, KEN HIV PREV RESP MO; National AIDS Prevention and Alleviation Committee, 2010, UNGASS COUNTR PROGR; National AIDS Prevention and Alleviation Committee, 2010, COUNTR PROGR REP THA; Ngugi E, 2012, CULT HEALTH SEX, V14, P17, DOI 10.1080/13691058.2011.608436; Ngugi EN, 2007, JAIDS-J ACQ IMM DEF, V45, P588, DOI 10.1097/QAI.0b013e3180f616db; Nitzsche AS, 2000, 13 INT AIDS C DURB 1; Odek WO, 2009, AIDS BEHAV, V13, P449, DOI 10.1007/s10461-008-9485-y; Padian NS, 2012, JAIDS-J ACQ IMM DEF, V60, pS22, DOI 10.1097/QAI.0b013e31825b7100; Pimenta M, 2009, SEXUALITY DEV BRAZIL; Piscitelli Adriana, 2008, Cad. Pagu, V0, P29, DOI 10.1590/S0104-83332008000200003; Platt L, 2013, HIV EUROPEAN REGION; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; SCHLEIFER R, 2006, RHETORIC RISK HUMAN; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Scorgie F., 2011, I EXPECT BE ABUSED I; Shah NS, 2011, J URBAN HEALTH, V88, P533, DOI 10.1007/s11524-010-9542-5; Shannon K, 2005, J URBAN HEALTH, V82, P488, DOI 10.1093/jurban/jti076; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Stover J, 2003, GOALS MODEL ESTIMATI; Strathdee SA, 2013, ANNU REV PUBL HEALTH, V34, P301, DOI 10.1146/annurev-publhealth-031912-114411; SWAN, 2009, ARR VIOL HUM RIGHTS; Szwarcwald CL, 2005, AIDS, V19, pS51, DOI 10.1097/01.aids.0000191491.66736.16; TAMPEP, 2007, NAT REP HIV SEX WORK; Tegang SP, 2010, SAHARA J-J SOC ASP H, V7, P10, DOI 10.1080/17290376.2010.9724972; Thomsen SC, 2006, SEX TRANSM INFECT, V82, P397, DOI 10.1136/sti.2006.019992; Tovanabutra S, 2010, AIDS RES HUM RETROV, V26, P123, DOI 10.1089/aid.2009.0115; Trevisol Fabiana Schuelter, 2005, Braz J Infect Dis, V9, P500, DOI 10.1590/S1413-86702005000600008; UNAIDS, 2010, REP GLOB AIDS EP 201; UNAIDS, 2012, THAIL AIDS RESP PROG; UNAIDS, 2010, BRAZ EP FACT SHEET H; UNAIDS Ministry of Health of Ukraine, 2008, UKR NAT REP MON PROG; UNAIDS Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; USAID Ministry of Health of Ukraine, 2010, UKR HIV AIDS HLTH PR; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Veldhuijzen NJ, 2011, SEX HEALTH, V8, P251, DOI 10.1071/SH10047; WHO, 2010, ANT THER HIV INF AD; WHO HIV/AIDS Programme, 2013, CONS GUID US ANT DRU; WHO UNFPA UNAIDS NSWP, 2012, PREV TREATM HIV OTH; Wirtz AL, 2013, INT J STD AIDS; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329	94	40	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88047	10.1371/journal.pone.0088047	http://dx.doi.org/10.1371/journal.pone.0088047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516580	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700039
J	Devaine, M; Hollard, G; Daunizeau, J				Devaine, Marie; Hollard, Guillaume; Daunizeau, Jean			Theory of Mind: Did Evolution Fool Us?	PLOS ONE			English	Article							FREE-ENERGY; COOPERATION	Theory of Mind (ToM) is the ability to attribute mental states (e. g., beliefs and desires) to other people in order to understand and predict their behaviour. If others are rewarded to compete or cooperate with you, then what they will do depends upon what they believe about you. This is the reason why social interaction induces recursive ToM, of the sort "I think that you think that I think, etc.''. Critically, recursion is the common notion behind the definition of sophistication of human language, strategic thinking in games, and, arguably, ToM. Although sophisticated ToM is believed to have high adaptive fitness, broad experimental evidence from behavioural economics, experimental psychology and linguistics point towards limited recursivity in representing other's beliefs. In this work, we test whether such apparent limitation may not in fact be proven to be adaptive, i.e. optimal in an evolutionary sense. First, we propose a meta-Bayesian approach that can predict the behaviour of ToM sophistication phenotypes who engage in social interactions. Second, we measure their adaptive fitness using evolutionary game theory. Our main contribution is to show that one does not have to appeal to biological costs to explain our limited ToM sophistication. In fact, the evolutionary cost/benefit ratio of ToM sophistication is non trivial. This is partly because an informational cost prevents highly sophisticated ToM phenotypes to fully exploit less sophisticated ones (in a competitive context). In addition, cooperation surprisingly favours lower levels of ToM sophistication. Taken together, these quantitative corollaries of the "social Bayesian brain'' hypothesis provide an evolutionary account for both the limitation of ToM sophistication in humans as well as the persistence of low ToM sophistication levels.	[Devaine, Marie; Daunizeau, Jean] Hop La Pitie Salpetriere, Brain & Spine Inst, Motivat Brain & Behav Lab, Paris, France; [Hollard, Guillaume] Maison Sci Econom, Paris, France; [Devaine, Marie; Daunizeau, Jean] UPMC Paris, INSERM, U975, CNRS UMR 7225, Paris, France; [Daunizeau, Jean] UCL, Wellcome Trust Ctr Neuroimaging, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London	Daunizeau, J (corresponding author), Hop La Pitie Salpetriere, Brain & Spine Inst, Motivat Brain & Behav Lab, Paris, France.	jean.daunizeau@gmail.com	Daunizeau, Jean/F-9225-2010; Daunizeau, Jean/AAB-3996-2019	Daunizeau, Jean/0000-0001-9142-1270; 	European Research Council; French Ministere de l'Education Nationale	European Research Council(European Research Council (ERC)European Commission); French Ministere de l'Education Nationale	This work was supported by the European Research Council (JD) and the French Ministere de l'Education Nationale (MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baron-Cohen S., 1991, NATURAL THEORIES MIN, V1, P233; Baron-Cohen S., 1999, DESCENT MIND PSYCHOL, P261, DOI DOI 10.1093/ACPROF:OSO/9780192632593.003.0013; Beal M.J., 2003, VARIATIONAL ALGORITH; Berger U, 2007, J ECON THEORY, V135, P572, DOI 10.1016/j.jet.2005.12.010; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Byrne C, 1988, MACHIAVELLIAN INTELL; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Camerer CF, 2002, J ECON THEORY, V104, P137, DOI 10.1006/jeth.2002.2927; Clayton NS, 2007, PHILOS T R SOC B, V362, P507, DOI 10.1098/rstb.2006.1992; Colman AM, 2003, TRENDS COG SCI, V7; Corballis MC, 2007, EVOLUTIONARY COGNITI; Daunizeau J, 2009, PHYSICA D, V238, P2089, DOI 10.1016/j.physd.2009.08.002; Daunizeau J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015554; Day T, 2001, ENCY LIFE SCI; Dennett D. C., 1996, INTENTIONAL STANCE; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P67, DOI 10.1007/BF02734136; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Easton A, 2005, COGNITIVE NEUROSCIENCE OF SOCIAL BEHAVIOUR, P1, DOI 10.4324/9780203311875; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2007, NEUROIMAGE, V34, P220, DOI 10.1016/j.neuroimage.2006.08.035; Frith U., 1994, SOCIAL DEVELOP, V2, P108, DOI [DOI 10.1111/J.1467-9507.1994.TB00031.X, 10.1111/j.1467-9507.1994.tb00031.x]; Fudenberg D., 1991, GAME THEORY; Gavrilets S, 2003, P NATL ACAD SCI USA, V103, P16823; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hadamard J., 1902, PRINCET U B, P49; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Harano T, 2010, CURR BIOL, V20, P2036, DOI 10.1016/j.cub.2010.10.023; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hedden T, 2002, COGNITION, V85, P1, DOI 10.1016/S0010-0277(02)00054-9; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Kinderman P, 1998, BRIT J PSYCHOL, V89, P191, DOI 10.1111/j.2044-8295.1998.tb02680.x; Kovacs AM, 2010, SCIENCE, V330, P1830, DOI 10.1126/science.1190792; Malle B. F, 2002, EVOLUTION LANGUAGE O, P265, DOI DOI 10.1075/TSL.53.14MAL; Mathys C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00039; Maynard Smith J., 1982, pi; McNally L, 2012, P ROY SOC B-BIOL SCI, V279, P3027, DOI 10.1098/rspb.2012.0206; Moll H, 2007, PHILOS T R SOC B, V362, P639, DOI 10.1098/rstb.2006.2000; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Nagel R, 1995, AM ECON REV, V85, P1313; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; POGGIO T, 1985, PROC R SOC SER B-BIO, V226, P303, DOI 10.1098/rspb.1985.0097; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Rapoport A, 1965, PRISONERS DILEMMA; Rasmusen E, 2006, GAMES INFORM INTRO G; Simon HA, 1991, ORGAN SCI, V2, P125, DOI 10.1287/orsc.2.1.125; Singh S, 2010, IEEE T AUTON MENT DE, V2, P70, DOI 10.1109/TAMD.2010.2051031; STAHL DO, 1995, GAME ECON BEHAV, V10, P218, DOI 10.1006/game.1995.1031; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Yoshida W, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000254; Zunshine L, 2007, STYLE, V41, P275	55	48	48	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87619	10.1371/journal.pone.0087619	http://dx.doi.org/10.1371/journal.pone.0087619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505296	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200055
J	Kang, J; Yeom, E; Lim, J; Choi, KW				Kang, Jongkyun; Yeom, Eunbyul; Lim, Janghoo; Choi, Kwang-Wook			Bar Represses dPax2 and Decapentaplegic to Regulate Cell Fate and Morphogenetic Cell Death in Drosophila Eye	PLOS ONE			English	Article							PRIMARY PIGMENT-CELLS; HOMEO BOX GENES; RETINAL NEUROGENESIS; SPECIFICATION; PUPAL; EXPRESSION; INDUCTION; DECISIONS; APOPTOSIS; RECEPTOR	The coordinated regulation of cell fate and cell survival is crucial for normal pattern formation in developing organisms. In Drosophila compound eye development, crystalline arrays of hexagonal ommatidia are established by precise assembly of diverse cell types, including the photoreceptor cells, cone cells and interommatidial (IOM) pigment cells. The molecular basis for controlling the number of cone and IOM pigment cells during ommatidial pattern formation is not well understood. Here we present evidence that BarH1 and BarH2 homeobox genes are essential for eye patterning by inhibiting excess cone cell differentiation and promoting programmed death of IOM cells. Specifically, we show that loss of Bar from the undifferentiated retinal precursor cells leads to ectopic expression of Prospero and dPax2, two transcription factors essential for cone cell specification, resulting in excess cone cell differentiation. We also show that loss of Bar causes ectopic expression of the TGF beta homolog Decapentaplegic (Dpp) posterior to the morphogenetic furrow in the larval eye imaginal disc. The ectopic Dpp expression is not responsible for the formation of excess cone cells in Bar loss-of-function mutant eyes. Instead, it causes reduction in IOM cell death in the pupal stage by antagonizing the function of pro-apoptotic gene reaper. Taken together, this study suggests a novel regulatory mechanism in the control of developmental cell death in which the repression of Dpp by Bar in larval eye disc is essential for IOM cell death in pupal retina.	[Kang, Jongkyun; Yeom, Eunbyul; Choi, Kwang-Wook] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lim, Janghoo] Yale Univ, Sch Med, Dept Genet, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Choi, Kwang-Wook] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Yale University; Korea Advanced Institute of Science & Technology (KAIST)	Choi, KW (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	kchoi100@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021; Choi, Kwang-Wook/C-1707-2011	Kang, Jongkyun/0000-0003-0259-110X; Choi, Kwang-Wook/0000-0002-8997-3065	World Class University Program through the National Research Foundation of Korea [R31-2008-000-10071-0]; National Research Laboratory grant through the National Research Foundation of Korea [20110028326]; Ministry of Education, Science Technology	World Class University Program through the National Research Foundation of Korea(National Research Foundation of Korea); National Research Laboratory grant through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by grants from the World Class University Program (R31-2008-000-10071-0) and National Research Laboratory grant (20110028326) through the National Research Foundation of Korea funded by the Ministry of Education, Science & Technology (http://www.nrf.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimaru H, 1991, Nucleic Acids Symp Ser, P29; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Charlton-Perkins M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-20; Cordero JB, 2007, DEVELOPMENT, V134, P1861, DOI 10.1242/dev.002972; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Hayashi T, 1998, DEV BIOL, V200, P131, DOI 10.1006/dbio.1998.8959; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Johnson RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007008; KOJIMA T, 1991, P NATL ACAD SCI USA, V88, P4343, DOI 10.1073/pnas.88.10.4343; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Lim JH, 2004, DEVELOPMENT, V131, P5573, DOI 10.1242/dev.01426; Lim JH, 2003, DEVELOPMENT, V130, P5965, DOI 10.1242/dev.00818; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nagaraj R, 2007, DEVELOPMENT, V134, P825, DOI 10.1242/dev.02788; Oeda E, 1998, J BIOL CHEM, V273, P9353, DOI 10.1074/jbc.273.16.9353; Pignoni F, 1997, DEVELOPMENT, V124, P271; Sato Y, 2000, J ORAL REHABIL, V27, P935, DOI 10.1046/j.1365-2842.2000.00621.x; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Steinberg AG, 1937, P NATL ACAD SCI USA, V23, P54, DOI 10.1073/pnas.23.2.54; Stowers RS, 1999, GENETICS, V152, P1631; Walther RF, 2006, NAT PROTOC, V1, P2635, DOI 10.1038/nprot.2006.379; XU T, 1993, DEVELOPMENT, V117, P1223	28	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88171	10.1371/journal.pone.0088171	http://dx.doi.org/10.1371/journal.pone.0088171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505414	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200128
J	Marquet, F; Teichert, T; Wu, SY; Tung, YS; Downs, M; Wang, ST; Chen, C; Ferrera, V; Konofagou, EE				Marquet, Fabrice; Teichert, Tobias; Wu, Shih-Ying; Tung, Yao-Sheng; Downs, Matthew; Wang, Shutao; Chen, Cherry; Ferrera, Vincent; Konofagou, Elisa E.			Real-Time, Transcranial Monitoring of Safe Blood-Brain Barrier Opening in Non-Human Primates	PLOS ONE			English	Article							FOCUSED ULTRASOUND; MICROBUBBLES; MICE	The delivery of drugs to specific neural targets faces two fundamental problems: (1) most drugs do not cross the blood-brain barrier, and (2) those that do, spread to the entire brain. To date, there exists only one non-invasive methodology with the potential to solve these problems: selective blood-brain barrier (BBB) opening using micro-bubble enhanced focused ultrasound. We have recently developed a single-element 500-kHz spherical transducer ultrasound setup for targeted BBB opening in the non-human primate that does not require simultaneous MRI monitoring. So far, however, the targeting accuracy that can be achieved with this system has not been quantified systematically. In this paper, the accuracy of this system was tested by targeting caudate nucleus and putamen of the basal ganglia in two macaque monkeys. The average lateral targeting error of the system was similar to 2.5 mm while the axial targeting error, i.e., along the ultrasound path, was similar to 1.5 mm. We have also developed a real-time treatment monitoring technique based on cavitation spectral analysis. This technique also allowed for delineation of a safe and reliable acoustic parameter window for BBB opening. In summary, the targeting accuracy of the system was deemed to be suitable to reliably open the BBB in specific sub-structures of the basal ganglia even in the absence of MRI-based verification of opening volume and position. This establishes the method and the system as a potentially highly useful tool for brain drug delivery.	[Marquet, Fabrice; Wu, Shih-Ying; Tung, Yao-Sheng; Downs, Matthew; Wang, Shutao; Chen, Cherry; Konofagou, Elisa E.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Teichert, Tobias; Ferrera, Vincent] Columbia Univ, Dept Neurosci, New York, NY USA; [Konofagou, Elisa E.] Columbia Univ, Dept Radiol, New York, NY USA	Columbia University; Columbia University; Columbia University	Konofagou, EE (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	ek2191@columbia.edu	Teichert, Tobias/F-6295-2014	Ferrera, Vincent/0000-0002-6599-7740; Downs, Matthew/0000-0001-6115-3156; Teichert, Tobias/0000-0001-6500-9573	National Institutes of Health [R01 EB009041, R01 AG038961]; Kinetics Foundation; NATIONAL EYE INSTITUTE [P30EY019007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038961] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kinetics Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by the National Institutes of Health (R01 EB009041, R01 AG038961), and the Kinetics Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeson P, 1997, ACTA RADIOL, V38, P19; Behrens S, 1999, ULTRASOUND MED BIOL, V25, P269, DOI 10.1016/S0301-5629(98)00158-6; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Cobbold R, 2006, BIOMEDICAL ENG SERIE; Deffieux T, 2010, IEEE T ULTRASON FERR, V57, P2637, DOI 10.1109/TUFFC.2010.1738; Dove A, 2008, NAT BIOTECHNOL, V26, P1213, DOI 10.1038/nbt1108-1213; Downs M, 2013, SOC NEUR M SAN DIEG; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; FRY F J, 1977, Ultrasound in Medicine and Biology, V3, P179, DOI 10.1016/0301-5629(77)90069-2; Marquet F, 2010, NANO LIFE, V1, P309, DOI 10.1142/S1793984410000286; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022598; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; MILLER DH, 1988, BRAIN, V111, P927, DOI 10.1093/brain/111.4.927; Olumolade O, 2012, 3 INT S FOC ULTR BET; Pardridge WA, 2009, ALZHEIMERS DEMENT, V5, P427, DOI 10.1016/j.jalz.2009.06.003; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Pardridge William M, 2005, NeuroRx, V2, P129, DOI 10.1007/BF03206649; Samiotaki G, 2012, MAGN RESON MED, V67, P769, DOI 10.1002/mrm.23063; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tung YS, 2011, J ACOUST SOC AM, V130, P3059, DOI 10.1121/1.3646905; Tung YS, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580763; Tung YS, 2010, PHYS MED BIOL, V55, P6141, DOI 10.1088/0031-9155/55/20/007; Wang S, 2013, 13 INT S THER ULTR S	25	59	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e84310	10.1371/journal.pone.0084310	http://dx.doi.org/10.1371/journal.pone.0084310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505248	gold, Green Published			2022-12-27	WOS:000330829200008
J	Sang, Q; Li, X; Wang, HJ; Wang, H; Zhang, SZ; Feng, RZ; Xu, Y; Li, QL; Zhao, XZ; Xing, QH; Jin, L; He, L; Wang, L				Sang, Qing; Li, Xin; Wang, Haojue; Wang, Huan; Zhang, Shaozhen; Feng, Ruizhi; Xu, Yao; Li, Qiaoli; Zhao, Xinzhi; Xing, Qinghe; Jin, Li; He, Lin; Wang, Lei			Quantitative Methylation Level of the EPHX1 Promoter in Peripheral Blood DNA Is Associated with Polycystic Ovary Syndrome	PLOS ONE			English	Article							MICROSOMAL EPOXIDE HYDROLASE; INSULIN-RESISTANCE; CANCER; GENE; POLYMORPHISM; PATHOGENESIS; EPIGENETICS; EXPRESSION; HIRSUTISM; ORIGINS	Steroid synthesis and metabolic pathways play important roles in the pathophysiology of PCOS, but until now there have been no studies on the methylation profiles of specific genes in steroid synthesis pathways that are known to be associated with PCOS. Here we used MassARRAY quantitative methylation analysis to determine the methylation levels of each CpG site or cluster in the promoters of EPHX1, SRD5A1, and CYP11A1 in 64 peripheral blood samples. We further examined the methylation level of EPHX1 in an independent cohort consisting of 116 people. Finally, we investigated the role of EPHX1 in steroidogenesis in the KGN cell line. For SRD5A1 and CYP11A1, there was no significant difference in methylation level between patients and controls. For EPHX1, however, the methylation levels of a few consecutive CpG sites and clusters were found to be significantly associated with PCOS. The methylation levels of a number of CpG clusters or sites were significantly lower in patients than in controls in the first cohort consisting of 64 people, such as clusters 13-14 (P<0.05), 15-16 (P<0.001), and 19-24 (P<0.001) and sites CpG_53 (P<0.01) and CpG_54 (P<0.05). Among differentiated methylation sites and clusters, the methylation levels of the CpG cluster 13-14 and CpG cluster 19-24 in PCOS patients were significantly lower than in controls in the second cohort of 116 people (P<0.05 for both). In addition, knockdown and overexpression experiments in KGN cells showed that EPHX1 can regulate estradiol concentrations, and this indicates a role for EPHX1 in steroidogenesis. Our study has demonstrated that methylation of the EPHX1 promoter might be associated with PCOS. This study provides direct evidence that methylation plays an important role in PCOS and demonstrates a novel role for EPHX1 in female reproduction.	[Sang, Qing; Wang, Haojue; Wang, Huan; Feng, Ruizhi; Xu, Yao; Li, Qiaoli; Zhao, Xinzhi; Jin, Li; Wang, Lei] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Sang, Qing; Wang, Haojue; Wang, Huan; Feng, Ruizhi; Xu, Yao; Li, Qiaoli; Zhao, Xinzhi; Jin, Li; Wang, Lei] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Sang, Qing; Wang, Haojue; Wang, Huan; Feng, Ruizhi; Xu, Yao; Li, Qiaoli; Zhao, Xinzhi; Xing, Qinghe; He, Lin; Wang, Lei] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xing, Qinghe; He, Lin; Wang, Lei] Shanghai Jiao Tong Univ, Minist Educ, Bio X Ctr, Key Lab Genet Dev & Neuropsychiat Disorders, Shanghai 200030, Peoples R China; [Zhang, Shaozhen] Shanghai Ninth Hosp, Shanghai, Peoples R China; [Li, Xin] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University	Wang, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	wangleiwanglei@fudan.edu.cn	Xu, Yao/AFL-6014-2022; Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Xu, Yao/0000-0002-0792-1158; Jin, Li/0000-0002-4546-2415; 	National Natural Science Foundation of China [81100467, 81270747]; Shanghai City Board of Education Scientific Research Innovation Key Projects [13ZZ001]; Fundamental Research Fund for Central University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai City Board of Education Scientific Research Innovation Key Projects; Fundamental Research Fund for Central University	This work was supported by the National Natural Science Foundation of China [grant numbers 81100467 and 81270747]; the Shanghai City Board of Education Scientific Research Innovation Key Projects [grant number 13ZZ001]; and the Fundamental Research Fund for Central University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2003, STEROIDS, V68, P861, DOI 10.1016/j.steroids.2003.09.003; Calvo RM, 2000, J CLIN ENDOCR METAB, V85, P1735, DOI 10.1210/jc.85.4.1735; Chimonidou M, 2013, CLIN CHEM, V59, P270, DOI 10.1373/clinchem.2012.191551; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Franks S, 1998, TRENDS ENDOCRIN MET, V9, P51, DOI 10.1016/S1043-2760(98)00018-6; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Gharani N, 1997, HUM MOL GENET, V6, P397, DOI 10.1093/hmg/6.3.397; Glossop JR, 2013, EPIGENETICS, V8; Goodarzi MO, 2006, J CLIN ENDOCR METAB, V91, P4085, DOI 10.1210/jc.2006-0227; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hartsfield JK, 1998, CYTOGENET CELL GENET, V83, P44, DOI 10.1159/000015164; Hattori N, 2000, ENDOCRINOLOGY, V141, P3353, DOI 10.1210/en.141.9.3353; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; Jones MR, 2009, J CLIN ENDOCR METAB, V94, P5034, DOI 10.1210/jc.2009-0931; Korhonen S, 2003, FERTIL STERIL, V79, P1353, DOI 10.1016/S0015-0282(03)00385-6; Lancaster JM, 1996, MOL CARCINOGEN, V17, P160, DOI 10.1002/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.3.CO;2-9; Luense LJ, 2011, ENDOCRINOLOGY, V152, P4974, DOI 10.1210/en.2011-1182; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; North ML, 2011, ANN ALLERG ASTHMA IM, V106, P355, DOI 10.1016/j.anai.2011.02.008; Popp SL, 2010, J MOL HISTOL, V41, P111, DOI 10.1007/s10735-010-9266-6; Rosenfield RL, 1999, ENDOCRIN METAB CLIN, V28, P265, DOI 10.1016/S0889-8529(05)70070-0; Sang Q, 2013, REPROD BIOMED ONLINE, V26, P157, DOI 10.1016/j.rbmo.2012.10.011; Simoni M, 2008, HUM REPROD UPDATE, V14, P459, DOI 10.1093/humupd/dmn024; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Walters RJ, 2013, EPIGENETICS-US, V8, P748, DOI 10.4161/epi.25178; Wang XB, 1998, EPIDEMIOLOGY, V9, P540, DOI 10.1097/00001648-199809000-00012; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506; Yao GD, 2010, MOL ENDOCRINOL, V24, P540, DOI 10.1210/me.2009-0432; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048; Zhu JQ, 2010, MOL HUM REPROD, V16, P260, DOI 10.1093/molehr/gap089; Zusterzeel PLM, 2001, J MED GENET, V38, P234, DOI 10.1136/jmg.38.4.234	39	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88013	10.1371/journal.pone.0088013	http://dx.doi.org/10.1371/journal.pone.0088013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505354	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200097
J	Uetake, R; Sakurai, T; Kamiyoshi, A; Ichikawa-Shindo, Y; Kawate, H; Iesato, Y; Yoshizawa, T; Koyama, T; Yang, L; Toriyama, Y; Yamauchi, A; Igarashi, K; Tanaka, M; Kuwabara, T; Mori, K; Yanagita, M; Mukoyama, M; Shindo, T				Uetake, Ryuichi; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Iesato, Yasuhiro; Yoshizawa, Takahiro; Koyama, Teruhide; Yang, Lei; Toriyama, Yuichi; Yamauchi, Akihiro; Igarashi, Kyoko; Tanaka, Megumu; Kuwabara, Takashige; Mori, Kiyoshi; Yanagita, Motoko; Mukoyama, Masashi; Shindo, Takayuki			Adrenomedullin-RAMP2 System Suppresses ER Stress-Induced Tubule Cell Death and Is Involved in Kidney Protection	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; RENAL INJURY; ENDOGENOUS ADRENOMEDULLIN; CISPLATIN NEPHROTOXICITY; HYPOTENSIVE PEPTIDE; VASCULAR INTEGRITY; INDUCED APOPTOSIS; PLASMA-LEVELS; GENE	Various bioactive peptides have been implicated in the homeostasis of organs and tissues. Adrenomedullin (AM) is a peptide with various bioactivities. AM-receptor, calcitonin-receptor-like receptor (CLR) associates with one of the subtypes of the accessory proteins, RAMPs. Among the RAMP subisoforms, only RAMP2 knockout mice (-/-) reproduce the phenotype of embryonic lethality of AM-/-, illustrating the importance of the AM-RAMP2-signaling system. Although AM and RAMP2 are abundantly expressed in kidney, their function there remains largely unknown. We used genetically modified mice to assess the pathophysiological functions of the AM-RAMP2 system. RAMP2+/- mice and their wild-type littermates were used in a streptozotocin (STZ)-induced renal injury model. The effect of STZ on glomeruli did not differ between the 2 types of mice. On the other hand, damage to the proximal urinary tubules was greater in RAMP2+/-. Tubular injury in RAMP2+/- was resistant to correction of blood glucose by insulin administration. We examined the effect of STZ on human renal proximal tubule epithelial cells (RPTECs), which express glucose transporter 2 (GLUT2), the glucose transporter that specifically takes up STZ. STZ activated the endoplasmic reticulum (ER) stress sensor protein kinase RNA-like endoplasmic reticulum kinase (PERK). AM suppressed PERK activation, its downstream signaling, and CCAAT/enhancer-binding homologous protein (CHOP)-induced cell death. We confirmed that the tubular damage was caused by ER stress-induced cell death using tunicamycin (TUN), which directly evokes ER stress. In RAMP2+/- kidneys, TUN caused severe injury with enhanced ER stress. In wild-type mice, TUN-induced tubular damage was reversed by AM administration. On the other hand, in RAMP2+/-, the rescue effect of exogenous AM was lost. These results indicate that the AM-RAMP2 system suppresses ER stress-induced tubule cell death, thereby exerting a protective effect on kidney. The AM-RAMP2 system thus has the potential to serve as a therapeutic target in kidney disease.	[Uetake, Ryuichi; Sakurai, Takayuki; Kamiyoshi, Akiko; Ichikawa-Shindo, Yuka; Kawate, Hisaka; Iesato, Yasuhiro; Yoshizawa, Takahiro; Koyama, Teruhide; Yang, Lei; Toriyama, Yuichi; Yamauchi, Akihiro; Igarashi, Kyoko; Tanaka, Megumu; Shindo, Takayuki] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Res, Matsumoto, Nagano 390, Japan; [Kuwabara, Takashige; Mori, Kiyoshi; Mukoyama, Masashi] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan; [Mori, Kiyoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto, Japan; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan	Shinshu University; Kyoto University; Kyoto University; Kyoto University	Shindo, T (corresponding author), Shinshu Univ, Grad Sch Med, Dept Cardiovasc Res, Matsumoto, Nagano 390, Japan.	tshindo@shinshu-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; 晃英, 小山/AAI-9805-2020; Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351; Yanagita, Motoko/0000-0002-0339-9008; Yoshizawa, Takahiro/0000-0002-9938-6569; Kuwabara, Takashige/0000-0003-3507-4328	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from Cabinet Office, Government of Japan; National Cardiovascular Center; Naito Foundation; SENSHIN Medical Research Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Novartis Foundation for Gerontological Research; Japan vascular disease research foundation	Funding Program for Next Generation World-Leading Researchers (NEXT Program) from Cabinet Office, Government of Japan; National Cardiovascular Center; Naito Foundation(Naito Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Japan vascular disease research foundation(Japan Vascular Disease Research Foundation)	This study was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) from the Cabinet Office, Government of Japan, Research Grant for Cardiovascular Disease from the National Cardiovascular Center, Research grant from the Naito Foundation, SENSHIN Medical Research Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science,Novartis Foundation for Gerontological Research, and Japan vascular disease research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2003, BIOCHEM BIOPH RES CO, V306, P10, DOI 10.1016/S0006-291X(03)00903-3; BELL AI, 1990, MOL MICROBIOL, V4, P1753, DOI 10.1111/j.1365-2958.1990.tb00553.x; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Cockcroft JR, 1997, BRIT J CLIN PHARMACO, V44, P57, DOI 10.1046/j.1365-2125.1997.00622.x; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Davis CA, 2001, J AM SOC NEPHROL, V12, P2683, DOI 10.1681/ASN.V12122683; DOMINGUEZ JH, 1992, AM J PHYSIOL, V262, pF807, DOI 10.1152/ajprenal.1992.262.5.F807; EBARA T, 1994, EUR J PHARMACOL, V263, P69, DOI 10.1016/0014-2999(94)90524-X; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Hanabusa K, 2005, STROKE, V36, P853, DOI 10.1161/01.STR.0000157661.69482.76; HARD GC, 1985, CANCER RES, V45, P703; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hay DL, 2006, PHARMACOL THERAPEUT, V109, P173, DOI 10.1016/j.pharmthera.2005.06.015; Ichikawa-Shindo Y, 2008, J CLIN INVEST, V118, P29, DOI 10.1172/JCI33022; Iimuro S, 2004, CIRC RES, V95, P415, DOI 10.1161/01.RES.0000138018.61065.d1; Imaizumi K, 2001, BBA-MOL BASIS DIS, V1536, P85, DOI 10.1016/S0925-4439(01)00049-7; Inagi R, 2010, CURR OPIN PHARMACOL, V10, P156, DOI 10.1016/j.coph.2009.11.006; ISHIMITSU T, 1994, J CLIN INVEST, V94, P2158, DOI 10.1172/JCI117573; Isumi Y, 1999, FEBS LETT, V463, P110, DOI 10.1016/S0014-5793(99)01615-4; Iwase T, 2005, CIRCULATION, V111, P356, DOI 10.1161/01.CIR.0000153352.29335.B9; Jaradat MI, 2002, SEMIN NEPHROL, V22, P459, DOI 10.1053/snep.2002.35964; JOUGASAKI M, 1995, AM J PHYSIOL-RENAL, V268, pF657, DOI 10.1152/ajprenal.1995.268.4.F657; Kato K, 2003, AM J PHYSIOL-HEART C, V285, pH1506, DOI 10.1152/ajpheart.00270.2003; Kawakami T, 2010, AM J PHYSIOL-RENAL, V299, pF568, DOI 10.1152/ajprenal.00659.2009; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Koyama T, 2013, CIRCULATION, V127, P842, DOI 10.1161/CIRCULATIONAHA.112.000756; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; LI SR, 1991, BIOCHIM BIOPHYS ACTA, V1097, P293, DOI 10.1016/0925-4439(91)90084-M; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu Xueguang, 2002, Chinese Medical Sciences Journal, V17, P129; Madhavan S, 2000, J INTERF CYTOK RES, V20, P281, DOI 10.1089/107999000312414; Mahfoudh-Boussaid A, 2011, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-7; Maki T, 2011, STROKE, V42, P1122, DOI 10.1161/STROKEAHA.110.603399; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MCLAWHON RW, 1986, BIOCHEM BIOPH RES CO, V134, P1387, DOI 10.1016/0006-291X(86)90403-1; Miyamoto N, 2009, J CEREBR BLOOD F MET, V29, P1769, DOI 10.1038/jcbfm.2009.92; Miyawaki Y, 2012, TOHOKU J EXP MED, V228, P215, DOI 10.1620/tjem.228.215; Mukoyama M, 2001, PEPTIDES, V22, P1925, DOI 10.1016/S0196-9781(01)00525-3; Nagae T, 2000, BIOCHEM BIOPH RES CO, V270, P89, DOI 10.1006/bbrc.2000.2390; Nagaya N, 2005, AM J PHYSIOL-REG I, V288, pR1432, DOI 10.1152/ajpregu.00662.2004; NISHIKIMI T, 1995, J AM COLL CARDIOL, V26, P1424, DOI 10.1016/0735-1097(95)00338-X; Nishikimi Toshio, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P231, DOI 10.2174/1568016054368241; Nishimatsu H, 2002, CIRC RES, V90, P657, DOI 10.1161/01.RES.0000013697.55301.E7; Niu P, 2004, CIRCULATION, V109, P1789, DOI 10.1161/01.CIR.0000118466.47982.CC; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Parameswaran N, 2001, PEPTIDES, V22, P1919, DOI 10.1016/S0196-9781(01)00523-X; Parameswaran N, 2006, TRENDS BIOCHEM SCI, V31, P631, DOI 10.1016/j.tibs.2006.09.006; Petrie MC, 2000, J HYPERTENS, V18, P61, DOI 10.1097/00004872-200018010-00009; Qi W, 2011, METABOLISM, V60, P594, DOI 10.1016/j.metabol.2010.07.021; Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; SAMSON WK, 1995, ENDOCRINOLOGY, V136, P2349, DOI 10.1210/en.136.5.2349; SCHNEDL WJ, 1994, DIABETES, V43, P1326, DOI 10.2337/diabetes.43.11.1326; Shimosawa T, 2003, HYPERTENSION, V41, P1080, DOI 10.1161/01.HYP.0000066846.46422.2C; Shimosawa T, 2002, CIRCULATION, V105, P106, DOI 10.1161/hc0102.101399; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Yao X, 2007, AM J MED SCI, V334, P115, DOI 10.1097/MAJ.0b013e31812dfe1e; Zou XJ, 2012, EXP BIOL MED, V237, P1341, DOI 10.1258/ebm.2012.012041	66	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87667	10.1371/journal.pone.0087667	http://dx.doi.org/10.1371/journal.pone.0087667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505304	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200063
J	Zhang, YP; Zheng, Y; Li, DS; Fan, YL				Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin			Transcriptomics and Identification of the Chemoreceptor Superfamily of the Pupal Parasitoid of the Oriental Fruit Fly, Spalangia endius Walker (Hymenoptera: Pteromalidae)	PLOS ONE			English	Article							BACTROCERA-DORSALIS; STABLE FLY; WD-REPEAT; GENE; RESISTANCE; EXPRESSION; DIPTERA; EVOLUTION; PROTEINS; FAMILY	Background: The oriental fruit fly, Bactrocera dorsalis Hendel, causes serious losses to fruit production and is one of the most economically important pests in many countries, including China, Spalangia endius Walker is a pupal parasitoid of various dipteran hosts, and may be considered a potentially important ectoparasitic pupal parasitoid of B. dorsalis. However, lack of genetic information on this organism is an obstacle to understanding the mechanisms behind its interaction with this host. Analysis of the S. endius transcriptome is essential to extend the resources of genetic information on this species and, to support studies on S. endius on the host B. dorsalis. Methodology/Principal Findings: We performed de novo assembly RNA-seq of S. endius. We obtained nearly 10 Gbp of data using a HiSeq platform, and 36319 high-quality transcripts using Trinity software. A total of 22443 (61.79%) unigenes were aligned to homologous sequences in the jewel wasp and honeybee (Apis florae) protein set from public databases. A total of 10037 protein domains were identified in 7892 S. endius transcripts using HMMER3 software. We identified expression of six gustatory receptor and 21 odorant receptor genes in the sample, with only one gene having a high expression level in each family. The other genes had a low expression level, including two genes regulated by splicing. This result may be due to the wasps being kept under laboratory conditions. Additionally, a total of 3727 SSR markers were predicted, which could facilitate the identification of polymorphisms and functional genes within wasp populations. Conclusion/Significance: This transcriptome greatly improves our genetic understanding of S. endius and provides a large number of gene sequences for further study.	[Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Prov Key Lab High Technol Plant Protect, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuping; Zheng, Yuan; Li, Dunsong; Fan, Yilin] Guangdong Acad Agr Sci, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences; Guangdong Academy of Agricultural Sciences	Li, DS (corresponding author), Guangdong Acad Agr Sci, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China.	dsli@gdppri.cn			National natural science foundation of China [31101492]	National natural science foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National natural science foundation of China (31101492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005651; [Anonymous], FRUIT FLIES EC IMPOR; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blow NS, 2005, PLOS PATHOG, V1, P92, DOI 10.1371/journal.ppat.0010008; Chen B, 2005, GENE, V347, P115, DOI 10.1016/j.gene.2004.12.026; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Clancy DW, 1950, P HAWAII ENTOMOL SOC, V14, P25; CLAUSEN C. P., 1965, US DEP AGR TECH BULL, V1322, P1; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Consoli FL, 2004, COMP BIOCHEM PHYS A, V138, P229, DOI 10.1016/j.cbpb.2004.04.002; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Glass Roger I., 1992, P129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; GUT LJ, 1994, ENTOMOPHAGA, V39, P41, DOI 10.1007/BF02373493; HOGSETTE JA, 1994, ENVIRON ENTOMOL, V23, P778, DOI 10.1093/ee/23.3.778; Hsu J. C, 2002, Plant Protection Bulletin (Taichung), V44, P303; Hsu JC, 2004, J ECON ENTOMOL, V97, P1682, DOI 10.1603/0022-0493-97.5.1682; Hsu JC, 2006, INSECT BIOCHEM MOLEC, V36, P396, DOI 10.1016/j.ibmb.2006.02.002; Hsu JuChun, 2000, Chinese Journal of Entomology, V20, P109; Jin T, 2010, PESTIC BIOCHEM PHYS, V96, P1, DOI 10.1016/j.pestbp.2009.07.013; Kitthawee Sangvorn, 2004, ScienceAsia, V30, P391, DOI 10.2306/scienceasia1513-1874.2004.30.391; Klug Aaron, 2010, Annu Rev Biochem, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Ladbury JE, 2007, ACTA CRYSTALLOGR D, V63, P26, DOI 10.1107/S09074449060; Lao C, 2009, MOD AGR SCI TECH, V16, P118; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Maier D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-74; Mayer BJ, 2001, J CELL SCI, V114, P1253; McCart C, 2008, PEST MANAG SCI, V64, P639, DOI 10.1002/ps.1567; McNeil GP, 2001, GENETICS, V159, P229; MEYER JA, 1991, ENVIRON ENTOMOL, V20, P915, DOI 10.1093/ee/20.3.915; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noguchi H, 2003, INSECT BIOCHEM MOLEC, V33, P209, DOI 10.1016/S0965-1748(02)00192-3; Ogura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008030; Pannebakker BA, 2008, ENTOMOL EXP APPL, V127, P48, DOI 10.1111/j.1570-7458.2008.00666.x; Perez-Maluf R, 2008, PHYSIOL ENTOMOL, V33, P226, DOI 10.1111/j.1365-3032.2008.00636.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; SCHMIDT C D, 1978, Southwestern Entomologist, V3, P69; Schurmann D, 2009, NATURWISSENSCHAFTEN, V96, P383, DOI 10.1007/s00114-008-0490-9; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stanewsky R, 1996, GENETICS, V143, P259; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wee SL, 2007, CHEMOECOLOGY, V17, P81, DOI 10.1007/s00049-006-0363-7; Wu WY, 2007, J INSECT PHYSIOL, V53, P509, DOI 10.1016/j.jinsphys.2007.02.003; Xue R., 1989, Chinese Journal of Biological Control, V5, P52; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; [詹予忠 ZHAN Yuzhong], 2007, [郑州大学学报. 工学版, Journal of Zhengzhou University. Engineering Science], V28, P20; Zhang B, 2000, J MOL BIOL, V299, P1121, DOI 10.1006/jmbi.2000.3803; Zhang Yu-ping, 2009, Yingyong Shengtai Xuebao, V20, P381; Zhang YuPing, 2008, Journal of Huazhong Agricultural University, V27, P456	68	12	17	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87800	10.1371/journal.pone.0087800	http://dx.doi.org/10.1371/journal.pone.0087800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505315	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200073
J	Bruns, P; Camargo, CJ; Campanella, H; Esteve, J; Dinse, HR; Roder, B				Bruns, Patrick; Camargo, Carlos J.; Campanella, Humberto; Esteve, Jaume; Dinse, Hubert R.; Roeder, Brigitte			Tactile Acuity Charts: A Reliable Measure of Spatial Acuity	PLOS ONE			English	Article							BLIND BRAILLE READERS; SOMATOSENSORY CORTEX; LIFE-SPAN; DISCRIMINATION PERFORMANCE; 2-POINT DISCRIMINATION; GRATING ORIENTATION; TEXTURE-PERCEPTION; NEURAL MECHANISMS; VISUAL-CORTEX; DOT PATTERNS	For assessing tactile spatial resolution it has recently been recommended to use tactile acuity charts which follow the design principles of the Snellen letter charts for visual acuity and involve active touch. However, it is currently unknown whether acuity thresholds obtained with this newly developed psychophysical procedure are in accordance with established measures of tactile acuity that involve passive contact with fixed duration and control of contact force. Here we directly compared tactile acuity thresholds obtained with the acuity charts to traditional two-point and grating orientation thresholds in a group of young healthy adults. For this purpose, two types of charts, using either Braille-like dot patterns or embossed Landolt rings with different orientations, were adapted from previous studies. Measurements with the two types of charts were equivalent, but generally more reliable with the dot pattern chart. A comparison with the two-point and grating orientation task data showed that the test-retest reliability of the acuity chart measurements after one week was superior to that of the passive methods. Individual thresholds obtained with the acuity charts agreed reasonably with the grating orientation threshold, but less so with the two-point threshold that yielded relatively distinct acuity estimates compared to the other methods. This potentially considerable amount of mismatch between different measures of tactile acuity suggests that tactile spatial resolution is a complex entity that should ideally be measured with different methods in parallel. The simple test procedure and high reliability of the acuity charts makes them a promising complement and alternative to the traditional two-point and grating orientation thresholds.	[Bruns, Patrick; Roeder, Brigitte] Univ Hamburg, Hamburg, Germany; [Camargo, Carlos J.; Campanella, Humberto; Esteve, Jaume] CSIC, Ctr Nacl Microelect, Inst Microelect Barcelona, Bellaterra, Spain; [Dinse, Hubert R.] Ruhr Univ Bochum, Neural Plast Lab, Inst Neuroinformat, Bochum, Germany	University of Hamburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Microelectronica (CNM); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); Ruhr University Bochum	Bruns, P (corresponding author), Univ Hamburg, Hamburg, Germany.	patrick.bruns@uni-hamburg.de	Bruns, Patrick/AAT-6268-2020; Esteve, Jaume/O-6493-2016	Bruns, Patrick/0000-0002-2977-8874; Esteve, Jaume/0000-0001-9440-7984; dinse, hubert/0000-0001-9024-0451	European Community through the NOMS project [228916]; Deutsche Forschungsgemeinschaft (DFG) [SFB 874]	European Community through the NOMS project; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the European Community's Seventh Framework Programme (grant agreement 228916) through the NOMS project (www.noms-project.eu) and the Deutsche Forschungsgemeinschaft (DFG) SFB 874 (to HRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary F, 2009, NEUROPSYCHOLOGIA, V47, P2037, DOI 10.1016/j.neuropsychologia.2009.03.014; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bar-Cohen Y, 2009, DYNAMIC BRAILLE, P12; Bensmaia SJ, 2006, J NEUROPHYSIOL, V95, P1783, DOI 10.1152/jn.00878.2005; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bleyenheuft Y, 2007, SOMATOSENS MOT RES, V24, P111, DOI 10.1080/08990220701496639; Brown PB, 2004, BRAIN RES, V1011, P14, DOI 10.1016/j.brainres.2004.03.009; Camargo CJ, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/7/075009; Craig JC, 1999, SOMATOSENS MOT RES, V16, P197, DOI 10.1080/08990229970456; Craig JC, 1998, SOMATOSENS MOT RES, V15, P29; Craig JC, 2000, CURR DIR PSYCHOL SCI, V9, P29, DOI 10.1111/1467-8721.00054; Dinse H R, 2001, Prog Brain Res, V130, P155; Dinse HR, 2003, SCIENCE, V301, P91, DOI 10.1126/science.1085423; Dinse HR, 2010, ENCY PERCEPTION, V1, P21; Dinse HR, 2006, ANN NEUROL, V60, P88, DOI 10.1002/ana.20862; Essock EA, 1997, J EXP PSYCHOL HUMAN, V23, P515, DOI 10.1037/0096-1523.23.2.515; Facchini S, 2003, NEUROLOGY, V60, P1998, DOI 10.1212/01.WNL.0000068026.15208.D0; Gastwirth JL, 2009, STAT SCI, V24, P343, DOI 10.1214/09-STS301; Gibson GO, 2006, EXP BRAIN RES, V170, P172, DOI 10.1007/s00221-005-0200-1; Gibson GO, 2005, PERCEPT PSYCHOPHYS, V67, P1061, DOI 10.3758/BF03193632; Godde B, 2000, J NEUROSCI, V20, P1597; Goldreich D, 2003, J NEUROSCI, V23, P3439; Goldreich Daniel, 2009, J Vis Exp, DOI 10.3791/1374; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Hsiao SS, 2002, BEHAV BRAIN RES, V135, P93, DOI 10.1016/S0166-4328(02)00160-2; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; JOHANSSON RS, 1980, BRAIN RES, V184, P353, DOI 10.1016/0006-8993(80)90804-5; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; JOHNSON KO, 1981, J PHYSIOL-LONDON, V310, P117, DOI 10.1113/jphysiol.1981.sp013540; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kalisch T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-58; Kalisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030420; Kalisch T, 2009, CEREB CORTEX, V19, P1530, DOI 10.1093/cercor/bhn190; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; Kerr CE, 2008, EXP BRAIN RES, V188, P317, DOI 10.1007/s00221-008-1409-6; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Lederman SJ, 2009, ATTEN PERCEPT PSYCHO, V71, P1439, DOI 10.3758/APP.71.7.1439; Legge GE, 2008, PERCEPT PSYCHOPHYS, V70, P1471, DOI 10.3758/PP.70.8.1471; Leon-Sarmiento FE, 2008, NEUROSCI LETT, V441, P332, DOI 10.1016/j.neulet.2008.06.016; Libouton X, 2010, BEHAV BRAIN RES, V208, P473, DOI 10.1016/j.bbr.2009.12.017; Lissek S, 2009, CURR BIOL, V19, P837, DOI 10.1016/j.cub.2009.03.065; LOOMIS JM, 1982, PERCEPT PSYCHOPHYS, V31, P41, DOI 10.3758/BF03206199; Lundborg G, 2004, J HAND SURG-BRIT EUR, V29B, P418, DOI 10.1016/j.jhsb.2004.02.008; Peters RM, 2009, J NEUROSCI, V29, P15756, DOI 10.1523/JNEUROSCI.3684-09.2009; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1192, DOI 10.1152/jn.1981.46.6.1192; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; Pleger B, 2003, NEURON, V40, P643, DOI 10.1016/S0896-6273(03)00677-9; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Raasch TW, 1998, OPTOMETRY VISION SCI, V75, P342, DOI 10.1097/00006324-199805000-00024; Ragert P, 2004, EUR J NEUROSCI, V19, P473, DOI 10.1111/j.0953-816X.2003.03142.x; Ragert P, 2008, CLIN NEUROPHYSIOL, V119, P805, DOI 10.1016/j.clinph.2007.12.001; Reuter EM, 2012, EXP BRAIN RES, V216, P287, DOI 10.1007/s00221-011-2931-5; Rosser DA, 2004, INVEST OPHTH VIS SCI, V45, P1076, DOI 10.1167/iovs.03-1320; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Sathian K, 1997, NEUROLOGY, V49, P168, DOI 10.1212/WNL.49.1.168; Sathian K, 1996, NEUROLOGY, V46, P1464, DOI 10.1212/WNL.46.5.1464; Simoes-Franklin C, 2011, HUM BRAIN MAPP, V32, P1067, DOI 10.1002/hbm.21091; SRINIVASAN MA, 1995, J NEUROPHYSIOL, V73, P88, DOI 10.1152/jn.1995.73.1.88; STEVENS JC, 1995, SOMATOSENS MOT RES, V12, P29, DOI 10.3109/08990229509063140; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Stevens JC, 1996, J EXP PSYCHOL-APPL, V2, P91, DOI 10.1037/1076-898X.2.2.91; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; Tong J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00579; Van Boven RW, 2000, NEUROLOGY, V54, P2230; VANBOVEN RW, 1994, BRAIN, V117, P149, DOI 10.1093/brain/117.1.149; VANBOVEN RW, 1994, NEUROLOGY, V44, P2361, DOI 10.1212/WNL.44.12.2361; Vega-Bermudez F, 2004, PERCEPT PSYCHOPHYS, V66, P60, DOI 10.3758/BF03194861; Vega-Bermudez F, 2001, NEUROLOGY, V56, P1389, DOI 10.1212/WNL.56.10.1389; Weber AI, 2013, P NATL ACAD SCI USA, V110, P17107, DOI 10.1073/pnas.1305509110; Wiest MC, 2010, J NEUROPHYSIOL, V104, P300, DOI 10.1152/jn.00194.2010; Wong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025277; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139	77	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87384	10.1371/journal.pone.0087384	http://dx.doi.org/10.1371/journal.pone.0087384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504346	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800030
J	Steele, S; Taft-Benz, S; Kawula, T				Steele, Shaun; Taft-Benz, Sharon; Kawula, Thomas			A Method for Functional Trans-Complementation of Intracellular Francisella tularensis	PLOS ONE			English	Article							PATHOGENICITY ISLAND; HUMAN MACROPHAGES; SCHU S4; VIRULENCE; ESCAPE; PATHOGENESIS; ATTENUATION; SUPPRESSION; PHAGOSOMES; NOVICIDA	Francisella tularensis is a highly infectious bacterial pathogen that invades and replicates within numerous host cell types. After uptake, F. tularensis bacteria escape the phagosome, replicate within the cytosol, and suppress cytokine responses. However, the mechanisms employed by F. tularensis to thrive within host cells are mostly unknown. Potential F. tularensis mutants involved in host-pathogen interactions are typically discovered by negative selection screens for intracellular replication or virulence. Mutants that fulfill these criteria fall into two categories: mutants with intrinsic intracellular growth defects and mutants that fail to modify detrimental host cell processes. It is often difficult and time consuming to discriminate between these two possibilities. We devised a method to functionally trans-complement and thus identify mutants that fail to modify the host response. In this assay, host cells are consistently and reproducibly infected with two different F. tularensis strains by physically tethering the bacteria to antibody-coated beads. To examine the efficacy of this protocol, we tested phagosomal escape, cytokine suppression, and intracellular replication for F. tularensis Delta ripA and Delta pdpC. Delta ripA has an intracellular growth defect that is likely due to an intrinsic defect and fails to suppress IL-1 beta secretion. In the co-infection model, Delta ripA was unable to replicate in the host cell when wild-type bacteria infected the same cell, but cytokine suppression was rescued. Therefore, Delta ripA intracellular growth is due to an intrinsic bacterial defect while cytokine secretion results from a failed host-pathogen interaction. Likewise, Delta pdpC is deficient for phagosomal escape, intracellular survival and suppression of IL-1 beta secretion. Wild-type bacteria that entered through the same phagosome as Delta pdpC rescued all of these phenotypes, indicating that Delta pdpC failed to properly manipulate the host. In summary, functional trans-complementation using bead-bound bacteria co-infections is a method to rapidly identify mutants that fail to modify a host response. Francisella tularensis is a facultative intracellular bacterial pathogen and is the causative agent of the disease tularemia. F. tularensis enters host cells through phagocytosis, escapes the phagosome, and replicates in the host cell cytosol while suppressing cytokine secretion [1-4]. Although substantial progress has been made in understanding the intracellular life cycle of F. tularensis, the F. tularensis proteins responsible for manipulating many host cell pathways are unknown. Identifying novel host-pathogen effector proteins is difficult because there is no rapid method to reliably distinguish between bacterial proteins that modify host processes and proteins that are involved in bacterial processes that are required for the bacteria to survive or replicate in the intracellular environment. The ability to identify mutants that are deficient for host-pathogen interactions is important because it can aid in prioritizing the investigation of genes of interest and in downstream experimental design. Moreover, certain mutant phenotypes, such as decreased phagosomal escape, hinder investigation of other potential phenotypes. A method to specifically complement these phenotypes would allow for further characterizations of certain F. tularensis mutants. Thus we sought to develop a method to easily identify and functionally complement mutants that are deficient for interactions with the host.	[Steele, Shaun; Taft-Benz, Sharon; Kawula, Thomas] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Kawula, T (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	Kawula@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , UNC Flow Cytometry Core/AGU-9839-2022		NIH [A1082870]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant A1082870 to THK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Broms JE, 2011, INFECT IMMUN, V79, P3683, DOI 10.1128/IAI.01344-10; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Fuller JR, 2008, INFECT IMMUN, V76, P4934, DOI 10.1128/IAI.00475-08; Fuller JR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-216; GREISMAN SE, 1963, J CLIN INVEST, V42, P1064, DOI 10.1172/JCI104792; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Huang MTH, 2010, J IMMUNOL, V185, P5476, DOI 10.4049/jimmunol.1002154; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lindgren M, 2013, INFECT IMMUN, V81, P2076, DOI 10.1128/IAI.00275-13; Long ME, 2013, INFECT IMMUN, V81, P850, DOI 10.1128/IAI.00822-12; LoVullo ED, 2009, MICROBIOL-SGM, V155, P1152, DOI 10.1099/mic.0.022491-0; LoVullo ED, 2009, FEMS MICROBIOL LETT, V291, P95, DOI 10.1111/j.1574-6968.2008.01440.x; Mortensen BL, 2010, INFECT IMMUN, V78, P5022, DOI 10.1128/IAI.00544-10; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Steele S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003562; Straskova A, 2012, MICROBES INFECT, V14, P177, DOI 10.1016/j.micinf.2011.08.017	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88194	10.1371/journal.pone.0088194	http://dx.doi.org/10.1371/journal.pone.0088194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505427	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300071
J	Wareham, AS; Tree, JA; Marsh, PD; Butcher, PD; Dennis, M; Sharpe, SA				Wareham, Alice S.; Tree, Julia A.; Marsh, Philip D.; Butcher, Philip D.; Dennis, Mike; Sharpe, Sally A.			Evidence for a Role for Interleukin-17, Th17 Cells and Iron Homeostasis in Protective Immunity against Tuberculosis in Cynomolgus Macaques	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; TRANSFERRIN RECEPTOR; ACTIVE TUBERCULOSIS; HOST RESPONSE; GUINEA-PIGS; T-CELLS; BCG; EXPRESSION; INFECTION	Tuberculosis (TB) remains a major global public health problem. The only vaccine, BCG, gives variable protection, especially in adults, so several new vaccines are in clinical trials. There are no correlates of protective immunity to TB; therefore vaccines progress through lengthy and expensive pre-clinical assessments and human trials. Correlates of protection could act as early end-points during clinical trials, accelerating vaccine development and reducing costs. A genome-wide microarray was utilised to identify potential correlates of protection and biomarkers of disease induced post-BCG vaccination and post-Mycobacterium tuberculosis challenge in PPD-stimulated peripheral blood mononuclear cells from cynomolgus macaques where the outcome of infection was known. Gene expression post BCG-vaccination and post challenge was compared with gene expression when the animals were naive. Differentially expressed genes were identified using a moderated T test with Benjamini Hochberg multiple testing correction. After BCG vaccination and six weeks post-M. tuberculosis challenge, up-regulation of genes related to a Th1 and Th17 response was observed in disease controllers. At post-mortem, RT-PCR revealed an up-regulation of iron regulatory genes in animals that developed TB and down-regulation of these genes in disease controllers, indicating the ability to successfully withhold iron may be important in the control of TB disease. The induction of a balanced Th1 and Th17 response, together with expression of effector cytokines, such as IFNG, IL2, IL17, IL21 and IL22, could be used as correlates of a protective host response.	[Wareham, Alice S.; Tree, Julia A.; Marsh, Philip D.; Dennis, Mike; Sharpe, Sally A.] Publ Hlth England, Microbiol Serv, Salisbury, Wilts, England; [Butcher, Philip D.] Univ London St Georges Hosp, Sch Med, Dept Med Microbiol, London SW17 0RE, England	Public Health England; St Georges University London	Wareham, AS (corresponding author), Publ Hlth England, Microbiol Serv, Salisbury, Wilts, England.	alice.wareham@phe.gov.uk		Butcher, Philip/0000-0003-1223-9097	Health Protection Agency	Health Protection Agency	The study was funded by a Health Protection Agency Studentship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bold TD, 2012, J IMMUNOL, V189, P2530, DOI 10.4049/jimmunol.1200994; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; BYRD TF, 1989, J CLIN INVEST, V83, P1457, DOI 10.1172/JCI114038; BYRD TF, 1993, J CLIN INVEST, V91, P969, DOI 10.1172/JCI116318; CAHILL J, 1984, INT J IMMUNOPHARMACO, V6, P9, DOI 10.1016/0192-0561(84)90029-8; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Cortes EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011319; Cowan J, 2012, CLIN EXP IMMUNOL, V167, P317, DOI 10.1111/j.1365-2249.2011.04520.x; Desel C, 2011, J INFECT DIS, V204, P1573, DOI 10.1093/infdis/jir592; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Fletcher HA, 2007, CURR MOL MED, V7, P319, DOI 10.2174/156652407780598520; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gopal R, 2013, MUCOSAL IMMUNOL, V6, P972, DOI 10.1038/mi.2012.135; Gruenheid S, 1999, J EXP MED, V189, P831, DOI 10.1084/jem.189.5.831; Jeevan A, 2009, IMMUNOLOGY, V128, pe296, DOI 10.1111/j.1365-2567.2008.02962.x; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; MURRAY JL, 1983, J CLIN IMMUNOL, V3, P268, DOI 10.1007/BF00915351; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Sharpe SA, 2009, TUBERCULOSIS, V89, P405, DOI 10.1016/j.tube.2009.09.002; Thom RE, 2012, VACCINE, V30, P3159, DOI 10.1016/j.vaccine.2012.03.008; Tree JA, 2006, INFECT IMMUN, V74, P1436, DOI 10.1128/IAI.74.2.1436-1441.2006; Tree JA, 2010, VACCINE, V28, P7979, DOI 10.1016/j.vaccine.2010.09.061; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; WHO, 2011, WHO GLOBAL TUBERCULO; Wozniak TM, 2010, INFECT IMMUN, V78, P4187, DOI 10.1128/IAI.01392-09; Xing Z, 2000, J LEUKOCYTE BIOL, V68, P897; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332	43	36	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88149	10.1371/journal.pone.0088149	http://dx.doi.org/10.1371/journal.pone.0088149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505407	Green Published, gold			2022-12-27	WOS:000336971300059
J	Zeng, LL; Yang, Y; Hu, YJ; Sun, Y; Du, ZD; Xie, Z; Zhou, T; Kong, WJ				Zeng, Lingling; Yang, Yang; Hu, Yujuan; Sun, Yu; Du, Zhengde; Xie, Zhen; Zhou, Tao; Kong, Weijia			Age-Related Decrease in the Mitochondrial Sirtuin Deacetylase Sirt3 Expression Associated with ROS Accumulation in the Auditory Cortex of the Mimetic Aging Rat Model	PLOS ONE			English	Article							4977 BP DELETION; SUPEROXIDE-DISMUTASE; DNA-DAMAGE; OXIDATIVE DAMAGE; SKELETAL-MUSCLE; CELL-DEATH; METABOLISM; RESTRICTION; DEFICIENCY; PROTEINS	Age-related dysfunction of the central auditory system, also known as central presbycusis, can affect speech perception and sound localization. Understanding the pathogenesis of central presbycusis will help to develop novel approaches to prevent or treat this disease. In this study, the mechanisms of central presbycusis were investigated using a mimetic aging rat model induced by chronic injection of D-galactose (D-Gal). We showed that malondialdehyde (MDA) levels were increased and manganese superoxide dismutase (SOD2) activity was reduced in the auditory cortex in natural aging and D-Gal-induced mimetic aging rats. Furthermore, mitochondrial DNA (mtDNA) 4834 bp deletion, abnormal ultrastructure and cell apoptosis in the auditory cortex were also found in natural aging and D-Gal mimetic aging rats. Sirt3, a mitochondrial NAD+dependent deacetylase, has been shown to play a crucial role in controlling cellular reactive oxygen species (ROS) homeostasis. However, the role of Sirt3 in the pathogenesis of age-related central auditory cortex deterioration is still unclear. Here, we showed that decreased Sirt3 expression might be associated with increased SOD2 acetylation, which negatively regulates SOD2 activity. Oxidative stress accumulation was likely the result of low SOD2 activity and a decline in ROS clearance. Our findings indicate that Sirt3 might play an essential role, via the mediation of SOD2, in central presbycusis and that manipulation of Sirt3 expression might provide a new approach to combat aging and oxidative stress-related diseases.	[Zeng, Lingling; Yang, Yang; Hu, Yujuan; Sun, Yu; Xie, Zhen; Zhou, Tao; Kong, Weijia] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Du, Zhengde] Guangdong Med Coll, Dept Otorhinolaryngol, Nanshan Affiliated Hosp, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Guangdong Medical University	Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	entwjkong@hust.edu.cn	Sun, Yu/AAX-9942-2021	Kong, Wei-Jia/0000-0001-5410-2297; Sun, Yu/0000-0002-1771-3715	Major State Basic Research Development Program of China (973 Program) [2011CB504504]; National twelfth-Five Year Research Program of China [2012BAI12B02]; National Natural Science Foundation of China [81230021, 30872865, 30672309]; National Nature Science Foundation of China [81200745, 81000409]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National twelfth-Five Year Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (No. 2011CB504504), the National twelfth-Five Year Research Program of China (No. 2012BAI12B02), the National Natural Science Foundation of China (No. 81230021, No. 30872865 and No. 30672309), the National Nature Science Foundation of China (No. 81200745), National Nature Science Foundation of China (No. 81000409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T; Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289; CUATRECASAS P, 1966, SCIENCE, V153, P549, DOI 10.1126/science.153.3735.549; Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3; D'Aquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Engle JR, 2012, FRONT AGING NEUROSCI, V4, DOI [10.3389/fnagi.2012.00036, 10.3389/fnagi.2012.00010]; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788; Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Jordens RG, 1999, NEUROCHEM RES, V24, P227, DOI 10.1023/A:1022510004220; King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001; Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008; Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lei H, 2003, ACTA PHARMACOL SIN, V24, P230; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014; Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005; Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218; McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4; Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498; Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; Reddy, 2009, CNS SPECTRUMS, V14, P16; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225; Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002; Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126	65	80	84	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88019	10.1371/journal.pone.0088019	http://dx.doi.org/10.1371/journal.pone.0088019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505357	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300037
J	Lee, D; Shenoy, S; Nigatu, Y; Plotkin, M				Lee, David; Shenoy, Shantheri; Nigatu, Yezina; Plotkin, Matt			Id Proteins Regulate Capillary Repair and Perivascular Cell Proliferation following Ischemia-Reperfusion Injury	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; PERITUBULAR CAPILLARIES; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; EXPRESSION; ANGIOGENESIS; MICE; DIFFERENTIATION; FIBROSIS; ABLATION	Acute kidney injury (AKI) results in microvascular damage that if not normally repaired, may lead to fibrosis. The Id1 and 3 proteins have a critical role in promoting angiogenesis during development, tumor growth and wound repair by functioning as dominant negative regulators of bHLH transcription factors. The goal of this study was to determine if Id proteins regulate microvascular repair and remodeling and if increased Id1 expression results in decreased capillary loss following AKI. The effect of changes in Id expression in vivo was examined using Id1-/-, Id3RFP/+ (Id1/Id3 KO) and Tek (Tie2)-rtTA, TRE-lacz/TRE Id1 (TRE Id1) mice with doxycycline inducible endothelial Id1 and beta-galactosidase expression. Id1 and 3 were co-localized in endothelial cells in normal adult kidneys and protein levels were increased at day 3 following ischemia-reperfusion injury (IRI) and contralateral nephrectomy. Id1/Id3 KO mice had decreased baseline capillary density and pericyte coverage and increased tubular damage following IRI but decreased interstitial cell proliferation and fibrosis compared with WT littermates. No compensatory increase in kidney size occurred in KO mice resulting in increased creatinine compared with WT and TRE Id1 mice. TRE Id1 mice had no capillary rarefaction within 1 week following IRI in comparison with WT littermates. TRE Id1 mice had increased proliferation of PDGFR beta positive interstitial cells and medullary collagen deposition and developed capillary rarefaction and albuminuria at later time points. These differences were associated with increased Angiopoietin 1 (Ang1) and decreased Ang2 expression in TRE Id1 mice. Examination of gene expression in microvascular cells isolated from WT, Id1/Id3 KO and TRE Id1 mice showed increased Ang1 and alpha SMA in Id1 overexpressing cells and decreased pericyte markers in cells from KO mice. These results suggest that increased Id levels following AKI result in microvascular remodeling associated with increased fibrosis.	[Lee, David; Shenoy, Shantheri; Nigatu, Yezina; Plotkin, Matt] New York Med Coll, Dept Med, Renal Res Div, Valhalla, NY 10595 USA	New York Medical College	Plotkin, M (corresponding author), New York Med Coll, Dept Med, Renal Res Div, Valhalla, NY 10595 USA.	matthew_plotkin@nymc.edu		NOIRI, Eisei/0000-0002-9515-7582	New York Medical College	New York Medical College	This work was supported by an intramural grant from New York Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; FINE LG, 1989, ANNU REV PHYSIOL, V51, P19, DOI 10.1146/annurev.ph.51.030189.000315; Flyvbjerg A, 1999, KIDNEY INT, V56, P2048, DOI 10.1046/j.1523-1755.1999.00776.x; Horbelt M, 2007, AM J PHYSIOL-RENAL, V293, pF688, DOI 10.1152/ajprenal.00452.2006; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kaneko K, 2008, ANN THORAC SURG, V85, P2090, DOI 10.1016/j.athoracsur.2008.02.027; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Long DA, 2001, J AM SOC NEPHROL, V12, P2721, DOI 10.1681/ASN.V12122721; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Moya IM, 2012, DEV CELL, V22, P501, DOI 10.1016/j.devcel.2012.01.007; Nishiyama K, 2005, CIRCULATION, V112, P2840, DOI 10.1161/CIRCULATIONAHA.104.516898; O'Brien CA, 2012, CANCER CELL, V21, P777, DOI 10.1016/j.ccr.2012.04.036; Pitera JE, 2004, AM J PATHOL, V165, P1895, DOI 10.1016/S0002-9440(10)63242-7; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Satyanarayana A, 2012, FASEB J, V26, P309, DOI 10.1096/fj.11-190892; Simon N, 1999, AM J PHYSIOL-RENAL, V276, pF382, DOI 10.1152/ajprenal.1999.276.3.F382; Sobczak M, 2010, J VIS EXP; Song XB, 2011, ACTA BIOCH BIOPH SIN, V43, P796, DOI 10.1093/abbs/gmr074; Suh HC, 2009, BLOOD, V114, P1186, DOI 10.1182/blood-2008-09-179788; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Teng PI, 2002, PHYSIOL GENOMICS, V11, P99, DOI 10.1152/physiolgenomics.00059.2002; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Villanueva S, 2006, AM J PHYSIOL-REG I, V290, pR861, DOI 10.1152/ajpregu.00384.2005; Willam C, 2000, CIRC RES, V87, P370; Wolstein JM, 2010, AM J PHYSIOL-RENAL, V299, pF1486, DOI 10.1152/ajprenal.00378.2010; Yan W, 1997, MOL CELL BIOL, V17, P7317, DOI 10.1128/MCB.17.12.7317; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang HM, 2007, AM J PATHOL, V171, P1113, DOI 10.2353/ajpath.2007.070226; Zhao QS, 2011, DEV BIOL, V349, P53, DOI 10.1016/j.ydbio.2010.10.004	35	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88417	10.1371/journal.pone.0088417	http://dx.doi.org/10.1371/journal.pone.0088417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516656	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400068
J	Patarroyo, ME; Alba, MP; Curtidor, H; Vanegas, M; Almonacid, H; Patarroyo, MA				Patarroyo, Manuel E.; Patricia Alba, Martha; Curtidor, Hernando; Vanegas, Magnolia; Almonacid, Hannia; Patarroyo, Manuel A.			Using the PfEMP1 Head Structure Binding Motif to Deal a Blow at Severe Malaria	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; PLASMODIUM-FALCIPARUM; CHONDROITIN-SULFATE; ALPHA-DOMAINS; VACCINE; EXPRESSION; PEPTIDES; ANTIBODY; REVEALS; DIVERSE	Plasmodium falciparum (Pf) malaria causes 200 million cases worldwide, 8 million being severe and complicated leading to similar to 1 million deaths and similar to 100,000 abortions annually. Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) has been implicated in cytoadherence and infected erythrocyte rosette formation, associated with cerebral malaria; chondroitin sulphate-A attachment and infected erythrocyte sequestration related to pregnancy-associated malaria and other severe forms of disease. An endothelial cell high activity binding peptide is described in several of this similar to 300 kDa hypervariable protein's domains displaying a conserved motif (GACxPxRRxxLC); it established H-bonds with other binding peptides to mediate red blood cell group A and chondroitin sulphate attachment. This motif (when properly modified) induced PfEMP1-specific strain-transcending, fully-protective immunity for the first time in experimental challenge in Aotus monkeys, opening the way forward for a long sought-after vaccine against severe malaria.	[Patarroyo, Manuel E.; Patricia Alba, Martha; Curtidor, Hernando; Vanegas, Magnolia; Almonacid, Hannia; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Patricia Alba, Martha; Curtidor, Hernando; Vanegas, Magnolia; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, ME (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia.	mepatarr@gmail.com	Patarroyo, Manuel A/I-8046-2016; Curtidor, Hernando/I-7997-2016; Vanegas, Magnolia/I-7968-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Curtidor, Hernando/0000-0002-6556-7812; Vanegas, Magnolia/0000-0001-7722-4115; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Alba, Martha patricia/0000-0003-0641-5162				Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Badaut C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011276; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Cifuentes G, 2007, BIOCHEM BIOPH RES CO, V360, P149, DOI 10.1016/j.bbrc.2007.06.024; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Curtidor H, 2011, CURR MED CHEM, V18, P4470, DOI 10.2174/092986711797287575; Curtidor H, 2007, BIOL CHEM, V388, P25, DOI 10.1515/BC.2007.003; D'Ombrain MC, 2007, CELL HOST MICROBE, V2, P130, DOI 10.1016/j.chom.2007.06.012; Patarroyo ME, 2011, CHEM REV, V111, P3459, DOI 10.1021/cr100223m; Espejo F, 2001, ANGEW CHEM INT EDIT, V40, P4654, DOI 10.1002/1521-3773(20011217)40:24<4654::AID-ANIE4654>3.0.CO;2-F; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gangnard S, 2013, J MOL BIOL, V425, P1697, DOI 10.1016/j.jmb.2013.02.014; Garcia JE, 2005, PEPTIDES, V26, P1133, DOI 10.1016/j.peptides.2005.01.013; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Lavstsen T, 2012, P NATL ACAD SCI USA, V109, pE1791, DOI 10.1073/pnas.1120455109; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research (US) and National Academies Press (US), 2011, GUIDE CARE USE LAB A; Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307; Oguariri RM, 2003, PARASITOL RES, V90, P467, DOI 10.1007/s00436-003-0884-8; Oguariri RM, 2001, INFECT IMMUN, V69, P7603, DOI 10.1128/IAI.69.12.7603-7609.2001; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; RODRIGUEZ R, 1990, AM J TROP MED HYG, V43, P339, DOI 10.4269/ajtmh.1990.43.339; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Zhang QF, 2011, CELL HOST MICROBE, V10, P451, DOI 10.1016/j.chom.2011.09.013	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88420	10.1371/journal.pone.0088420	http://dx.doi.org/10.1371/journal.pone.0088420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516657	Green Published, gold, Green Accepted			2022-12-27	WOS:000330834400069
J	Hasegawa, M; Asano, Y; Endo, H; Fujimoto, M; Goto, D; Ihn, H; Inoue, K; Ishikawa, O; Kawaguchi, Y; Kuwana, M; Ogawa, F; Takahashi, H; Tanaka, S; Sato, S; Takehara, K				Hasegawa, Minoru; Asano, Yoshihide; Endo, Hirahito; Fujimoto, Manabu; Goto, Daisuke; Ihn, Hironobu; Inoue, Katsumi; Ishikawa, Osamu; Kawaguchi, Yasushi; Kuwana, Masataka; Ogawa, Fumihide; Takahashi, Hiroki; Tanaka, Sumiaki; Sato, Shinichi; Takehara, Kazuhiko			Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; L-SELECTIN LEVELS; CELL-ADHESION; P-SELECTIN; LEUKOCYTE RECRUITMENT; CLINICAL CORRELATIONS; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; FIBROTIC PROCESS; SOLUBLE FORMS	Objective: To assess the utility of circulating adhesion molecule levels as a prognostic indicator of disease progression in systemic sclerosis (SSc) patients with early onset disease. Methods: Ninety-two Japanese patients with early onset SSc presenting with diffuse skin sclerosis and/or interstitial lung disease were registered in a multicentre, observational study. Concentrations of intercellular adhesion molecule (ICAM) 21, E-selectin, L-selectin, and P-selectin in serum samples from all patients were measured by enzyme-linked immunosorbent asssay (ELISA). In 39 patients, adhesion molecule levels were measured each year for four years. The ability of baseline adhesion molecule levels to predict subsequent progression and severity in clinical and laboratory features were evaluated statistically. Results: At their first visit, serum levels of ICAM-1, E-selection, P-selectin were significantly elevated and serum L-selectin levels were significantly reduced in patients with SSc compared with healthy controls. Overall, serum ICAM-1 levels at each time point were significantly inversely associated with the % vital capacity (VC) of the same time and subsequent years by univariate analysis. The initial serum ICAM-1 levels were significantly inversely associated with the % VC at the fourth year by multiple regression analysis. The initial serum P-selectin levels were significantly associated with the health assessment questionnaire disability index (HAQ-DI) at the fourth year by multiple regression analysis. Initial adhesion molecule levels were not significantly associated with other clinical features including skin thickness score. Baseline adhesion molecule levels were not significantly associated with subsequent rate of change of clinical parameters. Conclusion: In patients with SSc, serum levels of ICAM-1 and P-selectin may serve as prognostic indicators of respiratory dysfunction and physical disability, respectively. Further longitudinal studies of larger populations are needed to confirm these findings.	[Hasegawa, Minoru] Univ Fukui, Fac Med Sci, Sch Med, Dept Dermatol, Fukui 910, Japan; [Hasegawa, Minoru; Fujimoto, Manabu; Takehara, Kazuhiko] Kanazawa Univ, Sch Med, Dept Dermatol, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 920, Japan; [Asano, Yoshihide; Sato, Shinichi] Univ Tokyo, Dept Dermatol, Grad Sch Med, Bunkyo Ku, Tokyo 113, Japan; [Endo, Hirahito] Toho Univ, Sch Med, Dept Internal Med Omori, Ota Ku, Tokyo, Japan; [Fujimoto, Manabu] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan; [Goto, Daisuke] Univ Tsukuba, Fac Med, Dept Rheumatol, Tsukuba, Ibaraki, Japan; [Ihn, Hironobu] Kumamoto Univ, Sch Life Sci, Dept Dermatol & Plast Surg, Kumamoto, Japan; [Inoue, Katsumi] Kanazawa Univ, Grad Sch Med Sci, Div Rehabil Sci, Kanazawa, Ishikawa, Japan; [Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Dept Dermatol, Maebashi, Gunma 371, Japan; [Kawaguchi, Yasushi] Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo, Japan; [Kuwana, Masataka] Keio Univ, Sch Med, Dept Internal Med,Div Rheumatol, Shinjuku Ku, Tokyo, Japan; [Ogawa, Fumihide] Nagasaki Univ, Grad Sch Biomed Sci, Dept Dermatol, Nagasaki 852, Japan; [Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Sapporo, Hokkaido, Japan; [Tanaka, Sumiaki] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Sagamihara, Kanagawa 228, Japan	University of Fukui; Kanazawa University; University of Tokyo; University of Tsukuba; University of Tsukuba; Kumamoto University; Kanazawa University; Gunma University; Tokyo Women's Medical University; Keio University; Nagasaki University; Sapporo Medical University; Kitasato University	Hasegawa, M (corresponding author), Univ Fukui, Fac Med Sci, Sch Med, Dept Dermatol, Fukui 910, Japan.	minoruha@u-fukui.ac.jp		Hasegawa, Minoru/0000-0003-3738-2682; Fujimoto, Manabu/0000-0002-3062-4872; Ishikawa, Osamu/0000-0002-7655-0610	Ministry of Health, Labor, and Welfare of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by funds for research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM D, 1991, ARTHRITIS RHEUM, V34, P1164, DOI 10.1002/art.1780340913; Andersen GN, 2000, ARTHRITIS RHEUM-US, V43, P1085; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ASA D, 1995, J BIOL CHEM, V270, P11662, DOI 10.1074/jbc.270.19.11662; Ates A, 2004, SCAND J IMMUNOL, V59, P315, DOI 10.1111/j.0300-9475.2004.01389.x; Bhattacharyya S, 2012, NAT REV RHEUMATOL, V8, P42, DOI 10.1038/nrrheum.2011.149; Blann AD, 2003, THROMB RES, V109, P203, DOI 10.1016/S0049-3848(03)00209-3; Blann AD, 1996, BRIT J HAEMATOL, V95, P192, DOI 10.1046/j.1365-2141.1996.7562378.x; Bohgaki T, 2005, ANN RHEUM DIS, V64, P1165, DOI 10.1136/ard.2004.030338; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; CARSON CW, 1993, J RHEUMATOL, V20, P809; CLEMENTS P, 1995, J RHEUMATOL, V22, P1281; Dunne JV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044814; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Furst, 2004, SYSTEMIC SCLEROSIS, P17; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gho YS, 2004, CANCER RES, V59, P5128; GRUSCHWITZ M, 1991, IMMUNOBIOLOGY, V182, P234, DOI 10.1016/S0171-2985(11)80660-1; GRUSCHWITZ MS, 1995, ARTHRITIS RHEUM, V38, P184, DOI 10.1002/art.1780380206; Hamaguchi Y, 2002, AM J PATHOL, V161, P1607, DOI 10.1016/S0002-9440(10)64439-2; Hasegawa M, 2008, FRONT BIOSCI-LANDMRK, V13, P3637, DOI 10.2741/2955; Hasegawa M, 2013, MOD RHEUMATOL, V23, P1076, DOI [10.1007/s10165-012-0795-6, 10.3109/s10165-012-0795-6]; Haught WH, 1996, AM HEART J, V132, P1; Horikawa M, 2006, AM J PATHOL, V169, P740, DOI 10.2353/ajpath.2006.060086; Hou Y, 2010, ANN RHEUM DIS, V69, P249, DOI 10.1136/ard.2008.102624; Hsu E, 2008, AM J PATHOL, V172, P1580, DOI 10.2353/ajpath.2008.071021; Ihn H, 1998, BRIT J RHEUMATOL, V37, P1188; Ihn H, 1997, BRIT J RHEUMATOL, V36, P1270; KIENER H, 1994, CLIN EXP RHEUMATOL, V12, P483; Kusterer K, 1998, AM J PHYSIOL-GASTR L, V275, pG377, DOI 10.1152/ajpgi.1998.275.2.G377; Kuwana M, 2003, J RHEUMATOL, V30, P1253; LEROY EC, 1988, J RHEUMATOL, V15, P202; Matsushita Y, 2007, J IMMUNOL, V179, P698, DOI 10.4049/jimmunol.179.1.698; McEver RP, 1997, J CLIN INVEST, V100, pS97; Musial K, 2005, PEDIATR NEPHROL, V20, P52, DOI 10.1007/s00467-004-1691-x; Otto VI, 2002, J NEUROCHEM, V80, P824, DOI 10.1046/j.0022-3042.2001.00748.x; Pigott R., 1995, BIOCHEM BIOPH RES CO, V187, P584; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Rabquer BJ, 2009, RHEUMATOLOGY, V48, P734, DOI 10.1093/rheumatology/kep091; RIECKMANN P, 1995, J NEUROIMMUNOL, V60, P9, DOI 10.1016/0165-5728(95)00047-6; ROTHLEIN R, 1991, J IMMUNOL, V147, P3788; ROUMM AD, 1984, ARTHRITIS RHEUM, V27, P645, DOI 10.1002/art.1780270607; Schmal H, 1998, J IMMUNOL, V161, P3685; SFIKAKIS PP, 1993, CLIN IMMUNOL IMMUNOP, V68, P88, DOI 10.1006/clin.1993.1100; Sfikakis PP, 1999, CLIN RHEUMATOL, V18, P28, DOI 10.1007/s100670050047; Shimada Y, 2001, CLIN EXP IMMUNOL, V124, P474, DOI 10.1046/j.1365-2249.2001.01514.x; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2005, SEMIN ARTHRITIS RHEU, V35, P35, DOI 10.1016/j.semarthrit.2005.03.005; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; TEDDER TF, 1999, ADV MOL CEL, V28, P65; Tsakadze NL, 2004, AM J PHYSIOL-CELL PH, V287, pC55, DOI 10.1152/ajpcell.00585.2003; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994; Yoshizaki A, 2010, J IMMUNOL, V185, P2502, DOI 10.4049/jimmunol.0901778	56	26	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88150	10.1371/journal.pone.0088150	http://dx.doi.org/10.1371/journal.pone.0088150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516598	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700047
J	Wang, H; Liu, JN; Yin, Y; Wu, J; Wang, Z; Miao, DS; Sun, W				Wang, Hua; Liu, Jingning; Yin, Ying; Wu, Jun; Wang, Zilu; Miao, Dengshun; Sun, Wen			Recombinant Human Parathyroid Hormone Related Protein 1-34 and 1-84 and Their Roles in Osteoporosis Treatment	PLOS ONE			English	Article							PLACENTAL CALCIUM-TRANSPORT; SHORT-TERM TREATMENT; PTH-RELATED PROTEIN; EXTRACELLULAR CALCIUM; BONE-FORMATION; PEPTIDE PTHRP; VITAMIN-D; SKELETAL DEVELOPMENT; RAT OSTEOCLASTS; IN-VITRO	Osteoporosis is a common disorder characterized by compromised bone strength that predisposes patients to increased fracture risk. Parathyroid hormone related protein (PTHrP) is one of the candidates for clinical osteoporosis treatment. In this study, GST Gene Fusion System was used to express recombinant human PTHrP (hPTHrP) 1-34 and 1-84. To determine whether the recombinant hPTHrP1-34 and 1-84 can enhance renal calcium reabsorption and promote bone formation, we examined effects of recombinant hPTHrP1-34 and 1-84 on osteogenic lineage commitment in a primary bone marrow cell culture system and on osteoporosis treatment. Results revealed that both of recombinant hPTHrP1-34 and 1-84 increased colony formation and osteogenic cell differentiation and mineralization in vitro; however, the effect of recombinant hPTHrP1-84 is a little stronger than that of hPTHrP1-34. Next, ovariectomy was used to construct osteoporosis animal model (OVX) to test activities of these two recombinants in vivo. HPTHrP1-84 administration elevated serum calcium by up-regulating the expression of renal calcium transporters, which resulted in stimulation of osteoblastic bone formation. These factors contributed to augmented bone mass in hPTHrP1-84 treated OVX mice but did not affect bone resorption. There was no obvious bone mass alteration in hPTHrP1-34 treated OVX mice, which may be, at least partly, associated with shorter half-life of hPTHrP1-34 compared to hPTHrP1-84 in vivo. This study implies that recombinant hPTHrP1-84 is more effective than hPTHrP1-34 to enhance renal calcium reabsorption and to stimulate bone formation in vivo.	[Wang, Hua; Liu, Jingning; Yin, Ying; Wu, Jun; Miao, Dengshun; Sun, Wen] Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Jiangsu, Peoples R China; [Wang, Hua; Yin, Ying; Wang, Zilu] Nanjing Med Univ, Stomatol Coll, Inst Dent Res, Nanjing, Jiangsu, Peoples R China; [Liu, Jingning] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Sun, W (corresponding author), Nanjing Med Univ, Dept Anat Histol & Embryol, Res Ctr Bone & Stem Cells, Nanjing, Jiangsu, Peoples R China.	wensun@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; , Wen/0000-0002-8111-8865	National Natural Science Foundation of China [81200755]; Natural Science Foundation of Jiangsu Province, China [BK2012440]; Research Fund for the Doctoral Program of Higher Education of China [20123234120007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by Project grants from the National Natural Science Foundation of China (No. 81200755) and by Natural Science Foundation of Jiangsu Province, China (BK2012440) and by Research Fund for the Doctoral Program of Higher Education of China (20123234120007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS SK, 1989, Q J EXP PHYSIOL CMS, V74, P549, DOI 10.1113/expphysiol.1989.sp003303; ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Amizuka N, 1996, DEV BIOL, V175, P166, DOI 10.1006/dbio.1996.0104; Augustine M, 2013, CURR OSTEOPOROS REP; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Bisello A, 2004, ENDOCRINOLOGY, V145, P3551, DOI 10.1210/en.2004-0509; Cao GF, 2009, ENDOCRINOLOGY, V150, P561, DOI 10.1210/en.2008-0654; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Choi KC, 2011, J PHYSIOL PHARMACOL, V62, P499; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clemens TL, 2001, BRIT J PHARMACOL, V134, P1113, DOI 10.1038/sj.bjp.0704378; Borba VZC, 2010, ARQ BRAS ENDOCRINOL, V54, P213, DOI 10.1590/S0004-27302010000200018; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Erben RG, 1997, ENDOCRINOLOGY, V138, P4629, DOI 10.1210/en.138.11.4629; FENTON AJ, 1993, J CELL PHYSIOL, V155, P1, DOI 10.1002/jcp.1041550102; Girotra Monica, 2006, Arq Bras Endocrinol Metab, V50, P745, DOI 10.1590/S0004-27302006000400019; Girotra M, 2006, REV ENDOCR METAB DIS, V7, P113, DOI 10.1007/s11154-006-9007-z; Godwin SL, 1997, J BIOL CHEM, V272, P11307; Grill V, 1998, EUR J CANCER, V34, P222, DOI 10.1016/S0959-8049(97)10130-7; Ji J, 2011, AM J PHYSIOL-ENDOC M, V301, pE889, DOI 10.1152/ajpendo.00173.2011; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Khan AW, 2006, J OBSTET GYNAECOL CA, V28, P136, DOI 10.1016/S1701-2163(16)32063-1; Kovacs CS, 1996, P NATL ACAD SCI USA, V93, P15233, DOI 10.1073/pnas.93.26.15233; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kumar R, 2012, ARCH BIOCHEM BIOPHYS, V523, P77, DOI 10.1016/j.abb.2012.03.003; Liu JN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002294; Miao DS, 2008, P NATL ACAD SCI USA, V105, P20309, DOI 10.1073/pnas.0805690105; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Miao DS, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-16; Miao DS, 2001, J BIOL CHEM, V276, P32204, DOI 10.1074/jbc.M101084200; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Sobieszczanska M, 2013, ADV CLIN EXP MED, V22, P119; STREWLER GJ, 1990, WESTERN J MED, V153, P635; Sun W, 2010, DEVELOPMENT, V137, P985, DOI 10.1242/dev.045898; WALSH CA, 1995, J BONE MINER RES, V10, P17; Walters JRF, 2007, J STEROID BIOCHEM, V103, P509, DOI 10.1016/j.jsbmb.2006.11.013; Wealthall RJ, 2009, J CELL PHYSIOL, V219, P688, DOI 10.1002/jcp.21716; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Xue YB, 2005, J BONE MINER RES, V20, P1766, DOI 10.1359/JBMR.050608; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Yamaguchi T, 1998, J BONE MINER RES, V13, P1530, DOI 10.1359/jbmr.1998.13.10.1530	46	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88237	10.1371/journal.pone.0088237	http://dx.doi.org/10.1371/journal.pone.0088237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516619	Green Submitted, gold, Green Published			2022-12-27	WOS:000330830700058
J	Gao, F; Chen, J; Wang, T; Wang, G; Zhang, ZH; Shen, LZ				Gao, Fei; Chen, Jia; Wang, Tao; Wang, Gang; Zhang, Zhihong; Shen, Lizong			Incidence of Microscopically Positive Proximal Margins in Adenocarcinoma of the Gastroesophageal Junction	PLOS ONE			English	Article							GASTRIC-CANCER; ESOPHAGOGASTRIC JUNCTION; MANAGEMENT; RESECTION; CARDIA	Aim: To investigate the incidence and risk factors of microscopically positive proximal margins in Chinese patients with adenocarcinoma of the gastroesophageal junction. Methods: The medical records of 483 patients, who underwent surgical treatment with curative intent for adenocarcinoma of the gastroesophageal junction in a single high-volume tertiary medical center, were reviewed. Demographic, radiographic, endoscopic, pathologic, and treatment-related variables were evaluated. All proximal margins were re-evaluated by two experienced pathologists, and a positive proximal margin was defined as the microscopic presence of invasive tumor cells seen at the esophageal transaction margin submitted en face on final paraffin sections. Results: The incidence of positive proximal margins was 23.81% in this series. Siewert type, depth of tumor invasion, lymph node involvement, presence of vascular or lymphatic invasion, and presence of perineural invasion were significantly associated with positive proximal margins. On multivariate analysis, the presence of vascular or lymphatic invasion and advanced-stage disease were independent risk factors for positive proximal margins in patients with adenocarcinoma of the gastroesophageal junction. Conclusion: Residual cancer at proximal resection margins remains a major issue for the surgical treatment of adenocarcinoma of the gastroesophageal junction in China.	[Gao, Fei; Chen, Jia; Wang, Tao; Wang, Gang; Shen, Lizong] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shen, LZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing, Jiangsu, Peoples R China.	shenlz@163.com			National Natural Science Foundation of China [81272711]; 7th "Six Talent-Person-Peak Program,'' Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 7th "Six Talent-Person-Peak Program,'' Jiangsu Province, China	This work was supported by the National Natural Science Foundation of China (Grant No. 81272711) and the 7th "Six Talent-Person-Peak Program,'' Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AP, 2007, ANN SURG, V246, P1, DOI 10.1097/01.sla.0000255563.65157.d2; Bozzetti F, 2000, EUR J SURG ONCOL, V26, P810, DOI 10.1053/ejso.2000.1009; Chan WH, 2000, AUST NZ J SURG, V70, P700, DOI 10.1046/j.1440-1622.2000.01937.x; Chung JW, 2009, DIS ESOPHAGUS, V22, P676, DOI 10.1111/j.1442-2050.2009.00946.x; Fox MP, 2012, SURG CLIN N AM, V92, P1199, DOI 10.1016/j.suc.2012.07.011; Hasegawa S, 2010, GASTRIC CANCER, V13, P63, DOI 10.1007/s10120-010-0555-2; Ito H, 2004, J AM COLL SURGEONS, V199, P880, DOI 10.1016/j.jamcollsurg.2004.08.015; Ito H, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-2; Kusano C, 2008, J GASTROEN HEPATOL, V23, P1662, DOI 10.1111/j.1440-1746.2008.05572.x; Russell MC, 2013, J SURG ONCOL, V107, P250, DOI 10.1002/jso.23180; Sasako M, 2006, LANCET ONCOL, V7, P644, DOI 10.1016/S1470-2045(06)70766-5; Schuhmacher C, 2013, J GASTRIC CANCER, V13, P73, DOI 10.5230/jgc.2013.13.2.73; Shen JG, 2006, WORLD J GASTROENTERO, V12, P3883, DOI 10.3748/wjg.v12.i24.3883; Shen LZ, 2009, CAN J GASTROENTEROL, V23, P353, DOI 10.1155/2009/462678; Siewert JR, 2000, ANN SURG, V232, P353; Siewert JR, 1996, DIS ESOPHAGUS, V9, P173, DOI DOI 10.1093/DOTE/9.4.278; SIU KF, 1986, ANN SURG, V203, P173, DOI 10.1097/00000658-198602000-00011; Zhang LH, 2009, N AM J MED SCI, V2, P35; Zhang YF, 2012, WORLD J GASTROENTERO, V18, P3602, DOI 10.3748/wjg.v18.i27.3602	19	15	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88010	10.1371/journal.pone.0088010	http://dx.doi.org/10.1371/journal.pone.0088010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505353	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200096
J	Gomez, I; Benyahia, C; Louedec, L; Leseche, G; Jacob, MP; Longrois, D; Norel, X				Gomez, Ingrid; Benyahia, Chabha; Louedec, Liliane; Leseche, Guy; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier			Decreased PGE(2) Content Reduces MMP-1 Activity and Consequently Increases Collagen Density in Human Varicose Vein	PLOS ONE			English	Article							PROSTAGLANDIN-E SYNTHASE-1; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; EP4 RECEPTOR; MAMMARY ARTERY; SAPHENOUS-VEIN; VASCULAR WALL; E-2; EXPRESSION	Varicose veins are elongated and dilated saphenous veins. Despite the high prevalence of this disease, its pathogenesis remains unclear. Aims: In this study, we investigated the control of matrix metalloproteinases (MMPs) expression by prostaglandin (PG)E-2 during the vascular wall remodeling of human varicose veins. Methods and Results: Varicose (small (SDv) and large diameter (LDv)) and healthy saphenous veins (SV) were obtained after surgery. Microsomal and cytosolic PGE-synthases (mPGES and cPGES) protein and mRNA responsible for PGE(2) metabolism were analyzed in all veins. cPGES protein was absent while its mRNA was weakly expressed. mPGES-2 expression was similar in the different saphenous veins. mPGES-1 mRNA and protein were detected in healthy veins and a significant decrease was found in LDv. Additionally, 15-hydroxyprostaglandin dehydrogenase (15-PGDH), responsible for PGE(2) degradation, was over-expressed in varicose veins. These variations in mPGES-1 and 15-PGDH density account for the decreased PGE(2) level observed in varicose veins. Furthermore, a significant decrease in PGE(2) receptor (EP4) levels was also found in SDv and LDv. Active MMP-1 and total MMP-2 concentrations were significantly decreased in varicose veins while the tissue inhibitors of metalloproteinases (TIMP -1 and -2), were significantly increased, probably explaining the increased collagen content found in LDv. Finally, the MMP/TIMP ratio is restored by exogenous PGE(2) in varicose veins and reduced in presence of an EP4 receptor antagonist in healthy veins. Conclusions: In conclusion, PGE(2) could be responsible for the vascular wall thickening in human varicose veins. This mechanism could be protective, strengthening the vascular wall in order to counteract venous stasis.	[Gomez, Ingrid; Benyahia, Chabha; Louedec, Liliane; Leseche, Guy; Jacob, Marie-Paule; Longrois, Dan; Norel, Xavier] INSERM, U698, Paris, France; [Gomez, Ingrid; Benyahia, Chabha; Norel, Xavier] Univ Paris 13, UMR S698, Paris, France; [Longrois, Dan] Univ Paris Diderot, CHU X Bichat, Dept Anesthesia & Intens Care, Sorbonne Paris Cite,AP HP,UMR S698, Paris, France; [Leseche, Guy] Univ Paris Diderot, CHU X Bichat, Dept Vasc & Thorac Surg, AP HP,UMR S698,Sorbonne Paris Cite, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Norel, X (corresponding author), INSERM, U698, Paris, France.	xavier.norel@inserm.fr	Norel, Xavier/C-5978-2011	Norel, Xavier/0000-0003-0734-3359; ingrid, gomez/0000-0002-8967-2481	INSERM (Institut National de la Sante et de la Recherche Medicale)	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind B, 2010, EUR J VASC ENDOVASC, V40, P754, DOI 10.1016/j.ejvs.2010.04.028; Badier-Commander C, 2000, J PATHOL, V192, P105, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1; Badier-Commander C, 2001, J PATHOL, V193, P398, DOI 10.1002/path.819; Bage T, 2011, AM J PATHOL, V178, P1676, DOI 10.1016/j.ajpath.2010.12.048; Benjamin Mina M, 2012, Exp Suppl, V103, P209, DOI 10.1007/978-3-0348-0364-9_7; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; BishopBailey D, 1997, ARTERIOSCL THROM VAS, V17, P1644, DOI 10.1161/01.ATV.17.9.1644; Camacho M, 2007, J THROMB HAEMOST, V5, P1411, DOI 10.1111/j.1538-7836.2007.02555.x; Cao RY, 2012, AM J PATHOL, V181, P313, DOI 10.1016/j.ajpath.2012.03.016; Chang Jee Won, 2011, Korean J Thorac Cardiovasc Surg, V44, P387, DOI 10.5090/kjtcs.2011.44.6.387; Chen LH, 2013, CIRCULATION, V127, P233, DOI 10.1161/CIRCULATIONAHA.112.119479; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Foudi N, 2011, BRIT J PHARMACOL, V163, P826, DOI 10.1111/j.1476-5381.2011.01264.x; Foudi N, 2012, EUR J PHARMACOL, V695, P1, DOI 10.1016/j.ejphar.2012.08.009; Foudi N, 2009, CARDIOVASC RES, V81, P269, DOI 10.1093/cvr/cvn287; GANDHI RH, 1993, J VASC SURG, V18, P814, DOI 10.1016/0741-5214(93)90336-K; Gillespie DL, 2002, J SURG RES, V106, P233, DOI 10.1006/jsre.2002.6455; Golledge J, 2003, EUR J VASC ENDOVASC, V25, P319, DOI 10.1053/ejvs.2002.1843; Gomez I, 2013, PROSTAGLANDINS LEUKO; Gomez I, 2013, INFLAMM RES, V62, P299, DOI 10.1007/s00011-012-0578-8; Gomez PF, 2005, J IMMUNOL, V175, P6924, DOI 10.4049/jimmunol.175.10.6924; Gomez-Hernandez A, 2008, AM J CARDIOL, V102, P12, DOI 10.1016/j.amjcard.2008.02.090; Gudis K, 2005, LAB INVEST, V85, P225, DOI 10.1038/labinvest.3700200; Hasan D, 2012, STROKE, V43, P1964, DOI 10.1161/STROKEAHA.112.655829; Ho-Tin-Noe B, 2011, CIRC RES, V109, P1003, DOI 10.1161/CIRCRESAHA.110.235390; Ishikawa Y, 2000, VIRCHOWS ARCH, V437, P138, DOI 10.1007/s004280000200; Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kar S, 2010, RESP PHYSIOL NEUROBI, V174, P299, DOI 10.1016/j.resp.2010.08.019; Kowalewski R, 2004, INT ANGIOL, V23, P164; Kucukguven A, 2013, CURR DRUG TARGETS, V14, P287; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Lee J, 2011, MOL CELL ENDOCRINOL, V332, P306, DOI 10.1016/j.mce.2010.11.022; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Mendez M, 2003, HYPERTENSION, V42, P844, DOI 10.1161/01.HYP.0000085332.69777.D1; Murakami M, 2003, J BIOL CHEM, V278, P37937, DOI 10.1074/jbc.M305108200; Newby AC, 2012, VASC PHARMACOL, V56, P232, DOI 10.1016/j.vph.2012.01.007; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Oklu R, 2012, J VASC INTERV RADIOL, V23, P33, DOI 10.1016/j.jvir.2011.09.010; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Parra JR, 1998, J VASC SURG, V28, P669, DOI 10.1016/S0741-5214(98)70093-X; Payner T, 2006, MOL CANCER THER, V5, P1817, DOI 10.1158/1535-7163.MCT-05-0548; Pham H, 2010, PANCREAS, V39, P332, DOI 10.1097/MPA.0b013e3181baecbe; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Reilly JM, 1999, SURGERY, V126, P624, DOI 10.1016/S0039-6060(99)70114-5; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Sanchez C, 2009, OSTEOARTHR CARTILAGE, V17, P473, DOI 10.1016/j.joca.2008.09.007; Sansilvestri-Morel P, 2001, J VASC RES, V38, P560, DOI 10.1159/000051092; SanSilvestri-Morel P, 2007, CLIN SCI, V112, P229, DOI 10.1042/CS20060170; St-Jacques B, 2013, PAIN, V154, P313, DOI 10.1016/j.pain.2012.11.005; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; Vargova Viola, 2012, Exp Suppl, V103, P1, DOI 10.1007/978-3-0348-0364-9_1; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wilson RJ, 2006, BRIT J PHARMACOL, V148, P326, DOI 10.1038/sj.bjp.0706726; Woodside KJ, 2003, J VASC SURG, V38, P162, DOI 10.1016/S0741-5214(03)00134-4; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Yokoyama U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036724	59	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88021	10.1371/journal.pone.0088021	http://dx.doi.org/10.1371/journal.pone.0088021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505358	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200098
J	Koo, HM; Kim, CH; Doh, FM; Lee, MJ; Kim, EJ; Han, JH; Han, JS; Oh, HJ; Park, JT; Han, SH; Yoo, TH; Kang, SW				Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Lee, Mi Jung; Kim, Eun Jin; Han, Jae Hyun; Han, Ji Suk; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook			The Relationship of Initial Transferrin Saturation to Cardiovascular Parameters and Outcomes in Patients Initiating Dialysis	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; IRON-OVERLOAD CARDIOMYOPATHY; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; FERRIC CARBOXYMALTOSE; RISK-FACTOR; FOLLOW-UP; ANEMIA	Background: The prognostic importance of anemia for cardiovascular (CV) events and mortality has been extensively investigated. However, little is known about the impact of transferrin saturation (TSAT), a marker reflecting the availability of iron for erythropoiesis, on clinical outcome in dialysis patients. Methods: A total of 879 anemic incident dialysis patients were recruited from the Clinical Research Center for End-Stage Renal Disease in Korea and were divided into 3 groups according to baseline TSAT of <= 20%, 20-40%, and > 40%. Results: There were no differences in hemoglobin levels and the proportion of patients on erythropoiesis-stimulating agents or iron supplements among the 3 groups. During a mean follow-up duration of 19.3 months, 51 (5.8%) patients died. CV composite (11.71 vs. 5.55 events/100 patient-years, P = 0.001) and all-cause mortality rates (5.38 vs. 2.31 events/100 patient-years, P = 0.016) were significantly higher in patients with TSAT <= 20% compared to those with TSAT 20-40% (reference group). Cox regression analysis revealed that patients with TSAT <= 20% had 1.62- and 2.19-fold higher risks for CV composite outcome (P = 0.046) and all-cause mortality (P = 0.030). Moreover, TSAT <= 20% was significantly associated with left ventricular hypertrophy [odds ratio (OR) = 1.46], high-sensitivity C-reactive protein >= 3 mg/dL (OR = 2.09), N-terminal pro B-type natriuretic peptide >= 10000 pg/mL (OR = 2.04), and troponin-T >= 0.1 ng/mL (OR = 2.02), on logistic regression analysis. Conclusions: Low TSAT was a significant independent risk factor for adverse clinical outcome in incident dialysis patients with anemia, which may be partly attributed to cardiac dysfunction and inflammation.	[Koo, Hyang Mo; Kim, Chan Ho; Doh, Fa Mee; Lee, Mi Jung; Kim, Eun Jin; Han, Jae Hyun; Han, Ji Suk; Oh, Hyung Jung; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University	Kang, SW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kswkidney@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Park, Jung Tak/0000-0002-2325-8982; Yoo, Tae-Hyun/0000-0002-9183-4507; doh, fa mee/0000-0002-4780-6728; Kang, Shin-Wook/0000-0002-5677-4756; Lee, Mi Jung/0000-0001-8888-029X	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI10C2020]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	None of the authors received any significant primary financial arrangements with commercial companies that produce or sell products or with competitors of such companies. This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2008, J AM COLL CARDIOL, V52, P501, DOI 10.1016/j.jacc.2008.04.044; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Comin-Colet J, 2013, EUR HEART J, V34, P30, DOI 10.1093/eurheartj/ehr504; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dong F, 2005, CLIN SCI, V109, P277, DOI 10.1042/CS20040278; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ellervik C, 2011, CLIN CHEM, V57, P459, DOI 10.1373/clinchem.2010.156802; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Han SS, 2010, PERITON DIALYSIS INT, V30, P300, DOI 10.3747/pdi.2009.00064; Jankowska EA, 2013, EUR HEART J, V34, P816, DOI 10.1093/eurheartj/ehs224; Jankowska EA, 2010, EUR HEART J, V31, P1872, DOI 10.1093/eurheartj/ehq158; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Kovesdy CP, 2006, KIDNEY INT, V69, P560, DOI 10.1038/sj.ki.5000105; Kremastinos DT, 2011, CIRCULATION, V124, P2253, DOI 10.1161/CIRCULATIONAHA.111.050773; Levin A, 2006, AM J KIDNEY DIS, V47, pS9, DOI 10.1053/j.ajkd.2006.04.023; Li SY, 2004, KIDNEY INT, V65, P626, DOI 10.1111/j.1523-1755.2004.00425.x; Liao YL, 1997, J AM COLL CARDIOL, V29, P641, DOI 10.1016/S0735-1097(96)00552-9; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Maeder MT, 2011, J AM COLL CARDIOL, V58, P474, DOI 10.1016/j.jacc.2011.01.059; Mainous AG, 2004, ANN FAM MED, V2, P133, DOI 10.1370/afm.25; McClellan W, 2004, CURR MED RES OPIN, V20, P1501, DOI 10.1185/030079904X2763; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Nanas JN, 2006, J AM COLL CARDIOL, V48, P2485, DOI 10.1016/j.jacc.2006.08.034; Okonko DO, 2011, J AM COLL CARDIOL, V58, P1241, DOI 10.1016/j.jacc.2011.04.040; Park HJ, 2007, TOHOKU J EXP MED, V211, P321, DOI 10.1620/tjem.211.321; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Portoles J, 2007, NEPHROL DIAL TRANSPL, V22, P500, DOI 10.1093/ndt/gfl558; Robinson BE, 2006, J AM MED DIR ASSOC, V7, pS3, DOI 10.1016/j.jamda.2006.09.004; Robinson BM, 2009, CLIN J AM SOC NEPHRO, V4, pS12, DOI 10.2215/CJN.04720709; Silverberg DS, 2008, EUR J HEART FAIL, V10, P819, DOI 10.1016/j.ejheart.2008.06.015; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Steiber AL, 2004, J RENAL NUTR, V14, P191, DOI 10.1053/j.jrn.2004.08.004; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; van Veldhuisen DJ, 2011, NAT REV CARDIOL, V8, P485, DOI 10.1038/nrcardio.2011.77; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wish JB, 2006, CLIN J AM SOC NEPHRO, V1, pS4, DOI 10.2215/CJN.01490506; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x	47	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87231	10.1371/journal.pone.0087231	http://dx.doi.org/10.1371/journal.pone.0087231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505281	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200040
J	Murugaiah, C; Noor, NZNM; Mustafa, S; Manickam, R; Pattabhiraman, L				Murugaiah, Chandrika; Noor, Nik Zuraina Nik Mohd; Mustafa, Shyamoli; Manickam, Ravichandran; Pattabhiraman, Lalitha			Construction and Evaluation of V. cholerae O139 Mutant, VCUSM21P, as a Safe Live Attenuated Cholera Vaccine	PLOS ONE			English	Article							TOXIN GENE-CLUSTER; VIBRIO-CHOLERAE; EL-TOR; RTX TOXINS; IMMUNOGENICITY; ENTEROTOXIN; MODEL; BANGLADESH; EPIDEMIC; BURDEN	Cholera is a major infectious disease, affecting millions of lives annually. In endemic areas, implementation of vaccination strategy against cholera is vital. As the use of safer live vaccine that can induce protective immunity against Vibrio cholerae O139 infection is a promising approach for immunization, we have designed VCUSM21P, an oral cholera vaccine candidate, which has ctxA that encodes A subunit of ctx and mutated rtxA/C, ace and zot mutations. VCUSM21P was found not to disassemble the actin of HEp2 cells. It colonized the mice intestine approximately 1 log lower than that of the Wild Type (WT) strain obtained from Hospital Universiti Sains Malaysia. In the ileal loop assay, unlike WT challenge, 1 x 10(6) and 1 x 10(8) colony forming unit (CFU) of VCUSM21P was not reactogenic in non-immunized rabbits. Whereas, the reactogenicity caused by the WT in rabbits immunized with 1 x 10(10) CFU of VCUSM21P was found to be reduced as evidenced by absence of fluid in loops administered with 1 x 10(2) - 1 x 10(7) CFU of WT. Oral immunization using 1 x 10(10) CFU of VCUSM21P induced both IgA and IgG against Cholera Toxin (CT) and O139 lipopolysaccharides (LPS). The serum vibriocidal antibody titer had a peak rise of 2560 fold on week 4. Following Removable Intestinal Tie Adult Rabbit Diarrhoea (RITARD) experiment, the non-immunized rabbits were found not to be protected against lethal challenge with 1 x 10(9) CFU WT, but 100% of immunized rabbits survived the challenge. In the past eleven years, V. cholerae O139 induced cholera has not been observed. However, attenuated VCUSM21P vaccine could be used for vaccination program against potentially fatal endemic or emerging cholera caused by V. cholerae O139.	[Murugaiah, Chandrika; Mustafa, Shyamoli] Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia; [Murugaiah, Chandrika] Newcastle Univ Med Malaysia NUMed, Nusajaya, Johor, Malaysia; [Noor, Nik Zuraina Nik Mohd] Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Kubang Kerian, Kelantan, Malaysia; [Manickam, Ravichandran; Pattabhiraman, Lalitha] AIMST Univ, Dept Dept Biotechnol, Bedong, Kedah Darul Ama, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; AIMST University	Murugaiah, C (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Kubang Kerian, Kelantan, Malaysia.	chandri20@yahoo.co.uk	Zuraina, Nik Mohd Noor Nik/Q-1510-2018; RAVICHANDRAN, MANICKAM/A-7128-2011	Zuraina, Nik Mohd Noor Nik/0000-0002-0009-2772; RAVICHANDRAN, MANICKAM/0000-0001-5321-1344; Murugaiah, Chandrika/0000-0002-4301-8994	USM; SAGA GRANT [B M 27/304/PPSK/6153004A118]; Cuba Vaccine GRANT [305/PPSP/6150080]	USM(Universiti Sains Malaysia); SAGA GRANT; Cuba Vaccine GRANT	The first author is supported by USM Fellowship. This project was funded by SAGA GRANT (B M 27/304/PPSK/6153004A118) & Cuba Vaccine GRANT (305/PPSP/6150080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT MJ, 1993, LANCET, V341, P704; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Angelichio MJ, 1999, INFECT IMMUN, V67, P3733, DOI 10.1128/IAI.67.8.3733-3739.1999; [Anonymous], 1993, Lancet, V342, P387; Attridge SR, 2000, CLIN DIAGN LAB IMMUN, V7, P444, DOI 10.1128/CDLI.7.3.444-450.2000; BAUDRY B, 1992, INFECT IMMUN, V60, P428, DOI 10.1128/IAI.60.2.428-434.1992; BHADRA RK, 1994, INDIAN J BIOCHEM BIO, V31, P441; BHATTACHARYA SK, 1993, J INFECTION, V27, P11, DOI 10.1016/0163-4453(93)93488-P; Boris LR, 2007, REV CENIC CIENCIAS B, V38, P141; Calain P, 2004, VACCINE, V22, P2444, DOI 10.1016/j.vaccine.2003.11.070; Chaignat CL, 2007, J HEALTH POPUL NUTR, V25, P244; Chan M, 2010, MICROB PATHOGENESIS, V49, P211, DOI 10.1016/j.micpath.2010.06.001; COSTER TS, 1995, LANCET, V345, P949, DOI 10.1016/S0140-6736(95)90698-3; CRYZ SJ, 1995, DEV BIOL STAND, V84, P237; Czuprynski CJ, 1995, TRENDS MICROBIOL, V3, P480, DOI 10.1016/S0966-842X(00)89016-2; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; Emch M, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-31; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; JOHNSON JA, 1993, J CLIN MICROBIOL, V31, P732, DOI 10.1128/JCM.31.3.732-733.1993; KAPER JB, 1992, INDIAN J MED RES-A, V95, P163; Khetawat G, 1999, INFECT IMMUN, V67, P148, DOI 10.1128/IAI.67.1.148-154.1999; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Li L, 2008, INFECT IMMUN, V76, P2620, DOI 10.1128/IAI.01308-07; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lopez AL, 2008, HUM VACCINES, V4, P165, DOI 10.4161/hv.4.2.5122; Lu XH, 2002, VACCINE, V20, P1019, DOI 10.1016/S0264-410X(01)00452-2; NAIR GB, 1994, J INFECT DIS, V169, P1029, DOI 10.1093/infdis/169.5.1029; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Pizza M, 2001, VACCINE, V19, P2534, DOI 10.1016/S0264-410X(00)00137-7; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Rashed SM, 2013, EMERG INFECT DIS, V19, P1713, DOI 10.3201/eid1910.130626; Ravichandran M, 2006, VACCINE, V24, P3750, DOI 10.1016/j.vaccine.2005.07.016; RUSSELL RG, 1992, INFECT IMMUN, V60, P435, DOI 10.1128/IAI.60.2.435-442.1992; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Sanchez J, 2002, J BIOL CHEM, V277, P33369, DOI 10.1074/jbc.M112337200; Schaetti C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-99; Siddique AK, 1996, TROP MED INT HEALTH, V1, P393, DOI 10.1046/j.1365-3156.1996.d01-54.x; TACKET CO, 1993, J INFECT DIS, V168, P1536, DOI 10.1093/infdis/168.6.1536; Thungapathra M, 1999, IMMUNOL LETT, V68, P219, DOI 10.1016/S0165-2478(99)00076-0; Tormey M., 1993, Morbidity and Mortality Weekly Report, V42, P501; TRUCKSIS M, 1993, P NATL ACAD SCI USA, V90, P5267, DOI 10.1073/pnas.90.11.5267; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Walia K, 1999, INFECT IMMUN, V67, P5215, DOI 10.1128/IAI.67.10.5215-5222.1999; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X	47	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e81817	10.1371/journal.pone.0081817	http://dx.doi.org/10.1371/journal.pone.0081817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505241	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330829200001
J	Sogot, CE; Harper, EM; Taylor, PD				Sogot, Caroline E.; Harper, Elizabeth M.; Taylor, Paul D.			The Lilliput Effect in Colonial Organisms: Cheilostome Bryozoans at the Cretaceous-Paleogene Mass Extinction	PLOS ONE			English	Article							ZOOID SIZE; GROWTH-RATE; BODY-SIZE; BOUNDARY; RECOVERY; TEMPERATURE; PATTERNS; ALABAMA; END; SELECTIVITY	Consistent trends towards decreasing body size in the aftermath of mass extinctions - Lilliput effects - imply a predictable response among unitary animals to these events. The occurrence of Lilliput effects has yet to be widely tested in colonial organisms, which are of particular interest as size change may potentially occur at the two hierarchical levels of the colony and the individual zooids. Bryozoans are particularly useful organisms in which to study colonial size response as they have well-defined zooids. Additionally, a number of analyses of present-day bryozoans have shown that zooid size reflects local environmental conditions, most notably seawater temperature and possibly also food supply. Following the hypothesised decline in primary productivity at the Cretaceous-Paleogene (K-Pg) mass extinction, it is predicted that bryozoan zooid size should decline in the early Paleogene, resulting in a Lilliput effect. To test this prediction, zooid size was compared across the K-Pg boundary at the assemblage level and also within 4 surviving genera. Analysis of 59 bryozoan species from assemblages on either side of the K-Pg boundary showed no significant change in zooid length. Zooid size was also measured in 98 Maastrichtian colonies and 162 Danian colonies belonging to four congeneric species. Only one of these genera showed a significant size decrease across the K-Pg boundary, the other three maintaining constant zooidal lengths, widths and areas. Additionally, the sizes of 210 Maastrichtian colonies and 163 Danian colonies did not show consistent size decrease across the K-Pg boundary in these same species, although maximum colony size did decline in three out of four genera. Furthermore, this lack of consistent size change is uniform between two distinct biogeographical regions, Denmark and the southeastern USA.	[Sogot, Caroline E.; Harper, Elizabeth M.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Sogot, Caroline E.; Taylor, Paul D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Cambridge; Natural History Museum London	Sogot, CE (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	csogot@gmail.com	Harper, Elizabeth M/B-3890-2008	Harper, Elizabeth M/0000-0002-1092-3867; Taylor, Paul/0000-0002-3127-080X	Natural Environment Research Council studentship	Natural Environment Research Council studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a Natural Environment Research Council studentship to CES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberhan M, 2007, GEOLOGY, V35, P227, DOI 10.1130/G23197A.1; Amui-Vedel AM, 2007, J EXP MAR BIOL ECOL, V353, P1, DOI 10.1016/j.jembe.2007.02.020; Anderskouv K, 2007, SEDIMENT GEOL, V200, P57, DOI 10.1016/j.sedgeo.2007.03.005; ARTHUR M A, 1987, Cretaceous Research, V8, P43, DOI 10.1016/0195-6671(87)90011-5; Berning B, 2007, LETHAIA, V40, P221, DOI 10.1111/j.1502-3931.2007.00019.x; Boardman R.S., 1969, P NATL AM PALEONTOL, VPart C, P294; Brayard A, 2010, GEOLOGY, V38, P147, DOI 10.1130/G30553.1; BRYAN JR, 1989, PALAEOGEOGR PALAEOCL, V69, P279, DOI 10.1016/0031-0182(89)90170-3; Canu F, 1920, SMITHSON I US NATL M, V106; Dytham C, 2003, CHOOSING USING STAT; Fraiser ML, 2004, PALAIOS, V19, P259, DOI 10.1669/0883-1351(2004)019<0259:TNETGF>2.0.CO;2; Grafen A., 2002, MODERN STAT LIFE SCI; Hageman SJ, 2009, LETHAIA, V42, P438, DOI 10.1111/j.1502-3931.2009.00164.x; Harries PJ, 2009, PALAEOGEOGR PALAEOCL, V284, P4, DOI 10.1016/j.palaeo.2009.08.021; He WH, 2010, GEOBIOLOGY, V8, P391, DOI 10.1111/j.1472-4669.2010.00248.x; He WH, 2007, PALAEOGEOGR PALAEOCL, V252, P145, DOI 10.1016/j.palaeo.2006.11.040; Huang B, 2010, PALAEOGEOGR PALAEOCL, V285, P277, DOI 10.1016/j.palaeo.2009.11.020; HUNTER E, 1994, OLSEN INT S, P83; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jeffery CH, 2001, PALEOBIOLOGY, V27, P140, DOI 10.1666/0094-8373(2001)027<0140:HUATCT>2.0.CO;2; Kaljo D, 1996, GEOL SOC SP, P127, DOI 10.1144/GSL.SP.1996.001.01.10; Keller G, 2009, PALAEOGEOGR PALAEOCL, V284, P47, DOI 10.1016/j.palaeo.2009.08.029; Knowles T, 2010, MAR BIOL, V157, P1171, DOI 10.1007/s00227-010-1397-5; Knowles T, 2009, PALAEOGEOGR PALAEOCL, V277, P226, DOI 10.1016/j.palaeo.2009.04.006; Lockwood R, 2005, PALEOBIOLOGY, V31, P578, DOI 10.1666/0094-8373(2005)031[0578:BSEEAT]2.0.CO;2; Lombardi C, 2006, MAR BIOL, V149, P1103, DOI 10.1007/s00227-006-0295-3; Macleod N, 1997, J GEOL SOC LONDON, V154, P265, DOI 10.1144/gsjgs.154.2.0265; MANCINI E. A., 1995, T GULF COAST ASS GEO, V44, P377; Mcgowan AJ, 2009, AUST J EARTH SCI, V56, P859, DOI 10.1080/08120090903002839; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Morten SD, 2009, PALAEOGEOGR PALAEOCL, V284, P29, DOI 10.1016/j.palaeo.2009.08.023; Nutzel A, 2005, CR PALEVOL, V4, P501, DOI 10.1016/j.crpv.2005.02.007; Nutzel A, 2005, ACTA PALAEONTOL POL, V50, P19; O'Dea A, 2003, J MAR BIOL ASSOC UK, V83, P1107, DOI 10.1017/S0025315403008348h; O'Dea A, 2000, J MAR BIOL ASSOC UK, V80, P1127, DOI 10.1017/S0025315400003210; O'Dea A, 1999, MAR BIOL, V135, P581, DOI 10.1007/s002270050659; O'Dea A, 2000, PALAEOGEOGR PALAEOCL, V162, P319, DOI 10.1016/S0031-0182(00)00136-X; O'Dea A, 2007, MAR ECOL-EVOL PERSP, V28, P315, DOI 10.1111/j.1439-0485.2006.00144.x; O'Dea A, 2011, PALAEOGEOGR PALAEOCL, V308, P502, DOI 10.1016/j.palaeo.2011.06.001; OKAMURA B, 1988, PALAEOGEOGR PALAEOCL, V66, P145, DOI 10.1016/0031-0182(88)90197-6; Okamura B, 2011, MAR ECOL PROG SER, V430, P133, DOI 10.3354/meps08965; SAVRDA CE, 1993, GEOLOGY, V21, P1075, DOI 10.1130/0091-7613(1993)021<1075:IEFANO>2.3.CO;2; Schulte P, 2009, GEOL ACTA, V7, P11, DOI 10.1344/105.000000279; Smith AB, 1998, NATURE, V392, P69, DOI 10.1038/32155; Sogot CE, 2013, GEOLOGY, V41, P631, DOI 10.1130/G34020.1; Sokal RR, 1995, BIOMETRY; TAYLOR P. D., 2008, VIRGINIA MUSEUM NATU, V15, P101; Taylor Paul D., 2006, Scripta Geologica (Leiden), V132, P1; Tobin TS, 2012, PALAEOGEOGR PALAEOCL, V350, P180, DOI 10.1016/j.palaeo.2012.06.029; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Wade BS, 2009, PALAEOGEOGR PALAEOCL, V284, P39, DOI 10.1016/j.palaeo.2009.08.026; Wade BS, 2009, PALAEOGEOGR PALAEOCL, V284, P1, DOI 10.1016/j.palaeo.2009.08.019; WINSTON JE, 1976, BIOL BULL-US, V150, P318, DOI 10.2307/1540477; Yagunova EB, 2008, J MAR BIOL ASSOC UK, V88, P901, DOI 10.1017/S0025315408001847	55	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87048	10.1371/journal.pone.0087048	http://dx.doi.org/10.1371/journal.pone.0087048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505275	gold, Green Published			2022-12-27	WOS:000330829200034
J	Williams, RT; Barnhill, LM; Kuo, HH; Lin, WD; Batova, A; Yu, AL; Diccianni, MB				Williams, Richard T.; Barnhill, Lisa M.; Kuo, Huan-Hsien; Lin, Wen-Der; Batova, Ayse; Yu, Alice L.; Diccianni, Mitchell B.			Chimeras of p14ARF and p16: Functional Hybrids with the Ability to Arrest Growth	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; HUMAN CANCERS; P16(INK4A); MUTATIONS; MELANOMA; INACTIVATION; INHIBITION; P14(ARF)	The INK4A locus codes for two independent tumor suppressors, p14ARF and p16/CDKN2A, and is frequently mutated in many cancers. Here we report a novel deletion/substitution from CC to T in the shared exon 2 of p14ARF/p16 in a melanoma cell line. This mutation aligns the reading frames of p14ARF and p16 mid-transcript, producing one protein which is half p14ARF and half p16, chimera ARF (chARF), and another which is half p16 and half non-p14ARF/non-p16 amino acids, p16-Alternate Carboxyl Terminal (p16-ACT). In an effort to understand the cellular impact of this novel mutation and others like it, we expressed the two protein products in a tumor cell line and analyzed common p14ARF and p16 pathways, including the p53/p21 and CDK4/cyclin D1 pathways, as well as the influence of the two proteins on growth and the cell cycle. We report that chARF mimicked wild-type p14ARF by inducing the p53/p21 pathway, inhibiting cell growth through G2/M arrest and maintaining a certain percentage of cells in G1 during nocodazole-induced G2 arrest. chARF also demonstrated p16 activity by binding CDK4. However, rather than preventing cyclin D1 from binding CDK4, chARF stabilized this interaction through p21 which bound CDK4. p16-ACT had no p16-related function as it was unable to inhibit cyclin D1/CDK4 complex formation and was unable to arrest the cell cycle, though it did inhibit colony formation. We conclude that these novel chimeric proteins, which are very similar to predicted p16/p14ARF chimeric proteins found in other primary cancers, result in maintained p14ARF-p53-p21 signaling while p16-dependent CDK4 inhibition is lost.	[Williams, Richard T.; Barnhill, Lisa M.; Yu, Alice L.; Diccianni, Mitchell B.] Univ Calif San Diego, Dept Pediat Hematol Oncol, San Diego, CA 92103 USA; [Batova, Ayse] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Kuo, Huan-Hsien; Lin, Wen-Der] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	University of California System; University of California San Diego; University of California System; University of California San Diego; Academia Sinica - Taiwan	Diccianni, MB (corresponding author), Univ Calif San Diego, Dept Pediat Hematol Oncol, San Diego, CA 92103 USA.	mdiccianni@ucsd.edu	, MitchDiccianni/AAF-8486-2019	, MitchDiccianni/0000-0002-5017-9585; yu, alice/0000-0003-2444-0505	NIH [1R01CA164132-01]; NCI Cancer Center [2 P30 CA023100-23]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA164132] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by NIH 1R01CA164132-01 (AY). DNA sequencing was performed by the DNA Sequencing Shared Resource, Moores UCSD Cancer Center, which is funded in part by NCI Cancer Center Support Grant # 2 P30 CA023100-23. Support from the St. Baldrick's Foundation is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Diccianni MB, 1997, LEUKEMIA RES, V21, P549, DOI 10.1016/S0145-2126(97)00007-6; Diccianni MB, 2007, TRENDS CANC RES, V2, P135; Fahham N, 2010, J CELL BIOCHEM, V111, P1598, DOI 10.1002/jcb.22892; Fargnoli MC, 1998, J INVEST DERMATOL, V111, P1202, DOI 10.1046/j.1523-1747.1998.00412.x; FitzGerald MG, 1996, P NATL ACAD SCI USA, V93, P8541, DOI 10.1073/pnas.93.16.8541; Foulkes WD, 1997, MOL MED, V3, P5, DOI 10.1007/BF03401664; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Goldstein AM, 2007, J MED GENET, V44, P99, DOI 10.1136/jmg.2006.043802; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KANMITCHELL J, 1993, CANCER IMMUNOL IMMUN, V37, P15, DOI 10.1007/BF01516937; Kubo Y, 1997, BIOCHEM BIOPH RES CO, V232, P38, DOI 10.1006/bbrc.1997.6217; Lin YC, 2007, ONCOGENE, V26, P7017, DOI 10.1038/sj.onc.1210507; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Mitra J, 1999, MOL CELL BIOL, V19, P3916; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Omura-Minamisawa M, 2000, CLIN CANCER RES, V6, P1219; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Pollock PM, 1996, GENE CHROMOSOME CANC, V15, P77, DOI 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Qureshi MA, 2012, BIOMARKERS, V17, P552, DOI 10.3109/1354750X.2012.699556; Reed AL, 1996, CANCER RES, V56, P3630; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Schutte M, 1997, CANCER RES, V57, P3126; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Tang KS, 2003, STRUCTURE, V11, P67, DOI 10.1016/S0969-2126(02)00929-2; Zhang B, 2000, J MOL BIOL, V299, P1121, DOI 10.1006/jmbi.2000.3803	31	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88219	10.1371/journal.pone.0088219	http://dx.doi.org/10.1371/journal.pone.0088219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505435	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200141
J	Hu, DD; Chen, Y; Bihi, A; Li, XM; Wang, TL; Wang, BE; Zhao, XY				Hu, Dou-dou; Chen, Yu; Bihi, Ali; Li, Xin-min; Wang, Tai-ling; Wang, Bao-en; Zhao, Xin-yan			A New Conversation between Radiology and Pathology-Identifying Microvascular Architecture in Stages of Cirrhosis via Diffraction Enhanced Imaging In Vitro	PLOS ONE			English	Article							CHRONIC LIVER-DISEASE; PHASE-CONTRAST; ANGIOGENESIS; MAMMOGRAPHY; REGRESSION; RADIATION	Background/Aim: Diffraction enhanced imaging (DEI) is a synchrotron radiation X-ray phase-contrast imaging technique that can better reveal the microstructure of biological soft tissues than conventional X-rays. The aim of this study is to investigate the angio-architectural changes of the liver during fibrosis, cirrhosis and its subsequent regression by applying synchrotron radiation based DEI. Methods: DEI experiments were performed at the 4W1A station of Beijing Synchrotron Radiation Facility. Twenty-four Sprague-Dawley rats were induced with liver fibrosis by carbon tetrachloride (CCl4) for up to 10 weeks, after which spontaneous regression started and continued until week 30. Quantitative analysis of the DEI images yielded the mean vascular density and intercapillary distance, which was then re-confirmed by immunohistochemical analysis of CD34. Results: Based on the DEI results, the mean vascular density was 1.4-fold higher in fibrotic rats (at week 6) and 2-fold higher in cirrhotic rats (at week 10) compared with the control (p<0.05). Accordingly, the intercapillary distance decreased to 563.89 +/- 243.35 mu m in fibrotic rats and 392.90 +/- 92.68 mu m in cirrhotic rats compared with 673.85 +/- 214.16 mu m in the control (p<0.05). During fibrosis regression at week 30, vascular density was 0.7-fold lower and intercapillary distance increased to 548.60 +/- 210.94 mu m as compared with cirrhotic rats (p<0.05). In parallel to the DEI results, immunohistochemical analysis of CD34 showed similar changes. Conclusion: Synchrotron-based DEI can conduct radiological as well as pathological analysis. Our results are consistent with previous reports indicating that angiogenesis is directly proportional to fibrosis progression. Furthermore, by clarifying the vascular characteristics of liver diseases, DEI reveals that cirrhosis cannot fully reverse during fibrosis regression.	[Hu, Dou-dou; Li, Xin-min; Wang, Bao-en; Zhao, Xin-yan] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China; [Chen, Yu] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Bihi, Ali] Capital Med Univ Beijing, Int Sch, Beijing, Peoples R China; [Wang, Tai-ling] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Capital Medical University; China-Japan Friendship Hospital	Wang, BE (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China.	wangbbee@126.com; Zhao_xinyan@ccmu.edu.cn		zhao, xinyan/0000-0002-8016-4368; Chen, Yu/0000-0003-2110-4522	Beijing Nova program of China [2009 B45]; National Natural Science Foundation of China [81000178]	Beijing Nova program of China(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by a grant from the Beijing Nova program of China (Grant Number: 2009 B45, (http://210.76.125.50:8080/datainfo/public/kjxx.jsp) and a grant from National Natural Science Foundation of China (Grant Number: 81000178, http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; Coan P, 2010, PHYS MED BIOL, V55, P7649, DOI 10.1088/0031-9155/55/24/017; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; di Bonzo LV, 2009, HISTOL HISTOPATHOL, V24, P1323, DOI 10.14670/HH-24.1323; Di Viniclus I, 2005, PATHOL RES PRACT, V201, P449, DOI 10.1016/j.prp.2005.05.009; Donnelley M, 2012, GENE THER, V19, P8, DOI 10.1038/gt.2011.80; Faulconer LS, 2010, ACAD RADIOL, V17, P433, DOI 10.1016/j.acra.2009.10.020; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Gex L, 2010, REV MED SUISSE, V6, P1806; Iwakiri Y, 2012, LIVER INT, V32, P199, DOI 10.1111/j.1478-3231.2011.02579.x; Jia YL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3207121; Keyrilainen J, 2005, EUR J RADIOL, V53, P226, DOI 10.1016/j.ejrad.2004.03.015; Lemos QT, 2010, MEM I OSWALDO CRUZ, V105, P611, DOI 10.1590/S0074-02762010000500002; Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1259/bjr/32889803; Romanenko AM, 2012, VIRCHOWS ARCH, V460, P611, DOI 10.1007/s00428-012-1243-x; Sorensen HT, 2003, J CLIN EPIDEMIOL, V56, P88, DOI 10.1016/S0895-4356(02)00531-0; Takeda T, 2012, J SYNCHROTRON RADIAT, V19, P252, DOI 10.1107/S0909049511056226; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Tanaka J, 2013, Z MED PHYS, V23, P222, DOI 10.1016/j.zemedi.2012.11.004; Thabut D, 2010, J HEPATOL, V53, P976, DOI 10.1016/j.jhep.2010.07.004; Van Steenkiste C, 2010, LAB INVEST, V90, P1558, DOI 10.1038/labinvest.2010.138; Wanless IR, 2000, ARCH PATHOL LAB MED, V124, P1599; Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006; Yu YQ, 2006, SKELETAL RADIOL, V35, P156, DOI 10.1007/s00256-005-0026-8; Zhang X, 2008, PHYS MED BIOL, V53, P5735, DOI 10.1088/0031-9155/53/20/011; Zhang X, 2010, AM J ROENTGENOL, V195, P545, DOI 10.2214/AJR.09.4090; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109; Zois CD, 2008, ALIMENT PHARM THER, V28, P1175, DOI 10.1111/j.1365-2036.2008.03840.x	30	9	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87957	10.1371/journal.pone.0087957	http://dx.doi.org/10.1371/journal.pone.0087957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504507	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300023
J	Khan, RT; Yuki, KE; Malo, D				Khan, Rabia T.; Yuki, Kyoko E.; Malo, Danielle			Fine-Mapping and Phenotypic Analysis of the Ity3 Salmonella Susceptibility Locus Identify a Complex Genetic Structure	PLOS ONE			English	Article							SALMONELLA-TYPHIMURIUM INFECTION; WILD-DERIVED MICE; SEX-HORMONES; NATURAL-RESISTANCE; HOST RESPONSE; MACROPHAGES; EXPRESSION; PATHWAYS; ITY2	Experimental animal models of Salmonella infections have been widely used to identify genes important in the host immune response to infection. Using an F2 cross between the classical inbred strain C57BL/6J and the wild derived strain MOLF/Ei, we have previously identified Ity3 (Immunity to Typhimurium locus 3) as a locus contributing to the early susceptibility of MOLF/Ei mice to infection with Salmonella Typhimurium. We have also established a congenic strain (B6.MOLF-Ity/Ity3) with the MOLF/Ei Ity3 donor segment on a C57BL/6J background. The current study was designed to fine map and characterize functionally the Ity3 locus. We generated 12 recombinant sub-congenic strains that were characterized for susceptibility to infection, bacterial load in target organs, cytokine profile and anti-microbial mechanisms. These analyses showed that the impact of the Ity3 locus on survival and bacterial burden was stronger in male mice compared to female mice. Fine mapping of Ity3 indicated that two subloci contribute collectively to the susceptibility of B6.MOLF-Ity/Ity3 congenic mice to Salmonella infection. The Ity3.1 sublocus controls NADPH oxidase activity and is characterized by decreased ROS production, reduced inflammatory cytokine response and increased bacterial burden, thereby supporting a role for Ncf2 (neutrophil cytosolic factor 2 a subunit of NADPH oxidase) as the gene underlying this sublocus. The Ity3.2 sub-locus is characterized by a hyperresponsive inflammatory cytokine phenotype after exposure to Salmonella. Overall, this research provides support to the combined action of hormonal influences and complex genetic factors within the Ity3 locus in the innate immune response to Salmonella infection in wild-derived MOLF/Ei mice.	[Khan, Rabia T.; Yuki, Kyoko E.; Malo, Danielle] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Khan, Rabia T.; Yuki, Kyoko E.; Malo, Danielle] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Malo, Danielle] McGill Univ, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Malo, D (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	danielle.malo@mcgill.ca		Khan, Rabia/0000-0001-9230-6362; Malo, Danielle/0000-0003-3980-6610	Fonds de la Recherche en Sante du Quebec; Faculty of Medicine Internal Studentship; Canadian Institutes of Health Research	Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Faculty of Medicine Internal Studentship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	RTK is a recipient of a studentship award from the Fonds de la Recherche en Sante du Quebec. KEY is a recipient of a Faculty of Medicine Internal Studentship. This work was supported by a Canadian Institutes of Health Research Grant to DM. DM is a McGill Dawson Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Buckle Geoffrey C, 2012, J Glob Health, V2, P010401, DOI 10.7189/jogh.02.010401; Caron J, 2006, INFECT IMMUN, V74, P2787, DOI 10.1128/IAI.74.5.2787-2802.2006; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D'Agostino P, 1999, ANN NY ACAD SCI, V876, P426, DOI 10.1111/j.1749-6632.1999.tb07667.x; Fluit AC, 2005, FEMS IMMUNOL MED MIC, V43, P1, DOI 10.1016/j.femsim.2004.10.007; HOU J, 1988, INT J IMMUNOPHARMACO, V10, P15, DOI 10.1016/0192-0561(88)90145-2; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Khan R, 2012, GENES IMMUN, V13, P175, DOI 10.1038/gene.2011.69; KITA E, 1989, J LEUKOCYTE BIOL, V46, P538, DOI 10.1002/jlb.46.6.538; Lam GY, 2010, SEMIN IMMUNOPATHOL, V32, P415, DOI 10.1007/s00281-010-0221-0; Laroux FS, 2005, J IMMUNOL, V175, P5596, DOI 10.4049/jimmunol.175.9.5596; Loguercio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013920; Longley R, 2011, MAMM GENOME, V22, P32, DOI 10.1007/s00335-010-9302-6; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mastroeni Pietro, 2002, Current Molecular Medicine (Hilversum), V2, P393, DOI 10.2174/1566524023362492; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mishra RPN, 2012, CURR OPIN MICROBIOL, V15, P596, DOI 10.1016/j.mib.2012.08.002; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Sancho-Shimizu V, 2007, GENETICS, V177, P1125, DOI 10.1534/genetics.107.075523; Sancho-Shimizu V, 2006, J IMMUNOL, V176, P6954, DOI 10.4049/jimmunol.176.11.6954; Sebastiani G, 1998, GENOMICS, V47, P180, DOI 10.1006/geno.1997.5116; Trezena AG, 2002, MICROBES INFECT, V4, P1409, DOI 10.1016/S1286-4579(02)00023-0; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88009	10.1371/journal.pone.0088009	http://dx.doi.org/10.1371/journal.pone.0088009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505352	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300034
J	Nobili, V; Carpino, G; Alisi, A; De Vito, R; Franchitto, A; Alpini, G; Onori, P; Gaudio, E				Nobili, Valerio; Carpino, Guido; Alisi, Anna; De Vito, Rita; Franchitto, Antonio; Alpini, Gianfranco; Onori, Paolo; Gaudio, Eugenio			Role of Docosahexaenoic Acid Treatment in Improving Liver Histology in Pediatric Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							HEPATIC STEATOSIS; BILIARY TREE; GPR120; SUPPLEMENTATION; VALIDATION; ACTIVATION; CHILDREN; THERAPY; OBESITY; MOUSE	Introduction: Nonalcoholic fatty liver disease (NAFLD) is one of the most important causes of liver-related morbidity and mortality in children. Recently, we have reported the effects of docosahexaenoic acid (DHA), the major dietary long-chain polyunsaturated fatty acids, in children with NAFLD. DHA exerts a potent anti-inflammatory activity through the G proteincoupled receptor (GPR) 120. Our aim was to investigate in pediatric NAFLD the mechanisms underlying the effects of DHA administration on histo-pathological aspects, GPR120 expression, hepatic progenitor cell activation and macrophage pool. Patients and Methods: 20 children with untreated NAFLD were included. Children were treated with DHA for 18 months. Liver biopsies before and after the treatment were analyzed. Hepatic progenitor cell activation, macrophage pool and GPR120 expression were evaluated and correlated with clinical and histo-pathological parameters. Results: GPR120 was expressed by hepatocytes, liver macrophages, and hepatic progenitor cells. After DHA treatment, the following modifications were present: i) the improvement of histo-pathological parameters such as NAFLD activity score, ballooning, and steatosis; ii) the reduction of hepatic progenitor cell activation in correlation with histo-pathological parameters; iii) the reduction of the number of inflammatory macrophages; iv) the increase of GPR120 expression in hepatocytes; v) the reduction of serine-311-phosphorylated nuclear factor kappa B (NF-kappa B) nuclear translocation in hepatocytes and macrophages in correlation with serum inflammatory cytokines. Conclusions: DHA could modulate hepatic progenitor cell activation, hepatocyte survival and macrophage polarization through the interaction with GPR120 and NF-kappa B repression. In this scenario, the modulation of GPR120 exploits a novel crucial role in the regulation of the cell-to-cell cross-talk that drives inflammatory response, hepatic progenitor cell activation and hepatocyte survival.	[Nobili, Valerio; Alisi, Anna] Bambino Gesu Pediat Hosp, Unit Liver Res, Rome, Italy; [Carpino, Guido] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, Unit Pathol, Rome, Italy; [Franchitto, Antonio; Onori, Paolo; Gaudio, Eugenio] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, I-00185 Rome, Italy; [Franchitto, Antonio] Eleonora Lorillard Spencer Cenci Fdn, Rome, Italy; [Alpini, Gianfranco] Scott & White Mem Hosp & Clin, Dept Med, Temple, TX USA; [Alpini, Gianfranco] Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX USA	IRCCS Bambino Gesu; Foro Italico University of Rome; IRCCS Bambino Gesu; Sapienza University Rome; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Gaudio, E (corresponding author), Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	eugenio.gaudio@uniroma1.it	Onori, Paolo/J-9394-2013; Nobili, Valerio/K-8670-2018; Alisi, Anna/A-6469-2010; Franchitto, Antonio/C-8095-2009; Carpino, Guido/AAB-9692-2019	Onori, Paolo/0000-0002-7195-3760; Alisi, Anna/0000-0001-7241-6329; nobili, valerio/0000-0002-4570-3979; De Vito, rita/0000-0002-7450-8398; FRANCHITTO, Antonio/0000-0003-0822-3690; CARPINO, Guido/0000-0001-8570-2519	University "Sapienza" of Rome; FIRB grant [RBAP10Z7FS_001]; PRIN grant [2009X84L84_001]	University "Sapienza" of Rome; FIRB grant(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	Grant support: E. Gaudio was supported by research project grant from the University "Sapienza" of Rome, FIRB grant # RBAP10Z7FS_001 and by PRIN grant # 2009X84L84_001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2012, NAT REV GASTRO HEPAT, V9, P152, DOI 10.1038/nrgastro.2011.273; Alkhouri N, 2012, J HEPATOL, V57, P1312, DOI 10.1016/j.jhep.2012.07.027; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Carpino G, 2013, INT J MOL SCI, V14, P20112, DOI 10.3390/ijms141020112; Carpino G, 2012, J ANAT, V220, P186, DOI 10.1111/j.1469-7580.2011.01462.x; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Depner CM, 2013, J NUTR; Gaudio E, 2009, DIGEST LIVER DIS, V41, P455, DOI 10.1016/j.dld.2009.03.009; Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li L, 2011, HEPATOLOGY, V54, P1620, DOI 10.1002/hep.24552; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Masterton GS, 2010, ALIMENT PHARM THER, V31, P679, DOI 10.1111/j.1365-2036.2010.04230.x; Nobili V, 2013, NUTR METAB CARDIOVAS, V23, P1066, DOI 10.1016/j.numecd.2012.10.010; NOBILI V, 2012, NUTR METAB CARDIOVAS; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Nobili V, 2012, HEPATOLOGY, V56, P2142, DOI 10.1002/hep.25742; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Pettinelli P, 2009, BBA-MOL BASIS DIS, V1792, P1080, DOI 10.1016/j.bbadis.2009.08.015; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Shannon A, 2011, J PEDIATR GASTR NUTR, V53, P190, DOI 10.1097/MPG.0b013e31821b4b61; Spee B, 2010, GUT, V59, P247, DOI 10.1136/gut.2009.188367; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122	34	94	95	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88005	10.1371/journal.pone.0088005	http://dx.doi.org/10.1371/journal.pone.0088005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505350	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300032
J	Potze, W; Arshad, F; Adelmeijer, J; Blokzijl, H; van den Berg, AP; Meijers, JCM; Porte, RJ; Lisman, T				Potze, Wilma; Arshad, Freeha; Adelmeijer, Jelle; Blokzijl, Hans; van den Berg, Arie P.; Meijers, Joost C. M.; Porte, Robert J.; Lisman, Ton			Differential In Vitro Inhibition of Thrombin Generation by Anticoagulant Drugs in Plasma from Patients with Cirrhosis	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; CONVENTIONAL COAGULATION TESTS; LIVER-DISEASE; COAGULOPATHY; CONSEQUENCES; HEMOSTASIS	Background: Treatment and prevention of thrombotic complications is frequently required in patients with cirrhosis. However anticoagulant therapy is often withheld from these patients, because of the perceived bleeding diathesis. As a result of the limited clinical experience, the anticoagulant of choice for the various indications is still not known. Objectives: We evaluated the in vitro effect of clinically approved anticoagulant drugs in plasma from patients with cirrhosis. Patients/Methods: Thirty patients with cirrhosis and thirty healthy controls were studied. Thrombin generation assays were performed before and after addition of unfractionated heparin, low molecular weight heparin, fondaparinux, dabigatran, and rivaroxaban, to estimate anticoagulant potencies of these drugs. Results: Addition of dabigatran led to a much more pronounced reduction in endogenous thrombin potential in patients compared to controls (72.6% reduction in patients vs. 12.8% reduction in controls, P<0.0001). The enhanced effect of dabigatran was proportional to the severity of disease. In contrast, only a slightly increased anticoagulant response to heparin and low molecular weight heparin and even a reduced response to fondaparinux and rivaroxaban was observed in plasma from cirrhotic patients as compared to control plasma. Conclusions: The anticoagulant potency of clinically approved drugs differs substantially between patients with cirrhosis and healthy individuals. Whereas dabigatran and, to a lesser extent, heparin and low molecular weight heparin are more potent in plasma from patients with cirrhosis, fondaparinux and rivaroxaban showed a decreased anticoagulant effect. These results may imply that in addition to dose adjustments based on altered pharmacokinetics, drug-specific dose adjustments based on altered anticoagulant potency may be required in patients with cirrhosis.	[Potze, Wilma; Arshad, Freeha; Adelmeijer, Jelle; Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands; [Blokzijl, Hans; van den Berg, Arie P.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol, Groningen, Netherlands; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Porte, Robert J.; Lisman, Ton] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Lisman, T (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands.	j.a.lisman@umcg.nl	Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780; Lisman, Ton/0000-0002-3503-7140	Tekke Huizinga Fonds [THF-127]	Tekke Huizinga Fonds	This study was sponsored inpart by grant THF-127 from the Tekke Huizinga Fonds (http://tekkehuizingafonds.nl/). There are no other external current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitrano L, 2010, J CLIN GASTROENTEROL, V44, P448, DOI 10.1097/MCG.0b013e3181b3ab44; Bechmann LP, 2011, LIVER INT, V31, P75, DOI 10.1111/j.1478-3231.2010.02358.x; Bloemen S, 2013, HAEMATOLOGICA, V98, P549, DOI 10.3324/haematol.2012.073601; Delahousse B, 2010, THROMB HAEMOSTASIS, V104, P741, DOI 10.1160/TH10-01-0040; Durand F, 2008, SEMIN LIVER DIS, V28, P110, DOI 10.1055/s-2008-1040325; Gatt A, 2010, J THROMB HAEMOST, V8, P1994, DOI 10.1111/j.1538-7836.2010.03937.x; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Intagliata NM, 2014, LIVER INT, V34, P26, DOI 10.1111/liv.12211; Lisman T, 2002, J HEPATOL, V37, P280, DOI 10.1016/S0168-8278(02)00199-X; Lisman T, 2013, J HEPATOL, V59, P358, DOI 10.1016/j.jhep.2013.03.027; Lisman T, 2011, LIVER INT, V31, P1063, DOI 10.1111/j.1478-3231.2011.02489.x; Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; Lisman T, 2010, J HEPATOL, V52, P355, DOI 10.1016/j.jhep.2009.12.001; Loeffen R, 2012, J THROMB HAEMOST, V10, P2544, DOI 10.1111/jth.12012; Northup PG, 2008, J THROMB HAEMOST, V6, P2; Potze W, 2013, BRIT J HAEMATOL, V163, P666, DOI 10.1111/bjh.12593; Senzolo M, 2012, J THROMB HAEMOST, V10, P1823, DOI 10.1111/j.1538-7836.2012.04824.x; Tripodi A, 2011, J THROMB HAEMOST, V9, P1713, DOI 10.1111/j.1538-7836.2011.04429.x; Tripodi A, 2005, HEPATOLOGY, V41, P553, DOI 10.1002/hep.20569; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Tripodi A, 2010, HEPATOLOGY, V52, P249, DOI 10.1002/hep.23653; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; Villa E, 2012, GASTROENTEROLOGY, V143, P1253, DOI 10.1053/j.gastro.2012.07.018	24	64	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88390	10.1371/journal.pone.0088390	http://dx.doi.org/10.1371/journal.pone.0088390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505487	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300076
J	Yu, MM; Sun, JY; Thakur, C; Chen, BL; Lu, YJ; Zhao, HW; Chen, F				Yu, Miaomiao; Sun, Jiaying; Thakur, Chitra; Chen, Bailing; Lu, Yongju; Zhao, Hongwen; Chen, Fei			Paradoxical Roles of Mineral Dust Induced Gene on Cell Proliferation and Migration/Invasion	PLOS ONE			English	Article							MYC TARGET GENE; INCREASED EXPRESSION; MICROARRAY DATA; LUNG-CANCER; MINA53; CARCINOMA; MDIG; SURVIVAL; PROTEINS; TOOL	Increased expression of mineral dust-induced gene (mdig, also named as mina53, MINA, or NO52) has been observed in a number of human cancers. The mechanism of how mdig contribute to the pathogenesis of cancer remains to be fully elucidated. In this report, we demonstrated that overexpression of mdig decreased the nuclear staining signal by 4',6-diamidino-2-phenylindole (DAPI), along with a considerable enhancement in cell proliferation. Silencing mdig by shRNA resulted in a statistically significant decrease of cell proliferation. Intriguingly, mdig overexpression reduced the capacity of the cells in migration and invasion in vitro, whereas silencing mdig by shRNA/siRNA enhanced migration and invasion. Clinically, we found that increased expression of mdig in cancer tissues correlates with poorer overall survival of the lung cancer patients, esp., for those without lymph node metastasis. Taken together, our results suggest that mdig plays opposite roles on cell growth and motility, which possibly indicates the paradoxical effect of mdig at the different stages of carcinogenesis.	[Yu, Miaomiao; Sun, Jiaying; Thakur, Chitra; Chen, Bailing; Lu, Yongju; Chen, Fei] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm, Detroit, MI USA; [Yu, Miaomiao; Sun, Jiaying; Zhao, Hongwen] China Med Univ, Dept Pulm Med, Inst Resp Dis, Hosp 1, Shenyang, Peoples R China; [Yu, Miaomiao] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China; [Sun, Jiaying] China Med Univ, Affiliated Hosp 4, Shenyang, Peoples R China	Wayne State University; China Medical University; China Medical University	Zhao, HW (corresponding author), China Med Univ, Dept Pulm Med, Inst Resp Dis, Hosp 1, Shenyang, Peoples R China.	hwzhao2007@yahoo.com; fchen@wayne.edu			NIH [R01 ES017217, R01 ES020137]; Wayne State University; NIH; National Natural Science Foundation of China [30770956]; Bureau of Science and Technology of Shenyang [F12-193-9-02]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017217, R01ES020137] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Shenyang; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research project is supported by NIH R01 ES017217 and R01 ES020137 to FC. MY and JS are joint-training graduate students between China Medical University and the Wayne State University, and are supported by Wayne State University start-up fund and NIH grants to FC. HZ was supported by National Natural Science Foundation of China (Grant No.: 30770956) and Bureau of Science and Technology of Shenyang (Grant No.: F12-193-9-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen BL, 2013, ONCOTARGET, V4, P1427, DOI 10.18632/oncotarget.1155; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; Fukahori S, 2007, J PEDIATR SURG, V42, P1831, DOI 10.1016/j.jpedsurg.2007.07.008; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ishizaki H, 2007, PATHOL INT, V57, P672, DOI 10.1111/j.1440-1827.2007.02156.x; Komiya K, 2010, LUNG CANCER, V69, P232, DOI 10.1016/j.lungcan.2009.10.010; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Kuratomi Kettaro, 2006, Kurume Medical Journal, V53, P71, DOI 10.2739/kurumemedj.53.71; Lian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080638; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Ogasawara S, 2010, HEPATOL RES, V40, P330, DOI 10.1111/j.1872-034X.2009.00604.x; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; Tan XP, 2012, ONCOL LETT, V3, P1037, DOI 10.3892/ol.2012.620; Teye K, 2004, AM J PATHOL, V164, P205, DOI 10.1016/S0002-9440(10)63111-2; Teye K, 2007, ONCOL REP, V18, P841; Thakur C, 2014, GENE, V535, P218, DOI 10.1016/j.gene.2013.11.031; Tsuneoka M, 2004, CLIN CANCER RES, V10, P7347, DOI 10.1158/1078-0432.CCR-03-0543; Tsuneoka M, 2002, J BIOL CHEM, V277, P35450, DOI 10.1074/jbc.M204458200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang Q, 2008, INT J BIOL MARKER, V23, P83, DOI 10.1177/172460080802300204; Zhang YD, 2005, ONCOGENE, V24, P4873, DOI 10.1038/sj.onc.1208668	23	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87998	10.1371/journal.pone.0087998	http://dx.doi.org/10.1371/journal.pone.0087998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505346	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300029
J	Bergmann, JHM; Langdon, PM; Mayagoitia, RE; Howard, N				Bergmann, Jeroen H. M.; Langdon, Patrick M.; Mayagoitia, Ruth E.; Howard, Newton			Exploring the Use of Sensors to Measure Behavioral Interactions: An Experimental Evaluation of Using Hand Trajectories	PLOS ONE			English	Article							WAVELET COHERENCE; INERTIAL SENSORS; MOVEMENT; TIME; MOTION; PERSONALITY; ASSESSMENTS; PERSPECTIVE; PERFORMANCE; CONSISTENCY	Humans appear to be sensitive to relative small changes in their surroundings. These changes are often initially perceived as irrelevant, but they can cause significant changes in behavior. However, how exactly people's behavior changes is often hard to quantify. A reliable and valid tool is needed in order to address such a question, ideally measuring an important point of interaction, such as the hand. Wearable-body-sensor systems can be used to obtain valuable, behavioral information. These systems are particularly useful for assessing functional interactions that occur between the endpoints of the upper limbs and our surroundings. A new method is explored that consists of computing hand position using a wearable sensor system and validating it against a gold standard reference measurement (optical tracking device). Initial outcomes related well to the gold standard measurements (r = 0.81) showing an acceptable average root mean square error of 0.09 meters. Subsequently, the use of this approach was further investigated by measuring differences in motor behavior, in response to a changing environment. Three subjects were asked to perform a water pouring task with three slightly different containers. Wavelet analysis was introduced to assess how motor consistency was affected by these small environmental changes. Results showed that the behavioral motor adjustments to a variable environment could be assessed by applying wavelet coherence techniques. Applying these procedures in everyday life, combined with correct research methodologies, can assist in quantifying how environmental changes can cause alterations in our motor behavior.	[Bergmann, Jeroen H. M.; Howard, Newton] Brain Sci Fdn, Providence, RI 02906 USA; [Bergmann, Jeroen H. M.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Langdon, Patrick M.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Mayagoitia, Ruth E.] Kings Coll London, Div Hlth & Social Care Res, London, England; [Bergmann, Jeroen H. M.; Howard, Newton] MIT, Synthet Intelligence Lab, Boston, MA USA	University of London; King's College London; University of Cambridge; University of London; King's College London; Massachusetts Institute of Technology (MIT)	Bergmann, JHM (corresponding author), Brain Sci Fdn, Providence, RI 02906 USA.	jeroen.bergmann@media.mit.edu	Skrypchuk, Lee/AAF-3614-2019	Bergmann, Jeroen/0000-0001-7306-2630; Howard, Newton/0000-0002-8503-3973	Brain Sciences Foundation	Brain Sciences Foundation	The Brain Sciences Foundation (www.brainsciences.org) provided support through the fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2003, J HAND SURG-AM, V28A, P898, DOI 10.1016/S0363-5023(03)00424-6; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BELLIZZI JA, 1983, J RETAILING, V59, P21; Bergmann JHM, 2011, ANN BIOMED ENG, V39, P2299, DOI 10.1007/s10439-011-0339-9; Bergmann Jeroen H M, 2009, Dyn Med, V8, P3, DOI 10.1186/1476-5918-8-3; Bigot J, 2011, NEUROIMAGE, V55, P1504, DOI 10.1016/j.neuroimage.2011.01.033; Cappozzo A, 1996, CLIN BIOMECH, V11, P90, DOI 10.1016/0268-0033(95)00046-1; Catarino A, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-1; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Elgendi M, 2012, REAL TIME SPEED DETE; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Forner-Cordero A, 2008, PHYSIOL MEAS, V29, pN21, DOI 10.1088/0967-3334/29/4/N01; Furr RM, 2004, J RES PERS, V38, P421, DOI 10.1016/j.jrp.2003.10.001; Garling EH, 2007, J BIOMECH, V40, pS18, DOI 10.1016/j.jbiomech.2007.03.003; Halamek J., 2001, MEASUREMENT SCI REV, V1, P71; Hawkes C, 2009, J ANIM ECOL, V78, P894, DOI 10.1111/j.1365-2656.2009.01534.x; Howard N, 2011, LXIO MOOD DETECTION; Howard N, 2013, LECT NOTES IN PRESS; KEE DW, 1983, NEUROPSYCHOLOGIA, V21, P617, DOI 10.1016/0028-3932(83)90059-3; Lachaux JP, 2002, NEUROPHYSIOL CLIN, V32, P157, DOI 10.1016/S0987-7053(02)00301-5; Larson DR, 2006, ARXIVMATH060461504; Levitis DA, 2009, ANIM BEHAV, V78, P103, DOI 10.1016/j.anbehav.2009.03.018; Lichtwark GA, 2006, J EXP BIOL, V209, P4379, DOI 10.1242/jeb.02434; Loseu V, 2012, P IEEE, V100, P107, DOI 10.1109/JPROC.2011.2161238; May-Lisowski TL, 2008, AM J OCCUP THER, V62, P438, DOI 10.5014/ajot.62.4.438; Mioshi E, 2009, ALZ DIS ASSOC DIS, V23, P70, DOI 10.1097/WAD.0b013e318182d293; Nurse MA, 1999, CLIN BIOMECH, V14, P667, DOI 10.1016/S0268-0033(99)00020-0; O'Donovan KJ, 2007, J BIOMECH, V40, P2604, DOI 10.1016/j.jbiomech.2006.12.010; Ohgi S, 2008, PHYS THER, V88, P1022, DOI 10.2522/ptj.20070171; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Shamoun-Baranes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037997; Thatcher RW, 2012, DEV NEUROPSYCHOL, V37, P476, DOI 10.1080/87565641.2011.619241; Thies SB, 2007, MED ENG PHYS, V29, P967, DOI 10.1016/j.medengphy.2006.10.012; Vacha L, 2012, ENERG ECON, V34, P241, DOI 10.1016/j.eneco.2011.10.007; Verloigne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-34; Wiesendanger M, 1999, EXP BRAIN RES, V128, P1, DOI 10.1007/s002210050810; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x; Zhou H, 2008, MED ENG PHYS, V30, P123, DOI 10.1016/j.medengphy.2006.11.010; Zoia S, 2006, DEV NEUROPSYCHOL, V30, P719, DOI 10.1207/s15326942dn3002_4	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88080	10.1371/journal.pone.0088080	http://dx.doi.org/10.1371/journal.pone.0088080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516583	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400028
J	Lewis, MD; Pfeil, J; Heiss, K; Mueller, AK				Lewis, Matthew D.; Pfeil, Johannes; Heiss, Kirsten; Mueller, Ann-Kristin			CD8(+) T Cells Mediate Robust Stage-Specific Immunity to P. berghei under Chemoprophylaxis and This Protective Environment Is Not Downregulated by the Presence of Blood-Stage Infection	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; LIVER-STAGE; MALARIA PARASITES; SPOROZOITE STAGE; CHLOROQUINE; IMMUNIZATION; FALCIPARUM; VACCINE; SUSCEPTIBILITY; SUPPRESSION	Sterile protection against malaria infection can be achieved by the inoculation of intact sporozoites while treating concomitantly with the 4-aminoquinoline chloroquine. We present an analysis of protective immunity elicited by successive immunization with Plasmodium berghei sporozoites under chemoprophylaxis. Immunization resulted in a protective, stage-specific immune response. Protection appeared to be mediated by CD8(+) T cells and was abrogated upon their specific depletion. Adoptive transfer of splenocytes rendered recipient animals resistant to sporozoite infection, but not to blood-stage challenge. Immunization with sporozoites under chemoprophylaxis results in robust immunity, and the presence of blood-stage infection at sporozoite immunization had no downregulating effect on the protective immune response.	[Lewis, Matthew D.; Pfeil, Johannes; Heiss, Kirsten; Mueller, Ann-Kristin] Univ Heidelberg Hosp, Dept Infect Dis, Parasitol Unit, Heidelberg, Germany; [Pfeil, Johannes] Univ Heidelberg Hosp, Ctr Childhood & Adolescence Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mueller, AK (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Parasitol Unit, Heidelberg, Germany.	ann-kristin.mueller@uni-heidelberg.de		Pfeil, Johannes/0000-0003-0104-8375; Lewis, Matthew/0000-0003-4515-6896	Heidelberg University Hospital	Heidelberg University Hospital	This work was funded by the Heidelberg University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUDOIN RL, 1977, EXP PARASITOL, V42, P1, DOI 10.1016/0014-4894(77)90054-6; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Bijker EM, 2013, P NATL ACAD SCI US; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; FINK E, 1974, B WORLD HEALTH ORGAN, V50, P213; Fink E, 1974, BMC RES NOTES, V50, P213; Friesen J, 2011, VACCINE, V29, P7002, DOI 10.1016/j.vaccine.2011.07.034; Hill DR, 2006, AM J TROP MED HYG, V75, P402, DOI 10.4269/ajtmh.2006.75.402; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1986, NEW ENGL J MED, V315, P601, DOI 10.1056/NEJM198609043151001; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Menard R, 2013, NAT REV MICROBIOL, V11, P701, DOI 10.1038/nrmicro3111; MOST H, 1975, AM J TROP MED HYG, V24, P179, DOI 10.4269/ajtmh.1975.24.179; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nganou-Makamdop K, 2012, PARASITE IMMUNOL, V34, P562, DOI 10.1111/pim.12000.x; Nganou-Makamdop K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036508; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; ORJIH AU, 1985, CLIN EXP IMMUNOL, V61, P67; ORJIH AU, 1979, CLIN EXP IMMUNOL, V38, P1; ORJIH AU, 1994, EXPERIENTIA, V50, P34, DOI 10.1007/BF01992046; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Wang QF, 2012, CANCER RES, V72, P4417, DOI 10.1158/0008-5472.CAN-12-1339-T; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784; YOELI M, 1965, NATURE, V205, P715, DOI 10.1038/205715a0	34	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88117	10.1371/journal.pone.0088117	http://dx.doi.org/10.1371/journal.pone.0088117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516592	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400032
J	Chen, Y; Yu, CH; Li, YM				Chen, Yi; Yu, Chaohui; Li, Youming			Physical Activity and Risks of Esophageal and Gastric Cancers: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; POPULATION-BASED COHORT; INSULIN SENSITIVITY; ADIPOSE-TISSUE; LEISURE-TIME; BODY-MASS; EXERCISE; ADENOCARCINOMAS; MORTALITY; STOMACH	Background: The incidence of esophageal and gastric cancer has been increasing rapidly worldwide in recent years, although the reason for this increase is unclear. Here, a statistical synthesis of studies that evaluated the association between physical activity, a well-known protecting factor against death and other chronic diseases, and the risk of esophageal and gastric cancer was performed. Methods: Potentially suitable studies were identified using Medline and Embase. The reference lists of all included articles and those of several recent reviews were searched manually. Studies were included if they (1) were published as case-control or cohort studies evaluating the association between physical activity and risk of esophageal or gastric cancer; and (2) reported point estimates (i.e., risk ratios, odds ratios) and measures of variability (i.e., 95% confidence intervals [CIs]) for physical activity and risk of esophageal or gastric cancer. Results: Fifteen studies were identified (7 cohorts, 8 case-controls; 984 esophageal and 7,087 gastric cancers). Collectively, they indicated that the risk of gastric cancer was 13% lower among the most physically active people than among the least active people (RR = 0.87, 95% confidence interval [CI] = 0.78 to 0.97) and that of esophageal cancer was 27% lower (RR = 0.73, 95% CI = 0.56 to 0.97). Conclusions: Pooled results from observational studies support a protective effect of physical activity against both esophageal and gastric cancer.	[Chen, Yi; Yu, Chaohui; Li, Youming] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China.	zlym@zju.edu.cn		Ma, Han/0000-0001-9985-3035	National Key Basic Research Development Program [2012CB524905]; National Science and Technology Support Plan Project [2012BAI06B04]; National Natural Science Foundation of China [31070315, 81100278, 81170378]; Zhejiang Provincial Natural Science Foundation of China [Y2110026]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]	National Key Basic Research Development Program(National Basic Research Program of China); National Science and Technology Support Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science Foundation of Health Bureau of Zhejiang Province	This study was supported by National Key Basic Research Development Program (No. 2012CB524905), National Science and Technology Support Plan Project (No. 2012BAI06B04), National Natural Science Foundation of China (Nos. 31070315, 81100278, and 81170378), Zhejiang Provincial Natural Science Foundation of China (No. Y2110026), and Science Foundation of Health Bureau of Zhejiang Province (No. 2012RCA026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2008, WORLD CANC REPORT; Balbuena L, 2009, FUTURE ONCOL, V5, P1051, DOI 10.2217/FON.09.65; Batty GD, 2010, ANN EPIDEMIOL, V20, P661, DOI 10.1016/j.annepidem.2010.03.014; Batty GD, 2001, EUR J EPIDEMIOL, V17, P863, DOI 10.1023/A:1015609909969; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Boccia S, 2005, CANCER LETT, V229, P235, DOI 10.1016/j.canlet.2005.06.035; Boyle T, 2012, JNCI-J NATL CANCER I, V104, P1548, DOI 10.1093/jnci/djs354; Bradley RL, 2008, AM J PHYSIOL-ENDOC M, V295, pE586, DOI 10.1152/ajpendo.00309.2007; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; BROWNSON RC, 1991, AM J PUBLIC HEALTH, V81, P639, DOI 10.2105/AJPH.81.5.639; Campbell PT, 2007, EUR J CANCER, V43, P593, DOI 10.1016/j.ejca.2006.11.011; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chen MJ, 2009, WORLD J GASTROENTERO, V15, P5472, DOI 10.3748/wjg.15.5472; Daly JM, 1996, CANCER, V78, P1820, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z; Jonge PJF, 2007, ALIMENT PHARM THER, V26, P31, DOI 10.1111/j.1365-2036.2007.03344.x; DOSEMECI M, 1993, CANCER CAUSE CONTROL, V4, P313, DOI 10.1007/BF00051333; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Etemadi A, 2012, ANN ONCOL, V23, P1593, DOI 10.1093/annonc/mdr494; Hao JJ, 2013, GENE, V513, P196, DOI 10.1016/j.gene.2012.09.091; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; Jessri M, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-137; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Khushalani NI, 2008, MAYO CLIN PROC, V83, P712; Kim ES, 2007, OBESITY, V15, P3023, DOI 10.1038/oby.2007.360; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; Lam TH, 2004, ANN EPIDEMIOL, V14, P391, DOI 10.1016/j.annepidem.2003.09.005; Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D; Leitzmann MF, 2009, AM J PREV MED, V36, P112, DOI 10.1016/j.amepre.2008.09.033; Ligibel JA, 2008, J CLIN ONCOL, V26, P907, DOI 10.1200/JCO.2007.12.7357; Huerta JM, 2010, CANCER CAUSE CONTROL, V21, P657, DOI 10.1007/s10552-009-9493-x; Parent ME, 2011, CANCER EPIDEMIOL, V35, P151, DOI 10.1016/j.canep.2010.09.004; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; SEVERSON RK, 1989, AM J EPIDEMIOL, V130, P522, DOI 10.1093/oxfordjournals.aje.a115366; Sjodahl K, 2008, CANCER EPIDEM BIOMAR, V17, P135, DOI 10.1158/1055-9965.EPI-07-0704; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; STUKONIS M, 1969, INT J CANCER, V4, P248, DOI 10.1002/ijc.2910040215; Sun JY, 2012, ASIAN PAC J CANCER P, V13, P3143, DOI 10.7314/APJCP.2012.13.7.3143; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Vigen C, 2006, INT J CANCER, V118, P1004, DOI 10.1002/ijc.21419; Wannamethee SG, 2001, BRIT J CANCER, V85, P1311, DOI 10.1054/bjoc.2001.2096; Wen XY, 2010, ASIAN PAC J CANCER P, V11, P1473; Wolin KY, 2011, BRIT J CANCER, V104, P882, DOI 10.1038/sj.bjc.6606045; Wolin KY, 2011, RECENT RESULTS CANC, V186, P73, DOI 10.1007/978-3-642-04231-7_4; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Yun YH, 2004, CANCER DETECT PREV, V29, P15, DOI 10.1016/j.cdp.2004.08.006; Zhang ZF, 1996, CANCER EPIDEM BIOMAR, V5, P761	49	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88082	10.1371/journal.pone.0088082	http://dx.doi.org/10.1371/journal.pone.0088082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516584	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700040
J	Harris, MR; Siefferman, L				Harris, Morgan R.; Siefferman, Lynn			Interspecific Competition Influences Fitness Benefits of Assortative Mating for Territorial Aggression in Eastern Bluebirds (Sialia sialis)	PLOS ONE			English	Article							GREAT TITS; NEST-SITES; AVIAN PERSONALITIES; INDIVIDUAL-DIFFERENCES; EXPLORATORY-BEHAVIOR; SEXUAL SELECTION; PARUS-MAJOR; CONSEQUENCES; ECOLOGY; BIRDS	Territorial aggression influences fitness and, in monogamous pairs, the behavior of both individuals could impact reproductive success. Moreover, territorial aggression is particularly important in the context of interspecific competition. Tree swallows and eastern bluebirds are highly aggressive, secondary cavity-nesting birds that compete for limited nesting sites. We studied eastern bluebirds at a field site in the southern Appalachian Mountains that has been recently colonized (<40 yr) by tree swallows undergoing a natural range expansion. The field site is composed of distinct areas where bluebirds compete regularly with tree swallows and areas where there is little interaction between the two species. Once birds had settled, we measured how interspecific competition affects the relationship between assortative mating (paired individuals that behave similarly) and reproductive success in eastern bluebirds. We found a strong tendency toward assortative mating throughout the field site. In areas of high interspecific competition, pairs that behaved the most similarly and displayed either extremely aggressive or extremely non-aggressive phenotypes experienced higher reproductive success. Our data suggest that interspecific competition with tree swallows may select for bluebirds that express similar behavior to that of their mate. Furthermore, animal personality may be an important factor influencing the outcome of interactions between native and aggressive, invasive species.	[Harris, Morgan R.; Siefferman, Lynn] Appalachian State Univ, Dept Biol, Boone, NC 28608 USA	University of North Carolina; Appalachian State University	Harris, MR (corresponding author), Appalachian State Univ, Dept Biol, Boone, NC 28608 USA.	harrismr@appstate.edu		Siefferman, Lynn/0000-0002-9600-2902	Wilson Ornitholigical Society - Paul A. Stewart Award; Appalachian State University - Office of Student Research Grant; Appalachian State; University - URC Grant; High Country Audubon Society - Sue Wells Grant; North American Bluebird Society - NABS Grants; North Carolina Wildlife Federation - NCWF Scholarship Grant	Wilson Ornitholigical Society - Paul A. Stewart Award; Appalachian State University - Office of Student Research Grant; Appalachian State; University - URC Grant; High Country Audubon Society - Sue Wells Grant; North American Bluebird Society - NABS Grants; North Carolina Wildlife Federation - NCWF Scholarship Grant	Funding from Wilson Ornitholigical Society - Paul A. Stewart Award, http://www.wilsonsociety.org; Appalachian State University - Office of Student Research Grant, http://osr.appstate.edu; Appalachian State; University - URC Grant, http://orsp.appstate.edu; High Country Audubon Society - Sue Wells Grant, http://www.highcountryaudubon.org; North American Bluebird Society - NABS Grants, http://www.nabluebirdsociety.org; North Carolina Wildlife Federation - NCWF Scholarship Grant, http://www.ncwf.org. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SOURCE MEAT CAMP NC; Bentz AB, 2013, J AVIAN BIOL, V44, P80, DOI 10.1111/j.1600-048X.2012.05730.x; Betini GS, 2012, ANIM BEHAV, V83, P137, DOI 10.1016/j.anbehav.2011.10.018; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Budaev SV, 1999, ANIM BEHAV, V58, P195, DOI 10.1006/anbe.1999.1124; BURLEY N, 1983, ETHOL SOCIOBIOL, V4, P191, DOI 10.1016/0162-3095(83)90009-2; Burtka JL, 2013, ACTA ETHOL, V16, P135, DOI 10.1007/s10211-013-0143-7; Cain KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077816; Cain KE, 2012, BEHAV ECOL SOCIOBIOL, V66, P241, DOI 10.1007/s00265-011-1272-5; Cain KE, 2011, ETHOLOGY, V117, P786, DOI 10.1111/j.1439-0310.2011.01932.x; Carere C, 2004, PHYSIOL BEHAV, V82, P905, DOI 10.1016/j.physbeh.2004.07.009; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C, 2013, TRENDS ECOL EVOL, V28, P5, DOI 10.1016/j.tree.2012.10.006; Sanches FHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029746; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Duckworth RA, 2006, BEHAV ECOL, V17, P1011, DOI 10.1093/beheco/arl035; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gabriel PO, 2012, ETHOLOGY, V118, P76, DOI 10.1111/j.1439-0310.2011.01990.x; GIMELFARB A, 1988, AM NAT, V131, P865, DOI 10.1086/284827; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gowaty Patricia Adair, 1998, Birds of North America, V381, P1; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Guillette LM, 2011, P ROY SOC B-BIOL SCI, V278, P767, DOI 10.1098/rspb.2010.1669; Herborn KA, 2010, ANIM BEHAV, V79, P835, DOI 10.1016/j.anbehav.2009.12.026; Hersey F. S, 1933, AUK, V50, P109, DOI [10.2307/4076583, DOI 10.2307/4076583]; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; HOUTMAN AM, 1994, ANIM BEHAV, V48, P377, DOI 10.1006/anbe.1994.1251; HUNTINGFORD FA, 1976, ANIM BEHAV, V24, P485, DOI 10.1016/S0003-3472(76)80061-9; IBM Corp, 2011, IBM SPSS STAT MACOSX; Jawor JM, 2003, BEHAV ECOL, V14, P515, DOI 10.1093/beheco/arg041; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Kralj-Fiser S, 2013, BEHAV ECOL, V24, P824, DOI 10.1093/beheco/art030; Krist M, 2004, BIRD STUDY, V51, P41, DOI 10.1080/00063650409461331; LEE DS, 1993, BRIMLEYANA, P103; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lynn SE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P699, DOI 10.1086/605915; McCarty JP, 1999, CONDOR, V101, P246, DOI 10.2307/1369987; McGlothlin JW, 2007, AM NAT, V170, P864, DOI 10.1086/522838; MEEK SB, 1994, ANIM BEHAV, V47, P295, DOI 10.1006/anbe.1994.1042; Mettke-Hofmann C, 2005, BEHAVIOUR, V142, P1357, DOI 10.1163/156853905774539427; MURRAY BG, 1971, ECOLOGY, V52, P414, DOI 10.2307/1937624; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; O'Neill RV, 1989, LANDSCAPE ECOL, V3, P193, DOI 10.1007/BF00131538; Pearce D, 2011, AUK, V128, P497, DOI 10.1525/auk.2011.11085; PINKOWSKI BC, 1975, BIRD BANDING, V46, P273, DOI 10.2307/4512159; Robertson R.J., 1992, Birds of North America, V11, P1; ROBERTSON RJ, 1990, CAN J ZOOL, V68, P1046, DOI 10.1139/z90-152; ROBINSON SK, 1995, J ANIM ECOL, V64, P1, DOI 10.2307/5822; Rosvall KA, 2008, ANIM BEHAV, V75, P1603, DOI 10.1016/j.anbehav.2007.09.038; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rosvall KA, 2011, ETHOLOGY, V117, P332, DOI 10.1111/j.1439-0310.2011.01881.x; Scales J, 2013, ANIM BEHAV, V85, P441, DOI 10.1016/j.anbehav.2012.12.004; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Siefferman L, 2005, ANIM BEHAV, V69, P67, DOI 10.1016/j.anbehav.2003.12.026; Sinn DL, 2006, J EVOLUTION BIOL, V19, P1437, DOI 10.1111/j.1420-9101.2006.01136.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Spoon TR, 2006, ANIM BEHAV, V71, P315, DOI 10.1016/j.anbehav.2005.03.034; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Tuttle EM, 2003, BEHAV ECOL, V14, P425, DOI 10.1093/beheco/14.3.425; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Wagner Steve, 2002, Chat (Raleigh), V66, P145; Webster MM, 2009, BEHAV ECOL SOCIOBIOL, V63, P511, DOI 10.1007/s00265-008-0685-2; Wiebe KL, 2011, J FIELD ORNITHOL, V82, P239, DOI 10.1111/j.1557-9263.2011.00327.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001	67	40	40	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88668	10.1371/journal.pone.0088668	http://dx.doi.org/10.1371/journal.pone.0088668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516672	Green Submitted, gold, Green Published			2022-12-27	WOS:000330830700079
J	Chen, WW; Cheng, X; Chen, JZ; Yi, X; Nie, DK; Sun, XH; Qin, JB; Tian, ML; Jin, GH; Zhang, XH				Chen, Weiwei; Cheng, Xiang; Chen, Jinzhong; Yi, Xin; Nie, Dekang; Sun, Xiaohui; Qin, Jianbing; Tian, Meiling; Jin, Guohua; Zhang, Xinhua			Lycium barbarum Polysaccharides Prevent Memory and Neurogenesis Impairments in Scopolamine-Treated Rats	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; INDUCED OXIDATIVE STRESS; AMYLOID PEPTIDE NEUROTOXICITY; OCULAR HYPERTENSION MODEL; RETINAL GANGLION-CELLS; ANTIOXIDANT ACTIVITY; INDUCED AMNESIA; NEUROBLAST DIFFERENTIATION; ALZHEIMERS-DISEASE; PROTEIN COMPLEX	Lycium barbarum is used both as a food additive and as a medicinal herb in many countries, and L. barbarum polysaccharides (LBPs), a major cell component, are reported to have a wide range of beneficial effects including neuroprotection, anti-aging and anticancer properties, and immune modulation. The effects of LBPs on neuronal function, neurogenesis, and drug-induced learning and memory deficits have not been assessed. We report the therapeutic effects of LBPs on learning and memory and neurogenesis in scopolamine (SCO)-treated rats. LBPs were administered via gastric perfusion for 2 weeks before the onset of subcutaneous SCO treatment for a further 4 weeks. As expected, SCO impaired performance in novel object and object location recognition tasks, and Morris water maze. However, dual SCO- and LBP-treated rats spent significantly more time exploring the novel object or location in the recognition tasks and had significant shorter escape latency in the water maze. SCO administration led to a decrease in Ki67- or DCX-immunoreactive cells in the dentate gyrus and damage of dendritic development of the new neurons; LBP prevented these SCO-induced reductions in cell proliferation and neuroblast differentiation. LBP also protected SCO-induced loss of neuronal processes in DCX-immunoreactive neurons. Biochemical investigation indicated that LBP decreased the SCO-induced oxidative stress in hippocampus and reversed the ratio Bax/Bcl-2 that exhibited increase after SCO treatment. However, decrease of BDNF and increase of AChE induced by SCO showed no response to LBP administration. These results suggest that LBPs can prevent SCO-induced cognitive and memory deficits and reductions in cell proliferation and neuroblast differentiation. Suppression of oxidative stress and apoptosis may be involved in the above effects of LBPs that may be a promising candidate to restore memory functions and neurogenesis.	[Chen, Weiwei; Cheng, Xiang; Yi, Xin; Qin, Jianbing; Tian, Meiling; Jin, Guohua; Zhang, Xinhua] Nantong Univ, Dept Anat, Nantong, Jiangsu, Peoples R China; [Chen, Weiwei; Chen, Jinzhong] Southeast Univ, Affiliated Yancheng Hosp, Peoples Hosp Yancheng 3, Dept Radiotherapy, Yancheng, Jiangsu, Peoples R China; [Nie, Dekang] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Jiangsu, Peoples R China; [Sun, Xiaohui] Rehabil Hosp Agings, Cardiovasc Dept, Nantong, Jiangsu, Peoples R China	Nantong University; Southeast University - China; Nantong University	Jin, GH (corresponding author), Nantong Univ, Dept Anat, Nantong, Jiangsu, Peoples R China.	jguohua@ntu.edu.cn; zhangxinhua@ntu.edu.cn		Zhang, Xin-hua/0000-0002-5702-6733	National Natural Science Foundation of China [31171038]; Jiangsu Natural Science Foundation [BK2011385]; Jiangsu Natural College Foundation [11KJB180008]; Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Natural College Foundation; Nantong University for Innovation Talent; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 31171038), Jiangsu Natural Science Foundation (BK2011385), Jiangsu Natural College Foundation (11KJB180008), the Grant of Nantong University for Innovation Talent and a project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Bromley-Brits K, 2011, JOVE-J VIS EXP, DOI 10.3791/2920; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Cheng D, 2011, MOLECULES, V16, P2542, DOI 10.3390/molecules16032542; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cui BK, 2011, MOLECULES, V16, P9116, DOI 10.3390/molecules16119116; Deng HB, 2003, BIOMED ENVIRON SCI, V16, P267; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; El-Sherbiny DA, 2003, PHARMACOL BIOCHEM BE, V76, P525, DOI 10.1016/j.pbb.2003.09.014; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gan L, 2004, INT IMMUNOPHARMACOL, V4, P563, DOI 10.1016/j.intimp.2004.01.023; Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2; Gao XM., 2000, TRADITIONAL CHINESE; Hancianu M, 2013, PHYTOMEDICINE, V20, P446, DOI 10.1016/j.phymed.2012.12.005; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Ho YS, 2007, BRAIN RES, V1158, P123, DOI 10.1016/j.brainres.2007.04.075; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jahanshahi M, 2013, ANAT SCI INT, V88, P217, DOI 10.1007/s12565-013-0188-8; Jeong EJ, 2008, EUR J PHARMACOL, V588, P78, DOI 10.1016/j.ejphar.2008.04.015; Jing LJ, 2009, AFR J TRADIT COMPLEM, V6, P579; Kempermann G, 2000, NOVART FDN SYMP, V231, P220, DOI 10.1002/0470870834.ch14; Konar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027265; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Kotani S, 2008, CHEM-BIOL INTERACT, V175, P227, DOI 10.1016/j.cbi.2008.04.004; Kumar H, 2012, BIOSCI BIOTECH BIOCH, V76, P1518, DOI 10.1271/bbb.120247; Lau BWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033374; LI QY, 2001, HLTH FUNCTIONS MED P, P1; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li XM, 2007, J ETHNOPHARMACOL, V111, P504, DOI 10.1016/j.jep.2006.12.024; Li XM, 2007, EUR POLYM J, V43, P488, DOI 10.1016/j.eurpolymj.2006.10.025; Lin CL, 2009, INT J BIOL MACROMOL, V45, P146, DOI 10.1016/j.ijbiomac.2009.04.014; Luo Q, 2004, LIFE SCI, V76, P137, DOI 10.1016/j.lfs.2004.04.056; Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012; Luo Q, 2011, PHYTOTHER RES, V25, P694, DOI 10.1002/ptr.3314; Ma M, 2009, FOOD CHEM, V113, P872, DOI 10.1016/j.foodchem.2008.03.064; Mao F, 2011, MED ONCOL, V28, P121, DOI 10.1007/s12032-009-9415-5; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Nade VS, 2011, INDIAN J PHARMACOL, V43, P137, DOI 10.4103/0253-7613.77347; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Pandareesh MD, 2013, CELL MOL NEUROBIOL, V33, P875, DOI 10.1007/s10571-013-9952-5; Potterat O, 2010, PLANTA MED, V76, P7, DOI 10.1055/s-0029-1186218; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Shan XZ, 2011, INT J MOL SCI, V12, P1081, DOI 10.3390/ijms12021081; Tang Wai-Man, 2012, Inflammopharmacology, V20, P307, DOI 10.1007/s10787-011-0107-3; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang CC, 2010, FOOD CHEM, V120, P184, DOI 10.1016/j.foodchem.2009.10.005; Wang YR, 2002, J ETHNOPHARMACOL, V82, P169, DOI 10.1016/S0378-8741(02)00169-1; WINTERBOURN CC, 1975, J LAB CLIN MED, V85, P337; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xin YF, 2011, FOOD CHEM TOXICOL, V49, P259, DOI 10.1016/j.fct.2010.10.028; Yoo DY, 2013, NEUROL RES, V35, P813, DOI 10.1179/1743132813Y.0000000217; Yoo DY, 2011, NEUROCHEM INT, V59, P722, DOI 10.1016/j.neuint.2011.06.021; Yoo DY, 2011, PHYTOTHER RES, V25, P809, DOI 10.1002/ptr.3337; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zhang M, 2005, LIFE SCI, V76, P2115, DOI 10.1016/j.lfs.2004.11.009; Zhang ZP, 2011, CELL BIOL TOXICOL, V27, P107, DOI 10.1007/s10565-010-9174-2; Zhi Fei, 2004, Zhong Yao Cai, V27, P948	67	68	73	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88076	10.1371/journal.pone.0088076	http://dx.doi.org/10.1371/journal.pone.0088076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505383	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200111
J	Cho, HW; Hwang, EH; Lim, B; Heo, KH; Liu, JP; Tsutani, K; Lee, MS; Shin, BC				Cho, Hyun-Woo; Hwang, Eui-Hyoung; Lim, Byungmook; Heo, Kwang-Ho; Liu, Jian-Ping; Tsutani, Kiichiro; Lee, Myeong Soo; Shin, Byung-Cheul			How Current Clinical Practice Guidelines for Low Back Pain Reflect Traditional Medicine in East Asian Countries: A Systematic Review of Clinical Practice Guidelines and Systematic Reviews	PLOS ONE			English	Review							EVIDENCE-INFORMED MANAGEMENT; ALTERNATIVE MEDICINE; CHINESE MEDICINE; ACUPUNCTURE; QUALITY; COMPLEMENTARY; FRAMEWORK; HEALTH; METAANALYSIS; VALIDITY	Objectives: The aims of this study were to investigate whether there is a gap between evidence of traditional medicine (TM) interventions in East-Asian countries from the current Clinical Practice Guidelines (CPGs) and evidence from current systematic reviews and meta-analyses (SR-MAs) and to analyze the impact of this gap on present CPGs. Methods: We examined 5 representative TM interventions in the health care systems of East-Asian countries. We searched seven relevant databases for CPGs to identify whether core CPGs included evidence of TM interventions, and we searched 11 databases for SR-MAs to re-evaluate current evidence on TM interventions. We then compared the gap between the evidence from CPGs and SR-MAs. Results: Thirteen CPGs and 22 SR-MAs met our inclusion criteria. Of the 13 CPGs, 7 CPGs (54%) mentioned TM interventions, and all were for acupuncture (only one was for both acupuncture and acupressure). However, the CPGs did not recommend acupuncture (or acupressure). Of 22 SR-MAs, 16 were for acupuncture, 5 for manual therapy, 1 for cupping, and none for moxibustion and herbal medicine. Comparing the evidence from CPGs and SR-MAs, an underestimation or omission of evidence for acupuncture, cupping, and manual therapy in current CPGs was detected. Thus, applying the results from the SR-MAs, we moderately recommend acupuncture for chronic LBP, but we inconclusively recommend acupuncture for (sub) acute LBP due to the limited current evidence. Furthermore, we weakly recommend cupping and manual therapy for both (sub) acute and chronic LBP. We cannot provide recommendations for moxibustion and herbal medicine due to a lack of evidence. Conclusions: The current CPGs did not fully reflect the evidence for TM interventions. As relevant studies such as SR-MAs are conducted and evidence increases, the current evidence on acupuncture, cupping, and manual therapy should be rigorously considered in the process of developing or updating the CPG system.	[Cho, Hyun-Woo; Hwang, Eui-Hyoung; Heo, Kwang-Ho; Shin, Byung-Cheul] Pusan Natl Univ, Korean Med Hosp, Spine & Joint Ctr, Dept Rehabil Med Korean Med, Yangsan, South Korea; [Hwang, Eui-Hyoung; Shin, Byung-Cheul] Pusan Natl Univ, Sch Korean Med, Div Clin Med, Yangsan, South Korea; [Lim, Byungmook] Pusan Natl Univ, Sch Korean Med, Div Humanities & Social Sci, Yangsan, South Korea; [Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Tsutani, Kiichiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Drug Policy & Management, Tokyo, Japan; [Lee, Myeong Soo] Korea Inst Oriental Med, Brain Dis Res Ctr, Taejon, South Korea	Pusan National University; Pusan National University; Pusan National University; Beijing University of Chinese Medicine; University of Tokyo; Korea Institute of Oriental Medicine (KIOM)	Shin, BC (corresponding author), Pusan Natl Univ, Korean Med Hosp, Spine & Joint Ctr, Dept Rehabil Med Korean Med, Yangsan, South Korea.	drshinbc@gmail.com	Lee, Myeong Soo/C-8147-2013	Lee, Myeong Soo/0000-0001-6651-7641; Liu, Jianping/0000-0002-0320-061X				Ammendolia C, 2008, SPINE J, V8, P160, DOI 10.1016/j.spinee.2007.10.014; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bidwell S, 2004, EXTEXT HLTH TECHNOLO; Cao HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031793; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Dagenais S., 2011, EVIDENCE BASED MANAG; Dijkers M, 2013, TRY THIS KT UPDATE; Ernst E, 2005, Complement Ther Clin Pract, V11, P17, DOI 10.1016/j.ctnm.2004.09.005; Ernst E, 2002, SCHMERZ, V16, P129, DOI 10.1007/s004820100099; Field MJ, 1990, CLIN PRACTICE GUIDEL; Frass M, 2012, OCHSNER J, V12, P45; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Furlan AD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/953139; Furlan AD, 2009, SPINE, V34, P1669, DOI 10.1097/BRS.0b013e3181ad7bd6; Gagnier JJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004504; Goertz M, 2010, ADULT LOW BACK PAIN; Goertz MTD., 2012, I CLIN SYSTEMS IMPRO; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Hall H, 2008, CLIN EVID, V2008; Han Chnaghyun, 2007, Korean Journal of Acupuncture, V24, P17; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hegmann K, 2007, LOW BACK DISORDERS O; Henderson Helen, 2002, Br J Nurs, V11, P1395; Hesketh T, 1997, BRIT MED J, V315, P115, DOI 10.1136/bmj.315.7100.115; Hutchinson AJP, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-36; Imamura M, 2008, SPINE J, V8, P121, DOI 10.1016/j.spinee.2007.10.016; Kim Jong-In, 2011, Evid Based Complement Alternat Med, V2011, P467014, DOI 10.1093/ecam/nep035; Kim YC, 2012, J MUSCULOSKELET PAIN, V20, P116, DOI 10.3109/10582452.2012.673543; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kong LJ, 2012, EVID-BASED COMPL ALT, V2012; Lu SC, 2011, EVID-BASED COMPL ALT, V2011; MacDermid JC, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-18; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P699; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Michigan Quality Improvement Consortium, 2011, MAN AC LOW BACK PAIN; Moon TW, 2013, CHIN J INTEGR MED, V19, P228, DOI 10.1007/s11655-012-1238-0; Moret L, 2012, TRANSFUS CLIN BIOL, V19, P174, DOI 10.1016/j.tracli.2012.07.015; National Collaborating Centre for Primary Care, 2009, LOW BACK PAIN EARL M, P25; National Guideline Clearinghouse, 2009, OCC THER PRACT GUID; National Guideline Clearinghouse, 2011, LOW BACK LUMB THOR A; Park HL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/429103; Park JE, 2010, COMPLEMENT THER MED, V18, P215, DOI 10.1016/j.ctim.2010.07.001; Robinson N, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-88; Rubinstein SM, 2010, EUR SPINE J, V19, P1213, DOI 10.1007/s00586-010-1356-3; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SCHIN - Sowerby Centre for Health Informatics at Newcastle, 2009, BACK PAIN LOW RAD PR; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith LA, 2000, PAIN, V86, P119, DOI 10.1016/S0304-3959(00)00234-7; The Japanese Orthopaedic Association the Japanese Society of Lumbar Spine Disorders, 2012, CLIN PRACT GUID MAN; Toward Optimized Practice, 2009, GUID EV INF PRIM CAR; Trigkilidas D, 2010, ANN ROY COLL SURG, V92, P595, DOI 10.1308/003588410X12699663904196; University of Michigan Health System, 2010, ACT LOW BACK PAIN; van Tulder MW, 1999, SPINE, V24, P1113, DOI 10.1097/00007632-199906010-00011; van Tulder MW, 2005, BEST PRACT RES CL RH, V19, P639, DOI 10.1016/j.berh.2005.03.006; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; World Health Organization Media Centre, 2012, TRAD MED; Xu J, 2009, HEALTH POLICY, V90, P133, DOI 10.1016/j.healthpol.2008.09.003; Yu WY, 2011, J TRADIT CHIN MED, V31, P376, DOI 10.1016/S0254-6272(12)60021-1; Yuan J, 2008, SPINE, V33, pE887, DOI 10.1097/BRS.0b013e318186b276	61	10	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88027	10.1371/journal.pone.0088027	http://dx.doi.org/10.1371/journal.pone.0088027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505363	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200101
J	Janes, AC; Farmer, S; Frederick, BD; Nickerson, LD; Lukas, SE				Janes, Amy C.; Farmer, Stacey; Frederick, Blaise deB.; Nickerson, Lisa D.; Lukas, Scott E.			An Increase in Tobacco Craving Is Associated with Enhanced Medial Prefrontal Cortex Network Coupling	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; DOPAMINE; NICOTINE; ACTIVATION; SMOKING; CUES; SMOKERS; REWARD; SENSITIZATION	Craving is a key aspect of drug dependence that is thought to motivate continued drug use. Numerous brain regions have been associated with craving, suggesting that craving is mediated by a distributed brain network. Whether an increase in subjective craving is associated with enhanced interactions among brain regions was evaluated using resting state functional magnetic imaging (fMRI) in nicotine dependent participants. We focused on craving-related changes in the orbital and medial prefrontal cortex (OMPFC) network, which also included the subgenual anterior cingulate cortex (sgACC) extending into the ventral striatum. Brain regions in the OMPFC network are not only implicated in addiction and reward, but, due to their rich anatomic interconnections, may serve as the site of integration across craving-related brain regions. Subjective craving and resting state fMRI were evaluated twice with an,1 hour delay between the scans. Cigarette craving was significantly increased at the end, relative to the beginning of the scan session. Enhanced craving was associated with heightened coupling between the OMPFC network and other cortical, limbic, striatal, and visceromotor brain regions that are both anatomically interconnected with the OMPFC, and have been implicated in addiction and craving. This is the first demonstration confirming that an increase in craving is associated with enhanced brain region interactions, which may play a role in the experience of craving.	[Janes, Amy C.; Farmer, Stacey; Frederick, Blaise deB.; Nickerson, Lisa D.; Lukas, Scott E.] Harvard Univ, McLean Hosp, Sch Med, McLean Imaging Ctr, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Janes, AC (corresponding author), Harvard Univ, McLean Hosp, Sch Med, McLean Imaging Ctr, Belmont, MA 02478 USA.	ajanes@mclean.harvard.edu	Janes, Amy/A-5322-2013; Frederick, Blaise/G-6098-2012	Janes, Amy/0000-0002-3749-5006; Frederick, Blaise/0000-0001-5832-5279	National Institute on Drug Abuse [K01DA029645]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA029645] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse Grant K01DA029645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2008, NICOTINE TOB RES, V10, P35, DOI 10.1080/14622200701705076; Andreoli M, 2003, NEUROPSYCHOPHARMACOL, V28, P1272, DOI 10.1038/sj.npp.1300183; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Boy F, 2010, EXP BRAIN RES, V206, P441, DOI 10.1007/s00221-010-2417-x; Bray S, 2010, J NEUROPHYSIOL, V103, P2506, DOI 10.1152/jn.01030.2009; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Brody AL, 2007, BIOL PSYCHIAT, V62, P642, DOI 10.1016/j.biopsych.2006.10.026; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cole DM, 2012, CEREB CORTEX, V22, P2784, DOI 10.1093/cercor/bhr354; Cole DM, 2010, NEUROIMAGE, V52, P590, DOI 10.1016/j.neuroimage.2010.04.251; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; Delgado MR, 2005, NEUROIMAGE, V24, P862, DOI 10.1016/j.neuroimage.2004.10.002; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Fanous S, 2012, J NEUROSCI, V32, P11600, DOI 10.1523/JNEUROSCI.1914-12.2012; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hanlon CA, 2013, PSYCHIAT RES-NEUROIM, V213, P79, DOI 10.1016/j.pscychresns.2013.03.003; Hartwell KJ, 2011, ADDICT BIOL, V16, P654, DOI 10.1111/j.1369-1600.2011.00340.x; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Janes AC, 2012, DRUG ALCOHOL DEPEN, V125, P252, DOI 10.1016/j.drugalcdep.2012.02.020; Janes AC, 2012, DRUG ALCOHOL DEPEN, V120, P7, DOI 10.1016/j.drugalcdep.2011.06.009; Kober H, 2010, P NATL ACAD SCI USA, V107, P14811, DOI 10.1073/pnas.1007779107; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Le Foll B, 2003, SYNAPSE, V47, P176, DOI 10.1002/syn.10170; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; McClernon FJ, 2009, PSYCHOPHARMACOLOGY, V204, P25, DOI 10.1007/s00213-008-1436-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sinha R, 2013, CURR OPIN NEUROBIOL, V23, P649, DOI 10.1016/j.conb.2013.05.001; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sokoloff P, 2001, NEUROTOX RES, V3, DOI 10.1007/BF03033202; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Yalachkov Y, 2012, NEUROSCI BIOBEHAV R, V36, P825, DOI 10.1016/j.neubiorev.2011.12.004	54	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88228	10.1371/journal.pone.0088228	http://dx.doi.org/10.1371/journal.pone.0088228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505440	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200145
J	Kharroubi, AT; Darwish, HM; Abu Al-Halaweh, AI; Khammash, UM				Kharroubi, Akram T.; Darwish, Hisham M.; Abu Al-Halaweh, Ahmad I.; Khammash, Umaiyeh M.			Evaluation of Glycated Hemoglobin (HbA1c) for Diagnosing Type 2 Diabetes and Prediabetes among Palestinian Arab Population	PLOS ONE			English	Article							PLASMA-GLUCOSE; HBA(1C); A1C; PREVALENCE; MELLITUS; ASSOCIATION; CRITERIA; A(1C)	The purpose of the study is to compare the potential of HbA1c to diagnose diabetes among Palestinian Arabs compared to fasting plasma glucose (FPG). A cross-sectional sample of 1370 Palestinian men (468) and women (902) without known diabetes and above the age of 30 years were recruited. Whole blood was used to estimate HbA(1c) and plasma for FPG and total lipid profile. Fasting plasma glucose was used as a reference to diagnose diabetes (>= 126 mg/dL) and prediabetes (100-125 mg/dL). The area under the receiver operating characteristic curve (AUC) for HbA(1c) was 81.9% to diagnose diabetes and 63.9% for prediabetes. The agreement between HbA(1c) and diabetes as diagnosed by FPG was moderate (K = 0.498) and low with prediabetes (K = 0.142). The optimal cut-off value for HbA(1c) to diagnose diabetes was >= 6.3% (45 mmol/mol). The sensitivity, specificity and the discriminant ability were 65.6% (53.1-76.3%), 94.5% (93.1-95.6%), 80.0% (72.8-87.3%), respectively. However, using cut-off value of >= 6.5% (48 mmol/mol) improved specificity. At this cut-off value, the sensitivity, specificity and the discriminant ability were 57.4% (44.9-69.0%), 97.1% (96.0-97.9%) and 77.3% (71.0-83.5%). For diagnosing prediabetes with HbA1c between 5.7-6.4% (39-46 mmol/mol), the sensitivity, specificity and the discriminant ability were 62.7% (57.1-67.9%), 56.3% (53.1-59.4%) and 59.5% (56.3-62.5%), respectively. HbA(1c) at cut-off value of >= 6.5% (48 mmol/mol) by itself diagnosed 5.3% and 48.3% as having diabetes and prediabetes compared to 4.5% and 24.2% using FPG, respectively. Mean HbA(1c) and FPG increase significantly with increasing body mass index. In conclusion, the ROC curves showed HbA(1c) could be used for diagnosing diabetes when compared to FPG but not for prediabetes in Palestinians Arabs even though only about 50% of the diabetic subjects were identified by the both HbA(1c) and FPG.	[Kharroubi, Akram T.] Al Quds Univ, Fac Hlth Profess, Dept Med Lab Sci, Jerusalem, Israel; [Darwish, Hisham M.] Al Quds Univ, Mol Genet Lab, Fac Med, Jerusalem, Israel; [Abu Al-Halaweh, Ahmad I.] Augusta Victoria Hosp, Jerusalem, Israel; [Khammash, Umaiyeh M.] United Nation Relief & Working Agcy, Jerusalem, Israel		Kharroubi, AT (corresponding author), Al Quds Univ, Fac Hlth Profess, Dept Med Lab Sci, Jerusalem, Israel.	akram.kharroubi@gmail.com			United Nation Relief and Working Agency (UNRWA)	United Nation Relief and Working Agency (UNRWA)	This project was partially supported by United Nation Relief and Working Agency (UNRWA. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2010, Diabetes Care, V33 Suppl 1, pS11, DOI 10.2337/dc10-S011; Bernal-Lopez MR, 2011, DIABETIC MED, V28, P1319, DOI 10.1111/j.1464-5491.2011.03317.x; Bersoux S, 2011, AM J CLIN PATHOL, V135, P674, DOI 10.1309/AJCPJBG0WYRAHN0R; Cavagnolli G, 2012, DIABETIC MED, V29, P286, DOI 10.1111/j.1464-5491.2011.03397.x; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Costa B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-45; Dagogo-Jack S, 2010, NAT REV ENDOCRINOL, V6, P589, DOI 10.1038/nrendo.2010.126; Davidson MB, 2011, DIABETES CARE, V34, P524, DOI 10.2337/dc10-1689; Day A, 2012, ANN CLIN BIOCHEM, V49, P7, DOI 10.1258/acb.2011.011255; Fonseca VA, 2009, DIABETES CARE, V32, P1, DOI [10.2337/dc09-9033, 10.2337/dc09-S301]; Hajat C, 2011, DIABETES CARE, V34, P2400, DOI 10.2337/dc11-0284; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Hayes L, 2012, DIABETIC MED, V29, P115, DOI 10.1111/j.1464-5491.2011.03389.x; Miranda JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018069; Jorgensen ME, 2010, J CLIN ENDOCR METAB, V95, pE333, DOI 10.1210/jc.2010-0710; Kawada T, 2012, AM J CLIN PATHOL, V137, P500, DOI 10.1309/AJCPONIL38UYSHRH; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Lu ZX, 2010, DIABETES CARE, V33, P817, DOI 10.2337/dc09-1763; Ma H, 2013, BIOMED ENVIRON SCI, V26, P155, DOI 10.3967/0895-3988.2013.03.001; Malik M, 2005, DIABETES RES CLIN PR, V69, P188, DOI 10.1016/j.diabres.2004.12.005; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mukai N, 2012, DIABETIC MED, V29, P99, DOI 10.1111/j.1464-5491.2011.03378.x; Pinelli NR, 2011, J CLIN ENDOCR METAB, V96, pE1680, DOI 10.1210/jc.2011-1148; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Seo HA, 2012, KOREAN J INTERN MED, V27, P39, DOI 10.3904/kjim.2012.27.1.39; Shaw JE, 2011, MED J AUSTRALIA, V195, P7, DOI 10.5694/j.1326-5377.2011.tb03178.x; Soulimane S, 2011, DIABETIC MED, V28, P1311, DOI 10.1111/j.1464-5491.2011.03403.x; Tatsch E, 2012, CLIN LAB, V58, P347; Tsugawa Y, 2012, DIABETES, V61, P3280, DOI 10.2337/db12-0103; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Yu Y, 2012, KOREAN J INTERN MED, V27, P41, DOI 10.3904/kjim.2012.27.1.41	36	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88123	10.1371/journal.pone.0088123	http://dx.doi.org/10.1371/journal.pone.0088123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505401	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200121
J	Loffek, S; Hurskainen, T; Jackow, J; Sigloch, FC; Schilling, O; Tasanen, K; Bruckner-Tuderman, L; Franzke, CW				Loeffek, Stefanie; Hurskainen, Tiina; Jackow, Joanna; Sigloch, Florian Christoph; Schilling, Oliver; Tasanen, Kaisa; Bruckner-Tuderman, Leena; Franzke, Claus-Werner			Transmembrane Collagen XVII Modulates Integrin Dependent Keratinocyte Migration via PI3K/Rac1 Signaling	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PHOSPHOINOSITIDE 3-OH KINASE; ALPHA-6-BETA-4 INTEGRIN; FOCAL ADHESION; ALPHA(6)BETA(4) INTEGRIN; PROTEIN EXPRESSION; BETA-4 INTEGRIN; ACTIN; HEMIDESMOSOMES; PHOSPHORYLATION	The hemidesmosomal transmembrane component collagen XVII (ColXVII) plays an important role in the anchorage of the epidermis to the underlying basement membrane. However, this adhesion protein seems to be also involved in the regulation of keratinocyte migration, since its expression in these cells is strongly elevated during reepithelialization of acute wounds and in the invasive front of squamous cell carcinoma, while its absence in ColXVII-deficient keratinocytes leads to altered cell motility. Using a genetic model of murine Col17a1(-/-) keratinocytes we elucidated ColXVII mediated signaling pathways in cell adhesion and migration. Col17a1(-/-) keratinocytes exhibited increased spreading on laminin 332 and accelerated, but less directed cell motility. These effects were accompanied by increased expression of the integrin subunits beta 4 and beta 1. The migratory phenotype, as evidenced by formation of multiple unstable lamellipodia, was associated with enhanced phosphoinositide 3-kinase (PI3K) activity. Dissection of the signaling pathway uncovered enhanced phosphorylation of the beta 4 integrin subunit and the focal adhesion kinase (FAK) as activators of PI3K. This resulted in elevated Rac1 activity as a downstream consequence. These results provide mechanistic evidence that ColXVII coordinates keratinocyte adhesion and directed motility by interfering integrin dependent PI3K activation and by stabilizing lamellipodia at the leading edge of reepithelializing wounds and in invasive squamous cell carcinoma.	[Loeffek, Stefanie; Jackow, Joanna; Bruckner-Tuderman, Leena; Franzke, Claus-Werner] Univ Med Ctr Freiburg, Dept Dermatol & Venerol, Freiburg, Germany; [Hurskainen, Tiina; Tasanen, Kaisa] Univ Oulu, Dept Dermatol, Oulu Ctr Cell Matrix Res, SF-90220 Oulu, Finland; [Hurskainen, Tiina; Tasanen, Kaisa] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Sigloch, Florian Christoph; Schilling, Oliver] Univ Freiburg, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; [Sigloch, Florian Christoph] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schilling, Oliver] Univ Freiburg, Bioss Ctr Biol Studies, D-79106 Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, Sch Life Sci LifeNet, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Oulu; University of Oulu; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Loffek, S (corresponding author), Univ Med Ctr Freiburg, Dept Dermatol & Venerol, Freiburg, Germany.	stefanie.loeffek@uniklinik-freiburg.de; claus-werner.franzke@uniklinik-freiburg.de	Schilling, O/AAC-8302-2019	Jackow, Joanna/0000-0002-5744-7896; Sigloch, Florian/0000-0001-8130-6885; Schilling, Oliver/0000-0001-7678-7653; Tasanen, Kaisa/0000-0001-8056-5949	German Research Foundation DFG [SFB 850/B6]; Finnish Medical Society Duodecim of Oulu; Northern Finland Cancer Foundation; Finnish Cultural Foundation; Oulu University Hospital; Academy of Finland; Excellence Initiative of the German Federal and State Governments through Freiburg Institute for Advanced Studies (FRIAS), School of Life Sciences - LifeNet	German Research Foundation DFG(German Research Foundation (DFG)); Finnish Medical Society Duodecim of Oulu; Northern Finland Cancer Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Oulu University Hospital; Academy of Finland(Academy of Finland); Excellence Initiative of the German Federal and State Governments through Freiburg Institute for Advanced Studies (FRIAS), School of Life Sciences - LifeNet	This work was supported by grants from the German Research Foundation DFG (SFB 850/B6) to L.B.-T. and C.-W.F., the Excellence Initiative of the German Federal and State Governments through Freiburg Institute for Advanced Studies (FRIAS), School of Life Sciences - LifeNet, and the Finnish Medical Society Duodecim of Oulu, Northern Finland Cancer Foundation, Finnish Cultural Foundation, Oulu University Hospital and the Academy of Finland to K.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; Bruckner-Tuderman L, 2012, J INVEST DERMATOL, V132, pE2, DOI [10.1038/skinbio.2012.2, DOI 10.1038/SKINBIO.2012.2]; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Dabelsteen E, 1998, J INVEST DERMATOL, V111, P592, DOI 10.1046/j.1523-1747.1998.00346.x; Franzke CW, 2006, J BIOL CHEM, V281, P30260, DOI 10.1074/jbc.M604464200; Franzke CW, 2009, J BIOL CHEM, V284, P23386, DOI 10.1074/jbc.M109.034090; Franzke CW, 2002, EMBO J, V21, P5026, DOI 10.1093/emboj/cdf532; Frijns E, 2010, J BIOL CHEM, V285, P37650, DOI 10.1074/jbc.M110.138818; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Germain EC, 2009, MOL BIOL CELL, V20, P56, DOI 10.1091/mbc.E08-06-0646; Golubovskaya VM, 2008, J MED CHEM, V51, P7405, DOI 10.1021/jm800483v; Hamill KJ, 2011, J BIOL CHEM, V286, P26768, DOI 10.1074/jbc.M110.203646; Hurskainen T, 2012, CELL TISSUE RES, V348, P579, DOI 10.1007/s00441-012-1368-x; Kashyap T, 2011, LAB INVEST, V91, P1414, DOI 10.1038/labinvest.2011.104; Kligys KR, 2012, J BIOL CHEM; KONIG A, 1992, J INVEST DERMATOL, V99, P808, DOI 10.1111/1523-1747.ep12614773; Leivo T, 2000, BRIT J DERMATOL, V142, P991, DOI 10.1046/j.1365-2133.2000.03484.x; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Parikka M, 2006, EXP CELL RES, V312, P1431, DOI 10.1016/j.yexcr.2006.01.015; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Qiao HJ, 2009, J INVEST DERMATOL, V129, P2288, DOI 10.1038/jid.2009.20; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Schumann H, 1997, AM J HUM GENET, V60, P1344, DOI 10.1086/515463; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Stelkovics E, 2008, APPL IMMUNOHISTO M M, V16, P433, DOI 10.1097/PAI.0b013e318162f8aa; Tasanen K, 2004, AM J PATHOL, V164, P2027, DOI 10.1016/S0002-9440(10)63762-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005	38	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87263	10.1371/journal.pone.0087263	http://dx.doi.org/10.1371/journal.pone.0087263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505282	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200041
J	Martin, PT; Golden, B; Okerblom, J; Camboni, M; Chandrasekharan, K; Xu, R; Varki, A; Flanigan, KM; Kornegay, JN				Martin, Paul T.; Golden, Bethannie; Okerblom, Jonathan; Camboni, Marybeth; Chandrasekharan, Kumaran; Xu, Rui; Varki, Ajit; Flanigan, Kevin M.; Kornegay, Joe N.			A Comparative Study of N-glycolylneuraminic Acid (Neu5Gc) and Cytotoxic T Cell (CT) Carbohydrate Expression in Normal and Dystrophin-Deficient Dog and Human Skeletal Muscle	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GALNAC TRANSFERASE; MOLECULAR-CLONING; MOUSE MODEL; CANINE; OVEREXPRESSION; MICE; UTROPHIN; MDX; HYDROXYLASE	The expression of N-glycolylneuraminic acid (Neu5Gc) and the cytotoxic T cell (CT) carbohydrate can impact the severity of muscular dystrophy arising from the loss of dystrophin in mdx mice. Here, we describe the expression of these two glycans in skeletal muscles of dogs and humans with or without dystrophin-deficiency. Neu5Gc expression was highly reduced (>95%) in muscle from normal golden retriever crosses (GR, n = 3) and from golden retriever with muscular dystrophy (GRMD, n = 5) dogs at multiple ages (3, 6 and 13 months) when compared to mouse muscle, however, overall sialic acid expression in GR and GRMD muscles remained high at all ages. Neu5Gc was expressed on only a minority of GRMD satellite cells, CD8(+) T lymphocytes and macrophages. Human muscle from normal (no evident disease, n = 3), Becker (BMD, n = 3) and Duchenne (DMD, n = 3) muscular dystrophy individuals had absent to very low Neu5Gc staining, but some punctate intracellular muscle staining was present in BMD and DMD muscles. The CT carbohydrate was localized to the neuromuscular junction in GR muscle, while GRMD muscles had increased expression on a subset of myofibers and macrophages. In humans, the CT carbohydrate was ectopically expressed on the sarcolemmal membrane of some BMD muscles, but not normal human or DMD muscles. These data are consistent with the notion that altered Neu5Gc and CT carbohydrate expression may modify disease severity resulting from dystrophin deficiency in dogs and humans.	[Martin, Paul T.; Golden, Bethannie; Camboni, Marybeth; Chandrasekharan, Kumaran; Xu, Rui; Flanigan, Kevin M.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA; [Martin, Paul T.; Flanigan, Kevin M.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Martin, Paul T.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Okerblom, Jonathan; Varki, Ajit] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Okerblom, Jonathan; Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92103 USA; [Kornegay, Joe N.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; University of California System; University of California San Diego; Texas A&M University System; Texas A&M University College Station	Martin, PT (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH 43205 USA.	Paul.Martin@nationwidechildrens.org	Okerblom, Jonathan/M-1257-2016; Martin, Paul T/E-3599-2011	Okerblom, Jonathan/0000-0002-3705-9060; Kornegay, Joe/0000-0002-5594-1882; Martin, Paul/0000-0002-0674-6191; Flanigan, Kevin/0000-0001-6440-3376	NIH [R01 AR060949]; (NINDS) Co-operative Program in Translational Research: Proposal for Establishment of the Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD) [1U24NS059696-01A1]; Muscular Dystrophy Association Infrastructure Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS059696] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); (NINDS) Co-operative Program in Translational Research: Proposal for Establishment of the Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD); Muscular Dystrophy Association Infrastructure Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH grant R01 AR060949 to PTM. Support for dogs came from 1U24NS059696-01A1 (NINDS) Co-operative Program in Translational Research: Proposal for Establishment of the Center for Canine Models of Duchenne Muscular Dystrophy (NCDMD) to JNK and Muscular Dystrophy Association Infrastructure Grant to the Translational Research Advisory Committee (TRAC) to JNK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; Chandrasekharan K, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000692; Childers MK, 2002, ARCH PHYS MED REHAB, V83, P1572, DOI 10.1053/apmr.2002.35109; Childers MK, 2001, AM J PHYS MED REHAB, V80, P175, DOI 10.1097/00002060-200103000-00004; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; CONZELMANN A, 1988, J EXP MED, V167, P119, DOI 10.1084/jem.167.1.119; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; GASCHEN FP, 1992, J NEUROL SCI, V110, P149, DOI 10.1016/0022-510X(92)90022-D; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoyte K, 2002, MOL BRAIN RES, V109, P146, DOI 10.1016/S0169-328X(02)00551-X; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KORNEGAY JN, 1994, J NEUROL SCI, V123, P100, DOI 10.1016/0022-510X(94)90210-0; Kornegay JN, 2003, NEUROMUSCULAR DISORD, V13, P493, DOI 10.1016/S0960-8966(03)00025-7; Kornegay JN, 1999, J NEUROL SCI, V166, P115, DOI 10.1016/S0022-510X(99)00118-5; KORNEGAY JN, 1994, LAB ANIM SCI, V44, P331; KORNEGAY JN, 1988, MUSCLE NERVE, V11, P1056, DOI 10.1002/mus.880111008; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; LEFRANCOIS L, 1985, J IMMUNOL, V135, P374; LEFRANCOIS L, 1985, NATURE, V314, P449, DOI 10.1038/314449a0; Liu JMK, 2004, MUSCLE NERVE, V30, P767, DOI 10.1002/mus.20154; Lofling J, 2013, VIROLOGY, V440, P89, DOI 10.1016/j.virol.2013.02.009; Marshall JL, 2012, J CELL BIOL, V197, P1009, DOI 10.1083/jcb.201110032; Martin PT, 2013, GLYCOBIOLOGY, V23, P833, DOI 10.1093/glycob/cwt020; Martin PT, 2009, AM J PHYSIOL-CELL PH, V296, pC476, DOI 10.1152/ajpcell.00456.2008; Martin PT, 2006, NAT CLIN PRACT NEURO, V2, P222, DOI 10.1038/ncpneuro0155; Martin PT, 1999, MOL CELL NEUROSCI, V13, P105, DOI 10.1006/mcne.1999.0737; Megeney LA, 1999, P NATL ACAD SCI USA, V96, P220, DOI 10.1073/pnas.96.1.220; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; NAKAMURA K, 1983, J BIOCHEM-TOKYO, V94, P1359, DOI 10.1093/oxfordjournals.jbchem.a134482; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Parkhomovskiy N, 2000, MOL CELL NEUROSCI, V15, P380, DOI 10.1006/mcne.2000.0835; Peter AK, 2008, J CELL BIOL, V183, P419, DOI 10.1083/jcb.200808027; Peter AK, 2007, J CELL SCI, V120, P996, DOI 10.1242/jcs.03360; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; SHAW L, 1992, EUR J BIOCHEM, V206, P269, DOI 10.1111/j.1432-1033.1992.tb16925.x; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Singhal N, 2012, MOL CELL NEUROSCI; Singhal N, 2011, DEV NEUROBIOL, V71, P982, DOI 10.1002/dneu.20953; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; SMITH PL, 1994, J BIOL CHEM, V269, P15162; Song XZ, 2011, J BIOL CHEM, V286, P31610, DOI 10.1074/jbc.M111.274217; Spiro RG, 1996, BIOCHEM J, V319, P209, DOI 10.1042/bj3190209; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; VALENTINE BA, 1989, AM J VET RES, V50, P2145; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wang CM, 2010, NEUROBIOL DIS, V39, P409, DOI 10.1016/j.nbd.2010.05.013; Willmann R, 2009, NEUROMUSCUL DISORD; WINAND NJ, 1994, NEUROMUSCULAR DISORD, V4, P433, DOI 10.1016/0960-8966(94)90082-5; Xia B, 2002, DEV BIOL, V242, P58, DOI 10.1006/dbio.2001.0530; Xu R, 2007, AM J PATHOL, V171, P181, DOI 10.2353/ajpath.2007.060927; Xu R, 2007, NEUROMUSCULAR DISORD, V17, P209, DOI 10.1016/j.nmd.2006.12.004; Xu R, 2009, AM J PATHOL, V175, P235, DOI 10.2353/ajpath.2009.080967; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013	70	15	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88226	10.1371/journal.pone.0088226	http://dx.doi.org/10.1371/journal.pone.0088226			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505439	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200144
J	Mathers, C; Spencer, CM; Munger, J				Mathers, Chun; Spencer, Cody M.; Munger, Joshua			Distinct Domains within the Human Cytomegalovirus U(L)26 Protein Are Important for Wildtype Viral Replication and Virion Stability	PLOS ONE			English	Article							TEGUMENT PROTEIN; INFECTED-CELLS; GENE-EXPRESSION; PARTICLES; GENOME; CYCLE; CMV; DNA; IDENTIFICATION; RECOMBINATION	The human cytomegalovirus (HCMV) U(L)26 gene encodes a virion protein that is important for high titer viral replication. To identify specific domains within the U(L)26 protein that contribute to viral infection, we created a panel of site-directed U(L)26 mutant viruses and assessed their impact on phenotypes attributed to U(L)26. We find that the C-terminal 38 amino acids of the U(L)26 protein are absolutely necessary for U(L)26 function. A stop-insertion mutant that produced a truncated U(L)26 protein lacking this region behaved identically to U(L)26-null viruses. This included reduced accumulation of IE1 protein at early time points, smaller plaque size, reduced virion stability, and growth with similarly attenuated kinetics. This C-terminal truncation decreased the amount of U(L)26 packaged into the virion resulting in reduced delivery of U(L)26 to newly infected cells. Further, this C-terminal truncated U(L)26 exhibited substantially reduced nuclear localization compared to wildtype U(L)26. Translation of U(L)26 mRNA is initiated from two separate in frame methionines that give rise to a long and a short isoform of U(L)26. We find that the N-terminal 34 amino acids, which are unique to the long isoform of U(L)26, are also important for the function of the U(L)26 protein. A viral mutant that produces only the short isoform of U(L)26 and lacks these N-terminal 34 amino acids exhibits delayed IE1 accumulation, and demonstrates intermediate defects in viral plaque size, virion stability and viral growth kinetics. Ablation of the short U(L)26 isoform in the presence of the long U(L)26 isoform did not impact any of the in vitro phenotypes tested. These experiments highlight important domains within the U(L)26 protein that contribute to HCMV infection.	[Mathers, Chun; Spencer, Cody M.; Munger, Joshua] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Munger, J (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA.	josh.munger@rochester.edu	Munger, Joshua/ABA-6395-2020	Munger, Joshua/0000-0001-5379-9440	National Institute of Allergy and Infectious Diseases [R01AI081773]; Damon Runyon Cancer Research Foundation [DRR-09-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081773, R56AI081773] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases (R01AI081773). JM is a Damon Runyon-Rachleff Innovator supported (in part) by the Damon Runyon Cancer Research Foundation (DRR-09-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate DA, 2004, J VIROL, V78, P10995, DOI 10.1128/JVI.78.20.10995-11006.2004; Andrei G, 2008, CURR OPIN INVEST DR, V9, P132; AuCoin DP, 2006, J VIROL, V80, P8199, DOI 10.1128/JVI.00457-06; Baldick CJ, 1997, J VIROL, V71, P4400, DOI 10.1128/JVI.71.6.4400-4408.1997; Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; Browne EP, 2003, P NATL ACAD SCI USA, V100, P11439, DOI 10.1073/pnas.1534570100; Burny Wivine, 2004, Expert Rev Anti Infect Ther, V2, P881, DOI 10.1586/14789072.2.6.881; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Chambers J, 1999, J VIROL, V73, P5757, DOI 10.1128/JVI.73.7.5757-5766.1999; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Fitzgerald JT, 2004, TRANSPLANTATION, V77, P1405, DOI 10.1097/01.TP.0000122184.97674.20; Gerna G, 2004, HUM IMMUNOL, V65, P381, DOI 10.1016/j.humimm.2004.02.009; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lorz K, 2006, J VIROL, V80, P5423, DOI 10.1128/JVI.02585-05; MANAVALAN P, 1978, NATURE, V275, P673, DOI 10.1038/275673a0; Mitchell DP, 2009, J VIROL, V83, P10187, DOI 10.1128/JVI.00396-09; Mocarski ES, 2006, FIELDS VIROLOGY, P2701; Munger J, 2006, J VIROL, V80, P3541, DOI 10.1128/JVI.80.7.3541-3548.2006; NEIMAN P, 1973, TRANSPLANTATION, V15, P478, DOI 10.1097/00007890-197305000-00011; Passs RF, 2001, FIELDS VIROLOGY, P2675; PLOTKIN SA, 1975, INFECT IMMUN, V12, P521, DOI 10.1128/IAI.12.3.521-527.1975; ROWE WP, 1956, P SOC EXP BIOL MED, V92, P418, DOI 10.3181/00379727-92-22497; Silva MC, 2005, P NATL ACAD SCI USA, V102, P2081, DOI 10.1073/pnas.0409597102; Silva MC, 2003, J VIROL, V77, P10594, DOI 10.1128/JVI.77.19.10594-10605.2003; Stamminger T, 2002, J VIROL, V76, P4836, DOI 10.1128/JVI.76.10.4836-4847.2002; Streblow DN, 2008, AM J TRANSPLANT, V8, P277, DOI 10.1111/j.1600-6143.2007.02062.x; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; Yu D, 2002, J VIROL, V76, P2316, DOI 10.1128/JVI.76.5.2316-2328.2002	35	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88101	10.1371/journal.pone.0088101	http://dx.doi.org/10.1371/journal.pone.0088101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505393	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200115
J	Mercado, N; Kizawa, Y; Ueda, K; Xiong, YP; Kimura, G; Moses, A; Curtis, JM; Ito, K; Barnes, PJ				Mercado, Nicolas; Kizawa, Yasuo; Ueda, Keitaro; Xiong, Yeping; Kimura, Genki; Moses, Audric; Curtis, Jonathan M.; Ito, Kazuhiro; Barnes, Peter J.			Activation of Transcription Factor Nrf2 Signalling by the Sphingosine Kinase Inhibitor SKI-II Is Mediated by the Formation of Keap1 Dimers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; PROSTATE-CANCER; BREAST-CANCER; SENSOR KEAP1; EXPRESSION; SPHINGOSINE-1-PHOSPHATE; DECLINE	Background: Anti-oxidant capacity is crucial defence against environmental or endogenous oxidative stress. Nuclear factor erythroid 2-related factor 2 (Nrf2) is a redox-sensitive transcription factor that plays a key defensive role against oxidative and cytotoxic stress and cellular senescence. However, Nrf2 signalling is impaired in several aging-related diseases, such as chronic pulmonary obstructive disease (COPD), cancer, and neurodegenerative diseases. Thus, novel therapeutics that enhance Nrf2 signalling are an attractive approach to treat these diseases. Methodology/Principal Findings: Nrf2 was stabilized by SKI-II (2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole), which is a known sphingosine kinase inhibitor, in human bronchial epithelial cell line, BEAS2B, and in primary human bronchial epithelial cells, leading to enhancement of anti-oxidant proteins, such as HO-1, NQO1 and GCLM. The activation of Nrf2 was achieved by the generation of inactive dimerized form of Keap1, a negative regulator of Nrf2 expression, which was independent of sphingosine kinase inhibition. Using mice that were exposed to cigarette smoke, SKI-II induced Nrf2 expression together with HO-1 in their lungs. In addition, SKI-II reduced cigarette smoke mediated oxidative stress, macrophages and neutrophil infiltration and markers of inflammation in mice. Conclusions/Significance: SKI-II appears to be a novel activator of Nrf2 signalling via the inactivation of Keap1.	[Mercado, Nicolas; Ito, Kazuhiro; Barnes, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Kizawa, Yasuo; Ueda, Keitaro; Kimura, Genki] Nihon Univ, Sch Pharm, Dept Physiol & Anat, Funabashi, Chiba, Japan; [Xiong, Yeping; Moses, Audric; Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Imperial College London; Nihon University; University of Alberta	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airway Dis Sect, London, England.	p.j.barnes@imperial.ac.uk	Ito, Kazuhiro/AAF-5994-2019; Kizawa, Yasuo/E-3031-2010	Kizawa, Yasuo/0000-0001-9884-7186; Moses, Audric/0000-0002-2788-1739; Barnes, Peter/0000-0002-5122-4018; mercado, nicolas/0000-0002-8728-0994	Welcome Trust Programme Grant; Daiichi-Sankyo; National Institute for Health Research [NF-SI-0611-10148] Funding Source: researchfish	Welcome Trust Programme Grant(Wellcome Trust); Daiichi-Sankyo(Daiichi Sankyo Company Limited); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Welcome Trust Programme Grant and Daiichi-Sankyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Crunkhorn S, 2012, NAT REV DRUG DISCOV, V11, P96, DOI 10.1038/nrd3655; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fimognari C, 2008, CURR DRUG METAB, V9, P668, DOI 10.2174/138920008785821675; Fourquet S, 2010, J BIOL CHEM; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gandy K Alexa Orr, 2013, Handb Exp Pharmacol, P275, DOI 10.1007/978-3-7091-1511-4_14; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Ito K, 2012, INT J CHRONIC OBSTR, V7, P641, DOI 10.2147/COPD.S28250; Kansanen E, 2009, FREE RADICAL BIO MED, V47, P1310, DOI 10.1016/j.freeradbiomed.2009.06.030; Kim EH, 2011, CANCER PREV RES, V4, P425, DOI 10.1158/1940-6207.CAPR-10-0153; Kimura G, 2013, CHEST, V144, P99, DOI 10.1378/chest.12-2610; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Makabe S, 2010, ATHEROSCLEROSIS, V213, P377, DOI 10.1016/j.atherosclerosis.2010.07.059; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Mercado N, 2011, BIOCHEM BIOPH RES CO, V406, P292, DOI 10.1016/j.bbrc.2011.02.035; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noyan-Ashraf MH, 2006, FASEB J, V20, P371, DOI 10.1096/fj.05-4889fje; Ohnuma T, 2010, TOXICOL APPL PHARM, V244, P27, DOI 10.1016/j.taap.2009.12.012; Pang HY, 2011, THESCIENTIFICWORLDJO, V11, P1056, DOI 10.1100/tsw.2011.98; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Tonelli F, 2013, BRIT J PHARMACOL, V168, P1497, DOI 10.1111/bph.12035; Tonelli F, 2010, CELL SIGNAL, V22, P1536, DOI 10.1016/j.cellsig.2010.05.022; Van Brocklyn JR, 2012, COMP BIOCHEM PHYS B, V163, P26, DOI 10.1016/j.cbpb.2012.05.006; Wei C, 2009, MOL PHARMACOL, V76, P516, DOI 10.1124/mol.109.057489; Yang LC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005757; Yu SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008579	43	16	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88168	10.1371/journal.pone.0088168	http://dx.doi.org/10.1371/journal.pone.0088168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505412	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200126
J	Robinson, SD; Safavi-Hemami, H; McIntosh, LD; Purcell, AW; Norton, RS; Papenfuss, AT				Robinson, Samuel D.; Safavi-Hemami, Helena; McIntosh, Lachlan D.; Purcell, Anthony W.; Norton, Raymond S.; Papenfuss, Anthony T.			Diversity of Conotoxin Gene Superfamilies in the Venomous Snail, Conus victoriae	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; MOLECULAR PHYLOGENY; ALPHA-CONOTOXINS; SODIUM-CHANNELS; T-SUPERFAMILY; ION-CHANNEL; PEPTIDES; ACID; TEXTILE; IDENTIFICATION	Animal venoms represent a vast library of bioactive peptides and proteins with proven potential, not only as research tools but also as drug leads and therapeutics. This is illustrated clearly by marine cone snails (genus Conus), whose venoms consist of mixtures of hundreds of peptides (conotoxins) with a diverse array of molecular targets, including voltage-and ligand-gated ion channels, G-protein coupled receptors and neurotransmitter transporters. Several conotoxins have found applications as research tools, with some being used or developed as therapeutics. The primary objective of this study was the large-scale discovery of conotoxin sequences from the venom gland of an Australian cone snail species, Conus victoriae. Using cDNA library normalization, high-throughput 454 sequencing, de novo transcriptome assembly and annotation with BLASTX and profile hidden Markov models, we discovered over 100 unique conotoxin sequences from 20 gene superfamilies, the highest diversity of conotoxins so far reported in a single study. Many of the sequences identified are new members of known conotoxin superfamilies, some help to redefine these superfamilies and others represent altogether new classes of conotoxins. In addition, we have demonstrated an efficient combination of methods to mine an animal venom gland and generate a library of sequences encoding bioactive peptides.	[Robinson, Samuel D.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Safavi-Hemami, Helena; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Inst Bio21, Parkville, Vic 3052, Australia; [McIntosh, Lachlan D.; Papenfuss, Anthony T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Monash University; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Robinson, SD (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	sam.robinson@monash.edu; safavihelena@gmail.com	Purcell, Anthony/AAH-1942-2019; Robinson, Samuel/E-5602-2018; Papenfuss, Anthony T/C-6297-2008; Safavi-Hemami, Helena/E-7624-2015	Purcell, Anthony/0000-0003-0532-8331; Robinson, Samuel/0000-0002-3518-0377; Papenfuss, Anthony T/0000-0002-1102-8506; Safavi-Hemami, Helena/0000-0002-1984-2721; Norton, Raymond/0000-0001-8893-0584	Australian National Health and Medical Research Council; Marie Curie Fellowship of the European Union; NHMRC Career Development Fellowship; Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS; Australian Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Marie Curie Fellowship of the European Union(European Commission); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	RSN and AWP acknowledge fellowship support from the Australian National Health and Medical Research Council. HSH is support by a Marie Curie Fellowship of the European Union. ATP was supported by an NHMRC Career Development Fellowship. The work was partially supported by the Victorian State Government Operational Infrastructure Support, Australian Government NHMRC IRIISS and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadie FC, 2003, CONANTOKINS; Aguilar MB, 2010, PEPTIDES, V31, P1287, DOI 10.1016/j.peptides.2010.04.007; Akcan M, 2013, BIOORGANIC MED CHEM; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Bhattacharyya M, 2013, MOL BIOSYSTEMS; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Brown MA, 2005, BIOCHEMISTRY-US, V44, P9150, DOI 10.1021/bi0503293; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buczek O, 2005, FEBS J, V272, P4178, DOI 10.1111/j.1742-4658.2005.04830.x; Buczek O, 2008, TOXICON, V51, P218, DOI 10.1016/j.toxicon.2007.09.006; Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Callaghan B, 2008, J NEUROSCI, V28, P10943, DOI 10.1523/JNEUROSCI.3594-08.2008; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; CRUZ LJ, 1992, BIOL BULL, V183, P159, DOI 10.2307/1542418; Dutertre S, 2012, MOL CELLULAR PROTEOM; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; FAINZILBER M, 1991, EUR J BIOCHEM, V202, P589, DOI 10.1111/j.1432-1033.1991.tb16412.x; Fan CX, 2003, J BIOL CHEM, V278, P12624, DOI 10.1074/jbc.M210200200; Fiedler B, 2008, BIOCHEM PHARMACOL, V75, P2334, DOI 10.1016/j.bcp.2008.03.019; Han YH, 2008, FEBS J, V275, P1976, DOI 10.1111/j.1742-4658.2008.06352.x; Hansson K, 2004, J BIOL CHEM, V279, P32453, DOI 10.1074/jbc.M313825200; Hansson K, 2004, BIOCHEM BIOPH RES CO, V319, P1081, DOI 10.1016/j.bbrc.2004.05.088; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Hu H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-284; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Imperial JS, 2007, J EXP ZOOL PART B, V308B, P744, DOI 10.1002/jez.b.21195; Jacob RB, 2010, CELL MOL LIFE SCI, V67, P17, DOI 10.1007/s00018-009-0125-0; Jacobsen R, 1998, J PEPT RES, V51, P173; Jakubowski JA, 2004, ANAL CHEM, V76, P6541, DOI 10.1021/ac0494376; Jakubowski JA, 2004, J MASS SPECTROM, V39, P548, DOI 10.1002/jms.624; Jakubowski JA, 2006, TOXICON, V47, P688, DOI 10.1016/j.toxicon.2006.01.021; Jimenez EC, 2001, TOXICON, V39, P803, DOI 10.1016/S0041-0101(00)00210-5; Jimenez EC, 2003, J NEUROCHEM, V85, P610, DOI 10.1046/j.1471-4159.2003.01685.x; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kauferstein S, 2003, TOXICON, V42, P43, DOI 10.1016/S0041-0101(03)00099-0; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Laht S, 2012, BBA-PROTEINS PROTEOM, V1824, P488, DOI 10.1016/j.bbapap.2011.12.004; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; Liu JL, 2007, PEPTIDES, V28, P2313, DOI 10.1016/j.peptides.2007.09.006; Liu L, 2008, TOXICON, V51, P1331, DOI 10.1016/j.toxicon.2008.03.001; Liu ZG, 2010, ACTA BIOCH BIOPH SIN, V42, P656, DOI 10.1093/abbs/gmq066; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Massilia GR, 2003, BIOCHEM BIOPH RES CO, V303, P238, DOI 10.1016/S0006-291X(03)00331-0; McDougal OM, 2008, BIOCHEMISTRY-US, V47, P2826, DOI 10.1021/bi702388b; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; MCINTOSH JM, 1995, J BIOL CHEM, V270, P3518, DOI 10.1074/jbc.270.8.3518; McIntosh JM, 2000, J BIOL CHEM, V275, P32391, DOI 10.1074/jbc.M003619200; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Miles LA, 2002, J BIOL CHEM, V277, P43033, DOI 10.1074/jbc.M206690200; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Moller C, 2011, BIOPOLYMERS, V96, P158, DOI 10.1002/bip.21406; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Nakamura T, 1996, PROTEIN SCI, V5, P524; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; Pallaghy PK, 2000, BIOCHEMISTRY-US, V39, P12845, DOI 10.1021/bi0010930; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrel C, 2013, BIOCH PHARM; Pi CH, 2006, GENOMICS, V88, P809, DOI 10.1016/j.ygeno.2006.06.014; Pi CH, 2006, BIOCHIMIE, V88, P131, DOI 10.1016/j.biochi.2005.08.001; Poppe L, 2012, ANAL CHEM, V84, P262, DOI 10.1021/ac203078x; Puillandre N, 2012, J MOL EVOL, V74, P297, DOI 10.1007/s00239-012-9507-2; Quinton L, 2009, J PROTEOMICS, V72, P219, DOI 10.1016/j.jprot.2009.01.021; Rigby AC, 1999, P NATL ACAD SCI USA, V96, P5758, DOI 10.1073/pnas.96.10.5758; Sabareesh V, 2006, PEPTIDES, V27, P2647, DOI 10.1016/j.peptides.2006.07.009; Safavi-Hemami H, 2011, J BIOL CHEM, V286, P22546, DOI 10.1074/jbc.M110.217703; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Satkunanathan N, 2005, BRAIN RES, V1059, P149, DOI 10.1016/j.brainres.2005.08.009; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharpe IA, 2001, NAT NEUROSCI, V4, P902, DOI 10.1038/nn0901-902; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Teichertt RW, 2005, BIOCHEMISTRY-US, V44, P7897, DOI 10.1021/bi047274+; Terlau H, 1996, J NEUROPHYSIOL, V76, P1423, DOI 10.1152/jn.1996.76.3.1423; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Violette A, 2012, J PROTEOMICS; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Walker CS, 1999, J BIOL CHEM, V274, P30664, DOI 10.1074/jbc.274.43.30664; Wang L, 2009, ARCH TOXICOL, V83, P925, DOI 10.1007/s00204-009-0453-8; Wilson MJ, 2011, J PHARMACOL EXP THER, V338, P687, DOI 10.1124/jpet.110.178343; WOODWARD SR, 1990, EMBO J, V9, P1015, DOI 10.1002/j.1460-2075.1990.tb08204.x; Yuan DD, 2009, PEPTIDES, V30, P861, DOI 10.1016/j.peptides.2009.01.012	92	88	99	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87648	10.1371/journal.pone.0087648	http://dx.doi.org/10.1371/journal.pone.0087648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505301	Green Published, gold			2022-12-27	WOS:000330829200060
J	Sang, SW; Zhao, ZT; Suo, JJ; Xing, YB; Jia, N; Gao, Y; Xie, LJ; Du, MM; Liu, BW; Ren, SW; Liu, YX				Sang, Shaowei; Zhao, Zhongtang; Suo, Jijiang; Xing, Yubin; Jia, Ning; Gao, Yan; Xie, Lijun; Du, Mingmei; Liu, Bowei; Ren, Shiwang; Liu, Yunxi			Report of Recombinant Norovirus GII.g/GII.12 in Beijing, China	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; CAPSID PROTEIN; VARIANT; OUTBREAKS; CLASSIFICATION; DIVERSITY; EMERGENCE; GENOME	Background: Norovirus (NoV) has been recognized as the most important cause of nonbacterial acute gastroenteritis affecting all age group people in the world. Genetic recombination is a common occurance in RNA viruses and many recombinant NoV strains have been described since it was first reported in 1997. However, the knowledge of recombinant NoV in China is extremely limited. Methods: A total of 685 stool specimens were tested for NoV infection from the acute gastroenteritis patients who visited one general hospital in Beijing from April 2009 to November 2011. The virus recombination was identified by constructing phylogenetic trees of two genes, further SimPlot and the maximum chi-square analysis. Results: The overall positive rate was 9.6% (66/685). GII.4 New Orleans 2009 and GII.4 2006b variants were the dominant genotype. Four GII.g/GII.12 and one GII.12/GII.3 recombinant strains were confirmed, and all derived from adult outpatients. The predictive recombination point occurred at the open reading frame (ORF) 1/ORF2 overlap. Conclusions: The GII.g ORF1/GII.12ORF2 recombinant has been reported in several countries and it was the first report of this recombinant in China.	[Sang, Shaowei; Zhao, Zhongtang] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Shandong, Peoples R China; [Sang, Shaowei; Suo, Jijiang; Xing, Yubin; Jia, Ning; Gao, Yan; Xie, Lijun; Du, Mingmei; Liu, Bowei; Ren, Shiwang; Liu, Yunxi] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Infect Management & Dis Control, Beijing, Peoples R China	Shandong University	Liu, YX (corresponding author), Chinese Peoples Liberat Army PLA Gen Hosp, Dept Infect Management & Dis Control, Beijing, Peoples R China.	Yunxiliu6511@yahoo.com.cn	Xie, li/HGE-6052-2022		National Natural Science Foundation of China [30872155, 30972523]; China Special Grant for the Prevention and Control of Infectious Diseases [2009ZX10004-204]; twelfth five year research fundation of Military Medical Sciences and Technology [AWS11L009, 11BJZ01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Special Grant for the Prevention and Control of Infectious Diseases; twelfth five year research fundation of Military Medical Sciences and Technology	This work was supported by grants from National Natural Science Foundation of China (No. 30872155 and No. 30972523), China Special Grant for the Prevention and Control of Infectious Diseases (No. 2009ZX10004-204) and the twelfth five year research fundation of Military Medical Sciences and Technology [the key program (AWS11L009) and the Special Grant for health protection (11BJZ01)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Bertolotti-Ciarlet A, 2003, J VIROL, V77, P11603, DOI 10.1128/JVI.77.21.11603-11615.2003; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Chung JY, 2010, J MED VIROL, V82, P146, DOI 10.1002/jmv.21650; Dai YC, 2011, ARCH VIROL, V156, P1641, DOI 10.1007/s00705-011-1010-3; Eden JS, 2010, J CLIN VIROL, V49, P265, DOI 10.1016/j.jcv.2010.09.001; Giammanco GM, 2012, INFECT GENET EVOL, V12, P169, DOI 10.1016/j.meegid.2011.10.021; Green J, 2000, VIRUS GENES, V20, P227, DOI 10.1023/A:1008140611929; Han TH, 2011, ARCH VIROL, V156, P323, DOI 10.1007/s00705-010-0844-4; Hardy ME, 1997, ARCH VIROL, V142, P1469, DOI 10.1007/s007050050173; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; KAPIKIAN AZ, 1972, J VIROL, V10, P1075, DOI 10.1128/JVI.10.5.1075-1081.1972; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mathijs E, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-310; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Nakamura K, 2009, JPN J INFECT DIS, V62, P394; Phan TG, 2006, EMERG INFECT DIS, V12, P857, DOI 10.3201/eid1205.051566; Siebenga JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000884; SMITH JM, 1992, J MOL EVOL, V34, P126; Takanashi S, 2011, J CLIN MICROBIOL, V49, P3234, DOI 10.1128/JCM.00305-11; Vinje J, 1996, J INFECT DIS, V174, P610, DOI 10.1093/infdis/174.3.610; Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1; XI JA, 1990, SCIENCE, V250, P1580, DOI 10.1126/science.2177224; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Yang Y, 2010, J VIROL, V84, P9595, DOI 10.1128/JVI.02614-09; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	33	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88210	10.1371/journal.pone.0088210	http://dx.doi.org/10.1371/journal.pone.0088210			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505432	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200138
J	Tong, J; Buch, S; Yao, HH; Wu, CX; Tong, HI; Wang, YW; Lu, YN				Tong, Jing; Buch, Shilpa; Yao, Honghong; Wu, Chengxiang; Tong, Hsin-I; Wang, Youwei; Lu, Yuanan			Monocytes-Derived Macrophages Mediated Stable Expression of Human Brain-Derived Neurotrophic Factor, a Novel Therapeutic Strategy for NeuroAIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; DEFECTIVE LENTIVIRAL VECTORS; HIV-1 ASSOCIATED DEMENTIA; NECROSIS-FACTOR-ALPHA; GENE-THERAPY; PARKINSONS-DISEASE; FACTOR PREVENTS; CELL DELIVERY; PROTEIN GP120	HIV-1 associated dementia remains a significant public health burden. Clinical and experimental research has shown that reduced levels of brain-derived neurotrophic factor (BDNF) may be a risk factor for neurological complications associated with HIV-1 infection. We are actively testing genetically modified macrophages for their possible use as the cell-based gene delivery vehicle for the central nervous system (CNS). It can be an advantage to use the natural homing/migratory properties of monocyte-derived macrophages to deliver potentially neuroprotective BDNF into the CNS, as a non-invasive manner. Lentiviral-mediated gene transfer of human (h) BDNF plasmid was constructed and characterized. Defective lentiviral stocks were generated by transient transfection of 293T cells with lentiviral transfer plasmid together with packaging and envelope plasmids. High titer lentiviral vector stocks were harvested and used to transduce human neuronal cell lines, primary cultures of human peripheral mononocyte-derived macrophages (hMDM) and murine myeloid monocyte-derived macrophages (mMDM). These transduced cells were tested for hBDNF expression, stability, and neuroprotective activity. The GenomeLab GeXP Genetic Analysis System was used to evaluate transduced cells for any adverse effects by assessing gene profiles of 24 reference genes. High titer vectors were prepared for efficient transduction of neuronal cell lines, hMDM, and mMDM. Stable secretion of high levels of hBDNF was detected in supernatants of transduced cells using western blot and ELISA. The conditioned media containing hBDNF were shown to be protective to neuronal and monocytic cell lines from TNF-alpha and HIV-1 Tat mediated cytotoxicity. Lentiviral vector-mediated gene transduction of hMDM and mMDM resulted in high-level, stable expression of the neuroprotective factorBDNF in vitro. These findings form the basis for future research on the potential use of BDNF as a novel therapy for neuroAIDS.	[Tong, Jing; Wang, Youwei] Wuhan Univ, Sch Pharmaceut Sci, Inst TCM & Nat Prod, MOE Key Lab Combinatorial Biosynth & Drug Discove, Wuhan 430072, Peoples R China; [Tong, Jing; Wu, Chengxiang; Tong, Hsin-I; Lu, Yuanan] Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA; [Buch, Shilpa; Yao, Honghong] Univ Nebraska Med Ctr, Nebraska Med Ctr, Omaha, NE USA	Wuhan University; University of Hawaii System; University of Hawaii Manoa; University of Nebraska System; University of Nebraska Medical Center	Wang, YW (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Inst TCM & Nat Prod, MOE Key Lab Combinatorial Biosynth & Drug Discove, Wuhan 430072, Peoples R China.	wyw@whu.edu.cn; yuanan@hawaii.edu		Buch, Shilpa/0000-0002-3103-6685	National Institute of Mental Health, National Institutes of Health [R01 MH079717]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079717, P30MH062261] Funding Source: NIH RePORTER	National Institute of Mental Health, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Mental Health, National Institutes of Health (R01 MH079717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000215; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Asahchop EL, 2012, ANTIMICROB AGENTS CH; Avdoshina V, 2011, AIDS, V25, P1126, DOI 10.1097/QAD.0b013e32834671b3; Bachis A, 2005, ANN NY ACAD SCI, V1053, P247, DOI 10.1196/annals.1344.022; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bart J, 2000, CANCER TREAT REV, V26, P449, DOI 10.1053/ctrv.2000.0194; Batrakova EV, 2011, EXPERT OPIN DRUG DEL, V8, P415, DOI 10.1517/17425247.2011.559457; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; Burke B, 2003, EXPERT OPIN BIOL TH, V3, P919, DOI 10.1517/14712598.3.6.919; Buscemi L, 2007, NEUROBIOL DIS, V26, P661, DOI 10.1016/j.nbd.2007.03.004; Cao SB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-48; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Clay CC, 2007, J VIROL, V81, P12040, DOI 10.1128/JVI.00133-07; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Dore GJ, 1999, AIDS, V13, P1249, DOI 10.1097/00002030-199907090-00015; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Dou HY, 2004, NEUROTOX RES, V6, P503, DOI 10.1007/BF03033447; Farquharson AJ, 2012, MOL BIOL REP, V39, P5727, DOI 10.1007/s11033-011-1382-1; Foley Jessica, 2008, Curr HIV/AIDS Rep, V5, P204, DOI 10.1007/s11904-008-0029-x; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; KIDA K, 1973, J BIOCHEM, V73, P299; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Li J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-189; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; Liner Kevin J 2nd, 2008, Curr HIV/AIDS Rep, V5, P64, DOI 10.1007/s11904-008-0011-7; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; Major EO, 2000, SCIENCE, V288, P440; McMillan J, 2011, PROG MOL BIOL TRANSL, V104, P563, DOI 10.1016/B978-0-12-416020-0.00014-0; Meeker RB, 2011, J NEUROVIROL, V17, P258, DOI 10.1007/s13365-011-0034-5; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010; Mocchetti Italo, 2004, Critical Reviews in Neurobiology, V16, P51, DOI 10.1615/CritRevNeurobiol.v16.i12.50; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nicolini A, 2001, J NEUROCHEM, V79, P713, DOI 10.1046/j.1471-4159.2001.00568.x; Nosheny RL, 2007, EUR J NEUROSCI, V25, P2275, DOI 10.1111/j.1460-9568.2007.05506.x; Nosheny RL, 2006, J NEUROBIOL, V66, P1311, DOI 10.1002/neu.20288; Nosheny RL, 2005, NEUROTOX RES, V8, P187, DOI 10.1007/BF03033829; Nosheny RL, 2004, EUR J NEUROSCI, V20, P2857, DOI 10.1111/j.1460-9568.2004.03764.x; Rai AJ, 2009, ANAL BIOANAL CHEM, V393, P1505, DOI 10.1007/s00216-008-2436-7; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7; Thomas SA, 2004, CURR PHARM DESIGN, V10, P1313, DOI 10.2174/1381612043384835; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; Wu C, 2007, CELL MOL BIOL, V53, P67, DOI 10.1170/T810; Wu CX, 2010, J GEN VIROL, V91, P1909, DOI 10.1099/vir.0.020255-0; Wu JM, 2006, BRAIN RES, V1098, P79, DOI 10.1016/j.brainres.2006.04.074; YEUNG MC, 1995, AIDS, V9, P137, DOI 10.1097/00002030-199509020-00004; Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825; Zeng LB, 2006, J VIROL METHODS, V134, P66, DOI 10.1016/j.jviromet.2005.12.006	60	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e82030	10.1371/journal.pone.0082030	http://dx.doi.org/10.1371/journal.pone.0082030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505242	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200002
J	Dougal, K; de la Fuente, G; Harris, PA; Girdwood, SE; Pinloche, E; Geor, RJ; Nielsen, BD; Schott, HC; Elzinga, S; Newbold, CJ				Dougal, Kirsty; de la Fuente, Gabriel; Harris, Patricia A.; Girdwood, Susan E.; Pinloche, Eric; Geor, Raymond J.; Nielsen, Brian D.; Schott, Harold C., II; Elzinga, Sarah; Newbold, C. Jamie			Characterisation of the Faecal Bacterial Community in Adult and Elderly Horses Fed a High Fibre, High Oil or High Starch Diet Using 454 Pyrosequencing	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; CORE MICROBIOME; DIVERSITY; HINDGUT; POPULATIONS; ECOLOGY; PROFILE; TRACT; CECUM	Faecal samples were collected from seventeen animals, each fed three different diets (high fibre, high fibre with a starch rich supplement and high fibre with an oil rich supplement). DNA was extracted and the V1-V2 regions of 16SrDNA were 454-pyrosequenced to investigate the faecal microbiome of the horse. The effect of age was also considered by comparing mature (8 horses aged 5-12) versus elderly horses (9 horses aged 19-28). A reduction in diversity was found in the elderly horse group. Significant differences between diets were found at an OTU level (52 OTUs at corrected Q < 0.1). The majority of differences found were related to the Firmucutes phylum (37) with some changes in Bacteroidetes (6), Proteobacteria (3), Actinobacteria (2) and Spirochaetes (1). For the forage only diet, with no added starch or oil, we found 30/2934 OTUs (accounting for 15.9% of sequences) present in all horses. However the core (i.e. present in all horses) associated with the oil rich supplemented diet was somewhat smaller (25/3029 OTUs, 10.3%) and the core associated with the starch rich supplemented diet was even smaller (15/2884 OTUs, 5.4%). The core associated with samples across all three diets was extremely small (6/5689 OTUs accounting for only 2.3% of sequences) and dominated by the order Clostridiales, with the most abundant family being Lachnospiraceae. In conclusion, forage based diets plus starch or oil rich complementary feeds were associated with differences in the faecal bacterial community compared with the forage alone. Further, as observed in people, ageing is associated with a reduction in bacterial diversity. However there was no change in the bacterial community structure in these healthy animals associated with age.	[Dougal, Kirsty; de la Fuente, Gabriel; Girdwood, Susan E.; Pinloche, Eric; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England; [Geor, Raymond J.; Nielsen, Brian D.; Schott, Harold C., II; Elzinga, Sarah] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Mars; WALTHAM Petcare Science Institute; Michigan State University	Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	cjn@aber.ac.uk	de la Fuente Oliver, Gabriel/B-3793-2015; de la Fuente Oliver, Gabriel/M-6981-2019; Schott, Harold/AAD-7379-2021; Geor, Raymond J/P-4631-2017	de la Fuente Oliver, Gabriel/0000-0003-0083-776X; de la Fuente Oliver, Gabriel/0000-0003-0083-776X; Schott, Harold/0000-0002-7728-5409; Geor, Raymond J/0000-0002-6825-6737; Elzinga, Sarah/0000-0002-4219-2712	Biotechnology and Biological Sciences Research Council (BBSRC) Case studentship [BB/G017271/1]; BBSRC [BBS/E/W/10964A01A, BBS/E/W/10964A01C, BBS/E/W/10964A01B] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01A, BBS/E/W/10964A01B, BBS/E/W/10964A01C] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Case studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by a Biotechnology and Biological Sciences Research Council (BBSRC) Case studentship (BB/G017271/1). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Booijink CCGM, 2010, ENVIRON MICROBIOL, V12, P3213, DOI 10.1111/j.1462-2920.2010.02294.x; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Daly K., 2011, BR J NUTR, V5, P1; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Fombelle A, 2003, ANIM SCI, V77, P293; de Fombelle A, 2001, J EQUINE VET SCI, V21, P439, DOI 10.1016/S0737-0806(01)70018-4; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Durban A, 2011, MICROB ECOL, V61, P123, DOI 10.1007/s00248-010-9738-y; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Elzinga S., 2011, J EQUINE VET SCI, V31, P268; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; GOODSON J, 1988, APPL ENVIRON MICROB, V54, P1946, DOI 10.1128/AEM.54.8.1946-1950.1988; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448; Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lowe BA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-20; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Medina B, 2002, J ANIM SCI, V80, P2600; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Morley JE, 2007, CLIN GERIATR MED, V23, P757, DOI 10.1016/j.cger.2007.06.002; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; OHERRIN SM, 1993, APPL ENVIRON MICROB, V59, P748, DOI 10.1128/AEM.59.3.748-755.1993; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Petri RM, 2013, APPL ENVIRON MICROB, V79, P3744, DOI 10.1128/AEM.03983-12; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekelja M, 2011, ISME J, V5, P519, DOI 10.1038/ismej.2010.129; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Shirazi-Beechey SP, 2008, EQUINE VET J, V40, P414, DOI 10.2746/042516408X314075; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Varloud M, 2004, ANIM SCI, V79, P61, DOI 10.1017/S1357729800054539; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yamano H, 2008, ANIM SCI J, V79, P234, DOI 10.1111/j.1740-0929.2008.00522.x; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011; Zhang C, 2012, ISME J, V4, P232; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112; Zwielehner J, 2009, EXP GERONTOL, V44, P440, DOI 10.1016/j.exger.2009.04.002	66	98	100	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87424	10.1371/journal.pone.0087424	http://dx.doi.org/10.1371/journal.pone.0087424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504261	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800033
J	Falls, KC; Williams, AL; Bryksin, AV; Matsumura, I				Falls, Kelly C.; Williams, Aimee L.; Bryksin, Anton V.; Matsumura, Ichiro			Escherichia coli Deletion Mutants Illuminate Trade-Offs between Growth Rate and Flux through a Foreign Anabolic Pathway	PLOS ONE			English	Article							PRECURSOR; CLONING; OPERON; GENES	Metabolic engineers strive to improve the production yields of microbial fermentations, sometimes by mutating the genomes of production strains. Some mutations are detrimental to the health of the organism, so a quantitative and mechanistic understanding of the trade-offs could inform better designs. We employed the bacterial luciferase operon (luxABCDE), which uses ubiquitous energetic cofactors (NADPH, ATP, FMNH2, acetyl-CoA) from the host cell, as a proxy for a novel anabolic pathway. The strains in the Escherichia coli Keio collection, each of which contains a single deletion of a non-essential gene, represent mutational choices that an engineer might make to optimize fermentation yields. The Keio strains and the parental BW25113 strain were transformed with a luxABCDE expression vector. Each transformant was propagated in defined M9 medium at 37 degrees C for 48 hours; the cell density (optical density at 600 nanometers, OD600) and luminescence were measured every 30 minutes. The trade-offs were visualized by plotting the maximum growth rate and luminescence/OD600 of each transformant across a "production possibility frontier''. Our results show that some loss-of-function mutations enhance growth in vitro or light production, but that improvement in one trait generally comes at the expense of the other.	[Falls, Kelly C.; Williams, Aimee L.; Bryksin, Anton V.; Matsumura, Ichiro] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Matsumura, I (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	imatsum@emory.edu			National Science Foundation;  [EF-1104988 (NSF3)];  [MCB-0951076 (NSF2)]	National Science Foundation(National Science Foundation (NSF)); ; 	This work was supported by the National Science Foundation. KF and IM were supported by grant number EF-1104988 (NSF3); AB, AW and IM were supported by MCB-0951076 (NSF2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2008, APPL MICROBIOL BIOT, V78, P801, DOI 10.1007/s00253-008-1373-x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Hara KY, 2009, METAB ENG, V11, P1, DOI 10.1016/j.ymben.2008.07.003; Held P, 2005, BIOTEK APPL NOTE; Karp PD, 2007, NUCLEIC ACIDS RES, V35, P7577, DOI 10.1093/nar/gkm740; Lundholt BK, 2003, J BIOMOL SCREEN, V8, P566, DOI 10.1177/1087057103256465; LYNN SP, 1982, J BACTERIOL, V152, P363; MARR AG, 1991, MICROBIOL REV, V55, P316, DOI 10.1128/MMBR.55.2.316-333.1991; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; Murphy AC, 2011, NAT PROD REP, V28, P1406, DOI 10.1039/c1np00029b; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Skibinski DAG, 2002, J BACTERIOL, V184, P6642, DOI 10.1128/JB.184.23.6642-6653.2002; Skraly FA, 1998, APPL ENVIRON MICROB, V64, P98; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489	24	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88159	10.1371/journal.pone.0088159	http://dx.doi.org/10.1371/journal.pone.0088159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505410	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300062
J	Liu, CH; Liu, W; Lu, XZ; Ma, F; Chen, W; Yang, JB; Zheng, L				Liu, Changhong; Liu, Wei; Lu, Xuzhong; Ma, Fei; Chen, Wei; Yang, Jianbo; Zheng, Lei			Application of Multispectral Imaging to Determine Quality Attributes and Ripeness Stage in Strawberry Fruit	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; SOLUBLE SOLIDS CONTENT; FIRMNESS; IDENTIFICATION; COLOR	Multispectral imaging with 19 wavelengths in the range of 405-970 nm has been evaluated for nondestructive determination of firmness, total soluble solids (TSS) content and ripeness stage in strawberry fruit. Several analysis approaches, including partial least squares (PLS), support vector machine (SVM) and back propagation neural network (BPNN), were applied to develop theoretical models for predicting the firmness and TSS of intact strawberry fruit. Compared with PLS and SVM, BPNN considerably improved the performance of multispectral imaging for predicting firmness and total soluble solids content with the correlation coefficient (r) of 0.94 and 0.83, SEP of 0.375 and 0.573, and bias of 0.035 and 0.056, respectively. Subsequently, the ability of multispectral imaging technology to classify fruit based on ripeness stage was tested using SVM and principal component analysis-back propagation neural network (PCA-BPNN) models. The higher classification accuracy of 100% was achieved using SVM model. Moreover, the results of all these models demonstrated that the VIS parts of the spectra were the main contributor to the determination of firmness, TSS content estimation and classification of ripeness stage in strawberry fruit. These results suggest that multispectral imaging, together with suitable analysis model, is a promising technology for rapid estimation of quality attributes and classification of ripeness stage in strawberry fruit.	[Liu, Changhong; Ma, Fei; Chen, Wei; Zheng, Lei] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Liu, Wei] Hefei Univ, Intelligent Control & Compute Vis Lab, Hefei, Peoples R China; [Lu, Xuzhong; Yang, Jianbo] Anhui Acad Agr Sci, Inst Rice Res, Hefei, Peoples R China; [Zheng, Lei] Hefei Univ Technol, Sch Med Engn, Hefei, Peoples R China	Hefei University of Technology; Hefei University; Anhui Academy of Agricultural Sciences; Hefei University of Technology	Chen, W (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	chenweishnu@163.com; yjianbo@263.net; lzheng@hfut.edu.cn	Ma, Fei/S-4052-2016; Zheng, Lei/AAF-6159-2019; Liu, Changhong/HGE-5763-2022; yang, jian/HIK-0188-2022; Chen, Wei/F-4557-2010	Chen, Wei/0000-0003-3763-1183; Liu, Changhong/0000-0001-8386-5939	Specialized Research Fund for the Doctoral Program of 270 Higher Education [20120111110024]; Fundamental Research Funds for the Central Universities [2012HGCX0003, 2012HGZY0021]; National Key Technologies RD Programme [2012BAD07B01]; Funds for Huangshan Professorship of Hefei University of Technology	Specialized Research Fund for the Doctoral Program of 270 Higher Education; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Technologies RD Programme(National Key Technology R&D Program); Funds for Huangshan Professorship of Hefei University of Technology	This 269 study is supported by the Specialized Research Fund for the Doctoral Program of 270 Higher Education (20120111110024), the Fundamental Research Funds for the Central Universities (2012HGCX0003), (2012HGZY0021), the National Key Technologies R&D Programme (2012BAD07B01), and the Funds for Huangshan Professorship of Hefei University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J. A., 1997, Horticultural Reviews, V20, P1; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; CRUZCASTILLO JG, 1994, HORTSCIENCE, V29, P1115, DOI 10.21273/HORTSCI.29.10.1115; Gomez DD, 2007, COMPUT VIS IMAGE UND, V106, P183, DOI 10.1016/j.cviu.2006.06.011; Devos O, 2009, CHEMOMETR INTELL LAB, V96, P27, DOI 10.1016/j.chemolab.2008.11.005; Dissing BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019032; Dissing BS, 2013, FOOD BIOPROCESS TECH, V6, P2268, DOI 10.1007/s11947-012-0886-6; Dubey BP, 2006, BIOSYST ENG, V95, P61, DOI 10.1016/j.biosystemseng.2006.06.001; ElMasry G, 2007, J FOOD ENG, V81, P98, DOI 10.1016/j.jfoodeng.2006.10.016; Feng YZ, 2012, CRIT REV FOOD SCI, V52, P1039, DOI 10.1080/10408398.2011.651542; Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; Ito H, 2002, ACTA HORTIC, P751, DOI 10.17660/ActaHortic.2002.567.165; Kim MS, 2002, T ASAE, V45, P2027; Lawrence S., 1997, AAAIIAAI, P540; Lleo L, 2009, J FOOD ENG, V93, P229, DOI 10.1016/j.jfoodeng.2009.01.028; Lokke MM, 2013, POSTHARVEST BIOL TEC, V75, P86, DOI 10.1016/j.postharvbio.2012.06.018; Lorente D, 2012, FOOD BIOPROCESS TECH, V5, P1121, DOI 10.1007/s11947-011-0725-1; Lu RF, 2004, POSTHARVEST BIOL TEC, V31, P147, DOI 10.1016/j.postharvbio.2003.08.006; Lunadei L, 2012, POSTHARVEST BIOL TEC, V63, P74, DOI 10.1016/j.postharvbio.2011.08.004; Lunadei L, 2011, POSTHARVEST BIOL TEC, V60, P225, DOI 10.1016/j.postharvbio.2011.02.001; Nagata M, 2004, ANN INT M; Nishizawa T, 2009, J JPN SOC FOOD SCI, V56, P229, DOI 10.3136/nskkk.56.229; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peng YK, 2007, J FOOD ENG, V82, P142, DOI 10.1016/j.jfoodeng.2006.12.027; Peng YK, 2006, POSTHARVEST BIOL TEC, V41, P266, DOI 10.1016/j.postharvbio.2006.04.005; Sanchez MT, 2012, J FOOD ENG, V110, P102, DOI 10.1016/j.jfoodeng.2011.12.003; Seeram NP, 2006, FOOD CHEM, V97, P1, DOI 10.1016/j.foodchem.2005.02.047; Shao YN, 2008, INT J FOOD PROP, V11, P102, DOI 10.1080/10942910701257057; Sturm K, 2003, FOOD CHEM, V83, P417, DOI 10.1016/S0308-8146(03)00124-9; Sun X, 2012, MEAT SCI, V92, P386, DOI 10.1016/j.meatsci.2012.04.030; Tallada Jasper G., 2006, Environmental Control in Biology, V44, P245; Xing J, 2007, BIOSYST ENG, V96, P231, DOI 10.1016/j.biosystemseng.2006.10.018	33	66	72	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87818	10.1371/journal.pone.0087818	http://dx.doi.org/10.1371/journal.pone.0087818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505317	Green Published, gold			2022-12-27	WOS:000336971300001
J	Zhang, YJ; Zhao, Y; Jiang, GY; Zhang, XP; Zhao, HY; Wu, JH; Xu, K; Wang, EH				Zhang, Yijun; Zhao, Yue; Jiang, Guiyang; Zhang, Xiupeng; Zhao, Huanyu; Wu, Junhua; Xu, Ke; Wang, Enhua			Impact of p120-catenin Isoforms 1A and 3A on Epithelial Mesenchymal Transition of Lung Cancer Cells Expressing E-cadherin in Different Subcellular Locations	PLOS ONE			English	Article							HUMAN P120(CTN) CATENIN; P120 CATENIN; BREAST-CANCER; BETA-CATENIN; TUMOR PROGRESSION; GENE-EXPRESSION; COLON-CARCINOMA; METASTASIS; GROWTH; ADHESION	The epithelial mesenchymal transition (EMT) is an important process in tumor development. Despite previous investigations, it remains unclear how p120-catenin (p120ctn) isoforms 1A and 3A affect the EMT of tumor cells. Here we investigated expression of p120ctn, E-cadherin and vimentin in 78 human non-small cell lung cancer (NSCLC) samples by immunohistochemistry and found that p120ctn membrane expression positively correlated with E-cadherin expression (P<0.001) and negatively correlated with vimentin expression and lymph node metastasis (P<0.05). Meanwhile, p120ctn cytoplasmic expression negatively correlated with E-cadherin expression (P<0.001) and positively correlated with vimentin expression and lymph node metastasis (P<0.05). Cells expressing high (H460 and SPC) and low (H1299 and LK2) levels of p120ctn were screen to investigate its impact on EMT. E-cadherin was restricted to the cell membrane in H460 and H1299 cells, whereas it was expressed in the cytoplasm of SPC and LK2 cells. Ablation of endogenous p120ctn isoform 1A in cells expressing high levels of the protein resulted in decreased E-cadherin expression, increased N-cadherin, vimentin and snail expression and enhanced invasiveness in H460 cells. Meanwhile, completely opposite results were observed in SPC cells. Furthermore, transfection of in H1299 cells expressing low p120ctn levels with the p120ctn isoform 1A plasmid resulted in increased E-cadherin expression, decreased N-cadherin, vimentin and snail expression and weakened invasiveness, while LK2 cells showed completely opposite results. Both cell lines expressing low p120ctn levels and transfected with the p120ctn isoform 3A plasmid appeared to have increased E-cadherin expression, decreased N-cadherin, vimentin and snail expression and weakened invasiveness. In conclusion, in cells with membrane E-cadherin, both p120ctn isoforms 1A and 3A inhibited EMT and decreased cell invasiveness. In cells with cytoplasmic E-cadherin, p120ctn isoform 1A promoted EMT and increased cell invasiveness, while p120ctn isoform 3A inhibited the EMT and decreased cell invasiveness.	[Zhang, Yijun; Zhao, Yue; Jiang, Guiyang; Zhang, Xiupeng; Zhao, Huanyu; Wu, Junhua; Wang, Enhua] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China; [Zhang, Yijun; Zhao, Yue; Jiang, Guiyang; Zhang, Xiupeng; Zhao, Huanyu; Wu, Junhua; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Xu, Ke] China Med Univ, Dept Radiol, Affiliated Hosp 1, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Peoples R China.	wangeh@hotmail.com	Zhao, Yue/AGZ-4412-2022	Zhao, Yue/0000-0002-0110-0359	National Natural Science Foundation of China [81071905, 81272606, 81101780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (grants 81071905 and 81272606 to E.-H.W., grants 81101780 to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho S, 1999, J CELL BIOCHEM, V73, P390, DOI 10.1002/(SICI)1097-4644(19990601)73:3<390::AID-JCB10>3.3.CO;2-T; Aho S, 2002, J CELL SCI, V115, P1391; Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; Andreolas C, 2008, INT J CANCER, V122, P1745, DOI 10.1002/ijc.23309; Bellovin DI, 2005, CANCER RES, V65, P10938, DOI 10.1158/0008-5472.CAN-05-1947; Berx G, 2007, CLIN EXP METASTAS, V24, P587, DOI 10.1007/s10585-007-9114-6; Bukholm IK, 2000, J PATHOL, V190, P15; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Ferber EC, 2008, J BIOL CHEM, V283, P12691, DOI 10.1074/jbc.M708887200; Goldstraw P, 2011, SURG ONCOL CLIN N AM, V20, P655, DOI 10.1016/j.soc.2011.07.005; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Jiang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030303; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Knirsh R, 2009, MOL BIOL CELL, V20, P2121, DOI 10.1091/mbc.E08-12-1196; Liu Y, 2009, EXP CELL RES, V315, P890, DOI 10.1016/j.yexcr.2008.12.016; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Miranda KC, 2003, J BIOL CHEM, V278, P43480, DOI 10.1074/jbc.M305525200; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; Seidel B, 2004, ONCOGENE, V23, P5532, DOI 10.1038/sj.onc.1207718; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; Slorach EM, 2011, GENE DEV, V25, P471, DOI 10.1101/gad.1998111; Soto E, 2008, J CELL BIOL, V183, P737, DOI 10.1083/jcb.200805113; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Stockinger A, 2001, J CELL BIOL, V154, P1185, DOI 10.1083/jcb.200104036; teinhusen U, 2001, J BIOL CHEM, V276, P4972; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Travis WD., 2004, TRAVIS WB WHO CLASSI; Valdes F, 2002, MOL CANCER RES, V1, P68; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vernon AE, 2004, CURR BIOL, V14, pR719, DOI 10.1016/j.cub.2004.08.048; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wang EH, 2006, HISTOL HISTOPATHOL, V21, P841, DOI 10.14670/HH-21.841; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037008	44	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88064	10.1371/journal.pone.0088064	http://dx.doi.org/10.1371/journal.pone.0088064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505377	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300047
J	Hadziavdic, K; Lekang, K; Lanzen, A; Jonassen, I; Thompson, EM; Troedsson, C				Hadziavdic, Kenan; Lekang, Katrine; Lanzen, Anders; Jonassen, Inge; Thompson, Eric M.; Troedsson, Christofer			Characterization of the 18S rRNA Gene for Designing Universal Eukaryote Specific Primers	PLOS ONE			English	Article							MICROBIAL DIVERSITY; SECONDARY STRUCTURE; PCR PRIMERS; SEQUENCES; COMMUNITY; REGIONS; RDNA; PARASITES; SILVA; SITE	High throughput sequencing technology has great promise for biodiversity studies. However, an underlying assumption is that the primers used in these studies are universal for the prokaryotic or eukaryotic groups of interest. Full primer universality is difficult or impossible to achieve and studies using different primer sets make biodiversity comparisons problematic. The aim of this study was to design and optimize universal eukaryotic primers that could be used as a standard in future biodiversity studies. Using the alignment of all eukaryotic sequences from the publicly available SILVA database, we generated a full characterization of variable versus conserved regions in the 18S rRNA gene. All variable regions within this gene were analyzed and our results suggested that the V2, V4 and V9 regions were best suited for biodiversity assessments. Previously published universal eukaryotic primers as well as a number of self-designed primers were mapped to the alignment. Primer selection will depend on sequencing technology used, and this study focused on the 454 pyrosequencing GS FLX Titanium platform. The results generated a primer pair yielding theoretical matches to 80% of the eukaryotic and 0% of the prokaryotic sequences in the SILVA database. An empirical test of marine sediments using the AmpliconNoise pipeline for analysis of the high throughput sequencing data yielded amplification of sequences for 71% of all eukaryotic phyla with no isolation of prokaryotic sequences. To our knowledge this is the first characterization of the complete 18S rRNA gene using all eukaryotes present in the SILVA database, providing a robust test for universal eukaryotic primers. Since both in silico and empirical tests using high throughput sequencing retained high inclusion of eukaryotic phyla and exclusion of prokaryotes, we conclude that these primers are well suited for assessing eukaryote diversity, and can be used as a standard in biodiversity studies.	[Hadziavdic, Kenan; Lekang, Katrine; Lanzen, Anders; Thompson, Eric M.] Univ Bergen, Dept Biol, Bergen, Norway; [Lanzen, Anders; Jonassen, Inge] Uni Res AS, Uni Comp, Bergen, Norway; [Lanzen, Anders] NEIKER Tecnalia, Dept Ecol & Nat Resources, Derio, Spain; [Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Thompson, Eric M.] Univ Bergen, Sars Int Ctr Marine Mol Biol, Bergen, Norway; [Troedsson, Christofer] Uni Res AS, Uni Environm, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; University of Bergen	Troedsson, C (corresponding author), Uni Res AS, Uni Environm, Bergen, Norway.	Christofer.Troedsson@uni.no	Jonassen, Inge/AAC-7035-2020; Lanzén, Anders/F-3818-2016; Lanzén, Anders/AAG-5048-2019	Lanzén, Anders/0000-0002-7138-6364; Lanzén, Anders/0000-0002-7138-6364; Jonassen, Inge/0000-0003-4110-0748	Norwegian Research Council, Havet og Kysten [190265/S40]	Norwegian Research Council, Havet og Kysten(Research Council of Norway)	This work was supported by the Norwegian Research Council, Havet og Kysten, Project 190265/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bhadury P, 2010, HYDROBIOLOGIA, V641, P245, DOI 10.1007/s10750-009-0088-z; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CORNISHBOWDEN A, 1985, NUCLEIC ACIDS RES, V13, P3021, DOI 10.1093/nar/13.9.3021; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Dunthorn M, 2012, J EUKARYOT MICROBIOL, V59, P185, DOI 10.1111/j.1550-7408.2011.00602.x; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Gruebl T, 2002, DIS AQUAT ORGAN, V49, P61, DOI 10.3354/dao049061; HENDRIKS L, 1991, J MOL EVOL, V32, P167, DOI 10.1007/BF02515389; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lanzen A, 2011, FEMS MICROBIOL ECOL, V77, P577, DOI 10.1111/j.1574-6941.2011.01138.x; LIM EL, 1993, APPL ENVIRON MICROB, V59, P1647, DOI 10.1128/AEM.59.5.1647-1655.1993; Lovejoy C, 2011, J PLANKTON RES, V33, P431, DOI 10.1093/plankt/fbq124; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046180; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; NELLES L, 1984, NUCLEIC ACIDS RES, V12, P8749, DOI 10.1093/nar/12.23.8749; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Romari K, 2004, LIMNOL OCEANOGR, V49, P784, DOI 10.4319/lo.2004.49.3.0784; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schmalenberger A, 2001, APPL ENVIRON MICROB, V67, P3557, DOI 10.1128/AEM.67.8.3557-3563.2001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Troedsson C, 2008, APPL ENVIRON MICROB, V74, P4346, DOI 10.1128/AEM.02132-07; Troedsson C, 2008, APPL ENVIRON MICROB, V74, P4336, DOI 10.1128/AEM.02131-07; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; WINNEPENNINCKX B, 1994, NAUTILUS, V108, P98; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P5017, DOI 10.1093/nar/29.24.5017; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	54	252	262	8	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87624	10.1371/journal.pone.0087624	http://dx.doi.org/10.1371/journal.pone.0087624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516555	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400016
J	Martinez-Aranguren, R; Lizaso, MT; Goikoetxea, MJ; Garcia, BE; Cabrera-Freitag, P; Trellez, O; Sanz, ML				Martinez-Aranguren, Ruben; Lizaso, Maria T.; Goikoetxea, Maria J.; Garcia, Blanca E.; Cabrera-Freitag, Paula; Trellez, Oswaldo; Sanz, Maria L.			Is the Determination of Specific IgE against Components Using ISAC 112 a Reproducible Technique?	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; ALLERGIC PATIENTS; FOOD ALLERGY; CORRELATION-COEFFICIENT; SENSITIZATION PROFILES; MOLECULAR DIAGNOSIS; RESOLVED DIAGNOSIS; IMMUNOGLOBULIN-E; POLLEN ALLERGY; MICROARRAY	Background: The ImmunoCAP ISAC 112 is a fluoro-immunoassay that allows detection of specific IgE to 112 molecular components from 51 allergenic sources. We studied the reliability of this technique intra- and inter- assay, as well as inter-batch- and inter-laboratory-assay. Methods: Twenty samples were studied, nineteen sera from polysensitized allergic patients, and the technique calibrator provided by the manufacturer (CTR02). We measured the sIgE from CTR02 and three patients' sera ten times in the same and in different assays. Furthermore, all samples were tested in two laboratories and with two batches of ISAC kit. To evaluate the accuracy of ISAC 112, we contrasted the determinations of CTR02 calibrator with their expected values by T Student test. To analyse the precision, we calculated the coefficient of variation (CV) of the 15 allergens that generate the calibration curve, and to analyse the repeatability and the reproducibility, we calculated the intraclass coefficient correlation (ICC) to each allergen. Results: The results obtained for CTR02 were similar to those expected in 7 of 15 allergens that generate the calibration curve, whereas in 8 allergens the results showed significant differences. The mean CV obtained in the CTR02 determinations was of 9.4%, and the variability of sera from patients was of 22.9%. The agreement in the intra-and inter-assay analysis was very good to 94 allergens and good to one. In the inter-batch analyse, we obtained a very good agreement to 82 allergens, good to 14, moderate to 5 allergens, poor to one, and bad to 1 allergen. In the inter-laboratory analyse, we obtained a very good agreement to 73 allergens, good to 22, moderate to 6 and poor to two allergens. Conclusion: The allergen microarray immunoassay, ISAC 112, is a repeatable and reproducible in vitro diagnostic tool for determination of sIgE beyond the own laboratory.	[Martinez-Aranguren, Ruben; Goikoetxea, Maria J.; Cabrera-Freitag, Paula; Sanz, Maria L.] Univ Navarra Clin, Dept Allergol & Clin Immunol, Pamplona, Spain; [Lizaso, Maria T.; Garcia, Blanca E.] Complejo Hosp Navarra, Allergol Serv, Pamplona, Spain; [Trellez, Oswaldo] Univ Malaga, Dept Comp Architecture, E-29071 Malaga, Spain	University of Navarra; Servicio Navarro de Salud - Osasunbidea; Universidad de Malaga	Sanz, ML (corresponding author), Univ Navarra Clin, Dept Allergol & Clin Immunol, Pamplona, Spain.	mlsanzlar@unav.es	Goikoetxea, Maria Jose/AAJ-9054-2021	Goikoetxea, Maria Jose/0000-0003-2213-6999	Spanish Research Network on Adverse Reactions to Allergens and Drugs (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) of the Carlos III Health Institute, Madrid, Spain [RIRAAF RD12 00130010]; Carlos III Health Institute [FIS 11/01634]	Spanish Research Network on Adverse Reactions to Allergens and Drugs (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) of the Carlos III Health Institute, Madrid, Spain; Carlos III Health Institute(Instituto de Salud Carlos III)	RM is supported by a grant from the Spanish Research Network on Adverse Reactions to Allergens and Drugs (RIRAAF RD12 00130010: Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) of the Carlos III Health Institute, Madrid, Spain. All the authors (except PCF) belong to RIRAAF RD12 00130010. This study has been partly funded by a grant FIS 11/01634 from the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asero R, 2008, EUR ANN ALLERGY CLIN, V40, P115; Barber D, 2008, ALLERGY, V63, P1550, DOI 10.1111/j.1398-9995.2008.01807.x; Barber D, 2009, CLIN EXP ALLERGY, V39, P1764, DOI 10.1111/j.1365-2222.2009.03351.x; BRAVO G, 1991, J CLIN EPIDEMIOL, V44, P381, DOI 10.1016/0895-4356(91)90076-L; Cabrera-Freitag P, 2011, CLIN EXP ALLERGY, V41, P1440, DOI 10.1111/j.1365-2222.2011.03818.x; Cabrera-Freitag P, 2011, J INVEST ALLERG CLIN, V21, P414; Canonica GW, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-17; Diaz-Perales A, 2000, CLIN EXP ALLERGY, V30, P1403, DOI 10.1046/j.1365-2222.2000.00909.x; Ebo DG, 2010, CLIN EXP ALLERGY, V40, P339, DOI 10.1111/j.1365-2222.2009.03345.x; Ferrer M, 2009, J INVEST ALLERG CLIN, V19, P19; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Gamboa PM, 2009, J INVEST ALLERG CLIN, V19, P13; Goikoetxea MJ, 2010, ALLERGOL IMMUNOPATH, V38, P37, DOI 10.1016/j.aller.2009.11.001; Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje; Jahn-Schmid B, 2003, CLIN EXP ALLERGY, V33, P1443, DOI 10.1046/j.1365-2222.2003.01784.x; Lin J, 2009, J ALLERGY CLIN IMMUN, V124, P315, DOI 10.1016/j.jaci.2009.05.024; Mari A, 2001, INT ARCH ALLERGY IMM, V125, P57, DOI 10.1159/000053797; Ott H, 2008, ALLERGY, V63, P1521, DOI 10.1111/j.1398-9995.2008.01748.x; Palacin A, 2007, J ALLERGY CLIN IMMUN, V120, P1132, DOI 10.1016/j.jaci.2007.07.008; Prieto L, 1998, MED CLIN-BARCELONA, V110, P142; Renault NK, 2007, BIOTECHNOL LETT, V29, P333, DOI 10.1007/s10529-006-9251-z; Salcedo G, 2010, CLIN EXP ALLERGY, V40, P836, DOI 10.1111/j.1365-2222.2010.03506.x; Sanz ML, 2011, CURR OPIN ALLERGY CL, V11, P204, DOI 10.1097/ACI.0b013e3283466fe4; Sastre J, 2012, ALLERGY, V67, P709, DOI 10.1111/j.1398-9995.2012.02808.x; Scala E, 2010, CLIN EXP ALLERGY, V40, P911, DOI 10.1111/j.1365-2222.2010.03470.x; Twardosz-Kropfmuller A, 2010, ALLERGY, V65, P296, DOI 10.1111/j.1398-9995.2009.02202.x; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896; Villalta D, 2010, J ALLERGY CLIN IMMUN, V125, P1158, DOI 10.1016/j.jaci.2010.01.043; Wang J, 2008, J ALLERGY CLIN IMMUN, V121, P1219, DOI 10.1016/j.jaci.2007.12.1150; Wohrl S, 2006, ALLERGY, V61, P633, DOI 10.1111/j.1398-9995.2006.01078.x	30	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88394	10.1371/journal.pone.0088394	http://dx.doi.org/10.1371/journal.pone.0088394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516646	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700066
J	Martorell, O; Merlos-Suarez, A; Campbell, K; Barriga, FM; Christov, CP; Miguel-Aliaga, I; Batlle, E; Casanova, J; Casali, A				Martorell, Oscar; Merlos-Suarez, Anna; Campbell, Kyra; Barriga, Francisco M.; Christov, Christo P.; Miguel-Aliaga, Irene; Batlle, Eduard; Casanova, Jordi; Casali, Andreu			Conserved Mechanisms of Tumorigenesis in the Drosophila Adult Midgut	PLOS ONE			English	Article							INTESTINAL-STEM-CELLS; CONTROLS SELF-RENEWAL; BETA-CATENIN; COLON-CANCER; DIFFERENTIATION; EPITHELIUM; JAK/STAT; APC; PROLIFERATION; PROGRESSION	Whereas the series of genetic events leading to colorectal cancer (CRC) have been well established, the precise functions that these alterations play in tumor progression and how they disrupt intestinal homeostasis remain poorly characterized. Activation of the Wnt/Wg signaling pathway by a mutation in the gene APC is the most common trigger for CRC, inducing benign lesions that progress to carcinomas due to the accumulation of other genetic alterations. Among those, Ras mutations drive tumour progression in CRC, as well as in most epithelial cancers. As mammalian and Drosophila's intestines share many similarities, we decided to explore the alterations induced in the Drosophila midgut by the combined activation of the Wnt signaling pathway with gain of function of Ras signaling in the intestinal stem cells. Here we show that compound Apc-Ras clones, but not clones bearing the individual mutations, expand as aggressive intestinal tumor-like outgrowths. These lesions reproduce many of the human CRC hallmarks such as increased proliferation, blockade of cell differentiation and cell polarity and disrupted organ architecture. This process is followed by expression of tumoral markers present in human lesions. Finally, a metabolic behavioral assay shows that these flies suffer a progressive deterioration in intestinal homeostasis, providing a simple readout that could be used in screens for tumor modifiers or therapeutic compounds. Taken together, our results illustrate the conservation of the mechanisms of CRC tumorigenesis in Drosophila, providing an excellent model system to unravel the events that, upon mutation in Apc and Ras, lead to CRC initiation and progression.	[Martorell, Oscar; Campbell, Kyra; Casanova, Jordi; Casali, Andreu] Inst Res Biomed, Cell & Dev Biol Program, Barcelona, Spain; [Martorell, Oscar; Campbell, Kyra; Casanova, Jordi; Casali, Andreu] Inst Biol Mol Barcelona, Dept Dev Biol, Barcelona, Spain; [Merlos-Suarez, Anna; Barriga, Francisco M.; Batlle, Eduard] Inst Res Biomed, Oncol Program, Barcelona, Spain; [Christov, Christo P.] Univ Cambridge, Dept Zool, Cambridge, England; [Miguel-Aliaga, Irene] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London, England; [Batlle, Eduard] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Cambridge; Imperial College London; ICREA	Casali, A (corresponding author), Inst Res Biomed, Cell & Dev Biol Program, Barcelona, Spain.	andreu.casali@irbbarcelona.org	Tsai, Yu-Chen/B-5852-2008; Casanova, Jordi/L-5181-2014; Casali, Andreu/ABD-5226-2021; Batlle, Eduard/K-8080-2014; Casali, Andreu/Z-5620-2019; Campbell, Kyra/M-1513-2014	Casanova, Jordi/0000-0001-6121-8589; Casali, Andreu/0000-0003-1738-869X; Batlle, Eduard/0000-0003-2422-0326; Campbell, Kyra/0000-0001-8573-4756; Barriga, Francisco/0000-0002-0996-7707; Miguel-Aliaga, Irene/0000-0002-1082-5108	MICINN [BFU2010-16016, BFU2011-23479]; Medical Research Council [MC_UP_1102/3] Funding Source: researchfish; ICREA Funding Source: Custom; MRC [MC_UP_1102/3] Funding Source: UKRI	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MICINN (BFU2010-16016 and BFU2011-23479) to A. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; BRYAN J, 1993, P NATL ACAD SCI USA, V90, P9115, DOI 10.1073/pnas.90.19.9115; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cordero JB, 2012, DEVELOPMENT, V139, P4524, DOI 10.1242/dev.078261; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Gonzalez C, 2013, NAT REV CANC; Gonzalez-Roca E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014418; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Karim FD, 1998, DEVELOPMENT, V125, P1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Lin GN, 2010, J MOL CELL BIOL, V2, P37, DOI 10.1093/jmcb/mjp028; LONGO VD, 2004, SCI AGING KNOWLEDGE, pPE36; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Ohnishi T, 1997, BRIT J CANCER, V75, P341, DOI 10.1038/bjc.1997.56; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Wang CH, 2013, DEV BIOL, V378, P122, DOI 10.1016/j.ydbio.2013.03.020; Xu N, 2011, DEV BIOL, V354, P31, DOI 10.1016/j.ydbio.2011.03.018	49	31	31	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88413	10.1371/journal.pone.0088413	http://dx.doi.org/10.1371/journal.pone.0088413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516653	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700071
J	Moss, TP; Lawson, V; White, P				Moss, Timothy P.; Lawson, Victoria; White, Paul		Appearance Res Collaboration	Salience and Valence of Appearance in a Population with a Visible Difference of Appearance: Direct and Moderated Relationships with Self-Consciousness, Anxiety and Depression	PLOS ONE			English	Article							PARALLEL ANALYSIS; HOSPITAL ANXIETY; NUMBER; SCALE; COMPONENTS	Psychometric measures of appearance salience and valence, CARSAL and CARVAL, have been previously demonstrated to be key factors underpinning appearance related self-consciousness and negative affect in the general population. However, the extent to which the scales are appropriate for people with a visibly different appearance has not previously been reported. Neither has the moderating effect of appearance salience (CARSAL) on the relationship between appearance valence (CARVAL) and appearance self-consciousness, previously shown in a general population sample, been replicated with people who are visibly different. Twelve hundred and sixty five participants with a visible difference in either secondary care (n = 651) or the community (n = 614) provided data. Analysis confirmed the psychometric qualities of both CARSAL and CARVAL, and the conceptual independence of each scale. The scales also demonstrated independent and interdependent relationships with social anxiety and avoidance in relation to appearance, depression and anxiety. Appearance salience moderated the relationship with valence on these psychosocial measures. In summary, this paper corroborates the use of CARSAL and CARVAL with both visibly different and general adult populations for the measurement of appearance salience and valence.	[Moss, Timothy P.] Univ W England, Fac Hlth & Life Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England; [Lawson, Victoria] BPP Univ, Sch Hlth, Dept Psychol, London, England; [White, Paul] Univ W England, Fac Environm & Technol, Appl Stat Grp, Bristol BS16 1QY, Avon, England	University of West England; University of West England	Moss, TP (corresponding author), Univ W England, Fac Hlth & Life Sci, Ctr Appearance Res, Bristol BS16 1QY, Avon, England.	tim.moss@uwe.ac.uk	Jenkinson, Elizabeth/AAQ-7591-2021; Moss, Timothy/A-3501-2014	Jenkinson, Elizabeth/0000-0001-5686-5132; Lindenmeyer, Antje/0000-0001-5101-1648; Harcourt, Diana/0000-0002-4285-5678; Newman, Stanton/0000-0001-6712-6079; Thompson, Andrew/0000-0001-6788-7222; White, Paul/0000-0002-7503-9896; Moss, Timothy/0000-0003-0543-6228	Healing Foundation [1078666]; Welton Foundation; Worshipful Company of Tin Plate Workers; University of the West of England	Healing Foundation; Welton Foundation; Worshipful Company of Tin Plate Workers; University of the West of England	The original data collection was funded by Healing Foundation (registered charity 1078666) who funded this research in association with the Welton Foundation and the Worshipful Company of Tin Plate Workers. Time for the subsequent analysis and write up were funded by the University of the West of England during allocated research time for Moss and Lawson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], 2013, CBT APPEARANCE ANXIE; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Carr T, 2005, BRIT J HEALTH PSYCH, V10, P285, DOI 10.1348/135910705X27613; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; CHATTERJEE S, 1991, MARKET SCI, V10, P145, DOI 10.1287/mksc.10.2.145; Comrey AL., 1992, 1 COURSE FACTOR ANAL, V2nd ed., DOI DOI 10.4324/9781315827506; COTA AA, 1993, EDUC PSYCHOL MEAS, V53, P865, DOI 10.1177/0013164493053004001; Djan R, 2013, J PLASTIC RECONSTRUC, V6, P627; GLORFELD LW, 1995, EDUC PSYCHOL MEAS, V55, P377, DOI 10.1177/0013164495055003002; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Moss TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050605; Velicer W. F., 2000, PROBLEMS SOLUTIONS H; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	18	17	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88435	10.1371/journal.pone.0088435	http://dx.doi.org/10.1371/journal.pone.0088435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516660	gold, Green Published, Green Accepted			2022-12-27	WOS:000330830700074
J	Kung, HN; Weng, TY; Liu, YL; Lu, KS; Chau, YP				Kung, Hsiu-Ni; Weng, Tsai-Yun; Liu, Yu-Lin; Lu, Kuo-Shyan; Chau, Yat-Pang			Sulindac Compounds Facilitate the Cytotoxicity of beta-Lapachone by Up-Regulation of NAD(P)H Quinone Oxidoreductase in Human Lung Cancer Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DT-DIAPHORASE; NAD(P)H-QUINONE OXIDOREDUCTASE; NQO1 GENE; TUMOR-CELLS; EXPRESSION; APOPTOSIS; ACTIVATION; PATHWAYS; THERAPY	beta-lapachone, a major component in an ethanol extract of Tabebuia avellanedae bark, is a promising potential therapeutic drug for various tumors, including lung cancer, the leading cause of cancer-related deaths worldwide. In the first part of this study, we found that apoptotic cell death induced in lung cancer cells by high concentrations of beta-lapachone was mediated by increased activation of the pro-apoptotic factor JNK and decreased activation of the cell survival/proliferation factors PI3K, AKT, and ERK. In addition, beta-lapachone toxicity was positively correlated with the expression and activity of NAD(P)H quinone oxidoreductase 1 (NQO1) in the tumor cells. In the second part, we found that the FDA-approved non-steroidal anti-inflammatory drug sulindac and its metabolites, sulindac sulfide and sulindac sulfone, increased NQO1 expression and activity in the lung adenocarcinoma cell lines CL1-1 and CL1-5, which have lower NQO1 levels and lower sensitivity to beta-lapachone treatment than the A549 cell lines, and that inhibition of NQO1 by either dicoumarol treatment or NQO1 siRNA knockdown inhibited this sulindac-induced increase in beta-lapachone cytotoxicity. In conclusion, sulindac and its metabolites synergistically increase the anticancer effects of b-lapachone primarily by increasing NQO1 activity and expression, and these two drugs may provide a novel combination therapy for lung cancers.	[Kung, Hsiu-Ni; Lu, Kuo-Shyan] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Weng, Tsai-Yun; Liu, Yu-Lin; Chau, Yat-Pang] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 112, Taiwan; [Chau, Yat-Pang] Mackay Med Coll, Dept Med, New Taipei City, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Mackay Medical College	Kung, HN (corresponding author), Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan.	kunghsiuni@gmail.com; lks@ntu.edu.tw; leonchau@mmc.edu.tw	Kung, Hsiu-Ni/B-4832-2009	KUNG, HSIU-NI/0000-0001-6979-8346	National Science Council, Taiwan [NSC 101-2320-B-002-020-MY3, NSC 98-2320-B-715-001-MY3, NSC 101-2320-B-002-008]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants (NSC 101-2320-B-002-020-MY3, NSC 98-2320-B-715-001-MY3 (YPC) and NSC 101-2320-B-002-008) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PDQ CLIN TRAIL DAT; BELINSKY M, 1993, CANCER METAST REV, V12, P103, DOI 10.1007/BF00689804; Bentle MS, 2007, CANCER RES, V67, P6936, DOI 10.1158/0008-5472.CAN-07-0935; BERGER MS, 1985, J TOXICOL ENV HEALTH, V16, P713, DOI 10.1080/15287398509530781; Bottone FG, 2003, J BIOL CHEM, V278, P25790, DOI 10.1074/jbc.M301002200; Choi EK, 2007, NEOPLASIA, V9, P634, DOI 10.1593/neo.07397; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Ciolino HP, 2008, INT J CANCER, V122, P990, DOI 10.1002/ijc.23218; Ciolino HP, 2006, CARCINOGENESIS, V27, P1586, DOI 10.1093/carcin/bgi359; CRESTEIL T, 1991, BIOCHEM PHARMACOL, V42, P1021, DOI 10.1016/0006-2952(91)90284-C; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; de Witte NV, 2004, ARCH BIOCHEM BIOPHYS, V432, P129, DOI 10.1016/j.abb.2004.09.020; Dienstmann R, 2011, ONCOLOGIST, V16, P1729, DOI 10.1634/theoncologist.2011-0163; Dong GZ, 2009, INT J HYPERTHER, V25, P477, DOI 10.1080/02656730903049836; Earle Craig C, 2004, J Natl Cancer Inst Monogr, P56; Fernandes E, 2003, FREE RADICAL BIO MED, V35, P1008, DOI 10.1016/S0891-5849(03)00437-4; Gan Q, 2007, TOB CONTROL, V16, P417, DOI 10.1136/tc.2007.021477; Gupta AK, 2004, LUNG, V182, P151, DOI 10.1007/S00408/004/0310-8; Gustafson DL, 1996, MOL PHARMACOL, V50, P728; Hebbar V, 2005, LIFE SCI, V76, P2299, DOI 10.1016/j.lfs.2004.10.039; Hisamuddin IM, 2004, CLIN CANCER RES, V10, P8357, DOI 10.1158/1078-0432.CCR-04-1073; Horton JK, 1999, ANAL BIOCHEM, V271, P18, DOI 10.1006/abio.1999.4118; KARACHALIOS GN, 1982, INT J TISSUE REACT, V4, P297; KLASSEN DK, 1989, J CLIN PHARMACOL, V29, P1037, DOI 10.1002/j.1552-4604.1989.tb03275.x; Kolesar JM, 2002, INT J ONCOL, V21, P1119; Kutuk O, 2007, REDOX REP, V12, P30, DOI 10.1179/135100007X162329; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021533; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lien YC, 2008, HISTOL HISTOPATHOL, V23, P1299, DOI 10.14670/HH-23.1299; Lin XH, 2011, FREE RADICAL BIO MED, V51, P97, DOI 10.1016/j.freeradbiomed.2011.04.020; Marchetti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005804; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Minami T, 2005, CLIN CANCER RES, V11, P5248, DOI 10.1158/1078-0432.CCR-05-0085; MUNCIE HL, 1986, CLIN THER, V9, P4; Naime FR, 2007, CLINICS, V62, P397, DOI 10.1590/S1807-59322007000400005; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pardee AB, 2002, CURR CANCER DRUG TAR, V2, P227, DOI 10.2174/1568009023333854; Parka EJ, 2011, CHEM-BIOL INTERACT, V189, P37, DOI 10.1016/j.cbi.2010.10.013; Patten EJ, 1999, CANCER LETT, V147, P95, DOI 10.1016/S0304-3835(99)00282-7; Pink JJ, 2000, J BIOL CHEM, V275, P5416, DOI 10.1074/jbc.275.8.5416; Pink JJ, 2000, EXP CELL RES, V255, P144, DOI 10.1006/excr.1999.4790; Planchon SM, 2001, EXP CELL RES, V267, P95, DOI 10.1006/excr.2001.5234; Reinicke KE, 2005, CLIN CANCER RES, V11, P3055, DOI 10.1158/1078-0432.CCR-04-2185; Resnick L, 2009, J DRUGS DERMATOL, V8, P29; Ruegg C, 2003, ANN MED, V35, P476, DOI 10.1080/07853890310017053; Saeki K, 2002, BIOCHEM J, V368, P705, DOI 10.1042/BJ20020101; Satsu H, 2012, AMINO ACIDS; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Smaili SS, 2000, J BIOENERG BIOMEMBR, V32, P35, DOI 10.1023/A:1005508311495; SMITSKAMPWILMS E, 1995, BRIT J CANCER, V72, P917, DOI 10.1038/bjc.1995.433; Spivack SD, 2003, CLIN CANCER RES, V9, P6002; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Suzuki M, 2006, RADIAT RES, V165, P525, DOI 10.1667/RR3554.1; Tagliarino C, 2001, J BIOL CHEM, V276, P19150, DOI 10.1074/jbc.M100730200; Tagliarino C, 2003, CANCER BIOL THER, V2, P141, DOI 10.4161/cbt.2.2.237; Tan XL, 2012, AM J RESP CELL MOL, V46, P365, DOI 10.1165/rcmb.2011-0301OC; Terai K, 2009, ANTI-CANCER DRUG, V20, P901, DOI 10.1097/CAD.0b013e328330098d; Thill P G, 2011, Bull Soc Sci Med Grand Duche Luxemb, P43; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsai CW, 2011, J NUTR, V141, P2119, DOI 10.3945/jn.111.146779; Tugwell P, 1997, J RHEUMATOL, V24, P1122; VANE JR, 1990, STROKE, V21, P12; vanLieshout EMM, 1997, CARCINOGENESIS, V18, P485, DOI 10.1093/carcin/18.3.485; WADDELL WR, 1983, J SURG ONCOL, V24, P83, DOI 10.1002/jso.2930240119; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Zhang T, 2004, J PHARMACOL EXP THER, V308, P434, DOI 10.1124/jpet.103.059378	68	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88122	10.1371/journal.pone.0088122	http://dx.doi.org/10.1371/journal.pone.0088122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505400	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200120
J	Sett, S; Bach, LT; Schulz, KG; Koch-Klavsen, S; Lebrato, M; Riebesell, U				Sett, Scarlett; Bach, Lennart T.; Schulz, Kai G.; Koch-Klavsen, Signe; Lebrato, Mario; Riebesell, Ulf			Temperature Modulates Coccolithophorid Sensitivity of Growth, Photosynthesis and Calcification to Increasing Seawater pCO(2)	PLOS ONE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; GEPHYROCAPSA-OCEANICA; ORGANIC-CARBON; BERING-SEA; CO2; BLOOMS; SATELLITE; CHEMISTRY; RESPONSES; PLANKTON	Increasing atmospheric CO2 concentrations are expected to impact pelagic ecosystem functioning in the near future by driving ocean warming and acidification. While numerous studies have investigated impacts of rising temperature and seawater acidification on planktonic organisms separately, little is presently known on their combined effects. To test for possible synergistic effects we exposed two coccolithophore species, Emiliania huxleyi and Gephyrocapsa oceanica, to a CO2 gradient ranging from similar to 0.5-250 mu mol kg(-1) (i.e. similar to 20-6000 mu atm pCO(2)) at three different temperatures (i.e. 10, 15, 20 degrees C for E. huxleyi and 15, 20, 25 degrees C for G. oceanica). Both species showed CO2-dependent optimum-curve responses for growth, photosynthesis and calcification rates at all temperatures. Increased temperature generally enhanced growth and production rates and modified sensitivities of metabolic processes to increasing CO2. CO2 optimum concentrations for growth, calcification, and organic carbon fixation rates were only marginally influenced from low to intermediate temperatures. However, there was a clear optimum shift towards higher CO2 concentrations from intermediate to high temperatures in both species. Our results demonstrate that the CO2 concentration where optimum growth, calcification and carbon fixation rates occur is modulated by temperature. Thus, the response of a coccolithophore strain to ocean acidification at a given temperature can be negative, neutral or positive depending on that strain's temperature optimum. This emphasizes that the cellular responses of coccolithophores to ocean acidification can only be judged accurately when interpreted in the proper eco-physiological context of a given strain or species. Addressing the synergistic effects of changing carbonate chemistry and temperature is an essential step when assessing the success of coccolithophores in the future ocean.	[Sett, Scarlett; Bach, Lennart T.; Schulz, Kai G.; Koch-Klavsen, Signe; Lebrato, Mario; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Schulz, Kai G.] So Cross Univ, Sch Environm Sci & Management, Ctr Coastal Biogeochem, Lismore, NSW 2480, Australia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Southern Cross University	Sett, S (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	ssett@geomar.de	Schulz, Kai/AEZ-9073-2022; Riebesell, Ulf/AAC-9717-2020; Schulz, Kai G./Q-5608-2017	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; Bach, Lennart/0000-0003-0202-3671; Riebesell, Ulf/0000-0002-9442-452X	European project Network of leading MESOcosms facilities to advance the studies of future AQUAtic ecosystems from the Artic to the Mediterranean (MESOAQUA); German Federal Ministry of Education and Research [3.1.1]	European project Network of leading MESOcosms facilities to advance the studies of future AQUAtic ecosystems from the Artic to the Mediterranean (MESOAQUA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work was funded by the European project Network of leading MESOcosms facilities to advance the studies of future AQUAtic ecosystems from the Artic to the Mediterranean (MESOAQUA, subproject 7) and the German Federal Ministry of Education and Research in the framework of the Biological Impacts of Ocean Acidification (BIOACID, subproject 3.1.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach LT, 2013, NEW PHYTOL, V199, P121, DOI 10.1111/nph.12225; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Balch W, 2007, DEEP SEA RES 2, V54, P538; BALCH WM, 1991, LIMNOL OCEANOGR, V36, P629, DOI 10.4319/lo.1991.36.4.0629; BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S; Baumann EA, 2004, COCCOLITHOPHORES MOL, P99; Benner I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0049; Bollmann J, 2008, PROTIST, V159, P369, DOI 10.1016/j.protis.2008.02.001; Brattstrom H, 1992, BIOL STATION 1892 19; Broecker W, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2009PA001731; Broerse ATC, 2003, CONT SHELF RES, V23, P1579, DOI 10.1016/j.csr.2003.07.001; Buitenhuis ET, 2008, LIMNOL OCEANOGR, V53, P1181, DOI 10.4319/lo.2008.53.3.1181; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Conte MH, 1998, GEOCHIM COSMOCHIM AC, V62, P51, DOI 10.1016/S0016-7037(97)00327-X; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Eynaud F, 1999, DEEP-SEA RES PT I, V46, P451, DOI 10.1016/S0967-0637(98)00079-X; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Gle C, 2008, ESTUAR COAST SHELF S, V76, P642, DOI 10.1016/j.ecss.2007.07.043; Groom S. B., 1987, ADV SPACE RES, V7, P73, DOI DOI 10.1016/0273-1177(87)90166-9; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; Krug SA, 2011, BIOGEOSCIENCES, V8, P771, DOI 10.5194/bg-8-771-2011; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Langer G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001422; LaRoche J., 2010, GUIDE BEST PRACTICES, P81; Lewis E., 1998, ORNLCDIAC105 US DEP; LUND JWG, 1949, J ECOL, V37, P389, DOI 10.2307/2256614; Mackay A., 2008, J ENVIRON QUAL, V37, P2407, DOI [10.2134/jeq2008.0015br, DOI 10.2134/JEQ2008.0015BR]; Merico A, 2004, DEEP-SEA RES PT I, V51, P1803, DOI 10.1016/j.dsr.2004.07.003; Merico A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016648; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P538, DOI 10.1016/j.dsr2.2006.12.003; Raven JA, 2012, MAR ECOL PROG SER, V470, P137, DOI 10.3354/meps09993; RHODES LL, 1995, NEW ZEAL J MAR FRESH, V29, P345, DOI 10.1080/00288330.1995.9516669; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Saavedra-Pellitero M, 2010, GEOBIOS-LYON, V43, P131, DOI 10.1016/j.geobios.2009.09.004; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Shi D, 2009, BIOGEOSCIENCES, V6, P1199, DOI 10.5194/bg-6-1199-2009; TALLING J. F., 1955, ANN BOT, V19, P329; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Tyrrell T, 1996, J MARINE SYST, V9, P83, DOI 10.1016/0924-7963(96)00019-X; Tyrrell T, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P75; Winter A, 1994, BIOGEOGRAPHY LIVING; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	60	102	105	7	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88308	10.1371/journal.pone.0088308	http://dx.doi.org/10.1371/journal.pone.0088308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505472	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000330829200173
J	Vannini, C; Boscaro, V; Ferrantini, F; Benken, KA; Mironov, TI; Schweikert, M; Gortz, HD; Fokin, SI; Sabaneyeva, EV; Petroni, G				Vannini, Claudia; Boscaro, Vittorio; Ferrantini, Filippo; Benken, Konstantin A.; Mironov, Timofei I.; Schweikert, Michael; Goertz, Hans-Dieter; Fokin, Sergei I.; Sabaneyeva, Elena V.; Petroni, Giulio			Flagellar Movement in Two Bacteria of the Family Rickettsiaceae: A Re-Evaluation of Motility in an Evolutionary Perspective	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; TARGETED OLIGONUCLEOTIDE PROBES; PARAMECIUM-CAUDATUM; MOLECULAR CHARACTERIZATION; CANDIDATUS CYRTOBACTER; ORDER RICKETTSIALES; ONLINE RESOURCE; SEQUENCE DATA; IN-SITU; CILIOPHORA	Bacteria of the family Rickettsiaceae have always been largely studied not only for their importance in the medical field, but also as model systems in evolutionary biology. In fact, they share a recent common ancestor with mitochondria. The most studied species, belonging to genera Rickettsia and Orientia, are hosted by terrestrial arthropods and include many human pathogens. Nevertheless, recent findings show that a large part of Rickettsiaceae biodiversity actually resides outside the group of well-known pathogenic bacteria. Collecting data on these recently described non-conventional members of the family is crucial in order to gain information on ancestral features of the whole group. Although bacteria of the family Rickettsiaceae, and of the whole order Rickettsiales, are formally described as non-flagellated prokaryotes, some recent findings renewed the debate about this feature. In this paper we report the first finding of members of the family displaying numerous flagella and active movement inside their host cells. These two new taxa are hosted in aquatic environments by protist ciliates and are described here by means of ultrastructural and molecular characterization. Data here reported suggest that the ancestor of Rickettsiales displayed flagellar movement and re-evaluate the hypothesis that motility played a key-role in the origin of mitochondria. Moreover, our study highlights that the aquatic environment represents a well exploited habitat for bacteria of the family Rickettsiaceae. Our results encourage a deep re-consideration of ecological and morphological traits of the family and of the whole order.	[Vannini, Claudia; Boscaro, Vittorio; Ferrantini, Filippo; Fokin, Sergei I.; Petroni, Giulio] Univ Pisa, Dept Biol, Pisa, Italy; [Benken, Konstantin A.; Mironov, Timofei I.; Sabaneyeva, Elena V.] St Petersburg State Univ, Dept Cytol & Histol, St Petersburg 199034, Russia; [Schweikert, Michael; Goertz, Hans-Dieter] Univ Stuttgart, Inst Biol, D-70174 Stuttgart, Germany; [Fokin, Sergei I.] St Petersburg State Univ, Dept Invertebrate Zool, St Petersburg 199034, Russia	University of Pisa; Saint Petersburg State University; University of Stuttgart; Saint Petersburg State University	Vannini, C (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	cvannini@biologia.unipi.it	Benken, Konstantin A/B-1292-2015; Petroni, Giulio/B-6086-2008; Sabaneyeva, Elena/AAP-1699-2020; Boscaro, Vittorio/J-5857-2012; Sabaneyeva, Elena/H-1226-2013	Petroni, Giulio/0000-0001-9572-9897; Boscaro, Vittorio/0000-0003-4374-1231; Sabaneyeva, Elena/0000-0002-7939-8263; FOKIN, SERGEY/0000-0002-8359-2819; VANNINI, CLAUDIA/0000-0002-6195-695X	European Commission [247658]; Italian Research Ministry (MIUR) PRIN fellowship [2008R9WRTB]; COST action [BM1102]	European Commission(European CommissionEuropean Commission Joint Research Centre); Italian Research Ministry (MIUR) PRIN fellowship(Ministry of Education, Universities and Research (MIUR)); COST action(European Cooperation in Science and Technology (COST))	The study was supported by European Commission FP7-PEOPLE-2009-IRSES project CINAR-PATHOBACTER (247658), by Italian Research Ministry (MIUR) PRIN fellowship (protocol 2008R9WRTB), and by the COST action BM1102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Boscaro V, 2013, SCI REP-UK, V3, DOI 10.1038/srep03305; Boscaro V, 2013, P NATL ACAD SCI USA, V110, P18590, DOI 10.1073/pnas.1316687110; Boscaro V, 2013, MICROB ECOL, V65, P302, DOI 10.1007/s00248-012-0170-3; Boscaro V, 2013, MICROB ECOL, V65, P255, DOI 10.1007/s00248-012-0110-2; Boscaro V, 2012, SYST APPL MICROBIOL, V35, P432, DOI 10.1016/j.syapm.2012.07.003; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Campbell CL, 2004, J MED ENTOMOL, V41, P340, DOI 10.1603/0022-2585-41.3.340; Chen DQ, 1996, CURR MICROBIOL, V33, P123, DOI 10.1007/s002849900086; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Davidov Y, 2009, BIOESSAYS, V31, P748, DOI 10.1002/bies.200900018; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Dumler J.S., 2005, BERGEYS MANUAL SYSTE, V2; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Emelyanov VV, 2001, FEBS LETT, V501, P11, DOI 10.1016/S0014-5793(01)02618-7; Eschbach E, 2009, SYST APPL MICROBIOL, V32, P490, DOI 10.1016/j.syapm.2009.07.004; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fokin Sergei I., 2011, Protistology, V6, P227; Fournier PE, 2009, ANN NY ACAD SCI, V1166, P1, DOI 10.1111/j.1749-6632.2009.04528.x; Fournier PE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-166; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fukatsu T, 1999, APPL ENTOMOL ZOOL, V34, P391, DOI 10.1303/aez.34.391; GORTZ HD, 2006, PROKARYOTES, V1, P364; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Greene SE, 2012, J BACTERIOL, V194, P2973, DOI 10.1128/JB.00170-12; GUERRERO R, 1986, P NATL ACAD SCI USA, V83, P2138, DOI 10.1073/pnas.83.7.2138; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Hoshina R, 2006, ACTA PROTOZOOL, V45, P377; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kawafune K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031749; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lang B.F., 2005, JPN J PROTOZOOL, V38, P171; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Mariconti M, 2012, MICROBIOL-SGM, V158, P1677, DOI 10.1099/mic.0.057174-0; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Petroni G, 2003, MICROBIAL ECOL, V45, P156, DOI 10.1007/s00248-002-2016-x; PINKERTON H., 1936, Parasitology, V28, P172, DOI 10.1017/S003118200002237X; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosati G, 2004, J EUKARYOT MICROBIOL, V51, P49, DOI 10.1111/j.1550-7408.2004.tb00160.x; Sabaneyeva EV, 2009, PROTIST, V160, P205, DOI 10.1016/j.protis.2008.11.006; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; SCHMIDT HJ, 1987, INT J SYST BACTERIOL, V37, P459, DOI 10.1099/00207713-37-4-459; Schmidt SL, 2007, PROTIST, V158, P139, DOI 10.1016/j.protis.2006.11.005; Schrallhammer M, 2006, J EUKARYOT MICROBIOL, V53, P499, DOI 10.1111/j.1550-7408.2006.00133.x; Schrallhammer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072581; Sicheritz-Ponten T, 1998, BBA-BIOENERGETICS, V1365, P545, DOI 10.1016/S0005-2728(98)00099-1; SPRINGER N, 1993, P NATL ACAD SCI USA, V90, P9892, DOI 10.1073/pnas.90.21.9892; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V35, P153; Sun HY, 2009, APPL ENVIRON MICROB, V75, P7445, DOI 10.1128/AEM.00850-09; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Vannini C, 2005, MICROB ECOL, V49, P434, DOI 10.1007/s00248-004-0055-1; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vannini C, 2010, APPL ENVIRON MICROB, V76, P4047, DOI 10.1128/AEM.03105-09; VIALE AM, 1994, FEBS LETT, V341, P146, DOI 10.1016/0014-5793(94)80446-X; Vishnyakov A., 1999, SYMBIOSIS EUKARYOTIS, P169; Walker DH, 2005, ANN NY ACAD SCI, V1063, P13, DOI 10.1196/annals.1355.003; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WISOTZKEY JD, 1990, CURR MICROBIOL, V21, P325, DOI 10.1007/BF02092099; Yu X.J., 2005, BERGEYS MANUAL SYSTE, V2, P96	76	32	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87718	10.1371/journal.pone.0087718	http://dx.doi.org/10.1371/journal.pone.0087718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505307	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200066
J	Yang, CJ; Huang, GS; Xiao, FR; Lou, MF				Yang, Ching-Ju; Huang, Guey-Shiun; Xiao, Fu-Ren; Lou, Meei-Fang			Symptom Distress and Quality of Life after Stereotactic Radiosurgery in Patients with Pituitary Tumors: A Questionnaire Survey	PLOS ONE			English	Article							GAMMA-KNIFE RADIOSURGERY; FOLLOW-UP; COGNITIVE FUNCTION; RADIOTHERAPY; ADENOMAS; IMPROVEMENT; HEADACHE; DEFICITS; OUTCOMES; HORMONES	Background: Stereotactic radiosurgery (SRS) is a common treatment for recurrent or residual pituitary adenomas. The persistence of symptoms and treatment related complications may impair the patient's quality of life (QOL). Purpose: The purpose of this study was to examine symptom distress, QOL, and the relationship between them among patients with pituitary tumors who had undergone SRS. Methods: This study used a cross-sectional design and purposive sampling. We enrolled patients diagnosed with pituitary tumors who had undergone SRS. Data were collected at the CyberKnife Center at a medical center in Northern Taiwan in 2012. A questionnaire survey was used for data collection. Our questionnaire consisted of 3 parts the Pituitary Tumor Symptom Distress Questionnaire, the World Health Organization Quality of Life Instrument Short-Form (WHOQOL-BREF), and a demographic questionnaire. Results: Sixty patients were enrolled in the study. The most common symptoms reported by patients after SRS were memory loss, fatigue, blurred vision, headache, sleep problems, and altered libido. The highest and lowest scores for QOL were in the environmental and psychological domains, respectively. Age was positively correlated with general health and the psychological domains. Level of symptom distress was negatively correlated with overall QOL, general health, physical health, and the psychological and social relationships domains. The scores in the psychological and environmental domains were higher in males than in females. Patients with <= 6 symptoms had better overall QOL, general health, physical health, and psychological and social relationships than those with >6 symptoms. Conclusion: Symptom distress can affect different aspects of patient QOL. Levels of symptom distress, number of symptoms, age, and gender were variables significantly correlated with patient QOL. These results may be utilized by healthcare personnel to design educational and targeted interventional programs for symptom management to improve patient QOL.	[Yang, Ching-Ju; Huang, Guey-Shiun; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan; [Xiao, Fu-Ren] Natl Taiwan Univ Hosp, Div Neurosurg, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan.	mfalou@ntu.edu.tw		Xiao, Furen/0000-0001-9683-3979; LOU, MEEI-FANG/0000-0001-6574-8050; HUANG, GUEY-SHIUN/0000-0003-2170-0084	National Taiwan University; College of Medicine, National Taiwan University [10R71835, 100R311001]	National Taiwan University(National Taiwan University); College of Medicine, National Taiwan University(National Taiwan University)	This study was made possible by funding from National Taiwan University and College of Medicine, National Taiwan University (10R71835, 100R311001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeloff MD, 2008, ABELOFFS CLIN ONCOLO; Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; Baird Anne, 2003, Qual Manag Health Care, V12, P97; Born J, 2009, OBSTET GYN CLIN N AM, V36, P809, DOI 10.1016/j.ogc.2009.10.001; Davis RN, 2001, ALZ DIS ASSOC DIS, V15, P1, DOI 10.1097/00002093-200101000-00001; Dekkers OM, 2006, J CLIN ENDOCR METAB, V91, P3364, DOI 10.1210/jc.2006-0003; Devdhar M, 2007, ENDOCRIN METAB CLIN, V36, P595, DOI 10.1016/j.ecl.2007.04.008; Eckroth-Bucher M, 2009, AM J ALZHEIMERS DIS, V24, P234, DOI 10.1177/1533317509332624; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Erlanger DM, 1999, NEUROPSYCHOL REV, V9, P175, DOI 10.1023/A:1021634622577; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Fu MR, 2004, ONCOL NURS FORUM, V31, P65, DOI 10.1188/04.ONF.65-70; Gondim J, 2009, J HEADACHE PAIN, V10, P15, DOI 10.1007/s10194-008-0084-0; Gopalan R, 2011, NEUROSURGERY, V69, P284, DOI 10.1227/NEU.0b013e31821bc44e; Huang SH, 2009, FORMOS J MED, V13, P122; Kalyani RR, 2007, ENDOCRIN METAB CLIN, V36, P333, DOI 10.1016/j.ecl.2007.03.014; Kars M, 2007, EUR J ENDOCRINOL, V157, P133, DOI 10.1530/EJE-07-0259; Kobayashi T, 2009, PROG NEUROL SURG, V22, P77, DOI 10.1159/000163384; Levy MJ, 2004, ARCH NEUROL-CHICAGO, V61, P721, DOI 10.1001/archneur.61.5.721; Lien CY, 2009, J CLIN NURS, V18, P2311, DOI 10.1111/j.1365-2702.2008.02549.x; Lindsay JR, 2006, J CLIN ENDOCR METAB, V91, P447, DOI 10.1210/jc.2005-1058; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x; Noad R, 2004, CLIN ONCOL-UK, V16, P233, DOI 10.1016/j.clon.2004.01.012; Oruckaptan HH, 2000, SURG NEUROL, V53, P211, DOI 10.1016/S0090-3019(00)00171-3; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Powell M.P., 2003, MANAGEMENT PITUITARY; Rosen RC, 2012, MENOPAUSE, V19, P396, DOI 10.1097/gme.0b013e318230e286; Sheehan JP, 2011, J NEUROSURG, V114, P303, DOI 10.3171/2010.5.JNS091635; Skevington SM, 2012, HEALTH EXPECT, V15, P49, DOI 10.1111/j.1369-7625.2010.00650.x; Skugor M., 2010, CURRENT CLIN MED, P408; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; Theobald Dale E, 2004, Clin Cornerstone, V6 Suppl 1D, pS15, DOI 10.1016/S1098-3597(05)80003-1; Tooze A, 2009, CLIN ENDOCRINOL, V70, P503, DOI 10.1111/j.1365-2265.2008.03464.x; Tsay SL, 2012, SUPPORT CARE CANCER, V20, P57, DOI 10.1007/s00520-010-1053-0; Tseng CN, 2011, J NURS RES, V19, P119, DOI 10.1097/JNR.0b013e3182198837; van der Klaauw AA, 2008, CLIN ENDOCRINOL, V69, P775, DOI 10.1111/j.1365-2265.2008.03288.x; van der Klaauw AA, 2008, CLIN ENDOCRINOL, V69, P123, DOI 10.1111/j.1365-2265.2007.03169.x; Voges J, 2006, CANCER, V107, P1355, DOI 10.1002/cncr.22128; Wan H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-36; Wu YJ, 2008, THESIS NATL TAIWAN U; Yao K.G., 2002, FORMOSAN J MED, V6, P193, DOI DOI 10.6320/FJM.2002.6(2).09; Yao K. P., 2005, DEV MANUAL WHOQOL BR	45	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88460	10.1371/journal.pone.0088460	http://dx.doi.org/10.1371/journal.pone.0088460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505492	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200192
J	Babakhanyan, A; Leke, RGF; Salanti, A; Bobbili, N; Gwanmesia, P; Leke, RJI; Quakyi, IA; Chen, JJ; Taylor, DW				Babakhanyan, Anna; Leke, Rose G. F.; Salanti, Ali; Bobbili, Naveen; Gwanmesia, Philomina; Leke, Robert J. I.; Quakyi, Isabella A.; Chen, John J.; Taylor, Diane Wallace			The Antibody Response of Pregnant Cameroonian Women to VAR2CSA ID1-ID2a, a Small Recombinant Protein Containing the CSA-Binding Site	PLOS ONE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN SULFATE-A; VARIANT SURFACE-ANTIGENS; PARASITE ADHESION; PLACENTAL MALARIA; EPITOPES; EPIDEMIOLOGY; ACQUISITION; GRAVIDITY; DIVERSITY	In pregnant women, Plasmodium falciparum-infected erythrocytes expressing the VAR2CSA antigen bind to chondroitin sulfate A in the placenta causing placental malaria. The binding site of VAR2CSA is present in the ID1-ID2a region. This study sought to determine if pregnant Cameroonian women naturally acquire antibodies to ID1-ID2a and if antibodies to ID1-ID2a correlate with absence of placental malaria at delivery. Antibody levels to full-length VAR2CSA and ID1-ID2a were measured in plasma samples from 745 pregnant Cameroonian women, 144 Cameroonian men, and 66 US subjects. IgM levels and IgG avidity to ID1-ID2a were also determined. As expected, antibodies to ID1-ID2a were absent in US controls. Although pregnant Cameroonian women developed increasing levels of antibodies to full-length VAR2CSA during pregnancy, no increase in either IgM or IgG to ID1-ID2a was observed. Surprisingly, no differences in antibody levels to ID1-ID2a were detected between Cameroonian men and pregnant women. For example, in rural settings only 8-9% of males had antibodies to full-length VAR2CSA, but 90-96% had antibodies to ID1-ID2a. In addition, no significant difference in the avidity of IgG to ID1-ID2a was found between pregnant women and Cameroonian men, and no correlation between antibody levels at delivery and absence of placental malaria was found. Thus, the response to ID1-ID2a was not pregnancy specific, but predominantly against cross-reactivity epitopes, which may have been induced by other PfEMP1 antigens, malarial antigens, or microbes. Currently, ID1-ID2a is a leading vaccine candidate, since it binds to the CSA with the same affinity as the full-length molecule and elicits binding-inhibitory antibodies in animals. Further studies are needed to determine if the presence of naturally acquired cross-reactive antibodies in women living in malaria endemic countries will alter the response to ID1-ID2a following vaccination with ID1-ID2a.	[Babakhanyan, Anna; Bobbili, Naveen; Chen, John J.; Taylor, Diane Wallace] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Leke, Rose G. F.; Gwanmesia, Philomina; Leke, Robert J. I.] Univ Yaounde I, Ctr Biotechnol, Fac Med & Biomed Res, Yaounde, Cameroon; [Salanti, Ali] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Quakyi, Isabella A.] Univ Ghana, Sch Publ Hlth, Coll Hlth Sci, Legon, Ghana	University of Hawaii System; University of Hawaii Manoa; University of Yaounde I; University of Copenhagen; University of Ghana	Taylor, DW (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	dwtaylor@hawaii.edu	chen, JJ/HGB-6029-2022	Salanti, Ali/0000-0003-2207-5575	NIAID, NIH [UO1AI43888, RO1AI071160, 200889 (STOPPAM)]; NIMHD [U54MD007584]; NIH [G12MD007601]; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071160, U01AI043888] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584, G12MD007601] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMHD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The work was supported by grants from NIAID, NIH, UO1AI43888 and RO1AI071160 (DWT, RGFL, IAQ), FP7/2007-2013 grant agreement #200889 (STOPPAM) (AS), and NIMHD U54MD007584 (JJC) and NIH G12MD007601 (JJC). The authors acknowledge the support of T. Dye, University of Hawai'i Biorepository (HiBR) for plasma from the US pregnant women. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barfod L, 2010, J IMMUNOL, V185, P7553, DOI 10.4049/jimmunol.1002390; Beeson JG, 2006, J INFECT DIS, V193, P721, DOI 10.1086/500145; Bordbar B, 2012, VACCINE, V30, P1343, DOI 10.1016/j.vaccine.2011.12.065; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Brabin BJ, 2001, J NUTR, V131, p646S; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Dahlback M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191510; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Ferreira MU, 2004, CLIN DIAGN LAB IMMUN, V11, P987, DOI 10.1128/CDLI.11.6.987-995.2004; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Hommel M, 2010, INFECT IMMUN, V78, P1963, DOI 10.1128/IAI.01365-09; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Manga L., 1992, Memoires de la Societe Royale Belge d'Entomologie, V35, P155; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; O'Neil-Dunne I, 2001, INFECT IMMUN, V69, P7487, DOI 10.1128/IAI.69.12.7487-7492.2001; Quakyi IA, 2000, AM J TROP MED HYG, V63, P222; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Srivastava A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020270; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Tutterrow YL, 2012, INFECT IMMUN, V80, P1479, DOI 10.1128/IAI.00071-12; Tutterrow Yeung Lo, 2012, PLoS One, V7, pe40049, DOI 10.1371/journal.pone.0040049; Walker-Abbey A, 2005, AM J TROP MED HYG, V72, P229, DOI 10.4269/ajtmh.2005.72.229	34	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88173	10.1371/journal.pone.0088173	http://dx.doi.org/10.1371/journal.pone.0088173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505415	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300063
J	Cheng, LF; Yu, L; Wu, XA; Li, K; Wang, F; Zhang, L; Ye, W; Li, PY; Zhang, FL; Xu, ZK				Cheng, Linfeng; Yu, Lan; Wu, Xingan; Li, Kai; Wang, Fang; Zhang, Liang; Ye, Wei; Li, Puyuan; Zhang, Fanglin; Xu, Zhikai			Induction of Specific Humoral and Cellular Immune Responses in a Mouse Model following Gene Fusion of HSP70C and Hantaan Virus Gn and S0.7 in an Adenoviral Vector	PLOS ONE			English	Article							HANTAVIRUS NUCLEOCAPSID PROTEIN; NEUTRALIZING ANTIBODY-RESPONSE; DNA VACCINE POTENCY; HEAT-SHOCK PROTEINS; MONOCLONAL-ANTIBODIES; HEMORRHAGIC-FEVER; PUUMALA VIRUS; C57BL/6 MICE; IN-VITRO; PROTECTIVE IMMUNITY	Heat shock proteins (HSPs) display adjuvant functions when given as fusion proteins to enhance vaccination efficiency. To evaluate enhanced potency of Hantaan virus (HTNV) glycoprotein (GP) and nucleocapsid protein (NP) immunogenicity by heat shock protein 70 (HSP70), a recombinant adenovirus rAd-GnS0.7-pCAG-HSP70C expression vector was developed by genetically linking the HSP70 C-terminal gene (HSP70 359-610 aa, HSP70C) to the Gn and 0.7 kb fragment of the NP (aa1-274- S0.7). C57BL/6 mice were immunized with these recombinant adenoviral vectors. A series of immunological assays determined the immunogenicity of the recombinant adenoviral vectors. The results showed that rAd-GnS0.7-pCAG-HSP70C induced a stronger humoral and cellular immune response than other recombinant adenoviruses (rAd-GnS0.7-pCAG and rAd-GnS0.7) and the HFRS vaccine control. Animal protection experiments showed that rAd-GnS0.7-pCAG-HSP70C was effective at protecting C57BL/6 mice from HTNV infection. The results of the immunological experiments showed that HSP70C lead to enhanced vaccine potency, and suggested significant potential in the development of genetically engineered vaccines against HTNV.	[Cheng, Linfeng; Yu, Lan; Wu, Xingan; Li, Kai; Wang, Fang; Zhang, Liang; Ye, Wei; Li, Puyuan; Zhang, Fanglin; Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China	Air Force Military Medical University	Zhang, FL (corresponding author), Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China.	flzhang@fmmu.edu.cn; zhikaixu523@163.com	Zhang, Fang/HHN-2153-2022	Ye, Wei/0000-0002-3980-8547; Ye, Wei/0000-0002-5695-2073	National Key Basic Research Program (973 Program) [2012CB518905]; Natural Science Foundation of China [81001344, 31070810]	National Key Basic Research Program (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program (973 Program) (No. 2012CB518905), the Natural Science Foundation of China (No. 81001344 and No. 31070810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIKAWA J, 1989, J GEN VIROL, V70, P615, DOI 10.1099/0022-1317-70-3-615; Arnold-Schild D, 1999, J IMMUNOL, V162, P3757; Basu S, 2001, IMMUNITY, V14, P303, DOI 10.1016/S1074-7613(01)00111-X; Breloer M, 1999, J IMMUNOL, V162, P3141; Brun A, 2008, VACCINE, V26, P6508, DOI 10.1016/j.vaccine.2008.09.044; Castellino F, 2000, J EXP MED, V191, P1957, DOI 10.1084/jem.191.11.1957; Chen XH, 2002, IMMUNOL LETT, V84, P81, DOI 10.1016/S0165-2478(02)00042-1; Cho HW, 2002, INTERVIROLOGY, V45, P328, DOI 10.1159/000067925; DANTAS JR, 1986, VIROLOGY, V151, P379, DOI 10.1016/0042-6822(86)90058-9; Dargeviciute A, 2002, VACCINE, V20, P3523, DOI 10.1016/S0264-410X(02)00341-9; Ebihara H, 2000, J VIROL, V74, P9245, DOI 10.1128/JVI.74.19.9245-9255.2000; Gott P, 1997, VIRUS GENES, V14, P31, DOI 10.1023/A:1007983306341; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hjelle Brian, 2002, Expert Rev Vaccines, V1, P373, DOI 10.1586/14760584.1.3.373; Hooper JW, 2006, VIROLOGY, V347, P208, DOI 10.1016/j.virol.2005.11.035; Hooper JW, 2001, CURR TOP MICROBIOL, V256, P171; Hooper JW, 2001, J VIROL, V75, P8469, DOI 10.1128/JVI.75.18.8469-8477.2001; Johansson P, 2004, VIRUS RES, V105, P147, DOI 10.1016/j.virusres.2004.05.005; Kamrud KI, 1999, VIROLOGY, V263, P209, DOI 10.1006/viro.1999.9961; Kariwa H, 2007, COMP IMMUNOL MICROB, V30, P341, DOI 10.1016/j.cimid.2007.05.011; Khaiboullina SF, 2005, CURR MOL MED, V5, P773, DOI 10.2174/156652405774962317; Klingstrom J, 2004, VACCINE, V22, P4029, DOI 10.1016/j.vaccine.2004.03.045; Kruger DH, 2001, MICROBES INFECT, V3, P1129, DOI 10.1016/S1286-4579(01)01474-5; KURATA T, 1983, INFECT IMMUN, V41, P391, DOI 10.1128/IAI.41.1.391-398.1983; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LEE PW, 1986, ARCH VIROL, V88, P57, DOI 10.1007/BF01310890; Li CA, 2010, VACCINE, V28, P4294, DOI 10.1016/j.vaccine.2010.04.025; Li J, 2008, VACCINE, V26, P3175, DOI 10.1016/j.vaccine.2008.02.066; Li J, 2007, VACCINE, V25, P239, DOI 10.1016/j.vaccine.2006.07.040; Li PY, 2012, J VIROL METHODS, V179, P90, DOI 10.1016/j.jviromet.2011.10.005; Li XL, 2012, INT IMMUNOPHARMACOL, V14, P235, DOI 10.1016/j.intimp.2012.07.022; Li XM, 2006, VACCINE, V24, P3321, DOI 10.1016/j.vaccine.2006.01.012; Lindkvist M, 2007, VACCINE, V25, P1690, DOI 10.1016/j.vaccine.2006.09.082; Lundkvist A, 1996, VIROLOGY, V216, P397, DOI 10.1006/viro.1996.0075; Luo W, 2008, ACTA VIROL, V52, P243; MCKEE KT, 1985, J MED VIROL, V17, P107, DOI 10.1002/jmv.1890170203; Nicacio CD, 2002, J VIROL, V76, P6669, DOI 10.1128/JVI.76.13.6669-6677.2002; Razanskiene A, 2004, J BIOTECHNOL, V111, P319, DOI 10.1016/j.jbiotec.2004.04.010; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; SCHMALJOHN CS, 1990, J VIROL, V64, P3162, DOI 10.1128/JVI.64.7.3162-3170.1990; Seto T, 2012, VIRUS RES, V163, P284, DOI 10.1016/j.virusres.2011.10.016; Spik KW, 2008, VACCINE, V26, P5177, DOI 10.1016/j.vaccine.2008.03.097; Su CX, 2007, VET MICROBIOL, V124, P256, DOI 10.1016/j.vetmic.2007.04.030; Van Epps HL, 1999, J VIROL, V73, P5301, DOI 10.1128/JVI.73.7.5301-5308.1999; WANG M, 1993, VIROLOGY, V197, P757, DOI 10.1006/viro.1993.1652; Woo GJ, 2005, J MICROBIOL, V43, P537; Xu ZK, 2002, BIOCHEM BIOPH RES CO, V298, P552, DOI 10.1016/S0006-291X(02)02491-9; YANAGIHARA R, 1988, ARCH VIROL, V101, P125, DOI 10.1007/BF01314657; YOSHIMATSU K, 1993, ARCH VIROL, V130, P365, DOI 10.1007/BF01309667; Yu WY, 2011, VACCINE, V29, P3489, DOI 10.1016/j.vaccine.2011.02.031; Zeier M, 2005, VIRUS GENES, V30, P157, DOI 10.1007/s11262-004-5625-2; Zhang FL, 2007, BIOCHEM BIOPH RES CO, V354, P858, DOI 10.1016/j.bbrc.2007.01.020; Zheng LY, 2005, CHINESE MED J-PEKING, V118, P313; Zhu XY, 2010, CANCER SCI, V101, P2621, DOI 10.1111/j.1349-7006.2010.01722.x	55	16	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88183	10.1371/journal.pone.0088183	http://dx.doi.org/10.1371/journal.pone.0088183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505421	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300067
J	Huang, GJ; Edwards, A; Tsai, CY; Lee, YS; Peng, L; Era, T; Hirabayashi, Y; Tsai, CY; Nishikawa, SI; Iwakura, Y; Chen, SJ; Flint, J				Huang, Guo-Jen; Edwards, Andrew; Tsai, Cheng-Yu; Lee, Yi-Shin; Peng, Lei; Era, Takumi; Hirabayashi, Yoshio; Tsai, Ching-Yen; Nishikawa, Shin-Ichi; Iwakura, Yoichiro; Chen, Shu-Jen; Flint, Jonathan			Ectopic Cerebellar Cell Migration Causes Maldevelopment of Purkinje Cells and Abnormal Motor Behaviour in Cxcr4 Null Mice	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; DENTATE GYRUS; MUTATION; PTF1A; SDF1/CXCR4; ATAXIA	SDF-1/CXCR4 signalling plays an important role in neuronal cell migration and brain development. However, the impact of CXCR4 deficiency in the postnatal mouse brain is still poorly understood. Here, we demonstrate the importance of CXCR4 on cerebellar development and motor behaviour by conditional inactivation of Cxcr4 in the central nervous system. We found CXCR4 plays a key role in cerebellar development. Its loss leads to defects in Purkinje cell dentritogenesis and axonal projection in vivo but not in cell culture. Transcriptome analysis revealed the most significantly affected pathways in the Cxcr4 deficient developing cerebellum are involved in extra cellular matrix receptor interactions and focal adhesion. Consistent with functional impairment of the cerebellum, Cxcr4 knockout mice have poor coordination and balance performance in skilled motor tests. Together, these results suggest ectopic the migration of granule cells impairs development of Purkinje cells, causes gross cerebellar anatomical disruption and leads to behavioural motor defects in Cxcr4 null mice.	[Huang, Guo-Jen; Tsai, Cheng-Yu; Lee, Yi-Shin; Peng, Lei; Chen, Shu-Jen] Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Huang, Guo-Jen] Chang Gung Univ, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Edwards, Andrew; Flint, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Era, Takumi] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto, Japan; [Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama, Japan; [Tsai, Ching-Yen] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Nishikawa, Shin-Ichi] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Noda, Chiba 278, Japan	Chang Gung University; Chang Gung University; University of Oxford; Wellcome Centre for Human Genetics; Kumamoto University; RIKEN; Academia Sinica - Taiwan; RIKEN; Tokyo University of Science	Huang, GJ (corresponding author), Chang Gung Univ, Coll Med, Dept & Grad Inst Biomed Sci, Tao Yuan, Taiwan.	gjh30@mail.cgu.edu.tw	Iwakura, Yoichiro/E-5457-2011; Tsai, Ching-Yen/AEX-9366-2022	Iwakura, Yoichiro/0000-0002-9934-5775; Tsai, Ching-Yen/0000-0001-7964-6661; Hirabayashi, Yoshio/0000-0002-5774-7354; Flint, Jonathan/0000-0002-9427-4429; Huang, Guo-Jen/0000-0002-6392-2155	Chang Gung Memorial Hospital [CMRPD1A0213]; National Science Council of Taiwan [NSC101-2320-B-182-006-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Chang Gung Memorial Hospital (CMRPD1A0213) and the National Science Council (NSC101-2320-B-182-006-MY3) of Taiwan (to GJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shammari M, 2011, CLIN GENET, V80, P196, DOI 10.1111/j.1399-0004.2010.01613.x; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Chung SH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3158; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Florio M, 2012, DEVELOPMENT, V139, P2308, DOI 10.1242/dev.075861; Furuya S, 1998, BRAIN RES PROTOC, V3, P192, DOI 10.1016/S1385-299X(98)00040-3; Henke RM, 2009, DEVELOPMENT, V136, P2945, DOI 10.1242/dev.035352; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li GN, 2009, DEVELOPMENT, V136, P327, DOI 10.1242/dev.025742; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Li XH, 2010, J BIOL CHEM, V285, P32436, DOI 10.1074/jbc.M110.120451; Lin L, 2006, STEM CELLS, V24, P2504, DOI 10.1634/stemcells.2006-0119; Lu M, 2002, P NATL ACAD SCI USA, V99, P7090, DOI 10.1073/pnas.092013799; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Pascual M, 2007, P NATL ACAD SCI USA, V104, P5193, DOI 10.1073/pnas.0605699104; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tissir F, 2004, DEV BRAIN RES, V149, P63, DOI 10.1016/j.devbrainres.2004.01.002; Yu T, 2010, J NEUROSCI RES, V88, P2775, DOI 10.1002/jnr.22454; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zhu Y, 2009, DEVELOPMENT, V136, P1919, DOI 10.1242/dev.032276; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	28	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86471	10.1371/journal.pone.0086471	http://dx.doi.org/10.1371/journal.pone.0086471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516532	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400010
J	Schulke, S; Wolfheimer, S; Gadermaier, G; Wangorsch, A; Siebeneicher, S; Briza, P; Spreitzer, I; Schiller, D; Loeschner, B; Uematsu, S; Ryffel, B; Akira, S; Waibler, Z; Vieths, S; Toda, M; Scheurer, S				Schuelke, Stefan; Wolfheimer, Sonja; Gadermaier, Gabriele; Wangorsch, Andrea; Siebeneicher, Susanne; Briza, Peter; Spreitzer, Ingo; Schiller, Dirk; Loeschner, Bettina; Uematsu, Satoshi; Ryffel, Bernard; Akira, Shizuo; Waibler, Zoe; Vieths, Stefan; Toda, Masako; Scheurer, Stephan			Prevention of Intestinal Allergy in Mice by rflaA: Ova Is Associated with Enforced Antigen Processing and TLR5-Dependent IL-10 Secretion by mDC	PLOS ONE			English	Article							FUSION PROTEIN; BACTERIAL FLAGELLIN; ADJUVANT ACTIVITY; IMMUNE-RESPONSE; VACCINE; CELLS; EXPRESSION; STIMULATION; ACTIVATION; TOLERANCE	Conjugated vaccines consisting of flagellin and antigen activate TLR5 and induce strong innate and adaptive immune responses. Objective of the present study was to gain further insight into the mechanisms by which flagellin fusion proteins mediate their immune modulating effects. In a mouse model of Ova-induced intestinal allergy a fusion protein of flagellin and Ova (rflaA:Ova) was used for intranasal and intraperitoneal vaccination. Aggregation status of flaA, Ova and flaA: Ova were compared by light scattering, uptake of fluorescence labeled proteins into mDC was analyzed, processing was investigated by microsomal digestion experiments. Mechanism of DC-activation was investigated using proteasome and inflammasome inhibitors. Immune responses of wildtype, IL-10(-/-), TLR5(-/-) mDCs and Ova-transgenic T cells were investigated. Mucosal and i.p.-application of rflaA: Ova were able to prevent allergic sensitization, suppress disease-related symptoms, prevent body weight loss and reduction in food uptake. Intranasal vaccination resulted in strongest suppression of Ova-specific IgE production. These protective effects were associated with increased aggregation of rflaA: Ova and accompanied by tenfold higher uptake rates into mDC compared to the mixture of both proteins. Microsomal digestion showed that stimulation with rflaA: Ova resulted in faster degradation and the generation of different peptides compared to rOva. rflaA: Ova-mediated activation of mDC could be suppressed in a dose-dependent manner by the application of both inflammasome and proteasome inhibitors. Using TLR5(-/-) mDC the rflaA: Ova induced IL-10 secretion was shown to be TLR5 dependent. In co-cultures of IL-10(-/-) mDC with DO11.10 T cells the lack of rflaA: Ova-mediated IL-10 secretion resulted in enhanced levels of both TH2 (IL-4, IL-5) and TH1 (IL-2 and IFN-y) cytokines. In summary, mucosal vaccination with flaA: Ova showed strongest preventive effect. Stimulation with rflaA: Ova results in strong immune modulation mediated by enhanced uptake of the aggregated fusion protein, likely resulting in a different processing by DC as well as stronger TLR5 mediated cell activation.	[Schuelke, Stefan; Wolfheimer, Sonja; Wangorsch, Andrea; Schiller, Dirk; Vieths, Stefan; Scheurer, Stephan] Paul Ehrlich Inst, Div Allergol, Langen, Hessen, Germany; [Gadermaier, Gabriele] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Siebeneicher, Susanne; Toda, Masako] Paul Ehrlich Inst, Jr Res Grp Expt Allergy Models, Langen, Hessen, Germany; [Spreitzer, Ingo; Loeschner, Bettina] Paul Ehrlich Inst, Div Microbiol, Langen, Hessen, Germany; [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka, Osaka, Japan; [Ryffel, Bernard] Univ Orleans, CNRS, Dept Mol & Expt Immunol & Neurogenet, Orleans, France; [Waibler, Zoe] Paul Ehrlich Inst, Jr Res Grp Novel Vaccinat Strategies & Early Immu, Langen, Hessen, Germany	Paul Ehrlich Institute; Salzburg University; Paul Ehrlich Institute; Paul Ehrlich Institute; Osaka University; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Paul Ehrlich Institute	Schulke, S (corresponding author), Paul Ehrlich Inst, Div Allergol, Langen, Hessen, Germany.	stefan.schuelke@pei.de	Akira, Shizuo/C-3134-2009; Gadermaier, Gabriele/L-5997-2015; Scheurer, Stephan/A-6509-2019; Briza, Peter/D-7309-2012; Toda, Masako/S-9810-2019	Gadermaier, Gabriele/0000-0002-4886-417X; Scheurer, Stephan/0000-0002-2859-562X; Briza, Peter/0000-0002-4941-6782; 	Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG SCHE637/3]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The study was funded by Deutsche Forschungsgemeinschaft (German Research Foundation) DFG SCHE637/3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates JT, 2009, J IMMUNOL, V182, P7539, DOI 10.4049/jimmunol.0804225; Burggraf M, 2011, MOL NUTR FOOD RES, V55, P1475, DOI 10.1002/mnfr.201000634; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Egger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017278; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hoffmann S, 2005, J IMMUNOL METHODS, V298, P161, DOI 10.1016/j.jim.2005.01.010; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Lee SE, 2008, J CLIN IMMUNOL, V28, P157, DOI 10.1007/s10875-007-9138-3; Legge KL, 2000, J EXP MED, V191, P2039, DOI 10.1084/jem.191.12.2039; Letran SE, 2011, EUR J IMMUNOL, V41, P29, DOI 10.1002/eji.201040717; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Montag T, 2007, ALTEX-ALTERN TIEREXP, V24, P81; Schulke S, 2011, J ALLERGY CLIN IMMUN, V128, P1340, DOI 10.1016/j.jaci.2011.07.036; Schulke S, 2010, MOL IMMUNOL, V48, P341, DOI 10.1016/j.molimm.2010.07.006; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Uematsu S, 2009, J GASTROENTEROL; Way SS, 2004, CELL MICROBIOL, V6, P235, DOI 10.1046/j.1462-5822.2004.00360.x; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Weimer ET, 2009, INFECT IMMUN, V77, P2356, DOI 10.1128/IAI.00054-09; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	31	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87822	10.1371/journal.pone.0087822	http://dx.doi.org/10.1371/journal.pone.0087822			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516564	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400019
J	Braun, CD; Skomal, GB; Thorrold, SR; Berumen, ML				Braun, Camrin D.; Skomal, Gregory B.; Thorrold, Simon R.; Berumen, Michael L.			Diving Behavior of the Reef Manta Ray Links Coral Reefs with Adjacent Deep Pelagic Habitats	PLOS ONE			English	Article							MARINE PREDATOR MOVEMENTS; WHALE SHARKS; REPRODUCTIVE ECOLOGY; VERTICAL MOVEMENTS; ALFREDI; DIEL; ZOOPLANKTON; SWORDFISH; MIGRATION; DYNAMICS	Recent successful efforts to increase protection for manta rays has highlighted the lack of basic ecological information, including vertical and horizontal movement patterns, available for these species. We deployed pop-up satellite archival transmitting tags on nine reef manta rays, Manta alfredi, to determine diving behaviors and vertical habitat use. Transmitted and archived data were obtained from seven tagged mantas over deployment periods of 102-188 days, including three recovered tags containing 2.6 million depth, temperature, and light level data points collected every 10 or 15 seconds. Mantas frequented the upper 10 m during daylight hours and tended to occupy deeper water throughout the night. Six of the seven individuals performed a cumulative 76 deep dives (> 150 m) with one individual reaching 432 m, extending the known depth range of this coastal, reef-oriented species and confirming its role as an ecological link between epipelagic and mesopelagic habitats. Mean vertical velocities calculated from high-resolution dive data (62 dives > 150 m) from three individuals suggested that mantas may use gliding behavior during travel and that this behavior may prove more efficient than continuous horizontal swimming. The behaviors in this study indicate manta rays provide a previously unknown link between the epi- and mesopelagic layers of an extremely oligotrophic marine environment and provide evidence of a third marine species that utilizes gliding to maximize movement efficiency.	[Braun, Camrin D.; Berumen, Michael L.] King Abdullah Univ Sci & Technol Thuwal, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Skomal, Gregory B.] Massachusetts Div Marine Fisheries, New Bedford, MA USA; [Braun, Camrin D.; Thorrold, Simon R.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	King Abdullah University of Science & Technology; Massachusetts Division of Marine Fisheries; Woods Hole Oceanographic Institution	Braun, CD (corresponding author), King Abdullah Univ Sci & Technol Thuwal, Red Sea Res Ctr, Thuwal, Saudi Arabia.	cbraun@whoi.edu	Berumen, Michael L/F-7745-2011; Thorrold, Simon R/B-7565-2012	Berumen, Michael L/0000-0003-2463-2742; Thorrold, Simon R/0000-0002-1533-7517; Braun, Camrin/0000-0002-9317-9489	KAUST baseline research funds; KAUST award [USA00002, KSA 00011]; U.S. National Science Foundation [OCE 0825148]	KAUST baseline research funds; KAUST award; U.S. National Science Foundation(National Science Foundation (NSF))	Financial support was provided in part by KAUST baseline research funds (to MLB), KAUST award numbers USA00002 and KSA 00011 (to SRT), and the U.S. National Science Foundation (OCE 0825148 to SRT and GBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2010, ICES J MAR SCI, V67, P466, DOI 10.1093/icesjms/fsp252; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; [Anonymous], JOINT M ICHTH HERP M; Berumen M., 2013, CORAL REEFS, V32, P1; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; CAREY FG, 1981, FISH B-NOAA, V79, P277; Clark T. B., 2010, ABUNDANCE HOME RANGE; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077152; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Deakos MH, 2012, ENVIRON BIOL FISH, V94, P443, DOI 10.1007/s10641-011-9953-5; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Del Raye G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0836; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Fontanella JE, 2013, J EXP MAR BIOL ECOL, V446, P273, DOI 10.1016/j.jembe.2013.05.016; Gladstone W, 2003, OCEAN COAST MANAGE, V46, P741, DOI 10.1016/S0964-5691(03)00065-6; Gleiss AC, 2013, MAR BIOL, V160, P2981, DOI 10.1007/s00227-013-2288-3; Gleiss AC, 2011, FUNCT ECOL, V25, P595, DOI 10.1111/j.1365-2435.2010.01801.x; GLIWICZ MZ, 1986, NATURE, V320, P746, DOI 10.1038/320746a0; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Hueter RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071883; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Klevjer TA, 2012, MAR BIOL, V159, P1833, DOI 10.1007/s00227-012-1973-y; Marshall A., 2018, MOBULA ALFREDI IUCN, DOI [10.2305/IUCN.UK.20112.RLTS.T195459A126665723.en, DOI 10.2305/IUCN.UK.20112.RLTS.T195459A126665723.EN]; Marshall AD, 2010, J FISH BIOL, V77, P169, DOI 10.1111/j.1095-8649.2010.02669.x; Marshall Andrea D., 2009, Zootaxa, V2301, P1; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Musyl MK, 2011, FISH B-NOAA, V109, P341; Nelson DR, 1997, ENVIRON BIOL FISH, V49, P389, DOI 10.1023/A:1007369619576; Osada, 2010, RELATIONSHIP ZOOPLAN; Papastamatiou YP, 2012, MAR ECOL PROG SER, V456, P233, DOI 10.3354/meps09721; R Core Team, 2021, R LANGUAGE ENV STAT; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Spaet JLY, 2012, J FISH BIOL, V80, P952, DOI 10.1111/j.1095-8649.2011.03178.x; Takagi T, 2010, AQUAT BIOL, V9, P149, DOI 10.3354/ab00237; Weihs D, 1973, MECH EFFICIENT SWIMM; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Womble JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055386; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; Zar J. H., 1996, BIOSTATISTICAL ANAL	47	57	57	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88170	10.1371/journal.pone.0088170	http://dx.doi.org/10.1371/journal.pone.0088170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516605	Green Published, gold			2022-12-27	WOS:000330830700052
J	McCann, CP; Rericha, EC; Wang, CL; Losert, W; Parent, CA				McCann, Colin P.; Rericha, Erin C.; Wang, Chenlu; Losert, Wolfgang; Parent, Carole A.			Dictyostelium Cells Migrate Similarly on Surfaces of Varying Chemical Composition	PLOS ONE			English	Article							MYOSIN-II; TALIN HOMOLOG; LEADING-EDGE; WILD-TYPE; ADHESION; DYNAMICS; PROTEIN; MORPHOGENESIS; LOCALIZATION; DOMAIN	During cell migration, cell-substrate binding is required for pseudopod anchoring to move the cell forward, yet the interactions with the substrate must be sufficiently weak to allow parts of the cell to de-adhere in a controlled manner during typical protrusion/retraction cycles. Mammalian cells actively control cell-substrate binding and respond to extracellular conditions with localized integrin-containing focal adhesions mediating mechanotransduction. We asked whether mechanotransduction also occurs during non-integrin mediated migration by examining the motion of the social amoeba Dictyostelium discoideum, which is thought to bind non-specifically to surfaces. We discovered that Dictyostelium cells are able to regulate forces generated by the actomyosin cortex to maintain optimal cell-surface contact area and adhesion on surfaces of various chemical composition and that individual cells migrate with similar speed and contact area on the different surfaces. In contrast, during collective migration, as observed in wound healing and metastasis, the balance between surface forces and protrusive forces is altered. We found that Dictyostelium collective migration dynamics are strongly affected when cells are plated on different surfaces. These results suggest that the presence of cell-cell contacts, which appear as Dictyostelium cells enter development, alter the mechanism cells use to migrate on surfaces of varying composition.	[McCann, Colin P.; Rericha, Erin C.; Losert, Wolfgang] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [McCann, Colin P.; Rericha, Erin C.; Wang, Chenlu; Parent, Carole A.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Losert, Wolfgang; Parent, Carole A.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Wang, Chenlu] Univ Maryland, Biophys Grad Program, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Parent, CA (corresponding author), NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	parentc@mail.nih.gov			Intramural Research Program of the Center for Cancer Research in the National Cancer Institute; Burroughs Wellcome Fund; NSF-Physics of Living Systems Program [PHY07A50371]; NSF-Cyber Physical Systems Grant [CPS0931508]; Direct For Mathematical & Physical Scien [1205965] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [ZIABC010418] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research in the National Cancer Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF-Physics of Living Systems Program; NSF-Cyber Physical Systems Grant; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research in the National Cancer Institute. Erin Rericha holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. WL and ER acknowledge support from the NSF-Physics of Living Systems Program Grant PHY07A50371. WL and CW also received support from the NSF-Cyber Physical Systems Grant CPS0931508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Barr Valarie A, 2009, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0423s45; Buenemann M, 2010, BIOPHYS J, V99, P50, DOI 10.1016/j.bpj.2010.03.057; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; Fey Petra, 2013, Methods Mol Biol, V983, P59, DOI 10.1007/978-1-62703-302-2_4; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Jang W, 2008, J R SOC INTERFACE, V5, pS49, DOI 10.1098/rsif.2008.0067.focus; JAY PY, 1995, J CELL SCI, V108, P387; KESSLER DA, 1993, PHYS REV E, V48, P4801, DOI 10.1103/PhysRevE.48.4801; KNECHT DA, 1995, DEV BIOL, V170, P434, DOI 10.1006/dbio.1995.1227; KREITMEIER M, 1995, J CELL BIOL, V129, P179, DOI 10.1083/jcb.129.1.179; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; McCann CP, 2010, J CELL SCI, V123, P1724, DOI 10.1242/jcs.060137; Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Murrell M, 2011, BIOPHYS J, V100, P1400, DOI 10.1016/j.bpj.2011.01.038; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Reichl EM, 2008, CURR BIOL, V18, P471, DOI 10.1016/j.cub.2008.02.056; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robinson DN, 2004, CURR OPIN CELL BIOL, V16, P182, DOI 10.1016/j.ceb.2004.02.002; SCHINDL M, 1995, BIOPHYS J, V68, P1177, DOI 10.1016/S0006-3495(95)80294-8; Socol M, 2010, BIOELECTROCHEMISTRY, V79, P198, DOI 10.1016/j.bioelechem.2010.04.003; Tsujioka M, 1999, CURR BIOL, V9, P389, DOI 10.1016/S0960-9822(99)80169-9; Uchida K, 1999, EUR J CELL BIOL, V78, P757, DOI 10.1016/S0171-9335(99)80044-2; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012	39	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87981	10.1371/journal.pone.0087981	http://dx.doi.org/10.1371/journal.pone.0087981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516575	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700036
J	Zhou, Z; Wang, LL; Song, LS; Liu, R; Zhang, H; Huang, MM; Chen, H				Zhou, Zhi; Wang, Lingling; Song, Linsheng; Liu, Rui; Zhang, Huan; Huang, Mengmeng; Chen, Hao			The Identification and Characteristics of Immune-Related MicroRNAs in Haemocytes of Oyster Crassostrea gigas	PLOS ONE			English	Article							STRESS; BIOGENESIS; EVOLUTION; EXPRESSION; INFECTION; GENES; MIR-8	Background: MicroRNAs (miRNAs) represent a class of small ncRNAs that repress gene expression on the post-transcriptional level by the degradation or translation inhibition of target mRNA. Methodology: Three small RNA libraries from oyster haemocytes were sequenced on the Illumina platform to investigate the latent immunomodulation of miRNAs after bacteria challenge and heat stress. Totally, 10,498,663, 8,588,606 and 9,679,663 high-quality reads were obtained in the control, bacteria and bacteria+heat library, respectively, from which 199 oyster miRNAs including 71 known and 128 novel ones were identified. Among these miRNAs, 6 known and 23 novel ones were predicted to possess more than one precursor-coding region, and cgi-miR-10a, cgi-miR-184b, cgi-miR-100, cgi-miR-1984 and cgi-miR-67a were observed to be the most abundant miRNAs in the control library. The expression levels of 22 miRNAs in the bacteria library were significantly higher than those in the control library, while there were another 33 miRNAs whose expression levels were significantly lower than that in the control library. Meanwhile, the expression levels of 65 miRNAs in the bacteria+heat library changed significantly compared to those in the bacteria library. The target genes of these differentially expressed miRNAs were annotated, and they fell in immune and stress-related GO terms including antioxidant, cell killing, death, immune system process, and response to stimulus. Furthermore, there were 42 differentially expressed miRNAs detected in both control/bacteria and bacteria/bacteria+heat comparisons, among which 9 miRNAs displayed the identical pattern in the two comparisons, and the expression alterations of 8 miRNAs were confirmed using quantitative RT-PCR. Conclusions: These results indicated collectively that immune challenge could induce the expression of immune-related miRNAs, which might modulate the immune response such as redox reaction, phagocytosis and apoptosis, and the expression of some immune-related miRNAs could be also regulated by heat stress to improve the environmental adaption of oyster.	[Zhou, Zhi; Wang, Lingling; Song, Linsheng; Liu, Rui; Zhang, Huan; Huang, Mengmeng; Chen, Hao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Huang, Mengmeng; Chen, Hao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	wanglingling@ms.qdio.ac.cn; lshsong@ms.qdio.ac.cn			973 National Key Fundamental Research Program from the Chinese Ministry of Science and Technology [2010CB126404]; National High Technology Research and Development Program (863 Program) from the Chinese Ministry of Science and Technology [2012AA10A401]; NSFC [31072192, 30925028]; Shandong Provincial Natural Science Foundation [JQ201110]	973 National Key Fundamental Research Program from the Chinese Ministry of Science and Technology; National High Technology Research and Development Program (863 Program) from the Chinese Ministry of Science and Technology(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province)	This research was supported by 973 National Key Fundamental Research Program (No. 2010CB126404), National High Technology Research and Development Program (863 Program, No. 2012AA10A401) from the Chinese Ministry of Science and Technology (http://www.most.gov.cn/), grants from NSFC (No. 31072192 to L. W, 30925028 to L. S, http://www.nsfc.gov.cn/), and Shandong Provincial Natural Science Foundation (No. JQ201110 to L. W, http://www.sdnsf.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chen YHH, 2011, CELL MOL IMMUNOL, V8, P369, DOI 10.1038/cmi.2011.32; Choi IK, 2012, DEV COMP IMMUNOL, V37, P50, DOI 10.1016/j.dci.2011.12.008; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cristino AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019350; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Etebari K, 2013, RNA BIOL, V10, P1356, DOI 10.4161/rna.25481; Etebari K, 2013, INSECT BIOCHEM MOLEC, V43, P309, DOI 10.1016/j.ibmb.2013.01.004; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Huan P, 2012, J PROTEOMICS, V75, P3855, DOI 10.1016/j.jprot.2012.04.051; Izar B, 2012, INT J MOL SCI, V13, P1173, DOI 10.3390/ijms13011173; Lacoste A, 2001, APPL ENVIRON MICROB, V67, P2304, DOI 10.1128/AEM.67.5.2304-2309.2001; Lacoste A, 2001, DEV COMP IMMUNOL, V25, P285, DOI 10.1016/S0145-305X(00)00067-7; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Malham SK, 2003, J EXP ZOOL PART A, V295A, P136, DOI 10.1002/jez.a.10222; McCall CE, 2011, J LEUKOCYTE BIOL, V90, P439, DOI 10.1189/jlb.0211075; Milagro FI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054319; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Ou JT, 2012, FISH SHELLFISH IMMUN, V32, P345, DOI 10.1016/j.fsi.2011.11.027; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Thomas MP, 2013, IMMUNOL REV, V253, P237, DOI 10.1111/imr.12052; Vaz C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027774; Wang XQ, 2012, FISH SHELLFISH IMMUN, V33, P1016, DOI 10.1016/j.fsi.2012.08.026; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Weitzel RP, 2009, BLOOD, V113, P6648, DOI 10.1182/blood-2008-09-181156; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yu X, 2012, J EXP BOT, V63, P1025, DOI 10.1093/jxb/err337; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang LL, 2011, FISH SHELLFISH IMMUN, V30, P653, DOI 10.1016/j.fsi.2010.12.023; Zhang Y, 2013, J ZHEJIANG UNIV-SC B, V14, P1, DOI 10.1631/jzus.B1200292	49	31	36	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88397	10.1371/journal.pone.0088397	http://dx.doi.org/10.1371/journal.pone.0088397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516648	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700068
J	Bentahir, M; Laduron, F; Irenge, L; Ambroise, J; Gala, JL				Bentahir, Mostafa; Laduron, Frederic; Irenge, Leonid; Ambroise, Jerome; Gala, Jean-Luc			Rapid and Efficient Filtration-Based Procedure for Separation and Safe Analysis of CBRN Mixed Samples	PLOS ONE			English	Article							REAL-TIME PCR; CHEMICAL WARFARE AGENT; DEGRADATION-PRODUCTS; BIOTHREAT AGENTS; INACTIVATION; SPORES; ASSAY; VX	Separating CBRN mixed samples that contain both chemical and biological warfare agents (CB mixed sample) in liquid and solid matrices remains a very challenging issue. Parameters were set up to assess the performance of a simple filtration-based method first optimized on separate C-and B-agents, and then assessed on a model of CB mixed sample. In this model, MS2 bacteriophage, Autographa californica nuclear polyhedrosis baculovirus (AcNPV), Bacillus atrophaeus and Bacillus subtilis spores were used as biological agent simulants whereas ethyl methylphosphonic acid (EMPA) and pinacolyl methylphophonic acid (PMPA) were used as VX and soman (GD) nerve agent surrogates, respectively. Nanoseparation centrifugal devices with various pore size cut-off (30 kD up to 0.45 mu m) and three RNA extraction methods (Invisorb, EZ1 and Nuclisens) were compared. RNA (MS2) and DNA (AcNPV) quantification was carried out by means of specific and sensitive quantitative real-time PCRs (qPCR). Liquid chromatography coupled to time-of-flight mass spectrometry (LC/TOFMS) methods was used for quantifying EMPA and PMPA. Culture methods and qPCR demonstrated that membranes with a 30 kD cut-off retain more than 99.99% of biological agents (MS2, AcNPV, Bacillus Atrophaeus and Bacillus subtilis spores) tested separately. A rapid and reliable separation of CB mixed sample models (MS2/PEG-400 and MS2/EMPA/PMPA) contained in simple liquid or complex matrices such as sand and soil was also successfully achieved on a 30 kD filter with more than 99.99% retention of MS2 on the filter membrane, and up to 99% of PEG-400, EMPA and PMPA recovery in the filtrate. The whole separation process turnaround-time (TAT) was less than 10 minutes. The filtration method appears to be rapid, versatile and extremely efficient. The separation method developed in this work constitutes therefore a useful model for further evaluating and comparing additional separation alternative procedures for a safe handling and preparation of CB mixed samples.	[Bentahir, Mostafa; Irenge, Leonid; Gala, Jean-Luc] Belgian Armed Forces, Def Labs Dept, Biothreats Unit, Brussels, Belgium; [Ambroise, Jerome; Gala, Jean-Luc] Catholic Univ Louvain, Inst Rech Expt & Clin, Ctr Technol Mol Appl, B-1200 Brussels, Belgium; [Laduron, Frederic] Belgian Armed Forces, Def Labs Dept, Chem Anal Lab, Brussels, Belgium	Universite Catholique Louvain	Gala, JL (corresponding author), Belgian Armed Forces, Def Labs Dept, Biothreats Unit, Brussels, Belgium.	jean-luc.gala@uclouvain.be			Department Management of Scientific and Technological Research of Defence (IRSD-RSTD, Royal High Institute for Defence) [LAND-06]	Department Management of Scientific and Technological Research of Defence (IRSD-RSTD, Royal High Institute for Defence)	This project was funded by the Department Management of Scientific and Technological Research of Defence (IRSD-RSTD, Royal High Institute for Defence) supporting research and development (grant LAND-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher AM, 2009, J ENVIRON QUAL, V38, P2468, DOI 10.2134/jeq2008.0488; BITTON G, 1979, CAN J MICROBIOL, V25, P874, DOI 10.1139/m79-130; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carrera M, 2007, J APPL MICROBIOL, V102, P303, DOI 10.1111/j.1365-2672.2006.03111.x; Garnier L, 2009, APPL ENVIRON MICROB, V75, P1614, DOI 10.1128/AEM.02120-08; HANNAY T, 1995, NAT MED, V1, P396, DOI 10.1038/nm0595-396a; Heleg-Shabtai V, 2006, ELECTROPHORESIS, V27, P1996, DOI 10.1002/elps.200500683; Isabel S, 2012, APPL ENVIRON MICROB, V78, P1505, DOI 10.1128/AEM.06696-11; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Liu Q, 2004, ANAL CHIM ACTA, V512, P93, DOI 10.1016/j.aca.2004.02.023; O'Connell KP, 2006, APPL ENVIRON MICROB, V72, P478, DOI 10.1128/AEM.72.1.478-483.2006; Pei L, 2012, ENVIRON SCI TECHNOL, V46, P10073, DOI 10.1021/es302304t; Petrick LM, 2013, ENVIRON SCI TECHNOL, V47, P8751, DOI 10.1021/es4016537; Powell Bradford S, 2012, Methods Mol Biol, V881, P27, DOI 10.1007/978-1-61779-827-6_2; Raju D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-50; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; Reutter D, 2010, BIOSECUR BIOTERROR, V8, P343, DOI 10.1089/bsp.2010.0023; Rose LJ, 2009, APPL ENVIRON MICROB, V75, P2987, DOI 10.1128/AEM.02180-08; Sagripanti JL, 2011, APPL ENVIRON MICROB, V77, P7289, DOI 10.1128/AEM.05553-11; Schep LJ, 2009, ENVIRON INT, V35, P1267, DOI 10.1016/j.envint.2009.08.004; Smith JN, 2011, RAPID COMMUN MASS SP, V25, P1437, DOI 10.1002/rcm.5018; Talbot SR, 2010, ENG LIFE SCI, V10, P109, DOI 10.1002/elsc.200800078; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Tucker JB, 1999, EMERG INFECT DIS, V5, P498, DOI 10.3201/eid0504.990406; Wilkinson DA, 2007, J FORENSIC SCI, V52, P1272, DOI 10.1111/j.1556-4029.2007.00569.x; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	26	1	1	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88055	10.1371/journal.pone.0088055	http://dx.doi.org/10.1371/journal.pone.0088055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505375	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200107
J	Falavigna, A; Botelho, RV; Teles, AR; da Silva, PG; Martins, D; Guyot, JP; Gonzalez, AS; Avila, JMJ; Defino, HLA				Falavigna, Asdrubal; Botelho, Ricardo Vieira; Teles, Alisson Roberto; da Silva, Pedro Guarise; Martins, Delio; Guyot, Juan Pablo; Gonzalez, Alvaro Silva; Jimenez Avila, Jose Maria; Aparecido Defino, Helton Luiz			Twelve Years of Scientific Production on Medline by Latin American Spine Surgeons	PLOS ONE			English	Article							SURGICAL RESEARCH; LEVEL	Background: Despite the small contribution of LA in the Science Citation Index (SCI), a growing contribution by LA research to international literature has been observed in recent years. Study Design: Systematic review. Purpose: To evaluate the scientific contribution of Latin American (LA) Spine Surgeons in the last decade. Methods: A literature search of publications by LA spinal surgeons on topics concerning the spine or spinal cord was performed using an online database; Pubmed.gov. The results were limited to articles published from January 2000 to December 2011. The quality of the publication was evaluated with the journal impact factor (IF), Oxford classification and number of citations. Results: This study comprised 320 articles published in the Medline database by LA spine surgeons from 2000 to 2011. In recent years, there has been an increase in the number of publications by LA spine surgeons. It was observed that 38.4% of LA papers were published in LA journals. 46.6% of the articles were published in journals with an IF lower than 1, and there was no statistically significant difference in the number of articles published in journals with a higher IF during the period. Linear-by-linear association analysis demonstrated an improvement in the level of evidence provided by LA articles published in recent years. Conclusions: This study showed a growth in the number of publications in last 12 years by LA spinal surgeons. It is necessary to discuss a way to increase quantity and quality of scientific publications, mainly through a better education in research.	[Falavigna, Asdrubal; da Silva, Pedro Guarise] Univ Caxias do Sul, Dept Neurosurg, Caxias Do Sul, RS, Brazil; [Botelho, Ricardo Vieira] Hosp Servidor Publ Estadual Francisco Morato de O, Dept Neurosurg, Sao Paulo, Brazil; [Teles, Alisson Roberto] Hosp Sao Jose Santa Casa Porto Alegre, Dept Neurosurg, Porto Alegre, RS, Brazil; [Martins, Delio] Univ Fed Sao Paulo, Dept Orthoped, Sao Paulo, Brazil; [Guyot, Juan Pablo] Hosp Univ Fdn Favaloro, Dept Orthoped, Buenos Aires, DF, Argentina; [Gonzalez, Alvaro Silva] Univ Desarrollo, Dept Orthoped, Santiago De Compostela, Spain; [Jimenez Avila, Jose Maria] Ctr Med Nacl Occidente, Dept Orthoped, Guadalajara, Jalisco, Mexico; [Aparecido Defino, Helton Luiz] Univ Sao Paulo, Dept Orthoped, Sao Paulo, Brazil	Universidade de Caxias do Sul; Instituto de Assistencia Medica ao Servidor Publico Estadual (IAMSPE); Universidade Federal de Sao Paulo (UNIFESP); University of Buenos Aires; Universidade de Sao Paulo	Falavigna, A (corresponding author), Univ Caxias do Sul, Dept Neurosurg, Caxias Do Sul, RS, Brazil.	asdrubalmd@gmail.com	Martins, Delio E/B-2809-2013; Teles, Alisson R./U-5661-2018; Filho, Delio Eulalio Martins/AAN-9742-2021; Avila, José María Jiménez/AAZ-2463-2020; Falavigna, Asdrubal/H-5123-2012; Defino, Helton/O-1928-2013	Martins, Delio E/0000-0001-5510-3507; Teles, Alisson R./0000-0003-2169-8156; Filho, Delio Eulalio Martins/0000-0001-5510-3507; Falavigna, Asdrubal/0000-0002-0016-3198; Guyot, Juan Pablo/0000-0001-6524-4426; Defino, Helton/0000-0003-4274-0130	AOSpine Latin America	AOSpine Latin America	The authors assure that funds were received from AOSpine Latin America in support of this work, and that no benefits in any form have been or will be received from a commercial party related directly or indirectly to the subject of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandopadhayay P, 2008, J CLIN NEUROSCI, V15, P373, DOI 10.1016/j.jocn.2007.08.014; Bonilla M, 1999, INTERCIENCIA, V24, P102; Boschert SR, 2012, COLEGIO MEXICANO ORT, P1; Caedo Andalia R., 1999, ACIMED, V7, P30; Cetto AM, 1998, INTERCIENCIA, V23, P84; Dickersin K, 2007, BMJ, V334; Goldenberg S, 2008, ACTA CIR BRAS, V23, P1, DOI 10.1590/S0102-86502008000100001; Guimaraes JA, 2012, RAZOES PARA AVANCO P; Haines SJ, 2003, NEUROSURGERY, V52, P36, DOI 10.1097/00006123-200301000-00004; Heldwein FL, 2010, CLINICS, V65, P521, DOI 10.1590/S1807-59322010000500010; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Linskey Mark E, 2006, Prog Neurol Surg, V19, P1, DOI 10.1159/000095175; Lopez Leyva S., 2011, REV ED SUPERIOR, V2, P151; Macias-Chapula C. A., 1998, CIENCIA INFORMACOO, V27, P134, DOI DOI 10.1590/S0100-19651998000200005; Merton RK, 1957, SOCIAL THEORY SOCIAL, P550; Obremskey WT, 2005, J BONE JOINT SURG AM, V87A, P2632, DOI 10.2106/JBJS.E.00370; Ochoa Henríquez Haydée, 2004, Opcion, V20, P131; Pabon Silvia C., 2006, J SCI COMMUNICATION, V5, P1; Reuters Thomson, 2012, J CIT REP; Rothoerl RD, 2003, NEUROSURG REV, V26, P257, DOI 10.1007/s10143-003-0270-0; Tecnologia CNC, 2012, DES CIENT; Tess BH, 2009, CLINICS, V64, P571, DOI 10.1590/S1807-59322009000600013; Thakur A, 2001, J PEDIATR SURG, V36, P1160, DOI 10.1053/jpsu.2001.25737; Weisinger JR, 1999, KIDNEY INT, V56, P1584, DOI 10.1046/j.1523-1755.1999.00681.x; Yarascavitch BA, 2012, NEUROSURGERY, V71, P1131, DOI 10.1227/NEU.0b013e318271bc99	25	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87945	10.1371/journal.pone.0087945	http://dx.doi.org/10.1371/journal.pone.0087945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505336	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200088
J	Montarroyos, UR; Miranda, DB; Cesar, CC; Souza, WV; Lacerda, HR; Albuquerque, MDPM; Aguiar, MF; Ximenes, RAD				Montarroyos, Ulisses Ramos; Miranda-Filho, Democrito Barros; Cesar, Cibele Comini; Souza, Wayner Vieira; Lacerda, Heloisa Ramos; Pessoa Militao Albuquerque, Maria de Fatima; Aguiar, Mariana Freitas; de Alencar Ximenes, Ricardo Arraes			Factors Related to Changes in CD4+T-Cell Counts over Time in Patients Living with HIV/AIDS: A Multilevel Analysis	PLOS ONE			English	Article							HIV DISEASE PROGRESSION; T-CELL COUNT; CIGARETTE-SMOKING; ANTIRETROVIRAL THERAPY; MULTICENTER COHORT; CRACK-COCAINE; ADHERENCE; MORTALITY; HEALTH; WOMEN	Background: The measurement of CD4+ T-cell (CD4) counts is a strong predictor of progression to AIDS and a means of monitoring antiviral therapy (ART). The success or failure of controlling virus levels in untreated patients or those taking ART may be associated with treatment adherence, habits, correlated infections unrelated to HIV, cancer, immunosuppressive drugs; as well as socio-economic and psychosocial aspects and access to healthcare. The aim of the present study was to identify, using a multilevel model, the factors related to the variations of CD4 counts over time, in patients living with HIV. Methodology: A cohort study was conducted with patients living with HIV, selected from July 2007 to December 2010. Patients were monitored from records of their first CD4 count after being diagnosed with HIV. A multilevel model with 3 levels of aggregation was applied to analyze the associations of predictor variables and the behavior of CD4 over time. Principal Findings: A total of 1870 patients were enrolled. The mean number of CD4 at the beginning of the cohort was 393.1 cells/mm(3), and there was a mean increase of 1.529 cells/mm(3) per month. Patient's age, smoking, use of illicit drugs, hospital treatment, changing doctors and the use of ART, were factors that affected the kinetics of the CD4 count during the follow-up period. Conclusion/Significance: The results of this study indicated increased levels of CD4 over time in a cohort of patients living with HIV/AIDS and identified factors that may influence this increase and are liable to intervention.	[Montarroyos, Ulisses Ramos; Lacerda, Heloisa Ramos; de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil; [Montarroyos, Ulisses Ramos; Miranda-Filho, Democrito Barros; Aguiar, Mariana Freitas; de Alencar Ximenes, Ricardo Arraes] State Univ Pernambuco, Oswaldo Cruz Univ Hosp, Sch Med Sci, Recife, PE, Brazil; [Cesar, Cibele Comini] Univ Fed Minas Gerais, Dept Stat, Belo Horizonte, MG, Brazil; [Souza, Wayner Vieira; Pessoa Militao Albuquerque, Maria de Fatima] Osvaldo Cruz Fdn, Res Ctr Aggeu Magalhaes, Dept Publ Hlth, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Minas Gerais	Montarroyos, UR (corresponding author), Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.	ulisses_montarroyos@yahoo.com.br	Montarroyos, Ulisses/AAJ-7527-2020; Souza, Wayner V/H-3798-2013	Souza, Wayner/0000-0002-0939-9332	Ministerio da Saude/Programa DST/AIDS/UNESCO [CSV 182/06]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [310911/2009-5, 301779/2009-0, 300917/2006-6]	Ministerio da Saude/Programa DST/AIDS/UNESCO; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study received support from the Ministerio da Saude/Programa DST/AIDS/UNESCO (CSV 182/06 - Projeto "Investigacao prospectiva sobre lipodistrofia e alteracoes metabolicas como efeito adverso da terapia anti-retroviral em adultos, adolescentes e criancas com HIV/AIDS no estado de Pernambuco com avaliacao nao invasiva de dano vascular e estudo de polimorfismo genetico associado a resistencia a insulina"). The authors received partial support from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (scholarship 310911/2009-5 to HRL, scholarship 301779/2009-0 to MFPM and 300917/2006-6 to RAAX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DI, 2003, ANN INTERN MED, V139, P258, DOI 10.7326/0003-4819-139-4-200308190-00008; Barfod TS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-154; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Burns DN, 1996, J ACQ IMMUN DEF SYND, V13, P374, DOI 10.1097/00042560-199612010-00012; Chao C, 2008, DRUG ALCOHOL DEPEN, V94, P165, DOI 10.1016/j.drugalcdep.2007.11.010; Chu HT, 2005, AM J EPIDEMIOL, V162, P787, DOI 10.1093/aje/kwi268; Conley LJ, 1996, AIDS, V10, P1121, DOI 10.1097/00002030-199609000-00010; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; CRAIB KJP, 1992, CLIN INVEST MED, V15, P301; Crothers K, 2005, J GEN INTERN MED, V20, P1142, DOI 10.1111/j.1525-1497.2005.0255.x; Patroclo MAD, 2007, CAD SAUDE PUBLICA, V23, P1955, DOI 10.1590/S0102-311X2007000800022; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Garcia Rosa, 2005, Braz J Infect Dis, V9, P251, DOI 10.1590/S1413-86702005000300008; Herrera Cristina, 2008, Rev. Saúde Pública, V42, P249, DOI 10.1590/S0034-89102008000200009; Hoffman Jennifer, 2010, HIV Therapy, V4, P27, DOI 10.2217/HIV.09.58; Hoffman RM, 2011, J CLIN IMMUNOL, V31, P873, DOI 10.1007/s10875-011-9550-6; Howard AA, 2002, AIDS, V16, P2175, DOI 10.1097/00002030-200211080-00010; Kalichman SC, 1999, J GEN INTERN MED, V14, P267, DOI 10.1046/j.1525-1497.1999.00334.x; Langford Simone E, 2007, AIDS Res Ther, V4, P11, DOI 10.1186/1742-6405-4-11; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Lignani L, 2001, REV SAUDE PUBL, V35, P495, DOI 10.1590/S0034-89102001000600001; Melchior Regina, 2007, Rev. Saúde Pública, V41, P87, DOI 10.1590/S0034-89102007000900014; Nies-Kraske E, 2009, J INFECT DIS, V199, P1648, DOI 10.1086/598980; Robbins GK, 2008, J ACQ IMMUN DEF SYND, V44, P30; ROYCE RA, 1990, AIDS, V4, P327, DOI 10.1097/00002030-199004000-00007; Shuter J, 2008, NICOTINE TOB RES, V10, P731, DOI 10.1080/14622200801908190; Twisk JWR, 2003, APPL LONGITUDINAL DA, Vxvi, P301; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Webber MP, 1999, AIDS, V13, P257, DOI 10.1097/00002030-199902040-00014; Williams AB, 1999, NURS CLIN N AM, V34, P113; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	34	30	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e84276	10.1371/journal.pone.0084276	http://dx.doi.org/10.1371/journal.pone.0084276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505247	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200007
J	Morriss, GA; Warburton, B				Morriss, Grant A.; Warburton, Bruce			Modifying the Victor (R) Easy Set (R) Rat Trap to Improve the Animal Welfare of Stoats and Ship Rats Trapped in New Zealand	PLOS ONE			English	Article							KAKA NESTOR-MERIDIONALIS; MUSTELA-ERMINEA; STANDARDS; DECLINE	Stoats (Mustela erminea) and ship rats (Rattus rattus) in New Zealand are targeted by trapping to mitigate their predation on native wildlife. Internationally recognized guidelines for assessing the effectiveness and welfare performance of kill traps are supported by New Zealand legislation under the Animal Welfare Act 1999. The Victor (R) Easy Set (R) rat trap was tested and passed a similar standard for killing short-tailed weasels in Canada but failed for stoats when tested in New Zealand in 2002 (short-tailed weasels and stoats are the same species). We tested a modified version of the trap in 2011-12, modified by changing the treadle trigger to a pull trigger and adding a plastic shroud to direct and align approach by animals to the front of the trap. These traps, in vertical and horizontal sets, were tested with both stoats and ship rats. During each test the trap had to render 10 of 10 animals irreversibly unconscious within 3 minutes to meet approval requirements. The modified trap passed with both species in both trap sets. All stoats were struck across the cranium whereas rats were struck either on the cranium or neck. We recommend this trap design for use by community conservation groups for targeting stoats and ship rats in New Zealand.	[Morriss, Grant A.; Warburton, Bruce] Landcare Res, Lincoln, New Zealand	Landcare Research - New Zealand	Morriss, GA (corresponding author), Landcare Res, Lincoln, New Zealand.	morrissg@landcareresearch.co.nz			Ministry of Business, Innovation and Employment [C09X1007]	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This research was funded by the Ministry of Business, Innovation and Employment (Programme C09X1007 Strategic Technologies for Multi-Species Pest Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, 109904 ISO; Baker SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039334; Canadian Trapper, 1999, CANADIAN TRAPPER, V13, P19; Dilks P, 2003, NEW ZEAL J ECOL, V27, P1; Fagerstone K.A., 1987, P548; Hiltz M, 2000, PROC VERTEBR PEST C, P197; Jotham N, 1994, P 16 VERT PEST C, P308; KING CM, 1977, NEW ZEAL J ZOOL, V4, P193, DOI 10.1080/03014223.1977.9517953; KING CM, 1994, DEP CONSERVATION TEC, V3; King CM, 2005, HDB NZ MAMMALS, P261; McLennan JA, 1996, NEW ZEAL J ECOL, V20, P27; Moorhouse R, 2003, BIOL CONSERV, V110, P33, DOI 10.1016/S0006-3207(02)00173-8; PROULX G, 1993, J WILDLIFE DIS, V29, P317, DOI 10.7589/0090-3558-29.2.317; Rowsell HC, 1981, P WORLDW FURB C FROS, P1647; Warburton B, 2008, ANIM WELFARE, V17, P111; WARBURTON B, 1995, NEW ZEAL J ZOOL, V22, P39, DOI 10.1080/03014223.1995.9518022; WARBURTON B, 2002, DOC SCI INTERNAL SER, V83; Whitehead AL, 2008, BIOL CONSERV, V141, P2784, DOI 10.1016/j.biocon.2008.08.013	18	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86760	10.1371/journal.pone.0086760	http://dx.doi.org/10.1371/journal.pone.0086760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505264	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200024
J	Nygard, M; Hansen, BT; Dillner, J; Munk, C; Oddsson, K; Tryggvadottir, L; Hortlund, M; Liaw, KL; Dasbach, EJ; Kjaer, SK				Nygard, Mari; Hansen, Bo Terning; Dillner, Joakim; Munk, Christian; Oddsson, Kristjan; Tryggvadottir, Laufey; Hortlund, Maria; Liaw, Kai-Li; Dasbach, Erik J.; Kjaer, Susanne Kruger			Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance	PLOS ONE			English	Article							HPV-VACCINATION PROGRAM; 4 NORDIC COUNTRIES; INTRAEPITHELIAL NEOPLASIA; GENITAL WARTS; WOMEN; RISK; PREVALENCE; POPULATION; METAANALYSIS; LESIONS	Background: Infection with high-risk human papillomavirus (HPV) is causally related to cervical, vulvar and vaginal pre-invasive neoplasias and cancers. Highly effective vaccines against HPV types 16/18 have been available since 2006, and are currently used in many countries in combination with cervical cancer screening to control the burden of cervical cancer. We estimated the overall and age-specific incidence rate (IR) of cervical, vulvar and vaginal cancer and pre-invasive neoplasia in Denmark, Iceland, Norway and Sweden in 2004-2006, prior to the availability of HPV vaccines, in order to establish a baseline for surveillance. We also estimated the population attributable fraction to determine roughly the expected effect of HPV16/18 vaccination on the incidence of these diseases. Methods: Information on incident cervical, vulvar and vaginal cancers and high-grade pre-invasive neoplasias was obtained from high-quality national population-based registries. A literature review was conducted to define the fraction of these lesions attributable to HPV16/18, i.e., those that could be prevented by HPV vaccination. Results: Among the four countries, the age-standardised IR/10(5) of cervical, vaginal and vulvar cancer ranged from 8.4-13.8, 1.3-3.1 and 0.2-0.6, respectively. The risk for cervical cancer was highest in women aged 30-39, while vulvar and vaginal cancers were most common in women aged 70+. Age-standardised IR/10(5) of cervical, vulvar and vaginal pre-invasive neoplasia ranged between 138.8-183.2, 2.5-8.8 and 0.5-1.3, respectively. Women aged 20-29 had the highest risk for cervical pre-invasive neoplasia, while vulvar and vaginal pre-invasive neoplasia peaked in women aged 40-49 and 60-69, respectively. Over 50% of the observed 47,820 incident invasive and pre-invasive cancer cases in 2004-2006 can be attributed to HPV16/18. Conclusion: In the four countries, vaccination against HPV 16/18 could prevent approximately 8500 cases of gynecological cancer and pre-cancer annually. Population-based cancer and vaccination registries are essential to assess the predicted public health effects of HPV vaccination.	[Nygard, Mari; Hansen, Bo Terning] Canc Registry Norway, Dept Res, Oslo, Norway; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Munk, Christian; Kjaer, Susanne Kruger] Canc Soc Res Ctr, Unit Virus Lifestyle & Genes, Copenhagen, Denmark; [Oddsson, Kristjan] Icelandic Canc Soc, Canc Detect Clin, Reykjavik, Iceland; [Tryggvadottir, Laufey] Icelandic Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hortlund, Maria] Off Med Serv, Dept Clin Microbiol, Div Lab Med, Malmo, Sweden; [Liaw, Kai-Li] Merck Res Labs, Dept Epidemiol, N Wales, PA USA; [Dasbach, Erik J.] Merck Res Labs, N Wales, PA USA; [Kjaer, Susanne Kruger] Univ Copenhagen, Rigshosp, Dept Gynecol, DK-2100 Copenhagen, Denmark	University of Oslo; Karolinska Institutet; Karolinska Institutet; Danish Cancer Society; University of Iceland; Merck & Company; Merck & Company; Rigshospitalet; University of Copenhagen	Nygard, M (corresponding author), Canc Registry Norway, Dept Res, Oslo, Norway.	mari.nygard@kreftregisteret.no	Hansen, Bo Terning/B-1375-2008; Dasbach, Erik/AAP-6801-2021; Hortlund, Maria/AAA-1613-2020; Hansen, Bo Terning/AAG-1462-2019	Hansen, Bo Terning/0000-0003-2765-4488; Hortlund, Maria/0000-0002-2627-4451; Hansen, Bo Terning/0000-0003-2765-4488; Tryggvadottir, Laufey/0000-0001-8067-9030; Nygard, Mari/0000-0002-4100-4855; Kjaer, Susanne/0000-0002-8347-1398	Merck Co., Inc. [EPO 8014.033]	Merck Co., Inc.(Merck & Company)	Financial support from Merck & Co., Inc. (research grant EPO 8014.033) has been received. The registry data used in the current article were obtained from population-based registries that are funded by governments and non-profit cancer societies. Each country collected and analyzed data independently from the funding company as described in the Methods section. The lead author drafted the manuscript. KLL and ED are employees of the funding company and participated with the other coauthors in discussions of study design and manuscript revision. Anonymous data from the population-based registries are publicly available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Bjerregaard B, 2011, SCAND J PUBLIC HEALT, V39, P72, DOI 10.1177/1403494810393563; Brotherton J, 2011, COMMUN DIS INTELL, V35, P197; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Chao FY, 2010, GYNECOL ONCOL, V117, P302, DOI 10.1016/j.ygyno.2010.02.001; Chirila M, 2013, EUR ARCH OTORHINOLAR; de Blasio BF, 2012, J PUBLIC HEALTH-UK, V34, P539, DOI 10.1093/pubmed/fds040; de Martel C., 2012, LANCET ONCOL, V13, P607, DOI DOI 10.1016/S1470-2045(12)70137-7; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2009, EUR J CANCER, V45, P2632, DOI 10.1016/j.ejca.2009.07.019; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Dijkstra MG, 2012, J CLIN VIROL, V54, P147, DOI 10.1016/j.jcv.2012.02.022; Dos Santos Silva I., 1999, CANC EPIDEMIOLOGY PR; Eliasen M, 2009, EUR J PUBLIC HEALTH, V19, P378, DOI 10.1093/eurpub/ckp023; Enerly E, 2012, ACTA ONCOL, V51, P45, DOI 10.3109/0284186X.2011.624545; Garland SM, 2009, CANCER EPIDEM BIOMAR, V18, P1777, DOI 10.1158/1055-9965.EPI-09-0067; Hansen BT, 2010, SEX TRANSM INFECT, V86, P258, DOI 10.1136/sti.2009.038273; IARC, 2007, HUM PAP; Insinga RP, 2008, CANCER EPIDEM BIOMAR, V17, P1611, DOI 10.1158/1055-9965.EPI-07-2922; Jensen KE, 2011, ACTA OBSTET GYN SCAN, V90, P459, DOI 10.1111/j.1600-0412.2010.01066.x; Joura EA, 2002, CURR OPIN OBSTET GYN, V14, P39, DOI 10.1097/00001703-200202000-00007; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Leval A, 2013, J NATL CANC I; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Mannweiler S, 2013, J AM ACAD DERMATOL, V69, P73, DOI 10.1016/j.jaad.2012.12.973; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Moller B, 2002, EUR J CANCER PREV, V11, pS1; Moscicki AB, 2013, SEX HEALTH, V10, P583, DOI 10.1071/SHv10n6ab27; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Nohr B, 2007, ACTA OBSTET GYN SCAN, V86, P596, DOI 10.1080/00016340701279145; Nygard JE, 2006, ACTA CYTOL, V50, P295, DOI 10.1159/000325957; Olesen TB, 2012, EUR J PUBLIC HEALTH, V22, P220, DOI 10.1093/eurpub/ckr055; Ouhoummane N, 2013, CANC EPIDEMIOL; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Scudellari M, 2013, NATURE, V503, P330, DOI 10.1038/503330a; Sigurdsson K, 2010, CYTOPATHOLOGY, V21, P213, DOI 10.1111/j.1365-2303.2010.00783.x; Sigurdsson K, 1999, ACTA OBSTET GYN SCAN, V78, P478, DOI 10.1034/j.1600-0412.1999.780602.x; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Tavassoli FA, 2003, WHO CLASSIFICATION T; van de Nieuwenhof HP, 2008, CRIT REV ONCOL HEMAT, V68, P131, DOI 10.1016/j.critrevonc.2008.02.012; van de Nieuwenhof HP, 2009, EUR J CANCER, V45, P851, DOI 10.1016/j.ejca.2008.11.037; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; World Health Organization, 1992, ICD 10 CLASSIFICATIO	57	30	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88323	10.1371/journal.pone.0088323	http://dx.doi.org/10.1371/journal.pone.0088323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505474	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200175
J	Reusch, K; Russell, NA; Bellamy, TC				Reusch, Katharina; Russell, Noah A.; Bellamy, Tomas C.			Stimulus Discrimination in Cerebellar Purkinje Neurons	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; ACTION-POTENTIALS; GRANULE CELLS; SPIKE OUTPUT; BISTABILITY; INTEGRATION; DEPRESSION; INITIATION; CURRENTS; PATTERN	Cerebellar Purkinje neurons fire spontaneously in the absence of synaptic input. Overlaid on this intrinsic activity, excitatory input from parallel fibres can add simple spikes to the output train, whereas inhibitory input from interneurons can introduce pauses. These and other influences lead to an irregular spike train output in Purkinje neurons in vitro and in vivo, supplying a variable inhibitory drive to deep cerebellar nuclear neurons. From a computational perspective, this variability raises some questions, as individual spikes induced by excitatory inputs are indistinguishable from intrinsic firing activity. Although bursts of high-frequency excitatory input could be discriminated unambiguously from background activity, granule neurons are known to fire in vivo over a wide range of frequencies. This would mean that much of the sensory information relayed through the cerebellar cortex would be lost within the random variation in background activity. We speculated that alternative mechanisms for signal discrimination may exist, and sought to identify characteristic motifs within the sequence of spikes that followed stimulation events. We found that under certain conditions, parallel fibre stimulation could reliably add a "couplet'' of spikes with an unusually short interspike interval to the output train. Therefore, despite representing a small fraction of the total number of spikes, these signals can be reliably discriminated from background firing on a moment-to-moment basis, and could result in a differential downstream response.	[Reusch, Katharina; Bellamy, Tomas C.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Reusch, Katharina; Russell, Noah A.] Univ Nottingham, Sch Elect & Elect Engn, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Bellamy, TC (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.	tomas.bellamy@nottingham.ac.uk		Russell, N/0000-0002-0998-6094; Bellamy, Tomas/0000-0003-0204-7366	UK Biotechnology and Biological Sciences Research Council [BB/J015660/1]; Engineering and Physical Sciences Research Council [EP/H022112/1]; Biotechnology and Biological Sciences Research Council [BB/J015660/1] Funding Source: researchfish; BBSRC [BB/J015660/1] Funding Source: UKRI; EPSRC [EP/H022112/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (grant number: BB/J015660/1) and the Engineering and Physical Sciences Research Council (grant number: EP/H022112/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; De Schutter E, 2009, NEUROSCIENCE, V162, P816, DOI 10.1016/j.neuroscience.2009.02.040; Engbers JDT, 2013, NEURAL NETWORKS, V47, P18, DOI 10.1016/j.neunet.2012.09.006; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; James LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026889; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Raman IM, 1999, J NEUROSCI, V19, P1663; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Telgkamp P, 2002, J NEUROSCI, V22, P8447; Uusisaari M, 2011, J PHYSIOL-LONDON, V589, P3441, DOI 10.1113/jphysiol.2010.201582; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Walter JT, 2009, P NATL ACAD SCI USA, V106, P4471, DOI 10.1073/pnas.0812348106; Walter JT, 2006, J NEUROSCI, V26, P12861, DOI 10.1523/JNEUROSCI.4507-05.2006; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Yartsev MM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.002.2009; Zheng N, 2010, CEREBELLUM, V9, P56, DOI 10.1007/s12311-009-0140-6	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87828	10.1371/journal.pone.0087828	http://dx.doi.org/10.1371/journal.pone.0087828			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505320	Green Published, gold			2022-12-27	WOS:000330829200076
J	Rotem, A; Neef, A; Neef, NE; Agudelo-Toro, A; Rakhmilevitch, D; Paulus, W; Moses, E				Rotem, Assaf; Neef, Andreas; Neef, Nicole E.; Agudelo-Toro, Andres; Rakhmilevitch, David; Paulus, Walter; Moses, Elisha			Solving the Orientation Specific Constraints in Transcranial Magnetic Stimulation by Rotating Fields	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HUMAN MOTOR CORTEX; CONTROLLED-TRIAL; COIL; DEPRESSION; EFFICACY; SCHIZOPHRENIA; INHIBITION; MODULATION; CULTURES	Transcranial Magnetic Stimulation (TMS) is a promising technology for both neurology and psychiatry. Positive treatment outcome has been reported, for instance in double blind, multi-center studies on depression. Nonetheless, the application of TMS towards studying and treating brain disorders is still limited by inter-subject variability and lack of model systems accessible to TMS. The latter are required to obtain a deeper understanding of the biophysical foundations of TMS so that the stimulus protocol can be optimized for maximal brain response, while inter-subject variability hinders precise and reliable delivery of stimuli across subjects. Recent studies showed that both of these limitations are in part due to the angular sensitivity of TMS. Thus, a technique that would eradicate the need for precise angular orientation of the coil would improve both the inter-subject reliability of TMS and its effectiveness in model systems. We show here how rotation of the stimulating field relieves the angular sensitivity of TMS and provides improvements in both issues. Field rotation is attained by superposing the fields of two coils positioned orthogonal to each other and operated with a relative phase shift in time. Rotating field TMS (rfTMS) efficiently stimulates both cultured hippocampal networks and rat motor cortex, two neuronal systems that are notoriously difficult to excite magnetically. This opens the possibility of pharmacological and invasive TMS experiments in these model systems. Application of rfTMS to human subjects overcomes the orientation dependence of standard TMS. Thus, rfTMS yields optimal targeting of brain regions where correct orientation cannot be determined (e.g., via motor feedback) and will enable stimulation in brain regions where a preferred axonal orientation does not exist.	[Rotem, Assaf] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rotem, Assaf] Harvard Univ, SEAS, Cambridge, MA 02138 USA; [Neef, Andreas] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Neef, Nicole E.; Paulus, Walter] Univ Med Goettingen, Dept Clin Neurophysiol, Gottingen, Germany; [Neef, Nicole E.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Agudelo-Toro, Andres] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Rakhmilevitch, David] Weizmann Inst Sci, Dept Chem Phys, IL-76100 Rehovot, Israel; [Moses, Elisha] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Harvard University; Harvard University; Max Planck Society; Max Planck Society; Weizmann Institute of Science; Weizmann Institute of Science	Moses, E (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	elisha.moses@weizmann.ac.il	Paulus, Walter/A-3544-2009; Neef, Nicole E./F-4103-2018	Paulus, Walter/0000-0001-5549-8377; Neef, Nicole E./0000-0003-2414-7595; Agudelo-Toro, Andres/0000-0002-8528-3753; Neef, Andreas/0000-0003-4445-7478	German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen [01GQ0811, 01GQ0810]; Israel Science Foundation [1320/09]	German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen; Israel Science Foundation(Israel Science Foundation)	This work was partly funded by the German Ministry for Education and Research through the Bernstein Focus Neurotechnology Gottingen (01GQ0811, 01GQ0810) and the Israel Science Foundation under grant number 1320/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2007, J CLIN PSYCHIAT, V68, P416, DOI 10.4088/JCP.v68n0310; Berlim MT, 2014, PSYCHOL MED, V44, P225, DOI 10.1017/S0033291713000512; CHIAPPA KH, 1991, NEUROLOGY, V41, P1154, DOI 10.1212/WNL.41.7.1154; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P112, DOI 10.1016/S1388-2457(03)00320-1; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; George MS, 2009, BRAIN STIMUL, V2, P14, DOI 10.1016/j.brs.2008.06.001; George MS, 2000, BIOL PSYCHIAT, V48, P962, DOI 10.1016/S0006-3223(00)01048-9; Grisaru N, 1998, BIOL PSYCHIAT, V44, P52, DOI 10.1016/S0006-3223(98)00016-X; Huang YZ, 2009, BRAIN STIMUL, V2, P2, DOI 10.1016/j.brs.2008.09.007; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Luft AR, 2002, EXP BRAIN RES, V142, P562, DOI 10.1007/s00221-001-0952-1; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Nielsen JB, 2007, EUR J NEUROSCI, V25, P805, DOI 10.1111/j.1460-9568.2007.05326.x; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Opitz A, 2013, NEUROIMAGE, V81, P253, DOI 10.1016/j.neuroimage.2013.04.067; PAPA M, 1995, J NEUROSCI, V15, P1; Peterchev AV, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036016; Rotem A, 2008, BIOPHYS J, V94, P5065, DOI 10.1529/biophysj.107.125708; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; ROTH BJ, 1994, ELECTROEN CLIN NEURO, V93, P68, DOI 10.1016/0168-5597(94)90093-0; Ruohonen J, 1998, BIOELECTROCH BIOENER, V47, P213, DOI 10.1016/S0302-4598(98)00191-3; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Thielscher A, 2012, BIOMED ENG-BIOMED TE, V57, P312, DOI 10.1515/bmt-2012-4529; Tings T, 2005, EXP BRAIN RES, V164, P323, DOI 10.1007/s00221-005-2253-6; Wagner T, 2008, EXP BRAIN RES, V186, P539, DOI 10.1007/s00221-007-1258-8; Zhang YP, 2007, J NEUROSCI METH, V165, P9, DOI 10.1016/j.jneumeth.2007.05.021	29	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86794	10.1371/journal.pone.0086794	http://dx.doi.org/10.1371/journal.pone.0086794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505266	Green Published, gold			2022-12-27	WOS:000330829200025
J	Schreiber, L; Pietzsch, B; Floess, S; Farah, C; Jansch, L; Schmitz, I; Huehn, J				Schreiber, Lisa; Pietzsch, Beate; Floess, Stefan; Farah, Carla; Jaensch, Lothar; Schmitz, Ingo; Huehn, Jochen			The Treg-Specific Demethylated Region Stabilizes Foxp3 Expression Independently of NF-kappa B Signaling	PLOS ONE			English	Article							REGULATORY T-CELLS; C-REL; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DNA METHYLATION; LINEAGE; ACTIVATION; INDUCTION; CARMA1; STIMULATION	Regulatory T cells (Tregs) obtain immunosuppressive capacity by the upregulation of forkhead box protein 3 (Foxp3), and persistent expression of this transcription factor is required to maintain their immune regulatory function and ensure immune homeostasis. Stable Foxp3 expression is achieved through epigenetic modification of the Treg-specific demethylated region (TSDR), an evolutionarily conserved non-coding element within the Foxp3 gene locus. Here, we present molecular data suggesting that TSDR enhancer activity is restricted to T cells and cannot be induced in other immune cells such as macrophages or B cells. Since NF-kappa B signaling has been reported to be instrumental to induce Foxp3 expression during Treg development, we analyzed how NF-kappa B factors are involved in the molecular regulation of the TSDR. Unexpectedly, we neither observed transcriptional activity of a previously postulated NF-kappa B binding site within the TSDR nor did the entire TSDR show any transcriptional responsiveness to NF-kappa B activation at all. Finally, the NF-kappa B subunit c-Rel revealed to be dispensable for epigenetic imprinting of sustained Foxp3 expression by TSDR demethylation. In conclusion, we show that NF-kappa B signaling is not substantially involved in TSDR-mediated stabilization of Foxp3 expression in Tregs.	[Schreiber, Lisa; Pietzsch, Beate; Floess, Stefan; Farah, Carla; Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Jaensch, Lothar] Helmholtz Ctr Infect Res, Res Grp Cellular Prote, Braunschweig, Germany; [Schmitz, Ingo] Helmholtz Ctr Infect Res, Res Grp Syst Oriented Immunol & Inflammat Res, Braunschweig, Germany; [Schmitz, Ingo] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University	Huehn, J (corresponding author), Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany.	Jochen.Huehn@helmholtz-hzi.de	Schmitz, Ingo/G-2093-2013	Schmitz, Ingo/0000-0002-5360-0419	German Research Foundation [SFB738, SFB854]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (SFB738 and SFB854). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MJ, 2009, PLOS BIOL, V7, P513, DOI 10.1371/journal.pbio.1000051; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Eckerstorfer P, 2010, MOL IMMUNOL, V47, P2094, DOI 10.1016/j.molimm.2010.04.002; Ehlers M, 2003, J IMMUNOL, V171, P3594, DOI 10.4049/jimmunol.171.7.3594; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Flory E, 2000, J BIOL CHEM, V275, P8307, DOI 10.1074/jbc.275.12.8307; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grigoriadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026851; Guckel E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020003; Gupta S, 2008, MOL IMMUNOL; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; He HQ, 2011, IMMUNOBIOLOGY, V216, P678, DOI 10.1016/j.imbio.2010.11.002; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Hsieh CS, 2009, IMMUNITY, V31, P852, DOI 10.1016/j.immuni.2009.11.006; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; KIM KJ, 1979, J IMMUNOL, V122, P549; Leslie M, 2011, SCIENCE, V332, P1020, DOI 10.1126/science.332.6033.1020; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Medoff BD, 2009, EUR J IMMUNOL, V39, P78, DOI 10.1002/eji.200838734; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Molinero LL, 2009, J IMMUNOL, V182, P6736, DOI 10.4049/jimmunol.0900498; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; Schuster M, 2012, IMMUNITY, V37, P998, DOI 10.1016/j.immuni.2012.08.023; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Toker A, 2013, J IMMUNOL; Toker A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001783; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; VIVIER E, 1993, EUR J IMMUNOL, V23, P1872, DOI 10.1002/eji.1830230821; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	54	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88318	10.1371/journal.pone.0088318	http://dx.doi.org/10.1371/journal.pone.0088318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505473	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200174
J	Huang, FT; Tang, J; Zhuang, XH; Zhuang, YY; Cheng, WJ; Chen, WB; Yao, HR; Zhang, SN				Huang, Fengting; Tang, Jian; Zhuang, Xiaohong; Zhuang, Yanyan; Cheng, Wenjie; Chen, Wenbo; Yao, Herui; Zhang, Shineng			MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CELL-PROLIFERATION; COLORECTAL-CANCER; DOWN-REGULATION; UP-REGULATION; EXPRESSION; MICRORNA; ACTIVATION; METASTASIS; INVASION	Aberrant expression of miR-196a has been frequently reported in different cancers including pancreatic cancer. However, its function in pancreatic cancer has not been fully elucidated. Here, we investigated the expression pattern and the biological role of miR-196a in pancreatic cancer cell lines, as well as its interaction with a metastasis-related gene, nuclear factor-kappa-B-inhibitor alpha (NFKBIA). We demonstrated that miR-196a was up-regulated in human pancreatic cancer cell lines compared with immortalized pancreatic ductal epithelial cells by means of microRNAs microarray and qRT-PCR. Furthermore, down-regulation of miR-196a in PANC-1 suppressed its proliferation and migration with an increase in G(0)/G(1) transition and decreased expression of Cyclin D1 and CDK4/6. Meanwhile, an increased expression in E-cadherin and decreased expression in N-cadherin and Vimentin were also observed. We identified a novel miR-196a target, NFKBIA, and down-regulation of miR-196a enhanced the expression of NFKBIA protein. Luciferase assay confirmed that NFKBIA was a direct and specific target of miR-196a. Silencing NFKBIA in PANC-1 cells enhanced its proliferation and migration. Taken together, our findings indicate that miR-196a is highly expressed in pancreatic cancer cell lines, and may play a crucial role in pancreatic cancer proliferation and migration, possibly through its downstream target, NFKBIA. Thus, miR-196a may serve as a potential therapeutic target for pancreatic cancer.	[Huang, Fengting; Zhuang, Yanyan; Chen, Wenbo; Zhang, Shineng] Sun Yat Sen Univ, Dept Gastroenterol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Jian; Cheng, Wenjie] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Zhuang, Xiaohong] Hainan Prov Nongken Hosp, Dept Oncol & Hematol, Haikou, Peoples R China; [Yao, Herui] Sun Yat Sen Univ, Dept Med Oncol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yao, HR (corresponding author), Sun Yat Sen Univ, Dept Med Oncol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yaoherui@163.com; shinengz@hotmail.com		Yao, Herui/0000-0001-5520-6469; Tang, Jian/0000-0002-7611-7390; Huang, Fengting/0000-0002-3750-5673	National Natural Science Foundation of China [30973505]; Science and Technology Foundation of the Guangdong Province [2009B030801005]; Foundation of Guangzhou Science and Technology Bureau [2009Y-C011-1]; Foundation of Ministry of Education of China [20120171110075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of the Guangdong Province; Foundation of Guangzhou Science and Technology Bureau; Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants from the National Natural Science Foundation of China (30973505), the Science and Technology Foundation of the Guangdong Province (2009B030801005), the Foundation of Guangzhou Science and Technology Bureau (2009Y-C011-1) and the Foundation of Ministry of Education of China (20120171110075) to H. Yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Bredel M, 2011, NEW ENGL J MED, V364, P627, DOI 10.1056/NEJMoa1006312; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Kang YH, 2012, CELL SIGNAL, V24, P1940, DOI 10.1016/j.cellsig.2012.06.004; Kong R, 2010, CANCER LETT, V291, P90, DOI 10.1016/j.canlet.2009.10.001; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Lake A, 2009, INT J CANCER, V125, P1334, DOI 10.1002/ijc.24502; Laos S, 2006, INT J ONCOL, V28, P695; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035078; Liu J, 2012, FRONT BIOSCI-LANDMRK, V17, P2541, DOI 10.2741/4069; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Long HX, 2012, STEM CELLS, V30, P2309, DOI 10.1002/stem.1194; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; O'Leary DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044176; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Papaconstantinou IG, 2012, PANCREAS, V41, P671, DOI 10.1097/MPA.0b013e31823c9d21; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Qian JY, 2005, CANCER RES, V65, P5045, DOI 10.1158/0008-5472.CAN-04-3208; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song LB, 2012, J CLIN INVEST, V122, P3563, DOI 10.1172/JCI62339; Spink CF, 2007, CANCER LETT, V246, P92, DOI 10.1016/j.canlet.2006.02.001; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Wei WZ, 2012, MOL CELL BIOL, V32, P4662, DOI 10.1128/MCB.00935-12; Wu SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040727; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang H., 2012, COMP FUNCT GENOM, V2012, P1; Zhao QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044956	42	87	91	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87897	10.1371/journal.pone.0087897	http://dx.doi.org/10.1371/journal.pone.0087897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504166	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300014
J	Wong, D; von Keyserlingk, MAG; Richards, JG; Weary, DM				Wong, Devina; von Keyserlingk, Marina A. G.; Richards, Jeffrey G.; Weary, Daniel M.			Conditioned Place Avoidance of Zebrafish (Danio rerio) to Three Chemicals Used for Euthanasia and Anaesthesia	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; CLOVE OIL; RAINBOW-TROUT; QUINALDINE SULFATE; PREFERENCE; EFFICACY; MS-222; STRESS; FISH; BEHAVIOR	Zebrafish are becoming one of the most used vertebrates in developmental and biomedical research. Fish are commonly killed at the end of an experiment with an overdose of tricaine methanesulfonate (TMS, also known as MS-222), but to date little research has assessed if exposure to this or other agents qualifies as euthanasia (i.e. a "good death"). Alternative agents include metomidate hydrochloride and clove oil. We use a conditioned place avoidance paradigm to compare aversion to TMS, clove oil, and metomidate hydrochloride. Zebrafish (n = 51) were exposed to the different anaesthetics in the initially preferred side of a light/dark box. After exposure to TMS zebrafish spent less time in their previously preferred side; aversion was less pronounced following exposure to metomidate hydrochloride and clove oil. Nine of 17 fish exposed to TMS chose not to re-enter the previously preferred side, versus 2 of 18 and 3 of 16 refusals for metomidate hydrochloride and clove oil, respectively. We conclude that metomidate hydrochloride and clove oil are less aversive than TMS and that these agents be used as humane alternatives to TMS for killing zebrafish.	[Wong, Devina; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Richards, Jeffrey G.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Wong, D (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	danweary@mail.ubc.ca	Weary, Daniel M/A-8868-2010; von Keyserlingk, Marina/AAB-6353-2019	Weary, Daniel M/0000-0002-0917-3982; von Keyserlingk, Marina/0000-0002-1427-3152	NSERC [262278]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by an NSERC Discovery grant to D.M. Weary (Grant # 262278) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman P.A., 2006, ANESTHETICS; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Anderson W. Gary, 1997, North American Journal of Fisheries Management, V17, P301, DOI 10.1577/1548-8675(1997)017<0301:TUOCOA>2.3.CO;2; Borski RJ, 2003, ILAR J, V44, P286, DOI 10.1093/ilar.44.4.286; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; CCAC Canadian Council on Animal Care, 2012, 2010 CCAC SURV AN US; Chaouloff F, 1997, BEHAV BRAIN RES, V85, P27, DOI 10.1016/S0166-4328(96)00160-X; ENDO T, 1972, B JPN SOC SCI FISH, V38, P761; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Grush J, 2004, ZEBRAFISH, V1, P46, DOI 10.1089/154585404774101671; Hajek G. J., 2006, Acta Ichthyologica et Piscatoria, V36, P93; Holloway AC, 2004, AQUAC RES, V35, P1025, DOI 10.1111/j.1365-2109.2004.01108.x; HUNN JB, 1974, ANNU REV PHARMACOL, V14, P47, DOI 10.1146/annurev.pa.14.040174.000403; Iversen M, 2003, AQUACULTURE, V221, P549, DOI 10.1016/S0044-8486(03)00111-X; IWAMA GK, 1989, CAN J ZOOL, V67, P2065, DOI 10.1139/z89-294; Keene JL, 1998, AQUAC RES, V29, P89, DOI 10.1111/j.1365-2109.1998.tb01113.x; Kreiberg H, 2000, LAB FISH, P506; MARKING LL, 1985, FISHERIES, V10, P2, DOI 10.1577/1548-8446(1985)010<0002:ABANIF>2.0.CO;2; MASSEE KC, 1995, AQUACULTURE, V134, P351, DOI 10.1016/0044-8486(95)00057-9; Mathur P, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.201; Matthews M, 2012, ILAR J, V53, P192, DOI 10.1093/ilar.53.2.192; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Maximino C, 2010, NAT PROTOC, V5, P209, DOI 10.1038/nprot.2009.225; McFARLAND WILLIAM N., 1959, PUBL INST MARINE SCI, V6, P23; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; Nuffield Council on Bioethics, 2005, ETH RES INV AN; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Serra EL, 1999, BRAZ J MED BIOL RES, V32, P1551, DOI 10.1590/S0100-879X1999001200016; Sladky KK, 2001, AM J VET RES, V62, P337, DOI 10.2460/ajvr.2001.62.337; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; THOMAS P, 1991, AQUACULTURE, V96, P69, DOI 10.1016/0044-8486(91)90140-3; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; United States Department of Health and Human Services, 2007, GUID IND REL US CLOV; Wagner GN, 2003, AQUAC RES, V34, P1139, DOI 10.1046/j.1365-2109.2003.00916.x; WEDEMEYER G, 1970, J FISH RES BOARD CAN, V27, P909, DOI 10.1139/f70-097; Wong D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1000	38	50	51	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88030	10.1371/journal.pone.0088030	http://dx.doi.org/10.1371/journal.pone.0088030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505365	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300041
J	Yarosh, HL; Hyatt, CJ; Meda, SA; Jiantonio-Kelly, R; Potenza, MN; Assaf, M; Pearlson, GD				Yarosh, Haley L.; Hyatt, Christopher J.; Meda, Shashwath A.; Jiantonio-Kelly, Rachel; Potenza, Marc N.; Assaf, Michal; Pearlson, Godfrey D.			Relationships between Reward Sensitivity, Risk-Taking and Family History of Alcoholism during an Interactive Competitive fMRI Task	PLOS ONE			English	Article							FRONTAL-LOBE ACTIVITY; REACTION-TIME-TASK; ORBITOFRONTAL CORTEX; PARENTAL ALCOHOL; DECISION-MAKING; WORKING-MEMORY; BRAIN ACTIVITY; IMPULSIVITY; ACTIVATION; ADDICTION	Background: Individuals with a positive family history for alcoholism (FHP) have shown differences from family-history-negative (FHN) individuals in the neural correlates of reward processing. FHP, compared to FHN individuals, demonstrate relatively diminished ventral striatal activation during anticipation of monetary rewards, and the degree of ventral striatal activation shows an inverse correlation with specific impulsivity measures in alcohol-dependent individuals. Rewards in socially interactive contexts relate importantly to addictive propensities, yet have not been examined with respect to how their neural underpinnings relate to impulsivity-related measures. Here we describe impulsivity measures in FHN and FHP individuals as they relate to a socially interactive functional magnetic resonance imaging (fMRI) task. Methods: Forty FHP and 29 FHN subjects without histories of Axis-I disorders completed a socially interactive Domino task during functional magnetic resonance imaging and completed self-report and behavioral impulsivity-related assessments. Results: FHP compared to FHN individuals showed higher scores (p = .004) on one impulsivity-related factor relating to both compulsivity (Padua Inventory) and reward/punishment sensitivity (Sensitivity to Punishment/Sensitivity to Reward Questionnaire). Multiple regression analysis within a reward-related network revealed a correlation between risk-taking (involving another impulsivity-related factor, the Balloon Analog Risk Task (BART)) and right ventral striatum activation under reward >punishment contrast (p < 0.05 FWE corrected) in the social task. Conclusions: Behavioral risk-taking scores may be more closely associated with neural correlates of reward responsiveness in socially interactive contexts than are FH status or impulsivity-related self-report measures. These findings suggest that risk-taking assessments be examined further in socially interactive settings relevant to addictive behaviors.	[Yarosh, Haley L.; Hyatt, Christopher J.; Meda, Shashwath A.; Jiantonio-Kelly, Rachel; Assaf, Michal; Pearlson, Godfrey D.] Hartford Hosp, Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT 06115 USA; [Yarosh, Haley L.; Potenza, Marc N.; Assaf, Michal; Pearlson, Godfrey D.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Potenza, Marc N.; Pearlson, Godfrey D.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Potenza, Marc N.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA	Hartford Hospital; Yale University; Yale University; Yale University	Yarosh, HL (corresponding author), Hartford Hosp, Olin Neuropsychiat Res Ctr, Inst Living, Hartford, CT 06115 USA.	haley.yarosh@yale.edu			National Institute on Alcohol Abuse and Alcoholism (NIAAA) [5 P50 AA01280]; Project 4; National Institutes of Health (NIH) [RL1 AA017539]; NIH [P20 DA027844]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RL1AA017539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA027844] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Project 4; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded by the following sources: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Grant number 5 P50 AA01280; Project 4 (GDP); National Institutes of Health (NIH) Grant number RL1 AA017539 (MNP); and NIH Grant number P20 DA027844 (MNP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson A, 2011, DRUG ALCOHOL DEPEN, V117, P198, DOI 10.1016/j.drugalcdep.2011.02.001; Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Ahmadi A, 2013, NEUROPSYCHOPHARMACOL; Andrews MM, 2011, BIOL PSYCHIAT, V69, P675, DOI 10.1016/j.biopsych.2010.09.049; Assaf M, 2009, BRAIN IMAGING BEHAV, V3, P24, DOI 10.1007/s11682-008-9047-y; Balodis IM, 2013, BIOL PSYCHIAT, V73, P877, DOI 10.1016/j.biopsych.2013.01.014; Balodis IM, 2012, BIOL PSYCHIAT, V71, P749, DOI 10.1016/j.biopsych.2012.01.006; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Bjork JM, 2008, ADDICTION, V103, P1308, DOI 10.1111/j.1360-0443.2008.02250.x; Blum Kenneth, 2000, Journal of Psychoactive Drugs, V32, pi; Bornovalova MA, 2009, PHARMACOL BIOCHEM BE, V93, P258, DOI 10.1016/j.pbb.2008.10.023; Bryden DW, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00069; Camara E, 2009, FRONT NEUROSCI-SWITZ, V3, P350, DOI 10.3389/neuro.01.034.2009; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen ACH, 2007, ALCOHOL CLIN EXP RES, V31, P156, DOI 10.1111/j.1530-0277.2006.00277.x; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045938; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; Cservenka A, 2012, DRUG ALCOHOL DEPEN, V123, P98, DOI 10.1016/j.drugalcdep.2011.10.021; Cservenka A, 2012, ALCOHOL CLIN EXP RES, V36, P604, DOI 10.1111/j.1530-0277.2011.01650.x; Dager AD, 2013, ALCOHOL CLIN EXP RES, V37, pE161, DOI 10.1111/j.1530-0277.2012.01879.x; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Devito EE, 2013, NEUROPSYCHOPHARMACOL; Doremus-Fitzwater TL, 2010, BRAIN COGNITION, V72, P114, DOI 10.1016/j.bandc.2009.08.008; Dougherty DM, 2004, ALCOHOL CLIN EXP RES, V28, P408, DOI 10.1097/01.ALC.0000117834.53719.A8; Duka T, 2011, BIOL PSYCHIAT, V69, P612, DOI 10.1016/j.biopsych.2011.02.002; Eagle DM, 2008, CEREB CORTEX, V18, P178, DOI 10.1093/cercor/bhm044; Edel MA, 2012, J PSYCHIAT RES; Elkins IJ, 2004, AM J PSYCHIAT, V161, P670, DOI 10.1176/appi.ajp.161.4.670; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fareri DS, 2008, DEV PSYCHOPATHOL, V20, P1191, DOI 10.1017/S0954579408000576; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Galvan A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.006.2010; Geier CF, 2010, CEREB CORTEX, V20, P1613, DOI 10.1093/cercor/bhp225; Ginley MK, 2013, J GAMBL STUD; Goldstein RZ, 2007, DRUG ALCOHOL DEPEN, V87, P233, DOI 10.1016/j.drugalcdep.2006.08.022; Gordh AHVS, 2011, ALCOHOL CLIN EXP RES, V35, P1426, DOI 10.1111/j.1530-0277.2011.01478.x; Hansell NK, 2008, TWIN RES HUM GENET, V11, P287, DOI 10.1375/twin.11.3.287; Hayton SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023885; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Herting MM, 2010, ALCOHOL CLIN EXP RES, V34, P1590, DOI 10.1111/j.1530-0277.2010.01244.x; Hill SY, 2008, PSYCHIAT RES, V160, P155, DOI 10.1016/j.psychres.2008.04.017; Hill SY, 2009, BIOL PSYCHIAT, V65, P129, DOI 10.1016/j.biopsych.2008.09.001; Hyatt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034917; Jamadar S, 2012, PSYCHOPHARMACOLOGY, V222, P129, DOI 10.1007/s00213-011-2628-2; Kahn I, 2002, NEURON, V33, P983, DOI 10.1016/S0896-6273(02)00626-8; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Leroy PJRaAM, 1987, ROBUST REGRESSION OU; Liu X, 2007, J NEUROSCI, V27, P4587, DOI 10.1523/JNEUROSCI.5227-06.2007; Lovallo WR, 2006, ALCOHOL CLIN EXP RES, V30, P763, DOI 10.1111/j.1530-0277.2006.00089.x; McGue M, 1997, ALCOHOL HEALTH RES W, V21, P210; Meda SA, 2009, BEHAV PHARMACOL, V20, P390, DOI 10.1097/FBP.0b013e32833113a3; Padmanabhan A, 2011, DEV COGN NEUROS-NETH, V1, P517, DOI 10.1016/j.dcn.2011.06.004; Patel KT., 2013, BIOL PSYCHI IN PRESS; Patel KT, 2013, BIOL PSYCHIAT; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Reynolds B, 2004, BEHAV PROCESS, V67, P343, DOI 10.1016/j.beproc.2004.06.003; Robbins TW, 2012, PSYCHOPHARMACOLOGY, V219, P251, DOI 10.1007/s00213-011-2584-x; Ruocco AC, 2012, NEUROPSYCHOLOGY, V26, P473, DOI 10.1037/a0028715; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Saunders B, 2008, ALCOHOL CLIN EXP RES, V32, P888, DOI 10.1111/j.1530-0277.2008.00648.x; SHER KJ, 1991, J ABNORM PSYCHOL, V100, P427, DOI 10.1037/0021-843X.100.4.427; Sigvardsson S, 1996, ARCH GEN PSYCHIAT, V53, P681; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; Spear LP, 2010, DEV PSYCHOBIOL, V52, P236, DOI 10.1002/dev.20457; STERNBERGER LG, 1990, BEHAV RES THER, V28, P341, DOI 10.1016/0005-7967(90)90087-Y; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tessner KD, 2010, NEUROPSYCHOL REV, V20, P1, DOI 10.1007/s11065-009-9111-4; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Whelan R, 2012, NAT NEUROSCI, V15, P920, DOI 10.1038/nn.3092; Winstanley CA, 2007, ANN NY ACAD SCI, V1121, P639, DOI 10.1196/annals.1401.024; Wolen AR, 2012, ALCOHOL RES-CURR REV, V34, P306; Yan J, 2013, ADDICT BIOL; Yau WYW, 2012, J NEUROSCI, V32, P2544, DOI 10.1523/JNEUROSCI.1390-11.2012; Zalla T, 2000, EUR J NEUROSCI, V12, P1764, DOI 10.1046/j.1460-9568.2000.00064.x; Zuckerman M, 1979, ABBREVIATED MANUAL S	84	11	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88188	10.1371/journal.pone.0088188	http://dx.doi.org/10.1371/journal.pone.0088188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505424	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300070
J	Walters, A; Lea, MA; van den Hoff, J; Field, IC; Virtue, P; Sokolov, S; Pinkerton, MH; Hindell, MA				Walters, Andrea; Lea, Mary-Anne; van den Hoff, John; Field, Iain C.; Virtue, Patti; Sokolov, Sergei; Pinkerton, Matt H.; Hindell, Mark A.			Spatially Explicit Estimates of Prey Consumption Reveal a New Krill Predator in the Southern Ocean	PLOS ONE			English	Article							SEALS MIROUNGA-LEONINA; STABLE-ISOTOPE RATIOS; PENGUINS APTENODYTES-PATAGONICUS; ELEPHANT SEALS; FORAGING STRATEGIES; JUVENILE SOUTHERN; DIVING BEHAVIOR; KING PENGUINS; FOOD-WEB; PLANKTON DELTA-C-13	Development in foraging behaviour and dietary intake of many vertebrates are age-structured. Differences in feeding ecology may correlate with ontogenetic shifts in dispersal patterns, and therefore affect foraging habitat and resource utilization. Such life-history traits have important implications in interpreting tropho-dynamic linkages. Stable isotope ratios in the whiskers of sub-yearling southern elephant seals (Mirounga leonina; n = 12) were used, in conjunction with satellite telemetry and environmental data, to examine their foraging habitat and diet during their first foraging migration. The trophic position of seals from Macquarie Island (54 degrees 30'S, 158 degrees 57'E) was estimated using stable carbon (delta C-13) and nitrogen (delta N-15) ratios along the length of the whisker, which provided a temporal record of prey intake. Satellite-relayed data loggers provided details on seal movement patterns, which were related to isotopic concentrations along the whisker. Animals fed in waters south of the Polar Front (>60 degrees S) or within Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR) Statistical Subareas 88.1 and 88.2, as indicated by both their depleted delta C-13 (< -20%) values, and tracking data. They predominantly exploited varying proportions of mesopelagic fish and squid, and crustaceans, such as euphausiids, which have not been reported as a prey item for this species. Comparison of isotopic data between sub-yearlings, and 1, 2 and 3 yr olds indicated that sub-yearlings, limited by their size, dive capabilities and prey capture skills to feeding higher in the water column, fed at a lower trophic level than older seals. This is consistent with the consumption of euphausiids and most probably, Antarctic krill (Euphausia superba), which constitute an abundant, easily accessible source of prey in water masses used by this age class of seals. Isotopic assessment and concurrent tracking of seals are successfully used here to identify ontogenetic shifts in broad-scale foraging habitat use and diet preferences in a highly migratory predator.	[Walters, Andrea; Lea, Mary-Anne; Virtue, Patti; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Walters, Andrea; Virtue, Patti; Hindell, Mark A.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [van den Hoff, John] Australian Antarctic Div, Kingston, Tas, Australia; [Field, Iain C.] Macquarie Univ, Dept Geog & Environm, Marine Mammal Res Grp, Sydney, NSW 2109, Australia; [Sokolov, Sergei] Commonwealth Sci & Ind Res Org Marine & Atmospher, Hobart, Tas, Australia; [Pinkerton, Matt H.] Natl Inst Water & Atmospher Res Ltd, Wellington, New Zealand	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Australian Antarctic Division; Macquarie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Walters, A (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Andrea.Walters@utas.edu.au	Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299; Virtue, Patti/0000-0002-9870-1256; Walters, Andrea/0000-0002-7166-5689; Hindell, Mark/0000-0002-7823-7185	Sea World Research and Rescue Foundation Inc [SWR/4/2009]; Department of the Environment, Water, Heritage and the Arts, Australian Marine Mammal Centre, Australian Antarctic Division [0809/5]; New Zealand, International Polar Year (IPY), Census of Antarctic Marine Life (CAML), (IPY-CAML); Ministry of Science and Innovation (MSI) [C01X1001]	Sea World Research and Rescue Foundation Inc; Department of the Environment, Water, Heritage and the Arts, Australian Marine Mammal Centre, Australian Antarctic Division; New Zealand, International Polar Year (IPY), Census of Antarctic Marine Life (CAML), (IPY-CAML); Ministry of Science and Innovation (MSI)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was financially supported by The Sea World Research and Rescue Foundation Inc (Project SWR/4/2009, P. Virtue) and the Department of the Environment, Water, Heritage and the Arts, Australian Marine Mammal Centre, Australian Antarctic Division (Project 0809/5, M. Hindell). The authors would also like to acknowledge part funding from the New Zealand, International Polar Year (IPY), Census of Antarctic Marine Life (CAML), (IPY-CAML) and Ministry of Science and Innovation (MSI) project C01X1001, and Sarah Bury and Julie Brown for providing stable isotope data from these projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1987, J ZOOL, V212, P303, DOI 10.1111/j.1469-7998.1987.tb05992.x; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; ARNBOM T, 1993, CAN J ZOOL, V71, P1772, DOI 10.1139/z93-252; Arnbom T, 1997, ECOLOGY, V78, P471, DOI 10.1890/0012-9658(1997)078[0471:FAMEIS]2.0.CO;2; Bailleul Fdr, 2010, ECOGRAPHY, V33, P1; BAKER JR, 1990, VET REC, V126, P75; Bearhop S, 1999, J APPL ECOL, V36, P75, DOI 10.1046/j.1365-2664.1999.00378.x; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Bornemann H, 2000, ANTARCT SCI, V12, P3, DOI 10.1017/S095410200000002X; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Boyd Ian L., 1994, P98; Bradshaw CJA, 2004, ANIM BEHAV, V68, P1349, DOI 10.1016/j.anbehav.2003.12.013; Bradshaw CJA, 2003, P ROY SOC B-BIOL SCI, V270, P1283, DOI 10.1098/rspb.2003.2371; Breed GA, 2011, MAR ECOL PROG SER, V431, P267, DOI 10.3354/meps09134; Burns JM, 1999, CAN J ZOOL, V77, P737, DOI 10.1139/cjz-77-5-737; Bury SJ, 2008, WGEMM0827 CCAMLR; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Cherel Y, 2002, POLAR BIOL, V25, P898, DOI 10.1007/s00300-002-0419-2; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cherel Y, 2007, MAR ECOL PROG SER, V329, P281, DOI 10.3354/meps329281; Cherel Y, 2009, MAR BIOL, V156, P699, DOI 10.1007/s00227-008-1121-x; Clarke M.R, 1986, HDB IDENTIFICATION C; Constable AJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001270; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; CROXALL JP, 1985, J ANIM ECOL, V54, P1, DOI 10.2307/4616; Daneri G, 2000, ANTARCTIC SCI, V72, P76; DANERI GA, 1992, POLAR BIOL, V11, P565; Daneri GA, 2002, POLAR BIOL, V25, P739, DOI 10.1007/s00300-002-0408-5; Duhamel G, 2000, POLAR BIOL, V23, P106, DOI 10.1007/s003000050015; Fedak MA, 1996, J VISUAL COMP ANIMAT, V7, P141, DOI 10.1002/(SICI)1099-1778(199607)7:3<141::AID-VIS147>3.0.CO;2-N; FEDAK MA, 1983, J ZOOL, V200, P298, DOI 10.1111/j.1469-7998.1983.tb05794.x; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Field IC, 2007, MAR ECOL PROG SER, V331, P281, DOI 10.3354/meps331281; Field IC, 2007, MAR BIOL, V150, P1441, DOI 10.1007/s00227-006-0417-y; Field IC, 2005, OECOLOGIA, V142, P127, DOI 10.1007/s00442-004-1704-2; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; FRY B, 1984, CONTRIB MAR SCI, V27, P13; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; GREEN K, 1993, MAR MAMMAL SCI, V9, P10, DOI 10.1111/j.1748-7692.1993.tb00422.x; Habran S, 2010, MAR MAMMAL SCI, V26, P880, DOI 10.1111/j.1748-7692.2010.00372.x; HINDELL MA, 1994, AUST J ZOOL, V42, P723, DOI 10.1071/ZO9940723; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Hindell MA, 1999, CAN J ZOOL, V77, P1807, DOI 10.1139/cjz-77-11-1807; Hindell MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038307; Hirons A, 2001, TROPHIC DYNAMICS PIN; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; Hobson KA, 2006, CAN J ZOOL, V84, P766, DOI 10.1139/Z06-049; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 1996, CAN J FISH AQUAT SCI, V53, P528, DOI 10.1139/cjfas-53-3-528; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HOPKINS TL, 1989, DEEP-SEA RES, V36, P543, DOI 10.1016/0198-0149(89)90005-8; Hosie G, 2011, POLAR SCI, V5, P75, DOI 10.1016/j.polar.2011.04.009; Hull CL, 1997, MAR ECOL PROG SER, V153, P217, DOI 10.3354/meps153217; Hunt BPV, 2005, DEEP-SEA RES PT I, V52, P1241, DOI 10.1016/j.dsr.2004.11.019; Irvine LG, 2000, J ZOOL, V251, P463, DOI 10.1017/S0952836900008062; Iverson SJ, 1997, CAN J ZOOL, V75, P188, DOI 10.1139/z97-026; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; KOCH PL, 1995, SCIENCE, V267, P1340, DOI 10.1126/science.267.5202.1340; Kojadinovic J, 2008, WATERBIRDS, V31, P169, DOI 10.1675/1524-4695(2008)31[169:EOLEOC]2.0.CO;2; Lascara CM, 1999, DEEP-SEA RES PT I, V46, P951, DOI 10.1016/S0967-0637(98)00099-5; Lea MA, 2002, POLAR BIOL, V25, P843, DOI 10.1007/s00300-002-0428-1; LeBoeuf BJ, 1996, CAN J ZOOL, V74, P1632; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; LING J. K., 1966, AUSTRALIAN J ZOOL, V14, P855, DOI 10.1071/ZO9660855; Mayzaud P., 1985, P330; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMahon CR, 2005, MAMMAL REV, V35, P82, DOI 10.1111/j.1365-2907.2005.00055.x; McMahon CR, 2004, BEHAV ECOL SOCIOBIOL, V55, P349, DOI 10.1007/s00265-003-0721-1; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Miserez A, 2007, ACTA BIOMATER, V3, P139, DOI 10.1016/j.actbio.2006.09.004; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Moteki M, 2011, POLAR SCI, V5, P211, DOI 10.1016/j.polar.2011.04.001; Newland C, 2011, MAR ECOL PROG SER, V424, P247, DOI 10.3354/meps08769; Newland C, 2009, MAR ECOL PROG SER, V384, P303, DOI 10.3354/meps08010; Newsome SD, 2010, ECOL APPL, V20, P1744, DOI 10.1890/09-1502.1; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; PAKHOMOV EA, 1994, MAR ECOL PROG SER, V111, P155, DOI 10.3354/meps111155; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phleger CF, 2002, COMP BIOCHEM PHYS B, V131, P733, DOI 10.1016/S1096-4959(02)00021-0; Polischuk SC, 2001, CAN J ZOOL, V79, P499, DOI 10.1139/cjz-79-3-499; Polito MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026642; Popp BN, 1999, GLOBAL BIOGEOCHEM CY, V13, P827, DOI 10.1029/1999GB900041; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; R Development Core Team, 2012, R LANG ENV STAT COMP; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Robinson PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036728; RODHOUSE PG, 1989, AMBIO, V18, P56; RODHOUSE PG, 1992, CAN J ZOOL, V70, P1007, DOI 10.1139/z92-143; Roper C. F. E., 1969, Bulletin United States National Museum, V291, P1; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Schmidt K, 2004, MAR ECOL PROG SER, V266, P43, DOI 10.3354/meps266043; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; Slip D, 1994, ELEPHANT SEALS POPUL, P66; SLIP DJ, 1995, CAN J ZOOL, V73, P1519, DOI 10.1139/z95-180; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Sokolov S, 2007, J PHYS OCEANOGR, V37, P1394, DOI 10.1175/JPO3111.1; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005248; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; Sokolov S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004329; Stegall VK, 2008, CAN J ZOOL, V86, P17, DOI 10.1139/Z07-115; Thiebot JB, 2011, MAR ECOL PROG SER, V421, P279, DOI 10.3354/meps08907; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Tierney M, 2008, MAR ECOL PROG SER, V355, P297, DOI 10.3354/meps07235; Trull TW, 2001, DEEP-SEA RES PT II, V48, P2655, DOI 10.1016/S0967-0645(01)00013-3; van den Hoff J, 2004, POLAR BIOL, V27, P604, DOI 10.1007/s00300-004-0628-y; van den Hoff J, 2003, POLAR BIOL, V26, P27, DOI 10.1007/s00300-002-0447-y; van den Hoff J, 2002, ANTARCT SCI, V14, P134, DOI 10.1017/S095410200200069X; Weise MJ, 2010, ECOLOGY, V91, P1004, DOI 10.1890/08-1554.1; Wienecke B, 2006, POLAR BIOL, V29, P424, DOI 10.1007/s00300-005-0074-5; Wienecke B, 2002, ENVIRON MANAGE, V29, P662, DOI 10.1007/s00267-0015-1; WORBY AP, 1998, ANTAR RES S, V74, P41; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871; Zhao LY, 2004, MAR ECOL PROG SER, V281, P267, DOI 10.3354/meps281267	125	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86452	10.1371/journal.pone.0086452	http://dx.doi.org/10.1371/journal.pone.0086452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24516515	gold, Green Published, Green Submitted			2022-12-27	WOS:000330339800047
J	Belikov, N; Yakovleva, M; Feldman, T; Demina, O; Khodonov, A; Lindstrom, M; Donner, K; Ostrovsky, M				Belikov, Nikolai; Yakovleva, Marina; Feldman, Tatiana; Demina, Olga; Khodonov, Andrei; Lindstrom, Magnus; Donner, Kristian; Ostrovsky, Mikhail			Lake and Sea Populations of Mysis relicta (Crustacea, Mysida) with Different Visual-Pigment Absorbance Spectra Use the Same A1 Chromophore	PLOS ONE			English	Article							SPECIES GROUP CRUSTACEA; OPSIN GENE-EXPRESSION; PHOTOACTIVATION ENERGY; LIGHT ENVIRONMENTS; BULLFROG RETINA; MOLECULAR-BASIS; EUROPEAN EEL; EYE FUNCTION; BALTIC SEA; SENSITIVITY	Glacial-relict species of the genus Mysis (opossum shrimps) inhabiting both fresh-water lakes and brackish sea waters in northern Europe show a consistent lake/sea dichotomy in eye spectral sensitivity. The absorbance peak (lambda(max)) recorded by microspectrophotometry in isolated rhabdoms is invariably 20-30 nm red-shifted in "lake" compared with "sea" populations. The dichotomy holds across species, major opsin lineages and light environments. Chromophore exchange from A1 to A2 (retinal -> 3,4-didehydroretinal) is a well-known mechanism for red-shifting visual pigments depending on environmental conditions or stages of life history, present not only in fishes and amphibians, but in some crustaceans as well. We tested the hypothesis that the lake/sea dichotomy in Mysis is due to the use of different chromophores, focussing on two populations of M. relicta from, respectively, a Finnish lake and the Baltic Sea. They are genetically very similar, having been separated for less than 10 kyr, and their rhabdoms show a typical lake/sea difference in lambda(max) (554 nm vs. 529 nm). Gene sequencing has revealed no differences translating into amino acid substitutions in the transmembrane parts of their opsins. We determined the chromophore identity (A1 or A2) in the eyes of these two populations by HPLC, using as standards pure chromophores A1 and A2 as well as extracts from bovine (A1) and goldfish (A2) retinas. We found that the visual-pigment chromophore in both populations is A1 exclusively. Thus the spectral difference between these two populations of M. relicta is not due to the use of different chromophores. We argue that this conclusion is likely to hold for all populations of M. relicta as well as its European sibling species.	[Belikov, Nikolai; Yakovleva, Marina; Feldman, Tatiana; Demina, Olga; Khodonov, Andrei; Ostrovsky, Mikhail] Russian Acad Sci, Inst Biochem Phys, Moscow, Russia; [Feldman, Tatiana; Ostrovsky, Mikhail] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Lindstrom, Magnus] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Donner, Kristian] Univ Helsinki, Dept Biosci, Helsinki, Finland	Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Lomonosov Moscow State University; University of Helsinki; University of Helsinki	Donner, K (corresponding author), Russian Acad Sci, Inst Biochem Phys, Moscow, Russia.	kristian.donner@helsinki.fi	Belikov, Nikolay/N-1094-2016; Khodonov, Andrey/GRY-5426-2022; Khodonov, Andrey/AAA-8046-2019; Demina, Olga Victorovna/H-1993-2019	Belikov, Nikolay/0000-0001-9566-7227; Khodonov, Andrey/0000-0001-9123-8011; Khodonov, Andrey/0000-0001-9123-8011; Demina, Olga/0000-0001-8776-9987; Donner, Kristian/0000-0001-7833-4236	Academy of Finland [10, 125666, 128081]; Russian Academy of Sciences; Program for Basic Studies of the Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research (RFBR) [12-04-31190]; Russian Federation [MK-6901.2013.4]	Academy of Finland(Academy of Finland); Russian Academy of Sciences(Russian Academy of Sciences); Program for Basic Studies of the Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation)	The work formed part of Joint Research Project no. 10 (Molecular and physiological mechanisms of spectral sensitivity tuning in the eyes of invertebrates (Crustacea: Mysidacea)) of the Academy of Finland and the Russian Academy of Sciences. It was also supported by Academy of Finland grants 125666 and 128081, the Program for Basic Studies of the Presidium of the Russian Academy of Sciences "Molecular mechanisms of physiological functions," as well as a Grant for young scientists from the Russian Foundation for Basic Research (RFBR, project No 12-04-31190), and a Grant of the President of the Russian Federation for Young Ph.D. Scientists (project No. MK-6901.2013.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; Audzijonyte A, 2005, CLADISTICS, V21, P575, DOI 10.1111/j.1096-0031.2005.00081.x; Audzijonyte A, 2005, J EXP MAR BIOL ECOL, V325, P228, DOI 10.1016/j.jembe.2005.05.007; Audzijonyte A, 2006, MOL ECOL, V15, P3287, DOI 10.1111/j.1365-294X.2006.02998.x; Audzijonyte A, 2012, MOL ECOL, V21, P2176, DOI 10.1111/j.1365-294X.2012.05516.x; Beatty DD, 1974, VISION FISHES NEW AP, P635; Boscarino BT, 2009, CAN J FISH AQUAT SCI, V66, P101, DOI 10.1139/F08-190; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; Eronen M, 2001, BOREAS, V30, P17, DOI 10.1080/030094801300062248; Fomin MA, 2009, Patent RU, Patent No. 2417983; Gal G, 1999, CAN J FISH AQUAT SCI, V56, P311, DOI 10.1139/cjfas-56-2-311; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1994, VISION RES, V34, P1359, DOI 10.1016/0042-6989(94)90134-1; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Hunt DM, 2001, J EXP BIOL, V204, P3333; Jokela-Maatta M, 2005, J COMP PHYSIOL A, V191, P1087, DOI 10.1007/s00359-005-0039-8; Jokela-Maatta M, 2007, VISUAL NEUROSCI, V24, P389, DOI 10.1017/S0952523807070459; LINDSTROM M, 1988, J EXP MAR BIOL ECOL, V120, P23, DOI 10.1016/0022-0981(88)90216-X; Lindstrom M, 2000, J EXP MAR BIOL ECOL, V246, P85, DOI 10.1016/S0022-0981(99)00178-1; LIU RSH, 1984, TETRAHEDRON, V40, P1931, DOI 10.1016/S0040-4020(01)88435-0; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; Pahlberg J, 2005, J COMP PHYSIOL A, V191, P837, DOI 10.1007/s00359-005-0005-5; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Parry JWL, 2005, CURR BIOL, V15, P1734, DOI 10.1016/j.cub.2005.08.010; Reuter T., 1969, Acta Zoologica Fennica, V122, P1; REUTER TE, 1971, J GEN PHYSIOL, V58, P351, DOI 10.1085/jgp.58.4.351; Saarinen P, 2012, J EXP BIOL, V215, P2760, DOI 10.1242/jeb.068122; Shand J, 2002, J EXP BIOL, V205, P3661; SHAND J, 1993, J COMP PHYSIOL A, V173, P115; Spady TC, 2006, MOL BIOL EVOL, V23, P1538, DOI 10.1093/molbev/msl014; SUZUKI T, 1984, VISION RES, V24, P783, DOI 10.1016/0042-6989(84)90149-4; SUZUKI T, 1987, EXPERIENTIA, V43, P1111, DOI 10.1007/BF01956053; SUZUKI T, 1985, ZOOL SCI, V2, P455; Temple SE, 2006, J COMP PHYSIOL A, V192, P301, DOI 10.1007/s00359-005-0068-3; VAINOLA R, 1994, CAN J FISH AQUAT SCI, V51, P1490, DOI 10.1139/f94-149; VONPLANTA C, 1962, HELV CHIM ACTA, V45, P548; WALD G, 1946, BIOL BULL, V91, P239; WHITMORE AV, 1989, J COMP PHYSIOL A, V166, P103; WILLIAMS TP, 1968, VISION RES, V8, P359, DOI 10.1016/0042-6989(68)90105-3; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110, DOI DOI 10.1007/BF01876686; Zak P P, 2013, Dokl Biol Sci, V449, P68, DOI 10.1134/S0012496613020026	51	3	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88107	10.1371/journal.pone.0088107	http://dx.doi.org/10.1371/journal.pone.0088107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516590	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400031
J	Liang, BQ; Wu, TD; Sun, HJ; Vali, H; Guerquin-Kern, JL; Wang, CH; Bosak, T				Liang, Biqing; Wu, Ting-Di; Sun, Hao-Jhe; Vali, Hojatollah; Guerquin-Kern, Jean-Luc; Wang, Chung-Ho; Bosak, Tanja			Cyanophycin Mediates the Accumulation and Storage of Fixed Carbon in Non-Heterocystous Filamentous Cyanobacteria from Coniform Mats	PLOS ONE			English	Article							GRANULE POLYPEPTIDE; OXYGENIC PHOTOSYNTHESIS; ANABAENA-CYLINDRICA; ASPARTIC-ACID; DIVERSITY; FIXATION; PURIFICATION; DEGRADATION; COMPONENTS; CULTURES	Thin, filamentous, non-heterocystous, benthic cyanobacteria (Subsection III) from some marine, lacustrine and thermal environments aggregate into macroscopic cones and conical stromatolites. We investigate the uptake and storage of inorganic carbon by cone-forming cyanobacteria from Yellowstone National Park using high-resolution stable isotope mapping of labeled carbon ((HCO3-)-C-13) and immunoassays. Observations and incubation experiments in actively photosynthesizing enrichment cultures and field samples reveal the presence of abundant cyanophycin granules in the active growth layer of cones. These ultrastructurally heterogeneous granules rapidly accumulate newly fixed carbon and store 18% of the total particulate labeled carbon after 120 mins of incubation. The intracellular distribution of labeled carbon during the incubation experiment demonstrates an unexpectedly large contribution of PEP carboxylase to carbon fixation, and a large flow of carbon and nitrogen toward cyanophycin in thin filamentous, non-heterocystous cyanobacteria. This pattern does not occur in obvious response to a changing N or C status. Instead, it may suggest an unusual interplay between the regulation of carbon concentration mechanisms and accumulation of photorespiratory products that facilitates uptake of inorganic C and reduces photorespiration in the dense, surface-attached communities of cyanobacteria from Subsection III.	[Liang, Biqing; Wang, Chung-Ho] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan; [Liang, Biqing; Bosak, Tanja] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Liang, Biqing] Natl Cheng Kung Univ, Dept Earth Sci, Tainan 701, Taiwan; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Univ Paris 11, INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France; [Sun, Hao-Jhe] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan; [Vali, Hojatollah] McGill Univ, Facil Elect Microscopy Res, Montreal, PQ, Canada; [Vali, Hojatollah] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	Academia Sinica - Taiwan; Massachusetts Institute of Technology (MIT); National Cheng Kung University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Central University; McGill University; McGill University	Liang, BQ (corresponding author), Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan.	liangbq@mail.ncku.edu.tw; tbosak@mit.edu	Guerquin-Kern, Jean-Luc/M-5000-2018; Liang, Biqing/J-2799-2012	Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; Liang, Biqing/0000-0002-8502-2019; WU, Ting-Di/0000-0002-6398-0363	Academia Sinica; National Science Council of Taiwan ROC [NSC 102-2116-M-006-018-MY2, NSC 101-2116-M-001-007]; Solomon Buchsbaum fund (MIT); National Science and Engineering	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan ROC(Ministry of Science and Technology, Taiwan); Solomon Buchsbaum fund (MIT); National Science and Engineering	BL acknowledged a distinguished postdoctoral scholar award from Academia Sinica. BL and CHW acknowledged the National Science Council of Taiwan ROC (NSC 102-2116-M-006-018-MY2; NSC 101-2116-M-001-007). TB thanked the Solomon Buchsbaum fund (MIT). HV acknowledged the financial support by National Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MM, 1984, ANNU REV MICROBIOL, V38, P1, DOI 10.1146/annurev.mi.38.100184.000245; ALLEN MM, 1980, J BACTERIOL, V141, P687, DOI 10.1128/JB.141.2.687-693.1980; ALLEN MM, 1983, J BACTERIOL, V154, P1480, DOI 10.1128/JB.154.3.1480-1484.1983; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Benson D, 2003, HSI RAT METH; Bosak T, 2012, GEOBIOLOGY, V10, P384, DOI 10.1111/j.1472-4669.2012.00334.x; Bosak T, 2010, GEOBIOLOGY, V8, P45, DOI 10.1111/j.1472-4669.2009.00227.x; Bosak T, 2009, P NATL ACAD SCI USA, V106, P10939, DOI 10.1073/pnas.0900885106; Cannon GC, 2002, FUNCT PLANT BIOL, V29, P175, DOI 10.1071/PP01200; Castenholz RW, 2001, BERGEYS MANUAL SYSTE, P473, DOI DOI 10.1007/978-0-387-21609-6_27; Castenholz RW, 1988, METHOD ENZYMOL, P68; Congestri R, 2003, ARCH HYDROBIOL ALGOL, V109, P185, DOI [DOI 10.1127/1864-1318/2003/0109-0185, 10.1127/1864-1318/2003/0109-0185]; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Hackenberg C, 2012, MICROBIOL-SGM, V158, P398, DOI 10.1099/mic.0.054544-0; Hanson D, 2002, FUNCT PLANT BIOL, V29, P407, DOI 10.1071/PP01210; Huege J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016278; Jahnke LL, 2004, GEOBIOLOGY, V2, P31, DOI 10.1111/j.1472-4677.2004.00021.x; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; KELLY GJ, 1977, PLANT PHYSIOL, V60, P295, DOI 10.1104/pp.60.2.295; Kruskopf M, 2006, HYDROBIOLOGIA, V556, P357, DOI 10.1007/s10750-005-1061-0; Li H, 2001, ARCH MICROBIOL, V176, P9, DOI 10.1007/s002030100281; Loiacono ST, 2012, ENVIRON MICROBIOL, V14, P1272, DOI 10.1111/j.1462-2920.2012.02710.x; MACKERRAS AH, 1990, J GEN MICROBIOL, V136, P2057, DOI 10.1099/00221287-136-10-2057; Maheswaran M, 2006, J BACTERIOL, V188, P2730, DOI 10.1128/JB.188.7.2730-2734.2006; NORMAN EG, 1991, PLANT PHYSIOL, V95, P693, DOI 10.1104/pp.95.3.693; Obst Martin, 2006, V1, P167, DOI 10.1007/7171_007; PAERL HW, 1991, APPL ENVIRON MICROB, V57, P3086, DOI 10.1128/AEM.57.11.3086-3092.1991; Petroff AP, 2011, J THEOR BIOL, V289, P90, DOI 10.1016/j.jtbi.2011.08.004; Petroff AP, 2010, P NATL ACAD SCI USA, V107, P9956, DOI 10.1073/pnas.1001973107; Poczatek C., 2009, OPENMIMS IMAGEJ PLUG; Portis AR, 2007, PHOTOSYNTH RES, V94, P121, DOI 10.1007/s11120-007-9225-6; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Rasband W., 2006, IMAGEJ; Sim MS, 2012, GEOSCIENCES, V2, P235, DOI 10.3390/geosciences2040235; SIMON RD, 1973, J BACTERIOL, V114, P1213, DOI 10.1128/JB.114.3.1213-1216.1973; SIMON RD, 1971, P NATL ACAD SCI USA, V68, P265, DOI 10.1073/pnas.68.2.265; SIMON RD, 1976, BIOCHIM BIOPHYS ACTA, V420, P165, DOI 10.1016/0005-2795(76)90355-X; Walter MR, 1976, MICROBIOLOGY MORPHOG, P273; WEATHERS PJ, 1978, ARCH MICROBIOL, V116, P231, DOI 10.1007/BF00417844	40	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88142	10.1371/journal.pone.0088142	http://dx.doi.org/10.1371/journal.pone.0088142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516596	Green Published, gold			2022-12-27	WOS:000330834400035
J	Umene-Nakano, W; Yoshimura, R; Kakeda, S; Watanabe, K; Hayashi, K; Nishimura, J; Takahashi, H; Moriya, J; Ide, S; Ueda, I; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Atake, K; Abe, O; Korogi, Y; Nakamura, J				Umene-Nakano, Wakako; Yoshimura, Reiji; Kakeda, Shingo; Watanabe, Keita; Hayashi, Kenji; Nishimura, Joji; Takahashi, Hidehiko; Moriya, Junji; Ide, Satoru; Ueda, Issei; Hori, Hikaru; Ikenouchi-Sugita, Atsuko; Katsuki, Asuka; Atake, Kiyokazu; Abe, Osamu; Korogi, Yukunori; Nakamura, Jun			Abnormal White Matter Integrity in the Corpus Callosum among Smokers: Tract-Based Spatial Statistics	PLOS ONE			English	Article							DEPENDENT SUBJECTS; CIGARETTE-SMOKING; DIFFUSION; BRAIN; MRI; DEMYELINATION; TOPOGRAPHY; NICOTINE	In the present study, we aimed to investigate the difference in white matter between smokers and nonsmokers. In addition, we examined relationships between white matter integrity and nicotine dependence parameters in smoking subjects. Nineteen male smokers were enrolled in this study. Eighteen age-matched non-smokers with no current or past psychiatric history were included as controls. Diffusion tensor imaging scans were performed, and the analysis was conducted using a tract-based special statistics approach. Compared with nonsmokers, smokers exhibited a significant decrease in fractional anisotropy (FA) throughout the whole corpus callosum. There were no significant differences in radial diffusivity or axial diffusivity between the two groups. There was a significant negative correlation between FA in the whole corpus callosum and the amount of tobacco use (cigarettes/day; R = -0.580, p = 0.023). These results suggest that the corpus callosum may be one of the key areas influenced by chronic smoking.	[Umene-Nakano, Wakako; Yoshimura, Reiji; Hayashi, Kenji; Hori, Hikaru; Ikenouchi-Sugita, Atsuko; Katsuki, Asuka; Atake, Kiyokazu; Nakamura, Jun] Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan; [Kakeda, Shingo; Watanabe, Keita; Nishimura, Joji; Moriya, Junji; Ide, Satoru; Ueda, Issei; Korogi, Yukunori] Univ Occupat & Environm Hlth, Dept Radiol, Kitakyushu, Fukuoka 807, Japan; [Takahashi, Hidehiko] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Abe, Osamu] Nihon Univ, Sch Med, Dept Radiol, Tokyo, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; Kyoto University; Nihon University	Umene-Nakano, W (corresponding author), Univ Occupat & Environm Hlth, Dept Psychiat, Kitakyushu, Fukuoka 807, Japan.	wakako-u@med.uoeh-u.ac.jp	Hori, Hikaru/AFG-2767-2022; Ide, Satoru/AAJ-6850-2021; Hori, Hikaru/S-9838-2019	Takahashi, Hidehiko/0000-0002-5102-1982; Abe, Osamu/0000-0002-1180-2629; Watanabe, Keita/0000-0001-9592-8802	Dainippon Sumitomo Pharma Co. Ltd.; Otsuka Pharmaceutical Co. Ltd	Dainippon Sumitomo Pharma Co. Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Otsuka Pharmaceutical Co. Ltd(Otsuka Pharmaceutical)	Professor Jun Nakamura has received grant support from Dainippon Sumitomo Pharma Co. Ltd. and Otsuka Pharmaceutical Co. Ltd in 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2004, J COMPUT ASSIST TOMO, V28, P533, DOI 10.1097/00004728-200407000-00016; Arnone D, 2006, NEUROPSYCHOBIOLOGY, V54, P107, DOI 10.1159/000096992; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Azizian Allen, 2009, Handb Exp Pharmacol, P113, DOI 10.1007/978-3-540-69248-5_5; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Benowitz NL, 2008, CLIN PHARMACOL THER, V83, P531, DOI 10.1038/clpt.2008.3; Bora E, 2012, ADDICT BIOL, V17, P141, DOI 10.1111/j.1369-1600.2010.00266.x; Brody AL, 2004, BIOL PSYCHIAT, V55, P77, DOI 10.1016/S0006-3223(03)00610-3; De Bellis MD, 2008, ALCOHOL CLIN EXP RES, V32, P395, DOI 10.1111/j.1530-0277.2007.00603.x; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Gallinat J, 2006, EUR J NEUROSCI, V24, P1744, DOI 10.1111/j.1460-9568.2006.05050.x; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hiro H, 1996, Nihon Arukoru Yakubutsu Igakkai Zasshi, V31, P437; Hudkins M, 2012, PSYCHOPHARMACOLOGY, V221, P285, DOI 10.1007/s00213-011-2621-9; Jacobsen LK, 2007, J NEUROSCI, V27, P13491, DOI 10.1523/JNEUROSCI.2402-07.2007; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kamagata K, 2013, EUR RADIOL, V23, P1946, DOI 10.1007/s00330-013-2775-4; Kawakami N, 1999, ADDICT BEHAV, V24, P155, DOI 10.1016/S0306-4603(98)00127-0; Kuhn S, 2010, BIOL PSYCHIAT, V68, P1061, DOI 10.1016/j.biopsych.2010.08.004; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lin FC, 2013, DRUG ALCOHOL DEPEN, V129, P82, DOI 10.1016/j.drugalcdep.2012.09.013; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Moeller FG, 2007, AM J DRUG ALCOHOL AB, V33, P777, DOI 10.1080/00952990701651564; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S., 2004, MRI ATLAS HUMAN WHIT; Paul RH, 2008, NICOTINE TOB RES, V10, P137, DOI 10.1080/14622200701767829; Qiu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063212; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salo R, 2009, BIOL PSYCHIAT, V65, P122, DOI 10.1016/j.biopsych.2008.08.004; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029; Zhang XC, 2011, NEUROIMAGE, V54, P42, DOI 10.1016/j.neuroimage.2010.08.008; Zhang XC, 2010, BIOL PSYCHIAT, V68, P674, DOI 10.1016/j.biopsych.2010.06.018	44	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87890	10.1371/journal.pone.0087890	http://dx.doi.org/10.1371/journal.pone.0087890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516568	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400022
J	Inoue, K; Maeda, N; Mori, T; Sekimoto, R; Tsushima, Y; Matsuda, K; Yamaoka, M; Suganami, T; Nishizawa, H; Ogawa, Y; Funahashi, T; Shimomura, I				Inoue, Kana; Maeda, Norikazu; Mori, Takuya; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Suganami, Takayoshi; Nishizawa, Hitoshi; Ogawa, Yoshihiro; Funahashi, Tohru; Shimomura, Iichiro			Possible Involvement of Opa-Interacting Protein 5 in Adipose Proliferation and Obesity	PLOS ONE			English	Article							FAT-CELL TURNOVER; ADIPOCYTE DIFFERENTIATION; METABOLIC SYNDROME; GENE-EXPRESSION; WHITE FAT; IN-VIVO; TISSUE; BROWN; OIP5; HUMANS	Obesity is an epidemic matter increasing risk for cardiovascular diseases and metabolic disorders such as type 2 diabetes. We recently examined the association between visceral fat adiposity and gene expression profile of peripheral blood cells in human subjects. In a series of studies, Opa (Neisseria gonorrhoeae opacity-associated)-interacting protein 5 (OIP5) was nominated as a molecule of unknown function in adipocytes and thus the present study was performed to investigate the role of OIP5 in obesity. Adenovirus overexpressing Oip5 (Ad-Oip5) was generated and infected to 3T3-L1 cells stably expressing Coxsackie-Adenovirus Receptor (CAR-3T3-L1) and to mouse subcutaneous fat. For a knockdown experiment, siRNA against Oip5 (Oip5-siRNA) was introduced into 3T3-L1 cells. Proliferation of adipose cells was measured by BrdU uptake, EdU-staining, and cell count. Significant increase of Oip5 mRNA level was observed in obese white adipose tissues and such increase was detected in both mature adipocytes fraction and stromal vascular cell fraction. Ad-Oip5-infected CAR-3T3-L1 preadipocytes and adipocytes proliferated rapidly, while a significant reduction of proliferation was observed in Oip5-siRNA-introduced 3T3-L1 preadipocytes. Fat weight and number of adipocytes were significantly increased in Ad-Oip5-administered fat tissues. Oip5 promotes proliferation of pre- and mature-adipocytes and contributes adipose hyperplasia. Increase of Oip5 may associate with development of obesity.	[Inoue, Kana; Maeda, Norikazu; Mori, Takuya; Sekimoto, Ryohei; Tsushima, Yu; Matsuda, Keisuke; Yamaoka, Masaya; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Suita, Osaka, Japan	Osaka University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka University	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp	SUGANAMI, Takayoshi/A-9475-2016	Ogawa, Yoshihiro/0000-0002-0834-2836	Takeda Science Foundation;  [22590979];  [24390238];  [22126008]	Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; 	This work was supported in part by a Grants-in-Aid for Scientific Research (C) no. 22590979 (to N.M.), a Grants-in-Aid for Scientific Research (B) no. 24390238 (to I. S.), a Grants-in-Aid for Scientific Research on Innovative Areas no. 22126008 (to T. F.), and Takeda Science Foundation (to N.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Chun HK, 2010, BMB REP, V43, P349, DOI 10.5483/BMBRep.2010.43.5.349; COUSIN B, 1992, J CELL SCI, V103, P931; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Fukui Y, 2000, DIABETES, V49, P759, DOI 10.2337/diabetes.49.5.759; Gong M, 2013, ACTA HISTOC IN PRESS; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hosono T, 2005, GENE, V348, P157, DOI 10.1016/j.gene.2005.01.005; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Koinuma J, 2012, CANCER SCI, V103, P577, DOI 10.1111/j.1349-7006.2011.02167.x; Maeda K, 1997, GENE, V190, P227, DOI 10.1016/S0378-1119(96)00730-5; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Naaz A, 2004, FASEB J, V18, P1925, DOI 10.1096/fj.04-2631fje; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nagayama M, 2007, J LIPID RES, V48, P9, DOI 10.1194/jlr.M600155-JLR200; Nakamura Y, 2007, ANN SURG ONCOL, V14, P885, DOI 10.1245/s10434-006-9121-x; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakai T, 2007, J BIOL CHEM, V282, P2038, DOI 10.1074/jbc.M608144200; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Williams JM, 1998, MOL MICROBIOL, V27, P171, DOI 10.1046/j.1365-2958.1998.00670.x; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; Yamaoka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047377; Yazarloo F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0368-8; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	35	10	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87661	10.1371/journal.pone.0087661	http://dx.doi.org/10.1371/journal.pone.0087661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516558	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700026
J	Almeida, D; Merino-Aguirre, R; Vilizzi, L; Copp, GH				Almeida, David; Merino-Aguirre, Raquel; Vilizzi, Lorenzo; Copp, Gordon H.			Interspecific Aggressive Behaviour of Invasive Pumpkinseed Lepomis gibbosus in Iberian Fresh Waters	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; PERCH PERCA-FLUVIATILIS; INTRODUCED PUMPKINSEED; MICROPTERUS-SALMOIDES; LARGEMOUTH BASS; COMPETITIVE INTERACTIONS; CURRENT KNOWLEDGE; NONNATIVE FISHES; BROWN TROUT; HABITAT USE	Pumpkinseed Lepomis gibbosus (L.) are successful invaders in Europe, where this species exerts multiple ecological effects, mainly through trophic interactions. Behavioural interference represents a potential impact for native fauna and this is of particular conservation concern in the Iberian Peninsula because of the highly valuable endemic fauna inhabiting streams of this region. However, aggressive interactions have not previously been examined under natural conditions in Iberian fresh waters. To address this gap in knowledge, the aim of the present study was to assess the effect of pumpkinseed aggression on endemic fauna of an Iberian stream, the River Bullaque (central Spain). In September 2009, we analysed the aggression and environmental contexts of these behavioural interactions by snorkelling: aggressor size, aggression type, shoal size, previous activity to aggression, recipient species, response to aggression, microhabitat structure and prey availability. Small pumpkinseed displayed more threat and fewer pursuit behaviours relative to medium and large individuals, reflecting an ontogenetic behavioural shift from low to high aggression intensity. Small aggressors came from large shoals, with bottom feeding being the most frequently observed activity prior to an aggressive interaction; whereas large pumpkinseed were less gregarious and they were mostly ambulating within the water column prior to aggression. Recipient species of aggression included non-native crayfish and fishes, and more importantly, endemic fishes and frogs. Retreat was the most common response to aggression, irrespective of aggressor size. Small pumpkinseed displayed aggressive behaviours over coarse substrata containing elevated macrobenthos biomass; whereas aggression by large individuals was observed in deeper waters. These findings suggest that small and large pumpkinseed exert a high impact on other stream residents through aggression in competition for food and territory defence, respectively. This study highlights the usefulness of direct observations in the wild for assessing the effects of behavioural interference of invasive fishes on Iberian aquatic communities.	[Almeida, David; Copp, Gordon H.] Cefas, Salmon & Freshwater Team, Lowestoft, Suffolk, England; [Almeida, David; Copp, Gordon H.] Bournemouth Univ, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Merino-Aguirre, Raquel] Univ Complutense Madrid, Dept Ecol, Madrid, Spain; [Vilizzi, Lorenzo] Ichth Oz Environm Sci Res, Irymple, Vic, Australia; [Copp, Gordon H.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada	Centre for Environment Fisheries & Aquaculture Science; Bournemouth University; Complutense University of Madrid; Trent University	Almeida, D (corresponding author), Cefas, Salmon & Freshwater Team, Lowestoft, Suffolk, England.	dalmeida@bournemouth.ac.uk	Vilizzi, Lorenzo/C-6263-2012	Vilizzi, Lorenzo/0000-0001-8103-885X	JCMM-FSE through the University of Castilla-La Mancha [PO 2007-13]	JCMM-FSE through the University of Castilla-La Mancha	D. Almeida held a post-doctoral fellowship from JCMM-FSE 2009/2011 (PO 2007-13) through the University of Castilla-La Mancha. The participation of G. H. Copp was made possible through the support of the U. K. Department of Environment, Food & Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 2008, OECOLOGIA, V155, P205, DOI 10.1007/s00442-007-0899-4; Almeida D, 2009, ECOL FRESHW FISH, V18, P15, DOI 10.1111/j.1600-0633.2008.00317.x; Almeida D, 2012, CAN J ZOOL, V90, P1051, DOI [10.1139/Z2012-073, 10.1139/z2012-073]; Almeida D, 2012, FISHERIES MANAG ECOL, V19, P157, DOI 10.1111/j.1365-2400.2012.00847.x; Almeida D., 2008, THESIS COMPLUTENSE U; Almeida D, 2013, LIMNOLOGICA, V43, P34, DOI 10.1016/j.limno.2012.02.003; Almeida D, 2012, ANIM BEHAV, V84, P1475, DOI 10.1016/j.anbehav.2012.09.020; Almeida D, 2012, FISH RES, V113, P153, DOI 10.1016/j.fishres.2011.11.002; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Angeler DG, 2002, AQUAT SCI, V64, P76, DOI 10.1007/s00027-002-8056-y; [Anonymous], BIOL INVADERS INLAND; Bramard M, 2006, B FR PECHE PISCIC, P857, DOI 10.1051/kmae:2006027; Caiola N, 2005, J APPL ICHTHYOL, V21, P358, DOI 10.1111/j.1439-0426.2005.00684.x; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Copp GH, 2002, ARCH HYDROBIOL, V155, P585; Copp GH, 2010, AM FISH S S, V73, P347; Copp Gordon H., 2007, V2, P289; Cucherousset J, 2009, BIOL INVASIONS, V11, P2171, DOI 10.1007/s10530-009-9493-5; Declerck S, 2002, J FISH BIOL, V61, P1182, DOI 10.1111/j.1095-8649.2002.tb02464.x; Ferreira T, 2007, FISHERIES MANAG ECOL, V14, P473, DOI 10.1111/j.1365-2400.2007.00584.x; Fobert E, 2011, J FISH BIOL, V79, P1592, DOI 10.1111/j.1095-8649.2011.03083.x; Fobert E, 2013, ECOL FRESHW FISH, V22, P106, DOI 10.1111/eff.12008; Garcia-Berthou E, 2000, J FISH BIOL, V57, P29, DOI 10.1111/j.1095-8649.2000.tb00773.x; Godinho FN, 1997, ENVIRON BIOL FISH, V50, P105, DOI 10.1023/A:1007302718072; Godinho FN, 1998, FOLIA ZOOL, V47, P205; Godinho Francisco Nunes, 2000, Biological Invasions, V2, P231, DOI 10.1023/A:1010022123669; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; HARVEY BC, 1991, OECOLOGIA, V87, P336, DOI 10.1007/BF00634588; Hazelton PD, 2009, ECOL FRESHW FISH, V18, P427, DOI 10.1111/j.1600-0633.2009.00359.x; Hoare DJ, 2000, J FISH BIOL, V57, P1351, DOI 10.1006/jfbi.2000.1446; Hsu Y., 2011, FISH COGNITION BEHAV, P108, DOI [10.1002/9781444342536.ch6, DOI 10.1002/9781444342536.CH6]; Huntingford F.A., 1986, P47; Ilheu Maria, 2007, V2, P543; Keller K, 2008, J FISH BIOL, V73, P1714, DOI 10.1111/j.1095-8649.2008.02045.x; Klaar M, 2004, FOLIA ZOOL, V53, P189; Leunda PM, 2010, AQUAT INVASIONS, V5, P239, DOI 10.3391/ai.2010.5.3.03; LILEY NR, 1983, FISH PHYSIOL, V9, P1; Marchetti MP, 2004, FRESHWATER BIOL, V49, P646, DOI 10.1111/j.1365-2427.2004.01202.x; Martinez-Capel F, 2009, FISHERIES MANAG ECOL, V16, P52, DOI 10.1111/j.1365-2400.2008.00645.x; MILLER HELEN CARTER, 1963, BEHAVIOUR, V22, P88, DOI 10.1163/156853963X00329; Naspleda J, 2012, J FISH BIOL, V81, P1915, DOI 10.1111/j.1095-8649.2012.03416.x; O'Neal Jennifer S., 2007, P325; Pitcher T. J, 1993, BEHAV TELEOST FISHES; Platts WS, 1983, US DEP AGR FOREST SE, V138, P1; Polo-Cavia N, 2010, ANIM BEHAV, V80, P461, DOI 10.1016/j.anbehav.2010.06.004; Reyjol Y, 2007, GLOBAL ECOL BIOGEOGR, V16, P65, DOI 10.1111/j.1466-8238.2006.00264.x; Rezsu E, 2006, ECOL FRESHW FISH, V15, P339, DOI 10.1111/j.1600-0633.2006.00172.x; Ribeiro F, 2012, FISHERIES MANAG ECOL, V19, P142, DOI 10.1111/j.1365-2400.2011.00842.x; Rincon PA, 2002, J FISH BIOL, V61, P1560, DOI 10.1006/jfbi.2002.2175; Roule L, 1931, POISSONS MONDE VIVAN, VIV; Sakakura Y, 1996, J FISH BIOL, V48, P16, DOI 10.1111/j.1095-8649.1996.tb01415.x; Smith K. G., 2006, STATUS DISTRIBUTION; Stakenas S, 2013, ECOL FRESHW FISH, V22, P202, DOI 10.1111/eff.12015; STATZNER B, 1988, J N AM BENTHOL SOC, V7, P307, DOI 10.2307/1467296; van Kleef H, 2008, BIOL INVASIONS, V10, P1481, DOI 10.1007/s10530-008-9220-7; Vilizzi L, 2012, FUND APPL LIMNOL, V180, P69, DOI 10.1127/1863-9135/2012/0277; Villeneuve F, 2005, J APPL ICHTHYOL, V21, P275, DOI 10.1111/j.1439-0426.2005.00679.x	58	29	30	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88038	10.1371/journal.pone.0088038	http://dx.doi.org/10.1371/journal.pone.0088038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505367	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200102
J	Ezinne, CC; Yoshimitsu, M; White, Y; Arima, N				Ezinne, Chibueze Chioma; Yoshimitsu, Makoto; White, Yohann; Arima, Naomichi			HTLV-1 Specific CD8+T Cell Function Augmented by Blockade of 2B4/CD48 Interaction in HTLV-1 Infection	PLOS ONE			English	Article							CD8(+) T-CELLS; EXPRESSION; TAX; EXHAUSTION; CD48; LYMPHOCYTES; RESPONSES; DISEASE; CD244; RISK	CD8+ T cell response is important in the response to viral infections; this response though is regulated by inhibitory receptors. Expression of inhibitory receptors has been positively correlated with CD8+ T cell exhaustion; the consequent effect of simultaneous blockade of these inhibitory receptors on CD8+ T cell response in viral infections have been studied, however, the role of individual blockade of receptor-ligand pair is unclear. 2B4/CD48 interaction is involved in CD8+ T cell regulation, its signal transducer SAP (signaling lymphocyte activation molecule (SLAM)-associated protein) is required for stimulatory function of 2B4/CD244 on lymphocytes hence, we analyzed 2B4/CD244 (natural killer cell receptor) and SAP (signaling lymphocyte activation molecule(SLAM)-associated protein) on total CD8+ and HTLV-1 specific CD8+ T cells in HTLV-1 infection and the effect of blockade of interaction with ligand CD48 on HTLV-1 specific CD8+ T cell function. We observed a high expression of 2B4/CD244 on CD8+ T cells relative to uninfected and further upregulation on HTLV-1 specific CD8+ T cells. 2B4+ CD8+ T cells exhibited more of an effector and terminally differentiated memory phenotype. Blockade of 2B4/CD48 interaction resulted in improvement in function via perforin expression and degranulation as measured by CD107a surface mobilization on HTLV-1 specific CD8+ T cells. In the light of these findings, we thus propose an inhibitory role for 2B4/CD48 interaction on CD8+ T cell function.	[Ezinne, Chibueze Chioma; Yoshimitsu, Makoto; Arima, Naomichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, Kagoshima 890, Japan; [Yoshimitsu, Makoto; Arima, Naomichi] Kagoshima Univ Hosp, Dept Hematol & Immunol, Kagoshima, Japan; [White, Yohann] Univ W Indies, Dept Med, Kingston 7, Jamaica	Kagoshima University; Kagoshima University; University West Indies Mona Jamaica	Yoshimitsu, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Div Hematol & Immunol, Kagoshima 890, Japan.	myoshimi@m.kufm.kagoshima-u.ac.jp	Yoshimitsu, Makoto/GYD-7021-2022; Chibueze, Chioma/C-9403-2016	Chibueze, Chioma/0000-0002-7881-7374	Kagoshima University, Japan	Kagoshima University, Japan	This project was supported by funds from Kagoshima University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arnulf B, 2004, LEUKEMIA, V18, P126, DOI 10.1038/sj.leu.2403176; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Boles NC, 2011, BLOOD, V118, P80, DOI 10.1182/blood-2010-12-322339; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Enose-Akahata Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000682; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Furukawa Y, 2006, INT J CANCER, V118, P381, DOI 10.1002/ijc.21328; Furukawa Y, 2000, J INFECT DIS, V182, P1343, DOI 10.1086/315897; Gonzalez-Cabrero J, 1999, P NATL ACAD SCI USA, V96, P1019, DOI 10.1073/pnas.96.3.1019; Harashima N, 2004, CANCER RES, V64, P391, DOI 10.1158/0008-5472.CAN-03-1452; Jeffery KJM, 1999, P NATL ACAD SCI USA, V96, P3848, DOI 10.1073/pnas.96.7.3848; Johnson-Nauroth JM, 2006, J NEUROIMMUNOL, V176, P115, DOI 10.1016/j.jneuroim.2006.03.013; Kattan T, 2009, J IMMUNOL, V182, P5723, DOI 10.4049/jimmunol.0900069; KLAMAN LD, 1995, J VIROL, V69, P871, DOI 10.1128/JVI.69.2.871-881.1995; Kozako T, 2008, LEUKEMIA, V23, P375; Kozako T, 2006, J IMMUNOL, V177, P5718, DOI 10.4049/jimmunol.177.8.5718; Munitz A, 2007, RECENT PATENTS INFLA, V1, P9, DOI 10.2174/187221307779815057; Nakajima H, 1999, EUR J IMMUNOL, V29, P1676, DOI 10.1002/(SICI)1521-4141(199905)29:05<1676::AID-IMMU1676>3.0.CO;2-Y; OSAME M, 1986, LANCET, V1, P1031; Parish IA, 2009, CURR OPIN IMMUNOL, V21, P291, DOI 10.1016/j.coi.2009.05.008; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rey J, 2006, EUR J IMMUNOL, V36, P2359, DOI 10.1002/eji.200635935; Rowan Aileen G, 2012, Leuk Res Treatment, V2012, P391953, DOI 10.1155/2012/391953; Sabouri AH, 2005, J GEN VIROL, V86, P773, DOI 10.1099/vir.0.80509-0; Sabouri AH, 2008, BLOOD, V112, P2411, DOI 10.1182/blood-2008-02-140335; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Tabata Y, 2005, BLOOD, V105, P3066, DOI 10.1182/blood-2004-09-3651; Takamori A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-100; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; UCHIYAMA T, 1988, BLOOD REV, V2, P232, DOI 10.1016/0268-960X(88)90012-4; Urbani S, 2008, J HEPATOL, V48, P548, DOI 10.1016/j.jhep.2007.12.014; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Waggoner SN, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00377; Ward J, 2007, BLOOD, V110, P1207, DOI 10.1182/blood-2006-06-028175; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Yoshimitsu M, 2014, RECENT RESULTS CANC, V193, P211, DOI 10.1007/978-3-642-38965-8_12; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	47	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87631	10.1371/journal.pone.0087631	http://dx.doi.org/10.1371/journal.pone.0087631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505299	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200058
J	Hum, S; Rymer, C; Schaefer, C; Bushnell, D; Sims-Lucas, S				Hum, Stephanie; Rymer, Christopher; Schaefer, Caitlin; Bushnell, Daniel; Sims-Lucas, Sunder			Ablation of the Renal Stroma Defines Its Critical Role in Nephron Progenitor and Vasculature Patterning	PLOS ONE			English	Article							KIDNEY; MESENCHYME; ORIGIN; CELLS	The renal stroma is an embryonic cell population located in the cortex that provides a structural framework as well as a source of endothelial progenitors for the developing kidney. The exact role of the renal stroma in normal kidney development hasn't been clearly defined. However, previous studies have shown that the genetic deletion of Foxd1, a renal stroma specific gene, leads to severe kidney malformations confirming the importance of stroma in normal kidney development. This study further investigates the role of renal stroma by ablating Foxd1-derived stroma cells themselves and observing the response of the remaining cell populations. A Foxd1cre (renal stroma specific) mouse was crossed with a diphtheria toxin mouse (DTA) to specifically induce apoptosis in stromal cells. Histological examination of kidneys at embryonic day 13.5-18.5 showed a lack of stromal tissue, mispatterning of renal structures, and dysplastic and/or fused horseshoe kidneys. Immunofluorescence staining of nephron progenitors, vasculature, ureteric epithelium, differentiated nephron progenitors, and vascular supportive cells revealed that mutants had thickened nephron progenitor caps, cortical regions devoid of nephron progenitors, aberrant vessel patterning and thickening, ureteric branching defects and migration of differentiated nephron structures into the medulla. The similarities between the renal deformities caused by Foxd1 genetic knockout and Foxd1DTA mouse models reveal the importance of Foxd1 in mediating and maintaining the functional integrity of the renal stroma.	[Hum, Stephanie; Rymer, Christopher; Schaefer, Caitlin; Bushnell, Daniel; Sims-Lucas, Sunder] Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA 15213 USA; [Hum, Stephanie; Rymer, Christopher; Schaefer, Caitlin; Bushnell, Daniel; Sims-Lucas, Sunder] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sims-Lucas, S (corresponding author), Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA 15213 USA.	simslucass@upmc.edu		Sims-Lucas, Sunder/0000-0003-1908-4809	NIDDK [DK096996]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096996] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Sunder Sims-Lucas is supported by a NIDDK MENTORED RESEARCH SCIENTIST DEVELOPMENT AWARD (K01) (DK096996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn D, 1999, PEDIATR NEPHROL, V13, P347, DOI 10.1007/s004670050624; Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hyink DP, 1996, AM J PHYSIOL-RENAL, V270, pF886, DOI 10.1152/ajprenal.1996.270.5.F886; Kanwar YS, 1997, KIDNEY INT, V52, P589, DOI 10.1038/ki.1997.372; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Lopez MLSS, 2011, J AM SOC NEPHROL, V22, P2156, DOI 10.1681/ASN.2011080818; Lopez MLSS, 2001, AM J PHYSIOL-RENAL, V281, pF345, DOI 10.1152/ajprenal.2001.281.2.F345; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Potter SS, 2010, ORGANOGENESIS, V6, P263, DOI 10.4161/org.6.4.12682; Sariola H, 2002, NEPHROL DIAL TRANSPL, V17, P88, DOI 10.1093/ndt/17.suppl_9.88; Saxen L., 1987, ORGANOGENESIS KIDNEY; Sims-Lucas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065993; Sims-Lucas S, 2012, J AM SOC NEPHROL, V23, P607, DOI 10.1681/ASN.2011020165; Sims-Lucas S, 2009, AM J PHYSIOL-RENAL, V297, pF1208, DOI 10.1152/ajprenal.00262.2009; Yallowitz AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023410; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	18	48	48	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88400	10.1371/journal.pone.0088400	http://dx.doi.org/10.1371/journal.pone.0088400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505489	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200189
J	Johnson, MD; Moriarty, VW; Carpenter, RC				Johnson, Maggie D.; Moriarty, Vincent W.; Carpenter, Robert C.			Acclimatization of the Crustose Coralline Alga Porolithon onkodes to Variable pCO(2)	PLOS ONE			English	Article							TIAHURA REEF MOOREA; SEA CO2 FLUXES; OCEAN ACIDIFICATION; CARBON-DIOXIDE; COMMUNITY METABOLISM; CONCENTRATING MECHANISMS; CALCIFYING RHODOPHYTE; HYDROLITHON-ONKODES; CLIMATE-CHANGE; CALCIFICATION	Ocean acidification (OA) has important implications for the persistence of coral reef ecosystems, due to potentially negative effects on biomineralization. Many coral reefs are dynamic with respect to carbonate chemistry, and experience fluctuations in pCO(2) that exceed OA projections for the near future. To understand the influence of dynamic pCO(2) on an important reef calcifier, we tested the response of the crustose coralline alga Porolithon onkodes to oscillating pCO(2). Individuals were exposed to ambient (400 mu atm), high (660 mu atm), or variable pCO(2) (oscillating between 400/660 mu atm) treatments for 14 days. To explore the potential for coralline acclimatization, we collected individuals from low and high pCO(2) variability sites (upstream and downstream respectively) on a back reef characterized by unidirectional water flow in Moorea, French Polynesia. We quantified the effects of treatment on algal calcification by measuring the change in buoyant weight, and on algal metabolism by conducting sealed incubations to measure rates of photosynthesis and respiration. Net photosynthesis was higher in the ambient treatment than the variable treatment, regardless of habitat origin, and there was no effect on respiration or gross photosynthesis. Exposure to high pCO(2) decreased P. onkodes calcification by >70%, regardless of the original habitat. In the variable treatment, corallines from the high variability habitat calcified 42% more than corallines from the low variability habitat. The significance of the original habitat for the coralline calcification response to variable, high pCO(2) indicates that individuals existing in dynamic pCO(2) habitats may be acclimatized to OA within the scope of in situ variability. These results highlight the importance of accounting for natural pCO(2) variability in OA manipulations, and provide insight into the potential for plasticity in habitat and species-specific responses to changing ocean chemistry.	[Johnson, Maggie D.; Moriarty, Vincent W.; Carpenter, Robert C.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA	California State University System; California State University Northridge	Johnson, MD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	mdjohnson@ucsd.edu	Johnson, Maggie D/C-6469-2013	Johnson, Maggie D/0000-0002-1319-2545	National Science Foundation [OCE-0417412, OCE-10-26852, OCE-1041270]; Directorate For Geosciences [1236905] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by grants from the National Science Foundation (OCE-0417412, OCE-10-26852, OCE-1041270) and gifts from the Gordon and Betty Moore Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY WH, 1973, GEOL SOC AM BULL, V84, P883, DOI 10.1130/0016-7606(1973)84<883:CCAARI>2.0.CO;2; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Adey WH, 1982, SMITHSON CONTR MAR S, V15, P1; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Andersson AJ, 2012, BIOGEOSCIENCES, V9, P893, DOI 10.5194/bg-9-893-2012; Andersson AJ, 2009, BIOGEOSCIENCES, V6, P1811, DOI 10.5194/bg-6-1811-2009; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; BARNES DJ, 1983, J EXP MAR BIOL ECOL, V66, P149, DOI 10.1016/0022-0981(83)90036-9; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; Bensoussan N, 2007, MAR ECOL PROG SER, V334, P37, DOI 10.3354/meps334037; Borowitzka M. A., 1977, OCEANOGR MAR BIOL AN, V15, P189; BOROWITZKA MA, 1981, MAR BIOL, V62, P17, DOI 10.1007/BF00396947; Boucher G, 1998, J EXP MAR BIOL ECOL, V225, P269, DOI 10.1016/S0022-0981(97)00227-X; CAMOIN GF, 1994, SEDIMENTOLOGY, V41, P655, DOI 10.1111/j.1365-3091.1994.tb01416.x; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Comeau S, DIEL PCO2 OSCILLATIO; Crook ED, 2012, CORAL REEFS, V31, P239, DOI 10.1007/s00338-011-0839-y; DAVIES PS, 1989, MAR BIOL, V101, P389; Diaz-Pulido G, 2012, J PHYCOL, V48, P32, DOI 10.1111/j.1529-8817.2011.01084.x; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dickson AG, 2007, PISCES SPECIAL PUBLI; Doropoulos C, 2013, MAR ECOL PROG SER, V475, P93, DOI 10.3354/meps10096; Doropoulos C, 2012, ECOL LETT, V15, P338, DOI 10.1111/j.1461-0248.2012.01743.x; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; Edmunds PJ, 2011, LIMNOL OCEANOGR, V56, P2402, DOI 10.4319/lo.2011.56.6.2402; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Form AU, 2012, GLOBAL CHANGE BIOL, V18, P843, DOI 10.1111/j.1365-2486.2011.02583.x; FRANKIGNOULLE M, 1994, LIMNOL OCEANOGR, V39, P458, DOI 10.4319/lo.1994.39.2.0458; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; Gagliano M, 2010, MAR BIOL, V157, P1849, DOI 10.1007/s00227-010-1456-y; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; Gattuso JP, 1997, J PHYCOL, V33, P729, DOI 10.1111/j.0022-3646.1997.00729.x; GATTUSO JP, 1993, MAR ECOL PROG SER, V96, P259, DOI 10.3354/meps096259; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gowan J, 2011, THESIS CALIFORNIA ST; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hench JL, 2008, LIMNOL OCEANOGR, V53, P2681, DOI 10.4319/lo.2008.53.6.2681; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Hofmann LC, 2013, J EXP BOT, V64, P899, DOI 10.1093/jxb/ers369; Hofmann LC, 2012, MAR BIOL, V159, P783, DOI 10.1007/s00227-011-1854-9; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kato A, 2011, J PHYCOL, V47, P662, DOI 10.1111/j.1529-8817.2011.00996.x; Kerrison P, 2011, ESTUAR COAST SHELF S, V94, P129, DOI 10.1016/j.ecss.2011.05.025; KINSEY DW, 1978, LIMNOL OCEANOGR, V23, P989, DOI 10.4319/lo.1978.23.5.0989; Kleypas J. A., 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 2001, INT J EARTH SCI, V90, P426, DOI 10.1007/s005310000125; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; LECAMPIONALSUMARD T, 1993, MAR BIOL, V115, P685, DOI 10.1007/BF00349377; LITTLER M M, 1971, Journal of Experimental Marine Biology and Ecology, V6, P91, DOI 10.1016/0022-0981(71)90052-9; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Martin S, 2013, ECOL EVOL, V3, P676, DOI 10.1002/ece3.475; Martin S, 2009, GLOBAL CHANGE BIOL, V15, P2089, DOI 10.1111/j.1365-2486.2009.01874.x; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Nash MC, 2011, BIOGEOSCIENCES, V8, P3331, DOI 10.5194/bg-8-3331-2011; O'Leary JK, 2012, CORAL REEFS, V31, P547, DOI 10.1007/s00338-012-0872-5; Ohde S, 1999, B MAR SCI, V65, P559; Payri C. E., 2000, ALGUES POLYNESIE FRA; PAYRI CE, 1987, BOT MAR, V30, P141, DOI 10.1515/botm.1987.30.2.141; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Price N, 2010, OECOLOGIA, V163, P747, DOI 10.1007/s00442-010-1578-4; Price NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043843; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAVEN JA, 1970, BIOL REV, V45, P167, DOI 10.1111/j.1469-185X.1970.tb01629.x; Raven JA, 2011, PHOTOSYNTH RES, V109, P281, DOI 10.1007/s11120-011-9632-6; Ries JB, 2011, GEOCHIM COSMOCHIM AC, V75, P4053, DOI 10.1016/j.gca.2011.04.025; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SCHMALZ RF, 1969, J SEDIMENT PETROL, V39, P255; Seidel MP, 2008, MAR CHEM, V109, P18, DOI 10.1016/j.marchem.2007.11.013; Semesi IS, 2009, ESTUAR COAST SHELF S, V84, P337, DOI 10.1016/j.ecss.2009.03.038; Shaw EC, 2012, J GEOPHYS RES, V117; SMITH SV, 1973, LIMNOL OCEANOGR, V18, P106, DOI 10.4319/lo.1973.18.1.0106; SUZUKI A, 1995, SEDIMENT GEOL, V99, P259, DOI 10.1016/0037-0738(95)00048-D; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Tribollet A, 2001, OCEANOL ACTA, V24, P329, DOI 10.1016/S0399-1784(01)01150-1; WARE JR, 1992, CORAL REEFS, V11, P127, DOI 10.1007/BF00255465; Watanabe A, 2006, LIMNOL OCEANOGR, V51, P1614, DOI 10.4319/lo.2006.51.4.1614; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; Yates KK, 2006, BIOGEOSCIENCES, V3, P357, DOI 10.5194/bg-3-357-2006	97	57	57	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87678	10.1371/journal.pone.0087678	http://dx.doi.org/10.1371/journal.pone.0087678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505305	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200064
J	Mishchenko, Y				Mishchenko, Yuriy			Oscillations in Rational Economies	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; COMPLEXITY; PRINCIPLE; TRAGEDY; MARKETS	Economic ( business) cycles are some of the most noted features of market economies, also ranked among the most serious of economic problems. Despite long historical persistence, the nature and the origin of business cycles remain controversial. In this paper we investigate the problem of the nature of business cycles from the positions of the market systems viewed as complex systems of many interacting market agents. We show that the development of cyclic instabilities in these settings can be traced down to just two fundamental factors - the competition of market agents for market shares in the settings of an open market, and the depression of market caused by accumulation of durable overproduced commodities on the market. These findings present the problem of business cycles in a new light as a systemic property of efficient market systems emerging directly from the free market competition itself, and existing in market economies at a very fundamental level.	Toros Univ, Mersin, Turkey	Toros University	Mishchenko, Y (corresponding author), Toros Univ, Mersin, Turkey.	yuriy.mishchenko@gmail.com			Bilim Akademisi - The Science Academy, Turkey; BAP Scientific Research Projects Fund of Toros University	Bilim Akademisi - The Science Academy, Turkey; BAP Scientific Research Projects Fund of Toros University(Toros University)	This work had been supported by Bilim Akademisi - The Science Academy, Turkey, under the BAGEP program, and by BAP Scientific Research Projects Fund of Toros University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1951, WHAT HAPPENS BUSINES; Beaudreau BC, 2004, MASS PRODUCTION STOC; Bierman HS, 1998, GAME THEORY EC APPL; Borland L, 2012, QUANT FINANC, V12, P1367, DOI 10.1080/14697688.2011.653388; Burns AF, 1946, MEASURING BUSINESS C; Challet D., 2004, MINORITY GAMES INTER; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Eckstein O, 1990, AM BUSINESS CYCLE CO, P39; Faysse N, 2005, J ECON SURV, V19, P239, DOI 10.1111/j.0950-0804.2005.00246.x; Feigenbaum JA, 1996, INT J MOD PHYS B, V10, P3737, DOI 10.1142/S021797929600204X; Fisher I, 1933, ECONOMETRICA, V1, P337, DOI 10.2307/1907327; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gai P, 2011, J MONETARY ECON, V58, P453, DOI 10.1016/j.jmoneco.2011.05.005; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; George Henry, 1879, PROGR POVERTY INQUIR; Goodwin RM, 1967, SOCIALISM CAPITALISM, P367; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Grossman Henryk., 1992, LAW ACCUMULATION BRE; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Kenett DY, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/38001; Kenett DY, 2011, PLOS ONE, V7; Kitchin J, 1923, REV ECON STATISTICS, V5, P10, DOI 10.2307/1927031; KYDLAND FE, 1982, ECONOMETRICA, V50, P1345, DOI 10.2307/1913386; Lee M.W., 1955, EC FLUCTUATIONS ANAL; LONG JB, 1983, J POLIT ECON, V91, P39, DOI 10.1086/261128; LUCAS RE, 1977, CARN ROCH CONF SERIE, V5, P7, DOI 10.1016/0167-2231(77)90002-1; LUX T, 1995, ECON J, V105, P881, DOI 10.2307/2235156; Lux T., 2000, INT J THEORETICAL AP, V3, P675, DOI DOI 10.1142/S0219024900000826; Mankiw N. G, 2012, MACROECONOMICS; Markose SM, 2005, ECON J, V115, pF159, DOI 10.1111/j.1468-0297.2005.01000.x; Mattick P., 1969, MARX KEYNES LIMITS M; McConnel C, 2008, ECONOMICS; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; NORDHAUS WD, 1989, BROOKINGS PAP ECO AC, P1; NORDHAUS WD, 1975, REV ECON STUD, V42, P169, DOI 10.2307/2296528; Ostrom E, 1999, ANNU REV POLIT SCI, V2, P493, DOI 10.1146/annurev.polisci.2.1.493; Ostrom E., 2002, DRAMA COMMONS; Plerou V, 2000, PHYSICA A, V279, P443, DOI 10.1016/S0378-4371(00)00010-8; PLOSSER CI, 1989, J ECON PERSPECT, V3, P51, DOI 10.1257/jep.3.3.51; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Samuelson PA, 1939, REV ECON STATISTICS, V21, P75, DOI 10.2307/1927758; Samuelson PA, 1939, J POLIT ECON, V47, P786, DOI 10.1086/255469; Schumpeter, 2006, HIST EC ANAL; Schweitzer F., 2002, MODELING COMPLEXITY; Shapira Y, 2011, AIP ADV, V1, DOI 10.1063/1.3598412; Sornette D, 2009, WHY STOCK MARKETS CR; Tesfatsion L, 2003, INFORM SCIENCES, V149, P263, DOI 10.1016/S0020-0255(02)00280-3; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Westerhoff FH, 2004, PHYSICA A, V343, P635, DOI 10.1016/j.physa.2004.06.059	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87820	10.1371/journal.pone.0087820	http://dx.doi.org/10.1371/journal.pone.0087820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505319	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200075
J	Ren, WK; Yin, J; Wu, MM; Liu, G; Yang, G; Xion, Y; Su, DD; Wu, L; Li, TJ; Chen, S; Duan, JL; Yin, YL; Wu, GY				Ren, Wenkai; Yin, Jie; Wu, Miaomiao; Liu, Gang; Yang, Guan; Xion, Yan; Su, Dingding; Wu, Li; Li, Tiejun; Chen, Shuai; Duan, Jielin; Yin, Yulong; Wu, Guoyao			Serum Amino Acids Profile and the Beneficial Effects of L-Arginine or L-Glutamine Supplementation in Dextran Sulfate Sodium Colitis	PLOS ONE			English	Article							DIETARY SUPPLEMENTATION; EXPRESSION; MICE; TRANSCRIPTION; ANTIOXIDANT; THERAPY; PIGLETS	This study was conducted to investigate serum amino acids profile in dextran sulfate sodium (DSS)-induced colitis, and impacts of graded dose of arginine or glutamine supplementation on the colitis. Using DSS-induced colitis model, which is similar to human ulcerative colitis, we determined serum profile of amino acids at day 3, 7, 10 and 12 (5 days post DSS treatment). Meanwhile, effects of graded dose of arginine (0.4%, 0.8%, and 1.5%) or glutamine (0.5%, 1.0% and 2.0%) supplementation on clinical parameters, serum amino acids, colonic tight junction proteins, colonic anti-oxidative indicators [catalase, total superoxide dismutase (T-SOD), glutathione peroxidase (GSH-Px)], colonic pro-inflammatory cytokines [interleukin-1 beta (IL-1 beta), IL-6, IL-17 and tumor necrosis factor alpha (TNF-alpha)] in DSS-induced colitis were fully analyzed at day 7 and 12. Additionally, the activation of signal transduction pathways, including nuclear factor kappa B (NF-kappa B), mitogen-activated protein kinases (MAPK), phosphoinositide-3-kinases (PI3K)/PI3K-protein kinase B (Akt), and myosin light chain kinase (MLCK)-myosin light chain (MLC20), were analyzed using immunoblotting. Serum amino acids analysis showed that DSS treatment changed the serum contents of amino acids, such as Trp, Glu, and Gln (P < 0.05). Dietary arginine or glutamine supplementation had significant (P < 0.05) influence on the clinical and biochemical parameters (T-SOD, IL-17 and TNF-a) in colitis model. These results were associated with colonic NF-kappa B, PI3K-Akt and MLCK signaling pathways. In conclusion, arginine or glutamine could be a potential therapy for intestinal inflammatory diseases.	[Ren, Wenkai; Yin, Jie; Wu, Miaomiao; Liu, Gang; Wu, Li; Li, Tiejun; Chen, Shuai; Duan, Jielin; Yin, Yulong; Wu, Guoyao] Chinese Acad Sci, Hlth Livestock Key Lab Agroecol Proc Subtrop Reg, Hunan Prov Engn Res Ctr, Minist Agr,Inst Subtrop Agr,Sci Observing & Expt, Changsha, Hunan, Peoples R China; [Yang, Guan] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Xion, Yan] Northwest A&F Univ, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling, Peoples R China; [Su, Dingding] Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Ministry of Agriculture & Rural Affairs; Washington State University; Texas A&M University System; Texas A&M University College Station; Northwest A&F University - China	Liu, G (corresponding author), Chinese Acad Sci, Hlth Livestock Key Lab Agroecol Proc Subtrop Reg, Hunan Prov Engn Res Ctr, Minist Agr,Inst Subtrop Agr,Sci Observing & Expt, Changsha, Hunan, Peoples R China.	liugang@isa.ac.cn; tjli@isa.ac.cn; yinyulong@isa.ac.cn	CHEN, Shuai/O-1255-2018; Liu, Gang/G-5283-2017; YIN, Jie/H-3578-2019	CHEN, Shuai/0000-0002-9337-6191; Liu, Gang/0000-0002-9475-5134; YIN, Jie/0000-0003-1852-1042; YANG, Guan/0000-0002-2131-8435	National Basic Research Program of China [2013CB127301, 2012CB124704]; National Natural Science Foundation of China [31110103909, 30901040, 31272463, 30928018, 31101729]; National Scientific and Technology Support Project [2011BAD26B002-5]; Strategical scientific and technological research projects of emerging industries in Hunan Province [2011GK4061]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Scientific and Technology Support Project; Strategical scientific and technological research projects of emerging industries in Hunan Province	This study was in part supported by the National Basic Research Program of China (2013CB127301, 2012CB124704), National Natural Science Foundation of China (No. 31110103909,30901040, 31272463, 30928018, and 31101729), National Scientific and Technology Support Project (2011BAD26B002-5), and Strategical scientific and technological research projects of emerging industries in Hunan Province (2011GK4061, to T.J. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achitei D, 2013, DIGEST DIS SCI, V58, P1244, DOI 10.1007/s10620-012-2510-z; Bergstrom Anders, 2012, BMC Res Notes, V5, P402, DOI 10.1186/1756-0500-5-402; Borrelli F, 2013, BIOCHEM PHARMACOL, V85, P1306, DOI 10.1016/j.bcp.2013.01.017; Chiou YS, 2012, J AGR FOOD CHEM, V60, P3441, DOI 10.1021/jf300441p; Cho EJ, 2011, J ETHNOPHARMACOL, V136, P428, DOI 10.1016/j.jep.2010.04.047; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Chu CC, 2012, J NUTR BIOCHEM, V23, P1092, DOI 10.1016/j.jnutbio.2011.06.002; Coburn LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033546; Coeffier M, 2010, INFLAMM BOWEL DIS, V16, P518, DOI 10.1002/ibd.21017; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Froicu M, 2006, IMMUNOLOGY, V117, P310, DOI 10.1111/j.1365-2567.2005.02290.x; He QH, 2011, J PROTEOME RES, V10, P5214, DOI 10.1021/pr200688u; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; Hou YC, 2012, EUR J NUTR; Hou YC, 2013, INT IMMUNOPHARMACOL, V17, P1, DOI 10.1016/j.intimp.2013.05.004; Kannan N, 2013, INT IMMUNOPHARMACOL, V16, P57, DOI 10.1016/j.intimp.2013.03.008; Kawabata K, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/820415; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Lagranha CJ, 2007, CELL BIOCHEM FUNCT, V25, P563, DOI 10.1002/cbf.1421; Lechowski S, 2012, EUR J NUTR; Lechowski S, 2013, EUR J NUTR, V52, P505, DOI 10.1007/s00394-012-0353-1; Mueller Kristin, 2013, ISRN Gastroenterol, V2013, P710856, DOI 10.1155/2013/710856; Ren W, 2011, AMINO ACIDS; Ren WK, 2013, EUR J INFLAMM, V11, P315, DOI 10.1177/1721727X1301100201; Ren WK, 2013, AMINO ACIDS, V45, P947, DOI 10.1007/s00726-013-1551-8; Ren WK, 2012, J FOOD AGRIC ENVIRON, V10, P485; Ren WK, 2012, AMINO ACIDS, V42, P2089, DOI 10.1007/s00726-011-0942-y; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Verlinden L, 2012, J STEROID BIOCHEM; Viennois Emilie, 2013, BMC Res Notes, V6, P360, DOI 10.1186/1756-0500-6-360; Xiao YP, 2012, J ANIM SCI, V90, P4421, DOI 10.2527/jas.2012-5039; Xiao YP, 2012, J ZHEJIANG UNIV-SC B, V13, P567, DOI 10.1631/jzus.B1100343; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yang HS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050921, 10.1371/journal.pone.0029051]; Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013	38	126	136	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88335	10.1371/journal.pone.0088335	http://dx.doi.org/10.1371/journal.pone.0088335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505477	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200178
J	Sauvant, J; Delpech, JC; Palin, K; De Mota, N; Dudit, J; Aubert, A; Orcel, H; Roux, P; Laye, S; Moos, F; Llorens-Cortes, C; Nadjar, A				Sauvant, Julie; Delpech, Jean-Christophe; Palin, Karine; De Mota, Nadia; Dudit, Jennifer; Aubert, Agnes; Orcel, Helene; Roux, Pascale; Laye, Sophie; Moos, Francoise; Llorens-Cortes, Catherine; Nadjar, Agnes			Mechanisms Involved in Dual Vasopressin/Apelin Neuron Dysfunction during Aging	PLOS ONE			English	Article							RAT SUPRAOPTIC NUCLEUS; AGE-RELATED-CHANGES; PARAVENTRICULAR NUCLEUS; PROINFLAMMATORY CYTOKINES; AQUAPORIN RESPONSES; WATER-DEPRIVATION; OXYTOCIN NEURONS; UP-REGULATION; DEHYDRATION; ACTIVATION	Normal aging is associated with vasopressin neuron adaptation, but little is known about its effects on the release of apelin, an aquaretic peptide colocalized with vasopressin. We found that plasma vasopressin concentrations were higher and plasma apelin concentrations lower in aged rats than in younger adults. The response of AVP/apelin neurons to osmotic challenge was impaired in aged rats. The overactivity of vasopressin neurons was sustained partly by the increased expression of Transient receptor potential vanilloid2 (Trpv2), because central Trpv blocker injection reversed the age-induced increase in plasma vasopressin concentration without modifying plasma apelin concentration. The morphofunctional plasticity of the supraoptic nucleus neuron-astrocyte network normally observed during chronic dehydration in adults appeared to be impaired in aged rats as well. IL-6 overproduction by astrocytes and low-grade microglial neuroinflammation may contribute to the modification of neuronal functioning during aging. Indeed, central treatment with antibodies against IL-6 decreased plasma vasopressin levels and increased plasma apelin concentration toward the values observed in younger adults. Conversely, minocycline treatment (inhibiting microglial metabolism) did not affect plasma vasopressin concentration, but increased plasma apelin concentration toward control values for younger adults. This study is the first to demonstrate dual vasopressin/apelin adaptation mediated by inflammatory molecules and neuronal Trpv2, during aging.	[Sauvant, Julie; Delpech, Jean-Christophe; Palin, Karine; Dudit, Jennifer; Aubert, Agnes; Roux, Pascale; Laye, Sophie; Moos, Francoise; Nadjar, Agnes] INRA, UMR 1286, Bordeaux, France; [Sauvant, Julie; Delpech, Jean-Christophe; Palin, Karine; Dudit, Jennifer; Aubert, Agnes; Roux, Pascale; Laye, Sophie; Moos, Francoise; Nadjar, Agnes] Univ Bordeaux, UMR 1286, Bordeaux, France; [De Mota, Nadia; Llorens-Cortes, Catherine] Univ Paris 06, INSERM, Coll France, Ctr Interdisciplinary Res Biol,U1050, Paris, France; [Delpech, Jean-Christophe] CNRS, UMR 5203, Inst Genom Fonct, Montpellier, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Nadjar, A (corresponding author), INRA, UMR 1286, Bordeaux, France.	agnes.nadjar@u-bordeaux2.fr	SAUVANT, Julie/AAK-3263-2021; Laye, Sophie/AAX-2501-2020; Llorens-Cortès, catherine/AAL-3893-2021; Llorens-Cortes, Catherine/E-5839-2016	Laye, Sophie/0000-0002-3843-1012; Llorens-Cortès, catherine/0000-0002-7667-0401; Llorens-Cortes, Catherine/0000-0002-7667-0401; DE MOTA, Nadia/0000-0003-3754-3722; delpech, jean-christophe/0000-0003-2674-1598; NADJAR, Agnes/0000-0002-3969-6530	Fondation pour la Recherche Medicale [LLC20051005102]; Groupement d'interet Scientifique Institut National de la Sante et de la Recherche Medicale "Longevite et vieillissement'' [GISL0412]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Groupement d'interet Scientifique Institut National de la Sante et de la Recherche Medicale "Longevite et vieillissement''	This work was supported by the Fondation pour la Recherche Medicale (contract LLC20051005102) and by Groupement d'interet Scientifique Institut National de la Sante et de la Recherche Medicale "Longevite et vieillissement'' (contract no. GISL0412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2003, EUR J NEUROSCI, V18, P1889, DOI 10.1046/j.1460-9568.2003.02927.x; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; BERCIANO MT, 1995, ANAT RECORD, V243, P129, DOI 10.1002/ar.1092430115; BONFANTI L, 1993, J NEUROENDOCRINOL, V5, P1, DOI 10.1111/j.1365-2826.1993.tb00357.x; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Casolini P, 2002, J NEUROSCI RES, V68, P337, DOI 10.1002/jnr.10192; Castle SC, 2000, Z GERONTOL GERIATR, V33, P341, DOI 10.1007/s003910070030; Catudioc-Vallero J, 2000, J GERONTOL A-BIOL, V55, pB26; Chakfe Y, 2006, AM J PHYSIOL-REG I, V290, pR1183, DOI 10.1152/ajpregu.00716.2005; Ciosek J, 2002, J PHYSIOL PHARMACOL, V53, P423; Crawford DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008166; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; den Ouden DT, 2005, NETH J MED, V63, P4; Dyball REJ, 1988, PULSATILITY NEUROEND, P181; el Fazaa S, 2000, Tunis Med, V78, P132; FLIERS E, 1985, BRAIN RES, V342, P45, DOI 10.1016/0006-8993(85)91351-4; FLIERS E, 1983, PEPTIDES, V4, P165, DOI 10.1016/0196-9781(83)90108-0; GARCIASEGURA LM, 1994, PSYCHONEUROENDOCRINO, V19, P445, DOI 10.1016/0306-4530(94)90031-0; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Ghorbel MT, 2003, J BIOL CHEM, V278, P19280, DOI 10.1074/jbc.M209902200; Ginaldi L, 2001, MICROBES INFECT, V3, P851, DOI 10.1016/S1286-4579(01)01443-5; Gottlieb HB, 2006, AM J PHYSIOL-REG I, V290, pR1251, DOI 10.1152/ajpregu.00727.2005; Hawrylak N, 1998, GLIA, V22, P260, DOI 10.1002/(SICI)1098-1136(199803)22:3<260::AID-GLIA5>3.0.CO;2-9; Hawrylak N, 1999, NEUROSCI LETT, V277, P57, DOI 10.1016/S0304-3940(99)00864-2; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hensellek S, 2007, MOL CELL NEUROSCI, V36, P381, DOI 10.1016/j.mcn.2007.07.010; HOOGENDIJK JE, 1985, J NEUROL SCI, V69, P291, DOI 10.1016/0022-510X(85)90141-8; Hussy N, 2000, PROG NEUROBIOL, V62, P113, DOI 10.1016/S0301-0082(99)00071-4; Ishunina TA, 1999, J CLIN ENDOCR METAB, V84, P4637, DOI 10.1210/jc.84.12.4637; Jalenques I, 1997, HEARING RES, V107, P113, DOI 10.1016/S0378-5955(97)00026-9; Jequier E, 2010, EUR J CLIN NUTR, V64, P115, DOI 10.1038/ejcn.2009.111; Kaur M, 2008, BIOGERONTOLOGY, V9, P441, DOI 10.1007/s10522-008-9168-0; Konsman JP, 1999, NEUROSCIENCE, V89, P535, DOI 10.1016/S0306-4522(98)00368-6; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; LI ZH, 1992, NEUROREPORT, V3, P91, DOI 10.1097/00001756-199201000-00024; Llorens-Cortes C, 2008, PROG BRAIN RES, V170, P559, DOI 10.1016/S0079-6123(08)00443-3; LUCASSEN PJ, 1994, J NEUROENDOCRINOL, V6, P673, DOI 10.1111/j.1365-2826.1994.tb00634.x; LUCASSEN PJ, 1993, BRAIN RES, V632, P105, DOI 10.1016/0006-8993(93)91144-H; Ma X Y, 1995, Sheng Li Xue Bao, V47, P394; Miyata S, 2002, MICROSC RES TECHNIQ, V56, P143, DOI 10.1002/jemt.10012; Moreau ML, 2010, NEUROBIOL AGING, V31, P532, DOI 10.1016/j.neurobiolaging.2008.05.008; OGURA K, 1994, NEUROREPORT, V5, P1224, DOI 10.1097/00001756-199406020-00016; Oliet SHR, 2010, EUR J NEUROSCI, V32, P1989, DOI 10.1111/j.1460-9568.2010.07514.x; Palin K, 2009, NEUROBIOL AGING, V30, P1677, DOI 10.1016/j.neurobiolaging.2007.12.006; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Palin K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1289, DOI 10.1152/ajpendo.90489.2008; Panatier A, 2006, NEURON GLIA BIOL, V2, P51, DOI 10.1017/S1740925X06000019; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; PETERS A, 1991, ANAT REC, V229, P384, DOI 10.1002/ar.1092290311; PHILLIPS PA, 1984, NEW ENGL J MED, V311, P753, DOI 10.1056/NEJM198409203111202; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Robert Jessica, 2005, Journal de la Societe de Biologie, V199, P351, DOI 10.1051/jbio:2005037; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Salm AK, 1999, EXP NEUROL, V160, P425, DOI 10.1006/exnr.1999.7211; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schaible HG, 2010, ANN NY ACAD SCI, V1193, P60, DOI 10.1111/j.1749-6632.2009.05301.x; Sharif-Naeini R, 2008, KIDNEY INT, V73, P811, DOI 10.1038/sj.ki.5002788; Shimosato G, 2005, PAIN, V119, P225, DOI 10.1016/j.pain.2005.10.002; SLADEK CD, 1994, BRAIN RES, V652, P207, DOI 10.1016/0006-8993(94)90229-1; SLADEK CD, 1981, NEUROBIOL AGING, V2, P293, DOI 10.1016/0197-4580(81)90038-5; Stachenfeld NS, 1996, AM J PHYSIOL-REG I, V271, pR757, DOI 10.1152/ajpregu.1996.271.3.R757; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Straub RH, 2000, J NEUROIMMUNOL, V109, P10, DOI 10.1016/S0165-5728(00)00296-4; Sudbury JR, 2010, EUR J NEUROSCI, V32, P2022, DOI 10.1111/j.1460-9568.2010.07512.x; Swenson KL, 1997, AM J PHYSIOL-REG I, V273, pR35, DOI 10.1152/ajpregu.1997.273.1.R35; TERWEL D, 1992, MECH AGEING DEV, V65, P127, DOI 10.1016/0047-6374(92)90029-D; TERWEL D, 1992, ACTA ENDOCRINOL-COP, V126, P357, DOI 10.1530/acta.0.1260357; Theodosis DT, 2002, FRONT NEUROENDOCRIN, V23, P101, DOI 10.1006/frne.2001.0226; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wainwright A, 2004, J COMP NEUROL, V474, P24, DOI 10.1002/cne.20100; Yoshida T, 1996, NEUROSCI LETT, V215, P107, DOI 10.1016/0304-3940(96)12966-9; ZBUZEK VK, 1982, EXP GERONTOL, V17, P133, DOI 10.1016/0531-5565(82)90047-X	74	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87421	10.1371/journal.pone.0087421	http://dx.doi.org/10.1371/journal.pone.0087421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505289	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200048
J	Zhu, FY; Rypel, AL; Murphy, BR; Li, ZJ; Zhang, TL; Yuan, J; Guo, ZQ; Tang, JF; Liu, JS				Zhu, Fengyue; Rypel, Andrew L.; Murphy, Brian R.; Li, Zhongjie; Zhang, Tanglin; Yuan, Jing; Guo, Zhiqiang; Tang, Jianfeng; Liu, Jiashou			Rapid Life-History Diversification of an Introduced Fish Species across a Localized Thermal Gradient	PLOS ONE			English	Article							POPULATION-DYNAMIC CONSEQUENCES; GUPPIES POECILIA-RETICULATA; BODY-SIZE; MICROGEOGRAPHICAL VARIATION; TRADE-OFFS; LATITUDINAL VARIATION; REPRODUCTIVE-BIOLOGY; CLIMATE-CHANGE; GENETIC DRIFT; RANGE SHIFTS	Climatic variations are known to engender life-history diversification of species and populations at large spatial scales. However, the extent to which microgeographic variations in climate (e.g., those occurring within a single large ecosystem) can also drive life-history divergence is generally poorly documented. We exploited a spatial gradient in water temperatures at three sites across a large montane lake in southwest China (Lake Erhai) to examine the extent to which life histories of a short-lived fish species (icefish, Neosalanx taihuensis) diversified in response to thermal regime following introduction 25 y prior. In general, warmwater icefish variants grew faster, had larger adult body size and higher condition and fecundity, but matured at smaller sizes. Conversely, coldwater variants had smaller adult body size and lower condition, but matured at larger sizes and had larger eggs. These life-history differences strongly suggest that key ecological trade-offs exist for icefish populations exposed to different thermal regimes, and these trade-offs have driven relatively rapid diversification in the life histories of icefish within Lake Erhai. Results are surprisingly concordant with current knowledge on life-history evolution at macroecological scales, and suggest that improved conservation management might be possible by focusing on patterns operating at microgeographical, including, within-ecosystem scales.	[Zhu, Fengyue; Li, Zhongjie; Zhang, Tanglin; Yuan, Jing; Guo, Zhiqiang; Tang, Jianfeng; Liu, Jiashou] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Zhu, Fengyue; Guo, Zhiqiang; Tang, Jianfeng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Rypel, Andrew L.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Rypel, Andrew L.] Wisconsin Dept Nat Resources, Madison, WI USA; [Rypel, Andrew L.; Murphy, Brian R.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; Virginia Polytechnic Institute & State University	Liu, JS (corresponding author), Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China.	jsliu@ihb.ac.cn			project of the Special Fund for Agro-Scientific Research in the Public Interest of China [201303056]; National Natural Science Foundation of China [31172387]; National Science and Technology Supporting Program [2012BAD25B08]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07105-004]; Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology; Acorn Alcinda Foundation; Virginia Tech University, Department of Fish and Wildlife Conservation; University of Wisconsin, Center for Limnology; Wisconsin Department of Natural Resources	project of the Special Fund for Agro-Scientific Research in the Public Interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Supporting Program; Major Science and Technology Program for Water Pollution Control and Treatment of China; Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology; Acorn Alcinda Foundation; Virginia Tech University, Department of Fish and Wildlife Conservation; University of Wisconsin, Center for Limnology; Wisconsin Department of Natural Resources	The research was financially supported by the project of the Special Fund for Agro-Scientific Research in the Public Interest of China (201303056), the National Natural Science Foundation of China (No. 31172387), the National Science and Technology Supporting Program (No. 2012BAD25B08), the Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2012ZX07105-004) and the Fund of the State Key Laboratory of Freshwater Ecology and Biotechnology. B. R. Murphy and A. L. Rypel were supported by the Acorn Alcinda Foundation and the Virginia Tech University, Department of Fish and Wildlife Conservation. Additional support for AR was provided through the University of Wisconsin, Center for Limnology and the Wisconsin Department of Natural Resources. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1980, FISH B-NOAA, V78, P1; Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; ALLENDORF FW, 1980, T AM FISH SOC, V109, P537, DOI 10.1577/1548-8659(1980)109&lt;537:LOGVIA&gt;2.0.CO;2; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Angilletta MJ, 2004, AM NAT, V164, pE168, DOI 10.1086/425222; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Arendt JD, 2005, P ROY SOC B-BIOL SCI, V272, P333, DOI 10.1098/rspb.2004.2899; Arscott DB, 2001, CAN J FISH AQUAT SCI, V58, P2359, DOI 10.1139/cjfas-58-12-2359; BAUR B, 1988, BIOL J LINN SOC, V35, P247, DOI 10.1111/j.1095-8312.1988.tb00469.x; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; BERKE SK, 2012, GLOBAL ECOL BIOGEOGR, V22, P173, DOI DOI 10.1111/J.1466-8238.2012.00775.X; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Braaten PJ, 2002, T AM FISH SOC, V131, P931, DOI 10.1577/1548-8659(2002)131<0931:LHAOFA>2.0.CO;2; Bronikowski AM, 2002, ECOLOGY, V83, P2194, DOI 10.2307/3072051; Brown J. H., 1995, MACROECOLOGY; Charnov, 1993, LIFE HIST INVARIANTS; Chavarie L, 2010, HYDROBIOLOGIA, V650, P161, DOI 10.1007/s10750-009-0043-z; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen Y. R., 1998, BIODIVERS SCI, V06, P272, DOI DOI 10.1111/J.1752-1734.2007; Chown SL, 2003, ECOGRAPHY, V26, P445, DOI 10.1034/j.1600-0587.2003.03479.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Ciotti BJ, 2013, CAN J FISH AQUAT SCI, V70, P720, DOI 10.1139/cjfas-2012-0331; CLARK WG, 1991, CAN J FISH AQUAT SCI, V48, P734, DOI 10.1139/f91-088; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Colonello JC, 2011, J FISH BIOL, V78, P287, DOI 10.1111/j.1095-8649.2010.02864.x; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; COUTANT CC, 1985, T AM FISH SOC, V114, P31, DOI 10.1577/1548-8659(1985)114<31:SBTADO>2.0.CO;2; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; da Mata RA, 2010, BIOL INVASIONS, V12, P1231, DOI 10.1007/s10530-009-9542-0; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; DU B, 2001, RES ENV SCI, V14, P43; Fang X, 2012, T AM FISH SOC, V141, P1608, DOI 10.1080/00028487.2012.713888; FLEMING IA, 1990, ECOLOGY, V71, P1, DOI 10.2307/1940241; Freidenburg LK, 2004, ECOL LETT, V7, P369, DOI 10.1111/j.1461-0248.2004.00587.x; Gause G. F., 1934, STRUGGLE EXISTENCE; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gong WB, 2009, J FRESHWATER ECOL, V24, P529, DOI 10.1080/02705060.2009.9664329; Grift RE, 2003, MAR ECOL PROG SER, V257, P247, DOI 10.3354/meps257247; Guo ZQ, 2013, HYDROBIOLOGIA, V709, P89, DOI 10.1007/s10750-012-1439-8; Hamilton WJ, 2001, ECOL FRESHW FISH, V10, P105, DOI 10.1034/j.1600-0633.2001.100205.x; Heino M, 2008, B MAR SCI, V83, P69; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; HUTCHINSON GE, 1959, AM NAT, V93, P117, DOI 10.1086/282063; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jones G, 2002, BEHAV ECOL, V13, P375, DOI 10.1093/beheco/13.3.375; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; KORPELAINEN H, 1986, FRESHWATER BIOL, V16, P615, DOI 10.1111/j.1365-2427.1986.tb01004.x; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Liu J., 2009, SLEP SPARSE LEARNING; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; MACINTYRE S, 2013, CLIMATIC CH IN PRESS; MacNamara R, 2012, ICES J MAR SCI, V69, P1333, DOI 10.1093/icesjms/fss123; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Olsen EM, 2003, OIKOS, V100, P483, DOI 10.1034/j.1600-0706.2003.11900.x; Orizaola G, 2009, EVOL ECOL, V23, P979, DOI 10.1007/s10682-008-9285-x; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Passy SI, 2012, ECOL LETT, V15, P923, DOI 10.1111/j.1461-0248.2012.01809.x; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pincheira-Donoso D, 2010, THEOR BIOSCI, V129, P247, DOI 10.1007/s12064-010-0101-0; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; RAY CARLETON, 1960, JOUR MORPHOL, V106, P85, DOI 10.1002/jmor.1051060104; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick D, 2007, ANN ZOOL FENN, V44, P152; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; RYPEL AL, 2013, AM NATURALI IN PRESS; RYPEL AL, 2013, OIKOS IN PRESS; Rypel AL, 2012, ECOL FRESHW FISH, V21, P521, DOI 10.1111/j.1600-0633.2012.00570.x; Rypel AL, 2011, AM FISH S S, V77, P661; Rypel AL, 2012, ECOSYSTEMS, V15, P555, DOI 10.1007/s10021-012-9528-0; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Shuter B.J., 1992, Geojournal, V28, P7, DOI 10.1007/BF00216402; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2010, OIKOS, V119, P610, DOI 10.1111/j.1600-0706.2009.18039.x; Skelly DK, 2000, ECOL LETT, V3, P483, DOI 10.1046/j.1461-0248.2000.00186.x; SKELLY DK, 2001, EVOLUTIONARY RESPONS; Smith BB, 2004, J FISH BIOL, V64, P336, DOI 10.1111/j.0022-1112.2004.00293.x; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Soranno PA, 1999, ECOSYSTEMS, V2, P395, DOI 10.1007/s100219900089; Soranno PA, 1997, CAN J FISH AQUAT SCI, V54, P1883, DOI 10.1139/cjfas-54-8-1883; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Stillwell RC, 2005, ECOLOGY, V86, P924, DOI 10.1890/04-0547; TANG JF, 2013, J APPL ICHT IN PRESS; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walsh MR, 2008, P NATL ACAD SCI USA, V105, P594, DOI 10.1073/pnas.0710051105; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watt C, 2010, OIKOS, V119, P89, DOI 10.1111/j.1600-0706.2009.17959.x; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; YDENBERG RC, 1989, ECOLOGY, V70, P1494, DOI 10.2307/1938208; YU HT, 1995, BIOL J LINN SOC, V55, P69, DOI 10.1111/j.1095-8312.1995.tb01050.x; Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; ZHANG C, 2000, 9 ACPEU FISH RES IN; ZHU F, 2014, J APPL ICHT IN PRESS	113	7	7	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88033	10.1371/journal.pone.0088033	http://dx.doi.org/10.1371/journal.pone.0088033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505366	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300042
J	Chang, L; Pei, JR; Li, CL; Zhang, P; Zhou, D; Du, WZ; Liu, X; Jiang, CL				Chang, Liang; Pei, Junrui; Li, Chenlong; Zhang, Ping; Zhou, Dan; Du, Wenzhong; Liu, Xing; Jiang, Chuanlu			Incidence and Metastasis of Cutaneous Malignant Melanoma with Respect to ABO Blood Groups: A Case-Controlled Study in Northeast of China	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; GASTRIC-CANCER; PANCREATIC-CANCER; DISTINCT SUBTYPES; RISK; ASSOCIATION; POPULATION; CONSORTIUM; CARCINOMA; GENOTYPE	Background: ABO blood groups have been suggested to contribute to the development of certain tumors; however, the associations between ABO blood groups and the incidence and metastases of cutaneous malignant melanomas have not been fully evaluated in Chinese populations. Thus, we investigated these associations with a case-controlled study in northeast of China. Methods: A total of 482 patients with cutaneous malignant melanoma and 3,068 healthy-controls were enrolled for the study between 2001 and 2012 at The Tumor Hospital of Harbin Medical University. A multivariate logistic model was used to evaluate adjusted odds ratios (ORs) and 95% confidence intervals (CI) for the incidence and metastases of cutaneous malignant melanoma. Results: Blood type A individuals had higher tumor incidence and metastasis compared to those with blood type O (OR = 1.575; 95% CI = 1.208-2.053, p = 0.001; OR = 2.004; 95% CI = 1.032-3.889, p = 0.040), after adjusting for age, gender, smoking status and alcohol consumption. Conclusions: Blood type A was associated with higher incidence and metastasis of cutaneous malignant melanoma but future studies are needed to examine the mechanisms linking cutaneous malignant melanoma to ABO blood types.	[Chang, Liang; Zhou, Dan] Harbin Med Univ, Tumor Hosp, Dept Neurosurg, Harbin, Peoples R China; [Pei, Junrui] Harbin Med Univ, Chinese Ctr Endem Dis Control, Harbin, Peoples R China; [Pei, Junrui] Harbin Med Univ, Key Lab Etiol Epidemiol, Minist Hlth, Harbin, Peoples R China; [Li, Chenlong; Zhang, Ping; Du, Wenzhong; Liu, Xing; Jiang, Chuanlu] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Jiang, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China.	jcl_6688@163.com						AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; BECKMAN L, 1987, HUM HERED, V37, P140, DOI 10.1159/000153691; Ben QW, 2011, INT J CANCER, V128, P1179, DOI 10.1002/ijc.25426; de Lima VCC, 2013, CYTOKINE, V62, P217, DOI 10.1016/j.cyto.2013.02.022; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; de Giorgi V, 2011, EUR J CANCER PREV, V20, P121, DOI 10.1097/CEJ.0b013e3283429e1d; Gates MA, 2011, INT J CANCER, V128, P482, DOI 10.1002/ijc.25339; Greer JB, 2010, WORLD J GASTROENTERO, V16, P5588, DOI 10.3748/wjg.v16.i44.5588; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Jaff MS, 2010, INT J NANOMED, V5, P901, DOI 10.2147/IJN.S13980; Lee C, 2013, CLIN DERMATOL, V31, P141, DOI 10.1016/j.clindermatol.2012.08.015; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029928; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moan J, 2012, PHOTOCH PHOTOBIO SCI, V11, P191, DOI 10.1039/c1pp05215b; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Naldi L, 2005, CANCER CAUSE CONTROL, V16, P893, DOI 10.1007/s10552-005-2300-4; Pare G, 2008, PLOS GENET, V4; Poole EM, 2012, CANCER CAUSE CONTROL, V23, P1805, DOI 10.1007/s10552-012-0059-y; Rizzato C, 2013, ONCOL REP, V29, P1637, DOI 10.3892/or.2013.2285; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; Song HR, 2013, GASTRIC CANCER, V16, P254, DOI 10.1007/s10120-012-0176-z; Wang ZW, 2012, INT J MOL SCI, V13, P13308, DOI 10.3390/ijms131013308; Whiteman DC, 2011, PIGM CELL MELANOMA R, V24, P879, DOI 10.1111/j.1755-148X.2011.00880.x; Xie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011972; Yamada M, 2005, ARCH DERMATOL RES, V297, P256, DOI 10.1007/s00403-005-0605-5	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88096	10.1371/journal.pone.0088096	http://dx.doi.org/10.1371/journal.pone.0088096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516588	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400029
J	Moore, KS; Weissman, DH				Moore, Katherine Sledge; Weissman, Daniel H.			A Bottleneck Model of Set-Specific Capture	PLOS ONE			English	Article							ATTENTIONAL CONTROL SETTINGS; DUAL-TASK PERFORMANCE; PSYCHOLOGICAL REFRACTORY PERIOD; VISUAL WORKING-MEMORY; TOP-DOWN; CONTINGENT CAPTURE; TIME-COURSE; BLINK; SELECTION; BRAIN	Set-specific contingent attentional capture is a particularly strong form of capture that occurs when multiple attentional sets guide visual search (e. g., "search for green letters" and "search for orange letters"). In this type of capture, a potential target that matches one attentional set (e. g. a green stimulus) impairs the ability to identify a temporally proximal target that matches another attentional set (e. g. an orange stimulus). In the present study, we investigated whether set-specific capture stems from a bottleneck in working memory or from a depletion of limited resources that are distributed across multiple attentional sets. In each trial, participants searched a rapid serial visual presentation (RSVP) stream for up to three target letters (T1-T3) that could appear in any of three target colors (orange, green, or lavender). The most revealing findings came from trials in which T1 and T2 matched different attentional sets and were both identified. In these trials, T3 accuracy was lower when it did not match T1's set than when it did match, but only when participants failed to identify T2. These findings support a bottleneck model of set-specific capture in which a limited-capacity mechanism in working memory enhances only one attentional set at a time, rather than a resource model in which processing capacity is simultaneously distributed across multiple attentional sets.	[Moore, Katherine Sledge] Elmhurst Coll, Dept Psychol, Elmhurst, IL 60126 USA; [Weissman, Daniel H.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Moore, KS (corresponding author), Elmhurst Coll, Dept Psychol, Elmhurst, IL 60126 USA.	katherine.moore@elmhurst.edu	Moore, Katherine Sledge/B-8445-2009	Moore, Katherine Sledge/0000-0001-7982-1140	National Science Foundation; NIH [1R03DA021345-01]; University of Michigan's Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA021345] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Department of Psychology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by a National Science Foundation graduate fellowship (http://www.nsf.gov), a Rackham Graduate Research Award (http://www.rackham.umich.edu), and a Pillsbury award (http://www.lsa.umich.edu/psych) to KSM; by an NIH grant (1R03DA021345-01) (http://www.nih.gov) and start-up funds from the University of Michigan's Department of Psychology (http://www.lsa.umich.edu/psych) awarded to DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo M, 2008, COGNITION, V107, P295, DOI 10.1016/j.cognition.2007.07.003; Adamo M, 2010, COGN NEUROSCI-UK, V1, P102, DOI 10.1080/17588921003646149; Adamo M, 2010, ATTEN PERCEPT PSYCHO, V72, P1730, DOI 10.3758/APP.72.7.1730; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Ansorge U, 2003, J EXP PSYCHOL HUMAN, V29, P937, DOI 10.1037/0096-1523.29.5.937; Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Ariga A, 2008, PERCEPT PSYCHOPHYS, V70, P680, DOI 10.3758/PP.70.4.680; Beck VM, 2012, PSYCHOL SCI, V23, P887, DOI 10.1177/0956797612439068; Belopolsky AV, 2010, ATTEN PERCEPT PSYCHO, V72, P326, DOI 10.3758/APP.72.2.326; Berti S, 2008, NEUROSCI LETT, V434, P200, DOI 10.1016/j.neulet.2008.01.055; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; DZMURA M, 1991, VISION RES, V31, P951, DOI 10.1016/0042-6989(91)90203-H; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Folk CL, 2008, VIS COGN, V16, P616, DOI 10.1080/13506280601134018; Folk CL, 2008, VIS COGN, V16, P215, DOI 10.1080/13506280701458804; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Garavan H, 1998, MEM COGNITION, V26, P263, DOI 10.3758/BF03201138; Irons JL, 2012, J EXP PSYCHOL HUMAN, V38, P758, DOI 10.1037/a0026578; Jolicoeur P, 1998, MEM COGNITION, V26, P1014, DOI 10.3758/BF03201180; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Juola JF, 2004, PERCEPT PSYCHOPHYS, V66, P1303, DOI 10.3758/BF03195000; Leber AB, 2006, VIS COGN, V14, P565, DOI 10.1080/13506280500193438; Lleras A, 2009, J VISION, V9, DOI 10.1167/9.3.26; Maki WS, 2006, PSYCHON B REV, V13, P125, DOI 10.3758/BF03193823; Mayr U, 2000, J EXP PSYCHOL GEN, V129, P4, DOI 10.1037/0096-3445.129.1.4; McElree B, 2001, J EXP PSYCHOL LEARN, V27, P817, DOI 10.1037/0278-7393.27.3.817; MCLEOD P, 1977, ACTA PSYCHOL, V41, P381, DOI 10.1016/0001-6918(77)90016-6; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Moore KS, 2011, VIS COGN, V19, P417, DOI 10.1080/13506285.2011.558862; Moore KS, 2010, ATTEN PERCEPT PSYCHO, V72, P1495, DOI 10.3758/APP.72.6.1495; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Olivers CNL, 2008, FRONT BIOSCI-LANDMRK, V13, P1182, DOI 10.2741/2754; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Pashler H, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P277; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Rensink RA, 2000, VIS COGN, V7, P17, DOI 10.1080/135062800394667; Roper ZJJ, 2012, PSYCHON B REV, V19, P1114, DOI 10.3758/s13423-012-0297-8; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schumacher EH, 2001, PSYCHOL SCI, V12, P101, DOI 10.1111/1467-9280.00318; Spalek TM, 2006, PERCEPT PSYCHOPHYS, V68, P674, DOI 10.3758/BF03208767; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Tombu M, 2005, J EXP PSYCHOL HUMAN, V31, P790, DOI 10.1037/0096-1523.31.4.790; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Vergauwe E, 2009, J EXP PSYCHOL LEARN, V35, P1012, DOI 10.1037/a0015859; Visser TAW, 1999, PSYCHOL BULL, V125, P458, DOI 10.1037/0033-2909.125.4.458; Ward R, 1996, COGNITIVE PSYCHOL, V30, P79, DOI 10.1006/cogp.1996.0003; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; Wolfe JM, 2012, PSYCHOL SCI, V23, P698, DOI 10.1177/0956797612443968	53	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88313	10.1371/journal.pone.0088313	http://dx.doi.org/10.1371/journal.pone.0088313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516634	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400057
J	Drefahl, S; Ahlbom, A; Modig, K				Drefahl, Sven; Ahlbom, Anders; Modig, Karin			Losing Ground - Swedish Life Expectancy in a Comparative Perspective	PLOS ONE			English	Article							CANCER-MORTALITY; COUNTRIES; SWEDEN; POPULATIONS; EUROPE	Background: In the beginning of the 1970s, Sweden was the country where both women and men enjoyed the world's longest life expectancy. While life expectancy continues to be high and increasing, Sweden has been losing ground in relation to other leading countries. Methods: We look at life expectancy over the years 1970-2008 for men and women. To assess the relative contributions of age, causes of death, and smoking we decompose differences in life expectancy between Sweden and two leading countries, Japan and France. This study is the first to use this decomposition method to observe how smoking related deaths contribute to life expectancy differences between countries. Results: Sweden has maintained very low mortality at young and working ages for both men and women compared to France and Japan. However, mortality at ages above 65 has become considerably higher in Sweden than in the other leading countries because the decrease has been faster in those countries. Different trends for circulatory diseases were the largest contributor to this development in both sexes but for women also cancer played a role. Mortality from neoplasms has been considerably low for Swedish men. Smoking attributable mortality plays a modest role for women, whereas it is substantially lower in Swedish men than in French and Japanese men. Conclusions: Sweden is losing ground in relation to other leading countries with respect to life expectancy because mortality at high ages improves more slowly than in the leading countries, especially due to trends in cardiovascular disease mortality. Trends in smoking rates may provide a partial explanation for the trends in women; however, it is not possible to isolate one single explanatory factor for why Sweden is losing ground.	[Drefahl, Sven] Stockholm Univ, Demog Unit, Dept Sociol, S-10691 Stockholm, Sweden; [Drefahl, Sven; Ahlbom, Anders; Modig, Karin] Karolinska Inst, Div Epidemiol, Inst Environm Med, Stockholm, Sweden	Stockholm University; Karolinska Institutet	Drefahl, S (corresponding author), Stockholm Univ, Demog Unit, Dept Sociol, S-10691 Stockholm, Sweden.	sven.drefahl@sociology.su.se	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867; Drefahl, Sven/0000-0003-4533-7558	Swedish Research Council for Health, Working Life and Welfare (FORTE - the Swedish acronym); Swedish Research Council (Vetenskapsradet) via the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM) [839-2008-7495]	Swedish Research Council for Health, Working Life and Welfare (FORTE - the Swedish acronym); Swedish Research Council (Vetenskapsradet) via the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM)	This study was funded by the Swedish Research Council for Health, Working Life and Welfare (FORTE - the Swedish acronym). This work was also supported by the Swedish Research Council (Vetenskapsradet) via the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (SIMSAM), Register-based research in Nordic demography [grant number 839-2008-7495]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HUM MORT DAT; [Anonymous], WHO MORT DAT; Arriaga E. E., 1989, DIFFERENTIAL MORTALI, P105; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Drefahl S, 2012, J INTERN MED, V272, P100, DOI 10.1111/j.1365-2796.2012.02518.x; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Forey B, 2013, INT SMOKING STAT COM; Glei DA, 2007, POP STUD-J DEMOG, V61, P141, DOI 10.1080/00324720701331433; La Vecchia C, 2010, ANN ONCOL, V21, P1323, DOI 10.1093/annonc/mdp530; Modig K, 2013, INT J EPIDEMIOL, V42, P914, DOI 10.1093/ije/dyt035; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 2006, MORTALITY SMOKING DE; Preston S., 2000, DEMOGRAPHY MEASURING; Preston SH, 2010, INT J EPIDEMIOL, V39, P430, DOI 10.1093/ije/dyp360; Robine JM, 2003, POPUL DEV REV, V29, P208; Rodu B, 2009, SCAND J PUBLIC HEALT, V37, P481, DOI 10.1177/1403494809105797; Van Raalte A, 2012, POPULATION HLTH METR, V10; Vaupel JW, 2011, BMJ, V1	21	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88357	10.1371/journal.pone.0088357	http://dx.doi.org/10.1371/journal.pone.0088357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516639	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700062
J	Manning, L; Laman, M; Davis, WA; Davis, TME				Manning, Laurens; Laman, Moses; Davis, Wendy A.; Davis, Timothy M. E.			Clinical Features and Outcome in Children with Severe Plasmodium falciparum Malaria: A Meta-Analysis	PLOS ONE			English	Article							CHILDHOOD CEREBRAL MALARIA; LIFE-THREATENING MALARIA; SEVERE PEDIATRIC MALARIA; AFRICAN CHILDREN; INTRAVENOUS QUININE; INTRAMUSCULAR ARTEMETHER; MALAWIAN CHILDREN; NIGERIAN CHILDREN; INTENSIVE-CARE; BETA-ARTEETHER	Background: Although global malaria mortality is declining, estimates may not reflect better inpatient management of severe malaria (SM) where reported case fatality rates (CFRs) vary from 1-25%. Methods: A meta-analysis of prospective studies of SM was conducted to examine i) whether hypothesized differences between clinical features and outcome in Melanesian compared with African or Asian children really exist, and ii) to explore temporal changes in overall and complication-specific CFRs. The proportions of different SM complications and, overall and complication-specific CFRs were incorporated into the meta-analysis. Adjustments were made for study-level covariates including geographic region, SM definition, artemisinin treatment, median age of participants and time period. Findings: Sixty-five studies were included. Substantial heterogeneity (I-2>80%) was demonstrated for most outcomes. SM definition contributed to between-study heterogeneity in proportions of cerebral malaria (CM), metabolic acidosis (MA), severe anemia and overall CFR, whilst geographic region was a significant moderator in for CM and hypoglycemia (HG) rates. Compared with their African counterparts, Melanesian children had lower rates of HG (10% [CI95 7-13%] versus 1% [0-3%], P<0.05), lower overall CFR (2% [0-4%] versus 7% [6-9%], P<0.05) and lower CM-specific CFR (8% [0-17%] versus 19% [16-21%], P<0.05). There was no temporal trend for overall CFR and CM-specific CFR but declining HG- and MA-specific CFRs were observed. Interpretation: These data highlight that recent estimates of declining global malaria mortality are not replicated by improved outcomes for children hospitalized with SM. Significant geographic differences in the complication rates and subsequent CFRs exist and provide the first robust confirmation of lower CFRs in Melanesian children, perhaps due to less frequent HG.	[Manning, Laurens; Laman, Moses; Davis, Wendy A.; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia	University of Western Australia	Manning, L (corresponding author), Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia.	laurens.manning@uwa.edu.au	Davis, Timothy ME/M-5144-2014; Manning, Laurens A/H-5360-2014	Manning, Laurens A/0000-0003-4334-5351; Davis, Wendy/0000-0002-5709-8235; Davis, Timothy/0000-0003-0749-7411; Laman, Moses/0000-0003-0964-805X	National Health and Medical Research Council (NHMRC) [513782]; Basser scholarship from the Royal Australasian College of Physicians; NHMRC scholarship; Fogarty Foundation scholarship; NHMRC Practitioner Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Basser scholarship from the Royal Australasian College of Physicians; NHMRC scholarship(National Health and Medical Research Council (NHMRC) of Australia); Fogarty Foundation scholarship; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by a National Health and Medical Research Council (NHMRC) grant (#513782). LM was supported by a Basser scholarship from the Royal Australasian College of Physicians and an NHMRC scholarship, ML by a Fogarty Foundation scholarship, and TMED by an NHMRC Practitioner Fellowship. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceng JR, 2005, BMJ-BRIT MED J, V330, P334, DOI 10.1136/bmj.330.7487.334; Achan J, 2007, CLIN INFECT DIS, V45, P1446, DOI 10.1086/522972; Adam I, 2002, East Afr Med J, V79, P621; AKPEDE GO, 1993, J TROP MED HYG, V96, P146; Al-Taiar A, 2006, BMJ-BRIT MED J, V333, P827, DOI 10.1136/bmj.38959.368819.BE; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; Anberber S, 2003, ETHIOPIAN MED J, V41, P301; [Anonymous], 1990, Trans R Soc Trop Med Hyg, V84 Suppl 2, P1; [Anonymous], 1986, Trans R Soc Trop Med Hyg, V80 Suppl, P3; Assimadi JK, 2002, ARCH PEDIATRIE, V9, P587, DOI 10.1016/S0929-693X(01)00925-3; Barennes H, 1998, T ROY SOC TROP MED H, V92, P437, DOI 10.1016/S0035-9203(98)91083-5; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Bastien P, 1999, PARASITOL TODAY, V15, P167, DOI 10.1016/S0169-4758(99)01423-4; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; CARME B, 1993, AM J TROP MED HYG, V48, P216, DOI 10.4269/ajtmh.1993.48.216; Crawley J, 2000, LANCET, V355, P701, DOI 10.1016/S0140-6736(99)07148-2; DIPERRI G, 1995, J INFECT DIS, V171, P1317, DOI 10.1093/infdis/171.5.1317; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dzeing-Ella A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-1; Enwere G, 1998, ANN TROP PAEDIATR, V18, P275, DOI 10.1080/02724936.1998.11747959; Evans JA, 2006, J PEDIATR-US, V149, P676, DOI 10.1016/j.jpeds.2006.07.040; Faiz MA, 2005, LANCET, V366, P717; Gay-Andrieu F, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-10; Gbadoe AD, 2006, ARCH PEDIATRIE, V13, P1554, DOI 10.1016/j.arcped.2006.09.011; Genton B, 1997, INT J EPIDEMIOL, V26, P670, DOI 10.1093/ije/26.3.670; GENTON B, 1995, NATURE, V378, P564, DOI 10.1038/378564a0; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Giha HA, 2005, T ROY SOC TROP MED H, V99, P243, DOI 10.1016/j.trstmh.2004.04.002; Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409; Huda S N, 2003, Indian Pediatr, V40, P939; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Idro Richard, 2004, Afr Health Sci, V4, P50; IMBERT P, 1994, B SOC PATHOL EXOT, V87, P253; Imbert P, 2002, T ROY SOC TROP MED H, V96, P278, DOI 10.1016/S0035-9203(02)90099-4; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; Issifou S, 2007, AM J TROP MED HYG, V77, P1015, DOI 10.4269/ajtmh.2007.77.1015; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; Karunajeewa HA, 2006, ANTIMICROB AGENTS CH, V50, P968, DOI 10.1128/AAC.50.3.968-974.2006; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295; KREMSNER PG, 1995, ANTIMICROB AGENTS CH, V39, P1603, DOI 10.1128/AAC.39.7.1603; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; Lambert S, 1949, MALARIOLOGY, P824; Luckner D, 1998, T ROY SOC TROP MED H, V92, P478, DOI 10.1016/S0035-9203(98)90882-3; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Maitland K, 1998, PARASITOL TODAY, V14, P258, DOI 10.1016/S0169-4758(98)01257-5; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Maitland K, 1997, T ROY SOC TROP MED H, V91, P562, DOI 10.1016/S0035-9203(97)90026-2; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Manning L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029203; Manning L, 2011, AM J TROP MED HYG, V85, P50, DOI 10.4269/ajtmh.2011.11-0095; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; MOLYNEUX ME, 1989, Q J MED, V71, P441; Moyou-Somo R, 2001, AM J TROP MED HYG, V64, P229, DOI 10.4269/ajtmh.2001.64.229; Mpimbaza A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026892; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Namutangula B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-138; NEEQUAYE J, 1991, T ROY SOC TROP MED H, V85, P718, DOI 10.1016/0035-9203(91)90425-X; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Oduro AR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-96; Olumese PE, 1999, ACTA TROP, V73, P231, DOI 10.1016/S0001-706X(99)00031-5; PASVOL G, 1991, AM J TROP MED HYG, V45, P702, DOI 10.4269/ajtmh.1991.45.702; Phuong CXT, 1997, T ROY SOC TROP MED H, V91, P335, DOI 10.1016/S0035-9203(97)90099-7; Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536; PRADA J, 1993, LANCET, V342, P1114, DOI 10.1016/0140-6736(93)92096-C; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Rahman M E, 2001, Bangladesh Med Res Counc Bull, V27, P1; Ranque S, 2008, PEDIATR INFECT DIS J, V27, P130, DOI 10.1097/INF.0b013e31815988ed; Rosanas-Urgell A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001305; Saul A, 1998, PARASITOL TODAY, V14, P293, DOI 10.1016/S0169-4758(98)01260-5; SCHAPIRA A, 1993, T ROY SOC TROP MED H, V87, P299, DOI 10.1016/0035-9203(93)90136-E; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Serengbe GB, 2004, MED MALADIES INFECT, V34, P86, DOI 10.1016/j.medmal.2003.09.003; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stanisic DI, 2010, PARASITE IMMUNOL, V32, P623, DOI 10.1111/j.1365-3024.2010.01238.x; TAYLOR TE, 1993, LANCET, V341, P661, DOI 10.1016/0140-6736(93)90423-E; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Thuma PE, 2000, AM J TROP MED HYG, V62, P524, DOI 10.4269/ajtmh.2000.62.524; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Varandas L, 2000, ANN TROP PAEDIATR, V20, P265, DOI 10.1080/1465328002003852; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WALKER O, 1993, T ROY SOC TROP MED H, V87, P564, DOI 10.1016/0035-9203(93)90092-5; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; Were T, 2011, J CLIN MICROBIOL, V49, P671, DOI 10.1128/JCM.01864-10; WHITE NJ, 1992, LANCET, V339, P317, DOI 10.1016/0140-6736(92)91644-N; Winkler AS, 2008, J TROP PEDIATRICS, V54, P184, DOI 10.1093/tropej/fmm108	100	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86737	10.1371/journal.pone.0086737	http://dx.doi.org/10.1371/journal.pone.0086737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516538	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700013
J	Pesson, M; Volant, A; Uguen, A; Trillet, K; De La Grange, P; Aubry, M; Daoulas, M; Robaszkiewicz, M; Le Gac, G; Morel, A; Simon, B; Corcos, L				Pesson, Marine; Volant, Alain; Uguen, Arnaud; Trillet, Kilian; De La Grange, Pierre; Aubry, Marc; Daoulas, Melanie; Robaszkiewicz, Michel; Le Gac, Gerald; Morel, Alain; Simon, Brigitte; Corcos, Laurent			A Gene Expression and Pre-mRNA Splicing Signature That Marks the Adenoma-Adenocarcinoma Progression in Colorectal Cancer	PLOS ONE			English	Article							COLON-CANCER; IDENTIFICATION; OVEREXPRESSION; POLYPECTOMY; MICROARRAY; ENRICHMENT; MORPHOLOGY; BIOMARKERS; INHIBITOR; DIAGNOSIS	It is widely accepted that most colorectal cancers (CRCs) arise from colorectal adenomas (CRAs), but transcriptomic data characterizing the progression from colorectal normal mucosa to adenoma, and then to adenocarcinoma are scarce. These transition steps were investigated using microarrays, both at the level of gene expression and alternative pre-mRNA splicing. Many genes and exons were abnormally expressed in CRAs, even more than in CRCs, as compared to normal mucosae. Known biological pathways involved in CRC were altered in CRA, but several new enriched pathways were also recognized, such as the complement and coagulation cascades. We also identified four intersectional transcriptional signatures that could distinguish CRAs from normal mucosae or CRCs, including a signature of 40 genes differentially deregulated in both CRA and CRC samples. A majority of these genes had been described in different cancers, including FBLN1 or INHBA, but only a few in CRC. Several of these changes were also observed at the protein level. In addition, 20% of these genes (i.e. CFH, CRYAB, DPT, FBLN1, ITIH5, NR3C2, SLIT3 and TIMP1) showed altered pre-mRNA splicing in CRAs. As a global variation occurring since the CRA stage, and maintained in CRC, the expression and splicing changes of this 40-gene set may mark the risk of cancer occurrence from analysis of CRA biopsies.	[Pesson, Marine; Volant, Alain; Uguen, Arnaud; Trillet, Kilian; Le Gac, Gerald; Simon, Brigitte; Corcos, Laurent] Univ Bretagne Occidentale, INSERM, UMR 1078, Struct Federat Rech ScInBioS,Fac Med, Brest, France; [Volant, Alain; Uguen, Arnaud; Daoulas, Melanie; Robaszkiewicz, Michel; Le Gac, Gerald; Corcos, Laurent] Ctr Hosp Reg Univ Brest, Brest, France; [De La Grange, Pierre] Hop St Louis, Inst Univ Hematol, Ctr Hayem, GenoSplice Technol, Paris, France; [Aubry, Marc] Univ Rennes 1, CNRS, UMR 6290, Lab Genom Med,Inst Genet & Dev Rennes,Unite Mixte, Rennes, France; [Morel, Alain] Ctr Paul Papin, INSERM, UMR 892, Inst Rech Canc Nantes Atlantique, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Universite d'Angers	Corcos, L (corresponding author), Univ Bretagne Occidentale, INSERM, UMR 1078, Struct Federat Rech ScInBioS,Fac Med, Brest, France.	laurent.corcos@inserm.fr	Uguen, Arnaud/ABF-7583-2020; Corcos, Laurent/K-1859-2015; Le Gac, Gérald/AFQ-1679-2022; Corcos, Laurent/M-8915-2017; Corcos, Laurent/AAJ-2692-2020; Aubry, Marc/GNW-2661-2022; Morel, Alain/AAU-7496-2021; Kilian, TRILLET/K-9619-2015	Corcos, Laurent/0000-0001-8019-2505; Corcos, Laurent/0000-0001-8019-2505; LE GAC, Gerald/0000-0003-3236-7280; morel, alain/0000-0003-0125-1883	Inserm; Brest University; Brest University hospital Canceropole Grand Ouest; Ligue contre le Cancer; Oseo - BioIntelligence Program; ARC; Brittany region; Region Bretagne	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Brest University; Brest University hospital Canceropole Grand Ouest; Ligue contre le Cancer(Ligue nationale contre le cancer); Oseo - BioIntelligence Program; ARC(Australian Research Council); Brittany region(Region Bretagne); Region Bretagne(Region Bretagne)	Funded by Inserm, Brest University, Brest University hospital Canceropole Grand Ouest, Ligue contre le Cancer, Oseo - BioIntelligence Program, ARC, and Brittany region. MP was the recipient of a fellowship from the Region Bretagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YH, 2012, ANAL CHEM, V84, P1425, DOI 10.1021/ac2024987; Andre F, 2009, LANCET ONCOL, V10, P381, DOI 10.1016/S1470-2045(09)70024-5; Arber N, 2000, GASTROENTEROLOGY, V118, P1045, DOI 10.1016/S0016-5085(00)70357-X; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bianchini M, 2006, INT J ONCOL, V29, P83; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Cattaneo E, 2011, EMBO MOL MED, V3, P334, DOI 10.1002/emmm.201100141; Citarda F, 2001, GUT, V48, P812, DOI 10.1136/gut.48.6.812; Cui T, 2011, INT J ONCOLOGY; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; Di Fabio F, 2007, J GASTROINTEST SURG, V11, P1521, DOI 10.1007/s11605-007-0234-8; Fornasarig M, 1998, HEPATO-GASTROENTEROL, V45, P1565; Galamb O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048547; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Heslin MJ, 2001, ANN SURG, V233, P786, DOI 10.1097/00000658-200106000-00008; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2010, J CLIN INVEST, V120, P223, DOI 10.1172/JCI38012; Hubner RA, 2006, CLIN CANCER RES, V12, P6585, DOI 10.1158/1078-0432.CCR-06-0903; Jeffery N, 2009, HISTOPATHOLOGY, V54, P820, DOI 10.1111/j.1365-2559.2009.03301.x; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khamas A, 2012, CANCER GENOM PROTEOM, V9, P67; Kim YS, 2012, J BIOL CHEM, V287, P32467, DOI 10.1074/jbc.M112.370064; Lam AKY, 2008, HUM PATHOL, V39, P599, DOI 10.1016/j.humpath.2007.09.001; Lascorz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018867; Lin YM, 2002, ONCOGENE, V21, P4120, DOI 10.1038/sj.onc.1205518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma YL, 2012, INT J CANCER, V130, P2077, DOI 10.1002/ijc.26232; Miyoshi N, 2009, BRIT J CANCER, V101, P1664, DOI 10.1038/sj.bjc.6605361; Miyoshi N, 2009, ANN SURG ONCOL, V16, P3507, DOI 10.1245/s10434-009-0690-3; Pal S, 2012, PHARM THERAPEUTICS; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Tang H, 2010, INT J MOL MED, V26, P631, DOI 10.3892/ijmm_00000508; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; Yan N, 2012, CANCER SCI, V103, P1631, DOI 10.1111/j.1349-7006.2012.02350.x; Zhang H, 2011, TUMOR BIOL, V32, P1225, DOI 10.1007/s13277-011-0226-x	53	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87761	10.1371/journal.pone.0087761	http://dx.doi.org/10.1371/journal.pone.0087761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516561	Green Published, gold			2022-12-27	WOS:000330830700029
J	Frago, E; Bauce, E				Frago, Enric; Bauce, Eric			Life-History Consequences of Chronic Nutritional Stress in an Outbreaking Insect Defoliator	PLOS ONE			English	Article							SPRUCE BUDWORM GROWTH; CHORISTONEURA-FUMIFERANA LEPIDOPTERA; RESOURCE-ALLOCATION; CHRONIC MALNUTRITION; POPULATION-DYNAMICS; CARRY-OVER; EVOLUTION; FOOD; RESISTANCE; ECOLOGY	Food shortage is a common situation in nature but little is known about the strategies animals use to overcome it. This lack of knowledge is especially true for outbreaking insects, which commonly experience nutritional stress for several successive generations when they reach high population densities. The aim of this study is to evaluate the life history consequences of chronic nutritional stress in the outbreaking moth Choristoneura fumiferana. Larvae were reared on two different artificial diets that emulate nutritional conditions larvae face during their natural population density cycle (low and medium quality artificial diets). After four generations, a subset of larvae was fed on the same diet as their parents, and another on the opposite diet. We explored larval life-history strategies to cope with nutritional stress, its associated costs and the influence of nutritional conditions experienced in the parental generation. We found no evidence of nutritional stress in the parental generation increasing offspring ability to feed on low quality diet, but the contrary: compared to offspring from parents that were fed a medium quality diet, larvae from parents fed a low quality diet had increased mortality, reduced growth rate and reduced female reproductive output. Our results support a simple stress hypothesis because the negative effects of malnutrition accumulated over successive generations. Density-dependent deterioration in plant quality is thought to be an important factor governing the population dynamics of outbreaking insects and we hypothesize that chronic nutritional stress can be a driver of outbreak declines of C. fumiferana, and of forest insects in general.	[Frago, Enric; Bauce, Eric] Univ Laval, Fac Foresterie & Geomat, Quebec City, PQ G1K 7P4, Canada	Laval University	Frago, E (corresponding author), Univ Laval, Fac Foresterie & Geomat, Quebec City, PQ G1K 7P4, Canada.	enric.frago@wur.nl		bauce, eric/0000-0002-3455-0719	Natural Sciences and Engineering Research Council of Canada (NSERC); iFor research consortium; Ministerio de Educacion y Ciencia de Espana [I+D BOS2002-03820]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); iFor research consortium; Ministerio de Educacion y Ciencia de Espana(Spanish Government)	Financial support was provided by a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant to EB and by the iFor research consortium. The authors would like to thank the iFor research consortium partners: NSERC, the Ministere des Ressources Naturelles et de la Faune du Quebec, the Conseil de l'Industrie Forestiere du Quebec, the Canadian Forest Service and the Societe de Protection des Forets contre les Insectes et les Maladies du Quebec. EF visit to the Universite Laval was funded by the "Ministerio de Educacion y Ciencia de Espana" (project I+D BOS2002-03820 with an associate 4-year grant FPI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Karen C., 2012, P30; Akaike H., 1974, 2 INT S INF THEOR, P267; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; BAUCE E, 1994, OECOLOGIA, V97, P499, DOI 10.1007/BF00325888; BAUCE E, 1988, ENVIRON ENTOMOL, V17, P671, DOI 10.1093/ee/17.4.671; Bauce E, 1996, OECOLOGIA, V105, P126, DOI 10.1007/BF00328800; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Benz G, 1974, J APPL ECOL, V76, P196; Bidon Y, 1993, THESIS U LAVAL SAINT; BLAIS JR, 1983, CAN J FOREST RES, V13, P539, DOI 10.1139/x83-079; Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x; Boggs CL, 2005, OECOLOGIA, V144, P353, DOI 10.1007/s00442-005-0076-6; BOGGS CL, 1992, FUNCT ECOL, V6, P508, DOI 10.2307/2390047; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carisey N, 1997, J CHEM ECOL, V23, P1963, DOI 10.1023/B:JOEC.0000006483.52480.c4; Carisey N, 1997, CAN J FOREST RES, V27, P257, DOI 10.1139/cjfr-27-2-257; Carisey N, 2002, B ENTOMOL RES, V92, P101, DOI 10.1079/BER2001148; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; Colasurdo N, 2009, J EXP BIOL, V212, P1794, DOI 10.1242/jeb.027417; Delisle J, 1997, FUNCT ECOL, V11, P451, DOI 10.1046/j.1365-2435.1997.00114.x; Delvas N, 2011, ENTOMOL EXP APPL, V141, P35, DOI 10.1111/j.1570-7458.2011.01161.x; Fuentealba A, 2012, B ENTOMOL RES, V102, P275, DOI 10.1017/S0007485311000617; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Han Er-Ning, 2000, Recent Research Developments in Entomology, V3, P43; HAUKIOJA E, 1983, OIKOS, V40, P419, DOI 10.2307/3544314; HAUKIOJA E, 1991, ANNU REV ENTOMOL, V36, P25, DOI 10.1146/annurev.en.36.010191.000325; Haynes KJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2373; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Kessler Andre, 2012, P91; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; MCMORRAN A, 1965, CAN ENTOMOL, V97, P58, DOI 10.4039/Ent9758-1; MORAN NA, 1992, AM NAT, V139, P971, DOI 10.1086/285369; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Peltonen M, 2002, ECOLOGY, V83, P3120, DOI 10.1890/0012-9658(2002)083[3120:SSIFIO]2.0.CO;2; Postma E, 2007, J ORNITHOL, V148, pS633, DOI 10.1007/s10336-007-0191-8; RANTA E, 1995, P ROY SOC B-BIOL SCI, V262, P113, DOI 10.1098/rspb.1995.0184; RHOADES DF, 1985, AM NAT, V125, P205, DOI 10.1086/284338; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Roff Derek A., 1992; ROYAMA T, 1984, ECOL MONOGR, V54, P429, DOI 10.2307/1942595; Saastamoinen M, 2010, AM NAT, V176, P686, DOI 10.1086/657038; Sanders C.J., 1991, World Crop Pests, V5, P579; Schoonhoven L. M., 2005, Insect-plant biology; Stearns S.C., 1992, pi; Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Vijendravarma RK, 2012, J EVOLUTION BIOL, V25, P288, DOI 10.1111/j.1420-9101.2011.02419.x; Vijendravarma RK, 2012, P ROY SOC B-BIOL SCI, V279, P3540, DOI 10.1098/rspb.2012.0966; Vijendravarma RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030650; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; White TCR, 2005, WHY DOES THE WORLD STAY GREEN: NUTRITION AND SURVIVAL OF PLANT-EATERS, P1; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x	58	17	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88039	10.1371/journal.pone.0088039	http://dx.doi.org/10.1371/journal.pone.0088039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505368	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200103
J	Gasparini, P; Fassan, M; Cascione, L; Guler, G; Balci, S; Irkkan, C; Paisie, C; Lovat, F; Morrison, C; Zhang, JY; Scarpa, A; Croce, CM; Shapiro, CL; Huebner, K				Gasparini, Pierluigi; Fassan, Matteo; Cascione, Luciano; Guler, Gulnur; Balci, Serdar; Irkkan, Cigdem; Paisie, Carolyn; Lovat, Francesca; Morrison, Carl; Zhang, Jianying; Scarpa, Aldo; Croce, Carlo M.; Shapiro, Charles L.; Huebner, Kay			Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CDK4/6 INHIBITION; CLINICAL-SIGNIFICANCE; DISTANT METASTASES; EXPRESSION; TUMORS; PHENOTYPE; CARCINOMA; SURVIVAL; SUBTYPES	Triple negative breast cancers are a heterogeneous group of tumors characterized by poor patient survival and lack of targeted therapeutics. Androgen receptor has been associated with triple negative breast cancer pathogenesis, but its role in the different subtypes has not been clearly defined. We examined androgen receptor protein expression by immunohistochemical analysis in 678 breast cancers, including 396 triple negative cancers. Fifty matched lymph node metastases were also examined. Association of expression status with clinical (race, survival) and pathological (basal, non-basal subtype, stage, grade) features was also evaluated. In 160 triple negative breast cancers, mRNA microarray expression profiling was performed, and differences according to androgen receptor status were analyzed. In triple negative cancers the percentage of androgen receptor positive cases was lower (24.8% vs 81.6% of non-triple negative cases), especially in African American women (16.7% vs 25.5% of cancers of white women). No significant difference in androgen receptor expression was observed in primary tumors vs matched metastatic lesions. Positive androgen receptor immunoreactivity was inversely correlated with tumor grade (p<0.01) and associated with better overall patient survival (p = 0.032) in the non-basal triple negative cancer group. In the microarray study, expression of three genes (HER4, TNFSF10, CDK6) showed significant deregulation in association with androgen receptor status; eg CDK6, a novel therapeutic target in triple negative cancers, showed significantly higher expression level in androgen receptor negative cases (p<0.01). These findings confirm the prognostic impact of androgen receptor expression in non-basal triple negative breast cancers, and suggest targeting of new androgen receptor-related molecular pathways in patients with these cancers.	[Gasparini, Pierluigi; Fassan, Matteo; Cascione, Luciano; Paisie, Carolyn; Lovat, Francesca; Croce, Carlo M.; Huebner, Kay] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Gasparini, Pierluigi; Fassan, Matteo; Cascione, Luciano; Paisie, Carolyn; Lovat, Francesca; Croce, Carlo M.; Shapiro, Charles L.; Huebner, Kay] Ctr Comprehens Canc, Columbus, OH USA; [Fassan, Matteo; Scarpa, Aldo] Univ & Hosp Trust Verona, ARC NET Res Ctr, Verona, Italy; [Guler, Gulnur; Balci, Serdar; Irkkan, Cigdem] Hacettepe Univ, Dept Pathol, Ankara, Turkey; [Morrison, Carl] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Zhang, Jianying] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, James Canc Hosp, Div Med Oncol, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, James Canc Hosp, Breast Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Hacettepe University; Roswell Park Cancer Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Fassan, M (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	matteo.fassan@gmail.com	scarpa, aldo/K-6832-2016; Fassan, Matteo/F-5152-2012; BALCI, Serdar/B-6401-2011; Cascione, Luciano/X-3115-2019; Gasparini, Pierluigi/ABA-2811-2021; Young, Richard A/F-6495-2012	scarpa, aldo/0000-0003-1678-739X; Fassan, Matteo/0000-0001-6515-5482; BALCI, Serdar/0000-0002-7852-3851; Cascione, Luciano/0000-0002-4606-0637; Gasparini, Pierluigi/0000-0001-8311-8845; Young, Richard A/0000-0001-8855-8647	United States Public Health Service; National Cancer Institute [CA154200, CA120516, CA152758]; Stephanie Spielman Foundation for Breast Cancer Research; Italian Association for Cancer Research [12182]; NATIONAL CANCER INSTITUTE [P30CA016056, U01CA152758, U01CA154200, R01CA120516, P30CA016058] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stephanie Spielman Foundation for Breast Cancer Research; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by United States Public Health Service, National Cancer Institute grants, CA154200, CA120516, CA152758, and the Stephanie Spielman Foundation for Breast Cancer Research. MF is a fellow of the Italian Association for Cancer Research (grant 12182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoff SN, 2003, AM J CLIN PATHOL, V120, P725, DOI 10.1309/42F00D0DJD0J5EDT; BIRRELL SN, 1995, J STEROID BIOCHEM, V52, P459, DOI 10.1016/0960-0760(95)00005-K; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Chang C, 2013, ONCOGENE; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Dean JL, 2012, J BIOL CHEM, V287, P29075, DOI 10.1074/jbc.M112.365494; Dean JL, 2012, CELL CYCLE, V11, P2756, DOI 10.4161/cc.21195; Diaz-Chico BN, 2007, J STEROID BIOCHEM, V105, P1, DOI 10.1016/j.jsbmb.2006.11.019; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Elsawaf Z, 2013, BREAST, V22, P986, DOI 10.1016/j.breast.2013.05.012; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Gucalp A, 2010, CANCER J, V16, P62, DOI 10.1097/PPO.0b013e3181ce4ae1; Guler G, 2011, BREAST CANCER RES TR, V129, P421, DOI 10.1007/s10549-010-1248-6; Guler G, 2009, CANCER-AM CANCER SOC, V115, P899, DOI 10.1002/cncr.24103; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Higgins MJ, 2010, BREAST CANCER RES TR, V124, P619, DOI 10.1007/s10549-010-0864-5; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotsopoulos J, 2012, STEROIDS, V77, P1, DOI 10.1016/j.steroids.2011.10.002; KuenenBoumeester V, 1996, EUR J CANCER, V32A, P1560, DOI 10.1016/0959-8049(96)00112-8; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Masuda H, 2013, CLIN CANCER RES, V19, P5533, DOI 10.1158/1078-0432.CCR-13-0799; McClendon AK, 2012, CELL CYCLE, V11, P2747, DOI 10.4161/cc.21127; McGhan LJ, 2013, ANN SURG ONCOL; McNamara KM, 2013, J STEROID BIOCHEM, V133, P66, DOI 10.1016/j.jsbmb.2012.08.007; McNamara KM, 2013, CANCER SCI, V104, P639, DOI 10.1111/cas.12121; Moe RE, 2007, J SURG ONCOL, V95, P437, DOI 10.1002/jso.20722; Montagna E, 2013, CLIN BREAST CANCER, V13, P31, DOI 10.1016/j.clbc.2012.09.002; Nahleh Z, 2008, FUTURE ONCOL, V4, P15, DOI 10.2217/14796694.4.1.15; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; Park S, 2011, ANN ONCOL, V22, P1755, DOI 10.1093/annonc/mdq678; Park S, 2010, ANN ONCOL, V21, P488, DOI 10.1093/annonc/mdp510; Peters KM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-132; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Schonbrunn E, 2013, J MED CHEM, V56, P3768, DOI 10.1021/jm301234k; Secreto G, 2012, ANTICANCER RES, V32, P3223; Sutton LM, 2012, AM J CLIN PATHOL, V138, P511, DOI 10.1309/AJCP8AVF8FDPTZLH; Sutton LM, 2010, AM J CLIN PATHOL, V134, P782, DOI 10.1309/AJCPRMD3ARUO5WPN; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Tang LH, 2012, CLIN CANCER RES, V18, P4612, DOI 10.1158/1078-0432.CCR-11-3264; Thike AA, 2013, MOD PATHOL; Wolff AC, 2013, ARCH PATHOL LAB MED; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yeh SY, 2003, J EXP MED, V198, P1899, DOI 10.1084/jem.20031233	47	62	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88525	10.1371/journal.pone.0088525	http://dx.doi.org/10.1371/journal.pone.0088525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505496	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200196
J	Matuskova, Z; Anzenbacherova, E; Vecera, R; Tlaskalova-Hogenova, H; Kolar, M; Anzenbacher, P				Matuskova, Zuzana; Anzenbacherova, Eva; Vecera, Rostislav; Tlaskalova-Hogenova, Helena; Kolar, Milan; Anzenbacher, Pavel			Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats	PLOS ONE			English	Article							STRAIN NISSLE-1917; GUT MICROBIOTA; AMIODARONE; METABOLISM; BACTERIUM; DISEASES; THERAPY; BARRIER; ECN	The growing interest in the composition and effects of microbiota raised the question how drug pharmacokinetics could be influenced by concomitant application of probiotics. The aim of this study was to find whether probiotic E. coli strain Nissle 1917 (EcN) influences the pharmacokinetics of concomitantly taken antiarrhythmic drug amiodarone (AMI). Live bacterial suspension of probiotic EcN (or non-probiotic E. coli strain ATCC 25922) was applied orally to male Wistar rats for seven days, while a control group of rats was treated with a saline solution. On the eighth day, the amiodarone hydrochloride was administered as one single oral dose (50 mg/kg) to all rats (N = 60). After 0, 1, 2, 3, 4, 5.5, 7, 9, 14, 22, and 30 hours, blood samples were taken from the rat abdominal aorta. The plasma level of AMI and its metabolite N-desethylamiodarone (DEA) was determined using the HPLC with UV detection. Administration of EcN led to a 43% increase of AMI AUC(0-30) in comparison with control samples. However, this effect was not observed if EcN was replaced by a reference non-probiotic E. coli strain. Thus, EcN administration was most probably responsible for better drug absorption from the gastrointestinal tract. Plasma levels of DEA were also increased in plasma samples from animals treated with EcN. This change was again not found in the experiment with the reference non-probiotic strain. Higher DEA levels in samples from EcN-treated rats may be explained either by better absorption of AMI and/or by an increased activity of CYP2C forms, known to participate in metabolism of this drug, after EcN administration. In this paper, it is documented that concomitantly taken probiotic EcN may modulate pharmacokinetics of a drug; in this case, it led to an increased bioavailability of AMI.	[Matuskova, Zuzana; Vecera, Rostislav; Anzenbacher, Pavel] Palacky Univ, Fac Med & Dent, Dept Pharmacol, CR-77147 Olomouc, Czech Republic; [Matuskova, Zuzana; Vecera, Rostislav; Anzenbacher, Pavel] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, CR-77147 Olomouc, Czech Republic; [Anzenbacherova, Eva] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic; [Tlaskalova-Hogenova, Helena] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Kolar, Milan] Palacky Univ, Fac Med & Dent, Dept Microbiol, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Palacky University Olomouc	Anzenbacherova, E (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, CR-77147 Olomouc, Czech Republic.	anzeneva@tunw.upol.cz	Tlaskalová-Hogenová, Helena/J-8008-2014; Kolář, Milan/AAB-4423-2021; KOLÁŘ, Milan/ACL-9884-2022	Kolář, Milan/0000-0003-4621-8868; KOLÁŘ, Milan/0000-0003-4621-8868; Racova, Zuzana/0000-0001-9478-9513	Czech Science Foundation [P303/12/0535, P303/12/G163, P304/11/1252]; IGA Ministry of Health of the Czech Republic [NT 13482-4/2012]; students' project IGA UPOL [LF_2013_007]; Operational Programme Research and Development for Innovations [CZ.1.05/2.1.00/01.0030]	Czech Science Foundation(Grant Agency of the Czech Republic); IGA Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); students' project IGA UPOL; Operational Programme Research and Development for Innovations	The authors gratefully acknowledge financial support from Czech Science Foundation (P303/12/0535, P303/12/G163, P304/11/1252), IGA Ministry of Health of the Czech Republic (NT 13482-4/2012) as well as of the students' project IGA UPOL LF_2013_007 is gratefully acknowledged. Infrastructural part of this work (at the Institute of Molecular and Translational Medicine) was supported from the Operational Programme Research and Development for Innovations (CZ.1.05/2.1.00/01.0030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salami H, 2008, EUR J DRUG METAB PH, V33, P101; Al-Salami Hani, 2008, Arch Drug Inf, V1, P35, DOI 10.1111/j.1753-5174.2008.00006.x; Boury F, 2001, COLLOID SURFACE B, V20, P219, DOI 10.1016/S0927-7765(00)00195-8; CHATELAIN P, 1986, BIOCHEM PHARMACOL, V35, P3007, DOI 10.1016/0006-2952(86)90379-5; Darwich AS, 2010, CURR DRUG METAB, V11, P716; Elsherbiny ME, 2008, J PHARM PHARM SCI, V11, P146, DOI 10.18433/J3SG66; Goldschlager N, 2000, ARCH INTERN MED, V160, P1741, DOI 10.1001/archinte.160.12.1741; Grozdanov L, 2002, J BACTERIOL, V184, P5912, DOI 10.1128/JB.184.21.5912-5925.2002; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Henker J, 2007, EUR J PEDIATR, V166, P311, DOI 10.1007/s00431-007-0419-x; Jacobi CA, 2011, DIGEST DIS, V29, P600, DOI 10.1159/000333307; Jun AS, 2001, J PHARM PHARM SCI, V4, P263; Koenen Anna, 2011, Expert Rev Clin Pharmacol, V4, P729, DOI 10.1586/ecp.11.58; Krammer HJ, 2006, Z GASTROENTEROL, V44, P651, DOI 10.1055/s-2006-926909; Kunes M, 2011, NEUROENDOCRINOL LETT, V32, P46; Le Vee M, 2009, DRUG METAB DISPOS, V37, P685, DOI 10.1124/dmd.108.023630; Lee HJ, 2012, XENOBIOTICA, V42, P791, DOI 10.3109/00498254.2012.660508; Matuskova Z, 2009, NEUROENDOCRINOL LETT, V30, P41; Meijerink M, 2013, BENEF MICROBES, V4, P83, DOI 10.3920/BM2012.0035; Meng X, 2001, AM J CARDIOL, V87, P432, DOI 10.1016/S0002-9149(00)01396-5; Ohyama K, 2000, DRUG METAB DISPOS, V28, P1303; RODEN DM, 1993, AM J CARDIOL, V72, pB44, DOI 10.1016/0002-9149(93)90040-J; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Sigurdsson HH, 2013, INT J PHARMACEUT, V453, P56, DOI 10.1016/j.ijpharm.2013.05.040; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Stojancevic M, 2014, CURR ISSUES MOL BIOL, V16, P55; Tannock GW, 2011, J MED MICROBIOL, V60, P366, DOI 10.1099/jmm.0.025874-0; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Van Herendael H, 2010, VASC HEALTH RISK MAN, V6, P465; Westendorf AM, 2005, FEMS IMMUNOL MED MIC, V43, P373, DOI 10.1016/j.femsim.2004.10.023	32	53	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87150	10.1371/journal.pone.0087150	http://dx.doi.org/10.1371/journal.pone.0087150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505278	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200037
J	Mostovaya, IM; Bots, ML; van den Dorpel, MA; Goldschmeding, R; den Hoedt, CH; Kamp, O; Levesque, R; Mazairac, AHA; Penne, EL; Swinkels, DW; van der Weerd, NC; ter Wee, PM; Nube, MJ; Blankestijn, PJ; Grooteman, MPC				Mostovaya, Ira M.; Bots, Michiel L.; van den Dorpel, Marinus A.; Goldschmeding, Roel; den Hoedt, Claire H.; Kamp, Otto; Levesque, Renee; Mazairac, Albert H. A.; Penne, E. Lars; Swinkels, Dorine W.; van der Weerd, Neelke C.; ter Wee, Piet M.; Nube, Menso J.; Blankestijn, Peter J.; Grooteman, Muriel P. C.			Left Ventricular Mass in Dialysis Patients, Determinants and Relation with Outcome. Results from the COnvective TRansport STudy (CONTRAST)	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; CHRONIC KIDNEY-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; FOLLOW-UP; HYPERTROPHY; HEMODIALYSIS; RISK	Background and Objectives: Left ventricular mass (LVM) is known to be related to overall and cardiovascular mortality in end stage kidney disease (ESKD) patients. The aims of the present study are 1) to determine whether LVM is associated with mortality and various cardiovascular events and 2) to identify determinants of LVM including biomarkers of inflammation and fibrosis. Design, Setting, Participants, & Measurements: Analysis was performed with data of 327 ESKD patients, a subset from the CONvective TRAnsport STudy (CONTRAST). Echocardiography was performed at baseline. Cox regression analysis was used to assess the relation of LVM tertiles with clinical events. Multivariable linear regression models were used to identify factors associated with LVM. Results: Median age was 65 (IQR: 54-73) years, 203 (61%) were male and median LVM was 227 (IQR: 183-279) grams. The risk of all-cause mortality (hazard ratio (HR) = 1.73, 95% CI: 1.11-2.99), cardiovascular death (HR = 3.66, 95% CI: 1.35-10.05) and sudden death (HR = 13.06; 95% CI: 6.60-107) was increased in the highest tertile (>260grams) of LVM. In the multivariable analysis positive relations with LVM were found for male gender (B = 38.8 +/- 10.3), residual renal function (B = 17.9 +/- 8.0), phosphate binder therapy (B = 16.9 +/- 8.5), and an inverse relation for a previous kidney transplantation (B = -41.1 +/- 7.6) and albumin (B = -2.9 +/- 1.1). Interleukin-6 (Il-6), high-sensitivity C-reactive protein (hsCRP), hepcidin-25 and connective tissue growth factor (CTGF) were not related to LVM. Conclusion: We confirm the relation between a high LVM and outcome and expand the evidence for increased risk of sudden death. No relationship was found between LVM and markers of inflammation and fibrosis.	[Mostovaya, Ira M.; den Hoedt, Claire H.; Mazairac, Albert H. A.; Penne, E. Lars; van der Weerd, Neelke C.; Blankestijn, Peter J.] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van den Dorpel, Marinus A.; den Hoedt, Claire H.] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Kamp, Otto] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Levesque, Renee] Ctr Hosp Univ Montreal, St Luc Hosp, Dept Nephrol, Montreal, PQ, Canada; [Penne, E. Lars; van der Weerd, Neelke C.; ter Wee, Piet M.; Nube, Menso J.; Grooteman, Muriel P. C.] Vrije Univ Amsterdam, Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, Nijmegen, Netherlands; [ter Wee, Piet M.; Nube, Menso J.; Grooteman, Muriel P. C.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maasstad Hospital; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Universite de Montreal; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Mostovaya, IM (corresponding author), Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands.	I.M.Mostovaya@umcutrecht.nl	Grooteman, Muriel/AAA-2602-2019; Swinkels, Dorine W./H-8098-2014; Goldschmeding, Roel/I-1723-2014	Swinkels, Dorine W./0000-0002-1040-9446; Grooteman, Muriel/0000-0001-5447-2546; kamp, otto/0000-0003-2707-2090; Penne, Erik/0000-0002-6018-4679	Fresenius Medical Care (The Netherlands); Gambro Lundia AB (Sweden); Roche, the Netherlands; Fresenius; Gambro; Baxter; Roche; Amgen; Novartis; Solvay; Medtronic; Amgen Canada; Abbott	Fresenius Medical Care (The Netherlands)(Netherlands Government); Gambro Lundia AB (Sweden); Roche, the Netherlands(Netherlands GovernmentRoche Holding); Fresenius; Gambro; Baxter; Roche(Roche Holding); Amgen(Amgen); Novartis(Novartis); Solvay(Solvay SA); Medtronic(Medtronic); Amgen Canada(Amgen); Abbott(Abbott Laboratories)	CONTRAST is partly supported by unrestricted grants from Fresenius Medical Care (The Netherlands) and Gambro Lundia AB (Sweden). Additional support for CONTRAST was also received from Roche, the Netherlands. There are no patents, products in development or marketed products to declare. IM Mostovaya, CH den Hoedt, O Kamp, ML Bots, NC van der Weerd, EL Penne and AHA Mazairac report receiving no lecture fees, no consulting support, or grant support. MPC Grooteman reports research funded by Fresenius, Gambro, and Baxter. PJ Blankestijn reports research funded by Fresenius, Gambro, Roche, Amgen and Novartis, consultant fee and honoraria for lectures from Fresenius, Gambro, Solvay, Medtronic, and Novartis. R Levesque reports research funded by Amgen Canada. PM ter Wee reports research funded by Abbott, Baxter, Gambro, Fresenius, and Roche; honoraria for lectures received from Amgen, Roche, Genzyme, Fresenius. MJ Nube reports research funded by Baxter and Fresenius; honoraria for lectures received from Fresenius and Baxter. MA van den Dorpel reports research funded by Amgen. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achinger SG, 2006, J AM SOC NEPHROL, V17, pS255, DOI 10.1681/ASN.2006080923; Aoki J, 2005, KIDNEY INT, V67, P333, DOI 10.1111/j.1523-1755.2005.00086.x; Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Chue CD, 2012, HEART, V98, P219, DOI 10.1136/heartjnl-2011-300570; Clarkson MR, 1999, CURR OPIN NEPHROL HY, V8, P543, DOI 10.1097/00041552-199909000-00002; Cottone S, 2007, CLIN NEPHROL, V67, P209; DEVEREUX RB, 1987, J CLIN HYPERTENS, V3, P66; Ebinc FA, 2009, J NEPHROL, V22, P216; El-Shehaby AM, 2010, SCAND J CLIN LAB INV, V70, P421, DOI 10.3109/00365513.2010.504281; Fleming RE, 2001, P NATL ACAD SCI USA, V98, P8160, DOI 10.1073/pnas.161296298; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Gerritsen KG, 2010, AM J PHYSIOL-RENAL, V298, pF1457, DOI 10.1152/ajprenal.00694.2009; Glassock RJ, 2009, CLIN J AM SOC NEPHRO, V4, pS79, DOI 10.2215/CJN.04860709; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Guizar-Mendoza JM, 2006, PEDIATR NEPHROL, V21, P1413, DOI 10.1007/s00467-006-0238-8; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Kaneko K, 1997, RES COMMUN MOL PATH, V97, P3; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; LARSSON O, 1986, EUR HEART J, V7, P779, DOI 10.1093/oxfordjournals.eurheartj.a062140; London GM, 2001, J AM SOC NEPHROL, V12, P2759, DOI 10.1681/ASN.V12122759; Mora S, 2009, CLIN CHEM, V55, P219, DOI 10.1373/clinchem.2008.109728; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Nozari Younes, 2011, Acta Med Iran, V49, P531; Panichi V, 2000, BLOOD PURIFICAT, V18, P183, DOI 10.1159/000014417; Penne EL, 2005, SEMIN DIALYSIS, V18, P47, DOI 10.1111/j.1525-139X.2005.18107.x; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ritz E, 2008, CLIN J AM SOC NEPHRO, V3, P920, DOI 10.2215/CJN.04571007; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Sjolander A, 2009, STAT MED, V28, P1416, DOI 10.1002/sim.3532; Tatasciore A, 2008, HYPERTENS RES, V31, P2137, DOI 10.1291/hypres.31.2137; Tonelli M, 2010, NEW ENGL J MED, V362, P1312, DOI 10.1056/NEJMra0912522; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488; van der Weerd NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039783; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Zhang J, 2011, CARDIOVASC RES, V91, P90, DOI 10.1093/cvr/cvr068; Zoccali C, 2004, KIDNEY INT, V65, P1492, DOI 10.1111/j.1523-1755.2004.00530.x; Zoccali C, 2003, KIDNEY INT, V63, pS105, DOI 10.1046/j.1523-1755.63.s85.25.x; Zoccali C, 2001, J AM SOC NEPHROL, V12, P2768, DOI 10.1681/ASN.V12122768	41	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e84587	10.1371/journal.pone.0084587	http://dx.doi.org/10.1371/journal.pone.0084587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505249	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200009
J	Wawra, M; Fidzinski, P; Heinemann, U; Mody, I; Behr, J				Wawra, Matthias; Fidzinski, Pawel; Heinemann, Uwe; Mody, Istvan; Behr, Joachim			5-HT4-Receptors Modulate Induction of Long-Term Depression but Not Potentiation at Hippocampal Output Synapses in Acute Rat Brain Slices	PLOS ONE			English	Article							5-HT4 RECEPTOR AGONISTS; NEURONS IN-VITRO; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; GUINEA-PIG; PHARMACOLOGICAL CHARACTERIZATION; ELECTROPHYSIOLOGICAL PROPERTIES; INTRINSIC-PROPERTIES; PYRAMIDAL NEURONS; CA1 REGION	The subiculum is the principal target of CA1 pyramidal cells and mediates hippocampal output to various cortical and subcortical regions of the brain. The majority of subicular pyramidal cells are burst-spiking neurons. Previous studies indicated that high frequency stimulation in subicular burst-spiking cells causes presynaptic NMDA-receptor dependent long-term potentiation (LTP) whereas low frequency stimulation induces postsynaptic NMDA-receptor-dependent long-term depression (LTD). In the present study, we investigate the effect of 5-hydroxytryptamine type 4 (5-HT4) receptor activation and blockade on both forms of synaptic plasticity in burst-spiking cells. We demonstrate that neither activation nor block of 5-HT4 receptors modulate the induction or expression of LTP. In contrast, activation of 5-HT4 receptors facilitates expression of LTD, and block of the 5-HT4 receptor prevents induction of short-term depression and LTD. As 5-HT4 receptors are positively coupled to adenylate cyclase 1 (AC1), 5-HT4 receptors might modulate PKA activity through AC1. Since LTD is blocked in the presence of 5-HT4 receptor antagonists, our data are consistent with 5-HT4 receptor activation by ambient serotonin or intrinsically active 5-HT4 receptors. Our findings provide new insight into aminergic modulation of hippocampal output.	[Wawra, Matthias; Behr, Joachim] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Wawra, Matthias; Heinemann, Uwe; Behr, Joachim] Charite, Inst Neurophysiol, D-13353 Berlin, Germany; [Wawra, Matthias; Heinemann, Uwe; Mody, Istvan] Charite, Exzellenzcluster NeuroCure, D-13353 Berlin, Germany; [Fidzinski, Pawel] Charite, Dept Neurol, D-13353 Berlin, Germany; [Mody, Istvan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Behr, Joachim] Ruppiner Kliniken, Dept Psychiat Psychotherapy & Psychosomat, Neuruppin, Brandenburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ruppiner Kliniken GmbH	Behr, J (corresponding author), Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany.	joachim.behr@charite.de	Fidzinski, Pawel/AAM-8884-2020	Fidzinski, Pawel/0000-0001-6373-4763; Dipper-Wawra, Matthias/0000-0002-7311-1823	German Research Foundation (DFG) [BE 2011/6-1, GRK 1123]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Research Foundation (DFG, www.dfg.de) grants to JB. (BE 2011/6-1) and MW. (GRK 1123, NeuroCure, www.neurocure.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2000, NEUROSCI LETT, V279, P181, DOI 10.1016/S0304-3940(99)00996-9; Behr J, 1996, NEUROSCI LETT, V220, P41, DOI 10.1016/S0304-3940(96)13242-0; BERRY MS, 1976, BRAIN RES, V105, P1, DOI 10.1016/0006-8993(76)90919-7; Blank T, 1997, P NATL ACAD SCI USA, V94, P14859, DOI 10.1073/pnas.94.26.14859; Brodney MA, 2012, J MED CHEM, V55, P9240, DOI 10.1021/jm300953p; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Cho S, 2007, EXP NEUROL, V203, P274, DOI 10.1016/j.expneurol.2006.07.021; Claeysen S, 1999, MOL PHARMACOL, V55, P910; Cooper DC, 2002, NEUROCHEM INT, V41, P333, DOI 10.1016/S0197-0186(02)00068-2; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; Deadwyler SA, 2004, NEURON, V42, P465, DOI 10.1016/S0896-6273(04)00195-3; DESCARRIES L, 1990, ANN NY ACAD SCI, V600, P81, DOI 10.1111/j.1749-6632.1990.tb16874.x; EGLEN RM, 1995, BRIT J PHARMACOL, V115, P1387, DOI 10.1111/j.1476-5381.1995.tb16628.x; Eglen RM, 1995, TIPS, V16, P1043; Elzhov T V., 2012, MINPACK IM R INTERFA; Fidzinski P, 2008, EUR J NEUROSCI, V27, P1111, DOI 10.1111/j.1460-9568.2008.06089.x; Fidzinski P, 2011, HIPPOCAMPUS, V21, P733, DOI 10.1002/hipo.20791; Fontana DJ, 1997, NEUROPHARMACOLOGY, V36, P689, DOI 10.1016/S0028-3908(97)00055-5; GALE JD, 1994, BRIT J PHARMACOL, V111, P332, DOI 10.1111/j.1476-5381.1994.tb14064.x; Greene JRT, 1996, J NEUROPHYSIOL, V76, P1657, DOI 10.1152/jn.1996.76.3.1657; GROSSMAN CJ, 1993, BRIT J PHARMACOL, V109, P618, DOI 10.1111/j.1476-5381.1993.tb13617.x; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; HEGDE SS, 1995, BRIT J PHARMACOL, V115, P1087, DOI 10.1111/j.1476-5381.1995.tb15922.x; Huang YY, 2005, P NATL ACAD SCI USA, V102, P232, DOI 10.1073/pnas.0408368102; JAKEMAN LB, 1994, NEUROPHARMACOLOGY, V33, P1027, DOI 10.1016/0028-3908(94)90162-7; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Kemp A, 2005, CEREB CORTEX, V15, P1037, DOI 10.1093/cercor/bhh204; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kulla A, 2002, CEREB CORTEX, V12, P150, DOI 10.1093/cercor/12.2.150; Lamirault L, 2001, NEUROPHARMACOLOGY, V41, P844, DOI 10.1016/S0028-3908(01)00123-X; Lelong V, 2001, NEUROPHARMACOLOGY, V41, P517, DOI 10.1016/S0028-3908(01)00085-5; Letty S, 1997, NEUROPHARMACOLOGY, V36, P681, DOI 10.1016/S0028-3908(96)00169-4; Madsen K, 2011, J ALZHEIMERS DIS, V26, P457, DOI 10.3233/JAD-2011-110056; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marchetti E, 2000, NEUROPHARMACOLOGY, V39, P2017, DOI 10.1016/S0028-3908(00)00038-1; MarchettiGauthier E, 1997, NEUROPHARMACOLOGY, V36, P697, DOI 10.1016/S0028-3908(97)00058-0; Markstein R, 1999, N-S ARCH PHARMACOL, V359, P454, DOI 10.1007/PL00005375; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mengod G, 1996, HISTOCHEM J, V28, P747, DOI 10.1007/BF02272148; Mialet J, 2000, BRIT J PHARMACOL, V129, P771, DOI 10.1038/sj.bjp.0703101; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Mlinar B, 2006, EUR J NEUROSCI, V24, P719, DOI 10.1111/j.1460-9568.2006.04949.x; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; NICHOLLS JG, 1970, J PHYSIOL-LONDON, V209, P647, DOI 10.1113/jphysiol.1970.sp009184; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; Perez-Garcia G, 2008, BEHAV BRAIN RES, V195, P17, DOI 10.1016/j.bbr.2007.11.027; R Core Team, 2012, R LANG ENV STAT COMP; Roggenhofer E, 2010, EUR J NEUROSCI, V32, P598, DOI 10.1111/j.1460-9568.2010.07312.x; Russo O, 2009, J MED CHEM, V52, P2214, DOI 10.1021/jm801327q; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3188, DOI 10.1073/pnas.052712699; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Waeber C, 1995, BEHAV BRAIN RES, V73, P259; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; ZILLES K, 1985, ANAT EMBRYOL, V172, P255, DOI 10.1007/BF00318973; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	63	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88085	10.1371/journal.pone.0088085	http://dx.doi.org/10.1371/journal.pone.0088085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505387	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200113
J	Williams, S; Currid-Halkett, E				Williams, Sarah; Currid-Halkett, Elizabeth			Industry in Motion: Using Smart Phones to Explore the Spatial Network of the Garment Industry in New York City	PLOS ONE			English	Article							INNOVATION; ORGANIZATION; SPILLOVERS; GEOGRAPHY; MOBILITY	Industrial agglomerations have long been thought to offer economic and social benefits to firms and people that are only captured by location within their specified geographies. Using the case study of New York City's garment industry along with data acquired from cell phones and social media, this study set out to understand the discrete activities underpinning the economic dynamics of an industrial agglomeration. Over a two week period, data was collected by employing the geo-locative capabilities of Foursquare, a social media application, to record every movement of fashion workers employed at fashion design firms located both inside and outside the geographical boundaries of New York City's Garment District. This unique method of studying worker activity exposed the day-to-day dynamics of an industrial district with a precision thus far undocumented in literature. Our work suggests that having access to the cluster provides almost the same agglomeration economies as residing within its borders.	[Williams, Sarah] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA; [Currid-Halkett, Elizabeth] Univ So Calif, Sol Price Sch Publ Policy, Los Angeles, CA USA	Massachusetts Institute of Technology (MIT); University of Southern California	Williams, S (corresponding author), MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA.	sew@mit.edu; currid@usc.edu			Rockefeller Foundation	Rockefeller Foundation	Rockefeller Foundation partially funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelzaher T, 2007, IEEE PERVAS COMPUT, V6, P20, DOI 10.1109/MPRV.2007.38; Agrawal A, 2006, J ECON GEOGR, V6, P571, DOI 10.1093/jeg/lbl016; [Anonymous], 2011, COUNTY BUSINESS PATT; [Anonymous], 2011, ICWSM; Audretsch DB, 1996, AM ECON REV, V86, P630; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Buenstorf G, 2009, ECON J, V119, P705, DOI 10.1111/j.1468-0297.2009.02216.x; BURKE J., 2006, P WORLD SENS WEB WOR, P1; Cramer H., 2011, PERFORMING CHECK IN; Crandall D.J., 2009, P 18 INT C WORLD WID; Crean S, 2012, FUTURE FASHION FASHI; Currid E., 2007, WARHOL EC FASHION AR; Delgado M, 2010, US CENSUS BUREAU CTR; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Gertler M., 2004, MANUFACTURING CULTUR; Glaeser EL, 1998, J ECON PERSPECT, V12, P139, DOI 10.1257/jep.12.2.139; Glaeser EL, 2011, TRIUMPH CITY OUR GRE; Gluckler J, 2007, J ECON GEOGR, V7, P1; Granovetter M, 2005, J ECON PERSPECT, V19, P33, DOI 10.1257/0895330053147958; Hollenstein L, 2010, J SPAT INT SCI, P21, DOI 10.5311/JOSIS.2010.1.3; Jacobs J., 1969, EC CITIES; Jacobs J., 1961, DEATH LIFE GREAT AM; Jacobs J., 1970, EC CITIES, VFirst; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Klepper S, 2010, J URBAN ECON, V67, P15, DOI 10.1016/j.jue.2009.09.004; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Lane ND, 2010, IEEE COMMUN MAG, V48, P140, DOI 10.1109/MCOM.2010.5560598; Liao L, 2007, ARTIF INTELL, V171, P311, DOI 10.1016/j.artint.2007.01.006; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; Marshall A., 1890, PRINCIPLES EC; Mun M, 2009, MOBISYS'09: PROCEEDINGS OF THE 7TH ACM INTERNATIONAL CONFERENCE ON MOBILE SYSTEMS, APPLICATIONS, AND SERVICES, P55; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Piore M.J., 1984, 2 IND DIVIDE POSSIBI; Polanyi M., 1966, TACIT DIMENSION; Porter ME, 1998, HARVARD BUS REV, V76, P77; Porter ME, 1996, INT REGIONAL SCI REV, V19; Quigley JM, 1998, J ECON PERSPECT, V12, P127, DOI 10.1257/jep.12.2.127; Raento M, 2009, SOCIOL METHOD RES, V37, P426, DOI 10.1177/0049124108330005; Rantisi NM, 2002, REG STUD, V36, P587, DOI 10.1080/00343400220146740; Rantisi NM, 2004, INT J URBAN REGIONAL, V28, P86, DOI 10.1111/j.0309-1317.2004.00504.x; Rosenthal SS, 2003, REV ECON STAT, V85, P377, DOI 10.1162/003465303765299882; ROSS E. A., 1896, Q J ECON, P247; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Salesses P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068400; Saxenian A, 1994, LOCAL GLOBAL NETWORK; Scott AJ, 1997, INT J URBAN REGIONAL, V21, P323, DOI 10.1111/1468-2427.00075; Sohn T, 2006, LECT NOTES COMPUT SC, V4206, P212; Storper M, 2004, J ECON GEOGR, V4, P351, DOI 10.1093/jnlecg/lbh027; STORPER M, 1990, INT LABOUR REV, V129, P573; Storper M., 1997, REGIONAL WORLD TERRI; Williams S, 2011, URBAN STUD, V48, P3043, DOI 10.1177/0042098010392080; Zandbergen PA, 2009, T GIS, V13, P5, DOI 10.1111/j.1467-9671.2009.01152.x	53	7	9	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86165	10.1371/journal.pone.0086165	http://dx.doi.org/10.1371/journal.pone.0086165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505256	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200016
J	Berneman-Zeitouni, D; Molakandov, K; Elgart, M; Mor, E; Fornoni, A; Dominguez, MR; Kerr-Conte, J; Ott, M; Meivar-Levy, I; Ferber, S				Berneman-Zeitouni, Dana; Molakandov, Kfir; Elgart, Marina; Mor, Eytan; Fornoni, Alessia; Dominguez, Miriam Ramirez; Kerr-Conte, Julie; Ott, Michael; Meivar-Levy, Irit; Ferber, Sarah			The Temporal and Hierarchical Control of Transcription Factors-Induced Liver to Pancreas Transdifferentiation	PLOS ONE			English	Article							ISLET-CELL DIFFERENTIATION; INSULIN GENE-EXPRESSION; BETA-CELL; ENDOCRINE PANCREAS; REPLACEMENT THERAPY; FUNCTIONAL-NEURONS; DIRECT CONVERSION; HUMAN FIBROBLASTS; DEFINED FACTORS; PROTEIN	Lineage-specific transcription factors (TFs) display instructive roles in directly reprogramming adult cells into alternate developmental fates, in a process known as transdifferentiation. The present study analyses the hypothesis that despite being fast, transdifferentiation does not occur in one step but is rather a consecutive and hierarchical process. Using ectopic expression of Pdx1 in human liver cells, we demonstrate that while glugacon and somatostatin expression initiates within a day, insulin gene expression becomes evident only 2-3 days later. To both increase transdifferentiation efficiency and analyze whether the process indeed display consecutive and hierarchical characteristics, adult human liver cells were treated by three pancreatic transcription factors, Pdx1, Pax4 and Mafa (3pTFs) that control distinct hierarchical stages of pancreatic development in the embryo. Ectopic expression of the 3pTFs in human liver cells, increased the transdifferentiation yield, manifested by 300% increase in the number of insulin positive cells, compared to each of the ectopic factors alone. However, only when the 3pTFs were sequentially supplemented one day apart from each other in a direct hierarchical manner, the transdifferentiated cells displayed increased mature beta-cell-like characteristics. Ectopic expression of Pdx1 followed by Pax4 on the 2nd day and concluded by Mafa on the 3rd day resulted in increased yield of transdifferentiation that was associated by increased glucose regulated c-peptide secretion. By contrast, concerted or sequential administration of the ectopic 3pTFs in an indirect hierarchical mode resulted in the generation of insulin and somatostatin co-producing cells and diminished glucose regulated processed insulin secretion. In conclusion transcription factors induced liver to pancreas transdifferentiation is a progressive and hierarchical process. It is reasonable to assume that this characteristic is general to wide ranges of tissues. Therefore, our findings could facilitate the development of cell replacement therapy modalities for many degenerative diseases including diabetes.	[Berneman-Zeitouni, Dana; Molakandov, Kfir; Elgart, Marina; Meivar-Levy, Irit; Ferber, Sarah] Chaim Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, IL-52621 Tel Hashomer, Israel; [Berneman-Zeitouni, Dana; Molakandov, Kfir; Elgart, Marina; Ferber, Sarah] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; [Mor, Eytan] Rabin Med Ctr, Petah Tiqwa, Israel; [Fornoni, Alessia; Dominguez, Miriam Ramirez] Univ Miami, Leonard M Miller Sch Med, Diabet Res Inst, Miami, FL USA; [Kerr-Conte, Julie] Univ Lille Nord France, Lille, France; [Ott, Michael] Hannover Med Sch, Hannover, Germany; [Ott, Michael] Ctr Expt & Clin Infect Res, Twincore, Hannover, Germany	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; University of Miami; Universite de Lille - ISITE; Universite de Lille; Hannover Medical School	Ferber, S (corresponding author), Chaim Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, IL-52621 Tel Hashomer, Israel.	sferber@sheba.health.gov.il		fornoni, Alessia/0000-0002-1313-7773; Ferber, Sarah/0000-0003-2764-2786; Berneman, Zwi/0000-0002-9133-4588	Bundesministerium fur Bildung und Forschung through the BioDisc 6 program [AZ0101-31P6692]; Gutwirth Fund	Bundesministerium fur Bildung und Forschung through the BioDisc 6 program; Gutwirth Fund	The work was supported by a grant from the Bundesministerium fur Bildung und Forschung through the BioDisc 6 program (AZ0101-31P6692 to SF and MO) and part by the Gutwirth Fund (to SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Atala Anthony, 2008, Curr Aging Sci, V1, P73; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Bernardo AS, 2008, MOL CELL ENDOCRINOL, V294, P1, DOI 10.1016/j.mce.2008.07.006; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Borowiak Malgorzata, 2010, Rev Diabet Stud, V7, P93, DOI 10.1900/RDS.2010.7.93; Brun T, 2008, J MOL ENDOCRINOL, V40, P37, DOI 10.1677/JME-07-0134; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Courtney M, 2011, DIABETES OBES METAB, V13, P47, DOI 10.1111/j.1463-1326.2011.01441.x; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; Eberhard D, 2009, CURR OPIN GENET DEV, V19, P469, DOI 10.1016/j.gde.2009.07.003; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fernandes A, 1997, ENDOCRINOLOGY, V138, P1750, DOI 10.1210/en.138.4.1750; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Meivar-Levy I, 2003, TRENDS ENDOCRIN MET, V14, P460, DOI 10.1016/j.tem.2003.10.006; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Meivar-Levy I, 2006, ISR MED ASSOC J, V8, P430; Meivar-Levy I, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/252387; Meivar-Levy I, 2010, METHODS MOL BIOL, V636, P251, DOI 10.1007/978-1-60761-691-7_16; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Offield MF, 1996, DEVELOPMENT, V122, P983; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Russ Holger A, 2011, Pediatr Endocrinol Rev, V9, P590; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Seijffers R, 1999, ENDOCRINOLOGY, V140, P3311, DOI 10.1210/en.140.7.3311; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Sheyn D, 2010, ADV DRUG DELIVER REV, V62, P683, DOI 10.1016/j.addr.2010.01.002; Slack JMW, 2001, CURR OPIN GENET DEV, V11, P581, DOI 10.1016/S0959-437X(00)00236-7; Song YD, 2007, BIOCHEM BIOPH RES CO, V354, P334, DOI 10.1016/j.bbrc.2006.12.216; Stoffers DA, 1997, TRENDS ENDOCRIN MET, V8, P145, DOI 10.1016/S1043-2760(97)00008-8; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Varda-Bloom N, 2001, GENE THER, V8, P819, DOI 10.1038/sj.gt.3301472; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vincent M, 2003, ENDOCRINOLOGY, V144, P4061, DOI 10.1210/en.2003-0088; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Yechoor V, 2010, MOL ENDOCRINOL, V24, P1501, DOI 10.1210/me.2009-0311; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87812	10.1371/journal.pone.0087812	http://dx.doi.org/10.1371/journal.pone.0087812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504462	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800075
J	Guillard, T; Grillon, A; de Champs, C; Cartier, C; Madoux, J; Bercot, B; Lebreil, AL; Lozniewski, A; Riahi, J; Vernet-Garnier, V; Cambau, E				Guillard, Thomas; Grillon, Antoine; de Champs, Christophe; Cartier, Celine; Madoux, Janick; Bercot, Beatrice; Lebreil, Anne-Laure; Lozniewski, Alain; Riahi, Jacques; Vernet-Garnier, Veronique; Cambau, Emmanuelle			Mobile Insertion Cassette Elements Found in Small Non-Transmissible Plasmids in Proteeae May Explain qnrD Mobilization	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; ESCHERICHIA-COLI; GENE; PROVIDENCIA; STRAINS; DISSEMINATION; CIPROFLOXACIN; DETERMINANTS; VIBRIONACEAE; PREVALENCE	qnrD is a plasmid mediated quinolone resistance gene from unknown origin, recently described in Enterobacteriaceae. It encodes a pentapeptide repeat protein 36-60% different from the other Qnr (A, B, C, S and VC). Since most qnrD-positive strains were described as strains belonging to Proteus or Providencia genera, we hypothesized that qnrD originated in Proteeae before disseminating to other enterobacterial species. We screened 317 strains of Proteeae for qnrD and its genetic support by PCR. For all the seven qnrD-positive strains (4 Proteus mirabilis, 1 Proteus vulgaris and 2 Providencia rettgeri) the gene was carried onto a small non-transmissible plasmid, contrarily to other qnr genes that are usually carried onto large multi-resistant plasmids. Nucleotide sequences of the qnrD-bearing plasmids were 96% identical. Plasmids contained 3 ORFs apart from qnrD and belonged to an undescribed incompatibility group. Only one plasmid, in P. vulgaris, was slightly different with a 1,568-bp insertion between qnrD and its promoter, leading to absence of quinolone resistance. We sought for similar plasmids in 15 reference strains of Proteeae, but which were tested negative for qnrD, and found a 48% identical plasmid (pVERM) in Providencia vermicola. In order to explain how qnrD could have been inserted into such native plasmid, we sought for gene mobilization structures. qnrD was found to be located within a mobile insertion cassette (mic) element which sequences are similar to one mic also found in pVERM. Our conclusions are that (i) the small non-transmissible qnrD-plasmids described here may result from the recombination between an as-yet-unknown progenitor of qnrD and pVERM, (ii) these plasmids are maintained in Proteeae being a qnrD reservoir (iii) the mic element may explain qnrD mobilization from non-transmissible plasmids to mobilizable or conjugative plasmids from other Enterobacteriaceae, (iv) they can recombined with larger multiresistant plasmids conjugated in Proteeae.	[Guillard, Thomas; de Champs, Christophe; Lebreil, Anne-Laure; Vernet-Garnier, Veronique] Univ Reims, SFR CAP Sante, EA 4687, UFR Med, Reims, France; [Guillard, Thomas; Bercot, Beatrice; Cambau, Emmanuelle] Univ Paris 07, Sorbonne Paris Cite, PRES, EA3964, Paris, France; [Guillard, Thomas; Grillon, Antoine; de Champs, Christophe; Cartier, Celine; Madoux, Janick; Vernet-Garnier, Veronique] Hop Robert Debre, CHU Reims, Lab Bacteriol Virol Hyg, Reims, France; [Lozniewski, Alain] Hop Cent, CHU Nancy, Lab Bacteriol, Nancy, France; [Bercot, Beatrice; Riahi, Jacques; Cambau, Emmanuelle] Grp Hosp Lariboisiere St Louis, AP HP, Lab Bacteriol, Paris, France	Universite de Reims Champagne-Ardenne; UDICE-French Research Universities; Universite Paris Cite; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Cambau, E (corresponding author), Univ Paris 07, Sorbonne Paris Cite, PRES, EA3964, Paris, France.	Emmanuelle.cambau@lrb.aphp.fr	Cambau, Emmanuelle/G-7385-2014; Vernet-Garnier, Véronique/P-5729-2016; Guillard, Thomas/G-4065-2013; BERCOT, BEATRICE/G-3987-2014; DE CHAMPS, Christophe/P-5647-2016	Cambau, Emmanuelle/0000-0001-5944-2530; Guillard, Thomas/0000-0002-3795-0398; BERCOT, BEATRICE/0000-0003-1603-3635; DE CHAMPS, Christophe/0000-0002-4375-2080	Universite de Reims Champagne-Ardenne [EA 4687]; Universite Paris Diderot [EA 3964]	Universite de Reims Champagne-Ardenne; Universite Paris Diderot	TG was partially funded by an annual grant from Universite de Reims Champagne-Ardenne (EA 4687) and the study was found by an annual grant from Universite Paris Diderot (EA 3964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allou N, 2009, ANTIMICROB AGENTS CH, V53, P4292, DOI 10.1128/AAC.01664-08; Betley JN, 2002, CURR BIOL, V12, P1756, DOI 10.1016/S0960-9822(02)01220-4; Cambau E, 2006, CLIN MICROBIOL INFEC, V12, P1013, DOI 10.1111/j.1469-0691.2006.01529.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cattoir V, 2008, ANTIMICROB AGENTS CH, V52, P2929, DOI 10.1128/AAC.00349-08; Cattoir V, 2008, EMERG INFECT DIS, V14, P231, DOI 10.3201/eid1402.070677; Cattoir V, 2007, ANTIMICROB AGENTS CH, V51, P2650, DOI 10.1128/AAC.00070-07; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Cesaro A, 2008, J ANTIMICROB CHEMOTH, V61, P1007, DOI 10.1093/jac/dkn077; Chen YH, 1999, MOL MICROBIOL, V32, P657, DOI 10.1046/j.1365-2958.1999.01388.x; De Champs C, 2001, ANTIMICROB AGENTS CH, V45, P1278, DOI 10.1128/AAC.45.4.1278-1280.2001; De Palmenaer D, 2004, MOL MICROBIOL, V53, P457, DOI 10.1111/j.1365-2958.2004.04146.x; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Fonseca EL, 2013, J MED MICROBIOL, V62, P1628, DOI 10.1099/jmm.0.062661-0; Galac MR, 2011, MICROBES INFECT, V13, P673, DOI 10.1016/j.micinf.2011.02.005; Garau J, 1999, ANTIMICROB AGENTS CH, V43, P2736, DOI 10.1128/AAC.43.11.2736; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Guillard T, 2012, ANTIMICROB AGENTS CH, V56, P565, DOI 10.1128/AAC.00081-11; Guillard T, 2011, DIAGN MICR INFEC DIS, V70, P253, DOI 10.1016/j.diagmicrobio.2011.01.004; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1178, DOI 10.1128/AAC.50.4.1178-1182.2006; Jacoby G, 2008, ANTIMICROB AGENTS CH, V52, P2297, DOI 10.1128/AAC.00147-08; Jacoby GA, 2011, ANTIMICROB AGENTS CH, V55, P4979, DOI 10.1128/AAC.05187-11; Jakobsen L, 2012, J ANTIMICROB CHEMOTH, V67, P2438, DOI 10.1093/jac/dks224; Kehrenberg C, 2007, J ANTIMICROB CHEMOTH, V60, P903, DOI 10.1093/jac/dkm283; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Lascols C, 2008, J BACTERIOL, V190, P5217, DOI 10.1128/JB.00243-08; Li J, 2012, ENV HLTH PERSPECT; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mazzariol A, 2012, CLIN MICROBIOL INFEC, V18, pE46, DOI 10.1111/j.1469-0691.2011.03728.x; Michon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024552; Ogbolu DO, 2011, INT J ANTIMICROB AG, V37, P62, DOI 10.1016/j.ijantimicag.2010.08.019; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Poirel L, 2007, ANTIMICROB AGENTS CH, V51, P631, DOI 10.1128/AAC.01082-06; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rodriguez-Martinez JM, 2008, CLIN MICROBIOL INFEC, V14, P691, DOI 10.1111/j.1469-0691.2008.02020.x; Saga T, 2005, ANTIMICROB AGENTS CH, V49, P2144, DOI 10.1128/AAC.49.5.2144-2145.2005; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Wang MH, 2009, ANTIMICROB AGENTS CH, V53, P1892, DOI 10.1128/AAC.01400-08; Zhang S, 2013, MICROB DRUG RESIST, V19, P331, DOI 10.1089/mdr.2012.0146; Zhao J-Y, 2012, MICROB ECOL; Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10	45	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87801	10.1371/journal.pone.0087801	http://dx.doi.org/10.1371/journal.pone.0087801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504382	Green Published, gold			2022-12-27	WOS:000330631800073
J	Mu, Y; Cai, PF; Hu, SQ; Ma, SC; Gao, YH				Mu, Yi; Cai, Pengfei; Hu, Siqi; Ma, Sucan; Gao, Youhe			Characterization of Diverse Internal Binding Specificities of PDZ Domains by Yeast Two-Hybrid Screening of a Special Peptide Library	PLOS ONE			English	Article							ZONULA OCCLUDENS-1 ZO-1; C-TERMINAL MOTIF; FUNCTIONAL-ANALYSIS; LIGAND SPECIFICITY; RECOGNITION MOTIF; LIPID-BINDING; GENOME-WIDE; PROTEIN; COMPLEX; REVEALS	Protein-protein interactions (PPIs) are essential events to play important roles in a series of biological processes. There are probably more ways of PPIs than we currently realized. Structural and functional investigations of weak PPIs have lagged behind those of strong PPIs due to technical difficulties. Weak PPIs are often short-lived, which may result in more dynamic signals with important biological roles within and/or between cells. For example, the characteristics of PSD-95/Dlg/ZO-1 (PDZ) domain binding to internal sequences, which are primarily weak interactions, have not yet been systematically explored. In the present study, we constructed a nearly random octapeptide yeast two-hybrid library. A total of 24 PDZ domains were used as baits for screening the library. Fourteen of these domains were able to bind internal PDZ-domain binding motifs (PBMs), and PBMs screened for nine PDZ domains exhibited strong preferences. Among 11 PDZ domains that have not been reported their internal PBM binding ability, six were confirmed to bind internal PBMs. The first PDZ domain of LNX2, which has not been reported to bind C-terminal PBMs, was found to bind internal PBMs. These results suggest that the internal PBMs binding ability of PDZ domains may have been underestimated. The data provided diverse internal binding properties for several PDZ domains that may help identify their novel binding partners.	[Mu, Yi; Ma, Sucan; Gao, Youhe] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100730, Peoples R China; [Mu, Yi; Ma, Sucan; Gao, Youhe] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Cai, Pengfei; Hu, Siqi] Chinese Acad Med Sci, MOH Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Cai, Pengfei; Hu, Siqi] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, YH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100730, Peoples R China.	gaoyouhe@pumc.edu.cn	Cai, Pengfe/AAF-2759-2020	Cai, Pengfei/0000-0003-4975-4615	National Basic Research Program of China [2012CB517606, 2013CB530805]; 111 Project [B08007]; National Natural Science Foundation of China [31200614]; Beijing Natural Science Foundation [5132028]	National Basic Research Program of China(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the National Basic Research Program of China (2012CB517606, 2013CB530805), 111 Project (B08007), the National Natural Science Foundation of China (31200614) and the Beijing Natural Science Foundation (5132028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Banerjee M, 2012, BIOCHEMISTRY-US, V51, P6950, DOI 10.1021/bi3008033; Beekman JM, 2008, J CELL SCI, V121, P1349, DOI 10.1242/jcs.026401; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Chen VC, 2006, J PROTEOME RES, V5, P2123, DOI 10.1021/pr060216l; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Chi CN, 2012, BIOFACTORS, V38, P338, DOI 10.1002/biof.1031; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Ellencrona K, 2009, BIOL CHEM, V390, P319, DOI 10.1515/BC.2009.041; Flynn M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-235; Gfeller D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.18; Gosens I, 2007, HUM MOL GENET, V16, P1993, DOI 10.1093/hmg/ddm147; Grembecka J, 2006, BIOCHEMISTRY-US, V45, P3674, DOI 10.1021/bi052225y; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Huang HM, 2005, MOL BIOTECHNOL, V30, P135, DOI 10.1385/MB:30:2:135; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Lenfant N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-671; Li X, 2006, PROTEIN SCI, V15, P2149, DOI 10.1110/ps.062087506; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mu Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-227; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Slattery C, 2011, CELL PHYSIOL BIOCHEM, V27, P171, DOI 10.1159/000325219; Song E, 2006, MOL CELL PROTEOMICS, V5, P1368, DOI 10.1074/mcp.M600072-MCP200; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sun RH, 2012, J BIOL CHEM, V287, P37564, DOI 10.1074/jbc.M112.394585; Teyra J, 2012, FEBS LETT, V586, P2631, DOI 10.1016/j.febslet.2012.05.043; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Tochio H, 2000, J MOL BIOL, V303, P359, DOI 10.1006/jmbi.2000.4148; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wawrzyniak AM, 2012, FEBS LETT, V586, P1445, DOI 10.1016/j.febslet.2012.04.024; Wente W, 2005, J BIOL CHEM, V280, P32419, DOI 10.1074/jbc.M507198200; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Xu ZG, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-80; Yasumura M, 2008, NEUROSCI LETT, V433, P146, DOI 10.1016/j.neulet.2008.01.009; Zencir S, 2013, BIOCHEM BIOPH RES CO, V432, P10, DOI 10.1016/j.bbrc.2013.01.098; Zhang YN, 2007, PROTEIN SCI, V16, P1738, DOI 10.1110/ps.072833207; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhou L, 2010, NAT MED, V16, P1439, DOI 10.1038/nm.2245; 2004, NATURE, V431, P931	58	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88286	10.1371/journal.pone.0088286	http://dx.doi.org/10.1371/journal.pone.0088286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505465	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300075
J	Pragya, P; Shukla, AK; Murthy, RC; Abdin, MZ; Chowdhuri, DK				Pragya, Prakash; Shukla, Arvind Kumar; Murthy, Ramesh Chandra; Abdin, Malik Zainul; Chowdhuri, Debapratim Kar			Over-Expression of Superoxide Dismutase Ameliorates Cr(VI) Induced Adverse Effects via Modulating Cellular Immune System of Drosophila melanogaster	PLOS ONE			English	Article							IN-VITRO EXPOSURE; CHROMIUM; WATER; IMMUNOTOXICITY; HEMOCYTES; TOXICITY; DEATH; PEROXYNITRITE; MITOCHONDRIAL; PHAGOCYTOSIS	The evolutionarily conserved innate immune system plays critical role for maintaining the health of an organism. However, a number of environmental chemicals including metals are known to exert adverse effects on immune system. The present study assessed the in vivo effect of a major environmental chemical, Cr(VI), on cellular immune response using Drosophila melanogaster and subsequently the protective role of superoxide dismutase (SOD) based on the comparable performance of the tested anti-oxidant enzymes. The immuno-modulatory potential of Cr(VI) was demonstrated by observing a significant reduction in the total hemocyte count along with impaired phagocytic activity in exposed organism. Concurrently, a significant increase in the percentage of Annexin V-FITC positive cells, activation of DEVDase activity, generation of free radical species along with inhibition of anti-oxidant enzyme activities was observed in the hemocytes of exposed organism. In addition, we have shown that ONOO- is primarily responsible for Cr(VI) induced adverse effects on Drosophila hemocytes along with O-2(-). While generation of O-2(-)/ONOO- in Cr(VI) exposed Drosophila hemocytes was found to be responsible for the suppression of Drosophila cellular immune response, Cr(VI) induced alteration was significantly reduced by the over-expression of sod in Drosophila hemocytes. Overall, our results suggest that manipulation of one of the anti-oxidant genes, sod, benefits the organism from Cr(VI) induced alteration in cellular immunity. Further, this study demonstrates the applicability of D. melanogaster to examine the possible effects of environmental chemicals on innate immunity which can be extrapolated to higher organisms due to evolutionary conservation of innate immune system between Drosophila and mammals.	[Pragya, Prakash; Shukla, Arvind Kumar; Chowdhuri, Debapratim Kar] CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India; [Murthy, Ramesh Chandra] CSIR Indian Inst Toxicol Res, Analyt Sect, Lucknow, Uttar Pradesh, India; [Pragya, Prakash; Shukla, Arvind Kumar; Abdin, Malik Zainul] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Jamia Hamdard University	Chowdhuri, DK (corresponding author), CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India.	dkarchowdhuri@gmail.com	, AKS/I-3868-2019	Zainul Abdin, Malik/0000-0001-7346-0719	Council of Scientific and Industrial Research [31/029(0199)/2008-EMR-1, NWP-UNDO/2012-17]; University Grants Commission [EU249IV/2008/JUNE/318721]; Department of Biotechnology [BT/PR14716/BRB/10/876/2010]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Department of Biotechnology	This work was supported by Council of Scientific and Industrial Research (Grant number: 31/029(0199)/2008-EMR-1 to PP, NWP-UNDO/2012-17 to DKC); University Grants Commission (Grant number: EU249IV/2008/JUNE/318721 to AKS); and Department of Biotechnology (Grant Number: BT/PR14716/BRB/10/876/2010 to DKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravindhan R, 2004, ENVIRON SCI TECHNOL, V38, P300, DOI 10.1021/es034427s; Azad N, 2008, CARCINOGENESIS, V29, P1538, DOI 10.1093/carcin/bgn137; Bagchi D, 2001, MOL CELL BIOCHEM, V222, P149, DOI 10.1023/A:1017958028256; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173, DOI 10.1081/CLT-100102418; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Basset A, 2003, EMBO REP, V4, P205, DOI 10.1038/sj.embor.embor730; Benford DJ, 2000, ATLA-ALTERN LAB ANIM, V28, P119, DOI 10.1177/026119290002800104; Bernier J, 1995, ENVIRON HEALTH PERSP, V103, P23, DOI 10.2307/3432720; Ciacci C, 2011, FISH SHELLFISH IMMUN, V31, P1026, DOI 10.1016/j.fsi.2011.09.002; Cohn CA, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-2; Conners W, 2006, AM J PHYSIOL-RENAL, V290, pF357, DOI 10.1152/ajprenal.00261.2005; De Guise S, 2000, AM J VET RES, V61, P339, DOI 10.2460/ajvr.2000.61.339; Depledge MH, 2005, FRONT ECOL ENVIRON, V3, P251; Evans CJ, 2008, AD DEV BIOL, V18, P259, DOI 10.1016/S1574-3349(07)18011-X; Fournier M, 2000, AM ZOOL, V40, P412, DOI 10.1668/0003-1569(2000)040[0412:PAABOI]2.0.CO;2; Fugere N, 1996, TOXICOLOGY, V109, P157, DOI 10.1016/0300-483X(96)03315-X; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Gavin IM, 2007, ENVIRON MOL MUTAGEN, V48, P650, DOI 10.1002/em.20331; Geetha S, 2005, MOL CELL BIOCHEM, V278, P101, DOI 10.1007/s11010-005-7095-9; GLASER U, 1985, ARCH TOXICOL, V57, P250, DOI 10.1007/BF00324787; Harford AJ, 2005, AQUAT TOXICOL, V75, P330, DOI 10.1016/j.aquatox.2005.09.005; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P49; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lim SY, 2004, J BIOL CHEM, V279, P46263, DOI 10.1074/jbc.M406555200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lozinsky OV, 2012, ARCH INSECT BIOCHEM, V80, P166, DOI 10.1002/arch.21033; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; McCord JM., 1999, CURR PROTOC TOXICOL; Mishra M, 2013, MUTAT RES-FUND MOL M, V747, P28, DOI 10.1016/j.mrfmmm.2013.04.005; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pritchard Kirkwood A. Jr., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P251; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Sauve S, 2002, AQUAT TOXICOL, V58, P189, DOI 10.1016/S0166-445X(01)00232-6; SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270; Sharma P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047877; Shrivastava R, 2002, FEMS IMMUNOL MED MIC, V34, P1, DOI 10.1111/j.1574-695X.2002.tb00596.x; Singh MP, 2011, TOXICOL APPL PHARM, V253, P14, DOI 10.1016/j.taap.2011.03.006; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sokolova IM, 2004, J EXP BIOL, V207, P3369, DOI 10.1242/jeb.01152; Son YO, 2010, TOXICOL APPL PHARM, V245, P226, DOI 10.1016/j.taap.2010.03.004; Steinhagen D, 2004, DIS AQUAT ORGAN, V62, P155, DOI 10.3354/dao062155; SUGIYAMA M, 1992, FREE RADICAL BIO MED, V12, P397, DOI 10.1016/0891-5849(92)90089-Y; Sumner ER, 2005, MICROBIOL-SGM, V151, P1939, DOI 10.1099/mic.0.27945-0; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tirouvanziam R, 2004, P NATL ACAD SCI USA, V101, P2912, DOI 10.1073/pnas.0308734101; Troy CM, 1996, J NEUROSCI, V16, P253; Wang X, 2012, TOXICOL APPL PHARM, V262, P11, DOI 10.1016/j.taap.2012.04.014; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197	54	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88181	10.1371/journal.pone.0088181	http://dx.doi.org/10.1371/journal.pone.0088181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505420	Green Submitted, gold, Green Published			2022-12-27	WOS:000336971300066
J	Avargues-Weber, A; Chittka, L				Avargues-Weber, Aurore; Chittka, Lars			Observational Conditioning in Flower Choice Copying by Bumblebees (Bombus terrestris): Influence of Observer Distance and Demonstrator Movement	PLOS ONE			English	Article							FORAGING BUMBLEBEES; POSSIBLE MECHANISMS; SOCIAL INFORMATION; RHESUS-MONKEYS; INSECT MODEL; SNAKE FEAR; ANIMALS; BEES; CONSPECIFICS; BEHAVIOR	Background: Bumblebees use information provided inadvertently by conspecifics when deciding between different flower foraging options. Such social learning might be explained by relatively simple associative learning mechanism: the bee may learn to associate conspecifics with nectar or pollen reward through previous experience of foraging jointly. However, in some studies, observers were guided by choices of 'demonstrators' viewed through a screen, so no reward was given to the observers at the time of seeing other bees' flowers choice and no demonstrator bee was present at the moment of decision. This behaviour, referred to observational conditioning, implies an additional associative step as the positive value of conspecific is transferred to the associated flower. Here we explore the role of demonstrator movement, and the distance between observers and demonstrators that is required for observation conditioning to take place. Methodology/Principal Findings: We identify the conditions under which observational conditioning occurs in the widespread European species Bombus terrestris. The presence of artificial demonstrator bees leads to a significant change in individual colour preference toward the indicated colour if demonstrators were moving and observation distance was limited (15 cm), suggesting that observational conditioning could only influence relatively short-range foraging decisions. In addition, the movement of demonstrators is a crucial factor for observational conditioning, either due to the more life-like appearance of moving artificial bees or an enhanced detectability of moving demonstrators, and an increased efficiency at directing attention to the indicated flower colour. Conclusion: Bumblebees possess the capacity to learn the quality of a flower by distal observation of other foragers' choices. This confirms that social learning in bees involves more advanced processes than simple associative learning, and indicates that observational conditioning might be widespread in pollinating insects, raising intriguing questions for the underlying mechanisms as well as the spread of social information in pollinator-plant interactions.	[Avargues-Weber, Aurore; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Avargues-Weber, A (corresponding author), Univ Toulouse 3, CNRS, Ctr Rech Cognit Anim, F-31062 Toulouse, France.	a.avargues-weber@qmul.ac.uk	Avargues-Weber, Aurore/V-5795-2019; Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732	Fyssen fondation	Fyssen fondation	A. Avargues-Weber was funded by a postdoctoral fellowship from Fyssen fondation: http://www.fondationfyssen.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baude M, 2008, ANIM BEHAV, V76, P1863, DOI 10.1016/j.anbehav.2008.08.010; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; COOK M, 1985, J ABNORM PSYCHOL, V94, P591, DOI 10.1037/0021-843X.94.4.591; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dawson EH, 2013, CURR BIOL, V23, P727, DOI 10.1016/j.cub.2013.03.035; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; GALEF BG, 1995, ANIM BEHAV, V49, P1325, DOI 10.1006/anbe.1995.0164; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Goulson D, 1998, ANIM BEHAV, V55, P199, DOI 10.1006/anbe.1997.0570; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Leadbeater E, 2007, CURR BIOL, V17, pR703, DOI 10.1016/j.cub.2007.06.012; Leadbeater E, 2007, BEHAV ECOL SOCIOBIOL, V61, P1789, DOI 10.1007/s00265-007-0412-4; Leadbeater E, 2011, ANIM COGN, V14, P915, DOI 10.1007/s10071-011-0423-4; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; LEHRER M, 1992, J COMP PHYSIOL A, V171, P457, DOI 10.1007/BF00194578; MINEKA S, 1984, J ABNORM PSYCHOL, V93, P355, DOI 10.1037/0021-843X.93.4.355; Nieh JC, 1998, BEHAV ECOL SOCIOBIOL, V43, P133, DOI 10.1007/s002650050475; Nielsen M, 2012, J COMP PSYCHOL, V126, P109, DOI 10.1037/a0027758; Pavlov I.P., 1927, CONDITIONED REFLEXES; Plowright CMS, 2013, INSECT SOC, V60, P517, DOI 10.1007/s00040-013-0318-2; Raine NE, 2006, ADV STUD BEHAV, V36, P305, DOI 10.1016/S0065-3454(06)36007-X; Raine NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045096; Saleh N, 2006, BEHAV ECOL SOCIOBIOL, V61, P215, DOI 10.1007/s00265-006-0252-7; Skorupski P, 2010, J NEUROSCI, V30, P3896, DOI 10.1523/JNEUROSCI.5700-09.2010; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; Srinivasan MV, 1999, VISION RES, V39, P2749, DOI 10.1016/S0042-6989(99)00002-4; Stelzer RJ, 2010, J ZOOL, V282, P75, DOI 10.1111/j.1469-7998.2010.00709.x; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368; Zentall TR, 2012, J COMP PSYCHOL, V126, P114, DOI 10.1037/a0025381	38	26	26	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88415	10.1371/journal.pone.0088415	http://dx.doi.org/10.1371/journal.pone.0088415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516654	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400067
J	Staudacher, I; Jehle, J; Staudacher, K; Pledl, HW; Lemke, D; Schweizer, PA; Becker, R; Katus, HA; Thomas, D				Staudacher, Ingo; Jehle, Julian; Staudacher, Kathrin; Pledl, Hans-Werner; Lemke, Dieter; Schweizer, Patrick A.; Becker, Ruediger; Katus, Hugo A.; Thomas, Dierk			Herg K+ Channel-Dependent Apoptosis and Cell Cycle Arrest in Human Glioblastoma Cells	PLOS ONE			English	Article							PERSISTENT ATRIAL-FIBRILLATION; DOXAZOSIN INDUCES APOPTOSIS; POTASSIUM CHANNELS; PROTEIN TRAFFICKING; TYROSINE KINASE; GENE-THERAPY; INHIBITION; CARDIOMYOCYTES; RECEPTOR; GLIOMA	Glioblastoma (GB) is associated with poor patient survival owing to uncontrolled tumor proliferation and resistance to apoptosis. Human ether-a-go-go-related gene K+ channels (hERG; Kv11.1, KCNH2) are expressed in multiple cancer cells including GB and control cell proliferation and death. We hypothesized that pharmacological targeting of hERG protein would inhibit tumor growth by inducing apoptosis of GB cells. The small molecule hERG ligand doxazosin induced concentration-dependent apoptosis of human LNT-229 (EC50= 35 mu M) and U87MG (EC50= 29 mu M) GB cells, accompanied by cell cycle arrest in the G0/G1 phase. Apoptosis was associated with 64% reduction of hERG protein. HERG suppression via siRNA-mediated knock down mimicked pro-apoptotic effects of doxazosin. Antagonism of doxazosin binding by the non-apoptotic hERG ligand terazosin resulted in rescue of protein expression and in increased survival of GB cells. At the molecular level doxazosin-dependent apoptosis was characterized by activation of pro-apoptotic factors (phosphoerythropoietin-producing human hepatocellular carcinoma receptor tyrosine kinase A2, phospho-p38 mitogen-activated protein kinase, growth arrest and DNA damage inducible gene 153, cleaved caspases 9, 7, and 3), and by inactivation of antiapoptotic poly-ADP-ribose-polymerase, respectively. In summary, this work identifies doxazosin as small molecule compound that promotes apoptosis and exerts anti-proliferative effects in human GB cells. Suppression of hERG protein is a crucial molecular event in GB cell apoptosis. Doxazosin and future derivatives are proposed as novel options for more effective GB treatment.	[Staudacher, Ingo; Jehle, Julian; Schweizer, Patrick A.; Becker, Ruediger; Katus, Hugo A.; Thomas, Dierk] Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany; [Staudacher, Kathrin] Univ Heidelberg Hosp, Dept Neonatol, Heidelberg, Germany; [Pledl, Hans-Werner; Lemke, Dieter] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Pledl, Hans-Werner; Lemke, Dieter] German Canc Res Ctr, German Canc Consortium, Clin Cooperat Unit Neurooncol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Thomas, D (corresponding author), Univ Heidelberg Hosp, Dept Cardiol, Heidelberg, Germany.	dierk.thomas@med.uni-heidelberg.de	Thomas, Dierk/ABA-4706-2021; Thomas, Dierk/V-3940-2017	Thomas, Dierk/0000-0002-5687-7843; 	German Heart Foundation/German Foundation of Heart Research [F/06/10]; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation	German Heart Foundation/German Foundation of Heart Research; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation	This work was supported in part by grants from the German Heart Foundation/German Foundation of Heart Research (Kaltenbach Scholarship to J.J., project F/06/10 to D. T.), from the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research) (to H. A. K. and D. T.), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D. T.), and from the Joachim Siebeneicher Foundation (to D. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Assi H, 2012, NEUROSCI LETT, V527, P71, DOI 10.1016/j.neulet.2012.08.003; Bikou O, 2011, CARDIOVASC RES, V92, P218, DOI 10.1093/cvr/cvr209; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; El Harchi A, 2012, J MOL CELL CARDIOL, V52, P185, DOI 10.1016/j.yjmcc.2011.09.021; ELLIOTT HL, 1987, AM J CARDIOL, V59, pG78, DOI 10.1016/0002-9149(87)90162-7; Fawzy A, 1999, UROLOGY, V53, P329, DOI 10.1016/S0090-4295(98)00506-8; Fernando MA, 2005, MOL ENDOCRINOL, V19, P3085, DOI 10.1210/me.2004-0471; FRICK MH, 1986, BRIT J CLIN PHARMACO, V21, pS55, DOI 10.1111/j.1365-2125.1986.tb02854.x; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Glassmeier G, 2012, PFLUG ARCH EUR J PHY, V463, P365, DOI 10.1007/s00424-011-1045-z; Gonzalez-Juanatey JR, 2003, CIRCULATION, V107, P127, DOI 10.1161/01.CIR.0000043803.20822.D1; Jehle J, 2013, BRIT J PHARMACOL, V168, P1215, DOI 10.1111/bph.12002; Jehle J, 2012, BRIT J PHARMACOL, V167, P1563, DOI 10.1111/j.1476-5381.2012.02117.x; Jehle J, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.77; Kinch MS, 2003, CLIN EXP METASTAS, V20, P59, DOI 10.1023/A:1022546620495; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Lacerda AE, 2001, EUR HEART J SUPPL, V3, pK23, DOI 10.1016/S1520-765X(01)90003-3; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Obers S, 2010, N-S ARCH PHARMACOL, V381, P385, DOI 10.1007/s00210-010-0496-7; Petty A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042120; Ravens U, 2008, EUROPACE, V10, P1133, DOI 10.1093/europace/eun193; Rieger J, 2008, J NEUROCHEM, V106, P2436, DOI 10.1111/j.1471-4159.2008.05586.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SHIONOIRI H, 1987, J CARDIOVASC PHARM, V10, P90, DOI 10.1097/00005344-198707000-00013; Soucek R, 2012, HEART RHYTHM, V9, P265, DOI 10.1016/j.hrthm.2011.09.008; Staudacher I, 2011, N-S ARCH PHARMACOL, V383, P119, DOI 10.1007/s00210-010-0583-9; Staudacher I, 2010, CURR OPIN DRUG DISC, V13, P23; Thomas D, 2004, N-S ARCH PHARMACOL, V369, P462, DOI 10.1007/s00210-004-0931-8; Thomas D, 2006, CURR PHARM DESIGN, V12, P2271, DOI 10.2174/138161206777585102; Thomas D, 2003, N-S ARCH PHARMACOL, V368, P41, DOI 10.1007/s00210-003-0766-8; Thomas D, 2008, EUR J PHARMACOL, V579, P98, DOI 10.1016/j.ejphar.2007.10.051; Trappe K, 2013, EUR HEART J, V34, P147, DOI 10.1093/eurheartj/ehr269; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wick W, 1999, ONCOGENE, V18, P3936, DOI 10.1038/sj.onc.1202774; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244	36	37	39	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88164	10.1371/journal.pone.0088164	http://dx.doi.org/10.1371/journal.pone.0088164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516604	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700051
J	Maciejewski, K; Kerley, GIH				Maciejewski, Kristine; Kerley, Graham I. H.			Understanding Tourists' Preference for Mammal Species in Private Protected Areas: Is There a Case for Extralimital Species for Ecotourism?	PLOS ONE			English	Article							BIODIVERSITY	Private Protected Areas (PPAs) often use wildlife-based ecotourism as their primary means of generating business. Achieving tourist satisfaction has become a strong driving goal in the management of many PPAs, often at the expense of biodiversity. Many extralimitral species, those which historically did not occur in an area, are stocked in PPAs with the intention of increasing ecotourism attractions. Even though the ecological and economic costs of stocking these species are high, the social benefits are not understood and little information exists globally on the ecotourism role of extralimital species. This study assessed the value of stocking extralimital species using questionnaire-based surveys and observing tourists in Shamwari Private Game Reserve in the Eastern Cape Province of South Africa. No difference was found between indigenous and extralimital species with regards to the tourists' weighted scoring system, average amount tourists were willing to pay, total viewing time, average viewing time or the likelihood of stopping to view species when encountered on game drives. During game drives a strong preference was found for the elephant (Loxodonta africana), lion (Panthera leo), leopard (Panthera pardus) and cheetah (Acynonix jubatus). With the exception of the cheetah, these species are all members of the "big five" and are indigenous. Species availability and visibility, however, may influence the amount of time tourists spend at an animal sighting. Our analysis suggests that certain extralimital species (typically larger and charismatic species) contribute to tourist satisfaction, while particularly the smaller extralimital species add little to the game viewing experience, but add to the costs and risks of the PPAs. We recommend that extralimital species introductions for ecotourism purposes should be approached with caution with regards to the risks to the sustainability of PPAs.	[Maciejewski, Kristine; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa	Nelson Mandela University	Maciejewski, K (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa.	krismacski@gmail.com			National Research Foundation; Nelson Mandela Metropolitan University	National Research Foundation; Nelson Mandela Metropolitan University	This research was funded by the National Research Foundation and the Nelson Mandela Metropolitan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2004, PERS SOC PSYCHOL B, V30, P1108, DOI 10.1177/0146167204264079; Akama JS, 2003, TOURISM MANAGE, V24, P73, DOI 10.1016/S0261-5177(02)00044-4; ANGERMEIER PL, 1994, CONSERV BIOL, V8, P600, DOI 10.1046/j.1523-1739.1994.08020600.x; [Anonymous], 1979, ETHICAL PRINCIPLES G; Arponen A, 2005, CONSERV BIOL, V19, P2009, DOI 10.1111/j.1523-1739.2005.00218.x; Barnes JI, 1999, 15 DEA; BATEMAN I., 2002, EC VALUATION STATED; Blignaut JN, 2004, EC DEV LESS APPL ENV; Carter E, 2008, ORYX, V42, P177, DOI 10.1017/S0030605308007655; Castley JG, 2001, S AFR J SCI, V97, P344; Clasen DL, 1994, J AGR ED, V35; Cooke IR, 2009, J APPL ECOL, V46, P269, DOI 10.1111/j.1365-2664.2009.01615.x; Cousins J. A., 2010, ECOLOGY SOC, V15, P28, DOI DOI 10.5751/ES-03349-150228; Cousins JA, 2008, ECOL SOC, V13; Daehler CC, 1997, TRENDS ECOL EVOL, V12, P424, DOI 10.1016/S0169-5347(97)01206-8; Dharmaratne GS, 2000, ANN TOURISM RES, V27, P590, DOI 10.1016/S0160-7383(99)00109-7; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Hall-Martin A, 2002, ELEPHANT CONSERVATIO, P20; Horton B, 2003, ENVIRON CONSERV, V30, P139, DOI 10.1017/S0376892903000122; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kerley GIH, 2003, S AFR J WILDL RES, V33, P13; King L., 2012, PARKS, V18, P55, DOI [10.2305/IUCN.CH.2012.PARKS-18-2.LMK.en, DOI 10.2305/IUCN.CH.2012.PARKS-18-2.LMK.EN]; Langholz JA, 2006, 56 N MAND METR U CTR; Lindsey Peter A., 2007, Journal of Ecotourism, V6, P19, DOI 10.2167/joe133.0; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin-Lopez B, 2007, ENVIRON CONSERV, V34, P215, DOI 10.1017/S0376892907004067; Mucina L., 2006, STRELIZIA, V19; Novellie P, 1991, SPECIAL PUBLICATION, P11; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Parker DM, 2005, J ZOOL, V267, P203, DOI 10.1017/S0952836905007399; Pienaar DJ, 1994, P S RHIN GAM RANCH A; Seaton A. V., 2002, Journal of Vacation Marketing, V8, P309, DOI 10.1177/135676670200800402; Sims-Castley R., 2005, PARKS, V15, P6; Skead C.J., 2007, HIST INCIDENCE LARGE, V2nd Edn; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Tisdell C, 2007, ECOL ECON, V60, P627, DOI 10.1016/j.ecolecon.2006.01.007; Walpole MJ, 2002, BIODIVERS CONSERV, V11, P543, DOI 10.1023/A:1014864708777; Zar J.H., 2010, BIOSTAT ANAL	38	40	42	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88192	10.1371/journal.pone.0088192	http://dx.doi.org/10.1371/journal.pone.0088192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505426	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200133
J	Shen, MG; Tang, YH; Chen, J; Yang, X; Wang, C; Cui, XY; Yang, YP; Han, LJ; Li, L; Du, JH; Zhang, GX; Cong, N				Shen, Miaogen; Tang, Yanhong; Chen, Jin; Yang, Xi; Wang, Cong; Cui, Xiaoyong; Yang, Yongping; Han, Lijian; Li, Le; Du, Jianhui; Zhang, Gengxin; Cong, Nan			Earlier-Season Vegetation Has Greater Temperature Sensitivity of Spring Phenology in Northern Hemisphere	PLOS ONE			English	Article							LAND-SURFACE PHENOLOGY; GREEN-UP DATES; CLIMATE-CHANGE; FORECASTING PHENOLOGY; TIBETAN PLATEAU; THERMAL TIME; BUD-BURST; RESPONSES; BUDBURST; WINTER	In recent decades, satellite-derived start of vegetation growing season (SOS) has advanced in many northern temperate and boreal regions. Both the magnitude of temperature increase and the sensitivity of the greenness phenology to temperature-the phenological change per unit temperature-can contribute the advancement. To determine the temperature-sensitivity, we examined the satellite-derived SOS and the potentially effective pre-season temperature (T-eff) from 1982 to 2008 for vegetated land between 30 degrees N and 80 degrees N. Earlier season vegetation types, i.e., the vegetation types with earlier SOSmean (mean SOS for 1982-2008), showed greater advancement of SOS during 1982-2008. The advancing rate of SOS against year was also greater in the vegetation with earlier SOSmean even the T-eff increase was the same. These results suggest that the spring phenology of vegetation may have high temperature sensitivity in a warmer area. Therefore it is important to consider temperature-sensitivity in assessing broad-scale phenological responses to climatic warming. Further studies are needed to explore the mechanisms and ecological consequences of the temperature-sensitivity of start of growing season in a warming climate.	[Shen, Miaogen; Yang, Yongping; Zhang, Gengxin] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Shen, Miaogen; Tang, Yanhong] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Chen, Jin; Wang, Cong] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China; [Yang, Xi] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Cui, Xiaoyong] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Han, Lijian] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Li, Le] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Du, Jianhui] Sun Yat Sen Univ, Sch Geog Sci & Planning, Guangzhou 510275, Guangdong, Peoples R China; [Cong, Nan] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; National Institute for Environmental Studies - Japan; Beijing Normal University; Brown University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Botany, CAS; Sun Yat Sen University; Peking University	Shen, MG (corresponding author), Chinese Acad Sci, Inst Tibetan Plateau Res, 4A Datun Rd, Beijing, Peoples R China.	shen.miaogen@gmail.com; zhangg@itpcas.ac.cn	Tang, Yanhong/B-1699-2010; Yang, Xi/AAD-2060-2021; Shen, Miaogen/A-8374-2011; Cui, Xiaoyong/B-3669-2016; Yang, Xi/B-8064-2014; Chen, Jin/A-6417-2011	Tang, Yanhong/0000-0001-7207-1965; Yang, Xi/0000-0002-5095-6735; Shen, Miaogen/0000-0001-5742-8807; Cui, Xiaoyong/0000-0001-7592-5866; Yang, Xi/0000-0002-5095-6735; Chen, Jin/0000-0002-6497-4141; Shen, Mouquan/0000-0001-6448-4866; han, li jian/0000-0003-3118-2436	National Natural Science Foundation of China [41201459]; Strategic Japanese-Chinese Cooperative Program on Climate Change; Japan Science and Technology Agency; Centre for Global Environmental Research of the National Institute for Environmental Studies, Japan; Chinese Academy of Sciences [XDB03030404]; State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Japanese-Chinese Cooperative Program on Climate Change; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Centre for Global Environmental Research of the National Institute for Environmental Studies, Japan; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University	The study was supported by the following research funds: a grant from the National Natural Science Foundation of China to M. Shen (Grant No. 41201459), "Integrated assessment and prediction of carbon dynamics in relation to climate changes in grasslands on the Qinghai-Tibetan and Mongolian Plateaus", conducted under the auspices of the Strategic Japanese-Chinese Cooperative Program on Climate Change, funded by the Japan Science and Technology Agency; funds from the Centre for Global Environmental Research of the National Institute for Environmental Studies, Japan; a grant from the "Strategic Priority Research Program (B)" of the Chinese Academy of Sciences (Grant No. XDB03030404); and a project supported by the State Key Laboratory of Earth Surface Processes and Resource Ecology, Beijing Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Barr A, 2009, CLIMATIC PHENOLOGICA; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Basler D, 2012, AGR FOREST METEOROL, V165, P73, DOI 10.1016/j.agrformet.2012.06.001; Bennie J, 2010, GLOBAL CHANGE BIOL, V16, P1503, DOI 10.1111/j.1365-2486.2009.02095.x; Bicheron P., 2008, GLOBCOVER PRODUCTS D; Busetto L, 2010, GLOBAL CHANGE BIOL, V16, P2504, DOI 10.1111/j.1365-2486.2010.02189.x; CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Chuine I, 1999, NEW PHYTOL, V143, P339, DOI 10.1046/j.1469-8137.1999.00445.x; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 2010, SCIENCE, V329, P277, DOI 10.1126/science.329.5989.277-e; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Cong N, 2013, GLOBAL CHANGE BIOL, V19, P881, DOI 10.1111/gcb.12077; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Crimmins TM, 2010, J ECOL, V98, P1042, DOI 10.1111/j.1365-2745.2010.01696.x; de Beurs KM, 2005, GLOBAL CHANGE BIOL, V11, P779, DOI 10.1111/j.1365-2486.2005.00949.x; Delbart N, 2006, REMOTE SENS ENVIRON, V101, P52, DOI 10.1016/j.rse.2005.11.012; Diez JM, 2012, ECOL LETT, V15, P545, DOI 10.1111/j.1461-0248.2012.01765.x; Dunn AH, 2011, REMOTE SENS ENVIRON, V115, P1220, DOI 10.1016/j.rse.2011.01.005; Fisher JI, 2007, GLOBAL CHANGE BIOL, V13, P707, DOI 10.1111/j.1365-2486.2006.01311.x; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Fu YSH, 2013, AGR FOREST METEOROL, V181, P125, DOI 10.1016/j.agrformet.2013.07.016; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Fu YSH, 2012, ECOL MODEL, V230, P92, DOI 10.1016/j.ecolmodel.2012.01.010; Gu L, 2008, BIOSCIENCE, V58, P253, DOI 10.1641/B580311; Gunderson CA, 2012, GLOBAL CHANGE BIOL, V18, P2008, DOI 10.1111/j.1365-2486.2011.02632.x; Guyon D, 2011, REMOTE SENS ENVIRON, V115, P615, DOI 10.1016/j.rse.2010.10.006; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; HEIDE OM, 1993, PHYSIOL PLANTARUM, V88, P531, DOI 10.1111/j.1399-3054.1993.tb01368.x; Ibanez I, 2010, PHILOS T R SOC B, V365, P3247, DOI 10.1098/rstb.2010.0120; Jeong S.-J., 2009, GEOPHYS RES LETT, V36; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jeong SJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036583; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Mao JF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014010; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Migliavacca M, 2012, BIOGEOSCIENCES, V9, P2063, DOI 10.5194/bg-9-2063-2012; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morin X, 2010, NEW PHYTOL, V186, P900, DOI 10.1111/j.1469-8137.2010.03252.x; Morisette JT, 2009, FRONT ECOL ENVIRON, V7, P253, DOI 10.1890/070217; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Reed Bradley C., 2009, P231, DOI 10.1007/978-1-4419-0026-5_10; Richardson AD, 2012, GLOBAL CHANGE BIOL, V18, P566, DOI 10.1111/j.1365-2486.2011.02562.x; Richardson AD, 2009, ECOL APPL, V19, P1417, DOI 10.1890/08-2022.1; Richardson AD, 2009, TREE PHYSIOL, V29, P321, DOI 10.1093/treephys/tpn040; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Shen MG, 2014, AGR FOREST METEOROL, V189, P71, DOI 10.1016/j.agrformet.2014.01.003; Shen MG, 2013, P NATL ACAD SCI USA, V110, pE2329, DOI 10.1073/pnas.1304625110; Shen MG, 2012, CLIMATIC CHANGE, V114, P783, DOI 10.1007/s10584-012-0434-4; Shen MG, 2011, AGR FOREST METEOROL, V151, P1711, DOI 10.1016/j.agrformet.2011.07.003; Shen MG, 2011, P NATL ACAD SCI USA, V108, pE91, DOI 10.1073/pnas.1018390108; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tucker C.J., 2004, GLOBAL INVENTORY MOD; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Wang T, 2013, GLOBAL CHANGE BIOL; Wang T, 2013, P NATL ACAD SCI USA, V110, pE2854, DOI 10.1073/pnas.1306157110; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wolkovich EM, 2013, NEW PHYTOL; Xu L, 2013, NAT CLIM CHANGE, V3, P581, DOI [10.1038/nclimate1836, 10.1038/NCLIMATE1836]; Yang X, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001977; Yu FF, 2003, REMOTE SENS ENVIRON, V87, P42, DOI 10.1016/S0034-4257(03)00144-5; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang XY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031447; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x; Zhu ZC, 2013, REMOTE SENS-BASEL, V5, P927, DOI 10.3390/rs5020927	80	50	54	8	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88178	10.1371/journal.pone.0088178	http://dx.doi.org/10.1371/journal.pone.0088178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505418	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200130
J	Sola, I; Carrasco, JM; del Campo, PD; Gracia, J; Orrego, C; Martinez, F; Kotzeva, A; Guillamon, I; Calderon, E; de Gaminde, I; Louro, A; Rotaeche, R; Salcedo, F; Velazquez, P; Alonso-Coello, P				Sola, Ivan; Miguel Carrasco, Jose; Diaz del Campo, Petra; Gracia, Javier; Orrego, Carola; Martinez, Flora; Kotzeva, Anna; Guillamon, Imma; Calderon, Enrique; de Gaminde, Idoia; Louro, Arturo; Rotaeche, Rafael; Salcedo, Flavia; Velazquez, Paola; Alonso-Coello, Pablo			Attitudes and Perceptions about Clinical Guidelines: A Qualitative Study with Spanish Physicians	PLOS ONE			English	Article							GPS ATTITUDES; RECOMMENDATIONS; PREFERENCES; STRENGTH; SYSTEMS; SYMBOLS; NUMBERS; WORDS	Background: Clinical guidelines (CGs) are popular for healthcare decision making but their acceptability and use by healthcare providers is influenced by numerous factors. Some of these factors are professional-related, such as knowledge and perceptions of and attitudes toward CGs in general. The aim of our study was to evaluate attitudes and perceptions of Spanish physicians towards CGs. Methods: We coordinated six discussion groups with a total of 46 physicians. The participants were drawn from 12 medical specialties from both specialized and primary care. We recorded the sessions and transcribed the content verbatim. We analyzed the data using an approach based on the grounded theory. Results: We identified two main constructs that defined the physicians' perceptions towards guidelines: knowledge and usefulness. "Knowledge" defined the theoretical meanings of guidelines, while "Usefulness" referred to the pragmatic approach to guidelines. These constructs were interrelated through a series of categories such as confidence, usability, accessibility, dissemination and formats. Conclusions: In our study, the constructs that impacted most on physician's attitudes to clinical guidelines were knowledge and usefulness. The tension between the theoretical and the pragmatic constructs determined the attitudes and how physicians use guidelines. Groups developing guidelines should ask relevant clinical questions and develop implementable and context specific recommendations. Developers should be explicit and consistent in the development and presentation of recommendations.	[Sola, Ivan; Velazquez, Paola; Alonso-Coello, Pablo] Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Clin Epidemiol & Publ Hlth Dept, Barcelona, Spain; [Miguel Carrasco, Jose] Univ Navarra, Inst Culture & Soc, E-31080 Pamplona, Spain; [Kotzeva, Anna; Guillamon, Imma] Agcy Hlth Qual & Assessment Catalonia AQuAS, Barcelona, Spain; [Sola, Ivan; Alonso-Coello, Pablo] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Diaz del Campo, Petra; Gracia, Javier; de Gaminde, Idoia; Rotaeche, Rafael; Salcedo, Flavia; Alonso-Coello, Pablo] Sci Comm Guiasalud, Natl Clin Practice Guideline Programme NHS, Madrid, Spain; [Calderon, Enrique] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla, Seville, Spain; [de Gaminde, Idoia] Dept Salud Gobierno Navarra, Serv Docencia & Desarrollo Sanitarios, Navarra, Spain; [Louro, Arturo] Xerencia Atenc Primaria A Coruna, Ctr Saude Cambre, La Coruna, Spain; [Martinez, Flora] Andalusian Reg Minist Hlth & Social Well Being, Gen Secretariat Publ Hlth Social Inclus & Qual Li, Seville, Spain; [Orrego, Carola] Avedis Donabedian Res Inst FAD, Barcelona, Spain; [Rotaeche, Rafael] Ctr Salud Alza, Grp Kronikgune Gest Conocimiento, Donostia San Sebastian, Spain; [Salcedo, Flavia] Inst Aragones Ciencias Salud, Zaragoza, Spain; [Orrego, Carola] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Orrego, Carola] Red Invest Serv Salud Enfermedades Cronicas REDIS, Barcelona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Complejo Hospitalario Universitario A Coruna; Autonomous University of Barcelona	Alonso-Coello, P (corresponding author), Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, Clin Epidemiol & Publ Hlth Dept, Barcelona, Spain.	palonso@santpau.cat	IBIS, EPIDEMIOLOGIA/O-8791-2015; Carrasco, JosÃ© Miguel/I-3482-2015; Calderon, Enrique j/A-1997-2013; Gaminde, Idoia/B-7981-2008	Carrasco, JosÃ© Miguel/0000-0002-3847-8312; Calderon, Enrique j/0000-0002-3166-5086; Gaminde, Idoia/0000-0002-0275-8849; Louro-Gonzalez, Arturo/0000-0002-8334-9210; Orrego, Carola/0000-0002-2978-6268; Sola, Ivan/0000-0003-0078-3706; Alonso-Coello, Pablo/0000-0002-8001-8504; Rotaeche, Rafael/0000-0001-5594-3768	Instituto de Salud Carlos III; European Regional Development Fund [PI08/90647]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission)	This project has been funded by the Instituto de Salud Carlos III, co-financed by the European Regional Development Fund (PI08/90647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2007, J CLIN EPIDEMIOL, V60, P1298, DOI 10.1016/j.jclinepi.2007.03.011; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Carlsen B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-218; Curtis S, 2000, SOC SCI MED, V50, P1001, DOI 10.1016/S0277-9536(99)00350-0; Dahm P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-17; Farquhar CM, 2002, MED J AUSTRALIA, V177, P502, DOI 10.5694/j.1326-5377.2002.tb04920.x; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; Green J, 2009, QUALITATIVE METHODS; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hayward RSA, 1997, CAN MED ASSOC J, V156, P1715; Heselmans A, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-64; Hirsh J, 2009, LANCET, V374, P273, DOI 10.1016/S0140-6736(09)60787-X; Houlihan NG, 2011, FOCUS GROUP KIT, V23, P42; IOM (Institute of Medicine), 2011, CLIN PRACTICE GUIDEL; Kotzeva A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-328; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P367, DOI 10.1136/qshc.2005.014100; Michie S, 2004, BRIT MED J, V328, P343, DOI 10.1136/bmj.328.7435.343; Morillo Garcia A., 2005, 21 C SADEMI JER LIBR, P131; Phillips N., 2002, DISCOURSE ANAL INVES; Pope C., 2020, QUALITATIVE RES HLTH; Schunemann HJ, 2003, CAN MED ASSOC J, V169, P677; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Tuckett Anthony G, 2004, Nurse Res, V12, P47; van der Weijden T, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-10; Vandvik PO, 2013, CHEST, V144, P381, DOI 10.1378/chest.13-0746	27	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86065	10.1371/journal.pone.0086065	http://dx.doi.org/10.1371/journal.pone.0086065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505253	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200013
J	Sun, CC; Fuller, AK; Royle, JA				Sun, Catherine C.; Fuller, Angela K.; Royle, J. Andrew			Trap Configuration and Spacing Influences Parameter Estimates in Spatial Capture-Recapture Models	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; MARK-RECAPTURE; DENSITY-ESTIMATION; PROBABILITY; DESIGN; ROBUST; BEARS; BIAS	An increasing number of studies employ spatial capture-recapture models to estimate population size, but there has been limited research on how different spatial sampling designs and trap configurations influence parameter estimators. Spatial capture-recapture models provide an advantage over non-spatial models by explicitly accounting for heterogeneous detection probabilities among individuals that arise due to the spatial organization of individuals relative to sampling devices. We simulated black bear (Ursus americanus) populations and spatial capture-recapture data to evaluate the influence of trap configuration and trap spacing on estimates of population size and a spatial scale parameter, sigma, that relates to home range size. We varied detection probability and home range size, and considered three trap configurations common to large-mammal mark-recapture studies: regular spacing, clustered, and a temporal sequence of different cluster configurations (i.e., trap relocation). We explored trap spacing and number of traps per cluster by varying the number of traps. The clustered arrangement performed well when detection rates were low, and provides for easier field implementation than the sequential trap arrangement. However, performance differences between trap configurations diminished as home range size increased. Our simulations suggest it is important to consider trap spacing relative to home range sizes, with traps ideally spaced no more than twice the spatial scale parameter. While spatial capture-recapture models can accommodate different sampling designs and still estimate parameters with accuracy and precision, our simulations demonstrate that aspects of sampling design, namely trap configuration and spacing, must consider study area size, ranges of individual movement, and home range sizes in the study population.	[Sun, Catherine C.] Cornell Univ, Dept Nat Resources, New York Cooperat Fish & Wildlife Res Unit, Ithaca, NY 14853 USA; [Fuller, Angela K.] Cornell Univ, Dept Nat Resources, New York Cooperat Fish & Wildlife Res Unit, US Geol Survey, Ithaca, NY 14853 USA; [Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	Cornell University; Cornell University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Sun, CC (corresponding author), Cornell Univ, Dept Nat Resources, New York Cooperat Fish & Wildlife Res Unit, Fernow Hall, Ithaca, NY 14853 USA.	cs752@cornell.edu			The New York State Department of Environmental Conservation	The New York State Department of Environmental Conservation	The New York State Department of Environmental Conservation provided the funding that supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt G.L., 1980, Bear Biology Association Conference Series, P131; BONDRUPNIELSEN S, 1983, CAN J ZOOL, V61, P2361, DOI 10.1139/z83-313; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford Murry, 2004, Oikos, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Fecske DM, 2002, SOUTHEAST NAT, V1, P77, DOI 10.1656/1528-7092(2002)001[0077:HUBFBB]2.0.CO;2; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Frary VJ, 2011, WILDLIFE BIOL, V17, P404, DOI 10.2981/09-103; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Grogan Ronald G., 1999, Ursus, V11, P117; Harris Richard B., 2002, Acta Zoologica Sinica, V48, P812; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 1998, ECOLOGY, V79, P2852; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Knaus J, 2013, SNOWFALL EASIER CLUS; Long RA, 2007, J WILDLIFE MANAGE, V71, P2018, DOI 10.2193/2006-292; Marques TA, 2011, ECOLOGY, V92, P526, DOI 10.1890/10-1440.1; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Parmenter RR, 2003, ECOL MONOGR, V73, P1, DOI 10.1890/0012-9615(2003)073[0001:SMDEAF]2.0.CO;2; Pearson DE, 2003, WILDLIFE SOC B, V31, P454; Pledger S, 1998, BIOMETRICS, V54, P888, DOI 10.2307/2533843; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; R Core Team, 2012, R LANG ENV STAT COMP; READ VT, 1988, AUST WILDLIFE RES, V15, P673; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Settlage KE, 2008, J WILDLIFE MANAGE, V72, P1035, DOI 10.2193/2006-472; Sevcikova H., 2012, RLECUYER R INTERFACE; Sollmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034575; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441	42	129	130	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88025	10.1371/journal.pone.0088025	http://dx.doi.org/10.1371/journal.pone.0088025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505361	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200100
J	Chang, S; Song, S; Lee, J; Yoon, J; Park, J; Choi, S; Park, JK; Choi, K; Choi, C				Chang, Soyoung; Song, Seungjeong; Lee, Jungsul; Yoon, Jonghee; Park, Junseong; Choi, Sungyoung; Park, Je-Kyun; Choi, Kyungsun; Choi, Chulhee			Phenotypic Modulation of Primary Vascular Smooth Muscle Cells by Short-Term Culture on Micropatterned Substrate	PLOS ONE			English	Article							NEOINTIMAL LESION FORMATION; PROLIFERATION; MIGRATION; ATHEROSCLEROSIS; FIBRONECTIN; EXPRESSION; NANOSCALE; CUES	Loss of contractility and acquisition of an epithelial phenotype of vascular smooth muscle cells (VSMCs) are key events in proliferative vascular pathologies such as atherosclerosis and post-angioplastic restenosis. There is no proper cell culture system allowing differentiation of VSMCs so that it is difficult to delineate the molecular mechanism responsible for proliferative vasculopathy. We investigated whether a micropatterned substrate could restore the contractile phenotype of VSMCs in vitro. To induce and maintain the differentiated VSMC phenotype in vitro, we introduced a micropatterned groove substrate to modulate the morphology and function of VSMCs. Later than 7th passage of VSMCs showed typical synthetic phenotype characterized by epithelial morphology, increased proliferation rates and corresponding gene expression profiles; while short-term culture of these cells on a micropatterned groove induced a change to an intermediate phenotype characterized by low proliferation rates, increased migration, a spindle-like morphology associated with cytoskeletal rearrangement and expression of muscle-specific genes. Microarray analysis showed preferential expression of contractile and smooth muscle cell-specific genes in cells cultured on the micropatterned groove. Culture on a patterned groove may provide a valuable model for the study the role of VSMCs in normal vascular physiology and a variety of proliferative vascular diseases.	[Chang, Soyoung; Song, Seungjeong; Lee, Jungsul; Yoon, Jonghee; Park, Junseong; Park, Je-Kyun; Choi, Kyungsun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Park, Junseong; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea; [Choi, Sungyoung] Kyung Hee Univ, Dept Biomed Engn, Yongin, Gyeonggi Do, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Kyung Hee University	Choi, K (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	ccbioks@kaist.ac.kr; cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011; Park, Je-Kyun/A-4911-2011; Lee, Jungsul/A-7851-2013; Park, Junseong/C-1973-2012	Choi, Chulhee/0000-0001-5542-9136; Park, Je-Kyun/0000-0003-4522-2574; Lee, Jungsul/0000-0002-8600-5851; Yoon, Jonghee/0000-0003-3886-2792; Park, Junseong/0000-0003-0436-8614	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST) [2011-0019697]	Bio and Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MEST)	This work was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (No. 2011-0019697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axel DI, 1997, CIRCULATION, V96, P636; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; CHAMLEY JH, 1977, CELL TISSUE RES, V177, P503; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Gallego-Perez D, 2012, LAB CHIP, V12, P4424, DOI 10.1039/c2lc40726d; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Hasirci V, 2012, NANOMEDICINE-UK, V7, P1375, DOI 10.2217/NNM.12.7; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Park JM, 2013, BIORESOURCE TECHNOL, V135, P1, DOI 10.1016/j.biortech.2013.03.132; Park J, 2012, HEPATOLOGY, V56, P831, DOI 10.1002/hep.25726; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058	23	65	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88089	10.1371/journal.pone.0088089	http://dx.doi.org/10.1371/journal.pone.0088089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4NZ	24505388	gold, Green Published, Green Submitted			2022-12-27	WOS:000336843400002
J	Zhou, XF; Su, FY; Tian, YQ; Meldrum, DR				Zhou, Xianfeng; Su, Fengyu; Tian, Yanqing; Meldrum, Deirdre R.			Dually Fluorescent Core-Shell Microgels for Ratiometric Imaging in Live Antigen-Presenting Cells	PLOS ONE			English	Article							SINGLE LIVING CELLS; DISSOLVED-OXYGEN; OPTICAL NANOSENSORS; CHEMICAL-ANALYSIS; SENSORS; PH; LUMINESCENCE; MACROPHAGES; COPOLYMER; DELIVERY	Core-shell microgels containing sensors/dyes in a matrix were fabricated by two-stage free radical precipitation polymerization method for ratiometric sensing/imaging. The microgels composing of poly(N-isopropylacrylamide) (PNIPAm) shell exhibits a low critical solution temperature (LCST), underwent an entropically driven transition from a swollen state to a deswollen state, which exhibit a hydrodynamic radius of similar to 450 nm at 25 degrees C (in vitro) and similar to 190 nm at 37 degrees C (in vivo). The microgel's ability of escaping from lysosome into cytosol makes the microgel be a potential candidate for cytosolic delivery of sensors/probes. Non-invasive imaging/sensing in Antigen-presenting cells (APCs) was feasible by monitoring the changes of fluorescence intensity ratios. Thus, these biocompatible microgels-based imaging/sensing agents may be expected to expand current molecular imaging/sensing techniques into methods applicable to studies in vivo, which could further drive APC-based treatments.	[Zhou, Xianfeng; Su, Fengyu; Tian, Yanqing; Meldrum, Deirdre R.] Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Tian, YQ (corresponding author), Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85287 USA.	yanqing.tian@asu.edu	Su, Fengyu/ABE-2523-2021; Zhou, Xianfeng/B-6957-2013; Tian, Yanqing/N-1506-2019; Su, Fengyu/V-1014-2018; Tian, Yanqing/C-1423-2013	Zhou, Xianfeng/0000-0002-1408-3180; Tian, Yanqing/0000-0002-1441-2431; Su, Fengyu/0000-0003-1922-9182; Tian, Yanqing/0000-0002-1441-2431	NIH [5P50 HG002360]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH 5P50 HG002360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Burns A, 2006, SMALL, V2, P723, DOI 10.1002/smll.200600017; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Cao YF, 2004, ANALYST, V129, P745, DOI 10.1039/b403086a; Chen YC, 2010, NANOTECHNOLOGY, V21; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Clark HA, 1999, ANAL CHEM, V71, P4831, DOI 10.1021/ac990629o; Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n; Cohen JA, 2009, BIOCONJUGATE CHEM, V20, P111, DOI 10.1021/bc800338n; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Filipova TZ, 1997, J POLYM SCI POL CHEM, V35, P1069, DOI 10.1002/(SICI)1099-0518(19970430)35:6<1069::AID-POLA10>3.3.CO;2-M; Gan DJ, 2001, J AM CHEM SOC, V123, P8203, DOI 10.1021/ja015974l; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Grabtschev IK, 1996, Z NATURFORSCH A, V51, P1185, DOI 10.1515/zna-1996-1207; HARDING CV, 1994, J IMMUNOL, V153, P4925; Jakubiak R, 1999, J PHYS CHEM A, V103, P2394, DOI 10.1021/jp9839450; Jin YG, 2010, ANAL BIOANAL CHEM, V398, P1375, DOI 10.1007/s00216-010-4060-6; Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m; Kim TH, 2006, J NANOSCI NANOTECHNO, V6, P2796, DOI 10.1166/jnn.2006.434; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; LabatMoleur F, 1996, GENE THER, V3, P1010; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; McDonagh C, 1998, ANAL CHEM, V70, P45, DOI 10.1021/ac970461b; Molter TW, 2009, SENSOR ACTUAT B-CHEM, V135, P678, DOI 10.1016/j.snb.2008.10.036; Murata Y, 2002, EUR J IMMUNOL, V32, P2866, DOI 10.1002/1521-4141(2002010)32:10<2866::AID-IMMU2866>3.0.CO;2-V; Nayak S, 2004, J AM CHEM SOC, V126, P10258, DOI 10.1021/ja0474143; Nikolic D, 2012, EUR J NEUROSCI, V35, P742, DOI 10.1111/j.1460-9568.2011.07987.x; Rastogi SK, 2011, ACS APPL MATER INTER, V3, P1731, DOI 10.1021/am2002394; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Tian YQ, 2008, CHEM MATER, V20, P1977, DOI 10.1021/cm702527m; Tian YQ, 2010, SENSOR ACTUAT B-CHEM, V150, P579, DOI 10.1016/j.snb.2010.08.036; Tian YQ, 2010, BIOMATERIALS, V31, P7411, DOI 10.1016/j.biomaterials.2010.06.023; Tian YQ, 2010, SENSOR ACTUAT B-CHEM, V147, P714, DOI 10.1016/j.snb.2010.03.029; Tian YQ, 2010, CHEM MATER, V22, P2069, DOI 10.1021/cm903361y; Tian YQ, 2010, J MATER CHEM, V20, P1728, DOI 10.1039/b922435c; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; Vogel K, 1996, J AM CHEM SOC, V118, P1581, DOI 10.1021/ja952725m; XU WY, 1995, ANAL CHEM, V67, P3172, DOI 10.1021/ac00114a012; Yang CC, 2007, MACROMOL RAPID COMM, V28, P894, DOI 10.1002/marc.200600869; Yang CC, 2006, J POLYM SCI POL CHEM, V44, P5495, DOI 10.1002/pola.21629; Zhou XF, 2011, BIOMATERIALS, V32, P8574, DOI 10.1016/j.biomaterials.2011.07.081; Zhu LY, 2007, J AM CHEM SOC, V129, P3524, DOI 10.1021/ja068452k; Zuber G, 2001, ADV DRUG DELIVER REV, V52, P245, DOI 10.1016/S0169-409X(01)00213-7	44	14	14	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88185	10.1371/journal.pone.0088185	http://dx.doi.org/10.1371/journal.pone.0088185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505422	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300068
J	Alegre-Aguaron, E; Sampat, SR; Xiong, JC; Colligan, RM; Bulinski, JC; Cook, JL; Ateshian, GA; Brown, LM; Hung, CT				Alegre-Aguaron, Elena; Sampat, Sonal R.; Xiong, Jennifer C.; Colligan, Ryan M.; Bulinski, J. Chloe; Cook, James L.; Ateshian, Gerard A.; Brown, Lewis M.; Hung, Clark T.			Growth Factor Priming Differentially Modulates Components of the Extracellular Matrix Proteome in Chondrocytes and Synovium-Derived Stem Cells	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; HUMAN BONE-MARROW; ENGINEERED CARTILAGE; GENE-EXPRESSION; ADIPOSE-TISSUE; STROMAL CELLS; EXPANSION; COLLAGEN; DEFECTS; CHONDROGENESIS	To make progress in cartilage repair it is essential to optimize protocols for two-dimensional cell expansion. Chondrocytes and SDSCs are promising cell sources for cartilage repair. We previously observed that priming with a specific growth factor cocktail (1 ng/mL transforming growth factor-beta 1, 5 ng/mL basic fibroblast growth factor, and 10 ng/mL platelet-derived growth factor-BB) in two-dimensional culture, led to significant improvement in mechanical and biochemical properties of synovium-derived stem cell (SDSC)-seeded constructs. The current study assessed the effect of growth factor priming on the proteome of canine chondrocytes and SDSCs. In particular, growth factor priming modulated the proteins associated with the extracellular matrix in two-dimensional cultures of chondrocytes and SDSCs, inducing a partial dedifferentiation of chondrocytes (most proteins associated with cartilage were down-regulated in primed chondrocytes) and a partial differentiation of SDSCs (some collagen-related proteins were up-regulated in primed SDSCs). However, when chondrocytes and SDSCs were grown in pellet culture, growth factor-primed cells maintained their chondrogenic potential with respect to glycosaminoglycan and collagen production. In conclusion, the strength of the label-free proteomics technique is that it allows for the determination of changes in components of the extracellular matrix proteome in chondrocytes and SDSCs in response to growth factor priming, which could help in future tissue engineering strategies.	[Alegre-Aguaron, Elena; Sampat, Sonal R.; Xiong, Jennifer C.; Ateshian, Gerard A.; Hung, Clark T.] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Colligan, Ryan M.; Brown, Lewis M.] Columbia Univ, Quantitat Prote Ctr, New York, NY 10027 USA; [Bulinski, J. Chloe] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Cook, James L.] Univ Missouri, Comparat Orthopaed Lab, Columbia, MO USA; [Ateshian, Gerard A.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; University of Missouri System; University of Missouri Columbia; Columbia University	Brown, LM (corresponding author), Columbia Univ, Quantitat Prote Ctr, New York, NY 10027 USA.	lb2425@columbia.edu; cth6@columbia.edu		Sethi, Sonal/0000-0002-1556-5317; Cook, James/0000-0002-0862-995X	NIH [R01 AR46568-10S1, T32 AR059038]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR059038, R01AR046568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH R01 AR46568-10S1 (BIRT) and NIH T32 AR059038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arufe MC, 2009, J CELL BIOCHEM, V108, P145, DOI 10.1002/jcb.22238; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Bian LM, 2010, TISSUE ENG PT A, V16, P1781, DOI [10.1089/ten.tea.2009.0482, 10.1089/ten.TEA.2009.0482]; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; Chen FH, 2005, J BIOL CHEM, V280, P32655, DOI 10.1074/jbc.M504778200; Chiang HS, 2011, TISSUE ENG PT A, V17, P2919, DOI 10.1089/ten.tea.2010.0732; Chien KY, 2012, J PROTEOME RES, V11, P5663, DOI 10.1021/pr300471y; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Cyr DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021854; Dai HY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf085; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; DeLany JP, 2005, MOL CELL PROTEOMICS, V4, P731, DOI 10.1074/mcp.M400198-MCP200; Delorme Bruno, 2007, V140, P67; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662; Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fischer J, 2010, ARTHRITIS RHEUM-US, V62, P2696, DOI 10.1002/art.27565; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; Francioli SE, 2007, TISSUE ENG, V13, P1227, DOI 10.1089/ten.2006.0342; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Ibrahim Y, 2011, PERFORMANCE NEW SENS; Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbrc.2004.06.029; Jones BA, 2012, TISSUE ENG PART B-RE, V18, P301, DOI [10.1089/ten.teb.2012.0002, 10.1089/ten.TEB.2012.0002]; Juang YM, 2010, BIOMED CHROMATOGR, V24, P1273, DOI 10.1002/bmc.1436; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelly TAN, 2006, J BIOMECH, V39, P1489, DOI 10.1016/j.jbiomech.2005.03.031; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Lambrecht S, 2009, ARTHRITIS RHEUM-US, V60, P179, DOI 10.1002/art.24152; Levin Y, 2011, PROTEOMICS, V11, P3273, DOI 10.1002/pmic.201000661; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; Ng KW, 2010, TISSUE ENG PT A, V16, P1041, DOI [10.1089/ten.tea.2009.0581, 10.1089/ten.TEA.2009.0581]; ODRISCOLL SW, 1994, J BONE JOINT SURG AM, V76A, P1042, DOI 10.2106/00004623-199407000-00013; Oswald ES, 2011, J PROTEOME RES, V10, P3050, DOI 10.1021/pr200030v; Park HW, 2007, PROTEOMICS, V7, P2881, DOI 10.1002/pmic.200700089; Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017; Pei M, 2008, CLIN ORTHOP RELAT R, V466, P1880, DOI 10.1007/s11999-008-0316-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reidel B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002469; Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; Saha S, 2010, BIOCHEM BIOPH RES CO, V401, P333, DOI 10.1016/j.bbrc.2010.09.042; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sampat SR, 2011, TISSUE ENG PT A, V17, P2259, DOI [10.1089/ten.tea.2011.0155, 10.1089/ten.TEA.2011.0155]; Sampat SR, 2013, J BIOMECH; Schulz RM, 2008, BIO-MED MATER ENG, V18, pS55; Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Stewart K, 2003, CELL TISSUE RES, V313, P281, DOI 10.1007/s00441-003-0762-9; SUMEGI B, 1980, BIOCHIM BIOPHYS ACTA, V616, P158, DOI 10.1016/0005-2744(80)90134-5; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wilson R, 1998, J BIOL CHEM, V273, P9637, DOI 10.1074/jbc.273.16.9637; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	70	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88053	10.1371/journal.pone.0088053	http://dx.doi.org/10.1371/journal.pone.0088053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516581	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400026
J	Cordova, EJ; Martinez-Hernandez, A; Uribe-Figueroa, L; Centeno, F; Morales-Marin, M; Koneru, H; Coleman, MA; Orozco, L				Cordova, Emilio J.; Martinez-Hernandez, Angelica; Uribe-Figueroa, Laura; Centeno, Federico; Morales-Marin, Mirna; Koneru, Harsha; Coleman, Matthew A.; Orozco, Lorena			The NRF2-KEAP1 Pathway Is an Early Responsive Gene Network in Arsenic Exposed Lymphoblastoid Cells	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; TRANSCRIPTION FACTOR NRF2; EXPRESSION PROFILES; SODIUM ARSENITE; DRINKING-WATER; UROTHELIAL CELLS; KERATINOCYTES; IDENTIFICATION; LYMPHOCYTES; PROGRESSION	Inorganic arsenic (iAs), a major environmental contaminant, has risen as an important health problem worldwide. More detailed identification of the molecular mechanisms associated with iAs exposure would help to establish better strategies for prevention and treatment. Although chronic iAs exposures have been previously studied there is little to no information regarding the early events of exposure to iAs. To better characterize the early mechanisms of iAs exposure we conducted gene expression studies using sublethal doses of iAs at two different time-points. The major transcripts differentially regulated at 2 hrs of iAs exposure included antioxidants, detoxificants and chaperones. Moreover, after 12 hrs of exposure many of the down-regulated genes were associated with DNA replication and S phase cell cycle progression. Interestingly, the most affected biological pathway by both 2 or 12 hrs of iAs exposure were the Nrf2-Keap1 pathway, represented by the highly up-regulated HMOX1 transcript, which is transcriptionally regulated by the transcription factor Nrf2. Additional Nrf2 targets included SQSTM1 and ABCB6, which were not previously associated with acute iAs exposure. Signalling pathways such as interferon, B cell receptor and AhR route were also responsive to acute iAs exposure. Since HMOX1 expression increased early (20 min) and was responsive to low iAs concentrations (0.1 mu M), this gene could be a suitable early biomarker for iAs exposure. In addition, the novel Nrf2 targets SQSTM1 and ABCB6 could play an important and previously unrecognized role in cellular protection against iAs.	[Cordova, Emilio J.; Martinez-Hernandez, Angelica; Uribe-Figueroa, Laura; Centeno, Federico; Orozco, Lorena] Inst Nacl Med Genom, Immunogen & Metab Dis Lab, SS, Mexico City, DF, Mexico; [Morales-Marin, Mirna; Orozco, Lorena] Univ Autonoma Ciudad Mexico, Mexico City, DF, Mexico; [Koneru, Harsha; Coleman, Matthew A.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Coleman, Matthew A.] Univ Calif Davis, Davis Med Ctr, Dept Radiat Oncol, Sacramento, CA 95817 USA	Instituto Nacional de Medicina Genomica; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis	Orozco, L (corresponding author), Inst Nacl Med Genom, Immunogen & Metab Dis Lab, SS, Mexico City, DF, Mexico.	lorozco@inmegen.gob.mx	Centeno, Federico/H-3393-2018	Coleman, Matthew/0000-0003-1389-4018; Centeno Cruz, Federico/0000-0002-3512-4519; Orozco, Lorena/0000-0002-5801-9180	CONACyT-FOSSIS [71053]; U.S. Department of Energy [DE-AC52-07NA27344]; US DOE Low Dose Radiation Research Program [KP110202]	CONACyT-FOSSIS; U.S. Department of Energy(United States Department of Energy (DOE)); US DOE Low Dose Radiation Research Program	This work was supported by grant CONACyT-FOSSIS, No. 71053, and of the U.S. Department of Energy under contract number DE-AC52-07NA27344 with funding support from the US DOE Low Dose Radiation Research Program Grant KP110202. The sponsors of this study had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	Abiko Y, 2010, J TOXICOL SCI, V35, P419, DOI 10.2131/jts.35.419; Andrew AS, 2008, ENVIRON HEALTH PERSP, V116, P524, DOI 10.1289/ehp.10861; Andrew AS, 2007, TOXICOL SCI, V100, P75, DOI 10.1093/toxsci/kfm200; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Aono J, 2003, BIOCHEM BIOPH RES CO, V305, P271, DOI 10.1016/S0006-291X(03)00728-9; Argos M, 2006, CANCER EPIDEM BIOMAR, V15, P1367, DOI 10.1158/1055-9965.EPI-06-0106; Bailey KA, 2010, MOL CARCINOGEN, V49, P981, DOI 10.1002/mc.20677; Biswas R, 2007, J ENVIRON PATHOL TOX, V26, P29, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i1.40; Bolt AM, 2010, TOXICOL LETT, V199, P153, DOI 10.1016/j.toxlet.2010.08.017; Bosnjak Z, 2008, ENVIRON TOXICOL PHAR, V26, P181, DOI 10.1016/j.etap.2008.03.005; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Campbell MR, 2013, OXID MED CELL LONGEV, V2013, P1203; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chien V, 2010, BIOCHEM J, V432, P113, DOI 10.1042/BJ20100434; Das S, 2011, MOL BIOL REP, V38, P171, DOI 10.1007/s11033-010-0091-5; Ding W, 2005, MOL CELL BIOCH, V279, P05; Fujiwara Y, 2010, J TOXICOL SCI, V35, P275, DOI 10.2131/jts.35.275; Furuya KN, 1997, CANCER RES, V57, P3708; Han SG, 2005, MOL CELL BIOCHEM, V277, P153, DOI 10.1007/s11010-005-5874-y; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P1718, DOI 10.1289/ehp.0900566; Hernandez-Zavala A, 2005, TOXICOLOGY, V207, P49, DOI 10.1016/j.tox.2004.08.013; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Kawata K, 2009, ENVIRON MOL MUTAGEN, V50, P46, DOI 10.1002/em.20438; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Lehmann GM, 2007, TOXICOL SCI, V99, P70, DOI 10.1093/toxsci/kfm142; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Li B, 2011, ENV TOXICOL, DOI 10.1002/tox.20731; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; Martin-Chouly C, 2011, MOL IMMUNOL, V48, P956, DOI 10.1016/j.molimm.2011.01.005; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Navas-Acien A, 2008, JAMA-J AM MED ASSOC, V300, P814, DOI 10.1001/jama.300.7.814; Noreault TL, 2005, DRUG METAB DISPOS, V33, P993, DOI 10.1124/dmd.105.003954; Ojha J, 2011, MOL CELL BIOL, V31, P3146, DOI 10.1128/MCB.01187-10; Pi JB, 2003, EXP CELL RES, V290, P234, DOI 10.1016/S0014-4827(03)00341-0; Rahman MM, 2009, ENVIRON GEOCHEM HLTH, V31, P9, DOI 10.1007/s10653-008-9233-2; Rea MA, 2003, CARCINOGENESIS, V24, P747, DOI 10.1093/carcin/bgg010; Robichon C, 2006, BBA-MOL CELL BIOL L, V1761, P1107, DOI 10.1016/j.bbalip.2006.07.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen GX, 2009, BIOPHARM DRUG DISPOS, V30, P345, DOI 10.1002/bdd.680; Smeester L, 2011, CHEM RES TOXICOL, V24, P165, DOI 10.1021/tx1004419; Su PS, 2006, ENVIRON HEALTH PERSP, V114, P394, DOI 10.1289/ehp.8174; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wang XJ, 2007, TOXICOL APPL PHARM, V225, P206, DOI 10.1016/j.taap.2007.07.016; Yih LH, 2002, CARCINOGENESIS, V23, P867, DOI 10.1093/carcin/23.5.867; Zheng XH, 2003, TOXICOLOGY, V187, P39, DOI 10.1016/S0300-483X(03)00025-8	49	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88069	10.1371/journal.pone.0088069	http://dx.doi.org/10.1371/journal.pone.0088069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516582	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400027
J	Klemke, M; Muller, MH; Wosniok, W; Markowski, DN; Nimzyk, R; Helmke, BM; Bullerdiek, J				Klemke, Markus; Mueller, Marietta Henrike; Wosniok, Werner; Markowski, Dominique Nadine; Nimzyk, Rolf; Helmke, Burkhard Maria; Bullerdiek, Joern			Correlated Expression of HMGA2 and PLAG1 in Thyroid Tumors, Uterine Leiomyomas and Experimental Models	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; TRANSCRIPTION FACTOR HMGA2; HIGH-LEVEL EXPRESSION; PLEOMORPHIC ADENOMAS; STEM-CELLS; MOLECULAR CHARACTERIZATION; MESENCHYMAL TUMORS; FUSION TRANSCRIPTS; GENE-EXPRESSION; DNA-BINDING	In pleomorphic adenomas of the salivary glands (PASG) recurrent chromosomal rearrangements affecting either 8q12 or 12q14 similar to 15 lead to an overexpression of the genes of the genuine transcription factor PLAG1 or the architectural transcription factor HMGA2, respectively. Both genes are also affected by recurrent chromosomal rearrangements in benign adipocytic tumors as e. g. lipomas and lipoblastomas. Herein, we observed a strong correlation between the expression of HMGA2 and PLAG1 in 14 benign and 23 malignant thyroid tumors. To address the question if PLAG1 can be activated by HMGA2, the expression of both genes was quantified in 32 uterine leiomyomas 17 of which exhibited an overexpression of HMGA2. All leiomyomas with HMGA2 overexpression also revealed an activation of PLAG1 in the absence of detectable chromosome 8 abnormalities affecting the PLAG1 locus. To further investigate if the overexpression of PLAG1 is inducible by HMGA2 alone, HMGA2 was transiently overexpressed in MCF-7 cells. An increased PLAG1 expression was observed 24 and 48 h after transfection. Likewise, stimulation of HMGA2 by FGF1 in adipose tissue-derived stem cells led to a simultaneous increase of PLAG1 mRNA. Altogether, these data suggest that HMGA2 is an upstream activator of PLAG1. Accordingly, this may explain the formation of tumors as similar as lipomas and lipoblastomas resulting from an activation of either of both genes by chromosomal rearrangements.	[Klemke, Markus; Mueller, Marietta Henrike; Markowski, Dominique Nadine; Nimzyk, Rolf; Bullerdiek, Joern] Univ Bremen, Ctr Human Genet, D-28359 Bremen, Germany; [Wosniok, Werner] Univ Bremen, Inst Stat, D-28359 Bremen, Germany; [Helmke, Burkhard Maria] Heidelberg Univ, Inst Pathol, Heidelberg, Germany; [Bullerdiek, Joern] Univ Rostock, Univ Med, Inst Med Genet, D-18055 Rostock, Germany	University of Bremen; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; Ruprecht Karls University Heidelberg; University of Rostock	Bullerdiek, J (corresponding author), Univ Bremen, Ctr Human Genet, D-28359 Bremen, Germany.	bullerd@uni-bremen.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (DFG). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; ASHAR HR, 1995, CELL, V82, P57; Asp J, 2006, GENE CHROMOSOME CANC, V45, P820, DOI 10.1002/gcc.20346; Astrom AK, 1999, CANCER RES, V59, P918; Ayoubi TAY, 1999, ONCOGENE, V18, P5076, DOI 10.1038/sj.onc.1202881; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Bartuma H, 2008, CANCER GENET CYTOGEN, V183, P60, DOI 10.1016/j.cancergencyto.2008.01.017; Belge G, 2008, GENE CHROMOSOME CANC, V47, P56, DOI 10.1002/gcc.20505; Brants JR, 2004, FEBS LETT, V569, P277, DOI 10.1016/j.febslet.2004.05.075; BULLERDIEK J, 1987, CYTOGENET CELL GENET, V45, P187, DOI 10.1159/000132452; BULLERDIEK J, 1993, CANCER GENET CYTOGEN, V65, P27, DOI 10.1016/0165-4608(93)90054-P; BULLERDIEK J, 1989, CANCER, V64, P876, DOI 10.1002/1097-0142(19890815)64:4<876::AID-CNCR2820640419>3.0.CO;2-J; Bullerdiek J, 1989, ARCH OTORHINOLARYNGO, V245, P244; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Chiappetta G, 1996, ONCOGENE, V13, P2439; Chiappetta G, 2008, EUR J CANCER, V44, P1015, DOI 10.1016/j.ejca.2008.02.039; Cleynen I, 2007, MOL CANCER RES, V5, P363, DOI 10.1158/1541-7786.MCR-06-0331; Enlund F, 2002, INT J ONCOL, V20, P713; Fedele M, 1998, ONCOGENE, V17, P413, DOI 10.1038/sj.onc.1201952; German National Ethics Council, 2004, OP BIOB RES; Gisselsson D, 2001, AM J PATHOL, V159, P955, DOI 10.1016/S0002-9440(10)61771-3; Gross KL, 2003, GENE CHROMOSOME CANC, V38, P68, DOI 10.1002/gcc.10240; Hennig Y, 1999, MOL HUM REPROD, V5, P1150, DOI 10.1093/molehr/5.12.1150; Hennig Y, 1996, MOL HUM REPROD, V2, P277, DOI 10.1093/molehr/2.4.277; Hensen K, 2002, CANCER RES, V62, P1510; Hibbard MK, 2000, CANCER RES, V60, P4869; Hirning-Folz U, 1998, GENE CHROMOSOME CANC, V23, P350, DOI 10.1002/(SICI)1098-2264(199812)23:4<350::AID-GCC10>3.0.CO;2-E; Jin L, 2011, DIAGN MOL PATHOL, V20, P71, DOI 10.1097/PDM.0b013e3181ed784d; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kas K, 1997, NAT GENET, V15, P170, DOI 10.1038/ng0297-170; Klemke M, 2012, GENE CHROMOSOME CANC, V51, P402, DOI 10.1002/gcc.21925; Klemke M, 2009, GENE CHROMOSOME CANC, V48, P171, DOI 10.1002/gcc.20627; Lappinga PJ, 2010, CANCER CYTOPATHOL, V118, P287, DOI 10.1002/cncy.20095; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Mandahl N, 2009, CANC CYTOGENETICS, P675; Mantovani F, 1998, NUCLEIC ACIDS RES, V26, P1433, DOI 10.1093/nar/26.6.1433; Markowski DN, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-2; Markowski DN, 2011, GENE CHROMOSOME CANC, V50, P489, DOI 10.1002/gcc.20871; Markowski DN, 2010, CANCER GENET CYTOGEN, V202, P53, DOI 10.1016/j.cancergencyto.2010.06.010; Mussnich P, 2013, MOL ONCOL, V7, P531, DOI 10.1016/j.molonc.2013.01.002; Nielsen GP, 2002, WHO CLASSIFICATION T, P20; Noro B, 2003, BIOCHEMISTRY-US, V42, P4569, DOI 10.1021/bi026605k; Pallasch CP, 2009, BLOOD, V114, P3255, DOI 10.1182/blood-2009-06-229898; Pedeutour F, 2012, PEDIATR BLOOD CANCER, V58, P798, DOI 10.1002/pbc.23335; Prasad NB, 2008, CLIN CANCER RES, V14, P3327, DOI 10.1158/1078-0432.CCR-07-4495; Prasad NB, 2012, THYROID, V22, P275, DOI 10.1089/thy.2011.0169; Ropke A, 2007, CYTOGENET GENOME RES, V119, P33, DOI 10.1159/000109616; Rogalla P, 1996, AM J PATHOL, V149, P775; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; SANDROS J, 1990, CANCER GENET CYTOGEN, V44, P153, DOI 10.1016/0165-4608(90)90042-9; Schaffer LG, 2009, ISCN 2009 INT SYSTEM; SCHOENMAKERS EFPM, 1995, NAT GENET, V10, P436, DOI 10.1038/ng0895-436; STENMAN G, 1984, TUMOUR BIOL, V5, P103; Tallini G, 2000, LAB INVEST, V80, P359, DOI 10.1038/labinvest.3780040; VANDEVEN WJM, 1995, GENE CHROMOSOME CANC, V12, P296; Voz ML, 2000, CANCER RES, V60, P106; Voz ML, 2004, ONCOGENE, V23, P179, DOI 10.1038/sj.onc.1207013; World Medical Association, DECL HELS ETH PRINC; Zatkova A, 2004, GENE CHROMOSOME CANC, V39, P126, DOI 10.1002/gcc.10307	59	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88126	10.1371/journal.pone.0088126	http://dx.doi.org/10.1371/journal.pone.0088126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516594	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400033
J	Thomas, A; Suyesh, R; Biju, SD; Bee, MA				Thomas, Ashish; Suyesh, Robin; Biju, S. D.; Bee, Mark A.			Vocal Behavior of the Elusive Purple Frog of India (Nasikabatrachus sahyadrensis), a Fossorial Species Endemic to the Western Ghats	PLOS ONE			English	Article							TREEFROGS HYLA-ARBOREA; ADVERTISEMENT CALL; GENUS SOOGLOSSUS; ANURAN; REPERTOIRE; EVOLUTION; REVEALS; FAMILY; EAR	Quantitative descriptions of animal vocalizations can inform an understanding of their evolutionary functions, the mechanisms for their production and perception, and their potential utility in taxonomy, population monitoring, and conservation. The goal of this study was to provide the first acoustical and statistical analysis of the advertisement calls of Nasikabatrachus sahyadrensis. Commonly known as the Indian purple frog, N. sahyadrensis is an endangered species endemic to the Western Ghats of India. As the only known species in its family (Nasikabatrachidae), it has ancient evolutionary ties to frogs restricted to the Seychelles archipelago (Sooglossidae). The role of vocalizations in the behavior of this unique species poses interesting questions, as the animal is fossorial and potentially earless and it breeds explosively above the soil for only about two weeks a year. In this study, we quantified 19 acoustic properties of 208 calls recorded from 10 males. Vocalizations were organized into distinct call groups typically composed of two to six short (59 ms), pulsatile calls, each consisting of about five to seven pulses produced at a rate of about 106 pulses/s. The frequency content of the call consisted of a single dominant peak between 1200-1300 Hz and there was no frequency modulation. The patterns of variation within and among individuals were typical of those seen in other frogs. Few of the properties we measured were related to temperature, body size, or condition, though there was little variation in temperature. Field observations and recordings of captive individuals indicated that males engaged in both antiphonal calling and call overlap with nearby calling neighbors. We discuss our findings in relation to previous work on vocal behavior in other fossorial frogs and in sooglossid frogs.	[Thomas, Ashish; Suyesh, Robin; Biju, S. D.] Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India; [Bee, Mark A.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Delhi; University of Minnesota System; University of Minnesota Twin Cities	Biju, SD (corresponding author), Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India.	sdbiju@cemde.du.ac.in; mbee@umn.edu	Bee, Mark A/A-9410-2013	Bee, Mark A/0000-0002-6770-9730; THOMAS, ASHISH/0000-0002-0189-7580	Council for Scientific and Industrial Research (CSIR) [09/045(0715)2007-EMR-1]; Evolutionarily Distinct and Globally Endangered species (EDGE) Fellowship; University Grant Commission, India [AA/52/2009-2010]; People Trust for Endangered Species (PTES), London; Evolutionarily Distinct and Globally Endangered species (EDGE), London; Delhi University, India; Fulbright-Nehru Senior Research Fellowship; U.S.-India Educational Foundation	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Evolutionarily Distinct and Globally Endangered species (EDGE) Fellowship; University Grant Commission, India(University Grants Commission, India); People Trust for Endangered Species (PTES), London; Evolutionarily Distinct and Globally Endangered species (EDGE), London; Delhi University, India; Fulbright-Nehru Senior Research Fellowship; U.S.-India Educational Foundation	A. Thomas was supported by a fellowship from the Council for Scientific and Industrial Research (CSIR, Sanction No. 09/045(0715)2007-EMR-1) and the Evolutionarily Distinct and Globally Endangered species (EDGE) Fellowship. R. Suyesh was supported by University Grant Commission, Senior Research Fellowship, India (AA/52/2009-2010). S. D. Biju was supported by the People Trust for Endangered Species (PTES), London, Evolutionarily Distinct and Globally Endangered species (EDGE), London, and Delhi University, India. M. Bee was supported by a Fulbright-Nehru Senior Research Fellowship and the U.S.-India Educational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1972, EVOLUTION GENUS BUFO; BAKER JMR, 1992, ANIM BEHAV, V43, P157, DOI 10.1016/S0003-3472(05)80081-8; Bee MA, 2001, ANIM BEHAV, V62, P1129, DOI 10.1006/anbe.2001.1851; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Bee MA, 2013, BIOACOUSTICS, V22, P67, DOI 10.1080/09524622.2012.712750; Bee MA, 2013, HERPETOLOGICA, V69, P22, DOI 10.1655/HERPETOLOGICA-D-11-00042; Bee MA, 2010, ETHOLOGY, V116, P564, DOI 10.1111/j.1439-0310.2010.01773.x; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Biju SD, 2004, IUCN 2013 IUCN RED L; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boistel R, 2013, P NATL ACAD SCI USA, V110, P15360, DOI 10.1073/pnas.1302218110; Boistel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022080; Caldwell MS, 2010, CURR BIOL, V20, P1012, DOI 10.1016/j.cub.2010.03.069; Castellano S, 2002, ETHOLOGY, V108, P75, DOI 10.1046/j.1439-0310.2002.00761.x; Christensen-Dalsgaard Jakob, 2002, Bioacoustics, V13, P21; Cunnington GM, 2010, ACTA OECOL, V36, P463, DOI 10.1016/j.actao.2010.06.002; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dutta SK, 2004, CURR SCI INDIA, V86, P211; FLORES G, 1993, HERPETOLOGICA, V49, P427; Friedl TWP, 2002, BEHAVIOUR, V139, P113, DOI 10.1163/15685390252902319; Frost DR, 2013, AMPHIBIAN SPECIES WO; Gasser H, 2009, ETHOLOGY, V115, P596, DOI 10.1111/j.1439-0310.2009.01639.x; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gerlach J, 2002, AMPHIBIA-REPTILIA, V23, P445, DOI 10.1163/15685380260462356; Glaw F, 2010, ZOOTAXA, P1; Hetherington TE, 1999, J COMP PHYSIOL A, V184, P395, DOI 10.1007/s003590050338; Jones DL, 2009, J ACOUST SOC AM, V126, P895, DOI 10.1121/1.3158924; KLUMP GM, 1992, NATO ADV SCI I A-LIF, V228, P153; Laiolo P, 2010, BIOL CONSERV, V143, P1635, DOI 10.1016/j.biocon.2010.03.025; Larson KA, 2004, COPEIA, P676; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Lewis ER, 2001, AM ZOOL, V41, P1185, DOI 10.1668/0003-1569(2001)041[1185:DMWLFU]2.0.CO;2; LEWIS ER, 1985, SCIENCE, V227, P187, DOI 10.1126/science.227.4683.187; Lindquist ED, 1998, J COMP PHYSIOL A, V183, P265, DOI 10.1007/s003590050254; Lindquist ED, 1996, J HERPETOL, V30, P347, DOI 10.2307/1565171; LOMBARD RE, 1979, AM ZOOL, V19, P986; Mason MJ, 2007, SPR HDB AUD, V28, P147; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; Ngwava JM, 2009, AFR J HERPETOL, V58, P44, DOI 10.1080/21564574.2009.9635580; NUSSBAUM RA, 1982, J HERPETOL, V16, P198, DOI 10.2307/1563713; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Parris KM, 2009, ECOL SOC, V14; Pettitt BA, 2013, ETHOLOGY, V119, P244, DOI 10.1111/eth.12058; Raj P, 2012, ZOOTAXA, P65; ROBERTS JD, 1984, AUST WILDLIFE RES, V11, P191, DOI 10.1071/WR9840191; ROBERTS JD, 1981, AUST WILDLIFE RES, V8, P451; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Schwartz JJ, 2014, ANIMAL COMMUNICATION; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Terry AMR, 2002, ANIM CONSERV, V5, P103, DOI 10.1017/S1367943002002147; Terry Andrew M.R., 2005, Frontiers in Zoology, V2, P1; Van der Meijden A, 2007, BIOL J LINN SOC, V91, P347, DOI 10.1111/j.1095-8312.2007.00800.x; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; WAGNER WE, 1989, ETHOLOGY, V82, P27; Weir LA, 2005, J HERPETOL, V39, P627; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Zachariah A, 2012, ZOOTAXA, P53	64	12	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e84809	10.1371/journal.pone.0084809	http://dx.doi.org/10.1371/journal.pone.0084809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516517	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400001
J	Rodriguez, E; Ferrer, J; Zock, JP; Serra, I; Anto, JM; de Batlle, J; Kromhout, H; Vermeulen, R; Donaire-Gonzalez, D; Benet, M; Balcells, E; Monso, E; Gayete, A; Garcia-Aymerich, J				Rodriguez, Esther; Ferrer, Jaume; Zock, Jan-Paul; Serra, Ignasi; Anto, Josep M.; de Batlle, Jordi; Kromhout, Hans; Vermeulen, Roel; Donaire-Gonzalez, David; Benet, Marta; Balcells, Eva; Monso, Eduard; Gayete, Angel; Garcia-Aymerich, Judith		PAC-COPD Study Grp	Lifetime Occupational Exposure to Dusts, Gases and Fumes Is Associated with Bronchitis Symptoms and Higher Diffusion Capacity in COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC RESPIRATORY SYMPTOMS; LUNG-FUNCTION; EMPHYSEMA; POPULATION; ENDOTOXIN; BURDEN; INDIVIDUALS; STATEMENT; BIAS	Background: Occupational exposure to dusts, gases and fumes has been associated with reduced FEV1 and sputum production in COPD patients. The effect of occupational exposure on other characteristics of COPD, especially those reflecting emphysema, has not been studied in these patients. Methods: We studied 338 patients hospitalized for a first exacerbation of COPD in 9 Spanish hospitals, obtaining full occupational history in a face-to-face interview; job codes were linked to a job exposure matrix for semi-quantitative estimation of exposure to mineral/biological dust, and gases/fumes for each job held. Patients underwent spirometry, diffusing capacity testing and analysis of gases in stable conditions. Quality of life, dyspnea and chronic bronchitis symptoms were determined with a questionnaire interview. A high-resolution CT scan was available in 133 patients. Results: 94% of the patients included were men, with a mean age of 68(8.5) years and a mean FEV1% predicted 52 (16). High exposure to gases or fumes was associated with chronic bronchitis, and exposure to mineral dust and gases/fumes was associated with higher scores for symptom perception in the St. George's questionnaire. No occupational agent was associated with a lower FEV1. High exposure to all occupational agents was associated with better lung diffusion capacity, in long-term quitters. In the subgroup with CT data, patients with emphysema had 18% lower DLCO compared to those without emphysema. Conclusions: In our cohort of COPD patients, high exposure to gases or fumes was associated with chronic bronchitis, and high exposure to all occupational agents was consistently associated with better diffusion capacity in long-term quitters.	[Rodriguez, Esther; Ferrer, Jaume] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Pneumol, E-08193 Barcelona, Spain; [Rodriguez, Esther; Ferrer, Jaume; Balcells, Eva; Monso, Eduard] Inst Nacl Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Zock, Jan-Paul; Serra, Ignasi; Anto, Josep M.; de Batlle, Jordi; Donaire-Gonzalez, David; Benet, Marta; Garcia-Aymerich, Judith] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Zock, Jan-Paul; Serra, Ignasi; Anto, Josep M.; de Batlle, Jordi; Donaire-Gonzalez, David; Benet, Marta; Balcells, Eva; Garcia-Aymerich, Judith] Hosp del Mar, IMIM, Serv Pneumol, Barcelona, Spain; [Zock, Jan-Paul; Serra, Ignasi; Anto, Josep M.; de Batlle, Jordi; Donaire-Gonzalez, David; Benet, Marta; Garcia-Aymerich, Judith] Inst Nacl Salud Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Anto, Josep M.; de Batlle, Jordi; Donaire-Gonzalez, David; Benet, Marta; Garcia-Aymerich, Judith] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Kromhout, Hans; Vermeulen, Roel] Inst Risk Assessment Sci, Enviromental & Occupat Hlth Div, Utrecht, Netherlands; [Monso, Eduard] Hosp Univ Parc Tauli, Serv Pneumol, Sabadell, Spain; [Gayete, Angel] Hosp del Mar, IMIM, Serv Radiol, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Utrecht University; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Rodriguez, E (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Serv Pneumol, E-08193 Barcelona, Spain.	estherod@vhebron.net	de Batlle, Jordi/G-6724-2016; Vermeulen, Roel/F-8037-2011; Vollmer, Ivan/Y-5972-2019; Roca, Josep/J-2583-2015; J, Garcia-Aymerich/G-6867-2014; Gonzalez, David Donaire/AAB-9651-2020; Zock, Jan-Paul/P-5034-2018; Anto, J M/H-2676-2014; Kromhout, Hans/A-9159-2008	de Batlle, Jordi/0000-0003-3500-6608; Vermeulen, Roel/0000-0003-4082-8163; Vollmer, Ivan/0000-0002-8051-3994; Roca, Josep/0000-0003-4768-8722; J, Garcia-Aymerich/0000-0002-7097-4586; Gonzalez, David Donaire/0000-0003-2337-1712; Zock, Jan-Paul/0000-0002-2941-6259; Anto, J M/0000-0002-4736-8529; Kromhout, Hans/0000-0002-4233-1890; Barbera, Joan Albert/0000-0003-1469-4990; Marin, Alicia/0000-0002-9358-2120; Gimenez, Ana/0000-0002-3898-0652; Portillo, Karina/0000-0002-7804-1051; Benet Mora, Marta/0000-0001-9600-3510; Rodriguez Chiaradia, Diego A./0000-0002-8566-4011	Fondo de Investigacion Sanitaria, Ministry of Health, Spain [FIS PI020541]; Agencia d'Avaluacio de Tecnologia i Recerca Mediques, Catalan Government [AATRM 035/20/02]; Spanish Society of Pulmonology and Thoracic Surgery [SEPAR 2002/137]; Catalan Pulmonology Foundation (FUCAP Beca Maria Rava); Red RESPIRA [RTIC C03/11]; Red RCESP [RTIC C03/09]; Fondo de Investigacion Sanitaria [PI052486, PI052302, PI060684]; Fundacio La Marato de TV3 [041110]; Novartis Farmaceutica, Spain; Instituto de Salud Carlos III, Ministry of Health, Spain; Instituto de Salud Carlos III [CP05/00118]; Ministry of Health, Spain	Fondo de Investigacion Sanitaria, Ministry of Health, Spain(Spanish GovernmentInstituto de Salud Carlos III); Agencia d'Avaluacio de Tecnologia i Recerca Mediques, Catalan Government; Spanish Society of Pulmonology and Thoracic Surgery; Catalan Pulmonology Foundation (FUCAP Beca Maria Rava); Red RESPIRA; Red RCESP; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacio La Marato de TV3; Novartis Farmaceutica, Spain; Instituto de Salud Carlos III, Ministry of Health, Spain(Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministry of Health, Spain(Spanish Government)	The PAC-COPD Study is funded by grants from the Fondo de Investigacion Sanitaria (FIS PI020541), Ministry of Health, Spain; Agencia d'Avaluacio de Tecnologia i Recerca Mediques (AATRM 035/20/02), Catalan Government; Spanish Society of Pulmonology and Thoracic Surgery (SEPAR 2002/137); Catalan Pulmonology Foundation (FUCAP 2003 Beca Maria Rava); Red RESPIRA (RTIC C03/11); Red RCESP (RTIC C03/09); Fondo de Investigacion Sanitaria (PI052486); Fondo de Investigacion Sanitaria (PI052302); Fondo de Investigacion Sanitaria (PI060684); Fundacio La Marato de TV3 (num. 041110); and Novartis Farmaceutica, Spain. CIBERESP and CIBERES are funded by Instituto de Salud Carlos III, Ministry of Health, Spain. Judith Garcia-Aymerich has a researcher contract from Instituto de Salud Carlos III (CP05/00118), Ministry of Health, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKKE P, 1991, EUR RESPIR J, V4, P273; Balcells E, 2009, RESP MED, V103, P1293, DOI 10.1016/j.rmed.2009.04.001; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; BECKLAKE MR, 1987, AM REV RESPIR DIS, V135, P1234; Blanc PD, 2004, OCCUP ENVIRON MED, V61, P661, DOI 10.1136/oem.2003.010058; Bonner JC, 2000, AM J PHYSIOL-LUNG C, V278, pL209, DOI 10.1152/ajplung.2000.278.1.L209; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cerveri I, 2004, CHEST, V125, P1714, DOI 10.1378/chest.125.5.1714; CHURG A, 1989, EXP LUNG RES, V15, P813, DOI 10.3109/01902148909069628; COCKCROFT A, 1982, LANCET, V2, P600; Coggon D, 1998, THORAX, V53, P398, DOI 10.1136/thx.53.5.398; DAVISON AG, 1988, LANCET, V1, P663, DOI 10.1016/S0140-6736(88)91474-2; DOSEMECI M, 1990, AM J EPIDEMIOL, V132, P746, DOI 10.1093/oxfordjournals.aje.a115716; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Eltayara L, 1996, AM J RESP CRIT CARE, V154, P1726, DOI 10.1164/ajrccm.154.6.8970362; Ferrer M, 1996, EUR RESPIR J, V9, P1160, DOI 10.1183/09031936.96.09061160; Fishwick D, 1997, AM J RESP CRIT CARE, V156, P1440, DOI 10.1164/ajrccm.156.5.97-03007; Garcia-Aymerich J, 2009, ARCH BRONCONEUMOL, V45, P4, DOI 10.1016/j.arbres.2008.03.001; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; *GOLD, 2004, GLOB STRAT DIAGN MAN; Harber P, 2007, AM J RESP CRIT CARE, V176, P994, DOI 10.1164/rccm.200605-730OC; HARKEMA JR, 1993, MICROSC RES TECHNIQ, V26, P457, DOI 10.1002/jemt.1070260513; HARKEMA JR, 1993, TOXICOL LETT, V68, P251, DOI 10.1016/0378-4274(93)90136-L; HNIZDO E, 1990, SCAND J WORK ENV HEA, V16, P411, DOI 10.5271/sjweh.1768; HNIZDO E, 1991, AM REV RESPIR DIS, V143, P1241, DOI 10.1164/ajrccm/143.6.1241; International Labour Office, 1991, INT STAND CLASS OCC; KORN RJ, 1987, AM REV RESPIR DIS, V136, P298, DOI 10.1164/ajrccm/136.2.298; KRZYZANOWSKI M, 1988, INT J EPIDEMIOL, V17, P397, DOI 10.1093/ije/17.2.397; KRZYZANOWSKI M, 1990, INT ARCH OCC ENV HEA, V62, P311, DOI 10.1007/BF00640839; LEIGH J, 1994, OCCUP ENVIRON MED, V51, P400, DOI 10.1136/oem.51.6.400; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Manual SEPAR de Procedimientos, 2002, MOD 3 PROC EV FUNC P; Manual SEPAR de Procedimientos, 2004, MOD 4 PROC EV FUNC P; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matheson MC, 2005, THORAX, V60, P645, DOI 10.1136/thx.2004.035170; Mayer AS, 2000, AM J RESP CRIT CARE, V162, P553, DOI 10.1164/ajrccm.162.2.9907117; Mehta AJ, 2012, AM J RESP CRIT CARE, V185, P1292, DOI 10.1164/rccm.201110-1917OC; Pearce N, 2007, OCCUP ENVIRON MED, V64, P562, DOI 10.1136/oem.2006.026690; Piitulainen E, 1997, THORAX, V52, P244, DOI 10.1136/thx.52.3.244; POST WK, 1994, EUR RESPIR J, V7, P1048; Rodriguez E, 2008, CHEST, V134, P1237, DOI 10.1378/chest.08-0622; SCHWARTZ DA, 1995, AM J RESP CRIT CARE, V152, P603, DOI 10.1164/ajrccm.152.2.7633714; SEIXAS NS, 1993, BRIT J IND MED, V50, P929; SHORE S, 1995, AM J RESP CRIT CARE, V151, P1931, DOI 10.1164/ajrccm.151.6.7767542; Sunyer J, 2005, AM J RESP CRIT CARE, V172, P1139, DOI 10.1164/rccm.200504-648OC; Sunyer J, 1998, AM J RESP CRIT CARE, V157, P512, DOI 10.1164/ajrccm.157.2.9705029	46	17	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88426	10.1371/journal.pone.0088426	http://dx.doi.org/10.1371/journal.pone.0088426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516659	Green Published, gold			2022-12-27	WOS:000330830700073
J	Beiting, DP; Peixoto, L; Akopyants, NS; Beverley, SM; Wherry, EJ; Christian, DA; Hunter, CA; Brodsky, IE; Roos, DS				Beiting, Daniel P.; Peixoto, Lucia; Akopyants, Natalia S.; Beverley, Stephen M.; Wherry, E. John; Christian, David A.; Hunter, Christopher A.; Brodsky, Igor E.; Roos, David S.			Differential Induction of TLR3-Dependent Innate Immune Signaling by Closely Related Parasite Species	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; NEOSPORA-CANINUM INFECTION; LEISHMANIA RNA VIRUS; FALSE DISCOVERY RATE; GENE-EXPRESSION DATA; TOLL-LIKE RECEPTORS; TOXOPLASMA-GONDII; INTERFERON-GAMMA; PARASITOPHOROUS VACUOLE; HOST-RESISTANCE	The closely related protozoan parasites Toxoplasma gondii and Neospora caninum display similar life cycles, subcellular ultrastructure, invasion mechanisms, metabolic pathways, and genome organization, but differ in their host range and disease pathogenesis. Type II (gamma) interferon has long been known to be the major mediator of innate and adaptive immunity to Toxoplasma infection, but genome-wide expression profiling of infected host cells indicates that Neospora is a potent activator of the type I (alpha/beta) interferon pathways typically associated with antiviral responses. Infection of macrophages from mice with targeted deletions in various innate sensing genes demonstrates that host responses to Neospora are dependent on the toll-like receptor Tlr3 and the adapter protein Trif. Consistent with this observation, RNA from Neospora elicits TLR3-dependent type I interferon responses when targeted to the host endo-lysosomal system. Although live Toxoplasma fail to induce type I interferon, heat-killed parasites do trigger this response, albeit much weaker than Neospora, and co-infection studies reveal that T. gondii actively suppresses the production of type I interferon. These findings reveal that eukaryotic pathogens can be potent inducers of type I interferon and that related parasite species interact with this pathway in distinct ways.	[Beiting, Daniel P.; Peixoto, Lucia; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Christian, David A.; Hunter, Christopher A.; Brodsky, Igor E.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Akopyants, Natalia S.; Beverley, Stephen M.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Washington University (WUSTL)	Beiting, DP (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	beiting@vet.upenn.edu	Beiting, Daniel/AAG-6275-2019; Christian, David/AAE-6425-2019; Peixoto, Lucia/AAI-9378-2020; Wherry, John/ABI-1280-2020	Peixoto, Lucia/0000-0002-8444-9600; Roos, David Siker/0000-0001-6725-4089; Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [NIAID: F32-AI75846, R37-AI28724, RO1-AI29646, U19-AI083022]; McCabe Fund; Mari-Lowe Center for Comparative Oncology; University Research Foundation; NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306];  [R21-AI104998];  [R01-AI42334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042334, R01AI029646, F32AI075846, R21AI104998, U19AI083022, R37AI028724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCabe Fund; Mari-Lowe Center for Comparative Oncology; University Research Foundation; NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support was provided by the National Institutes of Health, NIAID: F32-AI75846 (DPB), R37-AI28724 (DSR), RO1-AI29646 (SMB), and U19-AI083022 (EJW). IEB was supported by pilot grants from the McCabe Fund, Mari-Lowe Center for Comparative Oncology, University Research Foundation, and NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306). CAH was supported by R21-AI104998 and R01-AI42334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anderson ML, 1997, J AM VET MED ASSOC, V210, P1169; Andrade WA, 2013, CELL HOST MICROBE, V13, P42, DOI 10.1016/j.chom.2012.12.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bliss SK, 1999, J IMMUNOL, V163, P2081; Bliss SK, 2000, J IMMUNOL, V165, P4515, DOI 10.4049/jimmunol.165.8.4515; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Butcher BA, 2002, INFECT IMMUN, V70, P5216, DOI 10.1128/IAI.70.9.5216-5224.2002; Caffaro CE, 2011, EUKARYOT CELL, V10, P1095, DOI 10.1128/EC.00002-11; Cheng K, 2011, J AM CHEM SOC, V133, P3764, DOI 10.1021/ja111312h; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Debierre-Grockiego F, 2010, GLYCOBIOLOGY, V20, P801, DOI 10.1093/glycob/cwq038; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; DUBEY JP, 1988, J AM VET MED ASSOC, V193, P1259; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533; Goldszmid RS, 2009, J EXP MED, V206, P399, DOI 10.1084/jem.20082108; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; HAY WH, 1990, J AM VET MED ASSOC, V197, P87; Hayward AR, 2000, J INFECT DIS, V182, P1001, DOI 10.1086/315802; Hertzog P, 2011, J INTERF CYTOK RES, V31, P5, DOI 10.1089/jir.2010.0126; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hou BD, 2011, P NATL ACAD SCI USA, V108, P278, DOI 10.1073/pnas.1011549108; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Koshy AA, 2010, NAT METHODS, V7, P307, DOI [10.1038/nmeth.1438, 10.1038/NMETH.1438]; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; Leng J, 2009, J IMMUNOL, V182, P489, DOI 10.4049/jimmunol.182.1.489; Liehl P, 2013, NAT MED; LINDENMANN J, 1964, P SOC EXP BIOL MED, V116, P506, DOI 10.3181/00379727-116-29292; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; McCann CM, 2008, EMERG INFECT DIS, V14, P978, DOI 10.3201/eid1406.071128; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meager A, 2002, J IMMUNOL METHODS, V261, P21, DOI 10.1016/S0022-1759(01)00570-1; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; MORISAKI JH, 1995, J CELL SCI, V108, P2457; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NAKAYAMA M, 1991, J BIOL CHEM, V266, P21404; Nishikawa Y, 2001, CLIN DIAGN LAB IMMUN, V8, P811, DOI 10.1128/CDLI.8.4.811-817.2001; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Robert-Gangneux F, 2009, EMERG INFECT DIS, V15, P987, DOI 10.3201/eid1506.081414; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SIBLEY LD, 1995, J CELL SCI, V108, P1669; SIBLEY LD, 1985, NATURE, V315, P416, DOI 10.1038/315416a0; SILVA JS, 1992, J EXP MED, V175, P169, DOI 10.1084/jem.175.1.169; Sinai AP, 1997, J CELL SCI, V110, P2117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Speer CA, 1999, INT J PARASITOL, V29, P1509, DOI 10.1016/S0020-7519(99)00132-0; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Voisine C, 2010, INT J PARASITOL, V40, P711, DOI 10.1016/j.ijpara.2009.11.005; WANG AL, 1991, ANNU REV MICROBIOL, V45, P251, DOI 10.1146/annurev.mi.45.100191.001343; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zangger H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002006	88	49	53	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88398	10.1371/journal.pone.0088398	http://dx.doi.org/10.1371/journal.pone.0088398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505488	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200188
J	Braakman, R; Smith, E				Braakman, Rogier; Smith, Eric			Metabolic Evolution of a Deep-Branching Hyperthermophilic Chemoautotrophic Bacterium	PLOS ONE			English	Article							HYDROGEN-OXIDIZING BACTERIUM; AUTOTROPHIC CO2 FIXATION; AMINO-ACID BIOSYNTHESIS; CITRATE CLEAVAGE REACTION; CARBON-DIOXIDE FIXATION; AQUIFEX-AEOLICUS; LIPOIC ACID; ISOLEUCINE BIOSYNTHESIS; ESCHERICHIA-COLI; REDUCTIVE CARBOXYLATION	Aquifex aeolicus is a deep-branching hyperthermophilic chemoautotrophic bacterium restricted to hydrothermal vents and hot springs. These characteristics make it an excellent model system for studying the early evolution of metabolism. Here we present the whole-genome metabolic network of this organism and examine in detail the driving forces that have shaped it. We make extensive use of phylometabolic analysis, a method we recently introduced that generates trees of metabolic phenotypes by integrating phylogenetic and metabolic constraints. We reconstruct the evolution of a range of metabolic sub-systems, including the reductive citric acid (rTCA) cycle, as well as the biosynthesis and functional roles of several amino acids and cofactors. We show that A. aeolicus uses the reconstructed ancestral pathways within many of these sub-systems, and highlight how the evolutionary interconnections between sub-systems facilitated several key innovations. Our analyses further highlight three general classes of driving forces in metabolic evolution. One is the duplication and divergence of genes for enzymes as these progress from lower to higher substrate specificity, improving the kinetics of certain sub-systems. A second is the kinetic optimization of established pathways through fusion of enzymes, or their organization into larger complexes. The third is the minimization of the ATP unit cost to synthesize biomass, improving thermodynamic efficiency. Quantifying the distribution of these classes of innovations across metabolic sub-systems and across the tree of life will allow us to assess how a tradeoff between maximizing growth rate and growth efficiency has shaped the long-term metabolic evolution of the biosphere.	[Braakman, Rogier; Smith, Eric] Santa Fe Inst, Santa Fe, NM 87501 USA; [Smith, Eric] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	The Santa Fe Institute; George Mason University	Braakman, R (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rogier@santafe.edu			NSF FIBR [0526747]; SFI Omidyar Fellowship at the Santa Fe Institute; Insight Venture Partners	NSF FIBR(National Science Foundation (NSF)); SFI Omidyar Fellowship at the Santa Fe Institute; Insight Venture Partners	Parts of this work were performed under support from NSF FIBR grant nr. 0526747-The Emergence of Life: From Geochemistry to the Genetic Code. RB was further supported by an SFI Omidyar Fellowship at the Santa Fe Institute. ES thanks Insight Venture Partners for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2004, J BIOL CHEM, V279, P53136, DOI 10.1074/jbc.M403009200; Ahuja A, 2001, J BIOL CHEM, V276, P45694, DOI 10.1074/jbc.M106382200; Aoshima M, 2004, MOL MICROBIOL, V51, P791, DOI 10.1046/j.1365-2958.2003.03863.x; Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Aoshima M, 2004, MOL MICROBIOL, V52, P751, DOI 10.1111/j.1365-2958.2004.04009.x; Aoshima M, 2008, J BACTERIOL, V190, P2050, DOI 10.1128/JB.01799-07; Aoshima M, 2006, MOL MICROBIOL, V62, P748, DOI 10.1111/j.1365-2958.2006.05399.x; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Austin SM, 1999, ORIGINS LIFE EVOL B, V29, P287, DOI 10.1023/A:1006532518221; Bar-Even A, 2012, BBA-BIOENERGETICS, V1817, P1646, DOI 10.1016/j.bbabio.2012.05.002; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; BARAK Z, 1987, J BACTERIOL, V169, P3750, DOI 10.1128/jb.169.8.3750-3756.1987; BEH M, 1993, ARCH MICROBIOL, V160, P306, DOI 10.1007/BF00292082; BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; BERG P, 1954, J BIOL CHEM, V210, P657; Booker SJ, 2004, CHEM BIOL, V11, P10, DOI 10.1016/j.chembiol.2004.01.002; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Boussau B, 2008, BMC EVOL BIOL, V8, P1; Braakman R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/011001; Braakman R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002455; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; BUCHANAN BB, 1990, PHOTOSYNTH RES, V24, P47, DOI 10.1007/BF00032643; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Carballeira NM, 1997, J BACTERIOL, V179, P2766, DOI 10.1128/jb.179.8.2766-2768.1997; CHARON NW, 1974, J BACTERIOL, V117, P203, DOI 10.1128/JB.117.1.203-211.1974; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Christensen QH, 2011, MOL MICROBIOL, V80, P350, DOI 10.1111/j.1365-2958.2011.07598.x; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Cronan JE, 2005, ADV MICROB PHYSIOL, V50, P103, DOI 10.1016/S0065-2911(05)50003-1; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Drevland RM, 2007, J BACTERIOL, V189, P4391, DOI 10.1128/JB.00166-07; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; EIKMANNS B, 1983, ARCH MICROBIOL, V136, P111, DOI 10.1007/BF00404783; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Feng XY, 2010, J BIOL CHEM, V285, P39544, DOI 10.1074/jbc.M110.162958; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Ghosh W, 2009, RES MICROBIOL, V160, P409, DOI 10.1016/j.resmic.2009.07.003; Giuliani MC, 2007, FEBS J, V274, P4572, DOI 10.1111/j.1742-4658.2007.05985.x; Giuliani MC, 2010, BIOCHIMIE, V92, P388, DOI 10.1016/j.biochi.2009.12.013; Griffiths E, 2004, INT MICROBIOL, V7, P41; GRIMMINGER H, 1979, J BACTERIOL, V137, P846, DOI 10.1128/JB.137.2.846-853.1979; Guiral M, 2005, BIOCHEM SOC T, V33, P22, DOI 10.1042/BST0330022; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Guiral M, 2012, ADV MICROB PHYSIOL, V61, P125, DOI 10.1016/B978-0-12-394423-8.00004-4; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Henry CS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r69; HEPPEL LA, 1951, J BIOL CHEM, V188, P665; Hermes FAM, 2009, J BACTERIOL, V191, P6796, DOI 10.1128/JB.00798-09; Hochuli M, 1999, J BACTERIOL, V181, P3226, DOI 10.1128/JB.181.10.3226-3237.1999; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; HUANG T, 1995, J BIOL CHEM, V270, P22296, DOI 10.1074/jbc.270.38.22296; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R., 2006, PROKARYOTES, V7, P925; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; Infossi P, 2010, INT J HYDROGEN ENERG, V35, P10778, DOI 10.1016/j.ijhydene.2010.02.054; ISHII M, 1987, J BACTERIOL, V169, P2380, DOI 10.1128/jb.169.6.2380-2384.1987; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jahn U, 2007, J BACTERIOL, V189, P4108, DOI 10.1128/JB.00047-07; Jahnke LL, 2001, APPL ENVIRON MICROB, V67, P5179, DOI 10.1128/AEM.67.11.5179-5189.2001; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Khersonsky O, 2011, BIOCHEMISTRY-US, V50, P2683, DOI 10.1021/bi101763c; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; Kim J, 2010, MOL SYSTEMS BIOL, V6, P1; Kummerfeld SK, 2005, TRENDS GENET, V21, P25, DOI 10.1016/j.tig.2004.11.007; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Lengeler J. W., 1999, BIOL PROKARYOTES; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; MAROLEWSKI A, 1994, BIOCHEMISTRY-US, V33, P2531, DOI 10.1021/bi00175a023; Martin N, 2011, MOL MICROBIOL, V80, P335, DOI 10.1111/j.1365-2958.2011.07597.x; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; MILLER SL, 1990, J PHYS CHEM REF DATA, V19, P1049, DOI 10.1063/1.555878; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; Miyake D, 2007, ARCH MICROBIOL, V188, P199, DOI 10.1007/s00203-007-0244-7; Morowitz HJ, 2006, COMPLEXITY, V11, P9, DOI 10.1002/cplx.20112; Nam H, 2012, SCIENCE, V337, P1101, DOI 10.1126/science.1216861; Nitscke W, 1995, PHOTOSYNTHESIS LIGHT, V1, P945; Nubel T, 2000, ARCH MICROBIOL, V173, P233, DOI 10.1007/s002030000135; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Omelchenko MV, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-57; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Pelletier N, 2008, EXTREMOPHILES, V12, P205, DOI 10.1007/s00792-007-0119-5; Peng GH, 2003, BIOCHEMISTRY-US, V42, P3032, DOI 10.1021/bi026876v; Peng GH, 2006, FEBS LETT, V580, P5934, DOI 10.1016/j.febslet.2006.09.062; Pereto J, 2012, CHEM SOC REV, V41, P5394, DOI 10.1039/c2cs35054h; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Prunetti L, 2010, J BIOL CHEM, V285, P41815, DOI 10.1074/jbc.M110.167841; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rock CO, 2009, J BACTERIOL, V191, P6782, DOI 10.1128/JB.01151-09; Sano R, 2010, BIOSCI BIOTECH BIOCH, V74, P892, DOI 10.1271/bbb.90948; Scapin G, 1998, ADV ENZYMOL RAMB, V72, P279; SCHAFER S, 1986, ARCH MICROBIOL, V146, P301, DOI 10.1007/BF00403234; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Schoepp-Cothenet B, 2009, P NATL ACAD SCI USA, V106, P8549, DOI 10.1073/pnas.0813173106; Schutz M, 2003, BIOCHEMISTRY-US, V42, P10800, DOI 10.1021/bi034452a; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; SHIMA S, 1993, INT J SYST BACTERIOL, V43, P703, DOI 10.1099/00207713-43-4-703; Sievert SM, 2012, OCEANOGRAPHY, V25, P218, DOI 10.5670/oceanog.2012.21; Smith E, 2004, P NATL ACAD SCI USA, V101, P13168, DOI 10.1073/pnas.0404922101; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Srinivasan V, 2009, BIOL BULL-US, V216, P126; Stohr R, 2001, INT J SYST EVOL MICR, V51, P1853, DOI 10.1099/00207713-51-5-1853; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; Tang KH, 2010, J BIOL CHEM, V285, P35104, DOI 10.1074/jbc.M110.163303; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang YJJ, 2009, J BACTERIOL, V191, P5224, DOI 10.1128/JB.00085-09; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Trouillard M, 2011, P NATL ACAD SCI USA, V108, pE1027, DOI 10.1073/pnas.1109510108; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; UMBARGER HE, 1957, J BACTERIOL, V73, P105, DOI 10.1128/JB.73.1.105-112.1957; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Verte F, 2002, BIOCHEMISTRY-US, V41, P2932, DOI 10.1021/bi011404m; Vetriani C, 2004, INT J SYST EVOL MICR, V54, P175, DOI 10.1099/ijs.0.02781-0; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; Wald G, 1962, HORIZONS BIOCH, P127; White RH, 1997, J BACTERIOL, V179, P3374, DOI 10.1128/jb.179.10.3374-3377.1997; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wiegel J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P654, DOI 10.1007/0-387-30744-3_20; Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h; Wu B, 2010, MICROBIOL-SGM, V156, P596, DOI 10.1099/mic.0.031799-0; Xie G, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002- 3-9-research0051, DOI 10.1186/GB-2002-3-9-RESEARCH0051, 10.1186/gb-2002-3-9-research0051]; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016; Zhaxybayeva O, 2009, P NATL ACAD SCI USA, V106, P5865, DOI 10.1073/pnas.0901260106	152	23	23	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87950	10.1371/journal.pone.0087950	http://dx.doi.org/10.1371/journal.pone.0087950			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24516572	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200089
J	Dey, S; Ghosh, N; Saha, D; Kesh, K; Gupta, A; Swarnakar, S				Dey, Sanjib; Ghosh, Nillu; Saha, Debjit; Kesh, Kousik; Gupta, Arnab; Swarnakar, Snehasikta			Matrix Metalloproteinase-1 (MMP-1) Promoter Polymorphisms are Well Linked with Lower Stomach Tumor Formation in Eastern Indian Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; GASTRIC CARDIAC CARCINOMA; MATRIX-METALLOPROTEINASE-1 PROMOTER; PLASMINOGEN-ACTIVATOR; GENETIC POLYMORPHISMS; ETS-1 PROTOONCOGENE; COLORECTAL-CANCER; EXPRESSION; ASSOCIATION; ESOPHAGEAL	Expression of matrix metalloproteinase-1 (MMP-1), an interstitial collagenase, plays a major role in cellular invasion during development of gastric cancer, a leading cause of death worldwide. A single-nucleotide polymorphism (SNP) 21607 1G/2G site of the MMP-1 gene promoter has been reported to alter transcription level. While the importance's of other SNPs in the MMP-1 promoter have not yet been studied in gastric cancer, our aim was to investigate MMP-1 gene promoter polymorphisms and gastric cancer susceptibility in eastern Indian population. A total of 145 gastric cancer patients and 145 healthy controls were genotyped for MMP-1 -1607 1G/2G (rs1799750) by PCR-restriction fragment length polymorphism (RFLP), while MMP-1 -519 A/G (rs1144393), MMP-1 -422 T/A (rs475007), MMP-1 -340 T/C (rs514921) and MMP-1 -320 T/C (rs494379) were genotyped by DNA sequencing. A positive association was found with MMP-1 -422 T/A SNP that showed significant risk for regional lymph node metastasis (P = 0.021, Odd's ratio (OR) = 3.044, Confidence intervals (CI) = 1.187-7.807). In addition, we found a significant association with lower stomach tumor formation among gastric cancer patients for three adjacent polymorphisms near the transcriptional start sites of [MMP-1 -422 T/A (P = 0.043, OR = 2.182, CI = 1.03-4.643), MMP-1 -340 T/C (P = 0.075, OR = 1.97, CI = 0.94-4.158) and MMP-1 -320 T/C (P = 0.034, OR = 2.224, CI = 1.064-40731)]. MMP-1 level in patients' serum was correlated with MMP-1 promoter haplotypes conferring these three SNPs to evaluate the functional importance of these polymorphisms in lower stomach tumor formation and significant correlation was observed. Furthermore, MMP-1 -519 A/G polymorphism displayed poor cellular differentiation (P = 0.024, OR = 3.8, CI = 1.69-8.56) attributing a higher risk of cancer progression. In conclusion, MMP-1 proximal promoter SNPs are associated with the risk of lower stomach tumor formation and node metastasis in eastern Indian population.	[Dey, Sanjib; Ghosh, Nillu; Saha, Debjit; Kesh, Kousik; Swarnakar, Snehasikta] Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, Kolkata, India; [Gupta, Arnab] Saroj Gupta Canc Ctr & Res Inst, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Swarnakar, S (corresponding author), Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, Kolkata, India.	snehasiktas@hotmail.com	Kesh, Kousik/AAR-9458-2021	Swarnakar, Snehasikta/0000-0002-7139-9683	Indian Council of Medical Research (ICMR), India; Council of Scientific and Industrial Research (CSIR); Council of Scientific and Industrial Research (CSIR), India [IAP001]; Department of Biotechnology (DBT), India [NBA07]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	Sanjib Dey was recipient of Senior Research Fellowship from Indian Council of Medical Research (ICMR), India. NG and KK are recipient of Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR). The work was supported by grant IAP001 of Council of Scientific and Industrial Research (CSIR), India, NBA07 of Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayrak S, 2007, UROL INT, V79, P312, DOI 10.1159/000109715; Baker EA, 2003, EUR J CANCER, V39, P981, DOI 10.1016/S0959-8049(03)00065-0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benbow U, 2002, J CELL BIOCHEM, V86, P307, DOI 10.1002/jcb.10225; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Dikshit RP, 2011, INDIAN J MED PAEDIAT, V32, P3, DOI 10.4103/0971-5851.81883; Elander N, 2006, ANTICANCER RES, V26, P791; Fang SM, 2005, CARCINOGENESIS, V26, P481, DOI 10.1093/carcin/bgh327; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong YC, 2004, CLIN CANCER RES, V10, P7329, DOI 10.1158/1078-0432.CCR-04-0900; Frisdal E, 2005, HUM MOL GENET, V14, P2607, DOI 10.1093/hmg/ddi291; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hettiaratchi A, 2007, BRIT J CANCER, V96, P783, DOI 10.1038/sj.bjc.6603630; HEWITT RE, 1991, INT J CANCER, V49, P666, DOI 10.1002/ijc.2910490507; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Inoue T, 1999, INT J MOL MED, V4, P73; ITO R, 1993, CANCER RES, V53, P4102; Ito T, 1998, MODERN PATHOL, V11, P209; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Kanamori Y, 1999, CANCER RES, V59, P4225; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; Miao XP, 2002, CANCER EPIDEM BIOMAR, V11, P1454; Murray GI, 1998, GUT, V43, P791, DOI 10.1136/gut.43.6.791; Murray GI, 1998, J PATHOL, V185, P256; Nakayama T, 1999, MODERN PATHOL, V12, P61; Nishioka Y, 2000, JPN J CANCER RES, V91, P612, DOI 10.1111/j.1349-7006.2000.tb00989.x; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Pearce E, 2005, CIRC RES, V97, P1070, DOI 10.1161/01.RES.0000189302.03303.11; Pearce EG, 2007, MOL CANCER RES, V5, P221, DOI 10.1158/1541-7786.MCR-06-0139; Przybylowska K, 2004, J EXP CLIN CANC RES, V23, P121; Pulukuri SMK, 2008, INT J ONCOL, V32, P757; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rutter JL, 1998, CANCER RES, V58, P5321; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P150; Singer CF, 1997, P NATL ACAD SCI USA, V94, P10341, DOI 10.1073/pnas.94.19.10341; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Tomimatsu S, 2001, CANCER, V91, P1272, DOI 10.1002/1097-0142(20010401)91:7<1272::AID-CNCR1128>3.0.CO;2-Z; Vincenti MP, 1996, CRIT REV EUKAR GENE, V6, P391, DOI 10.1615/CritRevEukarGeneExpr.v6.i4.40; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Woo M, 2007, J GASTROEN HEPATOL, V22, P1064, DOI 10.1111/j.1440-1746.2006.04424.x; Wyatt CA, 2002, CANCER RES, V62, P7200; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Ye S, 2001, CANCER RES, V61, P1296; Zhang JH, 2003, WORLD J GASTROENTERO, V9, P1390, DOI 10.3748/wjg.v9.i7.1390; Zhang JH, 2003, INT J CANCER, V105, P281, DOI 10.1002/ijc.11067; Zhu Y, 2001, CANCER RES, V61, P7825; Zinzindohoue F, 2005, CLIN CANCER RES, V11, P594	49	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88040	10.1371/journal.pone.0088040	http://dx.doi.org/10.1371/journal.pone.0088040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505369	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200104
J	Ding, XH; Hu, JB; Wen, CP; Ding, ZS; Yao, L; Fan, YS				Ding, Xinghong; Hu, Jinbo; Wen, Chengping; Ding, Zhishan; Yao, Li; Fan, Yongsheng			Rapid Resolution Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry-Based Metabolomics Approach to Study the Effects of Jieduquyuziyin Prescription on Systemic Lupus Erythematosus	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; INTESTINAL MICROBIOTA; SAMPLE PREPARATION; EXPRESSION; CELLS; MS; 12-LIPOXYGENASE; METABONOMICS; METHODOLOGY; TRYPTOPHAN	Jieduquyuziyin prescription (JP), a traditional Chinese medicine (TCM) prescription, has been widely used for the clinical treatment of systemic lupus erythematosus (SLE). However, the complex chemical constituents of JP and the multifactorial pathogenesis of SLE make research on the therapeutic mechanism of JP in SLE challenging. In this paper, a serum metabolomics approach based on rapid resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (RRLC-Q-TOF/MS) was employed to acquire the metabolic characteristics of serum samples obtained from mice in the SLE model group, JP-treated group, prednisone acetate (PA)-treated group and control group. The orthogonal partial least squares (OPLS) was applied to recognize metabolic patterns, and an obvious separation of groups was obtained. Thirteen metabolites, namely, phosphatidylethanolamine (PE 20:3), hepoxilin B3, lyso-phosphatidylethanolamine (lyso-PE 22:6), 12S-hydroxypentaenoic acid (12S-HEPE), traumatic acid, serotonin, platelet-activating factor (PAF), phosphatidylcholine (PC 20:5), eicosapentaenoic acid (EPA), 12(S)-hydroxyei-cosatetraenoic acid (12S-HETE), 14-hydroxy docosahexaenoic acid (14-HDOHE), lyso-phosphatidylcholine (lyso-PC 20:4), and indole acetaldehyde, were identified and characterized as differential metabolites involved in the pathogenesis of SLE. After treatment with JP, the relative content of 12(S)-HETE, PAF, 12(S)-HEPE, EPA, PE (20:3), Lyso-PE(22:6), and 14-HDOHE were effectively regulated, which suggested that the therapeutic effects of JP on SLE may involve regulating disturbances to the metabolism of unsaturated fatty acid, tryptophan and phospholipid. This research also demonstrated that metabolomics is a powerful tool for researching complex disease mechanisms and evaluating the mechanism of action of TCM.	[Ding, Xinghong] Zhejiang Chinese Med Univ, Anal & Testing Ctr, Hangzhou, Zhejiang, Peoples R China; [Hu, Jinbo; Yao, Li] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Wen, Chengping; Fan, Yongsheng] Zhejiang Chinese Med Univ, Coll Basic Med, Hangzhou, Zhejiang, Peoples R China; [Ding, Zhishan] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Fan, YS (corresponding author), Zhejiang Chinese Med Univ, Coll Basic Med, Hangzhou, Zhejiang, Peoples R China.	applezjtcm@126.com		Yao, Li/0000-0001-8720-3027; chengping, Wen/0000-0001-9254-6235	National Natural Science Foundation of China [81001515]; Research Fund for the Doctoral Program of Higher Education of China [20093322120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Natural Science Foundation of China (No. 81001515), the Research Fund for the Doctoral Program of Higher Education of China (No. 20093322120001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre E, 2008, CLIN CHIM ACTA, V393, P132, DOI 10.1016/j.cca.2008.03.011; An ZL, 2010, J PROTEOME RES, V9, P4071, DOI 10.1021/pr100265g; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; [范永升 Fan Yongsheng], 2005, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V20, P667; Gabrielsson J, 2006, CHEMOMETR INTELL LAB, V84, P153, DOI 10.1016/j.chemolab.2006.03.013; Gika H, 2011, BIOANALYSIS, V3, P1647, DOI [10.4155/BIO.11.122, 10.4155/bio.11.122]; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Goodpaster AM, 2011, CHEMOMETR INTELL LAB, V109, P162, DOI 10.1016/j.chemolab.2011.08.009; Gurevitz Samuel L, 2013, Consult Pharm, V28, P110, DOI 10.4140/TCP.n.2013.110; Hu JB, 2013, CHROMATOGRAPHIA, V76, P791, DOI 10.1007/s10337-013-2476-9; HWANG D, 1989, FASEB J, V3, P2052, DOI 10.1096/fasebj.3.9.2501132; Kang SW, 2001, KIDNEY INT, V59, P1354, DOI 10.1046/j.1523-1755.2001.0590041354.x; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Le Rond S, 2005, IMMUNOLOGY, V116, P297, DOI 10.1111/j.1365-2567.2005.02224.x; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Manzi S, 2000, ANN RHEUM DIS, V59, P321, DOI 10.1136/ard.59.5.321; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Minhas Ujla, 2012, Inflammopharmacology, V20, P195, DOI 10.1007/s10787-011-0102-8; Mori Trevor A, 2004, Curr Atheroscler Rep, V6, P461, DOI 10.1007/s11883-004-0087-5; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Papavasiliou EC, 2005, KIDNEY INT, V68, P246, DOI 10.1111/j.1523-1755.2005.00399.x; PERICO N, 1988, LAB INVEST, V58, P163; Price Sarah, 2010, Nat Rev Rheumatol, V6, P613, DOI 10.1038/nrrheum.2010.164; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Reddy MA, 2002, AM J PHYSIOL-RENAL, V283, pF985, DOI 10.1152/ajprenal.00181.2002; Reeves WH, 2009, TRENDS IMMUNOL, V30, P455, DOI 10.1016/j.it.2009.06.003; Ruiz-Irastorza G, 2012, RHEUMATOLOGY, V51, P1145, DOI 10.1093/rheumatology/ker410; Sana Theodore R, 2008, J Biomol Tech, V19, P258; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Thibault DL, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2771; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vuckovic D, 2012, ANAL BIOANAL CHEM, V403, P1523, DOI 10.1007/s00216-012-6039-y; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Wen C., 2007, CHIN ARCH TRADITI CH, V25, P1599, DOI DOI 10.3969/j.issn.1673-7717.2007.08.027; Xu G.W., 2009, WORLD SCI TECHNOL, V11, P107; Yost CC, 2010, BIOCHIMIE, V92, P692, DOI 10.1016/j.biochi.2010.02.011	40	23	23	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88223	10.1371/journal.pone.0088223	http://dx.doi.org/10.1371/journal.pone.0088223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505438	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200143
J	Greenberg, JA; David, MZ; Hall, JB; Kress, JP				Greenberg, Jared A.; David, Michael Z.; Hall, Jesse B.; Kress, John P.			Immune Dysfunction Prior to Staphylococcus aureus Bacteremia Is a Determinant of Long-Term Mortality	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTION; RISK-FACTORS; SEPSIS; IMMUNOSUPPRESSION; INTERLEUKIN-10; PREDICTORS; DIAGNOSIS; CRITERIA; EPISODES; OUTCOMES	Purpose: The clinical implications for patients who survive serious infections are not well understood. It has been hypothesized that the excess mortality for survivors of sepsis observed in epidemiological studies is due to increased vulnerability to subsequent infections. We undertook this study to identify characteristics of patients who are at high risk for death after surviving a common type of blood-stream infection. Materials and Methods: At a single academic medical center, 237 patients with Staphylococcus aureus bacteremia admitted during a three-year period were retrospectively identified. The primary outcomes were 30-day and 31 to 90-day mortality after the first positive blood culture. The primary predictor variable of interest was clinical immune dysfunction prior to bacteremia. Results: The 30-day mortality was not significantly different for patients with and without prior immune dysfunction. However, during days 31 to 90, 11 patients (20%) with prior immune dysfunction compared to 10 patients (8.6%) without prior immune dysfunction died (OR 2.59, 95% CI 1.03-6.53, p = 0.04). In a Cox-proportional hazard model controlling for age, there was a significant association between prior immune dysfunction and greater 31 to 90 day mortality (HR 2.44, 95% CI 1.01-5.90, p = 0.05) and a non-significant trend towards occurrence of subsequent infections and greater 31 to 90 day mortality (HR 2.12, 95% CI 0.89-5.07, p = 0.09). Conclusions: Patients with prior immune dysfunction are at high risk for death 31 to 90 days, but not,30 days, after S. aureus bacteremia. Further investigation is needed to determine if this finding is due to poor prognosis of chronic disease or increased vulnerability to subsequent infections.	[Greenberg, Jared A.; Hall, Jesse B.; Kress, John P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [David, Michael Z.] Univ Chicago, Dept Med, Sect Infect Dis & Global Hlth, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Greenberg, JA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jared.greenberg@uchospitals.edu	David, Michael Z./X-6737-2019	David, Michael Z./0000-0002-1926-7800	Research Training in Respiratory Biology [2 T32 HL007605-28]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI095361] Funding Source: NIH RePORTER	Research Training in Respiratory Biology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research Training in Respiratory Biology (2 T32 HL007605-28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Azoulay E, 2005, INTENS CARE MED, V31, P56, DOI 10.1007/s00134-004-2484-1; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Chen MJ, 2008, RHEUMATOLOGY, V47, P1352, DOI 10.1093/rheumatology/ken196; Chong YP, 2013, MEDICINE, V92, P98, DOI 10.1097/MD.0b013e318289ff1e; Dimopoulos G, 2007, EUR J CLIN MICROBIOL, V26, P377, DOI 10.1007/s10096-007-0316-2; Fatkenheuer G, 2004, EUR J CLIN MICROBIOL, V23, P157, DOI 10.1007/s10096-003-1083-3; Fowler VG, 1998, CLIN INFECT DIS, V27, P478, DOI 10.1086/514686; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; Kang CI, 2011, INT J INFECT DIS, V15, pE58, DOI 10.1016/j.ijid.2010.09.012; Kieslichova E, 2013, TRANSPL P, V45, P770, DOI 10.1016/j.transproceed.2012.07.159; Kollef MH, 2008, CLIN INFECT DIS, V47, pS55, DOI 10.1086/590937; Leentjens J, 2013, AM J RESP CRIT CARE; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lin SH, 2010, J ANTIMICROB CHEMOTH, V65, P1792, DOI 10.1093/jac/dkq188; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Monneret G, 2004, IMMUNOL LETT, V95, P193, DOI 10.1016/j.imlet.2004.07.009; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; Norgaard M, 2006, CLIN MICROBIOL INFEC, V12, P217, DOI 10.1111/j.1469-0691.2005.01298.x; Nseir S, 2007, CRIT CARE MED, V35, P1318, DOI 10.1097/01.CCM.0000261885.50604.20; Poutsiaka DD, 2009, SCAND J INFECT DIS, V41, P469, DOI 10.1080/00365540902962756; Rose WE, 2012, J INFECT DIS, V206, P1604, DOI 10.1093/infdis/jis552; Rubin LG, 2013, CLIN INFECT DIS, V2013; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Tacconelli E, 2006, J HOSP INFECT, V64, P251, DOI 10.1016/j.jhin.2006.07.001; Tavares E, 2005, CLIN DIAGN LAB IMMUN, V12, P1085, DOI 10.1128/CDLI.12.9.1085-1093.2005; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Yzerman EPF, 1996, J INFECT DIS, V173, P914, DOI 10.1093/infdis/173.4.914	36	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88197	10.1371/journal.pone.0088197	http://dx.doi.org/10.1371/journal.pone.0088197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505428	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200134
J	Stopczynski, A; Stahlhut, C; Larsen, JE; Petersen, MK; Hansen, LK				Stopczynski, Arkadiusz; Stahlhut, Carsten; Larsen, Jakob Eg; Petersen, Michael Kai; Hansen, Lars Kai			The Smartphone Brain Scanner: A Portable Real-Time Neuroimaging System	PLOS ONE			English	Article							EEG SOURCE RECONSTRUCTION; OPEN-SOURCE SOFTWARE; COMPUTER INTERFACE; CLASSIFICATION; DYNAMICS	Combining low-cost wireless EEG sensors with smartphones offers novel opportunities for mobile brain imaging in an everyday context. Here we present the technical details and validation of a framework for building multi-platform, portable EEG applications with real-time 3D source reconstruction. The system - Smartphone Brain Scanner - combines an off-the-shelf neuroheadset or EEG cap with a smartphone or tablet, and as such represents the first fully portable system for real-time 3D EEG imaging. We discuss the benefits and challenges, including technical limitations as well as details of real-time reconstruction of 3D images of brain activity. We present examples of brain activity captured in a simple experiment involving imagined finger tapping, which shows that the acquired signal in a relevant brain region is similar to that obtained with standard EEG lab equipment. Although the quality of the signal in a mobile solution using an off-the-shelf consumer neuroheadset is lower than the signal obtained using high-density standard EEG equipment, we propose mobile application development may offset the disadvantages and provide completely new opportunities for neuroimaging in natural settings.	[Stopczynski, Arkadiusz; Stahlhut, Carsten; Larsen, Jakob Eg; Petersen, Michael Kai; Hansen, Lars Kai] Tech Univ Denmark, DTU Compute, Sect Cognit Syst, DK-2800 Lyngby, Denmark	Technical University of Denmark	Stopczynski, A (corresponding author), Tech Univ Denmark, DTU Compute, Sect Cognit Syst, DK-2800 Lyngby, Denmark.	arks@dtu.dk		Hansen, Lars Kai/0000-0003-0442-5877; Petersen, Michael Kai/0000-0002-2156-9226; Larsen, Jakob Eg/0000-0002-7461-9901	Danish Lundbeck Foundation through CIMBI - Center for Integrated Molecular Brain Imaging; H. C. Orsted Foundation	Danish Lundbeck Foundation through CIMBI - Center for Integrated Molecular Brain Imaging; H. C. Orsted Foundation	This work is supported in part by the Danish Lundbeck Foundation through CIMBI - Center for Integrated Molecular Brain Imaging and a post-doctorate grant for CS, and by the H. C. Orsted Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharony N, 2011, PERVASIVE MOB COMPUT, V7, P643, DOI 10.1016/j.pmcj.2011.09.004; Babiloni F, 2000, IEEE T REHABIL ENG, V8, P186, DOI 10.1109/86.847810; Baillet S, 1997, IEEE T BIO-MED ENG, V44, P374, DOI 10.1109/10.568913; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Besserve M, 2011, NEUROIMAGE, V55, P1536, DOI 10.1016/j.neuroimage.2011.01.056; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Blankertz B, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00198; Brown B, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1657; Brunner C, 2011, PRACTICAL BRAIN COMP, P303; Chi YM, 2012, IEEE T NEUR SYS REH, V20, P228, DOI 10.1109/TNSRE.2011.2174652; Choudhury T, 2003, SEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P216, DOI 10.1109/ISWC.2003.1241414; Congedo M, 2006, PHYS MED BIOL, V51, P1971, DOI 10.1088/0031-9155/51/8/002; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dornhege G, 2004, IEEE T BIO-MED ENG, V51, P993, DOI 10.1109/TBME.2004.827088; Drechsler F, 2009, NEUROIMAGE, V46, P1055, DOI 10.1016/j.neuroimage.2009.02.024; Dumas Guillaume, 2011, Commun Integr Biol, V4, P349, DOI 10.4161/cib.4.3.15110; Gramann K, 2011, REV NEUROSCIENCE, V22, P593, DOI 10.1515/RNS.2011.047; Gramann K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00202; Gwin JT, 2010, J NEUROPHYSIOL, V103, P3526, DOI 10.1152/jn.00105.2010; Hallez H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-46; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Jensen Bjorn Sand, 2010, Proceedings of the 2010 IEEE International Workshop on Machine Learning for Signal Processing (MLSP), P196, DOI 10.1109/MLSP.2010.5588997; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Kwok R, 2009, NATURE, V458, P959, DOI 10.1038/458959a; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Looney D, 2012, IEEE PULSE, V3, P32, DOI 10.1109/MPUL.2012.2216717; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; Makeig S, 2009, INT J PSYCHOPHYSIOL, V73, P95, DOI 10.1016/j.ijpsycho.2008.11.008; Moraveji N., 2012, CHI 12 HUM FACT COMP, P2405, DOI [10.1145/2212776.2223810, DOI 10.1145/2212776.2223810.AVAILABLE:HTTP://D0I.ACM.0RG/10.1145/2212776.2223810]; Muller-Gerking J, 1999, CLIN NEUROPHYSIOL, V110, P787, DOI 10.1016/S1388-2457(98)00038-8; Noirhomme Q, 2008, IEEE T BIO-MED ENG, V55, P1592, DOI 10.1109/TBME.2007.913986; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Phillips C, 2002, NEUROIMAGE, V16, P678, DOI 10.1006/nimg.2002.1143; Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Renard Y, 2010, PRESENCE-TELEOP VIRT, V19, P35, DOI 10.1162/pres.19.1.35; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Stahlhut C, 2012, 34 ANN INT C IEEE EN, P1; Stopczynski A, 2014, INT J PSYCHOPHYSIOL, V91, P54, DOI 10.1016/j.ijpsycho.2013.08.007; Swan M, 2012, J SENS ACTUAR NETW, V1, P217, DOI 10.3390/jsan1030217; Van Laerhoven K, 2000, FOURTH INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, DIGEST OF PAPERS, P77, DOI 10.1109/ISWC.2000.888468; Vi Chi, 2012, P SIGCHI C HUM FACT, P493; Wolters CH, 2007, SIAM J SCI COMPUT, V30, P24, DOI 10.1137/060659053; Yasui Yoshitsugu, 2009, Journal of Physiological Anthropology, V28, P145, DOI 10.2114/jpa2.28.145	49	64	68	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86733	10.1371/journal.pone.0086733	http://dx.doi.org/10.1371/journal.pone.0086733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505263	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200023
J	Kishi, T; Matsuda, Y; Iwata, N				Kishi, Taro; Matsuda, Yuki; Iwata, Nakao			Cardiometabolic Risks of Blonanserin and Perospirone in the Management of Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							DOUBLE-BLIND; EFFICACY; TOLERABILITY; RISPERIDONE	Background: The present study aimed to evaluate cardiometabolic risks [weight gain, blood lipid levels (total cholesterol and triglycerides), blood glucose levels, hemoglobin A(1c) (HbA(1c)) levels, and corrected QT interval (QTc) prolongation] associated with the use of blonanserin and perospirone versus other antipsychotics in the management of patients with schizophrenia. Method: We conducted a systematic review and meta-analysis of patient data from randomized controlled trials comparing blonanserin or perospirone with other antipsychotics. Results: In total, 4 blonanserin studies (n = 1080) were identified [vs. risperidone (2 studies, n = 508); vs. haloperidol (2 studies, n = 572)]. Blonanserin produced less weight gain compared with risperidone (weighted mean difference = -0.86, 95% confidence intervals = -1.36 to -0.36, p = 0.0008; 2 studies, 480 patients). However, no significant differences were observed in blood lipid, glucose, and HbA(1c) levels or QTc prolongation between blonanserin and risperidone or haloperidol. For perospirone studies, 5 studies [562 adult patients with schizophrenia randomized to perospirone (n = 256), olanzapine (n = 20), quetiapine (n = 28), risperidone (n = 53), aripiprazole (n = 49), haloperidol (n = 75), or mosapramine (n = 81)] were identified. Perospirone did not differ from other antipsychotics with regard to weight gain and total cholesterol levels. Conclusions: Our results suggest that blonanserin is associated with a lower of weight gain compared with other antipsychotics. Because the number of studies was small, additional controlled clinical trials with larger number of patients are indicated.	[Kishi, Taro; Matsuda, Yuki; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Fujita Health University	Kishi, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	tarok@fujita-hu.ac.jp		IWATA, Nakao/0000-0003-3189-6076				Correll CU, 2011, TRENDS MOL MED, V17, P97, DOI 10.1016/j.molmed.2010.10.010; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; De Hert M, 2009, WORLD PSYCHIATRY, V8, P15; Deeks ED, 2010, CNS DRUGS, V24, P65, DOI 10.2165/11202620-000000000-00000; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Garcia E, 2009, CNS DRUGS, V23, P615, DOI 10.2165/00023210-200923070-00006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ishibashi Tadashi, 2008, Folia Pharmacologica Japonica, V132, P351, DOI 10.1254/fpj.132.351; Kishi T, 2012, J PSYCHIAT RES; Kishi T, 2013, CNS DRUGS, V27, P731, DOI 10.1007/s40263-013-0085-7; Kishi T, 2013, J PSYCHIATR RES, V47, P149, DOI 10.1016/j.jpsychires.2012.10.011; Kudo Y., 1997, CLIN EVAL, V24, P207; Leucht S, 2009, AM J PSYCHIAT, V166, P152, DOI 10.1176/appi.ajp.2008.08030368; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Miura S., 2008, JPN J CLIN PSYCHOPHA, V11, P297; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Murasaki M., 2007, JPN J CLIN PSYCHOPHA, V10; Murasaki M., 1997, CLIN EVAL, V24, P159; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Okugawa G, 2009, PSYCHIAT CLIN NEUROS, V63, P322, DOI 10.1111/j.1440-1819.2009.01947.x; Onrust SV, 2001, CNS DRUGS, V15, P329, DOI 10.2165/00023210-200115040-00006; Rummel-Kluge Christine, 2012, Schizophr Bull, V38, P167, DOI 10.1093/schbul/sbq042; Rummel-Kluge C, 2010, SCHIZOPHR RES, V123, P225, DOI 10.1016/j.schres.2010.07.012; Takekita Y, 2013, PROG NEURO-PSYCHOPH, V40, P110, DOI 10.1016/j.pnpbp.2012.09.010; Yamashita H, 2004, J CLIN PSYCHIAT, V65, P1525, DOI 10.4088/JCP.v65n1114; Yang J, 2010, CLIN NEUROPHARMACOL, V33, P169, DOI 10.1097/WNF.0b013e3181dcda50	26	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88049	10.1371/journal.pone.0088049	http://dx.doi.org/10.1371/journal.pone.0088049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505373	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300044
J	Vaskova, EA; Dementyeva, EV; Shevchenko, AI; Pavlova, SV; Grigor'eva, EV; Zhelezova, AI; VandeBerg, JL; Zakian, SM				Vaskova, Evgeniya A.; Dementyeva, Elena V.; Shevchenko, Alexander I.; Pavlova, Sophia V.; Grigor'eva, Elena V.; Zhelezova, Antonina I.; VandeBerg, John L.; Zakian, Suren M.			Dynamics of the Two Heterochromatin Types during Imprinted X Chromosome Inactivation in Vole Microtus levis	PLOS ONE			English	Article							TROPHOBLAST STEM-CELLS; EARLY MOUSE EMBRYOS; DOSAGE COMPENSATION; FACULTATIVE HETEROCHROMATIN; H2A UBIQUITINATION; Y-CHROMOSOMES; HISTONE H2A; COMMON VOLE; MAMMALS; MICE	In rodent female mammals, there are two forms of X-inactivation -imprinted and random which take place in extraembryonic and embryonic tissues, respectively. The inactive X-chromosome during random X-inactivation was shown to contain two types of facultative heterochromatin that alternate and do not overlap. However, chromatin structure of the inactive X-chromosome during imprinted X-inactivation, especially at early stages, is still not well understood. In this work, we studied chromatin modifications associated with the inactive X-chromosome at different stages of imprinted X-inactivation in a rodent, Microtus levis. It has been found that imprinted X-inactivation in vole occurs in a species-specific manner in two steps. The inactive X-chromosome at early stages of imprinted X-inactivation is characterized by accumulation of H3K9me3, HP1, H4K20me3, and uH2A, resembling to some extent the pattern of repressive chromatin modifications of meiotic sex chromatin. Later, the inactive X-chromosome recruits trimethylated H3K27 and acquires the two types of heterochromatin associated with random X-inactivation.	[Vaskova, Evgeniya A.; Dementyeva, Elena V.; Shevchenko, Alexander I.; Pavlova, Sophia V.; Grigor'eva, Elena V.; Zhelezova, Antonina I.; Zakian, Suren M.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia; [Vaskova, Evgeniya A.; Dementyeva, Elena V.; Shevchenko, Alexander I.; Pavlova, Sophia V.; Grigor'eva, Elena V.; Zakian, Suren M.] State Res Inst Circulat Pathol, Novosibirsk, Russia; [Vaskova, Evgeniya A.; Dementyeva, Elena V.; Shevchenko, Alexander I.; Pavlova, Sophia V.; Grigor'eva, Elena V.; Zakian, Suren M.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [VandeBerg, John L.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA; [VandeBerg, John L.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Meshalkin National Medical Research Center; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Texas Biomedical Research Institute; Texas Biomedical Research Institute	Zakian, SM (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.	zakian@bionet.nsc.ru	Vaskova, Evgeniya/J-8612-2015; Grigor'eva, Elena V/V-5416-2018; Shevchenko, Alexander I./T-3400-2018; Zakian, Suren/J-2196-2018; Pavlova, Sophia/I-5616-2017	Grigor'eva, Elena/0000-0002-9162-9108; Zakian, Suren/0000-0003-2448-6511; Pavlova, Sophia/0000-0003-1095-3692	Russian Foundation for Basic Research [12-04-31704, 11-04-00799]; Ministry of Education and Science of Russian Federation [8264]; Program of Russian Academy of Sciences, Molecular and Cellular Biology	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Program of Russian Academy of Sciences, Molecular and Cellular Biology	This work was supported by the Russian Foundation for Basic Research (grants no. 12-04-31704, 11-04-00799), The Ministry of Education and Science of Russian Federation, project 8264, and The Program of Russian Academy of Sciences, Molecular and Cellular Biology (http://www.rfbr.ru/rffi/ru/) (https://kias.rfbr.ru/) (http://www.fcpk.ru/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Borodin PM, 1995, HEREDITAS, V123, P17, DOI 10.1111/j.1601-5223.1995.00017.x; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chaumeil J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019040; Clerc P, 1998, NAT GENET, V19, P249, DOI 10.1038/924; Coppola G, 2008, SEX DEV, V2, P12, DOI 10.1159/000117715; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dementyeva EV, 2010, CHROMOSOMA, V119, P541, DOI 10.1007/s00412-010-0277-6; Dementyeva EV, 2009, BIOESSAYS, V31, P21, DOI 10.1002/bies.080149; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; Elisaphenko EA, 1998, CHROMOSOME RES, V6, P351, DOI 10.1023/A:1009284031287; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Goto Y, 1998, DEVELOPMENT, V125, P3353; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Grigor'eva EV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007161; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Namekawa SH, 2007, P NATL ACAD SCI USA, V104, P9730, DOI 10.1073/pnas.0700323104; Namekawa SH, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.195; Namekawa SH, 2010, MOL CELL BIOL, V30, P3187, DOI 10.1128/MCB.00227-10; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Oda M, 2006, METHOD ENZYMOL, V419, P387, DOI 10.1016/S0076-6879(06)19015-1; Okamoto I, 2006, CYTOGENET GENOME RES, V113, P318, DOI 10.1159/000090848; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2011, NATURE, V472, P370, DOI 10.1038/nature09872; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2011, HUM GENET, V130, P265, DOI 10.1007/s00439-011-1024-7; Rens W, 2010, P NATL ACAD SCI USA, V107, P17657, DOI 10.1073/pnas.0910322107; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Shevchenko AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022771; Shevchenko AI, 2009, MAMM GENOME, V20, P644, DOI 10.1007/s00335-009-9201-x; Smith KP, 2004, CHROMOSOMA, V113, P324, DOI 10.1007/s00412-004-0325-1; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; SOLARI AJ, 1975, CHROMOSOMA, V52, P11, DOI 10.1007/BF00285785; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Wongtawan T, 2011, J CELL SCI, V124, P1878, DOI 10.1242/jcs.080721; Zakharova IS, 2011, CHROMOSOMA, V120, P177, DOI 10.1007/s00412-010-0300-y	48	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88256	10.1371/journal.pone.0088256	http://dx.doi.org/10.1371/journal.pone.0088256			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505450	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300073
J	Yildiz, F; Fong, J; Sadovskaya, I; Grard, T; Vinogradov, E				Yildiz, Fitnat; Fong, Jiunn; Sadovskaya, Irina; Grard, Thierry; Vinogradov, Evgeny			Structural Characterization of the Extracellular Polysaccharide from Vibrio cholerae O1 El-Tor	PLOS ONE			English	Article							BIOFILM FORMATION; CAPSULAR POLYSACCHARIDE; STAPHYLOCOCCUS-EPIDERMIDIS; SIMPLE FILTRATION; BENGAL; PERSISTENCE; ENVIRONMENT; BANGLADESH; NON-O139; PLANKTON	The ability to form biofilms is important for environmental survival, transmission, and infectivity of Vibrio cholerae, the causative agent of cholera in humans. To form biofilms, V. cholerae produces an extracellular matrix composed of proteins, nucleic acids and a glycoconjugate, termed Vibrio exopolysaccharide (VPS). Here, we present the data on isolation and characterization of the polysaccharide part of the VPS (VPS-PS), which has the following structure: 4) alpha GulpNAcAGly3OAc (1 4) beta D Glcp (1 4) alpha Glcp (1 4) alpha D Galp (1 where alpha-D-Glc is partially (similar to 20%) replaced with alpha-D-GlcNAc. alpha-GulNAcAGly is an amide between 2-acetamido-2-deoxy-alpha-guluronic acid and glycine. Apparently, the polysaccharide is bound to a yet unidentified component, which gives it high viscosity and completely suppresses any NMR signals belonging to the sugar chains of the VPS. The only reliable method to remove this component at present is a treatment of the whole glycoconjugate with concentrated hydrochloric acid.	[Yildiz, Fitnat; Fong, Jiunn] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Vinogradov, Evgeny] CNR, Ottawa, ON, Canada; [Sadovskaya, Irina; Grard, Thierry] Univ Littoral Cote dOpale, Boulogne Sur Mer, France	University of California System; University of California Santa Cruz; National Research Council Canada; Universite du Littoral-Cote-d'Opale	Vinogradov, E (corresponding author), CNR, Ottawa, ON, Canada.	evguenii.vinogradov@nrc.ca	GRARD, Thierry/A-9953-2017	GRARD, Thierry/0000-0002-4636-8981	NIH [R01-AI055987]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055987] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an NIH grant R01-AI055987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, APPL ENVIRON MICROB, V72, P2849, DOI 10.1128/AEM.72.4.2849-2855.2006; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Broza M, 2005, ENVIRON MICROBIOL, V7, P576, DOI 10.1111/j.1462-2920.2005.00745.x; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Chen YS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-20; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Coulon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014220; Enos-Berlage JL, 2000, J BACTERIOL, V182, P5513, DOI 10.1128/JB.182.19.5513-5520.2000; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Halpern M, 2004, MICROB ECOL, V47, P341, DOI 10.1007/s00248-003-2007-6; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Huq A, 1996, APPL ENVIRON MICROB, V62, P2508, DOI 10.1128/AEM.62.7.2508-2512.1996; HUQ A, 1986, APPL ENVIRON MICROB, V52, P586, DOI 10.1128/AEM.52.3.586-588.1986; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; HUQ A, 1995, LANCET, V345, P1249, DOI 10.1016/S0140-6736(95)92038-2; Kamruzzaman M, 2010, P NATL ACAD SCI USA, V107, P1588, DOI 10.1073/pnas.0913404107; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KNIREL YA, 1995, EUR J BIOCHEM, V232, P391, DOI 10.1111/j.1432-1033.1995.tb20823.x; Li JP, 2010, PROG MOL BIOL TRANSL, V93, P59, DOI 10.1016/S1877-1173(10)93004-4; LIPKIND GM, 1988, CARBOHYD RES, V175, P59, DOI 10.1016/0008-6215(88)80156-3; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; PRESTON LM, 1995, J BACTERIOL, V177, P835, DOI 10.1128/jb.177.3.835-838.1995; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tondervik A, 2013, BIOMACROMOLECULES, V14, P2657, DOI 10.1021/bm4005194; VINOGRADOV EV, 1994, CARBOHYD RES, V258, P223, DOI 10.1016/0008-6215(94)84088-1; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Weintraub A, 1995, Prog Clin Biol Res, V392, P141; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yip ES, 2006, MOL MICROBIOL, V62, P1586, DOI 10.1111/j.1365-2958.2006.05475.x	37	48	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e86751	10.1371/journal.pone.0086751	http://dx.doi.org/10.1371/journal.pone.0086751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24520310	Green Published, gold, Green Submitted			2022-12-27	WOS:000330339800059
J	Burkert, NT; Muckenhuber, J; Grossschadl, F; Rasky, E; Freidl, W				Burkert, Nathalie T.; Muckenhuber, Johanna; Grossschaedl, Franziska; Rasky, Eva; Freidl, Wolfgang			Nutrition and Health - The Association between Eating Behavior and Various Health Parameters: A Matched Sample Study	PLOS ONE			English	Article							BODY-MASS INDEX; VEGETARIAN DIETS; PHYSICAL-ACTIVITY; ADVENTIST-HEALTH; WEIGHT; RISK; MORTALITY; CARCINOMA; OBESITY; CANCER	Population-based studies have consistently shown that our diet has an influence on health. Therefore, the aim of our study was to analyze differences between different dietary habit groups in terms of health-related variables. The sample used for this cross-sectional study was taken from the Austrian Health Interview Survey AT-HIS 2006/07. In a first step, subjects were matched according to their age, sex, and socioeconomic status (SES). After matching, the total number of subjects included in the analysis was 1320 (N = 330 for each form of diet - vegetarian, carnivorous diet rich in fruits and vegetables, carnivorous diet less rich in meat, and carnivorous diet rich in meat). Analyses of variance were conducted controlling for lifestyle factors in the following domains: health (self-assessed health, impairment, number of chronic conditions, vascular risk), health care (medical treatment, vaccinations, preventive check-ups), and quality of life. In addition, differences concerning the presence of 18 chronic conditions were analyzed by means of Chi-square tests. Overall, 76.4% of all subjects were female. 40.0% of the individuals were younger than 30 years, 35.4% between 30 and 49 years, and 24.0% older than 50 years. 30.3% of the subjects had a low SES, 48.8% a middle one, and 20.9% had a high SES. Our results revealed that a vegetarian diet is related to a lower BMI and less frequent alcohol consumption. Moreover, our results showed that a vegetarian diet is associated with poorer health (higher incidences of cancer, allergies, and mental health disorders), a higher need for health care, and poorer quality of life. Therefore, public health programs are needed in order to reduce the health risk due to nutritional factors.	[Burkert, Nathalie T.; Muckenhuber, Johanna; Grossschaedl, Franziska; Rasky, Eva; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria	Medical University of Graz	Burkert, NT (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria.	nathalie.burkert@medunigraz.at		Grossschadl, Franziska/0000-0002-6726-0443				Appleby PN, 1999, AM J CLIN NUTR, V70, p525S, DOI 10.1093/ajcn/70.3.525s; Appleby PN, 2002, PUBLIC HEALTH NUTR, V5, P29, DOI 10.1079/PHN2001248; Baines S, 2007, PUBLIC HEALTH NUTR, V10, P436, DOI 10.1017/S1368980007217938; Bauer GF, 2009, INT J PUBLIC HEALTH, V54, P23, DOI 10.1007/s00038-008-7077-2; Boutron-Ruault MC, 2001, NUTR CANCER, V39, P50, DOI 10.1207/S15327914nc391_7; Burkert N, 2012, WIEN KLIN WOCHENSCHR, V124, P256, DOI 10.1007/s00508-012-0164-7; Burkert NT, 2012, J NUTR THERAPEUTICS, V1, P19; Chang-Claude J, 2005, CANCER EPIDEM BIOMAR, V14, P963, DOI 10.1158/1055-9965.EPI-04-0696; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; Craig WJ, 2010, NUTR CLIN PRACT, V25, P613, DOI 10.1177/0884533610385707; Deriemaeker P, 2010, NUTRIENTS, V2, P770, DOI 10.3390/nu2070770; Dog TL, 2010, ALTERN THER HEALTH M, V16, P16; Dorner TE, 2010, DEUT MED WOCHENSCHR, V135, P413, DOI 10.1055/s-0030-1249178; DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712; Farmer B, 2011, J AM DIET ASSOC, V111, P819, DOI 10.1016/j.jada.2011.03.012; Flood A, 2003, AM J EPIDEMIOL, V158, P59, DOI 10.1093/aje/kwg099; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; FRENTZELBEYME R, 1994, AM J CLIN NUTR, V59, p1143S, DOI 10.1093/ajcn/59.5.1143S; Gacek Maria, 2010, Rocz Panstw Zakl Hig, V61, P65; Karlic H, 2008, ANN NUTR METAB, V53, P29, DOI 10.1159/000152871; Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Klimont J, 2007, AUSTR HLTH INTERVIEW; Kornsteiner M, 2008, ANN NUTR METAB, V52, P37, DOI 10.1159/000118629; Leitzmann C, 2005, FORUM NUTR, V57, P147, DOI 10.1159/000083787; Majchrzak D, 2006, ANN NUTR METAB, V50, P485, DOI 10.1159/000095828; Mangels AR, 2003, CAN J DIET PRACT RES, V64, P62, DOI 10.3148/64.2.2003.62; Mathew A, 2004, INT J CANCER, V108, P287, DOI 10.1002/ijc.10984; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; Michalak J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-67; OECD Social Policy Division, 2009, WHAT AR EQ SCAL; Pollard J, 2001, APPETITE, V37, P71, DOI 10.1006/appe.2001.0415; Rizzo NS, 2011, DIABETES CARE, V34, P1225, DOI 10.2337/dc10-1221; Sabate J, 2003, AM J CLIN NUTR, V78, p502S, DOI 10.1093/ajcn/78.3.502S; Sabate Joan, 2003, Forum Nutr, V56, P218; Schumacher M, 1993, Wien Med Wochenschr, V143, P329; Seow A, 2002, CANCER-AM CANCER SOC, V95, P2390, DOI 10.1002/cncr.10971; Singh PN, 2003, AM J CLIN NUTR, V78, p526S, DOI 10.1093/ajcn/78.3.526S; Tantamango-Bartley Y, 2013, CANCER EPIDEM BIOMAR, V22, DOI [10.1158/1055-9965.EPI-12.1060, DOI 10.1158/1055-9965.EPI-12.1060]; Tonstad S, 2009, DIABETES CARE, V32, P791, DOI 10.2337/dc08-1886; Vang A, 2008, ANN NUTR METAB, V52, P96, DOI 10.1159/000121365; Volkert D, 2006, AKTUEL ERNAHRUNGSMED, V31, P126, DOI 10.1055/s-2006-932601; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; World Health Organization (WHO), 2013, GLOB DAT BOD MASS IN	46	41	41	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88278	10.1371/journal.pone.0088278	http://dx.doi.org/10.1371/journal.pone.0088278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516625	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400049
J	Bach, M; Schimmelpfennig, C; Stolzing, A				Bach, Martin; Schimmelpfennig, Christoph; Stolzing, Alexandra			Influence of Murine Mesenchymal Stem Cells on Proliferation, Phenotype, Vitality, and Cytotoxicity of Murine Cytokine-Induced Killer Cells in Coculture	PLOS ONE			English	Article							MARROW STROMAL CELLS; BONE-MARROW; T-CELLS; INBRED MICE; TRANSPLANTATION; EXPANSION; STRAINS; INHIBIT; MSCS; DIFFERENTIATION	Stimulating lymphocytes with Ifn-gamma, anti-CD3, and interleukin-2 promotes the proliferation of a cell population coexpressing T-lymphocyte surface antigens such as CD3, CD8a, and CD25 as well as natural killer cell markers such as NK1.1, CD49, and CD69. These cells, referred to as cytokine-induced killer cells (CIKs), display cytotoxic activity against tumour cells, even without prior antigen presentation, and offer a new cell-based approach to the treatment of malignant diseases. Because CIKs are limited in vivo, strategies to optimize in vitro culture yield are required. In the last 10 years, mesenchymal stem cells (MSCs) have gathered considerable attention. Aside from their uses in tissue engineering and as support in haematopoietic stem cell transplantations, MSCs show notable immunomodulatory characteristics, providing further possibilities for therapeutic applications. In this study, we investigated the influence of murine MSCs on proliferation, phenotype, vitality, and cytotoxicity of murine CIKs in a coculture system. We found that CIKs in coculture proliferated within 7 days, with an average growth factor of 18.84, whereas controls grew with an average factor of 3.7 in the same period. Furthermore, higher vitality was noted in cocultured CIKs than in controls. Cell phenotype was unaffected by coculture with MSCs and, notably, coculture did not impact cytotoxicity against the tumour cells analysed. The findings suggest that cell-cell contact is primarily responsible for these effects. Humoral interactions play only a minor role. Furthermore, no phenotypical MSCs were detected after coculture for 4 h, suggesting the occurrence of immune reactions between CIKs and MSCs. Further investigations with DiD-labelled MSCs revealed that the observed disappearance of MSCs appears not to be due to differentiation processes.	[Bach, Martin; Schimmelpfennig, Christoph; Stolzing, Alexandra] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Bach, Martin] Univ Klin Leipzig, Dept Innere Med Neurol & Dermatol, Sekt Rheumatol, Leipzig, Germany; [Schimmelpfennig, Christoph] Klinikum St Georg, Klin Internist Onkol & Hamatol, Leipzig, Germany	Fraunhofer Gesellschaft; Leipzig University	Stolzing, A (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany.	alexandra.stolzing@izi.fraunhofer.de	Stolzing, Alexandra/S-4208-2019; Stolzing, Alexandra/O-7815-2016	Stolzing, Alexandra/0000-0002-2975-5736; Stolzing, Alexandra/0000-0002-2975-5736	Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany	Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany	Fraunhofer Institute for Cell Therapy and Immunology, Perlickstrasse 1, 04103 Leipzig, Germany, http://www.izi.fraunhofer.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Baker J, 2001, BLOOD, V97, P2923, DOI 10.1182/blood.V97.10.2923; Burr SP, 2013, IMMUNOL CELL BIOL, V91, P12, DOI 10.1038/icb.2012.60; Chan JK, 2006, CLIN CANCER RES, V12, P1859, DOI 10.1158/1078-0432.CCR-05-2019; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Copland I, 2008, EXP HEMATOL, V36, P93, DOI 10.1016/j.exphem.2007.08.032; De Ugarte DA, 2003, IMMUNOL LETT, V89, P267, DOI 10.1016/S0165-2478(03)00108-1; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gotherstrom C, 2007, TRANSPLANTATION, V84, pS35, DOI 10.1097/01.tp.0000269200.67707.c8; Introna M, 2007, HAEMATOLOGICA, V92, P952, DOI 10.3324/haematol.11132; Jones EA, 2004, ARTHRITIS RHEUM-US, V50, P817, DOI 10.1002/art.20203; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07; KUCIA M, 2006, J PHYSIOL PHARMAC S5, V57, P5; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Laport GG, 2006, ASH ANN M ABSTR, V108, P412; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Liu CR, 2007, BLOOD, V109, P4336, DOI 10.1182/blood-2006-09-046201; Maitra B, 2004, BONE MARROW TRANSPL, V33, P597, DOI 10.1038/sj.bmt.1704400; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Marin V, 2006, EXP HEMATOL, V34, P1219, DOI 10.1016/j.exphem.2006.05.004; Marten A, 2001, HAEMATOLOGICA, V86, P1029; Marten A, 2000, THESIS HUMBOLDT U BE; Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143; Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ratajczak MZ, 2008, STEM CELL REV, V4, P89, DOI 10.1007/s12015-008-9018-0; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018; Thorne SH, 2006, SCIENCE, V311, P1780, DOI 10.1126/science.1121411; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Vellasamy Shalini, 2012, World J Stem Cells, V4, P53; Verneris MR, 2001, BIOL BLOOD MARROW TR, V7, P532, DOI 10.1016/S1083-8791(01)70014-6; Wagey R, 2008, MINIREVIEW MESENCHYM; WALLER EK, 1995, BLOOD, V85, P2422, DOI 10.1182/blood.V85.9.2422.bloodjournal8592422; Wang L, 2012, J DENT RES, V91, P1003, DOI 10.1177/0022034512460404; Wei Xu-Cang, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P946; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Zoll B, 1998, CANCER IMMUNOL IMMUN, V47, P221, DOI 10.1007/s002620050524	57	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88115	10.1371/journal.pone.0088115	http://dx.doi.org/10.1371/journal.pone.0088115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516591	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700044
J	Gao, J; Ma, RS; Wang, W; Wang, N; Sasaki, R; Snyderman, D; Wu, JH; Ruan, K				Gao, Jia; Ma, Rongsheng; Wang, Wei; Wang, Na; Sasaki, Ryan; Snyderman, David; Wu, Jihui; Ruan, Ke			Automated NMR Fragment Based Screening Identified a Novel Interface Blocker to the LARG/RhoA Complex	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; TRANSFER DIFFERENCE NMR; PROSTATE-CANCER CELLS; DRUG DISCOVERY; PROTEIN; MOLECULE; INHIBITORS; LIGAND; LARG; WATERLOGSY	The small GTPase cycles between the inactive GDP form and the activated GTP form, catalyzed by the upstream guanine exchange factors. The modulation of such process by small molecules has been proven to be a fruitful route for therapeutic intervention to prevent the over-activation of the small GTPase. The fragment based approach emerging in the past decade has demonstrated its paramount potential in the discovery of inhibitors targeting such novel and challenging protein-protein interactions. The details regarding the procedure of NMR fragment screening from scratch have been rarely disclosed comprehensively, thus restricts its wider applications. To achieve a consistent screening applicable to a number of targets, we developed a highly automated protocol to cover every aspect of NMR fragment screening as possible, including the construction of small but diverse libray, determination of the aqueous solubility by NMR, grouping compounds with mutual dispersity to a cocktail, and the automated processing and visualization of the ligand based screening spectra. We exemplified our streamlined screening in RhoA alone and the complex of the small GTPase RhoA and its upstream guanine exchange factor LARG. Two hits were confirmed from the primary screening in cocktail and secondary screening over individual hits for LARG/RhoA complex, while one of them was also identified from the screening for RhoA alone. HSQC titration of the two hits over RhoA and LARG alone, respectively, identified one compound binding to RhoA. GDP at a 0.11 mM affinity, and perturbed the residues at the switch II region of RhoA. This hit blocked the formation of the LARG/RhoA complex, validated by the native gel electrophoresis, and the titration of RhoA to N-15 labeled LARG in the absence and presence the compound, respectively. It therefore provides us a starting point toward a more potent inhibitor to RhoA activation catalyzed by LARG.	[Gao, Jia; Ma, Rongsheng; Wang, Na; Wu, Jihui; Ruan, Ke] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Wang, Wei] Pfizer Worldwide Res & Dev, San Diego, CA USA; [Sasaki, Ryan; Snyderman, David] Adv Chem Dev Inc, Toronto, ON, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Pfizer	Ruan, K (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.	kruan@ustc.edu.cn	Ruan, Ke/N-1995-2013	Ruan, Ke/0000-0001-9358-0451	National Basic Research Program of China (973 Program) [2014CB910600, 2012CB917201]; Chinese National Natural Science Foundation [21273216, 31100613]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (973 Program Grants 2014CB910600, 2012CB917201); the Chinese National Natural Science Foundation (Grants 21273216 and 31100613). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058571; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Deng J, 2011, J MED CHEM, V54, P4508, DOI 10.1021/jm200161c; Gasmi-Seabrook GMC, J BIOL CHEM, V285, P5137; Golotvin SS, 2006, MAGN RESON CHEM, V44, P524, DOI 10.1002/mrc.1781; Gossert AD, 2009, J BIOMOL NMR, V43, P211, DOI 10.1007/s10858-009-9303-5; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Hubbard RE, 2007, CURR TOP MED CHEM, V7, P1568, DOI 10.2174/156802607782341109; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Liu XJ, 2012, ANAL CHEM, V84, P6914, DOI 10.1021/ac301544u; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rujkijyanont P, 2005, BLOOD, V106, p958A; Schade M, 2005, CURR OPIN DRUG DISC, V8, P365; Shang X, 2012, CHEM BIOL, V19, P699, DOI 10.1016/j.chembiol.2012.05.009; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Smurnyy YD, 2008, J CHEM INF MODEL, V48, P128, DOI 10.1021/ci700256n; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang Q, 2004, J BIOL CHEM, V279, P28831, DOI 10.1074/jbc.C400105200; Wang YX, 2013, J MED CHEM, V56, P5219, DOI 10.1021/jm3017706; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Zheng R, 2006, ONCOGENE, V25, P5942, DOI 10.1038/sj.onc.1209586	38	25	27	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88098	10.1371/journal.pone.0088098	http://dx.doi.org/10.1371/journal.pone.0088098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505392	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200114
J	Lally, PJ; Price, DL; Pauliah, SS; Bainbridge, A; Kurien, J; Sivasamy, N; Cowan, FM; Balraj, G; Ayer, M; Satheesan, K; Ceebi, S; Wade, A; Swamy, R; Padinjattel, S; Hutchon, B; Vijayakumar, M; Nair, M; Padinharath, K; Zhang, H; Cady, EB; Shankaran, S; Thayyil, S				Lally, Peter J.; Price, David L.; Pauliah, Shreela S.; Bainbridge, Alan; Kurien, Justin; Sivasamy, Neeraja; Cowan, Frances M.; Balraj, Guhan; Ayer, Manjula; Satheesan, Kariyapilly; Ceebi, Sreejith; Wade, Angie; Swamy, Ravi; Padinjattel, Shaji; Hutchon, Betty; Vijayakumar, Madhava; Nair, Mohandas; Padinharath, Krishnakumar; Zhang, Hui; Cady, Ernest B.; Shankaran, Seetha; Thayyil, Sudhin			Neonatal Encephalopathic Cerebral Injury in South India Assessed by Perinatal Magnetic Resonance Biomarkers and Early Childhood Neurodevelopmental Outcome	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; WHOLE-BODY HYPOTHERMIA; ENERGY FAILURE; REGISTRATION; SYSTEM; IMAGES	Although brain injury after neonatal encephalopathy has been characterised well in high-income countries, little is known about such injury in low-and middle-income countries. Such injury accounts for an estimated 1 million neonatal deaths per year. We used magnetic resonance (MR) biomarkers to characterise perinatal brain injury, and examined early childhood outcomes in South India. Methods: We recruited consecutive term or near term infants with evidence of perinatal asphyxia and a Thompson encephalopathy score >= 6 within 6 h of birth, over 6 months. We performed conventional MR imaging, diffusion tensor MR imaging and thalamic proton MR spectroscopy within 3 weeks of birth. We computed group-wise differences in white matter fractional anisotropy (FA) using tract based spatial statistics. We allocated Sarnat encephalopathy stage aged 3 days, and evaluated neurodevelopmental outcomes aged 3 1/2 years using Bayley III. Results: Of the 54 neonates recruited, Sarnat staging was mild in 30 (56%); moderate in 15 (28%) and severe in 6 (11%), with no encephalopathy in 3 (6%). Six infants died. Of the 48 survivors, 44 had images available for analysis. In these infants, imaging indicated perinatal rather than established antenatal origins to injury. Abnormalities were frequently observed in white matter (n = 40, 91%) and cortex (n = 31, 70%) while only 12 (27%) had abnormal basal ganglia/thalami. Reduced white matter FA was associated with Sarnat stage, deep grey nuclear injury, and MR spectroscopy N-acetylaspartate/choline, but not early Thompson scores. Outcome data were obtained in 44 infants (81%) with 38 (79%) survivors examined aged 3 1/2 years; of these, 16 (42%) had adverse neurodevelopmental outcomes. Conclusions: No infants had evidence for established brain lesions, suggesting potentially treatable perinatal origins. White matter injury was more common than deep brain nuclei injury. Our results support the need for rigorous evaluation of the efficacy of rescue hypothermic neuroprotection in low- and middle-income countries.	[Lally, Peter J.; Pauliah, Shreela S.; Cowan, Frances M.; Wade, Angie; Hutchon, Betty; Thayyil, Sudhin] Univ London Imperial Coll Sci Technol & Med, London, England; [Price, David L.; Bainbridge, Alan; Shankaran, Seetha] Univ Coll London Hosp, London, England; [Kurien, Justin; Sivasamy, Neeraja; Balraj, Guhan; Ayer, Manjula; Satheesan, Kariyapilly; Ceebi, Sreejith; Vijayakumar, Madhava; Nair, Mohandas; Padinharath, Krishnakumar] Govt Med Coll, Kozhikode, Kerala, India; [Swamy, Ravi] Manipal Hosp, Bangalore, Karnataka, India; [Padinjattel, Shaji] Dr Shajs MRI & Res Ctr, Kozhikode, Kerala, India; [Zhang, Hui] UCL, Ctr Med Image Comp, London, England; [Shankaran, Seetha] Wayne State Univ, Neonatal Perinatal Div, Detroit, MI USA	Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Wayne State University	Lally, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	p.lally@imperial.ac.uk	Krishnakumar, P./AAY-9037-2021	Krishnakumar, P./0000-0002-7648-4713; Zhang, Hui/0000-0002-5426-2140; Thayyil, Sudhin/0000-0001-8795-5165; Lally, Peter/0000-0003-0075-0103	Department of Health [NIHR/CS/010/022] Funding Source: Medline; National Institute for Health Research [NIHR/CS/010/022] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Aggarwal P, 1998, ANN TROP PAEDIATR, V18, P117, DOI 10.1080/02724936.1998.11747937; Azzopardi D, 2010, SEMIN FETAL NEONAT M, V15, P261, DOI 10.1016/j.siny.2010.03.001; Azzopardi DV, 2009, NEW ENGL J MED, V361, P1349, DOI 10.1056/NEJMoa0900854; Bayley N., 2019, BAYLEY SCALES INFANT; Cheong JLY, 2012, ARCH PEDIAT ADOL MED, V166, P634, DOI 10.1001/archpediatrics.2012.284; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; Ellis M, 1999, DEV MED CHILD NEUROL, V41, P689, DOI 10.1017/S0012162299001413; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gonzalez FF, 2006, ARCH DIS CHILD-FETAL, V91, pF454, DOI 10.1136/adc.2005.092445; Haneesh K, 2013, INDIAN PEDIATR, V50, P655, DOI 10.1007/s13312-013-0197-7; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jary S, 2013, DEV MED CHILD NEUROL; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lally PJ, 2013, 22 BRIT CHAPT ISMRM; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; Martinez-Biarge M, 2012, J PEDIATR-US, V161, P799, DOI 10.1016/j.jpeds.2012.04.054; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pauliah SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058834; Pierrat V, 2005, ARCH DIS CHILD-FETAL, V90, P257, DOI 10.1136/adc.2003.047985; Porter EJ, 2010, PEDIATR RES, V68, P205, DOI 10.1203/00006450-201011001-00399; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2012, ARCH DIS CHILD-FETAL, V97, pF398, DOI 10.1136/archdischild-2011-301524; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shankaran S, 2012, J PEDIATR-US, V160, P567, DOI 10.1016/j.jpeds.2011.09.018; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stefan D, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/104035; Thayyil S, 2013, ARCH DIS CHILD-FETAL, V98, pF280, DOI 10.1136/archdischild-2013-303840; Thayyil S, 2010, PEDIATRICS, V125, pE382, DOI 10.1542/peds.2009-1046; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Tusor N, 2012, PEDIATR RES, V72, P63, DOI 10.1038/pr.2012.40; Tustison N. J., 2012, HUM BRAIN MAPP; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	41	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87874	10.1371/journal.pone.0087874	http://dx.doi.org/10.1371/journal.pone.0087874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505327	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200081
J	Martin, HL; Adams, M; Higgins, J; Bond, J; Morrison, EE; Bell, SM; Warriner, S; Nelson, A; Tomlinson, DC				Martin, Heather L.; Adams, Matthew; Higgins, Julie; Bond, Jacquelyn; Morrison, Ewan E.; Bell, Sandra M.; Warriner, Stuart; Nelson, Adam; Tomlinson, Darren C.			High-Content, High-Throughput Screening for the Identification of Cytotoxic Compounds Based on Cell Morphology and Cell Proliferation Markers	PLOS ONE			English	Article							DRUG DISCOVERY; HEPATOTOXICITY; DOXORUBICIN; INHIBITION; MOLECULES; ASSAY	Toxicity is a major cause of failure in drug discovery and development, and whilst robust toxicological testing occurs, efficiency could be improved if compounds with cytotoxic characteristics were identified during primary compound screening. The use of high-content imaging in primary screening is becoming more widespread, and by utilising phenotypic approaches it should be possible to incorporate cytotoxicity counter-screens into primary screens. Here we present a novel phenotypic assay that can be used as a counter-screen to identify compounds with adverse cellular effects. This assay has been developed using U2OS cells, the PerkinElmer Operetta high-content/high-throughput imaging system and Columbus image analysis software. In Columbus, algorithms were devised to identify changes in nuclear morphology, cell shape and proliferation using DAPI, TOTO-3 and phosphohistone H3 staining, respectively. The algorithms were developed and tested on cells treated with doxorubicin, taxol and nocodazole. The assay was then used to screen a novel, chemical library, rich in natural product-like molecules of over 300 compounds, 13.6% of which were identified as having adverse cellular effects. This assay provides a relatively cheap and rapid approach for identifying compounds with adverse cellular effects during screening assays, potentially reducing compound rejection due to toxicity in subsequent in vitro and in vivo assays.	[Martin, Heather L.; Adams, Matthew; Higgins, Julie; Bond, Jacquelyn; Morrison, Ewan E.; Bell, Sandra M.; Tomlinson, Darren C.] Univ Leeds, Leeds Inst Mol Med, BioScreening Technol Grp, Leeds, W Yorkshire, England; [Martin, Heather L.; Warriner, Stuart] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Bond, Jacquelyn; Morrison, Ewan E.; Bell, Sandra M.; Tomlinson, Darren C.] Univ Leeds, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; [Warriner, Stuart; Nelson, Adam; Tomlinson, Darren C.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Leeds	Tomlinson, DC (corresponding author), Univ Leeds, Leeds Inst Mol Med, BioScreening Technol Grp, Leeds, W Yorkshire, England.	d.c.tomlinson@leeds.ac.uk		Tomlinson, Darren/0000-0003-4134-7484; Warriner, Stuart/0000-0002-7589-6011; Martin, Heather/0000-0002-5455-4434; Bell, Sandra/0000-0002-3022-9864; Nelson, Adam/0000-0003-3886-363X	Engineering and Physical Sciences Research Council [EP/F043503/1]; Biomedical Health Research Centre at Leeds; EPSRC [EP/F043503/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S99426/01, GR/S99419/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biomedical Health Research Centre at Leeds; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by The Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) EP/F043503/1 and The Biomedical Health Research Centre at Leeds www.bhrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2013, J BIOMOLECULAR SCREE; Barabasz A, 2006, ASSAY DRUG DEV TECHN, V4, P153, DOI 10.1089/adt.2006.4.153; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bray MA, 2012, SITTAMPALAM GS G EN; Elmehdawi F, 2013, EXP CELL RES, V319, P161, DOI 10.1016/j.yexcr.2012.10.002; Eom YW, 2005, ONCOGENE, V24, P4765, DOI 10.1038/sj.onc.1208627; Ghosh RN, 2005, J BIOMOL SCREEN, V10, P476, DOI 10.1177/1087057105274896; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kim Jung Hye, 2003, Cancer Res Treat, V35, P148, DOI 10.4143/crt.2003.35.2.148; Korn K, 2007, CURR OPIN CHEM BIOL, V11, P503, DOI 10.1016/j.cbpa.2007.08.030; Lin ZW, 2012, TOXICOL SCI, V126, P114, DOI 10.1093/toxsci/kfr339; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morton D, 2009, ANGEW CHEM INT EDIT, V48, P104, DOI 10.1002/anie.200804486; Mukherji M, 2006, P NATL ACAD SCI USA, V103, P14819, DOI 10.1073/pnas.0604320103; Murrison S, 2011, EUR J ORG CHEM, V2011, P2354, DOI 10.1002/ejoc.201100116; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; O'Leary-Steele C, 2010, CHEM-EUR J, V16, P9563, DOI 10.1002/chem.201000707; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Persson M, 2013, J PHARMACOL TOX MET, V68, P302, DOI 10.1016/j.vascn.2013.08.001; Slater K, 2001, CURR OPIN BIOTECH, V12, P70, DOI 10.1016/S0958-1669(00)00177-4; Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107; Torres-Guzman R, 2013, J BIOMOL SCREEN, V18, P556, DOI 10.1177/1087057112472539; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	28	50	51	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88338	10.1371/journal.pone.0088338	http://dx.doi.org/10.1371/journal.pone.0088338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505478	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200179
J	Schuttler, SG; Philbrick, JA; Jeffery, KJ; Eggert, LS				Schuttler, Stephanie G.; Philbrick, Jessica A.; Jeffery, Kathryn J.; Eggert, Lori S.			Fine-Scale Genetic Structure and Cryptic Associations Reveal Evidence of Kin-Based Sociality in the African Forest Elephant	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; BADGER MELES-MELES; LOPE-RESERVE; RAIN-FOREST; RELATEDNESS; POPULATION; DISPERSAL; DNA; FLOW; ORGANIZATION	Spatial patterns of relatedness within animal populations are important in the evolution of mating and social systems, and have the potential to reveal information on species that are difficult to observe in the wild. This study examines the fine-scale genetic structure and connectivity of groups within African forest elephants, Loxodonta cyclotis, which are often difficult to observe due to forest habitat. We tested the hypothesis that genetic similarity will decline with increasing geographic distance, as we expect kin to be in closer proximity, using spatial autocorrelation analyses and Tau K-r tests. Associations between individuals were investigated through a non-invasive genetic capture-recapture approach using network models, and were predicted to be more extensive than the small groups found in observational studies, similar to fission-fusion sociality found in African savanna (Loxodonta africana) and Asian (Elephas maximus) species. Dung samples were collected in Lope National Park, Gabon in 2008 and 2010 and genotyped at 10 microsatellite loci, genetically sexed, and sequenced at the mitochondrial DNA control region. We conducted analyses on samples collected at three different temporal scales: a day, within six-day sampling sessions, and within each year. Spatial autocorrelation and Tau K-r tests revealed genetic structure, but results were weak and inconsistent between sampling sessions. Positive spatial autocorrelation was found in distance classes of 0-5 km, and was strongest for the single day session. Despite weak genetic structure, individuals within groups were significantly more related to each other than to individuals between groups. Social networks revealed some components to have large, extensive groups of up to 22 individuals, and most groups were composed of individuals of the same matriline. Although fine-scale population genetic structure was weak, forest elephants are typically found in groups consisting of kin and based on matrilines, with some individuals having more associates than observed from group sizes alone.	[Schuttler, Stephanie G.; Philbrick, Jessica A.; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Jeffery, Kathryn J.] Agence Natl Parcs Nationaux, Libreville, Gabon; [Jeffery, Kathryn J.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Jeffery, Kathryn J.] Inst Rech Ecol Trop, Libreville, Gabon	University of Missouri System; University of Missouri Columbia; University of Stirling	Schuttler, SG (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	stephanie.schuttler@gmail.com	Jeffery, Kathryn J/G-2530-2013	Jeffery, Kathryn J/0000-0002-2632-0008	USFWS African Elephant Conservation Fund [98210-8-G753]; National Science Foundation [1045322]; University of Missouri Life Sciences fellowship	USFWS African Elephant Conservation Fund; National Science Foundation(National Science Foundation (NSF)); University of Missouri Life Sciences fellowship	The authors thank the USFWS African Elephant Conservation Fund (agreement #98210-8-G753 to LSE), National Science Foundation GK-12 Grant #1045322, and University of Missouri Life Sciences fellowship for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlering MA, 2012, DIVERS DISTRIB, V18, P952, DOI 10.1111/j.1472-4642.2012.00896.x; Ahlering MA, 2011, MOL ECOL RESOUR, V11, P831, DOI 10.1111/j.1755-0998.2011.03030.x; AMOS W, 1992, MAR MAMMAL SCI, V8, P275, DOI 10.1111/j.1748-7692.1992.tb00409.x; Archie EA, 2006, P ROY SOC B-BIOL SCI, V273, P513, DOI 10.1098/rspb.2005.3361; Archie EA, 2003, MOL ECOL NOTES, V3, P244, DOI 10.1046/j.1471-8286.2003.00412.x; Archie EA, 2008, MOL ECOL, V17, P2666, DOI 10.1111/j.1365-294X.2008.03797.x; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti S. P., 2002, NETDRAW SOFTWARE NET; Comstock KE, 2000, MOL ECOL, V9, P1004, DOI 10.1046/j.1365-294x.2000.00939-8.x; de Groot PJV, 2011, CONSERV GENET, V12, P783, DOI 10.1007/s10592-011-0185-1; Duchesne P, 2006, MOL ECOL NOTES, V6, P965, DOI 10.1111/j.1471-8286.2006.01414.x; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; Eggert LS, 2008, LESSONS GENETIC CENS, P157; Fernando P, 2000, HEREDITY, V84, P362, DOI 10.1046/j.1365-2540.2000.00674.x; Fishlock V, 2013, ANIM BEHAV, V85, P357, DOI 10.1016/j.anbehav.2012.11.004; Fishlock V, 2008, PACHYDERM, P17; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Gobush K, 2009, MOL ECOL, V18, P722, DOI 10.1111/j.1365-294X.2008.04043.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hansen H, 2008, MOL ECOL RESOUR, V8, P282, DOI 10.1111/j.1471-8286.2007.01992.x; Hazlitt SL, 2006, MOL ECOL, V15, P2997, DOI 10.1111/j.1365-294X.2006.02985.X; Hazlitt SL, 2004, MOL ECOL, V13, P3621, DOI 10.1111/j.1365-294X.2004.02342.x; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Johnstone RA, 2008, AM NAT, V172, P318, DOI 10.1086/589899; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Miller CR, 2002, GENETICS, V160, P357; Momont L, 2007, SELECTION HABITAT OR; Moss C, 1988, ELEPHANT MEMORIES; Munshi-South J, 2008, DIVERS DISTRIB, V14, P995, DOI 10.1111/j.1472-4642.2008.00509.x; Munshi-South J, 2011, J HERED, V102, P391, DOI 10.1093/jhered/esr030; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robinson SJ, 2012, MOL ECOL, V21, P4190, DOI 10.1111/j.1365-294X.2012.05681.x; Rossiter SJ, 2012, MOL ECOL, V21, P647, DOI 10.1111/j.1365-294X.2011.05391.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Sukumar R., 2003, LIVING ELEPHANTS EVO; Turkalo A, 1996, PACHYDERM, V21, P45; Van de Casteele T, 2001, MOL ECOL, V10, P1539, DOI 10.1046/j.1365-294X.2001.01288.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WHITE LJT, 1995, AFR J ECOL, V33, P142, DOI 10.1111/j.1365-2028.1995.tb00789.x; WHITE LJT, 1994, J ANIM ECOL, V63, P499, DOI 10.2307/5217; WHITE LJT, 1994, J TROP ECOL, V10, P121, DOI 10.1017/S0266467400007768; WHITE LJT, 1993, AFR J ECOL, V31, P181, DOI 10.1111/j.1365-2028.1993.tb00532.x; Wittemyer G, 2007, ANIM BEHAV, V73, P671, DOI 10.1016/j.anbehav.2006.10.008; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941; Woxvold IA, 2006, MOL ECOL, V15, P3139, DOI 10.1111/j.1365-294X.2006.03009.x; Wrege PH, 2012, AFR J ECOL, V50, P176, DOI 10.1111/j.1365-2028.2011.01310.x	60	27	27	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88074	10.1371/journal.pone.0088074	http://dx.doi.org/10.1371/journal.pone.0088074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505381	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200109
J	Su, LJ; Liu, RZ; Cheng, W; Zhu, MJ; Li, XP; Zhao, SH; Yu, M				Su, Lijie; Liu, Ruize; Cheng, Wei; Zhu, Mengjin; Li, Xiaoping; Zhao, Shuhong; Yu, Mei			Expression Patterns of MicroRNAs in Porcine Endometrium and Their Potential Roles in Embryo Implantation and Placentation	PLOS ONE			English	Article							OSTEOPONTIN EXPRESSION; CONCEPTUS DEVELOPMENT; ESTROGEN; RNA; INTEGRIN; PIG; PREGNANCY; PATHWAYS; INVASION; PROFILE	Implantation and placentation are critical steps for successful pregnancy. The pig has a non-invasive placenta and the uterine luminal epithelium is intact throughout pregnancy. To better understand the regulation mechanisms in functions of endometrium at three certain gestational stages that are critical for embryo/fetal loss in pigs, we characterized microRNA (miRNA) expression profiles in the endometrium on days 15 (implantation period), 26 (placentation period) and 50 (mid-gestation period) of gestation. The differentially expressed miRNAs across gestational days were detected and of which, 65 miRNAs were grouped into 4 distinct categories according to the similarities in their temporal expression patterns: (1) categories A and B contain majority of miRNAs (51 miRNAs, such as the miR-181 family) that were down-or up-regulated between gestational days 15 and 26, respectively; (2) categories C and D (14 miRNAs) consist miRNAs that were down-or up-regulated between gestational days 26 and 50, respectively. The expression patterns represented by eleven miRNAs were validated by qPCR. The majority of miRNAs were in categories A and B, suggesting that these miRNAs were involved in regulation of embryo implantation and placentation. The pathway analysis revealed that the predicted targets were involved in several pathways, such as focal adhesion, cell proliferation and tissue remolding. Furthermore, we identified that genes well-known to affect embryo implantation in pigs, namely SPP1, ITGB3 and ESR1, contain the miR-181a or miR-181c binding sites using the luciferase reporter system. The present study revealed distinctive miRNA expression patterns in the porcine endometrium during the implantation, placentation or mid-gestation periods. Additionally, our results suggested that miR-181a and miR-181c likely play important roles in the regulation of genes and pathways that are known to be involved in embryo implantation and placentation in pigs.	[Su, Lijie; Liu, Ruize; Cheng, Wei; Zhu, Mengjin; Li, Xiaoping; Zhao, Shuhong; Yu, Mei] Huazhong Cent China Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University	Yu, M (corresponding author), Huazhong Cent China Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	yumei@mail.hzau.edu.cn			National Natural Science Foundation of China [31272426]; National Basic Research Program of China [2014CB138500]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported financially by the National Natural Science Foundation of China (31272426), the National Basic Research Program of China (2014CB138500) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazer FW, 2011, BIOL REPROD, V85, P1094, DOI 10.1095/biolreprod.111.094722; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Bazer FW, 2009, REPRODUCTION, V138, P195, DOI 10.1530/REP-09-0158; Bhattacharya SD, 2010, SURGERY, V148, P291, DOI 10.1016/j.surg.2010.05.007; Bowen JA, 1996, BIOL REPROD, V55, P1098, DOI 10.1095/biolreprod55.5.1098; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; DANTZER V, 1985, ANAT EMBRYOL, V172, P281, DOI 10.1007/BF00318976; Erikson DW, 2009, BIOL REPROD, V81, P814, DOI 10.1095/biolreprod.109.078600; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; FRIESS AE, 1980, ANAT EMBRYOL, V158, P179, DOI 10.1007/BF00315905; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Geisert R., 2002, J ANIM SCI, V80, pE54, DOI [10.2527/animalsci2002.0021881200800ES10009x, DOI 10.2527/ANIMALSCI2002.0021881200800ES10009X]; GEISERT RD, 1993, REPROD FERT DEVELOP, V5, P247, DOI 10.1071/RD9930247; Grewal S, 2010, BIOL REPROD, V83, P75, DOI 10.1095/biolreprod.109.080630; Groothuis PG, 2007, HUM REPROD UPDATE, V13, P405, DOI 10.1093/humupd/dmm009; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Hull ML, 2008, AM J PATHOL, V173, P700, DOI 10.2353/ajpath.2008.071128; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Johnson GA, 2003, BIOL REPROD, V68, P1951, DOI 10.1095/biolreprod.102.012948; Joyce MM, 2007, ENDOCRINOLOGY, V148, P4420, DOI 10.1210/en.2007-0505; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Kaneko Y, 2008, REPROD FERT DEVELOP, V20, P892, DOI 10.1071/RD08148; Karaayvaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035158; KAUFMANN P, 1999, PHYSL REPROD, P441; KNIGHT JW, 1977, J ANIM SCI, V44, P620, DOI 10.2527/jas1977.444620x; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Majid S, 2011, CANCER RES, V71, P2611, DOI 10.1158/0008-5472.CAN-10-3666; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; REYNOLDS LP, 1995, J ANIM SCI, V73, P1839; Sharma Alok, 2012, J Hum Reprod Sci, V5, P2, DOI 10.4103/0974-1208.97777; Shiokawa S, 1998, MOL HUM REPROD, V4, P907, DOI 10.1093/molehr/4.9.907; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; Su LJ, 2010, REPROD FERT DEVELOP, V22, P1175, DOI 10.1071/RD10046; Symons M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-213; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Valastyan S, 2010, CANCER RES, V70, P5147, DOI 10.1158/0008-5472.CAN-10-0410; Vallet JL, 2007, J ANIM SCI, V85, P3267, DOI 10.2527/jas.2007-0368; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; VONHEYDEBRECK A, 2004, DIFFERENTIAL EXPRESS; Vonnahme KA, 2002, J ANIM SCI, V80, P1311; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; White FJ, 2005, BIOL REPROD, V73, P1294, DOI 10.1095/biolreprod.105.045153; WIGMORE PMC, 1985, ANAT EMBRYOL, V173, P263, DOI 10.1007/BF00316307; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xia HF, 2010, J REPROD DEVELOP, V56, P73, DOI 10.1262/jrd.09-088K; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669	57	63	66	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87867	10.1371/journal.pone.0087867	http://dx.doi.org/10.1371/journal.pone.0087867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505325	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200079
J	Zhou, YT; Liao, QF; Lin, MN; Deng, XJ; Zhang, PT; Yao, MC; Zhang, L; Xie, ZY				Zhou, Yuting; Liao, Qiongfeng; Lin, Manna; Deng, Xuejiao; Zhang, Peiting; Yao, Meicun; Zhang, Lei; Xie, Zhiyong			Combination of H-1 NMR- and GC-MS-Based Metabonomics to Study on the Toxicity of Coptidis Rhizome in Rats	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; METABOLOMICS; METABOLITES; DIARRHEA; EXTRACT	Background: Coptidis Rhizome (CR), widely applied to treat with heat and toxicity, is one of the most commonly used traditional Chinese medicine (TCM), however, an extensive dosage can induce toxicity. Diarrhea is one of the most frequent side effects of CR treatment. Methodology/Principal Findings: In this study, metabonomics was combined with the multivariate statistical analysis to discover the endogenous metabolites which related to the diarrheal induced by CR. The male Sprague-Dawley rats were dosed with 4.95 g CR/kg weight. Urine samples were collected at day 21 (before treatment), and days 14 and 21 for NMR analysis. Serum and tissues were collected at day 14 for GC-MS analysis and histopathological examination, respectively. The urine and serum metabolic profiles provided clearer distinction between CR-treated group and control group, which was confirmed by body weight change and diarrhea. Through multivariate statistical analysis, 12 marker metabolites from 1 H NMR and 8 ones from GC-MS have been found. Among those metabolites, hippurate, acetate, alanine, glycine and glutamate are likely to break the balance of gut microbiota, whereas, lactate and 2-ketoisovalerate showed association with energy metabolism. Meanwhile, we observed that the CR-induced toxicity will recover when the treatment was stopped. Conclusions/significance: These results suggest that the main reason for the CR-associated diarrhea might be disturbance in the normal gut microbiota. This metabonomics approach may provide an effective way to study the alteration of gut microbiota, which is expected to find broader application in other drug-induced gastrointestinal reaction assessment.	[Zhou, Yuting; Lin, Manna; Deng, Xuejiao; Zhang, Peiting; Yao, Meicun; Xie, Zhiyong] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Qiongfeng; Lin, Manna; Zhang, Lei] Guangzhou Univ Chinese Med, Sch Chinese Mat Med, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Guangzhou University of Chinese Medicine	Xie, ZY (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China.	xiezy2074@yahoo.com		Xie, Zhi/0000-0002-5589-4836	Natural Science Foundation of China [81274028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China, number 81274028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando K, 2011, J APPL TOXICOL, V31, P524, DOI 10.1002/jat.1591; Bao Yuqin, 1983, CHINESE J INTEGRATED, V3, P31; Boyd DR, 2005, CHEM COMMUN, P3989, DOI 10.1039/b506944k; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44; Choi UK, 2007, J MICROBIOL BIOTECHN, V17, P1880; Ciborowski M, 2012, J PROTEOME RES, V11, P6231, DOI 10.1021/pr3008946; CLAUSEN MR, 1991, GASTROENTEROLOGY, V101, P1497, DOI 10.1016/0016-5085(91)90384-W; Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564; Fan G, 2012, ANAL CHIM ACTA, V747, P76, DOI 10.1016/j.aca.2012.08.038; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Guirl MJ, 2003, AM J GASTROENTEROL, V98, P2219, DOI 10.1016/S0002-9270(03)00701-9; Hochrein J, 2012, J PROTEOME RES, V11, P6242, DOI 10.1021/pr3009034; HOLMES E, 1992, MOL PHARMACOL, V42, P922; Jung HA, 2009, BIOL PHARM BULL, V32, P1433, DOI 10.1248/bpb.32.1433; Kokushi E, 2012, ENVIRON TOXICOL, V27, P404, DOI 10.1002/tox.20653; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; LILY P, 2009, J TRADITIONAL CHINES, V2, P019; Lu JY, 2012, J PROTEOME RES, V11, P4705, DOI 10.1021/pr300523x; Lu J, 2011, J ETHNOPHARMACOL, V134, P911, DOI 10.1016/j.jep.2011.01.049; MacKinnon N, 2013, J MAGN RESON, V226, P93, DOI 10.1016/j.jmr.2012.11.008; March J., 1992, REACTIONS MECH STRUC, V4th; Ni Y, 2007, FEBS LETT, V581, P707, DOI 10.1016/j.febslet.2007.01.036; Nicholls AW, 2003, CHEM RES TOXICOL, V16, P1395, DOI 10.1021/tx0340293; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; O'Sullivan A, 2013, J PROTEOME RES, V12, P481, DOI 10.1021/pr3009176; Park JC, 2009, J TOXICOL ENV HEAL A, V72, P374, DOI 10.1080/15287390802647195; Pechlivanis A, 2013, J PROTEOME RES, V12, P470, DOI 10.1021/pr300846x; Phipps AN, 1998, XENOBIOTICA, V28, P527, DOI 10.1080/004982598239443; READ NW, 1986, CLIN GASTROENTEROL, V15, P657; Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Sun J, 2008, J CHROMATOGR B, V871, P328, DOI 10.1016/j.jchromb.2008.04.008; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tang BW, 2012, J ETHNOPHARMACOL, V141, P134, DOI 10.1016/j.jep.2012.02.011; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Tjong YW, 2011, J ETHNOPHARMACOL, V135, P754, DOI 10.1016/j.jep.2011.04.007; Um SY, 2012, ANAL CHIM ACTA, V722, P87, DOI 10.1016/j.aca.2012.01.062; Walker AW, 2013, PHARMACOL RES, V69, P75, DOI 10.1016/j.phrs.2012.09.008; Wang N, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-239; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Wang XJ, 2011, J PHARMACEUT BIOMED, V55, P859, DOI 10.1016/j.jpba.2011.01.042; Wuolikainen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017947; Xigyan Z, 2013, CHINA J CHINESE MAT, V38, P546; Xiyan Z, 2013, CHINA J CHINESE MAT, V38, P292; Yang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016641; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	48	12	17	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88281	10.1371/journal.pone.0088281	http://dx.doi.org/10.1371/journal.pone.0088281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505462	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200164
J	Leekitcharoenphon, P; Nielsen, EM; Kaas, RS; Lund, O; Aarestrup, FM				Leekitcharoenphon, Pimlapas; Nielsen, Eva M.; Kaas, Rolf S.; Lund, Ole; Aarestrup, Frank M.			Evaluation of Whole Genome Sequencing for Outbreak Detection of Salmonella enterica	PLOS ONE			English	Article							TANDEM REPEAT ANALYSIS; CLINICAL MICROBIOLOGY; NEXT-GENERATION; ALGORITHMS; ALIGNMENT	Salmonella enterica is a common cause of minor and large food borne outbreaks. To achieve successful and nearly 'real-time' monitoring and identification of outbreaks, reliable sub-typing is essential. Whole genome sequencing (WGS) shows great promises for using as a routine epidemiological typing tool. Here we evaluate WGS for typing of S. Typhimurium including different approaches for analyzing and comparing the data. A collection of 34 S. Typhimurium isolates was sequenced. This consisted of 18 isolates from six outbreaks and 16 epidemiologically unrelated background strains. In addition, 8 S. Enteritidis and 5 S. Derby were also sequenced and used for comparison. A number of different bioinformatics approaches were applied on the data; including pan-genome tree, k-mer tree, nucleotide difference tree and SNP tree. The outcome of each approach was evaluated in relation to the association of the isolates to specific outbreaks. The pan-genome tree clustered 65% of the S. Typhimurium isolates according to the pre-defined epidemiology, the k-mer tree 88%, the nucleotide difference tree 100% and the SNP tree 100% of the strains within S. Typhimurium. The resulting outcome of the four phylogenetic analyses were also compared to PFGE reveling that WGS typing achieved the greater performance than the traditional method. In conclusion, for S. Typhimurium, SNP analysis and nucleotide difference approach of WGS data seem to be the superior methods for epidemiological typing compared to other phylogenetic analytic approaches that may be used on WGS. These approaches were also superior to the more classical typing method, PFGE. Our study also indicates that WGS alone is insufficient to determine whether strains are related or un-related to outbreaks. This still requires the combination of epidemiological data and whole genome sequencing results.	[Leekitcharoenphon, Pimlapas; Kaas, Rolf S.; Aarestrup, Frank M.] Tech Univ Denmark, Div Epidemiol & Microbial Genom, Natl Food Inst, DK-2800 Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Kaas, Rolf S.; Lund, Ole] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Nielsen, Eva M.] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Statens Serum Institut	Leekitcharoenphon, P (corresponding author), Tech Univ Denmark, Div Epidemiol & Microbial Genom, Natl Food Inst, DK-2800 Lyngby, Denmark.	pile@food.dtu.dk	Nielsen, Eva Møller/B-9157-2011; Leekitcharoenphon, Pimlapas/AAB-5487-2021; Lund, Ole/F-4437-2014	Nielsen, Eva Møller/0000-0002-5349-7802; Lund, Ole/0000-0003-1108-0491; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723; Kaas, Rolf Sommer/0000-0002-5050-8668	Center for Genomic Epidemiology [09- 067103/DSF]	Center for Genomic Epidemiology	This study was supported by the Center for Genomic Epidemiology (09- 067103/DSF) http://www.genomicepidemiology.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Castillo-Ramirez S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002129; Cheng JK, 2013, MOL BIOL EVOL, V30, P1032, DOI 10.1093/molbev/mst021; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DeSantis Todd Z., 2011, BMC Ecology, V11, P11, DOI 10.1186/1472-6785-11-11; Dewaele I, 2012, FOODBORNE PATHOG DIS, V9, P885, DOI 10.1089/fpd.2012.1199; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Fisher I.S.T., 1999, Euro Surveill, V4, P56; Foley SL, 2007, FOODBORNE PATHOG DIS, V4, P253, DOI 10.1089/fpd.2007.0085; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gieraltowski L, 2013, EPIDEMIOL INFECT, V141, P1244, DOI 10.1017/S0950268812001859; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hendriksen RS, 2012, J CLIN MICROBIOL, V50, P709, DOI 10.1128/JCM.05943-11; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hoffmann M, 2012, J BACTERIOL, V194, P3274, DOI 10.1128/JB.00419-12; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leekitcharoenphon P, 2013, J INFECT DEV COUNTR, V7, P696, DOI 10.3855/jidc.3328; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-88; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Petersen RF, 2011, FOODBORNE PATHOG DIS, V8, P655, DOI 10.1089/fpd.2010.0683; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Snipen L, 2010, STAND GENOMIC SCI, V2, P135, DOI 10.4056/sigs.38923; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Torpdahl M, 2007, EMERG INFECT DIS, V13, P388, DOI 10.3201/eid1303.060460; Ussery DW, 2008, COMPUTATIONAL SERIES; Vesth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060120; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Yu HJ, 2013, GENE, V518, P419, DOI 10.1016/j.gene.2012.12.079; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	40	131	132	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87991	10.1371/journal.pone.0087991	http://dx.doi.org/10.1371/journal.pone.0087991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505344	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300028
J	Grammatikos, G; Lange, C; Susser, S; Schwendy, S; Dikopoulos, N; Buggisch, P; Encke, J; Teuber, G; Goeser, T; Thimme, R; Klinker, H; Boecher, WO; Schulte-Frohlinde, E; Penna-Martinez, M; Badenhoop, K; Zeuzem, S; Berg, T; Sarrazin, C				Grammatikos, Georgios; Lange, Christian; Susser, Simone; Schwendy, Susanne; Dikopoulos, Nektarios; Buggisch, Peter; Encke, Jens; Teuber, Gerlinde; Goeser, Tobias; Thimme, Robert; Klinker, Hartwig; Boecher, Wulf O.; Schulte-Frohlinde, Ewert; Penna-Martinez, Marissa; Badenhoop, Klaus; Zeuzem, Stefan; Berg, Thomas; Sarrazin, Christoph			Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUSTAINED VIROLOGICAL RESPONSE; COMMON GENETIC-DETERMINANTS; D SERUM-LEVELS; IL28B POLYMORPHISMS; INTERFERON-ALPHA; VIRAL CLEARANCE; VIRUS-INFECTION; SEVERE FIBROSIS; D INSUFFICIENCY	Background: Different parameters have been determined for prediction of treatment outcome in hepatitis c virus genotype 1 infected patients undergoing pegylated interferon, ribavirin combination therapy. Results on the importance of vitamin D levels are conflicting. In the present study, a comprehensive analysis of vitamin D levels before and during therapy together with single nucleotide polymorphisms involved in vitamin D metabolism in the context of other known treatment predictors has been performed. Methods: In a well characterized prospective cohort of 398 genotype 1 infected patients treated with pegylated interferon-alpha and ribavirin for 24-72 weeks (INDIV-2 study) 25-OH-vitamin D levels and different single nucleotide polymorphisms were analyzed together with known biochemical parameters for a correlation with virologic treatment outcome. Results: Fluctuations of more than 5 (10) ng/ml in 25-OH-vitamin D-levels have been observed in 66 (39) % of patients during the course of antiviral therapy and neither pretreatment nor under treatment 25-OH-vitamin D-levels were associated with treatment outcome. The DHCR7-TT-polymorphism within the 7-dehydrocholesterol-reductase showed a significant association (P = 0.031) to sustained viral response in univariate analysis. Among numerous further parameters analyzed we found that age (OR = 1.028, CI = 1.002-1.056, P = 0.035), cholesterol (OR = 0.983, CI = 0.975-0.991, P<0.001), ferritin (OR = 1.002, CI = 1.000-1.004, P = 0.033), gGT (OR = 1.467, CI = 1.073-2.006, P = 0.016) and IL28B-genotype (OR = 2.442, CI = 1.271-4.695, P = 0.007) constituted the strongest predictors of treatment response. Conclusions: While 25-OH-vitamin D-levels levels show considerable variations during the long-lasting course of antiviral therapy they do not show any significant association to treatment outcome in genotype 1 infected patients.	[Grammatikos, Georgios; Lange, Christian; Susser, Simone; Penna-Martinez, Marissa; Badenhoop, Klaus; Zeuzem, Stefan; Sarrazin, Christoph] JW Goethe Univ Hosp, Med Klin 1, Frankfurt, Germany; [Schwendy, Susanne; Schulte-Frohlinde, Ewert] Uniklin TU Munchen, Munich, Germany; [Dikopoulos, Nektarios] Uniklin Ulm, Ulm, Germany; [Buggisch, Peter] Uniklin Hamburg, Hamburg, Germany; [Encke, Jens] Uniklin Heidelberg, Heidelberg, Germany; [Teuber, Gerlinde] Interdisziplinares Facharztzentrum, Frankfurt, Germany; [Goeser, Tobias] Uniklin Koln, Cologne, Germany; [Thimme, Robert] Uniklin Freiburg, Freiburg, Germany; [Klinker, Hartwig] Uniklin Wurzburg, Wurzburg, Germany; [Boecher, Wulf O.] Uniklin Mainz, Mainz, Germany; [Berg, Thomas] Uniklin Leipzig, Leipzig, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ulm University; Ruprecht Karls University Heidelberg; University of Cologne; University of Freiburg; University of Wurzburg; Leipzig University	Sarrazin, C (corresponding author), JW Goethe Univ Hosp, Med Klin 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019; Klinker, Hartwig/AAC-1134-2021	Berg, Thomas/0000-0003-0003-6241	European Union [241447]	European Union(European Commission)	KB is supported by the European Union FP7 program NAIMIT, grant agreement 241447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Mouch S, 2011, WORLD J GASTROENTERO, V17, P5184, DOI 10.3748/wjg.v17.i47.5184; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Baur K, 2012, ANTIVIR THER, V17, P541, DOI 10.3851/IMP2018; Berg T, 2009, HEPATOLOGY, V50, P369, DOI 10.1002/hep.22991; Bitetto D, 2011, HEPATOLOGY, V53, P1118, DOI 10.1002/hep.24201; Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Dong LM, 2009, CANCER EPIDEM BIOMAR, V18, P2540, DOI 10.1158/1055-9965.EPI-09-0228; Falleti E, 2012, HEPATOLOGY, V56, P1641, DOI 10.1002/hep.25848; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Fisher L, 2007, CLIN GASTROENTEROL H, V5, P513, DOI 10.1016/j.cgh.2006.10.015; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Kau A, 2008, J HEPATOL, V49, P634, DOI 10.1016/j.jhep.2008.07.013; Lange CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064053; Lange CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040159; Lange CM, 2012, HEPATOLOGY, V55, P1038, DOI 10.1002/hep.24787; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Lee S, 2010, DIS MARKERS, V28, P273, DOI [10.1155/2010/706984, 10.3233/DMA-2010-0699]; Milazzo L, 2011, CURR HIV RES, V9, P186, DOI 10.2174/157016211795945269; Neal KR, 2007, GUT, V56, P1098, DOI 10.1136/gut.2006.113217; Penna-Martinez M, 2012, THYROID, V22, P709, DOI 10.1089/thy.2011.0330; Petta S, 2013, J VIRAL HEPATITIS, V20, P486, DOI 10.1111/jvh.12072; Petta S, 2012, ANTIVIR THER, V17, P823, DOI 10.3851/IMP2100; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Rose K, 2013, CLIN EXP IMMUNOL, V171, P171, DOI 10.1111/cei.12013; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sarrazin C, 2012, Z GASTROENTEROL, V50, P57, DOI 10.1055/s-0031-1282015; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Weich V, 2011, J GASTROENTEROL, V46, P1427, DOI 10.1007/s00535-011-0458-y	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87974	10.1371/journal.pone.0087974	http://dx.doi.org/10.1371/journal.pone.0087974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516573	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400023
J	Margolick, JB; Jacobson, LP; Schwartz, GJ; Abraham, AG; Darilay, AT; Kingsley, LA; Witt, MD; Palella, FJ				Margolick, Joseph B.; Jacobson, Lisa P.; Schwartz, George J.; Abraham, Alison G.; Darilay, Annie T.; Kingsley, Lawrence A.; Witt, Mallory D.; Palella, Frank J., Jr.			Factors Affecting Glomerular Filtration Rate, as Measured by Iohexol Disappearance, in Men with or at Risk for HIV Infection	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM CREATININE; RENAL-FUNCTION; PLASMA-CLEARANCE; VALIDATION; PREDICTION; CHILDREN; GFR; PERFORMANCE; MORTALITY	Objective: Formulae used to estimate glomerular filtration rate (GFR) underestimate higher GFRs and have not been well-studied in HIV-infected (HIV(+)) people; we evaluated the relationships of HIV infection and known or potential risk factors for kidney disease with directly measured GFR and the presence of chronic kidney disease (CKD). Design: Cross-sectional measurement of iohexol-based GFR (iGFR) in HIV(+) men (n = 455) receiving antiretroviral therapy, and HIV-uninfected (HIV(2)) men (n = 258) in the Multicenter AIDS Cohort Study. Methods: iGFR was calculated from disappearance of infused iohexol from plasma. Determinants of GFR and the presence of CKD were compared using iGFR and GFR estimated by the CKD-Epi equation (eGFR). Results: Median iGFR was higher among HIV(+) than HIV(2) men (109 vs. 106 ml/min/1.73 m(2), respectively, p = .046), and was 7 ml/min higher than median eGFR. Mean iGFR was lower in men who were older, had chronic hepatitis C virus (HCV) infection, or had a history of AIDS. Low iGFR (<= 90 ml/min/1.73 m(2)) was associated with these factors and with black race. Other than age, factors associated with low iGFR were not observed with low eGFR. CKD was more common in HIV(+) than HIV(2) men; predictors of CKD were similar using iGFR and eGFR. Conclusions: iGFR was higher than eGFR in this population of HIV-infected and -uninfected men who have sex with men. Presence of CKD was predicted equally well by iGFR and eGFR, but associations of chronic HCV infection and history of clinically-defined AIDS with mildly decreased GFR were seen only with iGFR.	[Margolick, Joseph B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Jacobson, Lisa P.; Abraham, Alison G.; Darilay, Annie T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Schwartz, George J.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Witt, Mallory D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Witt, Mallory D.] Univ Calif Los Angeles, Los Angeles Biomed Res Inst Harbor, Los Angeles, CA 90095 USA; [Palella, Frank J., Jr.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Northwestern University; Feinberg School of Medicine	Margolick, JB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	jmargoli@jhsph.edu		Kingsley, Lawrence/0000-0002-7000-8556; Jacobson, Lisa P./0000-0003-1722-6826	NIAID; National Cancer Institute; National Heart, Lung and Blood Institute [U01-AI35042, UM1-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, UL1-RR025005]; UCLA Clinical and Translational Science Institute; Harbor-UCLA Medical Center; Los Angeles Biomedical Research Institute;  [U01-DK-82194];  [1UL1-RR033176]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005, UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI035043, U01AI035041, U01AI035042, U01AI035040, U01AI035039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082194] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UCLA Clinical and Translational Science Institute; Harbor-UCLA Medical Center(University of California System); Los Angeles Biomedical Research Institute(University of California System); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Multicenter AIDS Cohort Study was supported by the NIAID, with additional supplemental funding from the National Cancer Institute and the National Heart, Lung and Blood Institute (U01-AI35042, UM1-AI35043, U01-AI35039, U01-AI35040, U01-AI35041, and UL1-RR025005); additional funding was provided by U01-DK-82194 and 1UL1-RR033176, and from the UCLA Clinical and Translational Science Institute, Harbor-UCLA Medical Center and Los Angeles Biomedical Research Institute. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham AG, 2011, CLIN J AM SOC NEPHRO, V6, P741, DOI 10.2215/CJN.08020910; Adih WK, 2010, J INT ASS PHYS AIDS; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Barlovic DP, 2009, CYTOKINE, V46, P142, DOI 10.1016/j.cyto.2009.01.001; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Bonjoch A, 2010, ANTIVIR RES, V88, P347, DOI 10.1016/j.antiviral.2010.09.015; Botev R, 2009, CLIN J AM SOC NEPHRO, V4, P899, DOI 10.2215/CJN.05371008; BROWN SCW, 1991, J UROLOGY, V146, P675, DOI 10.1016/S0022-5347(17)37891-6; Butt AA, 2011, AM J KIDNEY DIS, V57, P396, DOI 10.1053/j.ajkd.2010.09.023; Caliendo AM, 2006, J CLIN MICROBIOL, V44, P1726, DOI 10.1128/JCM.44.5.1726-1732.2006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DHHS, 2008, GUID US ANT AG HIV I; DUDLEY J, 1995, AM J EPIDEMIOL, V1, P142; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Falade-Nwulia O, 2012, CLIN INFECT DIS, V55, P507, DOI 10.1093/cid/cis432; Fehrman-Ekholm I, 2011, NEPHROL DIAL TRANSPL, V26, P2377, DOI 10.1093/ndt/gfr161; GASPARI F, 1995, J AM SOC NEPHROL, V6, P257; Gaspari F, 2013, KIDNEY INT, V84, P164, DOI 10.1038/ki.2013.47; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hultin LE, 2007, CYTOM PART B-CLIN CY, V72B, P249, DOI 10.1002/cyto.b.20176; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Judd A, 2010, AIDS, V24, P525, DOI 10.1097/QAD.0b013e3283333680; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; KRUTZEN E, 1984, J LAB CLIN MED, V104, P955; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Masia M, 2010, J INFECTION, V61, P189, DOI 10.1016/j.jinf.2010.04.011; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Milliken GA, 2002, ANAL MESSY DATA, VIII; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Ng DKS, 2011, KIDNEY INT, V80, P423, DOI 10.1038/ki.2011.155; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perico N, 2009, CLIN J AM SOC NEPHRO, V4, P207, DOI 10.2215/CJN.03710708; Praditpornsilpa K, 2012, AIDS, V26, P1781, DOI 10.1097/QAD.0b013e328356480d; Rahn KH, 1999, J HYPERTENS, V17, P309, DOI 10.1097/00004872-199917030-00002; Rodriguez-Novoa S, 2010, EXPERT OPIN DRUG SAF, V9, P545, DOI 10.1517/14740331003627458; Schwartz GJ, 2006, KIDNEY INT, V69, P2070, DOI 10.1038/sj.ki.5000385; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Schwartz GJ, 2009, PEDIATR NEPHROL, V24, P113, DOI 10.1007/s00467-008-0957-0; Silvestre AJ, 2006, AM J PUBLIC HEALTH, V96, P1020, DOI 10.2105/AJPH.2005.072801; Sterner G, 2008, SCAND J UROL NEPHROL, V42, P278, DOI 10.1080/00365590701701806; Vrouenraets SME, 2012, CLIN NEPHROL, V77, P311, DOI 10.5414/CN107214; Wever K, 2010, JAIDS-J ACQ IMM DEF, V55, P78, DOI 10.1097/QAI.0b013e3181d05579; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	49	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86311	10.1371/journal.pone.0086311	http://dx.doi.org/10.1371/journal.pone.0086311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516530	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330834400008
J	de Mello, RA; Geros, S; Alves, MP; Moreira, F; Avezedo, I; Dinis, J				de Mello, Ramon Andrade; Geros, Sandra; Alves, Marcos Pantarotto; Moreira, Filipa; Avezedo, Isabel; Dinis, Jose			Cetuximab Plus Platinum-Based Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Retrospective Study in a Single Comprehensive European Cancer Institution	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PHASE-II MULTICENTER; 1ST-LINE TREATMENT; ANTIBODY CETUXIMAB; INDUCED NAUSEA; RECURRENT; ASSOCIATION; CISPLATIN; POLYMORPHISM; COMBINATION	Background: The use of cetuximab in combination with platinum (P) plus 5-fluorouracil (F) has previously been demonstrated to be effective in the treatment of metastatic squamous cell cancer of head and neck (SCCHN). We investigated the efficacy and outcome of this protocol as a first-line treatment for patients with recurrent or metastatic disease. We evaluated overall-survival (OS), progression-free-survival (PFS), overall response rate (ORR) and the treatment toxicity profile in a retrospective cohort. Patients and Methods: This study enrolled 121 patients with untreated recurrent or metastatic SCCHN. The patients received PF+ cetuximab every 3 weeks for a maximum of 6 cycles. Patients with stable disease who received PF+ cetuximab continued to receive cetuximab until disease progressed or unacceptable toxic effects were experienced, whichever occurred first. Results: The median patient age was 53 (37-78) years. The patient cohort was 86.8% male. The addition of cetuximab to PF in the recurrent or metastatic setting provided an OS of 11 months (Confidential Interval, CI, 95%, 8.684-13.316) and PFS of 8 months (CI 95%, 6.051-9.949). The disease control rate was 48.9%, and the ORR was 23.91%. The most common grade 3 or 4 adverse events in the PF+ cetuximab regimen were febrile neutropenia (5.7%), skin rash (3.8%) and mucosistis (3.8%). Conclusions: The results of this study suggest that cetuximab plus platinum-fluorouracil chemotherapy is a good option for systemic treatment in advanced SSCHN patients. This regimen has a well-tolerated toxicity profile.	[de Mello, Ramon Andrade; Alves, Marcos Pantarotto; Avezedo, Isabel; Dinis, Jose] Portuguese Oncol Inst, Head & Neck Unit, Dept Med Oncol, Oporto, Portugal; [de Mello, Ramon Andrade] Univ Algarve, Dept Med & Biomed Sci, Sch Med, Faro, Portugal; [de Mello, Ramon Andrade; Moreira, Filipa] Univ Porto, Dept Med, Fac Med, P-4100 Oporto, Portugal; [Geros, Sandra] Portuguese Oncol Inst, Head & Neck Unit, Serv Otorhinolaryngol, Oporto, Portugal; [Geros, Sandra] Ctr Hosp Vila Nova de Gaia Espinho, Dept Otorhinolaryngol & Cerv Facial Surg, Vila Nova De Gaia, Portugal	Portuguese Institute of Oncology; Universidade do Algarve; Universidade do Porto; Portuguese Institute of Oncology	de Mello, RA (corresponding author), Portuguese Oncol Inst, Head & Neck Unit, Dept Med Oncol, Oporto, Portugal.	ramondemello@gmail.com	De+Mello, Ramon Andrade/ABG-4463-2020	De+Mello, Ramon Andrade/0000-0002-9640-4573; Pantarotto, Marcos/0000-0002-7863-8069				Araujo AP, 2011, WORLD J GASTROENTERO, V17, P488, DOI 10.3748/wjg.v17.i4.488; Argiris A, 2013, ANN ONCOL, V24, P220, DOI 10.1093/annonc/mds245; Barroso S, 2008, ACTA MEDICA PORT, V21, P7; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Brand TM, 2013, RADIOTHER ONCOL, V13, pS0167; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Burtness B, 2013, LANCET ONCOL, V14, pE302, DOI 10.1016/S1470-2045(13)70085-8; Celio L, 2013, PATIENT PREFER ADHER, V7, P391, DOI 10.2147/PPA.S31288; Clark JI, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0358-x; Cohen EEW, 2006, J CLIN ONCOL, V24, P2659, DOI 10.1200/JCO.2005.05.4577; Cohen EEW, 2009, LANCET ONCOL, V10, P247, DOI 10.1016/S1470-2045(09)70002-6; Cortinovis D, 2013, TUMORI J, V99, P45, DOI 10.1700/1248.13787; Costa BM, 2007, CLIN CANCER RES, V13, P2621, DOI 10.1158/1078-0432.CCR-06-2606; De Mello RA, 2012, CLINICS, V67, P1349, DOI 10.6061/clinics/2012(11)22; de Mello RA, 2012, TUMOR BIOL, V33, P1341, DOI 10.1007/s13277-012-0382-7; de Mello RA, 2011, WORLD J CLIN ONCOL, V2, P367, DOI 10.5306/wjco.v2.i11.367; De Oliveira MG, 2012, MOL MED REP, V6, P163, DOI 10.3892/mmr.2012.876; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Goodwin WJ, 2000, LARYNGOSCOPE, V110, P1, DOI 10.1097/00005537-200003001-00001; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Grunberg S, 2011, J CLIN ONCOL, V29, P1495, DOI 10.1200/JCO.2010.31.7859; Haddad R, 2003, ONCOLOGIST, V8, P35, DOI 10.1634/theoncologist.8-1-35; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Hitt R, 2012, ANN ONCOL, V23, P1016, DOI 10.1093/annonc/mdr367; Ho AS, 2013, HEAD NECK; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Link H, 2013, ONKOLOGIE, V36, P266, DOI 10.1159/000350306; Lynch TJ, 2010, J CLIN ONCOL, V28, P911, DOI 10.1200/JCO.2009.21.9618; Massa E, 2010, ORAL ONCOL, V46, P818, DOI 10.1016/j.oraloncology.2010.08.013; Mesia R, 2010, ANN ONCOL, V21, P1967, DOI 10.1093/annonc/mdq077; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Yoshino T, 2013, JPN J CLIN ONCOL, V43, P524, DOI 10.1093/jjco/hyt034; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	39	29	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86697	10.1371/journal.pone.0086697	http://dx.doi.org/10.1371/journal.pone.0086697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516537	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700012
J	Misra, UK; Pizzo, SV				Misra, Uma Kant; Pizzo, Salvatore Vincent			Activated alpha(2)-Macroglobulin Binding to Cell Surface GRP78 Induces T-Loop Phosphorylation of Akt1 by PDK1 in Association with Raptor	PLOS ONE			English	Article							RECEPTOR-RECOGNIZED FORMS; PROSTATE-CANCER CELLS; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; PDK1-INTERACTING PROTEIN; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; TERMINAL DOMAIN; REGULATES AKT; KINASE	PDK1 phosphorylates multiple substrates including Akt by PIP3-dependent mechanisms. In this report we provide evidence that in prostate cancer cells stimulated with activated alpha(2)-macroglobulin (alpha M-2*) PDK1 phosphorylates Akt in the T-loop at Thr(308) by using Raptor in the mTORC1 complex as a scaffold protein. First we demonstrate that PDK1, Raptor, and mTOR co-immunoprecipitate. Silencing the expression, not only of PDK1, but also Raptor by RNAi nearly abolished Akt phosphorylation at Akt(Thr308) in Raptor-immunoprecipitates of alpha 2M*-stimulated prostate cancer cells. Immunodepleting Raptor or PDK from cell lysates of cells treated with alpha 2M* drastically reduced Akt phosphorylation at Thr(308), which was recovered by adding the supernatant of Raptor- or PDK1-depleted cell lysates, respectively. Studies of insulin binding to its receptor on prostate cancer cells yielded similar results. We thus demonstrate that phosphorylating the T-loop Akt residue Thr(308) by PDK1 requires Raptor of the mTORC1 complex as a platform or scaffold protein.	[Misra, Uma Kant; Pizzo, Salvatore Vincent] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu						Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Biondi RM, 2004, TRENDS BIOCHEM SCI, V29, P136, DOI 10.1016/j.tibs.2004.01.005; Boulbes DR, 2011, BIOCHEM BIOPH RES CO, V413, P46, DOI 10.1016/j.bbrc.2011.08.034; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Bridges D, 2012, MOL BIOL CELL, V23, P2955, DOI 10.1091/mbc.E11-12-1034; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Ding ZY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009910; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Engstrom W, 2010, CELL PROLIFERAT, V43, P56, DOI 10.1111/j.1365-2184.2009.00654.x; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hart JP, 2006, HEMOSTASIS THROMBOSI; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huang BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061430; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; King CC, 2004, J BIOL CHEM, V279, P37518, DOI 10.1074/jbc.M405340200; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kurata A, 2008, CANCER SCI, V99, P1827, DOI 10.1111/j.1349-7006.2008.00874.x; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Masters TA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000738; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Misra UK, 2010, APOPTOSIS, V15, P173, DOI 10.1007/s10495-009-0430-y; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2005, J IMMUNOL, V175, P2525, DOI 10.4049/jimmunol.175.4.2525; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Misra UK, 2004, J CELL BIOCHEM, V93, P1020, DOI 10.1002/jcb.20233; Misra UK, 1998, J BIOL CHEM, V273, P13399, DOI 10.1074/jbc.273.22.13399; Misra UK, 2004, CELL SIGNAL, V16, P487, DOI 10.1016/j.cellsig.2003.09.010; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2013, J CANC THERAPY, V4, P74; Misra UK, 2013, J BIOCH PHARM RES, V4, P219; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Okamoto Y, 2007, DIABETES, V56, P1000, DOI 10.2337/db06-1322; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Bayascas JR, 2010, CURR TOP MICROBIOL, V346, P9, DOI 10.1007/82_2010_43; Rosner M, 2012, METHODS MOL BIOL, V821, P105, DOI 10.1007/978-1-61779-430-8_8; Shen XC, 2010, J BIOL CHEM, V285, P29416, DOI 10.1074/jbc.M110.155325; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Sundin T, 2013, MOL CELL BIOCHEM, V375, P97, DOI 10.1007/s11010-012-1532-3; Tian XJ, 2002, EMBO J, V21, P1327, DOI 10.1093/emboj/21.6.1327; Toker Alex, 2012, Subcell Biochem, V58, P95, DOI 10.1007/978-94-007-3012-0_4; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Ziemba BP, 2013, BIOCHEMISTRY-US, V52, P4820, DOI 10.1021/bi400488f; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	68	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88373	10.1371/journal.pone.0088373	http://dx.doi.org/10.1371/journal.pone.0088373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516643	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700065
J	Du, ZY; Shen, AN; Huang, YL; Su, L; Lai, WY; Wang, P; Xie, ZB; Xie, ZQ; Zeng, QC; Ren, H; Xu, DL				Du, Zhiyong; Shen, Anna; Huang, Yuli; Su, Liang; Lai, Wenyan; Wang, Peng; Xie, Zhibing; Xie, Zhiquan; Zeng, Qingchun; Ren, Hao; Xu, Dingli			1H-NMR-Based Metabolic Analysis of Human Serum Reveals Novel Markers of Myocardial Energy Expenditure in Heart Failure Patients	PLOS ONE			English	Article							ORTHOGONAL SIGNAL CORRECTION; KETONE-BODIES; FATTY-ACIDS; NMR-SPECTROSCOPY; BODY-COMPOSITION; FAILING HEART; OXIDATION; DEHYDROGENASE; DYSFUNCTION; MECHANISMS	Objective: Elevated myocardial energy expenditure (MEE) is related with reduced left ventricular ejection fraction, and has also been documented as an independent predictor of cardiovascular mortality. However, the serum small-molecule metabolite profiles and pathophysiological mechanisms of elevated MEE in heart failure (HF) are still lacking. Herein, we used 1H-NMR-based metabolomics analysis to screen for potential biomarkers of MEE in HF. Methods: A total of 61 subjects were enrolled, including 46 patients with heart failure and 15 age-matched controls. Venous serum samples were collected from subjects after an 8-hour fast. An INOVA 600 MHz nuclear magnetic resonance spectrometer with Carr-Purcell-Melboom-Gill (CPMG) pulse sequence was employed for the metabolomics analysis and MEE was calculated using colored Doppler echocardiography. Metabolomics data were processed using orthogonal signal correction and regression analysis was performed using the partial least squares method. Results: The mean MEE levels of HF patients and controls were 139.61 +/- 58.18 cal/min and 61.09 +/- 23.54 cal/min, respectively. Serum metabolomics varied with MEE changed, and 3-hydroxybutyrate, acetone and succinate were significantly elevated with the increasing MEE. Importantly, these three metabolites were independent of administration of angiotensin converting enzyme inhibitor, beta-receptor blockers, diuretics and statins (P>0.05). Conclusions: These results suggested that in patients with heart failure, MEE elevation was associated with significant changes in serum metabolomics profiles, especially the concentration of 3-hydroxybutyrate, acetone and succinate. These compounds could be used as potential serum biomarkers to study myocardial energy mechanism in HF patients.	[Du, Zhiyong; Shen, Anna; Huang, Yuli; Su, Liang; Lai, Wenyan; Wang, Peng; Xie, Zhibing; Zeng, Qingchun; Xu, Dingli] Southern Med Univ, Nanfang Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Du, Zhiyong; Su, Liang; Lai, Wenyan; Wang, Peng; Xie, Zhibing; Zeng, Qingchun; Ren, Hao; Xu, Dingli] Minist Educ Peoples Republ China, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; [Shen, Anna] Southern Med Univ, Hosp 3, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Xie, Zhiquan] Guangzhou Gen Hosp PLA, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Ren, Hao] Southern Med Univ, Nanfang Hosp, Dept Rheumatol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Ministry of Education, China; Southern Medical University - China; Southern Medical University - China	Ren, H (corresponding author), Minist Educ Peoples Republ China, Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	renhao67@aliyun.com; dinglixu@smu.edu.cn	Huang, Yuli/AAB-1006-2022; Xu, Dingli/AAA-6176-2019	Zeng, Qingchun/0000-0001-7665-8237	Natural Science Foundation of Guangdong Province [8151051501000048]; Guangdong Provincial Science and Technology projects [2009B030801204, 2012B031800184]; Guangzhou City Science and Technology projects [2010YC181]; National Natural Science Foundation of China [81270320]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Provincial Science and Technology projects; Guangzhou City Science and Technology projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants of Natural Science Foundation of Guangdong Province (No. 8151051501000048), Guangdong Provincial Science and Technology projects (No. 2009B030801204, No. 2012B031800184), Guangzhou City Science and Technology projects (No. 2010YC181) and National Natural Science Foundation of China (No. 81270320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquilani R, 2003, J AM COLL CARDIOL, V42, P1218, DOI 10.1016/S0735-1097(03)00946-X; AVOGARO A, 1990, AM J PHYSIOL, V258, pE606, DOI 10.1152/ajpendo.1990.258.4.E606; Beckwith-Hall BM, 2002, ANALYST, V127, P1283, DOI 10.1039/b205128c; CHEN V, 1984, HORM METAB RES, V16, P243, DOI 10.1055/s-2007-1014756; Davili Z, 2007, EUR J PEDIATR, V166, P867, DOI 10.1007/s00431-006-0310-1; FORSEY RGP, 1987, CAN J PHYSIOL PHARM, V65, P401, DOI 10.1139/y87-067; FOXALL PJD, 1993, J PHARMACEUT BIOMED, V11, P21, DOI 10.1016/0731-7085(93)80145-Q; Gavaghan CL, 2002, FEBS LETT, V530, P191, DOI 10.1016/S0014-5793(02)03476-2; Hagan SO, 2007, ANAL CHEM, V79, P464, DOI 10.1021/ac061443+; Hall JL, 1996, AM J PHYSIOL-HEART C, V271, pH2320, DOI 10.1152/ajpheart.1996.271.6.H2320; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kang SM, 2011, CLIN BIOCHEM, V44, P293, DOI 10.1016/j.clinbiochem.2010.11.010; KERBEY AL, 1976, BIOCHEM J, V154, P327, DOI 10.1042/bj1540327; Kim SH, 2009, ANAL BIOANAL CHEM, V395, P1117, DOI 10.1007/s00216-009-3054-8; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; Liang J., 2012, NAN FANG YI KE DA XU, V32, P1832; Liang Jianqiu, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P1816; Lommi J, 1997, J INTERN MED, V242, P231, DOI 10.1046/j.1365-2796.1997.00187.x; Lommi J, 1996, J AM COLL CARDIOL, V28, P665, DOI 10.1016/0735-1097(96)00214-8; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Nagoshi T, 2011, CURR PHARM DESIGN, V17, P3846, DOI 10.2174/138161211798357773; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Palmieri V, 2003, AM HEART J, V145, P1071, DOI 10.1016/S0002-8703(03)00099-1; Palmieri V, 2008, J AM SOC ECHOCARDIOG, V21, P66, DOI 10.1016/j.echo.2007.05.008; PISARENKO O, 1987, BIOMED BIOCHIM ACTA, V46, pS568; Rhee EP, 2012, CLIN CHEM, V58, P139, DOI 10.1373/clinchem.2011.169573; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shen An-na, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P209; Tenori L, 2013, INT J CARDIOL, V168, pE113, DOI 10.1016/j.ijcard.2013.08.042; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; van Bilsen M, 2009, CARDIOVASC RES, V81, P420, DOI 10.1093/cvr/cvn282	32	54	58	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88102	10.1371/journal.pone.0088102	http://dx.doi.org/10.1371/journal.pone.0088102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505394	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200116
J	Jagya, N; Varma, SPK; Thakral, D; Joshi, P; Durgapal, H; Panda, SK				Jagya, Neetu; Varma, Satya Pavan Kumar; Thakral, Deepshi; Joshi, Prashant; Durgapal, Hemlata; Panda, Subrat Kumar			RNA-Seq Based Transcriptome Analysis of Hepatitis E Virus (HEV) and Hepatitis B Virus (HBV) Replicon Transfected Huh-7 Cells	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC LIVER-DISEASE; CELLULAR IMMUNE-RESPONSE; INTRAFLAGELLAR TRANSPORT; ONLY PROTEIN-2; ORF3 PROTEIN; INFECTION; ACTIVATION; COMPLEX; DOMAIN	Pathogenesis of hepatitis B virus (HBV) and hepatitis E virus (HEV) infection is as varied as they appear similar; while HBV causes an acute and/or chronic liver disease and hepatocellular carcinoma, HEV mostly causes an acute self-limiting disease. In both infections, host responses are crucial in disease establishment and/or virus clearance. In the wake of worsening prognosis described during HEV super-infection over chronic HBV hepatitis, we investigated the host responses by studying alterations in gene expression in liver cells (Huh-7 cell line) by transfection with HEV replicon only (HEV-only), HBV replicon only (HBV-only) and both HBV and HEV replicons (HBV+HEV). Virus replication was validated by strand-specific real-time RTPCR for HEV and HBsAg ELISA of the culture supernatants for HBV. Indirect immunofluorescence for the respective viral proteins confirmed infection. Transcription profiling was carried out by RNA Sequencing (RNA-Seq) analysis of the poly-A enriched RNA from the transfected cells. Averages of 600 million bases within 5.6 million reads were sequenced in each sample and,15,800 genes were mapped with at least one or more reads. A total of 461 genes in HBV+HEV, 408 in HBV-only and 306 in HEV-only groups were differentially expressed as compared to mock transfection control by two folds (p < 0.05) or more. Majority of the significant genes with altered expression clustered into immune-associated, signal transduction, and metabolic process categories. Differential gene expression of functionally important genes in these categories was also validated by real-time RT-PCR based relative gene-expression analysis. To our knowledge, this is the first report of in vitro replicon transfected RNA-Seq based transcriptome analysis to understand the host responses against HEV and HBV.	[Jagya, Neetu; Varma, Satya Pavan Kumar; Thakral, Deepshi; Joshi, Prashant; Durgapal, Hemlata; Panda, Subrat Kumar] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Panda, SK (corresponding author), All India Inst Med Sci, Dept Pathol, New Delhi 110029, India.	subrat@gmail.com			Department of Science and Technology (DST), Government of India [SR/S0/HS/0114/2010, SR/S2/JCB-05/2007]; All India Institute of Medical Sciences, New Delhi, India; Council of Scientific and Industrial Research	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); All India Institute of Medical Sciences, New Delhi, India; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology (DST) grant ( No. SR/S0/HS/0114/2010; J C Bose Fellowship No. SR/S2/JCB-05/2007), Government of India to Prof. Subrat Kumar Panda. NJ is a recipient of fellowship from All India Institute of Medical Sciences, New Delhi, India. DT is a senior research associate supported by Council of Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Boomgaarden I, 2009, BIOCHEM GENET, V47, P739, DOI 10.1007/s10528-009-9273-z; Cantoni L, 1975, Minerva Med, V66, P101; Cao WS, 2002, AM J PHYSIOL-CELL PH, V283, pC327, DOI 10.1152/ajpcell.00442.2001; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chandra V, 2008, J VIROL, V82, P7100, DOI 10.1128/JVI.00403-08; Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022412; Chandra V, 2010, J VIROL, V84, P3857, DOI 10.1128/JVI.01994-09; Devhare PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063793; Diebold SS, 2008, ADV DRUG DELIVER REV, V60, P813, DOI 10.1016/j.addr.2007.11.004; Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y; Dorfleutner A, 2007, INFECT IMMUN, V75, P1484, DOI 10.1128/IAI.01315-06; Fan Zhen-ping, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P325; FERRARI C, 1990, J IMMUNOL, V145, P3442; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Geng YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056320; Gupta P, 2012, J VIRAL HEPATITIS, V19, pE177, DOI 10.1111/j.1365-2893.2011.01498.x; GURNEY AL, 1995, P NATL ACAD SCI USA, V92, P5292, DOI 10.1073/pnas.92.12.5292; Hamid SS, 2002, HEPATOLOGY, V36, P474, DOI 10.1053/jhep.2002.34856; Hayakawa M, 2008, GENES CELLS, V13, P329, DOI 10.1111/j.1365-2443.2008.01168.x; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Kamar N, 2013, SEMIN LIVER DIS, V33, P62, DOI 10.1055/s-0033-1338115; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Khuroo MS, 2011, VIRUS RES, V161, P3, DOI 10.1016/j.virusres.2011.02.007; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koziel K, 2013, EXP CELL RES, VS0014-4827, P00328; Kumar M, 2008, J GASTROEN HEPATOL, V23, P883, DOI 10.1111/j.1440-1746.2007.05243.x; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Makarov V. K., 2003, Klinicheskaya Laboratornaya Diagnostika, P41; Makarov V. K., 2004, Biomeditsinskaya Khimiya, V50, P498; Marion-Audibert AM, 2010, GASTROEN CLIN BIOL, V34, P334, DOI 10.1016/j.gcb.2010.02.003; Mavrogiannaki A, 2009, J VIRAL HEPATITIS, V16, P430, DOI 10.1111/j.1365-2893.2009.01077.x; Monga Rainish, 2004, Indian J Gastroenterol, V23, P50; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Mukherjee P, 2013, IMMUNITY, V38, P705, DOI 10.1016/j.immuni.2013.02.013; Ohnishi A, 2012, DIGESTION, V86, P122, DOI 10.1159/000339496; Prabhu SB, 2011, J VIRAL HEPATITIS, V18, P587, DOI 10.1111/j.1365-2893.2010.01338.x; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Purcell Robert H, 2010, J Infect Dis, V202, P819, DOI 10.1086/655900; Ramachandran J, 2004, J GASTROEN HEPATOL, V19, P134, DOI 10.1111/j.1440-1746.2004.03188.x; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Roy AK, 2004, J BIOL CHEM, V279, P28345, DOI 10.1074/jbc.M400457200; Ruvolo PP, 2001, LEUKEMIA, V15, P1153, DOI 10.1038/sj.leu.2402197; Sengupta S, 2007, J MED VIROL, V79, P220, DOI 10.1002/jmv.20790; Shang Qinghua, 2002, Zhonghua Nei Ke Za Zhi, V41, P656; Spertini C, 2012, J BIOL CHEM, V287, P10693, DOI 10.1074/jbc.M111.318022; Spradling PR, 2013, J VIRAL HEPATITIS, V20, P510, DOI 10.1111/jvh.12071; Varma SPK, 2011, J GEN VIROL, V92, P572, DOI 10.1099/vir.0.027714-0; Wang CC, 2008, J GASTROEN HEPATOL, V23, P779, DOI 10.1111/j.1440-1746.2007.05216.x; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Wu YZ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191031; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Youn BS, 1998, BLOOD, V91, P3118, DOI 10.1182/blood.V91.9.3118.3118_3118_3126; Zhang Guo-Shun, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P906	63	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87835	10.1371/journal.pone.0087835	http://dx.doi.org/10.1371/journal.pone.0087835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505321	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200077
J	Khalil, ISM; Magdanz, V; Sanchez, S; Schmidt, OG; Misra, S				Khalil, Islam S. M.; Magdanz, Veronika; Sanchez, Samuel; Schmidt, Oliver G.; Misra, Sarthak			Wireless Magnetic-Based Closed-Loop Control of Self-Propelled Microjets	PLOS ONE			English	Article							MICROROBOTS; PROPULSION; MOTION	In this study, we demonstrate closed-loop motion control of self-propelled microjets under the influence of external magnetic fields. We control the orientation of the microjets using external magnetic torque, whereas the linear motion towards a reference position is accomplished by the thrust and pulling magnetic forces generated by the ejecting oxygen bubbles and field gradients, respectively. The magnetic dipole moment of the microjets is characterized using the U-turn technique, and its average is calculated to be 1.3 x 10(-10) A.m(2) at magnetic field and linear velocity of 2 mT and 100 mu m/s, respectively. The characterized magnetic dipole moment is used in the realization of the magnetic force-current map of the microjets. This map in turn is used for the design of a closed-loop control system that does not depend on the exact dynamical model of the microjets and the accurate knowledge of the parameters of the magnetic system. The motion control characteristics in the transient- and steady-states depend on the concentration of the surrounding fluid (hydrogen peroxide solution) and the strength of the applied magnetic field. Our control system allows us to position microjets at an average velocity of 115 mu m/s, and within an average region-of-convergence of 365 mu m.	[Khalil, Islam S. M.] German Univ Cairo, Cairo, Egypt; [Magdanz, Veronika; Schmidt, Oliver G.] IFW Dresden, Inst Integrat Nanosci, Dresden, Germany; [Sanchez, Samuel] Max Planck Inst Intelligent Syst, Stuttgart, Germany; [Schmidt, Oliver G.] Univ Technol Chemnitz, Chemnitz, Germany; [Misra, Sarthak] Univ Twente, NL-7500 AE Enschede, Netherlands	Egyptian Knowledge Bank (EKB); German University in Cairo; Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden; Max Planck Society; University of Twente	Khalil, ISM (corresponding author), German Univ Cairo, Cairo, Egypt.	islam.shoukry@guc.edu.eg; s.misra@utwente.nl	Magdanz, Veronika/AAH-1709-2019; Sanchez, Samuel/B-6803-2015; Magdanz, Veronika/AAH-5564-2021; Misra, Sarthak/B-8338-2014; Schmidt, Oliver G/W-4877-2019	Sanchez, Samuel/0000-0002-5845-8941; Misra, Sarthak/0000-0003-4961-0144; Schmidt, Oliver G/0000-0001-9503-8367; Sanchez, Samuel/0000-0001-9713-9997	MIRA-Institute for Biomedical Technology and Technical Medicine; Volkswagen Foundation [86 362]; European Research Council (ERC)	MIRA-Institute for Biomedical Technology and Technical Medicine; Volkswagen Foundation(Volkswagen); European Research Council (ERC)(European Research Council (ERC))	Islam S. M. Khalil and Sarthak Misra thank MIRA-Institute for Biomedical Technology and Technical Medicine for supporting this research project. Veronika Magdanz, Samuel Sanchez, and Oliver G. Schmidt thank the Volkswagen Foundation (# 86 362). Samuel Sanchez thanks the European Research Council (ERC) for Starting Grant "Lab-in-a-tube and Nanorobotics biosensor". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JJ, 2009, INT J ROBOT RES, V28, P1434, DOI 10.1177/0278364909341658; Bahaj AS, 1996, IEEE T MAGN, V32, P5133, DOI 10.1109/20.539514; BAHAJ AS, 1993, IEEE T MAGN, V29, P3358, DOI 10.1109/20.281175; Bell DJ, 2007, IEEE INT CONF ROBOT, P1128, DOI 10.1109/ROBOT.2007.363136; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Chemla YR, 1999, BIOPHYS J, V76, P3323, DOI 10.1016/S0006-3495(99)77485-0; Floyd S, 2009, IEEE T ROBOT, V25, P1332, DOI 10.1109/TRO.2009.2028761; Fournier-Bidoz S., 2004, CHEM COMMUNICATION, V441, P441; Frankel R B, 2007, MICROBIOL MONOGR, V3, DOI DOI 10.1007/7171_2006_036; Ghosh A, 2009, NANO LETT, V9, P2243, DOI 10.1021/nl900186w; Gibbs JG, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3122346; Howse JR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.048102; Keuning JD, 2011, IEEE INT C INT ROBOT, P421, DOI 10.1109/IROS.2011.6048703; Khalil ISM, 2013, INT J ROBOT RES, V32, P637, DOI 10.1177/0278364913479412; Kratochvil BE, 2010, P 12 INT S EXP ROB S; Kummer MP, 2010, IEEE T ROBOT, V26, P1006, DOI 10.1109/TRO.2010.2073030; Lu Zhao, 2007, P IEEE INT C SOL STA, P683, DOI DOI 10.1109/SENSOR.2007.4300222; Martel S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2402221; Martel S, 2010, IEEE INT CONF ROBOT, P500, DOI 10.1109/ROBOT.2010.5509752; Mei YF, 2008, ADV MATER, V20, P4085, DOI 10.1002/adma.200801589; Mei YF, 2011, CHEM SOC REV, V40, P2109, DOI 10.1039/c0cs00078g; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Pawashe C, 2012, IEEE T ROBOT, V28, P467, DOI 10.1109/TRO.2011.2173835; Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; Sanchez S, 2011, CHEM COMMUN, V47, P698, DOI 10.1039/c0cc04126b; Schmidt OG, 2001, NATURE, V410, P168, DOI 10.1038/35065525; Sendoh M, 1999, IEEE T MAGN, V35, P3688, DOI 10.1109/20.800632; Solovev AA, 2010, ADV FUNCT MATER, V20, P2430, DOI 10.1002/adfm.200902376; Solovev AA, 2009, SMALL, V5, P1688, DOI 10.1002/smll.200900021; Utkin VI, 2002, MATH PROBL ENG, V8, P451, DOI 10.1080/10241230306724; Wang J, 2012, ACS NANO, V6, P5745, DOI 10.1021/nn3028997; Wang J, 2010, SMALL, V6, P338, DOI 10.1002/smll.200901746; Zhang L, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3079655	33	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e83053	10.1371/journal.pone.0083053	http://dx.doi.org/10.1371/journal.pone.0083053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505244	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200004
J	Li, BQ; You, J; Huang, T; Cai, YD				Li, Bi-Qing; You, Jin; Huang, Tao; Cai, Yu-Dong			Classification of Non-Small Cell Lung Cancer Based on Copy Number Alterations	PLOS ONE			English	Article							GENOMIC IMBALANCES; PLUS CARBOPLATIN; NEVER SMOKERS; FHIT PROTEIN; BEVACIZUMAB; EXPRESSION; PACLITAXEL; PREDICTION; SURVIVAL; PATHWAY	Lung cancer is one of the leading causes of cancer mortality worldwide and non-small cell lung cancer (NSCLC) accounts for the most part. NSCLC can be further divided into adenocarcinoma (ACA) and squamous cell carcinoma (SCC). It is of great value to distinguish these two subgroups clinically. In this study, we compared the genome-wide copy number alterations (CNAs) patterns of 208 early stage ACA and 93 early stage SCC tumor samples. As a result, 266 CNA probes stood out for better discrimination of ACA and SCC. It was revealed that the genes corresponding to these 266 probes were enriched in lung cancer related pathways and enriched in the chromosome regions where CNA usually occur in lung cancer. This study sheds lights on the CNA study of NSCLC and provides some insights on the epigenetic of NSCLC.	[Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [You, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai	Huang, T (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	tohuangtao@126.com; cai_yud@yahoo.com.cn		cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; grant of "The First-class Discipline of Universities in Shanghai''	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); grant of "The First-class Discipline of Universities in Shanghai''	This work was supported by grants from National Basic Research Program of China (2011CB510101, 2011CB510102), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and the grant of "The First-class Discipline of Universities in Shanghai''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedchenko EA, 2008, MOL BIOL+, V42, P859, DOI 10.1134/S0026893308060058; Barnes LD, 1996, BIOCHEMISTRY-US, V35, P11529, DOI 10.1021/bi961415t; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Carelli S, 2006, LUNG CANCER, V53, P263, DOI 10.1016/j.lungcan.2006.06.001; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Daraselia N, 2012, AM J CANCER RES, V2, P93; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Dmitriev AA, EPIGENETICS, V7, P502; Dong J, 2012, NAT GENET, V44, P895, DOI 10.1038/ng.2351; Faoro L, 2010, J BIOL CHEM, V285, P18575, DOI 10.1074/jbc.M109.075085; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; GAO YF, 2013, MOL BIOSYSTEMS; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoye AM, ADV BIOL REGULATION, V52, P326; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017291; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang YT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022961; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kargi A, 2007, APPL IMMUNOHISTO M M, V15, P415, DOI 10.1097/PAI.0b013e31802fab75; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Kim MJ, ANN DIAGNOSTIC PATHO; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Pasquale EB, NAT REV CANC, V10, P165; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Perez-Moreno P, CLIN CANC RES, V18, P2443; Roz L, 2004, ONCOGENE, V23, P9102, DOI 10.1038/sj.onc.1208142; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Toledo G, 2004, MODERN PATHOL, V17, P440, DOI 10.1038/modpathol.3800081; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Travis WD, 2011, CLIN CHEST MED, V32, P669, DOI 10.1016/j.ccm.2011.08.005; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Travis WD, 2010, J THORAC ONCOL, V5, P411, DOI 10.1097/JTO.0b013e3181d57f6e; Tseng JE, 1999, CANCER RES, V59, P4798; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Veugelers M, 1997, GENOMICS, V40, P24, DOI 10.1006/geno.1996.4518; Yang X, CANC LETT; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j	69	30	30	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88300	10.1371/journal.pone.0088300	http://dx.doi.org/10.1371/journal.pone.0088300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505469	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200170
J	Liu, B; Cai, JH; Xu, Y; Peng, XH; Zheng, HL; Huang, KP; Yang, J				Liu, Bo; Cai, Jinhua; Xu, Ye; Peng, Xuehua; Zheng, Helin; Huang, Kaiping; Yang, Jing			Three-Dimensional Magnetic Resonance Cholangiopancreatography for the Diagnosis of Biliary Atresia in Infants and Neonates	PLOS ONE			English	Article							STOOL COLOR CARD; MR CHOLANGIOGRAPHY; CHOLESTASIS; CHILDREN; SEDATION; JAUNDICE; HEPATITIS; TAIWAN	Background and Objective: Magnetic resonance cholangiopancreatography (MRCP) is widely accepted for visualization of the biliary system. However, the sensitivity and specificity of MRCP for the diagnosis of biliary atresia (BA) are still not fully elucidated. This study aimed to investigate the diagnostic value of three-dimensional MRCP (3D-MRCP) for BA in a large cohort of cholestatic infants and neonates. Methods: One hundred ninety patients with infant jaundice underwent 3D-MRCP and one or more of the following: (1) intraoperative cholangiography, (2) laparoscopic exploration and pathological examination, or/and (3) clinical therapy. Statistical analyses were performed to determine the diagnostic accuracy of 3D-MRCP for BA. Results: Our study demonstrated that 158 of 190 patients were interpreted as having BA by 3D-MRCP; of those, 103 patients were confirmed as having BA, whereas 55 patients did not have BA. Of the 32 patients interpreted as non-BA cases by 3D-MRCP, one patient was misdiagnosed. The diagnostic accuracy for 3D-MRCP was 70.53% (134 of 190), the sensitivity was 99.04% (103 of 104), the specificity was 36.05% (31 of 86), the negative predictive value was 96.88% (31 of 32), the positive predictive value was 65.19% (103 of 158), the positive likelihood ratio was 2.7473, the negative likelihood ratio was 0.0267, and the Youden index was 0.3509. Conclusions: The sensitivity of 3D-MRCP in diagnosing BA was excellent, but the specificity was not as high as described in previous reports. 3D-MRCP can be an effective screening method but should be combined with other modalities to identify BA and distinguish it from other causes of infant jaundice.	[Liu, Bo; Cai, Jinhua; Xu, Ye; Peng, Xuehua; Zheng, Helin; Huang, Kaiping; Yang, Jing] Chongqing Med Univ, Childrens Hosp, Dept Radiol, Chongqing, Peoples R China	Chongqing Medical University	Cai, JH (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Radiol, Chongqing, Peoples R China.	cai_jinhua@126.com			National Natural Science Foundation of China [81171387]; Natural Science Foundation Project of Chongqing (CQ CSTC) [CSTC, 2011BB5130]; Project Foundation of Chongqing Municipal Education Committee [KJ080313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing (CQ CSTC); Project Foundation of Chongqing Municipal Education Committee	This study was supported by Grants from the National Natural Science Foundation of China (No. 81171387; http://www.nsfc.gov.cn), Natural Science Foundation Project of Chongqing (CQ CSTC, No. CSTC, 2011BB5130; http://www.ctin.ac.cn) and Project Foundation of Chongqing Municipal Education Committee (KJ080313; http://www.cqjw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchimol EI, 2009, CAN FAM PHYSICIAN, V55, P1184; BILL AH, 1977, J PEDIATR SURG, V12, P977, DOI 10.1016/0022-3468(77)90609-1; BURTON EM, 1990, SOUTHERN MED J, V83, P294, DOI 10.1097/00007611-199003000-00010; Chen SM, 2006, PEDIATRICS, V117, P1147, DOI 10.1542/peds.2005-1267; Gilmour SM, 1997, J NUCL MED, V38, P1279; GUELRUD M, 1991, GASTROINTEST ENDOSC, V37, P522, DOI 10.1016/S0016-5107(91)70820-1; Gupta D. K., 2001, Indian Journal of Pediatrics, V68, P1039, DOI 10.1007/BF02722353; Han SJ, 2002, J PEDIATR SURG, V37, P599, DOI 10.1053/jpsu.2002.31617; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Holzknecht N, 1998, RADIOLOGY, V206, P657, DOI 10.1148/radiology.206.3.9494483; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Humphrey TM, 2007, RADIOLOGY, V244, P845, DOI 10.1148/radiol.2443061051; Hung PY, 2006, J PEDIATR GASTR NUTR, V42, P190, DOI 10.1097/01.mpg.0000189339.92891.64; Iinuma Y, 2000, J PEDIATR SURG, V35, P545, DOI 10.1053/jpsu.2000.0350545; Jaw TS, 1999, RADIOLOGY, V212, P249, DOI 10.1148/radiology.212.1.r99jl13249; Johnson K, 1998, PEDIATR RADIOL, V28, P937, DOI 10.1007/s002470050505; Khalil BA, 2010, EUR J PEDIATR, V169, P395, DOI 10.1007/s00431-009-1125-7; Kotb MA, 2001, PEDIATRICS, V108, P416, DOI 10.1542/peds.108.2.416; Larrosa-Haro A, 2001, J PEDIATR GASTR NUTR, V32, P311, DOI 10.1097/00005176-200103000-00015; Lee MS, 2009, RADIOLOGY, V252, P282, DOI 10.1148/radiol.2522080923; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Lin WY, 1996, PEDIATR SURG INT, V12, P30; Maitre NL, 2013, J PERINATOL, V33, P841, DOI 10.1038/jp.2013.116; MATSUI A, 1994, LANCET, V343, P925, DOI 10.1016/S0140-6736(94)90052-3; MATSUI A, 1995, LANCET, V345, P1181, DOI 10.1016/S0140-6736(95)91013-1; Metreweli C, 2004, BRIT J RADIOL, V77, P1059, DOI 10.1259/bjr/34655158; Meyer S, 2003, KLIN PADIATR, V215, P69, DOI 10.1055/s-2003-38500; Mieli-Vergani G, 2009, SEMIN IMMUNOPATHOL, V31, P371, DOI 10.1007/s00281-009-0171-6; Miyazaki T, 1998, AM J ROENTGENOL, V170, P33, DOI 10.2214/ajr.170.1.9423593; Norton KI, 2002, RADIOLOGY, V222, P687, DOI 10.1148/radiol.2223010969; Ohi R, 2001, LIVER, V21, P175, DOI 10.1034/j.1600-0676.2001.021003175.x; Reinhold C, 1996, AM J ROENTGENOL, V166, P1285, DOI 10.2214/ajr.166.6.8633434; Schulte-Uentrop L, 2010, CURR OPIN ANESTHESIO, V23, P513, DOI 10.1097/ACO.0b013e32833bb524; Starkey E, 2011, ARCH DIS CHILDHOOD-E, V96, P101, DOI 10.1136/adc.2008.153072; Takaya J, 2007, EUR J PEDIATR, V166, P211, DOI 10.1007/s00431-006-0230-0; Yang JG, 2009, CLIN IMAG, V33, P439, DOI 10.1016/j.clinimag.2009.01.003; Zerbini MCN, 1997, MODERN PATHOL, V10, P793	37	30	38	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88268	10.1371/journal.pone.0088268	http://dx.doi.org/10.1371/journal.pone.0088268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505457	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200159
J	Small, CM; Ajithdoss, DK; Hoffmann, AR; Mwangi, W; Esteve-Gassent, MD				Small, Christina M.; Ajithdoss, Dharani K.; Hoffmann, Aline Rodrigues; Mwangi, Waithaka; Esteve-Gassent, Maria D.			Immunization with a Borrelia burgdorferi BB0172-Derived Peptide Protects Mice against Lyme Disease	PLOS ONE			English	Article							MURINE MODEL; ANTIBODY-RESPONSE; PUBLIC-HEALTH; ORAL VACCINE; SERODIAGNOSTIC TEST; DNA VACCINATION; GENE-EXPRESSION; BORNE DISEASES; A OSPA; TRANSMISSION	Lyme disease is the most prevalent arthropod borne disease in the US and it is caused by the bacterial spirochete Borrelia burgdorferi (Bb), which is acquired through the bite of an infected Ixodes tick. Vaccine development efforts focused on the von Willebrand factor A domain of the borrelial protein BB0172 from which four peptides (A, B, C and D) were synthesized and conjugated to Keyhole Limpet Hemocyanin, formulated in Titer Max (R) adjuvant and used to immunize C3H/HeN mice subcutaneously at days 0, 14 and 21. Sera were collected to evaluate antibody responses and some mice were sacrificed for histopathology to evaluate vaccine safety. Twenty-eight days post-priming, protection was evaluated by needle inoculation of half the mice in each group with 10(3) Bb/mouse, whereas the rest were challenged with 10(5) Bb/mouse. Eight weeks post-priming, another four groups of similarly immunized mice were challenged using infected ticks. In both experiments, twenty-one days post-challenge, the mice were sacrificed to determine antibody responses, bacterial burdens and conduct histopathology. Results showed that only mice immunized with peptide B were protected against challenge with Bb. In addition, compared to the other the treatment groups, peptide B-immunized mice showed very limited inflammation in the heart and joint tissues. Peptide B-specific antibody titers peaked at 8 weeks post-priming and surprisingly, the anti-peptide B antibodies did not cross-react with Bb lysates. These findings strongly suggest that peptide B is a promising candidate for the development of a new DIVA vaccine (Differentiate between Infected and Vaccinated Animals) for protection against Lyme disease.	[Small, Christina M.; Ajithdoss, Dharani K.; Hoffmann, Aline Rodrigues; Mwangi, Waithaka; Esteve-Gassent, Maria D.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Esteve-Gassent, MD (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.	MEsteve-Gassent@cvm.tamu.edu	Esteve-Gassent, Maria/AAF-2597-2020; rodrigues hoffmann, aline/L-6859-2017	Esteve-Gassent, Maria/0000-0001-5921-2794; rodrigues hoffmann, aline/0000-0001-6148-2531; Brock, Christina/0000-0001-9204-8252	American Heart Association [AHA-0825175F]; Scientist Developing Grant [11SDG4990006]; Texas A & M International Research Travel Award Grant	American Heart Association(American Heart Association); Scientist Developing Grant; Texas A & M International Research Travel Award Grant	Funding provided by American Heart Association post-doctoral fellowship (AHA-0825175F) and the Scientist Developing Grant (11SDG4990006) together with the Texas A & M International Research Travel Award Grant (to MDE-G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguita J, 2000, INFECT IMMUN, V68, P1222, DOI 10.1128/IAI.68.3.1222-1230.2000; Anguita J, 1998, J INFECT DIS, V178, P1512, DOI 10.1086/314448; Aronowitz RA, 2012, MILBANK Q, V90, P250, DOI 10.1111/j.1468-0009.2012.00663.x; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barthold SW, 2006, INFECT IMMUN, V74, P4817, DOI 10.1128/IAI.00469-06; Bhate C, 2011, J AM ACAD DERMATOL, V64, P639, DOI 10.1016/j.jaad.2010.03.047; Bhate C, 2011, J AM ACAD DERMATOL, V64, P619, DOI 10.1016/j.jaad.2010.03.046; Bhattacharya D, 2011, VACCINE, V29, P7818, DOI 10.1016/j.vaccine.2011.07.100; Bouchard KR, 2004, BIOL DIS VECTORS, P705; Brisbois BW, 2010, ECOHEALTH, V7, P425, DOI 10.1007/s10393-010-0354-6; Brown EL, 2005, VACCINE, V23, P3687, DOI 10.1016/j.vaccine.2005.02.006; CALLISTER SM, 1993, J INFECT DIS, V167, P158, DOI 10.1093/infdis/167.1.158; CALLISTER SM, 1994, ARCH INTERN MED, V154, P1625, DOI 10.1001/archinte.154.14.1625; Callister SM, 2004, CURR PROTOC CYTOM; Conlon J A, 2000, Vet Ther, V1, P96; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Day MJ, 2011, PARASITE VECTOR, V4, DOI [10.1186/1756-3305-4-49, 10.1186/1756-3305-4-48]; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Earnhart CG, 2007, HUM VACCINES, V3, P281, DOI 10.4161/hv.4661; Earnhart CG, 2007, CLIN VACCINE IMMUNOL, V14, P628, DOI 10.1128/CVI.00409-06; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; Esteve-Gassent MD, 2009, MOL MICROBIOL, V71, P594, DOI 10.1111/j.1365-2958.2008.06549.x; Gomes-Solecki MJC, 2006, VACCINE, V24, P4440, DOI 10.1016/j.vaccine.2005.08.089; Hamer SA, 2009, AM J VET RES, V70, P49, DOI 10.2460/ajvr.70.1.49; Hegde NR, 2011, DRUG DISCOV TODAY, V16, P1061, DOI 10.1016/j.drudis.2011.07.004; Henderson LM, 2005, BIOLOGICALS, V33, P203, DOI 10.1016/j.biologicals.2005.08.006; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Johansen P, 2010, J CONTROL RELEASE, V148, P56, DOI 10.1016/j.jconrel.2010.05.019; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kramer MD, 1996, INFECTION, V24, P190, DOI 10.1007/BF01713338; Kumar M, 2011, VACCINE, V29, P9012, DOI 10.1016/j.vaccine.2011.09.035; Kumar M, 2010, J INFECT DIS, V201, P1084, DOI 10.1086/651172; LaFleur RL, 2010, CLIN VACCINE IMMUNOL, V17, P870, DOI 10.1128/CVI.00524-09; LaFleur RL, 2009, CLIN VACCINE IMMUNOL, V16, P253, DOI 10.1128/CVI.00373-08; Lederer S, 2005, MED MICROBIOL IMMUN, V194, P81, DOI 10.1007/s00430-004-0218-1; Leschnik MW, 2010, CLIN VACCINE IMMUNOL, V17, P828, DOI 10.1128/CVI.00427-09; Levy Steven A, 2002, Vet Ther, V3, P420; Littman MP, 2006, J VET INTERN MED, V20, P422, DOI 10.1892/0891-6640(2006)20[422:ASACSO]2.0.CO;2; Livey I, 2011, CLIN INFECT DIS, V52, pS266, DOI 10.1093/cid/ciq118; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; Naas Turaya, 2010, Comp Hepatol, V9, P7, DOI 10.1186/1476-5926-9-7; Njongmeta LM, 2012, VACCINE, V30, P1624, DOI 10.1016/j.vaccine.2011.12.110; Olson PE, 2000, J VET DIAGN INVEST, V12, P126, DOI 10.1177/104063870001200204; Ostfeld RS, 2011, LYME DIS ECOLOGY COM, pxii; Padilla ML, 1996, J INFECT DIS, V174, P739, DOI 10.1093/infdis/174.4.739; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2003, MICROBES INFECT, V5, P659, DOI 10.1016/S1286-4579(03)00097-2; Pasick John, 2004, Animal Health Research Reviews, V5, P257, DOI 10.1079/AHR200479; Plotkin SA, 2011, CLIN INFECT DIS, V52, pS271, DOI 10.1093/cid/ciq119; Poland GA, 2011, CLIN INFECT DIS, V52, pS253, DOI 10.1093/cid/ciq116; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Richer LM, 2011, CLIN VACCINE IMMUNOL, V18, P1809, DOI 10.1128/CVI.05226-11; Richter D, 2010, APPL ENVIRON MICROB, V76, P7650, DOI 10.1128/AEM.01649-10; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Scheckelhoff MR, 2006, VACCINE, V24, P1949, DOI 10.1016/j.vaccine.2005.10.044; Scheiblhofer S, 2003, MICROBES INFECT, V5, P939, DOI 10.1016/S1286-4579(03)00182-5; Schutzer SE, 2003, J MOL MICROB BIOTECH, V5, P167, DOI 10.1159/000070267; Shen AK, 2011, CLIN INFECT DIS, V52, pS247, DOI 10.1093/cid/ciq115; Song JM, 2012, MOL THER, V20, P1472, DOI 10.1038/mt.2012.69; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; SUK KH, 1995, P NATL ACAD SCI USA, V92, P4269, DOI 10.1073/pnas.92.10.4269; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Tsao K, 2012, VECTOR BORNE ZOONOTI; Ullmann AJ, 2013, TICKS TICK-BORNE DIS, V4, P160, DOI 10.1016/j.ttbdis.2012.08.006; van der Maaden K, 2012, J CONTROL RELEASE, V161, P645, DOI 10.1016/j.jconrel.2012.01.042; van Oirschot JT, 1999, J BIOTECHNOL, V73, P195, DOI 10.1016/S0168-1656(99)00121-2; Vesely DL, 2009, INFECT IMMUN, V77, P1881, DOI 10.1128/IAI.00030-09; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Wagner B, 2012, PREV VET MED, V107, P275, DOI 10.1016/j.prevetmed.2012.07.002; Wallich R, 1996, INFECTION, V24, P396, DOI 10.1007/BF01716093; Weis JJ, 1999, J IMMUNOL, V162, P948; Wood E, 2013, J BACTERIOL, V195, P3320, DOI 10.1128/JB.00187-13; Xiao S, 2011, VACCINE, V29, P5294, DOI 10.1016/j.vaccine.2011.05.010; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	79	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88245	10.1371/journal.pone.0088245	http://dx.doi.org/10.1371/journal.pone.0088245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505447	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200151
J	Strang, S; Utikal, V; Fischbacher, U; Weber, B; Falk, A				Strang, Sabrina; Utikal, Verena; Fischbacher, Urs; Weber, Bernd; Falk, Armin			Neural Correlates of Receiving an Apology and Active Forgiveness: An fMRI Study	PLOS ONE			English	Article							PARIETAL JUNCTION; MIRROR NEURON; EMPATHY; OTHERS; INTENTIONS; MECHANISMS; QUALITY; EMOTION; PEOPLE	Interpersonal conflicts are a common element of many social relationships. One possible process in rebuilding social relationships is the act of apologizing. Behavioral studies have shown that apologies promote forgiveness. However, the neural bases of receiving an apology and forgiveness are still unknown. Hence, the aim of the present fMRI study was to investigate brain processes involved in receiving an apology and active forgiveness of an ambiguous offense. We asked one group of participants ( player A) to make decisions, which were either positive or negative for another group of participants ( player B). The intention of player A was ambiguous to player B. In case of a negative impact, participants in the role of player A could send an apology message to participants in the role of player B. Subsequently players B were asked whether they wanted to forgive player A for making a decision with negative consequences. We found that receiving an apology yielded activation in the left inferior frontal gyrus, the left middle temporal gyrus, and left angular gyrus. In line with previous research we found that forgiving judgments activated the right angular gyrus.	[Strang, Sabrina; Weber, Bernd; Falk, Armin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Utikal, Verena] Univ Erlangen Nurnberg, Dept Econ, Nurnberg, Germany; [Fischbacher, Urs] Univ Konstanz, Dept Econ, Constance, Germany; [Fischbacher, Urs] Thurgau Inst Econ, Kreuzlingen, Switzerland; [Weber, Bernd] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany; [Falk, Armin] Univ Bonn, Dept Econ, Bonn, Germany	University of Bonn; University of Erlangen Nuremberg; University of Konstanz; University of Bonn; University of Bonn	Strang, S (corresponding author), Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany.	strang@uni-bonn.de	Fischbacher, Urs/H-2693-2014; Weber, Bernd/H-5244-2012	Fischbacher, Urs/0000-0002-5115-8815; Weber, Bernd/0000-0002-7811-9605	German Science Foundation [SFB/TR15]; European Research Council; Deutsche Forschungsgemeinschaft (DFG) [WE 4427/3-1]; German Research Foundation (DFG) [FOR 1882]	German Science Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	Armin Falk was supported by the German Science Foundation (through SFB/TR15) and the European Research Council (Starting Grant); Bernd Weber was supported by the Deutsche Forschungsgemeinschaft (DFG) with a Heisenberg grant (WE 4427/3-1); Urs Fischbacher was supported by the German Research Foundation (DFG) through research unit FOR 1882 "Psychoeconomics.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler J, 2010, ECON LETT, V107, P233, DOI 10.1016/j.econlet.2010.01.033; Baumgartner T, 2014, SOC COGN AFFECT NEUR, V9, P653, DOI 10.1093/scan/nst023; BENNETT M, 1994, J SOC PSYCHOL, V134, P457, DOI 10.1080/00224545.1994.9712196; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Farrow TFD, 2005, PSYCHIAT RES-NEUROIM, V140, P45, DOI 10.1016/j.pscychresns.2005.05.012; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Fincham FD, 2002, PERS RELATIONSHIP, V9, P27, DOI 10.1111/1475-6811.00002; Fischbacher U, 2010, TWI RES PAP SER; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Greiner B., 2004, FORSCHUNG WISSENSCHA, V63, P79; Hayashi A, 2010, BRAIN RES, V1332, P90, DOI 10.1016/j.brainres.2010.03.045; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Macaskill A, 2002, J SOC PSYCHOL, V142, P663, DOI 10.1080/00224540209603925; McCullough M.E., 1997, FORGIVE IS HUMAN PUT; McCullough ME, 2003, J PERS SOC PSYCHOL, V84, P540, DOI 10.1037/0022-3514.84.3.540; McCullough ME, 1998, J PERS SOC PSYCHOL, V75, P1586, DOI 10.1037/0022-3514.75.6.1586; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Paleari FG, 2005, PERS SOC PSYCHOL B, V31, P368, DOI 10.1177/0146167204271597; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rameson LT, 2012, J COGNITIVE NEUROSCI, V24, P235, DOI 10.1162/jocn_a_00130; Rameson LT, 2009, SOC PERSONAL PSYCHOL, V3, P94, DOI 10.1111/j.1751-9004.2008.00154.x; Santiesteban I, 2012, CURR BIOL, V22, P2274, DOI 10.1016/j.cub.2012.10.018; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Scher SJ, 1997, J PSYCHOLINGUIST RES, V26, P127, DOI 10.1023/A:1025068306386; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Streit M, 1999, COGNITIVE BRAIN RES, V7, P481, DOI 10.1016/S0926-6410(98)00048-2; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Young L, 2009, NEUROPSYCHOLOGIA, V47, P2065, DOI 10.1016/j.neuropsychologia.2009.03.020; Zechmeister JS, 2002, J PERS SOC PSYCHOL, V82, P675, DOI 10.1037//0022-3514.82.4.675	38	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87654	10.1371/journal.pone.0087654	http://dx.doi.org/10.1371/journal.pone.0087654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505303	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200062
J	Yamamichi, N; Shimamoto, T; Sakaguchi, Y; Takahashi, Y; Kodashima, S; Nakayama, C; Minatsuki, C; Ono, S; Mochizuki, S; Matsuda, R; Asada-Hirayama, I; Niimi, K; Fujishiro, M; Tsuji, Y; Takeuchi, C; Kakimoto, H; Goto, O; Mitsushima, T; Koike, K				Yamamichi, Nobutake; Shimamoto, Takeshi; Sakaguchi, Yoshiki; Takahashi, Yu; Kodashima, Shinya; Nakayama, Chiemi; Minatsuki, Chihiro; Ono, Satoshi; Mochizuki, Satoshi; Matsuda, Rie; Asada-Hirayama, Itsuko; Niimi, Keiko; Fujishiro, Mitsuhiro; Tsuji, Yosuke; Takeuchi, Chihiro; Kakimoto, Hikaru; Goto, Osamu; Mitsushima, Toru; Koike, Kazuhiko			Categorization of Upper Gastrointestinal Symptoms Is Useful in Predicting Background Factors and Studying Effects and Usages of Digestive Drugs	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; PROTON PUMP INHIBITORS; PEPTIC-ULCER DISEASE; NONULCER DYSPEPSIA; PREVALENCE; POPULATION; ESOPHAGITIS; THERAPY; FSSG; QUESTIONNAIRE	Background: There have been very few reports assessing the relationship between various upper gastrointestinal (GI) symptoms or evaluating each individual upper GI symptom separately. Methods: Based on the answers to Frequency Scale for the Symptoms of GERD from a large-scale population of healthy adults in Japan, a hierarchical cluster analysis was performed to categorize the typical 12 upper GI symptoms. The associations between the 12 symptoms and 13 background factors were systematically analyzed among the 18,097 digestive drug-free subjects, 364 proton-pump inhibitor (PPI) users, and 528 histamine H-2-receptor antagonist (H(2)RA) users. Results: The derived relationship between the 12 upper GI symptoms suggests the five symptom categories: heartburn (2), dyspepsia (4), acid regurgitation (3), pharyngo-upper esophageal discomfort (2), and fullness while eating (1). Among the digestive drug-free subjects, inadequate sleep, weight gain in adulthood, NSAID use, meals immediately prior to sleep, and frequent skipping of breakfast showed significant positive association with most upper GI symptoms. Compared to the digestive drug-free subjects, significantly associated factors for PPI and H(2)RA users are respectively different in "4 of 5" and "5 of 5" symptoms in heartburn and acid regurgitation categories, "1 of 2" and "1 of 2" symptoms in pharyngo-upper esophageal discomfort category, and "0 of 5" and "3 of 5" symptoms in dyspepsia and fullness while eating categories. These differences between digestive drug-free subjects and gastric acid suppressant users seem to correlate with our experiences in clinical situations: heartburn and acid regurgitation category symptoms are effectively controlled with PPI and H(2)RA whereas other category symptoms are not. Conclusions: The 12 upper GI symptoms can be classified into five categories, which are statistically associated with various background factors. The differences of associated factors between digestive drug-free subjects and digestive drug users may be useful in studying the drug effects upon diverse upper GI symptoms.	[Yamamichi, Nobutake; Sakaguchi, Yoshiki; Takahashi, Yu; Kodashima, Shinya; Nakayama, Chiemi; Minatsuki, Chihiro; Ono, Satoshi; Mochizuki, Satoshi; Matsuda, Rie; Asada-Hirayama, Itsuko; Niimi, Keiko; Fujishiro, Mitsuhiro; Tsuji, Yosuke; Takeuchi, Chihiro; Kakimoto, Hikaru; Goto, Osamu; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Shimamoto, Takeshi; Mitsushima, Toru] Kameda Med Ctr, Dept Gastroenterol, Chiba, Japan	University of Tokyo	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	Ono, Satoshi/H-7900-2019; 藤城, 光弘/AAN-3131-2020; Ono, Satoshi/AFP-6208-2022; Takahashi, Yu/I-4665-2015	Ono, Satoshi/0000-0002-9864-348X; Takeuchi, Chihiro/0000-0002-2746-9189; Takahashi, Yu/0000-0002-3066-9501; Sakaguchi, Yoshiki/0000-0001-5078-3750	All Japan Coffee Association; Tokyo Society of Medical Sciences	All Japan Coffee Association(All Japan Coffee Association); Tokyo Society of Medical Sciences	This work was supported in part by a research grant from the All Japan Coffee Association, and in part by a research grant from the Tokyo Society of Medical Sciences. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Bernersen B, 1996, GUT, V38, P822, DOI 10.1136/gut.38.6.822; BERNERSEN B, 1990, GUT, V31, P989, DOI 10.1136/gut.31.9.989; Bredenoord AJ, 2013, LANCET, V381, P1933, DOI 10.1016/S0140-6736(12)62171-0; Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023; Danjo A, 2009, J GASTROEN HEPATOL, V24, P633, DOI 10.1111/j.1440-1746.2008.05747.x; Dominitz JA, 1999, AM J GASTROENTEROL, V94, P2086; El-Serag HB, 2004, ALIMENT PHARM THER, V19, P643, DOI 10.1111/j.1365-2036.2004.01897.x; Fujinami H, 2008, ALIMENT PHARM THER, V28, P1259, DOI 10.1111/j.1365-2036.2008.03842.x; Haag S, 2011, ALIMENT PHARM THER, V33, P722, DOI 10.1111/j.1365-2036.2010.04564.x; Hongo M, 2011, J GASTROENTEROL, V46, P297, DOI 10.1007/s00535-010-0342-1; Hungin APS, 2009, ALIMENT PHARM THER, V30, P331, DOI 10.1111/j.1365-2036.2009.04047.x; HUNT RH, 1995, EUR J GASTROEN HEPAT, V7, P685; Japanese Society of Gastroenterology, 2009, Nihon Shokakibyo Gakkai Zasshi, VSuppl Ishokudo Gyakuryusho, P1; JONES R, 1989, BRIT MED J, V298, P30, DOI 10.1136/bmj.298.6665.30; Kindt S, 2006, GUT, V55, P1685, DOI 10.1136/gut.2005.085365; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Kusano M, 2004, J GASTROENTEROL, V39, P888, DOI 10.1007/s00535-004-1417-7; Lacy BE, 2012, ALIMENT PHARM THER, V36, P3, DOI 10.1111/j.1365-2036.2012.05128.x; Manterola C, 2002, J CLIN EPIDEMIOL, V55, P1041, DOI 10.1016/S0895-4356(02)00454-7; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Moayyedi P, 2004, GASTROENTEROLOGY, V127, P1329, DOI 10.1053/j.gastro.2004.08.026; Moayyedi P, 2003, ALIMENT PHARM THER, V17, P1215, DOI 10.1046/j.1365-2036.2003.01575.x; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; Nagahara A, 2010, J GASTROEN HEPATOL, V25, pS122, DOI 10.1111/j.1440-1746.2009.06218.x; PETERSON WL, 1990, J CLIN GASTROENTEROL, V12, pS1, DOI 10.1097/00004836-199000000-00002; Ronkainen J, 2005, SCAND J GASTROENTERO, V40, P275, DOI 10.1080/00365520510011579; Rosenstock S, 1997, GUT, V41, P169, DOI 10.1136/gut.41.2.169; Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996; Sobieraj DM, 2011, AM J MANAG CARE, V17, pE449; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Takahashi Y, 2013, J GASTROENTEROL; Talley NJ, 1999, GUT, V45, P37; Vaezi MF, 2003, CLIN GASTROENTEROL H, V1, P333, DOI 10.1053/S1542-3565(03)00177-0; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Yamaji Y, 2001, GUT, V49, P335, DOI 10.1136/gut.49.3.335; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45; Zagari RM, 2008, GUT, V57, P1354, DOI 10.1136/gut.2007.145177; Zagari RM, 2010, GASTROENTEROLOGY, V138, P1302, DOI 10.1053/j.gastro.2009.12.057; ZELL S, 1987, AM J MED, V82, P796, DOI 10.1016/0002-9343(87)90017-9; Zeng F, 2011, GASTROENTEROLOGY, V141, P499, DOI 10.1053/j.gastro.2011.05.003; Zimmerman J, 2004, SCAND J GASTROENTERO, V39, P212, DOI 10.1080/00365520310005333	43	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88277	10.1371/journal.pone.0088277	http://dx.doi.org/10.1371/journal.pone.0088277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505461	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200163
J	Ebrahimzadeh, E; Pooyan, M; Bijar, A				Ebrahimzadeh, Elias; Pooyan, Mohammad; Bijar, Ahmad			A Novel Approach to Predict Sudden Cardiac Death (SCD) Using Nonlinear and Time-Frequency Analyses from HRV Signals	PLOS ONE			English	Article							MULTIPLE SOURCE SURVEILLANCE; HEART-RATE-VARIABILITY; DISEASE; ARREST; POPULATION; MORTALITY	Investigations show that millions of people all around the world die as the result of sudden cardiac death (SCD). These deaths can be reduced by using medical equipment, such as defibrillators, after detection. We need to propose suitable ways to assist doctors to predict sudden cardiac death with a high level of accuracy. To do this, Linear, Time-Frequency (TF) and Nonlinear features have been extracted from HRV of ECG signal. Finally, healthy people and people at risk of SCD are classified by k-Nearest Neighbor (k-NN) and Multilayer Perceptron Neural Network (MLP). To evaluate, we have compared the classification rates for both separate and combined Nonlinear and TF features. The results show that HRV signals have special features in the vicinity of the occurrence of SCD that have the ability to distinguish between patients prone to SCD and normal people. We found that the combination of Time-Frequency and Nonlinear features have a better ability to achieve higher accuracy. The experimental results show that the combination of features can predict SCD by the accuracy of 99.73%, 96.52%, 90.37% and 83.96% for the first, second, third and forth one-minute intervals, respectively, before SCD occurrence.	[Ebrahimzadeh, Elias; Pooyan, Mohammad; Bijar, Ahmad] Shahed Univ, Dept Biomed Engn, Tehran, Iran	Shahed University	Ebrahimzadeh, E (corresponding author), Shahed Univ, Dept Biomed Engn, Tehran, Iran.	ebrahimzadeh@shahed.ac.ir	Ebrahimzadeh, Elias/AAI-5553-2020; Ebrahimzadeh, Elias/AAB-6724-2022	Ebrahimzadeh, Elias/0000-0001-8682-936X				Acharya RA, 2004, MED BIOL ENG COMPUT, V42, P288, DOI 10.1007/BF02344702; [Anonymous], 2006, NON TEST PRED SUDD C; Azuaje F, 1997, COMPUT CARDIOL, V24, P53, DOI 10.1109/CIC.1997.647828; Bianchi AM, 1997, IEEE ENG MED BIOL, V16, P64, DOI 10.1109/51.620497; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Byrne R, 2008, EUR HEART J, V29, P1418, DOI 10.1093/eurheartj/ehn155; Camm AJ, 1996, CIRCULATION, V93, P1043; Chen X, 2000, CHINESE J ARRHYTHMIA, V4, P307; Chugh S.S., 2001, CARD ELECTROPHYSIOL, V5, P394, DOI DOI 10.1023/A:1013254132689; Chugh SS, 2004, J AM COLL CARDIOL, V44, P1268, DOI 10.1016/j.jacc.2004.06.029; Chugh SS, 2000, CIRCULATION, V102, P649, DOI 10.1161/01.CIR.102.6.649; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Claria F, 2000, P ANN INT IEEE EMBS, V22, P71, DOI 10.1109/IEMBS.2000.900671; Clifford G, 2006, ADV METHODS TOOLS EC; COVER TM, 1968, IEEE T INFORM THEORY, V14, P50, DOI 10.1109/TIT.1968.1054098; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Ebrahimzadeh E., 2013, J BIOMED SCI ENG, V6, P8, DOI 10.4236/jbise.2013.61002; Ebrahimzadeh E., 2011, J BIOMEDICAL SCI ENG, V4, P699, DOI DOI 10.4236/JBISE.2011.411087; Fang ZX, 2009, IEEE ENG MED BIO, P1738, DOI 10.1109/IEMBS.2009.5333088; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Huikuri HV, 2000, CIRCULATION, V101, P47, DOI 10.1161/01.CIR.101.1.47; Ichimaru Y, 1988, P COMPUTERS CARDIOLO, P315; Iyengar N, 1996, AM J PHYSIOL-REG I, V271, pR1078, DOI 10.1152/ajpregu.1996.271.4.R1078; Jasson S, 1997, CIRCULATION, V96, P3521; Jones JL, 1996, P IEEE, V84, P392, DOI 10.1109/5.486742; Joo S, 2012, EXPERT SYST APPL, V39, P3862, DOI 10.1016/j.eswa.2011.09.097; Keselbrener L, 1996, IEEE T BIO-MED ENG, V43, P789, DOI 10.1109/10.508542; KURTHS J, 1995, CHAOS, V5, P88, DOI 10.1063/1.166090; Kutlu Y, 2012, COMPUT METH PROG BIO, V105, P257, DOI 10.1016/j.cmpb.2011.10.002; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mainardi LT, 2004, METHOD INFORM MED, V43, P17; Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8; MARTIN W, 1985, IEEE T ACOUST SPEECH, V33, P1461, DOI 10.1109/TASSP.1985.1164760; Martinmaki K, 2006, AM J PHYSIOL-HEART C, V290, pH2582, DOI 10.1152/ajpheart.00058.2005; Mohebbi M, 2008, IEEE ENG MED BIO, P177, DOI 10.1109/IEMBS.2008.4649119; Mrowka R, 1998, COMPUT CARDIOL, V25, P725, DOI 10.1109/CIC.1998.731976; Myerburg RJ, 2005, HEART DIS TXB CARDIO; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; NOVAK P, 1993, MED BIOL ENG COMPUT, V31, P103, DOI 10.1007/BF02446667; Obayya Marwa, 2008, 2008 International Conference on Computer Engineering & Systems (ICCES '08), P67, DOI 10.1109/ICCES.2008.4772968; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pola S, 1996, IEEE T BIO-MED ENG, V43, P46, DOI 10.1109/10.477700; Priori SG, 1997, CIRCULATION, V95, P265; Shen TW, 2007, P ANN INT IEEE EMBS, P2575, DOI 10.1109/IEMBS.2007.4352855; Suri JS, 2009, ADV CARDIAC SIGNAL P; Toledo E, 2003, AM J PHYSIOL-REG I, V284, pR1079, DOI 10.1152/ajpregu.00287.2002; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Vaillancourt C, 2004, CAN J CARDIOL, V20, P1081; VanHoogenhuyze D, 1989, P COMPUT CARDIOL, P65; Vapnik V., 1998, STAT LEARNING THEORY; WEVER EFD, 1993, CIRCULATION, V88, P1021, DOI 10.1161/01.CIR.88.3.1021; Yeh RG, 2006, BIOMED ENG-APP BAS C, V18, DOI 10.4015/S1016237206000130; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	57	70	73	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e81896	10.1371/journal.pone.0081896	http://dx.doi.org/10.1371/journal.pone.0081896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504331	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800001
J	Miller, LL; Pembrey, M; Smith, GD; Northstone, K; Golding, J				Miller, Laura L.; Pembrey, Marcus; Smith, George Davey; Northstone, Kate; Golding, Jean			Is the Growth of the Fetus of a Non-Smoking Mother Influenced by the Smoking of Either Grandmother while Pregnant?	PLOS ONE			English	Article							BIRTH-WEIGHT; MATERNAL SMOKING; EXPOSURE; PARENTS; SEX; NUTRITION; MORTALITY; CHILDREN; COHORT; ASTHMA	Background: There are animal data that indicate that prenatal environmental exposures have sex-specific effects on subsequent generations. In humans, an increase in birthweight has been reported if the maternal grandmother had smoked in the pregnancy giving rise to the mother. Here we assess whether prenatal exposure of either parent to cigarette smoke has a sex-specific effect on the grandchild's birth measurements. Methods: Information from 12707 maternal and 9677 paternal grandmothers of children in the Avon Longitudinal Study of Parents and Children (ALSPAC) concerned whether they had smoked while expecting the study parent. Study children were weighed and measured at birth. Analyses to test effects of grandmaternal prenatal smoking used multiple regression allowing for several potential confounders; analyses were restricted to births to non-smoking study mothers. Findings: After adjustment, the average birthweight, birth length and BMI measurements of the grandsons (but not granddaughters) were greater if the maternal grandmother smoked prenatally: birthweight = +61 [95% CI +30, +92] g; birth length = +0.19 [95% CI +0.02, +0.35] cm; BMI = +1.6 [95% CI +0.6, +2.6] g/m(2). Similar effects were seen in births to primiparae and multiparae. Additional allowance for maternal birthweight resulted in an average increase in boys to +100 g [95% CI +61, +140] g. There were no fetal growth differences if the paternal grandmother had smoked prenatally. Conclusions: The evidence from this study suggests that when the mother does not smoke in pregnancy the maternal grandmother's smoking habit in pregnancy has a positive association with her grandson's fetal growth.	[Miller, Laura L.; Pembrey, Marcus; Smith, George Davey; Northstone, Kate; Golding, Jean] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Pembrey, Marcus] UCL, Inst Child Hlth, London, England	University of Bristol; University of London; University College London	Golding, J (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Jean.Golding@bristol.ac.uk	Davey Smith, George/A-7407-2013; Northstone, Kate/A-8165-2011	Davey Smith, George/0000-0002-1407-8314; Northstone, Kate/0000-0002-0602-1983; Golding, Jean/0000-0003-2826-3307; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Medical Research Council [G1100226]; MRC [MC_UU_12013/1, G1100226] Funding Source: UKRI; Medical Research Council [G9815508, MC_UU_12013/1, MC_PC_15018] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (www.mrc.ac.uk), the Wellcome Trust (www.Wellcome.ac.uk) and the University of Bristol (www.bristol.ac.uk) currently provide core support for ALSPAC. The statistical analyses for this project were undertaken with funding from the Medical Research Council (grant no. G1100226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cole TJ, 1997, ANN HUM BIOL, V24, P289, DOI 10.1080/03014469700005032; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hypponen E, 2003, BMJ-BRIT MED J, V327, P898, DOI 10.1136/bmj.327.7420.898; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Lawlor DA, 2002, AM J EPIDEMIOL, V156, P1100, DOI 10.1093/aje/kwf154; Lewis S, 1996, THORAX, V51, P670, DOI 10.1136/thx.51.7.670; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Misra DP, 2005, EPIDEMIOLOGY, V16, P288, DOI 10.1097/01.ede.0000158198.59544.cf; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rehan VK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-129; Rillamas-Sun E, 2010, THESIS U MICHIGAN, P92; SIMPSON WJ, 1957, AM J OBSTET GYNECOL, V73, P808, DOI 10.1016/0002-9378(57)90391-5; Susser E, 2012, ANNU REV ANTHROPOL, V41, P577, DOI 10.1146/annurev-anthro-081309-145645; Syddall HE, 2005, AM J EPIDEMIOL, V161, P1074, DOI 10.1093/aje/kwi137; The Surgeon General's Advisory Committee on Smoking and Health, 1964, SURG GEN ADV COMM SM; Vedhara K, 2012, J NEUROENDOCRINOL, V24, P999, DOI 10.1111/j.1365-2826.2012.02309.x; Zaren B, 2000, PAEDIATR PERINAT EP, V14, P118, DOI 10.1046/j.1365-3016.2000.00247.x; Zeybel M, 2012, NAT MED, V18, P1369, DOI 10.1038/nm.2893	24	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e86781	10.1371/journal.pone.0086781	http://dx.doi.org/10.1371/journal.pone.0086781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504157	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800012
J	Resasco, J; Pelini, SL; Stuble, KL; Sanders, NJ; Dunn, RR; Diamond, SE; Ellison, AM; Gotelli, NJ; Levey, DJ				Resasco, Julian; Pelini, Shannon L.; Stuble, Katharine L.; Sanders, Nathan J.; Dunn, Robert R.; Diamond, Sarah E.; Ellison, Aaron M.; Gotelli, Nicholas J.; Levey, Douglas J.			Using Historical and Experimental Data to Reveal Warming Effects on Ant Assemblages	PLOS ONE			English	Article							SOLENOPSIS-INVICTA HYMENOPTERA; CLIMATE-CHANGE; DIVERSITY GRADIENTS; GLOBAL CHANGE; BOTTOM-UP; TOP-DOWN; FIRE ANT; RESPONSES; COMMUNITY; TEMPERATURE	Historical records of species are compared with current records to elucidate effects of recent climate change. However, confounding variables such as succession, land-use change, and species invasions make it difficult to demonstrate a causal link between changes in biota and changes in climate. Experiments that manipulate temperature can overcome this issue of attribution, but long-term impacts of warming are difficult to test directly. Here we combine historical and experimental data to explore effects of warming on ant assemblages in southeastern US. Observational data span a 35-year period (1976-2011), during which mean annual temperatures had an increasing trend. Mean summer temperatures in 2010-2011 were similar to 2.7 degrees C warmer than in 1976. Experimental data come from an ongoing study in the same region, for which temperatures have been increased similar to 1.5-5.5 degrees C above ambient from 2010 to 2012. Ant species richness and evenness decreased with warming under natural but not experimental warming. These discrepancies could have resulted from differences in timescales of warming, abiotic or biotic factors, or initial species pools. Species turnover tended to increase with temperature in observational and experimental datasets. At the species level, the observational and experimental datasets had four species in common, two of which exhibited consistent patterns between datasets. With natural and experimental warming, collections of the numerically dominant, thermophilic species, Crematogaster lineolata, increased roughly twofold. Myrmecina americana, a relatively heat intolerant species, decreased with temperature in natural and experimental warming. In contrast, species in the Solenopsis molesta group did not show consistent responses to warming, and Temenothorax pergandei was rare across temperatures. Our results highlight the difficulty of interpreting community responses to warming based on historical records or experiments alone. Because some species showed consistent responses to warming based on thermal tolerances, understanding functional traits may prove useful in explaining responses of species to warming.	[Resasco, Julian] Univ Florida, Dept Biol, Gainesville, FL USA; [Pelini, Shannon L.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Stuble, Katharine L.; Sanders, Nathan J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Dunn, Robert R.; Diamond, Sarah E.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Ellison, Aaron M.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT USA; [Levey, Douglas J.] Natl Sci Fdn, Arlington, VA 22230 USA	State University System of Florida; University of Florida; University System of Ohio; Bowling Green State University; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina State University; Harvard University; University of Vermont; National Science Foundation (NSF)	Resasco, J (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	jresasco@colorado.edu	Sanders, Nathan/A-6945-2009; Sanders, Nathan/ABE-4335-2020	Sanders, Nathan/0000-0001-6220-6731; Resasco, Julian/0000-0003-1605-3038; Dunn, Robert/0000-0002-6030-4837; Ellison, Aaron/0000-0003-4151-6081	National Science Foundation Graduate Research Fellowship [DGE-0802270]; National Science Foundation Dissertation Improvement Grant [NSF- 1208974]; US Department of Energy PER award [DEFG02-08ER64510]; National Science Foundation Dimensions of Biodiversity grant [NSF-1136703]; University of Colorado Boulder Libraries Open Access Fund; Division Of Environmental Biology [0953390] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1309192] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation Dissertation Improvement Grant(National Science Foundation (NSF)); US Department of Energy PER award(United States Department of Energy (DOE)); National Science Foundation Dimensions of Biodiversity grant(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); University of Colorado Boulder Libraries Open Access Fund; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by a National Science Foundation Graduate Research Fellowship (DGE-0802270) to JR, a National Science Foundation Dissertation Improvement Grant (NSF- 1208974) to KS, a US Department of Energy PER award (DEFG02-08ER64510) to RRD, NJS, AME, and NJG, and a National Science Foundation Dimensions of Biodiversity grant (NSF-1136703) to NJS, RRD, AME, and NJG. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 1995, NEW GEN CATALOGUE AN; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Bestelmeyer BT, 2000, ANTS STANDARD METHOD; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Colwell RK, 2013, ESTIMATES STAT ESTIM; Damschen EI, 2010, ECOLOGY, V91, P3609, DOI 10.1890/09-1057.1; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Diamond SE, 2013, INTEGR COMP BIOL, V53, P965, DOI 10.1093/icb/ict085; Diamond SE, 2012, ECOLOGY, V93, P2305, DOI 10.1890/11-2296.1; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Dunn RR, 2007, ECOL ENTOMOL, V32, P135, DOI 10.1111/j.1365-2311.2006.00839.x; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Dunn RR, 2004, CONSERV BIOL, V18, P302, DOI 10.1111/j.1523-1739.2004.00151.x; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Gotelli NJ, 2011, MYRMECOL NEWS, V15, P13; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Holldobler B., 1990, pi; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jochum M, 2012, PHILOS T R SOC B, V367, P2962, DOI 10.1098/rstb.2012.0237; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Kaspari M, 2003, AM NAT, V161, P459, DOI 10.1086/367906; Korzukhin MD, 2001, ENVIRON ENTOMOL, V30, P645, DOI 10.1603/0046-225X-30.4.645; MacGown J, 2013, ANTS FORMICIDAE SE U; Morrison LW, 2004, BIOL INVASIONS, V6, P183, DOI 10.1023/B:BINV.0000022135.96042.90; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelini SL, 2012, ECOL EVOL, V2, P3009, DOI 10.1002/ece3.407; Pelini SL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00097.1; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; PORTER SD, 1988, J INSECT PHYSIOL, V34, P1127, DOI 10.1016/0022-1910(88)90215-6; PORTER SD, 1987, ENVIRON ENTOMOL, V16, P802, DOI 10.1093/ee/16.3.802; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Resasco J, 2013, THESIS U FLORIDA GAI; Robinson WD, 1999, CONSERV BIOL, V13, P85, DOI 10.1046/j.1523-1739.1999.97492.x; Romo CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058136; Ruano F, 2000, BEHAV ECOL, V11, P396, DOI 10.1093/beheco/11.4.396; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Shurin JB, 2012, PHILOS T R SOC B, V367, P3008, DOI 10.1098/rstb.2012.0243; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Smith VG, 1928, ECOLOGY, V9, P479, DOI 10.2307/1929416; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; Stuble KL, 2013, THESIS U TENNESSEE K; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Van Pelt AF, 1985, SRONERP14156; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Woodcock BA, 2005, METH ECOL, P37, DOI 10.1002/9780470750513.ch3; Workman SW, 1990, SRONERP191137	57	20	20	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88029	10.1371/journal.pone.0088029	http://dx.doi.org/10.1371/journal.pone.0088029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505364	Green Published, gold			2022-12-27	WOS:000336971300040
J	Roos, J; Bejai, S; Oide, S; Dixelius, C				Roos, Jonas; Bejai, Sarosh; Oide, Shinichi; Dixelius, Christina			RabGAP22 Is Required for Defense to the Vascular Pathogen Verticillium longisporum and Contributes to Stomata Immunity	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; LIGAND-INDUCED ENDOCYTOSIS; INNATE IMMUNITY; BRASSINOSTEROID RECEPTORS; SUBCELLULAR-LOCALIZATION; ANTAGONISTIC INTERACTION; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; NONHOST RESISTANCE; GENE-EXPRESSION	Verticillium longisporum is a soil-borne pathogen with a preference for plants within the family Brassicaceae. Following invasion of the roots, the fungus proliferates in the plant vascular system leading to stunted plant growth, chlorosis and premature senescence. RabGTPases have been demonstrated to play a crucial role in regulating multiple responses in plants. Here, we report on the identification and characterization of the Rab GTPase-activating protein RabGAP22 gene from Arabidopsis, as an activator of multiple components in the immune responses to V. longisporum. RabGAP22(Pro): GUS transgenic lines showed GUS expression predominantly in root meristems, vascular tissues and stomata, whereas the RabGAP22 protein localized in the nucleus. Reduced RabGAP22 transcript levels in mutants of the brassinolide (BL) signaling gene BRI1-ASSOCIATED RECEPTOR KINASE 1, together with a reduction of fungal proliferation following BL pretreatment, suggested RabGAP22 to be involved in BL-mediated responses. Pull-down assays revealed SERINE: GLYOXYLATE AMINOTRANSFERASE (AGT1) as an interacting partner during V. longisporum infection and bimolecular fluorescence complementation (BiFC) showed the RabGAP22-AGT1 protein complex to be localized in the peroxisomes. Further, fungal-induced RabGAP22 expression was found to be associated with elevated endogenous levels of the plant hormones jasmonic acid (JA) and abscisic acid (ABA). An inadequate ABA response in rabgap22-1 mutants, coupled with a stomata-localized expression of RabGAP22 and impairment of guard cell closure in response to V. longisporum and Pseudomonas syringae, suggest that RabGAP22 has multiple roles in innate immunity.	[Roos, Jonas; Bejai, Sarosh; Dixelius, Christina] Swedish Univ Agr Sci, Dept Plant Biol, Linnean Ctr Plant Biol, Uppsala, Sweden; [Oide, Shinichi] Res Inst Innovat Technol Earth, Mol Microbiol & Biotechnol Grp, Kyoto, Japan	Swedish University of Agricultural Sciences; Research Institute of Innovative Technology for the Earth	Roos, J (corresponding author), Swedish Univ Agr Sci, Dept Plant Biol, Linnean Ctr Plant Biol, Uppsala, Sweden.	Jonas.Roos@slu.se			Nilsson-Ehle foundation; Helge Ax:son Johnson foundation; Memory of Oscar and Lili Lamm foundation; Research Councils VR; Formas; Swedish University of Agricultural Sciences	Nilsson-Ehle foundation; Helge Ax:son Johnson foundation; Memory of Oscar and Lili Lamm foundation; Research Councils VR; Formas(Swedish Research Council Formas); Swedish University of Agricultural Sciences	This work was supported by the following foundations: Nilsson-Ehle (http://www.fysiografen.se), Helge Ax:son Johnson (http://www.haxsonj.se/), Memory of Oscar and Lili Lamm (http://www.stiftelsenlamm.a.se/); the Research Councils VR (http://www.vr.se/) and Formas (http://www.formas.se/); and the Swedish University of Agricultural Sciences (http://www.slu.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2009, PLANT MOL BIOL, V69, P451, DOI 10.1007/s11103-008-9427-0; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Bar M, 2009, PLANT J, V59, P600, DOI 10.1111/j.1365-313X.2009.03897.x; BasuRay S, 2013, J BIOL CHEM, V288, P1135, DOI 10.1074/jbc.M112.417766; Bhadauria V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036266; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Bohman S, 2004, PLANT J, V37, P9, DOI 10.1046/j.1365-313X.2003.01927.x; Borck G, 2011, HUM GENET, V129, P45, DOI 10.1007/s00439-010-0896-2; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chitrakar Reejana, 2010, J Vis Exp, DOI 10.3791/2185; Cui S, 2013, J BIOL CHEM, V288, P6014, DOI 10.1074/jbc.M112.438143; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Fahleson J, 2003, EUR J PLANT PATHOL, V109, P361, DOI 10.1023/A:1023534005538; Floerl S, 2010, J PLANT PATHOL, V92, P693; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fridborg I, 2013, J EXP BOT, V64, P935, DOI 10.1093/jxb/ers372; Gabernet-Castello C, 2013, MOL BIOL CELL, V24, P1574, DOI 10.1091/mbc.E12-07-0557; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; Gronemeyer T, 2013, FEBS LETT, V587, P328, DOI 10.1016/j.febslet.2012.12.025; Happstadius I, 2003, PLANT BREEDING, V122, P30, DOI 10.1046/j.1439-0523.2003.00774.x; Heo JB, 2005, PLANT CELL PHYSIOL, V46, P2005, DOI 10.1093/pcp/pci215; Hong MJ, 2013, BIOCHEM BIOPH RES CO, V434, P797, DOI 10.1016/j.bbrc.2013.04.014; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeong YJ, 2010, MOL CELLS, V29, P259, DOI 10.1007/s10059-010-0024-0; Jiang SY, 2006, PHYSIOL GENOMICS, V24, P235, DOI 10.1152/physiolgenomics.00210.2005; Johansson A, 2006, EUR J PLANT PATHOL, V114, P139, DOI 10.1007/s10658-005-2333-2; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kaundal R, 2010, PLANT PHYSIOL, V154, P36, DOI 10.1104/pp.110.156851; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Kwon SI, 2009, J PLANT BIOL, V52, P79, DOI 10.1007/s12374-009-9011-4; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Lee S, 2013, PEERJ, V1, DOI 10.7717/peerj.34; Li M, 2010, EUR J CELL BIOL, V89, P126, DOI 10.1016/j.ejcb.2009.10.012; Li ZX, 2012, FEBS LETT, V586, P1253, DOI 10.1016/j.febslet.2012.03.040; Li ZX, 2012, J INTEGR PLANT BIOL, V54, P169, DOI 10.1111/j.1744-7909.2012.01100.x; Liepman AH, 2001, PLANT J, V25, P487, DOI 10.1046/j.1365-313x.2001.00961.x; Liu PP, 2011, PLANT PHYSIOL, V155, P1762, DOI 10.1104/pp.110.171694; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longatti A, 2012, J CELL BIOL, V197, P659, DOI 10.1083/jcb.201111079; Lopez A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002434; Martin TD, 2012, J BIOL CHEM, V287, P14827, DOI 10.1074/jbc.M112.344986; Martin T, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-151; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Millet YA, 2010, PLANT CELL, V22, P973, DOI 10.1105/tpc.109.069658; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Montillet JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001513; Moschou PN, 2008, PHYSIOL PLANTARUM, V133, P140, DOI 10.1111/j.1399-3054.2008.01049.x; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oide S, 2013, NEW PHYTOL, V200, P1187, DOI 10.1111/nph.12436; Ralhan A, 2012, PLANT PHYSIOL, V159, P1192, DOI 10.1104/pp.112.198598; Reusche M, 2012, PLANT CELL, V24, P3823, DOI 10.1105/tpc.112.103374; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Rozen S, 2000, Methods Mol Biol, V132, P365; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Saito C, 2009, INT REV CEL MOL BIO, V274, P183, DOI 10.1016/S1937-6448(08)02004-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuetze Katia, 2009, V479, P189, DOI 10.1007/978-1-59745-289-2_12; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Son YS, 2013, PLANT SCI, V198, P58, DOI 10.1016/j.plantsci.2012.09.003; Sorhagen K, 2013, PLANT BIOLOGY, V15, P723, DOI 10.1111/j.1438-8677.2012.00723.x; Steventon LA, 2002, MYCOL RES, V106, P570, DOI 10.1017/S0953756202005865; Steventon LA, 2001, J PHYTOPATHOL, V149, P395, DOI 10.1046/j.1439-0434.2001.00643.x; Taler D, 2004, PLANT CELL, V16, P172, DOI 10.1105/tpc.016352; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uma B, 2011, J PLANT PHYSIOL, V168, P2141, DOI 10.1016/j.jplph.2011.09.005; Wang GD, 2008, PLANT PHYSIOL, V147, P503, DOI 10.1104/pp.108.119487; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zhang QY, 2013, PHYTOCHEMISTRY, V85, P30, DOI 10.1016/j.phytochem.2012.09.017; Zheng XY, 2012, CELL HOST MICROBE, V11, P587, DOI 10.1016/j.chom.2012.04.014; Zhou L, 2006, PLANT PATHOL, V55, P137, DOI 10.1111/j.1365-3059.2005.01311.x	92	24	28	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88187	10.1371/journal.pone.0088187	http://dx.doi.org/10.1371/journal.pone.0088187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505423	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300069
J	Berardis, S; Lombard, C; Evraerts, J; El Taghdouini, A; Rosseels, V; Sancho-Bru, P; Lozano, JJ; van Grunsven, L; Sokal, E; Najimi, M				Berardis, Silvia; Lombard, Catherine; Evraerts, Jonathan; El Taghdouini, Adil; Rosseels, Valerie; Sancho-Bru, Pau; Jose Lozano, Juan; van Grunsven, Leo; Sokal, Etienne; Najimi, Mustapha			Gene Expression Profiling and Secretome Analysis Differentiate Adult-Derived Human Liver Stem/Progenitor Cells and Human Hepatic Stellate Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEPATOCYTE GROWTH-FACTOR; MOLECULE N-CAM; RAT-LIVER; BONE-MARROW; ACTIVATION; TISSUE; CHEMOKINES; MIGRATION; HGF	Adult-derived human liver stem/progenitor cells (ADHLSC) are obtained after primary culture of the liver parenchymal fraction. The cells are of fibroblastic morphology and exhibit a hepato-mesenchymal phenotype. Hepatic stellate cells (HSC) derived from the liver non-parenchymal fraction, present a comparable morphology as ADHLSC. Because both ADHLSC and HSC are described as liver stem/progenitor cells, we strived to extensively compare both cell populations at different levels and to propose tools demonstrating their singularity. ADHLSC and HSC were isolated from the liver of four different donors, expanded in vitro and followed from passage 5 until passage 11. Cell characterization was performed using immunocytochemistry, western blotting, flow cytometry, and gene microarray analyses. The secretion profile of the cells was evaluated using Elisa and multiplex Luminex assays. Both cell types expressed alpha-smooth muscle actin, vimentin, fibronectin, CD73 and CD90 in accordance with their mesenchymal origin. Microarray analysis revealed significant differences in gene expression profiles. HSC present high expression levels of neuronal markers as well as cytokeratins. Such differences were confirmed using immunocytochemistry and western blotting assays. Furthermore, both cell types displayed distinct secretion profiles as ADHLSC highly secreted cytokines of therapeutic and immuno-modulatory importance, like HGF, interferon-gamma and IL-10. Our study demonstrates that ADHLSC and HSC are distinct liver fibroblastic cell populations exhibiting significant different expression and secretion profiles.	[Berardis, Silvia; Lombard, Catherine; Evraerts, Jonathan; Rosseels, Valerie; Sokal, Etienne; Najimi, Mustapha] Catholic Univ Louvain, IREC, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium; [El Taghdouini, Adil; van Grunsven, Leo] Vrije Univ Brussel, Dept Cell Biol, Liver Cell Biol Lab, Brussels, Belgium; [Sancho-Bru, Pau; Jose Lozano, Juan] IDIBAPS, CIBERehd, Hosp Clin, Liver Unit, Barcelona, Spain	Universite Catholique Louvain; Vrije Universiteit Brussel; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Najimi, M (corresponding author), Catholic Univ Louvain, IREC, Lab Pediat Hepatol & Cell Therapy, B-1200 Brussels, Belgium.	mustapha.najimi@uclouvain.be	van Grunsven, Leo/E-5839-2010; Sancho-Bru, Pau/D-4900-2014	van Grunsven, Leo/0000-0002-0990-7034; Lombard, Catherine/0000-0002-5653-9545; Lozano, Juan Jose/0000-0001-7613-3908; Sancho-Bru, Pau/0000-0001-5569-9259; Sokal, Etienne/0000-0001-5597-4708	Region Bruxelloise; Innoviris (BruStem project); FNRS	Region Bruxelloise(Innoviris); Innoviris (BruStem project)(Innoviris); FNRS(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Region Bruxelloise, Innoviris (BruStem project) and FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankoma-Sey V, 1998, ONCOGENE, V17, P115, DOI 10.1038/sj.onc.1201912; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Bedossa P, 2002, LAB INVEST, V82, P1053, DOI 10.1097/01.LAB.0000024429.73158.DE; Binger T, 2009, EXP CELL RES, V315, P1468, DOI 10.1016/j.yexcr.2008.12.022; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Bockhorn M, 2007, J SURG RES, V138, P291, DOI 10.1016/j.jss.2006.07.027; Chen XG, 2010, GENOME, V53, P608, DOI [10.1139/G10-040, 10.1139/g10-040]; Colazzo F, 2011, BIOMATERIALS, V32, P119, DOI 10.1016/j.biomaterials.2010.09.003; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Khuu DN, 2013, CELL TRANSPLANT, V22, P1369, DOI 10.3727/096368912X659853; Khuu DN, 2011, CELL TRANSPLANT, V20, P287, DOI 10.3727/096368910X516655; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Fox SE, 2005, CYTOKINE, V29, P135, DOI 10.1016/j.cyto.2004.10.007; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Han GW, 2012, INT J BIOL SCI, V8, P228, DOI 10.7150/ijbs.8.228; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Horiguchi K, 2009, J HEPATO-BILIARY-PAN, V16, P171, DOI 10.1007/s00534-008-0029-7; Inoue H, 2006, INT J MOL MED, V17, P857; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jung KH, 2009, LIVER INT, V29, P898, DOI 10.1111/j.1478-3231.2009.02031.x; Knittel T, 1996, AM J PATHOL, V149, P449; Koike H, 2012, J HEPATO-BIL-PAN SCI, V19, P587, DOI 10.1007/s00534-012-0544-4; Kordes C, 2007, BIOCHEM BIOPH RES CO, V352, P410, DOI 10.1016/j.bbrc.2006.11.029; Ku CH, 2006, CARDIOVASC RES, V71, P548, DOI 10.1016/j.cardiores.2006.03.022; Kwiecinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024568; Lee JH, 2012, CELL TISSUE RES, V348, P475, DOI 10.1007/s00441-012-1392-x; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; Nakatani K, 1996, CELL TISSUE RES, V283, P159; NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643; Narmada BC, 2013, J CELL PHYSIOL, V228, P393, DOI 10.1002/jcp.24143; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Niki T, 1999, HEPATOLOGY, V29, P520, DOI 10.1002/hep.510290232; Novo E, 2007, AM J PATHOL, V170, P1942, DOI 10.2353/ajpath.2007.060887; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567; Ramadori G, 2002, LIVER, V22, P283, DOI 10.1034/j.1600-0676.2002.01726.x; Reich N, 2011, J CELL MOL MED, V15, P756, DOI 10.1111/j.1582-4934.2010.01051.x; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sana G, 2013, CELL TRANSP IN PRESS; Sancho-Bru P, 2005, J HEPATOL, V43, P272, DOI 10.1016/j.jhep.2005.02.035; Sato M, 2003, CELL STRUCT FUNCT, V28, P105; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shohara R, 2012, CYTOTHERAPY, V14, P1171, DOI 10.3109/14653249.2012.706705; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347	55	44	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86137	10.1371/journal.pone.0086137	http://dx.doi.org/10.1371/journal.pone.0086137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	24516514	Green Published, Green Submitted, gold			2022-12-27	WOS:000330244500193
J	de Castro-Miro, M; Pomares, E; Lores-Motta, L; Tonda, R; Dopazo, J; Marfany, G; Gonzalez-Duarte, R				de Castro-Miro, Marta; Pomares, Esther; Lores-Motta, Laura; Tonda, Raul; Dopazo, Joaquin; Marfany, Gemma; Gonzalez-Duarte, Roser			Combined Genetic and High-Throughput Strategies for Molecular Diagnosis of Inherited Retinal Dystrophies	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; BARDET-BIEDL SYNDROME; USH2A GENE; MUTATION SPECTRUM; SPANISH PATIENTS; MESSENGER-RNA; REVEALS; ACCURATE; PREDICTION; DISCOVERY	Most diagnostic laboratories are confronted with the increasing demand for molecular diagnosis from patients and families and the ever-increasing genetic heterogeneity of visual disorders. Concerning Retinal Dystrophies (RD), almost 200 causative genes have been reported to date, and most families carry private mutations. We aimed to approach RD genetic diagnosis using all the available genetic information to prioritize candidates for mutational screening, and then restrict the number of cases to be analyzed by massive sequencing. We constructed and optimized a comprehensive cosegregation RD-chip based on SNP genotyping and haplotype analysis. The RD-chip allows to genotype 768 selected SNPs (closely linked to 100 RD causative genes) in a single cost-, time-effective step. Full diagnosis was attained in 17/36 Spanish pedigrees, yielding 12 new and 12 previously reported mutations in 9 RD genes. The most frequently mutated genes were USH2A and CRB1. Notably, RD3-up to now only associated to Leber Congenital Amaurosis-was identified as causative of Retinitis Pigmentosa. The main assets of the RD-chip are: i) the robustness of the genetic information that underscores the most probable candidates, ii) the invaluable clues in cases of shared haplotypes, which are indicative of a common founder effect, and iii) the detection of extended haplotypes over closely mapping genes, which substantiates cosegregation, although the assumptions in which the genetic analysis is based could exceptionally lead astray. The combination of the genetic approach with whole exome sequencing (WES) greatly increases the diagnosis efficiency, and revealed novel mutations in USH2A and GUCY2D. Overall, the RD-chip diagnosis efficiency ranges from 16% in dominant, to 80% in consanguineous recessive pedigrees, with an average of 47%, well within the upper range of massive sequencing approaches, highlighting the validity of this time-and cost-effective approach whilst high-throughput methodologies become amenable for routine diagnosis in medium sized labs.	[de Castro-Miro, Marta; Pomares, Esther; Lores-Motta, Laura; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [de Castro-Miro, Marta; Pomares, Esther; Marfany, Gemma; Gonzalez-Duarte, Roser] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [de Castro-Miro, Marta; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Tonda, Raul] Ctr Nacl Anal Genom, PCB, Barcelona, Spain; [Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Computat Genom, Valencia, Spain; [Dopazo, Joaquin] Ctr Invest Biomed Red Enfermedades Raras CIBERER, BIER, Valencia, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona; Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	rgonzalez@ub.edu	Tonda, Raul/I-1606-2015; Lorés-Motta, Laura/M-6054-2015; Marfany, Gemma/I-5668-2015; Dopazo, Joaquin/A-9270-2014; /L-5926-2018	Tonda, Raul/0000-0001-7893-2404; Marfany, Gemma/0000-0001-7941-983X; Dopazo, Joaquin/0000-0003-3318-120X; /0000-0001-8685-3378; Lores-Motta, Laura/0000-0002-2423-9126; Pomares, Esther/0000-0002-3818-3303	Spanish MICINN; Ministerio de Ciencia e Innovacion [SAF2009-08079, BFU2010-15656, BIO2011-27069]; Generalitat de Catalunya [SGR2009-1427]; CIBERER [U718, U715]; Retina Asturias; ONCE	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Retina Asturias; ONCE	MdCM was a recipient of a FPI fellowship from the Spanish MICINN. This study was supported by grants SAF2009-08079 (RGD), BFU2010-15656 (GM), and BIO2011-27069 (JD) (Ministerio de Ciencia e Innovacion), SGR2009-1427 (RGD)(Generalitat de Catalunya), CIBERER (U718 and U715), Retina Asturias (RGD) and ONCE (RGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alazami AM, 2012, HUM MUTAT, V33, P1423, DOI 10.1002/humu.22134; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Aller E, 2004, EUR J HUM GENET, V12, P407, DOI 10.1038/sj.ejhg.5201138; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; Benaglio P, 2011, HUM MUTAT, V32, pE2246, DOI 10.1002/humu.21485; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Brea-Fernandez AJ, 2008, BRIT J OPHTHALMOL, V92, P1419, DOI 10.1136/bjo.2008.139204; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Bujakowska K, 2012, HUM MUTAT, V33, P306, DOI 10.1002/humu.21653; Chen XJ, 2013, INVEST OPHTH VIS SCI, V54, P2186, DOI 10.1167/iovs.12-10967; Churchill JD, 2013, INVEST OPHTH VIS SCI, V54, P1411, DOI 10.1167/iovs.12-11541; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Andrade LJD, 2009, ARQ BRAS OFTALMOL, V72, P694, DOI 10.1590/S0004-27492009000500019; den Hollander AI, 2004, HUM MUTAT, V24, P355, DOI 10.1002/humu.20093; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Estrada-Cuzcano A, 2012, HUM MOL GENET, V21, pR111, DOI 10.1093/hmg/dds298; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Garcia-Garcia G, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-65; Glockle N, 2013, EUR J HUM GENET; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hjortshoj TD, 2010, HUM MUTAT, V31, P429, DOI 10.1002/humu.21204; Huang XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063832; Kaiserman N, 2007, ARCH OPHTHALMOL-CHIC, V125, P219, DOI 10.1001/archopht.125.2.219; Koenekoop RK, 2007, CLIN EXP OPHTHALMOL, V35, P473, DOI 10.1111/j.1442-9071.2007.01534.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Licastro D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043799; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Medina I, 2012, NUCLEIC ACIDS RES, V40, pW54, DOI 10.1093/nar/gks572; Mendez-Vidal C, 2013, MOL VIS, V19, P2187; Najera Carmen, 2002, Hum Mutat, V20, P76, DOI 10.1002/humu.9042; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nishiguchi KM, 2013, P NATL ACAD SCI USA, V110, P16139, DOI 10.1073/pnas.1308243110; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pomares E, 2007, HUM MUTAT, V28, P511, DOI 10.1002/humu.20479; Pomares E, 2012, ADV EXP MED BIOL, V723, P329, DOI 10.1007/978-1-4614-0631-0_43; Pomares E, 2010, EUR J HUM GENET, V18, P118, DOI 10.1038/ejhg.2009.114; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005; Sharon D, 2000, INVEST OPHTH VIS SCI, V41, P2712; Steele-Stallard HB, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-122; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	54	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88410	10.1371/journal.pone.0088410	http://dx.doi.org/10.1371/journal.pone.0088410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516651	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400066
J	Shostak, AW				Shostak, Allen W.			Sublethal Exposure to Diatomaceous Earth Increases Net Fecundity of Flour Beetles (Tribolium confusum) by Inhibiting Egg Cannibalism	PLOS ONE			English	Article							RHYZOPERTHA-DOMINICA F; SITOPHILUS-ORYZAE L.; INSECTICIDAL EFFICACY; HYMENOLEPIS-DIMINUTA; VAL COLEOPTERA; TENEBRIONIDAE; POPULATIONS; TEMPERATURE; AGE; CURCULIONIDAE	Population regulation results from an interplay of numerous intrinsic and external factors, and for many insects cannibalism is such a factor. This study confirms a previously-reported observation that sublethal exposure to the fossilized remains of diatoms (i.e. diatomaceous earth) increases net fecundity (eggs produced minus eggs destroyed/day) of flour beetles, Tribolium confusum. The aim was to experimentally test two non-mutually-exclusive ecological mechanisms potentially responsible for the increased net fecundity: higher egg production and lower egg cannibalism. Adult T. confusum were maintained at low or high density in medium containing sublethal (0-4%) diatomaceous earth. Net fecundity increased up to 2.1x control values during diatomaceous earth exposure, and returned to control levels following removal from diatomaceous earth. Cannibalism assays on adults showed that diatomaceous earth reduced the number of eggs produced to 0.7x control values at low density and to 0.8x controls at high density, and also reduced egg cannibalism rates of adults to as little as 0.4x control values, but at high density only. Diatomaceous earth also reduced cannibalism by larvae on eggs to 0.3x control values. So, while the presence of diatomaceous earth reduced egg production, net fecundity increased as a result of strong suppression of the normal egg cannibalism by adults and larvae that occurs at high beetle density. Undisturbed cultures containing sublethal diatomaceous earth concentrations reached higher population densities than diatomaceous earth-free controls. Cohort studies on survival from egg to adult indicated that this population increase was due largely to decreased egg cannibalism by adult females. This is the first report of inhibition of egg cannibalism by diatomaceous earth on larval or adult insects. The ability of diatomaceous earth to alter cannibalism behavior without causing mortality makes it an ideal investigative tool for cannibalism studies.	Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Shostak, AW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ashostak@ualberta.ca	Shostak, Allen/A-3753-2014	Shostak, Allen/0000-0002-6290-6428				Alabi T, 2008, ECOL ENTOMOL, V33, P716, DOI 10.1111/j.1365-2311.2008.01020.x; Allen F, 1972, ORGANIC GARDENING FA, V19, P50; [Anonymous], 2006, SAS MIXED MODELS; Arnaud L, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.33; Arthur FH, 2000, J ECON ENTOMOL, V93, P526, DOI 10.1603/0022-0493-93.2.526; Athanassiou CG, 2005, J ECON ENTOMOL, V98, P1404, DOI 10.1603/0022-0493-98.4.1404; Athanassiou CG, 2005, J STORED PROD RES, V41, P47, DOI 10.1016/j.jspr.2003.12.001; BOYCE JM, 1946, ECOLOGY, V27, P290, DOI 10.2307/1933540; BOYER JF, 1976, J ANIM ECOL, V45, P865, DOI 10.2307/3585; Chanbang Y, 2007, CROP PROT, V26, P923, DOI 10.1016/j.cropro.2006.08.009; Chapman RN, 1928, ECOLOGY, V9, P111, DOI 10.2307/1929348; Dawson RD, 2004, J FIELD ORNITHOL, V75, P232, DOI 10.1648/0273-8570-75.3.232; de Paula MCZ, 2002, J KANSAS ENTOMOL SOC, V75, P158; Elgar M. A., 1992, CANNIBALISM ECOLOGY, P1; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Giray T, 2001, EVOLUTION, V55, P797, DOI 10.1554/0014-3820(2001)055[0797:PBOGDI]2.0.CO;2; Hamedi N, 2011, EXP APPL ACAROL, V53, P29, DOI 10.1007/s10493-010-9382-8; Heins DC, 2012, BIOL J LINN SOC, V106, P807, DOI 10.1111/j.1095-8312.2012.01907.x; Korunic Z, 1998, J STORED PROD RES, V34, P87, DOI 10.1016/S0022-474X(97)00039-8; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; MERTZ DB, 1969, ECOL MONOGR, V39, P1, DOI 10.2307/1948563; Michalaki MP, 2007, BIOL CONTROL, V40, P280, DOI 10.1016/j.biocontrol.2006.09.003; MINCHELLA DJ, 1985, PARASITOLOGY, V90, P205, DOI 10.1017/S0031182000049143; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; PARK T, 1965, PHYSIOL ZOOL, V38, P289, DOI 10.1086/physzool.38.3.30152840; Park T, 1934, Q REV BIOL, V9, P36, DOI 10.1086/394454; Parsons W, 2013, ANIM BEHAV, V85, P365, DOI 10.1016/j.anbehav.2012.11.006; Piepho HP, 2004, J COMPUT GRAPH STAT, V13, P456, DOI 10.1198/1061860043515; Ponsonby DJ, 1998, BIOCONTROL, V43, P39, DOI 10.1023/A:1009928305305; RICH ER, 1956, ECOLOGY, V37, P109, DOI 10.2307/1929674; Richardson ML, 2010, ANNU REV ENTOMOL, V55, P39, DOI 10.1146/annurev-ento-112408-085314; Ridley AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053356; Rimoldi F, 2012, J ECON ENTOMOL, V105, P1982, DOI 10.1603/EC12189; Shostak AW, 2008, J PARASITOL, V94, P152, DOI 10.1645/GE-1300.1; Shostak AW, 2012, J PARASITOL, V98, P453, DOI 10.1645/GE-3030.1; Sohrabi F, 2013, CROP PROT, V45, P98, DOI 10.1016/j.cropro.2012.11.024; Sonleitner F. J., 1961, Physiological Zoology Chicago, V34, P233; Stadler T, 2012, J STORED PROD RES, V48, P81, DOI 10.1016/j.jspr.2011.09.004; STEVENS L, 1985, BEHAV GENET, V15, P549, DOI 10.1007/BF01065450; Stevens Lori, 1992, P156; Szczepaniec A, 2013, EXP APPL ACAROL, V59, P307, DOI 10.1007/s10493-012-9614-1; Trewin B, 1997, J PEST SCI, V70, P51; Vale PF, 2012, J EVOLUTION BIOL, V25, P1888, DOI 10.1111/j.1420-9101.2012.02579.x; Vayias BJ, 2006, J ECON ENTOMOL, V99, P1899, DOI 10.1603/0022-0493-99.5.1899; Vayias BJ, 2004, CROP PROT, V23, P565, DOI 10.1016/j.cropro.2003.11.006; Via S, 1999, HEREDITY, V82, P267, DOI 10.1038/sj.hdy.6884820; YAN GY, 1994, AM NAT, V143, P830, DOI 10.1086/285635	47	6	6	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88500	10.1371/journal.pone.0088500	http://dx.doi.org/10.1371/journal.pone.0088500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516665	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400073
J	Federici, C; Petrucci, F; Caimi, S; Cesolini, A; Logozzi, M; Borghi, M; D'Ilio, S; Lugini, L; Violante, N; Azzarito, T; Majorani, C; Brambilla, D; Fais, S				Federici, Cristina; Petrucci, Francesco; Caimi, Stefano; Cesolini, Albino; Logozzi, Mariantonia; Borghi, Martina; D'Ilio, Sonia; Lugini, Luana; Violante, Nicola; Azzarito, Tommaso; Majorani, Costanza; Brambilla, Daria; Fais, Stefano			Exosome Release and Low pH Belong to a Framework of Resistance of Human Melanoma Cells to Cisplatin	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; INTRACELLULAR PH; H+-ATPASES; CHEMOTHERAPY; MECHANISMS; EXPRESSION; PLASMA; TRAFFICKING; APOPTOSIS; VESICLES	Intrinsic resistance to cytotoxic drugs has been a main issue in cancer therapy for decades. Microenvironmental acidity is a simple while highly efficient mechanism of chemoresistance, exploited through impairment of drug delivery. The latter is achieved by extracellular protonation and/or sequestration into acidic vesicles. This study investigates the importance of extracellular acidosis and nanovesicle (exosome) release in the resistance of human tumour cell to cisplatin (CisPt); in parallel to proton pump inhibitors (PPI) ability of interfering with these tumour cell features. The results showed that CisPt uptake by human tumour cells was markedly impaired by low pH conditions. Moreover, exosomes purified from supernatants of these cell cultures contained various amounts of CisPt, which correlated to the pH conditions of the culture medium. HPLC-Q-ICP-MS analysis revealed that exosome purified from tumour cell culture supernatants contained CisPt in its native form. PPI pre-treatment increased cellular uptake of CisPt, as compared to untreated cells, in an acidic-depend manner. Furthermore, it induced a clear inhibition of exosome release by tumour cells. Human tumours obtained from xenografts pretreated with PPI contained more CisPt as compared to tumours from xenografts treated with CisPt alone. Further analysis showed that in vivo PPI treatment induced a clear reduction in the plasmatic levels of tumour-derived exosomes which also contained lower level of CisPt. Altogether, these findings point to the identification of a double mechanism that human malignant melanoma use in resisting to a dreadful cellular poison such as cisplatin. This framework of resistance includes both low pH-dependent extracellular sequestration and an exosome-mediated elimination. Both mechanisms are markedly impaired by proton pump inhibition, leading to an increased CisPt-dependent cytotoxicity.	[Federici, Cristina; Logozzi, Mariantonia; Borghi, Martina; Lugini, Luana; Azzarito, Tommaso; Brambilla, Daria; Fais, Stefano] Natl Inst Hlth, Dept Therapeut Res & Med Evaluat, Rome, Italy; [Petrucci, Francesco; Caimi, Stefano; Violante, Nicola; Majorani, Costanza] Natl Inst Hlth, Dept Environm & Primary Prevent, Rome, Italy; [Cesolini, Albino] Natl Inst Hlth, Dept Ematol Oncol & Mol Biol, Rome, Italy; [D'Ilio, Sonia] Natl Inst Hlth, Natl Ctr Chem Subst, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Fais, S (corresponding author), Natl Inst Hlth, Dept Therapeut Res & Med Evaluat, Rome, Italy.	stefano.fais@iss.it	Fais, Stefano/J-8638-2016; Federici, Cristina/O-4676-2016; Lugini, Luana/J-8672-2016; BORGHI, MARTINA/M-4355-2015; Caimi, Stefano/HIR-3344-2022; Petrucci, Francesco/O-2564-2017	Fais, Stefano/0000-0001-9060-2766; Federici, Cristina/0000-0001-6366-0231; Lugini, Luana/0000-0002-8778-2601; BORGHI, MARTINA/0000-0001-6313-0273; Majorani, Costanza/0000-0002-4243-4902; Caimi, Stefano/0000-0001-5338-4026; Petrucci, Francesco/0000-0002-5661-6547				Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35; Barefoot RR, 2001, J CHROMATOGR B, V751, P205, DOI 10.1016/S0378-4347(00)00498-9; Bell DN, 2006, J CHROMATOGR B, V837, P29, DOI 10.1016/j.jchromb.2006.03.063; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Caroli S, 1988, TRACE ELEMENT ANAL C, V5, P308; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chau Q, 1999, CANCER CHEMOTH PHARM, V44, P193, DOI 10.1007/s002800050967; Chauhan SS, 2003, BRIT J CANCER, V88, P1327, DOI 10.1038/sj.bjc.6600861; De Milito A, 2005, EXPERT OPIN PHARMACO, V6, P1049, DOI 10.1517/14656566.6.7.1049; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; Fais S, 2010, J INTERN MED, V267, P515, DOI 10.1111/j.1365-2796.2010.02225.x; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fan S, 2013, ONCOGENE, V32, P1682, DOI 10.1038/onc.2012.183; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ichihashi N, 2001, BRIT J DERMATOL, V144, P745, DOI 10.1046/j.1365-2133.2001.04129.x; KELLAND LR, 1992, CANCER RES, V52, P1710; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; LARSSON H, 1985, SCAND J GASTROENTERO, V20, P23, DOI 10.3109/00365528509095817; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Lozupone F, 2000, INT J CANCER, V87, P569, DOI 10.1002/1097-0215(20000815)87:4<569::AID-IJC17>3.0.CO;2-U; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Molenaar C, 2000, J BIOL INORG CHEM, V5, P655, DOI 10.1007/s007750000153; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Ouar Z, 1999, CELL BIOL TOXICOL, V15, P91, DOI 10.1023/A:1007521430236; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; PEREZ RP, 1993, CANCER, V71, P1571, DOI 10.1002/cncr.2820710424; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Safaei R, 2005, CLIN CANCER RES, V11, P756; Shahzad MMK, 2009, DRUG RESIST UPDATE, V12, P148, DOI 10.1016/j.drup.2009.09.001; SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128; Spugnini EP, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-221; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596	46	241	250	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88193	10.1371/journal.pone.0088193	http://dx.doi.org/10.1371/journal.pone.0088193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516610	Green Submitted, gold, Green Published			2022-12-27	WOS:000330830700053
J	Jalewa, J; Joshi, A; McGinnity, TM; Prasad, G; Wong-Lin, K; Holscher, C				Jalewa, Jaishree; Joshi, Alok; McGinnity, T. Martin; Prasad, Girijesh; Wong-Lin, KongFatt; Hoelscher, Christian			Neural Circuit Interactions between the Dorsal Raphe Nucleus and the Lateral Hypothalamus: An Experimental and Computational Study	PLOS ONE			English	Article							SEROTONIN NEURONS; 5-HT1A RECEPTOR; OREXIN NEURONS; OREXIN/HYPOCRETIN NEURONS; COLOCALIZATION ANALYSIS; CEREBROSPINAL-FLUID; MATHEMATICAL-MODEL; K+ CURRENT; SLEEP; RAT	Orexinergic/hypocretinergic (Ox) neurotransmission plays an important role in regulating sleep, as well as in anxiety and depression, for which the serotonergic (5-HT) system is also involved in. However, little is known regarding the direct and indirect interactions between 5-HT in the dorsal raphe nucleus (DRN) and Ox neurons in the lateral hypothalamus (LHA). In this study, we report the additional presence of 5-HT1BR, 5-HT2AR, 5-HT2CR and fast ligand-gated 5-HT3AR subtypes on the Ox neurons of transgenic Ox-enhanced green fluorescent protein (Ox-EGFP) and wild type C57Bl/6 mice using single and double immunofluorescence (IF) staining, respectively, and quantify the colocalization for each 5-HT receptor subtype. We further reveal the presence of 5-HT3AR and 5-HT1AR on GABAergic neurons in LHA. We also identify NMDAR1, OX1R and OX2R on Ox neurons, but none on adjacent GABAergic neurons. This suggests a one-way relationship between LHA's GABAergic and Ox neurons, wherein GABAergic neurons exerts an inhibitory effect on Ox neurons under partial DRN's 5-HT control. We also show that Ox axonal projections receive glutamatergic (PSD-95 immunopositive) and GABAergic (Gephyrin immunopositive) inputs in the DRN. We consider these and other available findings into our computational model to explore possible effects of neural circuit connection types and timescales on the DRN-LHA system's dynamics. We find that if the connections from 5-HT to LHA's GABAergic neurons are weakly excitatory or inhibitory, the network exhibits slow oscillations; not observed when the connection is strongly excitatory. Furthermore, if Ox directly excites 5-HT neurons at a fast timescale, phasic Ox activation can lead to an increase in 5-HT activity; no significant effect with slower timescale. Overall, our experimental and computational approaches provide insights towards a more complete understanding of the complex relationship between 5-HT in the DRN and Ox in the LHA.	[Jalewa, Jaishree] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Joshi, Alok; McGinnity, T. Martin; Prasad, Girijesh; Wong-Lin, KongFatt] Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Coleraine BT52 1SA, Londonderry, North Ireland; [Hoelscher, Christian] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Ulster University; Ulster University; Lancaster University	Wong-Lin, K (corresponding author), Univ Ulster, Intelligent Syst Res Ctr, Magee Campus, Coleraine BT52 1SA, Londonderry, North Ireland.	k.wong-lin@ulster.ac.uk; c.holscher@lancaster.ac.uk	JALEWA, JAISHREE/O-4472-2019	JALEWA, JAISHREE/0000-0001-8290-3841; Holscher, Christian/0000-0002-8159-3260; Wong-Lin, KongFatt/0000-0001-8724-4398; McGinnity, Thomas Martin/0000-0002-9897-4748; Joshi, Alok/0000-0003-1259-4902; Prasad, Girijesh/0000-0003-3284-9589	Centre of Excellence in Intelligent Systems Project, ISRC, University of Ulster, Magee, Northern Ireland	Centre of Excellence in Intelligent Systems Project, ISRC, University of Ulster, Magee, Northern Ireland	The work has been supported by the Centre of Excellence in Intelligent Systems Project, ISRC, University of Ulster, Magee, Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Adrien J, 2002, SLEEP MED REV, V6, P341, DOI 10.1053/smrv.2001.0200; Alberto CO, 2010, BIOCHEM BIOPH RES CO, V400, P707, DOI 10.1016/j.bbrc.2010.08.132; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Artigas F, 2013, EUR NEUROPSYCHOPHARM; Artigas F, 2013, PHARMACOL THERAPEUT, V137, P119, DOI 10.1016/j.pharmthera.2012.09.006; Backberg M, 2004, J NEUROENDOCRINOL, V16, P589, DOI 10.1111/j.1365-2826.2004.01207.x; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borgland SL, 2010, NEUROPSYCHOPHARMACOL, V35, P353, DOI 10.1038/npp.2009.119; Bromberg-Martin ES, 2010, J NEUROSCI, V30, P6262, DOI 10.1523/JNEUROSCI.0015-10.2010; Brown RE, 2002, J NEUROSCI, V22, P8850; Brown RE, 2001, NEUROPHARMACOLOGY, V40, P457, DOI 10.1016/S0028-3908(00)00178-7; Brundin L, 2007, EUR NEUROPSYCHOPHARM, V17, P573, DOI 10.1016/j.euroneuro.2007.01.005; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; Catena-Dell'Osso M, 2012, CURR MED CHEM, V19, P428, DOI 10.2174/092986712803414277; Cooper MA, 2008, PSYCHONEUROENDOCRINO, V33, P1236, DOI 10.1016/j.psyneuen.2008.06.009; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crawford LK, 2010, J NEUROPHYSIOL, V103, P2652, DOI 10.1152/jn.01132.2009; Dayan P, 2001, THEORETICAL NEUROSCI; de Carvalho TB, 2012, SLEEP BREATH; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Diaz-Cabiale Z, 2011, NEUROPHARMACOLOGY, V61, P80, DOI 10.1016/j.neuropharm.2011.03.002; Doane DF, 2007, AM J PHYSIOL-REG I, V293, pR1022, DOI 10.1152/ajpregu.00282.2007; Ebrahim IO, 2003, J NEUROL NEUROSUR PS, V74, P127, DOI 10.1136/jnnp.74.1.127; ERMENTROUT GB, 1990, SIAM J APPL MATH, V50, P125, DOI 10.1137/0150009; Feng P, 2008, J PSYCHOPHARMACOL, V22, P784, DOI 10.1177/0269881106082899; Gocho Y, 2013, J PHYSIOL SCI, V63, P147, DOI 10.1007/s12576-012-0250-7; Grace KP, 2012, J NEUROSCI, V32, P1622, DOI 10.1523/JNEUROSCI.5700-10.2012; Harsing LG, 2004, NEUROCHEM RES, V29, P1487; Henny P, 2006, J COMP NEUROL, V499, P645, DOI 10.1002/cne.21131; Hu ZY, 2012, ANAT REC, V295, P127, DOI 10.1002/ar.21497; Ishibashi H, 2000, NEUROPHARMACOLOGY, V39, P2302, DOI 10.1016/S0028-3908(00)00092-7; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041852; Joshi A, 2011, IEEE ENG MED BIO, P7270, DOI 10.1109/IEMBS.2011.6091837; Karnani MM, 2013, J PHYSIOL-LONDON, V591, P933, DOI 10.1113/jphysiol.2012.243493; Katayama J, 1997, BRAIN RES, V745, P283, DOI 10.1016/S0006-8993(96)01141-9; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Kokare DM, 2006, NEUROPHARMACOLOGY, V50, P16, DOI 10.1016/j.neuropharm.2005.07.019; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042059; Kumar S, 2007, EUR J NEUROSCI, V25, P201, DOI 10.1111/j.1460-9568.2006.05268.x; Lanni C, 2009, CELL MOL LIFE SCI, V66, P2985, DOI 10.1007/s00018-009-0055-x; Lee HS, 2005, BRAIN RES, V1059, P35, DOI 10.1016/j.brainres.2005.08.016; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Liu RJ, 2000, BRAIN RES, V873, P34, DOI 10.1016/S0006-8993(00)02468-9; Liu RJ, 2002, J NEUROSCI, V22, P9453; Lopez M, 2010, FRONT NEUROENDOCRIN, V31, P113, DOI 10.1016/j.yfrne.2009.07.001; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; Mignot E, 2001, NEUROPSYCHOPHARMACOL, V25, pS5, DOI 10.1016/S0893-133X(01)00316-5; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Morikawa H, 2000, MOL PHARMACOL, V58, P1271, DOI 10.1124/mol.58.6.1271; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Muraki Y, 2004, J NEUROSCI, V24, P7159, DOI 10.1523/JNEUROSCI.1027-04.2004; Omenetti A, 2011, AM J PHYSIOL-GASTR L, V300, pG303, DOI 10.1152/ajpgi.00368.2010; Palasz A, 2014, INT J NEUROPSYCHOPH, V17, P157, DOI 10.1017/S1461145713000552; Patriarca M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002650; Peyron C, 1998, J NEUROSCI, V18, P9996; Postnova S, 2009, J BIOL RHYTHM, V24, P523, DOI 10.1177/0748730409346655; Ranade SP, 2009, J NEUROPHYSIOL, V102, P3026, DOI 10.1152/jn.00507.2009; Rempe MJ, 2010, J MATH BIOL, V60, P615, DOI 10.1007/s00285-009-0276-5; Ren LQ, 2013, NEUROSCIENCE; Rivera HM, 2012, PHYSIOL BEHAV, V105, P188, DOI 10.1016/j.physbeh.2011.08.018; Sakai K, 2011, NEUROSCIENCE, V197, P200, DOI 10.1016/j.neuroscience.2011.09.024; Sakurai T, 2005, REGUL PEPTIDES, V126, P3, DOI 10.1016/j.regpep.2004.08.006; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2010, ANN NY ACAD SCI, V1200, P149, DOI 10.1111/j.1749-6632.2010.05513.x; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Scammell TE, 2011, ANNU REV PHARMACOL, V51, P243, DOI 10.1146/annurev-pharmtox-010510-100528; Shriki O, 2003, NEURAL COMPUT, V15, P1809, DOI 10.1162/08997660360675053; Soffin EM, 2004, NEUROPHARMACOLOGY, V46, P1168, DOI 10.1016/j.neuropharm.2004.02.014; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tao R, 2003, BRAIN RES, V961, P109, DOI 10.1016/S0006-8993(02)03851-9; Urbanska A, 2012, J MOL NEUROSCI, V46, P10, DOI 10.1007/s12031-011-9526-2; VERGE D, 1985, EUR J PHARMACOL, V113, P463, DOI 10.1016/0014-2999(85)90099-8; Wai MSM, 2011, PSYCHIAT RES, V185, P238, DOI 10.1016/j.psychres.2010.05.003; Weber M, 2008, EUR J NEUROSCI, V28, P931, DOI 10.1111/j.1460-9568.2008.06400.x; WILLIAMS JT, 1988, J NEUROSCI, V8, P3499; Williams KS, 2011, J BIOL RHYTHM, V26, P171, DOI 10.1177/0748730410395471; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Wisor JP, 2003, NEUROREPORT, V14, P233, DOI 10.1097/00001756-200302100-00015; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Wong-Lin K, 2012, NEURAL NETWORKS, V32, P15, DOI 10.1016/j.neunet.2012.02.009; Xie XM, 2006, J PHYSIOL-LONDON, V574, P399, DOI 10.1113/jphysiol.2006.108266; Xu Tian-Rui, 2012, J Biol Chem, V287, P14937, DOI 10.1074/jbc.M111.334300; Yamanaka A, 2006, J NEUROPHYSIOL, V96, P284, DOI 10.1152/jn.01361.2005; Yamanaka A, 2003, BIOCHEM BIOPH RES CO, V303, P120, DOI 10.1016/S0006-291X(03)00299-7; Yamanaka A, 2010, J NEUROSCI, V30, P12642, DOI 10.1523/JNEUROSCI.2120-10.2010; Yeung LY, 2010, AGE, V32, P483, DOI 10.1007/s11357-010-9152-x; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002; Zinchuk V, 2009, PROG HISTOCHEM CYTO, V44, P125, DOI 10.1016/j.proghi.2009.03.001	93	23	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88003	10.1371/journal.pone.0088003	http://dx.doi.org/10.1371/journal.pone.0088003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516577	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000330830700037
J	Ouchi, Y; Yamamoto, J; Iwamoto, T				Ouchi, Yasuo; Yamamoto, Jyunya; Iwamoto, Takashi			The Heterochronic Genes lin-28a and lin-28b Play an Essential and Evolutionarily Conserved Role in Early Zebrafish Development	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; REGULATORY RNA; LET-7 MICRORNA; EXPRESSION; LIN-41; LIN28; DIFFERENTIATION; IDENTIFICATION; HOMOLOG	The Caenorhabditis elegans heterochronic gene pathway, which consists of a set of regulatory genes, plays an important regulatory role in the timing of stage-specific cell lineage development in nematodes. Research into the heterochronic gene pathway gave rise to landmark microRNA (miRNA) studies and showed that these genes are important in stem cell and cancer biology; however, their functions in vertebrate development are largely unknown. To elucidate the function of the heterochronic gene pathway during vertebrate development, we cloned the zebrafish homologs of the C. elegans let-7 miRNA-binding protein, Lin-28, and analyzed their function in zebrafish development. The zebrafish genome contains two Lin28-related genes, lin-28a and lin-28b. Similar to mammalian Lin28 proteins, both zebrafish Lin-28a and Lin-28b have a conserved cold-shock domain and a pair of CCHC zinc finger domains, and are ubiquitously expressed during early embryonic development. In a reciprocal fashion, the expression of downstream heterochronic genes, let-7 and lin-4/miR-125 miRNA, occurred subsequent to lin-28 expression. The knockdown of Lin-28a or Lin-28b function by morpholino microinjection into embryos resulted in severe cell proliferation defects during early morphogenesis. We found that the expression of let-7 miRNA was upregulated and its downstream target gene, lin-41, was downregulated in these embryos. Interestingly, the expression of miR-430, a key regulator of maternal mRNA decay, was downregulated in lin-28a and lin-28b morphant embryos, suggesting a role for Lin-28 in the maternal-to-zygotic transition in zebrafish. Taken together, our results suggest an evolutionarily conserved and pivotal role of the heterochronic gene pathway in early vertebrate embryogenesis.	[Ouchi, Yasuo; Iwamoto, Takashi] Chubu Univ, Ctr Educ Lab Anim Res, Kasugai, Aichi 487, Japan; [Ouchi, Yasuo; Yamamoto, Jyunya; Iwamoto, Takashi] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Kasugai, Aichi 487, Japan	Chubu University; Chubu University	Iwamoto, T (corresponding author), Chubu Univ, Ctr Educ Lab Anim Res, Kasugai, Aichi 487, Japan.	iwamoto@isc.chubu.ac.jp			Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [S0801055]; Grants-in-Aid for Scientific Research [25460506] Funding Source: KAKEN	Center of Excellence Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Center of Excellence Project for Private Universities (no. S0801055) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BRENNER S, 1974, GENETICS, V77, P71; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Faas L, 2013, DEVELOPMENT, V140, P976, DOI 10.1242/dev.089797; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kurita R, 2003, DEV BIOL, V255, P113, DOI 10.1016/S0012-1606(02)00079-9; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lin YC, 2007, MOL BIOL EVOL, V24, P2525, DOI 10.1093/molbev/msm195; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ouch Y, 2005, J CELL SCI, V118, P4473, DOI 10.1242/jcs.02575; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rougvie AE, 2001, NAT REV GENET, V2, P690, DOI 10.1038/35088566; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Schulman BRM, 2008, CELL CYCLE, V7, P3935; Schulman BRM, 2005, DEV DYNAM, V234, P1046, DOI 10.1002/dvdy.20599; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vogt EJ, 2012, DEVELOPMENT, V139, P4514, DOI 10.1242/dev.083279; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	40	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88086	10.1371/journal.pone.0088086	http://dx.doi.org/10.1371/journal.pone.0088086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516585	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700041
J	Suzuki, Y; Gatanaga, H; Tachikawa, N; Oka, S				Suzuki, Yasuhiro; Gatanaga, Hiroyuki; Tachikawa, Natsuo; Oka, Shinichi			Slow Turnover of HIV-1 Receptors on Quiescent CD4(+) T Cells Causes Prolonged Surface Retention of gp120 Immune Complexes In Vivo	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; IMMUNODEFICIENCY-VIRUS TYPE-1; NATURAL-KILLER-CELLS; HEMOPHILIA PATIENTS; DOWN-MODULATION; NK CELLS; LYMPHOCYTES; INFECTION; DYNAMICS; THERAPY	Peripheral blood CD4(+) T cells in HIV-1(+) patients are coated with Ig. However, the causes and consequences of the presence of Ig(+) CD4(+) T cells remain unknown. Previous studies have demonstrated the rapid turnover of viral receptors (VRs) on lymphoma and tumor cells. The present study investigates the turnover of VRs on peripheral quiescent CD4(+) T cells (qCD4s), which are the most abundant peripheral blood CD4(+) T cells. Utilizing pharmacological and immunological approaches, we found that the turnover of VRs on qCD4s is extremely slow. As a result, exposure to gp120 or HIV-1 virions in vitro causes gp120 to remain on the surface for a long period of time. It requires approximately three days for cell-bound gp120 on the surface to be reduced by 50%. In the presence of patient serum, gp120 forms surface immune complexes (ICs) that are also retained for a long time. Indeed, when examining the percentages of Ig(+) CD4(+) T cells at different stages of HIV-1 infection, approximately 70% of peripheral resting CD4+ T cells (rCD4s) were coated with surface VRs bound to slow-turnover gp120-Ig. The levels of circulating ICs in patient serum were insufficient to form surface ICs on qCD4s, suggesting that surface ICs on qCD4s require much higher concentrations of HIV-1 exposure such as might be found in lymph nodes. In the presence of macrophages, Ig(+) CD4(+) T cells generated in vitro or directly isolated from HIV-1(+) patients were ultimately phagocytosed. Similarly, the frequencies and percentages of Ig+ rCD4s were significantly increased in an HIV-1(+) patient after splenectomy, indicating that Ig(+) rCD4s might be removed from circulation and that non-neutralizing anti-envelope antibodies could play a detrimental role in HIV-1 pathogenesis. These findings provide novel insights for vaccine development and a rationale for using Ig(+) rCD4 levels as an independent clinical marker.	[Suzuki, Yasuhiro] Tohoku Univ, Grad Sch Med, Dept Infect Dis, Sendai, Miyagi 980, Japan; [Suzuki, Yasuhiro; Gatanaga, Hiroyuki; Tachikawa, Natsuo; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Tachikawa, Natsuo] Yokohama Municipal Citizens Hosp, Dept Infect Dis, Yokohama, Kanagawa, Japan	Tohoku University; National Center for Global Health & Medicine - Japan	Suzuki, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Infect Dis, Sendai, Miyagi 980, Japan.	suzukiy39@med.tohoku.ac.jp		Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor, and Welfare of Japan; Japanese Foundation of AIDS Prevention	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Foundation of AIDS Prevention	This work was supported by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan and by the Japanese Foundation of AIDS Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1996, FASEB J, V10, P258, DOI 10.1096/fasebj.10.2.8641559; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baldwin CE, 2003, CURR MED CHEM, V10, P1633, DOI 10.2174/0929867033457124; Bermejo M, 1998, EUR J IMMUNOL, V28, P3192; Blum KS, 2007, IMMUNOL LETT, V108, P45, DOI 10.1016/j.imlet.2006.10.009; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Daniel V, 2004, CLIN EXP IMMUNOL, V135, P94, DOI 10.1111/j.1365-2249.2004.02339.x; Daniel V, 1996, CLIN EXP IMMUNOL, V104, P4, DOI 10.1046/j.1365-2249.1996.d01-640.x; Daniel V, 1999, CLIN EXP IMMUNOL, V115, P477; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Fernandis AZ, 2002, J BIOL CHEM, V277, P18111, DOI 10.1074/jbc.M200750200; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Fujii N, 2003, EXPERT OPIN INV DRUG, V12, P185, DOI 10.1517/13543784.12.2.185; Gatanaga H, 2002, J BIOL CHEM, V277, P5952, DOI 10.1074/jbc.M108005200; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Jewett A, 1997, J IMMUNOL, V158, P5492; Kirschner D, 2000, J ACQ IMMUN DEF SYND, V24, P352; Kozak SL, 1999, J BIOL CHEM, V274, P23499, DOI 10.1074/jbc.274.33.23499; KRAPF FE, 1990, KLIN WOCHENSCHR, V68, P299, DOI 10.1007/BF01649020; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Loubeau M, 1997, J ACQ IMMUN DEF SYND, V16, P137, DOI 10.1097/00042560-199711010-00001; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; LYERLY HK, 1987, AIDS RES HUM RETROV, V3, P409, DOI 10.1089/aid.1987.3.409; Margolin DH, 2002, J VIROL, V76, P3965, DOI 10.1128/JVI.76.8.3965-3973.2002; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; NARA PL, 1991, FASEB J, V5, P2437, DOI 10.1096/fasebj.5.10.1712328; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; Peacock JW, 1999, J IMMUNOL, V162, P215; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; ROOK AH, 1985, J IMMUNOL, V134, P1503; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; RYAN TC, 1990, J IMMUNOL METHODS, V130, P223, DOI 10.1016/0022-1759(90)90052-W; Signoret N, 1998, J CELL SCI, V111, P2819; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Skowron G, 1997, AIDS, V11, P1807, DOI 10.1097/00002030-199715000-00004; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tarasova NI, 1998, J BIOL CHEM, V273, P15883, DOI 10.1074/jbc.273.26.15883; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zambetti EF, 1999, CLIN RADIOL, V54, P34, DOI 10.1016/S0009-9260(99)91237-0; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86479	10.1371/journal.pone.0086479	http://dx.doi.org/10.1371/journal.pone.0086479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516533	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700008
J	Geraci, DM; Giuffre, M; Bonura, C; Matranga, D; Aleo, A; Saporito, L; Corsello, G; Larsen, AR; Mammina, C				Geraci, Daniela M.; Giuffre, Mario; Bonura, Celestino; Matranga, Domenica; Aleo, Aurora; Saporito, Laura; Corsello, Giovanni; Larsen, Anders Rhod; Mammina, Caterina			Methicillin-Resistant Staphylococcus aureus Colonization: A Three-Year Prospective Study in a Neonatal Intensive Care Unit in Italy	PLOS ONE			English	Article							SEQUENCE TYPE; SCCMEC TYPE; INFECTION; SURVEILLANCE; TRANSMISSION; EPIDEMIOLOGY; PRESSURE; OUTBREAK; STRAINS; SPREAD	Background: Methicillin resistant Staphylococcus aureus (MRSA) is a major etiological agent of infection in neonatal intensive care units (NICUs). Routes of entry of this organism can be different and the transmission pathway complex. Colonized neonates are the main endogenous reservoir. Methods and Results: We conducted a prospective three-year study on MRSA colonization recruiting 722 neonates admitted between 2009 and 2012. Nasal swabs were cultured weekly and MRSA isolates were submitted to molecular typing. The annual incidence density of acquisition of MRSA ranged from a maximum of 20.2 cases for 1000 patient-days during the first year to a minimum of 8.8 cases in the second one to raise again up to 13.1 cases during the third year. The mean weekly colonization pressure fluctuated from 19.1% in the first year to 13.4% in the second year and 16.8% in the third year. It significantly correlated with the number of MRSA acquisitions in the following week. Overall, 187 (25.9%) subjects tested positive for MRSA. A non multiresistant, tst positive, ST22-MRSA-IVa spa t223 strain proved to be endemic in the NICU, being identified in 166 (88.8%) out of 187 colonized neonates. Sporadic or epidemic occurrence of other strains was detected. Conclusions: An MRSA strain belonging to the tst1 positive, UK-EMRSA-15/ "Middle Eastern Variant" appeared to be endemic in the NICU under investigation. During the three-year period, substantial changes occurred in case-mix of patients moving towards a higher susceptibility to MRSA colonization. The infection control procedures were able to decrease the colonization rate from more than 40% to approximately 10%, except for an outbreak due to a CA-MRSA strain, ST1-MRSA-IVa, and a transient increase in the colonization prevalence rate coincident with a period of substantial overcrowding of the ward. Active surveillance and molecular typing contributed to obtain a reliable picture of the MRSA dissemination in NICU.	[Geraci, Daniela M.; Giuffre, Mario; Bonura, Celestino; Matranga, Domenica; Aleo, Aurora; Saporito, Laura; Corsello, Giovanni; Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care G DAless, Palermo, Italy; [Geraci, Daniela M.] Univ Palermo, PhD Sch Food & Human Nutr, Palermo, Italy; [Saporito, Laura] Univ Palermo, Postgrad Specialty Sch Hyg & Prevent Med, Palermo, Italy; [Larsen, Anders Rhod] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of Palermo; University of Palermo; University of Palermo; Statens Serum Institut	Mammina, C (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother Child Care G DAless, Palermo, Italy.	caterina.mammina@unipa.it	Matranga, Domenica/I-4974-2019; Mammina, Caterina/M-9339-2013; Giuffre, Mario/AAO-6913-2021; Giuffrè, Mario/J-7804-2016	Matranga, Domenica/0000-0002-2466-937X; Mammina, Caterina/0000-0003-2881-8018; Giuffre, Mario/0000-0001-9576-1635; Giuffrè, Mario/0000-0001-9576-1635; Larsen, Anders Rhod/0000-0002-1713-8765; Geraci, Daniela Maria/0000-0002-4684-1273; SAPORITO, Laura/0000-0002-9756-0957				Al-Tawfiq JA, 2006, INFECT CONT HOSP EP, V27, P636, DOI 10.1086/505097; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Andersen BM, 2002, J HOSP INFECT, V50, P18, DOI 10.1053/jhin.2001.1128; Baldan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043153; Biber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042864; Brown DFJ, 2001, J ANTIMICROB CHEMOTH, V48, P65, DOI 10.1093/jac/48.suppl_1.65; Carey AJ, 2010, J PERINATOL, V30, P135, DOI 10.1038/jp.2009.119; Carey AJ, 2008, CLIN PERINATOL, V35, P223, DOI 10.1016/j.clp.2007.11.014; Chang CY, 2012, NEW ENGL J MED, V367, P2170, DOI 10.1056/NEJMp1212680; Geraci DM, 2014, INFECTION IN PRESS; Gerber SI, 2006, INFECT CONT HOSP EP, V27, P139, DOI 10.1086/501216; Giuffre M, 2013, J HOSP INFECT, V85, P233, DOI 10.1016/j.jhin.2013.08.004; Giuffre M, 2013, EXPERT REV ANTI-INFE, V11, P499, DOI [10.1586/eri.13.28, 10.1586/ERI.13.28]; Giuffre Mario, 2012, BMC Pediatr, V12, P64, DOI 10.1186/1471-2431-12-64; Glasner C, 2013, INT J MED MICROBIOL, V303, P70, DOI 10.1016/j.ijmm.2012.12.005; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Johnson AP, 2010, ARCH DIS CHILD, V95, P781, DOI 10.1136/adc.2010.162537; Karynski M, 2008, DIAGN MICR INFEC DIS, V62, P255, DOI 10.1016/j.diagmicrobio.2008.06.019; Laurent F, 2001, J ANTIMICROB CHEMOTH, V47, P277, DOI 10.1093/jac/47.3.277; Lawes T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000797; Lepelletier D, 2009, AM J INFECT CONTROL, V37, P195, DOI 10.1016/j.ajic.2008.09.024; Macnow T, 2013, PEDIAT INFECT DIS J; Mammina C, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-17; Merrer J, 2000, INFECT CONT HOSP EP, V21, P718, DOI 10.1086/501721; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Morel AS, 2002, AM J INFECT CONTROL, V30, P170, DOI 10.1067/mic.2002.119819; Park SH, 2013, EARLY HUM DEV, V89, P661, DOI 10.1016/j.earlhumdev.2013.04.014; Pavlov I, 2007, CLIN INFECT DIS, V44, P766, DOI 10.1086/511689; Pinter DM, 2009, AM J PERINAT, V26, P145, DOI 10.1055/s-0028-1095179; Ramsing BGU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066904; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Sakaki H, 2009, AM J INFECT CONTROL, V37, P580, DOI 10.1016/j.ajic.2009.02.008; Shore AC, 2012, ANTIMICROB AGENTS CH, V56, P5340, DOI 10.1128/AAC.01247-12; Simoes RR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017630, 10.1371/journal.pone.0029279]; Stein M, 2006, PEDIATR INFECT DIS J, V25, P557, DOI 10.1097/01.inf.0000219407.31195.44; Tamma PD, 2010, INFECT CONT HOSP EP, V31, P846, DOI 10.1086/655017; Tavares A, 2013, EUR J CLIN MICROBIOL	41	26	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87760	10.1371/journal.pone.0087760	http://dx.doi.org/10.1371/journal.pone.0087760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505312	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200071
J	Kumar, Y; Liang, C; Limmon, GV; Liang, L; Engelward, BP; Ooi, EE; Chen, JZ; Tannenbaum, SR				Kumar, Yadunanda; Liang, Cui; Limmon, Gino V.; Liang, Li; Engelward, Bevin P.; Ooi, Eng Eong; Chen, Jianzhu; Tannenbaum, Steven R.			Molecular Analysis of Serum and Bronchoalveolar Lavage in a Mouse Model of Influenza Reveals Markers of Disease Severity That Can Be Clinically Useful in Humans	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; DENGUE INFECTION; VIRUS; CYTOKINE; RESPONSES; A(H1N1)PDM09; PATHOGENESIS; INFLAMMATION; PROTEOMICS; PNEUMONIA	Background: Management of influenza, a major contributor to the worldwide disease burden, is complicated by lack of reliable methods for early identification of susceptible individuals. Identification of molecular markers that can augment existing diagnostic tools for prediction of severity can be expected to greatly improve disease management capabilities. Methodology/Principal Findings: We have analyzed cytokines, proteome flux and protein adducts in bronchoalveolar lavage (BAL) and sera from mice infected with influenza A virus (PR8 strain) using a previously established non-lethal model of influenza infection. Through detailed cytokine and protein adduct measurements of murine BAL, we first established the temporal profile of innate and adaptive responses as well as macrophage and neutrophil activities in response to influenza infection. A similar analysis was also performed with sera from a longitudinal cohort of influenza patients. We then used an iTRAQ-based, comparative serum proteome analysis to catalog the proteome flux in the murine BAL during the stages correlating with "peak viremia,'' "inflammatory damage,'' as well as the "recovery phase.'' In addition to activation of acute phase responses, a distinct class of lung proteins including surfactant proteins was found to be depleted from the BAL coincident with their "appearance'' in the serum, presumably due to leakage of the protein following loss of the integrity of the lung/epithelial barrier. Serum levels of at least two of these proteins were elevated in influenza patients during the febrile phase of infection compared to healthy controls or to the same patients at convalescence. Conclusions/Significance: The findings from this study provide a molecular description of disease progression in a mouse model of influenza and demonstrate its potential for translation into a novel class of markers for measurement of acute lung injury and improved case management.	[Kumar, Yadunanda; Liang, Cui; Limmon, Gino V.; Liang, Li; Engelward, Bevin P.; Ooi, Eng Eong; Chen, Jianzhu; Tannenbaum, Steven R.] Singapore MIT Alliance Res & Technol SMART, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Kumar, Yadunanda; Engelward, Bevin P.; Tannenbaum, Steven R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Ooi, Eng Eong] DUKE NUS Grad Med Sch, Singapore, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA	Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT); National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kumar, Y (corresponding author), Singapore MIT Alliance Res & Technol SMART, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore.	ybudigi@mit.edu	Limmon, Gino/X-5913-2019	Limmon, Gino/0000-0003-3030-7022; Ooi, Eng Eong/0000-0002-0520-1544	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's ID-IRG research program; NATIONAL CANCER INSTITUTE [P01CA026731] Funding Source: NIH RePORTER	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's ID-IRG research program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's ID-IRG research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akella A, 2013, INDIAN J EXP BIOL, V51, P5; Belongia EA, 2011, JAMA-J AM MED ASSOC, V304, P1091; Bradley-Stewart A, 2013, J CLIN VIROL, V58, P100, DOI 10.1016/j.jcv.2013.05.011; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; CONN CA, 1995, AM J PHYSIOL-REG I, V268, pR78, DOI 10.1152/ajpregu.1995.268.1.R78; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Greene KE, 2002, EUR RESPIR J, V19, P439, DOI 10.1183/09031936.02.00081102; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Magi B, 2006, PROTEOMICS, V6, P6354, DOI 10.1002/pmic.200600303; Martinez-Ocana J, 2013, J CLIN VIROL, V58, P108, DOI 10.1016/j.jcv.2013.05.013; Matsumoto Y, 2012, MICROBIOL IMMUNOL, V56, P651, DOI 10.1111/j.1348-0421.2012.00489.x; Ohlmeler S, 2008, J PROTEOME RES, V7, P5125, DOI 10.1021/pr800423x; Paquette SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038214; Steinberg BE, 2012, ANTIVIR RES, V93, P2, DOI 10.1016/j.antiviral.2011.10.019; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Wang RX, 2009, J CLIN MICROBIOL, V47, P2675, DOI 10.1128/JCM.01087-09; Wang SY, 2010, J INFECT DIS, V202, P991, DOI 10.1086/656044; Wattiez R, 2005, J CHROMATOGR B, V815, P169, DOI 10.1016/j.jchromb.2004.10.029; Yamada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031494; Yin L, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.046001; Zheng DH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048451, 10.1371/journal.pone.0049495]	31	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86912	10.1371/journal.pone.0086912	http://dx.doi.org/10.1371/journal.pone.0086912			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505273	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200032
J	Li, KL; Huang, T; Zheng, JS; Wu, KJ; Li, D				Li, Kelei; Huang, Tao; Zheng, Jusheng; Wu, Kejian; Li, Duo			Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on C-Reactive Protein, Interleukin 6 and Tumor Necrosis Factor alpha: A Meta-Analysis	PLOS ONE			English	Article							FISH-OIL SUPPLEMENTATION; CARDIOVASCULAR RISK-FACTORS; HUMAN ADIPOSE-TISSUE; NF-KAPPA-B; INFLAMMATORY MARKERS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; OXIDATIVE STRESS; WEIGHT-LOSS; OMEGA-3-FATTY-ACID SUPPLEMENTATION	Background: Previous studies did not draw a consistent conclusion about the effects of marine-derived n-3 polyunsaturated fatty acids (PUFAs) on fasting blood level of C-reactive protein (CRP), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha). Methods and Findings: A comprehensive search of Web of Science, PubMed, Embase and Medline (from 1950 to 2013) and bibliographies of relevant articles was undertaken. Sixty-eight RCTs with a total of 4601 subjects were included in the meta-analysis. Marine-derived n-3 PUFAs supplementation showed a lowering effect on Marine-derived n-3 PUFAs supplementation had a significant lowering effect on TNF-alpha, IL-6 and CRP in three groups of subjects (subjects with chronic non-autoimmune disease, subjects with chronic autoimmune disease and healthy subjects). A significant negative linear relationship between duration and effect size of marine-derived n-3 PUFAs supplementation on fasting blood levels of TNF-alpha and IL-6 in subjects with chronic non-autoimmune disease was observed, indicating that longer duration of supplementation could lead to a greater lowering effect. A similar linear relationship was also observed for IL-6 levels in healthy subjects. Restricted cubic spline analysis and subgroup analysis showed that the lowering effect of marine-derived n-3 PUFAs on CRP, IL-6 and TNF-alpha in subjects with chronic non-autoimmune disease became weakened when body mass index was greater than 30 kg/m(2). The effect of marine-derived n-3 PUFAs from dietary intake was only assessed in subjects with chronic non-autoimmune disease, and a significant lowering effect was observed on IL-6, but not on CRP and TNF-alpha. Conclusions: Marine-derived n-3 PUFAs supplementation had a significant lowering effect on CRP, IL-6 and TNF-alpha level. The lowering effect was most effective in non-obese subjects and consecutive long-term supplementation was recommended.	[Li, Kelei; Huang, Tao; Zheng, Jusheng; Wu, Kejian; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Kelei; Huang, Tao; Zheng, Jusheng; Wu, Kejian; Li, Duo] APCNS Ctr Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	duoli@zju.edu.cn	Huang, Tao/C-5641-2014; Li, Duo/N-3682-2013	Huang, Tao/0000-0002-0328-1368; Li, Duo/0000-0001-5227-5565	National High Technology Research and Development Program of China [N20080753]; National Natural Science Foundation of China [30972464]; Ph.D. Programs Foundation of Ministry of Education of China [20070335025]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	The study was supported by a grant from National High Technology Research and Development Program of China (No. N20080753), the National Natural Science Foundation of China (No. 30972464) and the Ph.D. Programs Foundation of Ministry of Education of China (No. 20070335025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa DS, 2003, NUTRITION, V19, P837, DOI 10.1016/S0899-9007(03)00162-X; BEG AA, 1993, MOL CELL BIOL, V13, P3301, DOI 10.1128/MCB.13.6.3301; Bent S, 2011, J AUTISM DEV DISORD, V41, P545, DOI 10.1007/s10803-010-1078-8; Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P23, DOI 10.1016/j.jnutbio.2006.02.005; BoltonSmith C, 1997, EUR J CLIN NUTR, V51, P619, DOI 10.1038/sj.ejcn.1600455; Bowden RG, 2009, NUTR CLIN PRACT, V24, P508, DOI 10.1177/0884533609335376; Bragt MCE, 2012, NUTR METAB CARDIOVAS, V22, P966, DOI 10.1016/j.numecd.2010.12.010; Browning LM, 2007, DIABETES OBES METAB, V9, P70, DOI 10.1111/j.1463-1326.2006.00576.x; Browning LM, 2003, P NUTR SOC, V62, P447, DOI 10.1079/PNS2003252; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Calder PC, 2003, BRAZ J MED BIOL RES, V36, P433, DOI 10.1590/S0100-879X2003000400004; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Camandola S, 1996, BIOCHEM BIOPH RES CO, V229, P643, DOI 10.1006/bbrc.1996.1857; Cappuccio FP, 2004, BMJ-BRIT MED J, V329, P145, DOI 10.1136/bmj.38121.684410.AE; Carrillo C, 2012, NUTR HOSP, V27, P978, DOI 10.3305/nh.2012.27.4.5783; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Chan DC, 2002, CLIN CHEM, V48, P877; Chiang YL, 2012, PROSTAG LEUKOTR ESS, V87, P111, DOI 10.1016/j.plefa.2012.07.007; Ciubotaru I, 2003, J NUTR BIOCHEM, V14, P513, DOI 10.1016/S0955-2863(03)00101-3; Conquer JA, 1997, LIPIDS, V32, P341, DOI 10.1007/s11745-997-0043-y; Damsgaard CT, 2008, J NUTR, V138, P1061, DOI 10.1093/jn/138.6.1061; Daud ZAM, 2012, VASC HEALTH RISK MAN, V8, P187, DOI 10.2147/VHRM.S28739; de Mello VDF, 2009, EUR J NUTR, V48, P447, DOI 10.1007/s00394-009-0033-y; Derosa G, 2009, EXPERT OPIN PHARMACO, V10, P1239, DOI 10.1517/14656560902865601; Derosa G, 2012, J CLIN LIPIDOL, V6, P553, DOI 10.1016/j.jacl.2012.02.010; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; Engler MM, 2004, INT J CLIN PHARM TH, V42, P672; Eschen O, 2010, CELL MOL BIOL, V56, P45, DOI 10.1170/T878; Faghihi T, 2012, DARU, V20, DOI 10.1186/2008-2231-20-43; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Ferrari R, 1999, PHARMACOL RES, V40, P97, DOI 10.1006/phrs.1998.0463; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Freund-Levi Y, 2009, DEMENT GERIATR COGN, V27, P481, DOI 10.1159/000218081; Fujioka S, 2006, J NUTR SCI VITAMINOL, V52, P261, DOI 10.3177/jnsv.52.261; Gammelmark A, 2012, NUTR RES, V32, P15, DOI 10.1016/j.nutres.2011.12.007; Garaulet M, 2001, AM J CLIN NUTR, V74, P585; Geelen A, 2004, EUR J CLIN NUTR, V58, P1440, DOI 10.1038/sj.ejcn.1601986; Harbord RM, 2008, STATA J, V8, P493, DOI 10.1177/1536867X0800800403; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Houseknecht KL, 2002, DOMEST ANIM ENDOCRIN, V22, P1, DOI 10.1016/S0739-7240(01)00117-5; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Irving GF, 2009, J AM GERIATR SOC, V57, P11, DOI 10.1111/j.1532-5415.2008.02055.x; Jones PJH, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-28; Jones RM, 2011, BRIT J PSYCHIAT, V198, P93, DOI 10.1192/bjp.bp.110.083030; Kabir M, 2007, AM J CLIN NUTR, V86, P1670; Katan MB, 1997, J LIPID RES, V38, P2012; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Koh KK, 2012, ATHEROSCLEROSIS, V220, P537, DOI 10.1016/j.atherosclerosis.2011.11.018; Kolahi S, 2010, CLIN BIOCHEM, V43, P576, DOI 10.1016/j.clinbiochem.2009.12.011; Kooshki A, 2011, ANN NUTR METAB, V58, P197, DOI 10.1159/000329727; Krebs JD, 2006, INT J OBESITY, V30, P1535, DOI 10.1038/sj.ijo.0803309; Krysiak R, 2012, EUR J INTERN MED, V23, pE171, DOI 10.1016/j.ejim.2012.07.005; Krysiak R, 2012, EUR J INTERN MED, V23, pE166, DOI 10.1016/j.ejim.2012.05.017; Krysiak R, 2011, EUR J CLIN PHARMACOL, V67, P1109, DOI 10.1007/s00228-011-1063-y; Krysiak R, 2011, BASIC CLIN PHARMACOL, V109, P23, DOI 10.1111/j.1742-7843.2011.00675.x; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; Lenn J, 2002, MED SCI SPORT EXER, V34, P1605, DOI 10.1097/00005768-200210000-00012; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Lindqvist H, 2007, EUR J CLIN NUTR, V61, P1106, DOI 10.1038/sj.ejcn.1602630; Liu YM, 2006, J AM SOC NEPHROL, V17, P863, DOI 10.1681/ASN.2005050465; Lobner K, 2004, MMW Fortschr Med, V146, P32; Lobner K, 2004, MMW-FORTSCH MEDIZIN, V46, P35; Mackay I, 2012, ATHEROSCLEROSIS, V221, P514, DOI 10.1016/j.atherosclerosis.2011.12.041; Madsen T, 2003, BRIT J NUTR, V89, P517, DOI 10.1079/BJN2002815; Madsen T, 2007, J RENAL NUTR, V17, P258, DOI 10.1053/j.jrn.2007.03.003; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P875; Mann NJ, 2010, LIPIDS, V45, P669, DOI 10.1007/s11745-010-3450-z; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P834, DOI 10.1016/j.healun.2006.03.005; MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484; Mocking RJT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049431; Moertl D, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2011.02.011; Mogensen TH, 2003, J IMMUNOL, V170, P6224, DOI 10.4049/jimmunol.170.12.6224; Moghadam AM, 2012, SINGAP MED J, V53, P615; Mohammadi E, 2012, ASIA PAC J CLIN NUTR, V21, P511; Mori TA, 2006, CURR OPIN CLIN NUTR, V9, P95, DOI 10.1097/01.mco.0000214566.67439.58; Mori TA, 2003, FREE RADICAL BIO MED, V35, P772, DOI 10.1016/S0891-5849(03)00407-6; Mori TA, 2009, J HYPERTENS, V27, P1863, DOI 10.1097/HJH.0b013e32832e1bd9; Munro IA, 2012, BRIT J NUTR, V108, P1466, DOI 10.1017/S0007114511006817; Murphy KJ, 2007, BRIT J NUTR, V97, P749, DOI 10.1017/S000711450747252X; Myhrstad MCW, 2011, INFLAMM RES, V60, P309, DOI 10.1007/s00011-010-0302-5; Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017; Nodari S, 2009, CARDIOVASC DRUG THER, V23, P5, DOI 10.1007/s10557-008-6142-7; O'Keefe JH, 2006, AM J CARDIOL, V97, P1127, DOI 10.1016/j.amjcard.2005.11.025; Ottestad I, 2012, BRIT J NUTR, V108, P315, DOI 10.1017/S0007114511005484; Ougrin D, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-200; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Pooya S, 2010, NUTR METAB CARDIOVAS, V20, P326, DOI 10.1016/j.numecd.2009.04.002; Pot GK, 2009, EUR J CLIN NUTR, V63, P1353, DOI 10.1038/ejcn.2009.63; Ramel A, 2010, EUR J CLIN NUTR, V64, P987, DOI 10.1038/ejcn.2010.99; Rangel-Huerta OD, 2012, BRIT J NUTR, V107, pS159, DOI 10.1017/S0007114512001559; Rees D, 2006, AM J CLIN NUTR, V83, P331; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Rizza S, 2009, ATHEROSCLEROSIS, V206, P569, DOI 10.1016/j.atherosclerosis.2009.03.006; Robinson LE, 2007, APPL PHYSIOL NUTR ME, V32, P1008, DOI 10.1139/H07-087; Rodrigo R, 2012, INTERACT CARDIOV TH, V15, P209, DOI 10.1093/icvts/ivs154; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Sabour H, 2012, J RES MED SCI, V17, P322; Saifullah A, 2007, NEPHROL DIAL TRANSPL, V22, P3561, DOI 10.1093/ndt/gfm422; Sanders TAB, 2006, BRIT J NUTR, V95, P525, DOI 10.1079/BJN20051658; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Shahbakhti H, 2004, PHOTOCHEM PHOTOBIOL, V80, P231, DOI 10.1562/2004-01-27-RA-066.1; Sierra S, 2008, NUTRITION, V24, P245, DOI 10.1016/j.nut.2007.11.005; Skulas-Ray AC, 2011, AM J CLIN NUTR, V93, P243, DOI 10.3945/ajcn.110.003871; Theobald HE, 2007, J NUTR, V137, P973, DOI 10.1093/jn/137.4.973; Thusgaard M, 2009, SCAND J INFECT DIS, V41, P760, DOI 10.1080/00365540903168056; Tierney AC, 2011, INT J OBESITY, V35, P800, DOI 10.1038/ijo.2010.209; Vega-Lopez S, 2004, METABOLISM, V53, P236, DOI 10.1016/j.metabol.2003.09.012; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Watanabe N, 2009, INT J FOOD SCI NUTR, V60, P136, DOI 10.1080/09637480802683942; Wee CC, 2008, OBESITY, V16, P875, DOI 10.1038/oby.2008.7; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156; Xin W, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-77; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yeh ETH, 2001, CIRCULATION, V104, P974, DOI 10.1161/01.CIR.104.9.974; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zhang J, 2012, BRIT J NUTR, V108, P1455, DOI 10.1017/S0007114511006866; Zhao YT, 2009, J INT MED RES, V37, P1831, DOI 10.1177/147323000903700619; Zheng JS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3706	125	145	148	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88103	10.1371/journal.pone.0088103	http://dx.doi.org/10.1371/journal.pone.0088103			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505395	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200117
J	Romeo, C; Wauters, LA; Ferrari, N; Lanfranchi, P; Martinoli, A; Pisanu, B; Preatoni, DG; Saino, N				Romeo, Claudia; Wauters, Lucas A.; Ferrari, Nicola; Lanfranchi, Paolo; Martinoli, Adriano; Pisanu, Benoit; Preatoni, Damiano G.; Saino, Nicola			Macroparasite Fauna of Alien Grey Squirrels (Sciurus carolinensis): Composition, Variability and Implications for Native Species	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; EURASIAN RED SQUIRRELS; INTERSPECIFIC COMPETITION; BIOLOGICAL INVASIONS; PARASITE COMMUNITIES; EXPERIMENTAL-ANIMALS; POPULATION-DYNAMICS; TAMIAS-SIBIRICUS; HOST DENSITIES; TREE SQUIRRELS	Introduced hosts populations may benefit of an "enemy release" through impoverishment of parasite communities made of both few imported species and few acquired local ones. Moreover, closely related competing native hosts can be affected by acquiring introduced taxa (spillover) and by increased transmission risk of native parasites (spillback). We determined the macroparasite fauna of invasive grey squirrels (Sciurus carolinensis) in Italy to detect any diversity loss, introduction of novel parasites or acquisition of local ones, and analysed variation in parasite burdens to identify factors that may increase transmission risk for native red squirrels (S. vulgaris). Based on 277 grey squirrels sampled from 7 populations characterised by different time scales in introduction events, we identified 7 gastro-intestinal helminths and 4 parasite arthropods. Parasite richness is lower than in grey squirrel's native range and independent from introduction time lags. The most common parasites are Nearctic nematodes Strongyloides robustus (prevalence: 56.6%) and Trichostrongylus calcaratus (6.5%), red squirrel flea Ceratophyllus sciurorum (26.0%) and Holarctic sucking louse Neohaematopinus sciuri (17.7%). All other parasites are European or cosmopolitan species with prevalence below 5%. S. robustus abundance is positively affected by host density and body mass, C. sciurorum abundance increases with host density and varies with seasons. Overall, we show that grey squirrels in Italy may benefit of an enemy release, and both spillback and spillover processes towards native red squirrels may occur.	[Romeo, Claudia; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Wauters, Lucas A.; Martinoli, Adriano; Preatoni, Damiano G.] Univ Insubria, Dept Theoret & Appl Sci, Varese, Italy; [Ferrari, Nicola; Lanfranchi, Paolo] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Pisanu, Benoit] Museum Natl Hist Nat, Dept Ecol & Biodivers Management, F-75231 Paris, France	University of Milan; University of Insubria; University of Milan; Museum National d'Histoire Naturelle (MNHN)	Romeo, C (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	claudia.romeo@unimi.it	Preatoni, Damiano G./A-8621-2010; Lanfranchi, Paolo/K-5976-2017; Romeo, Claudia/D-5916-2017; Ferrari, Nicola/E-6331-2013; Martinoli, Adriano/L-4924-2016	Preatoni, Damiano G./0000-0001-8760-1316; Lanfranchi, Paolo/0000-0002-8266-5481; Romeo, Claudia/0000-0002-5964-2847; Ferrari, Nicola/0000-0001-8959-3495; Saino, Nicola/0000-0002-0230-3967; Wauters, Lucas Armand/0000-0002-7012-9200; Martinoli, Adriano/0000-0003-0298-0869; Wauters, Lucas/0000-0002-4871-5035	Universita degli Studi di Milano; Universita degli Studi dell'Insubria	Universita degli Studi di Milano; Universita degli Studi dell'Insubria	This study was funded by Universita degli Studi di Milano and Universita degli Studi dell'Insubria and constitutes part of a Ph.D. thesis by CR at the Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Arneberg P, 2002, ECOGRAPHY, V25, P88, DOI 10.1034/j.1600-0587.2002.250110.x; Arneberg P, 2001, ECOGRAPHY, V24, P352, DOI 10.1034/j.1600-0587.2001.240313.x; Audebert F, 2002, J HELMINTHOL, V76, P189, DOI 10.1079/JOH2002126; Bertolino S, 2005, HYSTRIX ITAL J MAMMA, V16; Bertolino S, 2014, BIOL INVASIONS, V16, P53, DOI 10.1007/s10530-013-0502-3; Blumenthal D, 2009, P NATL ACAD SCI USA, V106, P7899, DOI 10.1073/pnas.0812607106; Boyer N, 2010, J ANIM ECOL, V79, P538, DOI 10.1111/j.1365-2656.2010.01659.x; CHANDLER ASA C., 1942, JOUR PARASITOL, V28, P135, DOI 10.2307/3272725; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Czaplinski B, 1994, FAMILY HYMENOLEPIDID, V1899, P595; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson WR, 1976, P HELMINTHOL SOC WAS, V43; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DON BAC, 1983, MAMMAL REV, V13, P123, DOI 10.1111/j.1365-2907.1983.tb00273.x; Dunn AM, 2012, FUNCT ECOL, V26, P1262, DOI 10.1111/j.1365-2435.2012.02041.x; Dunn AM, 2012, FUNCT ECOL, V26, P1234, DOI 10.1111/1365-2435.12022; Durden L. A., 1994, B AMNH, V218; Durden LA, 2004, J PARASITOL, V90, P485, DOI 10.1645/GE-3299; Eckerlin RP, 1974, THESIS U CONNECTICUT; Feliu C, 2000, J PARASITOL, V86, P442, DOI 10.1645/0022-3395(2000)086[0442:GAMHIS]2.0.CO;2; Gould WR, 1997, CAN J FISH AQUAT SCI, V54, P890, DOI 10.1139/cjfas-54-4-890; Gurnell J, 2004, J ANIM ECOL, V73, P26, DOI 10.1111/j.1365-2656.2004.00791.x; Gurnell J, 1996, J APPL ECOL, V33, P325, DOI 10.2307/2404754; HARKEMA REINARD, 1936, ECOL MONOGR, V6, P151, DOI 10.2307/1943242; HOLM S, 1979, SCAND J STAT, V6, P65; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Hudson P. J., 1995, P144, DOI 10.1017/CBO9780511629396.006; HUGOT J-P, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P711; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Katz JS, 1938, THESIS OHIO STATE U; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; Koprowski John L., 1994, Mammalian Species, V480, P1, DOI 10.2307/3504263; Krichbaum K, 2010, J WILDLIFE DIS, V46, P229, DOI 10.7589/0090-3558-46.1.229; Leary S, 2013, AVMA GUIDELINES EUTH; Leslie PH, 1939, J ANIM ECOL, V8, P94, DOI 10.2307/1255; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; MacLeod CJ, 2010, ECOL LETT, V13, P516, DOI 10.1111/j.1461-0248.2010.01446.x; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Martinoli A, 2010, HYSTRIX ITAL J MAMMA, V21; McInnes CJ, 2013, ANIM CONSERV, V16, P51, DOI 10.1111/j.1469-1795.2012.00570.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moravec Frantisek, 2000, Acta Societatis Zoologicae Bohemicae, V64, P271; Nelson G. A., 2013, FISHMETHODS FISHERY; Parker JC, 1971, THESIS VIRGINIA POLY; Pisanu B, 2009, PARASITOL RES, V104, P709, DOI 10.1007/s00436-008-1279-7; Pisanu B, 2007, PARASITOL RES, V100, P1375, DOI 10.1007/s00436-006-0389-3; Poulin R, 2011, FRESHWATER BIOL, V56, P676, DOI 10.1111/j.1365-2427.2010.02425.x; RAUSCH R, 1948, AM MIDL NAT, V39, P728, DOI 10.2307/2421532; Romeo C, 2013, PARASITOL RES, V112, P3527, DOI 10.1007/s00436-013-3535-8; Romeo C, 2010, ACTA OECOL, V36, P604, DOI 10.1016/j.actao.2010.09.005; Rushton SP, 2006, EPIDEMIOL INFECT, V134, P521, DOI 10.1017/S0950268805005303; SCHULZE TL, 1986, J MED ENTOMOL, V23, P105, DOI 10.1093/jmedent/23.1.105; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Shorten M, 1954, NEW NAT SQUIRRELS; Strauss A, 2012, FUNCT ECOL, V26, P1249, DOI 10.1111/1365-2435.12011; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Thieltges DW, 2009, BIOL INVASIONS, V11, P1421, DOI 10.1007/s10530-008-9350-y; Tizzani P, 2011, PARASITOL RES, V109, P963, DOI 10.1007/s00436-011-2375-7; Tompkins D.M., 2002, P45; Tompkins DM, 2000, ECOL LETT, V3, P10, DOI 10.1046/j.1461-0248.2000.00117.x; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Torchin ME, 2001, BIOL INVASIONS, V3, P333, DOI 10.1023/A:1015855019360; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Traub R., 1983, ROTHSCHILD COLLECTIO; Vila M, 2005, OECOLOGIA, V142, P474, DOI 10.1007/s00442-004-1731-z; Vila M, 2010, FRONT ECOL ENVIRON, V8, P135, DOI 10.1890/080083; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; WAUTERS L, 1989, J ANIM ECOL, V58, P637, DOI 10.2307/4853; WAUTERS L, 1992, ANIM BEHAV, V43, P297, DOI 10.1016/S0003-3472(05)80225-8; Wauters L, 2005, HYSTRIX ITAL J MAMMA, V16; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; Wauters LA, 2002, BEHAV ECOL SOCIOBIOL, V51, P360, DOI 10.1007/s00265-001-0446-y; Wauters LA, 2002, BEHAV ECOL SOCIOBIOL, V52, P332, DOI 10.1007/s00265-002-0516-9; Wauters LA, 2008, ECOGRAPHY, V31, P104, DOI 10.1111/j.2007.0906-7590.05251.x; Wauters LA, 2007, ECOGRAPHY, V30, P51, DOI [10.1111/j.0906-7590.2007.04646.x, 10.1111/j.2006.0906-7590.04646.x]; WIGGINS JP, 1980, J WILDLIFE DIS, V16, P541, DOI 10.7589/0090-3558-16.4.541; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	84	33	34	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88002	10.1371/journal.pone.0088002	http://dx.doi.org/10.1371/journal.pone.0088002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505348	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200095
J	Abdelbary, MMH; Wittenberg, A; Cuny, C; Layer, F; Kurt, K; Wieler, LH; Walther, B; Skov, R; Larsen, J; Hasman, H; Fitzgerald, JR; Smith, TC; Wagenaar, JA; Pantosti, A; Hallin, M; Struelens, MJ; Edwards, G; Bose, R; Nubel, U; Witte, W				Abdelbary, Mohamed M. H.; Wittenberg, Anne; Cuny, Christiane; Layer, Franziska; Kurt, Kevin; Wieler, Lothar H.; Walther, Birgit; Skov, Robert; Larsen, Jesper; Hasman, Henrik; Fitzgerald, J. Ross; Smith, Tara C.; Wagenaar, J. A.; Pantosti, Annalisa; Hallin, Marie; Struelens, Marc J.; Edwards, Giles; Boese, R.; Nuebel, Ulrich; Witte, Wolfgang			Phylogenetic Analysis of Staphylococcus aureus CC398 Reveals a Sub-Lineage Epidemiologically Associated with Infections in Horses	PLOS ONE			English	Article							METHICILLIN-RESISTANT; VETERINARY PERSONNEL; RISK-FACTORS; ST398; MRSA; COLONIZATION; EMERGENCE; ANIMALS; TRANSMISSION; EVOLUTION	In the early 2000s, a particular MRSA clonal complex (CC398) was found mainly in pigs and pig farmers in Europe. Since then, CC398 has been detected among a wide variety of animal species worldwide. We investigated the population structure of CC398 through mutation discovery at 97 genetic housekeeping loci, which are distributed along the CC398 chromosome within 195 CC398 isolates, collected from various countries and host species, including humans. Most of the isolates in this collection were received from collaborating microbiologists, who had preserved them over years. We discovered 96 bi-allelic polymorphisms, and phylogenetic analyses revealed that an epidemic sub-clone within CC398 (dubbed 'clade (C)') has spread within and between equine hospitals, where it causes nosocomial infections in horses and colonises the personnel. While clade (C) was strongly associated with S. aureus from horses in veterinary-care settings (p = 2x10(-7)), it remained extremely rare among S. aureus isolates from human infections.	[Abdelbary, Mohamed M. H.; Cuny, Christiane; Layer, Franziska; Kurt, Kevin; Nuebel, Ulrich; Witte, Wolfgang] Robert Koch Inst, Wernigerode, Germany; [Wittenberg, Anne; Wieler, Lothar H.; Walther, Birgit] Free Univ Berlin, Inst Microbiol & Epizoot, Berlin, Germany; [Skov, Robert; Larsen, Jesper] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Hasman, Henrik] Tech Univ Denmark, Natl Food Inst, DK-2800 Lyngby, Denmark; [Fitzgerald, J. Ross] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Smith, Tara C.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Wagenaar, J. A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Pantosti, Annalisa] Ist Super Sanita, I-00161 Rome, Italy; [Hallin, Marie] Univ Libre Bruxelles, Ctr Natl Reference Staphylococcus Aureus, Dept Microbiol, Erasme Univ Hosp, Brussels, Belgium; [Struelens, Marc J.] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Edwards, Giles] Glasgow Royal Infirm, Dept Microbiol, SMRSARL, Glasgow G4 0SF, Lanark, Scotland; [Boese, R.] Labor Dr Bose GmbH, Harsum, Germany	Robert Koch Institute; Free University of Berlin; Statens Serum Institut; Technical University of Denmark; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Iowa; Utrecht University; Istituto Superiore di Sanita (ISS); Universite Libre de Bruxelles; European Centre for Disease Prevention & Control; University of Glasgow	Abdelbary, MMH (corresponding author), Robert Koch Inst, Wernigerode, Germany.	abd-el-barym@rki.de	Larsen, Jesper/AAJ-3161-2021; Pantosti, Annalisa/A-7291-2013; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Pantosti, Annalisa/0000-0002-8409-4731; Skov, Robert/0000-0002-6079-5381; Struelens, Marc/0000-0001-5150-4944; Layer, Franziska/0000-0002-4613-6478; Hasman, Henrik/0000-0001-6314-2709; Smith, Tara C./0000-0003-3747-1116; Walther, Birgit/0000-0003-3112-5722; Wieler, Lothar H./0000-0003-4365-3717; Abdelbary, Mohamed/0000-0001-8569-0319	German Federal Ministry of Education and Research [D1KI10146]; BBSRC [BBS/E/D/20231761, BB/I013873/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I013873/1, BBS/E/D/20231761] Funding Source: researchfish	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by grant D1KI10146 from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerso Y, 2012, VET MICROBIOL, V157, P246, DOI 10.1016/j.vetmic.2011.12.023; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Anderson MEC, 2008, VET MICROBIOL, V129, P410, DOI 10.1016/j.vetmic.2007.11.031; CEFAI C, 1994, LANCET, V344, P539, DOI 10.1016/S0140-6736(94)91926-7; Cuny C, 2008, MICROB DRUG RESIST, V14, P307, DOI 10.1089/mdr.2008.0845; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; DEVRIESE LA, 1972, ZENTRALB VET RIEHE B, V19, P598; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellington MJ, 2010, J ANTIMICROB CHEMOTH, V65, P446, DOI 10.1093/jac/dkp448; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Guardabassi L, 2007, VET MICROBIOL, V122, P384, DOI 10.1016/j.vetmic.2007.03.021; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Hanselman BA, 2006, EMERG INFECT DIS, V12, P1933; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holden MTG, 2013, GENOME RES, V23, P653, DOI 10.1101/gr.147710.112; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kurt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058155; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Loeffler A, 2009, J HOSP INFECT, V72, P269, DOI 10.1016/j.jhin.2009.04.002; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Moodley A, 2008, SCAND J WORK ENV HEA, V34, P151, DOI 10.5271/sjweh.1219; Nemati M, 2008, ANTIMICROB AGENTS CH, V52, P3817, DOI 10.1128/AAC.00613-08; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Nulens E, 2005, EUR J CLIN MICROBIOL, V24, P145, DOI 10.1007/s10096-004-1258-6; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Pan A, 2009, EMERG INFECT DIS, V15, P845, DOI 10.3201/eid1505.081417; Panchaud Y, 2010, SCHWEIZ ARCH TIERH, V152, P176, DOI 10.1024/0036-7281/a000040; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Persoons D, 2009, EMERG INFECT DIS, V15, P452, DOI 10.3201/eid1503.080696; Porphyre T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047504; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Rohde SM, 2013, J ANTIMICROB CHEMOTH; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; SCOTT GM, 1988, J HOSP INFECT, V12, P29, DOI 10.1016/0195-6701(88)90119-3; Seguin JC, 1999, J CLIN MICROBIOL, V37, P1459, DOI 10.1128/JCM.37.5.1459-1463.1999; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Smith TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063704; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Tavakol M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-28; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van de Giessen AW, 2009, PREV VET MED, V91, P270, DOI 10.1016/j.prevetmed.2009.05.016; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Van den Eede A, 2009, VET MICROBIOL, V133, P138, DOI 10.1016/j.vetmic.2008.06.021; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Duijkeren E, 2010, VET MICROBIOL, V141, P96, DOI 10.1016/j.vetmic.2009.08.009; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vincze S, 2013, APPL ENVIRON MICROB, V79, P655, DOI 10.1128/AEM.02704-12; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weese JS, 2007, CAN VET J, V48, P921; Weese JS, 2005, J AM ANIM HOSP ASSOC, V41, P150, DOI 10.5326/0410150; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; Weese JS, 2006, VET MICROBIOL, V114, P160, DOI 10.1016/j.vetmic.2005.11.054; Werner G, 2012, VET MICROBIOL, V160, P162, DOI [10.1016/j.vetmic.2012.05.019, 10.1016/j.vetmic.2012.05.005]; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf M, 2006, EMERG INFECT DIS, V12, P1939	79	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88083	10.1371/journal.pone.0088083	http://dx.doi.org/10.1371/journal.pone.0088083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505386	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300051
J	Hattori, T; Shimizu, S; Koyama, Y; Emoto, H; Matsumoto, Y; Kumamoto, N; Yamada, K; Takamura, H; Matsuzaki, S; Katayama, T; Tohyama, M; Ito, A				Hattori, Tsuyoshi; Shimizu, Shoko; Koyama, Yoshihisa; Emoto, Hisayo; Matsumoto, Yuji; Kumamoto, Natsuko; Yamada, Kohei; Takamura, Hironori; Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya; Ito, Akira			DISC1 (Disrupted-in-Schizophrenia-1) Regulates Differentiation of Oligodendrocytes	PLOS ONE			English	Article							NEURITE OUTGROWTH; WHITE-MATTER; ADULT BRAIN; PROGENITOR PROLIFERATION; PSYCHIATRIC-DISORDERS; TRANSCRIPTION FACTOR; BIPOLAR DISORDER; MOOD DISORDERS; CANDIDATE GENE; SCHIZOPHRENIA	Disrupted-in-schizophrenia 1 (DISC1) is a gene disrupted by a translocation, t(1;11) (q42.1;q14.3), that segregates with major psychiatric disorders, including schizophrenia, recurrent major depression and bipolar affective disorder, in a Scottish family. Here we report that mammalian DISC1 endogenously expressed in oligodendroglial lineage cells negatively regulates differentiation of oligodendrocyte precursor cells into oligodendrocytes. DISC1 expression was detected in oligodendrocytes of the mouse corpus callosum at P14 and P70. DISC1 mRNA was expressed in primary cultured rat cortical oligodendrocyte precursor cells and decreased when oligodendrocyte precursor cells were induced to differentiate by PDGF deprivation. Immunocytochemical analysis showed that overexpressed DISC1 was localized in the cell bodies and processes of oligodendrocyte precursor cells and oligodendrocytes. We show that expression of the myelin related markers, CNPase and MBP, as well as the number of cells with a matured oligodendrocyte morphology, were decreased following full length DISC1 overexpression. Conversely, both expression of CNPase and the number of oligodendrocytes with a mature morphology were increased following knockdown of endogenous DISC1 by RNA interference. Overexpression of a truncated form of DISC1 also resulted in an increase in expression of myelin related proteins and the number of mature oligodendrocytes, potentially acting via a dominant negative mechanism. We also identified involvement of Sox10 and Nkx2.2 in the DISC1 regulatory pathway of oligodendrocyte differentiation, both well-known transcription factors involved in the regulation of myelin genes.	[Hattori, Tsuyoshi; Ito, Akira] Osaka Univ, Dept Mol Neuropsychiat, Grad Sch Med, Suita, Osaka, Japan; [Koyama, Yoshihisa; Matsuzaki, Shinsuke; Tohyama, Masaya] Osaka Univ, Dept Anat & Neurosci, Grad Sch Med, Suita, Osaka, Japan; [Yamada, Kohei; Takamura, Hironori; Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Yamada, Kohei; Takamura, Hironori; Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Suita, Osaka, Japan; [Shimizu, Shoko; Tohyama, Masaya] Kinki Univ, Div Mol Brain Sci, Res Inst Tradit Asian Med, Sayama, Osaka, Japan; [Emoto, Hisayo; Matsumoto, Yuji] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Suita, Osaka, Japan; [Kumamoto, Natsuko] Nagoya City Univ, Grad Sch Med Sci, Dept Neurobiol & Anat, Nagoya, Aichi, Japan	Osaka University; Osaka University; Kanazawa University; Osaka University; Kindai University (Kinki University); Dainippon Sumitomo Pharmaceutical Company; Nagoya City University	Hattori, T (corresponding author), Osaka Univ, Dept Mol Neuropsychiat, Grad Sch Med, Suita, Osaka, Japan.	hattori@anat2.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23123512, 23700415]; Dainippon Sumitomo Pharma Co., Ltd.	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.)	This work was partially supported by Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization", from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (No. 23123512 and No. 23700415), and by a grant from Dainippon Sumitomo Pharma Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenina N, 2006, STEM CELL REV, V2, P5, DOI 10.1385/SCR:2:1:5; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Baumann N, 2002, J PHYSIOLOGY-PARIS, V96, P301, DOI 10.1016/S0928-4257(02)00019-0; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI [10.1586/ern.09.59, 10.1586/ERN.09.59]; Brandon NJ, 2007, BIOCHEM SOC T, V35, P1283, DOI 10.1042/BST0351283; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo Luiz M, 2008, Novartis Found Symp, V289, P208; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Drerup CM, 2009, DEVELOPMENT, V136, P2623, DOI 10.1242/dev.030577; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Edgar N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.34; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Emery B, 2010, CURR OPIN NEUROBIOL, V20, P601, DOI 10.1016/j.conb.2010.05.005; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Feng Y, 2008, NEUROCHEM RES, V33, P1940, DOI 10.1007/s11064-008-9693-x; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hof PR, 2003, BIOL PSYCHIAT, V53, P1075, DOI 10.1016/S0006-3223(03)00237-3; Honda A, 2004, MOL BRAIN RES, V122, P89, DOI 10.1016/j.molbrainres.2003.11.020; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Jaaro-Peled H, 2013, HUM MOL GENET; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Katsel P, 2011, SCHIZOPHR RES, V130, P238, DOI 10.1016/j.schres.2011.04.021; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kosmidis MH, 2010, INT REV PSYCHIATR, V22, P55, DOI 10.3109/09540261003589612; Koyama Y, 2008, J CHEM NEUROANAT, V36, P209, DOI 10.1016/j.jchemneu.2008.08.006; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Maeno N, 2007, PSYCHIAT GENET, V17, P227, DOI 10.1097/YPG.0b013e3280ae6cd8; Maher BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034053; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Niwa M, 2013, SCIENCE, V339, P335, DOI 10.1126/science.1226931; Osbun N, 2011, AM J MED GENET A, V155A, P1865, DOI 10.1002/ajmg.a.34081; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002; Qi YC, 2001, DEVELOPMENT, V128, P2723; Roberts RC, 2007, SCHIZOPHRENIA BULL, V33, P11, DOI 10.1093/schbul/sbl063; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Seshadri S, 2010, P NATL ACAD SCI USA, V107, P5622, DOI 10.1073/pnas.0909284107; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Spencer KM, 2003, J NEUROSCI, V23, P7407; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Walterfang M, 2005, AUST NZ J PSYCHIAT, V39, P746, DOI 10.1080/j.1440-1614.2005.01678.x; Walterfang M, 2011, EXPERT REV NEUROTHER, V11, P971, DOI [10.1586/ern.11.76, 10.1586/ERN.11.76]; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wood JD, 2009, HUM MOL GENET, V18, P391, DOI 10.1093/hmg/ddn361	66	39	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88506	10.1371/journal.pone.0088506	http://dx.doi.org/10.1371/journal.pone.0088506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516667	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400075
J	Kanapathipillai, R; McManus, H; Kamarulzaman, A; Lim, PL; Templeton, DJ; Law, M; Woolley, I				Kanapathipillai, Rupa; McManus, Hamish; Kamarulzaman, Adeeba; Lim, Poh Lian; Templeton, David J.; Law, Matthew; Woolley, Ian			The Significance of HIV 'Blips' in Resource-Limited Settings: Is It the Same? Analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LOW-LEVEL VIREMIA; INTERMITTENT VIREMIA; INFECTED PATIENTS; DRUG-RESISTANCE; VIRAL LOAD; CLINICAL-SIGNIFICANCE; TRANSIENT VIREMIA; HAART; SUPPRESSION	Introduction Magnitude and frequency of HIV viral load blips in resource-limited settings, has not previously been assessed. This study was undertaken in a cohort from a high income country (Australia) known as AHOD (Australian HIV Observational Database) and another cohort from a mixture of Asian countries of varying national income per capita, TAHOD (TREAT Asia HIV Observational Database). Methods: Blips were defined as detectable VL (>= 50 copies/mL) preceded and followed by undetectable VL (<50 copies/mL). Virological failure (VF) was defined as two consecutive VL >= 50 copies/ml. Cox proportional hazard models of time to first VF after entry, were developed. Results: 5040 patients (AHOD n = 2597 and TAHOD n = 2521) were included; 910 (18%) of patients experienced blips. 744 (21%) and 166 (11%) of high-and middle/low-income participants, respectively, experienced blips ever. 711 (14%) experienced blips prior to virological failure. 559 (16%) and 152 (10%) of high- and middle/low-income participants, respectively, experienced blips prior to virological failure. VL testing occurred at a median frequency of 175 and 91 days in middle/low- and high-income sites, respectively. Longer time to VF occurred in middle/low income sites, compared with high-income sites (adjusted hazards ratio (AHR) 0.41; p<0.001), adjusted for year of first cART, Hepatitis C co-infection, cART regimen, and prior blips. Prior blips were not a significant predictor of VF in univariate analysis (AHR 0.97, p = 0.82). Differing magnitudes of blips were not significant in univariate analyses as predictors of virological failure (p = 0.360 for blip 50-<= 1000, p = 0.309 for blip 50-<= 400 and p = 0.300 for blip 50-<= 200). 209 of 866 (24%) patients were switched to an alternate regimen in the setting of a blip. Conclusion: Despite a lower proportion of blips occurring in low/middle-income settings, no significant difference was found between settings. Nonetheless, a substantial number of participants were switched to alternative regimens in the setting of blips.	[Kanapathipillai, Rupa; Woolley, Ian] Monash Med Ctr, Clayton, Vic 3168, Australia; [Kanapathipillai, Rupa; Woolley, Ian] Alfred Hosp, Prahran, Vic 3181, Australia; [McManus, Hamish; Templeton, David J.; Law, Matthew] Univ New S Wales, Kirby Inst, Darlinghurst, NSW, Australia; [Kamarulzaman, Adeeba] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Lim, Poh Lian] Tan Tock Seng Hosp, Dept Infect Dis, Singapore, Singapore; [Templeton, David J.] Royal Prince Alfred Hosp, RPA Sexual Hlth, Sydney, NSW, Australia; [Woolley, Ian] Monash Univ, Dept Med & Infect Dis, Clayton, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of New South Wales Sydney; Kirby Institute; Universiti Malaya; Tan Tock Seng Hospital; University of Sydney; Monash University	Woolley, I (corresponding author), Monash Med Ctr, Clayton, Vic 3168, Australia.	ian.woolley@monash.edu	KAMARULZAMAN, ADEEBA/B-5216-2010	McManus, Hamish/0000-0002-7264-8848; Woolley, Ian John/0000-0003-2928-1291; Law, Matthew/0000-0002-3540-8837; Templeton, David/0000-0003-2157-9587	U.S. National Institutes of Health (NIH): National Institute of Allergy and Infectious Diseases (NIAID); U.S. National Institutes of Health (NIH): National Institute of Child Health and Human Development (NICHD); U.S. National Institutes of Health (NIH): Office of the Director (OD); U.S. National Institutes of Health (NIH): National Cancer Institute (NCI), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) [U01AI069907]; Dutch Ministry of Foreign Affairs; Stichting Aids Fonds; Merck Sharp Dohme; Gilead; Bristol- Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen- Cilag; Australian Government Department of Health and Ageing; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH): National Institute of Allergy and Infectious Diseases (NIAID); U.S. National Institutes of Health (NIH): National Institute of Child Health and Human Development (NICHD); U.S. National Institutes of Health (NIH): Office of the Director (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health (NIH): National Cancer Institute (NCI), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA); Dutch Ministry of Foreign Affairs; Stichting Aids Fonds; Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences); Bristol- Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Janssen- Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The TREAT Asia HIV Observational Database and the Australian HIV Observational Database are part of the Asia Pacific HIV Observational Database and are initiatives of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the following institutes of the U.S. National Institutes of Health (NIH): National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), the Office of the Director (OD), and the National Cancer Institute (NCI), as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no. U01AI069907). Additional support is provided by the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds. The Australian HIV Observational Database is also funded by unconditional grants from Merck Sharp & Dohme; Gilead; Bristol- Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen- Cilag. The Kirby Institute for Infection and Immunity in society is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. There were no specific funding sources for the study in addition to the information supplied above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; Easterbrook PJ, 2002, AIDS, V16, P1521, DOI 10.1097/00002030-200207260-00009; Garcia-Gasco P, 2008, J ANTIMICROB CHEMOTH, V61, P699, DOI 10.1093/jac/dkm516; Grennan JT, 2012, J INFECT DIS, V205, P1230, DOI 10.1093/infdis/jis104; Greub G, 2002, AIDS, V16, P1967, DOI 10.1097/00002030-200209270-00017; Gueudin M, 2007, JAIDS-J ACQ IMM DEF, V44, P500, DOI 10.1097/QAI.0b013e31803260df; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Jones LE, 2005, B MATH BIOL, V67, P1227, DOI 10.1016/j.bulm.2005.01.006; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; Masquelier B, 2005, J CLIN VIROL, V33, P75, DOI 10.1016/j.jcv.2004.11.012; Mira JA, 2002, ANTIVIR THER, V7, P251; Moore AL, 2002, AIDS, V16, P615, DOI 10.1097/00002030-200203080-00013; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Podsadecki TJ, 2007, J INFECT DIS, V196, P1773, DOI 10.1086/523704; Raboud JM, 2002, AIDS, V16, P1627, DOI 10.1097/00002030-200208160-00008; Ruelle J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-100; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Stosor V, 2005, CLIN INFECT DIS, V41, P1671, DOI 10.1086/498025; Stuart JWTC, 2001, J ACQ IMMUN DEF SYND, V28, P105, DOI 10.1097/00042560-200110010-00001; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Verhofstede C, 2010, J CLIN VIROL, V47, P335, DOI 10.1016/j.jcv.2010.01.008	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86122	10.1371/journal.pone.0086122	http://dx.doi.org/10.1371/journal.pone.0086122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516527	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400006
J	Satten, GA; Allen, AS; Ikeda, M; Mulle, JG; Warren, ST				Satten, Glen A.; Allen, Andrew S.; Ikeda, Morna; Mulle, Jennifer G.; Warren, Stephen T.			Robust Regression Analysis of Copy Number Variation Data based on a Univariate Score	PLOS ONE			English	Article							ARRAY CGH DATA; HIGH-RISK; SEGMENTATION; AUTISM; MODEL	Motivation: The discovery that copy number variants (CNVs) are widespread in the human genome has motivated development of numerous algorithms that attempt to detect CNVs from intensity data. However, all approaches are plagued by high false discovery rates. Further, because CNVs are characterized by two dimensions (length and intensity) it is unclear how to order called CNVs to prioritize experimental validation. Results: We developed a univariate score that correlates with the likelihood that a CNV is true. This score can be used to order CNV calls in such a way that calls having larger scores are more likely to overlap a true CNV. We developed cnv.beast, a computationally efficient algorithm for calling CNVs that uses robust backward elimination regression to keep CNV calls with scores that exceed a user-defined threshold. Using an independent dataset that was measured using a different platform, we validated our score and showed that our approach performed better than six other currently-available methods. Availability: cnv.beast is available at http://www.duke.edu/similar to asallen/Software.html.	[Satten, Glen A.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30329 USA; [Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Allen, Andrew S.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Ikeda, Morna; Mulle, Jennifer G.] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Mulle, Jennifer G.; Warren, Stephen T.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Duke University; Duke University; Emory University; Emory University	Satten, GA (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30329 USA.	GSatten@cdc.gov		Allen, Andrew/0000-0002-7232-2143; Satten, Glen/0000-0001-7275-5371	NIH [MH080129, MH083722, MH080583, HL077663, MH084680]; Simons Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL077663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH080583, R01MH083722, R01MH080129, R01MH084680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MI, JGM, and STW are supported, in part, by NIH grants MH080129 and MH083722 and by the Simons Foundation (to STW). JGM was supported by a NIH fellowship award (MH080583). ASA is supported by NIH grants HL077663 and MH084680. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ely B, 2009, THESIS U WASHINGTON; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Huang J, 2007, BIOINFORMATICS, V23, P2463, DOI 10.1093/bioinformatics/btm359; Huang T, 2005, BIOINFORMATICS, V21, P3811, DOI 10.1093/bioinformatics/bti646; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jeng XJ, 2010, J AM STAT ASSOC, V105, P1156, DOI 10.1198/jasa.2010.tm10083; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Moreno-De-Luca D, 2011, AM J HUM GENET, V88, P121, DOI 10.1016/j.ajhg.2010.12.005; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Mulle JG, 2013, BIOL PSYCHI IN PRESS; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Picard F, 2007, BIOMETRICS, V63, P758, DOI 10.1111/j.1541-0420.2006.00729.x; Satten GA, 2012, TESTING COPY NUMBER; Tibshirani R, 2008, BIOSTATISTICS, V9, P18, DOI 10.1093/biostatistics/kxm013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Xing BF, 2007, BIOSTATISTICS, V8, P632, DOI 10.1093/biostatistics/kxl035	19	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86272	10.1371/journal.pone.0086272	http://dx.doi.org/10.1371/journal.pone.0086272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516529	Green Published, gold			2022-12-27	WOS:000330834400007
J	Smith, JB; Jenks, JA; Grovenburg, TW; Klaver, RW				Smith, Joshua B.; Jenks, Jonathan A.; Grovenburg, Troy W.; Klaver, Robert W.			Disease and Predation: Sorting out Causes of a Bighorn Sheep (Ovis canadensis) Decline	PLOS ONE			English	Article							MOUNTAIN LION PREDATION; TEMPORAL VARIATION; COUGAR PREDATION; CALF SURVIVAL; POPULATION; MORTALITY; DYNAMICS; GROWTH; RECRUITMENT; PNEUMONIA	Estimating survival and documenting causes and timing of mortality events in neonate bighorn sheep (Ovis canadensis) improves understanding of population ecology and factors influencing recruitment. During 2010-2012, we captured and radiocollared 74 neonates in the Black Hills, South Dakota, of which 95% (70) died before 52 weeks of age. Pneumonia (36%) was the leading cause of mortality followed by predation (30%). We used known fate analysis in Program MARK to estimate weekly survival rates and investigate the influence of intrinsic variables on 52-week survival. Model {S-1 wk,S- 2-8 wks,S- >8 wks} had the lowest AIC(c) (Akaike's Information Criterion corrected for small sample size) value, indicating that age (3-stage age-interval: 1 week, 2-8 weeks, and >8 weeks) best explained survival. Weekly survival estimates for 1 week, 2-8 weeks, and >8 weeks were 0.81 (95% CI = 0.70-0.88), 0.86 (95% CI = 0.81-0.90), and 0.94 (95% CI = 0.91-0.96), respectively. Overall probability of surviving 52 weeks was 0.02 (95% CI = 0.01-0.07). Of 70 documented mortalities, 21% occurred during the first week, 55% during weeks 2-8, and 23% occurred >8 weeks of age. We found pneumonia and predation were temporally heterogeneous with lambs most susceptible to predation during the first 2-3 weeks of life, while the greatest risk from pneumonia occurred from weeks 4-8. Our results indicated pneumonia was the major factor limiting recruitment followed by predation. Mortality from predation may have been partly compensatory to pneumonia and its effects were less pronounced as alternative prey became available. Given the high rates of pneumonia-caused mortality we observed, and the apparent lack of pneumonia-causing pathogens in bighorn populations in the western Black Hills, management activities should be geared towards eliminating contact between diseased and healthy populations.	[Smith, Joshua B.; Jenks, Jonathan A.; Grovenburg, Troy W.] S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA; [Klaver, Robert W.] Iowa State Univ, Iowa Cooperat Fish & Wildlife Res Unit, Ames, IA USA; [Klaver, Robert W.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA	South Dakota State University; Iowa State University; Iowa State University	Smith, JB (corresponding author), S Dakota State Univ, Dept Nat Resource Management, Brookings, SD 57007 USA.	joshua.smith@sdstate.edu	Jenks, Jonathan A/B-7321-2009; Grovenburg, Troy/K-3346-2012		Federal Aid to Wildlife Restoration [7537]; Wild Sheep Foundation	Federal Aid to Wildlife Restoration; Wild Sheep Foundation	Funding for this study was provided by Federal Aid to Wildlife Restoration administered by South Dakota Department of Game, Fish, and Parks (Study No. 7537), and the Wild Sheep Foundation (http://www.wildsheepfoundation.org/). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The authors acknowledge that members of the funding agency participated in capture of study animals.	Barber-Meyer SM, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-004; Bishop CJ, 2008, J WILDLIFE MANAGE, V72, P1085, DOI 10.2193/2007-423; Bishop CJ, 2007, J WILDLIFE MANAGE, V71, P945, DOI 10.2193/2006-123; Bishop CJ, 2011, J WILDLIFE MANAGE, V75, P1797, DOI 10.1002/jwmg.229; Buechner H.K., 1960, WILDLIFE MONOGR, V4, P3; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cassirer EF, 2007, J WILDLIFE MANAGE, V71, P1080, DOI 10.2193/2006-002; Cassirer EF, 2001, J WILDLIFE DIS, V37, P49, DOI 10.7589/0090-3558-37.1.49; Cook J., 1990, P BIENN S NO WILD SH, P19; Devries JH, 2003, J WILDLIFE MANAGE, V67, P551, DOI 10.2307/3802713; Enk TA, 2001, NORTHWEST SCI, V75, P280; Festa-Bianchet M, 1988, P 6 BIENN S NO WILD, V6, P66; Festa-Bianchet M, 2006, P ROY SOC B-BIOL SCI, V273, P1537, DOI 10.1098/rspb.2006.3467; FITZSIMMONS NN, 1995, CONSERV BIOL, V9, P314, DOI 10.1046/j.1523-1739.1995.9020314.x; Froiland S. G., 1990, NATURAL HIST BLACK H; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Heisey DM, 2006, J WILDLIFE MANAGE, V70, P1544, DOI 10.2193/0022-541X(2006)70[1544:AROMTE]2.0.CO;2; Kamler JF, 2002, J WILDLIFE MANAGE, V66, P1267, DOI 10.2307/3802959; KRAUSMAN PR, 2003, WILD MAMMALS N AM BI, P1095; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; Logan KA, 2001, DESERT PUMA EVOLUTIO, P1; Miller MW, 1997, J WILDLIFE DIS, V33, P738, DOI 10.7589/0090-3558-33.4.738; Monello RJ, 2001, CAN J ZOOL, V79, P1423, DOI 10.1139/cjz-79-8-1423; National Oceanic and Atmospheric Administration, 2013, SUMM MONTHL NORM 198; Onderka DK, 1984, BIENNIAL S NO WILD S, P356; Raithel JD, 2007, J WILDLIFE MANAGE, V71, P795, DOI 10.2193/2005-608; Rominger EM, 2004, J WILDLIFE MANAGE, V68, P993, DOI 10.2193/0022-541X(2004)068[0993:TIOMLP]2.0.CO;2; Ross PI, 1997, CAN J ZOOL, V75, P771, DOI 10.1139/z97-098; Sargeant G.A., 2011, WILD1 R TOOLS WILDLI; SCHMITZ L. E., 2010, 201005 S DAK GAM FIS; Schmitz LE, 2006, THESIS S DAKOTA STAT; Shackleton DM, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P78; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Singer FJ, 2000, RESTOR ECOL, V8, P75, DOI 10.1046/j.1526-100x.2000.80067.x; Singer FJ, 2001, CONSERV BIOL, V15, P1347, DOI 10.1046/j.1523-1739.2001.99488.x; Sirochman MA, 2012, J WILDLIFE DIS, V48, P781, DOI 10.7589/0090-3558-48.3.781; Smith JB, 2013, WILDL SOC B IN PRESS; South Dakota Department of Game Fish and Parks, 2007, ROCK MOUNT BIGH SHEE; Subramaniam R, 2011, CLIN VACCINE IMMUNOL, V18, P1689, DOI 10.1128/CVI.05276-11; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Theurer ME, 2013, J ANIM SCI, V91, P3917, DOI 10.2527/jas.2012-5823; USGS Gap Analysis Program, 2013, NAT GAP AN LANDC DAT; Valdez R, 1999, MOUNTAIN SHEEP OF NORTH AMERICA, P3; WEHAUSEN JD, 1987, J WILDLIFE MANAGE, V51, P86, DOI 10.2307/3801636; Wehausen JD, 1996, WILDLIFE SOC B, V24, P471; Wehausen JD, 2011, CALIF FISH GAME, V97, P7; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WOODARD TN, 1974, J WILDLIFE MANAGE, V38, P771, DOI 10.2307/3800043; ZIMMERMAN T. J., 2008, THESIS S DAKOTA STAT	50	21	25	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88271	10.1371/journal.pone.0088271	http://dx.doi.org/10.1371/journal.pone.0088271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516623	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400048
J	Suzuki, K; Saso, A; Hoshino, K; Sakurai, J; Tanigawa, K; Luo, YQ; Ishido, Y; Mori, S; Hirata, K; Ishii, N				Suzuki, Koichi; Saso, Aiko; Hoshino, Keigo; Sakurai, Junya; Tanigawa, Kazunari; Luo, Yuqian; Ishido, Yuko; Mori, Shuichi; Hirata, Kazuaki; Ishii, Norihisa			Paleopathological Evidence and Detection of Mycobacterium leprae DNA from Archaeological Skeletal Remains of Nabe-kaburi (Head-Covered with Iron Pots) Burials in Japan	PLOS ONE			English	Article							LEPROSY; MEDIEVAL; PERSPECTIVES	The Nabe-kaburi is a unique burial method, the purpose of which is shrouded in mystery. The burials were performed during the 15th to 18th centuries in eastern Japan, and involved covering the heads of the deceased with iron pots or mortars. The identification of leprosy-specific osteological lesions among some of the excavated remains has led to the suggestion that Nabe-kaburi burials were a reflection of the social stigma against certain infectious diseases, such as leprosy, tuberculosis or syphilis. However, molecular evidence for the presence of disease has been lacking. The goal of this study was to detect Mycobacterium leprae (M. leprae) DNA in archaeological human skeletal remains from Nabe-kaburi burials. The paleopathological data from three Nabe-kaburi burials were re-evaluated before small samples were taken from affected and control areas. DNA was extracted and used as a template to target the M. leprae-specific DNA using a combination of whole genome amplification, PCR analysis and DNA sequencing. M. leprae DNA fragments were detected in the two sets of skeletal remains that had also shown paleopathological evidence of leprosy. These findings provide definitive evidence that some of the Nabe-kaburi burials were performed for people affected by leprosy. Demonstration of the presence of M. leprae DNA, combined with archeological and anthropological examinations, will aid in solving the mystery of why Nabe-kaburi burials were performed in medieval Japan.	[Suzuki, Koichi; Tanigawa, Kazunari; Luo, Yuqian; Ishido, Yuko; Mori, Shuichi; Ishii, Norihisa] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Saso, Aiko] Univ Tokyo, Univ Museum, Tokyo, Japan; [Saso, Aiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Hoshino, Keigo; Hirata, Kazuaki] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan; [Sakurai, Junya] Shobi Univ, Fac Policy Management, Kawagoe, Saitama, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; University of Tokyo; Saint Marianna University	Suzuki, K (corresponding author), Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan.	koichis@nih.go.jp	; Suzuki, Koichi/C-4177-2013	Luo, Yuqian/0000-0003-2792-488X; Suzuki, Koichi/0000-0001-8659-4660	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid for Research on Emerging and Re-emerging Infectious Diseases from the Ministry of Health, Labour, and Welfare of Japan for K. S. and N.I. (http://www.mhlw.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Baba H, 1991, EXCAVATION REPORTS K, V80, P273; Boldsen JL, 2008, AM J PHYS ANTHROPOL, V135, P301, DOI 10.1002/ajpa.20744; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Donoghue H. D., 2002, PRESENT LEPROSY ARCH, V1054, P271; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Haas CJ, 2000, AM J CLIN PATHOL, V114, P428, DOI 10.1093/ajcp/114.3.428; Kanda K, 1887, B TOKYO ANTHR SOC, V2, P160; Kirihara K, 1974, SHINANO, V26, P673; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Kobayashi R, 1991, EXCAVATION REPORTS K, P54; Matsuda K, 1999, 60 KAN ARCH FDN; Moller-Christensen V., 1967, DISEASES ANTIQUITY, P295; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montiel R, 2003, FEMS MICROBIOL LETT, V226, P413, DOI 10.1016/S0378-1097(03)00617-7; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Ortner D. J., 2003, IDENTIFICATION PATHO, P263; Ozawa H, 1993, EXCAVATION REPORTS K, P80; RAFI A, 1994, LANCET, V343, P1360, DOI 10.1016/S0140-6736(94)92494-5; Roberts C., 2007, ARCHAEOLOGY DIS; Sakurai J, 2004, GRAVES BURIALS EDO P, P154; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Sekine T, 2003, CULTURAL SCI, V9, P23; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; Suzuki K, 2012, J DERMATOL, V39, P121, DOI 10.1111/j.1346-8138.2011.01370.x; Suzuki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012422; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; Taylor GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062406; Taylor GM, 2000, J ARCHAEOL SCI, V27, P1133, DOI 10.1006/jasc.1999.0532; Uede E, 1887, B TOKYO ANTHR SOC, V3, P75; Watson CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007547	33	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88356	10.1371/journal.pone.0088356	http://dx.doi.org/10.1371/journal.pone.0088356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516638	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400060
J	Wallat, GD; Huang, QF; Wang, WJ; Dong, HH; Ly, H; Liang, YY; Dong, CJ				Wallat, Gregor D.; Huang, Qinfeng; Wang, Wenjian; Dong, Haohao; Ly, Hinh; Liang, Yuying; Dong, Changjiang			High-Resolution Structure of the N-Terminal Endonuclease Domain of the Lassa Virus L Polymerase in Complex with Magnesium Ions	PLOS ONE			English	Article							L-PROTEIN; RNA REPLICATION; FINGER PROTEIN; CAP-BINDING; PA SUBUNIT; TRANSCRIPTION; FEVER; GENOME; SITE; NUCLEOPROTEIN	Lassa virus (LASV) causes deadly hemorrhagic fever disease for which there are no vaccines and limited treatments. LASV-encoded L polymerase is required for viral RNA replication and transcription. The functional domains of L-a large protein of 2218 amino acid residues-are largely undefined, except for the centrally located RNA-dependent RNA polymerase (RdRP) motif. Recent structural and functional analyses of the N-terminal region of the L protein from lymphocytic choriomeningitis virus (LCMV), which is in the same Arenaviridae family as LASV, have identified an endonuclease domain that presumably cleaves the cap structures of host mRNAs in order to initiate viral transcription. Here we present a high-resolution crystal structure of the N-terminal 173-aa region of the LASV L protein (LASV L173) in complex with magnesium ions at 1.72 angstrom. The structure is highly homologous to other known viral endonucleases of arena-(LCMV NL1), orthomyxo-(influenza virus PA), and bunyaviruses (La Crosse virus NL1). Although the catalytic residues (D89, E102 and K122) are highly conserved among the known viral endonucleases, LASV L endonuclease structure shows some notable differences. Our data collected from in vitro endonuclease assays and a reporter-based LASV minigenome transcriptional assay in mammalian cells confirm structural prediction of LASV L173 as an active endonuclease. The high-resolution structure of the LASV L endonuclease domain in complex with magnesium ions should aid the development of antivirals against lethal Lassa hemorrhagic fever.	[Wallat, Gregor D.; Dong, Haohao; Dong, Changjiang] Univ St Andrews, Sch Chem, St Andrews, Fife, Scotland; [Huang, Qinfeng; Ly, Hinh; Liang, Yuying] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Wang, Wenjian] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Dept Surg, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Changjiang] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of St Andrews; University of Minnesota System; University of Minnesota Twin Cities; Sun Yat Sen University; University of East Anglia	Ly, H (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	hly@umn.edu; liangy@umn.edu; c.dong@uea.ac.uk	Huang, Qinfeng/AAJ-7454-2021		Wellcome trust [WT08351]; MRC (Medical Research Council) [G1100110/1]; NIH [R01AI083409, R56AI091805, R01AI093580]; Medical Research Council [G1100110] Funding Source: researchfish; MRC [G1100110] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083409, R01AI093580, R56AI091805] Funding Source: NIH RePORTER	Wellcome trust(Wellcome TrustEuropean Commission); MRC (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in parts by the Wellcome trust fund (WT08351) and MRC (Medical Research Council) (G1100110/1) to CJD; NIH grants R01AI083409 to Y.L., and R56AI091805 and R01AI093580 to H.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; Atkin S, 2009, EUROSURVEILLANCE, P14; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GARCIN D, 1993, J VIROL, V67, P807, DOI 10.1128/JVI.67.2.807-812.1993; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hirabayashi Y, 1989, Nihon Rinsho, V47, P71; Jiang X, 2013, J BIOL CHEM, V288, P16949, DOI 10.1074/jbc.M112.420521; JIN H, 1993, J VIROL, V67, P1396, DOI 10.1128/JVI.67.3.1396-1404.1993; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Pinschewer DD, 2003, J VIROL, V77, P3882, DOI 10.1128/JVI.77.6.3882-3887.2003; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Reguera J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001101; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Wang JL, 2012, J VIROL, V86, P9794, DOI 10.1128/JVI.00385-12; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zhao C, 2009, J VIROL, V83, P9024, DOI 10.1128/JVI.00911-09	32	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87577	10.1371/journal.pone.0087577	http://dx.doi.org/10.1371/journal.pone.0087577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516554	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330834400015
J	Cao, HP; Zhang, L; Tan, XF; Long, HX; Shockey, JM				Cao, Heping; Zhang, Lin; Tan, Xiaofeng; Long, Hongxu; Shockey, Jay M.			Identification, Classification and Differential Expression of Oleosin Genes in Tung Tree (Vernicia fordii)	PLOS ONE			English	Article							OIL BODIES; FATTY-ACID; GENOME SEQUENCE; LIPID DROPLETS; DRAFT GENOME; CLUSTAL-W; PROTEINS; BIODIESEL; POLLEN; ACYLTRANSFERASE	Triacylglycerols (TAG) are the major molecules of energy storage in eukaryotes. TAG are packed in subcellular structures called oil bodies or lipid droplets. Oleosins (OLE) are the major proteins in plant oil bodies. Multiple isoforms of OLE are present in plants such as tung tree (Vernicia fordii), whose seeds are rich in novel TAG with a wide range of industrial applications. The objectives of this study were to identify OLE genes, classify OLE proteins and analyze OLE gene expression in tung trees. We identified five tung tree OLE genes coding for small hydrophobic proteins. Genome-wide phylogenetic analysis and multiple sequence alignment demonstrated that the five tung OLE genes represented the five OLE subfamilies and all contained the "proline knot'' motif (PX5SPX3P) shared among 65 OLE from 19 tree species, including the sequenced genomes of Prunus persica (peach), Populus trichocarpa (poplar), Ricinus communis (castor bean), Theobroma cacao (cacao) and Vitis vinifera (grapevine). Tung OLE1, OLE2 and OLE3 belong to the S type and OLE4 and OLE5 belong to the SM type of Arabidopsis OLE. TaqMan and SYBR Green qPCR methods were used to study the differential expression of OLE genes in tung tree tissues. Expression results demonstrated that 1) All five OLE genes were expressed in developing tung seeds, leaves and flowers; 2) OLE mRNA levels were much higher in seeds than leaves or flowers; 3) OLE1, OLE2 and OLE3 genes were expressed in tung seeds at much higher levels than OLE4 and OLE5 genes; 4) OLE mRNA levels rapidly increased during seed development; and 5) OLE gene expression was well-coordinated with tung oil accumulation in the seeds. These results suggest that tung OLE genes 1-3 probably play major roles in tung oil accumulation and/or oil body development. Therefore, they might be preferred targets for tung oil engineering in transgenic plants.	[Cao, Heping; Shockey, Jay M.] ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA 70130 USA; [Zhang, Lin; Tan, Xiaofeng; Long, Hongxu] Cent South Univ Forestry & Technol, Minist Educ, Key Lab Cultivat & Protect Nonwood Forest Trees, Changsha, Hunan, Peoples R China	United States Department of Agriculture (USDA); Central South University of Forestry & Technology	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA 70130 USA.	Heping.Cao@ars.usda.gov	tan, xiao/GZL-0264-2022; Cao, Heping/AAC-1666-2021	Cao, Heping/0000-0002-0958-1468; Shockey, Jay/0000-0002-5057-5457	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-102-00D, 6435-41000-102-10N]; National Forestry Public Welfare Industry Research Project of China [201204403]	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS; National Forestry Public Welfare Industry Research Project of China	This work was supported by the USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-102-00D and 6435-41000-102-10N and National Forestry Public Welfare Industry Research Project of China (201204403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CE, 1929, J AGRIC RES, V38, P0679; Akkerdaas JH, 2006, MOL NUTR FOOD RES, V50, P18, DOI 10.1002/mnfr.200500147; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranguren MI, 2012, POLYM TEST, V31, P7, DOI 10.1016/j.polymertesting.2011.09.001; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Cao H, 2014, BIOINFORMATICS COMPU, P71; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Cao HP, 2013, IND CROP PROD, V50, P248, DOI 10.1016/j.indcrop.2013.07.030; Cao HP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076946, 10.1371/journal.pone.0052853]; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Chen YH, 2010, BIORESOURCE TECHNOL, V101, P9521, DOI 10.1016/j.biortech.2010.06.117; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Chen YC, 2008, AFR J BIOTECHNOL, V7, P4743; Chua ACN, 2008, PLANT PHYSIOL BIOCH, V46, P525, DOI 10.1016/j.plaphy.2008.03.001; DEOLIVEIRA DE, 1993, PLANT J, V3, P495, DOI 10.1046/j.1365-313X.1993.03040495.x; Manh DV, 2012, ENERGY, V48, P519, DOI 10.1016/j.energy.2012.09.065; DONAIRE JP, 1987, REV ESP FISIOL, V43, P253; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; GARCIAMAS J, 1995, PLANT MOL BIOL, V27, P205, DOI 10.1007/BF00019192; Geuna F, 2005, TREE GENET GENOMES, V1, P69, DOI 10.1007/s11295-005-0010-4; Giannoulia K, 2007, J PLANT PHYSIOL, V164, P104, DOI 10.1016/j.jplph.2006.03.016; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Gu KY, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-47; Horn PJ, 2013, PLANT PHYSIOL, V162, P1926, DOI 10.1104/pp.113.222455; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Huang CY, 2013, P NATL ACAD SCI USA, V110, P14480, DOI 10.1073/pnas.1305299110; Huang CY, 2009, PLANT PHYSIOL, V150, P1192, DOI 10.1104/pp.109.138123; Huang NL, 2013, PLANT PHYSIOL, V161, P1862, DOI 10.1104/pp.112.212514; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; Hyun TK, 2013, GENE, V515, P454, DOI 10.1016/j.gene.2012.11.065; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jolivet P, 2013, PROTEOMICS, V13, P1836, DOI 10.1002/pmic.201200431; Jolivet P, 2011, J PLANT PHYSIOL, V168, P2015, DOI 10.1016/j.jplph.2011.06.007; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Kim HU, 2002, J BIOL CHEM, V277, P22677, DOI 10.1074/jbc.M109298200; KOPACZ BM, 1968, J AM OIL CHEM SOC, V45, P285, DOI 10.1007/BF02652428; Kovach A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-420; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Liu CG, 2013, IND CROP PROD, V43, P677, DOI 10.1016/j.indcrop.2012.07.072; Liu Q, 2012, GENE, V509, P247, DOI 10.1016/j.gene.2012.08.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [龙洪旭 Long Hongxu], 2010, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V30, P31; Lopez-Gomez R, 2007, ACT 6 C MUND AG, P1; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Mayfield JA, 2001, SCIENCE, V292, P2482, DOI 10.1126/science.1060972; Motamayor JC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r53; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; NAOT D, 1995, GENE, V161, P171, DOI 10.1016/0378-1119(95)00224-T; Park JY, 2008, APPL BIOCHEM BIOTECH, V148, P109, DOI 10.1007/s12010-007-8082-2; Parthibane V, 2012, PLANT PHYSIOL, V159, P95, DOI 10.1104/pp.112.197194; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Pastor S, 2013, PLANT SCI, V203, P79, DOI 10.1016/j.plantsci.2012.12.009; Pedron L, 2009, GENE, V437, P45, DOI 10.1016/j.gene.2008.12.012; Popluechai S, 2011, PLANT PHYSIOL BIOCH, V49, P352, DOI 10.1016/j.plaphy.2010.12.003; POTTER GF, 1968, J AM OIL CHEM SOC, V45, P281, DOI 10.1007/BF02652427; PRYDE EH, 1979, J AM OIL CHEM SOC, V56, pA719, DOI 10.1007/BF02667427; Regalado ES, 2008, PHILIPPINE AGR SCI, V91, P37; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salanoubat M, 2000, NATURE, V408, P820, DOI 10.1038/35048706; Samadzadeh M, 2011, PROG ORG COAT, V70, P383, DOI 10.1016/j.porgcoat.2010.08.017; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; Shepherd H. S., 2000, Plant Physiology, V122, P292; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Simkin AJ, 2006, J PLANT PHYSIOL, V163, P691, DOI 10.1016/j.jplph.2005.11.008; Somerville C., 2000, BIOCH MOL BIOL PLANT, P456; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Tabata S, 2000, NATURE, V408, P823, DOI 10.1038/35048507; Tang F, 1998, PLANT PHYSIOL, V117, P717; Theologis A, 2000, NATURE, V408, P816, DOI 10.1038/35048500; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wahlroos T, 2003, GENESIS, V35, P125, DOI 10.1002/gene.10172; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Yong S., 1999, Journal of Oil Palm Research, P18; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6	89	18	19	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88409	10.1371/journal.pone.0088409	http://dx.doi.org/10.1371/journal.pone.0088409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516650	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700069
J	Sunde, P; Thorup, K; Jacobsen, LB; Rahbek, C				Sunde, Peter; Thorup, Kasper; Jacobsen, Lars B.; Rahbek, Carsten			Weather Conditions Drive Dynamic Habitat Selection in a Generalist Predator	PLOS ONE			English	Article							OWLS ATHENE-NOCTUA; FUNCTIONAL-RESPONSES; FORAGING BEHAVIOR; BREEDING-SEASON; AVAILABILITY; SUCCESS; SCALE; PREY; PERFORMANCE; ECOLOGY	Despite the dynamic nature of habitat selection, temporal variation as arising from factors such as weather are rarely quantified in species-habitat relationships. We analysed habitat use and selection (use/availability) of foraging, radio-tagged little owls (Athene noctua), a nocturnal, year-round resident generalist predator, to see how this varied as a function of weather, season and availability. Use of the two most frequently used land cover types, gardens/buildings and cultivated fields varied more than 3-fold as a simple function of season and weather through linear effects of wind and quadratic effects of temperature. Even when controlling for the temporal context, both land cover types were used more evenly than predicted from variation in availability (functional response in habitat selection). Use of two other land cover categories (pastures and moist areas) increased linearly with temperature and was proportional to their availability. The study shows that habitat selection by generalist foragers may be highly dependent on temporal variables such as weather, probably because such foragers switch between weather dependent feeding opportunities offered by different land cover types. An opportunistic foraging strategy in a landscape with erratically appearing feeding opportunities in different land cover types, may possibly also explain decreasing selection of the two most frequently used land cover types with increasing availability.	[Sunde, Peter] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Thorup, Kasper; Jacobsen, Lars B.; Rahbek, Carsten] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Aarhus University; University of Copenhagen	Sunde, P (corresponding author), Aarhus Univ, Dept Biosci, Ronde, Denmark.	psu@dmu.dk	Sunde, Peter/AAE-8995-2021; Rahbek, Carsten/L-1129-2013; Sunde, Peter/AAZ-5824-2021; Sunde, Peter/E-9132-2013; Thorup, Kasper/A-4835-2013	Sunde, Peter/0000-0002-7485-037X; Rahbek, Carsten/0000-0003-4585-0300; Sunde, Peter/0000-0002-7485-037X; Sunde, Peter/0000-0002-7485-037X; Thorup, Kasper/0000-0002-0320-0601	Villum Kann Rasmussen Foundation	Villum Kann Rasmussen Foundation(Villum Fonden)	This study was funded by the Villum Kann Rasmussen Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; [Anonymous], 2006, SAS MIXED MODELS; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bjorneraas K, 2012, OECOLOGIA, V168, P231, DOI 10.1007/s00442-011-2072-3; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Cresswell W, 2010, J ANIM ECOL, V79, P556, DOI 10.1111/j.1365-2656.2010.01671.x; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Godvik IMR, 2009, ECOLOGY, V90, P699, DOI 10.1890/08-0576.1; Gottschalk TK, 2011, J RAPTOR RES, V45, P1, DOI 10.3356/JRR-09-11.1; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; Holsegard-Rasmussen MH, 2009, ARDEA, V97, P547, DOI 10.5253/078.097.0421; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Manly B.F.J., 2002, RESOURCE SELECTION A; MARTIN GR, 1986, IBIS, V128, P266, DOI 10.1111/j.1474-919X.1986.tb02674.x; Matthiopoulos J, 2011, ECOLOGY, V92, P583, DOI 10.1890/10-0751.1; Mauritzen M, 2003, OIKOS, V100, P112, DOI 10.1034/j.1600-0706.2003.12056.x; May R, 2010, ECOL MODEL, V221, P936, DOI 10.1016/j.ecolmodel.2009.12.024; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Nieuwenhuyse DV, 2008, LITTLE OWL CONSERVAT; Randler C, 2010, VERTEBR ZOOL, V60, P175; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; RICE WR, 1982, AUK, V99, P403; RODGERS AR, 2007, HOME RANGE TOOLS ARC; Roever CL, 2012, ECOGRAPHY, V35, P972, DOI 10.1111/j.1600-0587.2012.07359.x; RUNDGREN S, 1975, OIKOS, V26, P299, DOI 10.2307/3543500; Ruzicka RE, 2011, CAN FIELD NAT, V125, P132, DOI 10.22621/cfn.v125i2.1196; Saeki M, 2007, J MAMMAL, V88, P1098, DOI 10.1644/06-MAMM-A-208R1.1; Salek M, 2012, BIRD CONSERV INT, V22, P328, DOI 10.1017/S0959270911000268; Salek M, 2010, BIRD STUDY, V57, P495, DOI 10.1080/00063657.2010.494717; Sergio F, 2003, ANIM BEHAV, V66, P1109, DOI 10.1006/anbe.2003.2303; Smedshaug CA, 2002, ORNIS FENNICA, V79, P1; Statistical Analysis System, 2013, SAS STAT R 92 US GUI, Vsecond; Steen R, 2011, CAN J ZOOL, V89, P199, DOI 10.1139/Z10-109; Sunde P, 2006, ECOGRAPHY, V29, P152, DOI 10.1111/j.2006.0906-7590.04397.x; Sunde P, 2009, J ORNITHOL, V150, P537, DOI 10.1007/s10336-009-0378-2; Thorup K, 2013, J ORNITHOL, V154, P183, DOI 10.1007/s10336-012-0885-4; Thorup K, 2010, IBIS, V152, P803, DOI 10.1111/j.1474-919X.2010.01046.x; Tome R, 2004, J RAPTOR RES, V38, P35; Tome R, 2011, ARDEA, V99, P17, DOI 10.5253/078.099.0103; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; Van Moorter B, 2013, ECOGRAPHY, V36, P323, DOI 10.1111/j.1600-0587.2012.07291.x	50	21	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88221	10.1371/journal.pone.0088221	http://dx.doi.org/10.1371/journal.pone.0088221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516615	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700057
J	Barclay, VC; Smieszek, T; He, JP; Cao, GH; Rainey, JJ; Gao, HJ; Uzicanin, A; Salathe, M				Barclay, Victoria C.; Smieszek, Timo; He, Jianping; Cao, Guohong; Rainey, Jeanette J.; Gao, Hongjiang; Uzicanin, Amra; Salathe, Marcel			Positive Network Assortativity of Influenza Vaccination at a High School: Implications for Outbreak Risk and Herd Immunity	PLOS ONE			English	Article							SOCIAL MIXING BEHAVIOR; UNITED-STATES; DISEASE TRANSMISSION; INFECTIOUS-DISEASES; SEASONAL INFLUENZA; CHILDREN; CONTACTS; EFFICACY; PATTERNS; CLOSURE	Schools are known to play a significant role in the spread of influenza. High vaccination coverage can reduce infectious disease spread within schools and the wider community through vaccine-induced immunity in vaccinated individuals and through the indirect effects afforded by herd immunity. In general, herd immunity is greatest when vaccination coverage is highest, but clusters of unvaccinated individuals can reduce herd immunity. Here, we empirically assess the extent of such clustering by measuring whether vaccinated individuals are randomly distributed or demonstrate positive assortativity across a United States high school contact network. Using computational models based on these empirical measurements, we further assess the impact of assortativity on influenza disease dynamics. We found that the contact network was positively assortative with respect to influenza vaccination: unvaccinated individuals tended to be in contact more often with other unvaccinated individuals than with vaccinated individuals, and these effects were most pronounced when we analyzed contact data collected over multiple days. Of note, unvaccinated males contributed substantially more than unvaccinated females towards the measured positive vaccination assortativity. Influenza simulation models using a positively assortative network resulted in larger average outbreak size, and outbreaks were more likely, compared to an otherwise identical network where vaccinated individuals were not clustered. These findings highlight the importance of understanding and addressing heterogeneities in seasonal influenza vaccine uptake for prevention of large, protracted school-based outbreaks of influenza, in addition to continued efforts to increase overall vaccine coverage.	[Barclay, Victoria C.; Smieszek, Timo; Salathe, Marcel] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [He, Jianping; Cao, Guohong] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Rainey, Jeanette J.; Gao, Hongjiang; Uzicanin, Amra] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Centers for Disease Control & Prevention - USA	Barclay, VC (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	vickistar50@gmail.com	Smieszek, Timo/C-3677-2009	Salathe, Marcel/0000-0002-5079-7797; Smieszek, Timo/0000-0003-1681-9777	Centers for Disease Control and Prevention [U01 CK000178-01]; German Academic Exchange Service DAAD [D/10/52328]; Society in Science: Branco Weiss fellowship; NIH RAPIDD; National Science Foundation [OCI-0821527]; CENTERS FOR DISEASE CONTROL AND PREVENTION [U01CK000178] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); German Academic Exchange Service DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Society in Science: Branco Weiss fellowship; NIH RAPIDD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by a grant provided by the Centers for Disease Control and Prevention through grant U01 CK000178-01 (to M.S.), a fellowship from the German Academic Exchange Service DAAD through grant D/10/52328 (to T.S.), and a Society in Science: Branco Weiss fellowship (to M.S.). M.S. also acknowledges NIH RAPIDD support. Simulations were run on a computer cluster that was funded by the National Science Foundation through grant OCI-0821527. The CDC played a role in the study design, decision to publish and preparation of the manuscript.	Anderson R, 1992, AM J PUBLIC HEALTH, V16, P202; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Ball F, 1997, ANN APPL PROBAB, V7, P46; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Eames KTD, 2008, THEOR POPUL BIOL, V73, P104, DOI 10.1016/j.tpb.2007.09.007; Englund H, 2013, EPIDEMIOL INFECT, V141, P1807, DOI 10.1017/S0950268812002282; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glanz JM, 2009, PEDIATRICS, V123, P1446, DOI 10.1542/peds.2008-2150; Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Haas C.N., 1999, QUANTITATIVE MICROBI; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Holm MV, 2007, VACCINE, V25, P7931, DOI 10.1016/j.vaccine.2007.09.022; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; John TJ, 2000, EUR J EPIDEMIOL, V16, P601, DOI 10.1023/A:1007626510002; Kazandjieva MA, 2010, P 6 WORKSH HOT TOP E; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; Melegaro A, 2011, EPIDEMICS-NETH, V3, P143, DOI 10.1016/j.epidem.2011.04.001; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nichol KL, 2006, CLEV CLIN J MED, V73, P1009, DOI 10.3949/ccjm.73.11.1009; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Sauerbrei A, 2009, MED MICROBIOL IMMUN, V198, P93, DOI 10.1007/s00430-009-0108-7; Shim E, 2012, VACCINE, V30, P6700, DOI 10.1016/j.vaccine.2012.08.045; Smieszek T, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-11; Stephenson I, 2001, EUR RESPIR J, V17, P1282, DOI 10.1183/09031936.01.00084301; Szendroi B, 2004, P ROY SOC B-BIOL SCI, V271, pS364, DOI 10.1098/rsbl.2004.0188; Takayama M, 2012, PREV MED, V54, P358, DOI 10.1016/j.ypmed.2012.03.008; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; Wasserman S., 1995, SOCIAL NETWORK ANAL	52	57	58	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87042	10.1371/journal.pone.0087042	http://dx.doi.org/10.1371/journal.pone.0087042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505274	gold, Green Published			2022-12-27	WOS:000330829200033
J	Bonapace, S; Valbusa, F; Bertolini, L; Pichiri, I; Mantovani, A; Rossi, A; Zenari, L; Barbieri, E; Targher, G				Bonapace, Stefano; Valbusa, Filippo; Bertolini, Lorenzo; Pichiri, Isabella; Mantovani, Alessandro; Rossi, Andrea; Zenari, Luciano; Barbieri, Enrico; Targher, Giovanni			Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; MYOCARDIAL STEATOSIS; HEPATIC STEATOSIS; PERICARDIAL FAT; RISK-FACTORS; MORTALITY; HEART; CALCIFICATION; PREVALENCE	Background: Recent epidemiological data suggest that non-alcoholic fatty liver disease (NAFLD) is closely associated with aortic valve sclerosis (AVS), an emerging risk factor for adverse cardiovascular outcomes, in nondiabetic and type 2 diabetic individuals. To date, nobody has investigated the association between NAFLD and AVS in people with type 2 diabetes, a group of individuals in which the prevalence of these two diseases is high. Methods and Results: We recruited 180 consecutive type 2 diabetic patients without ischemic heart disease, valvular heart disease, hepatic diseases or excessive alcohol consumption. NAFLD was diagnosed by liver ultrasonography whereas AVS was determined by conventional echocardiography in all participants. In the whole sample, 120 (66.7%) patients had NAFLD and 53 (29.4%) had AVS. No patients had aortic stenosis. NAFLD was strongly associated with an increased risk of prevalent AVS (odds ratio [OR] 2.79, 95% CI 1.3-6.1, p<0.01). Adjustments for age, sex, duration of diabetes, diabetes treatment, body mass index, smoking, alcohol consumption, hypertension, dyslipidemia, hemoglobin A1c and estimated glomerular filtration rate did not attenuate the strong association between NAFLD and risk of prevalent AVS (adjusted-OR 3.04, 95% CI 1.3-7.3, p = 0.01). Conclusions: Our results provide the first demonstration of a positive and independent association between NAFLD and AVS in patients with type 2 diabetes mellitus.	[Bonapace, Stefano; Barbieri, Enrico] Sacro Cuore Hosp, Div Cardiol, Negrar, VR, Italy; [Valbusa, Filippo] Sacro Cuore Hosp, Div Gen Med, Negrar, VR, Italy; [Bertolini, Lorenzo; Zenari, Luciano] Sacro Cuore Hosp, Diabet Unit, Negrar, VR, Italy; [Pichiri, Isabella; Mantovani, Alessandro; Targher, Giovanni] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy; [Pichiri, Isabella; Mantovani, Alessandro; Rossi, Andrea; Targher, Giovanni] Azienda Osped Univ Integrata Verona, Verona, Italy; [Rossi, Andrea] Univ Verona, Dept Med, Cardiol Sect, I-37100 Verona, Italy	IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Targher, G (corresponding author), Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, I-37100 Verona, Italy.	giovanni.targher@univr.it	Mantovani, Alessandro/AAB-9015-2019; Targher, Giovanni/AAB-9008-2019; Rossi, Andrea/ABC-3858-2020	Mantovani, Alessandro/0000-0002-7271-6329; Targher, Giovanni/0000-0002-4325-3900; Valbusa, Filippo/0000-0001-7527-6974; Bonapace, Stefano/0000-0001-9122-2642				Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Barasch E, 2006, AM J CARDIOL, V97, P1281, DOI 10.1016/j.amjcard.2005.11.065; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bonapace S, 2012, DIABETES CARE, V35, P389, DOI 10.2337/dc11-1820; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Hallsworth K, 2013, J HEPATOL, V58, P757, DOI 10.1016/j.jhep.2012.11.015; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mahmod M, 2013, CIRC-CARDIOVASC IMAG, V6, P808, DOI 10.1161/CIRCIMAGING.113.000559; Markus MRP, 2013, ARTERIOSCL THROM VAS, V33, P1690, DOI 10.1161/ATVBAHA.112.300556; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Perseghin G, 2008, HEPATOLOGY, V47, P51, DOI 10.1002/hep.21983; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2010, J AM COLL CARDIOL, V56, P225, DOI 10.1016/j.jacc.2010.02.049; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Rossi A, 2012, DIABETES CARE, V35, P1781, DOI 10.2337/dc12-0134; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183; Targher G, 2013, SEMIN THROMB HEMOST, V39, P214, DOI 10.1055/s-0033-1334866; Targher G, 2011, J HEPATOL, V54, P1020, DOI 10.1016/j.jhep.2010.11.007; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229	27	40	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88371	10.1371/journal.pone.0088371	http://dx.doi.org/10.1371/journal.pone.0088371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505484	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200185
J	Crouzet, SM; Overgaard, M; Busch, NA				Crouzet, Sebastien M.; Overgaard, Morten; Busch, Niko A.			The Fastest Saccadic Responses Escape Visual Masking	PLOS ONE			English	Article							OBJECT-SUBSTITUTION-MASKING; BACKWARD-MASKING; CONSCIOUSNESS; AWARENESS; PSYCHOPHYSICS; CORTEX; SPEED; INFORMATION; FEEDFORWARD; COMPETITION	Object-substitution masking (OSM) occurs when a briefly presented target in a search array is surrounded by small dots that remain visible after the target disappears. The reduction of target visibility occurring after OSM has been suggested to result from a specific interference with reentrant visual processing while the initial feedforward processing is thought to be left intact. We tested a prediction derived from this hypothesis: the fastest responses, being triggered before the beginning of reentrant processing, should escape the OSM interference. In a saccadic choice reaction time task, which gives access to very early stages of visual processing, target visibility was reduced either by OSM, conventional backward masking, or low stimulus contrast. A general reduction of performance was observed in all three conditions. However, the fastest saccades did not show any sign of interference under either OSM or backward masking, as they did under the low-contrast condition. This finding supports the hypothesis that masking interferes mostly with reentrant processing at later stages, while leaving early feedforward processing largely intact.	[Crouzet, Sebastien M.; Busch, Niko A.] Charite, Inst Med Psychol, D-13353 Berlin, Germany; [Overgaard, Morten] Aalborg Univ, Dept Commun & Psychol, Ctr Cognit Neurosci, Aalborg, Denmark; [Overgaard, Morten] Aarhus Univ, Ctr Funct Integrat Neurosci, Cognit Neurosci Res Unit, Aarhus, Denmark; [Busch, Niko A.] Humboldt Univ, Berlin Sch Mind & Brain, D-10099 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Aalborg University; Aarhus University; Humboldt University of Berlin	Crouzet, SM (corresponding author), Charite, Inst Med Psychol, D-13353 Berlin, Germany.	sebastien.crouzet@hu-berlin.de	Crouzet, Sébastien M./B-6429-2013	Crouzet, Sébastien M./0000-0003-0898-9557; Busch, Niko/0000-0003-4837-0345; Overgaard, Morten/0000-0002-1215-5355	German Research Foundation (DFG) under the research network "Neuro-cognitive mechanisms of conscious and unconscious visual perception'' [BU2400/1-1]; ERC starting grant	German Research Foundation (DFG) under the research network "Neuro-cognitive mechanisms of conscious and unconscious visual perception''; ERC starting grant	This work was supported by the German Research Foundation (DFG) under the research network "Neuro-cognitive mechanisms of conscious and unconscious visual perception'' [Grant# BU2400/1-1]. MO was supported by an ERC starting grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyropoulos I, 2013, J EXP PSYCHOL HUMAN, V39, P646, DOI 10.1037/a0030240; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bouvier S, 2010, PSYCHOL SCI, V21, P200, DOI 10.1177/0956797609357858; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B., 2006, VISUAL MASKING; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Chen Z, 2009, PSYCHOL SCI, V20, P560, DOI 10.1111/j.1467-9280.2009.02328.x; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Dux PE, 2010, PSYCHOL SCI, V21, P1242, DOI 10.1177/0956797610379866; Enns JT, 2004, VISION RES, V44, P1321, DOI 10.1016/j.visres.2003.10.024; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Francis G, 2002, J EXP PSYCHOL GEN, V131, P590, DOI 10.1037//0096-3445.131.4.590; Francis G, 2007, PERCEPT PSYCHOPHYS, V69, P263, DOI 10.3758/BF03193748; Goodhew SC, 2013, PSYCHON B REV, V20, P859, DOI 10.3758/s13423-013-0400-9; Goodhew SC, 2011, J EXP PSYCHOL HUMAN, V37, P588, DOI 10.1037/a0018740; Hubert M, 2008, COMPUT STAT DATA AN, V52, P5186, DOI 10.1016/j.csda.2007.11.008; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Jannati A, 2013, ATTEN PERCEPT PSYCHO, V75, P1118, DOI 10.3758/s13414-013-0462-9; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Koivisto M, 2012, VISION RES, V63, P43, DOI 10.1016/j.visres.2012.05.001; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lleras A, 2003, J EXP PSYCHOL HUMAN, V29, P106, DOI 10.1037/0096-1523.29.1.106; Moore CM, 2005, J EXP PSYCHOL HUMAN, V31, P1171, DOI 10.1037/0096-1523.31.6.1171; Poder E, 2013, J EXP PSYCHOL GEN, V142, P1130, DOI 10.1037/a0030575; Ratcliff R, 2000, J EXP PSYCHOL HUMAN, V26, P127, DOI 10.1037/0096-1523.26.1.127; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; VanRullen R, 2003, J COGNITIVE NEUROSCI, V15, P209, DOI 10.1162/089892903321208141; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Woodman GF, 2003, PSYCHOL SCI, V14, P605, DOI 10.1046/j.0956-7976.2003.psci_1472.x	36	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87418	10.1371/journal.pone.0087418	http://dx.doi.org/10.1371/journal.pone.0087418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505288	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200047
J	Holm, AL; Veerman, L; Cobiac, L; Ekholm, O; Diderichsen, F				Holm, Astrid Ledgaard; Veerman, Lennert; Cobiac, Linda; Ekholm, Ola; Diderichsen, Finn			Cost-Effectiveness of Preventive Interventions to Reduce Alcohol Consumption in Denmark	PLOS ONE			English	Article							ROUTINE GENERAL-PRACTICE; ISCHEMIC-HEART-DISEASE; GLOBAL BURDEN; HEAVY DRINKERS; PRIMARY-CARE; RISK-FACTOR; LAST YEAR; METAANALYSIS; HEALTH; INJURY	Introduction: Excessive alcohol consumption increases the risk of many diseases and injuries, and the Global Burden of Disease 2010 study estimated that 6% of the burden of disease in Denmark is due to alcohol consumption. Alcohol consumption thus places a considerable economic burden on society. Methods: We analysed the cost-effectiveness of six interventions aimed at preventing alcohol abuse in the adult Danish population: 30% increased taxation, increased minimum legal drinking age, advertisement bans, limited hours of retail sales, and brief and longer individual interventions. Potential health effects were evaluated as changes in incidence, prevalence and mortality of alcohol-related diseases and injuries. Net costs were calculated as the sum of intervention costs and cost offsets related to treatment of alcohol-related outcomes, based on health care costs from Danish national registers. Cost-effectiveness was evaluated by calculating incremental cost-effectiveness ratios (ICERs) for each intervention. We also created an intervention pathway to determine the optimal sequence of interventions and their combined effects. Results: Three of the analysed interventions (advertising bans, limited hours of retail sales and taxation) were cost-saving, and the remaining three interventions were all cost-effective. Net costs varied from (sic) -17 million per year for advertisement ban to (sic) 8 million for longer individual intervention. Effectiveness varied from 115 disability-adjusted life years (DALY) per year for minimum legal drinking age to 2,900 DALY for advertisement ban. The total annual effect if all interventions were implemented would be 7,300 DALY, with a net cost of (sic) -30 million. Conclusion: Our results show that interventions targeting the whole population were more effective than individual-focused interventions. A ban on alcohol advertising, limited hours of retail sale and increased taxation had the highest probability of being cost-saving and should thus be first priority for implementation.	[Holm, Astrid Ledgaard; Diderichsen, Finn] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Veerman, Lennert; Cobiac, Linda] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Ekholm, Ola] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	University of Copenhagen; University of Queensland; University of Southern Denmark	Holm, AL (corresponding author), Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.	astrid.ledgaard.holm@sund.ku.dk	Diderichsen, Finn/P-4654-2019; Veerman, Lennert/A-9973-2011	Diderichsen, Finn/0000-0002-9998-4972; Veerman, Lennert/0000-0002-3206-8232; Holm, Astrid Ledgaard/0000-0003-4286-4854	Danish Ministry of Science, Innovation and Higher Education; City of Copenhagen	Danish Ministry of Science, Innovation and Higher Education; City of Copenhagen	This research is part of a PhD-project jointly funded by the Danish Ministry of Science, Innovation and Higher Education and the City of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2000, ALCOHOL CLIN EXP RES, V24, P1680, DOI 10.1097/00000374-200011000-00010; Aalto M, 2001, ALCOHOL ALCOHOLISM, V36, P224, DOI 10.1093/alcalc/36.3.224; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Bagnardi V, 2008, J EPIDEMIOL COMMUN H, V62, P615, DOI 10.1136/jech.2007.065607; Barendregt J J, 1998, Math Popul Stud, V7, P29; Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Briggs A, 2006, DECISION MODELLING H; Chisholm D, 2004, J STUD ALCOHOL, V65, P782, DOI 10.15288/jsa.2004.65.782; Chisholm D, 2006, DRUG ALCOHOL REV, V25, P553, DOI 10.1080/09595230600944487; Christensen AI, 2012, SCAND J PUBLIC HEALT, V40, P391, DOI 10.1177/1403494812451412; Cobiac L, 2009, ADDICTION, V104, P1646, DOI 10.1111/j.1360-0443.2009.02708.x; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danish Health and Medicines Authority, 2012, UD ALK REC REG ALC C; Denmark Statistics, 2012, ALKO2 CONS SAL ALC T; Drummond MF., 2005, METHODS EC EVALUATIO, P55; ECREPH (The European Centre for Register Based Health Related Population Research), 2011, REG DAT FIND INF 35; Forebyggelseskommissionen, 2009, VI KAN LEV LAENG SUN; Gandjour A, 2005, J HEALTH ECON, V24, P715, DOI 10.1016/j.jhealeco.2004.11.009; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Holmes J, 2012, DRUG ALCOHOL DEPEN, V123, P7, DOI 10.1016/j.drugalcdep.2011.12.005; Irving HM, 2009, J PANCREAS, V10, P387; Juel K, 2008, SCAND J PUBLIC HEALT, V36, P11, DOI 10.1177/1403494808097590; Kenkel DS, 2005, AM ECON REV, V95, P273, DOI 10.1257/000282805774670284; Laursen B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001521; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maisto SA, 2001, J STUD ALCOHOL, V62, P605, DOI 10.15288/jsa.2001.62.605; McIntosh MC, 1997, CAN FAM PHYSICIAN, V43, P1959; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Oxford Centre for Evidence-based Medicine, 2013, LEV EV; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Polder JJ, 2006, SOC SCI MED, V63, P1720, DOI 10.1016/j.socscimed.2006.04.018; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Stinnett AA, 1997, MED DECIS MAKING, V17, P483, DOI 10.1177/0272989X9701700414; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Tariq L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005696; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Taylor B, 2009, ADDICTION, V104, P1981, DOI 10.1111/j.1360-0443.2009.02694.x; van Baal PHM, 2011, HEALTH ECON, V20, P432, DOI 10.1002/hec.1599; van den Berg M, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-36; WHO, 2009, METR DIS ADJ LIF YEA; WHO, 2013, GLOB BURD DIS 2010; WHO, 2003, MAKING CHOICES HLTH; Wong A, 2011, HEALTH ECON, V20, P379, DOI 10.1002/hec.1597; World Bank, 2009, GDP PER CAP; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04	53	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88041	10.1371/journal.pone.0088041	http://dx.doi.org/10.1371/journal.pone.0088041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505370	Green Published, gold			2022-12-27	WOS:000330829200105
J	Qin, Q; Qian, JY; Ge, L; Shen, L; Jia, JG; Jin, JH; Ge, JB				Qin, Qing; Qian, Juying; Ge, Lei; Shen, Li; Jia, Jianguo; Jin, Jianhao; Ge, Junbo			Effect and Mechanism of Thrombospondin-1 on the Angiogenesis Potential in Human Endothelial Progenitor Cells: An In Vitro Study	PLOS ONE			English	Article							NITRIC-OXIDE; COLLATERAL CIRCULATION; VASCULAR INJURY; HUMAN-DISEASE; CD47; CD36; ASSOCIATION; INHIBITION; PLATELETS; OCCLUSION	Objective: Coronary collateral circulation plays a protective role in patients with coronary artery disease (CAD). We investigated whether thrombospondin-1(TSP-1) has an inhibitory effect on angiogenesis potential in endothelial progenitor cells(EPCs) and tested whether TSP-1 are altered in plasma of patients who had chronic total occlusion (CTO) in at least one coronary artery and with different collateral stages(according to Rentrop grading system). Methods and Results: We isolated early and late EPCs from human cord blood and investigated a dose-dependent effect of TSP-1 on their angiogenesis potential by Matrigel angiogenesis assay. We found that TSP-1 (5 mu g/ml) inhibited early EPCs incorporation into tubules after pretreatment for 1, 6 and 12 hours, respectively (83.3+/-11.9 versus 50.0+/-10.1 per field for 1 hour, 161.7+/-12.6 versus 124.0+/-14.4 for 6 hours, 118.3+/-12.6 versus 68.0+/-20.1 for 12 hours, p<0.05). TSP-1 also inhibited late EPCs tubule formation at 1 mu g/ml (6653.4+/-422.0 mu m/HPF versus 5552.8+/-136.0 mu m/HPF, p<0.05), and the inhibition was further enhanced at 5 mu g/ml (6653.4+/-422.0 mu m/HPF versus 2118.6+/-915.0 mu m/HPF p<0.01). To explore the mechanism involved, a small interfering RNA was used. In vitro, CD47 siRNA significantly attenuated TSP-1's inhibition of angiogenesis on late EPCs and similar results were obtained after functional blocking by anti-CD47 antibody. Then we investigated pathways downstream of CD47 and found TSP-1 regulated VEGF-induced VEGFR2 phosphorylation via CD47. Furthermore, we examined plasma TSP-1 levels in patients with CTO who developed different stages of collaterals and found a paradoxical higher level of TSP-1 in patients with good collaterals compared with bad ones (612.9+/-554.0 ng/ml versus 224.4+/-132.4 ng/ml, p<0.05). Conclusion: TSP-1 inhibited angiogenesis potential of early and late EPCs in vitro. This inhibition may be regulated by TSP-1's interaction with CD47, resulting in down regulation of VEGFR2 phosphorylation. In patients with CTO, there may be a self-adjustment mechanism in bad collaterals which is shown as low level of angiogenesis inhibitor TSP-1, and thus favoring collateral formation.	[Qin, Qing; Qian, Juying; Ge, Lei; Shen, Li; Jia, Jianguo; Jin, Jianhao; Ge, Junbo] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China	Fudan University	Ge, JB (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Shanghai 200433, Peoples R China.	ge.junbo@zs-hospital.sh.cn			National Nature Science Foundation for young scholars of China [81000044]	National Nature Science Foundation for young scholars of China	The authors use fundings from National Nature Science Foundation for young scholars of China, NO. 81000044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburakawa Y, 2013, CIRC J, V77, P1053, DOI 10.1253/circj.CJ-12-0897; Bauer EM, 2010, CARDIOVASC RES, V88, P471, DOI 10.1093/cvr/cvq218; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; de Boer HC, 2006, ARTERIOSCL THROM VAS, V26, P1653, DOI 10.1161/01.ATV.0000222982.55731.f1; Dias JV, 2012, BIOCHEM PHARMACOL, V84, P1014, DOI 10.1016/j.bcp.2012.07.006; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Esemuede N, 2004, J SURG RES, V122, P135, DOI 10.1016/j.jss.2004.05.015; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kanzler I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0310-4; Kaur S, 2010, J BIOL CHEM, V285, P38923, DOI 10.1074/jbc.M110.172304; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Mause SF, 2010, CIRCULATION, V122, P495, DOI 10.1161/CIRCULATIONAHA.109.909473; Meier P, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-143; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Nabors LB, 2010, ARCH NEUROL-CHICAGO, V67, P313, DOI 10.1001/archneurol.2010.16; Nguyen VA, 2009, J CELL MOL MED, V13, P522, DOI 10.1111/j.1582-4934.2008.00340.x; Primo L, 2005, FASEB J, V19, P1713, DOI 10.1096/fj.05-3697fje; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Roberts DD, 2007, CLIN CANCER RES, V13, P795, DOI 10.1158/1078-0432.CCR-06-1758; Sahora AI, 2012, J VET INTERN MED, V26, P1169, DOI 10.1111/j.1939-1676.2012.00966.x; Schirmer SH, 2009, J AM COLL CARDIOL, V53, P2141, DOI 10.1016/j.jacc.2009.02.049; Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624; Tokgozoglu L, 2011, ATHEROSCLEROSIS, V219, P851, DOI 10.1016/j.atherosclerosis.2011.08.045; Tongers J, 2010, MICROVASC RES, V79, P200, DOI 10.1016/j.mvr.2010.01.012; Uronis HE, 2013, CANCER MED-US, V2, P316, DOI 10.1002/cam4.65; Werner GS, 2004, CIRCULATION, V110, P1940, DOI 10.1161/01.CIR.0000143624.72027.11; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	40	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88213	10.1371/journal.pone.0088213	http://dx.doi.org/10.1371/journal.pone.0088213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505433	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200139
J	Urakawa, S; Mitsushima, D; Shimozuru, M; Sakuma, Y; Kondo, Y				Urakawa, Susumu; Mitsushima, Dai; Shimozuru, Michito; Sakuma, Yasuo; Kondo, Yasuhiko			An Enriched Rearing Environment Calms Adult Male Rat Sexual Activity: Implication for Distinct Serotonergic and Hormonal Responses to Females	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS SHELL; RECEPTOR MESSENGER-RNA; ANXIETY-LIKE BEHAVIOR; DECREASES ANXIETY; DOPAMINE; STRESS; MICE; TRANSPORTER; MOTIVATION	Early life events induce alterations in neural function in adulthood. Although rearing in an enriched environment (EE) has a great impact on behavioral development, the effects of enriched rearing on sociosexual behavior remain unclear. In this study, we investigated the effects of rearing in an EE on male copulatory behavior and its underlying neurobiological mechanisms in Wistar-Imamichi rats. Three-week-old, recently weaned rats were continuously subjected to a standard environment (SE) or an EE comprised of a large cage with several objects, such as toys, tunnels, ladders, and a running wheel. After 6 weeks, rats reared in an EE (EE rats) showed decreased sexual activity compared with rats reared in a SE (SE rats). This included a lower number of ejaculations and longer latencies in three consecutive copulatory tests. In addition, EE rats showed decreased emotional responsiveness and less locomotor behavior in an open field. In a runway test, on the other hand, sexual motivation toward receptive females in EE males was comparable to that of SE males. Furthermore, following exposure to a female, increases in serotonin levels in the nucleus accumbens and the striatum were significantly suppressed in EE males, whereas dopaminergic responses were similar between the groups. Female-exposure-induced increases in the levels of plasma corticosterone and testosterone were also suppressed in EE rats compared to SE rats. These data suggest that rearing in an EE decreases male copulatory behavior, and serotonin and hormonal regulating systems may regulate the differences in sociosexual interactions that result from distinct rearing environments.	[Urakawa, Susumu; Sakuma, Yasuo; Kondo, Yasuhiko] Nippon Med Sch, Dept Physiol, Tokyo 113, Japan; [Urakawa, Susumu] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Judo Neurophysiotherapy, Toyama 930, Japan; [Mitsushima, Dai] Yamaguchi Univ, Grad Sch Med, Dept Syst Neurosci, Yamaguchi, Japan; [Shimozuru, Michito] Hokkaido Univ, Dept Environm Vet Sci, Sapporo, Hokkaido 060, Japan; [Shimozuru, Michito] Univ Tokyo, Lab Vet Ethol, Tokyo, Japan; [Kondo, Yasuhiko] Teikyo Univ Sci, Dept Anim Sci, Tokyo, Japan	Nippon Medical School; University of Toyama; Yamaguchi University; Hokkaido University; University of Tokyo	Kondo, Y (corresponding author), Nippon Med Sch, Dept Physiol, 1-1-5 Sendagi, Tokyo 113, Japan.	ykondo@ntu.ac.jp	Sakuma, Yasuo/C-5604-2011	Sakuma, Yasuo/0000-0001-6816-3779; Kondo, Yasuhiko/0000-0003-1062-1524	Japan Society for the Promotion of Science [22590229, 16086210]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partly supported by Grants-in-Aid for Scientific Research to YK. (No. 22590229) and YS. (No. 16086210) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1999, J NEUROSCI, V19; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; BARFIELD RJ, 1968, SCIENCE, V161, P392, DOI 10.1126/science.161.3839.392; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Barrot M, 2005, P NATL ACAD SCI USA, V102, P8357, DOI 10.1073/pnas.0500587102; Belz EE, 2003, PHARMACOL BIOCHEM BE, V76, P481, DOI 10.1016/j.pbb.2003.09.005; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Bonilla-Jaime H, 2006, HORM BEHAV, V49, P376, DOI 10.1016/j.yhbeh.2005.08.005; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Chapillon P, 1999, BEHAV GENET, V29, P41, DOI 10.1023/A:1021437905913; de Jong TR, 2006, NEUROSCI BIOBEHAV R, V30, P893, DOI 10.1016/j.neubiorev.2006.01.001; Dell'Osso B, 2010, HUM PSYCHOPHARM CLIN, V25, P17, DOI 10.1002/hup.1074; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Fernandez-Teruel A, 1997, BEHAV GENET, V27, P513, DOI 10.1023/A:1021400830503; Fernandez-Teruel A, 2002, PHARMACOL BIOCHEM BE, V73, P225, DOI 10.1016/S0091-3057(02)00784-0; FERNANDEZGUASTI A, 1990, PHARMACOL BIOCHEM BE, V35, P263, DOI 10.1016/0091-3057(90)90237-C; Fiorino DF, 1997, J NEUROSCI, V17, P4849; Giuliano F, 2001, EUR UROL, V40, P601, DOI 10.1159/000049844; Giuliano F, 2007, TRENDS NEUROSCI, V30, P79, DOI 10.1016/j.tins.2006.12.002; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Hull EM, 2007, HORM BEHAV, V27, P2837; INOUE T, 1994, PHARMACOL BIOCHEM BE, V49, P911, DOI 10.1016/0091-3057(94)90243-7; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; KAMEL F, 1975, HORM BEHAV, V6, P277, DOI 10.1016/0018-506X(75)90014-8; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Kondo Y, 1997, BEHAV BRAIN RES, V88, P153, DOI 10.1016/S0166-4328(97)02287-0; Lopez HH, 1999, HORM BEHAV, V36, P176, DOI 10.1006/hbeh.1999.1535; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Macgillivray L, 2012, SYNAPSE, V66, P465, DOI 10.1002/syn.21511; Magalhaes A, 2007, HUM EXP TOXICOL, V26, P303, DOI 10.1177/0960327106070458; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185; Matsumoto J, 2012, J NEUROSCI, V32, P1672, DOI 10.1523/JNEUROSCI.5140-11.2012; MELIS MR, 1995, NEUROSCI BIOBEHAV R, V19, P19, DOI 10.1016/0149-7634(94)00020-2; Mitsushima D, 2006, EUR J NEUROSCI, V24, P3245, DOI 10.1111/j.1460-9568.2006.05214.x; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Moser MB, 1997, J COMP NEUROL, V380, P373, DOI 10.1002/(SICI)1096-9861(19970414)380:3<373::AID-CNE6>3.0.CO;2-#; Neugebauer NM, 2004, DEV BRAIN RES, V153, P213, DOI 10.1016/j.devbrainres.2004.09.001; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; PANKSEPP J, 1981, DEV PSYCHOBIOL, V14, P327, DOI 10.1002/dev.420140405; Patel K, 2009, CURR OPIN INVEST DR, V10, P681; Pietropaolo S, 2004, PHYSIOL BEHAV, V81, P443, DOI 10.1016/j.physbeh.2004.02.022; Rasmuson S, 1998, MOL BRAIN RES, V53, P285, DOI 10.1016/S0169-328X(97)00317-3; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Roy V, 2001, PHYSIOL BEHAV, V74, P313, DOI 10.1016/S0031-9384(01)00561-3; Rueter LE, 1996, BRAIN RES, V739, P57, DOI 10.1016/S0006-8993(96)00809-8; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Shimozuru M, 2006, PHYSIOL BEHAV, V89, P644, DOI 10.1016/j.physbeh.2006.08.001; SWANSON HH, 1983, J REPROD FERTIL, V69, P165, DOI 10.1530/jrf.0.0690165; SWANSON HH, 1983, BEHAV PROCESS, V8, P1, DOI 10.1016/0376-6357(83)90039-6; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Urakawa S, 2007, NEUROSCIENCE, V144, P920, DOI 10.1016/j.neuroscience.2006.10.038; Urakawa S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-13; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	61	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87911	10.1371/journal.pone.0087911	http://dx.doi.org/10.1371/journal.pone.0087911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505330	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200084
J	Yadeta, KA; Valkenburg, DJ; Hanemian, M; Marco, Y; Thomma, BPHJ				Yadeta, Koste A.; Valkenburg, Dirk-Jan; Hanemian, Mathieu; Marco, Yves; Thomma, Bart P. H. J.			The Brassicaceae-Specific EWR1 Gene Provides Resistance to Vascular Wilt Pathogens	PLOS ONE			English	Article							ASYMMETRIC INTERLACED PCR; ARABIDOPSIS-THALIANA; VERTICILLIUM WILT; ANTIMICROBIAL PEPTIDES; DEFENSE PEPTIDES; TOMATO VE1; PLANT; DAHLIAE; DISEASE; PROTEINS	Soil-borne vascular wilt diseases caused by Verticillium spp. are among the most destructive diseases worldwide in a wide range of plant species. The most effective means of controlling Verticillium wilt diseases is the use of genetic resistance. We have previously reported the identification of four activation-tagged Arabidopsis mutants which showed enhanced resistance to Verticillium wilt. Among these, one mutant also showed enhanced resistance to Ralstonia solanacearum, a bacterial vascular wilt pathogen. Cloning of the activation tag revealed an insertion upstream of gene At3g13437, which we designated as EWR1 (for Enhancer of vascular Wilt Resistance 1) that encodes a putatively secreted protein of unknown function. The search for homologs of Arabidopsis EWR1 (AtEWR1) in public databases only identified homologs within the Brassicaceae family. We subsequently cloned the EWR1 homolog from Brassica oleracea (BoEWR1) and show that overexpression in Arabidopsis results in V. dahliae resistance. Moreover, over-expression of AtEWR1 and BoEWR1 in N. benthamiana, a member of the Solanaceae family, results in V. dahliae resistance, suggesting that EWR1 homologs can be used to engineer Verticillium wilt resistance in non-Brassicaceae crops as well.	[Yadeta, Koste A.; Valkenburg, Dirk-Jan; Thomma, Bart P. H. J.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Hanemian, Mathieu; Marco, Yves] CNRS, Inst Natl Rech Agronom, Lab Interact Plantes Microorganismes, Castanet Tolosan, France	Wageningen University & Research; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Thomma, BPHJ (corresponding author), Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands.	bart.thomma@wur.nl	Thomma, Bart/E-5959-2011; Thomma, Bart/ABH-6344-2020	Thomma, Bart/0000-0003-4125-4181; Thomma, Bart/0000-0003-4125-4181; hanemian, mathieu/0000-0003-2012-6500	Dutch Technology Foundation STW, which is the applied science division of NWO; Technology Programme of the Ministry of Economic Affairs; Vici grant of the Research Council for Earth and Life sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); Van Gogh programme	Dutch Technology Foundation STW, which is the applied science division of NWO(Technologiestichting STW); Technology Programme of the Ministry of Economic Affairs; Vici grant of the Research Council for Earth and Life sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); Van Gogh programme	This research is supported by the Dutch Technology Foundation STW, which is the applied science division of NWO, and the Technology Programme of the Ministry of Economic Affairs. BPHJT is supported by a Vici grant of the Research Council for Earth and Life sciences (ALW) of the Netherlands Organization for Scientific Research (NWO). We acknowledge the Van Gogh programme for supporting the collaboration with CNRS-INRA in Toulouse, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2009, NEW PHYTOL, V183, P1163, DOI 10.1111/j.1469-8137.2009.02902.x; Aerts AM, 2007, PLANT CELL REP, V26, P1391, DOI 10.1007/s00299-007-0329-4; Agrios G. N., 2005, PLANT PATHOL; Arbogast M, 1999, PHYTOPATHOLOGY, V89, P782, DOI 10.1094/PHYTO.1999.89.9.782; Ayliffe MA, 2007, AUST J AGR RES, V58, P490, DOI 10.1071/AR06154; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Chen P, 2004, PHYSIOL MOL PLANT P, V64, P283, DOI 10.1016/j.pmpp.2004.10.002; Cirulli M, 2010, PLANT DIS, V94, P1176, DOI 10.1094/PDIS-12-09-0852; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Grant JJ, 2003, MOL PLANT MICROBE IN, V16, P669, DOI 10.1094/MPMI.2003.16.8.669; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Honee G, 1998, PLANT PHYSIOL, V117, P809, DOI 10.1104/pp.117.3.809; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028341; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Khurana Paramjit, 2008, Physiol Mol Biol Plants, V14, P277, DOI 10.1007/s12298-008-0026-y; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lewin B., 2008, GENES; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Marsch-Martinez N, 2002, PLANT PHYSIOL, V129, P1544, DOI 10.1104/pp.003327; Marsch-Martinez N, 2011, METHODS MOL BIOL, V678, P91, DOI 10.1007/978-1-60761-682-5_8; Pantelides IS, 2010, MOL PLANT PATHOL, V11, P191, DOI 10.1111/j.1364-3703.2009.00592.x; Pegg G, 2002, VERTICILLIUM WILT; Reusche M, 2012, PLANT CELL, V24, P3823, DOI 10.1105/tpc.112.103374; Rowe RC, 2002, PLANT DIS, V86, P1184, DOI 10.1094/PDIS.2002.86.11.1184; Schaefer SC, 2005, PLANTA, V222, P858, DOI 10.1007/s00425-005-0026-x; SCHAIBLE L, 1951, PHYTOPATHOLOGY, V41, P986; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; Thevissen K, 2007, DRUG DISCOV TODAY, V12, P966, DOI 10.1016/j.drudis.2007.07.016; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Wang K., 2006, AGROBACTERIUM PROTOC; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Xia YJ, 2004, EMBO J, V23, P980, DOI 10.1038/sj.emboj.7600086; Yadeta KA, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00086, 10.3389/fpls.2013.00097]; Yadeta KA, 2011, MOL PLANT MICROBE IN, V24, P1582, DOI 10.1094/MPMI-04-11-0090; Yang MG, 2011, PLANT CELL REP, V30, P373, DOI 10.1007/s00299-010-0940-7	51	19	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88230	10.1371/journal.pone.0088230	http://dx.doi.org/10.1371/journal.pone.0088230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505441	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200146
J	Chatterjee, S; Bacopulos, S; Yang, WY; Amemiya, Y; Spyropoulos, D; Raouf, A; Seth, A				Chatterjee, Sumanta; Bacopulos, Stephanie; Yang, Wenyi; Amemiya, Yutaka; Spyropoulos, Demetri; Raouf, Afshin; Seth, Arun			Loss of Igfbp7 Causes Precocious Involution in Lactating Mouse Mammary Gland	PLOS ONE			English	Article							GROWTH-FACTOR-I; BREAST EPITHELIAL-CELLS; PROGESTERONE-RECEPTOR; DISEASE PROGRESSION; DOWN-REGULATION; GENE; EXPRESSION; PROLACTIN; PROTEIN; CANCER	Background: Insulin like growth factors (IGFs) and their binding proteins (IGFBPs) are secreted peptides that play major roles in regulating the normal development and maturation of mammary gland. While Igfbp7 has been shown to decrease breast tumor growth, its role in regulating the normal mammary gland development has not been studied. To this end, we generated Igfbp7-null mice and examined the development and maturation of mammary glands in the virgin, pregnant and lactating animals. Results: We report here that loss of Igfbp7 significantly retards mammary gland development in the virgin animals. More significantly, the pregnant Igfpb7-null glands contained fewer alveolar structures and that during lactation these glands exhibit the morphological changes that are associated with involution. The transcriptome profile of the Igfbp7-null glands on the lactation day 3 revealed a distinct involution-related gene signature compared to the lactating WT glands. Interestingly, we found that the lactating Igfbp7-null glands exhibit increased expression of Stat3 and enhanced activation of (phosphorylated) Stat3, combined with decreased expression of Stat5 suggesting that the absence of Igfbp7 accelerates the onset of involution. We also found that in absence of Igfpb7, the lactating glands contain increased Igfbp5 protein along with decreased expression of IGF-1 Receptor and Akt activation. Finally, we show that during the normal course of involution, Igfbp7 expression is significantly decreased in the mammary gland. Conclusion: Our data suggest that loss of Igfbp7 induces precocious involution possibly through diminished cell survival signals. Our findings identify Igfbp7 as major regulator of involution in the mammary gland.	[Chatterjee, Sumanta; Raouf, Afshin] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Chatterjee, Sumanta; Raouf, Afshin] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; [Bacopulos, Stephanie; Yang, Wenyi; Amemiya, Yutaka; Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Bacopulos, Stephanie; Yang, Wenyi; Amemiya, Yutaka; Seth, Arun] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Spyropoulos, Demetri] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA	University of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Medical University of South Carolina	Raouf, A (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	raouf@cc.umanitoba.ca		Chatterjee, Sumanta/0000-0002-6832-0073	Canadian Breast Cancer Foundation-the Prairie-NWT; Manitoba Health Research Institute	Canadian Breast Cancer Foundation-the Prairie-NWT; Manitoba Health Research Institute	This work was made possible by generous research funds provided by the Canadian Breast Cancer Foundation-the Prairie-NWT to AR and AS, as well as funds from the Manitoba Health Research Institute to AR. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Y, 2011, BREAST CANCER RES TR, V126, P373, DOI 10.1007/s10549-010-0921-0; Bartella V, 2012, CELL SIGNAL, V24, P1515, DOI 10.1016/j.cellsig.2012.03.012; Benatar T, 2011, BREAST CANC RES TREA; Blanchard A, 2007, FRONT BIOSCI, V12, P2221, DOI 10.2741/2225; Bocchinfuso WP, 1997, J MAMMARY GLAND BIOL, V2, P323, DOI 10.1023/A:1026339111278; Bonnette SG, 2001, ENDOCRINOLOGY, V142, P4937, DOI 10.1210/en.142.11.4937; Brisken C, 2002, DEV CELL, V3, P877, DOI 10.1016/S1534-5807(02)00365-9; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Burger AM, 2005, EUR J CANCER, V41, P1515, DOI 10.1016/j.ejca.2005.04.023; Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772; Burger AM, 1998, EUR J CANCER PREV, V7, pS29, DOI 10.1097/00008469-199802001-00007; Burrows C, 2006, ENDOCRINOLOGY, V147, P3484, DOI 10.1210/en.2006-0005; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; Clarkson RWE, 2003, J MAMMARY GLAND BIOL, V8, P309, DOI 10.1023/B:JOMG.0000010031.53310.92; DOPPLER W, 1990, MOL ENDOCRINOL, V4, P912, DOI 10.1210/mend-4-6-912; Evdokimova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003184; Hadsell DL, 2002, J DAIRY SCI, V85, P365, DOI 10.3168/jds.S0022-0302(02)74083-6; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hovey RC, 2003, MOL ENDOCRINOL, V17, P460, DOI 10.1210/me.2002-0214; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphreys RC, 1997, J MAMMARY GLAND BIOL, V2, P343, DOI 10.1023/A:1026343212187; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Kleinberg DL, 2011, ENDOCRIN METAB CLIN, V40, P461, DOI 10.1016/j.ecl.2011.06.001; Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee HJ, 2012, MOL CELL ENDOCRINOL, V357, P101, DOI 10.1016/j.mce.2011.09.020; Leroith Derek, 1995, Progress in Growth Factor Research, V6, P433, DOI 10.1016/0955-2235(96)00009-9; Li ML, 1997, P NATL ACAD SCI USA, V94, P3425, DOI 10.1073/pnas.94.7.3425; McIntosh J, 2010, J BIOL CHEM, V285, P38788, DOI 10.1074/jbc.M110.177311; Neuenschwander S, 1996, J CLIN INVEST, V97, P2225, DOI 10.1172/JCI118663; Ning Y, 2007, ENDOCRINOLOGY, V148, P2138, DOI 10.1210/en.2006-0041; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Richards RG, 2004, ENDOCRINOLOGY, V145, P3106, DOI 10.1210/en.2003-1112; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Seth A, 2003, ANTICANCER RES, V23, P2043; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Stein T, 2009, J MAMMARY GLAND BIOL, V14, P99, DOI 10.1007/s10911-009-9120-1; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Tonner E, 1997, ENDOCRINOLOGY, V138, P5101, DOI 10.1210/en.138.12.5101; Watson Christine J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000196; Wilson HMP, 2002, CELL GROWTH DIFFER, V13, P205; Zuo SG, 2012, J CANCER RES CLIN, V138, P1045, DOI 10.1007/s00432-012-1153-y	47	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87858	10.1371/journal.pone.0087858	http://dx.doi.org/10.1371/journal.pone.0087858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505323	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300006
J	Choi, HY; Moon, SJ; Ratliff, BB; Ahn, SH; Jung, A; Lee, M; Lee, S; Lim, BJ; Kim, BS; Plotkin, MD; Ha, SK; Park, HC				Choi, Hoon Young; Moon, Sung Jin; Ratliff, Brian B.; Ahn, Sun Hee; Jung, Ara; Lee, Mirae; Lee, Seol; Lim, Beom Jin; Kim, Beom Seok; Plotkin, Matthew D.; Ha, Sung Kyu; Park, Hyeong Cheon			Microparticles from Kidney-Derived Mesenchymal Stem Cells Act as Carriers of Proangiogenic Signals and Contribute to Recovery from Acute Kidney Injury	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; ISCHEMIA-REPERFUSION INJURY; UMBILICAL VEIN; HORIZONTAL TRANSFER; MESSENGER-RNA; STROMAL CELLS; PROTECT; ANGIOGENESIS; THERAPY; REPAIR	We recently demonstrated the use of in vitro expanded kidney-derived mesenchymal stem cells (KMSC) protected peritubular capillary endothelial cells in acute renal ischemia-reperfusion injury. Herein, we isolated and characterized microparticles (MPs) from KMSC. We investigated their in vitro biologic effects on human endothelial cells and in vivo renoprotective effects in acute ischemia-reperfusion renal injury. MPs were isolated from the supernatants of KMSC cultured in anoxic conditions in serum-deprived media for 24 hours. KMSC-derived MPs demonstrated the presence of several adhesion molecules normally expressed on KMSC membranes, such as CD29, CD44, CD73, alpha 4, 5, and 6 integrins. Quantitative real time PCR confirmed the presence of 3 splicing variants of VEGF-A (120, 164, 188), bFGF and IGF-1 in isolated MPs. MPs labeled with PKH26 red fluorescence dye were incorporated by cultured human umbilical vein endothelial cells (HUVEC) via surface molecules such as CD44, CD29, and alpha 4, 5, and 6 integrins. MP dose dependently improved in vitro HUVEC proliferation and promoted endothelial tube formation on growth factor reduced Matrigel. Moreover, apoptosis of human microvascular endothelial cell was inhibited by MPs. Administration of KMSC-derived MPs into mice with acute renal ischemia was followed by selective engraftment in ischemic kidneys and significant improvement in renal function. This was achieved by improving proliferation, of peritubular capillary endothelial cell and amelioration of peritubular microvascular rarefaction. Our results support the hypothesis that KMSC-derived MPs may act as a source of proangiogenic signals and confer renoprotective effects in ischemic kidneys.	[Choi, Hoon Young; Ahn, Sun Hee; Jung, Ara; Lee, Mirae; Lee, Seol; Ha, Sung Kyu; Park, Hyeong Cheon] Gangnam Severance Hosp, Div Nephrol, Dept Internal Med, Seoul, South Korea; [Choi, Hoon Young; Park, Hyeong Cheon] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Moon, Sung Jin] Kwandong Univ, Coll Med, Dept Internal Med, Kangnung, South Korea; [Ratliff, Brian B.; Plotkin, Matthew D.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Ratliff, Brian B.; Plotkin, Matthew D.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Ratliff, Brian B.; Plotkin, Matthew D.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Lim, Beom Jin] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Div Nephrol,Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic Kwandong University; New York Medical College; New York Medical College; New York Medical College; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, HC (corresponding author), Gangnam Severance Hosp, Div Nephrol, Dept Internal Med, Seoul, South Korea.	amp97@yuhs.ac		Park, Hyeong-Cheon/0000-0002-1550-0812; Lim, Beom Jin/0000-0003-2856-0133; Kim, Beom Seok/0000-0002-5732-2583; CHOI, HOON YOUNG/0000-0002-4245-0339	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology of the Republic of Korea [NRF-2010-0013373]; Yonsei University College of Medicine [6-2010-0044]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology of the Republic of Korea; Yonsei University College of Medicine(General Electric)	This research was supported by the Basic Science Research Program (NRF-2010-0013373) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology of the Republic of Korea and by the faculty research grant of Yonsei University College of Medicine in 2010 (No. 6-2010-0044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Beck GC, 1999, CLIN EXP IMMUNOL, V118, P298; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bruno S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033115; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dib H, 2012, PROTEOMICS, V12, P2547, DOI 10.1002/pmic.201200060; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Kang DH, 2001, AM J PHYSIOL-RENAL, V280, pF727, DOI 10.1152/ajprenal.2001.280.4.F727; Kassem M, 2006, ANN NY ACAD SCI, V1067, P436, DOI 10.1196/annals.1354.062; Morel O, 2004, CURR OPIN HEMATOL, V11, P156, DOI 10.1097/01.moh.0000131441.10020.87; Nanobashvili J., 2003, EUR SURG, V35, P214, DOI 10.1007/s10353-003-0012-0; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Plotkin MD, 2006, AM J PHYSIOL-RENAL, V291, pF902, DOI 10.1152/ajprenal.00396.2005; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Robert B, 2000, AM J PHYSIOL-RENAL, V279, pF275, DOI 10.1152/ajprenal.2000.279.2.F275; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; ZETTER BR, 1981, DIABETES, V30, P24, DOI 10.2337/diab.30.2.S24; Zoja C, 2012, AM J PHYSIOL-RENAL, V303, pF1370, DOI 10.1152/ajprenal.00057.2012	29	68	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87853	10.1371/journal.pone.0087853	http://dx.doi.org/10.1371/journal.pone.0087853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504266	gold, Green Submitted, Green Published			2022-12-27	WOS:000336971300004
J	Fietz, J; Tomiuk, J; Loeschcke, V; Weis-Dootz, T; Segelbacher, G				Fietz, Joanna; Tomiuk, Jurgen; Loeschcke, Volker; Weis-Dootz, Tanja; Segelbacher, Gernot			Genetic Consequences of Forest Fragmentation for a Highly Specialized Arboreal Mammal - the Edible Dormouse	PLOS ONE			English	Article							POPULATION-STRUCTURE; GLIS; REPRODUCTION; MANAGEMENT; LANDSCAPE; DIVERSITY; INFERENCE; RESPONSES; SOFTWARE; RODENTS	Habitat loss and fragmentation represent the most serious extinction threats for many species and have been demonstrated to be especially detrimental for mammals. Particularly, highly specialized species with low dispersal abilities will encounter a high risk of extinction in fragmented landscapes. Here we studied the edible dormouse (Glis glis), a small arboreal mammal that is distributed throughout Central Europe, where forests are mostly fragmented at different spatial scales. The aim of this study was to investigate the effect of habitat fragmentation on genetic population structures using the example of edible dormouse populations inhabiting forest fragments in south western Germany. We genotyped 380 adult individuals captured between 2001 and 2009 in four different forest fragments and one large continuous forest using 14 speciesspecific microsatellites. We hypothesised, that populations in small forest patches have a lower genetic diversity and are more isolated compared to populations living in continuous forests. In accordance with our expectations we found that dormice inhabiting forest fragments were isolated from each other. Furthermore, their genetic population structure was more unstable over the study period than in the large continuous forest. Even though we could not detect lower genetic variability within individuals inhabiting forest fragments, strong genetic isolation and an overall high risk to mate with close relatives might be precursors to a reduced genetic variability and the onset of inbreeding depression. Results of this study highlight that connectivity among habitat fragments can already be strongly hampered before genetic erosion within small and isolated populations becomes evident.	[Fietz, Joanna] Univ Hohenheim, Stuttgart, Germany; [Tomiuk, Jurgen; Loeschcke, Volker] Aarhus Univ, Dept Biosci Integrat Ecol & Evolut, Aarhus, Denmark; [Weis-Dootz, Tanja] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Segelbacher, Gernot] Univ Freiburg, D-79106 Freiburg, Germany	University Hohenheim; Aarhus University; Ulm University; University of Freiburg	Fietz, J (corresponding author), Univ Hohenheim, Stuttgart, Germany.	Joanna.Fietz@uni-hohenheim.de	Segelbacher, Gernot/F-3633-2011; Loeschcke, Volker/J-2527-2013	Segelbacher, Gernot/0000-0002-8024-7008; Loeschcke, Volker/0000-0003-1450-0754	Margarete von Wrangell Program; Deutsche Forschungsgemeinschaft [DFG: FI 831/3-1, 831/3-2, FI 831/5-1, FI 831/6-1]; German Wildlife Foundation; Deutsche Bundesstiftung Umwelt (DBU)	Margarete von Wrangell Program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Wildlife Foundation; Deutsche Bundesstiftung Umwelt (DBU)	Financial support provided by the Margarete von Wrangell Program, the Deutsche Forschungsgemeinschaft (DFG: FI 831/3-1; 831/3-2; FI 831/5-1; FI 831/6-1), the German Wildlife Foundation to JF, and Deutsche Bundesstiftung Umwelt (DBU) to TW-D made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amori G, 1995, HYSTRIX, V6, P331; Aurelle D, 2010, MOL ECOL RESOUR, V10, P751, DOI 10.1111/j.1755-0998.2010.02871.x; Bieber C, 1998, J ZOOL, V244, P223, DOI 10.1111/j.1469-7998.1998.tb00027.x; Bieber C, 1995, HYSTRIX, V6, P257, DOI DOI 10.4404/HYSTRIX-6.1-2-4037; Bijlsma R, 2012, EVOL APPL, V5, P117, DOI 10.1111/j.1752-4571.2011.00214.x; Capizzi D, 2003, ACTA THERIOL, V48, P359, DOI 10.1007/BF03194175; Dabert M, 2009, CONSERV GENET, V10, P2029, DOI 10.1007/s10592-009-9886-0; Dieterlen, 2005, SAUGETIERE BADEN WUR, P199; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fietz J, 2005, J COMP PHYSIOL B, V175, P45, DOI 10.1007/s00360-004-0461-1; Fietz J, 2004, OECOLOGIA, V138, P202, DOI 10.1007/s00442-003-1423-0; Fietz J, 2012, POPUL ECOL, V54, P313, DOI 10.1007/s10144-012-0310-0; Fietz J, 2010, NATURWISSENSCHAFTEN, V97, P883, DOI 10.1007/s00114-010-0704-9; Fietz J, 2009, J COMP PHYSIOL B, V179, P829, DOI 10.1007/s00360-009-0364-2; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2001, FSTAT PROGRAM ESTIMA, P485; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Honel B, 1991, THESIS KARLSRUHE U; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurner H, 2009, MOL ECOL RESOUR, V9, P885, DOI 10.1111/j.1755-0998.2008.02365.x; Kalinowski ST, 2009, HEREDITY, V102, P506, DOI 10.1038/hdy.2008.136; Koprowski JL, 2005, ANIM CONSERV, V8, P369, DOI 10.1017/S1367943005002416; La Haye MJJ, 2012, CONSERV GENET, V13, P311, DOI 10.1007/s10592-011-0278-x; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; Lebl K, 2011, ECOGRAPHY, V34, P683, DOI 10.1111/j.1600-0587.2010.06691.x; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mortelliti A, 2009, CAN J ZOOL, V87, P662, DOI 10.1139/Z09-054; Mortelliti A, 2010, MAMMAL REV, V40, P125, DOI 10.1111/j.1365-2907.2009.00157.x; Mortelliti A, 2009, BIODIVERS CONSERV, V18, P1131, DOI 10.1007/s10531-008-9477-2; Muller H, 1989, THESIS SAARBRUCKEN U; Negro M, 2013, EUR J WILDLIFE RES, V59, P57, DOI 10.1007/s10344-012-0647-x; Nei M, 1987, MOL EVOLUTIONARY GEN, P283; Pertoldi C, 2007, OIKOS, V116, P769, DOI 10.1111/j.2007.0030-1299.15672.x; Pilastro A, 2003, ECOLOGY, V84, P1784, DOI 10.1890/0012-9658(2003)084[1784:LLARSI]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruf T, 2006, ECOLOGY, V87, P372, DOI 10.1890/05-0672; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schlumpberger O, 2010, THESIS U ULM; Schlund W, 1997, Z SAUGETIERKD, V62, P158; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Strand TM, 2012, ECOL EVOL, V2, P341, DOI 10.1002/ece3.86; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026651; Tomiuk J, 2009, MOL ECOL RESOUR, V9, P1364, DOI 10.1111/j.1755-0998.2009.02623.x; Von Vietinghoff-Riesch A., 1960, MONOGRAPHIEN WILDSAU, V14; Wade TG, 2003, CONSERV ECOL, V7; Worschech K, 2011, 8 INT DORM C, P173	54	27	28	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88092	10.1371/journal.pone.0088092	http://dx.doi.org/10.1371/journal.pone.0088092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505390	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300053
J	Misra, G; Paris, TA; Archer, DB; Coombes, SA				Misra, Gaurav; Paris, Tiffany A.; Archer, Derek B.; Coombes, Stephen A.			Dose-Response Effect of Isometric Force Production on the Perception of Pain	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; BLOOD-PRESSURE; EXERCISE; CONTRACTIONS; STIMULATION; VALIDATION; STROKE; MEMORY; SCALE	Isometric contractions can influence the way that we perceive pain, but conclusions on the dose-response effect of force amplitude on pain perception are limited because previous studies have not held the duration of force contractions constant while varying force amplitude. To address this issue we designed an experiment that allowed us to accurately guide the amplitude of an isometric pinch grip force contraction on a trial-by-trial basis, while a thermal pain eliciting stimulus was simultaneously delivered for the same duration to the non-contracting hand. Our results show that an increase in the amplitude of force produced by one hand corresponded with a decrease in pain perception in the opposite hand. Our observations provide novel evidence that the centralized inhibitory response that underlies analgesia is sensitive to and enhanced by stronger isometric contractions.	[Misra, Gaurav; Paris, Tiffany A.; Archer, Derek B.; Coombes, Stephen A.] Univ Florida, Lab Rehabil Neurosci, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Coombes, SA (corresponding author), Univ Florida, Lab Rehabil Neurosci, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	scoombes@ufl.edu						Adrian E.D., 1929, J PHYSL, V67, pi3, DOI DOI 10.1113/JPHYSIOL.1929.SP002557; Beck A.T., 1987, BECK DEPRESSION INVE; Bement MKH, 2008, MED SCI SPORT EXER, V40, P1880, DOI 10.1249/MSS.0b013e31817eeecc; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Buhle JT, 2012, PSYCHOL SCI, V23, P246, DOI 10.1177/0956797611427919; Coombes SA, 2012, CEREB CORTEX, V22, P616, DOI 10.1093/cercor/bhr141; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Koltyn KF, 2013, EUR J PAIN, V17, P1005, DOI 10.1002/j.1532-2149.2012.00264.x; Koltyn KF, 2007, J PAIN, V8, P887, DOI 10.1016/j.jpain.2007.06.003; Koltyn KF, 2006, SPORTS MED, V36, P207, DOI 10.2165/00007256-200636030-00003; Koltyn KF, 2000, SPORTS MED, V29, P85, DOI 10.2165/00007256-200029020-00002; Kori SH, 1990, PAIN MANAG, V3, P35; Kosek E, 2003, EUR J PAIN, V7, P251, DOI 10.1016/S1090-3801(02)00124-6; Lodha N, 2012, CLIN NEUROPHYSIOL, V123, P787, DOI 10.1016/j.clinph.2011.08.014; Lodha N, 2010, CLIN NEUROPHYSIOL, V121, P1952, DOI 10.1016/j.clinph.2010.04.005; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Neely KA, 2013, HUM BRAIN MAPP, V34, P698, DOI 10.1002/hbm.21467; Paris TA, 2013, J PAIN, V14, P1492, DOI 10.1016/j.jpain.2013.07.012; Ring C, 2008, BIOL PSYCHOL, V78, P123, DOI 10.1016/j.biopsycho.2008.01.008; Senapati AK, 2005, BRAIN RES, V1036, P173, DOI 10.1016/j.brainres.2004.12.043; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spraker MB, 2007, J NEUROPHYSIOL, V98, P821, DOI 10.1152/jn.00239.2007; Spraker MB, 2011, NEUROIMAGE; Sprenger C, 2012, CURR BIOL, V22, P1019, DOI 10.1016/j.cub.2012.04.006; Staud R, 2005, PAIN, V118, P176, DOI 10.1016/j.pain.2005.08.007; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Taylor AM, 2003, J NEUROPHYSIOL, V90, P1350, DOI 10.1152/jn.00056.2003; Umeda M, 2010, BIOL PSYCHOL, V85, P90, DOI 10.1016/j.biopsycho.2010.05.008; Vaillancourt DE, 2002, EXP BRAIN RES, V145, P275, DOI 10.1007/s00221-002-1081-1; YEZIERSKI RP, 1983, J NEUROPHYSIOL, V49, P424, DOI 10.1152/jn.1983.49.2.424	34	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88105	10.1371/journal.pone.0088105	http://dx.doi.org/10.1371/journal.pone.0088105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505397	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300055
J	Stewart, KR; Dutton, PH				Stewart, Kelly R.; Dutton, Peter H.			Breeding Sex Ratios in Adult Leatherback Turtles (Dermochelys coriacea) May Compensate for Female-Biased Hatchling Sex Ratios	PLOS ONE			English	Article							CLIMATE-CHANGE; INCUBATION TEMPERATURES; POPULATION; IMPACTS; RECONSTRUCTION; MARKERS	For vertebrates with temperature-dependent sex determination, primary (or hatchling) sex ratios are often skewed, an issue of particular relevance to concerns over effects of climate change on populations. However, the ratio of breeding males to females, or the operational sex ratio (OSR), is important to understand because it has consequences for population demographics and determines the capacity of a species to persist. The OSR also affects mating behaviors and mate choice, depending on the more abundant sex. For sea turtles, hatchling and juvenile sex ratios are generally female-biased, and with warming nesting beach temperatures, there is concern that populations may become feminized. Our purpose was to evaluate the breeding sex ratio for leatherback turtles at a nesting beach in St. Croix, USVI. In 2010, we sampled nesting females and later sampled their hatchlings as they emerged from nests. Total genomic DNA was extracted and all individuals were genotyped using 6 polymorphic microsatellite markers. We genotyped 662 hatchlings from 58 females, matching 55 females conclusively to their nests. Of the 55, 42 females mated with one male each, 9 mated with 2 males each and 4 mated with at least 3 males each, for a multiple paternity rate of 23.6%. Using GERUD1.0, we reconstructed parental genotypes, identifying 47 different males and 46 females for an estimated breeding sex ratio of 1.02 males for every female. Thus we demonstrate that there are as many actively breeding males as females in this population. Concerns about female-biased adult sex ratios may be premature, and mate choice or competition may play more of a role in sea turtle reproduction than previously thought. We recommend monitoring breeding sex ratios in the future to allow the integration of this demographic parameter in population models.	[Stewart, Kelly R.; Dutton, Peter H.] Natl Ocean & Atmospher Adm, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA; [Stewart, Kelly R.] Ocean Fdn, Washington, DC USA	National Oceanic Atmospheric Admin (NOAA) - USA	Stewart, KR (corresponding author), Natl Ocean & Atmospher Adm, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA.	Kelly.Stewart@noaa.gov			National Oceanic and Atmospheric Administration (NOAA) Fisheries; US Fish and Wildlife Service	National Oceanic and Atmospheric Administration (NOAA) Fisheries; US Fish and Wildlife Service(US Fish & Wildlife Service)	Funding sources: National Oceanic and Atmospheric Administration (NOAA) Fisheries and The US Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGLUND A, 1994, BEHAV ECOL, V5, P254, DOI 10.1093/beheco/5.3.254; Binckley CA, 1998, COPEIA, P291; CHAN EH, 1995, BIOL CONSERV, V74, P169, DOI 10.1016/0006-3207(95)00027-2; Crim JL, 2002, MOL ECOL, V11, P2097, DOI 10.1046/j.1365-294X.2002.01591.x; de Jong K, 2012, BEHAV ECOL, V23, P1170, DOI 10.1093/beheco/ars094; Dearborn DC, 2001, BEHAV ECOL, V12, P746, DOI 10.1093/beheco/12.6.746; Dutton Peter H., 2013, Marine Turtle Newsletter, P3; Dutton PH, 2013, CONSERV GENET, V14, P625, DOI 10.1007/s10592-013-0456-0; Dutton PH, 2009, MOL ECOL RESOUR, V9, P354, DOI 10.1111/j.1755-0998.2008.02443.x; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Girondot Marc, 2004, P148; Godfrey MH, 1996, CAN J ZOOL, V74, P267, DOI 10.1139/z96-033; HANOTTE O, 1991, GENOMICS, V9, P587, DOI 10.1016/0888-7543(91)90351-E; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hulin V, 2009, OECOLOGIA, V160, P493, DOI 10.1007/s00442-009-1313-1; HUTTON JM, 1987, J ZOOL, V211, P143, DOI 10.1111/j.1469-7998.1987.tb07458.x; Innis MA, 1990, PCR PROTOCOLS GUIDE; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; James MC, 2007, MAR ECOL PROG SER, V337, P245, DOI 10.3354/meps337245; Jensen MP, 2006, MOL ECOL, V15, P2567, DOI 10.1111/j.1365-294X.2006.02951.x; Jones AG, 2001, MOL ECOL NOTES, V1, P215, DOI 10.1046/j.1471-8278.2001.00062.x; Jouventin P, 2007, IBIS, V149, P67, DOI 10.1111/j.1474-919X.2006.00597.x; Lance VA, 2000, J ZOOL, V252, P71, DOI 10.1111/j.1469-7998.2000.tb00821.x; LOVICH JE, 1990, OIKOS, V59, P126, DOI 10.2307/3545132; Maness TJ, 2007, WATERBIRDS, V30, P10, DOI 10.1675/1524-4695(2007)030[0010:OSRVIN]2.0.CO;2; Miller D, 2004, FERTIL STERIL, V81, P954, DOI 10.1016/j.fertnstert.2003.09.051; Patino-Martinez J, 2012, GLOBAL CHANGE BIOL, V18, P401, DOI 10.1111/j.1365-2486.2011.02532.x; Phillips KP, 2013, MOL ECOL, V22, P2301, DOI 10.1111/mec.12235; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Roden SE, 2011, CONSERV GENET RESOUR, V3, P49, DOI 10.1007/s12686-010-9284-4; Shamblin BM, 2009, CONSERV GENET, V10, P577, DOI 10.1007/s10592-008-9573-6; Steckenreuter A, 2010, CHELONIAN CONSERV BI, V9, P123, DOI 10.2744/CCB-0763.1; Stewart KR, 2011, CONSERV GENET, V12, P1101, DOI 10.1007/s10592-011-0212-2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weimerskirch H, 2005, J ANIM ECOL, V74, P285, DOI 10.1111/j.1365-2656.2005.00922.x; WESTNEAT DF, 1987, BEHAV ECOL SOCIOBIOL, V21, P35, DOI 10.1007/BF00324433; Wibbels T, 2003, CRC MAR BIOL SER, P103; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; WOODWARD DE, 1993, P ROY SOC B-BIOL SCI, V252, P149, DOI 10.1098/rspb.1993.0059; Wright LI, 2012, MOL ECOL, V21, P3625, DOI 10.1111/j.1365-294X.2012.05616.x	41	24	24	1	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88138	10.1371/journal.pone.0088138	http://dx.doi.org/10.1371/journal.pone.0088138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505403	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300057
J	Watanabe, H; Saito, R; Nakano, T; Takahashi, H; Takahashi, Y; Sumiyoshi, K; Sato, K; Chen, XN; Okada, N; Iwasaki, S; Harjanti, DW; Sekiguchi, N; Sano, H; Kitazawa, H; Rose, MT; Ohwada, S; Watanabe, K; Aso, H				Watanabe, Hitoshi; Saito, Ryo; Nakano, Tatsuya; Takahashi, Hideyuki; Takahashi, Yu; Sumiyoshi, Keisuke; Sato, Katsuyoshi; Chen, Xiangning; Okada, Natsumi; Iwasaki, Shunsuke; Harjanti, Dian W.; Sekiguchi, Natsumi; Sano, Hiroaki; Kitazawa, Haruki; Rose, Michael T.; Ohwada, Shyuichi; Watanabe, Kouichi; Aso, Hisashi			Effect of Peripheral 5-HT on Glucose and Lipid Metabolism in Wether Sheep	PLOS ONE			English	Article							TRYPTOPHAN-HYDROXYLASE ISOFORM; CONSCIOUS DOGS; PANCREATIC HORMONES; ADIPOSE-TISSUE; BILE-SALT; SEROTONIN; 5-HYDROXYTRYPTAMINE; SECRETION; RECEPTOR; LIVER	In mice, peripheral 5-HT induces an increase in the plasma concentrations of glucose, insulin and bile acids, and a decrease in plasma triglyceride, NEFA and cholesterol concentrations. However, given the unique characteristics of the metabolism of ruminants relative to monogastric animals, the physiological role of peripheral 5-HT on glucose and lipid metabolism in sheep remains to be established. Therefore, in this study, we investigated the effect of 5-HT on the circulating concentrations of metabolites and insulin using five 5-HT receptor (5HTR) antagonists in sheep. After fasting for 24 h, sheep were intravenously injected with 5-HT, following which-, plasma glucose, insulin, triglyceride and NEFA concentrations were significantly elevated. In contrast, 5-HT did not affect the plasma cholesterol concentration, and it induced a decrease in bile acid concentrations. Increases in plasma glucose and insulin concentrations induced by 5-HT were attenuated by pretreatment with Methysergide, a 5HTR 1, 2 and 7 antagonist. Additionally, decreased plasma bile acid concentrations induced by 5-HT were blocked by pre-treatment with Ketanserin, a 5HTR 2A antagonist. However, none of the 5HTR antagonists inhibited the increase in plasma triglyceride and NEFA levels induced by 5-HT. On the other hand, mRNA expressions of 5HTR1D and 1E were observed in the liver, pancreas and skeletal muscle. These results suggest that there are a number of differences in the physiological functions of peripheral 5-HT with respect to lipid metabolism between mice and sheep, though its effect on glucose metabolism appears to be similar between these species.	[Watanabe, Hitoshi; Saito, Ryo; Nakano, Tatsuya; Takahashi, Hideyuki; Takahashi, Yu; Sumiyoshi, Keisuke; Sato, Katsuyoshi; Chen, Xiangning; Okada, Natsumi; Iwasaki, Shunsuke; Ohwada, Shyuichi; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Cellar Biol Lab, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Harjanti, Dian W.; Sekiguchi, Natsumi; Sano, Hiroaki] Iwate Univ, Fac Agr, Dept Anim Sci, Morioka, Iwate 020, Japan; [Kitazawa, Haruki] Tohoku Univ, Lab Food & Biomol Sci, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan; [Rose, Michael T.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	Tohoku University; Iwate University; Tohoku University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Aso, H (corresponding author), Tohoku Univ, Cellar Biol Lab, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	asosan@bios.tohoku.ac.jp	Rose, Michael/AAI-6335-2021	Kitazawa, Haruki/0000-0003-4586-5553; Chen, XN/0000-0002-9011-4946; Rose, Michael/0000-0001-6058-1319; Watanabe, Hitoshi/0000-0002-9236-7744	Ministry of Agriculture, Forestry and Fisheries; Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS)	Ministry of Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by grants from the Ministry of Agriculture, Forestry and Fisheries (2004), the Research Project on Development of Agricultural Products and Foods with Health-promoting benefits (NARO) and the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science (JSPS), Research Fellowship for Young Scientists Program, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMAN EN, 1970, AM J PHYSIOL, V219, P785, DOI 10.1152/ajplegacy.1970.219.3.785; Bergman EN, 1989, AM J PHYSIOL, V257, P772; Bogach PG, 1976, SECHENOVA, V62, P283; BROCKMAN RP, 1983, COMP BIOCHEM PHYS A, V74, P681, DOI 10.1016/0300-9629(83)90567-4; Centurion D, 2002, BRIT J PHARMACOL, V135, P1531, DOI 10.1038/sj.bjp.0704593; CHAOULOFF F, 1990, EUR J PHARMACOL, V185, P11, DOI 10.1016/0014-2999(90)90205-K; CHESTER AH, 1990, CARDIOVASC RES, V24, P932, DOI 10.1093/cvr/24.11.932; Fernandez JI, 1996, BRIT VET J, V152, P673, DOI 10.1016/S0007-1935(96)80121-7; FORTE TM, 1983, J LIPID RES, V24, P1358; Fukumori R, 2011, DOMEST ANIM ENDOCRIN, V41, P50, DOI 10.1016/j.domaniend.2011.04.001; Geba GP, 1996, J IMMUNOL, V157, P557; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563; Hampson LJ, 2007, DIABETOLOGIA, V50, P1743, DOI 10.1007/s00125-007-0696-y; HIXSON EJ, 1977, ARCH INT PHARMACOD T, V229, P4; HOLLAND JM, 1976, P SOC EXP BIOL MED, V151, P32; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Itoh F, 2006, COMP BIOCHEM PHYS A, V143, P97, DOI 10.1016/j.cbpa.2005.11.001; Jang JH, 2012, HEPATOLOGY, V56, P209, DOI 10.1002/hep.25626; JARRETT IG, 1953, AUST J EXP BIOL MED, V31, P311, DOI 10.1038/icb.1953.37; Kidd M, 2008, AM J PHYSIOL-GASTR L, V295, pG260, DOI 10.1152/ajpgi.00056.2008; Kozat S, 2010, J PARASITOL, V96, P657, DOI 10.1645/GE-2104.1; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; McCowen KC, 2002, J ENDOCRINOL, V175, pR7, DOI 10.1677/joe.0.175R007; MERRITT JH, 1978, RADIAT ENVIRON BIOPH, V15, P367, DOI 10.1007/BF01323461; Moore MC, 2005, AM J PHYSIOL-ENDOC M, V289, pE225, DOI 10.1152/ajpendo.00614.2004; Moore MC, 2004, DIABETES, V53, P14, DOI 10.2337/diabetes.53.1.14; Nakata K, 2011, NUTR RES PRACT, V5, P435, DOI 10.4162/nrp.2011.5.5.435; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peregrin AT, 1999, BRIT J PHARMACOL, V127, P887, DOI 10.1038/sj.bjp.0702615; Racke K, 1996, BEHAV BRAIN RES, V73, P83; RAPPORT MM, 1948, SCIENCE, V108, P329, DOI 10.1126/science.108.2804.329; ROBERTSON JP, 1982, BIOCHEM J, V206, P577, DOI 10.1042/bj2060577; Safsten B, 2006, SCAND J GASTROENTERO, V41, P1279, DOI 10.1080/00365520600641480; Schneider TJ, 1996, EUR J OBSTET GYN R B, V68, P179, DOI 10.1016/0301-2115(96)02478-5; Seal C. J., 1993, Nutrition Research Reviews, V6, P185, DOI 10.1079/NRR19930012; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; SMITH SB, 1984, J NUTR, V114, P792, DOI 10.1093/jn/114.4.792; SMITH SB, 1986, J NUTR, V116, P1279, DOI 10.1093/jn/116.7.1279; SUGIMOTO Y, 1992, JPN J PHARMACOL, V60, P145, DOI 10.1254/jjp.60.145; THOMAS GB, 1987, NEUROSCI LETT, V83, P323, DOI 10.1016/0304-3940(87)90108-X; VERNON R G, 1980, Progress in Lipid Research, V19, P23, DOI 10.1016/0163-7827(80)90007-7; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Watanabe H, 2011, CURR OPIN LIPIDOL, V22, P186, DOI 10.1097/MOL.0b013e3283462273; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; WOOLLEY DW, 1954, P NATL ACAD SCI USA, V40, P228, DOI 10.1073/pnas.40.4.228; YAMADA J, 1995, LIFE SCI, V57, P819, DOI 10.1016/0024-3205(95)02010-G; Zawalich WS, 2004, ENDOCRINE, V23, P11, DOI 10.1385/ENDO:23:1:11; Zhu JX, 2001, J PHYSIOL-LONDON, V530, P431, DOI 10.1111/j.1469-7793.2001.0431k.x; ZINNER MJ, 1983, J SURG RES, V34, P171, DOI 10.1016/0022-4804(83)90057-4	51	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88058	10.1371/journal.pone.0088058	http://dx.doi.org/10.1371/journal.pone.0088058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505376	Green Published, gold			2022-12-27	WOS:000336971300046
J	Fristedt, S; Dahl, AK; Wretstrand, A; Bjorklund, A; Falkmer, T				Fristedt, Sofi; Dahl, Anna K.; Wretstrand, Anders; Bjorklund, Anita; Falkmer, Torbjorn			Changes in Community Mobility in Older Men and Women. A 13-Year Prospective Study	PLOS ONE			English	Article							AGE; DISABILITY; PEOPLE; HEALTH; VALIDITY; ADULTS; ONSET; HOME	Community mobility, defined as "moving [ones] self in the community and using public or private transportation", has a unique ability to promote older peoples' wellbeing by enabling independence and access to activity arenas for interaction with others. Early predictors of decreased community mobility among older men and women are useful in developing health promoting strategies. However, long-term prediction is rare, especially when it comes to including both public and private transportation. The present study describes factors associated with community mobility and decreased community mobility over time among older men and women. In total, 119 men and 147 women responded to a questionnaire in 1994 and 2007. Respondents were between 82 and 96 years old at follow-up. After 13 years, 40% of men and 43% of women had decreased community mobility, but 47% of men and 45% of women still experienced some independent community mobility. Cross-sectional independent community mobility among men was associated with higher ratings of subjective health, reporting no depression and more involvement in sport activities. Among women, cross-sectional independent community mobility was associated with better subjective health and doing more instrumental activities of daily living outside the home. Lower subjective health predicted decreased community mobility for both men and women, whereas self-reported health conditions did not. Consequently, general policies and individual interventions aiming to improve community mobility should consider older persons' subjective health.	[Fristedt, Sofi; Bjorklund, Anita; Falkmer, Torbjorn] Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden; [Dahl, Anna K.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Dahl, Anna K.] Jonkoping Univ, Sch Hlth Sci, Inst Gerontol, Jonkoping, Sweden; [Wretstrand, Anders] Lund Univ, Fac Engn, Lund, Sweden; [Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Falkmer, Torbjorn] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci IMH, Linkoping, Sweden; [Falkmer, Torbjorn] UHL, Pain & Rehabil Ctr, Cty Council, Linkoping, Sweden; [Falkmer, Torbjorn] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia	Jonkoping University; Karolinska Institutet; Jonkoping University; Lund University; Curtin University; Linkoping University; La Trobe University	Fristedt, S (corresponding author), Jonkoping Univ, Sch Hlth Sci, Jonkoping, Sweden.	sofi.fristedt@hhj.hj.se	Aslan, Anna Dahl/P-3773-2019; Aslan, Anna Dahl/AAM-1261-2020; Wretstrand, Anders/E-4690-2011	Wretstrand, Anders/0000-0002-7394-4534	MacArthur Foundation Research Network on Successful Aging; Axel and Margaret Ax:son Johnson's Foundation; Swedish Council for Social Research; Swedish Foundation for Health Care Sciences and Allergy Research; King Gustaf V and Queen Viktoria Foundation; FORTE [2010-0704]; Future Leaders of Aging Research in Europe (FLARE) [2010-1852]	MacArthur Foundation Research Network on Successful Aging; Axel and Margaret Ax:son Johnson's Foundation; Swedish Council for Social Research; Swedish Foundation for Health Care Sciences and Allergy Research; King Gustaf V and Queen Viktoria Foundation; FORTE; Future Leaders of Aging Research in Europe (FLARE)	Data collection was supported by the MacArthur Foundation Research Network on Successful Aging, Axel and Margaret Ax:son Johnson's Foundation, Swedish Council for Social Research, Swedish Foundation for Health Care Sciences and Allergy Research, and the King Gustaf V and Queen Viktoria Foundation. Analyses have been supported by Swedish Council for Working Life and Social Research (FAS, currently FORTE) postdoc grant 2010-0704 and Future Leaders of Aging Research in Europe (FLARE) postdoc grant 2010-1852 to A.K.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGE Platform Europe, 2011, EV HAS ROL PLAY EUR; Avlund K, 2003, AGE AGEING, V32, P579, DOI 10.1093/ageing/afg101; Borg C, 2008, GERIATR NURS, V29, P48, DOI 10.1016/j.gerinurse.2007.05.002; Bravell ME, 2011, EUR J AGEING, V8, P199, DOI 10.1007/s10433-011-0192-6; Bruhl A, 2012, J CLIN GERONTOL GERI, V3, P29, DOI 10.1016/j.jcgg.2011.11.007; Chang M, 2004, J AM GERIATR SOC, V52, P2094, DOI 10.1111/j.1532-5415.2004.52570.x; Church A., 2000, TRANSPORT POLICY, V7, P195, DOI [10.1016/S0967-070X(00)00024-X, DOI 10.1016/S0967-070X(00)00024-X]; Fristedt S, 2012, OCCUPATIONAL PARTICI; Fristedt S, 2011, ACT ADAPT AGING, V35, P275, DOI 10.1080/01924788.2011.625213; Fristedt Sofi, 2012, Journal of Human Subjectivity, V10, P103; Frye A, 2010, GOOD PRACTICE GUIDE; Gill TM, 2012, ANN INTERN MED, V156, P131, DOI 10.7326/0003-4819-156-2-201201170-00009; Gold CH, 2002, J GERONTOL B-PSYCHOL, V57, pS168, DOI 10.1093/geronb/57.3.S168; Guindon S, 2010, AGEING INT, V35, P38, DOI 10.1007/s12126-009-9050-7; Hakamies-Blomqvist L, 2004, 497A VTI TRANSP RES; Hakamies-Blomqvist L, 1999, NYA PERSP TRAF KFB S; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kaiser HJ, 2009, J APPL GERONTOL, V28, P411, DOI 10.1177/0733464808329121; Law M., 1996, CANADIAN J OCCUPATIO, V63, P9, DOI [10.1177/000841749906600304, DOI 10.1177/000841749606300103]; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Lundberg J, 2008, SOC INDIC RES, V89, P375, DOI 10.1007/s11205-008-9238-3; Manty M, 2007, ARCH PHYS MED REHAB, V88, P1108, DOI 10.1016/j.apmr.2007.06.016; Marsden G, 2010, QUAL AGEING OLDER AD, V11, P16, DOI 10.5042/qiaoa.2010.0152; Meinow Bettina, 2006, Eur J Ageing, V3, P98, DOI 10.1007/s10433-006-0027-z; Moe JO, 2011, EUR J AGEING, V8, P49, DOI 10.1007/s10433-011-0179-3; Mollenkopf H, 2002, GERONTECHNOLOGY, V1, P231, DOI DOI 10.4017/GT.2002.01.04.003.00; Mollenkopf H, 2011, AGEING SOC, V31, P782, DOI 10.1017/S0144686X10000644; Nilsson CJ, 2011, AGE AGEING, V40, P607, DOI 10.1093/ageing/afr073; Nilsson SE, 2002, AGING CLIN EXP RES, V14, P178; OECD, 2001, TRANSP AG POP; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rantakokko M, 2010, J AM GERIATR SOC, V58, P707, DOI 10.1111/j.1532-5415.2010.02792.x; Schon P, 2011, AGING CLIN EXP RES, V23, P91, DOI 10.1007/BF03351074; Selander H, 2012, GERONTOLOGY, V58, P181, DOI 10.1159/000329769; Simmons SF, 1997, J AGING HEALTH, V9, P553, DOI 10.1177/089826439700900407; Siren A, 2004, TRANSPORT RES F-TRAF, V7, P107, DOI 10.1016/j.trf.2004.02.003; Siren A, 2009, TOP GERIATR REHABIL, V25, P3; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013; Weringren-Elgstrom M, 2008, AGING CLIN EXP RES, V20, P469; WHO, 2001, WHO INT CLASS FUNCT; Wilcock A.A, 2006, OCCUPATIONAL PERSPEC; Wretstrand A., 2009, J TRANSP LAND USE, V2, P49, DOI [10.5198/jtlu.v2i2.87, DOI 10.5198/JTLU.V2I2.87]; Youngstrom MJ, 2002, AM J OCCUP THER, V56, P609; Ziegler F, 2011, AGEING SOC, V31, P758, DOI 10.1017/S0144686X10000498	46	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87827	10.1371/journal.pone.0087827	http://dx.doi.org/10.1371/journal.pone.0087827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516565	Green Published, gold			2022-12-27	WOS:000330834400020
J	Nichols, NL; Powell, FL; Dean, JB; Putnam, RW				Nichols, Nicole L.; Powell, Frank L.; Dean, Jay B.; Putnam, Robert W.			Substance P Differentially Modulates Firing Rate of Solitary Complex (SC) Neurons from Control and Chronic Hypoxia-Adapted Adult Rats	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARII; ROSTRAL VENTROLATERAL MEDULLA; LOCUS-COERULEUS NEURONS; MAMMALIAN RESPIRATORY NETWORK; NK1 RECEPTOR; IN-VITRO; CHEMOSENSITIVE RESPONSE; RETROTRAPEZOID NUCLEUS; AFFERENT-PROJECTIONS; SYNAPTIC INPUT	NK1 receptors, which bind substance P, are present in the majority of brainstem regions that contain CO2/H+-sensitive neurons that play a role in central chemosensitivity. However, the effect of substance P on the chemosensitive response of neurons from these regions has not been studied. Hypoxia increases substance P release from peripheral afferents that terminate in the caudal nucleus tractus solitarius (NTS). Here we studied the effect of substance P on the chemosensitive responses of solitary complex (SC: NTS and dorsal motor nucleus) neurons from control and chronic hypoxia-adapted (CHx) adult rats. We simultaneously measured intracellular pH and electrical responses to hypercapnic acidosis in SC neurons from control and CHx adult rats using the blind whole cell patch clamp technique and fluorescence imaging microscopy. Substance P significantly increased the basal firing rate in SC neurons from control and CHx rats, although the increase was smaller in CHx rats. However, substance P did not affect the chemosensitive response of SC neurons from either group of rats. In conclusion, we found that substance P plays a role in modulating the basal firing rate of SC neurons but the magnitude of the effect is smaller for SC neurons from CHx adult rats, implying that NK1 receptors may be down regulated in CHx adult rats. Substance P does not appear to play a role in modulating the firing rate response to hypercapnic acidosis of SC neurons from either control or CHx adult rats.	[Nichols, Nicole L.; Putnam, Robert W.] Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Powell, Frank L.] Univ Calif San Diego, Sch Med, Div Physiol, La Jolla, CA 92093 USA; [Dean, Jay B.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL USA	University System of Ohio; Wright State University Dayton; University of California System; University of California San Diego; State University System of Florida; University of South Florida	Putnam, RW (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA.	robert.putnam@wright.edu		dean, jay/0000-0003-1362-0500	National Institutes of Health [R01 HL56683, R01 HL081823]; Biomedical Sciences PhD program at Wright State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056683, R01HL081823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Sciences PhD program at Wright State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01 HL56683 (RWP and JBD) and R01 HL081823 (FLP, RWP and JBD) (grants.nih.gov/grants/oer.htm). NLN received support from the Biomedical Sciences PhD program at Wright State University (www.wright.edu/academics/biomedical/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher SA, 1996, J COMP NEUROL, V373, P62, DOI 10.1002/(SICI)1096-9861(19960909)373:1<62::AID-CNE6>3.0.CO;2-B; Berner J, 2007, J APPL PHYSIOL, V103, P552, DOI 10.1152/japplphysiol.01389.2006; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; Chen CY, 2009, J NEUROSCI, V29, P2754, DOI 10.1523/JNEUROSCI.4413-08.2009; CHEN ZB, 1990, J APPL PHYSIOL, V68, P693, DOI 10.1152/jappl.1990.68.2.693; CHEN ZB, 1990, J APPL PHYSIOL, V68, P2631, DOI 10.1152/jappl.1990.68.6.2631; Conrad SC, 2009, RESP PHYSIOL NEUROBI, V166, P4, DOI 10.1016/j.resp.2008.11.005; DEAN JB, 1989, EXP BRAIN RES, V76, P656, DOI 10.1007/BF00248922; DEAN JB, 1990, NEUROSCIENCE, V36, P207, DOI 10.1016/0306-4522(90)90363-9; Dean JB, 1997, NEUROSCIENCE, V80, P21, DOI 10.1016/S0306-4522(97)00016-X; Dean JB, 1991, SOC NEUR ABSTR, V17, P1877; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; DONOGHUE S, 1984, J PHYSIOL-LONDON, V347, P397, DOI 10.1113/jphysiol.1984.sp015072; Filosa JA, 2003, AM J PHYSIOL-CELL PH, V284, pC145, DOI 10.1152/ajpcell.00346.2002; Filosa JA, 2002, J PHYSIOL-LONDON, V541, P493, DOI 10.1113/jphysiol.2001.014142; FINLEY JCW, 1992, BRAIN RES, V572, P108, DOI 10.1016/0006-8993(92)90458-L; FINLEY JCW, 1992, NEUROSCIENCE, V51, P973, DOI 10.1016/0306-4522(92)90534-9; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; HEDNER J, 1984, J PHARMACOL EXP THER, V228, P196; Hodges MR, 2004, J APPL PHYSIOL, V97, P2236, DOI 10.1152/japplphysiol.00584.2004; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; Huang RQ, 1997, NEUROSCIENCE, V80, P41, DOI 10.1016/S0306-4522(97)00017-1; LAGERCRANTZ H, 1991, ANN NY ACAD SCI, V632, P48, DOI 10.1111/j.1749-6632.1991.tb33093.x; Lessard A, 2010, EXP NEUROL, V223, P634, DOI 10.1016/j.expneurol.2010.02.013; LINDEFORS N, 1986, NEUROSCI LETT, V69, P94, DOI 10.1016/0304-3940(86)90421-0; Lopez-Barneo J, 2003, CURR OPIN NEUROBIOL, V13, P493, DOI 10.1016/S0959-4388(03)00093-X; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Mazza E, 2000, J APPL PHYSIOL, V88, P2319, DOI 10.1152/jappl.2000.88.6.2319; Mazzone SB, 1998, NEUROSCI LETT, V256, P9, DOI 10.1016/S0304-3940(98)00743-5; Mazzone SB, 2000, CLIN EXP PHARMACOL P, V27, P939, DOI 10.1046/j.1440-1681.2000.03365.x; MIFFLIN SW, 1992, AM J PHYSIOL, V263, pR368, DOI 10.1152/ajpregu.1992.263.2.R368; Mifflin SW, 1997, RESP PHYSL, V110, P227; MORINSURUN MP, 1984, BRAIN RES, V307, P388, DOI 10.1016/0006-8993(84)90502-X; Mulkey DK, 2004, AM J PHYSIOL-CELL PH, V286, pC940, DOI 10.1152/ajpcell.00323.2003; MURAKOSHI T, 1985, BRIT J PHARMACOL, V86, P95, DOI 10.1111/j.1476-5381.1985.tb09439.x; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nattie EE, 2002, J APPL PHYSIOL, V92, P2119, DOI 10.1152/japplphysiol.01128.2001; Nattie EE, 2002, J PHYSIOL-LONDON, V544, P603, DOI 10.1113/jphysiol.2002.020032; Nattie E, 2006, J APPL PHYSIOL, V101, P1596, DOI 10.1152/japplphysiol.00347.2006; Nattie EE, 2010, RESP PHYSIOL NEUROBI, V173, P193, DOI 10.1016/j.resp.2010.05.019; Nichols NL, 2009, RESP PHYSIOL NEUROBI, V168, P272, DOI 10.1016/j.resp.2009.07.012; Nichols NL, 2009, AM J PHYSIOL-REG I, V296, pR763, DOI 10.1152/ajpregu.90769.2008; Nichols NL, 2007, SOC NEUR, V33, P15; NOLAN PC, 1993, BRAIN RES, V630, P101, DOI 10.1016/0006-8993(93)90648-7; Onimaru H, 2012, J PHYSIOL-LONDON, V590, P1615, DOI 10.1113/jphysiol.2011.222687; OTAKE K, 1992, J COMP NEUROL, V324, P365, DOI 10.1002/cne.903240307; OTSUKA M, 1993, PHYSIOL REV, V73, P229, DOI 10.1152/physrev.1993.73.2.229; Pascual O, 2002, J PHYSIOL-LONDON, V544, P511, DOI 10.1113/jphysiol.2002.023994; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; PERNOW B, 1983, PHARMACOL REV, V35, P85; Ptak K, 2002, EUR J NEUROSCI, V16, P2245, DOI 10.1046/j.1460-9568.2002.02305.x; Ramirez JM, 1998, J PHYSIOL-LONDON, V507, P571, DOI 10.1111/j.1469-7793.1998.571bt.x; Ritucci NA, 2005, AM J PHYSIOL-CELL PH, V289, pC1094, DOI 10.1152/ajpcell.00329.2004; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Rosin DL, 2006, J COMP NEUROL, V499, P64, DOI 10.1002/cne.21105; Solomon IC, 2000, J NEUROPHYSIOL, V83, P2854, DOI 10.1152/jn.2000.83.5.2854; SRINIVASAN M, 1991, BRAIN RES, V546, P211, DOI 10.1016/0006-8993(91)91483-H; SUN MK, 1994, AM J PHYSIOL, V266, pR245, DOI 10.1152/ajpregu.1994.266.1.R245; Van Bockstaele EJ, 1999, J COMP NEUROL, V412, P410, DOI 10.1002/(SICI)1096-9861(19990927)412:3<410::AID-CNE3>3.0.CO;2-F; Villafuerte FC, 2007, RESP PHYSIOL NEUROBI, V158, P243, DOI 10.1016/j.resp.2007.06.010; Wang W, 1999, NEUROSCIENCE, V90, P1001, DOI 10.1016/S0306-4522(98)00505-3; Wickstrom HR, 2004, RESP PHYSIOL NEUROBI, V140, P19, DOI 10.1016/j.resp.2004.01.008; Wilkinson KA, 2011, AM J PHYSIOL-REG I, V301, pR343, DOI 10.1152/ajpregu.00375.2010; YAMAMOTO Y, 1985, ACTA PHYSIOL SCAND, V124, P449, DOI 10.1111/j.1748-1716.1985.tb07681.x	67	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88161	10.1371/journal.pone.0088161	http://dx.doi.org/10.1371/journal.pone.0088161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516602	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400037
J	Li, QF; Wang, Y; Chen, D; Wu, SSH				Li, Qifeng; Wang, Yang; Chen, Da; Wu, Sherry S. H.			2PE-STED Microscopy with a Single Ti: Sapphire Laser for Reduced Illumination	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STIMULATED-EMISSION; STED MICROSCOPY; RESOLUTION; LIMIT	We reported a new effective approach to carry out two-photon excitation stimulated emission depletion (2PE-STED) microscopy using a single Ti:sapphire laser system. With an acoustic-optic Bragg cell, the modulated-CW 2PE STED microscope had the benefits of both CW and pulse approaches: lower input power, simple optical scheme and no complicated synchronization. Additionally, it also took advantages of fluorescence yield increasing. The sub-diffraction-limit resolution was demonstrated using ATTO 425-tagged clathrin-coated vesicles.	[Li, Qifeng; Wang, Yang; Chen, Da] Tianjin Univ, Coll Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China; [Li, Qifeng; Chen, Da] Tianjin Key Lab Biomed Detecting Tech & Instrumen, Tianjin, Peoples R China; [Wu, Sherry S. H.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada	Tianjin University; University of British Columbia	Li, QF (corresponding author), Tianjin Univ, Coll Precis Instrument & Optoelect Engn, Tianjin 300072, Peoples R China.	qfli@tju.edu.cn; Dachen@tju.edu.cn	Li, Qifeng/C-4663-2011; Chen, Da/E-7364-2012	Chen, Da/0000-0001-5135-0615; Li, Qifeng/0000-0001-8813-5054	National Natural Science Foundation of China [61108088]; Program for New Century Excellent Talents in University [NCET-11-0368]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work is funding support from the National Natural Science Foundation of China (61108088), the Program for New Century Excellent Talents in University (NCET-11-0368). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366; Bethge P, 2013, BIOPHYS J, V104, P778, DOI 10.1016/j.bpj.2012.12.054; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Ding JB, 2009, NEURON, V63, P429, DOI 10.1016/j.neuron.2009.07.011; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; Donnert G, 2006, P NATL ACAD SCI USA, V103, P11440, DOI 10.1073/pnas.0604965103; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Leung BO, 2011, APPL SPECTROSC, V65, P967, DOI 10.1366/11-06398; Li QF, 2009, BIOPHYS J, V97, P3224, DOI 10.1016/j.bpj.2009.09.038; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Moneron G, 2009, OPT EXPRESS, V17, P14567, DOI 10.1364/OE.17.014567; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Takasaki KT, 2013, BIOPHYS J, V104, P770, DOI 10.1016/j.bpj.2012.12.053; Torok P, 2004, OPT EXPRESS, V12, P3605, DOI 10.1364/OPEX.12.003605; Vicidomini G, 2011, NAT METHODS, V8, P571, DOI [10.1038/NMETH.1624, 10.1038/nmeth.1624]; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	23	5	6	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88464	10.1371/journal.pone.0088464	http://dx.doi.org/10.1371/journal.pone.0088464			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516661	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700075
J	Tam, EMS; Yu, FWP; Hung, VWY; Liu, Z; Liu, KL; Ng, BKW; Lee, SKM; Qiu, Y; Cheng, JCY; Lam, TP				Tam, Elisa M. S.; Yu, Fiona W. P.; Hung, Vivian W. Y.; Liu, Zhen; Liu, King Lok; Ng, Bobby K. W.; Lee, Simon K. M.; Qiu, Yong; Cheng, Jack C. Y.; Lam, Tsz-Ping			Are Volumetric Bone Mineral Density and Bone Micro-Architecture Associated with Leptin and Soluble Leptin Receptor Levels in Adolescent Idiopathic Scoliosis? - A Case-Control Study	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; CIRCULATING LEPTIN; ANTHROPOMETRIC MEASUREMENTS; PERSISTENT OSTEOPENIA; HUMAN OSTEOBLASTS; HUMAN PHYSIOLOGY; GROWTH-PATTERN; CORTICAL BONE; SERUM LEPTIN; SKELETAL AGE	Background: Adolescent idiopathic scoliosis (AIS) is associated with low bone mineral density (BMD). The underlying etiology and how it may relate to the development of osteopenia remains unknown. Leptin has been postulated as one of the etiologic factors of AIS because of its profound effects on bone metabolism and pubertal growth. Its modulator, soluble leptin receptor (sOB-R), may affect leptin bioavailability and signaling. This study aimed to investigate whether serum leptin and sOB-R levels may be associated with bone quality, and whether these relationships may differ between young adolescent girls with and without AIS. Methods: This was a case-control study involving 94 newly diagnosed AIS girls (Cobb angle 12-48 degrees) aged 12 to 14 years old and 87 age and gender-matched normal controls. Subjects with BMI > 23.0 Kg/m(2) were excluded. Anthropometric measurements including body weight, height, arm span and sitting height were taken. Serum total leptin and sOB-R were assayed with ELISA. Non-dominant distal radius was scanned with High Resolution pQCT for assessing bone quality in terms of bone morphometry, volumetric BMD (vBMD) and trabecular bone micro-architecture. Results: Compared with normal controls, AIS girls had numerically higher sOB-R (p = 0.006), lower average vBMD (p = 0.048), lower cortical vBMD (p = 0.029), higher cortical bone perimeter (p = 0.014) and higher trabecular area (p = 0.027), but none remained statistically significant after the Hochberg-Benjamini procedure. Correlation analysis on serum leptin level indicated that distinctive correlations with trabecular bone parameters occurred only in AIS. Conclusion: This study showed that bone quality in AIS girls was deranged as compared with controls. In addition, the distinct differences in correlation pattern between leptin and trabecular bone parameters indicated possible abnormalities in bone metabolism and dysfunction of the leptin signaling pathway in AIS.	[Tam, Elisa M. S.; Yu, Fiona W. P.; Hung, Vivian W. Y.; Liu, King Lok; Ng, Bobby K. W.; Cheng, Jack C. Y.; Lam, Tsz-Ping] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Lee, Simon K. M.] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China; [Liu, Zhen; Qiu, Yong] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Tam, Elisa M. S.; Yu, Fiona W. P.; Liu, Zhen; Liu, King Lok; Ng, Bobby K. W.; Qiu, Yong; Cheng, Jack C. Y.; Lam, Tsz-Ping] Chinese Univ Hong Kong, Joint Scoliosis Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Tam, Elisa M. S.; Yu, Fiona W. P.; Liu, Zhen; Liu, King Lok; Ng, Bobby K. W.; Qiu, Yong; Cheng, Jack C. Y.; Lam, Tsz-Ping] Nanjing Univ, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Nanjing University; Chinese University of Hong Kong; Nanjing University	Lam, TP (corresponding author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	tplam@ort.cuhk.edu.hk	Cheng, Jack/J-3878-2018; Lam, Tsz Ping/P-9963-2016	Cheng, Jack/0000-0001-8153-364X; Lam, Tsz Ping/0000-0002-2427-2719	Fondation Yves Cotrel - Institut de France; RGC of Hong Kong SAR [467808, 468809]; CUHK Direct Grant [2010.2.042]	Fondation Yves Cotrel - Institut de France; RGC of Hong Kong SAR(Hong Kong Research Grants Council); CUHK Direct Grant(Chinese University of Hong Kong)	Research grants were received from Fondation Yves Cotrel - Institut de France, RGC of Hong Kong SAR (Project no: 467808 and 468809), and CUHK Direct Grant (2010.2.042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER IA, 1985, J BONE JOINT SURG BR, V67, P185, DOI 10.1302/0301-620X.67B2.3980522; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Beltowski J, 2012, CLIN EXP PHARMACOL P, V39, P168, DOI 10.1111/j.1440-1681.2011.05623.x; Bennett BD, 1996, CURR BIOL, V6, P1170, DOI 10.1016/S0960-9822(02)70684-2; BURIC M, 1982, CLIN ORTHOP RELAT R, P238; Celi F, 2005, J PEDIATR ENDOCR MET, V18, P1399; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Cheng JCY, 2006, ST HEAL T, V123, P47; Cheng JCY, 1996, CLIN ORTHOP RELAT R, P22; Cheng JCY, 1999, SPINE, V24, P1218, DOI 10.1097/00007632-199906150-00008; Cheng JCY, 2000, J BONE MINER RES, V15, P1587, DOI 10.1359/jbmr.2000.15.8.1587; Cheng JCY, 1997, SPINE, V22, P1716, DOI 10.1097/00007632-199708010-00006; Cheung CSK, 2006, SPINE, V31, P330, DOI 10.1097/01.brs.0000197410.92525.10; Cheung CSK, 2003, SPINE, V28, P2152, DOI 10.1097/01.BRS.0000084265.15201.D5; Cioffi JA, 1996, NAT MED, V2, P585, DOI 10.1038/nm0596-585; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; COOK SD, 1987, J PEDIATR ORTHOPED, V7, P168, DOI 10.1097/01241398-198703000-00011; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Dempster D., 1992, DISORDERS BONE MINER, P355; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gavrilova O, 1997, J BIOL CHEM, V272, P30546, DOI 10.1074/jbc.272.48.30546; Gordeladze JO, 2002, J CELL BIOCHEM, V85, P825, DOI 10.1002/jcb.10156; Grivas TB, 2009, SCOLIOSIS SPINAL DIS, V4, DOI 10.1186/1748-7161-4-13; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hamrick MW, 2005, J BONE MINER RES, V20, P994, DOI 10.1359/JBMR.050103; Hamrick MW, 2004, BONE, V34, P376, DOI 10.1016/j.bone.2003.11.020; Handschin AE, 2007, ANN PLAS SURG, V59, P329, DOI 10.1097/SAP.0b013e31802f6513; Hassink SG, 1996, PEDIATRICS, V98, P201; Hess R, 2005, J CELL BIOCHEM, V94, P50, DOI 10.1002/jcb.20330; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Holloway WR, 2002, J BONE MINER RES, V17, P200, DOI 10.1359/jbmr.2002.17.2.200; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kirmani S, 2009, J BONE MINER RES, V24, P1033, DOI [10.1359/JBMR.081255, 10.1359/jbmr.081255]; Kono K, 2000, J Orthop Surg (Hong Kong), V8, P19; Kratzsch J, 2002, J CLIN ENDOCR METAB, V87, P4587, DOI 10.1210/jc.2002-020001; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1997, BONE, V21, P541, DOI 10.1016/S8756-3282(97)00205-6; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Lam TP, 2011, SPINE, V36, P1211, DOI 10.1097/BRS.0b013e3181ebab39; Lamghari M, 2006, J CELL BIOCHEM, V98, P1123, DOI 10.1002/jcb.20853; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lee WTK, 2005, OSTEOPOROSIS INT, V16, P1024, DOI 10.1007/s00198-004-1792-1; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Li XF, 2008, EUR SPINE J, V17, P1431, DOI 10.1007/s00586-008-0757-z; Liu XS, 2010, J BONE MINER RES, V25, P2229, DOI 10.1002/jbmr.111; Liu Z, 2012, SPINE, V37, P599, DOI 10.1097/BRS.0b013e318227dd0c; LORENTZON R, 1986, Diabetes Research and Clinical Practice, V2, P157, DOI 10.1016/S0168-8227(86)80017-1; Lou PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011669; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Malincikova Jana, 2000, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V143, P51; Mann DR, 2003, J CLIN ENDOCR METAB, V88, P3339, DOI 10.1210/jc.2002-022030; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Maor G, 2002, J BONE MINER RES, V17, P1034, DOI 10.1359/jbmr.2002.17.6.1034; Matkovic V, 1997, J CLIN ENDOCR METAB, V82, P3239, DOI 10.1210/jc.82.10.3239; Misra M, 2004, J CLIN ENDOCR METAB, V89, P3486, DOI 10.1210/jc.2003-032251; NORDWALL A, 1975, CLIN ORTHOP RELAT R, P6; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Qiu Y, 2007, SPINE, V32, P2703, DOI 10.1097/BRS.0b013e31815a59e5; Quinton ND, 1999, J CLIN ENDOCR METAB, V84, P2336, DOI 10.1210/jc.84.7.2336; Reseland JE, 2001, J BONE MINER RES, V16, P1426, DOI 10.1359/jbmr.2001.16.8.1426; Saggese G, 2001, J PEDIATR ENDOCR MET, V14, P833; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Schaab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034787; Snyder BD, 2005, J PEDIATR ORTHOPED, V25, P423, DOI 10.1097/01.bpo.0000158001.23177.8d; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Thomas T, 2003, JOINT BONE SPINE, V70, P18, DOI 10.1016/S1297-319X(02)00005-2; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; VELIS KP, 1989, SPINE, V14, P706, DOI 10.1097/00007632-198907000-00010; Wang WJ, 2010, EUROPEAN SPINE J; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; WILLNER S, 1974, CLIN ORTHOP RELAT R, P129; WILLNER S, 1974, ACTA ORTHOP SCAND, V45, P854, DOI 10.3109/17453677408989696; Wren AM, 2002, ENDOCRINOLOGY, V143, P4227, DOI 10.1210/en.2002-220308; Wu T, 2012, STUD HEALTH TECHNOL, V176, P31, DOI 10.3233/978-1-61499-067-3-31; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Yannakoulia M, 2003, J CLIN ENDOCR METAB, V88, P1730, DOI 10.1210/jc.2002-021604; Yeung HY, 2006, STUD HEALTH TECHNOL, V123, P599; Ylikoski M, 2003, EUR SPINE J, V12, P288, DOI 10.1007/s00586-003-0527-x; Zastrow O, 2003, INT J OBESITY, V27, P1472, DOI 10.1038/sj.ijo.0802432; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; Zhang JJ, 2009, BRIT J PHARMACOL, V158, P475, DOI 10.1111/j.1476-5381.2009.00246.x	90	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87939	10.1371/journal.pone.0087939	http://dx.doi.org/10.1371/journal.pone.0087939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516571	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700034
J	Chen, F; Yu, YF; Haigh, S; Johnson, J; Lucas, R; Stepp, DW; Fulton, DJR				Chen, Feng; Yu, Yanfang; Haigh, Steven; Johnson, John; Lucas, Rudolf; Stepp, David W.; Fulton, David J. R.			Regulation of NADPH Oxidase 5 by Protein Kinase C Isoforms	PLOS ONE			English	Article							OXYGEN SPECIES PRODUCTION; ESOPHAGEAL ADENOCARCINOMA CELLS; SMOOTH-MUSCLE-CELLS; PKC-ALPHA; DEPENDENT ACTIVATION; EXPRESSION PROFILES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; HEART-FAILURE	NADPH oxidase5 (Nox5) is a novel Nox isoform which has recently been recognized as having important roles in the pathogenesis of coronary artery disease, acute myocardial infarction, fetal ventricular septal defect and cancer. The activity of Nox5 and production of reactive oxygen species is regulated by intracellular calcium levels and phosphorylation. However, the kinases that phosphorylate Nox5 remain poorly understood. Previous studies have shown that the phosphorylation of Nox5 is PKC dependent, but this contention was based on the use of pharmacological inhibitors and the isoforms of PKC involved remain unknown. Thus, the major goals of this study were to determine whether PKC can directly regulate Nox5 phosphorylation and activity, to identify which isoforms are involved in the process, and to understand the functional significance of this pathway in disease. We found that a relatively specific PKC alpha inhibitor, Ro-32-0432, dose-dependently inhibited PMA-induced superoxide production from Nox5. PMA-stimulated Nox5 activity was significantly reduced in cells with genetic silencing of PKC alpha and PKC epsilon, enhanced by loss of PKC delta and the silencing of PKC theta expression was without effect. A constitutively active form of PKC alpha robustly increased basal and PMA-stimulated Nox5 activity and promoted the phosphorylation of Nox5 on Ser490, Thr494, and Ser498. In contrast, constitutively active PKC epsilon potently inhibited both basal and PMA-dependent Nox5 activity. Co-IP and in vitro kinase assay experiments demonstrated that PKC alpha directly binds to Nox5 and modifies Nox5 phosphorylation and activity. Exposure of endothelial cells to high glucose significantly increased PKC alpha activation, and enhanced Nox5 derived superoxide in a manner that was in prevented by a PKC alpha inhibitor, Go 6976. In summary, our study reveals that PKC alpha is the primary isoform mediating the activation of Nox5 and this maybe of significance in our understanding of the vascular complications of diabetes and other diseases with increased ROS production.	[Chen, Feng; Yu, Yanfang] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Chen, Feng; Yu, Yanfang; Haigh, Steven; Lucas, Rudolf; Stepp, David W.; Fulton, David J. R.] Georgia Regents Univ, Vasc Biol Ctr, Augusta, GA USA; [Johnson, John; Lucas, Rudolf; Stepp, David W.; Fulton, David J. R.] Georgia Regents Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	Nanjing Medical University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Chen, F (corresponding author), Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China.	fchen@gru.edu; dfulton@gru.edu	Chen, Feng/E-1133-2011; Lucas, Rudolf/ABA-3011-2020	Lucas, Rudolf/0000-0003-3805-8868	National Institutes of Health [RO1 HL085827, P01 HL101902-01A1, R01HL092446]; American Heart Association [13POST14800025]; Nanjing Medical University [KY101RC041307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085827, P01HL101902, R01HL092446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nanjing Medical University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL085827, P01 HL101902-01A1 (DJRF), R01HL092446 (DF, DWS) and by the Postdoctoral Fellowship from the American Heart Association 13POST14800025 (FC), and an established investigator start funding from Nanjing Medical University KY101RC041307 (FC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony S, 2013, FREE RADICAL BIO MED, V65, P497, DOI 10.1016/j.freeradbiomed.2013.07.005; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Chen F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00184; Chen F, 2012, ARTERIOSCL THROM VAS, V32, P2989, DOI 10.1161/ATVBAHA.112.300361; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; Chen F, 2010, MOL PHARMACOL, V77, P280, DOI 10.1124/mol.109.061077; Chen F, 2009, J ZHEJIANG UNIV-SC B, V10, P711, DOI 10.1631/jzus.B0920140; Chen YJ, 2012, NEUROSCI BULL, V28, P222, DOI 10.1007/s12264-012-1236-4; Cheng JJ, 2001, J BIOL CHEM, V276, P31368, DOI 10.1074/jbc.M011317200; Downs CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054750; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P371, DOI 10.1016/j.yjmcc.2007.05.021; Elms S, 2013, AM J PHYSIOL-HEART C, V305, pH651, DOI 10.1152/ajpheart.00755.2012; Erdos B, 2004, DIABETES, V53, P1352, DOI 10.2337/diabetes.53.5.1352; Fan CY, 2005, BIOCHEM J, V390, P761, DOI 10.1042/BJ20050287; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Frisbee JC, 2001, AM J PHYSIOL-HEART C, V281, pH1304, DOI 10.1152/ajpheart.2001.281.3.H1304; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Gupte SA, 2009, AM J PHYSIOL-HEART C, V296, pH1048, DOI 10.1152/ajpheart.00491.2008; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hahn NE, 2012, AM J PATHOL, V180, P2222, DOI 10.1016/j.ajpath.2012.02.018; Hayashi K, 1999, HYPERTENS RES-CLIN E, V22, P31, DOI 10.1291/hypres.22.31; Hong J, 2011, AM J PHYSIOL-CELL PH, V301, pC413, DOI 10.1152/ajpcell.00027.2011; Hong J, 2010, AM J PHYSIOL-GASTR L, V299, pG697, DOI 10.1152/ajpgi.00186.2010; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-110; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kroviarski Y, 2010, FASEB J, V24, P2077, DOI 10.1096/fj.09-147629; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lang WH, 2004, CELL SIGNAL, V16, P457, DOI 10.1016/j.cellsig.2003.09.002; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lee HH, 2012, INT J BIOL SCI, V8, P353, DOI 10.7150/ijbs.3157; Leverence JT, 2011, CHEM-BIOL INTERACT, V189, P72, DOI 10.1016/j.cbi.2010.09.026; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Liu QH, 2009, CIRC RES, V105, P194, DOI 10.1161/CIRCRESAHA.109.195313; Lucas R, 2012, AM J RESP CELL MOL, V47, P445, DOI 10.1165/rcmb.2011-0332OC; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Nitti M, 2010, CELL SIGNAL, V22, P828, DOI 10.1016/j.cellsig.2010.01.007; Pal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063989; Pandey D, 2011, AM J PHYSIOL-HEART C, V300, pH1336, DOI 10.1152/ajpheart.01163.2010; Pandey D, 2012, AM J PHYSIOL-HEART C, V302, pH1919, DOI 10.1152/ajpheart.00910.2011; Pandey D, 2011, MOL PHARMACOL, V80, P407, DOI 10.1124/mol.110.070193; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Qian J, 2012, FREE RADICAL BIO MED, V52, P1806, DOI 10.1016/j.freeradbiomed.2012.02.029; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Rahman MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028065; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Richard D, 2009, BIOCHEM BIOPH RES CO, V389, P516, DOI 10.1016/j.bbrc.2009.09.013; Rizvi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034440; Sadok A, 2008, BBA-MOL CELL RES, V1783, P23, DOI 10.1016/j.bbamcr.2007.10.010; Salasznyk RM, 2005, STEM CELLS DEV, V14, P354, DOI 10.1089/scd.2005.14.354; Schwarzer E, 1996, BBA-MOL BASIS DIS, V1316, P169, DOI 10.1016/0925-4439(96)00021-X; Serrander L, 2007, BIOCHIMIE, V89, P1159, DOI 10.1016/j.biochi.2007.05.004; Simonis G, 2007, MOL CELL BIOCHEM, V305, P103, DOI 10.1007/s11010-007-9533-3; Sriramula S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063847; Umapathy NS, 2012, EXP LUNG RES, V38, P223, DOI 10.3109/01902148.2012.673049; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Violi F, 2009, FUTUR CARDIOL, V5, P83, DOI 10.2217/14796678.5.1.83; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076796; Wei HY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P304, DOI 10.1134/S0006297910030065; Wei XF, 2009, AM J PHYSIOL-RENAL, V296, pF427, DOI 10.1152/ajprenal.90536.2008; Xi G, 2012, DIABETES, V61, P104, DOI 10.2337/db11-0990; Xu H, 2008, FREE RADICAL BIO MED, V44, P1656, DOI 10.1016/j.freeradbiomed.2008.01.023; Yamamoto A, 2013, FEBS J, V280, P5145, DOI 10.1111/febs.12489; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Zhang Q, 2008, ARTERIOSCL THROM VAS, V28, P1627, DOI 10.1161/ATVBAHA.108.168278; Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052698; Zhou XX, 2013, MOL PHARMACOL, V83, P978, DOI 10.1124/mol.112.083287; Zhu C, 2011, EXP THER MED, V2, P1011, DOI 10.3892/etm.2011.294	80	64	65	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88405	10.1371/journal.pone.0088405	http://dx.doi.org/10.1371/journal.pone.0088405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505490	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200190
J	Fradin, EF; Zhang, Z; Rovenich, H; Song, Y; Liebrand, TWH; Masini, L; van den Berg, GCM; Joosten, MHAJ; Thomma, BPHJ				Fradin, Emilie F.; Zhang, Zhao; Rovenich, Hanna; Song, Yin; Liebrand, Thomas W. H.; Masini, Laura; van den Berg, Grardy C. M.; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.			Functional Analysis of the Tomato Immune Receptor Ve1 through Domain Swaps with Its Non-Functional Homolog Ve2	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; DISEASE RESISTANCE PROTEIN; CLADOSPORIUM-FULVUM; ARABIDOPSIS-THALIANA; ENDOPLASMIC-RETICULUM; HYPERSENSITIVE RESPONSE; VERTICILLIUM RESISTANCE; PLASMA-MEMBRANE; INNATE IMMUNITY; KINASE BRI1	Resistance in tomato against race 1 strains of the fungal vascular wilt pathogens Verticillium dahliae and V. albo-atrum is mediated by the Ve locus. This locus comprises two closely linked inversely oriented genes, Ve1 and Ve2, which encode cell surface receptors of the extracellular leucine-rich repeat receptor-like protein (eLRR-RLP) type. While Ve1 mediates Verticillium resistance through monitoring the presence of the recently identified V. dahliae Ave1 effector, no functionality for Ve2 has been demonstrated in tomato. Ve1 and Ve2 contain 37 eLRRs and share 84% amino acid identity, facilitating investigation of Ve protein functionality through domain swapping. In this study it is shown that Ve chimeras in which the first thirty eLRRs of Ve1 were replaced by those of Ve2 remain able to induce HR and activate Verticillium resistance, and that deletion of these thirty eLRRs from Ve1 resulted in loss of functionality. Also the region between eLRR30 and eLRR35 is required for Ve1-mediated resistance, and cannot be replaced by the region between eLRR30 and eLRR35 of Ve2. We furthermore show that the cytoplasmic tail of Ve1 is required for functionality, as truncation of this tail results in loss of functionality. Moreover, the C-terminus of Ve2 fails to activate immune signaling as chimeras containing the C-terminus of Ve2 do not provide Verticillium resistance. Furthermore, Ve1 was found to interact through its C-terminus with the eLRR-containing receptor-like kinase (eLRR-RLK) interactor SOBIR1 that was recently identified as an interactor of eLRR-RLP (immune) receptors. Intriguingly, also Ve2 was found to interact with SOBIR1.	[Fradin, Emilie F.; Zhang, Zhao; Rovenich, Hanna; Song, Yin; Liebrand, Thomas W. H.; Masini, Laura; van den Berg, Grardy C. M.; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Fradin, Emilie F.; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.] Ctr BioSyst Genom, Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics	Thomma, BPHJ (corresponding author), Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands.	bart.thomma@wur.nl	Thomma, Bart/E-5959-2011; Joosten, Matthieu/AAB-5150-2022; Joosten, Matthieu/AAB-5131-2022; Yin, SONG/AAG-6033-2020; van den Berg, Grardy/F-2337-2019; Zhang, Zhao/J-1615-2019; Thomma, Bart/ABH-6344-2020	Thomma, Bart/0000-0003-4125-4181; Joosten, Matthieu/0000-0002-6243-4547; Yin, SONG/0000-0002-6037-777X; Zhang, Zhao/0000-0002-7323-5500; Thomma, Bart/0000-0003-4125-4181; van Dijk-Fradin, Emilie/0000-0002-5186-4920; Rovenich, Hanna/0000-0001-6138-4480	Vici grant of the Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; ERA-NET Plant Genomics	Vici grant of the Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERA-NET Plant Genomics	BPHJT is supported by a Vici grant of the Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO). This research was funded in part by the Centre for BioSystems Genomics (CBSG) which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research and by ERA-NET Plant Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2000, PLANT CELL, V12, P1179, DOI 10.1105/tpc.12.7.1179; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Butaye KMJ, 2004, PLANT J, V39, P440, DOI 10.1111/j.1365-313X.2004.02144.x; Chakrabarti A, 2009, MOL PLANT MICROBE IN, V22, P1214, DOI 10.1094/MPMI-22-10-1214; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dixon MS, 1998, PLANT CELL, V10, P1915, DOI 10.1105/tpc.10.11.1915; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Ellendorff U, 2009, J EXP BOT, V60, P591, DOI 10.1093/jxb/ern306; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fritz-Laylin LK, 2005, PLANT PHYSIOL, V138, P611, DOI 10.1104/pp.104.054452; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Honee G, 1998, PLANT PHYSIOL, V117, P809, DOI 10.1104/pp.117.3.809; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jones DA, 1997, ADV BOT RES, V24, P89; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Leslie ME, 2010, DEVELOPMENT, V137, P467, DOI 10.1242/dev.041335; Li JM, 2011, P NATL ACAD SCI USA, V108, P8073, DOI 10.1073/pnas.1104057108; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liebrand TWH, 2012, PLANT PHYSIOL, V159, P1819, DOI 10.1104/pp.112.196741; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Matsushima N, 2009, BBA-GEN SUBJECTS, V1790, P1217, DOI 10.1016/j.bbagen.2009.06.014; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Panter SN, 2002, MOL PLANT MICROBE IN, V15, P1099, DOI 10.1094/MPMI.2002.15.11.1099; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pegg GF, 1974, REV PLANT PATHOL, V53, P26; Piedras P, 2000, PLANT J, V21, P529, DOI 10.1046/j.1365-313x.2000.00697.x; Pietraszewska-Bogiel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065055; Rivas S, 2005, ANNU REV PHYTOPATHOL, V43, P395, DOI 10.1146/annurev.phyto.43.040204.140224; Ruthardt N, 2007, CAN J PLANT PATHOL, V29, P3, DOI 10.1080/07060660709507431; Seear PJ, 2003, MOL PLANT PATHOL, V4, P199, DOI 10.1046/j.1364-3703.2003.00162.x; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Shimada TL, 2010, PLANT J, V61, P519, DOI 10.1111/j.1365-313X.2009.04060.x; Shinohara H, 2007, J BIOL CHEM, V282, P124, DOI 10.1074/jbc.M604558200; Takken FLW, 1999, PLANT J, V20, P279, DOI 10.1046/j.1365-313X.1999.t01-1-00601.x; Thomas CM, 1997, PLANT CELL, V9, P2209, DOI 10.1105/tpc.9.12.2209; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; van der Hoorn RAL, 2005, PLANT CELL, V17, P1000, DOI 10.1105/tpc.104.028118; Van der Hoorn RAL, 2000, MOL PLANT MICROBE IN, V13, P439, DOI 10.1094/MPMI.2000.13.4.439; Van der Hoorn RAL, 2001, PLANT CELL, V13, P273, DOI 10.1105/tpc.13.2.273; Wang GD, 2010, CRIT REV PLANT SCI, V29, P285, DOI 10.1080/07352689.2010.502082; Wang GD, 2010, PLANT PHYSIOL, V152, P320, DOI 10.1104/pp.109.148197; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wulff BBH, 2004, GENETICS, V167, P459, DOI 10.1534/genetics.167.1.459; Wulff BBH, 2001, PLANT CELL, V13, P255, DOI 10.1105/tpc.13.2.255; Wulff BBH, 2009, MOL PLANT MICROBE IN, V22, P1203, DOI 10.1094/MPMI-22-10-1203; Zhang LS, 2014, PLANT PHYSIOL, V164, P352, DOI 10.1104/pp.113.230698; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhang Y, 2011, PLANT CELL REP, V30, P2085, DOI 10.1007/s00299-011-1115-x; Zhang YX, 2010, PLANT CELL, V22, P3153, DOI 10.1105/tpc.110.074120; Zhang Z, 2013, J INTEGR PLANT BIOL, V55, P1212, DOI 10.1111/jipb.12080; Zhang Z, 2013, MOL PLANT PATHOL, V14, P719, DOI 10.1111/mpp.12042; Zhang Z, 2013, MOL PLANT MICROBE IN, V26, P182, DOI 10.1094/MPMI-06-12-0161-R	68	34	36	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88208	10.1371/journal.pone.0088208	http://dx.doi.org/10.1371/journal.pone.0088208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505431	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200137
J	Steffan, JJ; Dykes, SS; Coleman, DT; Adams, LK; Rogers, D; Carroll, JL; Williams, BJ; Cardelli, JA				Steffan, Joshua J.; Dykes, Samantha S.; Coleman, David T.; Adams, Lisa K.; Rogers, Donna; Carroll, Jennifer L.; Williams, B. Jill; Cardelli, James A.			Supporting a Role for the GTPase Rab7 in Prostate Cancer Progression	PLOS ONE			English	Article							NUTRIENT TRANSPORTER EXPRESSION; GROWTH-FACTOR; CATHEPSIN-B; CELL INVASION; RECEPTOR DEGRADATION; LYSOSOME TRAFFICKING; PROTEIN; THIAZOLIDINEDIONES; EXCHANGERS; SIGNATURES	Invasion and subsequent metastasis is the major cause of death from most cancers including prostate cancer. Herein we report on the potential tumor suppressive properties of Rab7, a GTPase that regulates trafficking of lysosomes. The movement of lysosomes to the cell surface in response to environmental cues increases the secretion of proteinases and cell invasion. We determined that Troglitazone and other members of the Thiazolidinedione family inhibit cell-surface directed lysosome trafficking and cathepsin B secretion through a Rab7-dependent mechanism. Moreover, Rab7 shRNA expressing cells were found to be more invasive in vitro and in vivo. Increased invasiveness was accompanied by elevated expression of the c-Met receptor and prolonged downstream signaling, thereby supporting a role for Rab7 as a mediator of signaling down-regulation. Taken together, these results suggested that Rab7 acts as a negative regulator of prostate tumor growth and invasion, providing further evidence for its potential as a tumor suppressor.	[Steffan, Joshua J.; Dykes, Samantha S.; Coleman, David T.; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA; [Steffan, Joshua J.; Dykes, Samantha S.; Coleman, David T.; Adams, Lisa K.; Rogers, Donna; Carroll, Jennifer L.; Williams, B. Jill; Cardelli, James A.] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Adams, Lisa K.; Rogers, Donna; Carroll, Jennifer L.; Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Williams, B. Jill] Louisiana State Univ, Hlth Sci Ctr, Dept Urol, Shreveport, LA 71105 USA; [Steffan, Joshua J.] Dickinson State Univ, Dept Nat Sci, Dickinson, ND USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Cardelli, JA (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71105 USA.	JCarde@lsuhsc.edu			National Institutes of Health [NIH R01 CA104242]; NATIONAL CANCER INSTITUTE [R01CA104242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by National Institutes of Health grant NIH R01 CA104242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagshaw RD, 2006, BIOCHEM BIOPH RES CO, V344, P1186, DOI 10.1016/j.bbrc.2006.03.221; BasuRay S, 2013, J BIOL CHEM, V288, P1135, DOI 10.1074/jbc.M112.417766; BasuRay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015351; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; Cordonnier MN, 2001, MOL BIOL CELL, V12, P4013, DOI 10.1091/mbc.12.12.4013; Croizet-Berger K, 2002, P NATL ACAD SCI USA, V99, P8277, DOI 10.1073/pnas.122187699; Davidson B, 2006, CLIN CANCER RES, V12, P5944, DOI 10.1158/1078-0432.CCR-06-1059; Edinger AL, 2005, BIOCHEM SOC T, V33, P225, DOI 10.1042/BST0330225; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2006, PIGM CELL RES, V19, P412, DOI 10.1111/j.1600-0749.2006.00329.x; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Kopelovich L, 2002, MOL CANCER THER, V1, P357; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Moellering RE, 2008, CLIN EXP METASTAS, V25, P411, DOI 10.1007/s10585-008-9145-7; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nishimura Y, 1998, Pathol Oncol Res, V4, P283; Progida C, 2007, J CELL SCI, V120, P3729, DOI 10.1242/jcs.017301; REMPEL SA, 1994, CANCER RES, V54, P6027; Rosales KR, 2009, MOL BIOL CELL, V20, P2831, DOI 10.1091/mbc.E08-09-0911; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; ROZHIN J, 1994, CANCER RES, V54, P6517; ROZHIN J, 1990, CANCER RES, V50, P6278; Sakane A, 2007, BIOCHEM BIOPH RES CO, V357, P1058, DOI 10.1016/j.bbrc.2007.04.052; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Skorobogata O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036489; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; Steffan JJ, 2010, TRAFFIC, V11, P274, DOI 10.1111/j.1600-0854.2009.01012.x; Steffan JJ, 2009, TRAFFIC, V10, P737, DOI 10.1111/j.1600-0854.2009.00904.x; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Weng JR, 2006, ENDOCR-RELAT CANCER, V13, P401, DOI 10.1677/erc.1.01182; Wright PK, 2008, RECENT PAT ANTI-CANC, V3, P137, DOI 10.2174/157489208784638730; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang M, 2009, BIOSCIENCE REP, V29, P193, DOI 10.1042/BSR20090032	45	42	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87882	10.1371/journal.pone.0087882	http://dx.doi.org/10.1371/journal.pone.0087882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505328	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200082
J	Yan, J; Li, X; Su, RN; Zhang, K; Yang, HX				Yan, Jie; Li, Xin; Su, Rina; Zhang, Kai; Yang, Huixia			Long-Term Effects of Maternal Diabetes on Blood Pressure and Renal Function in Rat Male Offspring	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; PIMA INDIAN WOMEN; PREGNANCY; HYPERTENSION; DISEASE; MORTALITY; MELLITUS; OUTCOMES; OBESITY; SALT	Aims/Hypothesis: Gestational diabetes mellitus (GDM) is increasing rapidly worldwide. Previous animal models were established to study consequences of offspring after exposure to severe intrauterine hyperglycemia. In this study we are aiming to characterize the blood pressure levels and renal function of male offspring obtained from diabetic mothers with moderate hyperglycemia. Methods: We established a rat model with moderate hyperglycemia after pregnancy by a single intraperitoneal injection of streptozotocin (STZ). The male offspring were studied and fed with either normal diet or high salt diet after weaning. Arterial pressure and renal function were measured. Results: Arterial pressure of male offspring increased from 12 weeks by exposure to intrauterine moderate hyperglycemia. At 20 weeks, high salt diet accelerated the blood pressure on diabetic offspring compared to diabetic offspring fed with normal diet. We found offspring exposed to intrauterine moderate hyperglycemia had a trend to have a higher creatinine clearance rate and significant increase of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion indicating an early stage of nephropathy progression. Conclusions/Interpretation: We observed the high blood pressure level and early renal dysfunction of male offspring obtained from diabetic mothers with moderate hyperglycemia. Furthermore, we investigated high salt diet after weaning on offspring exposed to intrauterine hyperglycemia could exacerbate the blood pressure and renal function. Renin angiotensin system (RAS) plays an important role in hypertension pathogenesis and altered gene expression of RAS components in offspring with in utero hyperglycemia exposure may account for the programmed hypertension. Therefore, our study provides evidence "fetal programming'' of maternal diabetes is critical for metabolic disease development.	[Yan, Jie; Li, Xin; Su, Rina; Zhang, Kai; Yang, Huixia] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Peking University	Yang, HX (corresponding author), Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China.	yanghuixia@bjmu.edu.cn		YANG, HUIXIA/0000-0001-9913-2721; Yang, Huixia/0000-0001-8954-2102	National Natural Science Foundation of China [30973212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 30973212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2006, AM J PHYSIOL-REG I, V290, pR1, DOI 10.1152/ajpregu.00417.2005; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001; HADDY FJ, 1995, J AM COLL NUTR, V14, P428; Holemans K, 1999, DIABETOLOGIA, V42, P81, DOI 10.1007/s001250051117; Krebs LT, 2000, J PHARMACOL EXP THER, V293, P260; Lelievre-Pegorier M, 2000, EXP NEPHROL, V8, P63; Manderson JG, 2002, DIABETOLOGIA, V45, P991, DOI 10.1007/s00125-002-0865-y; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; PETTITT DJ, 1993, DIABETES CARE, V16, P310, DOI 10.2337/diacare.16.1.310; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Simeoni U, 2009, SEMIN FETAL NEONAT M, V14, P119, DOI 10.1016/j.siny.2009.01.002; SPETH RC, 1988, BIOL REPROD, V38, P695, DOI 10.1095/biolreprod38.3.695; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Velazquez-Roman JA, 2011, CLIN EXP HYPERTENS, V33, P167, DOI 10.3109/10641963.2010.531843; VONLUTTEROTTI N, 1991, AM J HYPERTENS, V4, pS346, DOI 10.1093/ajh/4.4.346S; VORA JP, 1992, KIDNEY INT, V41, P829, DOI 10.1038/ki.1992.127; Zhu WW, 2012, DIABETES CARE	23	27	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88269	10.1371/journal.pone.0088269	http://dx.doi.org/10.1371/journal.pone.0088269			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505458	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200160
J	Berkenkamp, B; Susnik, N; Baisantry, A; Kuznetsova, I; Jacobi, C; Sorensen-Zender, I; Broecker, V; Haller, H; Melk, A; Schmitt, R				Berkenkamp, Birgit; Susnik, Nathan; Baisantry, Arpita; Kuznetsova, Inna; Jacobi, Christoph; Soerensen-Zender, Inga; Broecker, Verena; Haller, Hermann; Melk, Anette; Schmitt, Roland			In Vivo and In Vitro Analysis of Age-Associated Changes and Somatic Cellular Senescence in Renal Epithelial Cells	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE SECRETION; REGENERATIVE CAPACITY; CYCLIN D1; PROLIFERATION CAPACITY; ALLOGRAFT SURVIVAL; PROXIMAL TUBULE; KIDNEY INJURY; RAT KIDNEYS; EXPRESSION; GROWTH	Acute kidney injury is a major clinical problem and advanced age is associated with ineffective renal regeneration and poor functional outcome. Data from kidney injury models suggest that a loss of tubular epithelial proliferation contributes to a decrease in renal repair capacity with aging, but aging can also lead to a higher severity of inflammation and damage which may influence repair. In this study we tested intrinsic age-dependent changes in tubular epithelial proliferation in young and old mice, by injecting low-dose lead acetate as a non-injurious mitogen. In parallel, we explored in vitro techniques of studying cellular senescence in primary tubular epithelial cells (PTEC). Lead acetate induced tubular epithelial proliferation at a significantly higher rate in young as compared to old mice. Old kidneys showed significantly more senescence as demonstrated by increased p16(INK4 alpha), senescence associated beta-galactosidase, and gamma H2AX(+)/Ki-67(-) cells. This was paralleled in old kidneys by a higher number of Cyclin D1 positive tubular cells. This finding was corroborated by a positive correlation between Cyclin D1 positivity and age in human renal biopsies. When tubular cells were isolated from mouse kidneys they rapidly lost their age-associated differences under culture conditions. However, senescence was readily induced in PTEC by gamma-irradiation representing a future model for study of cellular senescence in the renal epithelium. Together, our data indicate that the tubular epithelium of aged kidney has an intrinsically reduced proliferative capacity probably due to a higher load of senescent cells. Moreover, stress induced models of cellular senescence are preferable for study of the renal epithelium in vitro. Finally, the positive correlation of Cyclin D1 with age and cellular senescence in PTEC needs further evaluation as to a functional role of renal epithelial aging.	[Berkenkamp, Birgit; Baisantry, Arpita; Kuznetsova, Inna; Jacobi, Christoph; Melk, Anette] Hannover Med Sch, Dept Pediat Nephrol & Gastroenterol, Hannover, Lower Saxony, Germany; [Susnik, Nathan; Kuznetsova, Inna; Soerensen-Zender, Inga; Haller, Hermann; Schmitt, Roland] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Lower Saxony, Germany; [Broecker, Verena] Hannover Med Sch, Dept Pathol, Hannover, Lower Saxony, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Melk, A (corresponding author), Hannover Med Sch, Dept Pediat Nephrol & Gastroenterol, Hannover, Lower Saxony, Germany.	melk.anette@mh-hannover.de; schmitt.roland@mh-hannover.de	Schmitt, Roland/AAP-4609-2021	Schmitt, Roland/0000-0003-4415-8355	Dr. Werner-Jackstadt Foundation (Junior Excellence Research Group Grant); Deutsche Forschungsgemeinschaft [SCHM 2146/3-1];  [Sonderforschungsbereich SFB 738]	Dr. Werner-Jackstadt Foundation (Junior Excellence Research Group Grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the Dr. Werner-Jackstadt Foundation (Junior Excellence Research Group Grant), Deutsche Forschungsgemeinschaft (SCHM 2146/3-1), and Sonderforschungsbereich SFB 738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Burton DGA, 2007, ANN NY ACAD SCI, V1119, P20, DOI 10.1196/annals.1404.026; CHOIE DD, 1972, AM J PATHOL, V66, P265; CHOIE DD, 1972, AM J PATHOL, V68, P359; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Coppe JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Han EKH, 1999, APOPTOSIS, V4, P213, DOI 10.1023/A:1009618824145; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Joosten SA, 2003, AM J PATHOL, V162, P1305, DOI 10.1016/S0002-9440(10)63926-0; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403; Leontieva OV, 2012, CELL CYCLE, V11, P4642, DOI 10.4161/cc.22937; Liu J, 2012, J CELL SCI, V125, P376, DOI 10.1242/jcs.089466; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Melk A, 2003, NEPHROL DIAL TRANSPL, V18, P2474, DOI 10.1093/ndt/gfg322; Melk A, 2000, J AM SOC NEPHROL, V11, P444, DOI 10.1681/ASN.V113444; Melk A, 2009, AM J TRANSPLANT, V9, P114, DOI 10.1111/j.1600-6143.2008.02500.x; MIURA K, 1987, TOXICOL APPL PHARM, V87, P284, DOI 10.1016/0041-008X(87)90290-0; Miya M, 2012, AM J PHYSIOL-RENAL, V302, pF694, DOI 10.1152/ajprenal.00249.2011; Naesens M, 2011, DISCOV MED, V11, P65; Qiao X, 2005, J GERONTOL A-BIOL, V60, P830, DOI 10.1093/gerona/60.7.830; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Schmitt R, 2012, AM J TRANSPLANT, V12, P2892, DOI 10.1111/j.1600-6143.2012.04214.x; Schmitt R, 2008, J AM SOC NEPHROL, V19, P2375, DOI 10.1681/ASN.2008010035; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sorensen I, 2011, J AM SOC NEPHROL, V22, P1887, DOI 10.1681/ASN.2011010031; Suzuki A, 2012, J SURG RES, V173, P267, DOI 10.1016/j.jss.2010.10.012; Verzola D, 2008, AM J PHYSIOL-RENAL, V295, pF1563, DOI 10.1152/ajprenal.90302.2008; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vogetseder A, 2008, AM J PHYSIOL-CELL PH, V294, pC22, DOI 10.1152/ajpcell.00227.2007; Vogetseder A, 2007, AM J PHYSIOL-CELL PH, V292, pC807, DOI 10.1152/ajpcell.00301.2006; Westhoff JH, 2010, J AM SOC NEPHROL, V21, P327, DOI 10.1681/ASN.2009010072; Westhoff JH, 2008, HYPERTENSION, V52, P123, DOI 10.1161/HYPERTENSIONAHA.107.099432; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214; Witzgall R, 2008, AM J PHYSIOL-CELL PH, V294, pC1, DOI 10.1152/ajpcell.00470.2007; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	45	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88071	10.1371/journal.pone.0088071	http://dx.doi.org/10.1371/journal.pone.0088071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505380	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300049
J	Ye, H; Liu, Q; Wei, J				Ye, Hao; Liu, Qi; Wei, Jia			Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning	PLOS ONE			English	Article							METHYLTRANSFERASE VAL(108/158)MET POLYMORPHISM; RESEARCH-AND-DEVELOPMENT; ANTIDEPRESSANT ACTIVITY; TREATMENT RESPONSE; TRAMADOL; TOLCAPONE; PRODUCTIVITY; PAROXETINE; MECHANISM; MARKERS	Drugs with similar side-effect profiles may share similar therapeutic properties through related mechanisms of action. In this study, a drug-drug network was constructed based on the similarities between their clinical side effects. The indications of a drug may be inferred by the enriched FDA-approved functions of its neighbouring drugs in the network. We systematically screened new indications for 1234 drugs with more than 2 network neighbours, 36.87% of the drugs achieved a performance score of Normalized Discounted Cumulative Gain in the top 5 positions (NDCG@5)>= 0.7, which means most of the known FDA-approved indications were well predicted at the top 5 positions. In particular, drugs for diabetes, obesity, laxatives and antimycobacterials had extremely high performance with more than 80% of them achieving NDCG@5 >= 0.7. Additionally, by manually checking the predicted 1858 drug-indication pairs with Expression Analysis Systematic Explorer (EASE) score <= 10(-5) (EASE score is a rigorously modified Fisher exact test p value), we found that 80.73% of such pairs could be verified by preclinical/clinical studies or scientific literature. Furthermore, our method could be extended to predict drugs not covered in the network. We took 98 external drugs not covered in the network as the test sample set. Based on our similarity criteria using side effects, we identified 41 drugs with significant similarities to other drugs in the network. Among them, 36.59% of the drugs achieved NDCG@5 >= 0.7. In all of the 106 drug-indication pairs with an EASE score <= 0.05, 50.94% of them are supported by FDA approval or preclinical/clinical studies. In summary, our method which is based on the indications enriched by network neighbors may provide new clues for drug repositioning using side effects.	[Ye, Hao; Wei, Jia] AstraZeneca, R&D Informat, Shanghai, Peoples R China; [Liu, Qi] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	AstraZeneca; Tongji University	Wei, J (corresponding author), AstraZeneca, R&D Informat, Shanghai, Peoples R China.	jenny.wei@astrazeneca.com						Aberg E, 2011, J AFFECT DISORDERS, V129, P158, DOI 10.1016/j.jad.2010.08.009; Arias B, 2006, J AFFECT DISORDERS, V90, P251, DOI 10.1016/j.jad.2005.11.008; Aronson J.K., 2006, MEYLERS SIDE EFFECTS, V15th ed.; Aronson JK, 2007, SIDE EFFECT, V29, P1; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Benedetti F, 2010, EUR PSYCHIAT, V25, P476, DOI 10.1016/j.eurpsy.2009.12.007; Benedetti F, 2009, PSYCHOPHARMACOLOGY, V203, P155, DOI 10.1007/s00213-008-1381-7; Berggren R, 2012, NAT REV DRUG DISCOV, V11, P435, DOI 10.1038/nrd3744; Berrocoso E, 2009, CURR PHARM DESIGN, V15, P1612, DOI 10.2174/138161209788168100; Bingham Clifton O 3rd, 2002, Cleve Clin J Med, V69 Suppl 1, pSI5; Borges Nuno, 2005, Expert Opin Drug Saf, V4, P69, DOI 10.1517/14740338.4.1.69; BRESSA GM, 1994, ACTA NEUROL SCAND, V89, P7, DOI 10.1111/j.1600-0404.1994.tb05403.x; Cheng FX, 2012, MOL BIOSYST, V8, P2373, DOI 10.1039/c2mb25110h; Chowta MN, 2011, J PHARMACOL PHARMACO, V2, P281, DOI 10.4103/0976-500X.85947; Dakshanamurthy S, 2012, J MED CHEM, V55, P6832, DOI 10.1021/jm300576q; David E, 2009, NAT REV DRUG DISCOV, V8, P609, DOI 10.1038/nrd2948; Desmeules JA, 1996, BRIT J CLIN PHARMACO, V41, P7, DOI 10.1111/j.1365-2125.1996.tb00152.x; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147, DOI 10.1111/j.1476-5381.1992.tb14226.x; Duran-Frigola M, 2012, GENOME MED, V4, DOI 10.1186/gm302; Fava M, 1999, J CLIN PSYCHOPHARM, V19, P329, DOI 10.1097/00004714-199908000-00008; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Jarvelin K, 2002, ACM T INFORM SYST, V20, P422, DOI 10.1145/582415.582418; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu X, 2013, CURR MED CHEM, V20, P1646; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; MOREAU JL, 1994, BEHAV PHARMACOL, V5, P344, DOI 10.1097/00008877-199406000-00012; Oprea TI, 2012, AAPS J, V14, P759, DOI 10.1208/s12248-012-9390-1; Pammolli F, 2011, NAT REV DRUG DISCOV, V10, P428, DOI 10.1038/nrd3405; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Prada DM, 1994, CLIN NEUROPHARMACOL, V17, pS26; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; ROBINSON DR, 1975, J CLIN INVEST, V56, P1181, DOI 10.1172/JCI108195; Rojas-Corrales MO, 1998, LIFE SCI, V63, pPL175, DOI 10.1016/S0024-3205(98)00369-5; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Spronk D, 2011, J AFFECT DISORDERS, V128, P41, DOI 10.1016/j.jad.2010.06.021; Sundy J S, 2001, Curr Rheumatol Rep, V3, P86, DOI 10.1007/s11926-001-0055-9; Szegedi A, 2005, PHARMACOGENOMICS J, V5, P49, DOI 10.1038/sj.tpj.6500289; Tayal V, 2008, INDIAN J PHARMACOL, V40, P129, DOI 10.4103/0253-7613.42307; Truong DD, 2009, CLIN INTERV AGING, V4, P109; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; [叶浩 Ye Hao], 2012, [华东理工大学学报. 自然科学版, Journal of East China University of Science and Technoloy. Natural Sciences Edition], V38, P301; Ye H, 2012, CHINESE SCI BULL, V57, P2106, DOI 10.1007/s11434-012-4982-9; Ye H, 2012, PROTEIN CELL, V3, P132, DOI 10.1007/s13238-012-2011-z; Yoshida K, 2008, HUM PSYCHOPHARM CLIN, V23, P121, DOI 10.1002/hup.907	51	67	70	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87864	10.1371/journal.pone.0087864	http://dx.doi.org/10.1371/journal.pone.0087864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505324	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300007
J	Wang, J; He, C; Hsi, JH; Xu, XQ; Liu, Y; He, JM; Ling, H; Ding, P; Tong, Y; Zou, XB; Zhou, QH; Liao, LJ; Wang, X; Ruan, YH; Shao, YM; Xing, H				Wang, Jing; He, Cui; Hsi, Jenny H.; Xu, Xiaoqin; Liu, Yong; He, Jianmei; Ling, Hua; Ding, Ping; Tong, Yi; Zou, Xiaobai; Zhou, Quanhua; Liao, Lingjie; Wang, Xia; Ruan, Yuhua; Shao, Yiming; Xing, Hui			Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011-2012	PLOS ONE			English	Article							TREATMENT PROGRAM; HIV-1 INFECTION; LOW-PREVALENCE; FOLLOW-UP; THERAPY; MORTALITY; HAART; SITES; INITIATION; MUTATIONS	Objective: To determine the prevalence of virological failure and HIV drug resistance among Chinese patients one year after initiating lamivudine-based first-line antiretroviral treatment. Methods: A prospective cohort study with follow-up at 12 months was conducted in four urban sentinel sites in China. Antiretroviral naive patients >= 18 years old were recruited. Blood samples were collected for testing CD4 cell count, viral load, and (for samples with HIV-1 RNA >= 1000 copies/ml) genotyping of drug resistance. Results: A total of 513 patients were enrolled in this cohort, of whom 448 (87.3%) were retained at 12 months. The median final CD4 cell count was 313 cells/mm(3), which increased from 192 cells/mm(3) at baseline (P<0.0001). Of the 448 remaining subjects, 394 (87.9%) had successful virological suppression (HIV RNA <1000 copies/ml). Among 54 samples with viral load >= 1000 copies/ml, 40 were successfully genotyped, and 11 were found with detectable HIV drug resistance mutations. Of these, the proportions of drug resistance to NNRTIs, NRTIs and PIs were 100%, 81.8% and 0%, respectively. Injecting drug use (AOR = 0.40, 95% CI: 0.19,0.84; P = 0.0154), CD4 count at baseline >= 350 cells/mm(3) (AOR = 0.32, 95% CI: 0.14,0.72; P = 0.0056), and missed doses in the past month (AOR = 0.30, 95% CI: 0.15,0.60; P = 0.0006) were significantly negatively associated with HIV RNA <1000 copies/ml. Conclusions: Our study demonstrates effective virological and immunological outcomes at 12 months among these who initiated first-line ART treatment. However, patients infected through drug injection, who missed doses, or with higher CD4 count at baseline are at increased risk for poor virological response.	[Wang, Jing; He, Cui; Hsi, Jenny H.; Liao, Lingjie; Wang, Xia; Ruan, Yuhua; Shao, Yiming; Xing, Hui] Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Xu, Xiaoqin; Ding, Ping] Jiangsu Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Liu, Yong; Tong, Yi] Guizhou Ctr Dis Control & Prevent, Guiyang, Peoples R China; [He, Jianmei; Zou, Xiaobai] Hunan Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Ling, Hua; Zhou, Quanhua] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Jiangsu Provincial Center for Disease Control & Prevention	Xing, H (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xingh@chinaaids.cn	Wang, Xia/C-3298-2018	Wang, Xia/0000-0002-1684-7076	Ministry of Science and Technology of China [2012ZX10001-002, 2009DFB30420]; Chinese State Key Laboratory for Infectious Disease Develop Grant [2012SKLID103]; International Development Research Center of Canada [104519-010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory for Infectious Disease Develop Grant; International Development Research Center of Canada	This study was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002 and 2009DFB30420), the Chinese State Key Laboratory for Infectious Disease Develop Grant (2012SKLID103), and the International Development Research Center of Canada (grant #104519-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boileau C, 2008, JAIDS-J ACQ IMM DEF, V48, P476, DOI 10.1097/QAI.0b013e31817dc416; Borrell C, 2006, EUR J PUBLIC HEALTH, V16, P601, DOI 10.1093/eurpub/ckl062; Chinese Center for Disease Control and Prevention, 2012, AN HIV STD EP 2012; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Resistance UKCGoHD Group UCS, 2010, CLIN INFECT DIS, V50, P1275; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Ruan YH, 2013, SEX TRANSM DIS, V40, P323, DOI 10.1097/OLQ.0b013e31827fd4d4; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Smith DM, 2000, J INFECT DIS, V182, P950, DOI 10.1086/315753; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Uy J, 2009, JAIDS-J ACQ IMM DEF, V51, P450, DOI 10.1097/QAI.0b013e3181acb630; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS362, DOI 10.1093/cid/cir987; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wang X, 2011, CURR HIV RES, V9, P103, DOI 10.2174/157016211795569122; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196; Zhu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039414	34	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88305	10.1371/journal.pone.0088305	http://dx.doi.org/10.1371/journal.pone.0088305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516631	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400054
J	Finitsis, DJ; Pellowski, JA; Johnson, BT				Finitsis, David J.; Pellowski, Jennifer A.; Johnson, Blair T.			Text Message Intervention Designs to Promote Adherence to Antiretroviral Therapy (ART): A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							INHIBITOR THERAPY; SELF-REPORT; OUTCOMES; NONADHERENCE; FEASIBILITY; SUPPRESSION; REMINDERS; SUPPORT; QUALITY; SYSTEM	Background: The efficacy of antiretroviral therapy depends on patient adherence to a daily medication regimen, yet many patients fail to adhere at high enough rates to maintain health and reduce the risk of transmitting HIV. Given the explosive global growth of cellular-mobile phone use, text-messaging interventions to promote adherence are especially appropriate. This meta-analysis synthesized available text messaging interventions to promote antiretroviral therapy adherence in people living with HIV. Methods: We performed Boolean searches of electronic databases, hand searches of recent year conference abstracts and reverse searches. Included studies (1) targeted antiretroviral therapy adherence in a sample of people living with HIV, (2) used a randomized-controlled trial design to examine a text messaging intervention, and (3) reported at least one adherence measurement or clinical outcome. Results: Eight studies, including 9 interventions, met inclusion criteria. Text-messaging interventions yielded significantly higher adherence than control conditions (OR = 1.39; 95% CI = 1.18, 1.64). Sensitivity analyses of intervention characteristics suggested that studies had larger effects when interventions (1) were sent less frequently than daily, (2) supported bidirectional communication, (3) included personalized message content, and (4) were matched to participants' antiretroviral therapy dosing schedule. Interventions were also associated with improved viral load and/or CD4+ count (k = 3; OR = 1.56; 95% CI = 1.11, 2.20). Conclusions: Text-messaging can support antiretroviral therapy adherence. Researchers should consider the adoption of less frequent messaging interventions with content and timing that is individually tailored and designed to evoke a reply from the recipient. Future research is needed in order to determine how best to optimize efficacy.	[Finitsis, David J.; Pellowski, Jennifer A.; Johnson, Blair T.] Univ Connecticut, Ctr Hlth Intervent & Prevent, Dept Psychol, Storrs, CT 06269 USA	University of Connecticut	Finitsis, DJ (corresponding author), Univ Connecticut, Ctr Hlth Intervent & Prevent, Dept Psychol, Storrs, CT 06269 USA.	david.finitsis@uconn.edu		Finitsis, David/0000-0003-1988-008X	U.S. Public Health Service Institutional National Research Service Award [T32-MH074387, R01-MH58563]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058563, T32MH074387] Funding Source: NIH RePORTER	U.S. Public Health Service Institutional National Research Service Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by U.S. Public Health Service Institutional National Research Service Award T32-MH074387 (PI: Seth C. Kalichman; trainees: David J. Finitsis and Jennifer A. Pellowski) and grant R01-MH58563 (PI: Blair T. Johnson). http://www.nimh.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041; Amico KR, 2006, JAIDS-J ACQ IMM DEF, V41, P285; Assoumou L, 2013, J ANTIMICROB CHEMOTH, V68, P1400, DOI 10.1093/jac/dkt033; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Brion J, 2013, J ASS NURSE IN PRESS, DOI DOI 10.1016/J.JANA.2013.01.006.ACCESSED; Buscher A, 2011, HIV CLIN TRIALS, V12, P244, DOI 10.1310/hct1205-244; Card N.A, 2012, APPL METAANALYSIS SO; Coomes CM, 2012, AIDS CARE, V24, P348, DOI 10.1080/09540121.2011.608421; Crankshaw T, 2010, AIDS PATIENT CARE ST, V24, P729, DOI 10.1089/apc.2010.0146; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; da Costa TM, 2012, INT J MED INFORM, V81, P257, DOI 10.1016/j.ijmedinf.2011.10.002; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7; Goggin G, 2006, CELL PHONE CULTURE M; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Harris LT, 2010, TELEMED J E-HEALTH, V16, P1024, DOI 10.1089/tmj.2010.0050; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horvath T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009756; Huedo-Medina T.B., 2011, ESTIMATING STANDARDI; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; International Association of Providers in AIDS Care, 2013, 8 INT C HIV TREATM P; Johnson BT, 2010, AIDS BEHAV, V14, pS204, DOI 10.1007/s10461-010-9803-z; Johnson BT, 2012, EHC201201001R2 AG HE; Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lima VD, 2010, JAIDS-J ACQ IMM DEF, V55, P460, DOI 10.1097/QAI.0b013e3181f2ac87; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mbuagbaw L, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-003950, 10.1136/bmjopen-2013-002954]; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mihalko SL, 2004, CONTROL CLIN TRIALS, V25, P447, DOI 10.1016/j.cct.2004.07.003; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Musser D, 2001, THESIS U MISSOURI ST; Ortego C, 2011, AIDS BEHAV, V15, P1381, DOI 10.1007/s10461-011-9942-x; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Park-Wyllie LY, 2009, ANN PHARMACOTHER, V43, P1036, DOI 10.1345/aph.1L663; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Ferreira JLP, 2013, ADV VIROL, V2013, DOI 10.1155/2013/878237; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Russell J, 2004, J ASSOC NURSE AIDS C, V15, P40, DOI 10.1177/1055329004269283; Safren SA, 2003, AIDS CARE, V15, P787, DOI 10.1080/09540120310001618630; Sahay S, 2011, INDIAN J MED RES, V134, P835, DOI 10.4103/0971-5916.92629; Samet JH., 2001, AIDS BEHAV, V5, P21, DOI DOI 10.1023/A:1009503320498; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Sanou Brahima, 2013, WORLD 2013 ICT FACTS; Sherr L, 2010, AIDS CARE, V22, P939, DOI 10.1080/09540121.2010.482126; Shi LZ, 2010, PHARMACOECONOMICS, V28, P1097, DOI 10.2165/11537400-000000000-00000; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Simoni Jane M, 2003, Top HIV Med, V11, P185; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; Sinha S, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/905823; Thao VP, 2012, ANTIVIR THER, DOI [10.3851/IMP2092, DOI 10.3851/IMP2092;10.3851/IMP2092]; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; WHO, 2006, WORK TOG HLTH WORLD; Wilson D. B., 2002, METAANALYSIS MACROS; Wilson Ira B, 2009, Curr HIV/AIDS Rep, V6, P177, DOI 10.1007/s11904-009-0024-x; Wise J, 2008, AIDS PATIENT CARE ST, V22, P495, DOI 10.1089/apc.2007.0180; World Health Organization, 2013, CONS GUID GEN HIV CA	64	237	241	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88166	10.1371/journal.pone.0088166	http://dx.doi.org/10.1371/journal.pone.0088166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505411	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200125
J	Longhi, MS; Moss, A; Bai, AP; Wu, Y; Huang, H; Cheifetz, A; Quintana, FJ; Robson, SC				Longhi, Maria Serena; Moss, Alan; Bai, Aiping; Wu, Yan; Huang, Huang; Cheifetz, Adam; Quintana, Francisco J.; Robson, Simon C.			Characterization of Human CD39(+) Th17 Cells with Suppressor Activity and Modulation in Inflammatory Bowel Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; TGF-BETA; T(H)17 CELLS; AUTOIMMUNE HEPATITIS; IMMUNE SUPPRESSION; CUTTING EDGE; IN-VITRO; EXPRESSION	Induced regulatory T-cells (iT-reg) and T helper type 17 (Th17) in the mouse share common CD4 progenitor cells and exhibit overlapping phenotypic and functional features. Here, we show that human Th17 cells endowed with suppressor activity (supTh17) can be derived following exposure of iT-reg populations to Th17 polarizing conditions. In contrast to "pathogenic'' Th17, supTh17 display immune suppressive function and express high levels of CD39, an ectonucleotidase that catalyzes the conversion of pro-inflammatory extracellular nucleotides ultimately generating nucleosides. Accordingly, supTh17 exhibit nucleoside triphosphate diphosphohydrolase activity, as demonstrated by the efficient generation of extracellular AMP, adenosine and other purine derivatives. In addition supTh17 cells are resistant to the effects of adenosine as result of the low expression of the A2A receptor and accelerated adenosine catalysis by adenosine deaminase (ADA). These supTh17 can be detected in the blood and in the lamina propria of healthy subjects. However, these supTh17 cells are diminished in patients with Crohn's disease. In summary, we describe a human Th17 subpopulation with suppressor activity, which expresses high levels of CD39 and consequently produces extracellular adenosine. As these uniquely suppressive CD39(+) Th17 cells are decreased in patients with inflammatory bowel disease, our findings might have implications for the development of novel anti-inflammatory therapeutic approaches in these and potentially other immune disorders.	[Longhi, Maria Serena; Moss, Alan; Bai, Aiping; Wu, Yan; Huang, Huang; Cheifetz, Adam; Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA; [Longhi, Maria Serena] Kings Coll Hosp London, Sch Med, Kings Coll London, Inst Liver Studies, London SE5 8RX, England; [Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Longhi, MS (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA.	maria.longhi@kcl.ac.uk; srobson@bidmc.harvard.edu	Quintana, Francisco Javier/AAB-6915-2020; Moss, Alan/B-9192-2019; Robson, Simon C./AAA-8537-2021	Moss, Alan/0000-0003-0179-5477; 	Medical Research Council; Royal College of Physicians (London, UK); National Institute of Health [R01HL094400, P01HL107152, P01HL087203, P01AI045897]; MRC [G0902288] Funding Source: UKRI; Medical Research Council [G0902288, MR/J006742/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087203, R01HL094400, P01HL107152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093903, P01AI045897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK084338] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Physicians (London, UK); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Maria Serena Longhi is supported by a Clinician Scientist Fellowship from the Medical Research Council and by a Sheila Sherlock Travel Fellowship from the Royal College of Physicians (London, UK). The study was supported by funds from the National Institute of Health to Prof Simon C Robson - R01HL094400, P01HL107152, P01HL087203 and P01AI045897. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chamouard P, 2009, DIGEST DIS SCI, V54, P2084, DOI 10.1007/s10620-008-0590-6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Dominguez-Villar M, 2011, NAT MED, V17, P673, DOI 10.1038/nm.2389; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Enjyoji K, 2008, DIABETES, V57, P2311, DOI 10.2337/db07-1265; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Grant CR, 2013, HEPATOLOGY; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Huber S, 2012, EUR J IMMUNOL, V42, P2238, DOI 10.1002/eji.201242619; Ishikawa D, 2012, MUCOSAL IMMUNOL; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Longhi MS, 2008, HEPATOLOGY, V47, P581, DOI 10.1002/hep.22071; Longhi MS, 2012, GASTROENTEROLOGY, V142, P1526, DOI 10.1053/j.gastro.2012.02.041; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Mills JH, 2012, J IMMUNOL, V188, P5713, DOI 10.4049/jimmunol.1200545; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moriyama K, 2010, J BIOL CHEM, V285, P39271, DOI 10.1074/jbc.M109.098293; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; O'Connor W, 2010, NAT IMMUNOL, V11, P471, DOI 10.1038/ni.1882; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shevach EM, 2006, IMMUNOL REV, V212, P60, DOI 10.1111/j.0105-2896.2006.00415.x; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang P, 2013, J IMMUNOL, V191, P5291, DOI 10.4049/jimmunol.1301181; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhoua Q, 2009, AM J TRANSPLANT, V9, P2303, DOI 10.1111/j.1600-6143.2009.02777.x	54	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87956	10.1371/journal.pone.0087956	http://dx.doi.org/10.1371/journal.pone.0087956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505337	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200090
J	Rahbek, M; Nazemi, S; Odum, L; Gupta, S; Poulsen, SS; Hay-Schmidt, A; Klaerke, DA				Rahbek, Mette; Nazemi, Sasan; Odum, Lars; Gupta, Saurabh; Poulsen, Steen Seier; Hay-Schmidt, Anders; Klaerke, Dan Arne			Expression of the Small Conductance Ca2+-Activated Potassium Channel Subtype 3 (SK3) in Rat Uterus after Stimulation with 17 beta-Estradiol	PLOS ONE			English	Article							HUMAN MYOMETRIUM; K+ CHANNELS; EPITHELIAL-CELLS; PRETERM BIRTH; PREGNANCY; ESTROGEN; ARTERIES; MICE; OVEREXPRESSION; CONTRACTILITY	Preterm births accounts for roughly 9% of all births worldwide and can have detrimental or even lethal consequences for the infant. However to develop new treatment that will lower the rate of preterm births, more knowledge is required on the factors contributing to the contraction and relaxation of the myometrium. The small conductance Ca2+-activated potassium channel subtype 3 (SK3) has been identified in the myometrium of several species including humans, mice and rats, but with great inter species variation of the expression pattern and regulation. The aim of this study was to investigate the expression of SK3 in the uterus of rats stimulated with 17 beta-estradiol and progesterone in order to get an in depth understanding of the rat uterine SK3. Using immunohistochemistry SK3 was localized to the glandular and luminal endometrial lamina epitheliali. Furthermore, a weak signal was observed in the myometrium. Using Western blot the protein level of SK3 was found to increase in uteri from animals treated with 17 beta-estradiol, an effect that was not reflected at the mRNA level. The levels of mRNA for SK3 were significantly lower in the uterus of 17 beta-estradiol-treated animals than in the uterus of ovariectomized animals. We conclude that the SK channels are present in the endometrial epithelium, and possibly also in the myometrium of the rat uterus. Furthermore, the hormonal effect on SK3 caused by 17 beta-estradiol includes divergent regulation at mRNA and protein levels.	[Rahbek, Mette; Odum, Lars] Roskilde Hosp, Dept Clin Biochem, Roskilde, Denmark; [Rahbek, Mette; Nazemi, Sasan; Klaerke, Dan Arne] Univ Copenhagen, Dept Physiol Biochem & Nutr IKVH, Fac Hlth & Med Sci, Frederiksberg, Denmark; [Gupta, Saurabh] Univ Copenhagen, Glostrup Hosp, Fac Hlth & Med Sci, Glostrup Res Inst,Danish Headache Ctr,Dept Neurol, Glostrup, Denmark; [Poulsen, Steen Seier] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen N, Denmark; [Hay-Schmidt, Anders] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Rahbek, M (corresponding author), Roskilde Hosp, Dept Clin Biochem, Roskilde, Denmark.	mette.rahbek@gmail.com		Gjerdrum, Lise Mette Rahbek/0000-0003-4377-3209; Poulsen, Steen Seier/0000-0003-4419-4911	Region Zealand	Region Zealand	This study was funded by Region Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Anderson L, 2009, REPROD SCI, V16, P1052, DOI 10.1177/1933719109340926; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Bosch MA, 2002, ENDOCRINOLOGY, V143, P1097, DOI 10.1210/en.143.3.1097; Brown A, 2007, AM J PHYSIOL-CELL PH, V292, pC832, DOI 10.1152/ajpcell.00268.2006; Buxton ILO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012372; Gao L, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-27; Gupta S, 2007, HEADACHE, V47, P564, DOI 10.1111/j.1526-4610.2006.00596.x; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Jacobson D, 2003, BIOCHEM BIOPH RES CO, V303, P660, DOI 10.1016/S0006-291X(03)00408-X; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Mazzone J, 2003, P W PHARMACOL SOC, V46, P74; Mazzone JN, 2002, P W PHARMACOL SOC, V45, P184; Noble K, 2010, CELL CALCIUM, V47, P47, DOI 10.1016/j.ceca.2009.11.004; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Palmer ML, 2008, J PHYSIOL-LONDON, V586, P717, DOI 10.1113/jphysiol.2007.142877; Pierce SL, 2008, BIOL REPROD, V78, P1058, DOI 10.1095/biolreprod.107.066423; Pierce SL, 2010, AM J PHYSIOL-ENDOC M, V299, pE640, DOI 10.1152/ajpendo.00063.2010; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rahbek M, 2013, PHYSL J, V2013, DOI 10.1155/2013/584717; Rosenbaum ST, 2012, J CELL MOL MED, V16, P3001, DOI 10.1111/j.1582-4934.2012.01627.x; Skarra DV, 2011, AM J PHYSIOL-CELL PH, V301, pC1027, DOI 10.1152/ajpcell.00082.2011; Smith RC, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-41; Soderman A, 2008, BRAIN RES, V1227, P240, DOI 10.1016/j.brainres.2008.06.062; Vedernikov YP, 2003, EUR J OBSTET GYN R B, V108, P59, DOI 10.1016/S0301-2115(02)00415-3; Xu C, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-35	30	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87652	10.1371/journal.pone.0087652	http://dx.doi.org/10.1371/journal.pone.0087652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505302	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200061
J	Russell, J; van Zonneveld, M; Dawson, IK; Booth, A; Waugh, R; Steffenson, B				Russell, Joanne; van Zonneveld, Maarten; Dawson, Ian K.; Booth, Allan; Waugh, Robbie; Steffenson, Brian			Genetic Diversity and Ecological Niche Modelling of Wild Barley: Refugia, Large-Scale Post-LGM Range Expansion and Limited Mid-Future Climate Threats?	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SPECIES DISTRIBUTIONS; FINE-SCALE; POPULATION; DOMESTICATION; INSIGHTS; BIODIVERSITY; WHEAT; CHLOROPLAST; UNCERTAINTY	Describing genetic diversity in wild barley (Hordeum vulgare ssp. spontaneum) in geographic and environmental space in the context of current, past and potential future climates is important for conservation and for breeding the domesticated crop (Hordeum vulgare ssp. vulgare). Spatial genetic diversity in wild barley was revealed by both nuclear- (2,505 SNP, 24 nSSR) and chloroplast-derived (5 cpSSR) markers in 256 widely-sampled geo-referenced accessions. Results were compared with MaxEnt-modelled geographic distributions under current, past (Last Glacial Maximum, LGM) and mid-term future (anthropogenic scenario A2, the 2080s) climates. Comparisons suggest large-scale post-LGM range expansion in Central Asia and relatively small, but statistically significant, reductions in range-wide genetic diversity under future climate. Our analyses support the utility of ecological niche modelling for locating genetic diversity hotspots and determine priority geographic areas for wild barley conservation under anthropogenic climate change. Similar research on other cereal crop progenitors could play an important role in tailoring conservation and crop improvement strategies to support future human food security.	[Russell, Joanne; Dawson, Ian K.; Booth, Allan; Waugh, Robbie] James Hutton Inst, Invergowrie, Scotland; [van Zonneveld, Maarten] Biovers Int, Reg Off Amer, Cali, Colombia; [Steffenson, Brian] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA	James Hutton Institute; Alliance; Bioversity International; University of Minnesota System; University of Minnesota Twin Cities	Dawson, IK (corresponding author), James Hutton Inst, Invergowrie, Scotland.	iankdawson@aol.com		Steffenson, Brian/0000-0001-7961-5363; Dawson, Ian/0000-0003-4245-6973; Kindt, Roeland/0000-0002-7672-0712; Dawson, Ian/0000-0003-1345-3642	CGIAR Research Programme on Climate Change, Agriculture and Food Security (CCAFS)	CGIAR Research Programme on Climate Change, Agriculture and Food Security (CCAFS)	We thank Shiaoman Chao, Nicola Cook, Linzi Jorgensen, Andrzej Kilian and Joy Roy who helped assemble the molecular marker data sets used in the current study, and Carlos Navarro and Denis Marechal who helped prepare future climate data. Dave Miller and Ian Williamson helped in the preparation of figures. Anonymous review greatly improved the manuscript. MvZ thanks the CGIAR Research Programme on Climate Change, Agriculture and Food Security (CCAFS) for support.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Bishaw Z, 2011, INT J PLANT PROD, V5, P323; BROWN AHD, 1978, HEREDITY, V41, P49, DOI 10.1038/hdy.1978.63; Brown TA, 2009, TRENDS ECOL EVOL, V24, P103, DOI 10.1016/j.tree.2008.09.008; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Burger JC, 2008, AM J BOT, V95, P113, DOI 10.3732/ajb.95.2.113; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2009, THEOR APPL GENET, V119, P175, DOI 10.1007/s00122-009-1027-0; Conlisk E, 2013, GLOBAL CHANGE BIOL, V19, P858, DOI 10.1111/gcb.12090; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; DAVIS AP, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0047981; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Fu YongBi, 2012, Diversity, V4, P239, DOI 10.3390/d4020239; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Groves CR, 2012, BIODIVERS CONSERV, V21, P1651, DOI 10.1007/s10531-012-0269-3; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Harlan J.R., 1975, CROPS MAN; Hijmans R.J., 2012, DIVA GIS; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; Kelly JK, 1997, GENETICS, V146, P1197; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Llaurens V, 2008, MOL ECOL, V17, P1577, DOI 10.1111/j.1365-294X.2007.03683.x; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McVean GAT, 2002, GENETICS, V162, P987; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Moragues M, 2010, THEOR APPL GENET, V120, P1525, DOI 10.1007/s00122-010-1273-1; Morrell PL, 2006, GENETICS, V173, P1705, DOI 10.1534/genetics.105.054502; Nevo E, 2012, P NATL ACAD SCI USA, V109, P3412, DOI 10.1073/pnas.1121411109; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Provan J, 1999, MOL ECOL, V8, P505, DOI 10.1046/j.1365-294X.1999.00545.x; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramirez J, 2010, 1 CTR INT AGR TROP C; Ramsay L, 2000, GENETICS, V156, P1997; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062700; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Roy JK, 2010, MOL BREEDING, V26, P243, DOI 10.1007/s11032-010-9402-8; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; Scheldeman X., 2010, TRAINING MANUAL SPAT; Shoo LP, 2013, CLIMATIC CHANGE, V119, P239, DOI 10.1007/s10584-013-0699-2; Siol M, 2010, NEW PHYTOL, V188, P313, DOI 10.1111/j.1469-8137.2010.03401.x; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Steffenson BJ, 2007, AUST J AGR RES, V58, P532, DOI 10.1071/AR07123; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Thomas E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047676; van Etten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012060; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; van Zonneveld M, 2009, FOREST ECOL MANAG, V257, P1566, DOI 10.1016/j.foreco.2008.12.027; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Vermeulen SJ, 2013, P NATL ACAD SCI USA, V110, P8357, DOI 10.1073/pnas.1219441110; Volis S, 2001, ANN BOT-LONDON, V87, P435, DOI 10.1006/anbo.2000.1354; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x	79	36	39	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86021	10.1371/journal.pone.0086021	http://dx.doi.org/10.1371/journal.pone.0086021			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505252	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200012
J	Watkin, EE; Arbez, N; Waldron-Roby, E; O'Meally, R; Ratovitski, T; Cole, RN; Ross, CA				Watkin, Erin E.; Arbez, Nicolas; Waldron-Roby, Elaine; O'Meally, Robert; Ratovitski, Tamara; Cole, Robert N.; Ross, Christopher A.			Phosphorylation of Mutant Huntingtin at Serine 116 Modulates Neuronal Toxicity	PLOS ONE			English	Article							INTRANUCLEAR INCLUSIONS; PROTEIN AGGREGATION; INDUCED DISEASE; MOUSE MODEL; WILD-TYPE; PATHOGENESIS; DYSFUNCTION; CLEAVAGE; LENGTH; EXCITOTOXICITY	Phosphorylation has been shown to have a significant impact on expanded huntingtin-mediated cellular toxicity. Several phosphorylation sites have been identified on the huntingtin (Htt) protein. To find new potential therapeutic targets for Huntington's Disease (HD), we used mass spectrometry to identify novel phosphorylation sites on N-terminal Htt, expressed in HEK293 cells. Using site-directed mutagenesis we introduced alterations of phosphorylation sites in a N586 Htt construct containing 82 polyglutamine repeats. The effects of these alterations on expanded Htt toxicity were evaluated in primary neurons using a nuclear condensation assay and a direct time-lapse imaging of neuronal death. As a result of these studies, we identified several novel phosphorylation sites, validated several known sites, and discovered one phospho-null alteration, S116A, that had a protective effect against expanded polyglutamine-mediated cellular toxicity. The results suggest that S116 is a potential therapeutic target, and indicate that our screening method is useful for identifying candidate phosphorylation sites.	[Watkin, Erin E.; Arbez, Nicolas; Waldron-Roby, Elaine; Ratovitski, Tamara; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; [O'Meally, Robert; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA.	caross@jhu.edu			NINDS grant [NS16375]	NINDS grant	This research was supported by NINDS grant NS16375 (http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Arrasate M, 2012, EXP NEUROL, V238, P1, DOI 10.1016/j.expneurol.2011.12.013; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Cong X, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009829; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dong GF, 2012, PROTEOMICS, V12, P2060, DOI 10.1002/pmic.201100380; Ehrlich ME, 2012, NEUROTHERAPEUTICS, V9, P270, DOI 10.1007/s13311-012-0112-2; Ehrnhoefer DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027680; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Finkbeiner S., 2011, COLD SPRING HARB PER, V3; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Greiner ER, 2011, NAT CHEM BIOL, V7, P412, DOI 10.1038/nchembio.604; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Guo ZH, 2012, MOVEMENT DISORD, V27, P1379, DOI 10.1002/mds.25159; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jablonski MR, 2011, J NEUROSCI, V31, P4357, DOI 10.1523/JNEUROSCI.6747-10.2011; Khoshnan A, 2011, NEUROBIOL DIS, V43, P305, DOI 10.1016/j.nbd.2011.04.015; Krobitsch S, 2011, INT J BIOCHEM CELL B, V43, P20, DOI 10.1016/j.biocel.2010.10.014; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MacDonald Marcy E, 2003, Sci STKE, V2003, ppe48; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Metzler M, 2010, J NEUROSCI, V30, P14318, DOI 10.1523/JNEUROSCI.1589-10.2010; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Qin ZH, 2004, ACTA PHARMACOL SIN, V25, P1243; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Reiner A, 2011, INT REV NEUROBIOL, V98, P325, DOI [10.1016/B978-0-12-387003-2.00014-8, 10.1016/B978-0-12-381328-2.00014-6]; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Ross CA, 2009, PARKINSONISM RELAT D, V15, pS135, DOI 10.1016/S1353-8020(09)70800-4; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shang Huifang, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS107, DOI 10.1016/S1353-8020(11)70034-7; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Vonsattel Jean Paul G, 2011, Handb Clin Neurol, V100, P83, DOI 10.1016/B978-0-444-52014-2.00004-5; Waldron-Roby E, 2012, J NEUROSCI, V32, P183, DOI 10.1523/JNEUROSCI.1305-11.2012; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Wang Y, 2010, NEUROSCI BULL, V26, P153, DOI 10.1007/s12264-010-1118-6; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Young FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036315; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zheng L, 2013, ENVIRON TOXICOL CHEM, V32, P468, DOI 10.1002/etc.2075; Zuccato C, 2005, PHYSIOL REV, V90, P905	73	33	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88284	10.1371/journal.pone.0088284	http://dx.doi.org/10.1371/journal.pone.0088284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505464	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200166
J	Zimmermann, J; Falcke, M				Zimmermann, Juliane; Falcke, Martin			Formation of Transient Lamellipodia	PLOS ONE			English	Article							ACTIN DYNAMICS; SELF-ORGANIZATION; RETROGRADE FLOW; CELL-MIGRATION; LEADING-EDGE; PROTRUSION; NETWORKS; ADHESION; RAC; CYTOSKELETON	Cell motility driven by actin polymerization is pivotal to the development and survival of organisms and individual cells. Motile cells plated on flat substrates form membrane protrusions called lamellipodia. The protrusions repeatedly appear and retract in all directions. If a lamellipodium is stabilized and lasts for some time, it can take over the lead and determine the direction of cell motion. Protrusions traveling along the cell perimeter have also been observed. Their initiation is in some situations the effect of the dynamics of the pathway linking plasma membrane receptors to actin filament nucleation, e. g. in chemotaxis. However, lamellipodia are also formed in many cells incessantly during motion with a constant state of the signaling pathways upstream from nucleation promoting factors (NPFs), or spontaneously in resting cells. These observations strongly suggest protrusion formation can also be a consequence of the dynamics downstream from NPFs, with signaling setting the dynamic regime but not initiating the formation of individual protrusions. A quantitative mechanism for this kind of lamellipodium dynamics has not been suggested yet. Here, we present a model exhibiting excitable actin network dynamics. Individual lamellipodia form due to random supercritical filament nucleation events amplified by autocatalytic branching. They last for about 30 seconds to many minutes and are terminated by filament bundling, severing and capping. We show the relevance of the model mechanism for experimentally observed protrusion dynamics by reproducing in very good approximation the repetitive protrusion formation measured by Burnette et al. with respect to the velocities of leading edge protrusion and retrograde flow, oscillation amplitudes, periods and shape, as well as the phase relation between protrusion and retrograde flow. Our modeling results agree with the mechanism of actin bundle formation during lamellipodium retraction suggested by Burnette et al. and Koestler et al.	[Zimmermann, Juliane; Falcke, Martin] Max Delbruck Ctr Mol Med, Berlin, Germany; [Zimmermann, Juliane] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Rice University	Falcke, M (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	martin.falcke@mdc-berlin.de	Falcke, Martin/I-2966-2012	Falcke, Martin/0000-0001-7137-1114	DFG [GRK 1772]	DFG(German Research Foundation (DFG))	JZ was supported by the DFG (GRK 1772) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Asano Y, 2009, HFSP J, V3, P194, DOI 10.2976/1.3100548; BAR M, 1992, SURF SCI, V269, P471, DOI 10.1016/0039-6028(92)91294-L; Barnhart EL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001059; Bernheim-Groswasser A, 2005, BIOPHYS J, V89; Bieling P, 2012, ANN M AM SOC CELL BI; Blanchoin L, 1998, J BIOL CHEM, V273, P25106, DOI 10.1074/jbc.273.39.25106; Bray D, 2001, CELL MOVEMENTS MOL M; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Cirit M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000688; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dobereiner HG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.038102; Enculescu M, 2012, ADV EXP MED BIOL, V736, P337, DOI 10.1007/978-1-4419-7210-1_20; Enculescu M, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053040; Enculescu M, 2010, BIOPHYS J, V98, P1571, DOI [10.1016/j.bpj.2009.12.4311, 10.1016/j.bpj.2009.12.431]; Enculescu M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031915; Gholami A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041803; Gholami A, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/11/115002; Gholami A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/3/033022; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hecht I, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002044; Huber F, 2008, BIOPHYS J, V95, P5508, DOI 10.1529/biophysj.108.134817; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Koestler SA, 2008, NAT CELL BIOL, V10, P306, DOI 10.1038/ncb1692; Kroy K, 1996, PHYS REV LETT, V77, P306, DOI 10.1103/PhysRevLett.77.306; Kruse K, 2006, PHYS BIOL, V3, P130, DOI 10.1088/1478-3975/3/2/005; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Machacek M, 2006, BIOPHYS J, V90, P1439, DOI 10.1529/biophysj.105.070383; Mikhailov A, 1994, SPRINGER SERIES SYNE, V1; Mikhailov A, 1994, SPRINGER SERIES SYNE, V2; Monypenny J, 2009, MOL CELL BIOL, V29, P2730, DOI 10.1128/MCB.01285-08; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ryan GL, 2012, CYTOSKELETON, V69, P195, DOI 10.1002/cm.21017; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; Shemesh T, 2012, BIOPHYS J, V102, P1746, DOI 10.1016/j.bpj.2012.03.006; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Welf ES, 2012, J CELL BIOL, V197, P105, DOI 10.1083/jcb.201108152; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zimmermann J, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/015021; Zimmermann J, 2012, BIOPHYS J, V102, P287, DOI 10.1016/j.bpj.2011.12.023; Zimmermann J, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051925	63	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87638	10.1371/journal.pone.0087638	http://dx.doi.org/10.1371/journal.pone.0087638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505300	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330829200059
J	Oppenheimer, BW; Berger, KI; Segal, LN; Stabile, A; Coles, KD; Parikh, M; Goldring, RM				Oppenheimer, Beno W.; Berger, Kenneth I.; Segal, Leopoldo N.; Stabile, Alexandra; Coles, Katherine D.; Parikh, Manish; Goldring, Roberta M.			Airway Dysfunction in Obesity: Response to Voluntary Restoration of End Expiratory Lung Volume	PLOS ONE			English	Article							FORCED OSCILLATION TECHNIQUE; RESPIRATORY RESISTANCE; BARIATRIC SURGERY; SMOOTH-MUSCLE; ASTHMA; HYPERRESPONSIVENESS; STANDARDIZATION; RESPONSIVENESS; SPIROMETRY; PHYSIOLOGY	Introduction: Abnormality in distal lung function may occur in obesity due to reduction in resting lung volume; however, airway inflammation, vascular congestion and/or concomitant intrinsic airway disease may also be present. The goal of this study is to 1) describe the phenotype of lung function in obese subjects utilizing spirometry, plethysmography and oscillometry; and 2) evaluate residual abnormality when the effect of mass loading is removed by voluntary elevation of end expiratory lung volume (EELV) to predicted FRC. Methods: 100 non-smoking obese subjects without cardio-pulmonary disease and with normal airflow on spirometry underwent impulse oscillometry (IOS) at baseline and at the elevated EELV. Results: FRC and ERV were reduced (44 +/- 22, 62 +/- 14% predicted) with normal RV/TLC (29 +/- 9%). IOS demonstrated elevated resistance at 20 Hz (R-20, 4.65 +/- 1.07 cmH(2)O/L/s); however, specific conductance was normal (0.14 +/- 0.04). Resistance at 5-20 Hz (R5-20, 1.86 +/- 1.11 cmH(2)O/L/s) and reactance at 5 Hz (X-5, -22.70 +/- 1.44 cmH(2)O/L/s) were abnormal. During elevation of EELV, IOS abnormalities reversed to or towards normal. Residual abnormality in R5-20 was observed in some subjects despite elevation of EELV (1.16 +/- 0.8 cmH(2)O/L/s). R5-20 responded to bronchodilator at baseline but not during elevation of EELV. Conclusions: This study describes the phenotype of lung dysfunction in obesity as reduction in FRC with airway narrowing, distal respiratory dysfunction and bronchodilator responsiveness. When R5-20 normalized during voluntary inflation, mass loading was considered the predominant mechanism. In contrast, when residual abnormality in R5-20 was demonstrable despite return of EELV to predicted FRC, mechanisms for airway dysfunction in addition to mass loading could be invoked.	[Oppenheimer, Beno W.; Berger, Kenneth I.; Segal, Leopoldo N.; Stabile, Alexandra; Coles, Katherine D.; Goldring, Roberta M.] NYU, Sch Med, Dept Med,Bellevue Hosp, Andre Cournand Pulm Physiol Lab,Div Pulm Crit Car, New York, NY 10012 USA; [Parikh, Manish] NYU, Sch Med, Bellevue Hosp, Bariatr Ctr,Dept Surg, New York, NY USA	Bellevue Hospital Center; New York University; Bellevue Hospital Center; New York University	Oppenheimer, BW (corresponding author), NYU, Sch Med, Dept Med,Bellevue Hosp, Andre Cournand Pulm Physiol Lab,Div Pulm Crit Car, New York, NY 10012 USA.	beno.oppenheimer@nyumc.org		Segal, Leopoldo/0000-0003-3559-9431; Berger, Kenneth/0000-0003-4879-6071; goldring, roberta/0000-0003-3319-4932; Parikh, Manish/0000-0002-8612-5407				Brown N, 2007, AM J RESP CRIT CARE, V176, P129, DOI 10.1164/rccm.200609-1317OC; Brown NJ, 2010, RESP PHYSIOL NEUROBI, V172, P162, DOI 10.1016/j.resp.2010.05.013; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; DUBOIS AB, 1956, J APPL PHYSIOL, V8, P587, DOI 10.1152/jappl.1956.8.6.587; FREEDMAN BJ, 1972, B PHYSIO-PATHOL RESP, V8, P545; Friedman SM, 2011, AM J RESP CRIT CARE, V184, P582, DOI 10.1164/rccm.201011-1909OC; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Herbert R, 2006, ENVIRON HEALTH PERSP, V114, P1853, DOI 10.1289/ehp.9592; Jones RL, 2006, CHEST, V130, P827, DOI 10.1378/chest.130.3.827; KAPPOS AD, 1981, J APPL PHYSIOL, V51, P621, DOI 10.1152/jappl.1981.51.3.621; King GG, 2005, EUR RESPIR J, V25, P896, DOI 10.1183/09031936.05.00104504; KNUDSON RJ, 1976, AM REV RESPIR DIS, V114, P871; Kohlhaufl M, 1906, J AEROSOL MED, V14, P1; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; LANDSER FJ, 1982, CHEST, V81, P586, DOI 10.1378/chest.81.5.586; LUTCHEN KR, 1994, J APPL PHYSIOL, V77, P373, DOI 10.1152/jappl.1994.77.1.373; Macklem PT, 1998, AM J RESP CRIT CARE, V157, pS181, DOI 10.1164/ajrccm.157.5.rsaa-2; MACKLEM PT, 1967, J APPL PHYSIOL, V22, P395, DOI 10.1152/jappl.1967.22.3.395; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; MEAD J, 1970, NEW ENGL J MED, V282, P1318, DOI 10.1056/NEJM197006042822311; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILLER TK, 1983, IEEE T BIO-MED ENG, V30, P826, DOI 10.1109/TBME.1983.325085; Oppenheimer BW, 2007, CHEST, V132, P1275, DOI 10.1378/chest.07-0913; Oppenheimer BW, 2006, OBESITY, V14, P1172, DOI 10.1038/oby.2006.134; Oppenheimer BW, 2012, SURG OBES RELAT DIS, V8, P582, DOI 10.1016/j.soard.2011.08.004; Oppenheimer BW, 2009, COPD, V6, P162, DOI 10.1080/15412550902918410; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; Pellegrino R, 2009, RESP PHYSIOL NEUROBI, V166, P47, DOI 10.1016/j.resp.2009.01.006; Peslin R., 1986, HDB PHYSL 3, VIII, P145, DOI [10.1002/cphy.cp030311, DOI 10.1002/CPHY.CP030311]; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Shiota S, 2005, RESPIROLOGY, V10, P310, DOI 10.1111/j.1440-1843.2005.00703.x; Shore SA, 2005, J ALLERGY CLIN IMMUN, V115, P925, DOI 10.1016/j.jaci.2005.01.064; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Sugerman H, 1997, J INTERN MED, V241, P71, DOI 10.1046/j.1365-2796.1997.89104000.x; Torchio R, 2009, J APPL PHYSIOL, V107, P408, DOI 10.1152/japplphysiol.00083.2009; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Watson RA, 2010, J APPL PHYSIOL, V108, P1605, DOI 10.1152/japplphysiol.01267.2009; Watson RA, 2005, J APPL PHYSIOL, V98, P512, DOI 10.1152/japplphysiol.00430.2004; ZERAH F, 1993, CHEST, V103, P1470, DOI 10.1378/chest.103.5.1470; Zerah-Lancner F, 2011, J ASTHMA, V48, P818, DOI 10.3109/02770903.2011.613508	42	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88015	10.1371/journal.pone.0088015	http://dx.doi.org/10.1371/journal.pone.0088015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505355	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300035
J	Patrick, SC; Weimerskirch, H				Patrick, Samantha C.; Weimerskirch, Henri			Personality, Foraging and Fitness Consequences in a Long Lived Seabird	PLOS ONE			English	Article							BEHAVIORAL SYNDROMES; COMMERCIAL FISHERIES; AVIAN PERSONALITIES; 1ST-PASSAGE TIME; BOLDNESS; ALBATROSSES; AGGRESSION; SEARCH; FOOD; PERFORMANCE	While personality differences in animals are defined as consistent behavioural variation between individuals, the widely studied field of foraging specialisation in marine vertebrates has rarely been addressed within this framework. However there is much overlap between the two fields, both aiming to measure the causes and consequences of consistent individual behaviour. Here for the first time we use both a classic measure of personality, the response to a novel object, and an estimate of foraging strategy, derived from GPS data, to examine individual personality differences in black browed albatross and their consequences for fitness. First, we examine the repeatability of personality scores and link these to variation in foraging habitat. Bolder individuals forage nearer the colony, in shallower regions, whereas shyer birds travel further from the colony, and fed in deeper oceanic waters. Interestingly, neither personality score predicted a bird's overlap with fisheries. Second, we show that both personality scores are correlated with fitness consequences, dependent on sex and year quality. Our data suggest that shyer males and bolder females have higher fitness, but the strength of this relationship depends on year quality. Females who forage further from the colony have higher breeding success in poor quality years, whereas males foraging close to the colony always have higher fitness. Together these results highlight the potential importance of personality variation in seabirds and that the fitness consequences of boldness and foraging strategy may be highly sex dependent.	[Patrick, Samantha C.; Weimerskirch, Henri] CNRS, UPR1934, Ctr Etud Biol Chize, Villiers En Bois, France; [Patrick, Samantha C.] Univ Gloucestershire, Cheltenham, Glos, England; [Patrick, Samantha C.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Centre National de la Recherche Scientifique (CNRS); University of Gloucestershire; University of Oxford	Patrick, SC (corresponding author), CNRS, UPR1934, Ctr Etud Biol Chize, Villiers En Bois, France.	spatrick@glos.ac.uk	Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	Weimerskirch, Henri/0000-0002-0457-586X	Institiut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes and Antarctique Francaises (TAAF); Marie Curie Intra-European fellowship ALBASPECIALISATION	Institiut Polaire Francais Paul Emile Victor (IPEV); Terres Australes and Antarctique Francaises (TAAF); Marie Curie Intra-European fellowship ALBASPECIALISATION	The Institiut Polaire Francais Paul Emile Victor (IPEV, programme 109) and the Terres Australes and Antarctique Francaises (TAAF) provided logistical and financial support, and SCP was funded by a Marie Curie Intra-European fellowship ALBASPECIALISATION. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 1998, AQUACULTURE, V167, P17, DOI 10.1016/S0044-8486(98)00302-0; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Angelier F, 2007, BEHAV ECOL SOCIOBIOL, V61, P611, DOI 10.1007/s00265-006-0290-1; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; Arcos JM, 2001, MAR BIOL, V139, P807; Barbraud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060353; Bates D., 2010, LME4 LINEAR MIXED EF; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Boon AK, 2008, OIKOS, V117, P1321, DOI 10.1111/j.0030-1299.2008.16567.x; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Catry P, 2010, J AVIAN BIOL, V41, P460, DOI 10.1111/j.1600-048X.2010.05029.x; Cherel Y, 2000, MAR ECOL PROG SER, V207, P183, DOI 10.3354/meps207183; Cherel Y, 1996, BIOL CONSERV, V75, P63, DOI 10.1016/0006-3207(95)00037-2; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Cole EF, 2012, P ROY SOC B-BIOL SCI, V279, P1168, DOI 10.1098/rspb.2011.1539; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Delord K, 2005, CCAMLR SCI, V12, P53; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; DUHAMEL G, 1997, CCAMLR SCI, V4, P175; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Gasco N., 2011, P 1 INT SCI S KERG P, P93; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Granadeiro JP, 2014, ANIM CONSERV, V17, P19, DOI 10.1111/acv.12050; Granadeiro JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017467; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Kazama K, 2012, J ETHOL, V30, P279, DOI 10.1007/s10164-011-0324-7; Kazama K, 2010, BEHAV ECOL SOCIOBIOL, V64, P1239, DOI 10.1007/s00265-010-0938-8; Kiesel AL, 2012, BEHAVIOUR, V149, P1155, DOI 10.1163/1568539X-00003015; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Martin A, 2007, PECHEKER RELATIONAL; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nevoux M, 2010, OECOLOGIA, V162, P383, DOI 10.1007/s00442-009-1482-y; Norton WHJ, 2012, BEHAVIOUR, V149, P1063, DOI 10.1163/1568539X-00003012; Norton WHJ, 2011, J NEUROSCI, V31, P13796, DOI 10.1523/JNEUROSCI.2892-11.2011; Page RA, 2012, ANIM COGN, V15, P495, DOI 10.1007/s10071-012-0474-1; Pardo D, 2013, ECOLOGY, V94, P208, DOI 10.1890/12-0215.1; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Patrick SC, 2013, ECOL EVOL, V3, P4291, DOI 10.1002/ece3.748; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pruvost P, 2012, P 1 INT SCI S KERG P, P263; Quinn JL, 2009, J ANIM ECOL, V78, P1203, DOI 10.1111/j.1365-2656.2009.01585.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; ROHWER S, 1981, EVOLUTION, V35, P441, DOI 10.1111/j.1558-5646.1981.tb04905.x; Ruiz-Gomez ML, 2012, J FISH BIOL, V81, P966, DOI 10.1111/j.1095-8649.2012.03340.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Taylor RW, 2012, J EVOLUTION BIOL, V25, P614, DOI 10.1111/j.1420-9101.2012.02456.x; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; van Oers K, 2004, BEHAV GENET, V34, P611, DOI 10.1007/s10519-004-5588-z; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Weimerskirch H, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P84; Weimerskirch H, 2000, POLAR BIOL, V23, P236, DOI 10.1007/s003000050440; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835	61	103	103	2	141	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87269	10.1371/journal.pone.0087269	http://dx.doi.org/10.1371/journal.pone.0087269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504180	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000330631800025
J	Zolla-Pazner, S; deCamp, A; Gilbert, PB; Williams, C; Yates, NL; Williams, WT; Howington, R; Fong, YY; Morris, DE; Soderberg, KA; Irene, C; Reichman, C; Pinter, A; Parks, R; Pitisuttithum, P; Kaewkungwal, J; Rerks-Ngarm, S; Nitayaphan, S; Andrews, C; O'Connell, RJ; Yang, ZY; Nabel, GJ; Kim, JH; Michael, NL; Montefiori, DC; Liao, HX; Haynes, BF; Tomaras, GD				Zolla-Pazner, Susan; deCamp, Allan; Gilbert, Peter B.; Williams, Constance; Yates, Nicole L.; Williams, William T.; Howington, Robert; Fong, Youyi; Morris, Daryl E.; Soderberg, Kelly A.; Irene, Carmela; Reichman, Charles; Pinter, Abraham; Parks, Robert; Pitisuttithum, Punnee; Kaewkungwal, Jaranit; Rerks-Ngarm, Supachai; Nitayaphan, Sorachai; Andrews, Charla; O'Connell, Robert J.; Yang, Zhi-yong; Nabel, Gary J.; Kim, Jerome H.; Michael, Nelson L.; Montefiori, David C.; Liao, Hua-Xin; Haynes, Barton F.; Tomaras, Georgia D.			Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; B-CELL RESPONSES; V1/V2 DOMAIN; ENVELOPE; NEUTRALIZATION; SEQUENCE; REACTIVITY; EPITOPES; BROAD	In the RV144 HIV-1 vaccine efficacy trial, IgG antibody (Ab) binding levels to variable regions 1 and 2 (V1V2) of the HIV-1 envelope glycoprotein gp120 were an inverse correlate of risk of HIV-1 infection. To determine if V1V2-specific Abs cross-react with V1V2 from different HIV-1 subtypes, if the nature of the V1V2 antigen used to asses cross-reactivity influenced infection risk, and to identify immune assays for upcoming HIV-1 vaccine efficacy trials, new V1V2-scaffold antigens were designed and tested. Protein scaffold antigens carrying the V1V2 regions from HIV-1 subtypes A, B, C, D or CRF01_AE were assayed in pilot studies, and six were selected to assess cross-reactive Abs in the plasma from the original RV144 case-control cohort (41 infected vaccinees, 205 frequency-matched uninfected vaccinees, and 40 placebo recipients) using ELISA and a binding Ab multiplex assay. IgG levels to these antigens were assessed as correlates of risk in vaccine recipients using weighted logistic regression models. Levels of Abs reactive with subtype A, B, C and CRF01_AE V1V2-scaffold antigens were all significant inverse correlates of risk (p-values of 0.0008-0.05; estimated odds ratios of 0.53-0.68 per 1 standard deviation increase). Thus, levels of vaccine-induced IgG Abs recognizing V1V2 regions from multiple HIV-1 subtypes, and presented on different scaffolds, constitute inverse correlates of risk for HIV-1 infection in the RV144 vaccine trial. The V1V2 antigens provide a link between RV144 and upcoming HIV-1 vaccine trials, and identify reagents and methods for evaluating V1V2 Abs as possible correlates of protection against HIV-1 infection.	[Zolla-Pazner, Susan] New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY 10010 USA; [Zolla-Pazner, Susan; Williams, Constance] NYU, Sch Med, New York, NY USA; [deCamp, Allan; Gilbert, Peter B.; Fong, Youyi; Morris, Daryl E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Yates, Nicole L.; Williams, William T.; Howington, Robert; Soderberg, Kelly A.; Parks, Robert; Montefiori, David C.; Liao, Hua-Xin; Haynes, Barton F.; Tomaras, Georgia D.] Duke Univ, Durham, NC USA; [Irene, Carmela; Reichman, Charles; Pinter, Abraham] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Pitisuttithum, Punnee; Kaewkungwal, Jaranit] Fac Trop Med, Mahidol, Thailand; [Rerks-Ngarm, Supachai] Minist Publ Hlth, Bangkok, Thailand; [Nitayaphan, Sorachai] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Andrews, Charla; O'Connell, Robert J.; Kim, Jerome H.; Michael, Nelson L.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD USA; [Yang, Zhi-yong; Nabel, Gary J.] NIAID, Virol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	New York University; Fred Hutchinson Cancer Center; Duke University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zolla-Pazner, S (corresponding author), New York Harbor Healthcare Syst, Dept Vet Affairs, New York, NY 10010 USA.	zollas01@med.nyu.edu	Tomaras, Georgia/J-5041-2016; Zolla-Pazner, Susan/S-1864-2019; Morris, Daryl E/H-2659-2013	Zolla-Pazner, Susan/0000-0002-0750-2666; Kaewkungwal, Jaranit/0000-0001-7916-8460	National Institutes of Health [P01 AI100151, R01 HL59725, P01 AI64518]; Bill and Melinda Gates Foundation [1040758, 3830913]; Military HIV Research Program; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense [W81XWH-07-2-0067]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, N01AI002642, P01AI100151, R01AI102718, UM1AI068635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Military HIV Research Program; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grant funds from the National Institutes of Health: P01 AI100151 (SZP), R01 HL59725 (SZP), P01 AI64518 (Duke Center for AIDS Research); from the Bill and Melinda Gates Foundation: 1040758 (BFH), and 3830913 (DCM); from the Military HIV Research Program, and research funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. The work was also supported in part by an Interagency Agreement Y1-AI-2642-12 between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre S, 1998, J VIROL, V72, P1497; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; de Souza MS, 2012, J IMMUNOL, V188, P5166, DOI 10.4049/jimmunol.1102756; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; Gorny MK, 2012, VIROLOGY, V427, P198, DOI 10.1016/j.virol.2012.02.003; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 1997, J IMMUNOL, V159, P5114; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu PH, 2013, J VIROL, V87, P7828, DOI 10.1128/JVI.02737-12; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; Parrish NF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002686; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	31	211	218	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87572	10.1371/journal.pone.0087572	http://dx.doi.org/10.1371/journal.pone.0087572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504509	Green Submitted, Green Published, gold			2022-12-27	WOS:000330631800045
J	Graf, F; Fahrer, J; Maus, S; Morgenstern, A; Bruchertseifer, F; Venkatachalam, S; Fottner, C; Weber, MM; Huelsenbeck, J; Schreckenberger, M; Kaina, B; Miederer, M				Graf, Franziska; Fahrer, Joerg; Maus, Stephan; Morgenstern, Alfred; Bruchertseifer, Frank; Venkatachalam, Senthil; Fottner, Christian; Weber, Matthias M.; Huelsenbeck, Johannes; Schreckenberger, Mathias; Kaina, Bernd; Miederer, Matthias			DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy	PLOS ONE			English	Article							LINEAR-ENERGY-TRANSFER; NEUROENDOCRINE TUMORS; THERAPEUTIC-EFFICACY; LABELED PEPTIDES; LEUKEMIA-CELLS; COMET ASSAY; AR42J CELLS; DAMAGE; RADIATION; BI-213	Rationale: Key biologic effects of the alpha-particle emitter Actinium-225 in comparison to the beta-particle emitter Lutetium-177 labeled somatostatin-analogue DOTATOC in vitro and in vivo were studied to evaluate the significance of gamma H2AX-foci formation. Methods: To determine the relative biological effectiveness (RBE) between the two isotopes (as - biological consequence of different ionisation-densities along a particle-track), somatostatin expressing AR42J cells were incubated with Ac-225-DOTATOC and Lu-177-DOTATOC up to 48 h and viability was analyzed using the MTT assay. DNA double strand breaks (DSB) were quantified by immunofluorescence staining of gamma H2AX-foci. Cell cycle was analyzed by flow cytometry. In vivo uptake of both radiolabeled somatostatin-analogues into subcutaneously growing AR42J tumors and the number of cells displaying gamma H2AX-foci were measured. Therapeutic efficacy was assayed by monitoring tumor growth after treatment with activities estimated from in vitro cytotoxicity. Results: Ac-225-DOTATOC resulted in ED50 values of 14 kBq/ml after 48 h, whereas Lu-177-DOTATOC displayed ED50 values of 10 MBq/ml. The number of DSB grew with increasing concentration of Ac-225-DOTATOC and similarly with Lu-177-DOTATOC when applying a factor of 700-fold higher activity compared to Ac-225. Already 24 h after incubation with 2.5-10 kBq/ml, Ac-225-DOTATOC cell-cycle studies showed up to a 60% increase in the percentage of tumor cells in G2/M phase. After 72 h an apoptotic subG1 peak was also detectable. Tumor uptake for both radio peptides at 48 h was identical (7.5% ID/g), though the overall number of cells with gamma H2AX-foci was higher in tumors treated with 48 kBq Ac-225-DOTATOC compared to tumors treated with 30 MBq Lu-177-DOTATOC (35% vs. 21%). Tumors with a volume of 0.34 ml reached delayed exponential tumor growth after 25 days (44 kBq Ac-225-DOTATOC) and after 21 days (34 MBq Lu-177-DOTATOC). Conclusion: gamma H2AX-foci formation, triggered by beta-and alpha-irradiation, is an early key parameter in predicting response to internal radiotherapy.	[Graf, Franziska; Maus, Stephan; Schreckenberger, Mathias; Miederer, Matthias] Univ Med Ctr, Dept Nucl Med, Mainz, Germany; [Fahrer, Joerg; Huelsenbeck, Johannes; Kaina, Bernd] Univ Med Ctr, Inst Toxicol, Mainz, Germany; [Morgenstern, Alfred; Bruchertseifer, Frank] European Commiss, Joint Res Ctr, Inst Transuranium Elements, Karlsruhe, Germany; [Venkatachalam, Senthil; Fottner, Christian; Weber, Matthias M.] Univ Med Ctr, Dept Endocrinol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; European Commission Joint Research Centre; EC JRC Institute for Transuranium Elements (ITU); Johannes Gutenberg University of Mainz	Miederer, M (corresponding author), Univ Med Ctr, Dept Nucl Med, Mainz, Germany.	matthias.miederer@unimedizin-mainz.de	Miederer, Matthias/ABA-5988-2020; Miederer, Matthias/C-4405-2014; Kaina, Bernd/AAE-4692-2020; Venkatachalam, Senthil/G-4112-2018	Miederer, Matthias/0000-0001-5075-5995; Venkatachalam, Senthil/0000-0003-3110-1229	Federal Ministry of Education and Research (BMBF)	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support provided by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de): ISIMEP collaborative research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolidis C, 2005, ANAL CHEM, V77, P6288, DOI 10.1021/ac0580114; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Behr TM, 1999, CANCER RES, V59, P2635; Chu JT, 2013, MOL CELL BIOCHEM, V382, P1, DOI 10.1007/s11010-013-1603-0; Dadachova E, 2010, SEMIN NUCL MED, V40, P204, DOI 10.1053/j.semnuclmed.2010.01.002; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Essler M, 2012, EUR J NUCL MED MOL I, V39, P602, DOI 10.1007/s00259-011-2023-6; Friesen C, 2007, CANCER RES, V67, P1950, DOI 10.1158/0008-5472.CAN-06-3569; Haro KJ, 2012, BLOOD, V120, P2087, DOI 10.1182/blood-2012-01-404509; Kam BLR, 2012, EUR J NUCL MED MOL I, V39, P103, DOI 10.1007/s00259-011-2039-y; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; McDevitt MR, 1998, EUR J NUCL MED, V25, P1341, DOI 10.1007/s002590050306; McDevitt MR, 2001, SCIENCE, V294, P1537, DOI 10.1126/science.1064126; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; Miederer M, 2008, ADV DRUG DELIVER REV, V60, P1371, DOI 10.1016/j.addr.2008.04.009; Miederer M, 2008, CLIN CANCER RES, V14, P3555, DOI 10.1158/1078-0432.CCR-07-4647; Morgenstern A, 2011, CURR RADIOPHARM, V4, P295, DOI 10.2174/1874471011104040295; Nayak TK, 2007, NUCL MED BIOL, V34, P185, DOI 10.1016/j.nucmedbio.2006.11.006; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Repetto-Llamazares AHV, 2013, CURR RADIOPHARM, V6, P20, DOI 10.2174/1874471011306010004; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Roscher M, 2013, ONCOTARGET, V4, P218, DOI 10.18632/oncotarget.817; Sgouros G, 2010, J NUCL MED, V51, P311, DOI 10.2967/jnumed.108.058651; Song H, 2009, CANCER RES, V69, P8941, DOI 10.1158/0008-5472.CAN-09-1828; Staaf Elina, 2012, Genome Integr, V3, P8, DOI 10.1186/2041-9414-3-8; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; White JS, 2011, MUTAT RES-FUND MOL M, V708, P28, DOI 10.1016/j.mrfmmm.2011.01.005; Wu J, 2013, CLIN CANCER RES, V19, P721, DOI 10.1158/1078-0432.CCR-12-2529; Xue DB, 2009, PANCREAS, V38, pE183, DOI 10.1097/MPA.0b013e3181b65dec	31	75	76	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88239	10.1371/journal.pone.0088239	http://dx.doi.org/10.1371/journal.pone.0088239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516620	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400045
J	Kodippili, K; Vince, L; Shin, JH; Yue, YP; Morris, GE; Mcintosh, MA; Duan, DS				Kodippili, Kasun; Vince, Lauren; Shin, Jin-Hong; Yue, Yongping; Morris, Glenn E.; Mcintosh, Mark A.; Duan, Dongsheng			Characterization of 65 Epitope-Specific Dystrophin Monoclonal Antibodies in Canine and Murine Models of Duchenne Muscular Dystrophy by Immunostaining and Western Blot	PLOS ONE			English	Article							DMD GENE; NONMUSCLE TISSUES; PROTEIN; MUSCLE; REVEALS; PRODUCT; EXON; SECTIONS; UTROPHIN; THERAPY	Epitope-specific monoclonal antibodies can provide unique insights for studying cellular proteins. Dystrophin is one of the largest cytoskeleton proteins encoded by 79 exons. The absence of dystrophin results in Duchenne muscular dystrophy (DMD). Over the last two decades, dozens of exon-specific human dystrophin monoclonal antibodies have been developed and successfully used for DMD diagnosis. Unfortunately, the majority of these antibodies have not been thoroughly characterized in dystrophin-deficient dogs, an outstanding large animal model for translational research. To fill the gap, we performed a comprehensive study on 65 dystrophin monoclonal antibodies in normal and dystrophic dogs (heart and skeletal muscle) by immunofluorescence staining and western blot. For comparison, we also included striated muscles from normal BL10 and dystrophin-null mdx mice. Our analysis revealed distinctive species, tissue and assay-dependent recognition patterns of different antibodies. Importantly, we identified 15 antibodies that can consistently detect full-length canine dystrophin in both immunostaining and western blot. Our results will serve as an important reference for studying DMD in the canine model.	[Kodippili, Kasun; Vince, Lauren; Shin, Jin-Hong; Yue, Yongping; Mcintosh, Mark A.; Duan, Dongsheng] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA; [Morris, Glenn E.] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England; [Morris, Glenn E.] Keele Univ, Keele ST5 5BG, Staffs, England	University of Missouri System; University of Missouri Columbia; Keele University; Keele University	Duan, DS (corresponding author), Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA.	duand@missouri.edu	Shin, Jin-Hong/AAZ-8809-2020	Shin, Jin-Hong/0000-0002-5174-286X; Duan, Dongsheng/0000-0003-4109-1132	National Institutes of Health (NIH) [AR-49419, HL-91883]; Jessey's Journey-The Foundation for Cell and Gene Therapy; Parent Project Muscular Dystrophy; Muscular Dystrophy Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049419] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jessey's Journey-The Foundation for Cell and Gene Therapy; Parent Project Muscular Dystrophy; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health (NIH) AR-49419 (DD), HL-91883 (DD), Jessey's Journey-The Foundation for Cell and Gene Therapy (DD), Parent Project Muscular Dystrophy (DD) and the Muscular Dystrophy Association (DD and GEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; Birmingham K, 1997, NAT MED, V3, P1058, DOI 10.1038/nm1097-1058a; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Duan D, 2011, RES REP BIOL, V2, P31, DOI 10.2147/RRB.S13463; ELLIS JM, 1990, LANCET, V336, P881, DOI 10.1016/0140-6736(90)92392-U; Emery AEH, 2003, DUCHENNE MUSCULAR DY, Vx, P270; Fine DM, 2011, NEUROMUSCULAR DISORD, V21, P453, DOI 10.1016/j.nmd.2011.03.010; HOFFMAN EP, 1988, NATURE, V336, P210, DOI 10.1038/336210a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1989, LANCET, V2, P1211; HOFFMAN EP, 1988, NEURON, V1, P411, DOI 10.1016/0896-6273(88)90191-2; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KULL FC, 1982, BIOCHEM BIOPH RES CO, V106, P1019, DOI 10.1016/0006-291X(82)91813-7; Kunkel LM, 2005, AM J HUM GENET, V76, P205, DOI 10.1086/428143; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lam LT, 2010, TRANSL NEUROSCI, V1, P233, DOI 10.2478/v10134-010-0034-7; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; Li DJ, 2010, J CELL SCI, V123, P2007, DOI 10.1242/jcs.064808; Lu QL, 1998, J HISTOCHEM CYTOCHEM, V46, P977, DOI 10.1177/002215549804600813; MAN NT, 1990, FEBS LETT, V262, P237, DOI 10.1016/0014-5793(90)80199-S; MAN NT, 1993, AM J HUM GENET, V52, P1057; Marx V, 2013, NAT METHODS, V10, P703, DOI 10.1038/nmeth.2570; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Morris GE, 1998, BIOCHEMISTRY-US, V37, P11117, DOI 10.1021/bi9805137; Morris G, 2011, METHODS MOL BIOL, V709, P39, DOI 10.1007/978-1-61737-982-6_3; Nguyen T M, 1996, Methods Mol Biol, V66, P377; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; NGUYEN TM, 1992, BIOCHEM J, V288, P663, DOI 10.1042/bj2880663; Partridge T, 1998, NAT MED, V4, P1208, DOI 10.1038/3167; Petrof BJ, 2002, AM J PHYS MED REHAB, V81, pS162, DOI 10.1097/00002060-200211001-00017; Shin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059875; Smith BF, 2011, LAB INVEST, V91, P216, DOI 10.1038/labinvest.2010.146; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; THANH LT, 1995, AM J HUM GENET, V56, P725; Wang B, 2008, GENE THER, V15, P1099, DOI 10.1038/gt.2008.70; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; Yang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044438	43	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88280	10.1371/journal.pone.0088280	http://dx.doi.org/10.1371/journal.pone.0088280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516626	gold, Green Submitted, Green Published			2022-12-27	WOS:000330834400050
J	Langel, FD; Chiang, CY; Lane, D; Kenny, T; Ojeda, JF; Zhong, Y; Che, JW; Zhou, YY; Ribot, W; Kota, KP; Bavari, S; Panchal, RG				Langel, Felicia D.; Chiang, Chih-Yuan; Lane, Douglas; Kenny, Tara; Ojeda, Jenifer F.; Zhong, Yang; Che, Jianwei; Zhou, Yingyao; Ribot, Wilson; Kota, Krishna P.; Bavari, Sina; Panchal, Rekha G.			Alveolar Macrophages Infected with Ames or Sterne Strain of Bacillus anthracis Elicit Differential Molecular Expression Patterns	PLOS ONE			English	Article							NF-KAPPA-B; LETHAL FACTOR; REGULATORY FACTOR-3; GENE-EXPRESSION; KINASE-KINASE; TNF-ALPHA; IN-VIVO; ACTIVATION; INFLAMMATION; APOPTOSIS	Alveolar macrophages (AMs) phagocytose Bacillus anthracis following inhalation and induce the production of proinflammatory cytokines and chemokines to mediate the activation of innate immunity. Ames, the virulent strain of B. anthracis, contains two plasmids that encode the antiphagocytic poly-gamma-d-glutamic acid capsule and the lethal toxin. The attenuated Sterne strain of B. anthracis, which lacks the plasmid encoding capsule, is widely adapted as a vaccine strain. Although differences in the outcome of infection with the two strains may have originated from the presence or absence of an anti-phagocytic capsule, the disease pathogenesis following infection will be manifested via the host responses, which is not well understood. To gain understanding of the host responses at cellular level, a microarray analysis was performed using primary rhesus macaque AMs infected with either Ames or Sterne spores. Notably, 528 human orthologs were identified to be differentially expressed in AMs infected with either strain of the B. anthracis. Meta-analyses revealed genes differentially expressed in response to B. anthracis infection were also induced upon infections with multiple pathogens such as Francisella Novicida or Staphylococcus aureus. This suggests the existence of a common molecular signature in response to pathogen infections. Importantly, the microarray and protein expression data for certain cytokines, chemokines and host factors provide further insights on how cellular processes such as innate immune sensing pathways, anti-apoptosis versus apoptosis may be differentially modulated in response to the virulent or vaccine strain of B. anthracis. The reported differences may account for the marked difference in pathogenicity between these two strains.	[Langel, Felicia D.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Chiang, Chih-Yuan; Ojeda, Jenifer F.; Bavari, Sina; Panchal, Rekha G.] US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD 21702 USA; [Lane, Douglas; Kenny, Tara] SAIC Frederick Inc, Frederick Natl Lab Canc Res, Frederick, MD USA; [Zhong, Yang; Che, Jianwei; Zhou, Yingyao] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Ribot, Wilson] US Army Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD USA; [Kota, Krishna P.] Perkin Elmer, Waltham, MA USA	Uniformed Services University of the Health Sciences - USA; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Novartis; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Panchal, RG (corresponding author), US Army Med Res Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD 21702 USA.	rekha.g.panchal.civ@mail.mil	Kota, Krishna/GPF-8474-2022; Bavari, Sina/L-3642-2019; Panchal, Rekha/None	Bavari, Sina/0000-0001-8424-5635; Ribot, Wilson/0000-0002-9691-4004; Panchal, Rekha/0000-0001-8621-9078	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) [JSTO-CBD 2.10019_09_RD_B]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Department of Defense Chemical Biological Defense Program through the Defense Threat Reduction Agency (DTRA) JSTO-CBD 2.10019_09_RD_B (to R.G.P). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Chiang E, 2006, J IMMUNOL, V176, P5720, DOI 10.4049/jimmunol.176.10.5720; Cote SC, 2009, MOL IMMUNOL, V46, P2682, DOI 10.1016/j.molimm.2008.08.269; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; Dinarello CA, 1999, CURR BIOL, V9, pR147, DOI 10.1016/S0960-9822(99)80085-2; Dozmorov M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-152; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Greaves DR, 2002, INT J HEMATOL, V76, P6, DOI 10.1007/BF02982713; Greaves DR, 2000, MICROBES INFECT, V2, P331, DOI 10.1016/S1286-4579(00)00293-8; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; IVINS BE, 1990, INFECT IMMUN, V58, P303, DOI 10.1128/IAI.58.2.303-308.1990; Jang J, 2011, INFECT IMMUN, V79, P3846, DOI 10.1128/IAI.01145-10; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Panchal RG, 2009, ANTIMICROB AGENTS CH, V53, P4283, DOI 10.1128/AAC.01709-08; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Rasko DA, 2011, P NATL ACAD SCI USA, V108, P5027, DOI 10.1073/pnas.1016657108; RECORD BR, 1956, BIOCHEM J, V63, P453; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Ruthel G, 2004, J INFECT DIS, V189, P1313, DOI 10.1086/382656; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; SHLYAKHOV EN, 1994, VACCINE, V12, P727, DOI 10.1016/0264-410X(94)90223-2; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Triantafilou M, 2007, CELL MICROBIOL, V9, P2880, DOI 10.1111/j.1462-5822.2007.01003.x; TURNBULL LW, 1991, BRIT HEART J, V66, P359; Vanbervliet A, 2002, EUR J IMMUNOL, V32, P231, DOI 10.1002/1521-4141(200201)32:1<231::AID-IMMU231>3.0.CO;2-8; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Williams CS, 1996, AM J PHYSIOL-GASTR L, V270, pG393	34	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87201	10.1371/journal.pone.0087201	http://dx.doi.org/10.1371/journal.pone.0087201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516547	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400011
J	Thomas, DK; Lone, AG; Selinger, LB; Taboada, EN; Uwiera, RRE; Abbott, DW; Inglis, GD				Thomas, Dallas K.; Lone, Abdul G.; Selinger, L. Brent; Taboada, Eduardo N.; Uwiera, Richard R. E.; Abbott, D. Wade; Inglis, G. Douglas			Comparative Variation within the Genome of Campylobacter jejuni NCTC 11168 in Human and Murine Hosts	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; C57BL/6 IL-10(-/-) MICE; INTERLEUKIN-10-DEFICIENT MICE; BLOODY DIARRHEA; PHASE VARIATION; IN-VIVO; C. COLI; ENTERITIS; COLONIZATION; SEQUENCE	Campylobacteriosis incited by C. jejuni is a significant enteric disease of human beings. A person working with two reference strains of C. jejuni National Collection of Type Cultures (NCTC) 11168 developed symptoms of severe enteritis including bloody diarrhea. The worker was determined to be infected by C. jejuni. In excess of 50 isolates were recovered from the worker's stool. All of the recovered isolates and the two reference strains were indistinguishable from each other based on comparative genomic fingerprint subtyping. Whole genome sequence analysis indicated that the worker was infected with a C. jejuni NCTC 11168 obtained from the American Type Culture Collection; this strain (NCTC 11168-GSv) is the genome sequence reference. After passage through the human host, major genetic changes including indel mutations within twelve contingency loci conferring phase variations were detected in the genome of C. jejuni. Specific and robust single nucleotide polymorphism (SNP) changes in the human host were also observed in two loci (Cj0144c, Cj1564). In mice inoculated with an isolate of C. jejuni NCTC 11168-GSv from the infected person, the isolate underwent further genetic variation. At nine loci, mutations specific to inoculated mice including five SNP changes were observed. The two predominant SNPs observed in the human host reverted in mice. Genetic variations occurring in the genome of C. jejuni in mice corresponded to increased densities of C. jejuni cells associated with cecal mucosa. In conclusion, C. jejuni NCTC 11168-GSv was found to be highly virulent in a human being inciting severe enteritis. Host-specific mutations in the person with enteritis occurred/were selected for in the genome of C. jejuni, and many were not maintained in mice. Information obtained in the current study provides new information on host-specific genetic adaptation by C. jejuni.	[Thomas, Dallas K.; Lone, Abdul G.; Abbott, D. Wade; Inglis, G. Douglas] Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada; [Lone, Abdul G.; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Taboada, Eduardo N.] Publ Hlth Agcy Canada, Lethbridge, AB, Canada; [Uwiera, Richard R. E.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Agriculture & Agri Food Canada; University of Lethbridge; Public Health Agency of Canada; University of Alberta	Inglis, GD (corresponding author), Agr & Agri Food Canada, Res Ctr, Lethbridge, AB, Canada.	Douglas.Inglis@agr.gc.ca	Taboada, Eduardo N/Y-4854-2018	Taboada, Eduardo N/0000-0001-8373-3653; Abbott, Wade/0000-0003-4893-5799	Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions; Advanced Foods and Materials Canada Ltd; Agriculture and Agri-Food Canada	Alberta Livestock and Meat Agency; Alberta Innovates Bio Solutions; Advanced Foods and Materials Canada Ltd; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was funded in-part by grants from the Alberta Livestock and Meat Agency, Alberta Innovates Bio Solutions, Advanced Foods and Materials Canada Ltd, and Agriculture and Agri-Food Canada (Peer Review Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IH, 2002, MICROBIOL-SGM, V148, P1203, DOI 10.1099/00221287-148-4-1203; Bell JA, 2013, MICROB PATHOGENESIS, V54, P1, DOI 10.1016/j.micpath.2012.08.001; Bell JA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-57; BLASER MJ, 1982, WESTERN J MED, V136, P287; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; BUTZLER JP, 1982, INFECTION, V10, pS67, DOI 10.1007/BF01640857; Carrillo CD, 2004, J BIOL CHEM, V279, P20327, DOI 10.1074/jbc.M401134200; CARY SG, 1964, J BACTERIOL, V88, P96, DOI 10.1128/JB.88.1.96-98.1964; CHAMOVITZ BN, 1983, PEDIATRICS, V71, P253; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Clark CG, 2012, J CLIN MICROBIOL, V50, P798, DOI 10.1128/JCM.05733-11; Collins C. H., 1999, LAB ACQUIRED INFECT; Cooper KK, 2013, RES MICROBIOL, V164, P6, DOI 10.1016/j.resmic.2012.10.002; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Denis M, 1999, LETT APPL MICROBIOL, V29, P406, DOI 10.1046/j.1472-765X.1999.00658.x; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gillespie IA, 2006, J MED MICROBIOL, V55, P741, DOI 10.1099/jmm.0.46422-0; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hitchen P, 2010, MICROBIOL-SGM, V156, P1953, DOI 10.1099/mic.0.038091-0; Inglis GD, 2004, APPL ENVIRON MICROB, V70, P2296, DOI 10.1128/AEM.70.4.2296-2306.2004; Inglis GD, 2003, APPL ENVIRON MICROB, V69, P3435, DOI 10.1128/AEM.69.6.3435-3447.2003; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Jones MA, 2004, INFECT IMMUN, V72, P3769, DOI 10.1128/IAI.72.7.3769-3776.2004; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim JS, 2012, MICROBIOL-SGM, V158, P1304, DOI 10.1099/mic.0.057158-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Linton D, 1996, RES MICROBIOL, V147, P707, DOI 10.1016/S0923-2508(97)85118-2; Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x; Lone AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075325; Louwen RPL, 2006, J CLIN MICROBIOL, V44, P1867, DOI 10.1128/JCM.44.5.1867-1868.2006; Manning G, 2001, APPL ENVIRON MICROB, V67, P1185, DOI 10.1128/AEM.67.3.1185-1189.2001; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; Miles TA, 1996, AUST NZ J PUBL HEAL, V20, P457, DOI 10.1111/j.1467-842X.1996.tb01621.x; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Nguyen Y, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00090; NICHOLSON MA, 1995, J CLIN MICROBIOL, V33, P1341, DOI 10.1128/JCM.33.5.1341-1343.1995; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ogden ID, 2009, FOODBORNE PATHOG DIS, V6, P1161, DOI 10.1089/fpd.2009.0327; op den Winkel M, 2010, CLIN NEPHROL, V74, P474, DOI 10.2379/CNX06474; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Rennick DM, 2000, AM J PHYSIOL-GASTR L, V278, pG829, DOI 10.1152/ajpgi.2000.278.6.G829; Revez J, 2012, J BACTERIOL, V194, P6298, DOI 10.1128/JB.01385-12; Ringoir DD, 2003, VET MICROBIOL, V92, P225, DOI 10.1016/S0378-1135(02)00378-4; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rotariu O, 2009, APPL ENVIRON MICROB, V75, P6275, DOI 10.1128/AEM.00499-09; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SANJOAQUIN VH, 1984, CLIN PEDIATR, V23, P311, DOI 10.1177/000992288402300601; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; SKIRROW MB, 1977, BRIT MED J, V2, P9, DOI 10.1136/bmj.2.6078.9; Slev PR, 2002, CURR OPIN IMMUNOL, V14, P609, DOI 10.1016/S0952-7915(02)00381-3; Taboada EN, 2012, J CLIN MICROBIOL, V50, P788, DOI 10.1128/JCM.00669-11; Taboada EN, 2004, J CLIN MICROBIOL, V42, P4566, DOI 10.1128/JCM.42.10.4566-4576.2004; Tracz DM, 2005, EMERG INFECT DIS, V11, P838; Wassenaar TM, 2002, FEMS MICROBIOL LETT, V212, P77, DOI 10.1111/j.1574-6968.2002.tb11248.x; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0	71	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88229	10.1371/journal.pone.0088229	http://dx.doi.org/10.1371/journal.pone.0088229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516617	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400043
J	Assmann, KE; Lassale, C; Galan, P; Hercberg, S; Kesse-Guyot, E				Assmann, Karen E.; Lassale, Camille; Galan, Pilar; Hercberg, Serge; Kesse-Guyot, Emmanuelle			Dietary Quality and 6-Year Anthropometric Changes in a Sample of French Middle-Aged Overweight and Obese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; WEIGHT CHANGE; PHYSICAL-ACTIVITIES; NATIONAL NUTRITION; RISK-FACTORS; PATTERNS; QUESTIONNAIRE; GAIN; ASSOCIATION; COMPENDIUM	Background: Understanding the role of dietary quality in the progression of adiposity in populations already affected by overweight or obesity is crucial for the guidance of secondary prevention strategies. Objective: To examine the association of diet quality, as reflected by the French Nutrition and Health Programme (Programme National Nutrition Sante, PNNS) - Guideline Score (GS), with 6-year-changes in weight and waist circumference. Design and Methods: Subjects were 1029 male and 450 female participants of the SUplementation en VItamines et Mineraux AntioXydants (SU.VI.MAX) cohort (1994-2002) with anthropometric variables at baseline and follow-up and available data for estimating diet quality at baseline. We employed analysis of variance and covariance models to investigate anthropometric changes (% of the initial value) by categories of the PNNS-GS, which contains both dietary components and a physical activity component, and of a modified score (mPNNS-GS) containing dietary components only. Results: In men, a low (<6 points) PNNS-GS was associated with greater 6-year weight gain (adjusted mean: 3.63% [95% confidence interval: 2.87%; 4.39%]) as compared to a high (>= 9 points) PNNS-GS (2.10% [1.39%; 2.81%]); p = 0.01. Results for the mPNNS-GS were very similar. In women, no associations between diet scores and weight change were observed. No significant relation between dietary quality and change in waist circumference was present among either men or women. Conclusions: These results support a beneficial role of high dietary quality - as characterized by good adherence to official French nutritional guidelines - in secondary obesity prevention, among men.	[Assmann, Karen E.; Lassale, Camille; Galan, Pilar; Hercberg, Serge; Kesse-Guyot, Emmanuelle] Univ Paris 13, Sorbonne Paris Cite, UREN Nutr Epidemiol Res Unit, Inserm,U557,Inra,Cnam,U1125, Bobigny, France; [Hercberg, Serge] Hop Avicenne, Dept Sante Publ, F-93009 Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Assmann, KE (corresponding author), Univ Paris 13, Sorbonne Paris Cite, UREN Nutr Epidemiol Res Unit, Inserm,U557,Inra,Cnam,U1125, Bobigny, France.	k.assmann@uren.smbh.univ-paris13.fr	Kesse-Guyot, Emmanuelle/ABH-7347-2020; Pilar, Galan/F-2908-2017; HERCBERG, Serge/B-4429-2008; Lassale, Camille/ABE-7813-2020; Kesse-Guyot, Emmanuelle/K-4689-2012; Serge, Hercberg/F-3038-2017; Kesse-Guyot, Emmanuelle/F-2692-2017	Pilar, Galan/0000-0003-1706-3107; HERCBERG, Serge/0000-0002-3168-1350; Lassale, Camille/0000-0002-9340-2708; Serge, Hercberg/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Assmann, Karen/0000-0003-3618-9573	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Karen Assmann was supported by a scholarship of the German Academic Exchange Service (DAAD): a private, publicly funded, self-governing organization of higher education institutions in Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Arabshahi S, 2012, BRIT J NUTR, V107, P1376, DOI 10.1017/S0007114511004351; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Branca F., 2007, CHALLENGE OBESITY WH; Bull F C, 2004, J Sci Med Sport, V7, P93, DOI 10.1016/S1440-2440(04)80283-4; Czernichow S, 2002, INT J OBESITY, V26, P1138, DOI 10.1038/sj.ijo.0802059; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Estaquio C, 2009, J AM DIET ASSOC, V109, P1031, DOI 10.1016/j.jada.2009.03.012; FAO/WHO/UNU, 2004, HUM EN REQ REP JOINT, V1; Gao SK, 2008, AM J CLIN NUTR, V88, P64; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 2005, TABLE COMPOSITION SU; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Hofler M, 2005, SOC PSYCH PSYCH EPID, V40, P291, DOI 10.1007/s00127-005-0882-5; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Inserm-TNS Healthcare-Roche, 2009, OBEPI ROCH 2009 ENQ; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Kesse-Guyot E, 2009, AM J EPIDEMIOL, V170, P757, DOI 10.1093/aje/kwp174; Kimokoti RW, 2010, J NUTR, V140, P1287, DOI 10.3945/jn.109.120808; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Lairon D, 2005, AM J CLIN NUTR, V82, P1185, DOI 10.1093/ajcn/82.6.1185; LASFARGUES G, 1990, PRESSE MED, V19, P953; Lassale C, 2012, INT J OBESITY, V36, P1455, DOI 10.1038/ijo.2011.264; Ma YS, 2009, ANN EPIDEMIOL, V19, P553, DOI 10.1016/j.annepidem.2009.04.010; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Mennen LI, 2002, EUR J CLIN NUTR, V56, P659, DOI 10.1038/sj.ejcn.1601374; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nakade M, 2009, OBES RES CLIN PRACT, V3, P85, DOI 10.1016/j.orcp.2008.12.001; Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417; Newby PK, 2006, J NUTR, V136, P2580, DOI 10.1093/jn/136.10.2580; Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504; Nordhamn K, 2000, INT J OBESITY, V24, P652, DOI 10.1038/sj.ijo.0801216; Organization WH, 2009, GLOB HLTH RISKS MORT; Painter J, 2002, J AM DIET ASSOC, V102, P483, DOI 10.1016/S0002-8223(02)90113-6; Quatromoni PA, 2006, OBESITY, V14, P1383, DOI 10.1038/oby.2006.157; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Schulz L O, 1994, Obes Res, V2, P541; Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Shen CY, 2011, BIOMETRICAL J, V53, P822, DOI 10.1002/bimj.201100042; Timperio A, 2000, PUBLIC HEALTH NUTR, V3, P417, DOI 10.1017/S1368980000000483; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Vuillemin A, 2000, MED SCI SPORT EXER, V32, P1119, DOI 10.1097/00005768-200006000-00013; W. H. Organization and Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, P147; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X; Wolongevicz DM, 2010, J OBES, V2010, DOI 10.1155/2010/945987; Wolongevicz DM, 2010, BRIT J NUTR, V103, P1223, DOI 10.1017/S0007114509992893; Zamora D, 2010, AM J CLIN NUTR, V92, P784, DOI 10.3945/ajcn.2010.29161	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87083	10.1371/journal.pone.0087083	http://dx.doi.org/10.1371/journal.pone.0087083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516542	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700017
J	Bacon, J; Alderwick, LJ; Allnutt, JA; Gabasova, E; Watson, R; Hatch, KA; Clark, SO; Jeeves, RE; Marriott, A; Rayner, E; Tolley, H; Pearson, G; Hall, G; Besra, GS; Wernisch, L; Williams, A; Marsh, PD				Bacon, Joanna; Alderwick, Luke J.; Allnutt, Jon A.; Gabasova, Evelina; Watson, Robert; Hatch, Kim A.; Clark, Simon O.; Jeeves, Rose E.; Marriott, Alice; Rayner, Emma; Tolley, Howard; Pearson, Geoff; Hall, Graham; Besra, Gurdyal S.; Wernisch, Lorenz; Williams, Ann; Marsh, Philip D.			Non-Replicating Mycobacterium tuberculosis Elicits a Reduced Infectivity Profile with Corresponding Modifications to the Cell Wall and Extracellular Matrix	PLOS ONE			English	Article							FREE MYCOLIC ACIDS; GENE-EXPRESSION; DRUG-TOLERANT; GUINEA-PIG; MODEL; IDENTIFICATION; GROWTH; METABOLISM; ADAPTATION; INSIGHTS	A key feature of Mycobacterium tuberculosis is its ability to become dormant in the host. Little is known of the mechanisms by which these bacilli are able to persist in this state. Therefore, the focus of this study was to emulate environmental conditions encountered by M. tuberculosis in the granuloma, and determine the effect of such conditions on the physiology and infectivity of the organism. Non-replicating persistent (NRP) M. tuberculosis was established by the gradual depletion of nutrients in an oxygen-replete and controlled environment. In contrast to rapidly dividing bacilli, NRP bacteria exhibited a distinct phenotype by accumulating an extracellular matrix rich in free mycolate and lipoglycans, with increased arabinosylation. Microarray studies demonstrated a substantial down-regulation of genes involved in energy metabolism in NRP bacteria. Despite this reduction in metabolic activity, cells were still able to infect guinea pigs, but with a delay in the development of disease when compared to exponential phase bacilli. Using these approaches to investigate the interplay between the changing environment of the host and altered physiology of NRP bacteria, this study sheds new light on the conditions that are pertinent to M. tuberculosis dormancy and how this organism could be establishing latent disease.	[Bacon, Joanna; Allnutt, Jon A.; Watson, Robert; Hatch, Kim A.; Clark, Simon O.; Jeeves, Rose E.; Marriott, Alice; Rayner, Emma; Tolley, Howard; Pearson, Geoff; Hall, Graham; Williams, Ann; Marsh, Philip D.] Publ Hlth England, Microbiol Serv, Salisbury, Wilts, England; [Alderwick, Luke J.; Besra, Gurdyal S.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham, W Midlands, England; [Gabasova, Evelina; Wernisch, Lorenz] Inst Publ Hlth, MRC Biostat Unit, Cambridge, England	Public Health England; University of Birmingham; MRC Biostatistics Unit; University of Cambridge	Bacon, J (corresponding author), Publ Hlth England, Microbiol Serv, Salisbury, Wilts, England.	joanna.bacon@phe.gov.uk	Marriott, Alice/E-3658-2015; Hatch, Kent/AAF-9886-2020	Marriott, Alice/0000-0003-1464-2517; Hatch, Kent/0000-0001-9486-2207; clark, simon/0000-0003-1923-6120; Besra, Gurdyal/0000-0002-5605-0395; Bacon, Joanna/0000-0002-2217-228X; Alderwick, Luke/0000-0002-1257-6053; Watson, Robert/0000-0003-3146-3457	Biological Investigations Group at PHE, Porton Down; MRC [MC_U105260799] Funding Source: UKRI; Medical Research Council [MC_U105260799] Funding Source: researchfish	Biological Investigations Group at PHE, Porton Down; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Mark Broughton at PHE Colindale for irradiation of the culture supernatants for carbohydrate analyses and the Biological Investigations Group at PHE, Porton Down, for support on the infectivity studies. Thanks to the Bugs Microarray Users Group at St Georges, University of London for technical help with the microarray and to Susan Gray at PHE, Porton Down, for her contribution to the cell staining.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Bacon J, 2007, MICROBIOL-SGM, V153, P1435, DOI 10.1099/mic.0.2006/004317-0; Bacon Joanna, 2008, V465, P153, DOI 10.1007/978-1-59745-207-6_10; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Birch HL, 2010, P NATL ACAD SCI USA, V107, P2634, DOI 10.1073/pnas.0915082107; CANETTI G, 1965, AM REV RESPIR DIS, V92, P687; Chambers MA, 2000, INFECT IMMUN, V68, P7094, DOI 10.1128/IAI.68.12.7094-7099.2000; Clark SO, 2011, J APPL MICROBIOL, V111, P350, DOI 10.1111/j.1365-2672.2011.05069.x; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; DEMAJUMDAR S, 2012, PLOS ONE, V0007; Dhiman RK, 2011, J BACTERIOL, V193, P5802, DOI 10.1128/JB.05299-11; Dobson G., 1985, SYSTEMATIC ANAL COMP; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Golby P, 2007, MICROBIOL-SGM, V153, P3323, DOI 10.1099/mic.0.2007/009894-0; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Heard NA, 2006, J AM STAT ASSOC, V101, P18, DOI 10.1198/016214505000000187; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; IRBY RB, 1994, J BIOL CHEM, V269, P23981; Jankute M, 2012, FUTURE MICROBIOL, V7, P129, DOI [10.2217/fmb.11.123, 10.2217/FMB.11.123]; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Karlyshev AV, 2001, J CLIN MICROBIOL, V39, P279, DOI 10.1128/JCM.39.1.279-284.2001; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Lever MS, 2000, LETT APPL MICROBIOL, V31, P238, DOI 10.1046/j.1365-2672.2000.00807.x; Loebel RO, 1933, J BACTERIOL, V26, P167, DOI 10.1128/JB.26.2.167-200.1933; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Miller RM, 2008, J BACTERIOL, V190, P4038, DOI 10.1128/JB.00129-08; Mishra AK, 2012, J BIOL CHEM, V287, P44173, DOI 10.1074/jbc.M112.402396; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; ORTALOMAGNE A, 1995, MICROBIOL-UK, V141, P1609, DOI 10.1099/13500872-141-7-1609; OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; R Core Team, 2012, R LANG ENV STAT COMP; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Rasmussen Carl Edward, 2006, MACHINE LEARNING; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Shi TY, 2011, J CELL BIOCHEM, V112, P2721, DOI 10.1002/jcb.23233; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Williams A, 2000, CLIN INFECT DIS, V30, pS299, DOI 10.1086/313878; Woolhiser L, 2007, INFECT IMMUN, V75, P2621, DOI 10.1128/IAI.00918-06	65	40	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87329	10.1371/journal.pone.0087329	http://dx.doi.org/10.1371/journal.pone.0087329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516549	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700023
J	Huang, J; Li, XM; Coelho-dos-Reis, JGA; Wilson, JM; Tsuji, M				Huang, Jing; Li, Xiangming; Coelho-dos-Reis, Jordana G. A.; Wilson, James M.; Tsuji, Moriya			An AAV Vector-Mediated Gene Delivery Approach Facilitates Reconstitution of Functional Human CD8(+) T Cells in Mice	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; ADENOASSOCIATED VIRUS VECTORS; SCID IL2R-GAMMA(NULL) MICE; INTRACELLULAR TRAFFICKING; TRANSGENIC EXPRESSION; HUMAN-BLOOD; IN-VIVO; RESPONSES; ENGRAFTMENT; INFECTION	In the present study, a novel adeno-associated virus (AAV) vector-mediated gene delivery approach was taken to improve the reconstitution of functional CD8(+) T cells in humanized mice, thereby mimicking the human immune system (HIS). Human genes encoding HLA-A2 and selected human cytokines (A2/hucytokines) were introduced to an immune-deficient mouse model [NOD/SCID/IL2r gamma(null) (NSG) mice] using AAV serotype 9 (AAV9) vectors, followed by transplantation of human hematopoietic stem cells. NSG mice transduced with AAV9 encoding A2/hucytokines resulted in higher levels of reconstitution of human CD45(+) cells compared to NSG mice transduced with AAV9 encoding HLA-A2 alone or HLA-A2-transgenic NSG mice. Furthermore, this group of HIS mice also mounted the highest level of antigen-specific A2-restricted human CD8(+) T-cell response upon vaccination with recombinant adenoviruses expressing human malaria and HIV antigens. Finally, the human CD8(+) T-cell response induced in human malaria vaccine-immunized HIS mice was shown to be functional by displaying cytotoxic activity against hepatocytes that express the human malaria antigen in the context of A2 molecules. Taken together, our data show that AAV vector-mediated gene delivery is a simple and efficient method to transfer multiple human genes to immune-deficient mice, thus facilitating successful reconstitution of HIS in mice. The HIS mice generated in this study should ultimately allow us to swiftly evaluate the T-cell immunogenicity of various human vaccine candidates in a pre-clinical setting.	[Huang, Jing; Li, Xiangming; Coelho-dos-Reis, Jordana G. A.; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, New York, NY 10021 USA; [Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA USA	Rockefeller University; University of Pennsylvania	Tsuji, M (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, 1230 York Ave, New York, NY 10021 USA.	mtsuji@adarc.org	Coelho-dos-Reis, Jordana/HGU-6453-2022	Tsuji, Moriya/0000-0001-8587-277X	Gates Foundation [OPP1007283 GCE]; Mark S. Bertuch AIDS Research Fund; Otsuka Pharmaceutical Co. Ltd.	Gates Foundation(Bill & Melinda Gates Foundation); Mark S. Bertuch AIDS Research Fund; Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical)	This work was supported by a Grand Challenges Exploration grant (OPP1007283 GCE) from the Gates Foundation, the Mark S. Bertuch AIDS Research Fund, and Otsuka Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Billerbeck E, 2011, BLOOD, V117, P3076, DOI 10.1182/blood-2010-08-301507; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2012, BLOOD, V119, P2778, DOI 10.1182/blood-2011-05-353243; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Dion S, 2013, J VIROL, V87, P5554, DOI 10.1128/JVI.03134-12; Douar AM, 2001, J VIROL, V75, P1824, DOI 10.1128/JVI.75.4.1824-1833.2001; Dudek T. E., 2012, SCI TRANSL MED, V4; Flageul M, 2009, J GENE MED, V11, P689, DOI 10.1002/jgm.1343; FLOTTE TR, 1995, GENE THER, V2, P357; FUJIOKA H, 1994, CELL TRANSPLANT, V3, P397, DOI 10.1177/096368979400300506; Ghosh A, 2006, J GENE MED, V8, P298, DOI 10.1002/jgm.835; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Hansen J, 2001, J VIROL, V75, P4080, DOI 10.1128/JVI.75.9.4080-4090.2001; He LW, 2005, J IMMUNOL METHODS, V304, P43, DOI 10.1016/j.jim.2005.06.005; Hicks MJ, 2012, SCI TRANSL MED, V4; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Jerome KR, 2003, APOPTOSIS, V8, P563, DOI 10.1023/A:1026123223387; Kitchen SG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002649; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Lepus CM, 2009, HUM IMMUNOL, V70, P790, DOI 10.1016/j.humimm.2009.06.005; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Li XM, 2010, P NATL ACAD SCI USA, V107, P13010, DOI 10.1073/pnas.1006662107; Lin HP, 2007, J VIROL, V81, P11840, DOI 10.1128/JVI.01253-07; Marks-Konczalik J, 2000, P NATL ACAD SCI USA, V97, P11445, DOI 10.1073/pnas.200363097; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Matsumura B, 2003, EXP HEMATOL, V31, P789, DOI 10.1016/S0301-472X(03)00193-0; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Nelson AJ, 1996, EUR J IMMUNOL, V26, P401, DOI 10.1002/eji.1830260220; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; Paul D, 2000, CANCER GENE THER, V7, P308, DOI 10.1038/sj.cgt.7700105; Rai U, 2012, BIOMOLECULES, V2, P23, DOI 10.3390/biom2010023; Sato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042776; Shiratsuchi T, 2010, J CLIN INVEST, V120, P3688, DOI 10.1172/JCI39812; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Skaricic D, 2008, VIROLOGY, V378, P79, DOI 10.1016/j.virol.2008.04.016; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; Unger WWJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049213; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Wang LL, 2005, BLOOD, V105, P3079, DOI 10.1182/blood-2004-10-3867; Watanabe M, 2010, GENE THER, V17, P1042, DOI 10.1038/gt.2010.87; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; Wendtner CM, 2002, BLOOD, V100, P1655, DOI 10.1182/blood.V100.5.1655.h81702001655_1655_1661; Whitfield-Larry F, 2011, DIABETES, V60, P1726, DOI 10.2337/db10-1287; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zou W, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-44	65	21	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88205	10.1371/journal.pone.0088205	http://dx.doi.org/10.1371/journal.pone.0088205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516613	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700055
J	Toruno, C; Carbonneau, S; Stewart, RA; Jette, C				Toruno, Cristhian; Carbonneau, Seth; Stewart, Rodney A.; Jette, Cicely			Interdependence of Bad and Puma during Ionizing-Radiation-Induced Apoptosis	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; BCL-X-L; CELL-SURVIVAL; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL APOPTOSIS; DEPENDENT APOPTOSIS; BH3 DOMAINS; PROTEINS; PHOSPHORYLATION; AKT	Ionizing radiation (IR)-induced DNA double-strand breaks trigger an extensive cellular signaling response that involves the coordination of hundreds of proteins to regulate DNA repair, cell cycle arrest and apoptotic pathways. The cellular outcome often depends on the level of DNA damage as well as the particular cell type. Proliferating zebrafish embryonic neurons are highly sensitive to IR-induced apoptosis, and both p53 and its transcriptional target puma are essential mediators of the response. The BH3-only protein Puma has previously been reported to activate mitochondrial apoptosis through direct interaction with the pro-apoptotic Bcl-2 family proteins Bax and Bak, thus constituting the role of an "activator" BH3-only protein. This distinguishes it from BH3-only proteins like Bad that are thought to indirectly promote apoptosis through binding to anti-apoptotic Bcl-2 family members, thereby preventing the sequestration of activator BH3-only proteins and allowing them to directly interact with and activate Bax and Bak. We have shown previously that overexpression of the BH3-only protein Bad in zebrafish embryos supports normal embryonic development but greatly sensitizes developing neurons to IR-induced apoptosis. While Bad has previously been shown to play only a minor role in promoting IR-induced apoptosis of T cells in mice, we demonstrate that Bad is essential for robust IR-induced apoptosis in zebrafish embryonic neural tissue. Moreover, we found that both p53 and Puma are required for Bad-mediated radiosensitization in vivo. Our findings show the existence of a hierarchical interdependence between Bad and Puma whereby Bad functions as an essential sensitizer and Puma as an essential activator of IR-induced mitochondrial apoptosis specifically in embryonic neural tissue.	[Toruno, Cristhian; Stewart, Rodney A.; Jette, Cicely] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Carbonneau, Seth] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Carbonneau, Seth] Harvard Univ, Sch Med, Boston, MA USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Jette, C (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	Cicely.Jette@hci.utah.edu	Stewart, Rodney/ABA-6757-2020	Stewart, Rodney/0000-0003-1220-1830	Huntsman Cancer Foundation; NIH [5K01DK074555-06]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK074555] Funding Source: NIH RePORTER	Huntsman Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Huntsman Cancer Foundation and NIH grant 5K01DK074555-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chiang CW, 2003, MOL CELL BIOL, V23, P6350, DOI 10.1128/MCB.23.18.6350-6362.2003; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Eves EM, 1998, MOL CELL BIOL, V18, P2143, DOI 10.1128/MCB.18.4.2143; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Houslay M.D., 2006, SCI STKE, V2006, ppe32; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jette CA, 2008, CELL DEATH DIFFER, V15, P1063, DOI 10.1038/cdd.2008.42; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kratz E, 2006, CELL DEATH DIFFER, V13, P1631, DOI 10.1038/sj.cdd.4402016; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Ottilie S, 1997, J BIOL CHEM, V272, P30866, DOI 10.1074/jbc.272.49.30866; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Salomoni P, 2000, BLOOD, V96, P676; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sorrells S, 2013, J VIS EXP IN PRESS; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Westerfield M, 1993, ZEBRAFISH BOOK; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101	43	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88151	10.1371/journal.pone.0088151	http://dx.doi.org/10.1371/journal.pone.0088151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516599	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700048
J	Ghazanfari, N; Morsch, M; Tse, N; Reddel, SW; Phillips, WD				Ghazanfari, Nazanin; Morsch, Marco; Tse, Nigel; Reddel, Stephen W.; Phillips, William D.			Effects of the beta 2-Adrenoceptor Agonist, Albuterol, in a Mouse Model of Anti-MuSK Myasthenia Gravis	PLOS ONE			English	Article							PLATE ACETYLCHOLINESTERASE DEFICIENCY; TYROSINE KINASE MUSK; NEUROMUSCULAR-TRANSMISSION; POSITIVE MG; AUTOANTIBODIES; ANTIBODIES; IMMUNIZATION; STIMULATION; DYSFUNCTION; SENSITIVITY	The beta 2-adrenergic receptor agonist, albuterol, has been reported beneficial in treating several forms of congenital myasthenia. Here, for the first time, we examined the potential benefit of albuterol in a mouse model of anti-Muscle Specific Kinase (MuSK) myasthenia gravis. Mice received 15 daily injections of IgG from anti-MuSK positive patients, which resulted in whole-body weakness. At neuromuscular junctions in the tibialis anterior and diaphragm muscles the autoantibodies caused loss of postsynaptic acetylcholine receptors, and reduced the amplitudes of the endplate potential and spontaneous miniature endplate potential in the diaphragm muscle. Treatment with albuterol (8 mg/kg/day) during the two-week anti-MuSK injection series reduced the degree of weakness and weight loss, compared to vehicle-treated mice. However, the compound muscle action potential recorded from the gastrocnemius muscle displayed a decremental response in anti-MuSK-injected mice whether treated with albuterol or vehicle. Ongoing albuterol treatment did not increase endplate potential amplitudes compared to vehicle-treated mice nor did it prevent the loss of acetylcholine receptors from motor endplates. On the other hand, albuterol treatment significantly reduced the degree of fragmentation of endplate acetylcholine receptor clusters and increased the extent to which the remaining receptor clusters were covered by synaptophysin-stained nerve terminals. The results provide the first evidence that short-term albuterol treatment can ameliorate weakness in a robust mouse model of anti-MuSK myasthenia gravis. The results also demonstrate that it is possible for albuterol treatment to reduce whole-body weakness without necessarily reversing myasthenic impairment to the structure and function of the neuromuscular junction.	[Ghazanfari, Nazanin; Morsch, Marco; Tse, Nigel; Phillips, William D.] Univ Sydney, Sydney, NSW 2006, Australia; [Ghazanfari, Nazanin; Morsch, Marco; Tse, Nigel; Phillips, William D.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Reddel, Stephen W.] Concord Hosp, Dept Mol Med, Concord, NSW, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital	Phillips, WD (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	william.phillips@sydney.edu.au		Morsch, Marco/0000-0001-9484-8050; Tse, Nigel/0000-0003-4472-7853; Phillips, William/0000-0002-5405-8422	Australian National Health and Medical Research Council [570930]; Brain Foundation; Beeren Foundation; Australian Myasthenic Association in New South Wales	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Brain Foundation; Beeren Foundation; Australian Myasthenic Association in New South Wales	The work presented was supported by a project grant from the Australian National Health and Medical Research Council (http://www.nhmrc.gov.au/; number 570930 to W. D. P & S. W. R.) and by the Brain Foundation, the Beeren Foundation and the Australian Myasthenic Association in New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson DC, 2012, J PHYSIOL-LONDON, V590, P6381, DOI 10.1113/jphysiol.2012.237925; Bergamin E, 2010, MOL CELL, V39, P100, DOI 10.1016/j.molcel.2010.06.007; Bestue-Cardiel M, 2005, NEUROLOGY, V65, P144, DOI 10.1212/01.wnl.0000167132.35865.31; Burke G, 2013, NEUROMUSCULAR DISORD, V23, P170, DOI 10.1016/j.nmd.2012.11.004; CAIRNS SP, 1993, BRIT J PHARMACOL, V110, P1133, DOI 10.1111/j.1476-5381.1993.tb13932.x; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Chan SHS, 2012, PEDIATR NEUROL, V47, P137, DOI 10.1016/j.pediatrneurol.2012.04.022; Choi KR, 2012, J CELL SCI, V125, P714, DOI 10.1242/jcs.092361; Cole RN, 2010, J PHYSIOL-LONDON, V588, P3217, DOI 10.1113/jphysiol.2010.190298; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Diaz-Manera J, 2012, NEUROLOGY, V78, P189, DOI 10.1212/WNL.0b013e3182407982; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Ghazanfari N, 2011, INT J BIOCHEM CELL B, V43, P295, DOI 10.1016/j.biocel.2010.10.008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; GOLDSCHMIDT PL, 1984, PHARMACOL BIOCHEM BE, V21, P177, DOI 10.1016/0091-3057(84)90210-7; Guptill JT, 2011, MUSCLE NERVE, V44, P36, DOI 10.1002/mus.22006; HARRIS JB, 1979, J PHYSIOL-LONDON, V296, P245, DOI 10.1113/jphysiol.1979.sp013003; Hatanaka Y, 2005, NEUROLOGY, V65, P1508, DOI 10.1212/01.wnl.0000183145.91579.74; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Joassard OR, 2013, INT J BIOCHEM CELL B, V45, P2309, DOI 10.1016/j.biocel.2013.06.025; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Klooster R, 2012, BRAIN, V135, P1081, DOI 10.1093/brain/aws025; Koneczny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080695; Koopman R, 2010, J PHYSIOL-LONDON, V588, P4811, DOI 10.1113/jphysiol.2010.196725; Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf; Liewluck T, 2011, MUSCLE NERVE, V44, P789, DOI 10.1002/mus.22176; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; Mori S, 2012, J NEUROIMMUNOL, V244, P1, DOI 10.1016/j.jneuroim.2011.12.005; Mori S, 2012, AM J PATHOL, V180, P798, DOI 10.1016/j.ajpath.2011.10.031; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Morsch M, 2012, EXP NEUROL, V237, P286, DOI 10.1016/j.expneurol.2012.06.034; ODONNELL JM, 1993, PSYCHOPHARMACOLOGY, V113, P243, DOI 10.1007/BF02245705; Ohta K, 2007, EUR J NEUROL, V14, P1029, DOI 10.1111/j.1468-1331.2007.01870.x; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P453, DOI 10.1001/archneurol.2011.2200; Richman DP, 2003, NEUROLOGY, V61, P1652, DOI 10.1212/01.WNL.0000098887.24618.A0; Riminton DS, 2011, CURR OPIN NEUROL, V24, P217, DOI 10.1097/WCO.0b013e328346d47d; Roatta S, 2013, J PHYSL, V590, P6381; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Sadeh M, 2011, MUSCLE NERVE, V44, P289, DOI 10.1002/mus.22153; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; Sartori C, 2002, J APPL PHYSIOL, V93, P1875, DOI 10.1152/japplphysiol.00275.2002; Schara U, 2009, NEUROMUSCULAR DISORD, V19, P828, DOI 10.1016/j.nmd.2009.09.008; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Stacy S, 2002, J IMMUNOL, V169, P6570, DOI 10.4049/jimmunol.169.11.6570; ter Beek WP, 2009, AM J PATHOL, V175, P1536, DOI 10.2353/ajpath.2009.090040; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Viegas S, 2012, EXP NEUROL, V234, P506, DOI 10.1016/j.expneurol.2012.01.025; WALKER MB, 1973, BRIT MED J, V2, P42, DOI 10.1136/bmj.2.5857.42; Webster RG, 2013, EXP NEUROL, V248, P286, DOI 10.1016/j.expneurol.2013.06.012; Westfall TC, 2012, GOODMAN GILMANS PHAR, V12th, P310; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	64	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87840	10.1371/journal.pone.0087840	http://dx.doi.org/10.1371/journal.pone.0087840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505322	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200078
J	Hachemi, M; Couturier, O; Vervueren, L; Fosse, P; Lacoeuille, F; Urban, T; Hureaux, J				Hachemi, Mammar; Couturier, Olivier; Vervueren, Laurent; Fosse, Pacome; Lacoeuille, Franck; Urban, Thierry; Hureaux, Jose			[F-18]FDG Positron Emission Tomography within Two Weeks of Starting Erlotinib Therapy Can Predict Response in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; 2ND-LINE TREATMENT; F-18-FDG PET/CT; OPEN-LABEL; FDG-PET; CHEMOTHERAPY; NSCLC; MULTICENTER; FLARE; RESPONSIVENESS	Purpose: The aim of this prospective study was to evaluate whether [F-18]FDG-PET/CT, performed within two weeks of starting erlotinib therapy can predict tumor response defined by RECIST 1.1 criteria after 8 weeks of treatment in patients with inoperable (stage IIIA to IV) non-small cell lung cancer patients. Patients and Methods: Three [18 F] FDG-PET/CT scans were acquired in 12 patients before (5 +/- 4 days) and after 9 +/- 3 days (early PET) and 60 +/- 6 days (late PET) of erlotinib therapy. Conventional evaluation, including at least chest CT (baseline versus after 8 weeks of treatment), was performed according to RECIST 1.1 criteria. Change in [F-18]FDG uptake was compared with conventional response, progression-free survival (PFS), and overall survival (OS). Results: By using ROC analysis, the Area Under the Curve for prediction of metabolic non-progressive disease (mNP) by early PET was 0.86 (95% CI, 0.62 to 1.1; P = 0.04) at a cut-off of 21.6% reduction in maximum Standardized Uptake Value (SUVmax). This correctly classified 11/12 patients (7 with true progressive disease; 4 with true non-progressive disease; 1 with false progressive disease). Non-progressive disease after 8 weeks of treatment according to RECIST 1.1 criteria was significantly more frequent in patients classified mNP (P = 0.01, Fisher's exact test). mNP patients showed prolonged PFS (HR = 0.27; 95% CI, 0.04 to 0.59; P<0.01) and OS (HR = 0.34; 95% CI, 0.06 to 0.84; P = 0.03). Late PET analysis provided concordant results. Conclusion: Morphologic response, PFS and OS survival in non-small cell lung cancer patients can be predicted by [F-18]FDG-PET/CT scan within 2 weeks after starting erlotinib therapy.	[Hachemi, Mammar; Couturier, Olivier; Vervueren, Laurent; Fosse, Pacome; Lacoeuille, Franck; Urban, Thierry; Hureaux, Jose] LUNAM Univ, F-49000 Angers, France; [Hachemi, Mammar; Couturier, Olivier; Vervueren, Laurent; Fosse, Pacome; Lacoeuille, Franck] Univ Angers, Pole Radiol, Nucl Med Serv, CHU Angers, Angers, France; [Couturier, Olivier; Lacoeuille, Franck; Urban, Thierry; Hureaux, Jose] INSERM, UMR Micro & Nanomed Biomimet S 1066, Angers, France; [Urban, Thierry; Hureaux, Jose] Univ Angers, Pole Specialites Med & Chirurg Integrees, CHU Angers, Dept Pneumol, Angers, France; [Urban, Thierry; Hureaux, Jose] Univ Angers, Equipe Pyver, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Hureaux, J (corresponding author), LUNAM Univ, F-49000 Angers, France.	JoHureaux@chu-angers.fr	LACOEUILLE, Franck/K-4430-2015; URBAN, Thierry/K-6093-2015; HUREAUX, Jose/K-4268-2015; Couturier, Olivier F/L-6635-2015	LACOEUILLE, Franck/0000-0002-7070-7664; HUREAUX, Jose/0000-0002-3941-3860; couturier, olivier-francois/0000-0002-4900-7807				ALBERTI W, 1995, BRIT MED J, V311, P899; Aukema TS, 2010, J NUCL MED, V51, P1344, DOI 10.2967/jnumed.110.076224; Benz MR, 2011, J NUCL MED, V52, P1684, DOI 10.2967/jnumed.111.095257; Berghmans T, 2008, J THORAC ONCOL, V3, P6, DOI 10.1097/JTO.0b013e31815e6d6b; Biersack HJ, 2004, EUR J NUCL MED MOL I, V31, pS112, DOI 10.1007/s00259-004-1533-x; Bjurberg M, 2009, CANCER BIOTHER RADIO, V24, P327, DOI 10.1089/cbr.2008.0556; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Dinan MA, 2012, J CLIN ONCOL, V30, P2725, DOI 10.1200/JCO.2011.40.4392; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fischer BMB, 2001, LANCET ONCOL, V2, P659, DOI 10.1016/S1470-2045(01)00555-1; Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kahraman D, 2011, J NUCL MED, V52, P1871, DOI 10.2967/jnumed.111.094458; Kobe C, 2012, EUR J NUCL MED MOL I, V39, P1117, DOI 10.1007/s00259-012-2118-8; Krupitskaya Y, 2009, J THORAC ONCOL, V4, P429, DOI 10.1097/JTO.0b013e3181989e12; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Lind JSW, 2010, J THORAC ONCOL, V5, P554, DOI 10.1097/JTO.0b013e3181d3e47e; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Messiou C, 2011, ACTA RADIOL, V52, P557, DOI 10.1258/ar.2011.100342; Mileshkin L, 2011, CLIN CANCER RES, V17, P3304, DOI 10.1158/1078-0432.CCR-10-2763; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mortimer JE, 2001, J CLIN ONCOL, V19, P2797, DOI 10.1200/JCO.2001.19.11.2797; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Stroobants S, 2003, EUR J CANCER, V39, P2012, DOI 10.1016/S0959-8049(03)00073-X; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Ullrich RT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003908; Van den Abbeele AD, 2008, ONCOLOGIST, V13, P8, DOI 10.1634/theoncologist.13-S2-8; Vansteenkiste JF, 1999, J CLIN ONCOL, V17, P3201, DOI 10.1200/JCO.1999.17.10.3201; Velazquez ER, 2010, ACTA ONCOL, V49, P1033, DOI 10.3109/0284186X.2010.498441; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939	37	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87629	10.1371/journal.pone.0087629	http://dx.doi.org/10.1371/journal.pone.0087629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505298	Green Published, gold			2022-12-27	WOS:000330829200057
J	Hagglof, C; Hammarsten, P; Stromvall, K; Egevad, L; Josefsson, A; Stattin, P; Granfors, T; Bergh, A				Hagglof, Christina; Hammarsten, Peter; Stromvall, Kerstin; Egevad, Lars; Josefsson, Andreas; Stattin, Par; Granfors, Torvald; Bergh, Anders			TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; ERG EXPRESSION; GLEASON SCORE; GENE FUSIONS; TUMOR-GROWTH; REARRANGEMENT; FIBROBLASTS; PROGRESSION; RECEPTOR; SUBTYPE	The TMPRSS2-ERG gene fusion is found in approximately half of all prostate cancers. The functional and prognostic significance of TMPRSS2-ERG is, however, not fully understood. Based on a historical watchful waiting cohort, an association between TMPRSS2-ERG, evaluated as positive immune staining, and shorter survival of prostate cancer patients was identified. Expression of ERG was also associated with clinical markers such as advanced tumor stage, high Gleason score, presence of metastasis and prognostic tumor cell markers such as high Ki67, pEGFR and pAkt. Novel associations between TMPRSS2-ERG and alterations in the tumor stroma, for example, increased vascular density, hyaluronan and PDGFR beta and decreased Caveolin-1, all known to be associated with an aggressive disease, were found. The present study suggests that the TMPRSS2-ERG fusion gene is associated with a more aggressive prostate cancer phenotype, supported by changes in the tumor stroma.	[Hagglof, Christina; Hammarsten, Peter; Stromvall, Kerstin; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden; [Egevad, Lars] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Josefsson, Andreas] Univ Gothenburg, Dept Urol, Gothenburg, Sweden; [Stattin, Par] Umea Univ, Dept Surg, Umea, Sweden; [Stattin, Par] Umea Univ, Dept Perioperat Sci, Umea, Sweden; [Granfors, Torvald] Vasteras Hosp, Dept Urol, Vasteras, Sweden	Umea University; Karolinska Institutet; University of Gothenburg; Umea University; Umea University; Vasteras Central Hospital	Hagglof, C (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	christina.hagglof@medbio.umu.se	Josefsson, Andreas/T-2311-2019	Josefsson, Andreas/0000-0002-2013-0887; Egevad, Lars/0000-0001-8531-222X	Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	The Swedish Research Council and the Swedish Cancer Society supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Demichelis F, 2007, ONCOGENE, V26, P4596, DOI 10.1038/sj.onc.1210237; Egevad L, 2002, BJU INT, V89, P538, DOI 10.1046/j.1464-410X.2002.02669.x; Furusato B, 2010, PROSTATE CANCER P D, V13, P228, DOI 10.1038/pcan.2010.23; Hagglof C, 2012, SROMA KEY REGULATOR, P531; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ishii K, 2011, J CELL BIOCHEM, V112, P3604, DOI 10.1002/jcb.23291; Johansson A, 2010, AM J PATHOL, V177, P1031, DOI 10.2353/ajpath.2010.100070; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Josefsson A, 2011, AM J PATHOL, V179, P1961, DOI 10.1016/j.ajpath.2011.06.005; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Klezovitch O, 2008, P NATL ACAD SCI USA, V105, P2105, DOI 10.1073/pnas.0711711105; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Mehra R, 2007, CANCER RES, V67, P7991, DOI 10.1158/0008-5472.CAN-07-2043; Miettinen M, 2011, AM J SURG PATHOL, V35, P432, DOI 10.1097/PAS.0b013e318206b67b; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Ostman A, 2012, NAT MED, V18, P1332, DOI 10.1038/nm.2938; Park K, 2010, NEOPLASIA, V12, P590, DOI 10.1593/neo.10726; Perner S, 2010, UROLOGY, V75, P762, DOI 10.1016/j.urology.2009.10.010; Pettersson A, 2012, CANCER EPIDEM BIOMAR, V21, P1497, DOI 10.1158/1055-9965.EPI-12-0042; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Sakai I, 2005, BJU INT, V96, P528, DOI 10.1111/j.1464-410X.2005.05678.x; Schoenborn JR, 2013, CLIN CANCER RES, V19, P4058, DOI 10.1158/1078-0432.CCR-12-3606; St John Jason, 2012, J Cancer Sci Ther, V4, P94; Tchou J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-39; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x; van Leenders GJLH, 2011, MODERN PATHOL, V24, P1128, DOI 10.1038/modpathol.2011.65; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927	37	81	83	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86824	10.1371/journal.pone.0086824	http://dx.doi.org/10.1371/journal.pone.0086824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505269	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200028
J	Jeukens, J; Boyle, B; Kukavica-Ibrulj, I; Ouellet, MM; Aaron, SD; Charette, SJ; Fothergill, JL; Tucker, NP; Winstanley, C; Levesque, RC				Jeukens, Julie; Boyle, Brian; Kukavica-Ibrulj, Irena; Ouellet, Myriam M.; Aaron, Shawn D.; Charette, Steve J.; Fothergill, Joanne L.; Tucker, Nicholas P.; Winstanley, Craig; Levesque, Roger C.			Comparative Genomics of Isolates of a Pseudomonas aeruginosa Epidemic Strain Associated with Chronic Lung Infections of Cystic Fibrosis Patients	PLOS ONE			English	Article							TRANSMISSIBLE STRAINS; ENHANCED VIRULENCE; ADAPTATION; RESISTANCE; SEQUENCE; PHENOTYPES; DIVERSITY; BACTERIA; PAO1; TOOL	Pseudomonas aeruginosa is the main cause of fatal chronic lung infections among individuals suffering from cystic fibrosis (CF). During the past 15 years, particularly aggressive strains transmitted among CF patients have been identified, initially in Europe and more recently in Canada. The aim of this study was to generate high-quality genome sequences for 7 isolates of the Liverpool epidemic strain (LES) from the United Kingdom and Canada representing different virulence characteristics in order to: (1) associate comparative genomics results with virulence factor variability and (2) identify genomic and/or phenotypic divergence between the two geographical locations. We performed phenotypic characterization of pyoverdine, pyocyanin, motility, biofilm formation, and proteolytic activity. We also assessed the degree of virulence using the Dictyostelium discoideum amoeba model. Comparative genomics analysis revealed at least one large deletion (40-50 kb) in 6 out of the 7 isolates compared to the reference genome of LESB58. These deletions correspond to prophages, which are known to increase the competitiveness of LESB58 in chronic lung infection. We also identified 308 non-synonymous polymorphisms, of which 28 were associated with virulence determinants and 52 with regulatory proteins. At the phenotypic level, isolates showed extensive variability in production of pyocyanin, pyoverdine, proteases and biofilm as well as in swimming motility, while being predominantly avirulent in the amoeba model. Isolates from the two continents were phylogenetically and phenotypically undistinguishable. Most regulatory mutations were isolate-specific and 29% of them were predicted to have high functional impact. Therefore, polymorphism in regulatory genes is likely to be an important basis for phenotypic diversity among LES isolates, which in turn might contribute to this strain's adaptability to varying conditions in the CF lung.	[Jeukens, Julie; Boyle, Brian; Kukavica-Ibrulj, Irena; Ouellet, Myriam M.; Charette, Steve J.; Levesque, Roger C.] Univ Laval, Inst Integrat & Syst Biol IBIS, Quebec City, PQ, Canada; [Ouellet, Myriam M.; Charette, Steve J.] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Aaron, Shawn D.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Fothergill, Joanne L.; Winstanley, Craig] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Tucker, Nicholas P.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	Laval University; Laval University; University of Ottawa; Ottawa Hospital Research Institute; University of Liverpool; University of Strathclyde	Jeukens, J (corresponding author), Univ Laval, Inst Integrat & Syst Biol IBIS, Quebec City, PQ, Canada.	julie.jeukens.1@ulaval.ca	Levesque, Roger C./ABD-8407-2021; Fothergill, Joanne L/B-8284-2011; Charette, Steve/GYJ-3058-2022	Fothergill, Joanne L/0000-0002-7012-1508; Tucker, Nicholas/0000-0002-6331-3704; Aaron, Shawn/0000-0002-4762-3542; Levesque, Roger/0000-0001-8315-5937; Winstanley, Craig/0000-0002-2662-8053	Quebec respiratory health training program; Cystic fibrosis Canada; Chaire de Pneumologie de la Fondation J.-D. Begin de l'Universite Laval; Fonds Alphonse L'Esperance de la Fondation de l'IUCPQ; Leverhulme Trust Early Career Fellowship; Society of General Microbiology; Strathclyde Institute of Pharmacy and Biomedical Science; Scottish Universities Life Science Alliance; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research	Quebec respiratory health training program; Cystic fibrosis Canada; Chaire de Pneumologie de la Fondation J.-D. Begin de l'Universite Laval; Fonds Alphonse L'Esperance de la Fondation de l'IUCPQ; Leverhulme Trust Early Career Fellowship(Leverhulme Trust); Society of General Microbiology; Strathclyde Institute of Pharmacy and Biomedical Science; Scottish Universities Life Science Alliance; Respiratory Health Network of the FRQS; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	J. Jeukens was supported by fellowships from the Quebec respiratory health training program (http://rsr.chus.qc.ca) and Cystic fibrosis Canada (http://www.cysticfibrosis.ca). The laboratory of S.J. Charette is funded by the Chaire de Pneumologie de la Fondation J.-D. Begin de l'Universite Laval (www.ulaval.ca) and the Fonds Alphonse L'Esperance de la Fondation de l'IUCPQ (http://www.fondation-iucpq.org/). J.L. Fothergill is supported by a Leverhulme Trust Early Career Fellowship (http://leverhulme.ac.uk/). N.P. Tucker is funded by a President's Fund grant from the Society of General Microbiology (http://www.sgm.ac.uk) as well as a Starter grant from Strathclyde Institute of Pharmacy and Biomedical Science (www.strath.ac.uk) and received a Research Exchange grant from the Scottish Universities Life Science Alliance(http://www.sulsa.ac.uk/). The laboratory of R.C. Levesque is funded by Cystic Fibrosis Canada (http://www.cysticfibrosis.ca), the Respiratory Health Network of the FRQS (http://rsr.chus.qc.ca) and the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashish A, 2012, J CYST FIBROS, V11, P173, DOI 10.1016/j.jcf.2011.11.004; Bezuidt OKI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-416; Boyle B, 2012, J BACTERIOL, V194, P529, DOI 10.1128/JB.06246-11; Bradbury RS, 2011, MICROBIOL IMMUNOL, V55, P224, DOI 10.1111/j.1348-0421.2011.00314.x; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; Carter MEK, 2010, J INFECT DIS, V202, P935, DOI 10.1086/655781; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Cosson P, 2002, J BACTERIOL, V184, P3027, DOI 10.1128/JB.184.11.3027-3033.2002; Cramer N, 2011, ENVIRON MICROBIOL, V13, P1690, DOI 10.1111/j.1462-2920.2011.02483.x; Dettman JR, 2013, P NATL ACAD SCI; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Filion G, 2013, METHODS PSE IN PRESS; Fothergill JL, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-45; Fothergill JL, 2012, EUR RESPIR J, V40, P227, DOI 10.1183/09031936.00204411; Fothergill JL, 2011, ANTIMICROB AGENTS CH, V55, P426, DOI 10.1128/AAC.01257-10; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Froquet R, 2009, NAT PROTOC, V4, P25, DOI 10.1038/nprot.2008.212; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Hart CA, 2002, BRIT MED BULL, V61, P81, DOI 10.1093/bmb/61.1.81; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hurt RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041295; Jeukens J, 2013, GENOME, V1, DOI DOI 10.1128/GENOMEA.00568-13.; Jeukens J, 2013, METHODS PSE IN PRESS; Kassen R, 2009, ANN NY ACAD SCI, V1168, P3, DOI 10.1111/j.1749-6632.2009.04574.x; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Laux DC, 2002, MICROBIOL-SGM, V148, P1709, DOI 10.1099/00221287-148-6-1709; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; RITCHINGS BW, 1995, INFECT IMMUN, V63, P4868, DOI 10.1128/IAI.63.12.4868-4876.1995; Sage AE, 1996, J BACTERIOL, V178, P6064, DOI 10.1128/jb.178.20.6064-6066.1996; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Shea April, 2012, Methods Mol Biol, V881, P331, DOI 10.1007/978-1-61779-827-6_12; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; TOTTEN PA, 1990, J BACTERIOL, V172, P389, DOI 10.1128/JB.172.1.389-396.1990; Tummler B, 2006, PSEUDOMONAS, VOL 4: MOLECULAR BIOLOGY OF EMERGING ISSUES, P35; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Workentine M, 2011, AM J RESP CRIT CARE, V183, P1581, DOI 10.1164/rccm.201105-0776ED; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	56	65	66	13	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87611	10.1371/journal.pone.0087611	http://dx.doi.org/10.1371/journal.pone.0087611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505294	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000330829200053
J	Liu, JX; Bousema, T; Zelman, B; Gesase, S; Hashim, R; Maxwell, C; Chandramohan, D; Gosling, R				Liu, Jenny X.; Bousema, Teun; Zelman, Brittany; Gesase, Samwel; Hashim, Ramadhan; Maxwell, Caroline; Chandramohan, Daniel; Gosling, Roly			Is Housing Quality Associated with Malaria Incidence among Young Children and Mosquito Vector Numbers? Evidence from Korogwe, Tanzania	PLOS ONE			English	Article							RISK-FACTORS; TRANSMISSION; INFECTION; DECLINE; BURDEN; ENTRY; COAST; AREA	Background: Several studies conducted in Northeast Tanzania have documented declines in malaria transmission even before interventions were scaled up. One explanation for these reductions may be the changes in socio-environmental conditions associated with economic development, and in particular improvements in housing construction. Objective: This analysis seeks to identify (1) risk factors for malaria incidence among young children and (2) household and environmental factors associated with mosquito vector numbers collected in the child's sleeping area. Both analyses focus on housing construction quality as a key determinant. Methodology: For 435 children enrolled in a larger trial of intermittent preventive treatment for malaria in infants in the Korogwe District in Tanga, Northeastern Tanzania, detailed information on their dwelling characteristics were collected in the last year of the trial. Principal components analysis was used to construct an index of housing structure quality and converted to quintile units for regression analysis. Univariate and multivariate random effects negative binomial regressions were used to predict risk factors for child malaria incidence and the mean total number of indoor female Anopheles gambiae and funestus mosquitoes collected per household across three occasions. Findings: Building materials have substantially improved in Korogwe over time. Multivariate regressions showed that residing in rural areas (versus urban) increased malaria incidence rates by over three-fold and mean indoor female A. gambiae and funestus numbers by nearly two-fold. Compared to those residing in the lowest quality houses, children residing in the highest quality houses had one-third lower malaria incidence rates, even when wealth and rural residence were controlled for. Living in the highest quality houses reduced vector numbers while having cattle near the house significantly increased them. Conclusions: Results corroborate findings from other studies that show associations between malaria incidence and housing quality; associations were concentrated amongst the highest quality houses.	[Liu, Jenny X.; Zelman, Brittany; Gosling, Roly] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Bousema, Teun; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Gesase, Samwel] Natl Inst Med Res, Tanga Res Ctr, Tanga, Tanzania; [Hashim, Ramadhan] Natl Inst Med Res, Mwanza Intervent Trial Unit Ctr, Mwanza, Tanzania; [Maxwell, Caroline] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Gosling, Roly] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; National Institute of Medical Research; National Institute of Medical Research; Liverpool School of Tropical Medicine; University of Liverpool; University of California System; University of California San Francisco	Liu, JX (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	liuj@globalhealth.ucsf.edu	Bousema, Teun/N-3574-2014	Bousema, Teun/0000-0003-2666-094X	Bill and Melinda Gates Foundation [OPP1013170]; Gates Grand Challenges Exploration Grant [51991]; Netherlands Organization for Scientific Research (NWO) [825.08.025]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gates Grand Challenges Exploration Grant; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The IPTi Consortium and the Gates Malaria Partnership, both of which are supported by the Bill and Melinda Gates Foundation. T.B. is supported by a Gates Grand Challenges Exploration Grant (#51991) and a Rubicon fellowship from the Netherlands Organization for Scientific Research (NWO; Rubicon 825.08.025). JL, BZ, and RG are supported by the Bill and Melinda Gates Foundation grant for the Malaria Elimination Initiative (OPP1013170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, MALARIA J, V10, P24; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Coleman M, 2010, T ROY SOC TROP MED H, V104, P143, DOI 10.1016/j.trstmh.2009.07.010; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Gosling RD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-132; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; Lwetoijera DW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-57; Massebo F, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-319; Mboera LEG, 1998, AM J TROP MED HYG, V59, P595, DOI 10.4269/ajtmh.1998.59.595; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mubyazi GM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-51; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Ogoma SB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000773; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sturrock HJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063830; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; Wolff CG, 2001, BRIT MED J, V322, P1209, DOI 10.1136/bmj.322.7296.1209; Ye Y, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-8	33	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87358	10.1371/journal.pone.0087358	http://dx.doi.org/10.1371/journal.pone.0087358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505285	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330829200044
J	Evers, E; de Vries, H; Spruijt, BM; Sterck, EHM				Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.			The EMO-Model: An Agent-Based Model of Primate Social Behavior Regulated by Two Emotional Dimensions, Anxiety-FEAR and Satisfaction-LIKE	PLOS ONE			English	Article							MONKEYS MACACA-FASCICULARIS; SELF-DIRECTED BEHAVIOR; WILD JAPANESE MACAQUES; POST-CONFLICT ANXIETY; RELATIONSHIP QUALITY; DOMINANCE RELATIONS; RHESUS-MONKEYS; LONG-TERM; DISPLACEMENT ACTIVITIES; PARTNER CHOICE	Agent-based models provide a promising tool to investigate the relationship between individuals' behavior and emerging group-level patterns. An individual's behavior may be regulated by its emotional state and its interaction history with specific individuals. Emotional bookkeeping is a candidate mechanism to keep track of received benefits from specific individuals without requiring high cognitive abilities. However, how this mechanism may work is difficult to study in real animals, due to the complexity of primate social life. To explore this theoretically, we introduce an agent-based model, dubbed EMO-model, in which we implemented emotional bookkeeping. In this model the social behaviors of primate-like individuals are regulated by emotional processes along two dimensions. An individual's emotional state is described by an aversive and a pleasant dimension (anxiety and satisfaction) and by its activating quality (arousal). Social behaviors affect the individuals' emotional state. To implement emotional bookkeeping, the receiver of grooming assigns an accumulated affiliative attitude (LIKE) to the groomer. Fixed partner-specific agonistic attitudes (FEAR) reflect the stable dominance relations between group members. While the emotional state affects an individual's general probability of executing certain behaviors, LIKE and FEAR affect the individual's partner-specific behavioral probabilities. In this way, emotional processes regulate both spontaneous behaviors and appropriate responses to received behaviors, while emotional bookkeeping via LIKE attitudes regulates the development and maintenance of affiliative relations. Using an array of empirical data, the model processes were substantiated and the emerging model patterns were partially validated. The EMO-model offers a framework to investigate the emotional bookkeeping hypothesis theoretically and pinpoints gaps that need to be investigated empirically.	[Evers, Ellen; de Vries, Han; Spruijt, Berry M.; Sterck, Elisabeth H. M.] Univ Utrecht, Utrecht, Netherlands; [Sterck, Elisabeth H. M.] Biomed Primate Res Ctr, Rijswijk, Netherlands	Utrecht University	Evers, E (corresponding author), Univ Utrecht, Utrecht, Netherlands.	E.Evers1@uu.nl	de Vries, Han/B-9359-2011; Sterck, Elisabeth/C-1063-2011	Sterck, Elisabeth/0000-0003-1101-6027	NWO Cognition and Behaviour program [864.05.009]	NWO Cognition and Behaviour program	This work was funded by the NWO Cognition and Behaviour program, grant number 864.05.009 (http://www.nwo.nl/projecten.nsf/pages/2300129002_Eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshan A, 2011, AM J PRIMATOL, V73, P1107, DOI 10.1002/ajp.20987; ANGST W, 1974, AUSDRUCKSVERHALTEN J; APA, 2000, DIAGN STAT MAN MENT; Aureli F, 1997, AGGRESSIVE BEHAV, V23, P315, DOI 10.1002/(SICI)1098-2337(1997)23:5<315::AID-AB2>3.0.CO;2-H; Aureli F, 2002, BEHAVIOUR, V139, P393, DOI 10.1163/156853902760102726; AURELI F, 1991, ETHOLOGY, V89, P89; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Aureli Filippo, 2003, P289; Aureli Filippo, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P38; Aureli Filippo, 2000, P199; Barrett LF, 1998, COGNITION EMOTION, V12, P579, DOI 10.1080/026999398379574; Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Beisner BA, 2009, ANIM BEHAV, V78, P1269, DOI 10.1016/j.anbehav.2009.09.004; Bergstrom ML, 2010, BEHAVIOUR, V147, P899, DOI 10.1163/000579510X497283; Berman CM, 2008, BEHAVIOUR, V145, P863, DOI 10.1163/156853908784089252; Berman CM, 2004, INT J PRIMATOL, V25, P1283, DOI 10.1023/B:IJOP.0000043963.77801.c3; BERNSTEIN IRWIN S., 1963, ANIMAL BEHAVIOUR, V11, P455, DOI 10.1016/0003-3472(63)90260-4; BERNSTEIN IS, 1969, ANIM BEHAV, V17, P452, DOI 10.1016/0003-3472(69)90146-8; Berridge KC, 2003, COGNITION EMOTION, V17, P181, DOI 10.1080/02699930302289; BOCCIA ML, 1989, PHYSIOL BEHAV, V45, P667, DOI 10.1016/0031-9384(89)90089-9; BOEKHORST IJA, 1994, BEHAVIOUR, V130, P229; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; BRAMBLETT CA, 1982, AM J PRIMATOL, V2, P43, DOI 10.1002/ajp.1350020107; Bryson JJ, 2007, PHILOS T R SOC B, V362, P1685, DOI 10.1098/rstb.2007.2061; Butovskaya M, 1995, FOLIA PRIMATOL, V65, P30, DOI 10.1159/000156865; Butovskaya M.L., 1994, Human Evolution, V9, P11, DOI 10.1007/BF02438136; BUZAS MA, 1969, SCIENCE, V163, P72, DOI 10.1126/science.163.3862.72; Carne C, 2011, AM J PRIMATOL, V73, P1127, DOI 10.1002/ajp.20979; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Castles DL, 1999, ANIM BEHAV, V58, P1207, DOI 10.1006/anbe.1999.1250; Cooper MA, 2005, AM J PRIMATOL, V65, P269, DOI 10.1002/ajp.20114; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; CROWLEY T J, 1972, Primates, V13, P149, DOI 10.1007/BF01840877; Crystal JD, 2009, BEHAV PROCESS, V80, P269, DOI 10.1016/j.beproc.2008.09.009; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; de Vries H, 2002, BEHAV ECOL SOCIOBIOL, V51, P557, DOI 10.1007/s00265-002-0454-6; De Waal FBM, 2000, ANIM BEHAV, V60, P253, DOI 10.1006/anbe.2000.1471; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; DEWAAL FBM, 1986, FOLIA PRIMATOL, V46, P215, DOI 10.1159/000156255; DEWAAL FBM, 1989, AM J PRIMATOL, V19, P83, DOI 10.1002/ajp.1350190203; DEWAAL FBM, 1991, ANIM BEHAV, V41, P383, DOI 10.1016/S0003-3472(05)80839-5; Duboscq J, 2013, AM J PRIMATOL, V75, P361, DOI 10.1002/ajp.22114; ESTRADA A, 1977, Primates, V18, P647, DOI 10.1007/BF02383141; Evers E, 2012, BEHAV ECOL SOCIOBIOL, V66, P931, DOI 10.1007/s00265-012-1342-3; Evers E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026189; FURUICHI T, 1983, Primates, V24, P445, DOI 10.1007/BF02381678; Goossens BMA, 2008, ANIM BEHAV, V75, P1673, DOI 10.1016/j.anbehav.2007.10.020; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; HAUDE RH, 1976, ANIM LEARN BEHAV, V4, P163, DOI 10.3758/BF03214028; HAUSFATER G, 1982, SCIENCE, V217, P752, DOI 10.1126/science.217.4561.752; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hemelrijk CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037271; Hemelrijk CK, 2010, ETHOLOGY, V116, P1099, DOI 10.1111/j.1439-0310.2010.01818.x; Hemelrijk CK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002678; Hemelrijk CK, 1999, P ROY SOC B-BIOL SCI, V266, P361, DOI 10.1098/rspb.1999.0646; Hemelrijk CK, 1999, LECT NOTES ARTIF INT, V1674, P524; Hemelrijk CK, 2000, ANIM BEHAV, V59, P1035, DOI 10.1006/anbe.2000.1400; HEMELRIJK CK, 1990, ANIM BEHAV, V39, P1013, DOI 10.1016/S0003-3472(05)80775-4; HEMELRIJK CK, 1998, ART LIF 6 P 6 INT C; Hildenbrandt H, 2010, BEHAV ECOL, V21, P1349, DOI 10.1093/beheco/arq149; HOGEWEG P, 1983, BEHAV ECOL SOCIOBIOL, V12, P271, DOI 10.1007/BF00302895; HOGEWEG P, 1985, J THEOR BIOL, V113, P311, DOI 10.1016/S0022-5193(85)80230-7; HOGEWEG P, 1990, MATH COMPUT MODEL, V13, P83, DOI 10.1016/0895-7177(90)90012-C; Jaeggi AV, 2013, EVOL HUM BEHAV, V34, P69, DOI 10.1016/j.evolhumbehav.2012.09.005; Jaman MF, 2008, AM J PRIMATOL, V70, P1133, DOI 10.1002/ajp.20612; Johnson BR, 2009, P ROY SOC B-BIOL SCI, V276, P255, DOI 10.1098/rspb.2008.0793; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; JUDGE PG, 1993, ANIM BEHAV, V46, P221, DOI 10.1006/anbe.1993.1184; KAPLAN JR, 1982, ARTERIOSCLEROSIS, V2, P359, DOI 10.1161/01.ATV.2.5.359; KAPLAN JR, 1990, AM J PRIMATOL, V21, P175, DOI 10.1002/ajp.1350210302; Koski SE, 2007, AM J PRIMATOL, V69, P158, DOI 10.1002/ajp.20338; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; Kutsukake N, 2001, Anim Cogn, V4, P259, DOI 10.1007/s10071-001-0119-2; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; LeDoux Joseph E., 1999, EMOTIONAL BRAIN MYST; Leiva D., 2010, P MEAS BEH 2010, P162; MAESTRIPIERI D, 1993, ETHOLOGY, V95, P32; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Maestripieri D, 1996, INT J PRIMATOL, V17, P785, DOI 10.1007/BF02735264; Maestripieri D, 1997, PRIMATES, V38, P127, DOI 10.1007/BF02382003; Maestripieri D, 1996, BEHAVIOUR, V133, P997, DOI 10.1163/156853996X00576; Majolo B, 2009, BEHAVIOUR, V146, P113, DOI 10.1163/156853908X390959; Manson JH, 2000, ETHOLOGY, V106, P301, DOI 10.1046/j.1439-0310.2000.00527.x; MARUHASHI T, 1981, Primates, V22, P1, DOI 10.1007/BF02382552; MASON WA, 1973, INT C ANTHR ETH SCI; MEHLMAN PT, 1988, PRIMATES, V29, P195, DOI 10.1007/BF02381122; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; Nakamichi M, 2003, INT J PRIMATOL, V24, P607, DOI 10.1023/A:1023744515134; Oosten JE, 2010, BEHAV ECOL SOCIOBIOL, V64, P793, DOI 10.1007/s00265-009-0896-1; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; PAVANI S, 1991, FOLIA PRIMATOL, V57, P34, DOI 10.1159/000156561; Petit O, 2011, INT J PRIMATOL, V32, P1433, DOI 10.1007/s10764-011-9545-4; Puga-Gonzalez I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000630; R Core Team, 2012, R LANG ENV STAT COMP; Reed C, 1997, INT J PRIMATOL, V18, P247, DOI 10.1023/A:1026376720249; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; RHINE RJ, 1989, AM J PRIMATOL, V19, P69, DOI 10.1002/ajp.1350190202; Richter C, 2009, INT J PRIMATOL, V30, P625, DOI 10.1007/s10764-009-9364-z; Robbins MM, 2005, BEHAVIOUR, V142, P779, DOI 10.1163/1568539054729123; ROLLS ET, 1999, BRAIN EMOTION; SAMUELS A, 1987, ANIM BEHAV, V35, P785, DOI 10.1016/S0003-3472(87)80115-X; Schino G, 1996, ANXIETY, V2, P186; SCHINO G, 1990, BEHAVIOUR, V113, P264, DOI 10.1163/156853990X00518; Schino G, 2007, J COMP PSYCHOL, V121, P181, DOI 10.1037/0735-7036.121.2.181; Schino G, 2007, ETHOLOGY, V113, P1081, DOI 10.1111/j.1439-0310.2007.01407.x; Schino G, 2009, ADV STUD BEHAV, V39, P45, DOI 10.1016/S0065-3454(09)39002-6; Schulke O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059789; Shively CA, 1998, BIOL PSYCHIAT, V44, P882, DOI 10.1016/S0006-3223(97)00437-X; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; Son Vo Dinh, 2004, Laboratory Primate Newsletter, V43, P1; SOUTHWICK CH, 1967, BEHAVIOUR, V28, P182, DOI 10.1163/156853967X00235; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Sueur C, 2009, ANIM BEHAV, V78, P1087, DOI 10.1016/j.anbehav.2009.07.029; SUGIYAMA Y, 1971, Primates, V12, P247, DOI 10.1007/BF01730414; Takahashi H, 1998, PRIMATES, V39, P365, DOI 10.1007/BF02573084; THIERRY B, 1990, INT J PRIMATOL, V11, P357, DOI 10.1007/BF02193006; Thierry B, 2008, ANIM BEHAV, V75, P847, DOI 10.1016/j.anbehav.2007.07.006; Thierry B, 2007, EVOL ANTHROPOL, V16, P224, DOI 10.1002/evan.20147; Thierry Bernard, 2000, P106; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; van der Post DJ, 2004, LECT NOTES COMPUT SC, V3305, P492; Ventura R, 2006, AM J PRIMATOL, V68, P1138, DOI 10.1002/ajp.20314; Viscido SV, 2005, ECOL MODEL, V183, P347, DOI 10.1016/j.ecolmodel.2004.08.019; Wascher CAF, 2009, ANIM BEHAV, V77, P955, DOI 10.1016/j.anbehav.2009.01.013; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Watson D, 1999, J PERS SOC PSYCHOL, V76, P820, DOI 10.1037/0022-3514.76.5.820; WILENSKI U, 2007, NETLOGO 4 0 3; WINSLOW JT, 1989, PHARMACOL BIOCHEM BE, V32, P919, DOI 10.1016/0091-3057(89)90059-2; Wittig RM, 2008, HORM BEHAV, V54, P170, DOI 10.1016/j.yhbeh.2008.02.009	136	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87955	10.1371/journal.pone.0087955	http://dx.doi.org/10.1371/journal.pone.0087955			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504194	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300022
J	Hartling, L; Hamm, MP; Fernandes, RM; Dryden, DM; Vandermeer, B				Hartling, Lisa; Hamm, Michele P.; Fernandes, Ricardo M.; Dryden, Donna M.; Vandermeer, Ben			Quantifying Bias in Randomized Controlled Trials in Child Health: A Meta-Epidemiological Study	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; DESIGN CHARACTERISTICS; EMPIRICAL-EVIDENCE; QUALITY; OUTCOMES; RISK; METAANALYSES; ASSOCIATION	Objective: To quantify bias related to specific methodological characteristics in child-relevant randomized controlled trials (RCTs). Design: Meta-epidemiological study. Data Sources: We identified systematic reviews containing a meta-analysis with 10-40 RCTs that were relevant to child health in the Cochrane Database of Systematic Reviews. Data Extraction: Two reviewers independently assessed RCTs using items in the Cochrane Risk of Bias tool and other study factors. We used meta-epidemiological methods to assess for differences in effect estimates between studies classified as high/unclear vs. low risk of bias. Results: We included 287 RCTs from 17 meta-analyses. The proportion of studies at high/unclear risk of bias was: 79% sequence generation, 83% allocation concealment, 67% blinding of participants, 47% blinding of outcome assessment, 49% incomplete outcome data, 32% selective outcome reporting, 44% other sources of bias, 97% overall risk of bias, 56% funding, 35% baseline imbalance, 13% blocked randomization in unblinded trials, and 1% early stopping for benefit. We found no significant differences in effect estimates for studies that were high/unclear vs. low risk of bias for any of the risk of bias domains, overall risk of bias, or other study factors. Conclusions: We found no differences in effect estimates between studies based on risk of bias. A potential explanation is the number of trials included, in particular the small number of studies with low risk of bias. Until further evidence is available, reviewers should not exclude RCTs from systematic reviews and meta-analyses based solely on risk of bias particularly in the area of child health.	[Hartling, Lisa; Hamm, Michele P.; Dryden, Donna M.; Vandermeer, Ben] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Fernandes, Ricardo M.] Univ Lisbon, Clin Pharmacol Unit, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Fernandes, Ricardo M.] Hosp Santa Maria, Dept Pediat, Lisbon, Portugal	University of Alberta; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	hartling@ualberta.ca	Fernandes, Ricardo M/C-7501-2015	Fernandes, Ricardo M/0000-0002-7253-6475	Canadian Institutes of Health Research (CIHR); CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded through the Canadian Institutes of Health Research (CIHR). Dr. Hartling holds a New Investigator Salary Award through CIHR. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Bow Simon, 2010, BMC Pediatr, V10, P34, DOI 10.1186/1471-2431-10-34; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Clarke M, 2002, INT J EPIDEMIOL, V31, P123, DOI 10.1093/ije/31.1.123; Collier A, 2006, BRIT J DERMATOL, V155, P1230, DOI 10.1111/j.1365-2133.2006.07496.x; Egger M, 2003, Health Technol Assess, V7, P1; Furukawa TA, 2007, JAMA-J AM MED ASSOC, V297, P468, DOI 10.1001/jama.297.5.468-b; Hamm MP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-96; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartling L, 2012, PEDIATRICS, V129, pS124, DOI 10.1542/peds.2012-0055E; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Juni P, 2008, Z EVID FORTBILD Q S6, V102, P62; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Klassen TP, 2009, LANCET, V374, P1310, DOI 10.1016/S0140-6736(09)61803-1; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P312, DOI 10.1016/0197-2456(88)90046-3; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; McDonagh M., 2013, METHODS GUIDE EFFECT; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Sheikh L, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-10; Siersma V, 2007, STAT MED, V26, P2745, DOI 10.1002/SIM.2752; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Tricco AC, 2009, J CLIN EPIDEMIOL, V62, P380, DOI 10.1016/j.jclinepi.2008.08.008; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	32	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88008	10.1371/journal.pone.0088008	http://dx.doi.org/10.1371/journal.pone.0088008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505351	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300033
J	Kurada, L; Yang, CX; Lei, SB				Kurada, Lalitha; Yang, Chuanxiu; Lei, Saobo			Corticotropin-Releasing Factor Facilitates Epileptiform Activity in the Entorhinal Cortex: Roles of CRF2 Receptors and PKA Pathway	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR-LIKE IMMUNOREACTIVITY; METABOTROPIC GLUTAMATE RECEPTORS; INHIBITS NEURONAL EXCITABILITY; OVINE FETAL HYPOTHALAMUS; MONKEY SAIMIRI-SCIUREUS; INCREASES GABA RELEASE; GABAERGIC TRANSMISSION; BINDING-PROTEIN; K+ CHANNELS	Whereas corticotropin-releasing factor (CRF) has been considered as the most potent epileptogenic neuropeptide in the brain, its action site and underlying mechanisms in epilepsy have not been determined. Here, we found that the entorhinal cortex (EC) expresses high level of CRF and CRF2 receptors without expression of CRF1 receptors. Bath application of CRF concentration-dependently increased the frequency of picrotoxin (PTX)-induced epileptiform activity recorded from layer III of the EC in entorhinal slices although CRF alone did not elicit epileptiform activity. CRF facilitated the induction of epileptiform activity in the presence of subthreshold concentration of PTX which normally would not elicit epileptiform activity. Bath application of the inhibitor for CRF-binding proteins, CRF6-33, also increased the frequency of PTX-induced epileptiform activity suggesting that endogenously released CRF is involved in epileptogenesis. CRF-induced facilitation of epileptiform activity was mediated via CRF2 receptors because pharmacological antagonism and knockout of CRF2 receptors blocked the facilitatory effects of CRF on epileptiform activity. Application of the adenylyl cyclase (AC) inhibitors blocked CRF-induced facilitation of epileptiform activity and elevation of intracellular cyclic AMP (cAMP) level by application of the AC activators or phosphodiesterase inhibitor increased the frequency of PTX-induced epileptiform activity, demonstrating that CRF-induced increases in epileptiform activity are mediated by an increase in intracellular cAMP. However, application of selective protein kinase A (PKA) inhibitors reduced, not completely blocked CRF-induced enhancement of epileptiform activity suggesting that PKA is only partially required. Our results provide a novel cellular and molecular mechanism whereby CRF modulates epilepsy.	[Kurada, Lalitha; Yang, Chuanxiu; Lei, Saobo] Univ N Dakota, Dept Basic Sci, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks	Lei, SB (corresponding author), Univ N Dakota, Dept Basic Sci, Grand Forks, ND 58201 USA.	saobo.lei@med.und.edu	Kurada, Lalitha/AAV-8844-2020	Kurada, Lalitha/0000-0001-5239-9285	National Institutes of Health [MH082881]; ND EPSCoR NSF [EPS 018442]; EPSCoR [0814442] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ND EPSCoR NSF; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health (MH082881); LK was supported by ND EPSCoR NSF grant #EPS 018442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2003, NEUROCHEM INT, V43, P39, DOI 10.1016/S0197-0186(02)00195-X; Baram TZ, 1998, TRENDS NEUROSCI, V21, P471, DOI 10.1016/S0166-2236(98)01275-2; BASSETT JL, 1992, J COMP NEUROL, V323, P91, DOI 10.1002/cne.903230108; BASSETT JL, 1992, J COMP NEUROL, V316, P348, DOI 10.1002/cne.903160306; BOULTON CL, 1993, EUR J PHARMACOL, V236, P131, DOI 10.1016/0014-2999(93)90235-A; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAIN ST, 1991, NEUROENDOCRINOLOGY, V54, P36; CHA CI, 1988, J NEUROSCI, V8, P4121; CHALMERS DT, 1995, J NEUROSCI, V15, P6340; Dautzenberg FM, 2002, TRENDS PHARMACOL SCI, V23, P71, DOI 10.1016/S0165-6147(02)01946-6; Deng PY, 2008, MOL CELL NEUROSCI, V39, P273, DOI 10.1016/j.mcn.2008.07.005; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; Deng PY, 2006, J PHYSIOL-LONDON, V577, P497, DOI 10.1113/jphysiol.2006.118141; Deng PY, 2010, HIPPOCAMPUS, V20, P980, DOI 10.1002/hipo.20697; Deng PY, 2010, J NEUROSCI, V30, P5136, DOI 10.1523/JNEUROSCI.5711-09.2010; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; EHLERS CL, 1983, BRAIN RES, V278, P332, DOI 10.1016/0006-8993(83)90266-4; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Greenwood RS, 1997, NEUROSCI LETT, V224, P66, DOI 10.1016/S0304-3940(97)13455-3; Higashima M, 2002, BRAIN RES, V949, P157, DOI 10.1016/S0006-8993(02)02976-1; Jahn O, 2005, MINI-REV MED CHEM, V5, P953, DOI 10.2174/138955705774329500; Jinde S, 1999, BRAIN RES, V833, P286, DOI 10.1016/S0006-8993(99)01510-3; LAUBER M, 1984, FEBS LETT, V173, P222, DOI 10.1016/0014-5793(84)81051-0; Lei S, 2007, J NEUROPHYSIOL, V98, P2868, DOI 10.1152/jn.00679.2007; LOVENBERG TW, 1995, P NATL ACAD SCI USA, V92, P836, DOI 10.1073/pnas.92.3.836; LOVENBERG TW, 1995, ENDOCRINOLOGY, V136, P4139, DOI 10.1210/en.136.9.4139; MARROSU F, 1987, BRAIN RES, V408, P394, DOI 10.1016/0006-8993(87)90413-6; MARROSU F, 1988, EPILEPSIA, V29, P369, DOI 10.1111/j.1528-1157.1988.tb03733.x; Miyata I, 1999, BIOCHEM BIOPH RES CO, V256, P692, DOI 10.1006/bbrc.1999.0392; Park SK, 2003, NEUROCHEM INT, V42, P57, DOI 10.1016/S0197-0186(02)00060-8; Piekut DT, 1998, BRAIN RES, V781, P100, DOI 10.1016/S0006-8993(97)01219-5; Primus RJ, 1997, NEUROPSYCHOPHARMACOL, V17, P308, DOI 10.1016/S0893-133X(97)00071-7; Radulovic J, 1998, J NEUROSCI RES, V54, P507, DOI 10.1002/(SICI)1097-4547(19981115)54:4<507::AID-JNR8>3.0.CO;2-E; Riegel AC, 2008, NEURON, V57, P559, DOI 10.1016/j.neuron.2007.12.029; Ristori C, 2008, N-S ARCH PHARMACOL, V378, P563, DOI 10.1007/s00210-008-0338-z; Rominger DH, 1998, J PHARMACOL EXP THER, V286, P459; Saoud CJ, 1996, PEPTIDES, V17, P55, DOI 10.1016/0196-9781(95)02060-8; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; SierraParedes G, 1996, J NEUROSCI METH, V67, P113; Smith MA, 1997, BRAIN RES, V745, P248; Spiess J, 1998, TRENDS ENDOCRIN MET, V9, P140, DOI 10.1016/S1043-2760(98)00037-X; Takahashi Y, 1997, BRAIN RES, V776, P255, DOI 10.1016/S0006-8993(97)01119-0; Ure A, 2006, NEUROSCI LETT, V392, P10, DOI 10.1016/j.neulet.2005.08.045; Valentino RJ, 2001, NEUROSCIENCE, V106, P375, DOI 10.1016/S0306-4522(01)00279-2; Vazquez-Lopez A, 2005, NEUROCHEM RES, V30, P613, DOI 10.1007/s11064-005-2748-3; Wang SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062185; Wang SP, 2012, CEREB CORTEX, V22, P584, DOI 10.1093/cercor/bhr131; Wang SP, 2011, J NEUROPHYSIOL, V106, P1515, DOI 10.1152/jn.00025.2011; Wang W, 2001, ANN NEUROL, V50, P404, DOI 10.1002/ana.1138; WATABE T, 1991, J ENDOCRINOL, V129, P335, DOI 10.1677/joe.0.1290335; WEISS SRB, 1986, BRAIN RES, V372, P345, DOI 10.1016/0006-8993(86)91142-X; Xiao ZY, 2009, J NEUROPHYSIOL, V102, P659, DOI 10.1152/jn.00226.2009; Xiao ZY, 2009, J BIOL CHEM, V284, P10980, DOI 10.1074/jbc.M806760200; Yan XX, 1998, HIPPOCAMPUS, V8, P231, DOI 10.1002/(SICI)1098-1063(1998)8:3<231::AID-HIPO6>3.0.CO;2-M; Yechikhov S, 2001, EPILEPSY RES, V46, P15, DOI 10.1016/S0920-1211(01)00255-8	58	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88109	10.1371/journal.pone.0088109	http://dx.doi.org/10.1371/journal.pone.0088109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505399	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300056
J	Wong, S; Flanagan, E; Savage, G; Hodges, JR; Hornberger, M				Wong, Stephanie; Flanagan, Emma; Savage, Greg; Hodges, John R.; Hornberger, Michael			Contrasting Prefrontal Cortex Contributions to Episodic Memory Dysfunction in Behavioural Variant Frontotemporal Dementia and Alzheimer's Disease	PLOS ONE			English	Article							FRONTAL VARIANT; AUTOBIOGRAPHICAL MEMORIES; EXECUTIVE DYSFUNCTION; LOBAR DEGENERATION; SELF-REFERENCE; HIPPOCAMPAL; BATTERY; REGIONS; BRAIN; MORPHOMETRY	Recent evidence has questioned the integrity of episodic memory in behavioural variant frontotemporal dementia (bvFTD), where recall performance is impaired to the same extent as in Alzheimer's disease (AD). While these deficits appear to be mediated by divergent patterns of brain atrophy, there is evidence to suggest that certain prefrontal regions are implicated across both patient groups. In this study we sought to further elucidate the dorsolateral (DLPFC) and ventromedial (VMPFC) prefrontal contributions to episodic memory impairment in bvFTD and AD. Performance on episodic memory tasks and neuropsychological measures typically tapping into either DLPFC or VMPFC functions was assessed in 22 bvFTD, 32 AD patients and 35 age-and education-matched controls. Behaviourally, patient groups did not differ on measures of episodic memory recall or DLPFC-mediated executive functions. BvFTD patients were significantly more impaired on measures of VMPFC-mediated executive functions. Composite measures of the recall, DLPFC and VMPFC task scores were covaried against the T1 MRI scans of all participants to identify regions of atrophy correlating with performance on these tasks. Imaging analysis showed that impaired recall performance is associated with divergent patterns of PFC atrophy in bvFTD and AD. Whereas in bvFTD, PFC atrophy covariates for recall encompassed both DLPFC and VMPFC regions, only the DLPFC was implicated in AD. Our results suggest that episodic memory deficits in bvFTD and AD are underpinned by divergent prefrontal mechanisms. Moreover, we argue that these differences are not adequately captured by existing neuropsychological measures.	[Wong, Stephanie; Flanagan, Emma; Hodges, John R.; Hornberger, Michael] Neurosci Res Australia, Sydney, NSW, Australia; [Wong, Stephanie; Savage, Greg] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Wong, Stephanie; Savage, Greg; Hodges, John R.; Hornberger, Michael] Australian Res Council, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Hodges, John R.; Hornberger, Michael] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Neuroscience Research Australia; Macquarie University; University of New South Wales Sydney	Hornberger, M (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	m.hornberger@neura.edu.au	Hornberger, Michael/C-9610-2011	Hornberger, Michael/0000-0002-2214-3788; Wong, Stephanie/0000-0002-0990-5039; Savage, Gregory/0000-0002-5895-1947; Flanagan, Emma/0000-0003-1492-7061	Australian Research Council (ARC) Centre of Excellence for Cognition and its Disorders; National Health and Medical Research Council (NHMRC) of Australia; Australian Postgraduate Award Scholarship	Australian Research Council (ARC) Centre of Excellence for Cognition and its Disorders(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award Scholarship	This work was supported by the Australian Research Council (ARC) Centre of Excellence for Cognition and its Disorders; the National Health and Medical Research Council (NHMRC) of Australia; and an Australian Postgraduate Award Scholarship (to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Baudic S, 2006, ARCH CLIN NEUROPSYCH, V21, P15, DOI 10.1016/j.acn.2005.07.002; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Becker S, 2003, J COGNITIVE NEUROSCI, V15, P821, DOI 10.1162/089892903322370744; Benton AL, 1994, MULTILINGUAL APHASIA; Binetti G, 1996, J NEUROL NEUROSUR PS, V60, P91, DOI 10.1136/jnnp.60.1.91; Burgess P.W., 1997, HAYLING BRIXTON TEST; Caine D, 2001, NEUROCASE, V7, P57, DOI 10.1093/neucas/7.1.57; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Collette F, 1999, CORTEX, V35, P57, DOI 10.1016/S0010-9452(08)70785-8; D'Argembeau A, 2007, J COGNITIVE NEUROSCI, V19, P935, DOI 10.1162/jocn.2007.19.6.935; Duarte A, 2010, J COGNITIVE NEUROSCI, V22, P1819, DOI 10.1162/jocn.2009.21316; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Frisch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055251; Giovagnoli AR, 2008, NEUROPSYCHOLOGIA, V46, P1495, DOI 10.1016/j.neuropsychologia.2007.12.023; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Graham A, 2005, BRAIN, V128, P597, DOI 10.1093/brain/awh348; Gregory CA, 1997, INT J GERIATR PSYCH, V12, P375, DOI 10.1002/(SICI)1099-1166(199703)12:3<375::AID-GPS518>3.0.CO;2-#; Harciarek M, 2005, NEUROPSYCHOL REV, V15, P131, DOI 10.1007/s11065-005-7093-4; Hodges JR, 2004, ANN NEUROL, V56, P399, DOI 10.1002/ana.20203; Hodges JR, 2003, NEUROLOGY, V61, P349, DOI 10.1212/01.WNL.0000078928.20107.52; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hornberger M, 2010, DEMENT GERIATR COGN, V30, P547, DOI 10.1159/000321670; Hornberger M, 2010, NEUROLOGY, V74, P472, DOI 10.1212/WNL.0b013e3181cef85d; Hornberger M, 2012, BRAIN, V135, P3015, DOI 10.1093/brain/aws239; Hoshi Y, 2000, COGNITIVE BRAIN RES, V9, P339, DOI 10.1016/S0926-6410(00)00006-9; Hutchinson AD, 2007, J NEUROL NEUROSUR PS, V78, P917, DOI 10.1136/jnnp.2006.100669; Irish M, 2013, HUMAN BRAIN IN PRESS; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Kipps CM, 2009, BRAIN, V132, P2566, DOI 10.1093/brain/awp077; Kipps CM, 2009, BRAIN, V132, P592, DOI 10.1093/brain/awn314; Kramer JH, 2005, NEUROPSYCHOLOGY, V19, P799, DOI 10.1037/0894-4105.19.6.799; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; Leshikar ED, 2012, SOC NEUROSCI-UK, V7, P126, DOI 10.1080/17470919.2011.585242; Long NM, 2010, J NEUROSCI, V30, P10967, DOI 10.1523/JNEUROSCI.2611-10.2010; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Matuszewski V, 2006, NEUROPSYCHOLOGIA, V44, P2386, DOI 10.1016/j.neuropsychologia.2006.04.031; McDonald S, 2007, AWARENESS SOCIAL INF; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mercy L, 2008, NEUROLOGY, V71, P1496, DOI 10.1212/01.wnl.0000334277.16896.fa; Meyers J., 1995, MEYERS SCORING SYSTE; Mioshi E, 2010, NEUROLOGY, V74, P1591, DOI 10.1212/WNL.0b013e3181e04070; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Morris JC, 1997, ALZ DIS ASSOC DIS, V11, P1, DOI 10.1097/00002093-199706001-00001; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Newman LM, 2007, BRAIN IMAGING BEHAV, V1, P3, DOI 10.1007/s11682-007-9000-5; Pachana N A, 1996, J Int Neuropsychol Soc, V2, P505; Pasquier F, 2001, NEUROCASE, V7, P161, DOI 10.1093/neucas/7.2.161; Pennington C, 2011, J ALZHEIMERS DIS, V24, P261, DOI 10.3233/JAD-2011-101668; Philippi CL, 2012, J COGNITIVE NEUROSCI, V24, P475, DOI 10.1162/jocn_a_00138; Piguet O, 2011, NEUROLOGY, V76, P253, DOI 10.1212/WNL.0b013e318207b1ce; Piolino P, 2007, NEUROPSYCHOLOGIA, V45, P2730, DOI 10.1016/j.neuropsychologia.2007.04.013; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rama P, 2001, COGN AFFECT BEHAV NE, V1, P161, DOI 10.3758/CABN.1.2.161; Ranjith N, 2010, ANN INDIAN ACAD NEUR, V13, P117, DOI 10.4103/0972-2327.64639; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reverberi C, 2005, NEUROPSYCHOLOGIA, V43, P460, DOI 10.1016/j.neuropsychologia.2004.06.008; Roca M, 2013, NEUROPSYCHOLOGIA, V51, P725, DOI 10.1016/j.neuropsychologia.2013.01.008; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; Schmidt M., 1996, W PSYCHOL SERVICES; Seeley WW, 2008, ARCH NEUROL-CHICAGO, V65, P249, DOI 10.1001/archneurol.2007.38; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; van De Pol LA, 2006, J NEUROL NEUROSUR PS, V77, P439, DOI 10.1136/jnnp.2005.075341; Wear Helen J., 2008, Dement. neuropsychol., V2, P102, DOI 10.1590/S1980-57642009DN20200005; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wicklund AH, 2006, ALZ DIS ASSOC DIS, V20, P86, DOI 10.1097/01.wad.0000213811.97305.49; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	76	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87778	10.1371/journal.pone.0087778	http://dx.doi.org/10.1371/journal.pone.0087778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24505314	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800071
J	Yu, XH; Zheng, JF; Collin, M; Schmidt, E; Zillikens, D; Petersen, F				Yu, Xinhua; Zheng, Junfeng; Collin, Mattias; Schmidt, Enno; Zillikens, Detlef; Petersen, Frank			EndoS Reduces the Pathogenicity of Anti-mCOL7 IgG through Reduced Binding of Immune Complexes to Neutrophils	PLOS ONE			English	Article							DERMAL-EPIDERMAL SEPARATION; INDUCED TISSUE-DAMAGE; GLYCAN HYDROLYSIS; VII COLLAGEN; STREPTOCOCCUS-PYOGENES; GLYCOSYLATION; AUTOANTIBODIES; ACTIVATION; INDUCTION; IMPACT	Endo-beta-N-acetylglucosaminidase (EndoS) has been shown to act as a potent pathogen-derived immunomodulatory molecule in autoimmune diseases. Here we investigated how EndoS treatment reduces the pathogenicity of rabbit anti-mCOL7 IgG using different experimental models of epidermolysis bullosa acquisita (EBA). Our results show that the EndoS treatment does not interfere with the binding of the antibody to the antigen but reduces immune complex (IC)-mediated neutrophil activation by impairing the binding of the IC to Fc gamma R on neutrophils. On the basis of this newly identified EndoS-mediated mechanism we hope to develop new strategies in the treatment of the disease.	[Yu, Xinhua; Petersen, Frank] Airway Res Ctr North ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany; [Yu, Xinhua; Zheng, Junfeng] Xiamen Univ, Coll Med, Lab Autoimmun, Xiamen, Peoples R China; [Collin, Mattias] Lund Univ, Dept Clin Sci, Div Infect Med, Lund, Sweden; [Schmidt, Enno; Zillikens, Detlef] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany	Forschungszentrum Borstel; Xiamen University; Lund University; University of Lubeck	Petersen, F (corresponding author), Airway Res Ctr North ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany.	fpetersen@fz-borstel.de	Schmidt, Enno/C-4008-2009; Collin, Mattias/C-6398-2009; Yu, Xinhua/F-6125-2011	Schmidt, Enno/0000-0002-1206-8913; Collin, Mattias/0000-0002-6166-7410; 	Deutsche Forschungsgemeinschaft, Cluster of Excellence "Inflammation at Interfaces" [EXC 306/1, EXC 306/2]; Swedish Research Council [2010-57X-20240]; Foundation of Ake Wiberg; Foundation of Alfred Osterlund; Foundation of King Gustaf V's 80 years fund; Foundation of Hansa Medical AB; Medical College of Xiamen University	Deutsche Forschungsgemeinschaft, Cluster of Excellence "Inflammation at Interfaces"(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation of Ake Wiberg; Foundation of Alfred Osterlund; Foundation of King Gustaf V's 80 years fund; Foundation of Hansa Medical AB; Medical College of Xiamen University	This work was supported by Deutsche Forschungsgemeinschaft, Cluster of Excellence "Inflammation at Interfaces'' (EXC 306/1 and 2), Swedish Research Council (2010-57X-20240), the Foundations of Ake Wiberg, Alfred Osterlund, King Gustaf V's 80 years fund, Hansa Medical AB, and by the startup packages from the Medical College of Xiamen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2008, P NATL ACAD SCI USA, V105, P15005, DOI 10.1073/pnas.0808248105; Allhorn M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001413; Allhorn M, 2010, BLOOD, V115, P5080, DOI 10.1182/blood-2009-08-239020; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Collin M, 2002, INFECT IMMUN, V70, P6646, DOI 10.1128/IAI.70.12.6646-6651.2002; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2008, P NATL ACAD SCI USA, V105, P4265, DOI 10.1073/pnas.0711271105; Hirose M, 2012, J AUTOIMMUN; Kasper B, 2004, BLOOD, V103, P1602, DOI 10.1182/blood-2003-08-2802; Lood C, 2012, ARTHRITIS RHEUM-US, V64, P2698, DOI 10.1002/art.34454; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; Nandakumar KS, 2007, EUR J IMMUNOL, V37, P2973, DOI 10.1002/eji.200737581; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, AM J PATHOL, V161, P301, DOI 10.1016/S0002-9440(10)64182-X; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; van Timmeren MM, 2010, J AM SOC NEPHROL, V21, P1103, DOI 10.1681/ASN.2009090984; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373; Yu XH, 2010, J INVEST DERMATOL, V130, P2841, DOI 10.1038/jid.2010.230	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e85317	10.1371/journal.pone.0085317	http://dx.doi.org/10.1371/journal.pone.0085317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504190	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800005
J	Assmann, G; Shihadeh, K; Poeschel, V; Murawski, N; Conigliarou, J; Ong, MF; Pfreundschuh, M				Assmann, Gunter; Shihadeh, Klara; Poeschel, Viola; Murawski, Niels; Conigliarou, Jutta; Ong, Mei Fang; Pfreundschuh, Michael			Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study	PLOS ONE			English	Article							3-WEEKLY CHOP CHEMOTHERAPY; HIGH-DOSE CHEMOTHERAPY; NON-HODGKINS-LYMPHOMA; RHEUMATOID-ARTHRITIS; ANTINUCLEAR ANTIBODY; AGGRESSIVE LYMPHOMAS; AUTOANTIBODIES; ASSOCIATION; AUTOIMMUNE; PEPTIDES	Background: Antibodies against citrullinated proteins (ACPA) have been recognised as the most specific serum marker for rheumatoid arthritis. However, serum autoantibodies such as anti-nuclear antibodies have also been detected in the sera of different lymphatic malignancies without accompanying rheumatologic disease. Therefore, we conducted a study to evaluate the prevalence of ACPA in diffuse large B-cell non-Hodgkin lymphoma (DLBCL). Methods: Sera of 395 DLBCL patients and 258 age-matched healthy controls were investigated to evaluate the prevalence of ACPA and RF. ACPA-positive data were stratified into subgroups of RF positivity and established prognostic parameters for DLBCL, including overall survival. In addition, the ACPA serum concentrations levels were compared to an ACPA-positive RA cohort (n = 175). The statistics were performed with chi(2) test and Mann-Whitney-U test; Kaplan-Meyer curves (log rank test) were used to analyse the overall survival. P-value <0.05 was statistically significant. Results: ACPA, but not RF, occurred significantly more frequently in the sera of DLBCL patients than in healthy controls (3.5% versus 0.8%, p = 0.030). However, the ACPA serum concentration levels were significantly lower than in RA patients (median 10.4 versus 124.1 U/ml, p = 0.0001). After subgroup stratification, ACPA positivity in DLBCL was significantly associated with male gender (4.4% versus 0%, p = 0.022; odds ratio 1.046, CI 1.014-1.079) and with RF-IgM seropositivity (1.77% versus 0%, p = 0.043), but not with prognostic parameters for DLBCL. Conclusions: DLBCL is associated with a significantly higher prevalence of ACPA, with an increased prevalence in male patients, and simultaneous RF-IgM positivity. However, ACPA is not prognostic for DLBCL. The prevalence of RF-IgM, -IgA, or -IgG did not differ from healthy controls.	[Assmann, Gunter; Poeschel, Viola; Murawski, Niels; Conigliarou, Jutta; Pfreundschuh, Michael] Univ Med Sch Saarland, Jose Carreras Ctr Immuno & Gene Therapy, Dept Internal Med 1, Homburg, Germany; [Shihadeh, Klara] Gen Hosp Herrenberg, Dept Internal Med, Esslingen Herrenberg, Germany; [Ong, Mei Fang] Univ Saarland, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany	Universitatsklinikum des Saarlandes; Saarland University	Assmann, G (corresponding author), Univ Med Sch Saarland, Jose Carreras Ctr Immuno & Gene Therapy, Dept Internal Med 1, Homburg, Germany.	gunter.assmann@uks.eu	Aßmann, Gunter/AAM-7734-2021; Assmann, Gunter/AAM-7173-2021					Altintas A, 2008, Minerva Med, V99, P7; Amur S, 2012, J AUTOIMMUN, V38, pJ254, DOI 10.1016/j.jaut.2011.12.001; Assmann G, 2010, J RHEUMATOL, V37, P900, DOI 10.3899/jrheum.091110; Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675; Bilici A, 2012, J BUON, V17, P502; Brickmann K, 2010, CLIN EXP RHEUMATOL, V28, P888; Cambridge G, 2013, ATHEROSCLEROSIS, V228, P243, DOI 10.1016/j.atherosclerosis.2013.02.009; Chloraki-Bobota A, 2006, J BUON, V11, P485; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; Ehrenfeld M, 2001, BLOOD CELL MOL DIS, V27, P750, DOI 10.1006/bcmd.2001.0442; Frisell T, 2013, ARTHRITIS RHEUM-US, V65, P2773, DOI 10.1002/art.38097; Goldin LR, 2009, INT J CANCER, V124, P1497, DOI 10.1002/ijc.24141; Guyomard S, 2003, BRIT J HAEMATOL, V123, P90, DOI 10.1046/j.1365-2141.2003.04587.x; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Klareskog L, 2009, J MOL MED-JMM, V87, P357, DOI 10.1007/s00109-008-0437-9; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Meyer O, 2003, ANN RHEUM DIS, V62, P120, DOI 10.1136/ard.62.2.120; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Nishimura S, 1996, ACTA MED OKAYAMA, V50, P261; Pfreundschuh M, 2004, BLOOD, V104, P626, DOI 10.1182/blood-2003-06-2094; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Rifkin IR, 1998, J IMMUNOL, V161, P5164; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Ryu YS, 2013, RHEUMATOL INT, V33, P1443, DOI 10.1007/s00296-012-2572-4; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; Sebbag M, 2004, JOINT BONE SPINE, V71, P493, DOI 10.1016/j.jbspin.2004.07.004; Smedby KE, 2008, J INTERN MED, V264, P514, DOI 10.1111/j.1365-2796.2008.02029.x; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Trouw LA, 2013, ANN RHEUM DIS, V72, P132, DOI 10.1136/annrheumdis-2012-202349; Verburg RJ, 2002, HUM IMMUNOL, V63, P627, DOI 10.1016/S0198-8859(02)00414-7; Verburg RJ, 2001, ARTHRITIS RHEUM, V44, P754, DOI 10.1002/1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N; Wesley A, 2013, ARTHRIT CARE RES, V65, P107, DOI 10.1002/acr.21749	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88177	10.1371/journal.pone.0088177	http://dx.doi.org/10.1371/journal.pone.0088177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516607	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400039
J	Culina, S; Mauvais, FX; Hsu, HT; Burgevin, A; Guenette, S; Moser, A; van Endert, P				Culina, Slobodan; Mauvais, Francois-Xavier; Hsu, Hsiang-Ting; Burgevin, Anne; Guenette, Suzanne; Moser, Anna; van Endert, Peter			No Major Role for Insulin-Degrading Enzyme in Antigen Presentation by MHC Molecules	PLOS ONE			English	Article							TRIPEPTIDYL-PEPTIDASE-II; CROSS-PRESENTATION; PROTEASOME INHIBITORS; ENDOPLASMIC-RETICULUM; IMMUNE-RESPONSES; LIGANDS; GENERATION; MICE; IDENTIFICATION; DEGRADATION	Antigen presentation by MHC class I molecules requires degradation of epitope source proteins in the cytosol. Although the preeminent role of the proteasome is clearly established, evidence suggesting a significant role for proteasome-independent generation of class I ligands has been reported repeatedly. However, an enzyme responsible for such a role has not been identified. Recently insulin-degrading enzyme (IDE) was shown to produce an antigenic peptide derived from the tumor antigen MAGE-A3 in an entirely proteasome-independent manner, raising the question of the global impact of IDE in MHC class I antigen processing. Here we report that IDE knockdown in human cell lines, or knockout in two different mouse strains, has no effect on cell surface expression of various MHC class I molecules, including allomorphs such as HLA-A3 and HLA-B27 suggested to be loaded in an at least a partly proteasome-independent manner. Moreover, reduced or absent IDE expression does not affect presentation of five epitopes including epitopes derived from beta amyloid and proinsulin, two preferred IDE substrates. Thus, IDE does not play a major role in MHC class I antigen processing, confirming the dominant and almost exclusive role of the proteasome in cytosolic production of MHC class I ligands.	[Culina, Slobodan; Mauvais, Francois-Xavier; Hsu, Hsiang-Ting; Burgevin, Anne; Moser, Anna; van Endert, Peter] Inst Natl Sante & Rech Med, Unite 1013, Paris, France; [Culina, Slobodan; Mauvais, Francois-Xavier; Hsu, Hsiang-Ting; Burgevin, Anne; Moser, Anna; van Endert, Peter] Univ Paris 05, Fac Med Paris Descrates, Paris, France; [Guenette, Suzanne] MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	van Endert, P (corresponding author), Inst Natl Sante & Rech Med, Unite 1013, Paris, France.	peter.van-endert@inserm.fr	Mauvais, François-Xavier/AAA-4989-2019; van Endert, Peter/R-4606-2017	Mauvais, François-Xavier/0000-0002-5240-4280; van Endert, Peter/0000-0003-3782-0750; Culina, Slobodan/0000-0001-6461-6953	Agence Nationale de Recherche (Paris, France) [05-Blanc-0162]	Agence Nationale de Recherche (Paris, France)(French National Research Agency (ANR))	This work was supported by grant 05-Blanc-0162 of the Agence Nationale de Recherche (Paris, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benham AM, 1998, J IMMUNOL, V161, P83; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Ebstein F, 2013, CELL, V152, P935, DOI 10.1016/j.cell.2013.02.018; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Firat E, 2007, J IMMUNOL, V179, P8137, DOI 10.4049/jimmunol.179.12.8137; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Guil S, 2006, J BIOL CHEM, V281, P39925, DOI 10.1074/jbc.M608522200; Hassainya Y, 2005, DIABETES, V54, P2053, DOI 10.2337/diabetes.54.7.2053; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Judkowski V, 2001, J IMMUNOL, V166, P908, DOI 10.4049/jimmunol.166.2.908; Kessler JH, 2011, NAT IMMUNOL, V12, P45, DOI 10.1038/ni.1974; Kratzer R, 2010, J IMMUNOL, V184, P6855, DOI 10.4049/jimmunol.0902555; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Luckey CJ, 2001, J IMMUNOL, V167, P1212, DOI 10.4049/jimmunol.167.3.1212; Marcilla M, 2007, MOL CELL PROTEOMICS, V6, P923, DOI 10.1074/mcp.M600302-MCP200; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; Rock KL, 2010, J IMMUNOL, V184, P9, DOI 10.4049/jimmunol.0903399; Saveanu L, 2002, MOL IMMUNOL, V39, P203, DOI 10.1016/S0161-5890(02)00102-5; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Shen XZ, 2011, NAT IMMUNOL, V12, P1078, DOI 10.1038/ni.2107; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015; van Endert P, 2008, EUR J IMMUNOL, V38, P609, DOI 10.1002/eji.200838181; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Vinitsky A, 1997, J IMMUNOL, V159, P554; Weimershaus M, 2013, CURR OPIN IMMUNOL, V25, P90, DOI 10.1016/j.coi.2012.10.001; Weimershaus Mirjana, 2013, Methods Mol Biol, V960, P351, DOI 10.1007/978-1-62703-218-6_25; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; York IA, 2006, J IMMUNOL, V177, P1434, DOI 10.4049/jimmunol.177.3.1434	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88365	10.1371/journal.pone.0088365	http://dx.doi.org/10.1371/journal.pone.0088365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516642	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400061
J	Fan, NG; Sun, HY; Wang, YF; Zhang, LJ; Xia, ZH; Peng, L; Hou, YQ; Shen, WQ; Liu, R; Peng, YD				Fan, Nengguang; Sun, Haiyan; Wang, Yifei; Zhang, Lijuan; Xia, Zhenhua; Peng, Liang; Hou, Yanqiang; Shen, Weiqin; Liu, Rui; Peng, Yongde			Midkine, a Potential Link between Obesity and Insulin Resistance	PLOS ONE			English	Article							BINDING GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; ANAPLASTIC LYMPHOMA KINASE; ACID RESPONSIVE GENE; ADIPOSE-TISSUE; RECEPTOR SUBSTRATE-1; CIRCULATING MIDKINE; METABOLIC DISEASE; INFLAMMATION	Obesity is associated with increased production of inflammatory mediators in adipose tissue, which contributes to chronic inflammation and insulin resistance. Midkine (MK) is a heparin-binding growth factor with potent proinflammatory activities. We aimed to test whether MK is associated with obesity and has a role in insulin resistance. It was found that MK was expressed in adipocytes and regulated by inflammatory modulators (TNF-alpha and rosiglitazone). In addition, a significant increase in MK levels was observed in adipose tissue of obese ob/ob mice as well as in serum of overweight/obese subjects when compared with their respective controls. In vitro studies further revealed that MK impaired insulin signaling in 3T3-L1 adipocytes, as indicated by reduced phosphorylation of Akt and IRS-1 and decreased translocation of glucose transporter 4 (GLUT4) to the plasma membrane in response to insulin stimulation. Moreover, MK activated the STAT3-suppressor of cytokine signaling 3 (SOCS3) pathway in adipocytes. Thus, MK is a novel adipocyte-secreted factor associated with obesity and inhibition of insulin signaling in adipocytes. It may provide a potential link between obesity and insulin resistance.	[Fan, Nengguang; Sun, Haiyan; Wang, Yifei; Liu, Rui; Peng, Yongde] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Endocrinol, Shanghai 200030, Peoples R China; [Fan, Nengguang; Zhang, Lijuan; Xia, Zhenhua] Shanghai Songjiang Ctr Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Peng, Liang; Hou, Yanqiang; Shen, Weiqin] Shanghai Songjiang Ctr Hosp, Dept Lab Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Peng, YD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Endocrinol, Shanghai 200030, Peoples R China.	pengyongde0908@126.com	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of China [81370904, 81070682, 30800562]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 81370904, 81070682 and 30800562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Cernkovich ER, 2007, ENDOCRINOLOGY, V148, P1598, DOI 10.1210/en.2006-1106; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Dai LC, 2009, WORLD J GASTROENTERO, V15, P1966, DOI 10.3748/wjg.15.1966; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang Y, 2008, CELL CYCLE, V7, P1613, DOI 10.4161/cc.7.11.5952; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu K, 1997, BRIT J CANCER, V75, P354, DOI 10.1038/bjc.1997.58; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Krzystek-Korpacka M, 2010, INFLAMM BOWEL DIS, V16, P208, DOI 10.1002/ibd.21011; Krzystek-Korpacka M, 2009, CLIN CHEM LAB MED, V47, P1085, DOI 10.1515/CCLM.2009.248; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maruyama K, 2004, ARTHRITIS RHEUM-US, V50, P1420, DOI 10.1002/art.20175; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; MICHIKAWA M, 1993, J NEUROSCI RES, V35, P530, DOI 10.1002/jnr.490350509; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; MURAMATSU T, 1993, INT J DEV BIOL, V37, P183; Narita H, 2008, MIDKINE EXPRESSED IN; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Palanivel R, 2012, DIABETOLOGIA, V55, P3083, DOI 10.1007/s00125-012-2665-3; Ratovitski EA, 1998, J BIOL CHEM, V273, P3654, DOI 10.1074/jbc.273.6.3654; Serrano-Marco L, 2011, DIABETES, V60, P1990, DOI 10.2337/db10-0704; Shang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066479; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sueyoshi T, 2012, CANCER LETT, V316, P23, DOI 10.1016/j.canlet.2011.10.013; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Weckbach LT, 2011, THESCIENTIFICWORLDJO, V11, P2491, DOI 10.1100/2011/517152; Yazihan N, 2008, ADV THER, V25, P502, DOI 10.1007/s12325-008-0055-5; You ZB, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-6	47	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88299	10.1371/journal.pone.0088299	http://dx.doi.org/10.1371/journal.pone.0088299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516630	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400053
J	Combemale, P; Valeyrie-Allanore, L; Giammarile, F; Pinson, S; Guillot, B; Goulart, DM; Wolkenstein, P; Blay, JY; Mognetti, T				Combemale, Patrick; Valeyrie-Allanore, Laurence; Giammarile, Francesco; Pinson, Stephane; Guillot, Bernard; Goulart, Denis Mariano; Wolkenstein, Pierre; Blay, Jean Yves; Mognetti, Thomas			Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1	PLOS ONE			English	Article							PERIPHERAL-NERVE-SHEATH; POSITRON-EMISSION-TOMOGRAPHY; FDG-PET; SOFT-TISSUE; PLEXIFORM NEUROFIBROMAS; DIFFERENTIATING BENIGN; LIVER METASTASES; F-18-FDG PET; TUMORS; LESIONS	Background: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious complications of neurofibromatosis type 1 associated with poor prognosis and deeper lesions can be difficult to diagnose. 18-FDG PET improves the detection of malignancies. However, the criteria for malignancy, notably the SUVmax threshold, are not standardized. Therefore, the aim of the study was to evaluate a semi-quantitative index for the reproducible detection of MPNST with FDG PET. Methods: It is a multicenter retrospective study conducted between 2000 to 2012. All patients with NF1 referred for suspected MPNST underwent PET. Since SUVmax was not available until 2004 in our centers, we had to settle for the semiquantitative method used at that time, the uptake ratio between the tumor and the normal liver (T/L ratio) with 1.5 as the cut-off for malignancy. When dedicated PET with SUVmax became available, the semi-quantitative analysis of PET images remained, along with SUVmax. Results: 113 patients with 145 tumors were included. PET assessment revealed 65 suspected lesions with T/L > 1.5 and among these, 40 were MPNSTs. 80 tumors were classified as non-suspicious, and 79 were benign. The 1.5 T/L cut-off had a negative predictive value (NPV) of 98,8% and a positive predictive value of 61,5%. The positive likelihood ratio (LR) was 4,059, the negative LR was 0,032 with 97% sensitivity and 76% specificity. Conclusions: This study, which is among the largest published, confirms the utility of PET for detecting NF1-associated MPNSTs. A semi-quantitative index, the T/L ratio with a cut-off of 1.5, allowed sensitive and specific differentiation of malignant from benign tumors better than SUVmax. When T/L was < 1.5, MPNSTs were ruled out with 98,8% NPV. When T/L was > 1.5, there was a strong suspicion of malignancy. This semi-quantitative analytical method is as simple as SUVmax, but is more sensitive, more reproducible and non-user-dependent.	[Combemale, Patrick; Pinson, Stephane; Blay, Jean Yves] Leon Berard Comprehens Canc Ctr, Rhone Alpes Multidisciplinary Ctr Treatment Neuro, Lyon, France; [Valeyrie-Allanore, Laurence] UPEC, Dept Dermatol, Henri Mondor Hosp, Natl Reference Ctr Neurofibromatosis Type 1, Creteil, France; [Giammarile, Francesco; Mognetti, Thomas] Leon Berard Comprehens Canc Ctr, Dept Nucl Med, Lyon, France; [Guillot, Bernard] St Eloi Univ Hosp, Languedoc Multidisciplinary Ctr Treatment Neurofi, Montpellier, France; [Goulart, Denis Mariano] St Eloi Univ Hosp, Dept Nucl Med, Montpellier, France; [Blay, Jean Yves] Leon Berard Comprehens Canc Ctr, Natl Reference Ctr Sarcoma, Lyon, France	UNICANCER; Centre Leon Berard; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UNICANCER; Centre Leon Berard; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; UNICANCER; Centre Leon Berard	Combemale, P (corresponding author), Leon Berard Comprehens Canc Ctr, Rhone Alpes Multidisciplinary Ctr Treatment Neuro, Lyon, France.	patrick.combemale@lyon.unicancer.fr	Giammarile, Francesco/AFV-7435-2022; Blay, Jean-Yves/N-3966-2016	Giammarile, Francesco/0000-0002-0550-7893; Blay, Jean-Yves/0000-0001-7190-120X; Mariano-Goulart, Denis/0000-0001-7044-2961				Banks KP, 2005, RADIOLOGY, V234, P899, DOI 10.1148/radiol.2343030946; Bastiaannet E, 2004, CANCER TREAT REV, V30, P83, DOI 10.1016/j.ctrv.2003.07.004; Bensaid B, 2007, ANN DERMATOL VENER, V134, P735, DOI 10.1016/S0151-9638(07)92528-4; Benz MR, 2010, CANCER-AM CANCER SOC, V116, P451, DOI 10.1002/cncr.24755; Brenner W, 2006, EUR J NUCL MED MOL I, V33, P428, DOI 10.1007/s00259-005-0030-1; Cardona S, 2003, EUR J SURG ONCOL, V29, P536, DOI 10.1016/S0748-7983(03)00055-6; Chander S, 2004, CLIN NUCL MED, V29, P415, DOI 10.1097/01.rlu.0000129121.55248.f5; Cheng G, 2013, MOL IMAGING BIOL, V15, P345, DOI 10.1007/s11307-012-0600-0; CRIM JR, 1992, RADIOLOGY, V185, P581, DOI 10.1148/radiology.185.2.1410377; de Langen AJ, 2012, J NUCL MED, V53, P701, DOI 10.2967/jnumed.111.095299; De Schepper A M, 1992, J Belge Radiol, V75, P286; DEMAS BE, 1988, AM J ROENTGENOL, V150, P615, DOI 10.2214/ajr.150.3.615; Doorn P F, 1995, Eur J Surg Oncol, V21, P78, DOI 10.1016/S0748-7983(05)80073-3; DUCATMAN BS, 1986, CANCER-AM CANCER SOC, V57, P2006, DOI 10.1002/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Ferner RE, 2008, ANN ONCOL, V19, P390, DOI 10.1093/annonc/mdm450; Ferner RE, 2000, J NEUROL NEUROSUR PS, V68, P353, DOI 10.1136/jnnp.68.3.353; Ferner RE, 2002, CANCER RES, V62, P1573; Frohlich A, 1999, J NUCL MED, V40, P250; Hubner KF, 1996, CLIN NUCL MED, V21, P941, DOI 10.1097/00003072-199612000-00005; Karabatsou K, 2009, NEUROSURGERY, V65, pA160, DOI 10.1227/01.NEU.0000337597.18599.D3; King AA, 2000, AM J MED GENET, V93, P388, DOI 10.1002/1096-8628(20000828)93:5<388::AID-AJMG8>3.0.CO;2-#; Knight SB, 1996, CHEST, V109, P982, DOI 10.1378/chest.109.4.982; Kumar V, 2013, CLIN NUCL MED, V38, P175, DOI 10.1097/RLU.0b013e318279ffdf; Laffon E, 2011, J NUCL MED TECHNOL, V39, P258, DOI 10.2967/jnmt.111.090027; Le Pechoux C, 2006, Cancer Radiother, V10, P185; Loree TR, 2000, OTOLARYNG HEAD NECK, V122, P667, DOI 10.1016/S0194-5998(00)70193-8; LOWE VJ, 1994, J NUCL MED, V35, P1771; Mantaka P, 1999, ANTICANCER RES, V19, P4443; Meany H, 2013, PEDIATR BLOOD CANCER, V60, P59, DOI 10.1002/pbc.24212; Miyamoto J, 2008, NEUROL MED-CHIR, V48, P495, DOI 10.2176/nmc.48.495; Neurofibromatosis Conference statement, 1998, ARCH NEUROL-CHICAGO, V45, P575; Okada M, 2009, ANN NUCL MED, V23, P349, DOI 10.1007/s12149-009-0246-4; Otsuka H, 2005, ANN NUCL MED, V19, P55, DOI 10.1007/BF02986337; Pinson S, 2001, ANN DERMATOL VENER, V128, P567; Porter D. E., 2009, Sarcoma, V2009, P1, DOI 10.1155/2009/756395; Ramanathan RC, 1999, EUR J SURG ONCOL, V25, P190, DOI 10.1053/ejso.1998.0625; Rasmussen SA, 2001, AM J HUM GENET, V68, P1110, DOI 10.1086/320121; Santaella Y, 2005, Rev Esp Med Nucl, V24, P127, DOI 10.1157/13071688; Schmidt M, 2004, NUKLEARMED-NUCL MED, V43, P91, DOI 10.1055/s-0038-1625597; Shahid Kameron R, 2011, J Surg Orthop Adv, V20, P132; Solomon SB, 2001, CLIN NUCL MED, V26, P525, DOI 10.1097/00003072-200106000-00009; Stucky CCH, 2012, ANN SURG ONCOL, V19, P878, DOI 10.1245/s10434-011-1978-7; Tessonnier L, 2008, EUR J NUCL MED MOL I, V35, P2018, DOI 10.1007/s00259-008-0849-3; Tsai LL, 2012, J NEURO-ONCOL, V108, P469, DOI 10.1007/s11060-012-0840-5; Tucker T, 2005, NEUROLOGY, V65, P205, DOI 10.1212/01.wnl.0000168830.79997.13; Valeyrie-Allanore L, 2005, BRIT J DERMATOL, V153, P79, DOI 10.1111/j.1365-2133.2005.06558.x; Van Herendael BH, 2006, SKELETAL RADIOL, V35, P745, DOI 10.1007/s00256-006-0160-y; Warbey VS, 2009, EUR J NUCL MED MOL I, V36, P751, DOI 10.1007/s00259-008-1038-0; WICK MR, 1987, AM J CLIN PATHOL, V87, P425, DOI 10.1093/ajcp/87.4.425; Woodruff JM, 1999, AM J MED GENET, V89, P23, DOI 10.1002/(SICI)1096-8628(19990326)89:1<23::AID-AJMG6>3.0.CO;2-#	51	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e85954	10.1371/journal.pone.0085954	http://dx.doi.org/10.1371/journal.pone.0085954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516522	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700004
J	Garg, G; Kumar, J; McGuigan, FE; Ridderstrale, M; Gerdhem, P; Luthman, H; Akesson, K				Garg, Gaurav; Kumar, Jitender; McGuigan, Fiona E.; Ridderstrale, Martin; Gerdhem, Paul; Luthman, Holger; Akesson, Kristina			Variation in the MC4R Gene Is Associated with Bone Phenotypes in Elderly Swedish Women	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; MINERAL DENSITY; COMMON VARIANTS; FAT MASS; HOMOCYSTEINE LEVELS; YOUNG-ADULT; FTO GENE; OBESITY; FRACTURE	Osteoporosis is characterized by reduced bone mineral density (BMD) and increased fracture risk. Fat mass is a determinant of bone strength and both phenotypes have a strong genetic component. In this study, we examined the association between obesity associated polymorphisms (SNPs) with body composition, BMD, Ultrasound (QUS), fracture and biomarkers (Homocysteine (Hcy), folate, Vitamin D and Vitamin B12) for obesity and osteoporosis. Five common variants: rs17782313 and rs1770633 (melanocortin 4 receptor (MC4R); rs7566605 (insulin induced gene 2 (INSIG2); rs9939609 and rs1121980 (fat mass and obesity associated (FTO) were genotyped in 2 cohorts of Swedish women: PEAK-25 (age 25, n = 1061) and OPRA (age 75, n = 1044). Body mass index (BMI), total body fat and lean mass were strongly positively correlated with QUS and BMD in both cohorts (r(2) = 0.2-0.6). MC4R rs17782313 was associated with QUS in the OPRA cohort and individuals with the minor C-allele had higher values compared to T-allele homozygotes (TT vs. CT vs. CC: BUA: 100 vs. 103 vs. 103; p = 0.002); (SOS: 1521 vs. 1526 vs. 1524; p = 0.008); (Stiffness index: 69 vs. 73 vs. 74; p = 0.0006) after adjustment for confounders. They also had low folate (18 vs. 17 vs. 16; p = 0.03) and vitamin D (93 vs. 91 vs. 90; p = 0.03) and high Hcy levels (13.7 vs 14.4 vs. 14.5; p = 0.06). Fracture incidence was lower among women with the C-allele, (52% vs. 58%; p = 0.067). Variation in MC4R was not associated with BMD or body composition in either OPRA or PEAK-25. SNPs close to FTO and INSIG2 were not associated with any bone phenotypes in either cohort and FTO SNPs were only associated with body composition in PEAK-25 (p <= 0.001). Our results suggest that genetic variation close to MC4R is associated with quantitative ultrasound and risk of fracture.	[Garg, Gaurav; McGuigan, Fiona E.; Akesson, Kristina] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Malmo, Sweden; [Garg, Gaurav; McGuigan, Fiona E.; Akesson, Kristina] Skane Univ Hosp, Dept Orthopaed, Malmo, Sweden; [Kumar, Jitender] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ridderstrale, Martin] Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden; [Gerdhem, Paul] Karolinska Univ Hosp, Dept Orthopaed, Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Luthman, Holger] Lund Univ, Dept Clin Sci, Med Genet Unit, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Uppsala University; Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University	Akesson, K (corresponding author), Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Malmo, Sweden.	Kristina.Akesson@med.lu.se	Garg, Gaurav/F-4925-2012	Kumar, Jitender/0000-0002-4917-8892; Gerdhem, Paul/0000-0001-8061-7163	Swedish Research Council [K2009-53X-14691-07-3]; Greta and Johan Kock Foundation; A Pahlsson Foundation; A Osterlund Foundation; Herman Jarnhardt Foundation; King Gustav V and Queen Victoria Foundation; Malmo University Hospital Research Foundation; Research and Development Council of Region Skane, Sweden; Swedish Medical Society; Novo Nordisk Fonden [NNF11OC1014660] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock Foundation; A Pahlsson Foundation; A Osterlund Foundation; Herman Jarnhardt Foundation; King Gustav V and Queen Victoria Foundation; Malmo University Hospital Research Foundation; Research and Development Council of Region Skane, Sweden; Swedish Medical Society; Novo Nordisk Fonden(Novo Nordisk Foundation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Financial support for the study was received from the Swedish Research Council (Grant K2009-53X-14691-07-3)(www.vr.se), Greta and Johan Kock Foundation, A Pahlsson Foundation, A Osterlund Foundation, Herman Jarnhardt Foundation, King Gustav V and Queen Victoria Foundation, Malmo University Hospital Research Foundation, Research and Development Council of Region Skane, Sweden and the Swedish Medical Society.	Ackert-Bicknell CL, 2008, J BONE MINER RES, V23, P1398, DOI 10.1359/JBMR.080419; Ahn JD, 2006, ENDOCRINOLOGY, V147, P3196, DOI 10.1210/en.2006-0281; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bustamante M, 2007, EUR J ENDOCRINOL, V157, P677, DOI 10.1530/EJE-07-0389; Carnevale V, 2010, J Endocrinol Invest, V33, P4; Cha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053013; Chen Y, 2010, BONE, V46, P129, DOI 10.1016/j.bone.2009.09.025; Deng FY, 2006, OSTEOPOROSIS INT, V17, P119, DOI 10.1007/s00198-005-1930-4; Ensrud KE, 2010, J CLIN ENDOCR METAB, V95, P5266, DOI 10.1210/jc.2010-2317; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fairbrother UL, 2007, J BONE MINER RES, V22, P544, DOI 10.1359/jbmr.070114; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerdhem P, 2007, J BONE JOINT SURG BR, V89B, P1627, DOI 10.1302/0301-620X.89B12.18946; Gerdhem P, 2004, CALCIFIED TISSUE INT, V74, P264, DOI 10.1007/s00223-002-2159-2; Gerdhem P, 2003, OSTEOPOROSIS INT, V14, P768, DOI 10.1007/s00198-003-1444-x; Gerdhem P, 2007, J BONE MINER RES, V22, P127, DOI 10.1359/JBMR.061003; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Gong Y, 2006, P NATL ACAD SCI USA, V103, P6154, DOI 10.1073/pnas.0601923103; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027312; Hawamdeh ZM, 2013, J CLIN DENSITOM; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Jungert A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-42; Karlsson MK, 1998, ACTA ORTHOP SCAND, V69, P189, DOI 10.3109/17453679809117626; Kumar J, 2011, BONE, V49, P343, DOI 10.1016/j.bone.2011.05.018; Kvaloy K, 2013, INT J OBESITY, V37, P1221, DOI 10.1038/ijo.2012.220; Lenora J, 2010, J CLIN DENSITOM, V13, P407, DOI 10.1016/j.jocd.2010.04.004; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Liu YZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006827; Liu YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003160; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; McGuigan F, 2008, EUR J ENDOCRINOL, V158, P661, DOI 10.1530/EJE-07-0757; McGuigan FE, 2007, CALCIFIED TISSUE INT, V81, P254, DOI 10.1007/s00223-007-9054-9; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Morris MS, 2005, BONE, V37, P234, DOI 10.1016/j.bone.2005.04.017; Nakazato M, 2011, EUR J NUTR, V50, P581, DOI 10.1007/s00394-010-0165-0; Namwongprom S, 2013, INT J WOMENS HEALTH, V5, P87, DOI 10.2147/IJWH.S41884; Patel MS, 2007, CALCIFIED TISSUE INT, V80, P337, DOI 10.1007/s00223-007-9015-3; Piters E, 2012, CALCIFIED TISSUE INT, V90, P30, DOI 10.1007/s00223-011-9546-5; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Skerry TM, 2003, CELL BIOCHEM FUNCT, V21, P223, DOI 10.1002/cbf.1077; Sun X, 2006, CALCIFIED TISSUE INT, V79, P43, DOI 10.1007/s00223-006-0041-3; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tenne M, 2010, CALCIFIED TISSUE INT, V86, P359, DOI 10.1007/s00223-010-9351-6; Timpson NJ, 2009, J BONE MINER RES, V24, P522, DOI 10.1359/JBMR.081109; Vacek TP, 2013, CLIN CHEM LAB MED, V51, P579, DOI 10.1515/cclm-2012-0605; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vaya A, 2011, CLIN HEMORHEOL MICRO, V47, P53, DOI 10.3233/CH-2010-1365; Vaya A, 2012, CLIN HEMORHEOL MICRO, V52, P49, DOI 10.3233/CH-2012-1544; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wardlaw GM, 1996, AM J CLIN NUTR, V63, P433; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xiao WJ, 2011, INT J OBESITY, V35, P378, DOI 10.1038/ijo.2010.157; Zhao JH, 2011, OBESITY, V19, P1311, DOI 10.1038/oby.2010.324; Zhao LJ, 2006, HUM GENET, V120, P561, DOI 10.1007/s00439-006-0243-9; Zhao LJ, 2010, J BONE MINER RES, V25, P320, DOI 10.1359/jbmr.090726	63	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88565	10.1371/journal.pone.0088565	http://dx.doi.org/10.1371/journal.pone.0088565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516669	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700077
J	Gauthier, A; Trouvelot, S; Kelloniemi, J; Frettinger, P; Wendehenne, D; Daire, X; Joubert, JM; Ferrarini, A; Delledonne, M; Flors, V; Poinssot, B				Gauthier, Adrien; Trouvelot, Sophie; Kelloniemi, Jani; Frettinger, Patrick; Wendehenne, David; Daire, Xavier; Joubert, Jean-Marie; Ferrarini, Alberto; Delledonne, Massimo; Flors, Victor; Poinssot, Benoit			The Sulfated Laminarin Triggers a Stress Transcriptome before Priming the SA- and ROS-Dependent Defenses during Grapevine's Induced Resistance against Plasmopara viticola	PLOS ONE			English	Article							BETA-AMINOBUTYRIC ACID; TRICHODERMA-HARZIANUM T39; PATTERN-RECOGNITION RECEPTORS; HYPERSENSITIVE CELL-DEATH; BOTRYTIS-CINEREA; PLANT IMMUNITY; DOWNY MILDEW; ENHANCED RESISTANCE; SYSTEMIC RESISTANCE; SIGNALING PATHWAY	Grapevine (Vitis vinifera) is susceptible to many pathogens which cause significant losses to viticulture worldwide. Chemical control is available, but agro-ecological concerns have raised interest in alternative methods, especially in triggering plant immunity by elicitor treatments. The beta-glucan laminarin (Lam) and its sulfated derivative (PS3) have been previously demonstrated to induce resistance in grapevine against downy mildew (Plasmopara viticola). However, if Lam elicits classical grapevine defenses such as oxidative burst, pathogenesis-related (PR)-proteins and phytoalexin production, PS3 triggered grapevine resistance via a poorly understood priming phenomenon. The aim of this study was to identify the molecular mechanisms of the PS3-induced resistance. For this purpose we studied i) the signaling events and transcriptome reprogramming triggered by PS3 treatment on uninfected grapevine, ii) grapevine immune responses primed by PS3 during P. viticola infection. Our results showed that i) PS3 was unable to elicit reactive oxygen species (ROS) production, cytosolic Ca2+ concentration variations, mitogen-activated protein kinase (MAPK) activation but triggered a long lasting plasma membrane depolarization in grapevine cells, ii) PS3 and Lam shared a common stress-responsive transcriptome profile that partly overlapped the salicylate-(SA) and jasmonate-(JA)-dependent ones. After P. viticola inoculation, PS3 specifically primed the SA-and ROS-dependent defense pathways leading to grapevine induced resistance against this biotroph. Interestingly pharmacological approaches suggested that the plasma membrane depolarization and the downstream ROS production are key events of the PS3-induced resistance.	[Gauthier, Adrien; Trouvelot, Sophie; Kelloniemi, Jani; Frettinger, Patrick; Wendehenne, David; Poinssot, Benoit] Univ Bourgogne, UMR Agroecol 1347, Dijon, France; [Daire, Xavier] INRA, UMR Agroecol 1347, F-21034 Dijon, France; [Joubert, Jean-Marie] Lab Goemar, St Malo, France; [Ferrarini, Alberto; Delledonne, Massimo] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy; [Flors, Victor] Univ Jaume 1, Plant Physiol Sect, Castellon de La Plana, Spain	Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Verona; Universitat Jaume I	Poinssot, B (corresponding author), Univ Bourgogne, UMR Agroecol 1347, Dijon, France.	benoit.poinssot@dijon.inra.fr	Poinssot, Benoit/AAK-5527-2020; Gauthier, Adrien/J-7862-2019; TROUVELOT, Sophie/AAE-4528-2020; poinssot, benoit/B-2569-2009; GAUTHIER, Adrien/H-5745-2013; Flors, Victor/H-4903-2015; Delledonne, Massimo/O-8685-2017	Poinssot, Benoit/0000-0001-5890-4318; Gauthier, Adrien/0000-0002-1351-353X; TROUVELOT, Sophie/0000-0003-1044-7458; poinssot, benoit/0000-0001-5890-4318; GAUTHIER, Adrien/0000-0002-1351-353X; Flors, Victor/0000-0003-3974-9652; Delledonne, Massimo/0000-0002-7100-4581; Wendehenne, David/0000-0002-1088-102X	Agence Nationale de la Recherche; Comite National des Interprofessions des Vins d'appelation d'origine (Genoplante "Safegrape" project) [08-GENO-148G]; Conseil Regional de Bourgogne; Bureau Interprofessionnel des Vins de Bourgogne [PARI AGRALE12]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Comite National des Interprofessions des Vins d'appelation d'origine (Genoplante "Safegrape" project); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Bureau Interprofessionnel des Vins de Bourgogne	This work was funded by Agence Nationale de la Recherche and Comite National des Interprofessions des Vins d'appelation d'origine (Genoplante "Safegrape" project 08-GENO-148G, Jani Kelloniemi), Conseil Regional de Bourgogne and Bureau Interprofessionnel des Vins de Bourgogne (PARI AGRALE12, Adrien Gauthier and Jani Kelloniemi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IP, 2007, PLANT PHYSIOL, V143, P838, DOI 10.1104/pp.106.092627; Aziz A, 2003, MOL PLANT MICROBE IN, V16, P1118, DOI 10.1094/MPMI.2003.16.12.1118; Aziz A, 2007, J EXP BOT, V58, P1463, DOI 10.1093/jxb/erm008; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Boubakri H, 2013, EUR J PLANT PATHOL, V136, P837, DOI 10.1007/s10658-013-0211-x; Boubakri H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-31; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; COHEN Y, 1994, PLANT PHYSIOL, V104, P59, DOI 10.1104/pp.104.1.59; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubreuil-Maurizi C, 2011, PLANT PHYSIOL, V157, P2000, DOI 10.1104/pp.111.182667; Dubreuil-Maurizi C, 2010, MOL PLANT MICROBE IN, V23, P1012, DOI 10.1094/MPMI-23-8-1012; Dufour MC, 2013, PLANT PATHOL, V62, P370, DOI 10.1111/j.1365-3059.2012.02628.x; Durgbanshi A, 2005, J AGR FOOD CHEM, V53, P8437, DOI 10.1021/jf050884b; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Galletti R, 2008, PLANT PHYSIOL, V148, P1695, DOI 10.1104/pp.108.127845; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gauthier A, 2007, PLANT SIGNAL BEHAV, V2, P86, DOI 10.4161/psb.2.2.4015; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Jeworutzki E, 2010, PLANT J, V62, P367, DOI 10.1111/j.1365-313X.2010.04155.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kachroo A, 2003, TRANSGENIC RES, V12, P577, DOI 10.1023/A:1025896513472; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Marchive C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054185; Menard R, 2005, PLANT CELL PHYSIOL, V46, P1964, DOI 10.1093/pcp/pci212; Menard R, 2004, PLANT CELL, V16, P3020, DOI 10.1105/tpc.104.024968; Mithofer A, 2005, MOL PLANT MICROBE IN, V18, P983, DOI 10.1094/MPMI-18-0983; Palmieri MC, 2012, J EXP BOT, V63, P6237, DOI 10.1093/jxb/ers279; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Perazzolli M, 2008, BIOL CONTROL, V47, P228, DOI 10.1016/j.biocontrol.2008.08.008; Perazzolli M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-660; Pick T, 2012, PLANT PHYSIOL, V159, P52, DOI 10.1104/pp.111.191841; Pinfield-Wells H, 2005, PLANT J, V43, P861, DOI 10.1111/j.1365-313X.2005.02498.x; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Poinssot B, 2003, MOL PLANT MICROBE IN, V16, P553, DOI 10.1094/MPMI.2003.16.6.553; PONTIER D, 1994, PLANT J, V5, P507, DOI 10.1046/j.1365-313X.1994.5040507.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Simon-Plas F, 2002, PLANT J, V31, P137, DOI 10.1046/j.1365-313X.2002.01342.x; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Steimetz E, 2012, PHYSIOL MOL PLANT P, V79, P89, DOI 10.1016/j.pmpp.2012.05.004; Ton J, 2005, PLANT CELL, V17, P987, DOI 10.1105/tpc.104.029728; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Tsai CH, 2011, PLANT J, V65, P469, DOI 10.1111/j.1365-313X.2010.04436.x; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Vandelle E, 2006, MOL PLANT MICROBE IN, V19, P429, DOI 10.1094/MPMI-19-0429; Verhagen BWM, 2004, MOL PLANT MICROBE IN, V17, P895, DOI 10.1094/MPMI.2004.17.8.895; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Zimmerli L, 2000, P NATL ACAD SCI USA, V97, P12920, DOI 10.1073/pnas.230416897	69	83	84	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88145	10.1371/journal.pone.0088145	http://dx.doi.org/10.1371/journal.pone.0088145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516597	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700046
J	Kreshuk, A; Koethe, U; Pax, E; Bock, DD; Hamprecht, FA				Kreshuk, Anna; Koethe, Ullrich; Pax, Elizabeth; Bock, Davi D.; Hamprecht, Fred A.			Automated Detection of Synapses in Serial Section Transmission Electron Microscopy Image Stacks	PLOS ONE			English	Article							SEGMENTATION; CIRCUIT; CHALLENGES; NEUROPIL	We describe a method for fully automated detection of chemical synapses in serial electron microscopy images with highly anisotropic axial and lateral resolution, such as images taken on transmission electron microscopes. Our pipeline starts from classification of the pixels based on 3D pixel features, which is followed by segmentation with an Ising model MRF and another classification step, based on object-level features. Classifiers are learned on sparse user labels; a fully annotated data subvolume is not required for training. The algorithm was validated on a set of 238 synapses in 20 serial 719767351 pixel images (4.5x4.5x45 nm resolution) of mouse visual cortex, manually labeled by three independent human annotators and additionally re-verified by an expert neuroscientist. The error rate of the algorithm (12% false negative, 7% false positive detections) is better than state-of-the-art, even though, unlike the state-of-the-art method, our algorithm does not require a prior segmentation of the image volume into cells. The software is based on the ilastik learning and segmentation toolkit and the vigra image processing library and is freely available on our website, along with the test data and gold standard annotations (http://www.ilastik.org/synapse-detection/sstem).	[Kreshuk, Anna; Koethe, Ullrich; Hamprecht, Fred A.] Heidelberg Univ, HCI IWR, Heidelberg, Germany; [Pax, Elizabeth] Wheaton Coll, Wheaton, IL 60187 USA; [Pax, Elizabeth; Bock, Davi D.; Hamprecht, Fred A.] Howard Hughes Med Inst, Ashburn, VA USA	Ruprecht Karls University Heidelberg; Wheaton College; Howard Hughes Medical Institute	Hamprecht, FA (corresponding author), Heidelberg Univ, HCI IWR, Heidelberg, Germany.	fred.hamprecht@iwr.uni-heidelberg.de		Koethe, Ullrich/0000-0001-6036-1287; Kreshuk, Anna/0000-0003-1334-6388	Howard Hughes Medical Institute (HHMI); Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; DFG [HA4364/6-1]	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; DFG(German Research Foundation (DFG))	The authors gratefully acknowledge partial funding by the Howard Hughes Medical Institute (HHMI, www.hhmi.org), Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences (http://mathcomp.uni-heidelberg.de/), and by the DFG under grant no. HA4364/6-1 (www.dfg.de). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 2011, J MICROSC-OXFORD, V241, P13, DOI 10.1111/j.1365-2818.20.10.03402.x; Anderson JR, 2011, MOL VIS, V17; Andres B, 2012, MED IMAGE ANAL, V16, P796, DOI 10.1016/j.media.2011.11.004; Becker C, 2012, MIC CAI INT C MED IM, P1; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Busse B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002976; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Ciresan D., 2012, ADV NEURAL INF PROCE, V25; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Funke J, 2012, PROC CVPR IEEE, P1004, DOI 10.1109/CVPR.2012.6247777; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Jagadeesh V, 2013, PATTERN RECOGNITION; Jain V., 2011, ADV NEURAL INFORM PR; Jurrus E, 2013, NEUROINFORMATICS, V11, P5, DOI 10.1007/s12021-012-9149-y; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kothe U, 2003, LECT NOTES COMPUT SC, V2781, P25; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; Kroeger T, 2013, INT C MED IM COMP CO; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Morales J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00018; Morgan JL, 2013, NAT METHODS, V10, P494, DOI 10.1038/nmeth.2480; Navlakha S, 2013, BIOINFORMATICS, V29, P9, DOI 10.1093/bioinformatics/btt222; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Peters A., 1991, FINE STRUCTURE NERVO; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Turaga S. C., 2009, P ADV NEUR INF PROC, V22, P1; Vazquez-Reina A, 2011, IEEE I CONF COMP VIS, P177, DOI 10.1109/ICCV.2011.6126240	37	34	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87351	10.1371/journal.pone.0087351	http://dx.doi.org/10.1371/journal.pone.0087351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516550	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700024
J	Liu, TJ; Yu, HF; Ullenbruch, M; Jin, H; Ito, T; Wu, Z; Liu, JH; Phan, SH				Liu, Tianju; Yu, Hongfeng; Ullenbruch, Matthew; Jin, Hong; Ito, Toshihiro; Wu, Zhe; Liu, Jianhua; Phan, Sem H.			The In Vivo Fibrotic Role of FIZZ1 in Pulmonary Fibrosis	PLOS ONE			English	Article							RESISTIN-LIKE MOLECULE; INDUCED MITOGENIC FACTOR; STEM-CELL FACTOR; DENDRITIC CELLS; MYOFIBROBLAST DIFFERENTIATION; TYPE-2 INFLAMMATION; LUNG; HYPOXIA; EXPRESSION; AIRWAY	FIZZ (found in inflammatory zone) 1, a member of a cysteine-rich secreted protein family, is highly induced in lung allergic inflammation and bleomycin induced lung fibrosis, and primarily expressed by airway and type II alveolar epithelial cells. This novel mediator is known to stimulate alpha-smooth muscle actin and collagen expression in lung fibroblasts. The objective of this study was to investigate the in vivo effects of FIZZ1 on the development of lung fibrosis by evaluating bleomycin-induced pulmonary fibrosis in FIZZ1 deficient mice. FIZZ1 knockout mice exhibited no detectable abnormality. When these mice were treated with bleomycin they exhibited significantly impaired pulmonary fibrosis relative to wild type mice, along with impaired proinflammatory cytokine/chemokine expression. Deficient lung fibroblast activation was also noted in the FIZZ1 knockout mice. Moreover, recruitment of bone marrow-derived cells to injured lung was deficient in FIZZ1 knockout mice. Interestingly in vitro FIZZ1 was shown to have chemoattractant activity for bone marrow cells, including bone marrow-derived dendritic cells. Finally, overexpression of FIZZ1 exacerbated fibrosis. These findings suggested that FIZZ1 exhibited profibrogenic properties essential for bleomycin induced pulmonary fibrosis, as reflected by its ability to induce myofibroblast differentiation and recruit bone marrow-derived cells.	[Liu, Tianju; Yu, Hongfeng; Ullenbruch, Matthew; Jin, Hong; Ito, Toshihiro; Wu, Zhe; Liu, Jianhua; Phan, Sem H.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Liu, TJ (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	tianliu@med.umich.edu	Phan, Sem H/A-7033-2009	Phan, Sem H/0000-0002-3711-2159	National Institutes of Health [HL028737, HL052285, HL091775, HL112880]; National Institute of Diabetes and Digestive and Kidney Diseases [DK020572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028737, R01HL052285, P01HL091775, R01HL028737, R01HL112880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grants HL028737, HL052285, HL091775 and HL112880). This work utilized the Vector and Transgenic Cores of the Michigan Diabetes Research and Training Center funded by DK020572 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011251; Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008; Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Bantsimba-Malanda C, 2010, AM J RESP CRIT CARE, V182, P385, DOI 10.1164/rccm.200907-1164OC; Blagoev B, 2002, J BIOL CHEM, V277, P42011, DOI 10.1074/jbc.M206975200; Chung MJ, 2007, J PATHOL, V212, P180, DOI 10.1002/path.2161; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Cook PC, 2012, P NATL ACAD SCI USA, V109, P9977, DOI 10.1073/pnas.1121231109; Ding L, 2013, J PATHOL, V230, P205, DOI 10.1002/path.4177; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Dolgachev VA, 2009, AM J PATHOL, V174, P390, DOI 10.2353/ajpath.2009.080513; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Ito T, 2009, AM J RESP CRIT CARE, V180, P1227, DOI 10.1164/rccm.200906-0892OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2011, J IMMUNOL, V187, P450, DOI 10.4049/jimmunol.1000964; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Madala SK, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-51; Medoff BD, 2009, J IMMUNOL, V182, P623, DOI 10.4049/jimmunol.182.1.623; Mishra A, 2007, AM J PHYSIOL-LUNG C, V293, pL305, DOI 10.1152/ajplung.00147.2007; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Osborne LC, 2013, J IMMUNOL, V190, P2292, DOI 10.4049/jimmunol.1200706; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Renigunta A, 2006, FEBS LETT, V580, P900, DOI 10.1016/j.febslet.2006.01.012; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Su QN, 2007, FASEB J, V21, P1376, DOI 10.1096/fj.06-6527com; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; Tsoumakidou M, 2009, RESPIRATION, V78, P446, DOI 10.1159/000226244; Wagner KF, 2004, AM J RESP CELL MOL, V31, P276, DOI 10.1165/rcmb.2003-0319OC; Yamaji-Kegan K, 2006, AM J PHYSIOL-LUNG C, V291, pL1159, DOI 10.1152/ajplung.00168.2006	50	39	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88362	10.1371/journal.pone.0088362	http://dx.doi.org/10.1371/journal.pone.0088362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516640	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700063
J	Mutke, MA; Madai, VI; von Samson-Himmelstjerna, FC; Weber, OZ; Revankar, GS; Martin, SZ; Stengl, KL; Bauer, M; Hetzer, S; Gunther, M; Sobesky, J				Mutke, Matthias A.; Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Weber, Olivier Zaro; Revankar, Gajanan S.; Martin, Steve Z.; Stengl, Katharina L.; Bauer, Miriam; Hetzer, Stefan; Guenther, Matthias; Sobesky, Jan			Clinical Evaluation of an Arterial-Spin-Labeling Product Sequence in Steno-Occlusive Disease of the Brain	PLOS ONE			English	Article							SUSCEPTIBILITY CONTRAST; MISMATCH; MRI; STROKE; DELAYS; QUIPSS; TIME; FLOW; PET	Introduction: In brain perfusion imaging, arterial spin labeling (ASL) is a noninvasive alternative to dynamic susceptibility contrast-magnetic resonance imaging (DSC-MRI). For clinical imaging, only product sequences can be used. We therefore analyzed the performance of a product sequence (PICORE-PASL) included in an MRI software-package compared with DSC-MRI in patients with steno-occlusion of the MCA or ICA > 70%. Methods: Images were acquired on a 3T MRI system and qualitatively analyzed by 3 raters. For a quantitative analysis, cortical ROIs were placed in co-registered ASL and DSC images. Pooled data for ASL-cerebral blood flow (CBF) and DSC-CBF were analyzed by Spearman's correlation and the Bland-Altman (BA)-plot. Results: In 28 patients, 11 ASL studies were uninterpretable due to patient motion. Of the remaining patients, 71% showed signs of delayed tracer arrival. A weak correlation for DSC-relCBF vs ASL-relCBF (r = 0.24) and a large spread of values in the BA-plot owing to unreliable CBF-measurement was found. Conclusion: The PICORE ASL product sequence is sensitive for estimation of delayed tracer arrival, but cannot be recommended to measure CBF in steno-occlusive disease. ASL-sequences that are less sensitive to patient motion and correcting for delayed blood flow should be available in the clinical setting.	[Mutke, Matthias A.; Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Weber, Olivier Zaro; Revankar, Gajanan S.; Martin, Steve Z.; Stengl, Katharina L.; Bauer, Miriam; Sobesky, Jan] Charite, Ctr Stroke Res, D-13353 Berlin, Germany; [von Samson-Himmelstjerna, Federico C.; Guenther, Matthias] Fraunhofer MEVIS, Bremen, Germany; [Hetzer, Stefan] Berlin Ctr Adv Neuroimaging, Berlin, Germany; [Weber, Olivier Zaro] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [Mutke, Matthias A.; Madai, Vince I.; von Samson-Himmelstjerna, Federico C.; Weber, Olivier Zaro; Martin, Steve Z.; Stengl, Katharina L.; Bauer, Miriam; Sobesky, Jan] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sobesky, J (corresponding author), Charite, Ctr Stroke Res, D-13353 Berlin, Germany.	jan.sobesky@charite.de	Madai, Vince/AAF-5525-2020; Madai, Vince/GYD-7365-2022	Madai, Vince/0000-0002-8552-6954; Madai, Vince/0000-0002-8552-6954; Sobesky, Jan/0000-0001-5459-3655; Martin, Steve/0000-0003-0653-6458; Revankar, Gajanan/0000-0002-3753-4140	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin'' [01 EO 0801]	German Federal Ministry of Education and Research via "Center for Stroke Research Berlin''	The research leading to these results has received funding from the German Federal Ministry of Education and Research via the grant "Center for Stroke Research Berlin'' (01 EO 0801; http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Bivard A, 2014, STROKE, V45, P127, DOI 10.1161/STROKEAHA.113.003218; Bivard A, 2013, J NEUROIMAGING, V23, P391, DOI 10.1111/j.1552-6569.2012.00728.x; Bokkers RPH, 2010, RADIOLOGY, V256, P201, DOI 10.1148/radiol.10091262; Bokkers RP, 2009, J CEREB BLOOD FLOW M, V30, P222, DOI DOI 10.1038/jcbfm.2009.204; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Chng SM, 2008, STROKE, V39, P3248, DOI 10.1161/STROKEAHA.108.520593; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Donahue MJ, 2012, STROKE, V43, P903, DOI 10.1161/STROKEAHA.111.635995; Golay Xavier, 2004, Top Magn Reson Imaging, V15, P10, DOI 10.1097/00002142-200402000-00003; Golay X, 2012, MAGN RESON MATER PHY, V25, P79, DOI 10.1007/s10334-012-0308-9; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; Gunther M, 2001, MAGNET RESON MED, V46, P974, DOI 10.1002/mrm.1284; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069085; Huck S, 2012, CLIN NEURORADIOL, V22, P29, DOI 10.1007/s00062-011-0126-x; Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144; Kamano H, 2013, ACTA RADIOL, V54, P99, DOI 10.1258/ar.2012.120450; Lehmann P, 2010, EUR NEUROL, V64, P21, DOI 10.1159/000311520; LEVIN JM, 1995, MAGN RESON MED, V34, P655, DOI 10.1002/mrm.1910340503; Lim YM, 2008, EPILEPSY RES, V82, P183, DOI 10.1016/j.eplepsyres.2008.08.001; Luh WM, 1999, MAGNET RESON MED, V41, P1246, DOI 10.1002/(SICI)1522-2594(199906)41:6<1246::AID-MRM22>3.0.CO;2-N; Maclntosh BJ, 2010, AM J NEURORADIOL, V31, P1892, DOI 10.3174/ajnr.A2008; Matsushima S, 2008, J MAGN RESON IMAGING, V27, P1103, DOI 10.1002/jmri.21362; Niibo T, 2013, STROKE, V44, P2601, DOI 10.1161/STROKEAHA.113.002097; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Qiu DQ, 2012, J MAGN RESON IMAGING, V36, P110, DOI 10.1002/jmri.23613; Sobesky J, 2012, J CEREBR BLOOD F MET, V32, P1416, DOI 10.1038/jcbfm.2012.54; Tatu L, 2012, FRONT NEUROL NEUROSC, V30, P99, DOI 10.1159/000333602; Uchihashi Y, 2011, AM J NEURORADIOL, V32, P1545, DOI 10.3174/ajnr.A2525; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b; Wolf RL, 2003, J NEUROIMAGING, V13, P17, DOI 10.1177/105122842003013001002; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522; Ye FQ, 1997, MAGN RESON MED, V37, P226, DOI 10.1002/mrm.1910370215; Zaharchuk G, 2012, TRANSL STROKE RES, V3, P228, DOI 10.1007/s12975-012-0159-8; Zaharchuk G, 2012, STROKE, V43, P1843, DOI 10.1161/STROKEAHA.111.639773	38	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87143	10.1371/journal.pone.0087143	http://dx.doi.org/10.1371/journal.pone.0087143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516546	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700021
J	Egan, JB; Barrett, MT; Champion, MD; Middha, S; Lenkiewicz, E; Evers, L; Francis, P; Shi, CX; Van Wier, S; Badar, S; Ahmann, G; Kortuem, KM; Boczek, NJ; Fonseca, R; Craig, DW; Carpten, JD; Borad, MJ; Stewart, AK				Egan, Jan B.; Barrett, Michael T.; Champion, Mia D.; Middha, Sumit; Lenkiewicz, Elizabeth; Evers, Lisa; Francis, Princy; Shi, Chang-Xin; Van Wier, Scott; Badar, Sandra; Ahmann, Gregory; Kortuem, K. Martin; Boczek, Nicole J.; Fonseca, Rafael; Craig, David W.; Carpten, John D.; Borad, Mitesh J.; Stewart, A. Keith			Whole Genome Analyses of a Well-Differentiated Liposarcoma Reveals Novel SYT1 and DDR2 Rearrangements	PLOS ONE			English	Article							HUMAN MYELOID-LEUKEMIA; RNA-BINDING PROTEIN; L1 RETROTRANSPOSITION; EXTRACELLULAR-MATRIX; TYROSINE KINASES; GENE; HYBRIDIZATION; EXPRESSION; SEQUENCES; CELLS	Liposarcoma is the most common soft tissue sarcoma, but little is known about the genomic basis of this disease. Given the low cell content of this tumor type, we utilized flow cytometry to isolate the diploid normal and aneuploid tumor populations from a well-differentiated liposarcoma prior to array comparative genomic hybridization and whole genome sequencing. This work revealed massive highly focal amplifications throughout the aneuploid tumor genome including MDM2, a gene that has previously been found to be amplified in well-differentiated liposarcoma. Structural analysis revealed massive rearrangement of chromosome 12 and 11 gene fusions, some of which may be part of double minute chromosomes commonly present in well-differentiated liposarcoma. We identified a hotspot of genomic instability localized to a region of chromosome 12 that includes a highly conserved, putative L1 retrotransposon element, LOC100507498 which resides within a gene cluster (NAV3, SYT1, PAWR) where 6 of the 11 fusion events occurred. Interestingly, a potential gene fusion was also identified in amplified DDR2, which is a potential therapeutic target of kinase inhibitors such as dastinib, that are not routinely used in the treatment of patients with liposarcoma. Furthermore, 7 somatic, damaging single nucleotide variants have also been identified, including D125N in the PTPRQ protein. In conclusion, this work is the first to report the entire genome of a well-differentiated liposarcoma with novel chromosomal rearrangements associated with amplification of therapeutically targetable genes such as MDM2 and DDR2.	[Egan, Jan B.; Fonseca, Rafael; Borad, Mitesh J.; Stewart, A. Keith] Mayo Clin Scottsdale, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA; [Barrett, Michael T.; Lenkiewicz, Elizabeth; Evers, Lisa] Translat Genom Res Inst, Clin Translat Res Div, Phoenix, AZ USA; [Champion, Mia D.] Mayo Clin Scottsdale, Dept Biomed Stat & Informat, Scottsdale, AZ USA; [Champion, Mia D.] Mayo Clin, Ctr Individualized Med, Rochester, MN USA; [Middha, Sumit] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Francis, Princy; Shi, Chang-Xin; Van Wier, Scott; Badar, Sandra; Ahmann, Gregory; Kortuem, K. Martin; Boczek, Nicole J.] Mayo Clin Scottsdale, Scottsdale, AZ USA; [Boczek, Nicole J.] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Fonseca, Rafael; Borad, Mitesh J.; Stewart, A. Keith] Mayo Clin Scottsdale, Div Hematol Oncol, Scottsdale, AZ USA; [Craig, David W.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ USA; [Carpten, John D.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Translational Genomics Research Institute; Translational Genomics Research Institute	Stewart, AK (corresponding author), Mayo Clin Scottsdale, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA.	stewart.keith@mayo.edu	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955; Middha, Sumit/0000-0003-4135-6268	National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]; Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation; NIH [K12 CA90628];  [SPORE CA90297052];  [P01 CA62242];  [R01 CA83724];  [ECOG CA 21115T]; NATIONAL CANCER INSTITUTE [K12CA090628, P01CA062242, U10CA021115, R01CA083724] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This publication was made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. Rafael Fonseca is a Clinical Investigator of the Damon Runyon Cancer Research Fund. This work is supported by grants SPORE CA90297052, P01 CA62242, R01 CA83724, ECOG CA 21115T, Predolin Foundation, Mayo Clinic Cancer Center and the Mayo Foundation. This study was supported by NIH Grant Number K12 CA90628. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aksoy O, 2012, GENE DEV, V26, P1546, DOI 10.1101/gad.196238.112; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ALVES F, 1995, ONCOGENE, V10, P609; Asmann YW, 2012, BIOINFORMATICS, V28, P277, DOI 10.1093/bioinformatics/btr612; Badiola I, 2012, GUT, V61, P1465, DOI 10.1136/gutjnl-2011-300810; Badiola I, 2011, ONCOL REP, V26, P971, DOI 10.3892/or.2011.1356; Bai Y, 2012, CANCER RES, V72, P2501, DOI 10.1158/0008-5472.CAN-11-3015; Boland MV, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-6; Carlini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014221; Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111; Chin SF, 2003, J CLIN PATHOL-MOL PA, V56, P275, DOI 10.1136/mp.56.5.275; Chua HH, 2008, HEAD NECK-J SCI SPEC, V30, P427, DOI 10.1002/hed.20724; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; Crago AM, 2011, CURR OPIN ONCOL, V23, P373, DOI 10.1097/CCO.0b013e32834796e6; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Erickson-Johnson MR, 2009, MODERN PATHOL, V22, P1541, DOI 10.1038/modpathol.2009.149; Fletcher CDM., 2002, WHO CLASSIFICATION T; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Ford CE, 2007, BRIT J CANCER, V96, P808, DOI 10.1038/sj.bjc.6603614; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P8, DOI 10.1002/gcc.2870140103; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Haines DS, 1997, LEUKEMIA LYMPHOMA, V26, P227, DOI 10.3109/10428199709051772; Hameed M, 2007, CYTOGENET GENOME RES, V118, P138, DOI 10.1159/000108294; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; ICHIKAWA H, 1994, CANCER RES, V54, P2865; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jones RL, 2005, EUR J CANCER, V41, P2853, DOI 10.1016/j.ejca.2005.07.023; Jung H, 2009, BIOCHEM BIOPH RES CO, V383, P252, DOI 10.1016/j.bbrc.2009.04.001; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kathir KM, 2010, BBA-BIOMEMBRANES, V1798, P297, DOI 10.1016/j.bbamem.2009.09.024; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Koso H, 2012, P NATL ACAD SCI USA, V109, pE2998, DOI 10.1073/pnas.1215899109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurino L, 2001, SEMIN DIAGN PATHOL, V18, P258, DOI 10.1053/sdia.2001.28254; Lee NO, 2012, J CANCER RES CLIN, V138, P73, DOI 10.1007/s00432-011-1075-0; Maeyama M, 2008, CANCER, V113, P2823, DOI 10.1002/cncr.23900; MANDAHL N, 1994, GENE CHROMOSOME CANC, V9, P207, DOI 10.1002/gcc.2870090309; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; PANAGOPOULOS I, 1995, ONCOGENE, V11, P1133; Pedeutour F, 1999, GENE CHROMOSOME CANC, V24, P30, DOI 10.1002/(SICI)1098-2264(199901)24:1<30::AID-GCC5>3.0.CO;2-P; Peng PD, 2009, GENE THER, V16, P1042, DOI 10.1038/gt.2009.54; Pfeiffer MJ, 2011, MOL MED, V17, P657, DOI 10.2119/molmed.2010.00143; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pilotti S, 1998, J PATHOL, V185, P188; Pitini V, 2013, LUNG CANCER, V82, P171, DOI 10.1016/j.lungcan.2013.07.004; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodrigues R, 2007, ONCOL REP, V18, P917; Rubin BP, 2001, SEMIN DIAGN PATHOL, V18, P286, DOI 10.1053/sdia.2001.27844; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Ruiz PA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-3; SHIMIZU K, 1993, P NATL ACAD SCI USA, V90, P10280, DOI 10.1073/pnas.90.21.10280; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; SREEKANTAIAH C, 1992, CANCER, V69, P2484; Szak ST, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r30; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tap WD, 2011, GENE CHROMOSOME CANC, V50, P95, DOI 10.1002/gcc.20835; Tos APD, 2000, J PATHOL, V190, P531; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Willenbrock K, 2006, HAEMATOLOGICA, V91, P596	79	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87113	10.1371/journal.pone.0087113	http://dx.doi.org/10.1371/journal.pone.0087113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505276	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200035
J	Hyun, TK; Lee, S; Rim, Y; Kumar, R; Han, X; Lee, SY; Lee, CH; Kim, JY				Hyun, Tae Kyung; Lee, Sarah; Rim, Yeonggil; Kumar, Ritesh; Han, Xiao; Lee, Sang Yeol; Lee, Choong Hwan; Kim, Jae-Yean			De-novo RNA Sequencing and Metabolite Profiling to Identify Genes Involved in Anthocyanin Biosynthesis in Korean Black Raspberry (Rubus coreanus Miquel)	PLOS ONE			English	Article							TOMATO SOLANUM-LYCOPERSICON; GRAPE BERRY DEVELOPMENT; FRUIT-DEVELOPMENT; CHALCONE ISOMERASE; ANTIOXIDANT ACTIVITY; FLAVONOID MUTANTS; MASS-SPECTROMETRY; SHELF-LIFE; EXPRESSION; STRAWBERRY	The Korean black raspberry (Rubus coreanus Miquel, KB) on ripening is usually consumed as fresh fruit, whereas the unripe KB has been widely used as a source of traditional herbal medicine. Such a stage specific utilization of KB has been assumed due to the changing metabolite profile during fruit ripening process, but so far molecular and biochemical changes during its fruit maturation are poorly understood. To analyze biochemical changes during fruit ripening process at molecular level, firstly, we have sequenced, assembled, and annotated the transcriptome of KB fruits. Over 4.86 Gb of normalized cDNA prepared from fruits was sequenced using Illumina HiSeq (TM) 2000, and assembled into 43,723 unigenes. Secondly, we have reported that alterations in anthocyanins and proanthocyanidins are the major factors facilitating variations in these stages of fruits. In addition, up-regulation of F3'H1, DFR4 and LDOX1 resulted in the accumulation of cyanidin derivatives during the ripening process of KB, indicating the positive relationship between the expression of anthocyanin biosynthetic genes and the anthocyanin accumulation. Furthermore, the ability of RcMCHI2 (R. coreanus Miquel chalcone flavanone isomerase 2) gene to complement Arabidopsis transparent testa 5 mutant supported the feasibility of our transcriptome library to provide the gene resources for improving plant nutrition and pigmentation. Taken together, these datasets obtained from transcriptome library and metabolic profiling would be helpful to define the gene-metabolite relationships in this non-model plant.	[Hyun, Tae Kyung; Rim, Yeonggil; Kumar, Ritesh; Han, Xiao; Lee, Sang Yeol; Kim, Jae-Yean] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci BK21plus, Jinju, South Korea; [Lee, Sarah; Lee, Choong Hwan] Konkuk Univ, Div Biosci & Biotechnol, Seoul, South Korea	Gyeongsang National University; Konkuk University	Lee, CH (corresponding author), Konkuk Univ, Div Biosci & Biotechnol, Seoul, South Korea.	chlee123@konkuk.ac.kr; kimjy@gnu.ac.kr	Kumar, Ritesh/GQP-7630-2022; han, xiao/CAI-6839-2022; han, xiao/CAG-0473-2022; Kumar, Ritesh/AAU-5863-2020	Kumar, Ritesh/0000-0002-2836-6181; han, xiao/0000-0002-4557-1304; Kumar, Ritesh/0000-0002-2836-6181	Next-Generation BioGreen 21 Program (SSAC grant), Rural Development Administration, Republic of Korea [PJ009495, PJ00952004]	Next-Generation BioGreen 21 Program (SSAC grant), Rural Development Administration, Republic of Korea	This work was supported by Science and Technology and a grant from the Next-Generation BioGreen 21 Program (SSAC grant PJ009495; PJ00952004), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Ali K, 2011, FOOD CHEM, V124, P1760, DOI 10.1016/j.foodchem.2010.08.015; Ash MM, 2011, J MED FOOD, V14, P1032, DOI 10.1089/jmf.2010.0181; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Bovy A, 2007, METABOLOMICS, V3, P399, DOI 10.1007/s11306-007-0074-2; Burbulis IE, 1999, P NATL ACAD SCI USA, V96, P12929, DOI 10.1073/pnas.96.22.12929; Bushakra JM, 2012, THEOR APPL GENET, V125, P311, DOI 10.1007/s00122-012-1835-5; Carrari F, 2006, J EXP BOT, V57, P1883, DOI 10.1093/jxb/erj020; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Centeno DC, 2011, PLANT CELL, V23, P162, DOI 10.1105/tpc.109.072231; Chen HS, 2011, J FOOD SCI, V76, pT192, DOI 10.1111/j.1750-3841.2011.02373.x; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Dong XY, 2001, PLANT PHYSIOL, V127, P46, DOI 10.1104/pp.127.1.46; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; Etienne A, 2013, J EXP BOT, V64, P1451, DOI 10.1093/jxb/ert035; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Faurobert M, 2007, PLANT PHYSIOL, V143, P1327, DOI 10.1104/pp.106.092817; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Heppel SC, 2013, PLANT MOL BIOL, V82, P457, DOI 10.1007/s11103-013-0074-8; Hong LL, 2012, PLANTA, V236, P141, DOI 10.1007/s00425-012-1598-x; Hummer KE, 2010, HORTSCIENCE, V45, P1587, DOI 10.21273/HORTSCI.45.11.1587; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Hyun TK, 2009, FUNCT PLANT BIOL, V36, P1088, DOI 10.1071/FP09136; Jaakola L, 2002, PLANT PHYSIOL, V130, P729, DOI 10.1104/pp.006957; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Ju HK, 2009, J PHARMACEUT BIOMED, V49, P820, DOI 10.1016/j.jpba.2008.12.024; Kim HS, 2011, FOOD RES INT, V44, P1977, DOI 10.1016/j.foodres.2011.01.023; Lee JS, 2005, RAPID COMMUN MASS SP, V19, P3539, DOI 10.1002/rcm.2230; Lee J, 2012, FOOD CHEM, V130, P785, DOI 10.1016/j.foodchem.2011.08.022; Lee S, 2012, J AGR FOOD CHEM, V60, P11222, DOI 10.1021/jf3026309; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046070; Lim JW, 2012, J AGR FOOD CHEM, V60, P5121, DOI 10.1021/jf205350k; Lombardo VA, 2011, PLANT PHYSIOL, V157, P1696, DOI 10.1104/pp.111.186064; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meyer E, 2012, PLANT J, V70, P879, DOI 10.1111/j.1365-313X.2012.04938.x; Montrose DC, 2011, CARCINOGENESIS, V32, P343, DOI 10.1093/carcin/bgq248; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Oms-Oliu G, 2011, POSTHARVEST BIOL TEC, V62, P7, DOI 10.1016/j.postharvbio.2011.04.010; Ozgen M, 2008, HORTSCIENCE, V43, P2039, DOI 10.21273/HORTSCI.43.7.2039; Park JH, 2012, ASIAN J ANIM VET ADV, V7, P970, DOI 10.3923/ajava.2012.970.979; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Reuber S, 1997, PHYSIOL PLANTARUM, V101, P827, DOI 10.1111/j.1399-3054.1997.tb01070.x; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schwarz R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-135; SEON LEE IN, 2007, [Journal of Life Science, 생명과학회지], V17, P1723; Shimada N, 2003, PLANT PHYSIOL, V131, P941, DOI 10.1104/pp.004820; Shin TY, 2002, PHYTOTHER RES, V16, P508, DOI 10.1002/ptr.925; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Smith ED, 2011, METABOLOMICS, V7, P126, DOI 10.1007/s11306-010-0238-3; Steinhauser MC, 2010, PLANT PHYSIOL, V153, P80, DOI 10.1104/pp.110.154336; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Yin YG, 2010, PLANT CELL PHYSIOL, V51, P1300, DOI 10.1093/pcp/pcq090; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang Y, 2013, CURR BIOL, V23, P1094, DOI 10.1016/j.cub.2013.04.072; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950; 권민철, 2007, [KOREAN JOURNAL OF MEDICINAL CROP SCIENCE, 한국약용작물학회지], V15, P398	66	51	54	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88292	10.1371/journal.pone.0088292	http://dx.doi.org/10.1371/journal.pone.0088292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505466	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200167
J	Li, Y; Yue, XF; Que, YW; Yan, X; Ma, ZH; Talbot, NJ; Wang, ZY				Li, Ya; Yue, Xiaofeng; Que, Yawei; Yan, Xia; Ma, Zhonghua; Talbot, Nicholas J.; Wang, Zhengyi			Characterisation of Four LIM Protein-Encoding Genes Involved in Infection-Related Development and Pathogenicity by the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PAXILLIN-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; PLANT INFECTION; DOMAIN PROTEINS; BINDING; MOTIFS; IDENTIFICATION; ADHESION; GROWTH	LIM domain proteins contain contiguous double-zinc finger domains and play important roles in cytoskeletal reorganisation and organ development in multi-cellular eukaryotes. Here, we report the characterization of four genes encoding LIM proteins in the rice blast fungus Magnaporthe oryzae. Targeted gene replacement of either the paxillin-encoding gene, PAX1, or LRG1 resulted in a significant reduction in hyphal growth and loss of pathogenicity, while deletion of RGA1 caused defects in conidiogenesis and appressorium development. A fourth LIM domain gene, LDP1, was not required for infection-associated development by M. oryzae. Live cell imaging revealed that Lrg1-GFP and Rga1-GFP both localize to septal pores, while Pax1-GFP is present in the cytoplasm. To explore the function of individual LIM domains, we carried out systematic deletion of each LIM domain, which revealed the importance of the Lrg1-LIM2 and Lrg1-RhoGAP domains for Lrg1 function and overlapping functions of the three LIM domains of Pax1. Interestingly, deletion of either PAX1 or LRG1 led to decreased sensitivity to cell wall-perturbing agents, such as Congo Red and SDS (sodium dodecyl sulfate). qRT-PCR analysis demonstrated the importance of both Lrg1 and Pax1 to regulation of genes associated with cell wall biogenesis. When considered together, our results indicate that LIM domain proteins are key regulators of infection-associated morphogenesis by the rice blast fungus.	[Li, Ya; Yue, Xiaofeng; Que, Yawei; Yan, Xia; Ma, Zhonghua; Wang, Zhengyi] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Yan, Xia; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Zhejiang University; University of Exeter	Wang, ZY (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	zhywang@zju.edu.cn	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	National Key Basic Research and Development Program of China [2012CB114002]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; Natural Science Foundation of China [31071648, 30970129]; Ministry of Education of China [20100101110097]; ERC Advanced Investigator Award GENBLAST	National Key Basic Research and Development Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); ERC Advanced Investigator Award GENBLAST	This work was supported by National Key Basic Research and Development Program of China (2012CB114002), by Program for Changjiang Scholars and Innovative Research Team in University (IRT0943), by the Natural Science Foundation of China (Grant No. 31071648 and 30970129) and the Doctoral Fund of Ministry of Education of China (20100101110097) to ZW. NJT is supported by an ERC Advanced Investigator Award GENBLAST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2002, INT J BIOCHEM CELL B, V34, P855, DOI 10.1016/S1357-2725(01)00154-6; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Feng QY, 2002, J BIOL CHEM, V277, P5644, DOI 10.1074/jbc.M107704200; FEUERSTEIN R, 1994, P NATL ACAD SCI USA, V91, P10655, DOI 10.1073/pnas.91.22.10655; Fitch PG, 2004, GENETICS, V168, P733, DOI 10.1534/genetics.104.028027; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Ge WZ, 2008, MOL BIOL CELL, V19, P1680, DOI 10.1091/mbc.E07-07-0715; Herreros L, 2000, J BIOL CHEM, V275, P26436, DOI 10.1074/jbc.M003970200; Jurata LW, 1998, CURR TOP MICROBIOL, V228, P75; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; Khurana T, 2002, PROTOPLASMA, V219, P1, DOI 10.1007/s007090200000; Knechtle P, 2008, FUNGAL GENET BIOL, V45, P829, DOI 10.1016/j.fgb.2008.03.010; Koch BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033261; LEUNG H, 1988, PHYTOPATHOLOGY, V78, P1227, DOI 10.1094/Phyto-78-1227; Li Y, 2010, MOL PLANT MICROBE IN, V23, P1260, DOI 10.1094/MPMI-03-10-0052; Li Y, 2010, MOL PLANT MICROBE IN, V23, P317, DOI 10.1094/MPMI-23-3-0317; Lickfeld M, 2012, MOL MICROBIOL, V85, P574, DOI 10.1111/j.1365-2958.2012.08128.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorberg A, 2001, MOL GENET GENOMICS, V266, P514; Mackin NA, 2004, MOL BIOL CELL, V15, P1904, DOI 10.1091/mbc.E04-01-0004; MULLER L, 1994, NUCLEIC ACIDS RES, V22, P3151, DOI 10.1093/nar/22.15.3151; Pinar M, 2008, MOL BIOL CELL, V19, P1727, DOI 10.1091/mbc.E07-07-0718; SADLER I, 1992, J CELL BIOL, V119, P1573, DOI 10.1083/jcb.119.6.1573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMEICHEL KL, 1994, CELL, V79, P211, DOI 10.1016/0092-8674(94)90191-0; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; Stanyon CA, 1999, INT J BIOCHEM CELL B, V31, P389, DOI 10.1016/S1357-2725(98)00116-2; STEVENSON BJ, 1995, GENE DEV, V9, P2949, DOI 10.1101/gad.9.23.2949; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Svarovsky MJ, 2005, YEAST, V22, P1117, DOI 10.1002/yea.1301; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; TAIRA M, 1995, TRENDS GENET, V11, P431, DOI 10.1016/S0168-9525(00)89139-8; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; TURNER CE, 1994, J CELL SCI, V107, P1583; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Villalba F, 2008, FUNGAL GENET BIOL, V45, P68, DOI 10.1016/j.fgb.2007.06.006; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Watanabe D, 2001, YEAST, V18, P943, DOI 10.1002/yea.742; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yan X, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002385; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126	55	9	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88246	10.1371/journal.pone.0088246	http://dx.doi.org/10.1371/journal.pone.0088246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505448	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200152
J	Lv, CQ; Kong, HR; Dong, GH; Liu, LW; Tong, K; Sun, HW; Chen, BC; Zhang, CW; Zhou, MT				Lv, Chongqing; Kong, Hongru; Dong, Guohua; Liu, Lewei; Tong, Kun; Sun, Hongwei; Chen, Bicheng; Zhang, Chunwu; Zhou, Mengtao			Antitumor Efficacy of alpha-Solanine against Pancreatic Cancer In Vitro and In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; STEROIDAL GLYCOALKALOIDS; TRANSCRIPTION FACTORS; CELLS; GROWTH; METASTASIS; INHIBITION; PATHWAY; PROLIFERATION; ANGIOGENESIS	alpha-solanine, a steroidal glycoalkaloid in potato, was found to have proliferation-inhibiting and apoptosis-promoting effect on multiple cancer cells, such as clone, liver, melanoma cancer cells. However, the antitumor efficacy of alpha-solanine on pancreatic cancer has not been fully evaluated. In this study, we inquired into the anti-carcinogenic effect of alpha-solanine against human pancreatic cancer cells. In the present study, we investigated the anti-carcinogenic effect of alpha-solanine against human pancreatic cancer cells. In vitro, alpha-solanine inhibited proliferation of PANC-1, sw1990, MIA PaCa-2 cells in a dose-dependent manner, as well as cell migration and invasion with atoxic doses. The expression of MMP-2/9, extracellular inducer of matrix metalloproteinase (EMMPRIN), CD44, eNOS and E-cadherin were suppressed by alpha-solanine in PANC-1 cells. Moreover, significantly decreased vascular endothelial growth factor (VEGF) expression and tube formation of endothelial cells were discerned following alpha-solanine treatment. Suppressed phosphorylation of Akt, mTOR, and Stat3, and strengthen phosphorylation of beta-catenin was found, along with markedly decreased tran-nuclear of NF-kappa B, beta-catenin and TCF-1. Following the administration of alpha-solanine (6 mu g/g for 2 weeks) in xenograft model, tumor volume and weight were decreased by 61% and 43% (p<0.05) respectively, showing decreased MMP-2/9, PCNA and VEGF expression. In conclusion, alpha-solanine showed beneficial effects on pancreatic cancer in vitro and in vivo, which may via suppressing the pathway proliferation, angiogenesis and metastasis.	[Lv, Chongqing; Kong, Hongru; Dong, Guohua; Liu, Lewei; Tong, Kun; Sun, Hongwei; Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Chen, Bicheng; Zhang, Chunwu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou Key Lab Surg,Zhejiang Prov Top Key Discip, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China.	zmt0417@hotmail.com		Zhou, Mengtao/0000-0002-2455-250X	China National Natural Science Foundation [81070372, 81370563]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China [WKJ2012-2-033, 2011ZA072]; District Research and Development Program of Longwan District of Wenzhou, Zhejiang, China [2010YS5]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China; District Research and Development Program of Longwan District of Wenzhou, Zhejiang, China	The study was sponsored from China National Natural Science Foundation (No. 81070372, No. 81370563), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents and a Provincial Administration of Traditional Chinese Medicine of Zhejiang Province, China (NO. WKJ2012-2-033, No. 2011ZA072), a District Research and Development Program of Longwan District of Wenzhou, Zhejiang, China (No. 2010YS5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankemeyer JT, 1998, FOOD CHEM TOXICOL, V36, P383, DOI 10.1016/S0278-6915(97)00164-6; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bosetti C, 2012, MOL CARCINOGEN, V51, P3, DOI 10.1002/mc.20785; Buda A, 2011, CELL COMMUN ADHES, V18, P131, DOI 10.3109/15419061.2011.636465; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; DANIAL NN, 1995, SCIENCE, V269, P1875, DOI 10.1126/science.7569929; Ding X, 2013, FOOD CHEM, V141, P1181, DOI 10.1016/j.foodchem.2013.03.062; Ducreux M, 2007, BEST PRACT RES CL GA, V21, P997, DOI 10.1016/j.bpg.2007.10.025; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gao L, 2013, CANC CYTOPATHOL; Gateley K, 1990, J Tenn Med Assoc, V83, P512; GouilleuxGruart V, 1996, BLOOD, V87, P1692; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Guo C, 2009, ONCOGENE, V28, P1151, DOI 10.1038/onc.2008.460; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kang H, 2011, AM J CHINESE MED, V39, P1261, DOI 10.1142/S0192415X11009548; Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim H, 2012, MOL CANCER THER, V11, P405, DOI 10.1158/1535-7163.MCT-11-0581; Kim J, 2012, CYTOKINE, V60, P242, DOI 10.1016/j.cyto.2012.06.013; Ksiazkiewicz M, 2012, PATHOBIOLOGY, V79, P195, DOI 10.1159/000337106; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Mohsenikia M, 2013, EUR J PHARMACOL, V718, P1, DOI 10.1016/j.ejphar.2013.09.015; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Ohara Y, 2013, CANC SCI; Ceballos MP, 2011, BIOCHEM PHARMACOL, V82, P1682, DOI 10.1016/j.bcp.2011.08.001; Prajapati V., 2012, CANC LETT; Riethdorf S, 2006, INT J CANCER, V119, P1800, DOI 10.1002/ijc.22062; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Smigielski J, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-137; Wang S, 2005, ANIM REPROD SCI, V85, P243, DOI 10.1016/j.anireprosci.2004.06.002; WATSON CJ, 1995, BRIT J CANCER, V71, P840, DOI 10.1038/bjc.1995.162; Yamamoto T, 2012, CANCER LETT, V320, P31, DOI 10.1016/j.canlet.2012.01.023; Yamashoji S, 2013, FOOD CHEM, V141, P669, DOI 10.1016/j.foodchem.2013.03.104; Yang SA, 2006, FOOD CHEM TOXICOL, V44, P839, DOI 10.1016/j.fct.2005.11.007; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhao M, 2013, CANCER LETT, V337, P210, DOI 10.1016/j.canlet.2013.05.009	45	56	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87868	10.1371/journal.pone.0087868	http://dx.doi.org/10.1371/journal.pone.0087868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505326	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200080
J	Petrov, AS; Bernier, CR; Gulen, B; Waterbury, CC; Hershkovits, E; Hsiao, CL; Harvey, SC; Hud, NV; Fox, GE; Wartell, RM; Williams, LD				Petrov, Anton S.; Bernier, Chad R.; Gulen, Burak; Waterbury, Chris C.; Hershkovits, Eli; Hsiao, Chiaolong; Harvey, Stephen C.; Hud, Nicholas V.; Fox, George E.; Wartell, Roger M.; Williams, Loren Dean			Secondary Structures of rRNAs from All Three Domains of Life	PLOS ONE			English	Article							EUKARYOTIC RIBOSOME; BACTERIAL RIBOSOME; STRUCTURE MODEL; 80S RIBOSOME; 16S; PSEUDOKNOT; 23S; RESOLUTION; NETWORKS; MOTIFS	Accurate secondary structures are important for understanding ribosomes, which are extremely large and highly complex. Using 3D structures of ribosomes as input, we have revised and corrected traditional secondary (2 degrees) structures of rRNAs. We identify helices by specific geometric and molecular interaction criteria, not by co-variation. The structural approach allows us to incorporate non-canonical base pairs on parity with Watson-Crick base pairs. The resulting rRNA 2 degrees structures are up-to-date and consistent with three-dimensional structures, and are information-rich. These 2 degrees structures are relatively simple to understand and are amenable to reproduction and modification by end-users. The 2 degrees structures made available here broadly sample the phylogenetic tree and are mapped with a variety of data related to molecular interactions and geometry, phylogeny and evolution. We have generated 2 degrees structures for both large subunit (LSU) 23S/28S and small subunit (SSU) 16S/18S rRNAs of Escherichia coli, Thermus thermophilus, Haloarcula marismortui (LSU rRNA only), Saccharomyces cerevisiae, Drosophila melanogaster, and Homo sapiens. We provide high-resolution editable versions of the 2 degrees structures in several file formats. For the SSU rRNA, the 2 degrees structures use an intuitive representation of the central pseudoknot where base triples are presented as pairs of base pairs. Both LSU and SSU secondary maps are available (http://apollo.chemistry.gatech.edu/RibosomeGallery). Mapping of data onto 2 degrees structures was performed on the RiboVision server (http://apollo.chemistry.gatech.edu/RiboVision).	[Petrov, Anton S.; Bernier, Chad R.; Gulen, Burak; Waterbury, Chris C.; Hershkovits, Eli; Hsiao, Chiaolong; Harvey, Stephen C.; Hud, Nicholas V.; Fox, George E.; Wartell, Roger M.; Williams, Loren Dean] Georgia Inst Technol, Ctr Ribosomal Origins & Evolut, Atlanta, GA 30332 USA; [Petrov, Anton S.; Bernier, Chad R.; Gulen, Burak; Waterbury, Chris C.; Hershkovits, Eli; Hsiao, Chiaolong; Harvey, Stephen C.; Hud, Nicholas V.; Wartell, Roger M.; Williams, Loren Dean] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Fox, George E.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Houston System; University of Houston	Petrov, AS (corresponding author), Georgia Inst Technol, Ctr Ribosomal Origins & Evolut, Atlanta, GA 30332 USA.	anton.petrov@biology.gatech.edu	Hud, Nicholas V/T-7017-2017; Willson, richard/AAD-4832-2019; Bernier, Chad/C-7554-2013	Gulen, Burak/0000-0003-2945-3428; Bernier, Chad/0000-0003-2368-548X	NASA Astrobiology Institute [NNA09DA78A]	NASA Astrobiology Institute	This work was supported by the NASA Astrobiology Institute (NNA09DA78A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Belanger F, 2005, RNA, V11, P906, DOI 10.1261/rna.2160405; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bernier C, 2014, DISCUSSIONS IN PRESS; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; Gregory ST, 2009, RNA, V15, P215, DOI 10.1261/rna.1374809; Gutell RR, 2002, CURR OPIN STRUC BIOL, V12, P301, DOI 10.1016/S0959-440X(02)00339-1; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Leontis NB, 1998, J MOL BIOL, V283, P571, DOI 10.1006/jmbi.1998.2106; Leontis NB, 2002, NUCLEIC ACIDS RES, V30, P3497, DOI 10.1093/nar/gkf481; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; NOLLER HF, 1981, NUCLEIC ACIDS RES, V9, P6167, DOI 10.1093/nar/9.22.6167; Petrov AS, 2013, NUCLEIC ACIDS RES, V41, P7522, DOI 10.1093/nar/gkt513; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; RICHARDS EG, 1969, EUR J BIOCHEM, V10, P36; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Sarver M, 2008, J MATH BIOL, V56, P215, DOI 10.1007/s00285-007-0110-x; SEARLS DB, 1992, AM SCI, V80, P579; Segerstolpe A, 2013, NUCLEIC ACIDS RES, V41, P1178, DOI 10.1093/nar/gks1129; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Serra MJ, 2002, RNA, V8, P307, DOI 10.1017/S1355838202024226; Sim AYL, 2011, P NATL ACAD SCI USA, V108, P3590, DOI 10.1073/pnas.1018653108; Smit S, 2008, RNA, V14, P410, DOI 10.1261/rna.881308; Weijia X., 2011, P 2011 IEEE INT C BI, P613; WOESE CR, 1980, NUCLEIC ACIDS RES, V8, P2275, DOI 10.1093/nar/8.10.2275; Xie Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029468; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	91	92	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88222	10.1371/journal.pone.0088222	http://dx.doi.org/10.1371/journal.pone.0088222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505437	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200142
J	Rakesh; Bruhn, DF; Scherman, MS; Woolhiser, LK; Madhura, DB; Maddox, MM; Singh, AP; Lee, RB; Hurdle, JG; McNeil, MR; Lenaerts, AJ; Meibohm, B; Lee, RE				Rakesh; Bruhn, David F.; Scherman, Michael S.; Woolhiser, Lisa K.; Madhura, Dora B.; Maddox, Marcus M.; Singh, Aman P.; Lee, Robin B.; Hurdle, Julian G.; McNeil, Michael R.; Lenaerts, Anne J.; Meibohm, Bernd; Lee, Richard E.			Pentacyclic Nitrofurans with In Vivo Efficacy and Activity against Nonreplicating Mycobacterium tuberculosis	PLOS ONE			English	Article							DEAZAFLAVIN-DEPENDENT NITROREDUCTASE; MULTIDRUG-RESISTANT TUBERCULOSIS; ANTITUBERCULOSIS AGENTS; BIOREDUCTIVE ACTIVATION; BACTERICIDAL ACTIVITY; HELICOBACTER-PYLORI; DOSR REGULON; PA-824; VITRO; DERIVATIVES	The reductively activated nitroaromatic class of antimicrobials, which include nitroimidazole and the more metabolically labile nitrofuran antitubercular agents, have demonstrated some potential for development as therapeutics against dormant TB bacilli. In previous studies, the pharmacokinetic properties of nitrofuranyl isoxazolines were improved by incorporation of the outer ring elements of the antitubercular nitroimidazole OPC-67683. This successfully increased stability of the resulting pentacyclic nitrofuran lead compound Lee1106 (referred to herein as 9a). In the current study, we report the synthesis and antimicrobial properties of 9a and panel of 9a analogs, which were developed to increase oral bioavailability. These hybrid nitrofurans remained potent inhibitors of Mycobacterium tuberculosis with favorable selectivity indices (>150) and a narrow spectrum of activity. In vivo, the pentacyclic nitrofuran compounds showed long half-lives and high volumes of distribution. Based on pharmacokinetic testing and lack of toxicity in vivo, 9a remained the series lead. 9a exerted a lengthy post antibiotic effect and was highly active against nonreplicating M. tuberculosis grown under hypoxia. 9a showed a low potential for cross resistance to current antitubercular agents, and a mechanism of activation distinct from pre-clinical tuberculosis candidates PA-824 and OPC-67683. Together these studies show that 9a is a nanomolar inhibitor of actively growing as well as nonreplicating M. tuberculosis.	[Rakesh; Bruhn, David F.; Maddox, Marcus M.; Singh, Aman P.; Lee, Robin B.; Hurdle, Julian G.; Lee, Richard E.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Scherman, Michael S.; Woolhiser, Lisa K.; McNeil, Michael R.; Lenaerts, Anne J.] Colorado State Univ, Dept Microbiol, Mycobacterial Res Labs, Ft Collins, CO 80523 USA; [Madhura, Dora B.; Meibohm, Bernd] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Singh, Aman P.; Lee, Richard E.] Univ Tennessee, Ctr Hlth Sci, Program Biomed Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; Colorado State University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Lee, RE (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.Lee@StJude.org	McNeil, Michael/G-3325-2019; Lenaerts, Anne/F-1353-2017; Lee, Richard/J-4997-2013; Lee, Richard/AAX-3996-2021	Lee, Richard/0000-0002-2397-0443; Lee, Richard/0000-0002-2397-0443; hurdle, julian/0000-0003-2214-8105; Meibohm, Bernd/0000-0003-3923-3648	National Institutes of Health [AI062415]; American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health grant AI062415 and the American Lebanese Syrian Associated Charities (ALSAC), St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTEKAR DR, 1993, ANTIMICROB AGENTS CH, V37, P183, DOI 10.1128/AAC.37.2.183; Baker W.R., 1997, Patent No. [9701562 A1, 9701562]; Barry CE, 2004, CURR PHARM DESIGN, V10, P3239, DOI 10.2174/1381612043383214; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Budha NR, 2008, AAPS J, V10, P157, DOI 10.1208/s12248-008-9017-8; Cellitti SE, 2012, STRUCTURE, V20, P101, DOI 10.1016/j.str.2011.11.001; CRAIG WA, 1987, ANN INTERN MED, V106, P900, DOI 10.7326/0003-4819-106-6-900; de Carvalho LPS, 2009, J MED CHEM, V52, P5789, DOI 10.1021/jm9010719; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3271, DOI 10.1128/AAC.06126-11; Diacon AH, 2012, ANTIMICROB AGENTS CH, V56, P3027, DOI 10.1128/AAC.06125-11; Esmail H, 2012, DRUG DISCOV TODAY, V17, P514, DOI 10.1016/j.drudis.2011.12.013; Gler MT, 2012, NEW ENGL J MED, V366, P2151, DOI 10.1056/NEJMoa1112433; Griffith DE, 2012, CURR OPIN INFECT DIS, V25, P218, DOI 10.1097/QCO.0b013e3283511a64; Gurumurthy M, 2012, FEBS J, V279, P113, DOI 10.1111/j.1742-4658.2011.08404.x; HAMPER BC, 1995, J AGR FOOD CHEM, V43, P219, DOI 10.1021/jf00049a040; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hurdle JG, 2008, J ANTIMICROB CHEMOTH, V62, P1037, DOI 10.1093/jac/dkn307; Ji BH, 2006, ANTIMICROB AGENTS CH, V50, P1921, DOI [10.1128/AAC.00052-06, 10.1128/AAC.50.4.1558-1560.2006]; Koenig R, 2008, SCIENCE, V319, P894, DOI 10.1126/science.319.5865.894; Lafontaine D, 2004, LANCET, V363, P246, DOI 10.1016/S0140-6736(03)15344-5; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lenaerts AJ, 2005, ANTIMICROB AGENTS CH, V49, P2294, DOI 10.1128/AAC.49.6.2294-2301.2005; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Murugasu-Oei B, 2000, J ANTIMICROB CHEMOTH, V46, P917, DOI 10.1093/jac/46.6.917; PARSLEY TL, 1977, ANTIMICROB AGENTS CH, V12, P349, DOI 10.1128/AAC.12.3.349; Rakesh, 2012, BIOORGAN MED CHEM, V20, P6063, DOI 10.1016/j.bmc.2012.08.023; Ramon-Garcia S, 2011, ANTIMICROB AGENTS CH, V55, P3861, DOI 10.1128/AAC.00474-11; Sasaki H, 2006, J MED CHEM, V49, P7854, DOI 10.1021/jm060957y; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Sisson G, 2002, ANTIMICROB AGENTS CH, V46, P2116, DOI 10.1128/AAC.46.7.2116-2123.2002; SMITH MA, 1995, J ANTIMICROB CHEMOTH, V35, P751, DOI 10.1093/jac/35.6.751; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tangallapally RP, 2007, BIOORG MED CHEM LETT, V17, P6638, DOI 10.1016/j.bmcl.2007.09.048; Tsubouchi H, 2003, Patent No. [WO2004033463A1, 2004033463]; Van der Walt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058817; Vicente E, 2008, ANTIMICROB AGENTS CH, V52, P3321, DOI 10.1128/AAC.00379-08; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	40	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87909	10.1371/journal.pone.0087909	http://dx.doi.org/10.1371/journal.pone.0087909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505329	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200083
J	Randall, JR; Doku, D; Wilson, ML; Peltzer, K				Randall, Jason R.; Doku, David; Wilson, Michael L.; Peltzer, Karl			Suicidal Behaviour and Related Risk Factors among School-Aged Youth in the Republic of Benin	PLOS ONE			English	Article							SELF-HARM; GOING ADOLESCENTS; IDEATION; PHILIPPINE; PREVALENCE; THOUGHTS; SMOKING; GENDER; HEALTH; INCOME	Introduction: Research on factors associated with suicidal ideation and suicide attempts has been conducted largely in developed countries. Research on West African countries in particular is lacking. Methods: Data were obtained from the Global School-based Health Survey conducted in Benin in 2009. This was a cross-sectional study of three grades, spanning Junior and Senior High, which sampled a total of 2,690 adolescents. Data on the occurrence of demographic, psycho-social and socio-environmental risk factors were tested using multinomial logistic regression for their association with suicidal ideation and suicide attempts. Results: The survey indicated that 23.2% had thought about suicide and 28.3% had made a suicide attempt in the previous year. Anxiety, loneliness, being bullied, alcohol misuse, illicit drug use, and lack of parental support were independently related to the ideation outcomes, suicidal ideation without planning and suicidal ideation with planning. Multinomial regression analysis, using one suicide attempt and multiple suicide attempts as outcomes, revealed that female sex, anxiety, loneliness, being physically attacked, and illicit drug use were associated these outcomes. Discussion: The prevalence of suicide attempts reported in the survey is relatively high. It is possible that there are cultural factors that could explain this finding. Our research indicates that many factors are related to the occurrence of suicidal ideation and suicide attempts among youth in Benin. Illicit drug use and violence in particular are associated with a high rate of suicide attempts in Benin. Measures to address these issues may reduce the risk of self-inflicted violence.	[Randall, Jason R.; Wilson, Michael L.] PeerCorps Trust Fund, Ctr Injury Prevent & Community Safety, Dar Es Salaam, Tanzania; [Randall, Jason R.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Doku, David] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Wilson, Michael L.] Univ Turku, Turku Univ Hosp, Dept Adolescent Psychiat, Unit Adolescent Psychiat, Turku, Finland; [Peltzer, Karl] Human Sci Res Council, Pretoria, South Africa; [Peltzer, Karl] Univ Limpopo, Dept Psychol, Mangkwang E, South Africa	University of Manitoba; University of Cape Coast; University of Turku; Human Sciences Research Council-South Africa; University of Limpopo	Randall, JR (corresponding author), PeerCorps Trust Fund, Ctr Injury Prevent & Community Safety, Dar Es Salaam, Tanzania.	jason.randall@peercorpstrust.org	Peltzer, Karl/D-1518-2019; Peltzer, Karl/Q-7334-2019	Peltzer, Karl/0000-0002-5980-0876; Peltzer, Karl/0000-0002-5980-0876; Doku, David/0000-0001-9503-2520; Randall, Jason/0000-0002-0288-3551	Suomen Kuulturirahsto (Helsinki, Finland)	Suomen Kuulturirahsto (Helsinki, Finland)	The authors would like to thank the Republic of Benin Ministry of Health; the World Health Organization (Geneva, Switzerland); and the Centers for Disease Control and Prevention (Atlanta, GA, USA). We would also like to thank all the survey officers and students who took part in the study. Author MLW's participation was supported by a grant from Suomen Kuulturirahsto (Helsinki, Finland).	African Economic Outlook, 2013, BEN; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; BERTSCHY G, 1992, J AFFECT DISORDERS, V25, P173, DOI 10.1016/0165-0327(92)90003-O; Blum R, 2012, J ADOLESCENT HEALTH, V50, pS37, DOI 10.1016/j.jadohealth.2011.12.006; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Burrows S, 2010, INT J INJ CONTROL SA, V17, P23, DOI 10.1080/17457300903309231; Cooper Gregory D, 2011, Issues Ment Health Nurs, V32, P696, DOI 10.3109/01612840.2011.597911; Eaton Danice K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Fergusson DM, 2000, PSYCHOL MED, V30, P23, DOI 10.1017/S003329179900135X; Gao X, 2009, AM J CLIN NUTR, V89, P1197, DOI 10.3945/ajcn.2008.26941; GARRISON CZ, 1993, AM J PUBLIC HEALTH, V83, P179, DOI 10.2105/AJPH.83.2.179; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hepburn L, 2012, J ADOLESCENT HEALTH, V51, P93, DOI 10.1016/j.jadohealth.2011.12.014; Innamorati M, 2011, J ADDICT DIS, V30, P359, DOI 10.1080/10550887.2011.609802; Johnson JG, 2002, ARCH GEN PSYCHIAT, V59, P741, DOI 10.1001/archpsyc.59.8.741; Khan MM, 2005, J ROY SOC MED, V98, P459, DOI 10.1258/jrsm.98.10.459; Kidger J, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-69; King RA, 2001, J AM ACAD CHILD PSY, V40, P837, DOI 10.1097/00004583-200107000-00019; Kirchner T, 2011, ACTAS ESP PSIQUIATRI, V39, P226; Knizek B.L., 2011, J MEN MASCULINITIES, V5, P4; Langille DB, 2012, SOC PSYCH PSYCH EPID, V47, P1549, DOI 10.1007/s00127-011-0461-x; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; McGee R, 2005, AM J PSYCHIAT, V162, P619, DOI 10.1176/appi.ajp.162.3.619; Mulye TP, 2009, J ADOLESCENT HEALTH, V45, P8, DOI 10.1016/j.jadohealth.2009.03.013; Muula A S, 2007, Tanzan Health Res Bull, V9, P202; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Omigbodun O, 2008, INT J SOC PSYCHIATR, V54, P34, DOI 10.1177/0020764007078360; Osafo J, 2011, TRANSCULT PSYCHIATRY, V48, P643, DOI 10.1177/1363461511417319; Page RM, 2006, SCHOOL PSYCHOL INT, V27, P583, DOI 10.1177/0143034306073415; Page RM, 2011, ASIA-PAC J PUBLIC HE, V23, P774, DOI 10.1177/1010539509353113; Page RM, 2004, AM J HEALTH BEHAV, V35, P129; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Peltzer K, 2000, E AFR MED J, V77, P165; Peltzer K, 2012, INT J ENV RES PUB HE, V9, P462, DOI 10.3390/ijerph9020462; Prevention O, 2003, 2001 NATL YOUTH GANG; Randall JR, 2012, CAN J PSYCHIAT, V57, P21, DOI 10.1177/070674371205700105; Rudatsikira Emmanuel, 2007, Clin Pract Epidemiol Ment Health, V3, P13, DOI 10.1186/1745-0179-3-13; Rudatsikira E, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-67; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Spirito A, 2006, ANNU REV CLIN PSYCHO, V2, P237, DOI 10.1146/annurev.clinpsy.2.022305.095323; StataCorp, 2013, STAT STAT SOFTW REL; Swahn MH, 2007, J ADOLESCENT HEALTH, V41, P175, DOI 10.1016/j.jadohealth.2007.03.003; The World Bank, 2011, BEN OV; VEGA WA, 1993, SUICIDE LIFE-THREAT, V23, P110; Whitley E, 1999, BRIT MED J, V319, P1034, DOI 10.1136/bmj.319.7216.1034; Wichstrom L, 2000, J AM ACAD CHILD PSY, V39, P603, DOI 10.1097/00004583-200005000-00014; Wilson ML, 2012, INT J ENV RES PUB HE, V9, P4122, DOI 10.3390/ijerph9114122; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2012, GLOB SCH BAS STUD HL; Zayas L, 2010, SOC SCI MED, V70, P1773, DOI 10.1016/j.socscimed.2010.02.013; Zayas LH, 2012, TRANSCULT PSYCHIATRY, V49, P718, DOI 10.1177/1363461512463262	52	71	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88233	10.1371/journal.pone.0088233	http://dx.doi.org/10.1371/journal.pone.0088233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505443	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200147
J	Teixeira, A; Venancio, R; Brito, C				Teixeira, Antonio; Venancio, Rui; Brito, Cristina			Archaeological Remains Accounting for the Presence and Exploitation of the North Atlantic Right Whale Eubalaena glacialis on the Portuguese Coast (Peniche, West Iberia), 16th to 17th Century	PLOS ONE			English	Article								The former occurrence of the North Atlantic right whale Eubalaena glacialis on the Portuguese coast may be inferred from the historical range of that species in Europe and in NW Africa. It is generally accepted that it was the main prey of coastal whaling in the Middle Ages and in the pre-modern period, but this assumption still needs firming up based on biological and archaeological evidence. We describe the skeletal remains of right whales excavated at Peniche in 2001-2002, in association with archaeological artefacts. The whale bones were covered by sandy sediments on the old seashore and they have been tentatively dated around the 16th to 17th centuries. This study contributes material evidence to the former occurrence of E. glacialis in Portugal (West Iberia). Some whale bones show unequivocal man-made scars. These are associated to wounds from instruments with a sharp-cutting blade. This evidence for past human interaction may suggest that whaling for that species was active at Peniche around the early 17th century.	[Teixeira, Antonio] Minist Agr & Mar, Inst Conservacao Nat & Florestas, Lisbon, Portugal; [Venancio, Rui] Camara Municipal Peniche, Museu Municipal Peniche, Peniche, Portugal; [Brito, Cristina] Univ Nova Lisboa, Fac Ciencias Sociais & Humanas, Ctr Hist Alem Mar CHAM, P-1200 Lisbon, Portugal; [Brito, Cristina] Univ Acores, Lisbon, Portugal	Universidade Nova de Lisboa; Universidade dos Acores	Brito, C (corresponding author), Univ Nova Lisboa, Fac Ciencias Sociais & Humanas, Ctr Hist Alem Mar CHAM, P-1200 Lisbon, Portugal.	cristina.brito@escolademar.pt	Brito, Cristina/P-1071-2016	Brito, Cristina/0000-0001-7895-0784	Portuguese Foundation for Science and Technology [SFRH/BPD/63433/2009]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	CB was supported by a post-doctoral grant from the Portuguese Foundation for Science and Technology (SFRH/BPD/63433/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A., 1986, Reports of the International Whaling Commission Special Issue, P191; Aguilar A., 1981, REPORT INT WHALING C, V31, P457; [Anonymous], 1885, INTRO OSTEOLOGY MAMM; Arcos F, 1993, EUBALAENA, V3, P21; Azpiazu J.A., 2000, REV ESTUDIOS MARITMO, V3, P77; Bernal-Casasola D, 2010, W ROMAN ATLANTIC FA, P67; BOCAGE J. V. Barbosa du, 1863, REV MAG ZOOL PURE AP, V9, P329; Brito C., 2007, MARINE BIODIVERSITY, V2007, P1; Brito C, 2009, ECS SPECIAL PUBLICAT, P11; Brito C, 2011, ANTHROZOOS, V24, P287, DOI 10.2752/175303711X13045914865303; Brown S.G., 1986, Reports of the International Whaling Commission Special Issue, P121; Brownell RL, 1986, RIGHT WHALES PRESENT, V10; Calado M., 1994, ILHA PENICHE; Calvo Delcan C, 1990, BIBLIOTECA CLASICA G, V134, P345; CASTRO A, 1966, EVOLUCAO EC PORTUGAL; Ciriquiain M, 1979, VASCOS PESCA BALLENA; Cumbaa SL., 1986, REPORTS INT WHALING, V10, P187; Du Pasquier T, 2000, COLLECTION KRONOS, P31; Duguy R, 1972, 97 C NAT SOC SAV NAN; Eschricht DF, 1866, RECENT MEMOIRS CETAC, P1; Fairley J., 1981, IRISH WHALES WHALING; FERNANDEZ OCHOA C., 1994, AESPA, V67, P115, DOI DOI 10.3989/AESPA.1994.V67.429; Fischer P, 1881, ACTES SOC LINNEENNE, V5, P5; Gonzalez Echegaray R, 1978, BALLENEROS CANTABROS; Graells MP, 1889, MEM REAL ACAD CIEN E, V13, P115; IUCN, 2012, IUCN RED LIST THREAT; Markham C. R., 1881, Proceedings of the Zoological Society, P969; MARTIN AD, 1990, WHALES DOLPHINS; Martin AR, 1997, MAR MAMMAL SCI, V13, P139, DOI 10.1111/j.1748-7692.1997.tb00617.x; Maul G. E, 1977, Bocagiana, VNo. 43, P1; Notarbartolo di Sciara G., 1998, REP INT WHALING COMM, V48, P547; Pereira MB, 2006, ATOUGUIA BALEIA SEUS; Redman N, 2004, WHALES BONES BRIT IS, P417; Reeves R.R., 1983, Whalewatcher, V17, P3; Reeves R.R., 1986, Reports of the International Whaling Commission Special Issue, P221; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; REEVES RR, 1990, AM NEPTUNE, V50, P119; Salvador A., 2011, ENCICLOPEDIA VIRTUAL; Schuhmacher TX, 2013, TRABAJOS PREHIST, V70, P185, DOI 10.3989/tp.2013.12109; SCHULTEN A., 1940, FONTES HISPANIAE ANT; Silva Monica A., 2012, Journal of Cetacean Research and Management, V12, P65; Sousa A, 2011, MARINE BIODIVERSITY, V4, P1; TEIXEIRA AMAP, 1979, Z SAUGETIERKD, V44, P221; Turner W., 1913, T R SOC EDINBURGH 4, V48, P889; Van Beneden P.-J., 1880, OSTEOGRAPHIE CETACES; Venancio R, 2006, INTERVENCAO ARQUEOLO, P14	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e85971	10.1371/journal.pone.0085971	http://dx.doi.org/10.1371/journal.pone.0085971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AA1AT	24505251	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200011
J	Lin, YL; Liang, YH; Tsai, JH; Liau, JY; Liang, JT; Lin, BR; Hung, JS; Lin, LI; Tseng, LH; Chang, YL; Yeh, KH; Cheng, AL				Lin, Yu-Lin; Liang, Yi-Hsin; Tsai, Jia-Huei; Liau, Jau-Yu; Liang, Jin-Tung; Lin, Been-Ren; Hung, Ji-Shiang; Lin, Liang-In; Tseng, Li-Hui; Chang, Yih-Leong; Yeh, Kun-Huei; Cheng, Ann-Lii			Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients	PLOS ONE			English	Article							PROGRESSION-FREE SURVIVAL; 1ST-LINE TREATMENT; END-POINTS; CETUXIMAB; FLUOROURACIL; LEUCOVORIN; SURROGATE	To identify better regimens in currently available chemotherapy would be beneficial to KRAS mutant metastatic colorectal cancer (mCRC) patients because they have fewer treatment options than KRAS wild-type mCRC patients. Clinicopathologic features and overall survival (OS) of KRAS mutant and wild-type mCRC patients who had used oxaliplatin-based, irinotecan-based, bevacizumab-based, as well as cetuximab-based regimens were compared to those who had never-used oxaliplatin-based, irinotecan-based, bevacizumab-based, as well as cetuximab-based regimens respectively. Between 2007 and 2012, a total of 394 mCRC patients, in whom 169 KRAS mutant and 225 KRAS wild-type, were enrolled. In KRAS mutant patients who had used oxaliplatin-based regimens (N = 131), the OS was significantly longer than that in KRAS mutant patients who had never-used oxaliplatin-based regimens (N = 38). The OS was 28.8 months [95% confidence interval (CI): 23.2-34.4] in KRAS mutant patients who had used oxaliplatin-based regimens versus 17.8 months [95% CI: 6.5-29.1] in KRAS mutant patients who had never-used oxaliplatin-based regimens (P = 0.026). Notably, OS in KRAS wild-type mCRC patients who had used oxaliplatin-based regimens (N = 185) was not significantly longer than that in KRAS wild-type mCRC patients who had never-used oxaliplatin-based regimens (N = 40) (P = 0.25). Furthermore, the OS in KRAS mutant patients who had used either irinotecan-based, bevacizumab-based or cetuximab-based regimens was not significantly different than that in KRAS mutant patients who had never-used either irinotecan-based, bevacizumab-based or cetuximab-based regimens respectively. In multivariate analyses, patients who had used oxaliplatin-based regimens remains an independent prognostic factor for longer OS in KRAS mutant mCRC patients. In conclusion, oxaliplatin-based regimens are more beneficial in KRAS mutant than in KRAS wild-type mCRC patients.	[Lin, Yu-Lin; Liang, Yi-Hsin; Yeh, Kun-Huei; Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Tsai, Jia-Huei; Liau, Jau-Yu; Chang, Yih-Leong] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Liang, Jin-Tung; Lin, Been-Ren] Natl Taiwan Univ Hosp, Div Colorectal Surg, Taipei, Taiwan; [Liang, Jin-Tung; Lin, Been-Ren] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Hung, Ji-Shiang] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Lin, Liang-In] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Tseng, Li-Hui] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Cheng, Ann-Lii] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lin, Liang-In] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Yeh, Kun-Huei; Cheng, Ann-Lii] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Lin, Yu-Lin; Yeh, Kun-Huei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Yih-Leong] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Liang, Yi-Hsin] E Da Hosp, Dept Hematooncol, Kaohsiung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; E-Da Hospital	Yeh, KH (corresponding author), Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan.	khyeh@ntu.edu.tw	Yeh, Kun-Huei/HGD-3316-2022; Lin, Liang-In/K-4600-2019	LIAU, JAU-YU/0000-0002-1336-3850; Liang, Jin-Tung/0000-0002-0264-7735; YEH, Kun-Huei/0000-0002-7306-174X; Cheng, Ann-Lii/0000-0002-9152-6512; TSENG, LI-HUI/0000-0002-8308-6772; CHANG, YIH-LEONG/0000-0001-5309-0554; Hung, Ji-Shiang/0000-0001-7392-5694; LIN, LIANG-IN/0000-0002-3561-1093; LIN, BEEN-REN/0000-0001-8354-1758; LIANG, YI-HSIN/0000-0002-7224-9687	Department of Health, Executive Yuan, Taipei, Taiwan [DOH102-TD-C-111-001]	Department of Health, Executive Yuan, Taipei, Taiwan	This study was supported by grants from the Department of Health, Executive Yuan (DOH102-TD-C-111-001), Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso M, 2013, BRIT J CANCER, V108, P115, DOI 10.1038/bjc.2012.526; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Chibaudel B, 2011, J CLIN ONCOL, V29, P4199, DOI 10.1200/JCO.2011.35.5867; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lin YL, 2013, TRANSL ONCOL, V6, P363, DOI 10.1593/tlo.13166; Lin YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050701; Roth BJ, 2013, J CLIN ONCOL, V31, P131, DOI 10.1200/JCO.2012.47.1938; Tang PA, 2007, J CLIN ONCOL, V25, P4562, DOI 10.1200/JCO.2006.08.1935; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	12	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e86789	10.1371/journal.pone.0086789	http://dx.doi.org/10.1371/journal.pone.0086789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24505265	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800013
J	Silverman, J; Hendricks, G				Silverman, Jerald; Hendricks, Gregory			Sensory Neuron Development in Mouse Coccygeal Vertebrae and Its Relationship to Tail Biopsies for Genotyping	PLOS ONE			English	Article							IMMUNOREACTIVE NERVES; TRANSGENIC MICE; SUBSTANCE-P; BONE; INNERVATION; GROWTH; DNA; OSSIFICATION; MAINTENANCE; GENERATION	A common method of genotyping mice is via tissue obtained from tail biopsies. However, there is no available information on the temporal development of sensory neurons in the tail and how their presence or absence might affect the age for performing tail biopsies. The goals of this study were to determine if afferent sensory neurons, and in particular nociceptive neurons, are present in the coccygeal vertebrae at or near the time of birth and if not, when they first can be visualized on or in those vertebrae. Using toluidine blue neuronal staining, transmission electron microscopy, and calcitonin-related gene peptide immunostaining, we found proximal to distal maturation of coccygeal nerve growth in the C57BL/6J mouse. Single nerve bundles were first seen on postpartum day (PPD) 0. On PPD 3 presumptive nociceptive sensory nerve fibers were seen entering the vertebral perichondrium. Neural development continued through the last time point (PPD 7) but at no time were neural fibers seen entering the body of the vertebrae. The effect of age on the development of pain perception in the neonatal mouse is discussed.	[Silverman, Jerald] Univ Massachusetts, Sch Med, Dept Anim Med, Worcester, MA 01605 USA; [Hendricks, Gregory] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Silverman, J (corresponding author), Univ Massachusetts, Sch Med, Dept Anim Med, Worcester, MA 01605 USA.	jerald.silverman@umassmed.edu			University of Massachusetts Medical School	University of Massachusetts Medical School	All funding for this study was from internal institutional funds provided to the Department of Animal Medicine by the University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr GA, 2011, J PAIN, V12, P263, DOI 10.1016/j.jpain.2010.09.005; BJURHOLM A, 1988, PEPTIDES, V9, P165, DOI 10.1016/0196-9781(88)90023-X; Bonaparte D, 2013, LAB ANIM-UK, V47, P134, DOI 10.1177/0023677212473918; CALVO W, 1969, AM J ANAT, V126, P355, DOI 10.1002/aja.1001260308; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Davidson S, 2010, J COMP NEUROL, V518, P3193, DOI 10.1002/cne.22392; Diesch TJ, 2009, LAB ANIM-UK, V43, P224, DOI 10.1258/la.2008.0080083; FEIK SA, 1983, J ANAT, V136, P1; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; Gajda M, 2005, J ANAT, V207, P135, DOI 10.1111/j.1469-7580.2005.00434.x; Hankenson FC, 2008, J AM ASSOC LAB ANIM, V47, P10; Henneberger C, 2000, J NEUROSCI METH, V100, P123, DOI 10.1016/S0165-0270(00)00241-7; HUKKANEN M, 1993, NEUROSCIENCE, V54, P969, DOI 10.1016/0306-4522(93)90588-7; HUNTER C, 1973, J ANAT, V116, P227; Irwin MH, 1996, NAT BIOTECHNOL, V14, P1146, DOI 10.1038/nbt0996-1146; Jerome C, 2012, COMP ANATOMY HISTOLO, P53; Jimenez-Andrade JM, 2009, NEUROSCIENCE, V162, P1244, DOI 10.1016/j.neuroscience.2009.05.065; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karas A, 2007, IACUC HDB, P241; Koshi T, 2010, EUR SPINE J, V19, P593, DOI 10.1007/s00586-009-1237-9; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; MCLAUGHLIN CR, 1990, PHARMACOL BIOCHEM BE, V36, P859, DOI 10.1016/0091-3057(90)90090-5; Meldgaard M, 2004, LAB ANIM-UK, V38, P413, DOI 10.1258/0023677041958981; Mellor DJ, 2010, J VET MED EDUC, V37, P94, DOI 10.3138/jvme.37.1.94; Morales MEP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006457; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; Narsinghani U, 2000, LAB ANIMAL, V29, P27; Ohtori S, 2007, J PAIN, V8, P483, DOI 10.1016/j.jpain.2007.01.004; Orita S, 2010, SPINE, V35, P1346, DOI 10.1097/BRS.0b013e3181c099b0; PATTON JT, 1995, J ANAT, V186, P175; Schmitteckert EM, 1999, LAB ANIM, V33, P385, DOI 10.1258/002367799780487922; Shinohara Harumichi, 1999, Okajimas Folia Anatomica Japonica, V76, P17; SISASK G, 1995, ANAT REC, V243, P234, DOI 10.1002/ar.1092430210; Sorensen DB, 2007, LAB ANIM-UK, V41, P19, DOI 10.1258/002367707779399383; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; TODD ME, 1981, AM J ANAT, V160, P195, DOI 10.1002/aja.1001600206; ZAIDI M, 1993, EXP PHYSIOL, V78, P721, DOI 10.1113/expphysiol.1993.sp003721; Zhuo M, 1998, EUR J PHARMACOL, V349, P211, DOI 10.1016/S0014-2999(98)00197-6	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88158	10.1371/journal.pone.0088158	http://dx.doi.org/10.1371/journal.pone.0088158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505409	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300061
J	Veerbeek, JM; van Wegen, E; van Peppen, R; van der Wees, PJ; Hendriks, E; Rietberg, M; Kwakkel, G				Veerbeek, Janne Marieke; van Wegen, Erwin; van Peppen, Roland; van der Wees, Philip Jan; Hendriks, Erik; Rietberg, Marc; Kwakkel, Gert			What Is the Evidence for Physical Therapy Poststroke? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CONSTRAINT-INDUCED MOVEMENT; RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL ELECTRICAL-STIMULATION; BODY-WEIGHT SUPPORT; SUBACUTE STROKE PATIENTS; ROBOT-ASSISTED THERAPY; TRIGGERED NEUROMUSCULAR STIMULATION; ELECTROMECHANICAL GAIT TRAINER; EXTREMITY MOTOR RECOVERY; UPPER-LIMB FUNCTION	Background: Physical therapy (PT) is one of the key disciplines in interdisciplinary stroke rehabilitation. The aim of this systematic review was to provide an update of the evidence for stroke rehabilitation interventions in the domain of PT. Methods and Findings: Randomized controlled trials (RCTs) regarding PT in stroke rehabilitation were retrieved through a systematic search. Outcomes were classified according to the ICF. RCTs with a low risk of bias were quantitatively analyzed. Differences between phases poststroke were explored in subgroup analyses. A best evidence synthesis was performed for neurological treatment approaches. The search yielded 467 RCTs (N = 25373; median PEDro score 6 [IQR 5-7]), identifying 53 interventions. No adverse events were reported. Strong evidence was found for significant positive effects of 13 interventions related to gait, 11 interventions related to arm-hand activities, 1 intervention for ADL, and 3 interventions for physical fitness. Summary Effect Sizes (SESs) ranged from 0.17 (95%CI 0.03-0.70; I-2 = 0%) for therapeutic positioning of the paretic arm to 2.47 (95%CI 0.84-4.11; I-2 = 77%) for training of sitting balance. There is strong evidence that a higher dose of practice is better, with SESs ranging from 0.21 (95%CI 0.02-0.39; I-2 = 6%) for motor function of the paretic arm to 0.61 (95%CI 0.41-0.82; I-2 = 41%) for muscle strength of the paretic leg. Subgroup analyses yielded significant differences with respect to timing poststroke for 10 interventions. Neurological treatment approaches to training of body functions and activities showed equal or unfavorable effects when compared to other training interventions. Main limitations of the present review are not using individual patient data for meta-analyses and absence of correction for multiple testing. Conclusions: There is strong evidence for PT interventions favoring intensive high repetitive task-oriented and task-specific training in all phases poststroke. Effects are mostly restricted to the actually trained functions and activities. Suggestions for prioritizing PT stroke research are given.	[Veerbeek, Janne Marieke; van Wegen, Erwin; Rietberg, Marc; Kwakkel, Gert] Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands; [van Peppen, Roland] Univ Appl Sci Utrecht, Dept Physiotherapy, Utrecht, Netherlands; [van der Wees, Philip Jan] Radboud Univ Nijmegen, Sci Inst Qual Healthcare IQ Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Hendriks, Erik] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Kwakkel, Gert] Reade Ctr Rehabil & Rheumatol, Dept Neurorehabil, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen; Maastricht University	Kwakkel, G (corresponding author), Vrije Univ Amsterdam Med Ctr, MOVE Res Inst Amsterdam, Dept Rehabil Med, Amsterdam, Netherlands.	g.kwakkel@vumc.nl	van der Wees, Philip Jan/L-4748-2015; Veerbeek, Janne/W-7424-2019	Veerbeek, Janne/0000-0002-6337-6780; van Wegen, Erwin/0000-0002-7920-9995; Kwakkel, Gert/0000-0002-4041-4043	Royal Dutch Society for Physical Therapy (KNGF) [8091.1]	Royal Dutch Society for Physical Therapy (KNGF)	This research project was supported by the Royal Dutch Society for Physical Therapy (KNGF grant no. 8091.1; http://www.fysionet.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Tariah H, 2010, INT J THER REHABIL, V17, P638; Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; Ada L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003863.pub2; Ada L, 2003, ARCH PHYS MED REHAB, V84, P1486, DOI 10.1016/S0003-9993(03)00349-6; Ada L, 2010, STROKE, V41, P1237, DOI 10.1161/STROKEAHA.109.569483; Aidar FJ, 2007, REV NEUROLOGIA, V45, P518, DOI 10.33588/rn.4509.2006366; Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Akbari A., 2006, J MED SCI, V6, P382, DOI [10.3923/jms.2006.382.388, DOI 10.3923/JMS.2006.382.388]; Alberts JL, 2004, NEUROREHAB NEURAL RE, V18, P250, DOI 10.1177/1545968304271370; Ali M, 2013, INT J STROKE, V8, P18, DOI 10.1111/j.1747-4949.2012.00973.x; Allison R, 2007, CLIN REHABIL, V21, P614, DOI 10.1177/0269215507077364; Alon G, 2008, AM J PHYS MED REHAB, V87, P627, DOI 10.1097/PHM.0b013e31817fabc1; Alon G, 2007, NEUROREHAB NEURAL RE, V21, P207, DOI 10.1177/1545968306297871; Altman DG, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-6; Altschuler EL, 1999, LANCET, V353, P2035, DOI 10.1016/S0140-6736(99)00920-4; Ambrosini E, 2011, STROKE, V42, P1068, DOI 10.1161/STROKEAHA.110.599068; American Physical Therapy Association, 2011, TOD PHYS THER COMPR; Andersen HE, 2002, CLIN REHABIL, V16, P593, DOI 10.1191/0269215502cr528oa; [Anonymous], 2004, J GERIATR PHYS THER, DOI [10.1519/00139143-200408000-00004, DOI 10.1519/00139143-200408000-00004]; Ansari N N, 2007, Electromyogr Clin Neurophysiol, V47, P137; Appel C, 2011, CLIN REHABIL, V25, P833, DOI 10.1177/0269215510397392; Argstatter H, 2007, NEUROLOGIE REHABILIT, V13, P159; Armagan O, 2003, AM J PHYS MED REHAB, V82, P856, DOI [10.1097/01.PHM.0000091984.72486.E0, 10.1097/01.PHM.0000091984.72486.EO]; Askim T, 2010, STROKE, V41, P1697, DOI 10.1161/STROKEAHA.110.584284; Atteya Abdul-Alim A, 2004, Neurosciences (Riyadh), V9, P24; Azab M, 2009, TOP STROKE REHABIL, V16, P207, DOI 10.1310/tsr1603-207; Bagley P, 2005, CLIN REHABIL, V19, P354, DOI 10.1191/0269215505cr874oa; BAKER LL, 1986, PHYS THER, V66, P1930, DOI 10.1093/ptj/66.12.1930; Bakhtiary AH, 2008, CLIN REHABIL, V22, P418, DOI 10.1177/0269215507084008; Bale M, 2008, CLIN REHABIL, V22, P911, DOI 10.1177/0269215508090092; Barbeau H, 2003, ARCH PHYS MED REHAB, V84, P1458, DOI 10.1016/S0003-9993(03)00361-7; Barclay-Goddard RE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005950.pub4; Barker RN, 2008, STROKE, V39, P1800, DOI 10.1161/STROKEAHA.107.498485; Barker RN, 2009, EXP BRAIN RES, V196, P483, DOI 10.1007/s00221-009-1872-8; Barrett JA, 2001, CLIN REHABIL, V15, P32, DOI 10.1191/026921501672264719; Baskett JJ, 1999, CLIN REHABIL, V13, P23, DOI 10.1191/026921599701532090; BASMAJIAN JV, 1987, ARCH PHYS MED REHAB, V68, P267; BASMAJIAN JV, 1975, ARCH PHYS MED REHAB, V56, P231; BASMAJIAN JV, 1982, ARCH PHYS MED REHAB, V63, P613; BATE PJ, 1992, ARCH PHYS MED REHAB, V73, P1050; Bayouk JF, 2006, INT J REHABIL RES, V29, P51, DOI 10.1097/01.mrr.0000192100.67425.84; Beckerman H, 1996, CLIN REHABIL, V10, P112, DOI DOI 10.1177/026921559601000205; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2007, CEREBROVASC DIS, V24, P157, DOI 10.1159/000103626; Bhatt E, 2007, EXP BRAIN RES, V182, P435, DOI 10.1007/s00221-007-1001-5; BINDER SA, 1981, PHYS THER, V61, P886, DOI 10.1093/ptj/61.6.886; Blennerhassett J, 2004, AUST J PHYSIOTHER, V50, P219, DOI 10.1016/S0004-9514(14)60111-2; Boake C, 2007, NEUROREHAB NEURAL RE, V21, P14, DOI 10.1177/1545968306291858; BOGATAJ U, 1995, PHYS THER, V75, P490, DOI 10.1093/ptj/75.6.490; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Borenstein M, 2009, SUBGROUP ANAL INTRO, P149; Borenstein M, 2013, PREV SCI, V14, P134, DOI 10.1007/s11121-013-0377-7; Bourbonnais D, 2002, AM J PHYS MED REHAB, V81, P890, DOI 10.1097/00002060-200212000-00002; BOWMAN BR, 1979, ARCH PHYS MED REHAB, V60, P497; Bradley L, 1998, CLIN REHABIL, V12, P11, DOI 10.1191/026921598677671932; Braun SM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2010.07.009; Brazzelli M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub4; Britto RR, 2011, ARCH PHYS MED REHAB, V92, P184, DOI 10.1016/j.apmr.2010.09.029; Britton E, 2008, CLIN REHABIL, V22, P458, DOI 10.1177/0269215507084644; Brock K, 2011, CLIN REHABIL, V25, P903, DOI 10.1177/0269215511406557; Broeren J, 2008, CEREBROVASC DIS, V26, P289, DOI 10.1159/000149576; Brogardh C, 2006, CLIN REHABIL, V20, P218, DOI 10.1191/0269215506cr937oa; Brogardh C, 2010, ARCH PHYS MED REHAB, V91, P460, DOI 10.1016/j.apmr.2009.11.009; Brogardh C, 2009, J REHABIL MED, V41, P231, DOI 10.2340/16501977-0312; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Burgar CG, 2011, J REHABIL RES DEV, V48, P445, DOI 10.1682/JRRD.2010.04.0062; Burge E, 2008, ARCH PHYS MED REHAB, V89, P1857, DOI 10.1016/j.apmr.2008.03.023; Burridge JH, 1997, CLIN REHABIL, V11, P201, DOI 10.1177/026921559701100303; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Byl N, 2003, NEUROREHAB NEURAL RE, V17, P176, DOI 10.1177/0888439003257137; Byl NN, 2008, NEUROREHAB NEURAL RE, V22, P494, DOI 10.1177/1545968308317431; Cacchio A, 2009, NEUROREHAB NEURAL RE, V23, P792, DOI 10.1177/1545968309335977; Cacchio A, 2009, NEW ENGL J MED, V361, P634, DOI 10.1056/NEJMc0902799; Cambier DC, 2003, CLIN REHABIL, V17, P14, DOI 10.1191/0269215503cr580oa; Carey JR, 2007, NEUROREHAB NEURAL RE, V21, P216, DOI 10.1177/1545968306292381; CAREY JR, 1990, ARCH PHYS MED REHAB, V71, P888; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Carey L, 2011, NEUROREHAB NEURAL RE, V25, P304, DOI 10.1177/1545968310397705; Carmeli E, 2011, PHYSIOTHER RES INT, V16, P191, DOI 10.1002/pri.485; Carr Mitchell, 2003, Top Stroke Rehabil, V9, P57; Cauraugh J, 2000, STROKE, V31, P1360, DOI 10.1161/01.STR.31.6.1360; Cauraugh JH, 2008, CEREBROVASC DIS, V25, P115, DOI 10.1159/000112321; Cauraugh JH, 2009, RESTOR NEUROL NEUROS, V27, P17, DOI 10.3233/RNN-2009-0455; Cauraugh JH, 2005, NEUROSCI LETT, V382, P39, DOI 10.1016/j.neulet.2005.02.060; Cauraugh JH, 2003, J NEUROL SCI, V215, P13, DOI 10.1016/S0022-510X(03)00169-2; Cauraugh JH, 2003, J NEUROL NEUROSUR PS, V74, P1562, DOI 10.1136/jnnp.74.11.1562; Cauraugh JH, 2003, J NEUROL SCI, V207, P25, DOI 10.1016/S0022-510X(02)00355-6; Cauraugh JH, 2002, STROKE, V33, P1589, DOI 10.1161/01.STR.0000016926.77114.A6; Chae J, 1998, STROKE, V29, P975, DOI 10.1161/01.STR.29.5.975; Chan MKL, 2009, NEUROREHAB NEURAL RE, V23, P357, DOI 10.1177/1545968308326428; Chang WH, 2012, NEUROREHAB NEURAL RE, V26, P318, DOI 10.1177/1545968311408916; Chen I-Chun, 2002, Chang Gung Med J, V25, P583; Chen JC, 2005, STROKE, V36, P2665, DOI 10.1161/01.STR.0000189992.06654.ab; Chen JC, 2011, CLIN REHABIL, V25, P823, DOI 10.1177/0269215511399591; Chen SC, 2005, DISABIL REHABIL, V27, P105, DOI 10.1080/09638280400009022; Cheng JS, 2010, ARCH PHYS MED REHAB, V91, P505, DOI 10.1016/j.apmr.2009.11.022; Cheng PT, 2001, ARCH PHYS MED REHAB, V82, P1650, DOI 10.1053/apmr.2001.26256; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Chow Daniel S, 2012, Surg Neurol Int, V3, P27, DOI 10.4103/2152-7806.92941; Chu KS, 2004, ARCH PHYS MED REHAB, V85, P870, DOI 10.1016/j.apmr.2003.11.001; Church C, 2006, STROKE, V37, P2995, DOI 10.1161/01.STR.0000248969.78880.82; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; COLBORNE GR, 1993, ARCH PHYS MED REHAB, V74, P1100, DOI 10.1016/0003-9993(93)90069-M; Conroy SS, 2011, ARCH PHYS MED REHAB, V92, P1754, DOI 10.1016/j.apmr.2011.06.016; Cooke EV, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-60; Cooke EV, 2010, NEUROREHAB NEURAL RE, V24, P88, DOI 10.1177/1545968309343216; COZEAN CD, 1988, ARCH PHYS MED REHAB, V69, P401; Craig LE, 2008, NURS EDUC TODAY, V28, P77, DOI 10.1016/j.nedt.2007.02.011; Crosbie J, 2007, UK STROK FOR C, P9; Crow J L, 1989, Int Disabil Stud, V11, P155; da Cunha IT, 2002, ARCH PHYS MED REHAB, V83, P1258, DOI 10.1053/apmr.2002.34267; da Cunha IT, 2001, J REHABIL RES DEV, V38, P245; Cameirao MDS, 2011, RESTOR NEUROL NEUROS, V29, P287, DOI 10.3233/RNN-2011-0599; Dahl AE, 2008, CLIN REHABIL, V22, P436, DOI 10.1177/0269215507084581; Daly JJ, 2005, J REHABIL RES DEV, V42, P723, DOI 10.1682/JRRD.2005.02.0048; Davidson I, 2005, CLIN REHABIL, V19, P126, DOI 10.1191/0269215505cr841oa; De Boissezon X, 2005, ISOKINET EXERC SCI, P91; de Jong LD, 2006, CLIN REHABIL, V20, P656, DOI 10.1191/0269215506cre1007oa; de Kroon JR, 2008, CLIN REHABIL, V22, P690, DOI 10.1177/0269215508088984; de Kroon JR, 2004, AM J PHYS MED REHAB, V83, P592, DOI 10.1097/01.phm.0000133435.61610.55; de Seze M, 2001, ARCH PHYS MED REHAB, V82, P793, DOI 10.1053/apmr.2001.0820793; Dean CM, 2007, AUST J PHYSIOTHER, V53, P97, DOI 10.1016/S0004-9514(07)70042-9; Dean CM, 2010, J PHYSIOTHER, V56, P97, DOI 10.1016/S1836-9553(10)70039-4; Dean CM, 2000, ARCH PHYS MED REHAB, V81, P409, DOI 10.1053/mr.2000.3839; Dean CM, 2000, AUST J PHYSIOTHER, V46, P35, DOI 10.1016/S0004-9514(14)60312-3; Dean CM, 1997, STROKE, V28, P722, DOI 10.1161/01.STR.28.4.722; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; Desrosiers J, 2005, CLIN REHABIL, V19, P581, DOI 10.1191/0269215505cr896oa; Desrosiers J, 2007, ARCH PHYS MED REHAB, V88, P1095, DOI 10.1016/j.apmr.2007.06.017; Di Lauro A, 2003, J NEUROL, V250, P1206, DOI 10.1007/s00415-003-0185-2; Dias D, 2007, Eura Medicophys, V43, P499; Dobke B, 2010, NEUROL REHABIL, V16, P173; Dobkin BH, 2012, NEUROREHAB NEURAL RE, V26, P308, DOI 10.1177/1545968312439687; Dobkin BH, 2010, NEUROREHAB NEURAL RE, V24, P235, DOI 10.1177/1545968309357558; Dobkin BH, 2007, NEUROREHAB NEURAL RE, V21, P3, DOI 10.1177/1545968306297329; Dogan-Aslan M, 2012, J STROKE CEREBROVASC, V21, P187, DOI 10.1016/j.jstrokecerebrovasdis.2010.06.006; Dohle C, 2009, NEUROREHAB NEURAL RE, V23, P209, DOI 10.1177/1545968308324786; Donaldson C, 2009, NEUROREHAB NEURAL RE, V23, P389, DOI 10.1177/1545968308326635; Donkervoort M, 2001, NEUROPSYCHOL REHABIL, V11, P549, DOI 10.1080/09602010143000093; Doyle S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006331.pub2; Dromerick AW, 2009, NEUROLOGY, V73, P195, DOI 10.1212/WNL.0b013e3181ab2b27; Dromerick AW, 2000, STROKE, V31, P2984, DOI 10.1161/01.STR.31.12.2984; Drummond A, 1995, CLIN REHABIL, V9, P283, DOI DOI 10.1177/026921559500900402; Drummond A, 1996, BRIT J OCCUPATIONAL, V59, P330, DOI DOI 10.1177/030802269605900712; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Duncan PW, 2011, NEW ENGL J MED, V364, P2026, DOI 10.1056/NEJMoa1010790; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eich HJ, 2004, CLIN REHABIL, V18, P640, DOI 10.1191/0269215504cr779oa; Ellis MD, 2009, NEUROREHAB NEURAL RE, V23, P862, DOI 10.1177/1545968309332927; Elsner B, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.00009645, DOI 10.1002/14651858]; ENGARDT M, 1993, SCAND J REHABIL MED, V25, P41; English C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007513.pub2; Sucar LE, 2010, IEEE ENG MED BIO, P3690, DOI 10.1109/IEMBS.2010.5627458; Erel S, 2011, CLIN REHABIL, V25, P515, DOI 10.1177/0269215510390719; Eser F, 2008, EUR J PHYS REHAB MED, V44, P19; Faghri P D, 1997, J Hand Ther, V10, P29; FAGHRI PD, 1994, ARCH PHYS MED REHAB, V75, P73; Fang YN, 2003, CLIN REHABIL, V17, P608, DOI 10.1191/0269215503cr655oa; Ferrante S, 2008, EUR J PHYS REHAB MED, V44, P159; Ferreira HP, 2011, TOP STROKE REHABIL, V18, P155, DOI 10.1310/tsr1802-155; Feys H, 2004, STROKE, V35, P924, DOI 10.1161/01.STR.0000121645.44752.f7; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; Fil A, 2011, CLIN REHABIL, V25, P51, DOI 10.1177/0269215510375919; Fischer HC, 2007, TOP STROKE REHABIL, V14, P1, DOI 10.1310/tsr1401-1; Fisher S, 2011, TOP STROKE REHABIL, V18, P269, DOI 10.1310/tsr1803-269; Flansbjer UB, 2008, J REHABIL MED, V40, P42, DOI 10.2340/16501977-0129; Franceschini M, 2009, STROKE, V40, P3079, DOI 10.1161/STROKEAHA.109.555540; Francisco G, 1998, ARCH PHYS MED REHAB, V79, P570, DOI 10.1016/S0003-9993(98)90074-0; French B, 2008, HEALTH TECHNOL ASSES, V12, P1; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; French B, 2008, Health Technol Assess, V12, pix; French B, 2008, HEALTH TECHNOL ASSES, V12, pix; Gabler NB, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-43; Gabr U, 2005, CLIN REHABIL, V19, P737, DOI 10.1191/0269215505cr909oa; Galvin R, 2011, STROKE, V42, P681, DOI 10.1161/STROKEAHA.110.594689; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Gelber DA, 1995, J NEUROL REHABIL, V9, P191; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Gilbertson L, 2000, BRIT MED J, V320, P603, DOI 10.1136/bmj.320.7235.603; GLASSER L, 1986, PHYS THER, V66, P673, DOI 10.1093/ptj/66.5.673; Gok H, 2008, CLIN REHABIL, V22, P922, DOI 10.1177/0269215508090673; Goljar N, 2010, INT J REHABIL RES, V33, P205, DOI 10.1097/MRR.0b013e328333de61; Gordon NF, 2004, STROKE, V35, P1230, DOI 10.1161/01.STR.0000127303.19261.19; Grant T, 1997, CAN J REHABIL, V11, P69; Green J, 2002, LANCET, V359, P199, DOI 10.1016/S0140-6736(02)07443-3; GREENBERG S, 1980, AM J OCCUP THER, V34, P738, DOI 10.5014/ajot.34.11.738; Griffin A, 2006, CLIN REHABIL, V20, P287, DOI 10.1191/0269215505cr941oa; Grimshaw J, 1995, J Eval Clin Pract, V1, P37, DOI 10.1111/j.1365-2753.1995.tb00006.x; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gustafsson L, 2006, CLIN REHABIL, V20, P277, DOI 10.1191/0269215506cr944oa; Hammer A, 2009, CLIN REHABIL, V23, P424, DOI 10.1177/0269215508101734; Hanger HC, 2000, CLIN REHABIL, V14, P370, DOI 10.1191/0269215500cr339oa; Hara Y, 2008, DISABIL REHABIL, V30, P296, DOI 10.1080/09638280701265539; Hara Y, 2006, AM J PHYS MED REHAB, V85, P977, DOI 10.1097/01.phm.0000247853.61055.f8; Harrington R, 2010, CLIN REHABIL, V24, P3, DOI 10.1177/0269215509347437; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hayner K, 2010, AM J OCCUP THER, V64, P528, DOI 10.5014/ajot.2010.08027; HEBB D. O., 1949; Heckmann J, 1997, EUR J PHYS MED REHAB, V7, P138; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Heidari M, 2011, QOM U MED SCI J, V4, P48; Heldmann B, 2000, NEUROREPORT, V11, P3193, DOI 10.1097/00001756-200009280-00029; Heller F., 2005, Annales de Readaptation et de Medecine Physique, V48, P187, DOI 10.1016/j.annrmp.2005.02.002; Hemmen B, 2007, CLIN REHABIL, V21, P587, DOI 10.1177/0269215507075502; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Hesse S, 2008, AM J PHYS MED REHAB, V87, P779, DOI 10.1097/PHM.0b013e318186b4bc; Hesse S, 2005, STROKE, V36, P1960, DOI 10.1161/01.STR.0000177865.37334.ce; Hesse S, 2011, CLIN REHABIL, V25, P146, DOI 10.1177/0269215510382148; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hirst A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035621; Holmgren E, 2010, EUR J PHYSIOTHER, V12, P115, DOI 10.3109/14038196.2010.491555; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Howe TE, 2005, CLIN REHABIL, V19, P45, DOI 10.1191/0269215505cr786oa; Hsieh YW, 2011, NEUROREHAB NEURAL RE, V25, P503, DOI 10.1177/1545968310394871; Hsu SS, 2010, STROKE, V41, P821, DOI 10.1161/STROKEAHA.109.574160; Hsu WY, 2012, STROKE, V43, P1849, DOI 10.1161/STROKEAHA.111.649756; Hu XL, 2009, NEUROREHAB NEURAL RE, V23, P837, DOI 10.1177/1545968309338191; Hui-Chan Christina W Y, 2009, Hong Kong Med J, V15, P42; Huijgen BCH, 2008, J TELEMED TELECARE, V14, P249, DOI 10.1258/jtt.2008.080104; Hunter SM, 2011, NEUROREHAB NEURAL RE, V25, P314, DOI 10.1177/1545968310390223; HURD WW, 1980, AM J PHYS MED REHAB, V59, P73; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Inaba M, 1973, Phys Ther, V53, P28; INGLIS J, 1984, ARCH PHYS MED REHAB, V65, P755; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; INTISO D, 1994, STROKE, V25, P1189, DOI 10.1161/01.STR.25.6.1189; Ivey FM, 2007, STROKE, V38, P2752, DOI 10.1161/STROKEAHA.107.490391; Ivey FM, 2011, STROKE, V42, P1994, DOI 10.1161/STROKEAHA.110.607879; Ivey FM, 2010, STROKE, V41, P2913, DOI 10.1161/STROKEAHA.110.599977; Jaffe DL, 2004, J REHABIL RES DEV, V41, P283, DOI 10.1682/JRRD.2004.03.0283; Janssen TW, 2008, ARCH PHYS MED REHAB, V89, P463, DOI 10.1016/j.apmr.2007.09.028; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Jeong SH, 2007, APPL NURS RES, V20, P125, DOI 10.1016/j.apnr.2007.04.005; Johannsen L, 2010, NEUROREHAB NEURAL RE, V24, P243, DOI 10.1177/1545968309347679; Johansson T, 2011, J TELEMED TELECARE, V17, P1, DOI 10.1258/jtt.2010.100105; JOHN J, 1986, INT J REHABIL RES, V9, P35, DOI 10.1097/00004356-198603000-00004; Johnstone M., 1989, PHYSIOTHERAPY, V75, P381; JONGBLOED L, 1991, AM J OCCUP THER, V45, P420, DOI 10.5014/ajot.45.5.420; Jonsdottir J, 2010, NEUROREHAB NEURAL RE, V24, P478, DOI 10.1177/1545968309355986; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P2218, DOI 10.1016/j.apmr.2005.04.015; Kahn LE, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-12; Kalra L, 2004, BMJ-BRIT MED J, V328, P1099, DOI 10.1136/bmj.328.7448.1099; Kamps A., 2005, NEUROL REHABIL, V11, P1; Karthikbabu S, 2011, CLIN REHABIL, V25, P709, DOI 10.1177/0269215510397393; Katz-Leurer M, 2006, CLIN REHABIL, V20, P398, DOI 10.1191/0269215505cr960oa; Katz-Leurer M, 2003, CLIN REHABIL, V17, P735, DOI 10.1191/0269215503cr671oa; Katz-Leurer M, 2007, NEUROREHABILITATION, V22, P267; Keith RA, 1996, J ROY SOC MED, V89, P631, DOI 10.1177/014107689608901109; Kennisnetwerk CVA Nederland, 2012, ZORGST CVA TIA; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kerdoncuff V., 2004, Annales de Readaptation et de Medecine Physique, V47, P169, DOI 10.1016/j.annrmp.2003.11.005; Kim C M, 2001, J Stroke Cerebrovasc Dis, V10, P265, DOI 10.1053/jscd.2001.123775; Kim DG, 2008, NEUROREHABILITATION, V23, P239; Kim JH, 2009, AM J PHYS MED REHAB, V88, P693, DOI 10.1097/PHM.0b013e3181b33350; Kimberley TJ, 2004, EXP BRAIN RES, V154, P450, DOI 10.1007/s00221-003-1695-y; King TI, 1996, AM J OCCUP THER, V50, P62, DOI 10.5014/ajot.50.1.62; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjellstrom T, 2007, CEREBROVASC DIS, V23, P231; Klaiput A, 2009, NEUROREHAB NEURAL RE, V23, P351, DOI 10.1177/1545968308324227; Kluding PM, 2008, ARCH PHYS MED REHAB, V89, P449, DOI 10.1016/j.apmr.2007.12.005; Kojovic J, 2009, J NEUROSCI METH, V181, P100, DOI 10.1016/j.jneumeth.2009.04.005; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Kosak MC, 2000, NEUROREHAB NEURAL RE, V14, P13, DOI 10.1177/154596830001400102; Kowalczewski J, 2007, ARCH PHYS MED REHAB, V88, P833, DOI 10.1016/j.apmr.2007.03.036; Koyuncu E, 2010, DISABIL REHABIL, V32, P560, DOI 10.3109/09638280903183811; Kutner NG, 2010, PHYS THER, V90, P493, DOI 10.2522/ptj.20090160; Kuys SS, 2011, CLIN REHABIL, V25, P316, DOI 10.1177/0269215510382928; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lai SM, 2006, J AM GERIATR SOC, V54, P240, DOI 10.1111/j.1532-5415.2006.00573.x; Lam YS, 2006, NEUROREHABILITATION, V21, P245; Langhammer B, 2003, CLIN REHABIL, V17, P731, DOI 10.1191/0269215503cr670oa; Langhammer B, 2000, CLIN REHABIL, V14, P361, DOI 10.1191/0269215500cr338oa; Langhammer B, 2007, CLIN REHABIL, V21, P495, DOI 10.1177/0269215507075207; Langhammer B, 2010, CLIN REHABIL, V24, P46, DOI 10.1177/0269215509343328; Langhorne P, 2003, J NEUROL NEUROSUR PS, V74, P18; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2010, CEREBROVASC DIS, V29, P352, DOI 10.1159/000278931; Lannin NA, 2007, STROKE, V38, P111, DOI 10.1161/01.STR.0000251722.77088.12; Lau KWK, 2011, J REHABIL MED, V43, P709, DOI 10.2340/16501977-0838; Laufer Y, 2001, J REHABIL RES DEV, V38, P69; LEANDRI M, 1990, SCAND J REHABIL MED, V22, P69; Lee MJ, 2008, J AM GERIATR SOC, V56, P976, DOI 10.1111/j.1532-5415.2008.01707.x; Lee MJ, 2010, MED SCI SPORT EXER, V42, P23, DOI 10.1249/MSS.0b013e3181b07a31; LEE TD, 1991, PHYS THER, V71, P150, DOI 10.1093/ptj/71.2.150; Lennon O, 2008, CLIN REHABIL, V22, P125, DOI 10.1177/0269215507081580; Letombe A., 2010, Annals of Physical and Rehabilitation Medicine, V53, P632, DOI 10.1016/j.rehab.2010.09.004; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lewek MD, 2009, PHYS THER, V89, P829, DOI 10.2522/ptj.20080180; Lin Jau-Hong, 2004, Kaohsiung Journal of Medical Sciences, V20, P18; Lin KC, 2007, CLIN REHABIL, V21, P1075, DOI 10.1177/0269215507079843; Lin KC, 2010, AM J PHYS MED REHAB, V89, P177, DOI 10.1097/PHM.0b013e3181cf1c78; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P42, DOI 10.1177/1545968309345268; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P441, DOI 10.1177/1545968308328719; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P160, DOI 10.1177/1545968308320642; Lin ZL, 2011, J REHABIL MED, V43, P506, DOI 10.2340/16501977-0807; Lincoln NB, 1999, STROKE, V30, P573, DOI 10.1161/01.STR.30.3.573; Linn SL, 1999, STROKE, V30, P963, DOI 10.1161/01.STR.30.5.963; Lippert-Gruner M, 1999, NEUROLOGICAL REHABIL, V5, P275; Liston R, 2000, AGE AGEING, V29, P311, DOI 10.1093/ageing/29.4.311; Liu Karen P Y, 2009, Hong Kong Med J, V15, P37; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Logan PA, 1997, CLIN REHABIL, V11, P107, DOI 10.1177/026921559701100203; Lord S, 2008, CLIN REHABIL, V22, P215, DOI 10.1177/0269215507081922; Luft AR, 2008, STROKE, V39, P3341, DOI 10.1161/STROKEAHA.108.527531; Luft AR, 2004, JAMA-J AM MED ASSOC, V292, P1853, DOI 10.1001/jama.292.15.1853; Lum PS, 2006, J REHABIL RES DEV, V43, P631, DOI 10.1682/JRRD.2005.02.0044; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Lynch D, 2005, CLIN REHABIL, V19, P594, DOI 10.1191/0269215505cr901oa; Lynch EA, 2007, ARCH PHYS MED REHAB, V88, P1101, DOI 10.1016/j.apmr.2007.06.010; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Macdonell R A, 1994, J Stroke Cerebrovasc Dis, V4, P155, DOI 10.1016/S1052-3057(10)80178-8; MacKinnon JR, 1991, CANADIAN J OCCUPATIO, V58, P17, DOI DOI 10.1161/01.STR.0000251722.77088.12; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Malouin F, 2009, J NEUROL PHYS THER, V33, P195, DOI 10.1097/NPT.0b013e3181c2112b; MANDEL AR, 1990, ARCH PHYS MED REHAB, V71, P649; Mangold S, 2009, NEUROREHAB NEURAL RE, V23, P184, DOI 10.1177/1545968308324548; Mann GE, 2005, NEUROMODULATION, V8, P193, DOI 10.1111/j.1525-1403.2005.05238.x; Marigold DS, 2005, J AM GERIATR SOC, V53, P416, DOI 10.1111/j.1532-5415.2005.53158.x; Masiero S, 2007, ARCH PHYS MED REHAB, V88, P142, DOI 10.1016/j.apmr.2006.10.032; Masiero S, 2011, J REHABIL RES DEV, V48, P355, DOI 10.1682/JRRD.2010.04.0063; Mayr A, 2008, HANDCHIR MIKROCHIR P, V40, P66, DOI 10.1055/s-2007-989425; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; McClellan R, 2004, AUST J PHYSIOTHER, V50, P163, DOI 10.1016/S0004-9514(14)60154-9; McDonnell MN, 2007, NEUROREHAB NEURAL RE, V21, P435, DOI 10.1177/1545968307300437; Mead GE, 2007, J AM GERIATR SOC, V55, P892, DOI 10.1111/j.1532-5415.2007.01185.x; *MED RES COUNC, 2000, FRAM DEV EV RCTS COM; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Mehrholz J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006676.pub2; Mehrholz J, 2008, DISABIL REHABIL, V30, P830, DOI 10.1080/09638280701419326; Mehrholz J, 2012, J REHABIL MED, V44, P193, DOI 10.2340/16501977-0943; Mehrholz J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008186.pub2; Merkert J, 2011, Z GERONTOL GERIATR, V44, P256, DOI 10.1007/s00391-011-0170-9; MERLETTI R, 1978, SCAND J REHABIL MED, V10, P147; Mesci N, 2009, DISABIL REHABIL, V31, P2047, DOI 10.3109/09638280902893626; Michaelsen SM, 2006, STROKE, V37, P186, DOI 10.1161/01.STR.0000196940.20446.c9; Michaelsen SM, 2004, STROKE, V35, P1914, DOI 10.1161/01.STR.0000132569.33572.75; Michielsen ME, 2011, NEUROREHAB NEURAL RE, V25, P223, DOI 10.1177/1545968310385127; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Mirelman A, 2010, GAIT POSTURE, V31, P433, DOI 10.1016/j.gaitpost.2010.01.016; Mirelman A, 2009, STROKE, V40, P169, DOI 10.1161/STROKEAHA.108.516328; Moore JL, 2010, STROKE, V41, P129, DOI 10.1161/STROKEAHA.109.563247; Moreland JD, 2003, ARCH PHYS MED REHAB, V84, P1433, DOI 10.1016/S0003-9993(03)00360-5; Moreland JD, 1998, ARCH PHYS MED REHAB, V79, P134, DOI 10.1016/S0003-9993(98)90289-1; Morioka S, 2003, CLIN REHABIL, V17, P600, DOI 10.1191/0269215503cr654oa; Morone G, 2011, NEUROREHAB NEURAL RE, V25, P636, DOI 10.1177/1545968311401034; Morris JH, 2008, ARCH PHYS MED REHAB, V89, P1237, DOI 10.1016/j.apmr.2007.11.039; Moseley AM, 2002, AUST J PHYSIOTHER, V48, P43, DOI 10.1016/S0004-9514(14)60281-6; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P1989, DOI 10.1016/j.apmr.2009.07.015; Mudie MH, 2001, NEUROREHAB NEURAL RE, V15, P129, DOI 10.1177/154596830101500206; Mudie MH, 2002, CLIN REHABIL, V16, P582, DOI 10.1191/0269215502cr527oa; Mudie MH, 2000, DISABIL REHABIL, V22, P23, DOI 10.1080/096382800297097; Mueller K, 2007, RESTOR NEUROL NEUROS, V25, P501; Muir KW, 2002, STROKE, V33, P1545, DOI 10.1161/01.STR.0000018684.86293.AB; MULDER T, 1986, AM J PHYS MED REHAB, V65, P173; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Myint JMWW, 2008, CLIN REHABIL, V22, P112, DOI 10.1177/0269215507080141; Myint M W W, 2008, Hong Kong Med J, V14, P40; Newsam CJ, 2004, ARCH PHYS MED REHAB, V85, P2040, DOI 10.1016/j.apmr.2004.02.029; Ng MFW, 2008, STROKE, V39, P154, DOI 10.1161/STROKEAHA.107.495705; Ng SSM, 2007, STROKE, V38, P2953, DOI 10.1161/STROKEAHA.107.490318; Ng SSM, 2009, CLIN REHABIL, V23, P1093, DOI 10.1177/0269215509342327; Nilsson L, 2001, CLIN REHABIL, V15, P515, DOI 10.1191/026921501680425234; Noh DK, 2008, CLIN REHABIL, V22, P966, DOI 10.1177/0269215508091434; Norrving Bo, 2007, Int J Stroke, V2, P139, DOI 10.1111/j.1747-4949.2007.00109.x; Nour K., 2002, Therapeutic Recreation Journal, V36, P48; O'Connor RJ, 2004, NEUROLOGY, V62, P1842, DOI 10.1212/01.WNL.0000116136.22922.D6; Olawale OA, 2011, CLIN REHABIL, V25, P442, DOI 10.1177/0269215510389199; Olney SJ, 2006, STROKE, V37, P476, DOI 10.1161/01.STR.0000199061.85897.b7; Otterman NM, 2012, STROKE, V43, P2395, DOI 10.1161/STROKEAHA.112.660092; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Outermans JC, 2010, CLIN REHABIL, V24, P979, DOI 10.1177/0269215509360647; Page SJ, 2005, ARCH PHYS MED REHAB, V86, P399, DOI 10.1016/j.apmr.2004.10.002; Page SJ, 2002, NEUROREHAB NEURAL RE, V16, P290, DOI 10.1177/154596802401105225; Page SJ, 2001, J REHABIL RES DEV, V38, P583; Page SJ, 2005, NEUROREHAB NEURAL RE, V19, P27, DOI 10.1177/1545968304272701; Page SJ, 2000, OCCUP THER J RES, V20, P200, DOI 10.1177/153944920002000304; Page SJ, 2001, PHYS THER, V81, P1455, DOI 10.1093/ptj/81.8.1455; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P14, DOI 10.1016/S0003-9993(03)00481-7; Page SJ, 2008, CLIN REHABIL, V22, P610, DOI 10.1177/0269215508088987; Page SJ, 2008, PHYS THER, V88, P333, DOI 10.2522/ptj.20060029; Page SJ, 2007, STROKE, V38, P1293, DOI 10.1161/01.STR.0000260205.67348.2b; Page SJ, 2011, CLIN REHABIL, V25, P627, DOI 10.1177/0269215510395793; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; Pang MY, 2006, ARCH PHYS MED REHAB, V87, P1, DOI 10.1016/j.apmr.2005.08.113; Pang MYC, 2005, J AM GERIATR SOC, V53, P1667, DOI 10.1111/j.1532-5415.2005.53521.x; Paoloni M, 2010, NEUROREHAB NEURAL RE, V24, P254, DOI 10.1177/1545968309349940; Park HJ, 2011, CLIN REHABIL, V25, P451, DOI 10.1177/0269215510389200; Parker CJ, 2001, CLIN REHABIL, V15, P42, DOI 10.1191/026921501666968247; Partridge C, 2000, Physiother Res Int, V5, P230, DOI 10.1002/pri.203; Patil P, 2011, EUR J PHYS REHAB MED, V47, P427; Peurala SH, 2005, ARCH PHYS MED REHAB, V86, P1557, DOI 10.1016/j.apmr.2005.02.005; Peurala SH, 2009, J REHABIL MED, V41, P166, DOI 10.2340/16501977-0304; Piron L, 2003, ST HEAL T, V94, P265; Piron L, 2008, J TELEMED TELECARE, V14, P257, DOI 10.1258/jtt.2008.080304; Piron L, 2007, 2007 VIRTUAL REHABILITATION, P119; Piron L, 2010, NEUROREHAB NEURAL RE, V24, P501, DOI 10.1177/1545968310362672; Piron L, 2009, J REHABIL MED, V41, P1016, DOI 10.2340/16501977-0459; Platz T, 2005, CLIN REHABIL, V19, P714, DOI 10.1191/0269215505cr904oa; Platz T, 2001, NEUROPSYCHOLOGIA, V39, P687, DOI 10.1016/S0028-3932(01)00005-7; Platz T, 2009, NEUROREHAB NEURAL RE, V23, P706, DOI 10.1177/1545968309335974; Ploughman M, 2004, ARCH PHYS MED REHAB, V85, P1417, DOI 10.1016/j.apmr.2004.01.018; Pohl M, 2007, CLIN REHABIL, V21, P17, DOI 10.1177/0269215506071281; Pohl M, 2002, STROKE, V33, P553, DOI 10.1161/hs0202.102365; Pollock A, 2012, LANCET NEUROL, V11, P209, DOI 10.1016/S1474-4422(12)70029-7; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Pollock AS, 2002, CLIN REHABIL, V16, P473, DOI 10.1191/0269215502cr520oa; Pomeroy VM, 2006, STROKE, V37, P2441, DOI 10.1161/01.STR.0000236634.26819.cc; Pomeroy VM, 2001, CLIN REHABIL, V15, P390, DOI 10.1191/026921501678310199; POOLE JL, 1990, OCCUP THER J RES, V10, P360, DOI 10.1177/153944929001000605; Popovic MB, 2003, J REHABIL RES DEV, V40, P443, DOI 10.1682/JRRD.2003.09.0443; Popovic MR, 2005, NEUROMODULATION, V8, P58, DOI 10.1111/j.1094-7159.2005.05221.x; POTEMPA K, 1995, STROKE, V26, P101, DOI 10.1161/01.STR.26.1.101; Powell J, 1999, STROKE, V30, P1384, DOI 10.1161/01.STR.30.7.1384; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Rabadi MH, 2008, CLIN REHABIL, V22, P1071, DOI 10.1177/0269215508095358; Riccio I, 2010, EUR J PHYS REHAB MED, V46, P19; Richards CL, 2004, NEUROREHAB NEURAL RE, V18, P199, DOI 10.1177/1545968304269397; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Rimmer JH, 2000, MED SCI SPORT EXER, V32, P1990, DOI 10.1097/00005768-200012000-00004; Ring H, 2005, J REHABIL MED, V37, P32, DOI 10.1080/16501970410035387; Ro T, 2006, NEUROCASE, V12, P50, DOI 10.1080/13554790500493415; ROBICHAUD JA, 1992, PHYS THER, V72, P176, DOI 10.1093/ptj/72.3.176; Robinson W, 2008, AUST J PHYSIOTHER, V54, P33, DOI 10.1016/S0004-9514(08)70063-1; Rodgers H, 2003, CLIN REHABIL, V17, P579, DOI 10.1191/0269215503cr652oa; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Roper TA, 1999, AGE AGEING, V28, P9, DOI 10.1093/ageing/28.1.9; Rose V, 1980, AUST OCCUP THER J, V34, P59; Rothgangel AS, 2004, NEDERLANDS TIJD SCHR, V114, P36; Royal College of Physicians Clinical Effectiveness and Evaluation Unit on behalf of the Intercollegiate Stroke Working Party, 2013, SENT STROK NAT AUD P; Rydwik E, 2006, CLIN REHABIL, V20, P645, DOI 10.1191/0269215506cre986oa; Sackley CM, 1997, DISABIL REHABIL, V19, P536, DOI 10.3109/09638289709166047; Salbach NM, 2005, J AM GERIATR SOC, V53, P576, DOI 10.1111/j.1532-5415.2005.53203.x; Salbach NM, 2004, CLIN REHABIL, V18, P509, DOI 10.1191/0269215504cr763oa; Sangvatanakul P, 2010, J VASC NURS, V28, P121, DOI 10.1016/j.jvn.2010.09.001; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Sawaki L, 2008, NEUROREHAB NEURAL RE, V22, P505, DOI 10.1177/1545968308317531; Schauer M, 2003, CLIN REHABIL, V17, P713, DOI 10.1191/0269215503cr668oa; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Mano TS, 2011, MED CLIN-BARCELONA, V137, P297, DOI 10.1016/j.medcli.2010.10.024; Sheehan JL, 2006, CLIN REHABIL, V20, P1032, DOI 10.1177/0269215506071267; Sherrington C, 2000, MANUAL THER, V5, P223, DOI 10.1054/math.2000.0372; Shin HK, 2008, NEUROSCI LETT, V442, P174, DOI 10.1016/j.neulet.2008.07.026; Shindo K, 2011, NEUROREHAB NEURAL RE, V25, P830, DOI 10.1177/1545968311408917; SHUMWAYCOOK A, 1988, ARCH PHYS MED REHAB, V69, P395; Sims J, 2009, INT J GERIATR PSYCH, V24, P76, DOI 10.1002/gps.2082; Singh S, 2008, PHYSIOTHER OCCUP THE, V1, P73; SIVENIUS J, 1985, STROKE, V16, P928, DOI 10.1161/01.STR.16.6.928; Slade A, 2002, J REHABIL MED, V34, P260, DOI 10.1080/165019702760390347; Smania N, 2000, ARCH PHYS MED REHAB, V81, P379, DOI 10.1053/mr.2000.6921; Smania N, 2006, NEUROLOGY, V67, P2050, DOI 10.1212/01.wnl.0000247279.63483.1f; SMITH DS, 1981, BMJ-BRIT MED J, V282, P517, DOI 10.1136/bmj.282.6263.517; Smith K N, 1979, Aust J Physiother, V25, P155, DOI 10.1016/S0004-9514(14)61038-2; Smith LN, 2008, NURS EDUC TODAY, V28, P337, DOI 10.1016/j.nedt.2007.06.008; Sonde L, 1998, SCAND J REHABIL MED, V30, P95; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; States RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006075.pub2; Stein J, 2004, AM J PHYS MED REHAB, V83, P720, DOI 10.1097/01.PHM.0000137313.14480.CE; Stein J, 2010, AM J PHYS MED REHAB, V89, P697, DOI 10.1097/PHM.0b013e3181ec9aa8; Stern P H, 1970, Arch Phys Med Rehabil, V51, P526; Stinear CM, 2008, BRAIN, V131, P1381, DOI 10.1093/brain/awn051; Stoykov ME, 2009, NEUROREHAB NEURAL RE, V23, P945, DOI 10.1177/1545968309338190; Stroke Unit Trialists' Collaboration, 2007, COCHRANE DATABASE SY; Studenski S, 2005, STROKE, V36, P1764, DOI 10.1161/01.STR.0000174192.87887.70; Suat E, 2011, TOP STROKE REHABIL, V18, P231, DOI 10.1310/tsr1803-231; Sullivan KJ, 2007, PHYS THER, V87, P1580, DOI 10.2522/ptj.20060310; Sullivan KJ, 2002, ARCH PHYS MED REHAB, V83, P683, DOI 10.1053/apmr.2002.32488; Summers JJ, 2007, J NEUROL SCI, V252, P76, DOI 10.1016/j.jns.2006.10.011; Sun SF, 2010, NEUROREHAB NEURAL RE, V24, P34, DOI 10.1177/1545968309341060; SUNDERLAND A, 1992, J NEUROL NEUROSUR PS, V55, P530, DOI 10.1136/jnnp.55.7.530; Sungkarat S, 2011, CLIN REHABIL, V25, P360, DOI 10.1177/0269215510386125; Suputtitada Areerat, 2004, Journal of the Medical Association of Thailand, V87, P1482; Suputtitada Areerat, 2004, Journal of the Medical Association of Thailand, V87, pS107; Sutbeyaz S, 2007, ARCH PHYS MED REHAB, V88, P555, DOI 10.1016/j.apmr.2007.02.034; Sutbeyaz ST, 2010, CLIN REHABIL, V24, P240, DOI 10.1177/0269215509358932; Takahashi CD, 2008, BRAIN, V131, P425, DOI 10.1093/brain/awm311; Takami A, 2010, J PHYS THER SCI, V22, P177, DOI 10.1589/jpts.22.177; Tang QP, 2005, PHYS THER, V85, P1020, DOI 10.1093/ptj/85.10.1020; Tarkka IM, 2011, TOHOKU J EXP MED, V225, P71, DOI 10.1620/tjem.225.71; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; Tekeoolu Y, 1998, CLIN REHABIL, V12, P277, DOI 10.1191/026921598672873816; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Tufel S, 2010, IND J PHYSIOTHER OCC, V4, P40; Wellwood I, 2004, CLIN REHABIL, V18, P529, DOI 10.1191/0269215504cr768oa; World Confederation for Physical Therapy, 2013, WORLD CONF PHYS THER; World Health Organization, 2001, ICF INT CLASFUNCT; Thaut MH, 1997, J NEUROL SCI, V151, P207, DOI 10.1016/S0022-510X(97)00146-9; Thielman G, 2008, NEUROREHAB NEURAL RE, V22, P697, DOI 10.1177/1545968308315998; Thielman G, 2010, J NEUROL PHYS THER, V34, P138, DOI 10.1097/NPT.0b013e3181efa1e8; Thielman GT, 2004, ARCH PHYS MED REHAB, V85, P1613, DOI 10.1016/j.apmr.2004.01.028; Thrasher TA, 2008, NEUROREHAB NEURAL RE, V22, P706, DOI 10.1177/1545968308317436; Tihanyi J, 2010, ACTA PHYSIOL HUNG, V97, P172, DOI 10.1556/APhysiol.97.2010.2.3; Tihanyi TK, 2007, CLIN REHABIL, V21, P782, DOI 10.1177/0269215507077814; Toledano-Zarhi A, 2011, NEUROREHABILITATION, V28, P85, DOI 10.3233/NRE-2011-0636; Tong RK, 2006, ARCH PHYS MED REHAB, V87, P1298, DOI 10.1016/j.apmr.2006.06.016; Torriani C, 2008, REV NEUROCIENC, V16, P25; Tung FL, 2010, CLIN REHABIL, V24, P533, DOI 10.1177/0269215509360751; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; Turton AJ, 2005, CLIN REHABIL, V19, P600, DOI 10.1191/0269215505cr891oa; van Delden AEQ, 2013, DISABIL REHABIL, V35, P1961, DOI 10.3109/09638288.2013.768303; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; van Nes IJW, 2006, STROKE, V37, P2331, DOI 10.1161/01.STR.0000236494.62957.f3; Van Peppen RPS, 2004, CLIN REHABIL, V18, P833, DOI 10.1191/0269215504cr843oa; van Tulder MW, 1999, SPINE, V24, P1113, DOI 10.1097/00007632-199906010-00011; van Vliet PM, 2005, J NEUROL NEUROSUR PS, V76, P503, DOI 10.1136/jnnp.2004.040436; Varoqui D, 2011, MOTOR CONTROL, V15, P187, DOI 10.1123/mcj.15.2.187; Veerbeek JM, 2011, STROKE, V42, P3311, DOI 10.1161/STROKEAHA.111.623819; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Verheyden G, 2009, NEUROREHAB NEURAL RE, V23, P281, DOI 10.1177/1545968308321776; Vickrey BG, 2013, STROKE, V44, P2338, DOI 10.1161/STROKEAHA.113.001196; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Volpe BT, 2008, NEUROREHAB NEURAL RE, V22, P305, DOI 10.1177/1545968307311102; Volpe BT, 1999, NEUROLOGY, V53, P1874, DOI 10.1212/WNL.53.8.1874; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609; WADE DT, 1987, J NEUROL NEUROSUR PS, V50, P177, DOI 10.1136/jnnp.50.2.177; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; Wall J, 1987, NEUROREHAB NEURAL RE, V1, P115; Waller SM, 2008, HUM MOVEMENT SCI, V27, P749, DOI 10.1016/j.humov.2008.03.006; Wang Q, 2011, J REHABIL MED, V43, P619, DOI 10.2340/16501977-0819; Wang RY, 2000, AM J PHYS MED REHAB, V79, P385, DOI 10.1097/00002060-200007000-00011; Wang RY, 2005, CLIN REHABIL, V19, P155, DOI 10.1191/0269215505cr850oa; Wang RY, 2002, AM J PHYS MED REHAB, V81, P283, DOI 10.1097/00002060-200204000-00007; Wang T, 2007, BRAIN INJURY, V21, P1203, DOI 10.1080/02699050701633064; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Weaver CS, 2004, STROKE, V35, P1216, DOI 10.1161/01.STR.0000125010.70652.93; Werner C, 2002, STROKE, V33, P2895, DOI 10.1161/01.STR.0000035734.61539.f6; Werner RA, 1996, AM J PHYS MED REHAB, V75, P114, DOI 10.1097/00002060-199603000-00006; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Wevers L, 2009, STROKE, V40, P2450, DOI 10.1161/STROKEAHA.108.541946; Whitall J, 2011, NEUROREHAB NEURAL RE, V25, P118, DOI 10.1177/1545968310380685; Williams JM, 1982, PHYSIOTHER CAN, V34, P327; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; WINCHESTER P, 1983, PHYS THER, V63, P1096, DOI 10.1093/ptj/63.7.1096; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Wittenberg GF, 2003, NEUROREHAB NEURAL RE, V17, P48, DOI 10.1177/0888439002250456; Wolf SL, 2010, STROKE, V41, P2309, DOI 10.1161/STROKEAHA.110.588723; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Wolny T, 2010, CLIN REHABIL, V24, P810, DOI 10.1177/0269215510367561; Woodbury ML, 2009, NEUROREHAB NEURAL RE, V23, P78, DOI 10.1177/1545968308318836; Woodford H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004585.pub2; Wright P, 2004, COMP ELECT STIMULATI; Wu CY, 2007, NEUROREHAB NEURAL RE, V21, P460, DOI 10.1177/1545968307303411; Wu CY, 2007, ARCH PHYS MED REHAB, V88, P964, DOI 10.1016/j.apmr.2007.05.012; Wu CY, 2007, ARCH PHYS MED REHAB, V88, P273, DOI 10.1016/j.apmr.2006.11.021; Wu CY, 2011, NEUROREHAB NEURAL RE, V25, P130, DOI 10.1177/1545968310380686; Wu Ching-Yi, 2010, Chang Gung Med J, V33, P628; Wu HC, 2010, STROKE, V41, P2378, DOI 10.1161/STROKEAHA.110.593673; Yagura H, 2006, ARCH PHYS MED REHAB, V87, P529, DOI 10.1016/j.apmr.2005.11.035; Yan TB, 2005, STROKE, V36, P80, DOI 10.1161/01.STR.0000149623.24906.63; Yan TB, 2009, J REHABIL MED, V41, P312, DOI 10.2340/16501977-0325; Yang YR, 2008, GAIT POSTURE, V28, P201, DOI 10.1016/j.gaitpost.2007.11.007; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762; Yang YR, 2006, CLIN REHABIL, V20, P860, DOI 10.1177/0269215506070701; Yang YR, 2010, ARCH PHYS MED REHAB, V91, P513, DOI 10.1016/j.apmr.2009.11.021; Yang YR, 2005, CLIN REHABIL, V19, P264, DOI 10.1191/0269215505cr860oa; Yavuzer G, 2008, EUR J PHYS REHAB MED, V44, P237; Yavuzer G, 2006, ARCH PHYS MED REHAB, V87, P536, DOI 10.1016/j.apmr.2005.12.041; Yavuzer G, 2008, ARCH PHYS MED REHAB, V89, P393, DOI 10.1016/j.apmr.2007.08.162; Yavuzer G, 2007, ARCH PHYS MED REHAB, V88, P710, DOI 10.1016/j.apmr.2007.02.030; Yavuzer G, 2006, CLIN REHABIL, V20, P960, DOI 10.1177/0269215506070315; Yelnik AP, 2008, NEUROREHAB NEURAL RE, V22, P468, DOI 10.1177/1545968308315996; Yen CL, 2008, NEUROREHAB NEURAL RE, V22, P22, DOI 10.1177/1545968307301875; Yen Jyh-Geng, 2005, Acta Neurol Taiwan, V14, P16; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91; Young J, 1991, CLIN REHABIL, V5, P283; YOUNG JB, 1992, BRIT MED J, V304, P1085, DOI 10.1136/bmj.304.6834.1085	582	594	619	14	224	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87987	10.1371/journal.pone.0087987	http://dx.doi.org/10.1371/journal.pone.0087987			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505342	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300027
J	Li, ZD; Liu, XK; Zhang, Y; Shi, JS; Zhang, Y; Xie, P; Yu, T				Li, Zhaoduan; Liu, Xingkui; Zhang, Yi; Shi, Jinshan; Zhang, Yu; Xie, Peng; Yu, Tian			Connection Changes in Somatosensory Cortex Induced by Different Doses of Propofol	PLOS ONE			English	Article							GENERAL-ANESTHETICS; FUNCTIONAL CONNECTIVITY; GABA(A) RECEPTOR; RAT; RESPONSES; NUCLEUS; NEURONS; BRAIN; DISCRIMINATION; ORGANIZATION	Background: The mechanism by which general anesthetics, widely used in clinical practice for over 160 years, effects on sensory responsiveness has been unclear until now. In the present study, the authors sought to explore the effect of different doses of propofol on somatosensory cortex by whisker stimulation in rats. Methods: In a fixed cage, rats were anesthetized with propofol 80 mg/kg intraperitoneally and then cathetered tail vein with 23-gauge metal needle connected with a pump. Two holes (2 mm diameter) were drilled and recording electrodes implantated in the primary somatosensory cortex barrel field (S1BF) and secondary somatosensory cortex (S2). The extracellular (20 rats) and intracellular (8 rats) recordings were used to test the neuron activity in both cortices at different doses of propofol (20, 40 and 80 mg/kg/h) through tail vein by pump. Meantime, vibrissal, olfactory, corneal responses (VOCR, sedation), and tail-pinch response (TRP, analgesia) were tested every 10 min during the doses of propofol 20, 40 and 80 mg/kg/h. Results: VOCR and TRP were depressed by propofol in a dose-dependent manner. The amplitude by whisker stimulation in S1BF was stronger and the peak latency was shorter compared with that of in S2. The response latency of S1BF and S2 was increased by raising infusion rate of propofol with the response latency in S2 being longer than that in S1BF at the same doses of propofol. The cross-correlation between S1BF and S2 decreased as the propofol infusion rate increased. The input resistance was higher by increasing infusion rate of propofol. Conclusion: The sedation and analgesia effects of propofol were dose-dependent. Both the connectivity and instinctive oscillation between S1BF and S2 were proportionally modulated by the different doses of propofol.	[Li, Zhaoduan; Liu, Xingkui; Zhang, Yi; Shi, Jinshan; Zhang, Yu; Xie, Peng; Yu, Tian] Zunyi Med Coll, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China	Zunyi Medical University	Yu, T (corresponding author), Zunyi Med Coll, Dept Anesthesiol, Zunyi, Guizhou, Peoples R China.	zyyutian@hotmail.com	Zhang, Yi/AAQ-6320-2021		National Natural Science Foundation [81060266]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation (Grant Nos. 81060266). In addition, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antkowiak B, 1999, ANESTHESIOLOGY, V91, P500, DOI 10.1097/00000542-199908000-00025; Antognini JF, 2000, CAN J ANAESTH, V47, P273, DOI 10.1007/BF03018926; Antunes LM, 2003, J VET PHARMACOL THER, V26, P369, DOI 10.1046/j.1365-2885.2003.00499.x; Antunes LM, 2003, VET ANAESTH ANALG, V30, P15, DOI 10.1046/j.1467-2995.2003.00085.x; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Benison AM, 2007, J NEUROPHYSIOL, V97, P200, DOI 10.1152/jn.00673.2006; Brett-Green B, 2004, J NEUROPHYSIOL, V91, P1327, DOI 10.1152/jn.00905.2003; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; BURTON H, 1990, J COMP NEUROL, V291, P395, DOI 10.1002/cne.902910307; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Dong XP, 2002, ANESTH ANALG, V95, P907, DOI 10.1097/00000539-200210000-00021; Dong YF, 1999, NEUROSCI LETT, V271, P17, DOI 10.1016/S0304-3940(99)00506-6; Fassl J, 2011, J CLIN PHARMACOL, V51, P719, DOI 10.1177/0091270010373098; GUICROBLES E, 1992, BEHAV BRAIN RES, V48, P145, DOI 10.1016/S0166-4328(05)80150-0; Ishizawa Y, 2007, J ANESTH, V21, P187, DOI 10.1007/s00540-006-0482-x; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jugovac I, 2006, ANESTHESIOLOGY, V105, P764, DOI 10.1097/00000542-200610000-00023; KORALEK KA, 1990, J COMP NEUROL, V299, P133, DOI 10.1002/cne.902990202; Kwegyir-Afful EE, 2004, J NEUROPHYSIOL, V92, P2083, DOI 10.1152/jn.00262.2004; Liao CC, 2008, ANAT REC, V291, P960, DOI 10.1002/ar.20696; LIN CS, 1979, J COMP NEUROL, V185, P355, DOI 10.1002/cne.901850209; Ma JY, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0004.2002; Mc Alonan K, 2002, NEUROSCIENTIST, V8, P302, DOI 10.1177/107385840200800405; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Narimatsu E, 2002, BRAIN RES, V953, P272, DOI 10.1016/S0006-8993(02)03375-9; O'Toole KK, 2012, MOL PHARMACOL, V81, P189, DOI 10.1124/mol.111.074476; Pashkov VN, 2002, ANESTH ANALG, V95, P1274, DOI 10.1097/00000539-200211000-00032; PONS TP, 1987, SCIENCE, V237, P417, DOI 10.1126/science.3603028; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Sheeba JH, 2008, BIOPHYS J, V95, P2722, DOI 10.1529/biophysj.108.134635; Tu Y, 2011, PHARMACOLOGY, V88, P322, DOI 10.1159/000334168; WELLER RE, 1987, SOMATOSENS MOT RES, V5, P107; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082377	36	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87829	10.1371/journal.pone.0087829	http://dx.doi.org/10.1371/journal.pone.0087829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516566	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400021
J	Bergvall, N; Makin, C; Lahoz, R; Agashivala, N; Pradhan, A; Capkun, G; Petrilla, AA; Karkare, SU; McGuiness, CB; Korn, JR				Bergvall, Niklas; Makin, Charles; Lahoz, Raquel; Agashivala, Neetu; Pradhan, Ashish; Capkun, Gorana; Petrilla, Allison A.; Karkare, Swapna U.; McGuiness, Catherine Balderston; Korn, Jonathan R.			Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study	PLOS ONE			English	Article							DISEASE-MODIFYING THERAPIES; INTRAMUSCULAR INTERFERON; CLINICAL-COURSE; DOUBLE-BLIND; MULTICENTER; TOLERABILITY; DISABILITY; ADHERENCE; IMPACT	Background: Approximately one-third of patients with multiple sclerosis (MS) are unresponsive to, or intolerant of, interferon (IFN) therapy, prompting a switch to other disease-modifying therapies. Clinical outcomes of switching therapy are unknown. This retrospective study assessed differences in relapse rates among patients with MS switching from IFN to fingolimod or glatiramer acetate (GA) in a real-world setting. Methods: US administrative claims data from the PharMetrics Plus (TM) database were used to identify patients with MS who switched from IFN to fingolimod or GA between October 1, 2010 and March 31, 2012. Patients were matched 1: 1 using propensity scores within strata (number of pre-index relapses) on demographic (e. g. age and gender) and disease (e. g. timing of pre-index relapse, comorbidities and symptoms) characteristics. A claims-based algorithm was used to identify relapses while patients were persistent with therapy over 360 days post-switch. Differences in both the probability of experiencing a relapse and the annualized relapse rate (ARR) while persistent with therapy were assessed. Results: The matched sample population contained 264 patients (n = 132 in each cohort). Before switching, 33.3% of patients in both cohorts had experienced at least one relapse. During the post-index persistence period, the proportion of patients with at least one relapse was lower in the fingolimod cohort (12.9%) than in the GA cohort (25.0%), and ARRs were lower with fingolimod (0.19) than with GA (0.51). Patients treated with fingolimod had a 59% lower probability of relapse (odds ratio, 0.41; 95% confidence interval [CI], 0.21-0.80; p = 0.0091) and 62% fewer relapses per year (rate ratio, 0.38; 95% CI, 0.21-0.68; p = 0.0013) compared with those treated with GA. Conclusions: In a real-world setting, patients with MS who switched from IFNs to fingolimod were significantly less likely to experience relapses than those who switched to GA.	[Bergvall, Niklas; Lahoz, Raquel; Capkun, Gorana] Novartis Pharma AG, Basel, Switzerland; [Makin, Charles; Petrilla, Allison A.; Karkare, Swapna U.; McGuiness, Catherine Balderston; Korn, Jonathan R.] IMS Hlth, Plymouth Meeting, PA USA; [Agashivala, Neetu; Pradhan, Ashish] Novartis Pharmaceut, E Hanover, NJ USA	Novartis; Novartis	Bergvall, N (corresponding author), Novartis Pharma AG, Basel, Switzerland.	niklas.bergvall@novartis.com			Novartis Pharma AG, Basel, Switzerland	Novartis Pharma AG, Basel, Switzerland	Analyses were funded by Novartis Pharma AG, Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashivala N, 2012, ECTRIMS 28 C EUR COM; Agashivala N, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-138; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bainbridge JL, 2008, PHARMACOTHERAPY PATH; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; Caon C, 2006, EUR J NEUROL, V13, P471, DOI 10.1111/j.1468-1331.2006.01273.x; CAPKUNNIGGLI G, 2013, VALUE HEALTH, V16, pA582; Chastek Benjamin J, 2010, J Med Econ, V13, P618, DOI 10.3111/13696998.2010.523670; Chin PS, 2012, ECTRIMS 10 13 OCT 20; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Collins W, 2010, MULT SCLER S10, V16, pS295; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Cree B, 2013, ECTRIMS 29 C EUR COM; Derwenskus J, 2011, MT SINAI J MED, V78, P161, DOI 10.1002/msj.20239; DHOORE W, 1993, METHOD INFORM MED, V32, P382; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Edwards KR, 2013, ECTRIMS 29 C EUR COM; Fernandez O, 2005, ACTA NEUROL SCAND, V112, P391, DOI 10.1111/j.1600-0404.2005.00415.x; Fox E, 2013, 5 COOP M CONS MULT S; Freedman SM, 2009, CURR MED RES OPIN, V25, P547, DOI [10.1185/03007990802677787, 10.1185/03007990802677787 ]; Giovannoni G, 2012, MULT SCLER J, V18, P932, DOI 10.1177/1352458511433302; Goodin DS, 2008, NEUROLOGY, V71, pS8, DOI 10.1212/WNL.0b013e31818f3d8b; Halpern R, 2011, PATIENT PREFER ADHER, V5, P73, DOI 10.2147/PPA.S15702; Hartung HP, 2013, 23 M EUR NEUR SOC 8, P8; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Johnson KP, 2000, MULT SCLER J, V6, P255, DOI 10.1191/135245800678827806; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lublin Fred D., 2003, Neurology, V61, P1528; Margolis JM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-122; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; O'Connor P, 2009, LANCET NEUROL, V8, P889, DOI 10.1016/S1474-4422(09)70226-1; Ollendorf Daniel A, 2002, J Manag Care Pharm, V8, P469; Ollendorf DA, 2008, J NEUROSCI NURS, V40, P281, DOI 10.1097/01376517-200810000-00006; Ontaneda D, 2012, J NEUROL SCI, V323, P167, DOI 10.1016/j.jns.2012.09.009; Reynolds Matthew W, 2010, J Med Econ, V13, P90, DOI 10.3111/13696990903579501; Rich Sheldon R, 2004, J Manag Care Pharm, V10, pS26; Rolak Loren A, 2003, Clin Med Res, V1, P57; Roos LL, 1997, HEALTH SERV RES, V32, P229; Roskell NS, 2012, CURR MED RES OPIN, V28, P767, DOI 10.1185/03007995.2012.681637; Sormani MP, 2011, NEUROLOGY, V77, P1684, DOI 10.1212/WNL.0b013e31823648b9; Stavnitser A, 2013, AJMP; Steinberg SC, 2010, CLIN DRUG INVEST, V30, P89, DOI 10.2165/11533330-000000000-00000; Tan H, 2011, ADV THER, V28, P51, DOI 10.1007/s12325-010-0093-7; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; Zwibel Howard L, 2011, Am J Manag Care, V17 Suppl 5 Improving, pS139	49	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88472	10.1371/journal.pone.0088472	http://dx.doi.org/10.1371/journal.pone.0088472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516663	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700076
J	Sisco, PN; Wilson, CG; Chernak, D; Clark, JC; Grzincic, EM; Ako-Asare, K; Goldsmith, EC; Murphy, CJ				Sisco, Patrick N.; Wilson, Christopher G.; Chernak, Davin; Clark, Jessica C.; Grzincic, Elissa M.; Ako-Asare, Kayla; Goldsmith, Edie C.; Murphy, Catherine J.			Adsorption of Cellular Proteins to Polyelectrolyte-Functionalized Gold Nanorods: A Mechanism for Nanoparticle Regulation of Cell Phenotype?	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; IRON-OXIDE NANOPARTICLES; SURFACE; SIZE; BIGLYCAN; CORONA; NANOMATERIALS; RECOGNITION; FIBROBLAST; EXPRESSION	Cell behavior in the presence of nanomaterials is typically explored through simple viability assays, but there is mounting evidence that nanomaterials can have more subtle effects on a variety of cellular functions. Previously our lab demonstrated that gold nanorods functionalized with polyelectrolyte multi-layers inhibited rat cardiac fibroblast-mediated remodeling of type I collagen scaffolds by altering fibroblast phenotype and the mechanical properties of the collagen network. In this work, we examine a possible mechanism for these effects: adsorption of cellular proteins by the nanorods. Mass spectrometric and gel electrophoresis of media collected from cultured cells suggests that a number of proteins, some of which mediate cell-cell and cell-matrix interactions, adsorb onto the surface of these nanoparticles in vitro. Polyethylene glycol coating of the nanorods largely mitigates protein adsorption and fibroblast-mediated collagen remodeling. These results suggest that adsorption of proteins by nanorods could have a significant effect on cell functions, including fibroblast-mediated matrix remodeling.	[Sisco, Patrick N.; Chernak, Davin; Grzincic, Elissa M.; Murphy, Catherine J.] Univ Illinois, Dept Chem, Urbana, IL USA; [Wilson, Christopher G.; Clark, Jessica C.; Ako-Asare, Kayla; Goldsmith, Edie C.] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Goldsmith, EC (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29208 USA.	Edie.Goldsmith@uscmed.sc.edu; Murphycj@illinois.edu		Murphy, Catherine/0000-0001-7066-5575	NIH [HL73937, HL097214, P20 RR-016461]; NSF [CHE-1011980]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097214, R01HL073937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by NIH grants HL73937, HL097214, and P20 RR-016461, as well as NSF grant CHE-1011980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Asuri P, 2007, J NANOSCI NANOTECHNO, V7, P1675, DOI 10.1166/jnn.2007.453; Bardhan R, 2011, ACCOUNTS CHEM RES, V44, P936, DOI 10.1021/ar200023x; BORG TK, 1984, DEV BIOL, V104, P86, DOI 10.1016/0012-1606(84)90038-1; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Brown SD, 2010, J AM CHEM SOC, V132, P4678, DOI 10.1021/ja908117a; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Comfort KK, 2011, ACS NANO, V5, P10000, DOI 10.1021/nn203785a; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069; Gole A, 2005, CHEM MATER, V17, P1325, DOI 10.1021/cm048297d; Gole A, 2008, LANGMUIR, V24, P266, DOI 10.1021/la7026303; Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Hauck TS, 2008, SMALL, V4, P153, DOI 10.1002/smll.200700217; Hong R, 2004, J AM CHEM SOC, V126, P739, DOI 10.1021/ja037470o; Huang KY, 2012, ACS NANO, V6, P4483, DOI 10.1021/nn301282m; Huff TB, 2007, LANGMUIR, V23, P1596, DOI 10.1021/la062642r; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jain PK, 2006, J PHYS CHEM B, V110, P7238, DOI 10.1021/jp057170o; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; Lartigue L, 2012, ACS NANO, V6, P2665, DOI 10.1021/nn300060u; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lundqvist M, 2006, ANGEW CHEM INT EDIT, V45, P8169, DOI 10.1002/anie.200600965; Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g; Maiorano G, 2010, ACS NANO, V4, P7481, DOI 10.1021/nn101557e; Mandal HS, 2007, J AM CHEM SOC, V129, P6356, DOI 10.1021/ja0703372; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Ramos C, 2006, AM J PHYSIOL-LUNG C, V291, pL871, DOI 10.1152/ajplung.00019.2006; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r; Shaw CP, 2012, ACS NANO, V6, P1416, DOI 10.1021/nn204214x; Sisco PN, 2008, NANO LETT, V8, P3409, DOI 10.1021/nl802142h; Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a; Stone JW, 2007, NANO LETT, V7, P116, DOI 10.1021/nl062248d; Sund J, 2011, ACS NANO, V5, P4300, DOI 10.1021/nn101492k; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011; Wilson CG, 2009, J MATER CHEM, V19, P6332, DOI 10.1039/b902760b; Wu X, 2010, ACS NANO, V4, P113, DOI 10.1021/nn901064m; Xia XR, 2011, ACS NANO, V5, P9074, DOI 10.1021/nn203303c; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59	54	27	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86670	10.1371/journal.pone.0086670	http://dx.doi.org/10.1371/journal.pone.0086670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516536	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700011
J	van Vliet, M; Manyakov, NV; Storms, G; Fias, W; Wiersema, JR; Van Hulle, MM				van Vliet, Marijn; Manyakov, Nikolay V.; Storms, Gert; Fias, Wim; Wiersema, Jan R.; Van Hulle, Marc M.			Response-Related Potentials during Semantic Priming: The Effect of a Speeded Button Response Task on ERPs	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; REACTION-TIME; FACILITATION; RETRIEVAL; MEMORY; EEG	This study examines the influence of a button response task on the event-related potential (ERP) in a semantic priming experiment. Of particular interest is the N400 component. In many semantic priming studies, subjects are asked to respond to a stimulus as fast and accurately as possible by pressing a button. Response time (RT) is recorded in parallel with an electroencephalogram (EEG) for ERP analysis. In this case, the response occurs in the time window used for ERP analysis and response-related components may overlap with stimulus-locked ones such as the N400. This has led to a recommendation against such a design, although the issue has not been explored in depth. Since studies keep being published that disregard this issue, a more detailed examination of influence of response-related potentials on the ERP is needed. Two experiments were performed in which subjects pressed one of two buttons with their dominant hand in response to word-pairs with varying association strength (AS), indicating a personal judgement of association between the two words. In the first experiment, subjects were instructed to respond as fast and accurately as possible. In the second experiment, subjects delayed their button response to enforce a one second interval between the onset of the target word and the button response. Results show that in the first experiment a P3 component and motor-related potentials (MRPs) overlap with the N400 component, which can cause a misinterpretation of the latter. In order to study the N400 component, the button response should be delayed to avoid contamination of the ERP with response-related components.	[van Vliet, Marijn; Manyakov, Nikolay V.; Van Hulle, Marc M.] Katholieke Univ Leuven, Neurophysiol Lab, Louvain, Belgium; [Storms, Gert] Katholieke Univ Leuven, Dept Expt Psychol, Louvain, Belgium; [Fias, Wim] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Wiersema, Jan R.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	KU Leuven; KU Leuven; Ghent University; Ghent University	van Vliet, M (corresponding author), Katholieke Univ Leuven, Neurophysiol Lab, Louvain, Belgium.	marijn.vanvliet@med.kuleuven.be	Van Vliet, Marijn/K-7359-2015; Fias, Wim/D-6861-2010	Van Vliet, Marijn/0000-0002-6537-6899; Fias, Wim/0000-0002-5788-7306; Van Hulle, Marc/0000-0003-1060-7044; Manyakov, Nikolay/0000-0001-9037-1400; Storms, Gert/0000-0002-4100-8725	Belgian Fund for Scientific Research - Flanders [G.0588.09, G.0436.13, G088314N]; Interuniversity Attraction Poles Programme - Belgian Science Policy [IUAP P7/11]; UGent MRP "The integrative neuroscience of behavioral control''; CREA Financing program of the K.U. Leuven [CREA/07/027]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Flemish Agency for Innovation by Science and Technology (TETRA project "Spellbinder'');  [PFV/10/008]	Belgian Fund for Scientific Research - Flanders(FWO); Interuniversity Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); UGent MRP "The integrative neuroscience of behavioral control''; CREA Financing program of the K.U. Leuven; Flemish Regional Ministry of Education (Belgium)(FWO); Flemish Agency for Innovation by Science and Technology (TETRA project "Spellbinder''); 	MVV is supported by the Belgian Fund for Scientific Research - Flanders (G.0588.09) and the Interuniversity Attraction Poles Programme - Belgian Science Policy (IUAP P7/11). NVM is currently employed by Johnson & Johnson (Beerse, Belgium), but the result reported here was carried out when employed at the LU Leuven and funded by grant G.0588.09. GS is supported by the Belgian Fund for Scientific Research - Flanders (G.0436.13). WF and JRW are supported by grant IUAP P7/11 and UGent MRP "The integrative neuroscience of behavioral control''. MMVH is supported by grants G.0588.09, IUAP P7/11, the financing program (PFV/10/008) and the CREA Financing program (CREA/07/027) of the K.U. Leuven, the Belgian Fund for Scientific Research - Flanders (G088314N), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), the Flemish Agency for Innovation by Science and Technology (TETRA project "Spellbinder''), and by the SWIFT prize of the King Baudouin Foundation of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BAJO MT, 1988, J EXP PSYCHOL LEARN, V14, P579, DOI 10.1037/0278-7393.14.4.579; BENTIN S, 1985, ELECTROEN CLIN NEURO, V60, P343, DOI 10.1016/0013-4694(85)90008-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; De Deyne S, 2008, BEHAV RES METHODS, V40, P213, DOI 10.3758/BRM.40.1.213; De Deyne Simon, BEHAV RES M IN PRESS; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Ford J M, 1980, Prog Brain Res, V54, P661, DOI 10.1016/S0079-6123(08)61687-8; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kiang M, 2013, CLIN NEUROPHYSIOL, V124, P667, DOI 10.1016/j.clinph.2012.09.029; Koivisto M, 2001, COGNITIVE BRAIN RES, V12, P487, DOI 10.1016/S0926-6410(01)00069-6; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M., 2006, HDB PSYCHOLINGUISTIC, P659, DOI [10.1016/B978-012369374-7/50018-3, DOI 10.1016/B978-012369374-7/50018-3]; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Luck S.J., 2005, INTRO EVENT RELATED; Maki WS, 2007, COGNITIVE PSYCHOL, V54, P319, DOI 10.1016/j.cogpsych.2006.08.002; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; MITCHELL PF, 1993, PSYCHOPHYSIOLOGY, V30, P496, DOI 10.1111/j.1469-8986.1993.tb02073.x; NEELY JH, 1976, MEM COGNITION, V4, P648, DOI 10.3758/BF03213230; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Pinheiro J., 2019, NLME LINEAR NONLINEA; RITTER W, 1972, ELECTROEN CLIN NEURO, V33, P547, DOI 10.1016/0013-4694(72)90245-3; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Takeda Y, 2008, NEUROIMAGE, V39, P742, DOI 10.1016/j.neuroimage.2007.09.003; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247	33	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87650	10.1371/journal.pone.0087650	http://dx.doi.org/10.1371/journal.pone.0087650			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516556	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700025
J	Wu, T; Schwender, H; Ruczinski, I; Murray, JC; Marazita, ML; Munger, RG; Hetmanski, JB; Parker, MM; Wang, P; Murray, T; Taub, M; Li, S; Redett, RJ; Fallin, MD; Liang, KY; Wu-Chou, YH; Chong, SS; Yeow, V; Ye, XQ; Wang, H; Huang, SZ; Jabs, EW; Shi, B; Wilcox, AJ; Jee, SH; Scott, AF; Beaty, TH				Wu, Tao; Schwender, Holger; Ruczinski, Ingo; Murray, Jeffrey C.; Marazita, Mary L.; Munger, Ronald G.; Hetmanski, Jacqueline B.; Parker, Margaret M.; Wang, Ping; Murray, Tanda; Taub, Margaret; Li, Shuai; Redett, Richard J.; Fallin, M. Daniele; Liang, Kung Yee; Wu-Chou, Yah Huei; Chong, Samuel S.; Yeow, Vincent; Ye, Xiaoqian; Wang, Hong; Huang, Shangzhi; Jabs, Ethylin W.; Shi, Bing; Wilcox, Allen J.; Jee, Sun Ha; Scott, Alan F.; Beaty, Terri H.			Evidence of Gene-Environment Interaction for Two Genes on Chromosome 4 and Environmental Tobacco Smoke in Controlling the Risk of Nonsyndromic Cleft Palate	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYNDROMIC ORAL CLEFTS; SERUM URIC-ACID; OROFACIAL CLEFTS; CANDIDATE GENES; MATERNAL SMOKING; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; LIP; POPULATION	Nonsyndromic cleft palate (CP) is one of the most common human birth defects and both genetic and environmental risk factors contribute to its etiology. We conducted a genome-wide association study (GWAS) using 550 CP case-parent trios ascertained in an international consortium. Stratified analysis among trios with different ancestries was performed to test for GxE interactions with common maternal exposures using conditional logistic regression models. While no single nucleotide polymorphism (SNP) achieved genome-wide significance when considered alone, markers in SLC2A9 and the neighboring WDR1 on chromosome 4p16.1 gave suggestive evidence of gene-environment interaction with environmental tobacco smoke (ETS) among 259 Asian trios when the models included a term for GxE interaction. Multiple SNPs in these two genes were associated with increased risk of nonsyndromic CP if the mother was exposed to ETS during the peri-conceptual period (3 months prior to conception through the first trimester). When maternal ETS was considered, fifteen of 135 SNPs mapping to SLC2A9 and 9 of 59 SNPs in WDR1 gave P values approaching genome-wide significance (10(-6)<P<10(-4)) in a test for GxETS interaction. SNPs rs3733585 and rs12508991 in SLC2A9 yielded P = 2.26x10(-7) in a test for GxETS interaction. SNPs rs6820756 and rs7699512 in WDR1 also yielded P = 1.79x10(-7) and P = 1.98x10(-7) in a 1 df test for GxE interaction. Although further replication studies are critical to confirming these findings, these results illustrate how genetic associations for nonsyndromic CP can be missed if potential GxE interaction is not taken into account, and this study suggest SLC2A9 and WDR1 should be considered as candidate genes for CP.	[Wu, Tao; Wang, Ping; Li, Shuai; Wang, Hong] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Wu, Tao; Ruczinski, Ingo; Hetmanski, Jacqueline B.; Parker, Margaret M.; Murray, Tanda; Taub, Margaret; Fallin, M. Daniele; Liang, Kung Yee; Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA; [Schwender, Holger] Univ Dusseldorf, Math Inst, Dusseldorf, Germany; [Murray, Jeffrey C.] Univ Iowa, Childrens Hosp, Iowa City, IA USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Munger, Ronald G.] Utah State Univ, Logan, UT 84322 USA; [Redett, Richard J.; Jabs, Ethylin W.; Scott, Alan F.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Liang, Kung Yee] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu-Chou, Yah Huei] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Chong, Samuel S.] Natl Univ Singapore, Singapore 117548, Singapore; [Yeow, Vincent] KK Womens & Childrens Hosp, Singapore, Singapore; [Ye, Xiaoqian] Wuhan Univ, Sch Stomatol, Wuhan 430072, Peoples R China; [Ye, Xiaoqian; Jabs, Ethylin W.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Huang, Shangzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Bing] Sichuan Univ, West China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Wilcox, Allen J.] NIEHS, NIH, Epidemiol Branch, Durham, NC USA; [Jee, Sun Ha] Yonsei Univ, Sch Publ Hlth, Seoul 120749, South Korea	Peking University; Johns Hopkins University; Heinrich Heine University Dusseldorf; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; Utah State University; Johns Hopkins University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; National University of Singapore; KK Women's & Children's Hospital; Wuhan University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Yonsei University	Wu, T (corresponding author), Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China.	twu@bjmu.edu.cn	Li, Shuai/K-2164-2015; Wilcox, Allen J/C-7723-2019; Chong, Samuel S./D-8098-2015	Li, Shuai/0000-0002-8696-8594; Wilcox, Allen J/0000-0002-3376-1311; Chong, Samuel S./0000-0002-1872-5937; Jabs, Ethylin/0000-0001-8983-5466; Jee, Sun Ha/0000-0001-9519-3068; Parker, PhD, Margaret/0000-0001-6368-5033	National Human Genome Research Institute (NHGRI); National Institute for Dental and Craniofacial Research [U01-DE-018993]; International Collaborative Genetics Research Training Program (ICGRTP), NIH from National Natural Science of China [D43 TW06176, 81102178];  [R01-DE-014581];  [R01-DE-016148];  [P50-DE-016215];  [R21-DE-016930];  [R01-DE-09886];  [R37-DE-08559];  [U01-DE-020057];  [R37-DE-0-8559];  [R01-DE-012472];  [R01-DE-0106877]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559, R01DE016148, U01DE020057, R01DE014581, U01DE020073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018993, R01DE012472, R21DE016930, P50DE016215, R21DE013707, R01DE009886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); International Collaborative Genetics Research Training Program (ICGRTP), NIH from National Natural Science of China; ; ; ; ; ; ; ; ; ; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding to support data collection, genotyping and analysis came from several sources, some to individual investigators (R01-DE-014581, R01-DE-016148, P50-DE-016215, R21-DE-016930, R01-DE-09886, R37-DE-08559, U01-DE-020057, R37-DE-0-8559, U01-DE-020057, R01-DE-012472, R01-DE-0106877) and some to the cleft consortium itself (U01-DE-018993). This project was part of the Gene, Environment Association Studies (GENEVA) Consortium funded by the National Human Genome Research Institute (NHGRI) to enhance communication and collaboration among researchers conducting genome-wide studies of complex diseases. The authors' group benefited greatly from the work and efforts of the entire consortium, especially the Coordinating Center (directed by B. Weir and C. Laurie of the University of Washington; U01-HG004446) in data cleaning and preparation for submission to the Database for Genotypes and Phenotypes (dbGaP). The authors also acknowledge the leadership of T. Manolio of NHGRI and E. Harris of National Institute of Dental and Craniofacial Research (NIDCR). Genotyping services were provided by the Center for Inherited Disease Research (CIDR). The International Cleft Consortium including genotyping and analysis was supported by the National Institute for Dental and Craniofacial Research through U01-DE-018993; "International Consortium to Identify Genes & Interactions Controlling Oral Clefts", 2007-2009; TH Beaty, PI. TW was supported by the International Collaborative Genetics Research Training Program (ICGRTP), NIH D43 TW06176 and 81102178 from National Natural Science of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Beaty TH, 2002, GENET EPIDEMIOL, V22, P1, DOI 10.1002/gepi.1039; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Carter TC, 2010, BIRTH DEFECTS RES A, V88, P84, DOI 10.1002/bdra.20639; Charles BA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-17; Chevrier C, 2008, AM J MED GENET A, V146A, P2396, DOI 10.1002/ajmg.a.32505; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Gearing M, 2002, ANN NEUROL, V52, P465, DOI 10.1002/ana.10319; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Gu DF, 2004, AM J PUBLIC HEALTH, V94, P1972, DOI 10.2105/AJPH.94.11.1972; Honein MA, 2007, EPIDEMIOLOGY, V18, P226, DOI 10.1097/01.ede.0000254430.61294.c0; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; Ingersoll RG, 2010, EUR J HUM GENET, V18, P726, DOI 10.1038/ejhg.2009.228; Jia ZL, 2010, DNA CELL BIOL, V29, P25, DOI 10.1089/dna.2009.0935; Jianyan L, 2010, INT J ORAL MAX SURG, V39, P50, DOI 10.1016/j.ijom.2009.10.010; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024561; Li L, 2011, AM J MED GENET A, V155A, P2940, DOI 10.1002/ajmg.a.34254; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; McArdle PF, 2008, ARTHRITIS RHEUM-US, V58, P2874, DOI 10.1002/art.23752; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Romitti PA, 1999, TERATOLOGY, V59, P39, DOI 10.1002/(SICI)1096-9926(199901)59:1<39::AID-TERA9>3.0.CO;2-7; Schwender H, 2012, BIOMETRICS, V68, P766, DOI 10.1111/j.1541-0420.2011.01713.x; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Starr JR, 2005, EPIDEMIOLOGY, V16, P294, DOI 10.1097/01.ede.0000158223.98649.eb; Tolarova MM, 1998, AM J MED GENET, V75, P126; van den Boogaard MJH, 2008, HUM GENET, V124, P525, DOI 10.1007/s00439-008-0569-6; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Wu T, 2012, BIRTH DEFECTS RES A, V94, P76, DOI 10.1002/bdra.22885; Wu T, 2010, HUM GENET, V128, P401, DOI 10.1007/s00439-010-0863-y; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zeiger JS, 2005, CLEFT PALATE-CRAN J, V42, P58, DOI 10.1597/02-128.1	47	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88088	10.1371/journal.pone.0088088	http://dx.doi.org/10.1371/journal.pone.0088088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516586	Green Published, Green Accepted, gold			2022-12-27	WOS:000330830700042
J	Burke, SJ; Lass, E; Thistle, P; Katumbe, L; Jetha, A; Schwarz, D; Bolotin, S; Barker, RD; Simor, A; Silverman, M				Burke, Stephen J.; Lass, Elliot; Thistle, Paul; Katumbe, Lovemore; Jetha, Arif; Schwarz, Dan; Bolotin, Shelly; Barker, R. D.; Simor, Andrew; Silverman, Michael			Increased Incidence of Tuberculosis in Zimbabwe, in Association with Food Insecurity, and Economic Collapse: An Ecological Analysis	PLOS ONE			English	Article							RISK-FACTORS; AFRICA; SEASONALITY; HEALTH; DETERMINANTS; COUNTRIES	Background: Zimbabwe underwent a socioeconomic crisis and resultant increase in food insecurity in 2008-9. The impact of the crisis on Tuberculosis (TB) incidence is unknown. Methods: Prospective databases from two mission hospitals, which were geographically widely separated, and remained open during the crisis, were reviewed. Results: At the Howard Hospital (HH) in northern Zimbabwe, TB incidence increased 35% in 2008 from baseline rates in 2003-2007 (p<0.01) and remained at that level in 2009. Murambinda Hospital (MH) in Eastern Zimbabwe also demonstrated a 29% rise in TB incidence from 2007 to 2008 (p<0.01) and remained at that level in 2009. Data collected post-crisis at HH showed a decrease of 33% in TB incidence between 2009 to 2010 (p<0.001) and 2010/2011 TB incidence remained below that of the crisis years of 2008/2009 (p<0.01). Antenatal clinic HIV seroprevalence at HH decreased between 2001(23%) to 2011(11%) (p<0.001). Seasonality of TB incidence was analyzed at both MH and HH. There was a higher TB incidence in the dry season when food is least available (September-November) compared to post harvest (April-June) (p<0.001). Conclusion: This study suggests that an epidemic of TB mirrored socioeconomic collapse and recovery in Zimbabwe. The seasonal data suggests that food security may have been associated with TB incidence both annually and during the crisis in this high HIV prevalence country.	[Burke, Stephen J.] Univ Ottawa, Ottawa, ON, Canada; [Lass, Elliot; Thistle, Paul; Jetha, Arif; Simor, Andrew; Silverman, Michael] Univ Toronto, Toronto, ON, Canada; [Thistle, Paul] Karanda Hosp, Mt Darwin, Zimbabwe; [Thistle, Paul] Univ Zimbabwe, Harare, Zimbabwe; [Katumbe, Lovemore] Howard Hosp, Glendale, Zimbabwe; [Jetha, Arif; Bolotin, Shelly; Silverman, Michael] Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Schwarz, Dan] Brigham & Womens Hosp, Boston, MA 02115 USA; [Schwarz, Dan] Childrens Hosp, Boston, MA 02115 USA; [Barker, R. D.] Murambinda Mission Hosp, Murambinda, Zimbabwe; [Barker, R. D.] NHS Fdn Trust, Kings Coll Hosp London, London, England; [Silverman, Michael] Lakeridge Hlth Corp, Oshawa, ON, Canada	University of Ottawa; University of Toronto; University of Zimbabwe; University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; Oxford University Hospitals NHS Foundation Trust	Silverman, M (corresponding author), Univ Toronto, Toronto, ON, Canada.	Michael.Silverman@utoronto.ca	Silverman, Michael/J-3776-2014	Silverman, Michael/0000-0002-0389-7656; Jetha, Arif/0000-0003-0322-7027				[Anonymous], 2011, ZIMB FOOD SEC OUTL S; [Anonymous], IMPR DIAGN TREATM SM, DOI DOI 10.1186/s12879-016-1967-3; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Cramm JM, 2011, J PUBLIC HEALTH AFR, V2, P143, DOI 10.4081/jphia.2011.e34; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Engstrom L, 2010, ZIMBABWE CHALLENGES; Food and Agriculture Organization of the United Nations/World Food Programme - Rome, 2008, FAO WFP CROP FOOD SU; Garcia S, 2007, ZIMBABWE EXODUS TOO; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; HINMAN AR, 1976, AM J EPIDEMIOL, V103, P486, DOI 10.1093/oxfordjournals.aje.a112250; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Mahomva A, 2006, SEX TRANSM INFECT, V82, pI42, DOI 10.1136/sti.2005.019174; Meldrum A, 2008, LANCET, V371, P1059, DOI 10.1016/S0140-6736(08)60468-7; Meteorological Services Department of Zimbabwe, 2013, CLIM ZIMB; Mintz ED, 2009, NEW ENGL J MED, V360, P1060, DOI 10.1056/NEJMp0810559; Ploch L, 2010, ZIMBABWE TRANSITIONA; Schaaf HS, 1996, TUBERCLE LUNG DIS, V77, P43, DOI 10.1016/S0962-8479(96)90074-X; Sollom Richard, 2009, HLTH RUINS MAN MADE; Sydenstricker E, 1933, MILB MEML FUND Q BU, V11, P273, DOI 10.2307/3347444; Wilkinson D, 1997, S AFR MED J, V87, P447; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; World Health Organization, 2008, EPIDEMIOLOGICAL B, V24; World Health Organization, 2000, REPORTS; Zimstat, 2002, POP CENS 2002	32	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e83387	10.1371/journal.pone.0083387	http://dx.doi.org/10.1371/journal.pone.0083387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505245	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200005
J	Du, BW; Wang, Z; Zhang, X; Feng, SP; Wang, GX; He, JX; Zhang, BL				Du, Bowen; Wang, Zhe; Zhang, Xin; Feng, Shipeng; Wang, Guoxin; He, Jianxing; Zhang, Biliang			MicroRNA-545 Suppresses Cell Proliferation by Targeting Cyclin D1 and CDK4 in Lung Cancer Cells	PLOS ONE			English	Article							EXPRESSION	An increasing number of reports have shown that diverse microRNAs are involved in tumorigenesis and tumor progression. We performed this study to identify novel miRNAs that may be involved in lung cancer and study on their functions. We tested the expression of 450 miRNAs in lung tumor tissues and adjacent non-cancerous tissues. We found that miRNA-545 was less abundant in cancerous lung tissues than in adjacent non-cancerous tissues. Our further studies showed that miR-545 suppressed cell proliferation in vitro and in vivo. We also found that miR-545 caused cell cycle arrest at the G0/G1 phase and induced cell apoptosis in lung cancer cells by targeting cyclin D1 and CDK4 genes. The effects of cyclin D1 and CDK4 down-regulated by miR-545 were similar to those caused by siRNAs of cyclin D1 and CDK4, and overexpression of cyclin D1 and CDK4 could abolish the miR-545-induced inhibition of cell proliferation. In conclusion, miR-545 suppressed cell proliferation by inhibiting the expression of cyclin D1 and CDK4. Our findings provide new knowledge regarding the role of miR-545 in the development of lung cancer and indicate the potential application of miR-545 in cancer therapy.	[Du, Bowen; Wang, Zhe; Wang, Guoxin; Zhang, Biliang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Du, Bowen] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Zhang, Xin; He, Jianxing] Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Feng, Shipeng] Guangzhou RiboBioCo Ltd, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	He, JX (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	hejx@vip.163.com; zhang_biliang@gibh.ac.cn		Feng, Shipeng/0000-0002-3365-9990; He, Jianxing/0000-0003-1737-8192	National Natural Science Foundation of China [30870535, 90913017]; Combination Project of Guangdong Province; Ministry of Education [2009B090300080, 2011B090400478]; Introduced Innovative R&D Team Program of Guangdong Province [201001Y0104789252]; 863 Program of China [2012AA022501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Combination Project of Guangdong Province; Ministry of Education; Introduced Innovative R&D Team Program of Guangdong Province; 863 Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (No. 30870535 and 90913017), the Combination Project of Guangdong Province and the Ministry of Education (No. 2009B090300080 and 2011B090400478), the Introduced Innovative R&D Team Program of Guangdong Province (No. 201001Y0104789252) and the 863 Program of China (No. 2012AA022501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Goljanek-Whysall K, 2012, CLIN SCI, V123, P611, DOI 10.1042/CS20110634; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kong LF, 1998, CANCER LETT, V130, P93, DOI 10.1016/S0304-3835(98)00115-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HC, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-82; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; NAITO S, 1986, CANCER RES, V46, P4109; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Puissegur MP, 2011, CELL DEATH DIFFER, V18, P465, DOI 10.1038/cdd.2010.119; Saini SS, 2011, ANTICANCER RES, V31, P3683; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38	25	99	102	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88022	10.1371/journal.pone.0088022	http://dx.doi.org/10.1371/journal.pone.0088022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505359	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200099
J	Kauffman, RC; Villalobos, A; Bowen, JH; Adamson, L; Schinazi, RF				Kauffman, Robert C.; Villalobos, Andradi; Bowen, Joanne H.; Adamson, Lourdes; Schinazi, Raymond F.			Residual Viremia in an RT-SHIV Rhesus Macaque HAART Model Marked by the Presence of a Predominant Plasma Clone and a Lack of Viral Evolution	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; HIV-1 DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; RALTEGRAVIR INTENSIFICATION; INFECTION; REPLICATION; RESERVOIR; PCR	Highly active antiretroviral therapy (HAART) significantly reduces HIV-1 replication and prevents progression to AIDS. However, residual low-level viremia (LLV) persists and long-lived viral reservoirs are maintained in anatomical sites. These reservoirs permit a recrudescence of viremia upon cessation of therapy and thus HAART must be maintained indefinitely. HIV-1 reservoirs include latently infected resting memory CD4(+) T-cells and macrophages which may contribute to residual viremia. It has not been conclusively determined if a component of LLV may also be due to residual replication in cells with sub-therapeutic drug levels and/or long-lived chronically infected cells. In this study, RT-SHIVmac239 diversity was characterized in five rhesus macaques that received a five-drug HAART regimen [tenofovir, emtricitabine, zidovudine, amdoxovir, (A, C, T, G nucleoside analogs) and the non-nucleoside reverse transcriptase (RT) inhibitor efavirenz]. Before maximal viral load suppression, longitudinal plasma viral RNA RT diversity was analyzed using a 454 sequencer. After suppression, LLV RT diversity (amino acids 65-210) was also assessed. LLV samples had viral levels less than our standard detection limit (50 viral RNA copies/mL) and few transient blips <200 RNA copies/mL. HAART was discontinued in three macaques after 42 weeks of therapy resulting in viral rebound. The level of viral divergence and the prevalence of specific alleles in LLV was similar to pre-suppression viremia. While some LLV sequences contained mutations not observed in the pre-suppression profile, LLV was not characterized by temporal viral evolution or apparent selection of drug resistance mutations. Similarly, resistance mutations were not detected in the viral rebound population. Interestingly, one macaque maintained a putative LLV predominant plasma clone sequence. Together, these results suggest that residual replication did not markedly contribute to LLV and that this model mimics the prevalence and phylogenetic characteristics of LLV during human HAART. Therefore, this model may be ideal for testing HIV-1 eradication strategies.	[Kauffman, Robert C.; Villalobos, Andradi; Bowen, Joanne H.; Adamson, Lourdes] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Kauffman, Robert C.; Villalobos, Andradi; Schinazi, Raymond F.] Emory Univ, Sch Med, Biochem Pharmacol Lab, Dept Pediat,Ctr AIDS Res, Atlanta, GA 30322 USA; [Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Schinazi, RF (corresponding author), Emory Univ, Sch Med, Biochem Pharmacol Lab, Dept Pediat,Ctr AIDS Res, Atlanta, GA 30322 USA.	rschina@emory.edu	Schinazi, Raymond F/B-6777-2017		California HIV/AIDS Research Program - Predoctoral Fellowship [D09-B-311]; NIH [R01-0D011094]; Emory University Center for AIDS NIG grant [2P30AI050409]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	California HIV/AIDS Research Program - Predoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Center for AIDS NIG grant; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Study was supported by: California HIV/AIDS Research Program - Predoctoral Fellowship # D09-B-311 to Robert C. Kauffman; NIH grants # R01-0D011094 to Drs. Thomas W. North and Raymond F. Schinazi, and the Emory University Center for AIDS NIG grant 2P30AI050409. Dr. Schinazi is also funded by the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Apetrei C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002892; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Brennan TP, 2009, J VIROL, V83, P8470, DOI 10.1128/JVI.02568-08; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Daigle D SB, 2011, CURR PROTOC MOL BIOL; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deere JD, 2010, UNPUB; Deere JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011640; Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; GRANT CK, 1977, J IMMUNOL, V119, P401; Gunthard HF, 1999, J VIROL, V73, P9404; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Johnson Jennifer A, 2009, Curr Infect Dis Rep, V11, P311, DOI 10.1007/s11908-009-0046-y; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnston R, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-16; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Judo MSB, 1998, NUCLEIC ACIDS RES, V26, P1819, DOI 10.1093/nar/26.7.1819; Kearney M, 2011, J VIROL, V85, P1067, DOI 10.1128/JVI.01701-10; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Koppensteiner H, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-82; Lee GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046181; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; LJUNGDAHLSTAHLE E, 1992, ANTIMICROB AGENTS CH, V36, P2418, DOI 10.1128/AAC.36.11.2418; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Martinez-Picado J, 2002, J VIROL, V76, P12344, DOI 10.1128/JVI.76.23.12344-12348.2002; Mavigner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007658; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Nottet HSLM, 2009, JAIDS-J ACQ IMM DEF, V50, P345, DOI 10.1097/QAI.0b013e318197eb04; ODELBERG SJ, 1995, NUCLEIC ACIDS RES, V23, P2049, DOI 10.1093/nar/23.11.2049; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sahu GK, 2009, J MED VIROL, V81, P9, DOI 10.1002/jmv.21366; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Shao W, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-101; Shiu C, 2009, J VIROL, V83, P9731, DOI 10.1128/JVI.00570-09; Shytaj IL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002774; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Van Rompay KKA, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-25; Van Rompay KKA, 2012, ANTIMICROB AGENTS CH, V56, P4980, DOI 10.1128/AAC.01095-12; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733; Wu JY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-255; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	78	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88258	10.1371/journal.pone.0088258	http://dx.doi.org/10.1371/journal.pone.0088258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505452	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200155
J	Peixinho, CC; Martins, NSD; de Oliveira, LF; Machado, JC				Peixinho, Carolina Carneiro; da Fonseca Martins, Natalia Santos; de Oliveira, Liliam Fernandes; Machado, Joao Carlos			Reliability of Measurements of Rat Lateral Gastrocnemius Architectural Parameters Obtained from Ultrasound Biomicroscopic Images	PLOS ONE			English	Article							IN-VIVO; MUSCLE ARCHITECTURE; MEDIAL GASTROCNEMIUS; TRICEPS SURAE; ADAPTATION	This study used ultrasound biomicroscopy (UBM) to quantify the pennation angle (PA) and muscle thickness (MT) of rat skeletal muscle and evaluated the reliability and reproducibility of the method by statistical analysis, determining the coefficient of variation (CV), intraclass correlation coefficient (ICC) and typical error of measurement. A UBM system with a center frequency of 40 MHz was used to acquire images of the right lateral gastrocnemius of ten male Wistar rats on two different days and with two ankle positions (90 degrees or 150 degrees). Two independent measurements of the PA and MT were randomly performed in each of three picture frames. The analysis resulted in CVs of 10.47% and 4.81% for the PA and the MT, respectively, for the ankle at 90 degrees and 9.24% and 5.98% for the ankle at 150 degrees. Additionally, the ICC values ranged from 0.75 to 0.92 for the PA and 0.57 to 0.99 for the MT. Statistically significant differences between the ankle positions were observed for the PA (p = 0.00013). The reliability of the PA and MT measurements for the rat right lateral gastrocnemius, determined from the ultrasound biomicroscopy images, was high (>0.90) for the methodology proposed. This finding indicates the potential of ultrasound biomicroscopy for quantitative muscle characterization and the longitudinal examination of tissue adaptation to different conditions of use, disease and rehabilitation.	[Peixinho, Carolina Carneiro; da Fonseca Martins, Natalia Santos; de Oliveira, Liliam Fernandes; Machado, Joao Carlos] Univ Fed Rio de Janeiro, COPPE, Biomed Engn Program, BR-21941 Rio De Janeiro, RJ, Brazil; [Peixinho, Carolina Carneiro; da Fonseca Martins, Natalia Santos; de Oliveira, Liliam Fernandes] Univ Fed Rio de Janeiro, Dept Biosci Phys Act, Biomech Lab, Rio De Janeiro, RJ, Brazil; [Machado, Joao Carlos] Univ Fed Rio de Janeiro, Sch Med, Dept Surg, Postgrad Program Surg Sci, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Peixinho, CC (corresponding author), Univ Fed Rio de Janeiro, COPPE, Biomed Engn Program, BR-21941 Rio De Janeiro, RJ, Brazil.	carolina@peb.ufrj.br	Machado, João Carlos/G-2646-2019		CAPES/PROEX; CNPq; FAPERJ	CAPES/PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors are thankful for the financial support provided by CAPES/PROEX, CNPq, and FAPERJ (scholarships and material). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellaneda S, 2009, J APPL PHYSIOL, V106, P169, DOI 10.1152/japplphysiol.90577.2008; Blazevich AJ, 2005, CELLS TISSUES ORGANS, V181, P1, DOI 10.1159/000089964; Blazevich AJ, 2007, MUSCLE NERVE, V35, P78, DOI 10.1002/mus.20666; Blazevich AJ, 2006, SPORTS MED, V36, P1003, DOI 10.2165/00007256-200636120-00002; da Martins NS F, 2012, BRAZILIAN J KINANTHR, V14, P212; Eng CM, 2008, J EXP BIOL, V211, P2336, DOI 10.1242/jeb.017640; Fukunaga T, 1997, J BIOMECH, V30, P457, DOI 10.1016/S0021-9290(96)00171-6; Hashimoto BE, 1999, J CLIN ULTRASOUND, V27, P293, DOI 10.1002/(SICI)1097-0096(199907/08)27:6<293::AID-JCU1>3.0.CO;2-C; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Ito L, 1998, J APPL PHYSIOL, V85, P1230, DOI 10.1152/jappl.1998.85.4.1230; Jacobson JA, 1999, RADIOL CLIN N AM, V37, P713, DOI 10.1016/S0033-8389(05)70125-1; Koryak Yu. A., 2008, Human Physiology, V34, P482, DOI 10.1134/S0362119708040130; Legerlotz K, 2010, CLIN PHYSIOL FUNCT I, V30, P198, DOI 10.1111/j.1475-097X.2010.00925.x; LIEBER RL, 1993, PHYS THER, V73, P844, DOI 10.1093/ptj/73.12.844; Loram ID, 2006, J APPL PHYSIOL, V100, P1311, DOI 10.1152/japplphysiol.01229.2005; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; Martin DC, 2001, J ANAT, V199, P429, DOI 10.1046/j.1469-7580.2001.19940429.x; Megliola A, 2006, RADIOL MED, V111, P836, DOI 10.1007/s11547-006-0077-5; Narici M, 1999, J ELECTROMYOGR KINES, V9, P97, DOI 10.1016/S1050-6411(98)00041-8; Narici MV, 1996, J PHYSIOL-LONDON, V496, P287, DOI 10.1113/jphysiol.1996.sp021685; Nijhuis THJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054041; Peixinho CC, 2011, J EXP BIOL, V214, P3880, DOI 10.1242/jeb.059808; Seynnes OR, 2007, J APPL PHYSIOL, V102, P368, DOI 10.1152/japplphysiol.00789.2006; Witte RS, 2004, ULTRASON, P764	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87691	10.1371/journal.pone.0087691	http://dx.doi.org/10.1371/journal.pone.0087691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505306	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200065
J	Yu, ZH; Zhao, XP; Ge, YY; Zhang, T; Huang, LQ; Zhou, X; Xie, L; Liu, JJ; Huang, G				Yu, Zhenhai; Zhao, Xiaoping; Ge, Yingying; Zhang, Teng; Huang, Liangqian; Zhou, Xiang; Xie, Lei; Liu, Jianjun; Huang, Gang			A Regulatory Feedback Loop between HIF-1 alpha and PIM2 in HepG2 Cells	PLOS ONE			English	Article							SERINE/THREONINE KINASE PIM-2; HYPOXIA-INDUCIBLE FACTORS; EXPRESSION; PROMOTE; GROWTH; PROGRESSION; LEUKEMIA; MYELOMA; GENE; PHOSPHORYLATION	To survive under hypoxic conditions, cancer cells remodel glucose metabolism to support tumor progression. HIF transcription factor is essential for cellular response to hypoxia. The underlying mechanism how HIF is constitutively activated in cancer cells remains elusive. In the present study, we characterized a regulatory feedback loop between HIF-1 alpha and PIM2 in HepG2 cells. Serine/threonine kinase proto-oncogene PIM2 level was induced upon hypoxia in a HIF-1 alpha-mediated manner in cancer cells. HIF-1 alpha induced PIM2 expression via binding to the hypoxia-responsive elements (HREs) of the PIM2 promoter. In turn, PIM2 interacted with HIF-1 alpha, especially a transactivation domain of HIF-1 alpha. PIM2 as a co-factor but not an upstream kinase of HIF-1 alpha, enhanced HIF-1 alpha effect in response to hypoxia. The positive feedback loop between PIM2 and HIF-1 alpha was correlated with glucose metabolism as well as cell survival in HepG2 cells. Such a regulatory mode may be important for the adaptive responses of cancer cells in antagonizing hypoxia during cancer progression.	[Yu, Zhenhai; Huang, Gang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Zhao, Xiaoping; Zhang, Teng; Zhou, Xiang; Xie, Lei; Liu, Jianjun; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Ren Ji Hosp, Shanghai 200030, Peoples R China; [Ge, Yingying] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Liangqian; Huang, Gang] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200030, Peoples R China; [Huang, Liangqian; Huang, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Sun Yat Sen University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nucl Med, Ren Ji Hosp, Shanghai 200030, Peoples R China.	ljjsh@133sh.com; huang2802@163.com			973 Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai Leading Academic Discipline Project [S30203]; National Natural Science Foundation of China [81071180, 81001008]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]	973 Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The study was supported by research grants from 973 Project (No. 2012CB932604), New Drug Discovery Project (No. 2012ZX09506-001-005), Shanghai Leading Academic Discipline Project (No. S30203), National Natural Science Foundation of China (No. 81071180 & 81001008), Shanghai Pujiang Program (No. 13PJ1406000) and Science and Technology Commission of Shanghai Municipality (No. 134119a5600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Singh S, 2010, BLOOD, V115, P4507, DOI 10.1182/blood-2009-03-210070; Asano J, 2011, LEUKEMIA, V25, P1182, DOI 10.1038/leu.2011.60; Bader HL, 2012, FEBS LETT, V586, P1562, DOI 10.1016/j.febslet.2012.04.032; BERGERON D, 1991, J VIROL, V65, P7, DOI 10.1128/JVI.65.1.7-15.1991; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Brault L, 2012, BRIT J CANCER, V107, P491, DOI 10.1038/bjc.2012.272; Burgess DJ, 2012, NAT REV CANCER, V12, P316, DOI 10.1038/nrc3266; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; Ding G, 2013, FEBS LETT, V587, P930, DOI 10.1016/j.febslet.2013.02.020; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Galanis A, 2008, CANCER LETT, V266, P12, DOI 10.1016/j.canlet.2008.02.028; Giatromanolaki A, 2008, CANCER LETT, V262, P87, DOI 10.1016/j.canlet.2007.11.041; Gomez-Abad C, 2011, BLOOD, V118, P5517, DOI 10.1182/blood-2011-03-344374; Gong JP, 2009, J SURG RES, V153, P17, DOI 10.1016/j.jss.2008.03.033; Huang LE, 2013, SCIENCE, V339, P1285, DOI 10.1126/science.1236966; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Levy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034736; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Luo WB, 2012, P NATL ACAD SCI USA, V109, pE3367, DOI 10.1073/pnas.1217394109; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Neri P, 2013, BLOOD, V122, P1534, DOI 10.1182/blood-2013-07-514091; Ren K, 2013, PROSTATE, V73, P1462, DOI 10.1002/pros.22693; Ren K, 2010, PATHOL ONCOL RES, V16, P229, DOI 10.1007/s12253-009-9215-4; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2013, J MOL MED, V91, P409, DOI 10.1007/s00109-013-1024-2; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Seton-Rogers S, 2011, NAT REV CANCER, V11, P391, DOI 10.1038/nrc3074; Tahvanainen J, 2013, J BIOL CHEM, V288, P3048, DOI 10.1074/jbc.M112.361709; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; VANDERLUGT NMT, 1995, EMBO J, V14, P2536, DOI 10.1002/j.1460-2075.1995.tb07251.x; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Wu DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062014; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Yuan LL, 2013, LEUKEMIA, V10, P1038; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhukova Iu N, 2011, Mol Biol (Mosk), V45, P755; Zirkin S, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.458851	52	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88301	10.1371/journal.pone.0088301	http://dx.doi.org/10.1371/journal.pone.0088301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505470	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200171
J	Gagnon, D; Parent, M				Gagnon, Dave; Parent, Martin			Distribution of VGLUT3 in Highly Collateralized Axons from the Rat Dorsal Raphe Nucleus as Revealed by Single-Neuron Reconstructions	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; VESICULAR GLUTAMATE TRANSPORTER-3; HIPPOCAMPAL THETA-RHYTHM; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-CORTEX; MIDBRAIN RAPHE; BRAIN-STEM; ADULT-RAT; IN-VIVO; ULTRASTRUCTURAL FEATURES	This study aimed at providing the first detailed morphological description, at the single-cell level, of the rat dorsal raphe nucleus neurons, including the distribution of the VGLUT3 protein within their axons. Electrophysiological guidance procedures were used to label dorsal raphe nucleus neurons with biotinylated dextran amine. The somatodendritic and axonal arborization domains of labeled neurons were reconstructed entirely from serial sagittal sections using a computerized image analysis system. Under anaesthesia, dorsal raphe nucleus neurons display highly regular (1.72 +/- 0.50 Hz) spontaneous firing patterns. They have a medium size cell body (9.8 +/- 1.7 mu m) with 2-4 primary dendrites mainly oriented anteroposteriorly. The ascending axons of dorsal raphe nucleus are all highly collateralized and widely distributed (total axonal length up to 18.7 cm), so that they can contact, in various combinations, forebrain structures as diverse as the striatum, the prefrontal cortex and the amygdala. Their morphological features and VGLUT3 content vary significantly according to their target sites. For example, high-resolution confocal analysis of the distribution of VGLUT3 within individually labeled-axons reveals that serotonin axon varicosities displaying VGLUT3 are larger (0.74 +/- 0.03 mu m) than those devoid of this protein (0.55 +/- 0.03 mu m). Furthermore, the percentage of axon varicosities that contain VGLUT3 is higher in the striatum (93%) than in the motor cortex (75%), suggesting that a complex trafficking mechanism of the VGLUT3 protein is at play within highly collateralized axons of the dorsal raphe nucleus neurons. Our results provide the first direct evidence that the dorsal raphe nucleus ascending projections are composed of widely distributed neuronal systems, whose capacity to co-release serotonin and glutamate varies from one forebrain locus to the other.	[Gagnon, Dave; Parent, Martin] Univ Laval, Fac Med, Dept Psychiat & Neurosci, Ctr Rech,Inst Univ Sante Mentale Quebec, Quebec City, PQ G1K 7P4, Canada	Laval University	Parent, M (corresponding author), Univ Laval, Fac Med, Dept Psychiat & Neurosci, Ctr Rech,Inst Univ Sante Mentale Quebec, Quebec City, PQ G1K 7P4, Canada.	martin.parent@crulrg.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [386396-2010]; Centre Thematique de Recherche en Neurosciences	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Centre Thematique de Recherche en Neurosciences	This research was supported by grant from the Natural Sciences and Engineering Research Council of Canada (#386396-2010, www.nserc-crsng.gc.ca). DG was the recipient of a PhD fellowship from the "Centre Thematique de Recherche en Neurosciences." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; Amilhon B, 2010, J NEUROSCI, V30, P2198, DOI 10.1523/JNEUROSCI.5196-09.2010; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Bunin MA, 1998, J NEUROSCI, V18, P4854; Commons KG, 2009, J CHEM NEUROANAT, V38, P273, DOI 10.1016/j.jchemneu.2009.05.005; CONDESLARA M, 1989, BRAIN RES, V499, P141, DOI 10.1016/0006-8993(89)91143-8; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; DESCARRIES L, 1975, BRAIN RES, V100, P563, DOI 10.1016/0006-8993(75)90158-4; Descarries L., 2008, HDB NEUROCHEMISTRY M, P1; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; Descarries L, 2010, HBK BEHAV NEUROSCI, V21, P65, DOI 10.1016/B978-0-12-374634-4.00004-6; Fortune T, 2009, J COMP NEUROL, V513, P542, DOI 10.1002/cne.21978; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Gao KM, 1997, J COMP NEUROL, V389, P309; Gaspar P, 2012, PHILOS T R SOC B, V367, P2382, DOI 10.1098/rstb.2011.0378; Gras C, 2002, J NEUROSCI, V22, P5442; Gras C, 2008, NAT NEUROSCI, V11, P292, DOI 10.1038/nn2052; Hioki H, 2004, CEREB CORTEX, V14, P1266, DOI 10.1093/cercor/bhh088; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; IMAI H, 1986, J COMP NEUROL, V243, P363, DOI 10.1002/cne.902430307; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; JOHNSON MD, 1994, NEURON, V12, P433, DOI 10.1016/0896-6273(94)90283-6; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kiyasova V, 2011, J NEUROSCI, V31, P2756, DOI 10.1523/JNEUROSCI.4080-10.2011; KOCSIS B, 1992, J NEUROPHYSIOL, V68, P1463, DOI 10.1152/jn.1992.68.4.1463; Kocsis B, 2006, P NATL ACAD SCI USA, V103, P1059, DOI 10.1073/pnas.0508360103; KOHLER C, 1982, NEUROSCIENCE, V7, P951, DOI 10.1016/0306-4522(82)90054-9; KOHLER C, 1982, J COMP NEUROL, V209, P91, DOI 10.1002/cne.902090109; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Li YQ, 2001, NEUROSCI LETT, V299, P33, DOI 10.1016/S0304-3940(00)01771-7; Li YQ, 2001, BRAIN RES, V900, P110, DOI 10.1016/S0006-8993(01)02272-7; Mintz EM, 2006, NEUROSCI LETT, V394, P97, DOI 10.1016/j.neulet.2005.10.033; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Morin LP, 1999, NEUROSCIENCE, V91, P81, DOI 10.1016/S0306-4522(98)00585-5; Olsson C, 2008, J COMP NEUROL, V508, P756, DOI 10.1002/cne.21705; PALKOVIT.M, 1974, BRAIN RES, V80, P237, DOI 10.1016/0006-8993(74)90688-X; PARENT A, 1981, NEUROSCIENCE, V6, P115, DOI 10.1016/0306-4522(81)90050-6; Parent M, 2006, J NEURAL TRANSM-SUPP, P85; Parent M, 2010, EUR J NEUROSCI, V31, P1233, DOI 10.1111/j.1460-9568.2010.07143.x; PARK MR, 1982, BRAIN RES, V240, P321, DOI 10.1016/0006-8993(82)90227-X; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; Ramon y Cajal S., 1909, HISTOLOGIE SYSTEME N, DOI [DOI 10.5962/BHL.TITLE.48637, 10.5962/bhl.title.48637]; SARTER M, 1984, J COMP NEUROL, V224, P445, DOI 10.1002/cne.902240312; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schmidt H, 2010, BIOESSAYS, V32, P977, DOI 10.1002/bies.201000054; SEGUELA P, 1989, J COMP NEUROL, V289, P129, DOI 10.1002/cne.902890111; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Shutoh F, 2008, NEUROSCI LETT, V432, P132, DOI 10.1016/j.neulet.2007.12.050; Smiley JF, 1996, J COMP NEUROL, V367, P431, DOI 10.1002/(SICI)1096-9861(19960408)367:3<431::AID-CNE8>3.0.CO;2-6; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takamori S, 2002, EMBO REP, V3, P798, DOI 10.1093/embo-reports/kvf159; TORK I, 1990, ANN NY ACAD SCI, V600, P9; VANDERKOOY D, 1980, BRAIN RES, V186, P1, DOI 10.1016/0006-8993(80)90250-4; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Vertes RP, 1999, J COMP NEUROL, V407, P555; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; Waselus M, 2011, J CHEM NEUROANAT, V41, P266, DOI 10.1016/j.jchemneu.2011.05.011; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5	65	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87709	10.1371/journal.pone.0087709	http://dx.doi.org/10.1371/journal.pone.0087709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504335	gold, Green Submitted, Green Published			2022-12-27	WOS:000330631800064
J	Mahon, LV; Lomax, M; Grant, S; Cross, E; Hare, DJ; Wraith, JE; Jones, S; Bigger, B; Langford-Smith, K; Canal, M				Mahon, Louise Victoria; Lomax, Michelle; Grant, Sheena; Cross, Elaine; Hare, Dougal Julian; Wraith, James Ed; Jones, Simon; Bigger, Brian; Langford-Smith, Kia; Canal, Maria			Assessment of Sleep in Children with Mucopolysaccharidosis Type III	PLOS ONE			English	Article							SANFILIPPO-SYNDROME; MELATONIN TREATMENT; CIRCADIAN-RHYTHM; DISEASE; DISRUPTIONS; DISTURBANCE; PATTERNS	Sleep disturbances are prevalent in mucopolysaccharidosis Type III (MPS III), yet there is a lack of objective, ecologically valid evidence detailing sleep quantity, quality or circadian system. Eight children with MPS III and eight age-matched typically developing children wore an actigraph for 7-10 days/nights. Saliva samples were collected at three time-points on two separate days, to permit analysis of endogenous melatonin levels. Parents completed a sleep questionnaire and a daily sleep diary. Actigraphic data revealed that children with MPS III had significantly longer sleep onset latencies and greater daytime sleep compared to controls, but night-time sleep duration did not differ between groups. In the MPS III group, sleep efficiency declined, and sleep onset latency increased, with age. Questionnaire responses showed that MPS III patients had significantly more sleep difficulties in all domains compared to controls. Melatonin concentrations showed an alteration in the circadian system in MPS III, which suggests that treatment for sleep problems should attempt to synchronise the sleep-wake cycle to a more regular pattern. Actigraphy was tolerated by children and this monitoring device can be recommended as a measure of treatment success in research and clinical practice.	[Mahon, Louise Victoria; Lomax, Michelle; Grant, Sheena; Cross, Elaine; Hare, Dougal Julian] Univ Manchester, Div Clin Psychol, Manchester, Lancs, England; [Wraith, James Ed; Jones, Simon] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Bigger, Brian; Langford-Smith, Kia] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Canal, Maria] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Mahon, LV (corresponding author), Univ Manchester, Div Clin Psychol, Manchester, Lancs, England.	louise_mahon@hotmail.com	Bigger, Brian/I-3553-2012	Bigger, Brian/0000-0002-9708-1112	MPS Society UK	MPS Society UK	The MPS Society UK (http://www.mpssociety.org.uk/) partially funded the study. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Colville GA, 1996, DEV MED CHILD NEUROL, V38, P538; Cross E, 2012, THESIS U MANCHESTER; De Leersnyder H, 2001, J PEDIATR-US, V139, P111, DOI 10.1067/mpd.2001.115018; De Leersnyder H, 2006, MOL CELL ENDOCRINOL, V252, P88, DOI 10.1016/j.mce.2006.03.043; de Ruijter J, 2011, CURR PHARM BIOTECHNO, V12, P923, DOI 1389-2010/11 $58.00+.00; El-Sheikh M, 2008, HEALTH PSYCHOL, V27, P26, DOI 10.1037/0278-6133.27.1.26; Fraser J, 2005, ARCH DIS CHILD, V90, P1239, DOI 10.1136/adc.2004.065482; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Galland BC, 2012, SLEEP MED REV, V16, P213, DOI 10.1016/j.smrv.2011.06.001; Guerrero JM, 2006, J PINEAL RES, V40, P192, DOI 10.1111/j.1600-079X.2005.00294.x; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Jan JE, 2000, J PINEAL RES, V29, P34, DOI 10.1034/j.1600-079X.2000.290105.x; Jean-Louis G, 2001, J NEUROSCI METH, V105, P185, DOI 10.1016/S0165-0270(00)00364-2; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Lin HY, 2010, PEDIATR PULM, V45, P1205, DOI 10.1002/ppul.21309; Mariotti R, 2003, CLIN ELECTROENCEPHAL, V34, P18, DOI 10.1177/155005940303400108; Meyer A, 2007, PEDIATRICS, V120, pE1255, DOI 10.1542/peds.2007-0282; Owens JA, 2000, SLEEP, V23, P1043; Paavonen EJ, 2002, SLEEP, V25, P235, DOI 10.1093/sleep/25.2.235; Phillips L, 2004, DEV MED CHILD NEUROL, V46, P771, DOI 10.1017/S001216220400132X; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; SAMEL A, 1991, J BIOL RHYTHM, V6, P235, DOI 10.1177/074873049100600304; Santamaria F, 2007, J INHERIT METAB DIS, V30, P743, DOI 10.1007/s10545-007-0555-5; Scholle S, 2011, SLEEP MED, V12, P542, DOI 10.1016/j.sleep.2010.11.011; Sheldon SH, 1998, LANCET, V351, P1254, DOI 10.1016/S0140-6736(05)79321-1; Stores G, 2003, ARCH DIS CHILD, V88, P899, DOI 10.1136/adc.88.10.899; Stores G, 2006, PEDIATRICS, V118, pE1116, DOI 10.1542/peds.2006-0647; Tikotzky L, 2001, J CLIN CHILD PSYCHOL, V30, P581, DOI 10.1207/S15374424JCCP3004_13; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152	35	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e84128	10.1371/journal.pone.0084128	http://dx.doi.org/10.1371/journal.pone.0084128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504123	Green Published, gold, Green Accepted			2022-12-27	WOS:000330631800003
J	Hakozaki, M; Tajino, T; Konno, S; Kikuchi, S; Yamada, H; Yanagisawa, M; Nishida, J; Nagasawa, H; Tsuchiya, T; Ogose, A; Abe, M; Hojo, H				Hakozaki, Michiyuki; Tajino, Takahiro; Konno, Shinichi; Kikuchi, Shinichi; Yamada, Hitoshi; Yanagisawa, Michiro; Nishida, Jun; Nagasawa, Hiroyuki; Tsuchiya, Takashi; Ogose, Akira; Abe, Masafumi; Hojo, Hiroshi			Overexpression of Cyclooxygenase-2 in Malignant Peripheral Nerve Sheath Tumor and Selective Cyclooxygenase-2 Inhibitor-Induced Apoptosis by Activating Caspases in Human Malignant Peripheral Nerve Sheath Tumor Cells	PLOS ONE			English	Article							COLON-CANCER CELLS; FIBROUS HISTIOCYTOMA; OSTEOSARCOMA CELLS; MEDIATED APOPTOSIS; POOR-PROGNOSIS; GROWTH-FACTOR; EXPRESSION; SARCOMA; CELECOXIB; SURVIVAL	Background: Cyclooxygenase-2 (COX-2) is a key enzyme in the conversion of arachidonic acid to prostanoids, and its activation is associated with carcinogenesis as well as inflammation. The antitumor effect of selective COX-2 inhibitors has been noted in various malignancies. Malignant peripheral nerve sheath tumor (MPNST) is a rare and aggressive soft tissue sarcoma for which effective treatments have not yet been established. The purpose of this study was to investigate a potential therapeutic role of COX-2 in MPNST. Methods: We evaluated the expression of COX-2 in 44 cases of high-grade MPNST using immunohistochemical staining and compared the staining results with the characteristics and outcome of the patients. We also investigated the antitumor effect of etodolac, a selective COX-2 inhibitor, on MPNST cells in vitro using the MPNST cell line, FMS-1. Results: Overexpression of COX-2 (>= 50% positive cells) was observed in 29 cases (65.9%), was significantly associated with a poor overall survival (P = 0.0495), and was considered an independent risk factor for a poor outcome by the results of both univariate and multivariate analysis. Etodolac induced apoptosis of FMS-1 cells through the activation of caspase-8, -9, and -3. Moreover, several caspase inhibitors significantly inhibited etodolac-induced apoptosis. Conclusions: Selective COX-2 inhibitors including etodolac had an antitumor effect on MPNST cells, and their use holds promise as a novel therapeutic strategy for patients with MPNST to improve their prognoses.	[Hakozaki, Michiyuki; Tajino, Takahiro; Konno, Shinichi; Kikuchi, Shinichi; Yamada, Hitoshi] Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan; [Hakozaki, Michiyuki; Abe, Masafumi; Hojo, Hiroshi] Fukushima Med Univ, Sch Med, Dept Pathol & Diagnost Pathol, Fukushima, Japan; [Yanagisawa, Michiro] Hirosaki Univ, Grad Sch Med, Dept Orthopaed Surg, Aomori, Japan; [Nishida, Jun] Iwate Med Univ, Sch Med, Dept Orthopaed Surg, Morioka, Iwate, Japan; [Nagasawa, Hiroyuki] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita 010, Japan; [Tsuchiya, Takashi] Yamagata Univ, Fac Med, Dept Orthopaed Surg, Yamagata 990, Japan; [Ogose, Akira] Niigata Univ, Grad Sch Med & Dent Sci, Dept Regenerat & Transplant Med, Div Orthoped Surg, Niigata, Japan; [Hakozaki, Michiyuki; Tajino, Takahiro; Konno, Shinichi; Yamada, Hitoshi; Yanagisawa, Michiro; Nishida, Jun; Nagasawa, Hiroyuki; Tsuchiya, Takashi; Ogose, Akira] Tohoku Musculoskeletal Tumor Soc, Yamagata, Japan	Fukushima Medical University; Fukushima Medical University; Hirosaki University; Iwate Medical University; Akita University; Yamagata University; Niigata University	Hakozaki, M (corresponding author), Fukushima Med Univ, Sch Med, Dept Orthopaed Surg, Fukushima, Japan.	paco@fmu.ac.jp			Japan Society for the Promotion of Science (JSPS) [25861331]; Fukushima Medical University Research Project [KKI22057]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fukushima Medical University Research Project	This research was supported in part by a Grant-in-Aid for Young Scientists (B) (no. 25861331) from the Japan Society for the Promotion of Science (JSPS) and the Fukushima Medical University Research Project (KKI22057). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anghileri M, 2006, CANCER-AM CANCER SOC, V107, P1065, DOI 10.1002/cncr.22098; Baehring JM, 2003, NEUROLOGY, V61, P696, DOI 10.1212/01.WNL.0000078813.05925.2C; Bajorath J, 1999, J COMPUT AID MOL DES, V13, P409, DOI 10.1023/A:1008031200961; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Boulytcheva IV, 2010, B EXP BIOL MED+, V150, P237, DOI 10.1007/s10517-010-1114-x; BRATER DC, 1989, CLIN RHEUMATOL, V8, P25, DOI 10.1007/BF02214107; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Dickens DS, 2003, J PEDIAT HEMATOL ONC, V25, P282, DOI 10.1097/00043426-200304000-00003; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Endo M, 2006, HUM PATHOL, V37, P471, DOI 10.1016/j.humpath.2005.12.001; Endo M, 2011, CLIN CANCER RES, V17, P3771, DOI 10.1158/1078-0432.CCR-10-2393; ENNEKING WF, 1988, CANCER-AM CANCER SOC, V62, P1251, DOI 10.1002/1097-0142(19881001)62:7<1251::AID-CNCR2820620702>3.0.CO;2-4; Fletcher CDM, 1999, AM J PATHOL, V154, P1841, DOI 10.1016/S0002-9440(10)65441-7; Fletcher CDM, 2000, DIAGNOSTIC HISTOPATH, P1695; Gendy AS, 2011, J PEDIATR SURG, V46, P108, DOI 10.1016/j.jpedsurg.2010.09.074; Grobmyer SR, 2008, J SURG ONCOL, V97, P340, DOI 10.1002/jso.20971; Hakozaki M, 2007, ONCOL REP, V17, P169; Hakozaki M, 2006, ANTICANCER RES, V26, P3393; Hakozaki M, 2009, VIRCHOWS ARCH, V455, P517, DOI 10.1007/s00428-009-0848-1; Herceg ME, 2009, ANTICANCER RES, V29, P2913; Hsu AL, 2000, J BIOL CHEM, V275, P11397, DOI 10.1074/jbc.275.15.11397; Jendrossek V, 2013, CANCER LETT, V332, P313, DOI 10.1016/j.canlet.2011.01.012; Kasper Bernd, 2005, Int J Clin Oncol, V10, P438, DOI 10.1007/s10147-005-0514-9; Lee CH, 2011, INT J GYNECOL CANCER, V21, P668, DOI 10.1097/IGC.0b013e3182150d56; Li M, 2001, CLIN CANCER RES, V7, P1010; Liu B, 2008, CELL BIOL INT, V32, P494, DOI 10.1016/j.cellbi.2007.10.008; Liu XH, 1998, CANCER RES, V58, P4245; Masi L, 2007, APPL IMMUNOHISTO M M, V15, P70, DOI 10.1097/01.pai.0000213131.63417.fa; Mazhar D, 2006, BRIT J CANCER, V94, P346, DOI 10.1038/sj.bjc.6602942; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Moalic S, 2001, INT J ONCOL, V18, P533; Moalic-Juge S, 2002, INT J ONCOL, V20, P1255; Nakagawa SA, 2010, J BONE JOINT SURG AM, V92A, P1738, DOI 10.2106/JBJS.H.00717; Naruse T, 2006, CARCINOGENESIS, V27, P584, DOI 10.1093/carcin/bgi240; Neurofibromatosis Conference statement, 1998, ARCH NEUROL-CHICAGO, V45, P575; Nielsen GP, 2013, WHO CLASSIFICATION T, P187; Nzeako UC, 2002, HEPATOLOGY, V35, P552, DOI 10.1053/jhep.2002.31774; Okada K, 2007, ANN SURG ONCOL, V14, P597, DOI 10.1245/s10434-006-9053-5; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Reed S, 2011, BIOCHEM BIOPH RES CO, V407, P450, DOI 10.1016/j.bbrc.2011.03.014; Rodriguez NI, 2008, J PEDIAT HEMATOL ONC, V30, P507, DOI 10.1097/MPH.0b013e31816e238c; Salas S, 2009, ANN ONCOL, V20, P1127, DOI 10.1093/annonc/mdn757; Schrage YM, 2010, EUR J CANCER, V46, P616, DOI 10.1016/j.ejca.2009.11.002; Soni EEC, 2011, ONCOL REP, V26, P1513, DOI 10.3892/or.2011.1431; Sutton KM, 2004, ONCOLOGY-BASEL, V66, P275, DOI 10.1159/000078327; Tang XM, 2002, CANCER RES, V62, P4903; Urakawa H, 2009, CLIN ORTHOP RELAT R, V467, P2932, DOI 10.1007/s11999-009-0814-x; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Weiss SW, 2007, ENZINGER WEISSS SOFT, P903; Wong WW, 1998, INT J RADIAT ONCOL, V42, P351, DOI 10.1016/S0360-3016(98)00223-5; Yamashita H, 2004, INT J MOL MED, V14, P565; Yamashita H, 2003, ANTICANCER RES, V23, P4671	53	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88035	10.1371/journal.pone.0088035	http://dx.doi.org/10.1371/journal.pone.0088035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516579	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700038
J	Roland, MCP; Friis, CM; Godang, K; Bollerslev, J; Haugen, G; Henriksen, T				Roland, Marie Cecilie Paasche; Friis, Camilla M.; Godang, Kristin; Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore			Maternal Factors Associated with Fetal Growth and Birthweight Are Independent Determinants of Placental Weight and Exhibit Differential Effects by Fetal Sex	PLOS ONE			English	Article							PREGNANCY; HYPERGLYCEMIA; MACROSOMIA; EXPRESSION; TRANSPORT; FAMINE; GENDER; SIZE; RISK; TERM	Introduction: Maternal nutritional and metabolic factors influence the developmental environment of the fetus. Virtually any nutritional factor in the maternal blood has to pass the placental membranes to reach the fetal blood. Placental weight is a commonly used measure to summarize placental growth and function. Placental weight is an independent determinant of fetal growth and birthweight and modifies the associations between maternal metabolic factors and fetal growth. We hypothesized that maternal factors known to be related to fetal growth, newborn size and body composition are determinants of placental weight and that effects of maternal metabolic factors on placental weight differ between the genders. Methods: The STORK study is a prospective longitudinal study including 1031 healthy pregnant women of Scandinavian heritage with singleton pregnancies. Maternal determinants (parity, body mass index, gestational weight gain and fasting plasma glucose) of placental weight were explored by linear regression models, stratified by fetal sex. Results: Parity, maternal BMI, gestational weight gain and fasting glucose had positive effects on placental weight. There was a sex specific effect in these associations. Fasting glucose was significantly associated with placental weight in females but not in males. Conclusion: Maternal factors known to influence fetal growth, birthweight and neonatal body composition are determinants of placental weight. The effect of maternal factors on placental weight is influenced by sex as illustrated in the relation between maternal glucose and placental weight.	[Roland, Marie Cecilie Paasche; Friis, Camilla M.; Haugen, Guttorm; Henriksen, Tore] Oslo Univ Hosp, Dept Obstet, Oslo, Norway; [Godang, Kristin; Bollerslev, Jens] Oslo Univ Hosp, Dept Specialized Endocrinol, Oslo, Norway; [Bollerslev, Jens; Haugen, Guttorm; Henriksen, Tore] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Roland, MCP (corresponding author), Oslo Univ Hosp, Dept Obstet, Oslo, Norway.	mcpaasche@hotmail.com			Norwegian Extrafoundation For Health and Research; Norwegian Health Association; University of Oslo	Norwegian Extrafoundation For Health and Research; Norwegian Health Association; University of Oslo	The work has been supported by the Norwegian Extrafoundation For Health and Research, The Norwegian Health Association and the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERNE W, 1966, BIOL NEONATORUM, V10, P113; Alwasel SH, 2010, PLACENTA, V31, P607, DOI 10.1016/j.placenta.2010.04.010; Baptiste-Roberts K, 2009, J MATERN-FETAL NEO M, V22, P13, DOI 10.1080/14767050802415728; Baumann MU, 2002, ENDOCRINE, V19, P13, DOI 10.1385/ENDO:19:1:13; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; BURTON GJ, 1995, BRIT J OBSTET GYNAEC, V102, P818, DOI 10.1111/j.1471-0528.1995.tb10849.x; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Diouf I, 2012, MATERN CHILD NUTR; Ericsson A, 2007, J PHYSIOL-LONDON, V581, P1323, DOI 10.1113/jphysiol.2007.131185; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Friis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057467; Froslie KF, 2011, CLIN BIOCHEM, V44, P1483, DOI 10.1016/j.clinbiochem.2011.08.1150; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15; HAY WW, 1994, HORM RES, V42, P215; Ingemarsson I, 2003, BJOG-INT J OBSTET GY, V110, P34, DOI 10.1016/S1470-0328(03)00022-3; Jansson T, 1999, AM J OBSTET GYNECOL, V180, P163, DOI 10.1016/S0002-9378(99)70169-9; L'Abee C, 2011, J PERINAT MED, V39, P27, DOI 10.1515/jpm.2010.119; LAGA EM, 1973, BIOL NEONATE, V23, P231; Leary SD, 2003, PLACENTA, V24, P276, DOI 10.1053/plac.2002.0888; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Roseboom TJ, 2011, PLACENTA, V32, P395, DOI 10.1016/j.placenta.2011.03.001; Salafia CM, 2006, CLIN OBSTET GYNECOL, V49, P236, DOI 10.1097/00003081-200606000-00007; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; van Abeelen AFM, 2011, PLACENTA, V32, P694, DOI 10.1016/j.placenta.2011.06.012; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Voldner N, 2013, HUMAN ONTOGENETICS, V3, P7; Voldner N, 2008, ACTA OBSTET GYN SCAN, V87, P423, DOI 10.1080/00016340801989825; Wallace JM, 2013, PLACENTA, V34, P269, DOI 10.1016/j.placenta.2012.12.007; Wallace JM, 2012, PLACENTA, V33, P611, DOI 10.1016/j.placenta.2012.05.006	37	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87303	10.1371/journal.pone.0087303	http://dx.doi.org/10.1371/journal.pone.0087303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516548	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700022
J	Xu, MH; Gao, X; Luo, D; Zhou, XD; Xiong, W; Liu, GX				Xu, Mei-Hua; Gao, Xuan; Luo, Dan; Zhou, Xiang-Dong; Xiong, Wei; Liu, Guo-Xiang			EMT and Acquisition of Stem Cell-Like Properties Are Involved in Spontaneous Formation of Tumorigenic Hybrids between Lung Cancer and Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							BREAST-CANCER; METASTASIS; FUSION; INFLAMMATION; PROGRESSION; TRANSITION; IDENTIFICATION; TUMORS; FOCUS; MSCS	The most deadly phase in cancer progression is metastatic conversion. Epithelial-to-mesenchymal transition (EMT) is a key process by which cancer cells acquire invasive and metastatic phenotypes. In order to spawn macroscopic metastases, disseminated cancer cells would seem to require self-renewal capability. However, the underlying mechanism defining these processes is poorly understood. One possible mechanism underlying metastasis is fusion between myeloid cells and cancer cells. In this study, we found that spontaneously-formed tumorigenic hybrids between bone marrow-derived mesenchymal stem cells (MSCs) and three different non-small cell lung cancer (NSCLC) cell lines contributed to highly malignant subpopulations with both EMT and stem cell-like properties. Hybrids lost their epithelial morphology and assumed a fibroblast-like appearance. Up-regulation of vimentin, alpha-smooth muscle actin (alpha-SMA), and fibronectin, and down-regulation of E-cadherin and pancytokeratin were observed in tumorigenic hybrids. These cells also exhibited increased expression of the stem cell marker prominin-1 (CD133) and over-expression of transcription factors OCT4, Nanog, BMI1, Notch1, ALDH1 as well as Sox2, all genes responsible for regulating and maintaining the stem cell phenotype. In addition, in spontaneously-formed tumorigenic hybrids, increased pneumosphere-forming capacity and tumor-forming ability in NOD/SCID mice were detectable. Thus, cell fusion between lung cancer cells and MSCs provides a nonmutational mechanism that could contribute to aberrant gene expression patterns and give rise to highly malignant subpopulations both capable of EMT and with properties of cancer stem cells (CSCs).	[Xu, Mei-Hua; Gao, Xuan; Luo, Dan; Zhou, Xiang-Dong; Xiong, Wei; Liu, Guo-Xiang] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China	Army Medical University	Liu, GX (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China.	guoxiangliu63@126.com			National Natural Science Foundation of China [81071728]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Natural Science Foundation of China (81071728). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bianchi G, 2011, HISTOL HISTOPATHOL, V26, P941, DOI 10.14670/HH-26.941; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Cogle CR, 2007, STEM CELLS, V25, P1881, DOI 10.1634/stemcells.2007-0163; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254; Gottschling S, 2013, LUNG CANCER, V80, P19, DOI 10.1016/j.lungcan.2012.12.015; Gu P, 2007, MOL VIS, V13, P1045; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Guo S, 2012, LUNG CANCER, V77, P389, DOI 10.1016/j.lungcan.2012.03.028; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Koh BI, 2012, EMBO REP, V13, P412, DOI 10.1038/embor.2012.41; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martinez-Moreno P, 2006, CARCINOGENESIS, V27, P429, DOI 10.1093/carcin/bgi250; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Talmadge JE, 2011, SEMIN CANCER BIOL, V21, P131, DOI 10.1016/j.semcancer.2010.12.002; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torsvik A, 2013, CANCER TREAT REV, V39, P180, DOI 10.1016/j.ctrv.2012.03.005; Wang RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042653; Wang S, 2013, FRONT BIOSCI-LANDMRK, V18, P447, DOI 10.2741/4113; Zhang BC, 2011, MED ONCOL, V28, P1447, DOI 10.1007/s12032-010-9638-5; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033655	36	79	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87893	10.1371/journal.pone.0087893	http://dx.doi.org/10.1371/journal.pone.0087893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516569	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700032
J	Grayson, DS; Ray, S; Carpenter, S; Iyer, S; Dias, TGC; Stevens, C; Nigg, JT; Fair, DA				Grayson, David S.; Ray, Siddharth; Carpenter, Samuel; Iyer, Swathi; Dias, Taciana G. Costa; Stevens, Corinne; Nigg, Joel T.; Fair, Damien A.			Structural and Functional Rich Club Organization of the Brain in Children and Adults	PLOS ONE			English	Article							DEFAULT MODE; CONNECTIVITY; NETWORKS; SCHIZOPHRENIA; ARCHITECTURE; CORTEX; MRI	Recent studies using Magnetic Resonance Imaging (MRI) have proposed that the brain's white matter is organized as a rich club, whereby the most highly connected regions of the brain are also highly connected to each other. Here we use both functional and diffusion-weighted MRI in the human brain to investigate whether the rich club phenomena is present with functional connectivity, and how this organization relates to the structural phenomena. We also examine whether rich club regions serve to integrate information between distinct brain systems, and conclude with a brief investigation of the developmental trajectory of rich-club phenomena. In agreement with prior work, both adults and children showed robust structural rich club organization, comprising regions of the superior medial frontal/dACC, medial parietal/PCC, insula, and inferior temporal cortex. We also show that these regions were highly integrated across the brain's major networks. Functional brain networks were found to have rich club phenomena in a similar spatial layout, but a high level of segregation between systems. While no significant differences between adults and children were found structurally, adults showed significantly greater functional rich club organization. This difference appeared to be driven by a specific set of connections between superior parietal, insula, and supramarginal cortex. In sum, this work highlights the existence of both a structural and functional rich club in adult and child populations with some functional changes over development. It also offers a potential target in examining atypical network organization in common developmental brain disorders, such as ADHD and Autism.	[Grayson, David S.; Ray, Siddharth; Carpenter, Samuel; Iyer, Swathi; Dias, Taciana G. Costa; Stevens, Corinne; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Grayson, David S.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Dias, Taciana G. Costa] Univ Sao Paulo, Sch Med, Hosp Clin, Inst Psychiat, Sao Paulo, Brazil; [Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; University of California System; University of California Davis; Universidade de Sao Paulo; Oregon Health & Science University; Oregon Health & Science University	Grayson, DS (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	dgrayson@ucdavis.edu; faird@ohsu.edu		, David/0000-0002-4270-2911	National Institutes of Health [R00 MH091238, R01 MH096773, R01 MH086654]; National Institute of Mental Health [R00 MH091238, R01 MH096773, R01 MH086654]; Oregon Clinical and Translational Research Institute; Medical Research Foundation; McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086654, R01MH096773, R00MH091238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Oregon Clinical and Translational Research Institute; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funders for grants R00 MH091238 (DF), R01 MH096773 (DF) and R01 MH086654 (JN) are National Institutes of Health and National Institute of Mental Health. Funding also included Oregon Clinical and Translational Research Institute (DF), Medical Research Foundation (DF), R01 MH096773 (DF), and McDonnell Foundation (Petersen/Sporns/DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; de Reus MA, 2013, J NEUROSCI, V33, P12929, DOI 10.1523/JNEUROSCI.1448-13.2013; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hwang K, 2013, CEREB CORTEX, V23, P2380, DOI 10.1093/cercor/bhs227; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Raichle ME, 2009, J NEUROSCI, V29, P12729, DOI 10.1523/JNEUROSCI.4366-09.2009; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhou S, 2004, IEEE COMMUN LETT, V8, P180, DOI 10.1109/LCOMM.2004.823426	56	120	123	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88297	10.1371/journal.pone.0088297	http://dx.doi.org/10.1371/journal.pone.0088297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505468	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200169
J	Groner, ML; Gettinby, G; Stormoen, M; Revie, CW; Cox, R				Groner, Maya L.; Gettinby, George; Stormoen, Marit; Revie, Crawford W.; Cox, Ruth			Modelling the Impact of Temperature-Induced Life History Plasticity and Mate Limitation on the Epidemic Potential of a Marine Ectoparasite	PLOS ONE			English	Article							LICE LEPEOPHTHEIRUS-SALMONIS; FARMED ATLANTIC SALMON; SEA LICE; SALAR L; EMAMECTIN BENZOATE; BROUGHTON ARCHIPELAGO; MATHEMATICAL-MODEL; COPEPODA CALIGIDAE; WATER TEMPERATURE; BRITISH-COLUMBIA	Temperature is hypothesized to contribute to increased pathogenicity and virulence of many marine diseases. The sea louse (Lepeophtheirus salmonis) is an ectoparasite of salmonids that exhibits strong life-history plasticity in response to temperature; however, the effect of temperature on the epidemiology of this parasite has not been rigorously examined. We used matrix population modelling to examine the influence of temperature on demographic parameters of sea lice parasitizing farmed salmon. Demographically-stochastic population projection matrices were created using parameters from the existing literature on vital rates of sea lice at different fixed temperatures and yearly temperature profiles. In addition, we quantified the effectiveness of a single stage-specific control applied at different times during a year with seasonal temperature changes. We found that the epidemic potential of sea lice increased with temperature due to a decrease in generation time and an increase in the net reproductive rate. In addition, mate limitation constrained population growth more at low temperatures than at high temperatures. Our model predicts that control measures targeting preadults and chalimus are most effective regardless of the temperature. The predictions from this model suggest that temperature can dramatically change vital rates of sea lice and can increase population growth. The results of this study suggest that sea surface temperatures should be considered when choosing salmon farm sites and designing management plans to control sea louse infestations. More broadly, this study demonstrates the utility of matrix population modelling for epidemiological studies.	[Groner, Maya L.; Revie, Crawford W.; Cox, Ruth] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada; [Gettinby, George] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Stormoen, Marit] Norwegian Sch Vet Sci, Ctr Epidemiol & Biostat, Oslo, Norway	University of Prince Edward Island; University of Strathclyde; Norwegian University of Life Sciences	Groner, ML (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Ctr Vet Epidemiol Res, Charlottetown, PE C1A 4P3, Canada.	mgroner@upei.ca	Groner, Maya L/J-4261-2014; Revie, Crawford/B-5002-2011	Groner, Maya L/0000-0002-3381-6415; Revie, Crawford/0000-0002-5018-0340; Stormoen, Marit/0000-0002-3385-8762	Canada Excellence Research Chairs Program; SALMODIS project; Atlantic Innovation Fund	Canada Excellence Research Chairs Program(Canada Research Chairs); SALMODIS project; Atlantic Innovation Fund	This research was undertaken thanks to funding from the Canada Excellence Research Chairs Program (http://www.cerc.gc.ca/chairholders-titulaires/gardner-eng.aspx), the SALMODIS project (http://www.sintef.no/salmodis), and the Atlantic Innovation Fund (http://www.acoa-apeca.gc.ca/eng/ImLookingFor/ProgramInformation/AtlanticInnovationFund/Pages/AtlanticInnovationFund.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Armstrong R, 2000, CAN VET J, V41, P607; Belahradek J, 1935, PROTOPLASMA MONOGRAP, V8; Bjorn PA, 1998, CAN J ZOOL, V76, P970, DOI 10.1139/cjz-76-5-970; Bommarco R, 2001, AGR FOREST ENTOMOL, V3, P275, DOI 10.1046/j.1461-9555.2001.00114.x; Boxaspen K, 1997, ICES J MAR SCI, V54, P1144, DOI 10.1016/S1054-3139(97)80020-3; Boxaspen K, 2006, ICES J MAR SCI, V63, P1304, DOI 10.1016/j.icesjms.2006.04.017; Bricknell IR, 2006, DIS AQUAT ORGAN, V71, P201, DOI 10.3354/dao071201; Brooks KM, 2005, REV FISH SCI, V13, P177, DOI 10.1080/10641260500207109; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Burka JF, 1997, J VET PHARMACOL THER, V20, P333, DOI 10.1046/j.1365-2885.1997.00094.x; Burridge L, 2010, AQUACULTURE, V306, P7, DOI 10.1016/j.aquaculture.2010.05.020; Caswell, 2000, MATRIX POPULATION MO; Connors BM, 2011, BEHAV ECOL, V22, P588, DOI 10.1093/beheco/arr024; Connors BM, 2010, J APPL ECOL, V47, P1372, DOI 10.1111/j.1365-2664.2010.01889.x; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Covello JM, 2012, AQUACULTURE, V366, P9, DOI 10.1016/j.aquaculture.2012.08.051; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Elston RA, 2008, DIS AQUAT ORGAN, V82, P119, DOI 10.3354/dao01982; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Frazer LN, 2012, P ROY SOC B-BIOL SCI, V279, P1950, DOI 10.1098/rspb.2011.2210; Genna RL, 2005, CAN J FISH AQUAT SCI, V62, P2675, DOI 10.1139/F05-163; GETTINBY G, 1979, P ROY IRISH ACAD B, V79, P155; Gettinby G, 2011, AQUACULTURE, V320, P164, DOI 10.1016/j.aquaculture.2011.03.017; Govindarajulu P, 2005, ECOL APPL, V15, P2161, DOI 10.1890/05-0486; Grimnes A, 1996, J FISH BIOL, V48, P1179, DOI 10.1111/j.1095-8649.1996.tb01813.x; Groner ML, 2013, J FISH DIS, V36, P195, DOI 10.1111/jfd.12017; Groot C., 1995, PHYSL ECOLOGY PACIFI; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Heuch PA, 2002, J MAR BIOL ASSOC UK, V82, P887, DOI 10.1017/S0025315402006306; Heuch PA, 2000, AQUAC RES, V31, P805, DOI 10.1046/j.1365-2109.2000.00512.x; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; JOHANNESSEN A, 1978, SARSIA, V63, P169; Jones PG, 2012, DIS AQUAT ORGAN, V102, P53, DOI 10.3354/dao02517; Jones SRM, 2007, DIS AQUAT ORGAN, V75, P229, DOI 10.3354/dao075229; Krkosek M, 2005, P ROY SOC B-BIOL SCI, V272, P689, DOI 10.1098/rspb.2004.3027; Krkosek M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2359; Krkosek M, 2012, AM NAT, V179, P401, DOI 10.1086/664458; Krkosek M, 2011, P NATL ACAD SCI USA, V108, P14700, DOI 10.1073/pnas.1101845108; Lees F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001549; Maran BAV, 2013, PARASITE, V20, DOI 10.1051/parasite/2013015; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; Parry M. L., 2007, CLIMATE CHANGE 2007; POWELL EN, 1992, MAR ECOL-P S Z N I, V13, P243, DOI 10.1111/j.1439-0485.1992.tb00354.x; Rae GH, 2002, PEST MANAG SCI, V58, P515, DOI 10.1002/ps.491; Revie C.W., 2006, THESIS U STRATHCLYDE; Revie CW, 2005, J FISH DIS, V28, P603, DOI 10.1111/j.1365-2761.2005.00665.x; Revie CW, 2003, DIS AQUAT ORGAN, V57, P85, DOI 10.3354/dao057085; Revie CW, 2002, PEST MANAG SCI, V58, P576, DOI 10.1002/ps.476; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Rogers LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060096; Roth M, 1996, AQUACULTURE, V140, P217, DOI 10.1016/0044-8486(95)01181-1; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Saksida S, 2007, AQUAC RES, V38, P219, DOI 10.1111/j.1365-2109.2007.01651.x; Stien A, 2005, MAR ECOL PROG SER, V290, P263, DOI 10.3354/meps290263; Stone J, 1999, J FISH DIS, V22, P261, DOI 10.1046/j.1365-2761.1999.00176.x; Stormoen M, 2013, J FISH DIS, V36, P25, DOI 10.1111/j.1365-2761.2012.01415.x; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Todd CD, 2005, MAR ECOL PROG SER, V303, P225, DOI 10.3354/meps303225; Travers MA, 2009, GLOBAL CHANGE BIOL, V15, P1365, DOI 10.1111/j.1365-2486.2008.01764.x; Tucker CS, 2000, J FISH DIS, V23, P309, DOI 10.1046/j.1365-2761.2000.00219.x; TULLY O, 1992, INVERTEBR REPROD DEV, V22, P91, DOI 10.1080/07924259.1992.9672261; VERGEER LHT, 1995, AQUAT BOT, V52, P35, DOI 10.1016/0304-3770(95)00480-N	65	49	49	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88465	10.1371/journal.pone.0088465	http://dx.doi.org/10.1371/journal.pone.0088465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505493	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000330829200193
J	Reiche, J; Jacobsen, S; Neubauer, K; Hafemann, S; Nitsche, A; Milde, J; Wolff, T; Schweiger, B				Reiche, Janine; Jacobsen, Sonja; Neubauer, Katrin; Hafemann, Susi; Nitsche, Andreas; Milde, Jeanette; Wolff, Thorsten; Schweiger, Brunhilde			Human Metapneumovirus: Insights from a Ten-Year Molecular and Epidemiological Analysis in Germany	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENETIC DIVERSITY; YOUNG-CHILDREN; HOSPITALIZED CHILDREN; SEASONAL DISTRIBUTION; TRACT INFECTIONS; P-GENE; VARIABILITY; DISEASE; FUSION	Human metapneumovirus (HMPV) is a cause of respiratory tract illness at all ages. In this study the epidemiological and molecular diversity among patients of different ages was investigated. Between 2000-2001 and 2009-2010, HMPV was detected in 3% (138/4,549) of samples from outpatients with influenza-like illness with a new, sensitive real-time RT-PCR assay. Several hundred (797) clinical specimens from hospitalized children below the age of 4 years with acute respiratory illness were investigated and HMPV was detected in 11.9% of them. Investigation of outpatients revealed that HMPV infections occurred in individuals of all ages but were most prevalent in children (0-4 years) and the elderly (>60 years). The most present clinical features of HMPV infections were cough, bronchitis, fever/shivers and pneumonia. About two thirds of HMPV-positive samples were detected in February and March throughout the study period. Molecular characterization of HMPV revealed a complex cyclic pattern of group dominance where HMPV subgroup A and B viruses predominated in general for three consecutive seasons. German HMPV represented all genetic lineages including A1, A2, B1, B2, sub-clusters A2a and A2b. For Germany, not only time-dependent circulation of lineages and sub-clusters was observed but also co-circulation of two or three predominant lineages. Two newly emerging amino acid substitutions (positions 223 and 280) of lineage B2 were detected in seven German HMPV sequences. Our study gives new insights into the molecular epidemiology of HMPV in in-and outpatients over a time period of 10 years for the first time. It is one of only few long-term surveillance studies in Europe, and allows comparative molecular analyses of HMPV circulating worldwide.	[Reiche, Janine; Jacobsen, Sonja; Neubauer, Katrin; Hafemann, Susi; Milde, Jeanette; Wolff, Thorsten; Schweiger, Brunhilde] Robert Koch Inst, Div Influenza Viruses & Other Resp Viruses, Natl Reference Ctr Influenza, Berlin, Germany; [Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Jacobsen, S (corresponding author), Robert Koch Inst, Div Influenza Viruses & Other Resp Viruses, Natl Reference Ctr Influenza, Berlin, Germany.	jacobsens@rki.de		Nitsche, Andreas/0000-0001-8185-3176				Aberle SW, 2008, PEDIATR INFECT DIS J, V27, P1065, DOI 10.1097/INF.0b013e31817ef4fd; Banerjee S, 2011, J MED VIROL, V83, P1799, DOI 10.1002/jmv.22176; Bastien N, 2003, VIRUS RES, V93, P51, DOI 10.1016/S0168-1702(03)00065-0; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; Boivin G, 2004, EMERG INFECT DIS, V10, P1154, DOI 10.3201/eid1006.031097; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Broor S, 2008, J BIOSCIENCES, V33, P483, DOI 10.1007/s12038-008-0067-y; Chung JY, 2008, J MED VIROL, V80, P902, DOI 10.1002/jmv.21129; Ebihara T, 2003, J MED VIROL, V70, P281, DOI 10.1002/jmv.10391; Embarek Mohamed M, 2013, INT J MICRO IN PRESS; Escobar C, 2009, J MED VIROL, V81, P340, DOI 10.1002/jmv.21399; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Falsey AR, 2008, PEDIATR INFECT DIS J, V27, pS80, DOI 10.1097/INF.0b013e3181684dac; Gerna G, 2005, ARCH VIROL, V150, P2365, DOI 10.1007/s00705-005-0581-2; Gioula G, 2010, EURO SURVEILL, V15, P19149; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamelin ME, 2004, CLIN INFECT DIS, V38, P983, DOI 10.1086/382536; Hopkins MJ, 2008, J CLIN VIROL, V42, P273, DOI 10.1016/j.jcv.2008.03.011; Huck B, 2006, EMERG INFECT DIS, V12, P147, DOI 10.3201/eid1201.050772; Jartti T, 2004, EMERG INFECT DIS, V10, P1095, DOI 10.3201/eid1006.030629; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kaida A, 2006, J CLIN VIROL, V35, P394, DOI 10.1016/j.jcv.2005.12.009; Li XY, 2009, ARCH VIROL, V154, P1831, DOI 10.1007/s00705-009-0492-8; Ljubin-Sternak S, 2008, J MED VIROL, V80, P1282, DOI 10.1002/jmv.21196; Ludewick HP, 2005, EMERG INFECT DIS, V11, P1074, DOI 10.3201/eid1107.050050; Mackay IM, 2006, J INFECT DIS, V193, P1630, DOI 10.1086/504260; Mackay IM, 2004, J INFECT DIS, V190, P1913, DOI 10.1086/425013; Maggi F, 2003, J CLIN MICROBIOL, V41, P2987, DOI 10.1128/JCM.41.7.2987-2991.2003; McIntosh K, 2004, NEW ENGL J MED, V350, P431, DOI 10.1056/NEJMp038212; Oliveira DBL, 2009, J MED VIROL, V81, P915, DOI 10.1002/jmv.21436; Ordas J, 2006, J CLIN MICROBIOL, V44, P2739, DOI 10.1128/JCM.00164-06; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Pitoiset C, 2010, J MED VIROL, V82, P1782, DOI 10.1002/jmv.21884; Rafiefard F, 2008, J MED VIROL, V80, P1631, DOI 10.1002/jmv.21242; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Schowalter RM, 2006, J VIROL, V80, P10931, DOI 10.1128/JVI.01287-06; Skiadopoulos MH, 2006, VIROLOGY, V345, P492, DOI 10.1016/j.virol.2005.10.016; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Viazov S, 2003, J CLIN MICROBIOL, V41, P3043, DOI 10.1128/JCM.41.7.3043-3045.2003; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Widmer K, 2012, J INFECT DIS, V206, P56, DOI 10.1093/infdis/jis309; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xiao NG, 2013, J MED VIROL; Yang CF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-138; Zhang C, 2012, J CLIN MICROBIOL, V50, P2714, DOI 10.1128/JCM.00809-12	51	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88342	10.1371/journal.pone.0088342	http://dx.doi.org/10.1371/journal.pone.0088342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505479	Green Published, gold			2022-12-27	WOS:000330829200180
J	Shen, C; Wu, XL; Xu, CF; Yu, CH; Chen, P; Li, YM				Shen, Chao; Wu, Xiaoliang; Xu, Chengfu; Yu, Chaohui; Chen, Peng; Li, Youming			Association of Cholecystectomy with Metabolic Syndrome in a Chinese Population	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; RISK-FACTORS; WEIGHT-GAIN; PREVALENCE; GALLBLADDER; RESPONSES; NONOBESE	An association between cholecystectomy and metabolic syndrome has not been fully established. Here we analyzed the association between cholecystectomy and metabolic syndrome in a Chinese population of 5672 subjects who undergone annual health checkups at the First Affiliated Hospital, College of Medicine, Zhejiang University between January 2011 and December 2012. The prevalences of gallstones, cholecystectomy and metabolic syndrome were 6.0%, 3.6%, and 32.5%, respectively. The prevalence of metabolic syndrome was significantly higher in subjects with a history of cholecystectomy (63.5%) than in those with gallstones (47.0%) or in those without gallstone disease (30.3%; P<0.01 for both). Multivariate logistic regression analysis showed that cholecystectomy was significantly associated with increased risk of metabolic syndrome (OR = 1.872; 95% CI: 1.193-2.937). However, the association of gallstones with metabolic syndrome was not statistically significant (OR = 1.267; 95% CI: 0.901-1.782). Altogether, our results suggest that cholecystectomy significantly increases the risk of metabolic syndrome.	[Shen, Chao; Chen, Peng] Zhejiang Univ, Affiliated Hosp 1, Int Hlth Care Ctr, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xiaoliang] Zhejiang Univ, Affiliated Hosp 1, Intens Care Unit, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Chengfu; Yu, Chaohui; Li, Youming] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiaofu@zju.edu.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81070366, 81100278, 81170378, 81230012, 81270487]; International Science and Technology Cooperation Projects of Zhejiang Province [2013C24010]; Science Foundation of Health Bureau of Zhejiang Province [2012RCA026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Projects of Zhejiang Province; Science Foundation of Health Bureau of Zhejiang Province	This study was supported by National Natural Science Foundation of China (numbers 81070366, 81100278, 81170378, 81230012, and 81270487), International Science and Technology Cooperation Projects of Zhejiang Province (number 2013C24010), and Science Foundation of Health Bureau of Zhejiang Province (number 2012RCA026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2009, NAT REV NEPHROL, V5, P520, DOI 10.1038/nrneph.2009.114; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Ali RB, 2004, IRISH J MED SCI, V173, P9, DOI 10.1007/BF02914515; Amigo L, 2011, LIVER INT, V31, P52, DOI 10.1111/j.1478-3231.2010.02361.x; Ata N, 2011, CAN J GASTROENTEROL, V25, P274, DOI 10.1155/2011/356761; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Chang Y, 2008, J KOREAN MED SCI, V23, P644, DOI 10.3346/jkms.2008.23.4.644; Chavez-Tapia NC, 2012, ANN HEPATOL, V11, P85, DOI 10.1016/S1665-2681(19)31490-5; Chen LY, 2012, WORLD J GASTROENTERO, V18, P4215, DOI 10.3748/wjg.v18.i31.4215; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Johnson WD, 2009, ARCH PEDIAT ADOL MED, V163, P371, DOI 10.1001/archpediatrics.2009.3; JUVONEN T, 1995, HEPATO-GASTROENTEROL, V42, P377; Kenary AY, 2012, INT J FOOD SCI NUTR, V63, P645, DOI 10.3109/09637486.2011.644767; Kim Sang Soo, 2011, Korean Journal of Internal Medicine, V26, P285, DOI 10.3904/kjim.2011.26.3.285; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; MALAGELADA JR, 1973, AM J DIG DIS, V18, P455, DOI 10.1007/BF01076595; Mendez-Sanchez N, 2005, WORLD J GASTROENTERO, V11, P1653, DOI 10.3748/wjg.v11.i11.1653; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pols TWH, 2011, DIGEST DIS, V29, P37, DOI 10.1159/000324126; Ravikiran M, 2010, DIABETES RES CLIN PR, V89, P181, DOI 10.1016/j.diabres.2010.03.010; Ruhl CE, 2013, AM J GASTROENTEROL, V108, P952, DOI 10.1038/ajg.2013.70; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Sonne DP, 2013, AM J PHYSIOL-GASTR L, V304, pG413, DOI 10.1152/ajpgi.00435.2012; TANAKA M, 1984, GASTROENTEROLOGY, V87, P1154; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104; Yu CH, 2012, J HEPATOL, V56, P241, DOI 10.1016/j.jhep.2011.05.027; Yudkin JS, 2004, METABOLISM, V53, P852, DOI 10.1016/j.metabol.2004.02.004; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	32	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88189	10.1371/journal.pone.0088189	http://dx.doi.org/10.1371/journal.pone.0088189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505425	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200131
J	Martinez-Granero, F; Navazo, A; Barahona, E; Redondo-Nieto, M; de Heredia, EG; Baena, I; Martin-Martin, I; Rivilla, R; Martin, M				Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Gonzalez de Heredia, Elena; Baena, Irene; Martin-Martin, Irene; Rivilla, Rafael; Martin, Marta			Identification of flgZ as a Flagellar Gene Encoding a PilZ Domain Protein That Regulates Swimming Motility and Biofilm Formation in Pseudomonas	PLOS ONE			English	Article							CYCLIC-DI-GMP; SWARMING MOTILITY; CELLULOSE SYNTHESIS; GENOME SEQUENCE; MOTOR FUNCTION; FLUORESCENS; AERUGINOSA; COLONIZATION; SELECTION; PHOSPHODIESTERASE	Diguanylate cyclase and phosphodiesterase enzymatic activities control c-di-GMP levels modulating planktonic versus sessile lifestyle behavior in bacteria. The PilZ domain is described as a sensor of c-di-GMP intracellular levels and the proteins containing a PilZ domain represent the best studied class of c-di-GMP receptors forming part of the c-di-GMP signaling cascade. In P. fluorescens F113 we have found two diguanylate cyclases (WspR, SadC) and one phosphodiesterase (BifA) implicated in regulation of swimming motility and biofilm formation. Here we identify a flgZ gene located in a flagellar operon encoding a protein that contains a PilZ domain. Moreover, we show that FlgZ subcellular localization depends on the c-di-GMP intracellular levels. The overexpression analysis of flgZ in P. fluorescens F113 and P. putida KT2440 backgrounds reveal a participation of FlgZ in Pseudomonas swimming motility regulation. Besides, the epistasis of flgZ over wspR and bifA clearly shows that c-di-GMP intracellular levels produced by the enzymatic activity of the diguanylate cyclase WspR and the phosphodiesterase BifA regulates biofilm formation through FlgZ.	[Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Gonzalez de Heredia, Elena; Baena, Irene; Martin-Martin, Irene; Rivilla, Rafael; Martin, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Martin, M (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	m.martin@uam.es	martin, marta/H-2169-2015; Redondo-Nieto, Miguel/A-6169-2011; Rivilla, Rafael/A-1659-2008; Basanta, Marta Martin/AAI-5459-2020; Barahona, Emma/L-6421-2014	martin, marta/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X; Rivilla, Rafael/0000-0003-0701-2939; Basanta, Marta Martin/0000-0003-2498-9768; 	Spanish Ministry of Economy and Competitivity [BIO2012-31634]; Research Program MICROAMBIENTE-CM from Comunidad de Madrid; Comunidad de Madrid; FPI fellowship from the Spanish Ministry of Science and Education	Spanish Ministry of Economy and Competitivity(Spanish Government); Research Program MICROAMBIENTE-CM from Comunidad de Madrid; Comunidad de Madrid(Comunidad de Madrid); FPI fellowship from the Spanish Ministry of Science and Education(German Research Foundation (DFG))	This work was funded by the Spanish Ministry of Economy and Competitivity grant BIO2012-31634, and by the Research Program MICROAMBIENTE-CM from Comunidad de Madrid. Francisco Martinez-Granero is the recipient of a postdoctoral contract from Comunidad de Madrid. Ana Navazo was the recipient of an FPI fellowship from the Spanish Ministry of Science and Education. Emma Barahona was the recipient of a predoctoral contract from Comunidad de Madrid. Irene Baena is the recipient of an FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; AMIKAM D, 1989, J BACTERIOL, V171, P6649, DOI 10.1128/jb.171.12.6649-6655.1989; [Anonymous], TITLE ERROR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Barahona E, 2010, ENVIRON MICROBIOL, V12, P3185, DOI 10.1111/j.1462-2920.2010.02291.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Christensen LD, 2013, INFECT IMMUN, V81, P2705, DOI 10.1128/IAI.00332-13; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; FLETCHER M, 1977, CAN J MICROBIOL, V23, P1, DOI 10.1139/m77-001; Gjermansen M, 2006, FEMS MICROBIOL LETT, V265, P215, DOI 10.1111/j.1574-6968.2006.00493.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huangyutitham V, 2013, MBIO, V4, DOI 10.1128/mBio.00242-13; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Li Y, 2013, J BACTERIOL, V195, P3531, DOI 10.1128/JB.01156-12; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Matilla MA, 2011, ENVIRON MICROBIOL, V13, P1745, DOI 10.1111/j.1462-2920.2011.02499.x; Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07; Nakazawa T, 2002, ENVIRON MICROBIOL, V4, P782, DOI 10.1046/j.1462-2920.2002.00310.x; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; WILSON KJ, 1995, MICROBIOL-SGM, V141, P1691, DOI 10.1099/13500872-141-7-1691; Zorraquino V, 2013, J BACTERIOL, V195, P417, DOI 10.1128/JB.01789-12	52	43	44	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87608	10.1371/journal.pone.0087608	http://dx.doi.org/10.1371/journal.pone.0087608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504373	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800051
J	Orts-Del'Immagine, A; Kastner, A; Tillement, V; Tardivel, C; Trouslard, J; Wanaverbecq, N				Orts-Del'Immagine, Adeline; Kastner, Anne; Tillement, Vanessa; Tardivel, Catherine; Trouslard, Jerome; Wanaverbecq, Nicolas			Morphology, Distribution and Phenotype of Polycystin Kidney Disease 2-like 1-Positive Cerebrospinal Fluid Contacting Neurons in The Brainstem of Adult Mice	PLOS ONE			English	Article							DORSAL VAGAL COMPLEX; AMINO-ACID DECARBOXYLASE; CELL-ADHESION MOLECULE; CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; PRIMARY CILIA; IMMATURE NEURONS; MOUSE; LOCALIZATION; NEUROGENESIS	The mammalian spinal cord and medulla oblongata harbor unique neurons that remain in contact with the cerebrospinal fluid (CSF-cNs). These neurons were shown recently to express a polycystin member of the TRP channels family (PKD2L1) that potentially acts as a chemo-or mechanoreceptor. Recent studies carried out in young rodents indicate that spinal CSF-cNs express immature neuronal markers that appear to persist even in adult cells. Nevertheless, little is known about the phenotype and morphological properties of medullar CSF-cNs. Using immunohistochemistry and confocal microscopy techniques on tissues obtained from three-month old PKD2L1:EGFP transgenic mice, we analyzed the morphology, distribution, localization and phenotype of PKD2L1(+) CSF-cNs around the brainstem and cervical spinal cord central canal. We show that PKD2L1(+) CSF-cNs are GABAergic neurons with a subependymal localization, projecting a dendrite towards the central canal and an axon-like process running through the parenchyma. These neurons display a primary cilium on the soma and the dendritic process appears to bear ciliary-like structures in contact with the CSF. PKD2L1(+) CSF-cNs present a conserved morphology along the length of the medullospinal central canal with a change in their density, localization and dendritic length according to the rostro-caudal axis. At adult stages, PKD2L1(+) medullar CSF-cNs appear to remain in an intermediate state of maturation since they still exhibit characteristics of neuronal immaturity (DCX positive, neurofilament 160 kDa negative) along with the expression of a marker representative of neuronal maturation (NeuN). In addition, PKD2L1(+) CSF-cNs express Nkx6.1, a homeodomain protein that enables the differentiation of ventral progenitors into somatic motoneurons and interneurons. The present study provides valuable information on the cellular properties of this peculiar neuronal population that will be crucial for understanding the physiological role of CSF-cNs in mammals and their link with the stem cells contained in the region surrounding the medullospinal central canal.	[Orts-Del'Immagine, Adeline; Kastner, Anne; Tillement, Vanessa; Tardivel, Catherine; Trouslard, Jerome; Wanaverbecq, Nicolas] Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somatomot, EA 4674, Fac Sci St Jerome, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite	Wanaverbecq, N (corresponding author), Aix Marseille Univ, Lab Physiol & Physiopathol Syst Nerveux Somatomot, EA 4674, Fac Sci St Jerome, Marseille, France.	nicolas.wanaverbecq@univ-amu.fr	Orts-Del'Immagine, Adeline/AAA-7412-2020	Orts-Del'Immagine, Adeline/0000-0003-2954-6739; Wanaverbecq, Nicolas/0000-0001-5486-2771	Aix-Marseille University; "Region Provence-Alpes-Cote d'Azur"; "Conseil General des Bouches-du-Rhone" (PACA) [CG13 - Neuracid]; PEPS from the CNRS INSB (Neuracil)	Aix-Marseille University; "Region Provence-Alpes-Cote d'Azur"(Region Provence-Alpes-Cote d'Azur); "Conseil General des Bouches-du-Rhone" (PACA)(Region Provence-Alpes-Cote d'Azur); PEPS from the CNRS INSB (Neuracil)	This research was supported by funding obtained from Aix-Marseille University, the "Region Provence-Alpes-Cote d'Azur", the "Conseil General des Bouches-du-Rhone" (PACA, CG13 - Neuracid, JT), and the PEPS from the CNRS INSB (Neuracil, NW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Alaiwi WA, 2009, SENSORS-BASEL, V9, P7003, DOI 10.3390/s90907003; Alfaro-Cervello C, 2012, J COMP NEUROL, V520, P3528, DOI 10.1002/cne.23104; Alonso G, 1999, J COMP NEUROL, V414, P149, DOI 10.1002/(SICI)1096-9861(19991115)414:2<149::AID-CNE2>3.0.CO;2-O; BARBER RP, 1982, BRAIN RES, V238, P305, DOI 10.1016/0006-8993(82)90107-X; Barreiro-Iglesias A, 2009, J ANAT, V215, P601, DOI 10.1111/j.1469-7580.2009.01159.x; Basora N, 2002, J AM SOC NEPHROL, V13, P293, DOI 10.1681/ASN.V132293; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; Bay Sarah N, 2012, Cilia, V1, P19, DOI 10.1186/2046-2530-1-19; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; BJUGN R, 1988, J ANAT, V160, P117; BONFANTI L, 1992, NEUROSCIENCE, V49, P419, DOI 10.1016/0306-4522(92)90107-D; Bonfanti L, 2012, PROG NEUROBIOL, V98, P1, DOI 10.1016/j.pneurobio.2012.05.002; BRUNI JE, 1987, J ANAT, V152, P55; Charrier C, 2006, NEUROSCIENCE, V138, P5, DOI 10.1016/j.neuroscience.2005.10.046; Chatelin S, 2001, MOL BRAIN RES, V97, P149, DOI 10.1016/S0169-328X(01)00318-7; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481; Fuchs JL, 2004, CELL BIOL INT, V28, P111, DOI 10.1016/j.cellbi.2003.11.008; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hamilton LK, 2009, NEUROSCIENCE, V164, P1044, DOI 10.1016/j.neuroscience.2009.09.006; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hugnot JP, 2011, FRONT BIOSCI-LANDMRK, V16, P1044, DOI 10.2741/3734; JAEGER CB, 1983, SCIENCE, V219, P1233, DOI 10.1126/science.6131537; Kaiser E, 2010, NEURODEGENER DIS, V7, P251, DOI 10.1159/000287953; Kim HJ, 2012, INT NEUROUROL J, V16, P57, DOI 10.5213/inj.2012.16.2.57; Kutna V, 2014, ACTA HISTOCHEM, V116, P278, DOI 10.1016/j.acthis.2013.08.004; Leak RK, 2012, BRAIN RES, V1463, P51, DOI 10.1016/j.brainres.2012.04.055; Lee-Liu D, 2013, GENESIS, V51, P529, DOI 10.1002/dvg.22406; Lehtinen MK, 2011, ANNU REV CELL DEV BI, V27, P653, DOI 10.1146/annurev-cellbio-092910-154026; Mackie M, 2003, NEUROSCIENCE, V119, P461, DOI 10.1016/S0306-4522(03)00174-X; Marichal N, 2009, J NEUROSCI, V29, P10010, DOI 10.1523/JNEUROSCI.6183-08.2009; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NAGATSU I, 1988, BRAIN RES, V475, P91, DOI 10.1016/0006-8993(88)90202-8; Nelson TM, 2010, CHEM SENSES, V35, P565, DOI 10.1093/chemse/bjq070; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Orts-Del'Immagine A, 2012, J PHYSIOL-LONDON, V590, P3719, DOI 10.1113/jphysiol.2012.227959; Perrot R, 2009, BRAIN RES BULL, V80, P282, DOI 10.1016/j.brainresbull.2009.06.004; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Reali C, 2011, J PHYSIOL-LONDON, V589, P5633, DOI 10.1113/jphysiol.2011.214312; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Russo RE, 2004, J PHYSIOL-LONDON, V560, P831, DOI 10.1113/jphysiol.2004.072405; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Schwartz GJ, 2006, PHILOS T R SOC B, V361, P1275, DOI 10.1098/rstb.2006.1862; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Shechter R, 2007, STEM CELLS, V25, P2277, DOI 10.1634/stemcells.2006-0705; SHIMOSEGAWA T, 1986, BRAIN RES, V379, P1, DOI 10.1016/0006-8993(86)90249-0; Stoeckel ME, 2003, J COMP NEUROL, V457, P159, DOI 10.1002/cne.10565; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Vigh B, 2002, HISTOL HISTOPATHOL, V17, P555, DOI 10.14670/HH-17.555; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; WARD RP, 1995, NEUROSCIENCE, V64, P1105, DOI 10.1016/0306-4522(94)00439-C; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001	63	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87748	10.1371/journal.pone.0087748	http://dx.doi.org/10.1371/journal.pone.0087748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504595	Green Published, gold			2022-12-27	WOS:000330631800067
J	Pereira, I; Madeira, A; Prista, C; Loureiro-Dias, MC; Leandro, MJ				Pereira, Iliana; Madeira, Ana; Prista, Catarina; Loureiro-Dias, Maria C.; Leandro, Maria Jose			Characterization of New Polyol/H+ Symporters in Debaryomyces hansenii	PLOS ONE			English	Article							RHODOTORULA-GRACILIS GLUTINIS; MEDIATES H+-SYMPORT; SACCHAROMYCES-CEREVISIAE; CANDIDA-INTERMEDIA; TRANSPORTER GENES; YEAST; MYOINOSITOL; MANNITOL; GLYCEROL; INOSITOL	Debaryomyces hansenii is a halotolerant yeast that produces and assimilates a wide variety of polyols. In this work we evaluate polyol transport in D. hansenii CBS 767, detecting the occurrence of polyol/H+ (and sugar/H+) symporter activity, through the transient extracellular alkalinization of unbuffered starved cell suspensions. From the D. hansenii genome database, we selected nine ORFs encoding putative transporter proteins to clone in a centromeric plasmid with C-terminal GFP tagging and screened for polyol/H+ symporters by heterologous expression in Saccharomyces cerevisiae. Five distinct D. hansenii polyol/H+ symporters were identified and characterized, with different specificities and affinities for polyols, namely one glycerol-specific (DhStl1), one D-galactitol-specific (DhSgl1, Symporter galactitol/H+ 1), one D-(+)-chiro-inositol-specific (DhSyi1, Symporter D-(+)-chiro-inositol/H+ 1), one for D-sorbitol/D-mannitol/ribitol/D-arabitol/D-galactitol (DhSyl1, Symporter Polyols 1) and another for D-sorbitol/D-mannitol/ribitol/D-arabitol (DhSyl2, Symporter Polyols 2). This work contributed to the annotation of new yeast polyol transporters, including two specific for uncommon substrates as galactitol and D-(+)-chiro-inositol.	[Pereira, Iliana; Madeira, Ana; Prista, Catarina; Loureiro-Dias, Maria C.; Leandro, Maria Jose] Univ Lisbon, CBAA, Inst Super Agron, P-1699 Lisbon, Portugal; [Madeira, Ana] Univ Lisbon, Res Inst Med & Pharmaceut Sci IMed UL, Fac Pharm, P-1699 Lisbon, Portugal; [Madeira, Ana] Univ Lisbon, Dept Biochem & Human Biol, Fac Pharm, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Leandro, MJ (corresponding author), Univ Lisbon, CBAA, Inst Super Agron, P-1699 Lisbon, Portugal.	mjleandro@isa.utl.pt	Prista, C./H-9049-2019; Prista, Catarina/N-7079-2013; Leandro, Maria/K-5461-2015; Madeira, Ana/K-4714-2014	Prista, C./0000-0001-9307-1905; Prista, Catarina/0000-0001-9307-1905; Leandro, Maria/0000-0002-2254-4610; Madeira, Ana/0000-0003-3186-359X	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/41812/2007, SFRH/BPD/85143/2012, SFRH/BD/45930/2008]; FCT Ciencia; FCT Ciencia and Research Project "To promote xylitol release to improve bioethanol business" [PTDC/AGR-CFL/71792/2006]	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT Ciencia(Portuguese Foundation for Science and Technology); FCT Ciencia and Research Project "To promote xylitol release to improve bioethanol business"	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal (Post-Doctoral fellowships SFRH/BPD/41812/2007 to M.J.L. and SFRH/BPD/85143/2012 to C. P., PhD fellowship SFRH/BD/45930/2008 to A. M., FCT Ciencia 2007 and Research Project "To promote xylitol release to improve bioethanol business" (PTDC/AGR-CFL/71792/2006)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro A, 2000, INT J FOOD MICROBIOL, V56, P191, DOI 10.1016/S0168-1605(00)00220-8; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Carvalheiro F, 2007, BIOTECHNOL LETT, V29, P1887, DOI 10.1007/s10529-007-9468-5; Chen X, 2010, INT J BIOL SCI, V6, P834; Conde C, 2007, PLANT CELL PHYSIOL, V48, P42, DOI 10.1093/pcp/pcl035; Cryer D R, 1975, Methods Cell Biol, V12, P39; De Boeck R, 2010, APPL MICROBIOL BIOT, V85, P1915, DOI 10.1007/s00253-009-2260-9; Dusotoit-Coucaud A, 2010, PLANT CELL PHYSIOL, V51, P1878, DOI 10.1093/pcp/pcq151; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferreira C, 2005, MOL BIOL CELL, V16, P2068, DOI 10.1091/mbc.E04-10-0884; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Gao ZF, 2003, PLANT PHYSIOL, V131, P1566, DOI 10.1104/pp.102.016725; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Jin JHQ, 2003, MICROBIOL-SGM, V149, P3371, DOI 10.1099/mic.0.26644-0; Kalliampakou KI, 2011, MOL MEMBR BIOL, V28, P1, DOI 10.3109/09687688.2010.500626; Kayingo G, 2009, MICROBIOL-SGM, V155, P1547, DOI 10.1099/mic.0.023457-0; Klepek YS, 2005, PLANT CELL, V17, P204, DOI 10.1105/tpc.104.026641; Klepek YS, 2010, J EXP BOT, V61, P537, DOI 10.1093/jxb/erp322; KLOPPEL R, 1976, ARCH MICROBIOL, V107, P335, DOI 10.1007/BF00425349; KLOPPEL R, 1976, ARCH MICROBIOL, V107, P329, DOI 10.1007/BF00425348; Koganti S, 2011, APPL MICROBIOL BIOT, V90, P257, DOI 10.1007/s00253-010-3015-3; Kurtzman CP, 1998, YEASTS TAXONOMIC STU, P915; Leandro MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068165; Leandro MJ, 2011, MICROBIOL-SGM, V157, P601, DOI 10.1099/mic.0.044446-0; Leandro MJ, 2009, FEMS YEAST RES, V9, P511, DOI 10.1111/j.1567-1364.2009.00509.x; Leandro MJ, 2006, BIOCHEM J, V395, P543, DOI 10.1042/BJ20051465; Lepingle A, 2000, FEBS LETT, V487, P82, DOI 10.1016/S0014-5793(00)02285-7; LOUREIRODIAS MC, 1987, J GEN MICROBIOL, V133, P2737; LOUREIRODIAS MC, 1984, BIOCHEM J, V222, P293, DOI 10.1042/bj2220293; LOUREIRODIAS MC, 1988, A VAN LEEUW J MICROB, V54, P331, DOI 10.1007/BF00393524; LUCAS C, 1990, YEAST, V6, P187, DOI 10.1002/yea.320060303; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Monedero V, 2010, APPL MICROBIOL BIOT, V86, P1003, DOI 10.1007/s00253-010-2494-6; Mussato S, 2002, BRAZ J PHARM SCI, V38, P401; Niederberger C, 1998, CURR GENET, V33, P255, DOI 10.1007/s002940050334; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; Nobre A, 1999, APPL ENVIRON MICROB, V65, P3594; Noiraud N, 2001, PLANT CELL, V13, P695, DOI 10.1105/tpc.13.3.695; Ostlund RE, 1996, J BIOL CHEM, V271, P10073, DOI 10.1074/jbc.271.17.10073; Palma M, 2007, J MOL MICROB BIOTECH, V12, P241, DOI 10.1159/000099645; Prista C, 1997, APPL ENVIRON MICROB, V63, P4005, DOI 10.1128/AEM.63.10.4005-4009.1997; Saha BC, 2011, APPL MICROBIOL BIOT, V89, P879, DOI 10.1007/s00253-010-2979-3; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos MAS, 2011, CR BIOL, V334, P607, DOI 10.1016/j.crvi.2011.05.008; Schneider S, 2007, PLANT PHYSIOL, V145, P1395, DOI 10.1104/pp.107.109033; Soveral G, 2006, MICROBIOL-SGM, V152, P1515, DOI 10.1099/mic.0.28679-0; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tanghe A, 2002, APPL ENVIRON MICROB, V68, P5981, DOI 10.1128/AEM.68.12.5981-5989.2002; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; VANZYL PJ, 1990, APPL MICROBIOL BIOT, V34, P231, DOI 10.1007/BF00166787; Zaragoza O, 2003, J MICROBIOL METH, V52, P141, DOI 10.1016/S0167-7012(02)00154-9	53	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88180	10.1371/journal.pone.0088180	http://dx.doi.org/10.1371/journal.pone.0088180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505419	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300065
J	Corvino, V; Marchese, E; Podda, MV; Lattanzi, W; Giannetti, S; Di Maria, V; Cocco, S; Grassi, C; Michetti, F; Geloso, MC				Corvino, Valentina; Marchese, Elisa; Podda, Maria Vittoria; Lattanzi, Wanda; Giannetti, Stefano; Di Maria, Valentina; Cocco, Sara; Grassi, Claudio; Michetti, Fabrizio; Geloso, Maria Concetta			The Neurogenic Effects of Exogenous Neuropeptide Y: Early Molecular Events and Long-Lasting Effects in the Hippocampus of Trimethyltin-Treated Rats	PLOS ONE			English	Article							INTRACELLULAR CALCIUM HOMEOSTASIS; NUCLEOTIDE-GATED CHANNELS; NEURAL STEM-CELLS; INDUCED NEURODEGENERATION; SYNAPTIC PLASTICITY; PRIMARY CILIA; ADULT NEUROGENESIS; EXPERIMENTAL-MODEL; GENERATED NEURONS; FUNCTIONAL-ROLE	Modulation of endogenous neurogenesis is regarded as a promising challenge in neuroprotection. In the rat model of hippocampal neurodegeneration obtained by Trimethyltin (TMT) administration (8 mg/kg), characterised by selective pyramidal cell loss, enhanced neurogenesis, seizures and cognitive impairment, we previously demonstrated a proliferative role of exogenous neuropeptide Y (NPY), on dentate progenitors in the early phases of neurodegeneration. To investigate the functional integration of newly-born neurons, here we studied in adult rats the long-term effects of intracerebroventricular administration of NPY (2 mu g/2 mu l, 4 days after TMT-treatment), which plays an adjuvant role in neurodegeneration and epilepsy. Our results indicate that 30 days after NPY administration the number of new neurons was still higher in TMT+NPY-treated rats than in control+saline group. As a functional correlate of the integration of new neurons into the hippocampal network, long-term potentiation recorded in Dentate Gyrus (DG) in the absence of GABA(A) receptor blockade was higher in the TMT+NPY-treated group than in all other groups. Furthermore, qPCR analysis of Kruppel-like factor 9, a transcription factor essential for late-phase maturation of neurons in the DG, and of the cyclin-dependent kinase 5, critically involved in the maturation and dendrite extension of newly-born neurons, revealed a significant up-regulation of both genes in TMT+NPY-treated rats compared with all other groups. To explore the early molecular events activated by NPY administration, the Sonic Hedgehog (Shh) signalling pathway, which participates in the maintenance of the neurogenic hippocampal niche, was evaluated by qPCR 1, 3 and 5 days after NPY-treatment. An early significant up-regulation of Shh expression was detected in TMT+NPY-treated rats compared with all other groups, associated with a modulation of downstream genes. Our data indicate that the neurogenic effect of NPY administration during TMT-induced neurodegeneration involves early Shh pathway activation and results in a functional integration of newly-generated neurons into the local circuit.	[Corvino, Valentina; Marchese, Elisa; Lattanzi, Wanda; Giannetti, Stefano; Di Maria, Valentina; Michetti, Fabrizio; Geloso, Maria Concetta] Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Rome, Italy; [Podda, Maria Vittoria; Cocco, Sara; Grassi, Claudio] Univ Cattolica Sacro Cuore, Inst Human Physiol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Geloso, MC (corresponding author), Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Rome, Italy.	mc.geloso@rm.unicatt.it	COCCO, Sara/S-3742-2019; COCCO, Sara/K-7883-2018; Lattanzi, Wanda/K-5978-2016; Geloso, Maria Concetta/AAV-7884-2021; Grassi, Claudio/C-3188-2017; Podda, Maria V/K-8947-2016	COCCO, Sara/0000-0002-9769-1519; COCCO, Sara/0000-0002-9769-1519; Lattanzi, Wanda/0000-0003-3092-4936; Geloso, Maria Concetta/0000-0002-0622-9813; Grassi, Claudio/0000-0001-7253-1685; Podda, Maria V/0000-0002-2779-8417	Universita' Cattolica del S. Cuore	Universita' Cattolica del S. Cuore	This work was supported by funds from Universita' Cattolica del S. Cuore (D3.2 line) to C. G. and F. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Balu DT, 2009, NEUROSCI BIOBEHAV R, V33, P232, DOI 10.1016/j.neubiorev.2008.08.007; Banerjee SB, 2005, EUR J NEUROSCI, V22, P1570, DOI 10.1111/j.1460-9568.2005.04317.x; Baptista S, 2012, NEUROPHARMACOLOGY, V62, P2413, DOI 10.1016/j.neuropharm.2012.02.015; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Brabeck C, 2002, EXP NEUROL, V177, P341, DOI 10.1006/exnr.2002.7985; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Caria MA, 1996, NEUROREPORT, V7, P2303, DOI 10.1097/00001756-199610020-00007; Corvino V, 2005, BRAIN RES BULL, V65, P471, DOI 10.1016/j.brainresbull.2005.02.031; Corvino V, 2013, NEUROCHEM RES, V38, P240, DOI 10.1007/s11064-012-0932-9; Corvino V, 2012, J NEUROCHEM, V122, P415, DOI 10.1111/j.1471-4159.2012.07770.x; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Decressac M, 2012, EXP NEUROL, V238, P265, DOI 10.1016/j.expneurol.2012.09.004; Decressac M, 2010, EXP NEUROL, V226, P24, DOI 10.1016/j.expneurol.2010.07.022; Decressac M, 2011, HIPPOCAMPUS, V21, P233, DOI 10.1002/hipo.20765; Fang M, 2011, NEUROSCIENCE, V182, P62, DOI 10.1016/j.neuroscience.2011.02.060; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Florea AM, 2005, TOXICOLOGY, V216, P1, DOI 10.1016/j.tox.2005.05.029; Florea AM, 2005, CELL CALCIUM, V37, P251, DOI 10.1016/j.ceca.2004.10.005; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Geloso MC, 2007, NEUROCHEM RES, V32, P2054, DOI 10.1007/s11064-007-9353-6; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Geloso MC, 2004, NEUROSCI LETT, V357, P103, DOI 10.1016/j.neulet.2003.11.076; Geloso MC, 1998, EXP NEUROL, V154, P645, DOI 10.1006/exnr.1998.6949; Geloso MC, 1996, EXP NEUROL, V139, P269, DOI 10.1006/exnr.1996.0100; Geloso MC, 1997, EXP NEUROL, V146, P67, DOI 10.1006/exnr.1997.6491; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gray WP, 2008, MOL CELL ENDOCRINOL, V288, P52, DOI 10.1016/j.mce.2008.02.021; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Harry GJ, 2008, J NEUROCHEM, V106, P281, DOI 10.1111/j.1471-4159.2008.05382.x; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Howell OW, 2007, NEUROBIOL DIS, V26, P174, DOI 10.1016/j.nbd.2006.12.014; Huang SS, 2013, EXP NEUROL, DOI [10.1016/j.expneurol.2013.03.004, DOI 10.1016/J.EXPNEUR0L.2013.03.004]; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishikura N, 2002, NEUROSCI RES, V44, P237, DOI 10.1016/S0168-0102(02)00132-3; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kuruba R, 2009, EPILEPSY BEHAV, V14, P65, DOI 10.1016/j.yebeh.2008.08.020; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Latini L, 2010, J NEUROSCI RES, V88, P500, DOI 10.1002/jnr.22238; Lattanzi W, 2013, INT J MOL SCI, V14, P16817, DOI 10.3390/ijms140816817; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Markakis EA, 1999, J COMP NEUROL, V406, P449; Massa F, 2011, P NATL ACAD SCI USA, V108, P6644, DOI 10.1073/pnas.1016928108; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; Parent J. M., 2012, JASPERS BASIC MECH E; Piacentini R, 2008, J NEUROCHEM, V105, P2109, DOI 10.1111/j.1471-4159.2008.05297.x; Podda MV, 2008, J PHYSIOL-LONDON, V586, P803, DOI 10.1113/jphysiol.2007.146019; Podda MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073246; Podda MV, 2012, GLIA, V60, P1391, DOI 10.1002/glia.22360; Pompili E, 2004, MOL BRAIN RES, V122, P93, DOI 10.1016/j.molbrainres.2003.12.001; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sasai N, 2012, WIRES DEV BIOL, V1, P753, DOI 10.1002/wdev.43; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Smialowska M, 2009, NEUROPEPTIDES, V43, P235, DOI 10.1016/j.npep.2009.02.002; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; Suwelack D, 2004, GENE THER, V11, P1742, DOI 10.1038/sj.gt.3302377; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Tsunashima K, 1998, SYNAPSE, V29, P333; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vezzani A, 2004, NEUROPEPTIDES, V38, P245, DOI 10.1016/j.npep.2004.05.004; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang F, 2008, HIPPOCAMPUS, V18, P460, DOI 10.1002/hipo.20409	77	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88294	10.1371/journal.pone.0088294	http://dx.doi.org/10.1371/journal.pone.0088294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516629	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400052
J	Chaudhury, A; Cristofaro, V; Carew, JA; Goyal, RK; Sullivan, MP				Chaudhury, Arun; Cristofaro, Vivian; Carew, Josephine A.; Goyal, Raj K.; Sullivan, Maryrose P.			Myosin Va Plays a Role in Nitrergic Smooth Muscle Relaxation in Gastric Fundus and Corpora Cavernosa of Penis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INHIBITORY NEUROTRANSMISSION; ERECTILE DYSFUNCTION; PROTEIN INHIBITOR; MOUSE STRAINS; KNOCKOUT MICE; NEURONAL NOS; NNOS-ALPHA; RAT; EXPRESSION	The intracellular motor protein myosin Va is involved in nitrergic neurotransmission possibly by trafficking of neuronal nitric oxide synthase (nNOS) within the nerve terminals. In this study, we examined the role of myosin Va in the stomach and penis, proto-typical smooth muscle organs in which nitric oxide (NO) mediated relaxation is critical for function. We used confocal microscopy and co-immunoprecipitation of tissue from the gastric fundus (GF) and penile corpus cavernosum (CCP) to localize myosin Va with nNOS and demonstrate their molecular interaction. We utilized in vitro mechanical studies to test whether smooth muscle relaxations during nitrergic neuromuscular neurotransmission is altered in DBA (dilute, brown, non-agouti) mice which lack functional myosin Va. Myosin Va was localized in nNOS-positive nerve terminals and was co-immunoprecipitated with nNOS in both GF and CCP. In comparison to C57BL/6J wild type (WT) mice, electrical field stimulation (EFS) of precontracted smooth muscles of GF and CCP from DBA animals showed significant impairment of nitrergic relaxation. An NO donor, Sodium nitroprusside (SNP), caused comparable levels of relaxation in smooth muscles of WT and DBA mice. These normal postjunctional responses to SNP in DBA tissues suggest that impairment of smooth muscle relaxation resulted from inhibition of NO synthesis in prejunctional nerve terminals. Our results suggest that normal physiological processes of relaxation of gastric and cavernosal smooth muscles that facilitate food accommodation and penile erection, respectively, may be disrupted under conditions of myosin Va deficiency, resulting in complications like gastroparesis and erectile dysfunction.	[Chaudhury, Arun] VA Boston Healthcare Syst, Div Surg, Boston, MA USA; [Chaudhury, Arun; Cristofaro, Vivian; Carew, Josephine A.; Goyal, Raj K.; Sullivan, Maryrose P.] Harvard Univ, Sch Med, Boston, MA USA; [Cristofaro, Vivian; Sullivan, Maryrose P.] VA Boston Healthcare Syst, Div Urol, Boston, MA 02130 USA; [Carew, Josephine A.; Goyal, Raj K.] VA Boston Healthcare Syst, Div Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Sullivan, MP (corresponding author), VA Boston Healthcare Syst, Div Urol, Boston, MA 02130 USA.	msullivan@rics.bwh.harvard.edu			Public Health Service [DK062867]; Medical Research Service, Department of Veterans Affairs, Washington, D.C. [BX001790]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062867] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002806, I01BX001790] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Medical Research Service, Department of Veterans Affairs, Washington, D.C.(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by a Public Health Service grant (DK062867, RKG) and Medical Research Service, Department of Veterans Affairs, Washington, D.C. (BX001790, MPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chaudhury A, 2008, AM J PHYSIOL-GASTR L, V295, pG442, DOI 10.1152/ajpgi.90280.2008; Chaudhury A, 2011, AM J PHYSIOL-GASTR L, V301, pG498, DOI 10.1152/ajpgi.00164.2011; Chaudhury A, 2009, AM J PHYSIOL-GASTR L, V297, pG806, DOI 10.1152/ajpgi.00279.2009; da Costa AV, 2011, METAB BRAIN DIS, V26, P247, DOI 10.1007/s11011-011-9259-5; Dean RC, 2005, UROL CLIN N AM, V32, P379, DOI 10.1016/j.ucl.2005.08.007; Gangula PRR, 2007, AM J PHYSIOL-GASTR L, V292, pG725, DOI 10.1152/ajpgi.00406.2006; Gil V, 2013, NEUROGASTROENT MOTIL, V25, pE170, DOI 10.1111/nmo.12060; Gonzalez-Cadavid NF, 2000, BIOL REPROD, V63, P704, DOI 10.1095/biolreprod63.3.704; Goyal RK, 2010, GASTROENTEROLOGY, V139, P1086, DOI 10.1053/j.gastro.2010.08.013; Grover M, 2011, GASTROENTEROLOGY, V140, P1575, DOI 10.1053/j.gastro.2011.01.046; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; JENKINS NA, 1981, NATURE, V293, P370, DOI 10.1038/293370a0; Jung AP, 2010, MED SCI SPORT EXER, V42, P1826, DOI 10.1249/MSS.0b013e3181daf5e8; Kim CD, 1999, AM J PHYSIOL-GASTR L, V277, pG280, DOI 10.1152/ajpgi.1999.277.2.G280; KIM N, 1991, J CLIN INVEST, V88, P112, DOI 10.1172/JCI115266; Lajoix AD, 2006, DIABETES, V55, P3279, DOI 10.2337/db06-0257; LEFEBVRE RA, 1995, ANN MED, V27, P379, DOI 10.3109/07853899509002591; Magee T, 1996, BIOCHEM BIOPH RES CO, V226, P145, DOI 10.1006/bbrc.1996.1324; Magee TR, 2003, BIOL REPROD, V68, P478, DOI 10.1095/biolreprod.102.007310; Mashimo H, 2000, GASTROENTEROLOGY, V119, P766, DOI 10.1053/gast.2000.16509; Mashimo H, 1996, J CLIN INVEST, V98, P8, DOI 10.1172/JCI118781; MCGILL TE, 1967, ANAT REC, V157, P151, DOI 10.1002/ar.1091570205; Mukhopadhyay S, 2011, FREE RADICAL BIO MED, V51, P619, DOI 10.1016/j.freeradbiomed.2011.04.044; Mule F, 2003, BRIT J PHARMACOL, V140, P431, DOI 10.1038/sj.bjp.0705431; Musicki B, 2006, EXP BIOL MED, V231, P154; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Roszer T, 2012, BIOL SUBCELLULAR NIT, P105; Sanchez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036027; SEPERACK PK, 1995, EMBO J, V14, P2326, DOI 10.1002/j.1460-2075.1995.tb07227.x; Takahashi T, 2003, J GASTROENTEROL, V38, P421, DOI 10.1007/s00535-003-1094-y; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Toda N, 2005, PHARMACOL THERAPEUT, V106, P233, DOI 10.1016/j.pharmthera.2004.11.011; Tsai PP, 2003, LAB ANIM-UK, V37, P314, DOI 10.1258/002367703322389889; Villanueva C, 2010, FREE RADICAL BIO MED, V49, P307, DOI 10.1016/j.freeradbiomed.2010.04.004	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86778	10.1371/journal.pone.0086778	http://dx.doi.org/10.1371/journal.pone.0086778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516539	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700014
J	Crowther, GS; Chilton, CH; Todhunter, SL; Nicholson, S; Freeman, J; Baines, SD; Wilcox, MH				Crowther, Grace S.; Chilton, Caroline H.; Todhunter, Sharie L.; Nicholson, Scott; Freeman, Jane; Baines, Simon D.; Wilcox, Mark H.			Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota	PLOS ONE			English	Article							CONTINUOUS-CULTURE SYSTEM; IN-VITRO; TOXIN PRODUCTION; HUMAN-COLON; PSEUDOMONAS-AERUGINOSA; BACTERIAL-POPULATIONS; INFECTION; VANCOMYCIN; PROLIFERATION; RIBOTYPE-027	The human gastrointestinal tract harbours a complex microbial community which exist in planktonic and sessile form. The degree to which composition and function of faecal and mucosal microbiota differ remains unclear. We describe the development and characterisation of an in vitro human gut model, which can be used to facilitate the formation and longitudinal analysis of mature mixed species biofilms. This enables the investigation of the role of biofilms in Clostridium difficile infection (CDI). A well established and validated human gut model of simulated CDI was adapted to incorporate glass rods that create a solid-gaseous-liquid interface for biofilm formation. The continuous chemostat model was inoculated with a pooled human faecal emulsion and controlled to mimic colonic conditions in vivo. Planktonic and sessile bacterial populations were enumerated for up to 46 days. Biofilm consistently formed macroscopic structures on all glass rods over extended periods of time, providing a framework to sample and analyse biofilm structures independently. Whilst variation in biofilm biomass is evident between rods, populations of sessile bacterial groups (log(10) cfu/g of biofilm) remain relatively consistent between rods at each sampling point. All bacterial groups enumerated within the planktonic communities were also present within biofilm structures. The planktonic mode of growth of C. difficile and gut microbiota closely reflected observations within the original gut model. However, distinct differences were observed in the behaviour of sessile and planktonic C. difficile populations, with C. difficile spores preferentially persisting within biofilm structures. The redesigned biofilm chemostat model has been validated for reproducible and consistent formation of mixed species intestinal biofilms. This model can be utilised for the analysis of sessile mixed species communities longitudinally, potentially providing information of the role of biofilms in CDI.	[Crowther, Grace S.; Chilton, Caroline H.; Todhunter, Sharie L.; Wilcox, Mark H.] Univ Leeds, Fac Med & Hlth, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Freeman, Jane; Wilcox, Mark H.] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England; [Baines, Simon D.] Univ Hertfordshire, Dept Human & Environm Sci, Sch Life & Med Sci, Hatfield AL10 9AB, Herts, England; [Nicholson, Scott] Univ W Scotland, Sch Sci, Hamilton, Scotland	University of Leeds; University of Leeds; University of Hertfordshire; University of West Scotland	Wilcox, MH (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.	mark.wilcox@leedsth.nhs.uk		Freeman, Jane/0000-0001-9580-4586	Novacta Biosystems; Astellas; Bayer; Wyeth; Targenta Therapeutics; AstraZeneca; bioMerieux; Ceraxa; Nabriva; Novacta; Pfizer; Summit; The Medicines Company; Viropharma	Novacta Biosystems; Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Wyeth(Wyeth); Targenta Therapeutics; AstraZeneca(AstraZeneca); bioMerieux; Ceraxa; Nabriva; Novacta; Pfizer(Pfizer); Summit; The Medicines Company; Viropharma	GSC has recieved finanical support to attend meetings from Novacta Biosystems. CHC has recieved financial support to attend meetings from Astellas. JF has received financial support to attend meetings from Bayer and Wyeth. SDB has received financial support to attend meetings from Bayer and Targenta Therapeutics. MHW has received honoraria consultancy work, financial support to attend meetings and research funding from Astellas, AstraZeneca, Bayer, bioMerieux, Ceraxa, Nabriva, Novacta, Pfizer, Summit, The Medicines Company and Viropharma. SLT and SN, none to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Baines SD, 2005, J ANTIMICROB CHEMOTH, V55, P974, DOI 10.1093/jac/dki120; Baines SD, 2006, USE TRIPLE STAGE CHE; Baines SD, 2013, J ANTIMICROB CHEMOTH; Baines SD, 2008, J ANTIMICROB CHEMOTH, V62, P1078, DOI 10.1093/jac/dkn358; Baines SD, 2006, J ANTIMICROB CHEMOTH, V58, P1062, DOI 10.1093/jac/dkl364; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P838, DOI 10.1093/jac/dkp017; Barbut F, 2000, J CLIN MICROBIOL, V38, P2386; Bauer MP, 2009, CLIN MICROBIOL INFEC, V15, P1067, DOI 10.1111/j.1469-0691.2009.03099.x; Bjarnsholt T, 2013, APMIS, V121, P1, DOI 10.1111/apm.12099; Chilton CH, 2012, J ANTIMICROB CHEMOTH, V67, P2434, DOI 10.1093/jac/dks243; Chilton CH, 2013, J ANTIMICROB CHEMOTH; CROUCHER SC, 1983, APPL ENVIRON MICROB, V45, P1025, DOI 10.1128/AEM.45.3.1025-1033.1983; Crowther GS, 2013, J ANTIMICROB CHEMOTH, V68, P168, DOI 10.1093/jac/dks359; Dawson LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050527; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDMISTON CE, 1982, APPL ENVIRON MICROB, V43, P1173, DOI 10.1128/AEM.43.5.1173-1181.1982; Ethapa T, 2012, J BACTERIOLOGY; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Freeman J, 2005, J ANTIMICROB CHEMOTH, V56, P717, DOI 10.1093/jac/dki321; Freeman J, 2003, J ANTIMICROB CHEMOTH, V52, P96, DOI 10.1093/jac/dkg267; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Gibson HMPaGR, 2004, BIOFILMS, V1, P13; Gjaltema A, 1997, BIOTECHNOL BIOENG, V55, P880, DOI 10.1002/(SICI)1097-0290(19970920)55:6<880::AID-BIT6>3.0.CO;2-C; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; HEIJNEN JJ, 1992, WATER SCI TECHNOL, V26, P647, DOI 10.2166/wst.1992.0445; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Macfarlane S, 2005, APPL ENVIRON MICROB, V71, P7483, DOI 10.1128/AEM.71.11.7483-7492.2005; Owens RC, 2008, CLIN INFECT DIS, V46, pS19, DOI 10.1086/521859; Probert H M, 2002, Curr Issues Intest Microbiol, V3, P23; Richards M, 2011, MED J AUSTRALIA, V194, P369, DOI 10.5694/j.1326-5377.2011.tb03012.x; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; STANLEY PM, 1983, CAN J MICROBIOL, V29, P1493, DOI 10.1139/m83-230; Stoodley P, 1999, J APPL MICROBIOL, V85, p19S, DOI 10.1111/j.1365-2672.1998.tb05279.x; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; van der Waaij LA, 2005, INFLAMM BOWEL DIS, V11, P865, DOI 10.1097/01.mib.0000179212.80778.d3; van der Waal SV, 2011, INT ENDOD J, V44, P1110, DOI 10.1111/j.1365-2591.2011.01929.x; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Wheeldon LJ, 2008, J APPL MICROBIOL, V105, P2223, DOI 10.1111/j.1365-2672.2008.03965.x; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	42	33	33	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88396	10.1371/journal.pone.0088396	http://dx.doi.org/10.1371/journal.pone.0088396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516647	Green Published, gold			2022-12-27	WOS:000330830700067
J	Sievers, C; Comoglio, F; Seimiya, M; Merdes, G; Paro, R				Sievers, Cem; Comoglio, Federico; Seimiya, Makiko; Merdes, Gunter; Paro, Renato			A Deterministic Analysis of Genome Integrity during Neoplastic Growth in Drosophila	PLOS ONE			English	Article							PAIRED-END; STRUCTURAL VARIATION; MELANOGASTER; SEQUENCE; SINGLE; DISCOVERY; DNA; CONSTRAINTS; BREAKPOINTS; EPIGENETICS	The development of cancer has been associated with the gradual acquisition of genetic alterations leading to a progressive increase in malignancy. In various cancer types this process is enabled and accelerated by genome instability. While genome sequencing-based analysis of tumor genomes becomes increasingly a standard procedure in human cancer research, the potential necessity of genome instability for tumorigenesis in Drosophila melanogaster has, to our knowledge, never been determined at DNA sequence level. Therefore, we induced formation of tumors by depletion of the Drosophila tumor suppressor Polyhomeotic and subjected them to genome sequencing. To achieve a highly resolved delineation of the genome structure we developed the Deterministic Structural Variation Detection (DSVD) algorithm, which identifies structural variations (SVs) with high accuracy and at single base resolution. The employment of long overlapping paired-end reads enables DSVD to perform a deterministic, i.e. fragment size distribution independent, identification of a large size spectrum of SVs. Application of DSVD and other algorithms to our sequencing data reveals substantial genetic variation with respect to the reference genome reflecting temporal separation of the reference and laboratory strains. The majority of SVs, constituted by small insertions/deletions, is potentially caused by erroneous replication or transposition of mobile elements. Nevertheless, the tumor did not depict a loss of genome integrity compared to the control. Altogether, our results demonstrate that genome stability is not affected inevitably during sustained tumor growth in Drosophila implying that tumorigenesis, in this model organism, can occur irrespective of genome instability and the accumulation of specific genetic alterations.	[Sievers, Cem; Comoglio, Federico; Seimiya, Makiko; Merdes, Gunter; Paro, Renato] Swiss Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, Basel, Switzerland; [Paro, Renato] Univ Basel, Fac Sci, Basel, Switzerland	University of Basel	Merdes, G (corresponding author), Swiss Fed Inst Technol Zurich, Dept Biosyst Sci & Engn, Basel, Switzerland.	gunter.merdes@bsse.ethz.ch; renato.paro@bsse.ethz.ch		Comoglio, Federico/0000-0002-8970-6610	Swiss National Science Foundation; Novartis Foundation for Medical Biological Research; Krebsliga Schweiz and ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Krebsliga Schweiz and ETH Zurich	This research has been funded by contributions from the Swiss National Science Foundation and the Novartis Foundation for Medical Biological Research (to G.M.), and the Krebsliga Schweiz and ETH Zurich (to R.P. and G. M.). F.C. is a member of the Life Science Zurich Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, BIOINFORMATICS, V27, P595, DOI 10.1093/bioinformatics/btq713; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Beerenwinkel N, 2007, PLOS COMPUT BIOL, V3, P2239, DOI 10.1371/journal.pcbi.0030225; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Brumby AM, 2008, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0020862, DOI 10.1002/9780470015902.A0020862]; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Dekanty A, 2012, P NATL ACAD SCI USA, V109, P20549, DOI 10.1073/pnas.1206675109; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emde AK, 2012, BIOINFORMATICS, V28, P619, DOI 10.1093/bioinformatics/bts019; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Geissler K, 2012, ANN HEMATOL, V91, P645, DOI 10.1007/s00277-012-1435-0; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; GRIFFITHS AJ, 2008, INTRO GENETIC ANAL; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Korbel JO, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r23; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Marschall T, 2012, BIOINFORMATICS, V28, P2875, DOI 10.1093/bioinformatics/bts566; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; Miles WO, 2011, DIS MODEL MECH, V4, P753, DOI 10.1242/dmm.006908; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; Ogurtsov AY, 2004, GENOME RES, V14, P1610, DOI 10.1101/gr.2450504; Ometto L, 2005, GENETICS, V169, P1521, DOI 10.1534/genetics.104.037689; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Sievers C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks697; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tsai HC, 2011, CELL RES, V21, P502, DOI 10.1038/cr.2011.24; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zichner T, 2013, GENOME RES, V23, P568, DOI 10.1101/gr.142646.112	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87090	10.1371/journal.pone.0087090	http://dx.doi.org/10.1371/journal.pone.0087090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516544	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700019
J	Szigeti, A; Tatrai, E; Szamosi, A; Vargha, P; Nagy, ZZ; Nemeth, J; DeBuc, DC; Somfai, GM				Szigeti, Andrea; Tatrai, Erika; Szamosi, Anna; Vargha, Peter; Nagy, Zoltan Zsolt; Nemeth, Janos; DeBuc, Delia Cabrera; Somfai, Gabor Mark			A Morphological Study of Retinal Changes in Unilateral Amblyopia Using Optical Coherence Tomography Image Segmentation	PLOS ONE			English	Article							NERVE-FIBER LAYER; LATERAL GENICULATE-NUCLEUS; INNER PLEXIFORM LAYER; MACULAR THICKNESS; POSTNATAL-DEVELOPMENT; STRABISMIC AMBLYOPIA; VISUAL DEPRIVATION; GANGLION-CELLS; AXIAL LENGTH; EYES	Objective: The purpose of this study was to evaluate the possible structural changes of the macula in patients with unilateral amblyopia using optical coherence tomography (OCT) image segmentation. Patients and Methods: 38 consecutive patients (16 male; mean age 32.4 +/- 17.6 years; range 6-67 years) with unilateral amblyopia were involved in this study. OCT examinations were performed with a time-domain OCT device, and a custom-built OCT image analysis software (OCTRIMA) was used for OCT image segmentation. The axial length (AL) was measured by a LenStar LS 900 device. Macular layer thickness, AL and manifest spherical equivalent refraction (MRSE) of the amblyopic eye were compared to that of the fellow eye. We studied if the type of amblyopia (strabismus without anisometropia, anisometropia without strabismus, strabismus with anisometropia) had any influence on macular layer thickness values. Results: There was significant difference between the amblyopic and fellow eyes in MRSE and AL in all subgroups. Comparing the amblyopic and fellow eyes, we found a statistically significant difference only in the thickness of the outer nuclear layer in the central region using linear mixed model analysis keeping AL and age under control (p = 0.032). There was no significant difference in interocular difference in the thickness of any macular layers between the subgroups with one-way between-groups ANCOVA while statistically controlling for interocular difference in AL and age. Conclusions: According to our results there are subtle changes in amblyopic eyes affecting the outer nuclear layer of the fovea suggesting the possible involvement of the photoreceptors. However, further studies are warranted to support this hypothesis.	[Szigeti, Andrea; Tatrai, Erika; Szamosi, Anna; Nagy, Zoltan Zsolt; Nemeth, Janos; Somfai, Gabor Mark] Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary; [Vargha, Peter] Semmelweis Univ, Cardiovasc Ctr, H-1085 Budapest, Hungary; [DeBuc, Delia Cabrera] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Semmelweis University; Semmelweis University; Bascom Palmer Eye Institute; University of Miami	Szigeti, A (corresponding author), Semmelweis Univ, Dept Ophthalmol, H-1085 Budapest, Hungary.	szigandi@gmail.com	Nagy, Zoltan Zsolt/T-6180-2017	Nemeth, Janos/0000-0001-8575-4888; Cabrera DeBuc, Delia/0000-0002-4726-894X; Somfai, Gabor Mark/0000-0001-6329-442X	National Institutes of Health (NIH) center core grant [P30-EY014801]; Research to Prevent Blindness, Inc.; Hungarian Academy of Sciences; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health (NIH) center core grant; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by a National Institutes of Health (NIH) center core grant P30-EY014801, by an unrestricted grant to the University of Miami from Research to Prevent Blindness, Inc. and by the Zsigmond Diabetes Fund of the Hungarian Academy of Sciences. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad CE, 2011, BRIT J OPHTHALMOL, V95, P1696, DOI 10.1136/bjo.2010.195081; Al-Haddad CE, 2013, BRIT J OPHTHALMOL, V97, P318, DOI 10.1136/bjophthalmol-2012-302434; Alamouti B, 2003, BRIT J OPHTHALMOL, V87, P899, DOI 10.1136/bjo.87.7.899; Alotaibi AG, 2011, SAUDI J OPHTHALMOL, V25, P405, DOI 10.1016/j.sjopt.2011.06.001; Altintas O, 2005, J PEDIAT OPHTH STRAB, V42, P216; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; ARDEN GB, 1985, INVEST OPHTH VIS SCI, V26, P88; Banko EM, 2013, CORTEX, V49, P1013, DOI 10.1016/j.cortex.2012.03.021; BEDELL HE, 1980, INVEST OPHTH VIS SCI, V19, P49; CAMPOS EC, 1995, GRAEF ARCH CLIN EXP, V233, P307, DOI 10.1007/BF00177654; CHOW KL, 1955, J COMP NEUROL, V102, P597, DOI 10.1002/cne.901020303; CHOW KL, 1957, J COMP NEUROL, V107, P27, DOI 10.1002/cne.901070103; Colen T P, 2000, Binocul Vis Strabismus Q, V15, P141; Debuc DC, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3470116; DeBuc DC, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268773; Delint PJ, 1998, VISION RES, V38, P613, DOI 10.1016/S0042-6989(97)00191-0; Dickmann A, 2012, J AAPOS, V16, P86, DOI 10.1016/j.jaapos.2011.09.011; Dickmann A, 2011, J AAPOS, V15, P338, DOI 10.1016/j.jaapos.2011.03.019; Dickmann A, 2009, J AAPOS, V13, P148, DOI 10.1016/j.jaapos.2008.10.009; ENOCH JM, 1959, AM J OPHTHALMOL, V48, P262, DOI 10.1016/0002-9394(59)90267-3; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; FIFKOVA E, 1972, EXP NEUROL, V35, P458, DOI 10.1016/0014-4886(72)90116-1; FLYNN JT, 1991, J PEDIATR OPHTHALMOL, V28, P183; France TD, 2006, AM ORTHOPT J, V56, P7; GRAHAM PA, 1974, BRIT J OPHTHALMOL, V58, P224, DOI 10.1136/bjo.58.3.224; Hatef E, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/354783; HEADON MP, 1973, J ANAT, V116, P135; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; Kashani AH, 2010, AM J OPHTHALMOL, V149, P496, DOI 10.1016/j.ajo.2009.09.025; Kee Se-Young, 2006, Korean J Ophthalmol, V20, P177; Kelty PJ, 2008, INVEST OPHTH VIS SCI, V49, P2668, DOI 10.1167/iovs.07-1000; Kiorpes L, 1999, CURR OPIN NEUROBIOL, V9, P480, DOI 10.1016/S0959-4388(99)80072-5; Knighton RW, 2000, J GLAUCOMA, V9, P56; Leone Josie, 2008, Binocul Vis Strabismus Q, V23, P227; Massin P, 2001, ARCH OPHTHALMOL-CHIC, V119, P1135, DOI 10.1001/archopht.119.8.1135; Noorden G K, 1977, Adv Ophthalmol, V34, P93; Pang Y, 2011, INVEST OPHTH VIS SCI, V52, P2444, DOI 10.1167/iovs.10-5550; Park KA, 2011, BRIT J OPHTHALMOL, V95, P1700, DOI 10.1136/bjo.2010.192765; RASCH E, 1961, EXP CELL RES, V25, P348, DOI 10.1016/0014-4827(61)90285-3; Repka MX, 2006, AM J OPHTHALMOL, V142, P247, DOI 10.1016/j.ajo.2006.02.030; Repka MX, 2009, AM J OPHTHALMOL, V148, P143, DOI 10.1016/j.ajo.2009.01.015; Roper-Hall G., 2007, AM ORTHOP J, V57, P2, DOI [10.3368/aoj.57.1.2, DOI 10.3368/AOJ.57.1.2]; SHERMAN SM, 1975, J COMP NEUROL, V161, P183, DOI 10.1002/cne.901610204; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; Tatrai E, 2012, ARVO M, V53, P4102; Tatrai E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3573817; Tugcu B, 2013, CURR EYE RES, V38, P802, DOI 10.3109/02713683.2013.779721; von Noorden G K, 1973, Invest Ophthalmol, V12, P727; VONNOORDEN GK, 1977, BRAIN RES, V122, P437, DOI 10.1016/0006-8993(77)90455-3; VONNOORDEN GK, 1983, INVEST OPHTH VIS SCI, V24, P788; VONNOORDEN GK, 1992, INVEST OPHTH VIS SCI, V33, P2729; Walker RA, 2011, CAN J OPHTHALMOL, V46, P425, DOI 10.1016/j.jcjo.2011.07.013; WEISKRANTZ L, 1958, NATURE, V181, P1047, DOI 10.1038/1811047b0; WENDELLSMITH CP, 1964, NATURE, V204, P707, DOI 10.1038/204707a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WILLIAMS C, 1995, BRIT J OPHTHALMOL, V79, P218, DOI 10.1136/bjo.79.3.218; Wong ACM, 2005, EYE, V19, P292, DOI 10.1038/sj.eye.6701466; Yen MY, 2004, INVEST OPHTH VIS SCI, V45, P2224, DOI 10.1167/iovs.03-0297; Yoon Sang Won, 2005, Korean J Ophthalmol, V19, P62	60	16	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88363	10.1371/journal.pone.0088363	http://dx.doi.org/10.1371/journal.pone.0088363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516641	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700064
J	Zhang, XW; Wang, YS; Qian, YF; Wu, X; Zhang, ZJ; Liu, XJ; Zhao, R; Zhou, L; Ruan, YY; Xu, JJ; Liu, HO; Ren, SF; Xu, CJ; Gu, JX				Zhang, Xingwang; Wang, Yisheng; Qian, Yifan; Wu, Xin; Zhang, Zejian; Liu, Xijun; Zhao, Ran; Zhou, Lei; Ruan, Yuanyuan; Xu, Jiejie; Liu, Haiou; Ren, Shifang; Xu, Congjian; Gu, Jianxin			Discovery of Specific Metastasis-Related N-Glycan Alterations in Epithelial Ovarian Cancer Based on Quantitative Glycomics	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ACETYLGLUCOSAMINYLTRANSFERASE-III; BISECTING GLCNAC; CELL-ADHESION; GLYCOSYLATION; EXPRESSION; PROMOTES; BINDING; SUPPRESSION; PROTEINS	Generally, most of ovarian cancer cannot be detected until large scale and remote metastasis occurs, which is the major cause of high mortality in ovarian cancer. Therefore, it is urgent to discover metastasis-related biomarkers for the detection of ovarian cancer in its occult metastasis stage. Altered glycosylation is a universal feature of malignancy and certain types of glycan structures are well-known markers for tumor progressions. Thus, this study aimed to reveal specific changes of N-glycans in the secretome of the metastatic ovarian cancer. We employed a quantitative glycomics approach based on metabolic stable isotope labeling to compare the differential N-glycosylation of secretome between an ovarian cancer cell line SKOV3 and its high metastatic derivative SKOV3-ip. Intriguingly, among total 17 N-glycans identified, the N-glycans with bisecting GlcNAc were all significantly decreased in SKOV3-ip in comparison to SKOV3. This alteration in bisecting GlcNAc glycoforms as well as its corresponding association with ovarian cancer metastatic behavior was further validated at the glycotransferase level with multiple techniques including real-time PCR, western blotting, transwell assay, lectin blotting and immunohistochemistry analysis. This study illustrated metastasis-related N-glycan alterations in ovarian cancer secretome in vitro for the first time, which is a valuable source for biomarker discovery as well. Moreover, N-glycans with bisecting GlcNAc shed light on the detection of ovarian cancer in early peritoneal metastasis stage which may accordingly improve the prognosis of ovarian cancer patients.	[Zhang, Xingwang; Qian, Yifan; Zhang, Zejian; Liu, Xijun; Zhou, Lei; Ruan, Yuanyuan; Xu, Jiejie; Liu, Haiou; Ren, Shifang; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Yisheng; Wu, Xin; Xu, Congjian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Xu, Congjian] Fudan Univ, Dept Obstet & Gynecol, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Zhao, Ran; Xu, Congjian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xu, Congjian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Ren, SF (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res,Minist Publ Hlth, Shanghai 200433, Peoples R China.	renshifang@fudan.edu.cn; xucongjian@gmail.com	Zhang, Zejian/GQG-9538-2022; Zhang, Zejian/GQG-9492-2022	Liu, Xijun/0000-0002-5712-9142	National Basic Research Program of China (973 Program) [2012CB8221004, 2013CB910503]; National High-tech R&D Program (863 Program) [2012AA020203]; National natural science fund [31100586, 31010103906, 30930025, 31170766, 81272879, 81302258]; Shanghai Leading Academic Discipline Project [B117]; Shanghai fundamental research emphasis project [11JC1401502]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National natural science fund(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai fundamental research emphasis project	This work was supported by grants from National Basic Research Program of China (973 Program) (2012CB8221004, 2013CB910503), National High-tech R&D Program (863 Program) (2012AA020203) and National natural science fund (31100586, 31010103906, 30930025, 31170766, 81272879, 81302258), the Shanghai Leading Academic Discipline Project (B117), and Shanghai fundamental research emphasis project (11JC1401502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2010, CANCER BIOMARK, V8, P273, DOI 10.3233/CBM-2011-0218; Abbott KL, 2010, PROTEOMICS, V10, P470, DOI 10.1002/pmic.200900537; Aletti GD, 2007, MAYO CLIN PROC, V82, P751; Alley WR, 2012, J PROTEOME RES, V11, P2282, DOI 10.1021/pr201070k; Atwood JA, 2008, J PROTEOME RES, V7, P367, DOI 10.1021/pr070476i; Boersema PJ, 2013, MOL CELL PROTEOMICS, V12, P158, DOI 10.1074/mcp.M112.023614; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Casey RC, 2003, CLIN EXP METASTAS, V20, P143, DOI 10.1023/A:1022670501667; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dennis JW, 1999, BIOESSAYS, V21, P412, DOI 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5; Doig T, 2006, INT J GYNECOL CANCER, V16, P36, DOI 10.1111/j.1525-1438.2006.00273.x; Dowling P, 2011, PROTEOMICS, V11, P794, DOI 10.1002/pmic.201000530; Fang Meng, 2010, Curr Protoc Chem Biol, V2, P55; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Granovsky M, 2000, NAT MED, V6, P306; Gu JG, 2004, GLYCOBIOLOGY, V14, P177, DOI 10.1093/glycob/cwh016; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo R, 2013, INT J BIOCHEM CELL B, V45, P347, DOI 10.1016/j.biocel.2012.10.006; Hakomori SI, 2012, GLYCOCONJUGATE J, V29, P565, DOI 10.1007/s10719-012-9448-4; Handerson T, 2005, CLIN CANCER RES, V11, P2969, DOI 10.1158/1078-0432.CCR-04-2211; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; He YF, 2010, J PROTEOME RES, V9, P6180, DOI 10.1021/pr100822v; Hu YL, 2013, RAPID COMMUN MASS SP, V27, P865, DOI 10.1002/rcm.6512; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Kameyama A, 2005, ANAL CHEM, V77, P4719, DOI 10.1021/ac048350h; Kang XN, 2012, EXP THER MED, V3, P415, DOI 10.3892/etm.2011.430; Kannagi R, 2004, TRENDS GLYCOSCI GLYC, V16, P211, DOI 10.4052/tigg.16.211; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Ma SQ, 2003, CHINESE MED J-PEKING, V116, P396; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Meany Danni L, 2011, Clin Proteomics, V8, P7, DOI 10.1186/1559-0275-8-7; Mechref Y, 2013, MOL CELL PROTEOMICS, V12, P874, DOI 10.1074/mcp.R112.026310; Miwa HE, 2012, GLYCOCONJUGATE J, V29, P609, DOI 10.1007/s10719-012-9373-6; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Orlando Ron, 2013, Methods Mol Biol, V951, P197, DOI 10.1007/978-1-62703-146-2_13; Orlando R, 2009, J PROTEOME RES, V8, P3816, DOI 10.1021/pr8010028; Ozols RF, 2004, CANCER CELL, V5, P19, DOI 10.1016/S1535-6108(04)00002-9; Pavlou MP, 2010, J PROTEOMICS, V73, P1896, DOI 10.1016/j.jprot.2010.04.003; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Pochec E, 2003, BBA-MOL CELL RES, V1643, P113, DOI 10.1016/j.bbamcr.2003.10.004; Qian YF, 2012, GLYCOCONJUGATE J, V29, P399, DOI 10.1007/s10719-012-9408-z; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Schachter H, 1986, Adv Exp Med Biol, V205, P53; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song YH, 2010, CANCER RES, V70, P3361, DOI 10.1158/0008-5472.CAN-09-2719; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Tetsche MS, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-31; Torres José Carlos Campos, 2002, Sao Paulo Med. J., V120, P72, DOI 10.1590/S1516-31802002000300003; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilken JA, 2012, FUTURE MED CHEM, V4, P447, DOI [10.4155/fmc.12.11, 10.4155/FMC.12.11]; Woodward ER, 2007, BJOG-INT J OBSTET GY, V114, P1500, DOI 10.1111/j.1471-0528.2007.01499.x; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Wu WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029920; Yoshimura M, 1996, CANCER RES, V56, P412; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; YU DH, 1993, CANCER RES, V53, P891; Yue TT, 2009, MOL CELL PROTEOMICS, V8, P1697, DOI 10.1074/mcp.M900135-MCP200; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhang W, 2011, ANAL CHEM, V83, P4975, DOI 10.1021/ac200753e; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	80	24	25	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87978	10.1371/journal.pone.0087978	http://dx.doi.org/10.1371/journal.pone.0087978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516574	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700035
J	Kruger, NJ; Buhler, C; Iwobi, AN; Huber, I; Ellerbroek, L; Appel, B; Stingl, K				Krueger, Nora-Johanna; Buhler, Christiane; Iwobi, Azuka N.; Huber, Ingrid; Ellerbroek, Lueppo; Appel, Bernd; Stingl, Kerstin			"Limits of Control" - Crucial Parameters for a Reliable Quantification of Viable Campylobacter by Real-Time PCR	PLOS ONE			English	Article							ETHIDIUM MONOAZIDE; PROPIDIUM MONOAZIDE; SELECTIVE DETECTION; DEAD CAMPYLOBACTER; CHICKEN CARCASSES; CELLS; LIVE; DIFFERENTIATION; COMBINATION; BACTERIA	The unsuitability of the "CFU" parameter and the usefulness of cultivation-independent quantification of Campylobacter on chicken products, reflecting the actual risk for infection, is increasingly becoming obvious. Recently, real-time PCR methods in combination with the use of DNA intercalators, which block DNA amplification from dead bacteria, have seen wide application. However, much confusion exists in the correct interpretation of such assays. Campylobacter is confronted by oxidative and cold stress outside the intestine. Hence, damage caused by oxidative stress probably represents the most frequent natural death of Campylobacter on food products. Treatment of Campylobacter with peroxide led to complete loss of CFU and to significant entry of any tested DNA intercalator, indicating disruption of membrane integrity. When we transiently altered the metabolic state of Campylobacter by abolishing the proton-motive force or by inhibiting active efflux, CFU was constant but enhanced entry of ethidium bromide (EtBr) was observed. Consistently, ethidium monoazide (EMA) also entered viable Campylobacter, in particular when nutrients for bacterial energization were lacking (in PBS) or when the cells were less metabolically active (in stationary phase). In contrast, propidium iodide (PI) and propidium monoazide (PMA) were excluded from viable bacterial cells, irrespective of their metabolic state. As expected for a diffusion-limited process, the extent of signal reduction from dead cells depended on the temperature, incubation time and concentration of the dyes during staining, prior to crosslinking. Consistently, free protein and/or DNA present in varying amounts in the heterogeneous matrix lowered the concentration of the DNA dyes at the bacterial membrane and led to considerable variation of the residual signal from dead cells. In conclusion, we propose an improved approach, taking into account principles of method variability and recommend the implementation of process sample controls for reliable quantification of intact and potentially infectious units (IPIU) of Campylobacter by real-time PCR.	[Krueger, Nora-Johanna; Buhler, Christiane; Ellerbroek, Lueppo; Appel, Bernd; Stingl, Kerstin] Fed Inst Risk Assessment, Natl Reference Lab Campylobacter, Berlin, Germany; [Iwobi, Azuka N.; Huber, Ingrid] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany	Federal Institute for Risk Assessment; Bavarian Health & Food Safety Authority	Stingl, K (corresponding author), Fed Inst Risk Assessment, Natl Reference Lab Campylobacter, Berlin, Germany.	kerstin.stingl@bfr.bund.de		Stingl, Kerstin/0000-0002-8338-717X	Federal Institute for Risk Assessment	Federal Institute for Risk Assessment	The study was funded by the Federal Institute for Risk Assessment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2011, FOOD ANAL METHOD, V4, P259, DOI 10.1007/s12161-010-9142-8; BOLTON PH, 1978, NUCLEIC ACIDS RES, V5, P4891; Cawthorn DM, 2008, J APPL MICROBIOL, V105, P1178, DOI 10.1111/j.1365-2672.2008.03851.x; Chang B, 2010, JPN J INFECT DIS, V63, P119; EFSA, 2011, EFSA J, V9, P2105, DOI DOI 10.2903/J.EFSA.2011.2105; El-Shibiny A, 2009, INT J FOOD MICROBIOL, V131, P197, DOI 10.1016/j.ijfoodmicro.2009.02.024; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Flekna G, 2007, RES MICROBIOL, V158, P405, DOI 10.1016/j.resmic.2007.02.008; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Josefsen MH, 2004, APPL ENVIRON MICROB, V70, P3588, DOI 10.1128/AEM.70.6.3588-3592.2004; Kobayashi H, 2009, LETT APPL MICROBIOL, V48, P633, DOI 10.1111/j.1472-765X.2009.02585.x; Loozen G, 2011, MOL ORAL MICROBIOL, V26, P253, DOI 10.1111/j.2041-1014.2011.00615.x; Lubeck PS, 2003, APPL ENVIRON MICROB, V69, P5664, DOI 10.1128/AEM.69.9.5664-5669.2003; Mamelli L, 2005, J ANTIMICROB CHEMOTH, V56, P491, DOI 10.1093/jac/dki253; Nebe-von-Caron G, 2000, J MICROBIOL METH, V42, P97, DOI 10.1016/S0167-7012(00)00181-0; Nkuipou-Kenfack E, 2013, J MICROBIOL METH, V93, P20, DOI 10.1016/j.mimet.2013.01.018; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Pacholewicz E, 2013, J MICROBIOL METH, V95, P32, DOI 10.1016/j.mimet.2013.06.003; Rossmanith P, 2011, APPL ENVIRON MICROB, V77, P2531, DOI 10.1128/AEM.02601-10; Rossmanith P, 2011, APPL MICROBIOL BIOT, V89, P407, DOI 10.1007/s00253-010-2943-2; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Stingl K, 2012, EUR J MICROBIOL IMMU, V2, P88, DOI 10.1556/EuJMI.2.2012.1.12; van Alphen LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045343	23	37	37	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88108	10.1371/journal.pone.0088108	http://dx.doi.org/10.1371/journal.pone.0088108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505398	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200119
J	Weyhenmeyer, GA; Prairie, YT; Tranvik, LJ				Weyhenmeyer, Gesa A.; Prairie, Yves T.; Tranvik, Lars J.			Browning of Boreal Freshwaters Coupled to Carbon-Iron Interactions along the Aquatic Continuum	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; MATTER; LAKES; COLOR; ABSORPTION; ABSORBENCY	The color of freshwaters, often measured as absorbance, influences a number of ecosystem services including biodiversity, fish production, and drinking water quality. Many countries have recently reported on increasing trends of water color in freshwaters, for which drivers are still not fully understood. We show here with more than 58000 water samples from the boreal and hemiboreal region of Sweden and Canada that absorbance of filtered water (a(420)) co-varied with dissolved organic carbon (DOC) concentrations (R-2 = 0.85, P<0.0001), but that a(420) relative to DOC is increased by the presence of iron (Fe). We found that concentrations of Fe significantly declined with increasing water retention in the landscape, resulting in significantly lower Fe concentrations in lakes compared to running waters. The Fe loss along the aquatic continuum corresponded to a proportional loss in a(420), suggesting a tight biogeochemical coupling between colored dissolved organic matter and Fe. Since water is being flushed at increasing rates due to enhanced runoff in the studied regions, diminished loss of Fe along the aquatic continuum may be one reason for observed trends in a(420), and in particular in a(420)/DOC increases. If trends of increased Fe concentrations in freshwaters continue, water color will further increase with various effects on ecosystem services and biogeochemical cycles.	[Weyhenmeyer, Gesa A.; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden; [Prairie, Yves T.] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Uppsala University; University of Quebec; University of Quebec Montreal	Weyhenmeyer, GA (corresponding author), Uppsala Univ, Dept Ecol & Genet Limnol, Uppsala, Sweden.	Gesa.Weyhenmeyer@ebc.uu.se	Weyhenmeyer, Gesa/Y-6135-2019; Prairie, Yves T./B-9108-2008	Weyhenmeyer, Gesa/0000-0002-4013-2281; Prairie, Yves T./0000-0003-1210-992X; Tranvik, Lars J./0000-0003-3509-8266	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Nordforsk (CRAICC); Nordforsk (DomAQUA); Norwegian Research Council (Norklima ECCO)	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Nordforsk (CRAICC); Nordforsk (DomAQUA); Norwegian Research Council (Norklima ECCO)	Financial support was received from the Swedish Research Council (VR) and the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas). This work is part of and profited from the networks financed by Nordforsk (CRAICC and DomAQUA) and the Norwegian Research Council (Norklima ECCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvola L, 2010, BIOGEOCHEMISTRY, V101, P269, DOI 10.1007/s10533-010-9473-y; CANFIELD DE, 1984, WATER RESOUR BULL, V20, P323; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Dillon PJ, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2004JG000003; Doane TA, 2010, CHEMOSPHERE, V78, P1409, DOI 10.1016/j.chemosphere.2009.12.062; Haaland S, 2010, ENVIRON SCI TECHNOL, V44, P2975, DOI 10.1021/es903179j; Helsel D. R., 1992, STAT METHODS WATER R; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; Hu CM, 2002, LIMNOL OCEANOGR, V47, P1261; Humborg C, 2010, GLOBAL CHANGE BIOL, V16, P1966, DOI 10.1111/j.1365-2486.2009.02092.x; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kohler SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070598; Kokorite I, 2012, ENVIRON MONIT ASSESS, V184, P4999, DOI 10.1007/s10661-011-2315-0; Kritzberg ES, 2012, BIOGEOSCIENCES, V9, P1465, DOI 10.5194/bg-9-1465-2012; Lalonde K, 2012, NATURE, V483, P198, DOI 10.1038/nature10855; Lundstrom US, 2000, GEODERMA, V94, P91, DOI 10.1016/S0016-7061(99)00036-1; Maloney KO, 2005, BIOGEOCHEMISTRY, V75, P393, DOI 10.1007/s10533-005-1675-3; Maranger R, 2003, AQUATIC ECOSYSTEMS I; Molot LA, 1997, CAN J FISH AQUAT SCI, V54, P2789, DOI 10.1139/cjfas-54-12-2789; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Morris DP, 1997, LIMNOL OCEANOGR, V42, P239, DOI 10.4319/lo.1997.42.2.0239; Muller RA, 2013, AQUAT SCI, V75, P535, DOI 10.1007/s00027-013-0298-3; Neal C, 2008, AQUAT GEOCHEM, V14, P263, DOI 10.1007/s10498-008-9036-1; Pace ML, 2012, BIOGEOCHEMISTRY, V108, P109, DOI 10.1007/s10533-011-9576-0; Pace ML, 2002, LIMNOL OCEANOGR, V47, P333, DOI 10.4319/lo.2002.47.2.0333; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; SONDERGAARD M, 1995, MAR ECOL PROG SER, V118, P283, DOI 10.3354/meps118283; Spencer RGM, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001928; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Vahatalo AV, 2003, ARCH HYDROBIOL, V156, P287, DOI 10.1127/0003-9136/2003/0156-0287; von Wachenfeldt E, 2008, ECOSYSTEMS, V11, P803, DOI 10.1007/s10021-008-9162-z; Wallstedt T, 2010, APPL GEOCHEM, V25, P1162, DOI 10.1016/j.apgeochem.2010.05.002; Weyhenmeyer GA, 2012, GLOBAL CHANGE BIOL, V18, P349, DOI 10.1111/j.1365-2486.2011.02544.x; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xiao YH, 2013, LIMNOL OCEANOGR, V58, P653, DOI 10.4319/lo.2013.58.2.0653	37	100	100	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88104	10.1371/journal.pone.0088104	http://dx.doi.org/10.1371/journal.pone.0088104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505396	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200118
J	Bhaduri, A; Misra, R; Maji, A; Bhetaria, PJ; Mishra, S; Arora, G; Singh, LK; Dhasmana, N; Dubey, N; Virdi, JS; Singh, Y				Bhaduri, Asani; Misra, Richa; Maji, Abhijit; Bhetaria, Preetida J.; Mishra, Sonakshi; Arora, Gunjan; Singh, Lalit Kumar; Dhasmana, Neha; Dubey, Neha; Virdi, Jugsharan Singh; Singh, Yogendra			Mycobacterium tuberculosis Cyclophilin A Uses Novel Signal Sequence for Secretion and Mimics Eukaryotic Cyclophilins for Interaction with Host Protein Repertoire	PLOS ONE			English	Article							PEPTIDYLPROLYL CIS/TRANS ISOMERASES; PROLYL ISOMERASE; ELECTROPHORESIS; PEPTIDES; PIN1	Cyclophilins are prolyl isomerases with multitude of functions in different cellular processes and pathological conditions. Cyclophilin A (PpiA) of Mycobacterium tuberculosis is secreted during infection in intraphagosomal niche. However, our understanding about the evolutionary origin, secretory mechanism or the interactome of M. tuberculosis PpiA is limited. This study demonstrates through phylogenetic and structural analyses that PpiA has more proximity to human cyclophilins than the prokaryotic counterparts. We report a unique N-terminal sequence (MADCDSVTNSP) present in pathogenic mycobacterial PpiA and absent in non-pathogenic strains. This sequence stretch was shown to be essential for PpiA secretion. The overexpression of full-length PpiA from M. tuberculosis in non-pathogenic Mycobacterium smegmatis resulted in PpiA secretion while truncation of the N-terminal stretch obstructed the secretion. In addition, presence of an ESX pathway substrate motif in M. tuberculosis PpiA suggested possible involvement of Type VII secretion system. Site-directed mutagenesis of key residues in this motif in full-length PpiA also hindered the secretion in M. smegmatis. Bacterial two-hybrid screens with human lung cDNA library as target were utilized to identify interaction partners of PpiA from host repertoire, and a number of substrates with functional representation in iron storage, signal transduction and immune responses were detected. The extensive host interactome coupled with the sequence and structural similarity to human cyclophilins is strongly suggestive of PpiA being deployed by M. tuberculosis as an effector mimic against the host cyclophilins.	[Bhaduri, Asani; Misra, Richa; Maji, Abhijit; Bhetaria, Preetida J.; Mishra, Sonakshi; Arora, Gunjan; Singh, Lalit Kumar; Dhasmana, Neha; Dubey, Neha; Singh, Yogendra] CSIR Inst Genom & Integrat Biol, Delhi, India; [Bhaduri, Asani; Virdi, Jugsharan Singh] Univ Delhi, Dept Microbiol, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Singh, Y (corresponding author), CSIR Inst Genom & Integrat Biol, Delhi, India.	ysingh@igib.res.in	Misra, Richa/AAE-6257-2019; Dhasmana, Neha/AAE-5903-2019; Arora, Gunjan/AAL-3448-2020; Bhetariya, Preetida/K-4132-2018; Misra, Richa/B-3860-2018; Virdi, Jugsharan Singh/L-8241-2015	Dhasmana, Neha/0000-0003-4648-7056; Arora, Gunjan/0000-0003-0575-6205; Bhetariya, Preetida/0000-0002-1988-3830; Misra, Richa/0000-0003-3630-827X; Virdi, Jugsharan Singh/0000-0002-6282-0018	Council of Scientific and Industrial Research (CSIR), India [BSC0104]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grant BSC0104 from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Bang N, 2000, EUR J BIOCHEM, V267, P3270, DOI 10.1046/j.1432-1327.2000.01355.x; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Deenadayalan A, 2010, EXP MOL PATHOL, V88, P156, DOI 10.1016/j.yexmp.2009.11.008; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Friebel A, 2001, J BIOL CHEM, V276, P34035, DOI 10.1074/jbc.M100609200; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gama JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002503; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Henriksson LM, 2004, EUR J BIOCHEM, V271, P4107, DOI 10.1111/j.1432-1033.2004.04348.x; Jayachandran R, 2012, EXPERT REV ANTI-INFE, V10, P1007, DOI [10.1586/ERI.12.95, 10.1586/eri.12.95]; Krucken J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-27; Kulkarni MM, 2013, J BIOL CHEM, V288, P8772, DOI 10.1074/jbc.M112.421057; Kumar K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007615; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee J, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-97; Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Manteca A, 2006, J MOL EVOL, V63, P719, DOI 10.1007/s00239-005-0130-3; Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547; Mitra D, 2006, FEBS LETT, V580, P6846, DOI 10.1016/j.febslet.2006.11.042; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; Orchard RC, 2012, CELL MICROBIOL, V14, P10, DOI 10.1111/j.1462-5822.2011.01703.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Reffuveille F, 2012, INFECT IMMUN, V80, P1728, DOI 10.1128/IAI.06251-11; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Weldingh K, 1998, INFECT IMMUN, V66, P3492, DOI 10.1128/IAI.66.8.3492-3500.1998; Wolf YI, 2000, GENOME BIOL, V1; Wong DK, 1999, INFECT IMMUN, V67, P327, DOI 10.1128/IAI.67.1.327-336.1999	41	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88090	10.1371/journal.pone.0088090	http://dx.doi.org/10.1371/journal.pone.0088090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505389	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300052
J	Danilov, SM; Wade, MS; Schwager, SL; Douglas, RG; Nesterovitch, AB; Popova, IA; Hogarth, KD; Bhardwaj, N; Schwartz, DE; Sturrock, ED; Garcia, JGN				Danilov, Sergei M.; Wade, Michael S.; Schwager, Sylva L.; Douglas, Ross G.; Nesterovitch, Andrew B.; Popova, Isolda A.; Hogarth, Kyle D.; Bhardwaj, Nakul; Schwartz, David E.; Sturrock, Edward D.; Garcia, Joe G. N.			A Novel Angiotensin I-Converting Enzyme Mutation (S333W) Impairs N-Domain Enzymatic Cleavage of the Anti-Fibrotic Peptide, AcSDKP	PLOS ONE			English	Article							ASPARTYL-LYSYL-PROLINE; 2 ACTIVE-SITES; MONOCLONAL-ANTIBODIES; DRAMATIC INCREASE; CRYSTAL-STRUCTURE; SOMATIC ACE; INHIBITOR; ASSAY; INACTIVATION; BRADYKININ	Background: Angiotensin I-converting enzyme (ACE) has two functional N- and C-domain active centers that display differences in the metabolism of biologically-active peptides including the hemoregulatory tetrapeptide, Ac-SDKP, hydrolysed preferentially by the N domain active center. Elevated Ac-SDKP concentrations are associated with reduced tissue fibrosis. Results: We identified a patient of African descent exhibiting unusual blood ACE kinetics with reduced relative hydrolysis of two synthetic ACE substrates (ZPHL/HHL ratio) suggestive of the ACE N domain center inactivation. Inhibition of blood ACE activity by anti-catalytic mAbs and ACE inhibitors and conformational fingerprint of blood ACE suggested overall conformational changes in the ACE molecule and sequencing identified Ser333Trp substitution in the N domain of ACE. In silico analysis demonstrated S333W localized in the S-1 pocket of the active site of the N domain with the bulky Trp adversely affecting binding of ACE substrates due to steric hindrance. Expression of mutant ACE (S333W) in CHO cells confirmed altered kinetic properties of mutant ACE and conformational changes in the N domain. Further, the S333W mutant displayed decreased ability (5-fold) to cleave the physiological substrate AcSDKP compared to wild-type ACE. Conclusions and Significance: A novel Ser333Trp ACE mutation results in dramatic changes in ACE kinetic properties and lowered clearance of Ac-SDKP. Individuals with this mutation (likely with significantly increased levels of the hemoregulatory tetrapeptide in blood and tissues), may confer protection against fibrosis.	[Danilov, Sergei M.; Wade, Michael S.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA; [Danilov, Sergei M.; Schwartz, David E.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Schwager, Sylva L.; Douglas, Ross G.; Sturrock, Edward D.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Schwager, Sylva L.; Douglas, Ross G.; Sturrock, Edward D.] Univ Cape Town, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Nesterovitch, Andrew B.] Rush Univ, Dept Dermatol, Chicago, IL 60612 USA; [Popova, Isolda A.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL USA; [Hogarth, Kyle D.; Bhardwaj, Nakul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Garcia, Joe G. N.] Univ Arizona, Dept Med, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Cape Town; University of Cape Town; Rush University; Northwestern University; University of Chicago; University of Arizona	Danilov, SM (corresponding author), Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60612 USA.	danilov@uic.edu	Nesterovitch, Andrew/K-7286-2014; Douglas, Ross/GLQ-7922-2022	Nesterovitch, Andrew/0000-0002-9508-5363; 	Institute of Personalized Respiratory Medicine; Department of Anesthesiology, University of Illinois at Chicago; Bernie Mac Foundation	Institute of Personalized Respiratory Medicine; Department of Anesthesiology, University of Illinois at Chicago; Bernie Mac Foundation	This work was supported by the Institute of Personalized Respiratory Medicine, the Department of Anesthesiology, University of Illinois at Chicago and the Bernie Mac Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anthony CS, 2010, J BIOL CHEM, V285, P35685, DOI 10.1074/jbc.M110.167866; Azizi M, 1996, J CLIN INVEST, V97, P839, DOI 10.1172/JCI118484; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2005, TISSUE ANTIGENS, V65, P240, DOI 10.1111/j.1399-0039.2005.00364.x; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Bernstein KE, 2013, PHARMACOL REV, V65, P1, DOI 10.1124/pr.112.006809; Bernstein KE, 2011, CURR OPIN PHARMACOL, V11, P105, DOI 10.1016/j.coph.2010.11.001; Chen HL, 2010, MICRON, V41, P674, DOI 10.1016/j.micron.2010.01.005; CONROY JM, 1978, ANAL BIOCHEM, V87, P556, DOI 10.1016/0003-2697(78)90705-4; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2011, AM J RESP CLIN CARE, V183, pA5509; Dufour C, 2000, GENOMICS, V69, P14, DOI 10.1006/geno.2000.6313; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Georgiadis D, 2003, CIRC RES, V93, P148, DOI 10.1161/01.RES.0000081593.33848.FC; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gribouval O, 2012, HUM MUTAT, V33, P316, DOI 10.1002/humu.21661; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kanasaki M, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-25; Kramers C, 2001, CIRCULATION, V104, P1236, DOI 10.1161/hc3601.095932; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; Li P, 2010, AM J PATHOL, V177, P1113, DOI 10.2353/ajpath.2010.081127; Linnebank M, 2003, NEUROLOGY, V61, P1819, DOI 10.1212/01.WNL.0000098990.12845.DA; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Peng HM, 2001, HYPERTENSION, V37, P794, DOI 10.1161/01.HYP.37.2.794; Persu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059537; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; Salvesen G., 2012, HDB PROTEOLYTIC ENZY, V3rd, P480; Semmler A, 2006, CLIN CHEM LAB MED, V44, P1088, DOI 10.1515/CCLM.2006.200; Shibuya K, 2005, DIABETES, V54, P838, DOI 10.2337/diabetes.54.3.838; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; Skirgello OE, 2005, BIOCHEM J, V391, P641, DOI 10.1042/BJ20050702; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Watermeyer JM, 2010, BIOCHEM J, V428, P67, DOI 10.1042/BJ20100056; WEI L, 1991, J BIOL CHEM, V266, P9002; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89	50	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88001	10.1371/journal.pone.0088001	http://dx.doi.org/10.1371/journal.pone.0088001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505347	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300030
J	Dijkstra, H; Handayani, A; Kappert, P; Oudkerk, M; Sijens, PE				Dijkstra, Hildebrand; Handayani, Astri; Kappert, Peter; Oudkerk, Matthijs; Sijens, Paul E.			Clinical Implications of Non-Steatotic Hepatic Fat Fractions on Quantitative Diffusion-Weighted Imaging of the Liver	PLOS ONE			English	Article							MR; WATER; QUANTIFICATION; DISEASE; IRON; SPECTROSCOPY; COEFFICIENT; SUPPRESSION; RELAXATION; DIAGNOSIS	Diffusion-weighted imaging (DWI) is an important diagnostic tool in the assessment of focal liver lesions and diffuse liver diseases such as cirrhosis and fibrosis. Quantitative DWI parameters such as molecular diffusion, microperfusion and their fractions, are known to be affected when hepatic fat fractions (HFF) are higher than 5.5% (steatosis). However, less is known about the effect on DWI for HFF in the normal non-steatotic range below 5.5%, which can be found in a large part of the population. The aim of this study was therefore to evaluate the diagnostic implications of non-steatotic HFF on quantitative DWI parameters in eight liver segments. For this purpose, eleven healthy volunteers (2 men, mean-age 31.0) were prospectively examined with DWI and three series of in-/out-of-phase dual-echo spoiled gradient-recalled MRI sequences to obtain the HFF and T-2*. DWI data were analyzed using the intravoxel incoherent motion (IVIM) model. Four circular regions (circle divide 22.3 mm) were drawn in each of eight liver segments and averaged. Measurements were divided in group 1 (HFF <= 2.75%), group 2 (2.75< HFF <= 5.5%) and group 3 (HFF>5.5%). DWI parameters and T-2* were compared between the three groups and between the segments. It was observed that the molecular diffusion (0.85, 0.72 and 0.49610 23 mm(2)/s) and T-2* (32.2, 27.2 and 21.0 ms) differed significantly between the three groups of increasing HFF (2.18, 3.50 and 19.91%). Microperfusion and its fraction remained similar for different HFF. Correlations with HFF were observed for the molecular diffusion (r = -0.514, p<0.001) and T-2* (-0.714, p<0.001). Similar results were obtained for the majority of individual liver segments. It was concluded that fat significantly decreases molecular diffusion in the liver, also in absence of steatosis (HFF <= 5.5%). Also, it was confirmed that fat influences T-2*. Determination of HFF prior to quantitative DWI is therefore crucial.	[Dijkstra, Hildebrand; Handayani, Astri; Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Dijkstra, Hildebrand; Kappert, Peter; Sijens, Paul E.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen	Dijkstra, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands.	h.dijkstra01@umcg.nl	Handayani, Astri/V-8412-2019	Dijkstra, Hildebrand/0000-0001-6664-902X; Oudkerk, Matthijs/0000-0003-2800-4110				Amano Y, 1998, ACTA RADIOL, V39, P440; Anderson SW, 2011, J MAGN RESON IMAGING, V33, P882, DOI 10.1002/jmri.22481; Bakan AA, 2012, EUR RADIOL, V22, P682, DOI 10.1007/s00330-011-2295-z; Baron P, 2010, NMR BIOMED, V23, P399, DOI 10.1002/nbm.1475; BISMUTH H, 1982, WORLD J SURG, V6, P3, DOI 10.1007/BF01656368; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; CALLAGHAN PT, 1983, J COLLOID INTERF SCI, V93, P521, DOI 10.1016/0021-9797(83)90436-8; Capitan V, 2012, EUR RADIOL, V22, P2161, DOI 10.1007/s00330-012-2468-4; Chai JW, 2001, J MAGN RESON IMAGING, V14, P35, DOI 10.1002/jmri.1148; Chandarana H, 2009, AM J ROENTGENOL, V193, P1261, DOI 10.2214/AJR.08.1996; Chawla S, 2009, FUTURE ONCOL, V5, P959, DOI [10.2217/fon.09.77, 10.2217/FON.09.77]; Couinaud C, 1957, FOIE ETUDES ANATOMIQ; Delfaut EM, 1999, RADIOGRAPHICS, V19, P373, DOI 10.1148/radiographics.19.2.g99mr03373; Dijkstra H, 2012, EUR RADIOL, V22, P891, DOI 10.1007/s00330-011-2313-1; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Gilman AJ, 2011, P INT SOC MAG RESON, V19; Guiu B, 2012, RADIOLOGY, V265, P96, DOI 10.1148/radiol.12112478; Hernando D, 2013, J MAGN RESON IMAGING, V37, P717, DOI 10.1002/jmri.23851; Hiwatashi A, 2003, AM J ROENTGENOL, V181, P1705, DOI 10.2214/ajr.181.6.1811705; Hussain HK, 2005, RADIOLOGY, V237, P1048, DOI 10.1148/radiol.2373041639; Ichikawa T, 1998, AM J ROENTGENOL, V170, P397, DOI 10.2214/ajr.170.2.9456953; Irwan R, 2008, EUR RADIOL, V18, P806, DOI 10.1007/s00330-007-0801-0; KAMMAN RL, 1987, MAGN RESON IMAGING, V5, P381, DOI 10.1016/0730-725X(87)90127-5; Kele PG, 2010, WORLD J GASTROENTERO, V16, P1567, DOI 10.3748/wjg.v16.i13.1567; Kuhn JP, 2012, RADIOLOGY, V265, P133, DOI 10.1148/radiol.12112520; Kuntz E, 2008, HEPATOLOGY TXB ATLAS, V3rd; Kwee TC, 2009, MAGN RESON MATER PHY, V22, P319, DOI 10.1007/s10334-009-0183-1; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Liska D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000569; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Meisamy S, 2011, RADIOLOGY, V258, P767, DOI 10.1148/radiol.10100708; Meloni A, 2011, J MAGN RESON IMAGING, V33, P348, DOI 10.1002/jmri.22417; Morelli JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061898; MULLER MF, 1994, RADIOLOGY, V190, P475; Okada M, 2011, ACTA RADIOL, V52, P658, DOI 10.1258/ar.2011.100360; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Poyraz AK, 2012, J MAGN RESON IMAGING, V35, P1108, DOI 10.1002/jmri.23519; Rao RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032613; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tachibana Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063869; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; THOMSEN C, 1994, MAGN RESON IMAGING, V12, P487, DOI 10.1016/0730-725X(94)92543-7; Toussaint JF, 1997, ARTERIOSCL THROM VAS, V17, P542, DOI 10.1161/01.ATV.17.3.542; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Wignall O, 2008, P INT SOC MAG RESON, V16; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Yu HZ, 2007, J MAGN RESON IMAGING, V26, P1153, DOI 10.1002/jmri.21090; Yu SM, 2013, APPL MAGN RESON, V44, P791, DOI 10.1007/s00723-013-0443-0; Zaitoun AM, 2001, J CLIN PATHOL, V54, P461, DOI 10.1136/jcp.54.6.461	53	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87926	10.1371/journal.pone.0087926	http://dx.doi.org/10.1371/journal.pone.0087926			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505333	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300018
J	Long, ZY; Li, XR; Xu, J; Edden, RAE; Qin, WP; Long, LL; Murdoch, JB; Zheng, W; Jiang, YM; Dydak, U				Long, Zaiyang; Li, Xiang-Rong; Xu, Jun; Edden, Richard A. E.; Qin, Wei-Ping; Long, Li-Ling; Murdoch, James B.; Zheng, Wei; Jiang, Yue-Ming; Dydak, Ulrike			Thalamic GABA Predicts Fine Motor Performance in Manganese-Exposed Smelter Workers	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; METABOLITE CONCENTRATIONS; SYSTEM DYSFUNCTION; SIGNAL INTENSITY; BASAL GANGLIA; BRAIN; PARKINSONISM; ACCUMULATION; STRIATUM; DEFICITS	Overexposure to manganese (Mn) may lead to parkinsonian symptoms including motor deficits. The main inhibitory neurotransmitter gamma-aminobutyric acid (GABA) is known to play a pivotal role in the regulation and performance of movement. Therefore this study was aimed at testing the hypothesis that an alteration of GABA following Mn exposure may be associated with fine motor performance in occupationally exposed workers and may underlie the mechanism of Mn-induced motor deficits. A cohort of nine Mn-exposed male smelter workers from an Mn-iron alloy factory and 23 genderand age-matched controls were recruited and underwent neurological exams, magnetic resonance spectroscopy (MRS) measurements, and Purdue pegboard motor testing. Short-echo-time MRS was used to measure N-Acetyl-aspartate (NAA) and myo-inositol (mI). GABA was detected with a MEGA-PRESS J-editing MRS sequence. The mean thalamic GABA level was significantly increased in smelter workers compared to controls (p = 0.009). Multiple linear regression analysis reveals (1) a significant association between the increase in GABA level and the duration of exposure (R-2 = 0.660, p = 0.039), and (2) significant inverse associations between GABA levels and all Purdue pegboard test scores (for summation of all scores R-2 = 0.902, p = 0.001) in the smelter workers. In addition, levels of mI were reduced significantly in the thalamus and PCC of smelter workers compared to controls (p = 0.030 and p = 0.009, respectively). In conclusion, our results show clear associations between thalamic GABA levels and fine motor performance. Thus in Mn-exposed subjects, increased thalamic GABA levels may serve as a biomarker for subtle deficits in motor control and may become valuable for early diagnosis of Mn poisoning.	[Long, Zaiyang; Xu, Jun; Zheng, Wei; Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Long, Zaiyang; Xu, Jun; Dydak, Ulrike] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Li, Xiang-Rong; Long, Li-Ling] Guangxi Med Univ, Dept Radiol, Affiliated Hosp 1, Nanning, Peoples R China; [Edden, Richard A. E.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Edden, Richard A. E.] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Qin, Wei-Ping] Guangxi Inst Occupat Dis Prevent & Treatment, Dept Occupat Poisoning, Nanning, Peoples R China; [Murdoch, James B.] Toshiba Med Res Inst USA, Mayfield Village, OH USA; [Jiang, Yue-Ming] Guangxi Med Univ, Dept Hlth Toxicol, Nanning, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Guangxi Medical University; Johns Hopkins University; Kennedy Krieger Institute; Toshiba Corporation; Guangxi Medical University	Jiang, YM (corresponding author), Guangxi Med Univ, Dept Hlth Toxicol, Nanning, Peoples R China.	ymjiang@163.com; udydak@purdue.edu	Jiang, Yueming/AAJ-5538-2020	Jiang, Yueming/0000-0002-4648-9572; Long, Liling/0000-0003-3369-8532; Edden, Richard/0000-0002-0671-7374	National Institute of Environmental Health Science at the National Institutes of Health [R21 ES017498]; National Science Foundation of China [81072320, 30760210]; Guangxi Science and Technology Commission [0640129]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017498, R01ES020529] Funding Source: NIH RePORTER	National Institute of Environmental Health Science at the National Institutes of Health; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science and Technology Commission; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the National Institute of Environmental Health Science at the National Institutes of Health Grant R21 ES017498, National Science Foundation of China Grant #81072320 and #30760210, and Guangxi Science and Technology Commission Grant #0640129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Bhattacharyya PK, 2013, AM J NEURORADIOL, V34, P1733, DOI 10.3174/ajnr.A3483; Bianchi L, 2003, EUR J NEUROSCI, V18, P856, DOI 10.1046/j.1460-9568.2003.02795.x; BONILLA E, 1978, J NEUROCHEM, V31, P551, DOI 10.1111/j.1471-4159.1978.tb02672.x; Bonilla E, 1994, Invest Clin, V35, P175; Bowler RM, 2007, OCCUP ENVIRON MED, V64, P167, DOI 10.1136/oem.2006.028761; Bowler RM, 2006, NEUROTOXICOLOGY, V27, P315, DOI 10.1016/j.neuro.2005.10.007; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; BROUILLET EP, 1993, EXP NEUROL, V120, P89, DOI 10.1006/exnr.1993.1042; Chang Y, 2009, NEUROTOXICOLOGY, V30, P950, DOI 10.1016/j.neuro.2009.07.008; Chang Y, 2009, NEUROTOXICOLOGY, V30, P555, DOI 10.1016/j.neuro.2009.04.002; Cowan DM, 2009, NEUROTOXICOLOGY, V30, P1214, DOI 10.1016/j.neuro.2009.02.005; Criswell SR, 2011, NEUROLOGY, V76, P1296, DOI 10.1212/WNL.0b013e3182152830; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Edden RAE, 2007, MAGN RESON MED, V58, P1276, DOI 10.1002/mrm.21383; Emir UE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030918; Fordahl SC, 2010, NEUROTOXICOLOGY, V31, P639, DOI 10.1016/j.neuro.2010.09.002; Galvan A, 2007, PROG BRAIN RES, V160, P287, DOI 10.1016/S0079-6123(06)60017-4; Geurts JJG, 2004, J MAGN RESON IMAGING, V20, P366, DOI 10.1002/jmri.20138; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Guilarte TR, 2006, TOXICOL SCI, V94, P351, DOI 10.1093/toxsci/kfl106; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Hornykiewicz O, 2001, J CHEM NEUROANAT, V22, P3, DOI 10.1016/S0891-0618(01)00100-4; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; Kim SH, 1999, INVEST RADIOL, V34, P383, DOI 10.1097/00004424-199906000-00001; Kish S, 1987, Adv Neurol, V45, P75; Kurata K, 2005, J NEUROPHYSIOL, V94, P550, DOI 10.1152/jn.01034.2004; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; Lucchini R, 2000, NEUROTOXICOLOGY, V21, P769; MERGLER D, 1994, ENVIRON RES, V64, P151, DOI 10.1006/enrs.1994.1013; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Park RM, 2009, J OCCUP ENVIRON MED, V51, P1125, DOI 10.1097/JOM.0b013e3181bd8114; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Racette BA, 2001, NEUROLOGY, V56, P8, DOI 10.1212/WNL.56.1.8; Sen S, 2011, TOXICOL SCI, V121, P160, DOI 10.1093/toxsci/kfr033; SETH PK, 1981, TOXICOL LETT, V9, P247, DOI 10.1016/0378-4274(81)90157-0; Soares J, 2004, J NEUROSCI, V24, P6417, DOI 10.1523/JNEUROSCI.0836-04.2004; Spreen O, 1998, COMPENDIUM NEUROPSYC; Wastensson G, 2012, INT ARCH OCC ENV HEA, V85, P703, DOI 10.1007/s00420-011-0716-6; Zhao F, 2009, TOXICOL SCI, V107, P156, DOI 10.1093/toxsci/kfn213	46	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88220	10.1371/journal.pone.0088220	http://dx.doi.org/10.1371/journal.pone.0088220			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505436	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300072
J	Miller, JA; Miller, JH; Pham, DS; Beentjes, KK				Miller, Jeremy A.; Miller, Joshua H.; Dinh-Sac Pham; Beentjes, Kevin K.			Cyberdiversity: Improving the Informatic Value of Diverse Tropical Arthropod Inventories	PLOS ONE			English	Article							SPIDER SPECIES RICHNESS; BETA-DIVERSITY; STRUCTURED INVENTORY; MITOCHONDRIAL-DNA; RAIN-FOREST; BIODIVERSITY ASSESSMENT; SAMPLING METHODS; POPULATION-SIZE; VASCULAR PLANTS; DISTANCE-DECAY	In an era of biodiversity crisis, arthropods have great potential to inform conservation assessment and test hypotheses about community assembly. This is because their relatively narrow geographic distributions and high diversity offer high-resolution data on landscape-scale patterns of biodiversity. However, a major impediment to the more widespread application of arthropod data to a range of scientific and policy questions is the poor state of modern arthropod taxonomy, especially in the tropics. Inventories of spiders and other megadiverse arthropods from tropical forests are dominated by undescribed species. Such studies typically organize their data using morphospecies codes, which make it difficult for data from independent inventories to be compared and combined. To combat this shortcoming, we offer cyberdiversity, an online community-based approach for reconciling results of independent inventory studies where current taxonomic knowledge is incomplete. Participating scientists can upload images and DNA barcode sequences to dedicated databases and submit occurrence data and links to a web site (www.digitalSpiders.org). Taxonomic determinations can be shared with a crowdsourcing comments feature, and researchers can discover specimens of interest available for loan and request aliquots of genomic DNA extract. To demonstrate the value of the cyberdiversity framework, we reconcile data from three rapid structured inventories of spiders conducted in Vietnam with an independent inventory (Doi Inthanon, Thailand) using online image libraries. Species richness and inventory completeness were assessed using non-parametric estimators. Community similarity was evaluated using a novel index based on the Jaccard replacing observed with estimated values to correct for unobserved species. We use a distance-decay framework to demonstrate a rudimentary model of landscape-scale changes in community composition that will become increasingly informative as additional inventories participate. With broader adoption of the cyberdiversity approach, networks of information-sharing taxonomists can more efficiently and effectively address taxonomic impediments while elucidating landscape scale patterns of biodiversity.	[Miller, Jeremy A.] Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands; [Miller, Jeremy A.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Miller, Jeremy A.] Plazi, Bern, Switzerland; [Miller, Joshua H.] Univ Cincinnati, Dept Geol, Cincinnati, OH USA; [Miller, Joshua H.] Univ Alaska Museum, Fairbanks, AK USA; [Miller, Joshua H.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Dinh-Sac Pham] Vietnam Acad Sci & Technol, Inst Ecol & Biol Resources, Hanoi, Vietnam; [Beentjes, Kevin K.] Naturalis Biodivers Ctr, Naturalis DNA Barcoding Facil, Leiden, Netherlands	Naturalis Biodiversity Center; California Academy of Sciences; University System of Ohio; University of Cincinnati; University of Alaska System; University of Alaska Fairbanks; State University System of Florida; University of Florida; Vietnam Academy of Science & Technology (VAST); Naturalis Biodiversity Center	Miller, JA (corresponding author), Naturalis Biodivers Ctr, Dept Terr Zool, Leiden, Netherlands.	jeremy.miller@naturalis.nl	Beentjes, Kevin/O-1238-2015; Miller, Jeremy/F-7592-2019; Beentjes, Kevin/AAA-6143-2021	Miller, Jeremy/0000-0001-8918-9775; Beentjes, Kevin/0000-0001-7669-3809	John D. and Catherine T. MacArthur Foundation [08-90235-000-GSS]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, T32DA007237, R01DA009580] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Support for field work and DNA barcoding was provided by the Naturalis Biodiversity Center. The digitalSpiders.org web site is based on a design by Grace Woo of New Year Designs. Her participation was supported by a grant from the John D. and Catherine T. MacArthur Foundation to David Kavanaugh of the California Academy of Sciences and JAM (08-90235-000-GSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2003, INVERTEBR SYST, V17, P719, DOI 10.1071/IS03002; Agosti Donat, 2000, P204; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bonaldo Alexandre B., 2010, Acta Amaz., V40, P357, DOI 10.1590/S0044-59672010000200014; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cabra-Garcia J, 2010, J ARACHNOL, V38, P192, DOI 10.1636/P09-68.1; Cardoso P, 2008, J INSECT CONSERVATIO; Cardoso P, 2009, COBRA 1 0; Cardoso P, 2008, ACTA OECOL, V33, P114, DOI 10.1016/j.actao.2007.10.003; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cardoso P, 2009, BIODIVERS CONSERV, V18, P3949, DOI 10.1007/s10531-009-9690-7; Cardoso P, 2008, INSECT CONSERV DIVER, V1, P71, DOI 10.1111/j.1752-4598.2007.00008.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2000, STAT SINICA, V10, P227; Chao A, 2009, SPADE; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chao A, 2006, AUST NZ J STAT, V48, P117, DOI 10.1111/j.1467-842X.2006.00430.x; Chernik MR, 2008, BOOTSTRAP METHODS GU; Coddington JA, 1996, J ARACHNOL, V24, P111; CODDINGTON JA, 1991, UNITY OF EVOLUTIONARY BIOLOGY, VOLS 1 AND 2, P44; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2009, ESTIMATES STAT ESTIM; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; D'Amen M, 2013, ANIM CONSERV, V16, P370, DOI 10.1111/acv.12016; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dobyns JR, 1997, ENVIRON ENTOMOL, V26, P150, DOI 10.1093/ee/26.2.150; Erwin Terry L., 2005, Proceedings of the California Academy of Sciences, V56, P72; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Ferrier S, 1999, TRZS NSW, P68; Fitzpatrick MC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1201; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Galimberti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040122; GASTON KJ, 1994, BIOL CONSERV, V67, P37, DOI 10.1016/0006-3207(94)90006-X; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gotelli N., 2013, ENCY BIODIVERSITY, V5, P195, DOI DOI 10.1016/B978-0-12-384719-5.00424-X; Grismado Cristian J., 2002, Iheringia, Sér. Zool., V92, P13, DOI 10.1590/S0073-47212002000300002; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofer H., 1990, Acta Zoologica Fennica, P173; Hubbell Stephen P., 2001, V32, pi; Kapoor Vena, 2006, Zoos Print Journal, V21, P2483; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kremen C, 1995, CONSERV BIOL, V7, P796; LEE SM, 1994, BIOMETRICS, V50, P88, DOI 10.2307/2533199; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Longino JT, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00200.1; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; Maddison DR, 2012, TRENDS ECOL EVOL, V27, P72, DOI 10.1016/j.tree.2011.10.010; Magurran A.E, 2004, MEASURING BIOL DIVER; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Millar RB, 2011, ECOLOGY, V92, P1717, DOI 10.1890/11-0029.1; MILLER JA, 2010, ZOOTAXA, V2534, P1, DOI DOI 10.11646/ZOOTAXA.2534.1.1; Miller JA, 2009, ZOOKEYS, P9, DOI 10.3897/zookeys.11.160; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Novotny V, 2005, ANN ZOOL FENN, V42, P463; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Paquin P, 2004, MOL ECOL, V13, P3239, DOI 10.1111/j.1365-294X.2004.02296.x; Peterson AT, 2010, SYST BIODIVERS, V8, P159, DOI 10.1080/14772001003739369; Pinkus-Rendon MA, 2006, DIVERS DISTRIB, V12, P61, DOI 10.1111/j.1366-9516.2006.00217.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qian H, 2005, ECOL LETT, V8, P15, DOI 10.1111/j.1461-0248.2004.00682.x; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rego FNAA, 2009, REV IBERICA ARACNOLO, V17, P85; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Scharff N, 2003, J ARACHNOL, V31, P246, DOI 10.1636/0161-8202(2003)031[0246:WTQESS]2.0.CO;2; Schindel David E., 2010, P109, DOI 10.1201/EBK1420095012-c10; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Silva Davila D, 1996, BIODIVERSITY SE PERU, P253, DOI DOI 10.1017/S0266467498260391; Smith MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036514; Smith VS, 2015, DESCRIPTIVE IN PRESS; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sorensen LL, 2002, ENVIRON ENTOMOL, V31, P319, DOI 10.1603/0046-225X-31.2.319; Sperling F, 2003, NEWSLETTER BIOL SURV, V22; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Thessen AE, 2011, ZOOKEYS, P15, DOI 10.3897/zookeys.150.1766; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toti DS, 2000, J ARACHNOL, V28, P329, DOI 10.1636/0161-8202(2000)028[0329:ASIOAG]2.0.CO;2; Vink CJ, 2005, INVERTEBR SYST, V19, P99, DOI 10.1071/IS04039; Wheeler QD, 2008, SYSTEMATICS ASS, V76; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Whittaker RH, 1960, ECOL MONOGR, V30, P270; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E	113	46	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2014	9	12							e115750	10.1371/journal.pone.0115750	http://dx.doi.org/10.1371/journal.pone.0115750			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX9RO	24505362	Green Published, gold, Green Submitted			2022-12-27	WOS:000347239900077
J	Fan, YZ; Wang, ZZ; Xin, Y; Li, Q; Zhang, ZL; Wang, YX				Fan, Yunzhao; Wang, Zizi; Xin, Ying; Li, Qian; Zhang, Zhaoliang; Wang, Yingxia			Significant Improvement of Thermal Stability for CeZrPrNd Oxides Simply by Supercritical CO2 Drying	PLOS ONE			English	Article							OXYGEN STORAGE CAPACITY; CONTINUOUS HYDROTHERMAL SYNTHESIS; ZIRCONIA MIXED OXIDES; ONLY 3-WAY CATALYST; SOLID-SOLUTIONS; CARBON-DIOXIDE; SURFACE-AREA; AEROGEL; PERFORMANCE; WATER	Pr and Nd co-doped Ce-Zr oxide solid solutions (CZPN) were prepared using co-precipitation and microemulsion methods. It is found that only using supercritical CO2 drying can result in a significant improvement of specific surface area and oxygen storage capacity at lower temperatures for CZPN after aging at 1000 degrees C for 12 h in comparison with those using conventional air drying and even supercritical ethanol drying. Furthermore, the cubic structure was obtained in spite of the fact that the atomic ratio of Ce/(Ce+Zr+Pr+Nd) is as low as 29%. The high thermal stability can be attributed to the loosely aggregated morphology and the resultant Ce enrichment on the nanoparticle surface, which are caused by supercritical CO2 drying due to the elimination of surface tension effects on the gas-liquid interface.	[Fan, Yunzhao; Wang, Zizi; Xin, Ying; Li, Qian; Zhang, Zhaoliang] Univ Jinan, Sch Chem & Chem Engn, Jinan, Peoples R China; [Wang, Yingxia] Peking Univ, State Key Lab Rare Earth Mat Chem & Applicat, Beijing 100871, Peoples R China	University of Jinan; Peking University	Zhang, ZL (corresponding author), Univ Jinan, Sch Chem & Chem Engn, Jinan, Peoples R China.	chm_zhangzl@ujn.edu.cn			National Natural Science Foundation of China [21077043, 21107030, 21277060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 21077043, 21107030 and 21277060) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JX, 2005, J MOL CATAL A-CHEM, V235, P302, DOI 10.1016/j.molcata.2005.04.023; Dobrosz-Gomez I, 2012, CATAL TODAY, V191, P142, DOI 10.1016/j.cattod.2011.12.031; Epifani M, 2012, ADV FUNCT MATER, V22, P2867, DOI 10.1002/adfm.201200380; Gennari FC, 2011, APPL CATAL A-GEN, V398, P123, DOI 10.1016/j.apcata.2011.03.022; Kaspar J, 2003, J SOLID STATE CHEM, V171, P19, DOI 10.1016/S0022-4596(02)00141-X; Kaspar J, 2001, TOP CATAL, V16, P83, DOI 10.1023/A:1016682831177; Kaspar J, 1999, CATAL TODAY, V50, P285, DOI 10.1016/S0920-5861(98)00510-0; Kim JR, 2007, APPL CATAL B-ENVIRON, V71, P57, DOI 10.1016/j.apcatb.2006.08.015; Kim JR, 2012, CATAL TODAY, V185, P25, DOI 10.1016/j.cattod.2011.08.018; Li P, 2012, ENVIRON SCI TECHNOL, V46, P9600, DOI 10.1021/es301661r; Morikawa A, 2008, APPL CATAL B-ENVIRON, V78, P210, DOI 10.1016/j.apcatb.2007.09.013; Putna ES, 1998, CATAL LETT, V54, P17, DOI 10.1023/A:1019059401500; Shimoyama Y, 2010, CHEM ENG RES DES, V88, P1427, DOI 10.1016/j.cherd.2010.02.018; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Sugiura M, 2003, CATAL SURV ASIA, V7, P77, DOI 10.1023/A:1023488709527; Sui RH, 2006, LANGMUIR, V22, P4390, DOI 10.1021/la053513y; Thundathil MA, 2004, J AM CERAM SOC, V87, P1442, DOI 10.1111/j.1551-2916.2004.01442.x; Wang QY, 2011, J MOL CATAL A-CHEM, V344, P132, DOI 10.1016/j.molcata.2011.05.011; Wang QY, 2010, APPL CATAL B-ENVIRON, V100, P516, DOI 10.1016/j.apcatb.2010.09.004; Wang QY, 2010, ENVIRON SCI TECHNOL, V44, P3870, DOI 10.1021/es903957e; Wang XH, 2007, CATAL TODAY, V126, P412, DOI 10.1016/j.cattod.2007.06.009; WARD DA, 1993, CHEM MATER, V5, P956, DOI 10.1021/cm00031a014; Wu XD, 2007, SOLID STATE SCI, V9, P636, DOI 10.1016/j.solidstatesciences.2007.04.016; Yamazaki S, 2000, SOLID STATE IONICS, V136, P913, DOI 10.1016/S0167-2738(00)00569-5; Ye L, 2013, J SOL-GEL SCI TECHN, V65, P150, DOI 10.1007/s10971-012-2919-z; Ye Q, 2012, APPL CATAL A-GEN, V431, P42, DOI 10.1016/j.apcata.2012.04.014; Zhang F, 2006, J AM CERAM SOC, V89, P1028, DOI 10.1111/j.1551-2916.2005.00788.x; Zhang ZL, 2007, APPL CATAL B-ENVIRON, V76, P335, DOI 10.1016/j.apcatb.2007.06.011; Zhang ZL, 2010, J CATAL, V276, P16, DOI 10.1016/j.jcat.2010.08.017	29	2	2	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88236	10.1371/journal.pone.0088236	http://dx.doi.org/10.1371/journal.pone.0088236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516618	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400044
J	Geuze, J; Farquhar, J; Desain, P				Geuze, Jeroen; Farquhar, Jason; Desain, Peter			Towards a Communication Brain Computer Interface Based on Semantic Relations	PLOS ONE			English	Article							P300	This article investigates a possible Brain Computer Interface (BCI) based on semantic relations. The BCI determines which prime word a subject has in mind by presenting probe words using an intelligent algorithm. Subjects indicate when a presented probe word is related to the prime word by a single finger tap. The detection of the neural signal associated with this movement is used by the BCI to decode the prime word. The movement detector combined both the evoked (ERP) and induced (ERD) responses elicited with the movement. Single trial movement detection had an average accuracy of 67%. The decoding of the prime word had an average accuracy of 38% when using 100 probes and 150 possible targets, and 41% after applying a dynamic stopping criterium, reducing the average number of probes to 47. The article shows that the intelligent algorithm used to present the probe words has a significantly higher performance than a random selection of probes. Simulations demonstrate that the BCI also works with larger vocabulary sizes, and the performance scales logarithmically with vocabulary size.	[Geuze, Jeroen; Farquhar, Jason; Desain, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Geuze, J (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	j.geuze@donders.ru.nl			BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This research was funded by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2013, BIOL MED PHYS BIOMED, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]; Belitski A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025022; Blankertz B., 2006, P 3 INT BRAIN COMP I; Blokland Y, 2013, IEEE T NEURAL SYSTEM; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; De Deyne S, 2008, BEHAV RES METHODS, V40, P198, DOI 10.3758/BRM.40.1.198; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Field A., 2012, DISCOVERING STAT USI; Geuze J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060377; Hohne J, 2010, IEEE ENG MED BIO, P4185, DOI 10.1109/IEMBS.2010.5627379; Huth AG, 2012, NEURON, V76, P1210, DOI 10.1016/j.neuron.2012.10.014; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Kleiner M, 2007, PERCEPTION, V36, P14; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Scherer R, 2008, IEEE T BIO-MED ENG, V55, P675, DOI 10.1109/TBME.2007.903709; Schoenmakers S, 2013, NEUROIMAGE, V83, P951, DOI 10.1016/j.neuroimage.2013.07.043; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00112; Simanova I, 2012, CEREBRAL CORTEX; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	31	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87511	10.1371/journal.pone.0087511	http://dx.doi.org/10.1371/journal.pone.0087511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516552	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400013
J	Elbaz, HA; Lee, I; Antwih, DA; Liu, J; Huttemann, M; Zielske, SP				Elbaz, Hosam A.; Lee, Icksoo; Antwih, Deborah A.; Liu, Jenney; Huettemann, Maik; Zielske, Steven P.			Epicatechin Stimulates Mitochondrial Activity and Selectively Sensitizes Cancer Cells to Radiation	PLOS ONE			English	Article							IN-VITRO; POLYPHENOLS; SENESCENCE; DISEASE; GROWTH; COCOA; CHAIN	Radiotherapy is the treatment of choice for solid tumors including pancreatic cancer, but the effectiveness of treatment is limited by radiation resistance. Resistance to chemotherapy or radiotherapy is associated with reduced mitochondrial respiration and drugs that stimulate mitochondrial respiration may decrease radiation resistance. The objectives of this study were to evaluate the potential of (-)-epicatechin to stimulate mitochondrial respiration in cancer cells and to selectively sensitize cancer cells to radiation. We investigated the natural compound (-)-epicatechin for effects on mitochondrial respiration and radiation resistance of pancreatic and glioblastoma cancer cells using a Clark type oxygen electrode, clonogenic survival assays, and Western blot analyses. (-)-Epicatechin stimulated mitochondrial respiration and oxygen consumption in Panc-1 cells. Human normal fibroblasts were not affected. (-)-Epicatechin sensitized Panc-1, U87, and MIA PaCa-2 cells with an average radiation enhancement factor (REF) of 1.7, 1.5, and 1.2, respectively. (-)-Epicatechin did not sensitize normal fibroblast cells to ionizing radiation with a REF of 0.9, suggesting cancer cell selectivity. (-)-Epicatechin enhanced Chk2 phosphorylation and p21 induction when combined with radiation in cancer, but not normal, cells. Taken together, (-)-epicatechin radiosensitized cancer cells, but not normal cells, and may be a promising candidate for pancreatic cancer treatment when combined with radiation.	[Elbaz, Hosam A.; Antwih, Deborah A.; Zielske, Steven P.] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA; [Elbaz, Hosam A.; Liu, Jenney; Huettemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Huettemann, Maik] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI USA; [Elbaz, Hosam A.; Antwih, Deborah A.; Liu, Jenney; Huettemann, Maik; Zielske, Steven P.] Wayne State Univ, Detroit, MI USA; [Elbaz, Hosam A.; Antwih, Deborah A.; Liu, Jenney; Huettemann, Maik; Zielske, Steven P.] Karmanos Canc Inst, Detroit, MI USA; [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si, Chungcheongnam, South Korea	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Dankook University	Huttemann, M (corresponding author), Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	mhuttema@med.wayne.edu; szielske@med.wayne.edu	Elbaz, Hosam Abdelmonaim/J-6792-2012	Elbaz, Hosam Abdelmonaim/0000-0001-8713-5626; Huttemann, Maik/0000-0001-6310-7081; Multhoff, Gabriele/0000-0002-2616-3137	Karmanos Cancer Institute; Department of Radiation Oncology, Wayne State University; NIH [GM089900]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089900] Funding Source: NIH RePORTER	Karmanos Cancer Institute; Department of Radiation Oncology, Wayne State University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Angelika Burger Joint Postdoctoral Fellowship from the Karmanos Cancer Institute (SPZ and MH), startup funds from the Department of Radiation Oncology, Wayne State University (SPZ), and NIH grant GM089900 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Babich H, 2009, IN VITRO CELL DEV-AN, V45, P226, DOI 10.1007/s11626-008-9168-z; Budworth H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048619; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; Huttemann M, 2012, FASEB J, V26, P1413, DOI 10.1096/fj.11-196154; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Lee JS, 2010, TOXICOL LETT, V199, P308, DOI 10.1016/j.toxlet.2010.09.013; Liu Y, 2013, EMBO MOL MED, V5, P149, DOI 10.1002/emmm.201201378; Mah Li-Jeen, 2011, Genome Integr, V2, P3, DOI 10.1186/2041-9414-2-3; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Raffoul JJ, 2007, INT J CANCER, V120, P2491, DOI 10.1002/ijc.22548; Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Shin HA, 2013, J RAD RES; Shin YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069151; Siddique HR, 2012, INT J CANCER, V131, P1720, DOI 10.1002/ijc.27409; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stan SD, 2010, NAT REV GASTRO HEPAT, V7, P347, DOI 10.1038/nrgastro.2010.61; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Wang Z, 2012, EVIDENCE BASED COMPL, V2012; Ward IM, 2001, J BIOL CHEM, V276, P47755, DOI 10.1074/jbc.C100587200; Yamamori T, 2012, FREE RADICAL BIO MED, V53, P260, DOI 10.1016/j.freeradbiomed.2012.04.033; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079; Yin CQ, 2012, CRIT REV EUKAR GENE, V22, P17, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.20; Zhang JH, 2012, CHEM RES CHINESE U, V28, P153	33	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88322	10.1371/journal.pone.0088322	http://dx.doi.org/10.1371/journal.pone.0088322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516636	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700061
J	McArthur, CC; Meredith, JM; Eggleston, P				McArthur, Clare C.; Meredith, Janet M.; Eggleston, Paul			Transgenic Anopheles gambiae Expressing an Antimalarial Peptide Suffer No Significant Fitness Cost	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSPOSABLE ELEMENT; STEPHENSI MOSQUITOS; MALARIA PARASITE; BODY-SIZE; CULICIDAE; FECUNDITY; DIPTERA; GENE; DROSOPHILA	Mosquito-borne diseases present some of the greatest health challenges faced by the world today. In many cases, existing control measures are compromised by insecticide resistance, pathogen tolerance to drugs and the lack of effective vaccines. In light of these difficulties, new genetic tools for disease control programmes, based on the deployment of genetically modified mosquitoes, are seen as having great promise. Transgenic strains may be used to control disease transmission either by suppressing vector populations or by replacing susceptible with refractory genotypes. In practice, the fitness of the transgenic strain relative to natural mosquitoes will be a critical determinant of success. We previously described a transgenic strain of Anopheles gambiae expressing the Vida3 peptide into the female midgut following a blood-meal, which exhibited significant protection against malaria parasites. Here, we investigated the fitness of this strain relative to non-transgenic controls through comparisons of various life history traits. Experiments were designed, as far as possible, to equalize genetic backgrounds and heterogeneity such that fitness comparisons focussed on the presence and expression of the transgene cassette. We also employed reciprocal crosses to identify any fitness disturbance associated with inheritance of the transgene from either the male or female parent. We found no evidence that the presence or expression of the effector transgene or associated fluorescence markers caused any significant fitness cost in relation to larval mortality, pupal sex ratio, fecundity, hatch rate or longevity of blood-fed females. In fact, fecundity was increased in transgenic strains. We did, however, observe some fitness disturbances associated with the route of inheritance of the transgene. Maternal inheritance delayed male pupation whilst paternal inheritance increased adult longevity for both males and unfed females. Overall, in comparison to controls, there was no evidence of significant fitness costs associated with the presence or expression of transgenes in this strain.	[McArthur, Clare C.; Meredith, Janet M.; Eggleston, Paul] Keele Univ, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England	Keele University	Eggleston, P (corresponding author), Keele Univ, Ctr Appl Entomol & Parasitol, Keele ST5 5BG, Staffs, England.	p.eggleston@keele.ac.uk			Wellcome Trust [084582]; European Union [228421]	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission)	The authors are grateful for financial support from the Wellcome Trust (http://www.wellcome.ac.uk/) through Programme Grant 084582 to PE and to the European Union (http://cordis.europa.eu/fp7/home_en.html) through FP7 Infrastructures Award 228421 to PE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Amenya DA, 2010, INSECT MOL BIOL, V19, P263, DOI 10.1111/j.1365-2583.2009.00986.x; An CJ, 2011, CELL MOL LIFE SCI, V68, P1929, DOI 10.1007/s00018-010-0543-z; Arrighi RBG, 2002, ANTIMICROB AGENTS CH, V46, P2104, DOI 10.1128/AAC.46.7.2104-2110.2002; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; Corby-Harris V, 2010, PLOS PATHOG, V6, DOI [10.1371/journal.ppat.1001003, 10.1371/annotation/738ac91f-8c41-4bf5-9a39-bddf0b777a89]; Dao A, 2010, J MED ENTOMOL, V47, P769, DOI 10.1603/ME10052; Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184; Diaz H, 2011, J THEOR BIOL, V276, P57, DOI 10.1016/j.jtbi.2011.01.053; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; Huho BJ, 2007, J EXP BIOL, V210, P2939, DOI 10.1242/jeb.005033; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; Isaacs AT, 2012, P NATL ACAD SCI USA, V109, pE1922, DOI 10.1073/pnas.1207738109; Isaacs AT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002017; Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a; Kirby MJ, 2009, ACTA TROP, V109, P118, DOI 10.1016/j.actatropica.2008.09.025; Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261; Koenraadt CJM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-92; Lambrechts L, 2007, AM J TROP MED HYG, V76, P475, DOI 10.4269/ajtmh.2007.76.475; Li CY, 2008, J HERED, V99, P275, DOI 10.1093/jhered/esn004; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Meredith JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014587; Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337; Moreira LA, 2002, J BIOL CHEM, V277, P40839, DOI 10.1074/jbc.M206647200; Nghabi KR, 2008, ANIM BEHAV, V76, P105, DOI 10.1016/j.anbehav.2008.01.014; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; Okanda F.M., 2002, Malaria Journal, pUnpaginated, DOI 10.1186/1475-2875-1-10; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; Yoshida S, 2007, PLOS PATHOG, V3, P1962, DOI 10.1371/journal.ppat.0030192	43	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88625	10.1371/journal.pone.0088625	http://dx.doi.org/10.1371/journal.pone.0088625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516671	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000330830700078
J	Acheva, A; Ghita, M; Patel, G; Prise, KM; Schettino, G				Acheva, Anna; Ghita, Mihaela; Patel, Gaurang; Prise, Kevin M.; Schettino, Giuseppe			Mechanisms of DNA Damage Response to Targeted Irradiation in Organotypic 3D Skin Cultures	PLOS ONE			English	Article							NF-KAPPA-B; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; HUMAN KERATINOCYTES; DIFFERENTIATION; BYSTANDER; CELLS; EXPRESSION; INDUCTION; PATHWAYS	DNA damage (caused by direct cellular exposure and bystander signaling) and the complex pathways involved in its repair are critical events underpinning cellular and tissue response following radiation exposures. There are limited data addressing the dynamics of DNA damage induction and repair in the skin particularly in areas not directly exposed. Here we investigate the mechanisms regulating DNA damage, repair, intracellular signalling and their impact on premature differentiation and development of inflammatory-like response in the irradiated and surrounding areas of a 3D organotypic skin model. Following localized low-LET irradiation (225 kVp X-rays), low levels of 53BP1 foci were observed in the 3D model (3.8 +/- 0.28 foci/Gy/cell) with foci persisting and increasing in size up to 48 h post irradiation. In contrast, in cell monolayers 14.2 +/- 0.6 foci/Gy/cell and biphasic repair kinetics with repair completed before 24 h was observed. These differences are linked to differences in cellular status with variable level of p21 driving apoptotic signalling in 2D and accelerated differentiation in both the directly irradiated and bystander areas of the 3D model. The signalling pathways utilized by irradiated keratinocytes to induce DNA damage in non-exposed areas of the skin involved the NF-kappa B transcription factor and its downstream target COX-2.	[Acheva, Anna; Ghita, Mihaela; Patel, Gaurang; Prise, Kevin M.; Schettino, Giuseppe] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Acheva, Anna] Radiat & Nucl Safety Author, Helsinki, Finland; [Schettino, Giuseppe] Natl Phys Lab, London, England	Queens University Belfast; Radiation & Nuclear Safety Authority (STUK); National Physical Laboratory - UK	Acheva, A (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	Anna.Acheva@stuk.fi	Prise, Kevin/N-7872-2015; Schettino, Giuseppe/X-1983-2018; Ghita, Mihaela/J-3797-2019	Prise, Kevin/0000-0001-6134-7946; Schettino, Giuseppe/0000-0003-3284-3953; Acheva, Anna/0000-0001-9447-8977	Non-targeted Effects of Ionizing Radiation project under the Euratom specific programme for research and training on nuclear energy, 6th Framework Programme [FI6R474 CT-2006-036465]; Cancer Research UK [CR-UK] [C1513/A7047]	Non-targeted Effects of Ionizing Radiation project under the Euratom specific programme for research and training on nuclear energy, 6th Framework Programme; Cancer Research UK [CR-UK](Cancer Research UK)	This work was supported by financial grant Non-targeted Effects of Ionizing Radiation) project (FI6R474 CT-2006-036465) under the Euratom specific programme for research and training on nuclear energy, 6th Framework Programme; and also Cancer Research UK [CR-UK] (C1513/A7047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Asaithamby A, 2011, P NATL ACAD SCI USA, V108, P8293, DOI 10.1073/pnas.1016045108; ASSELINEAU D, 1984, BRIT J DERMATOL, V111, P219, DOI 10.1111/j.1365-2133.1984.tb15608.x; Barcellos-Hoff MH, 2001, RADIAT RES, V156, P618, DOI 10.1667/0033-7587(2001)156[0618:ESTTMA]2.0.CO;2; BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Belyakov OV, 2006, MUTAT RES-FUND MOL M, V597, P43, DOI 10.1016/j.mrfmmm.2005.08.012; Blundell R.A., 2006, AM J BIOCH BIOTECHNO, V2, P33, DOI DOI 10.3844/AJBBSP.2006.33.40; Bouquet F, 2006, CELL CYCLE, V5, P1116, DOI 10.4161/cc.5.10.2799; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Hung JH, 2004, J BIOL CHEM, V279, P46384, DOI 10.1074/jbc.M403568200; ILIAKIS G, 1990, CANCER RES, V50, P6575; Iversen L, 2005, EUR J DERMATOL, V15, P4; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kuechle MK, 2000, CELL DEATH DIFFER, V7, P566, DOI 10.1038/sj.cdd.4400687; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lee SJ, 1998, ONCOGENE, V17, P1821, DOI 10.1038/sj.onc.1202088; Lyng FM, 2006, RADIAT RES, V165, P400, DOI 10.1667/RR3527.1; Maalouf SW, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-58; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Muller K, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2007.01.017; NAMBA H, 1995, CANCER RES, V55, P2075; Pataky K, 2009, RADIAT RES, V172, P252, DOI 10.1667/RR1483.1; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Regnier MP, 1981, FRONT MATRIX BIOL, V9, P4; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Schettino G, 2010, INT J RADIAT BIOL, V86, P593, DOI 10.3109/09553001003734535; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Sonis ST, 2004, ORAL ONCOL, V40, P170, DOI 10.1016/S1368-8375(03)00148-9; Suzuki K, 2010, RADIAT RES, V174, P415, DOI 10.1667/RR2007.1; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; TSUNENAGA M, 1994, JPN J CANCER RES, V85, P238, DOI 10.1111/j.1349-7006.1994.tb02088.x; van den Bosch M, 2003, EMBO REP, V4, P844, DOI 10.1038/sj.embor.embor925; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wu KK, 1996, J LAB CLIN MED, V128, P242, DOI 10.1016/S0022-2143(96)90023-2; Yamauchi M, 2008, DNA REPAIR, V7, P405, DOI 10.1016/j.dnarep.2007.11.011; Zhou H, 2008, P NATL ACAD SCI USA, V97, P2099	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86092	10.1371/journal.pone.0086092	http://dx.doi.org/10.1371/journal.pone.0086092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505255	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200015
J	Anantharaman, D; Chabrier, A; Gaborieau, V; Franceschi, S; Herrero, R; Rajkumar, T; Samant, T; Mahimkar, MB; Brennan, P; Mckay, JD				Anantharaman, Devasena; Chabrier, Amelie; Gaborieau, Valerie; Franceschi, Silvia; Herrero, Rolando; Rajkumar, Thangarajan; Samant, Tanuja; Mahimkar, Manoj B.; Brennan, Paul; Mckay, James D.			Genetic Variants in Nicotine Addiction and Alcohol Metabolism Genes, Oral Cancer Risk and the Propensity to Smoke and Drink Alcohol: A Replication Study in India	PLOS ONE			English	Article							AERODIGESTIVE TRACT CANCERS; SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; SOUTHERN INDIA; SUSCEPTIBILITY LOCUS; HUMAN-PAPILLOMAVIRUS; TOBACCO SMOKING; POLYMORPHISMS; ASSOCIATION; EXPOSURE	Background: Genetic variants in nicotinic acetylcholine receptor and alcohol metabolism genes have been associated with propensity to smoke tobacco and drink alcohol, respectively, and also implicated in genetic susceptibility to head and neck cancer. In addition to smoking and alcohol, tobacco chewing is an important oral cancer risk factor in India. It is not known if these genetic variants influence propensity or oral cancer susceptibility in the context of this distinct etiology. Methods: We examined 639 oral and pharyngeal cancer cases and 791 controls from two case-control studies conducted in India. We investigated six variants known to influence nicotine addiction or alcohol metabolism, including rs16969968 (CHRNA5), rs578776 (CHRNA3), rs1229984 (ADH1B), rs698 (ADH1C), rs1573496 (ADH7), and rs4767364 (ALDH2). Results: The CHRN variants were associated with the number of chewing events per day, including in those who chewed tobacco but never smoked (P = 0.003, P = 0.01 for rs16969968 and rs578776 respectively). Presence of the variant allele contributed to approximately 13% difference in chewing frequency compared to non-carriers. While no association was observed between rs16969968 and oral cancer risk (OR = 1.01, 95% CI = 0.83-1.22), rs578776 was modestly associated with a 16% decreased risk of oral cancer (OR = 0.84, 95% CI = 0.72-0.98). There was little evidence for association between polymorphisms in genes encoding alcohol metabolism and oral cancer in this population. Conclusion: The association between rs16969968 and number of chewing events implies that the effect on smoking propensity conferred by this gene variant extends to the use of smokeless tobacco.	[Anantharaman, Devasena; Gaborieau, Valerie; Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Chabrier, Amelie; Mckay, James D.] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France; [Franceschi, Silvia] Int Agcy Res Canc, Infect & Canc Epidemiol Grp, F-69372 Lyon, France; [Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, F-69372 Lyon, France; [Rajkumar, Thangarajan] Inst Canc Res, Dept Mol Oncol, Chennai, Tamil Nadu, India; [Samant, Tanuja; Mahimkar, Manoj B.] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Mahimkar Lab, Navi Mumbai, India	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Mckay, JD (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	gcs@iarc.fr	RAJKUMAR, THANGARAJAN/AAZ-5663-2020; franceschi, silvia/M-2452-2014	franceschi, silvia/0000-0003-4181-8071	International Agency for Research on Cancer; Department of Biotechnology, Government of India [BT/PR 2277/09/333/2000]; National Institute of Dental and Craniofacial Research [R03 DE020116]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020116] Funding Source: NIH RePORTER	International Agency for Research on Cancer; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The International oral cancer study was funded by the International Agency for Research on Cancer. The Mumbai study was supported by the Department of Biotechnology, Government of India (BT/PR 2277/09/333/2000). The National Institute of Dental and Craniofacial Research grant funded the laboratory analyses for this study (R03 DE020116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anantharaman D, 2007, CARCINOGENESIS, V28, P1455, DOI 10.1093/carcin/bgm038; Anantharaman D, 2013, JNCI-J NATL CANCER I, V105, P536, DOI 10.1093/jnci/djt053; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Balaram P, 2002, INT J CANCER, V98, P440, DOI 10.1002/ijc.10200; Cancela MD, 2009, COMMUNITY DENT ORAL, V37, P342, DOI 10.1111/j.1600-0528.2009.00475.x; Chang JS, 2012, MUTAGENESIS, V27, P275, DOI 10.1093/mutage/ger073; Chen D, 2011, CANCER EPIDEM BIOMAR, V20, P658, DOI 10.1158/1055-9965.EPI-10-1008; Ding JH, 2009, WORLD J GASTROENTERO, V15, P2395, DOI 10.3748/wjg.15.2395; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Ferlay J, 2012, IARC CANC BASE; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gajalakshmi V, 2003, INT J CANCER, V107, P441, DOI 10.1002/ijc.11377; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hindorff LA, CATALOG PUBLISHED GE; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; IARC, 2012, ARSENIC METALS FIBRE, V100C; Jaworowska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025057; Li MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012183; Lips EH, 2010, INT J EPIDEMIOL, V39, P563, DOI 10.1093/ije/dyp288; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Muwonge R, 2008, ORAL ONCOL, V44, P446, DOI 10.1016/j.oraloncology.2007.06.002; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Rajkumar T, 2003, EUR J CANCER PREV, V12, P135, DOI 10.1097/00008469-200304000-00007; Rothman KJ GS, 2009, MODERN EPIDEMIOLOGY; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANKARANARAYANAN R, 1990, INT J CANCER, V45, P879, DOI 10.1002/ijc.2910450517; Seitz HK, 2007, NAT REV CANCER, V7, P599, DOI 10.1038/nrc2191; Solomon PR, 2008, ORAL DIS, V14, P633, DOI 10.1111/j.1601-0825.2007.01437.x; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; Timofeeva MN, 2011, CANCER EPIDEM BIOMAR, V20, P2250, DOI 10.1158/1055-9965.EPI-11-0496; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201	38	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88240	10.1371/journal.pone.0088240	http://dx.doi.org/10.1371/journal.pone.0088240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505444	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200148
J	Dunning, KR; Anastasi, MR; Zhang, VJ; Russell, DL; Robker, RL				Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L.			Regulation of Fatty Acid Oxidation in Mouse Cumulus-Oocyte Complexes during Maturation and Modulation by PPAR Agonists	PLOS ONE			English	Article							IN-VITRO MATURATION; MESSENGER-RNA LEVELS; ACYL-COA SYNTHETASE; L-CARNITINE; LIPID-METABOLISM; DEVELOPMENTAL COMPETENCE; BETA-OXIDATION; ATP CONTENT; ROSIGLITAZONE; CELLS	Fatty acid oxidation is an important energy source for the oocyte; however, little is known about how this metabolic pathway is regulated in cumulus-oocyte complexes. Analysis of genes involved in fatty acid oxidation showed that many are regulated by the luteinizing hormone surge during in vivo maturation, including acyl-CoA synthetases, carnitine transporters, acyl-CoA dehydrogenases and acetyl-CoA transferase, but that many are dysregulated when cumulus-oocyte complexes are matured under in vitro maturation conditions using follicle stimulating hormone and epidermal growth factor. Fatty acid oxidation, measured as production of (H2O)-H-3 from [H-3] palmitic acid, occurs in mouse cumulus-oocyte complexes in response to the luteinizing hormone surge but is significantly reduced in cumulus-oocyte complexes matured in vitro. Thus we sought to determine whether fatty acid oxidation in cumulus-oocyte complexes could be modulated during in vitro maturation by lipid metabolism regulators, namely peroxisome proliferator activated receptor (PPAR) agonists bezafibrate and rosiglitazone. Bezafibrate showed no effect with increasing dose, while rosiglitazone dose dependently inhibited fatty acid oxidation in cumulus-oocyte complexes during in vitro maturation. To determine the impact of rosiglitazone on oocyte developmental competence, cumulus-oocyte complexes were treated with rosiglitazone during in vitro maturation and gene expression, oocyte mitochondrial activity and embryo development following in vitro fertilization were assessed. Rosiglitazone restored Acsl1, Cpt1b and Acaa2 levels in cumulus-oocyte complexes and increased oocyte mitochondrial membrane potential yet resulted in significantly fewer embryos reaching the morula and hatching blastocyst stages. Thus fatty acid oxidation is increased in cumulus-oocyte complexes matured in vivo and deficient during in vitro maturation, a known model of poor oocyte quality. That rosiglitazone further decreased fatty acid oxidation during in vitro maturation and resulted in poor embryo development points to the developmental importance of fatty acid oxidation and the need for it to be optimized during in vitro maturation to improve this reproductive technology.	[Dunning, Kylie R.; Anastasi, Marie R.; Zhang, Voueleng J.; Russell, Darryl L.; Robker, Rebecca L.] Univ Adelaide, Robinson Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Dunning, KR (corresponding author), Univ Adelaide, Robinson Inst, Sch Paediat & Reprod Hlth, Adelaide, SA, Australia.	kylie.dunning@adelaide.edu.au	Dunning, Kylie/GLU-0471-2022; Russell, Darryl L/I-6654-2012	Dunning, Kylie/0000-0002-0462-6479; Russell, Darryl L/0000-0002-4930-7658; Robker, Rebecca/0000-0002-1538-4604	Discovery Early Career Award from the Australian Research Council [DE120100304]; R.D. Wright Biomedical Research Fellowship from the National Health and Medical Research Council of Australia [1044969]	Discovery Early Career Award from the Australian Research Council; R.D. Wright Biomedical Research Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a Discovery Early Career Award from the Australian Research Council (to KRD, DE120100304) and a R.D. Wright Biomedical Research Fellowship from the National Health and Medical Research Council of Australia (to RLR, 1044969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton BM, 2004, MOL HUM REPROD, V10, P23, DOI 10.1093/molehr/gah004; Benton CR, 2008, J PHYSIOL-LONDON, V586, P1755, DOI 10.1113/jphysiol.2007.146563; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Buckett WM, 2008, FERTIL STERIL, V90, P546, DOI 10.1016/j.fertnstert.2007.06.107; Cabrero A, 2003, METABOLISM, V52, P652, DOI 10.1053/meta.2003.50100; Cabrero A, 2001, DIABETES, V50, P1883, DOI 10.2337/diabetes.50.8.1883; Child TJ, 2002, OBSTET GYNECOL, V100, P665, DOI 10.1016/S0029-7844(02)02193-2; Cho YY, 2001, BIOCHEM BIOPH RES CO, V284, P993, DOI 10.1006/bbrc.2001.5065; Djaouti L, 2010, DIABETES-METAB RES, V26, P297, DOI 10.1002/dmrr.1081; Djouadi F, 2005, J CLIN ENDOCR METAB, V90, P1791, DOI 10.1210/jc.2004-1936; Djouadi F, 2003, PEDIATR RES, V54, P446, DOI 10.1203/01.PDR.0000083001.91588.BB; DOWNS SM, 1995, DEV BIOL, V167, P502, DOI 10.1006/dbio.1995.1044; Downs SM, 2009, MOL REPROD DEV, V76, P844, DOI 10.1002/mrd.21047; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dunning KR, 2007, HUM REPROD, V22, P2842, DOI 10.1093/humrep/dem277; Dunning KR, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096271; Dunning KR, 2011, BIOL REPROD, V85, P548, DOI 10.1095/biolreprod.110.090415; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; EDWARDS RG, 1965, LANCET, V2, P926; Ferguson EM, 2006, MOL REPROD DEV, V73, P1195, DOI 10.1002/mrd.20494; FINOCCHIARO G, 1988, J BIOL CHEM, V263, P15773; Froment P, 2006, J ENDOCRINOL, V189, P199, DOI 10.1677/joe.1.06667; Gilchrist RB, 2007, THERIOGENOLOGY, V67, P6, DOI 10.1016/j.theriogenology.2006.09.027; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Hashimoto S, 2009, J REPROD DEVELOP, V55, P1, DOI 10.1262/jrd.20127; He M, 2003, J BIOL CHEM, V278, P37974, DOI 10.1074/jbc.M306882200; HOMA ST, 1992, J REPROD FERTIL, V94, P153, DOI 10.1530/jrf.0.0940153; Iijima H, 1996, EUR J BIOCHEM, V242, P186, DOI 10.1111/j.1432-1033.1996.0186r.x; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Kang MJ, 1997, P NATL ACAD SCI USA, V94, P2880, DOI 10.1073/pnas.94.7.2880; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Martino NA, 2012, FERTIL STERIL, V97, P720, DOI 10.1016/j.fertnstert.2011.12.014; McKeegan PJ, 2012, REPROD FERT DEVELOP, V24, P59, DOI 10.1071/RD11907; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; O'Gorman A, 2013, REPRODUCTION; Oikawa E, 1998, J BIOCHEM, V124, P679, DOI 10.1093/oxfordjournals.jbchem.a022165; Pei ZT, 2006, J BIOL CHEM, V281, P6632, DOI 10.1074/jbc.M511558200; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Preis KA, 2007, MOL REPROD DEV, V74, P893, DOI 10.1002/mrd.20655; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Somfai T, 2011, REPROD FERT DEVELOP, V23, P912, DOI 10.1071/RD10339; Sprecher DL, 2007, ARTERIOSCL THROM VAS, V27, P359, DOI 10.1161/01.ATV.0000252790.70572.0c; Sugiura K, 2005, REPROD FERT DEVELOP, V17, P667, DOI 10.1071/RD05071; Sutton-McDowall ML, 2004, REPRODUCTION, V128, P313, DOI 10.1530/rep.1.00225; Takahashi T, 2013, REPROD FERT DEVELOP, V25, P589, DOI 10.1071/RD11262; Thompson J G, 2007, Soc Reprod Fertil Suppl, V64, P179; Tsujii H, 2001, J MAMM OVA RES, V18, P73, DOI [DOI 10.1274/JMOR.18.73, 10.1274/jmor.18.73]; Valsangkar D, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109058; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Van Blerkom J, 2003, HUM REPROD, V18, P2429, DOI 10.1093/humrep/deg466; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Van Blerkom J, 2006, REPROD BIOMED ONLINE, V13, P246, DOI 10.1016/S1472-6483(10)60622-0; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vandewalle B, 2008, BIOCHEM BIOPH RES CO, V366, P1096, DOI 10.1016/j.bbrc.2007.12.088; Wang P, 2007, DIABETOLOGIA, V50, P654, DOI 10.1007/s00125-006-0565-0; Wilmsen HM, 2003, AM J PHYSIOL-ENDOC M, V285, pE354, DOI 10.1152/ajpendo.00491.2001; Wu GQ, 2011, THERIOGENOLOGY, V76, P785, DOI 10.1016/j.theriogenology.2011.04.011; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; You J, 2012, THERIOGENOLOGY, V78, P235, DOI 10.1016/j.theriogenology.2012.02.027; Zander-Fox D, 2013, J ASSIST REPROD GEN, V30, P107, DOI 10.1007/s10815-012-9898-4	65	94	96	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87327	10.1371/journal.pone.0087327	http://dx.doi.org/10.1371/journal.pone.0087327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505284	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200043
J	Neuner, I; Arrubla, J; Werner, CJ; Hitz, K; Boers, F; Kawohl, W; Shah, NJ				Neuner, Irene; Arrubla, Jorge; Werner, Cornelius J.; Hitz, Konrad; Boers, Frank; Kawohl, Wolfram; Shah, N. Jon			The Default Mode Network and EEG Regional Spectral Power: A Simultaneous fMRI-EEG Study	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; RESTING-STATE NETWORKS; FUNCTIONAL CONNECTIVITY; BRAIN ACTIVITY; SIGNAL FLUCTUATIONS; ELECTRICAL-ACTIVITY; ALPHA OSCILLATIONS; NEURONAL-ACTIVITY; BLOOD-FLOW; DYNAMICS	Electroencephalography (EEG) frequencies have been linked to specific functions as an "electrophysiological signature" of a function. A combination of oscillatory rhythms has also been described for specific functions, with or without predominance of one specific frequency-band. In a simultaneous fMRI-EEG study at 3 T we studied the relationship between the default mode network (DMN) and the power of EEG frequency bands. As a methodological approach, we applied Multivariate Exploratory Linear Optimized Decomposition into Independent Components (MELODIC) and dual regression analysis for fMRI resting state data. EEG power for the alpha, beta, delta and theta-bands were extracted from the structures forming the DMN in a region-of-interest approach by applying Low Resolution Electromagnetic Tomography (LORETA). A strong link between the spontaneous BOLD response of the left parahippocampal gyrus and the delta-band extracted from the anterior cingulate cortex was found. A positive correlation between the beta-1 frequency power extracted from the posterior cingulate cortex (PCC) and the spontaneous BOLD response of the right supplementary motor cortex was also established. The beta-2 frequency power extracted from the PCC and the precuneus showed a positive correlation with the BOLD response of the right frontal cortex. Our results support the notion of beta-band activity governing the "status quo" in cognitive and motor setup. The highly significant correlation found between the delta power within the DMN and the parahippocampal gyrus is in line with the association of delta frequencies with memory processes. We assumed "ongoing activity" during "resting state" in bringing events from the past to the mind, in which the parahippocampal gyrus is a relevant structure. Our data demonstrate that spontaneous BOLD fluctuations within the DMN are associated with different EEG-bands and strengthen the conclusion that this network is characterized by a specific electrophysiological signature created by combination of different brain rhythms subserving different putative functions.	[Neuner, Irene; Arrubla, Jorge; Boers, Frank; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, INM 4, D-52425 Julich, Germany; [Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Neuner, Irene; Shah, N. Jon] Rhein Westfal TH Aachen, JARA BRAIN Translat Med, Aachen, Germany; [Werner, Cornelius J.; Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Hitz, Konrad; Kawohl, Wolfram] Psychiat Univ Hosp Zurich, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Zurich	Neuner, I (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med 4, INM 4, D-52425 Julich, Germany.	i.neuner@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Neuner, Irene/0000-0002-5164-8873	Marie Curie Initial Training Network (MC-ITN) "Methods in Neuroimaging" [MC-ITN-238593]; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	Marie Curie Initial Training Network (MC-ITN) "Methods in Neuroimaging"; Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association	The authors acknowledge the Marie Curie Initial Training Network (MC-ITN) "Methods in Neuroimaging", project number MC-ITN-238593. This work (NJS) was funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Networking Fund of the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Basar E, 2008, BRAIN RES, V1214, P105, DOI 10.1016/j.brainres.2008.03.042; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Benjamini Y, 2001, ANN STAT, V29, P1165; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Chen ACN, 2008, NEUROIMAGE, V41, P561, DOI 10.1016/j.neuroimage.2007.12.064; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cuspineda ER, 2009, CLIN EEG NEUROSCI, V40, P150, DOI 10.1177/155005940904000306; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; Ekstrom AD, 2013, NEUROIMAGE; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hlinka J, 2010, NEUROIMAGE, V53, P239, DOI 10.1016/j.neuroimage.2010.06.002; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Koles ZJ, 1998, ELECTROEN CLIN NEURO, V106, P127, DOI 10.1016/S0013-4694(97)00115-6; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Laufs H, 2006, NEUROIMAGE, V31, P1408, DOI 10.1016/j.neuroimage.2006.02.002; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2013, NEUROSCIENTIST, V19, P76, DOI 10.1177/1073858412446202; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunez PL, 2000, BRAIN TOPOGR, V13, P79, DOI 10.1023/A:1026683200895; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Sadaghiani S, 2010, J NEUROSCI, V30, P10243, DOI 10.1523/JNEUROSCI.1004-10.2010; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Shah NJ, 2013, J MAGN RESON, V229, P101, DOI 10.1016/j.jmr.2012.11.027; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tagliazucchi E, 2013, P NATL ACAD SCI USA, V110, P15419, DOI 10.1073/pnas.1312848110; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Vanderperren K, 2010, NEUROIMAGE, V50, P920, DOI 10.1016/j.neuroimage.2010.01.010; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Walter D. O., 1968, ELECTROEN CLIN NEURO, P53; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025	71	89	92	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88214	10.1371/journal.pone.0088214	http://dx.doi.org/10.1371/journal.pone.0088214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505434	gold, Green Published, Green Accepted			2022-12-27	WOS:000330829200140
J	Ono, T; Suzuki, Y; Kato, Y; Fujita, R; Araki, T; Yamashita, T; Kato, H; Torii, R; Sato, N				Ono, Takashi; Suzuki, Yutaka; Kato, Yosuke; Fujita, Risako; Araki, Toshihiro; Yamashita, Tomoko; Kato, Hidemasa; Torii, Ryuzo; Sato, Naoya			A Single-Cell and Feeder-Free Culture System for Monkey Embryonic Stem Cells	PLOS ONE			English	Article							ROCK INHIBITOR; SELF-RENEWAL; RECEPTOR; GROWTH; DERIVATION; EXPANSION; ESTABLISHMENT; DISSOCIATION; SURVIVAL; SUPPORTS	Primate pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), hold great potential for research and application in regenerative medicine and drug discovery. To maximize primate PSC potential, a practical system is required for generating desired functional cells and reproducible differentiation techniques. Much progress regarding their culture systems has been reported to date; however, better methods would still be required for their practical use, particularly in industrial and clinical fields. Here we report a new single-cell and feeder-free culture system for primate PSCs, the key feature of which is an originally formulated serum-free medium containing FGF and activin. In this culture system, cynomolgus monkey ESCs can be passaged many times by single-cell dissociation with traditional trypsin treatment and can be propagated with a high proliferation rate as a monolayer without any feeder cells; further, typical PSC properties and genomic stability can be retained. In addition, it has been demonstrated that monkey ESCs maintained in the culture system can be used for various experiments such as in vitro differentiation and gene manipulation. Thus, compared with the conventional culture system, monkey ESCs grown in the aforementioned culture system can serve as a cell source with the following practical advantages: simple, stable, and easy cell maintenance; gene manipulation; cryopreservation; and desired differentiation. We propose that this culture system can serve as a reliable platform to prepare primate PSCs useful for future research and application.	[Ono, Takashi; Suzuki, Yutaka; Kato, Yosuke; Fujita, Risako; Araki, Toshihiro; Yamashita, Tomoko; Sato, Naoya] Mitsubishi Tanabe Pharma Corp, Discovery Screening Ctr, Discovery Mol Pharmacol Dept, Yokohama, Kanagawa, Japan; [Kato, Hidemasa] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama, Japan; [Torii, Ryuzo] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Otsu, Shiga 52021, Japan	Mitsubishi Tanabe Pharma Corporation; Saitama Medical University; Shiga University of Medical Science	Ono, T (corresponding author), Mitsubishi Tanabe Pharma Corp, Discovery Screening Ctr, Discovery Mol Pharmacol Dept, Yokohama, Kanagawa, Japan.	Ono.Takashi@mc.mt-pharma.co.jp		Ono, Takashi/0000-0002-1820-8040	Mitsubishi Tanabe Pharma Corporation	Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This study was funded by Mitsubishi Tanabe Pharma Corporation. The funders had role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Baker M, 2011, NAT METHODS, V8, P293, DOI 10.1038/nmeth0411-293; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chen KG, 2012, STEM CELL RES, V9, P237, DOI 10.1016/j.scr.2012.06.003; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Eiges R, 2001, CURR BIOL, V11, P514, DOI 10.1016/S0960-9822(01)00144-0; Frank S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041958; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kunova M, 2013, STEM CELL TRANSL MED, V2, P246, DOI 10.5966/sctm.2012-0081; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Okahara-Narita J, 2012, PRIMATES, V53, P205, DOI 10.1007/s10329-011-0283-1; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Tonge PD, 2011, STEM CELL RES, V7, P145, DOI 10.1016/j.scr.2011.04.006; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Tsutsui H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1165; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2011, METHODS MOL BIOL, V690, P57, DOI 10.1007/978-1-60761-962-8_3; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wianny F, 2011, DIFFERENTIATION, V81, P142, DOI 10.1016/j.diff.2011.01.008; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	40	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88346	10.1371/journal.pone.0088346	http://dx.doi.org/10.1371/journal.pone.0088346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505480	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200181
J	Sun, C; VanRaden, PM				Sun, Chuanyu; VanRaden, Paul M.			Increasing Long-Term Response by Selecting for Favorable Minor Alleles	PLOS ONE			English	Article							ACCURACY	Long-term response of genomic selection can be improved by considering allele frequencies of selected markers or quantitative trait loci (QTLs). A previous formula to weight allele frequency of favorable minor alleles was tested, and 2 new formulas were developed. The previous formula used nonlinear weights based on square root of frequency of the favorable allele. The new formulas included a parameter delta to balance long- and short-term progress; one used square root and the other used simple linear weights. The formulas were tested by simulation of 20 generations (population size of 3,000 for each generation) with direct selection on 3,000 QTLs (100 per chromosome). A QTL distribution with normally distributed allele effects and a heavy-tailed distribution were tested. Optimum delta from simulation was applied to data from Holstein, Jersey and Brown Swiss dairy cattle to compare differences of adjusted and official genomic evaluations. From simulation, optimum delta was 0.4 for the heavy-tailed QTL distribution but only 0.1 or 0.2 for a normal distribution. The previous formula had slower response than unweighted selection in early generations and did not recover by generation 20. Long-term response was slightly greater with the new formulas than with unweighted selection; the linear formula may be best for routine use because of more progress in early generations compared to nonlinear formula. Official and adjusted U. S. evaluations based on actual genotypes and estimated marker effects were correlated by 0.994 for Holsteins and Jerseys and 0.989 for Brown Swiss using linear weighting of allele frequency, which was higher than nonlinear weighting. The difference between adjusted and official evaluations was highly correlated negatively with an animal's average genomic relationship to the population. Thus, strategies to reduce genomic inbreeding may achieve almost as much long-term progress as selection of favorable minor alleles.	[Sun, Chuanyu] Natl Assoc Anim Breeders, Columbia, MO 65205 USA; [VanRaden, Paul M.] ARS, USDA, Anim Improvement Programs Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Sun, C (corresponding author), Natl Assoc Anim Breeders, Columbia, MO 65205 USA.	chuanyu.sun@ars.usda.gov			National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in United States Department of Agriculture	National Association of Animal Breeders, United States of America; Animal Improvement Programs Laboratory of Agricultural research service in United States Department of Agriculture	The work was performed in the project funded regularly by National Association of Animal Breeders, United States of America (http://www.naab-css.org/) and Animal Improvement Programs Laboratory of Agricultural research service in United States Department of Agriculture (http://aipl.arsusda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREESE E. L., 1956, HEREDITY, V10, P323, DOI 10.1038/hdy.1956.30; Cole JB, 2011, J ANIM BREED GENET, V128, P446, DOI 10.1111/j.1439-0388.2011.00922.x; Dekkers JCM, 1998, GENET RES, V71, P257, DOI 10.1017/S0016672398003267; Falconer D. S., 1989, Introduction to quantitative genetics.; FERNANDO RL, 1986, THEOR APPL GENET, V72, P395, DOI 10.1007/BF00288579; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Jannink JL, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-35; Lu Shao-xiong, 2003, Acta Genetica Sinica, V30, P989; Muir WM, 2007, J ANIM BREED GENET, V124, P342, DOI 10.1111/j.1439-0388.2007.00700.x; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sonesson AK, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-27; Sun C, 2013, J DAIRY, P8014; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VANRADEN PM, 1984, J DAIRY SCI, V67, P1761, DOI 10.3168/jds.S0022-0302(84)81502-7; WILSON SP, 1965, GENET RES, V6, P341, DOI 10.1017/S0016672300004237	17	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88510	10.1371/journal.pone.0088510	http://dx.doi.org/10.1371/journal.pone.0088510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505495	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200195
J	Zhang, JQ; Shen, M; Zhu, CC; Yu, FX; Liu, ZQ; Ally, N; Sun, SC; Li, K; Liu, HL				Zhang, Jia-Qing; Shen, Ming; Zhu, Cheng-Cheng; Yu, Feng-Xiang; Liu, Ze-Qun; Ally, Nazim; Sun, Shao-Chen; Li, Kui; Liu, Hong-Lin			3-Nitropropionic Acid Induces Ovarian Oxidative Stress and Impairs Follicle in Mouse	PLOS ONE			English	Article							IN-VITRO MATURATION; CUMULUS CELLS; MITOCHONDRIAL TOXIN; TELOMERE LENGTH; GRANULOSA-CELLS; IMMUNOHISTOCHEMICAL LOCALIZATION; BLASTOCYST DEVELOPMENT; SUPEROXIDE-DISMUTASE; STIMULATING-HORMONE; HUNTINGTONS-DISEASE	Oxidative stress induces many serious reproductive diseases in female mammals and thus poses a serious threat to reproductive health. However, the relationship between reactive oxygen species (ROS)-induced oxidative stress and follicular development, oocyte and embryo quality is not clear. The aim of this study was to investigate the effect of ovarian oxidative stress on the health of follicle and oocyte development. Female ICR mice were dosed with 3-nitropropionic acid (3-NPA) at three different concentrations (6.25, 12.5 and 25 mg/kg) and saline (control) via continuous intraperitoneal injection for 7 days. The treatment with 12.5 mg/kg reduced the weight of mouse ovaries, and significantly increased ROS levels and the activities of antioxidant enzymes-total superoxide dismutase (T-SOD), glutathione peroxidase (GPx) and catalase (CAT) - in granulosa cells and ovarian tissues, but not in other tissues (brain, liver, kidney and spleen). The same treatment significantly increased the percentage of atretic large follicles, and reduced the number of large follicles, the number of ovulated oocytes, and the capacity for early embryonic development compared with controls. It also significantly decreased the ratio of Bcl-2 to Bax, while causing an increase in the mRNA expression of (SOD2, CAT and GP(X)) and ROS levels in granulosa cells. Collectively, these data indicate that 3-NPA induces granulosa cell apoptosis, large follicle atresia, and an increase of ROS levels in the ovary. Therefore, we have established an in vivo model of ovarian oxidative stress for studying the mechanism of resulting damage induced by free radicals and for the screening of novel antioxidants.	[Zhang, Jia-Qing; Shen, Ming; Zhu, Cheng-Cheng; Yu, Feng-Xiang; Liu, Ze-Qun; Ally, Nazim; Sun, Shao-Chen; Liu, Hong-Lin] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China; [Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Liu, HL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China.	liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	key project of the Chinese National Programs for Fundamental Research and Development (973 Program) [2014CB138502]	key project of the Chinese National Programs for Fundamental Research and Development (973 Program)(National Basic Research Program of China)	This work was supported by a grant from a key project of the Chinese National Programs for Fundamental Research and Development (973 Program 2014CB138502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2006, CURR OPIN OBSTET GYN, V18, P325, DOI 10.1097/01.gco.0000193003.58158.4e; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Bacsi A, 2006, MITOCHONDRION, V6, P235, DOI 10.1016/j.mito.2006.07.008; Banu SK, 2008, TOXICOL APPL PHARM, V232, P180, DOI 10.1016/j.taap.2008.06.002; Behrman HR, 2001, J SOC GYNECOL INVEST, V8, pS40, DOI 10.1016/S1071-5576(00)00106-4; Bernal AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015558; Binienda Z, 1999, ANN NY ACAD SCI, V890, P173, DOI 10.1111/j.1749-6632.1999.tb07992.x; Bogdanov MB, 1998, J NEUROCHEM, V71, P2642; Bojovic B., 2012, ONCOGENE; Borgeest C, 2002, TOXICOL SCI, V68, P473, DOI 10.1093/toxsci/68.2.473; Buczynska Alina, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P331; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cetica PD, 2001, IUBMB LIFE, V51, P57, DOI 10.1080/15216540152035073; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; Corn CM, 2005, FERTIL STERIL, V84, P627, DOI 10.1016/j.fertnstert.2005.03.061; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Das S, 2006, HUM REPROD, V21, P2403, DOI 10.1093/humrep/del156; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Fatehi AN, 2005, ZYGOTE, V13, P177, DOI 10.1017/S0967199405003126; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Fontaine M A, 2000, J Neurochem, V75, P1709, DOI 10.1046/j.1471-4159.2000.0751709.x; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Goud AP, 2008, FREE RADICAL BIO MED, V44, P1295, DOI 10.1016/j.freeradbiomed.2007.11.014; Gupta RK, 2006, TOXICOL SCI, V93, P382, DOI 10.1093/toxsci/kfl052; Hanoux V, 2007, CELL DEATH DIFFER, V14, P671, DOI 10.1038/sj.cdd.4402052; Hoyer PB, 2001, TOXICOL PATHOL, V29, P91, DOI 10.1080/019262301301418892; Hubscher CH, 2005, BIOTECH HISTOCHEM, V80, P79, DOI 10.1080/10520290500138422; Jancar N, 2007, J ASSIST REPROD GEN, V24, P91, DOI 10.1007/s10815-006-9103-8; Jewgenow K, 1999, THERIOGENOLOGY, V51, P745, DOI 10.1016/S0093-691X(99)00023-0; Jurisicova A, 2007, J CLIN INVEST, V117, P3971, DOI 10.1172/JCI28493; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Kulkarni SK, 1999, HDB EXPT PHARM, P123; Lee CJ, 2000, ANIM REPROD SCI, V59, P109, DOI 10.1016/S0378-4320(00)00072-5; Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353; Lima-Verde IB, 2007, MED VET-RECIFE, V1, P81; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Miyamoto K, 2010, FREE RADICAL BIO MED, V49, P674, DOI 10.1016/j.freeradbiomed.2010.05.025; NODA Y, 1991, MOL REPROD DEV, V28, P356, DOI 10.1002/mrd.1080280408; Ohgoh M, 2000, J NEUROCHEM, V75, P925, DOI 10.1046/j.1471-4159.2000.0750925.x; Ortega-Camarillo C, 2009, REPRODUCTION, V137, P979, DOI 10.1530/REP-08-0463; Pang Z, 1997, J NEUROSCI, V17, P3064; Paszkowski T, 2002, HUM REPROD, V17, P921, DOI 10.1093/humrep/17.4.921; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Sandhir R, 2010, NEUROCHEM INT, V57, P579, DOI 10.1016/j.neuint.2010.07.005; Seino T, 2002, FERTIL STERIL, V77, P1184, DOI 10.1016/S0015-0282(02)03103-5; Shen M, 2012, J BIOL CHEM, V287, P25727, DOI 10.1074/jbc.M112.349902; SHIOTANI M, 1991, HUM REPROD, V6, P1349, DOI 10.1093/oxfordjournals.humrep.a137267; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sugino Norihiro, 2005, Reprod Med Biol, V4, P31, DOI 10.1111/j.1447-0578.2005.00086.x; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Suzuki T, 1999, FERTIL STERIL, V72, P720, DOI 10.1016/S0015-0282(99)00332-5; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; Tamura H, 2008, J PINEAL RES, V44, P280, DOI 10.1111/j.1600-079X.2007.00524.X; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; Taupeau C, 2001, REPROD TOXICOL, V15, P385, DOI 10.1016/S0890-6238(01)00139-3; TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242; Tilly JL, 1998, TOXICOL LETT, V103, P497, DOI 10.1016/S0378-4274(98)00240-9; Tsai-Turton M, 2006, ENDOCRINOLOGY, V147, P1224, DOI 10.1210/en.2005-1281; Tunez I, 2004, J PINEAL RES, V37, P252, DOI 10.1111/j.1600-079X.2004.00163.x; Tuttle AM, 2009, HUM REPROD, V24, P1452, DOI 10.1093/humrep/dep023; Urani A, 2001, J PHARMACOL EXP THER, V298, P1269; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; WANG XN, 1991, BIOL REPROD, V44, P857, DOI 10.1095/biolreprod44.5.857; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054; Zhang X, 2006, J SOC GYNECOL INVEST, V13, P451, DOI 10.1016/j.jsgi.2006.05.005	69	64	71	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86589	10.1371/journal.pone.0086589	http://dx.doi.org/10.1371/journal.pone.0086589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505260	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200020
J	de Biase, D; Visani, M; Baccarini, P; Polifemo, AM; Maimone, A; Fornelli, A; Giuliani, A; Zanini, N; Fabbri, C; Pession, A; Tallini, G				de Biase, Dario; Visani, Michela; Baccarini, Paola; Polifemo, Anna Maria; Maimone, Antonella; Fornelli, Adele; Giuliani, Adriana; Zanini, Nicola; Fabbri, Carlo; Pession, Annalisa; Tallini, Giovanni			Next Generation Sequencing Improves the Accuracy of KRAS Mutation Analysis in Endoscopic Ultrasound Fine Needle Aspiration Pancreatic Lesions	PLOS ONE			English	Article							K-RAS GENE; CANCER; DIAGNOSIS; NEOPLASMS; UTILITY; CLASSIFICATION; HYBRIDIZATION; TISSUE; TUMORS; BRAF	The use of endoscopic ultrasonography has allowed for improved detection and pathologic analysis of fine needle aspirate material for pancreatic lesion diagnosis. The molecular analysis of KRAS has further improved the clinical sensitivity of preoperative analysis. For this reason, the use of highly analytical sensitive and specific molecular tests in the analysis of material from fine needle aspirate specimens has become of great importance. In the present study, 60 specimens from endoscopic ultrasonography fine needle aspirate were analyzed for KRAS exon 2 and exon 3 mutations, using three different techniques: Sanger sequencing, allele specific locked nucleic acid PCR and Next Generation sequencing (454 GS-Junior, Roche). Moreover, KRAS was also tested in wild-type samples, starting from DNA obtained from cytological smears after pathological evaluation. Sanger sequencing showed a clinical sensitivity for the detection of the KRAS mutation of 42.1%, allele specific locked nucleic acid of 52.8% and Next Generation of 73.7%. In two wild-type cases the re-sequencing starting from selected material allowed to detect a KRAS mutation, increasing the clinical sensitivity of next generation sequencing to 78.95%. The present study demonstrated that the performance of molecular analysis could be improved by using highly analytical sensitive techniques. The Next Generation Sequencing allowed to increase the clinical sensitivity of the test without decreasing the specificity of the analysis. Moreover we observed that it could be useful to repeat the analysis starting from selectable material, such as cytological smears to avoid false negative results.	[de Biase, Dario; Baccarini, Paola; Tallini, Giovanni] Univ Bologna, Bellaria Hosp, Anat Pathol Unit, Dept Med DIMES, Bologna, Italy; [de Biase, Dario; Visani, Michela; Pession, Annalisa] Univ Bologna, Dept Pharmacol & Biotechnol FaBiT, Bologna, Italy; [Polifemo, Anna Maria; Fabbri, Carlo] Bellaria Hosp, Azienda Unita Sanit Locale Bologna, Gastroenterol Unit, Bologna, Italy; [Maimone, Antonella] Univ Ferrara, Sch Gastroenterol, I-44100 Ferrara, Italy; [Fornelli, Adele] Maggiore Hosp, Azienda Unita Sanit Locale Bologna, Anat Pathol Unit, Bologna, Italy; [Giuliani, Adriana] Indiana Univ, Bloomington, IN USA; [Zanini, Nicola] Maggiore Hosp, Azienda Unita Sanit Locale Bologna, Unit Gen Surg, Bologna, Italy	AUSL di Bologna; University of Bologna; University of Bologna; AUSL di Bologna; University of Ferrara; AUSL di Bologna; Indiana University System; Indiana University Bloomington; AUSL di Bologna	de Biase, D (corresponding author), Univ Bologna, Bellaria Hosp, Anat Pathol Unit, Dept Med DIMES, Bologna, Italy.	dario.debiase@unibo.it	Visani, Michela/K-5597-2016; de Biase, Dario/B-9274-2012; Tallini, Giovanni/F-7850-2013; Fabbri, Carlo/AAC-4467-2022; Foschini, Maria P./A-6306-2016	Visani, Michela/0000-0002-9051-2231; de Biase, Dario/0000-0002-0609-8817; Tallini, Giovanni/0000-0003-0113-6682; Fabbri, Carlo/0000-0003-0670-9910; Zanini, Nicola/0000-0002-4877-5759; Foschini, Maria P./0000-0001-7079-7260; Pession, Annalisa/0000-0001-9035-9698	Italian Government MURST [20093XZC57_003]	Italian Government MURST	This study was supported in part by an Italian Government MURST grant (Grant no.20093XZC57_003) to GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Altimari A, 2013, ONCOTARGETS THER, V6, P1057, DOI 10.2147/OTT.S42369; Arvanitakis M, 2004, ENDOSCOPY, V36, P535, DOI 10.1055/s-2004-814401; Bournet B, 2009, ENDOSCOPY, V41, P552, DOI 10.1055/s-0029-1214717; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Chhieng DC, 2007, PANCREATIC CYTOPATHO; Corbo V, 2012, CURR DRUG TARGETS, V13, P744, DOI 10.2174/138945012800564103; Dabritz J, 2005, BRIT J CANCER, V92, P405, DOI 10.1038/sj.bjc.6602319; De Angelis C, 2007, J PANCREAS, V8, P85; Dillon DA, 2000, CANCER J, V6, P294; Fuccio L, 2013, GASTROINTEST ENDOSC; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071; Hong SM, 2011, ARCH PATHOL LAB MED, V135, P716, DOI 10.1043/2010-0566-RA.1; Hruban RH, 2009, HUM PATHOL, V40, P612, DOI 10.1016/j.humpath.2009.01.008; Hruban RHPM., 2007, TUMORS PANCREAS, V4th ed; Iqbal Shahzad, 2012, Patholog Res Int, V2012, P317167, DOI 10.1155/2012/317167; Kamisawa T, 2011, HEPATO-GASTROENTEROL, V58, P174; Kato K, 2012, GASTROENT RES PRACT, V2012; Khalid A, 2006, AM J GASTROENTEROL, V101, P2493, DOI 10.1111/j.1572-0241.2006.00740.x; Khalid A, 2011, PANCREATOLOGY, V11, P482, DOI 10.1159/000331505; Klimstra DS, 2010, INTRADUCTAL PANCREAT; Lauwers GY, 2010, CLASSIFICATION TUMOU; Maluf-Filho F, 2007, J CLIN GASTROENTEROL, V41, P906, DOI 10.1097/MCG.0b013e31805905e9; Matthaei H, 2012, ANN SURG, V255, P326, DOI 10.1097/SLA.0b013e3182378a18; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; Morandi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036084; Oliveira-Cunha M, 2012, PANCREAS, V41, P428, DOI 10.1097/MPA.0b013e3182327a03; Ottenhof Niki A, 2011, Patholog Res Int, V2011, P620601, DOI 10.4061/2011/620601; Panarelli NC, 2012, AM J SURG PATHOL, V36, P1434, DOI 10.1097/PAS.0b013e31825d534a; Petrone MC, 2008, DIGEST LIVER DIS, V40, P847, DOI 10.1016/j.dld.2008.03.019; Reicher S, 2011, PANCREAS, V40, P1057, DOI 10.1097/MPA.0b013e3182200201; Saftoiu A, 2009, J CLIN ULTRASOUND, V37, P1, DOI 10.1002/jcu.20534; Schonleben F, 2008, LANGENBECK ARCH SURG, V393, P289, DOI 10.1007/s00423-008-0285-7; Schonleben F, 2007, CANCER LETT, V249, P242, DOI 10.1016/j.canlet.2006.09.007; SESSA F, 1994, VIRCHOWS ARCH, V425, P357; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Tada M, 2002, CLIN CHIM ACTA, V324, P105, DOI 10.1016/S0009-8981(02)00237-1; Tada M, 2002, AM J GASTROENTEROL, V97, P2263; Traverso L William, 2012, Curr Gastroenterol Rep, V14, P106, DOI 10.1007/s11894-012-0239-7; Turner BG, 2010, WORLD J GASTRO SURG, V2, P337, DOI 10.4240/wjgs.v2.i10.337; Varadarajulu S, 2012, CLIN GASTROENTEROL H, V10, P697, DOI 10.1016/j.cgh.2012.03.017; Visani M, 2013, INT J SURG PATHOL	42	57	57	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87651	10.1371/journal.pone.0087651	http://dx.doi.org/10.1371/journal.pone.0087651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504548	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800055
J	Kojima, M; Higuchi, Y; Yokota, M; Ishii, G; Saito, N; Aoyagi, K; Sasaki, H; Ochiai, A				Kojima, Motohiro; Higuchi, Youichi; Yokota, Mitsuru; Ishii, Genichiro; Saito, Norio; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ochiai, Atsushi			Human Subperitoneal Fibroblast and Cancer Cell Interaction Creates Microenvironment That Enhances Tumor Progression and Metastasis	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; COLORECTAL-CARCINOMA; IN-VITRO; INVASION; DISEASE; TISSUE; EXPRESSION	Backgrounds: Peritoneal invasion in colon cancer is an important prognostic factor. Peritoneal invasion can be objectively identified as periotoneal elastic laminal invasion (ELI) by using elastica stain, and the cancer microenvironment formed by the peritoneal invasion (CMPI) can also be observed. Cases with ELI more frequently show distant metastasis and recurrence. Therefore, CMPI may represent a particular milieu that facilitates tumor progression. Pathological and biological investigations into CMPI may shed light on this possibly distinctive cancer microenvironment. Methods: We analyzed area-specific tissue microarrays to determine the pathological features of CMPI, and propagated subperitoneal fibroblasts (SPFs) and submucosal fibroblasts (SMFs) from human colonic tissue. Biological characteristics and results of gene expression profile analyses were compared to better understand the peritoneal invasion of colon cancer and how this may form a special microenvironment through the interaction with SPFs. Mouse xenograft tumors, derived by coinjection of cancer cells with either SPFs or SMFs, were established to evaluate their active role on tumor progression and metastasis. Results: We found that fibrosis with alpha smooth muscle actin (alpha-SMA) expression was a significant pathological feature of CMPI. The differences in proliferation and gene expression profile analyses suggested SPFs and SMFs were distinct populations, and that SPFs were characterized by a higher expressions of extracellular matrix (ECM)-associated genes. Furthermore, compared with SMFs, SPFs showed more variable alteration in gene expressions after cancer-cell-conditioned medium stimulation. Gene ontology analysis revealed that SPFs-specific upregulated genes were enriched by actin-binding or contractile-associated genes including alpha-SMA encoding ACTA2. Mouse xenograft tumors derived by co-injection of cancer cells with SPFs showed enhancement of tumor growth, metastasis, and capacity for tumor formation compared to those derived from co-injection with cancer cells and SMFs. Conclusions: CMPI is a special microenvironment, and interaction of SPFs and cancer cells within CMPI promote tumor growth and metastasis.	[Kojima, Motohiro; Higuchi, Youichi; Ishii, Genichiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Yokota, Mitsuru; Saito, Norio] Natl Canc Ctr Hosp East, Colorectal & Pelv Surg Div, Kashiwa, Chiba, Japan; [Aoyagi, Kazuhiko; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Ochiai, A (corresponding author), Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan.	aochiai@east.ncc.go.jp	Ishii, Genichiro/E-2913-2012		JSPS KAKENHI [24590458]; 3rd-term Comprehensive 10-year Strategy for Cancer Control [23-A-3]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 3rd-term Comprehensive 10-year Strategy for Cancer Control	This work was supported by JSPS KAKENHI grant number 24590458, and a grant of a 3rd-term Comprehensive 10-year Strategy for Cancer Control (23-A-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, J CLIN PATHOL; BAE YK, 2013, HUM PATHOL IN PRESS; Brannigan AE, 2002, ANN SURG, V235, P507, DOI 10.1097/00000658-200204000-00008; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; DEVRIES JE, 1995, BRIT J CANCER, V71, P271, DOI 10.1038/bjc.1995.55; Dotan E, 2011, SEMIN ONCOL, V38, P511, DOI 10.1053/j.seminoncol.2011.05.005; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoshino A, 2011, CANCER RES, V71, P4769, DOI 10.1158/0008-5472.CAN-10-3228; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawada K, 2007, ONCOGENE, V26, P4679, DOI 10.1038/sj.onc.1210267; KAYE GI, 1968, GASTROENTEROLOGY, V54, P852; KOJIMA M, 2012, FRONT ONCOL IN PRESS; Kojima M, 2010, AM J SURG PATHOL, V34, P1351, DOI 10.1097/PAS.0b013e3181ecfe98; Kumper S, 2011, CANCER CELL, V19, P695, DOI 10.1016/j.ccr.2011.05.021; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LIANG WY, 2013, AM J SURG P IN PRESS; LOCKHARTMUMMERY JP, 1926, BRIT J SURG, V14, P110; MAXIMOW AA, 1942, TXB HISTOLOGY, P54; NEWLAND RC, 1994, CANCER, V73, P2076, DOI 10.1002/1097-0142(19940415)73:8<2076::AID-CNCR2820730811>3.0.CO;2-6; NEWLAND RC, 1987, CANCER, V60, P852, DOI 10.1002/1097-0142(19870815)60:4<852::AID-CNCR2820600422>3.0.CO;2-5; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Oikonomou E, 2007, BRIT J CANCER, V97, P73, DOI 10.1038/sj.bjc.6603835; Polanska UM, 2013, J CELL PHYSIOL, V228, P1651, DOI 10.1002/jcp.24347; Regan MC, 2000, ANN SURG, V231, P46, DOI 10.1097/00000658-200001000-00007; Shepherd NA, 1997, GASTROENTEROLOGY, V112, P1096, DOI 10.1016/S0016-5085(97)70119-7; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Shinto E, 2004, DIS COLON RECTUM, V47, P467, DOI 10.1007/s10350-003-0083-9; Sobin L, 2009, TNM CLASSIFICATION M; Stewart CJR, 2007, HISTOPATHOLOGY, V51, P372, DOI 10.1111/j.1365-2559.2007.02787.x; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; van der Wal JBC, 2007, COLORECTAL DIS, V9, P9, DOI 10.1111/j.1463-1318.2007.01345.x; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Witowski J, 2001, AM J PATHOL, V158, P1441, DOI 10.1016/S0002-9440(10)64095-3; Witowski J, 2006, PERITON DIALYSIS INT, V26, P292	39	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88018	10.1371/journal.pone.0088018	http://dx.doi.org/10.1371/journal.pone.0088018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505356	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300036
J	Ashton, N; Lewis, SG; De Groote, I; Duffy, SM; Bates, M; Bates, R; Hoare, P; Lewis, M; Parfitt, SA; Peglar, S; Williams, C; Stringer, C				Ashton, Nick; Lewis, Simon G.; De Groote, Isabelle; Duffy, Sarah M.; Bates, Martin; Bates, Richard; Hoare, Peter; Lewis, Mark; Parfitt, Simon A.; Peglar, Sylvia; Williams, Craig; Stringer, Chris			Hominin Footprints from Early Pleistocene Deposits at Happisburgh, UK	PLOS ONE			English	Article							EARLY MIDDLE PLEISTOCENE; HUMAN OCCUPATION; WILLANDRA LAKES; STATURE; BRITAIN; LAETOLI; FOOT; ATAPUERCA; HUMANS; ILERET	Investigations at Happisburgh, UK, have revealed the oldest known hominin footprint surface outside Africa at between ca. 1 million and 0.78 million years ago. The site has long been recognised for the preservation of sediments containing Early Pleistocene fauna and flora, but since 2005 has also yielded humanly made flint artefacts, extending the record of human occupation of northern Europe by at least 350,000 years. The sediments consist of sands, gravels and laminated silts laid down by a large river within the upper reaches of its estuary. In May 2013 extensive areas of the laminated sediments were exposed on the foreshore. On the surface of one of the laminated silt horizons a series of hollows was revealed in an area of ca. 12 m(2). The surface was recorded using multi-image photogrammetry which showed that the hollows are distinctly elongated and the majority fall within the range of juvenile to adult hominin foot sizes. In many cases the arch and front/back of the foot can be identified and in one case the impression of toes can be seen. Using foot length to stature ratios, the hominins are estimated to have been between ca. 0.93 and 1.73 m in height, suggestive of a group of mixed ages. The orientation of the prints indicates movement in a southerly direction on mud-flats along the river edge. Early Pleistocene human fossils are extremely rare in Europe, with no evidence from the UK. The only known species in western Europe of a similar age is Homo antecessor, whose fossil remains have been found at Atapuerca, Spain. The foot sizes and estimated stature of the hominins from Happisburgh fall within the range derived from the fossil evidence of Homo antecessor.	[Ashton, Nick; Williams, Craig] British Museum, Dept Prehist & Europe, London WC1B 3DG, England; [Ashton, Nick; Parfitt, Simon A.] UCL, Inst Archaeol, London, England; [Lewis, Simon G.] Queen Mary Univ London, Sch Geog, London, England; [De Groote, Isabelle] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 5UX, Merseyside, England; [Duffy, Sarah M.] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Bates, Martin] Univ Wales Trinity St David, Dept Archaeol, Lampeter, Dyfed, Wales; [Bates, Richard] Andrews Univ, Sch Geog & Geosci, St Andrews, Fife, Scotland; [Hoare, Peter] Norwich Castle Museum & Art Gallery, Dept Geol, Norwich, Norfolk, England; [Lewis, Mark; Parfitt, Simon A.; Stringer, Chris] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Peglar, Sylvia] Univ Cambridge, Sch Bot, Cambridge, England	Natural History Museum London; University of London; University College London; University of London; Queen Mary University London; Liverpool John Moores University; University of York - UK; University of Wales Trinity St David; University of St Andrews; Natural History Museum London; University of Cambridge	Ashton, N (corresponding author), British Museum, Dept Prehist & Europe, London WC1B 3DG, England.	nashton@thebritishmuseum.ac.uk	De Groote, Isabelle/AAB-4086-2020	Bates, Charles Richard/0000-0001-9147-7151; Ashton, Nick/0000-0001-9787-3892	Calleva Foundation	Calleva Foundation	The research was funded by the Calleva Foundation as part of the Pathways to Ancient Britain Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhouse-Green, 1992, ARCHAEOLOGIA CAMBREN, V141, P14; Allen J, 2004, ARCHAEOLOGY SEVERN E, V14, P55; Allen JRL, 1997, PHILOS T ROY SOC B, V352, P481, DOI 10.1098/rstb.1997.0035; ANDERSON M, 1956, AM J PHYS ANTHROPOL, V14, P287, DOI 10.1002/ajpa.1330140221; Ashton N, 2012, QUATERN INT, V271, P50, DOI 10.1016/j.quaint.2011.10.022; Balter M, 2013, SCIENCE, V340, P426, DOI 10.1126/science.340.6131.426-b; BEHRENSMEYER AK, 1981, NATURE, V289, P167, DOI 10.1038/289167a0; Bell M., 2000, 120 CBA; Bennett MR, 2010, P GEOLOGIST ASSOC, V121, P66, DOI 10.1016/j.pgeola.2010.01.002; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Candy I, 2011, DEV QUATER SCI, V14, P11; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carretero JM, 2012, J HUM EVOL, V62, P242, DOI 10.1016/j.jhevol.2011.11.004; Chakrabarti A, 2005, J EARTH SYST SCI, V114, P353, DOI 10.1007/BF02702954; CHARTERIS J, 1981, NATURE, V290, P496, DOI 10.1038/290496a0; Cowell RW, 1993, N W WETLANDS SURVEY, P43; Crompton RH, 2009, SCIENCE, V323, P1174, DOI 10.1126/science.1170916; Davenport CB, 1932, AM J PHYS ANTHROPOL, V17, P167, DOI 10.1002/ajpa.1330170213; DAY MH, 1980, NATURE, V286, P385, DOI 10.1038/286385a0; Deino AL, 2011, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-90-481-9956-3_4; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Gonzalez S, 2006, QUATERNARY SCI REV, V25, P201, DOI 10.1016/j.quascirev.2005.10.004; Hrdlicka A, 1935, AM J PHYS ANTHROPOL, V20, P235, DOI 10.1002/ajpa.1330200302; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Martin R., 1914, LEHRBUCH ANTHR, V2; Mietto P, 2003, NATURE, V422, P133, DOI 10.1038/422133a; Morse SA, 2010, QUATERNARY SCI REV, V29, P2571, DOI 10.1016/j.quascirev.2010.03.012; Onac BP, 2005, QUATERNARY SCI REV, V24, P1151, DOI 10.1016/j.quascirev.2004.12.001; Pablos A, 2012, J HUM EVOL, V63, P610, DOI 10.1016/j.jhevol.2012.06.008; Pales L, 1976, MEMOIRES, V36; Parfitt SA, 2005, NATURE, V438, P1008, DOI 10.1038/nature04227; Preece RC, 2012, QUATERN INT, V271, P6, DOI 10.1016/j.quaint.2012.04.018; Preece RC, 2009, J QUATERNARY SCI, V24, P557, DOI 10.1002/jqs.1245; Reid C, 1882, GEOLOGY COUNTRY CROM; Reineck H.E., 1975, DEPOSITIONAL SEDIMEN, DOI [10.1007/978-3-642-81498-3, DOI 10.1007/978-3-642-81498-3]; Robbins L, 1985, FOOTPRINTS COLLECTIO; Roberts D, 1997, S AFR J SCI, V93, P349; Roberts D, 2008, ICHNOS, V15, P190, DOI 10.1080/10420940802470482; Roberts G, 2009, ICHNOS, V16, P33, DOI 10.1080/10420940802470730; Stringer C, 2012, EVOL ANTHROPOL, V21, P101, DOI 10.1002/evan.21311; Stuart AJ, 2010, QUAT INT, V228; Webb S, 2006, J HUM EVOL, V50, P405, DOI 10.1016/j.jhevol.2005.10.002; Webb S, 2007, J HUM EVOL, V52, P711, DOI 10.1016/j.jhevol.2007.02.001; WEST R. G., 1980, PREGLACIAL PLEISTOCE	45	98	101	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88329	10.1371/journal.pone.0088329	http://dx.doi.org/10.1371/journal.pone.0088329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516637	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400059
J	Berenshtein, I; Kiflawi, M; Shashar, N; Wieler, U; Agiv, H; Paris, CB				Berenshtein, Igal; Kiflawi, Moshe; Shashar, Nadav; Wieler, Uri; Agiv, Haim; Paris, Claire B.			Polarized Light Sensitivity and Orientation in Coral Reef Fish Post-Larvae	PLOS ONE			English	Article							SKYLIGHT POLARIZATION; NAVIGATION; RETENTION; COMPASS; CONNECTIVITY; RECRUITMENT; BEHAVIOR; PISCES; TROUT; CLEAR	Recent studies of the larvae of coral-reef fishes reveal that these tiny vertebrates possess remarkable swimming capabilities, as well as the ability to orient to olfactory, auditory, and visual cues. While navigation according to reef-generated chemicals and sounds can significantly affect dispersal, the effect is limited to the vicinity of the reef. Effective long-distance navigation requires at least one other capacity-the ability to maintain a bearing using, for example, a sun compass. Directional information in the sun's position can take the form of polarized-light related cues (i.e., e-vector orientation and percent polarization) and/or non-polarized-light related cues (i.e., the direct image of the sun, and the brightness and spectral gradients). We examined the response to both types of cues using commercially-reared post-larvae of the spine-cheeked anemonefish Premnas biaculeatus. Initial optomotor trials indicated that the post-larval stages are sensitive to linearly polarized light. Swimming directionality was then tested using a Drifting In-Situ Chamber (DISC), which allowed us to examine the response of the post-larvae to natural variation in light conditions and to manipulated levels of light polarization. Under natural light conditions, 28 of 29 post-larvae showed significant directional swimming (Rayleigh's test p<0.05, R = 0.74 +/- 0.23), but to no particular direction. Swimming directionality was positively affected by sky clarity (absence of clouds and haze), which explained 38% of the observed variation. Moreover, post-larvae swimming under fully polarized light exhibited a distinct behavior of tracking the polarization axis, as it rotated along with the DISC. This behavior was not observed under partially-polarized illumination. We view these findings as an indication for the use of sun-related cues, and polarized light signal in specific, by orienting coral-reef fish larvae.	[Berenshtein, Igal; Kiflawi, Moshe; Shashar, Nadav; Wieler, Uri] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Berenshtein, Igal; Kiflawi, Moshe] Interuniv Inst Marine Sci Eilat, Elat, Israel; [Agiv, Haim] Hebrew Univ Jerusalem, Dept Anim Sci, IL-76100 Rehovot, Israel; [Paris, Claire B.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Ben Gurion University; Hebrew University of Jerusalem; University of Miami	Berenshtein, I (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Eilat Campus, IL-84105 Beer Sheva, Israel.	igalbe@post.bgu.ac.il	KIFLAWI, MOSHE/AAH-7991-2021; Shashar, Nadav/Y-8552-2019	Kiflawi, Moshe/0000-0002-9705-6486; Paris-Limouzy, Claire Beatrix/0000-0002-0637-1334	United States-Israel Binational Science Foundation (BSF) [2008/144]; Israeli Science Foundation (ISF) [1081/10]; NSF-OTIC [1155698]	United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israeli Science Foundation (ISF)(Israel Science Foundation); NSF-OTIC	This research was supported by Grant No 2008/144 from the United States-Israel Binational Science Foundation (BSF; http://www.bsf.org.il/BSFPublic/Default.aspx) to MK and CP, and Israeli Science Foundation Grant # 1081/10 to NS (ISF; http://www.isf.org.il/). DISC instrument development was funded by NSF-OTIC 1155698 to C. B. Paris. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2011, R PACKAGE CIRCULAR C; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Ben-Tzvi O, 2010, MAR ECOL PROG SER, V409, P181, DOI 10.3354/meps08627; Brokovich E, 2010, PHYSIOL BEHAV, V101, P413, DOI 10.1016/j.physbeh.2010.07.006; Cartron L, 2013, J EXP BIOL, V216, P2039, DOI 10.1242/jeb.080390; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Darmaillacq AS, 2008, PHYSIOL BEHAV, V94, P616, DOI 10.1016/j.physbeh.2008.01.018; DUSENBERY DB, 1989, J THEOR BIOL, V136, P309, DOI 10.1016/S0022-5193(89)80166-3; Fautin D. G., 1992, FIELD GUIDE ANEMONEF; Fisher R, 2005, MAR ECOL PROG SER, V285, P223, DOI 10.3354/meps285223; Flamarique IN, 1997, VISION RES, V37, P975, DOI 10.1016/S0042-6989(96)00236-2; Frank Kenneth T., 1993, Fisheries Oceanography, V2, P114, DOI 10.1111/j.1365-2419.1993.tb00129.x; GODDARD SM, 1991, J COMP PHYSIOL A, V169, P479; HAMNER WM, 1994, MAR BIOL, V119, P347, DOI 10.1007/BF00347531; Hawryshyn CW, 2003, J COMP PHYSIOL A, V189, P213, DOI 10.1007/s00359-003-0392-4; HAWRYSHYN CW, 1990, J COMP PHYSIOL A, V167, P691; Hegedus R, 2007, P ROY SOC A-MATH PHY, V463, P1081, DOI 10.1098/rspa.2007.1811; Horvath G., 2004, POLARIZED LIGHT ANIM; Irisson JO, 2009, LIMNOL OCEANOGR-METH, V7, P664, DOI 10.4319/lom.2009.7.664; JANDER R, 1975, ANNU REV ECOL SYST, V6, P171, DOI 10.1146/annurev.es.06.110175.001131; Job SD, 1996, J FISH BIOL, V48, P952; Leis Jeffrey L., 2002, P171, DOI 10.1016/B978-012615185-5/50011-6; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 1996, MAR FRESHWATER RES, V47, P401, DOI 10.1071/MF9960401; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 1999, MAR BIOL, V134, P51, DOI 10.1007/s002270050524; Lerner A, 2011, PHILOS T R SOC B, V366, P671, DOI 10.1098/rstb.2010.0189; MATTHEWS GVT, 1953, J EXP BIOL, V30, P243; Mouritsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066039; Mussi M, 2005, J EXP BIOL, V208, P3037, DOI 10.1242/jeb.01750; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2008, MARINE SANCTUARIES C, VONMS-08-07; Paris CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072808; R Development Core Team, 2011, R LANG ENV STAT COMP; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Sabbah S, 2006, J OPT SOC AM A, V23, P1978, DOI 10.1364/JOSAA.23.001978; Sabbah Shai, 2005, Recent Research Developments in Theoretical Biology, V1, P123; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Schwind R, 1999, J EXP BIOL, V202, P3631; Shashar N, 2011, PHILOS T R SOC B, V366, P649, DOI 10.1098/rstb.2010.0190; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Staaterman E, 2012, J THEOR BIOL, V304, P188, DOI 10.1016/j.jtbi.2012.03.016; Therneau T. M., 2010, RPART RECURSIVE PART; WATERMAN TALBOT H., 1955, DEEP SEA RES, V3, P426; Waterman TH, 2006, BIOL REV, V81, P111, DOI 10.1017/S1464793105006883; WATERMAN TH, 1972, J EXP ZOOL, V180, P33, DOI 10.1002/jez.1401800104; Waterman TH., 1988, P SOC PHOTO-OPT INS, V0925, P431; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z; You Y, 2011, APPL OPTICS, V50, P4873, DOI 10.1364/AO.50.004873; Zar JH., 2010, BIOSTAT ANAL, V5th; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	53	23	23	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88468	10.1371/journal.pone.0088468	http://dx.doi.org/10.1371/journal.pone.0088468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516662	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400071
J	Biswas, R; Prabhu, S; Lynd, LR; Guss, AM				Biswas, Ranjita; Prabhu, Sandeep; Lynd, Lee R.; Guss, Adam M.			Increase in Ethanol Yield via Elimination of Lactate Production in an Ethanol-Tolerant Mutant of Clostridium thermocellum	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; ATCC 27405; CELLULOSE; FERMENTATION; EXPRESSION; GENE	Large-scale production of lignocellulosic biofuel is a potential solution to sustainably meet global energy needs. One-step consolidated bioprocessing (CBP) is a potentially advantageous approach for the production of biofuels, but requires an organism capable of hydrolyzing biomass to sugars and fermenting the sugars to ethanol at commercially viable titers and yields. Clostridium thermocellum, a thermophilic anaerobe, can ferment cellulosic biomass to ethanol and organic acids, but low yield, low titer, and ethanol sensitivity remain barriers to industrial production. Here, we deleted the hypoxanthine phosphoribosyltransferase gene in ethanol tolerant strain of C. thermocellum adhE*(EA) in order to allow use of previously developed gene deletion tools, then deleted lactate dehydrogenase (ldh) to redirect carbon flux towards ethanol. Upon deletion of ldh, the adhE*(EA) Delta ldh strain produced 30% more ethanol than wild type on minimal medium. The adhE*(EA) Dldh strain retained tolerance to 5% v/v ethanol, resulting in an ethanol tolerant platform strain of C. thermocellum for future metabolic engineering efforts.	[Biswas, Ranjita; Guss, Adam M.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Biswas, Ranjita; Lynd, Lee R.; Guss, Adam M.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN USA; [Prabhu, Sandeep] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Lynd, Lee R.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); University of California System; University of California Berkeley; Dartmouth College	Guss, AM (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	gussam@ornl.gov	Guss, Adam/A-6204-2011; Lynd, Lee R/N-1260-2013	Guss, Adam/0000-0001-5823-5329; Lynd, Lee R/0000-0002-5642-668X	BioEnergy Science Center, a U.S. DOE Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science; U.S. DOE [DE-AC05-00OR22725]; U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program	BioEnergy Science Center, a U.S. DOE Bioenergy Research Center; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. DOE(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program(United States Department of Energy (DOE))	This work was supported by the BioEnergy Science Center, a U.S. DOE Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, for the U.S. DOE under contract DE-AC05-00OR22725. This work was also supported in part by the U.S. Department of Energy, Office of Science, Office of Workforce Development for Teachers and Scientists (WDTS) under the Science Undergraduate Laboratory Internship (SULI) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyros DA, 2011, APPL ENVIRON MICROB, V77, P8288, DOI 10.1128/AEM.00646-11; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Brown SD, 2011, P NATL ACAD SCI USA, V108, P13752, DOI 10.1073/pnas.1102444108; Burton E, 2012, CAN J MICROBIOL, V58, P1378, DOI 10.1139/cjm-2012-0412; Deng Y, 2013, METAB ENG, V15, P151, DOI 10.1016/j.ymben.2012.11.006; Ellis LD, 2012, BIORESOURCE TECHNOL, V103, P293, DOI 10.1016/j.biortech.2011.09.128; Guss AM, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-30; HERRERO AA, 1980, APPL ENVIRON MICROB, V40, P571, DOI 10.1128/AEM.40.3.571-577.1980; Hogsett D., 1995, CELLULOSE HYDROLYSIS; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Ozkan M, 2004, CAN J MICROBIOL, V50, P845, DOI 10.1139/W04-071; Perlack RD, 2011, US BILL TON UPD BIOM; Rydzak T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-214; Shao XJ, 2011, APPL MICROBIOL BIOT, V92, P641, DOI 10.1007/s00253-011-3492-z; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; van der Veen D, 2013, J IND MICROBIOL BIOT, V40, P725, DOI 10.1007/s10295-013-1275-5; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; Williams TI, 2007, APPL MICROBIOL BIOT, V74, P422, DOI 10.1007/s00253-006-0689-7; Zhou JL, 2013, APPL ENVIRON MICROB, V79, P3000, DOI 10.1128/AEM.04037-12	20	43	47	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86389	10.1371/journal.pone.0086389	http://dx.doi.org/10.1371/journal.pone.0086389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516531	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400009
J	Deen, J; Ali, M; Sack, D				Deen, Jacqueline; Ali, Mohammad; Sack, David			Methods to Assess the Impact of Mass Oral Cholera Vaccination Campaigns under Real Field Conditions	PLOS ONE			English	Article							B HIB DISEASE; VACCINES; ELIMINATION; EFFICACY; IMMUNIZATION; BANGLADESH; PROTECTION; DIARRHEA; GAMBIA; COST	There is increasing interest to use oral cholera vaccination as an additional strategy to water and sanitation interventions against endemic and epidemic cholera. There are two internationally-available and WHO-prequalified oral cholera vaccines: an inactivated vaccine containing killed whole-cells of V. cholerae O1 with recombinant cholera toxin B-subunit (WC/rBS) and a bivalent inactivated vaccine containing killed whole cells of V. cholerae O1 and V. cholerae O139 (BivWC). The efficacy, effectiveness, direct and indirect (herd) protection conferred by WC/rBS and BivWC are well established. Yet governments may need local evidence of vaccine impact to justify and scale-up mass oral cholera vaccination campaigns. We discuss various approaches to assess oral cholera vaccine protection, which may be useful to policymakers and public health workers considering deployment and evaluation of the vaccine.	[Deen, Jacqueline] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Ali, Mohammad; Sack, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Charles Darwin University; Menzies School of Health Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Deen, J (corresponding author), Menzies Sch Hlth Res, Casuarina, NT, Australia.	deen.jacqueline@gmail.com	Ali, Mohammad/E-2365-2017	Ali, Mohammad/0000-0003-1410-388X	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work is included under the Delivering Oral Vaccine Effectively (DOVE) project funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali Mohammad, 2005, Int J Health Geogr, V4, P12, DOI 10.1186/1476-072X-4-12; Ali M, 2013, CLIN INFECT DIS, V56, P1123, DOI 10.1093/cid/cit009; Belmaker I, 2007, PEDIATR INFECT DIS J, V26, P36, DOI 10.1097/01.inf.0000247105.45185.13; Bhattacharya SK, 2013, LANCET INFECT DIS; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; Chao DL, 2013, CURR TOP MICROBIOL I; Clemens J, 1996, JAMA-J AM MED ASSOC, V275, P390, DOI 10.1001/jama.275.5.390; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; CLEMENS JD, 1988, J INFECT DIS, V158, P372, DOI 10.1093/infdis/158.2.372; Donner A, 2010, DESIGN ANAL CLUSTER; Emch M, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-2; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Gessner BD, 2013, VACCINE, V31, P3222, DOI 10.1016/j.vaccine.2013.05.017; Howie SRC, 2007, VACCINE, V25, P6305, DOI 10.1016/j.vaccine.2007.06.023; Jeuland M, 2009, VALUE HEALTH, V12, P899, DOI 10.1111/j.1524-4733.2009.00562.x; Khatib AM, 2012, LANCET INFECT DIS, V12, P837, DOI 10.1016/S1473-3099(12)70196-2; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Lucas MES, 2005, NEW ENGL J MED, V352, P757, DOI 10.1056/NEJMoa043323; Martin S, 2013, POSTLICENSURE UNPUB; Martin S, 2012, B WORLD HEALTH ORGAN, V90, P714, DOI 10.2471/BLT.12.112433; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meyers LA, 2003, EMERG INFECT DIS, V9, P204, DOI 10.3201/eid0902.020188; Meyers LA, 2007, B AM MATH SOC, V44, P63; Morris M, 2005, NETWORK EPIDEMIOLOGY; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; PELTOLA H, 1991, LANCET, V338, P1285, DOI 10.1016/0140-6736(91)92590-X; Salkind N., 2007, ENCY MEASUREMENT STA; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Sinclair D, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD008603.PUB2; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Torvaldsen Siranda, 2002, Commun Dis Intell Q Rep, V26, P451; WHO, 2009, WEEKLY EPIDEMIOLOGIC, V50, P526; WHO, 2010, OR CHOL VACC MASS IM; World Health Organization, 2008, GEN PROT MON IMP ROT; World Health Organization (2012), MEAS IMP STREPT PNEU, P4	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88139	10.1371/journal.pone.0088139	http://dx.doi.org/10.1371/journal.pone.0088139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516595	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400034
J	Kingston, A; Davies, K; Collerton, J; Robinson, L; Duncan, R; Bond, J; Kirkwood, TBL; Jagger, C				Kingston, Andrew; Davies, Karen; Collerton, Joanna; Robinson, Louise; Duncan, Rachel; Bond, John; Kirkwood, Thomas B. L.; Jagger, Carol			The Contribution of Diseases to the Male-Female Disability-Survival Paradox in the Very Old: Results from the Newcastle 85+Study	PLOS ONE			English	Article							HEALTH; WOMEN; GENDER; MEN; MULTIMORBIDITY; PREVALENCE; MEMANTINE; MORTALITY; DONEPEZIL; DEMENTIA	Background: Explanations for the male-female disability-survival paradox - that woman live longer than men but with more disability - include sex differences in diseases and their impact on disability and death. Less is known about the paradox in the very old. We examine sex differences in the presence and impact of disabling and fatal diseases accounting for the male-female disability-survival paradox in very late life. Methods: We use data from the Newcastle 85+ Study, a cohort of people born in 1921 and all recruited at age 85 in 2006. Participants underwent a health assessment (HA) at baseline, 18 months, 36 months, 60 months, and a review of their GP records (GPRR) at baseline and 36 months. We used multi-state modelling to assess the impact of specific diseases on disability and death. Disability (measured via ADLs/IADLs) was categorised as no disability (difficulty with 0 activities), or disabled (difficulty with one or more activities). Diseases were ascertained from review of general practice records and cognitive impairment which was defined as an sMMSE of 21 or less (from health assessment). Results: In participants who had complete HA and GPRR, women had more arthritis (RR = 1.2, 95% CI: 1.1-1.3) and hypertension (RR = 1.2, 95% CI 1.0-1.3), more disability, and were more likely disabled at all follow-ups. From multistate models, women with cerebrovascular disease (HR: 2.6, 95% CI: 2.1-3.4) or respiratory disease (HR: 2.0, 95% CI: 1.4-3.0) were more likely to become disabled than those without but this did not hold for men (sex difference p<0.01). Men were more likely to die from respiratory disease (HR: 2.2, 95% CI: 1.8-2.8) but this did not hold for women (p = 0.002). Conclusion: The disability-survival paradox was still evident at age 85 and appears due to sex differences in the types of diseases and their impact on the disability pathway.	[Kingston, Andrew; Davies, Karen; Collerton, Joanna; Kirkwood, Thomas B. L.; Jagger, Carol] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Robinson, Louise; Duncan, Rachel; Bond, John] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Kingston, A (corresponding author), Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	andrew.kingston@ncl.ac.uk		Davies, Karen/0000-0002-2820-9397; Robinson, Louise/0000-0003-0209-2503; Kingston, Andrew/0000-0003-4211-7007; Jagger, Carol/0000-0002-6377-9926	Medical Research Council; Biotechnology and Biological Sciences Research Council [G0500997]; Newcastle Healthcare Charity; Dunhill Medical Trust; Medical Research Council [G0500997, MR/K006312/1, MR/J50001X/1] Funding Source: researchfish; MRC [G0500997, MR/J50001X/1, MR/K006312/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle Healthcare Charity; Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Newcastle 85+ Study was supported by a combined grant from the Medical Research Council and Biotechnology and Biological Sciences Research Council (reference G0500997), and a grant from the Newcastle Healthcare Charity and the Dunhill Medical Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2000, QUAL LIFE RES, V9, P901, DOI 10.1023/A:1008938326604; Bittner V, 2008, CIRCULATION, V117, P1505, DOI 10.1161/CIRCULATIONAHA.108.764217; Blagosklonny MV, 2010, AGING-US, V2, P265, DOI 10.18632/aging.100149; Bond M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16210; Bootsma-van der Wiel A, 2002, J AM GERIATR SOC, V50, P1405; Bronnum-Hansen H, 2009, AGE AGEING, V38, P47, DOI 10.1093/ageing/afn239; Case A, 2005, DEMOGRAPHY, V42, P189, DOI 10.1353/dem.2005.0011; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; Collerton J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4904; Crimmins EM, 2002, J WOMEN AGING, V14, P47, DOI 10.1300/J074v14n01_04; Davies K, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-64; Doblhammer G, 2010, J GERONTOL B-PSYCHOL, V65, P482, DOI 10.1093/geronb/gbp051; Ferrucci L, 1996, J GERONTOL A-BIOL, V51, pM123, DOI 10.1093/gerona/51A.3.M123; Gill TM, 2009, J AM GERIATR SOC, V57, P195, DOI 10.1111/j.1532-5415.2008.02107.x; Gold CH, 2002, J GERONTOL B-PSYCHOL, V57, pS168, DOI 10.1093/geronb/57.3.S168; Gorman BK, 2006, J HEALTH SOC BEHAV, V47, P95, DOI 10.1177/002214650604700201; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Jackson CH, 2011, J STAT SOFTW, V38, P1; Jagger C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-21; Jagger C, 2009, AGE AGEING, V38, P319, DOI 10.1093/ageing/afp016; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Kim DH, 2013, AM J EPIDEMIOLOGY; Kingston A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031665; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Le Couteur DG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5125; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Mikhail GW, 2005, BMJ-BRIT MED J, V331, P467, DOI 10.1136/bmj.331.7515.467; Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Noble M, 2007, ENGLISH INDICES DEPR; Oksuzyan A, 2009, ANN EPIDEMIOL, V19, P504, DOI 10.1016/j.annepidem.2009.03.014; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; STRAWBRIDGE WJ, 1992, J AM GERIATR SOC, V40, P799, DOI 10.1111/j.1532-5415.1992.tb01852.x; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; TAKATA Y, 2013, DOVEPRESS, V8, P721, DOI DOI 10.2147/CIA.S43480; Thielke Stephen, 2012, J Aging Res, V2012, P243263, DOI 10.1155/2012/243263; Tiainen K, 2013, AGE AGEING, V42, P468, DOI 10.1093/ageing/aft030; UN Department of Economic and Social Affairs, 2009, WORLD POP AG 2009; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Whitson HE, 2010, J GERONTOL A-BIOL, V65, P1325, DOI 10.1093/gerona/glq139	42	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88016	10.1371/journal.pone.0088016	http://dx.doi.org/10.1371/journal.pone.0088016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516578	Green Submitted, Green Published, gold			2022-12-27	WOS:000330834400025
J	Espana-Romero, V; Golubic, R; Martin, KR; Hardy, R; Ekelund, U; Kuh, D; Wareham, NJ; Cooper, R; Brage, S				Espana-Romero, Vanesa; Golubic, Rajna; Martin, Kathryn R.; Hardy, Rebecca; Ekelund, Ulf; Kuh, Diana; Wareham, Nicholas J.; Cooper, Rachel; Brage, Soren		NSHD Sci Data Collection Teams	Comparison of the EPIC Physical Activity Questionnaire with Combined Heart Rate and Movement Sensing in a Nationally Representative Sample of Older British Adults	PLOS ONE			English	Article							ACTIVITY ENERGY-EXPENDITURE; ACTIVITY SCALE; ELDERLY PASE; VALIDITY; RELIABILITY; REPEATABILITY; ACCURACY; ACCELEROMETRY; INACTIVITY; JAPANESE	Objectives: To compare physical activity (PA) subcomponents from EPIC Physical Activity Questionnaire (EPAQ2) and combined heart rate and movement sensing in older adults. Methods: Participants aged 60-64y from the MRC National Survey of Health and Development in Great Britain completed EPAQ2, which assesses self-report PA in 4 domains (leisure time, occupation, transportation and domestic life) during the past year and wore a combined sensor for 5 consecutive days. Estimates of PA energy expenditure (PAEE), sedentary behaviour, light (LPA) and moderate-to-vigorous PA (MVPA) were obtained from EPAQ2 and combined sensing and compared. Complete data were available in 1689 participants (52% women). Results: EPAQ2 estimates of PAEE and MVPA were higher than objective estimates and sedentary time and LPA estimates were lower [bias (95% limits of agreement) in men and women were 32.3 (-61.5 to 122.6) and 29.0 (-39.2 to 94.6) kJ/kg/day for PAEE; -4.6 (-10.6 to 1.3) and -6.0 (-10.9 to -1.0) h/day for sedentary time; -171.8 (-454.5 to 110.8) and -60.4 (-367.5 to 246.6) min/day for LPA; 91.1 (-159.5 to 341.8) and 55.4 (-117.2 to 228.0) min/day for MVPA]. There were significant positive correlations between all self-reported and objectively assessed PA subcomponents (rho = 0.12 to 0.36); the strongest were observed for MVPA (rho = 0.30 men; rho = 0.36 women) and PAEE (rho = 0.26 men; rho = 0.25 women). Conclusion: EPAQ2 produces higher estimates of PAEE and MVPA and lower estimates of sedentary and LPA than objective assessment. However, both methodologies rank individuals similarly, suggesting that EPAQ2 may be used in etiological studies in this population.	[Espana-Romero, Vanesa; Golubic, Rajna; Ekelund, Ulf; Wareham, Nicholas J.; Brage, Soren] Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge, England; [Martin, Kathryn R.; Hardy, Rebecca; Kuh, Diana; Cooper, Rachel] UCL, MRC, Unit Lifelong Hlth & Ageing, London, England; [Martin, Kathryn R.] Univ Aberdeen, Inst Appl Hlth Sci, Sch Med & Dent, Epidemiol Grp, Aberdeen, Scotland; [Ekelund, Ulf] Norges Idrettshogskole, Norwegian Sch Sport Sci, Oslo, Norway	University of Cambridge; University of London; University College London; University of Aberdeen; Norwegian School of Sport Sciences	Espana-Romero, V (corresponding author), Univ Cambridge, MRC, Epidemiol Unit, Sch Clin Med,Inst Metab Sci, Cambridge, England.	vanesa.espana@mrc.epid-cam.ac.uk	Golubic, Rajna/GNH-4374-2022; Hardy, Rebecca/AFR-1989-2022; Ekelund, Ulf/AAE-8471-2019; Brage, Soren/C-6415-2013; Cooper, Rachel/ABE-3768-2021; Osika, Walter/AAH-7966-2020; Wong, Andrew/M-8899-2016; Espana Romero, Vanesa/AAA-2354-2019; Kuh, Diana/L-6019-2014	Golubic, Rajna/0000-0003-0419-9582; Ekelund, Ulf/0000-0003-2115-9267; Brage, Soren/0000-0002-1265-7355; Cooper, Rachel/0000-0003-3370-5720; Osika, Walter/0000-0002-1583-7319; Wong, Andrew/0000-0003-2079-4779; Espana Romero, Vanesa/0000-0002-7984-1077; Kuh, Diana/0000-0001-7386-2857; Chowienczyk, Phil/0000-0003-4507-038X; Hardy, Rebecca/0000-0001-9949-0799; Westgate, Kate/0000-0002-0283-3562	MRC [U1200632239, U123092720, U106179473]; Gates Cambridge Trust; St. John's College Cambridge; School of Clinical Medicine, University of Cambridge; Medical Research Council [MC_UU_12015/3, MC_U106179471, MC_UU_12019/1, MC_UU_12015/1, MC_U106179473] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; MRC [MC_UU_12019/1, MC_U106179473, MC_UU_12015/1, MC_UU_12015/3] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Gates Cambridge Trust; St. John's College Cambridge; School of Clinical Medicine, University of Cambridge(University of Cambridge); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC grant numbers U1200632239, U123092720 and U106179473. Rajna Golubic is financially supported by a scholarship from the Gates Cambridge Trust, Benefactors' Scholarship from St. John's College Cambridge and Raymond and Beverly Sackler Studentship from the School of Clinical Medicine, University of Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; AINSWORTH BE, 1993, J OCCUP ENVIRON MED, V35, P1017; Assah FK, 2011, INT J EPIDEMIOL, V40, P112, DOI 10.1093/ije/dyq098; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borch KB, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-2; Brage S, 2006, EUR J APPL PHYSIOL, V96, P517, DOI 10.1007/s00421-005-0112-6; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Chatburn R L, 1996, AANA J, V64, P261; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Crouter SE, 2008, EUR J CLIN NUTR, V62, P704, DOI 10.1038/sj.ejcn.1602766; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Dahl-Petersen IK, 2013, MED SCI SPORTS EXERC; Day N, 1999, BRIT J CANCER, V80, P95; Deng HB, 2008, MED SCI SPORT EXER, V40, P303, DOI 10.1249/mss.0b013e31815b0db5; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Mesas AE, 2010, J AM GERIATR SOC, V58, P1870, DOI 10.1111/j.1532-5415.2010.03071.x; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Forsen L, 2010, SPORTS MED, V40, P601, DOI 10.2165/11531350-000000000-00000; Giles K, 2009, J PHYS ACT HEALTH, V6, P221, DOI 10.1123/jpah.6.2.221; Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hankinson AL, 2010, JAMA-J AM MED ASSOC, V304, P2603, DOI 10.1001/jama.2010.1843; Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; KLESGES RC, 1990, MED SCI SPORT EXER, V22, P690, DOI 10.1249/00005768-199010000-00022; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; KUH DJL, 1992, J EPIDEMIOL COMMUN H, V46, P114, DOI 10.1136/jech.46.2.114; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-81; Matton L, 2007, RES Q EXERCISE SPORT, V78, P293; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Orsini N, 2008, EUR J EPIDEMIOL, V23, P661, DOI 10.1007/s10654-008-9273-z; PAFFENBARGER RS, 1993, MED SCI SPORT EXER, V25, P60, DOI 10.1249/00005768-199301000-00010; Peters T, 2012, EUR J EPIDEMIOL, V27, P15, DOI 10.1007/s10654-011-9625-y; Peters TM, 2010, MED SCI SPORT EXER, V42, P2222, DOI 10.1249/MSS.0b013e3181e1fcd5; Pols MA, 1996, MED SCI SPORT EXER, V28, P1020, DOI 10.1097/00005768-199608000-00012; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Schuit AJ, 1997, J CLIN EPIDEMIOL, V50, P541, DOI 10.1016/S0895-4356(97)00010-3; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Stafford M, EUROPEAN J IN PRESS; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Stewart AL, 2001, MED SCI SPORT EXER, V33, P1126, DOI 10.1097/00005768-200107000-00010; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Yasunaga A, 2007, J AGING PHYS ACTIV, V15, P398, DOI 10.1123/japa.15.4.398	61	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87085	10.1371/journal.pone.0087085	http://dx.doi.org/10.1371/journal.pone.0087085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516543	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000330830700018
J	Liu, DH; Huang, X; Guo, X; Meng, XM; Wu, YS; Lu, HL; Zhang, CM; Kim, YC; Xu, WX				Liu, Dong-Hai; Huang, Xu; Guo, Xin; Meng, Xiang-Min; Wu, Yi-Song; Lu, Hong-Li; Zhang, Chun-Mei; Kim, Young-chul; Xu, Wen-Xie			Voltage Dependent Potassium Channel Remodeling in Murine Intestinal Smooth Muscle Hypertrophy Induced by Partial Obstruction	PLOS ONE			English	Article							DELAYED RECTIFIER; ELECTRICAL RHYTHMICITY; INTERSTITIAL-CELLS; K+ CURRENTS; PROTEIN; PHOSPHORYLATION; KV2.1; IDENTIFICATION; EXPRESSION; COMPONENT	Partial obstruction of the small intestine causes obvious hypertrophy of smooth muscle cells and motility disorder in the bowel proximate to the obstruction. To identify electric remodeling of hypertrophic smooth muscles in partially obstructed murine small intestine, the patch-clamp and intracellular microelectrode recording methods were used to identify the possible electric remodeling and Western blot, immunofluorescence and immunoprecipitation were utilized to examine the channel protein expression and phosphorylation level changes in this research. After 14 days of obstruction, partial obstruction caused obvious smooth muscle hypertrophy in the proximally located intestine. The slow waves of intestinal smooth muscles in the dilated region were significantly suppressed, their amplitude and frequency were reduced, whilst the resting membrane potentials were depolarized compared with normal and sham animals. The current density of voltage dependent potassium channel (K-V) was significantly decreased in the hypertrophic smooth muscle cells and the voltage sensitivity of K-V activation was altered. The sensitivity of K-V currents (IKV) to TEA, a nonselective potassium channel blocker, increased significantly, but the sensitivity of IKv to 4-AP, a K-V blocker, stays the same. The protein levels of K(V)4.3 and K(V)2.2 were up-regulated in the hypertrophic smooth muscle cell membrane. The serine and threonine phosphorylation levels of K(V)4.3 and K(V)2.2 were significantly increased in the hypertrophic smooth muscle cells. Thus this study represents the first identification of K-V channel remodeling in murine small intestinal smooth muscle hypertrophy induced by partial obstruction. The enhanced phosphorylations of K(V)4.3 and K(V)2.2 may be involved in this process.	[Liu, Dong-Hai; Huang, Xu; Guo, Xin; Meng, Xiang-Min; Wu, Yi-Song; Lu, Hong-Li; Zhang, Chun-Mei; Xu, Wen-Xie] Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China; [Kim, Young-chul] Chungbuk Natl Univ, Dept Physiol, Coll Med, Cheongju, Chungbuk, South Korea	Shanghai Jiao Tong University; Chungbuk National University	Xu, WX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Physiol, Shanghai 200030, Peoples R China.	wenxiexu@sjtu.edu.cn			National Natural Science Foundation of China [31271236, 31171107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 31271236; 31171107; website: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Akbarali HI, 2000, BIOCHEM BIOPH RES CO, V275, P637, DOI 10.1006/bbrc.2000.3346; Akbarali HI, 2010, NEUROGASTROENT MOTIL, V22; Amberg GC, 2002, J PHYSIOL-LONDON, V544, P403, DOI 10.1113/jphysiol.2002.025163; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Anderson AE, 2000, J BIOL CHEM, V275, P5337, DOI 10.1074/jbc.275.8.5337; APKON M, 1988, P NATL ACAD SCI USA, V85, P8756, DOI 10.1073/pnas.85.22.8756; Ashpole NM, 2012, J BIOL CHEM, V287, P19856, DOI 10.1074/jbc.M111.322537; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Bertoni S, 2004, NEUROGASTROENT MOTIL, V16, P365, DOI 10.1111/j.1365-2982.2004.00510.x; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; FRIESEN DL, 1983, AM J CLIN PATHOL, V79, P319, DOI 10.1093/ajcp/79.3.319; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048249; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Kang MH, 2004, PFLUG ARCH EUR J PHY, V449, P288, DOI 10.1007/s00424-004-1339-5; Kito Y, 2007, PFLUG ARCH EUR J PHY, V455, P505, DOI 10.1007/s00424-007-0306-3; Koh SD, 1999, J PHYSIOL-LONDON, V515, P475, DOI 10.1111/j.1469-7793.1999.475ac.x; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Leung YM, 2012, PHARMACOL THERAPEUT, V133, P151, DOI 10.1016/j.pharmthera.2011.10.005; Liu XR, 2001, GASTROENTEROLOGY, V120, P480, DOI 10.1053/gast.2001.21167; Mohapatra DP, 2007, BIOCHEM SOC T, V35, P1064, DOI 10.1042/BST0351064; MOLLEMAN A, 1993, J PHYSIOL-LONDON, V470, P211, DOI 10.1113/jphysiol.1993.sp019855; Oue T, 1999, PEDIATR RES, V45, P853, DOI 10.1203/00006450-199906000-00012; Po SS, 2001, AM J PHYSIOL-HEART C, V281, pH2518, DOI 10.1152/ajpheart.2001.281.6.H2518; SANDERS KM, 1992, ANNU REV PHYSIOL, V54, P439; Schmalz F, 1998, AM J PHYSIOL-GASTR L, V274, pG901, DOI 10.1152/ajpgi.1998.274.5.G901; Schrader LA, 2002, J NEUROSCI, V22, P10123; Serodio P, 1996, J NEUROPHYSIOL, V75, P2174, DOI 10.1152/jn.1996.75.5.2174; SMITH B, 1982, SCAND J GASTROENTERO, V17, P103; Tseng GN, 1999, J PHARMACOL EXP THER, V290, P569; VOGALIS F, 1994, PFLUG ARCH EUR J PHY, V429, P160, DOI 10.1007/BF00374307; VOGALIS F, 1993, AM J PHYSIOL, V264, pC527, DOI 10.1152/ajpcell.1993.264.3.C527; Vogalis F, 2000, J AUTON PHARMACOL, V20, P207, DOI 10.1046/j.1365-2680.2000.00183.x; Wade GR, 1999, AM J PHYSIOL-GASTR L, V277, pG885, DOI 10.1152/ajpgi.1999.277.4.G885; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; WEBSTER W, 1973, J EMBRYOL EXP MORPH, V30, P573; Zhao JB, 2010, J BIOMECH, V43, P1322, DOI 10.1016/j.jbiomech.2010.01.018	41	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86109	10.1371/journal.pone.0086109	http://dx.doi.org/10.1371/journal.pone.0086109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516526	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700006
J	Etherington, TR; Perry, GLW; Cowan, PE; Clout, MN				Etherington, Thomas R.; Perry, George L. W.; Cowan, Phil E.; Clout, Mick N.			Quantifying the Direct Transfer Costs of Common Brushtail Possum Dispersal using Least-Cost Modelling: A Combined Cost-Surface and Accumulated-Cost Dispersal Kernel Approach	PLOS ONE			English	Article							TRICHOSURUS-VULPECULA; NEW-ZEALAND; FUNCTIONAL CONNECTIVITY; LANDSCAPE CONNECTIVITY; RESISTANCE SURFACES; GENE FLOW; DISTANCE; FARMLAND; SETTLEMENT; MOVEMENTS	Dispersal costs need to be quantified from empirical data and incorporated into dispersal models to improve our understanding of the dispersal process. We are interested in quantifying how landscape features affect the immediately incurred direct costs associated with the transfer of an organism from one location to another. We propose that least-cost modelling is one method that can be used to quantify direct transfer costs. By representing the landscape as a cost-surface, which describes the costs associated with traversing different landscape features, least-cost modelling is often applied to measure connectivity between locations in accumulated-cost units that are a combination of both the distance travelled and the costs traversed. However, we take an additional step by defining an accumulated-cost dispersal kernel, which describes the probability of dispersal in accumulated-cost units. This novel combination of cost-surface and accumulated-cost dispersal kernel enables the transfer stage of dispersal to incorporate the effects of landscape features by modifying the direction of dispersal based on the cost-surface and the distance of dispersal based on the accumulated-cost dispersal kernel. We apply this approach to the common brushtail possum (Trichosurus vulpecula) within the North Island of New Zealand, demonstrating how commonly collected empirical dispersal data can be used to calibrate a cost-surface and associated accumulated-cost dispersal kernel. Our results indicate that considerable improvements could be made to the modelling of the transfer stage of possum dispersal by using a cost-surface and associated accumulated-cost dispersal kernel instead of a more traditional straight-line distance based dispersal kernel. We envisage a variety of ways in which the information from this novel combination of a cost-surface and accumulated-cost dispersal kernel could be gainfully incorporated into existing dispersal models. This would enable more realistic modelling of the direct transfer costs associated with the dispersal process, without requiring existing dispersal models to be abandoned.	[Etherington, Thomas R.; Perry, George L. W.; Clout, Mick N.] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Perry, George L. W.; Clout, Mick N.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Cowan, Phil E.] Landcare Res, Lincoln, New Zealand	University of Auckland; University of Auckland; Landcare Research - New Zealand	Etherington, TR (corresponding author), Univ Auckland, Sch Environm, Auckland 1, New Zealand.	thomas.etherington@auckland.ac.nz		Perry, George/0000-0001-9672-9135; Clout, Mick/0000-0003-2864-4628; Etherington, Thomas/0000-0002-3187-075X	New Zealand Government	New Zealand Government	The New Zealand Government provided funding for TRE through a New Zealand International Doctoral Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2005, HDB NZ MAMMALS; [Anonymous], 2006, PROGR SPATIAL DATA H, DOI DOI 10.1007/3-540-35589-8_49; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Bonte D, 2012, BIOL REV, V87, P290, DOI 10.1111/j.1469-185X.2011.00201.x; Brockie R, 2007, NEW ZEAL J ZOOL, V34, P311, DOI 10.1080/03014220709510090; Brockie RE, 2009, NEW ZEAL J ZOOL, V36, P123, DOI 10.1080/03014220909510147; Chardon JP, 2003, LANDSCAPE ECOL, V18, P561, DOI 10.1023/A:1026062530600; CLOUT MN, 1984, J ANIM ECOL, V53, P737, DOI 10.2307/4656; Compton BW, 2007, CONSERV BIOL, V21, P788, DOI 10.1111/j.1523-1739.2007.00674.x; Cowan PE, 2001, WILDLIFE RES, V28, P277, DOI 10.1071/WR99097; Cowan PE, 1997, WILDLIFE RES, V24, P279, DOI 10.1071/WR96005; Cowan PE, 1996, WILDLIFE RES, V23, P237, DOI 10.1071/WR9960237; COWAN PE, 1993, WILDLIFE RES, V20, P671, DOI 10.1071/WR9930671; Cowan PE, 2006, R10625 LANDC RES; Douglas D. H., 1994, CARTOGRAPHICA, V31, P37, DOI [10.3138/D327-0323-2JUT-016M, DOI 10.3138/D327-0323-2JUT-016M]; Etherington TR, 2012, LANDSCAPE ECOL, V27, P1083, DOI 10.1007/s10980-012-9789-1; Etherington TR, 2012, LANDSCAPE ECOL, V27, P957, DOI 10.1007/s10980-012-9747-y; Etherington TR, 2012, INT J GEOGR INF SCI, V26, P541, DOI 10.1080/13658816.2011.598459; Gisborne District Council, 2012, COMMUNICATION; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goodchild M. F., 1986, SPATIAL AUTOCORRELAT; Janin A, 2009, J APPL ECOL, V46, P833, DOI 10.1111/j.1365-2664.2009.01665.x; Keller D, 2013, MOL ECOL, V22, P2467, DOI 10.1111/mec.12265; Land Information New Zealand, 2012, NZ TOP DAT DICT; Land Information New Zealand, 2012, NZ TOPO50 DAT; Landcare Research, 2011, NZ NAT DIG EL MOD N; Landcare Research, 2012, LAND COV DAT VERS 3; Leathwick J, 2003, LAND ENV NZ; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Ministry for the Environment National Institute of Water and Atmospheric Research, 2011, NZ RIV ENV CLASS; NZ Transport Agency, 2012, NZ STAT HIGHW CENTR; O'Sullivan D., 2010, GEOGRAPHIC INFORM AN; Palmer SCF, 2011, METHODS ECOL EVOL, V2, P258, DOI 10.1111/j.2041-210X.2010.00073.x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Richard Y, 2010, J APPL ECOL, V47, P603, DOI 10.1111/j.1365-2664.2010.01806.x; Rothley K, 2005, ECOL SOC, V10; Rousset F, 1997, GENETICS, V145, P1219; Shiode N, 2011, T GIS, V15, P457, DOI 10.1111/j.1467-9671.2011.01278.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Stevens VM, 2006, MOL ECOL, V15, P2333, DOI 10.1111/j.1365-294X.2006.02936.x; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Transit New Zealand, 2007, STAT HIGHW TRAFF DAT; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Venables WN., 2002, MODERN APPL STAT S 4; Verbeylen G, 2003, LANDSCAPE ECOL, V18, P791, DOI 10.1023/B:LAND.0000014492.50765.05; Wairoa District Council, 2012, COMMUNICATION; Walker RS, 2007, LANDSCAPE ECOL, V22, P1303, DOI 10.1007/s10980-007-9118-2; WARD GD, 1985, AUST WILDLIFE RES, V12, P145; Wiens John A., 2001, P96; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	53	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88293	10.1371/journal.pone.0088293	http://dx.doi.org/10.1371/journal.pone.0088293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505467	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200168
J	LaConte, LEW; Chavan, V; Mukherjee, K				LaConte, Leslie E. W.; Chavan, Vrushali; Mukherjee, Konark			Identification and Glycerol-Induced Correction of Misfolding Mutations in the X-Linked Mental Retardation Gene CASK	PLOS ONE			English	Article							PROTEIN STABILITY CHANGES; AMYLOID-FIBRIL FORMATION; DE-NOVO MUTATIONS; CHEMICAL CHAPERONES; SECONDARY STRUCTURE; DISORDERED REGIONS; STRUCTURAL BASIS; LIPRIN-ALPHA; WEB SERVER; SEQUENCE	The overwhelming amount of available genomic sequence variation information demands a streamlined approach to examine known pathogenic mutations of any given protein. Here we seek to outline a strategy to easily classify pathogenic missense mutations that cause protein misfolding and are thus good candidates for chaperone-based therapeutic strategies, using previously identified mutations in the gene CASK. We applied a battery of bioinformatics algorithms designed to predict potential impact on protein structure to five pathogenic missense mutations in the protein CASK that have been shown to underlie pathologies ranging from X-linked mental retardation to autism spectrum disorder. A successful classification of the mutations as damaging was not consistently achieved despite the known pathogenicity. In addition to the bioinformatics analyses, we performed molecular modeling and phylogenetic comparisons. Finally, we developed a simple high-throughput imaging assay to measure the misfolding propensity of the CASK mutants in situ. Our data suggests that a phylogenetic analysis may be a robust method for predicting structurally damaging mutations in CASK. Mutations in two evolutionarily invariant residues (Y728C and W919R) exhibited a strong propensity to misfold and form visible aggregates in the cytosolic milieu. The remaining mutations (R28L, Y268H, and P396S) showed no evidence of aggregation and maintained their interactions with known CASK binding partners liprin-alpha 3 Mint-1, and Veli, indicating an intact structure. Intriguingly, the protein aggregation caused by the Y728C and W919R mutations was reversed by treating the cells with a chemical chaperone (glycerol), providing a possible therapeutic strategy for treating structural mutations in CASK in the future.	[LaConte, Leslie E. W.; Chavan, Vrushali; Mukherjee, Konark] Virginia Tech, Virginia Tech Carilion Res Inst, Roanoke, VA 24016 USA; [Mukherjee, Konark] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukherjee, K (corresponding author), Virginia Tech, Virginia Tech Carilion Res Inst, Roanoke, VA 24016 USA.	konark@vtc.vt.edu		LaConte, Leslie/0000-0003-3747-0973				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ami D, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-17; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Burglen L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-18; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dai Y, 2006, NAT NEUROSCI, V9, P1479, DOI 10.1038/nn1808; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Deocaris CC, 2008, BIOGERONTOLOGY, V9, P269, DOI 10.1007/s10522-008-9136-8; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Feng W, 2004, NAT STRUCT MOL BIOL, V11, P475, DOI 10.1038/nsmb751; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hackett A, 2010, EUR J HUM GENET, V18, P544, DOI 10.1038/ejhg.2009.220; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Ignatova Z, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-23; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LaConte LEW, BIOCH SOC T IN PRESS; Li YH, 2002, J BIOL CHEM, V277, P4159, DOI 10.1074/jbc.M110792200; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Mukherjee K, 2008, CELL, V133, P328, DOI 10.1016/j.cell.2008.02.036; Mukherjee K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000800; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nakamura K, 2013, BRAIN DEV; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Olatubosun A, 2012, HUM MUTAT, V33, P1166, DOI 10.1002/humu.22102; Papp E, 2006, HANDB EXP PHARM, V172, P405; Patel MR, 2006, NAT NEUROSCI, V9, P1488, DOI 10.1038/nn1806; Petrosky KY, 2005, J BIOL CHEM, V280, P38528, DOI 10.1074/jbc.M506536200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Picken M, 2012, AMYLOID RELATED DISO; Piluso G, 2009, AM J HUM GENET, V84, P162, DOI 10.1016/j.ajhg.2008.12.018; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smajlovic A, 2009, FEBS LETT, V583, P1114, DOI 10.1016/j.febslet.2009.02.037; Spangler SA, 2013, J CELL BIOL, V201, P915, DOI 10.1083/jcb.201301011; Stafford RL, 2011, J MOL BIOL, V412, P3, DOI 10.1016/j.jmb.2011.07.005; Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Walsh I, 2011, NUCLEIC ACIDS RES, V39, pW190, DOI 10.1093/nar/gkr411; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watkins RJ, 2013, HUM MOL GENET, V22, P2105, DOI 10.1093/hmg/ddt060; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Wilschanski M, 2011, EXPERT OPIN INV DRUG, V20, P1285, DOI 10.1517/13543784.2011.600304; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang DS, 1999, J BIOL CHEM, V274, P32970, DOI 10.1074/jbc.274.46.32970; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zerovnik E, 2011, FEBS J, V278, P2263, DOI 10.1111/j.1742-4658.2011.08149.x; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	93	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88276	10.1371/journal.pone.0088276	http://dx.doi.org/10.1371/journal.pone.0088276			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505460	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200162
J	Ponitz, B; Schmitz, A; Fischer, D; Bleckmann, H; Brucker, C				Ponitz, Benjamin; Schmitz, Anke; Fischer, Dominik; Bleckmann, Horst; Bruecker, Christoph			Diving-Flight Aerodynamics of a Peregrine Falcon (Falco peregrinus)	PLOS ONE			English	Article							SEPARATION CONTROL; GLIDING FLIGHT; FLOW; WINGS	This study investigates the aerodynamics of the falcon Falco peregrinus while diving. During a dive peregrines can reach velocities of more than 320 km h(-1). Unfortunately, in freely roaming falcons, these high velocities prohibit a precise determination of flight parameters such as velocity and acceleration as well as body shape and wing contour. Therefore, individual F. peregrinus were trained to dive in front of a vertical dam with a height of 60 m. The presence of a well-defined background allowed us to reconstruct the flight path and the body shape of the falcon during certain flight phases. Flight trajectories were obtained with a stereo high-speed camera system. In addition, body images of the falcon were taken from two perspectives with a high-resolution digital camera. The dam allowed us to match the high-resolution images obtained from the digital camera with the corresponding images taken with the high-speed cameras. Using these data we built a life-size model of F. peregrinus and used it to measure the drag and lift forces in a wind-tunnel. We compared these forces acting on the model with the data obtained from the 3-D flight path trajectory of the diving F. peregrinus. Visualizations of the flow in the wind-tunnel uncovered details of the flow structure around the falcon's body, which suggests local regions with separation of flow. High-resolution pictures of the diving peregrine indicate that feathers pop-up in the equivalent regions, where flow separation in the model falcon occurred.	[Ponitz, Benjamin; Bruecker, Christoph] TU Bergakad Freiberg, Inst Mech & Fluid Dynam, Freiberg, Germany; [Schmitz, Anke; Bleckmann, Horst] Univ Bonn, Inst Zool, Bonn, Germany; [Fischer, Dominik] Univ Giessen, Clin Birds Reptiles Amphibians & Fish, D-35390 Giessen, Germany	Technical University Freiberg; University of Bonn; Justus Liebig University Giessen	Ponitz, B (corresponding author), TU Bergakad Freiberg, Inst Mech & Fluid Dynam, Freiberg, Germany.	Benjamin.Ponitz@imfd.tu-freiberg.de		Bruecker, Christoph/0000-0001-5834-3020	Deutsche Forschungsgemeinschaft [BL 242/19-1, BR 1494/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study is funded by the Deutsche Forschungsgemeinschaft (BL 242/19-1; BR 1494/21-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH E, 1972, J FLUID MECH, V54, P565, DOI 10.1017/S0022112072000874; ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401; ALERSTAM T, 1987, IBIS, V129, P267, DOI 10.1111/j.1474-919X.1987.tb03207.x; Anderson GW, 1973, AD769492 AIR FORC I, P492; Bechert DW, 1997, 971960 AIAA; Brown L., 1976, BRIT BIRDS PREY; Brucker C, 2013, P INT S ERCOFTAC UNS; Carruthers AC, 2007, J EXP BIOL, V210, P4136, DOI 10.1242/jeb.011197; Chitty J, 2008, RAPTOR HUSBANDRY FAL, P7; Clark WS, 1995, WILDBIRD, V9, P42; Del Hoyo J, 1999, HDB BIRDS WORLD, V5; Favier J, 2012, CR MECANIQUE, V340, P107, DOI 10.1016/j.crme.2011.11.004; Favier J, 2009, J FLUID MECH, V627, P451, DOI 10.1017/S0022112009006119; Franklin DC, 1999, BIOL CONSERV, V90, P53, DOI 10.1016/S0006-3207(99)00010-5; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; HUSSAIN AKMF, 1986, J FLUID MECH, V173, P303, DOI 10.1017/S0022112086001192; HUSTLER K, 1983, OSTRICH, V54, P161, DOI 10.1080/00306525.1983.9634466; Krause E, 2003, STROMUNGSLEHRE; Lawson NJ, 1997, MEAS SCI TECHNOL, V8, P894, DOI 10.1088/0957-0233/8/8/010; Lentink D, 2007, NATURE, V446, P1082, DOI 10.1038/nature05733; Lu FK, 2010, EUR PHYS J-SPEC TOP, V182, P51, DOI 10.1140/epjst/e2010-01225-0; Luthi B, 2005, J FLUID MECH, V528, P87; NACHTIGALL W, 1975, Journal fuer Ornithologie, V116, P1, DOI 10.1007/BF01643073; Nachtigall W, 1998, PHYS UNSERVER Z, P29; National Geographic, 2011, NATL GEOGRAPHIC; Orton DA., 1975, FIELD            SEP, P588; Podbregar N, 2013, GEHEIMNIS FLIEGENS T, P227; Ratcliffe Derek A., 1980, PEREGRINE FALCON; ROBINSON SK, 1991, ANNU REV FLUID MECH, V23, P601, DOI 10.1146/annurev.fl.23.010191.003125; Savage C, 1992, PEREGRINE FALCONS; Schatz M, 2001, NOTE NUM FL, V76, P385; Schlichting H., 2017, BOUNDARY LAYER THEOR; Seitz K, 1999, NAFA J, P68; Tucker VA, 1998, J EXP BIOL, V201, P403; TUCKER VA, 1990, J EXP BIOL, V149, P449; TUCKER VA, 1970, J EXP BIOL, V52, P345	36	18	21	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86506	10.1371/journal.pone.0086506	http://dx.doi.org/10.1371/journal.pone.0086506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505258	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000330829200018
J	Sang, YM; Brichalli, W; Rowland, RRR; Blecha, F				Sang, Yongming; Brichalli, Wyatt; Rowland, Raymond R. R.; Blecha, Frank			Genome-Wide Analysis of Antiviral Signature Genes in Porcine Macrophages at Different Activation Statuses	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; ALVEOLAR MACROPHAGES; ALTERNATIVE ACTIVATION; FUNCTIONAL-ANALYSIS; INFECTION; HIV-1; POLARIZATION; IMMUNITY; REPLICATION; EXPRESSION	Macrophages (M phi s) can be polarized to various activation statuses, including classical (M1), alternative (M2), and antiviral states. To study the antiviral activation status of porcine M Phi s during porcine reproductive and respiratory syndrome virus (PRRSV) infection, we used RNA Sequencing (RNA-Seq) for transcriptomic analysis of differentially expressed genes (DEGs). Sequencing assessment and quality evaluation showed that our RNA-Seq data met the criteria for genome-wide transcriptomic analysis. Comparisons of any two activation statuses revealed more than 20,000 DEGs that were normalized to filter out 153-5,303 significant DEGs [false discovery rate (FDR) <= 0.001, fold change >= 2] in each comparison. The highest 5,303 significant DEGs were found between lipopolysaccharide- (LPS) and interferon (IFN)gamma-stimulated M1 cells, whereas only 153 significant DEGs were detected between interleukin (IL)-10-polarized M2 cells and control mock-activated cells. To identify signature genes for antiviral regulation pertaining to each activation status, we identified a set of DEGs that showed significant up-regulation in only one activation state. In addition, pathway analyses defined the top 20-50 significantly regulated pathways at each activation status, and we further analyzed DEGs pertinent to pathways mediated by AMP kinase (AMPK) and epigenetic mechanisms. For the first time in porcine macrophages, our transcriptomic analyses not only compared family-wide differential expression of most known immune genes at different activation statuses, but also revealed transcription evidence of multiple gene families. These findings show that using RNA-Seq transcriptomic analyses in virus-infected and status-synchronized macrophages effectively profiled signature genes and gene response pathways for antiviral regulation, which may provide a framework for optimizing antiviral immunity and immune homeostasis.	[Sang, Yongming; Brichalli, Wyatt; Blecha, Frank] Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA; [Rowland, Raymond R. R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Sang, YM (corresponding author), Kansas State Univ, Coll Vet Med, Dept Anat & Physiol, Manhattan, KS 66506 USA.	ysang@vet.k-state.edu; blecha@vet.k-state.edu			USDA NIFA/DHS [2010-39559-21860]; USDA NIFA [2013-67015-21236]	USDA NIFA/DHS(United States Department of Agriculture (USDA)); USDA NIFA(United States Department of Agriculture (USDA))	This work was supported in part by USDA NIFA/DHS 2010-39559-21860 and USDA NIFA 2013-67015-21236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Andreoli F, 2013, CURR PHARM DESIGN, V19, P578, DOI 10.2174/138161213804581918; Arceo Maria E., 2013, Frontiers in Genetics, V3, P321, DOI 10.3389/fgene.2012.00321; Calzada-Nova G, 2011, J VIROL, V85, P2703, DOI 10.1128/JVI.01616-10; Cassol E, 2010, J LEUKOCYTE BIOL, V87, P599, DOI 10.1189/jlb.1009673; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Charerntantanakul W, 2006, VIRAL IMMUNOL, V19, P646, DOI 10.1089/vim.2006.19.646; Che TM, 2011, J ANIM SCI, V89, P3016, DOI 10.2527/jas.2010-3366; Chen WH, 2012, IMMUNOL LETT, V141, P227, DOI 10.1016/j.imlet.2011.10.009; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; CHITKOMCKOWN CG, 1991, J LEUKOCYTE BIOL, V50, P364, DOI 10.1002/jlb.50.4.364; Darwich L, 2010, VIRUS RES, V154, P123, DOI 10.1016/j.virusres.2010.07.017; Duan X, 1997, ARCH VIROL, V142, P2483, DOI 10.1007/s007050050256; Ezquerra A, 2009, DEV COMP IMMUNOL, V33, P284, DOI 10.1016/j.dci.2008.06.002; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-33; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kaisho T, 2008, FRONT BIOSCI-LANDMRK, V13, P6034, DOI 10.2741/3134; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Loving CL, 2006, J IMMUNOL, V177, P8432, DOI 10.4049/jimmunol.177.12.8432; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Molitor TW, 1997, VET MICROBIOL, V55, P265, DOI 10.1016/S0378-1135(96)01327-2; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sang YM, 2008, VIRAL IMMUNOL, V21, P303, DOI 10.1089/vim.2008.0042; Sang YM, 2012, VIRUSES-BASEL, V4, P102, DOI 10.3390/v4010102; Sang Yongming, 2011, Animal Health Research Reviews, V12, P149, DOI 10.1017/S1466252311000144; Sang YM, 2010, PHYSIOL GENOMICS, V42, P248, DOI 10.1152/physiolgenomics.00198.2009; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; Stolfa DA, 2012, FUTURE MED CHEM, V4, P2029, DOI [10.4155/FMC.12.144, 10.4155/fmc.12.144]; Summerfield A, 2009, DEV COMP IMMUNOL, V33, P299, DOI 10.1016/j.dci.2008.05.005; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Thacker EL, 2001, VET CLIN N AM-FOOD A, V17, P551, DOI 10.1016/S0749-0720(15)30006-2; Walson JL, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947	57	30	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87613	10.1371/journal.pone.0087613	http://dx.doi.org/10.1371/journal.pone.0087613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505295	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200054
J	Sarkar, J; McHardy, IH; Simanian, EJ; Shi, WY; Lux, R				Sarkar, Juni; McHardy, Ian H.; Simanian, Emil J.; Shi, Wenyuan; Lux, Renate			Transcriptional Responses of Treponema denticola to Other Oral Bacterial Species	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; TANNERELLA-FORSYTHIA; RED COMPLEX; COAGGREGATION; PROTEIN; GROWTH; PERIODONTITIS; CONSERVATION	The classic organization by Socransky and coworkers categorized the oral bacteria of the subgingival plaque into different complexes. Treponema denticola, Porphyromonas gingivalis and Tannerella forsythia are grouped into the red complex that is highly correlated with periodontal disease. Socransky's work closely associates red with orange complex species such as Fusobacterium nucleatum and Prevotella intermedia but not with members of the other complexes. While the relationship between species contained by these complexes is in part supported by their ability to physically attach to each other, the physiological consequences of these interactions and associations are less clear. In this study, we employed T. denticola as a model organism to analyze contact-dependent responses to interactions with species belonging to the same complex (P. gingivalis and T. forsythia), the closely associated orange complex (using F. nucleatum and P. intermedia as representatives) and the unconnected yellow complex (using Streptococcus sanguinis and S. gordonii as representatives). RNA was extracted from T. denticola alone as well as after pairwise co-incubation for 5 hrs with representatives of the different complexes, and the respective gene expression profiles were determined using microarrays. Numerous genes related to motility, metabolism, transport, outer membrane and hypothetical proteins were differentially regulated in T. denticola in the presence of the tested partner species. Further analysis revealed a significant overlap in the affected genes and we identified a general response to the presence of other species, those specific to two of the three complexes as well as individual complexes. Most interestingly, many predicted major antigens (e. g. flagella, Msp, CTLP) were suppressed in responses that included red complex species indicating that the presence of the most closely associated species induces immune-evasive strategies. In summary, the data presented here provide an in-depth understanding of the transcriptional responses triggered by contact-dependent interactions between microorganisms inhabiting the periodontal pocket.	[Sarkar, Juni; Simanian, Emil J.; Shi, Wenyuan; Lux, Renate] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [McHardy, Ian H.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Shi, Wenyuan] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lux, R (corresponding author), Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA.	rlux@dentistry.ucla.edu	SHI, wen/GPW-9531-2022	McHardy, Ian/0000-0002-2121-5460	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research [DE021108]; NIH; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021108] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health (NIH)/National Institute of Dental and Craniofacial Research grant DE021108 to RL and a NIH T32 training grant to IM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JK, 2010, TRENDS MICROBIOL, V18, P30, DOI 10.1016/j.tim.2009.11.001; Andrade José Alexandre de, 2010, Braz. oral res., V24, P224, DOI 10.1590/S1806-83242010000200016; Buonavoglia A, 2013, ODONTOLOGY, V101, P84, DOI 10.1007/s10266-011-0053-y; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; Ellen RP, 2005, PERIODONTOL 2000, V38, P13, DOI 10.1111/j.1600-0757.2005.00108.x; Fenno JC, 1997, J BACTERIOL, V179, P1082, DOI 10.1128/jb.179.4.1082-1089.1997; Fenno JC, 1998, INFECT IMMUN, V66, P1869, DOI 10.1128/IAI.66.5.1869-1877.1998; Frederick JR, 2008, J BACTERIOL, V190, P6162, DOI 10.1128/JB.00046-08; Goetting-Minesky MP, 2013, MOL ORAL MICROBIOL, V28, P181, DOI 10.1111/omi.12013; GRENIER D, 1992, INFECT IMMUN, V60, P5298, DOI 10.1128/IAI.60.12.5298-5301.1992; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hashimoto M, 2003, FEMS MICROBIOL LETT, V226, P267, DOI 10.1016/S0378-1097(03)00615-3; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Houry A, 2010, MICROBIOL-SGM, V156, P1009, DOI 10.1099/mic.0.034827-0; Ishihara K, 2010, PERIODONTOL 2000, V54, P117, DOI 10.1111/j.1600-0757.2009.00345.x; KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4584, DOI 10.1128/IAI.63.12.4584-4588.1995; Kolenbrander PE, 1999, METHOD ENZYMOL, V310, P322; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Lee SH, 2010, INT J ANTIMICROB AG, V35, P138, DOI 10.1016/j.ijantimicag.2009.09.024; Martinez-Pabon MC, 2010, ORAL DIS, V16, P278, DOI 10.1111/j.1601-0825.2009.01639.x; McHardy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013655; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; O'Brien-Simpson NM, 2004, PERIODONTOL 2000, V35, P101, DOI 10.1111/j.0906-6713.2004.003559.x; OHTA K, 1986, INFECT IMMUN, V53, P213, DOI 10.1128/IAI.53.1.213-220.1986; Palmer RJ, 1995, J MICROBIOL METH, V24, P171, DOI 10.1016/0167-7012(95)00068-2; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Rosen G, 2006, FEMS MICROBIOL LETT, V256, P304, DOI 10.1111/j.1574-6968.2006.00131.x; Rosen G, 2008, FEMS MICROBIOL LETT, V289, P59, DOI 10.1111/j.1574-6968.2008.01373.x; Rother M, 2001, ARCH MICROBIOL, V177, P113, DOI 10.1007/s002030100351; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Sarkar J, 2010, MOL ORAL MICROBIOL, V25, P241, DOI 10.1111/j.2041-1014.2010.00578.x; SIMONSON LG, 1988, INFECT IMMUN, V56, P726, DOI 10.1128/IAI.56.4.726-728.1988; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stadtman TC, 2005, PLOS BIOL, V3, P2077, DOI 10.1371/journal.pbio.0030421; Suzuki N, 2013, INT J DENT, V2013, DOI 10.1155/2013/587279; Tamai R, 2009, ANAEROBE, V15, P87, DOI 10.1016/j.anaerobe.2008.12.004; TERSTEEG PF, 1990, ANTON LEEUW INT J G, V57, P63, DOI 10.1007/BF00403156; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veith PD, 2009, BBA-PROTEINS PROTEOM, V1794, P1421, DOI 10.1016/j.bbapap.2009.06.001; Verma RK, 2010, INTERDISCIP PERSPECT, V2010, DOI DOI 10.1155/2010/605125; WONG HC, 1979, J BACTERIOL, V140, P240, DOI 10.1128/JB.140.1.240-245.1979; Yamada M, 2005, FEMS MICROBIOL LETT, V250, P271, DOI 10.1016/j.femsle.2005.07.019; Yao ES, 1996, ORAL MICROBIOL IMMUN, V11, P35, DOI 10.1111/j.1399-302X.1996.tb00334.x; Yoshida A, 2004, ORAL MICROBIOL IMMUN, V19, P196, DOI 10.1111/j.0902-0055.2004.00142.x; Zainal-Abidin Z, 2012, J PROTEOME RES, V11, P4449, DOI 10.1021/pr300201c; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727	49	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88361	10.1371/journal.pone.0088361	http://dx.doi.org/10.1371/journal.pone.0088361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505483	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200184
J	Savell, E; Gilmore, AB; Fooks, G				Savell, Emily; Gilmore, Anna B.; Fooks, Gary			How Does the Tobacco Industry Attempt to Influence Marketing Regulations? A Systematic Review	PLOS ONE			English	Review							YOUTH SMOKING PREVENTION; FRAMEWORK CONVENTION; ADOLESCENT SMOKING; HEALTH WARNINGS; MEDIA COVERAGE; IMPACT; PROMOTION; EXPOSURE; MOVIES; CIGARETTES	Background: The Framework Convention on Tobacco Control makes a number of recommendations aimed at restricting the marketing of tobacco products. Tobacco industry political activity has been identified as an obstacle to Parties' development and implementation of these provisions. This study systematically reviews the existing literature on tobacco industry efforts to influence marketing regulations and develops taxonomies of 1) industry strategies and tactics and 2) industry frames and arguments. Methods: Searches were conducted between April-July 2011, and updated in March 2013. Articles were included if they made reference to tobacco industry efforts to influence marketing regulations; supported claims with verifiable evidence; were written in English; and concerned the period 1990-2013. 48 articles met the review criteria. Narrative synthesis was used to combine the evidence. Results: 56% of articles focused on activity in North America, Europe or Australasia, the rest focusing on Asia (17%), South America, Africa or transnational activity. Six main political strategies and four main frames were identified. The tobacco industry frequently claims that the proposed policy will have negative unintended consequences, that there are legal barriers to regulation, and that the regulation is unnecessary because, for example, industry does not market to youth or adheres to a voluntary code. The industry primarily conveys these arguments through direct and indirect lobbying, the promotion of voluntary codes and alternative policies, and the formation of alliances with other industrial sectors. The majority of tactics and arguments were used in multiple jurisdictions. Conclusions: Tobacco industry political activity is far more diverse than suggested by existing taxonomies of corporate political activity. Tactics and arguments are repeated across jurisdictions, suggesting that the taxonomies of industry tactics and arguments developed in this paper are generalisable to multiple jurisdictions and can be used to predict industry activity.	[Savell, Emily; Gilmore, Anna B.; Fooks, Gary] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Savell, Emily; Gilmore, Anna B.; Fooks, Gary] UK Ctr Tobacco & Alcohol Studies, Bath, Avon, England	University of Bath	Savell, E (corresponding author), Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England.	e.savell@bath.ac.uk	gilmore, anna B/I-7130-2012	gilmore, anna B/0000-0003-0281-1248; Savell, Emily/0000-0002-2174-6413; Fooks, Gary/0000-0003-0080-4802	National Cancer Institute of the United States National Institutes of Health [R01CA160695]; Economic and Social Research Council [ES/I900284/1]; NATIONAL CANCER INSTITUTE [R01CA160695] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1B, MR/K023195/1] Funding Source: researchfish	National Cancer Institute of the United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is supported by the National Cancer Institute of the United States National Institutes of Health [Grant Number R01CA160695]. ES is supported by the Economic and Social Research Council [Grant Number ES/I900284/1]. The content of this article is solely the responsibility of the authors and does not necessarily represent the views of the funders. The funders played no role in the study design, analysis and interpretation of data, nor writing of the report or the decision to submit the article for publication.	Alechnowicz K, 2004, TOB CONTROL, V13, P71, DOI 10.1136/tc.2004.009324; [Anonymous], 2001, PRACTICAL ASSESSMENT; [Anonymous], 2010, JOINT NAT CAP ASS IM; Apollonio DE, 2010, AM J PUBLIC HEALTH, V100, P1188, DOI 10.2105/AJPH.2009.169573; ASH, 2012, FACTSH SMOK STAT; ASH, 2010, SMOK FILL ROOM BIG T; Assunta M, 2004, TOB CONTROL, V13, P43, DOI 10.1136/tc.2004.008094; BAT Australia, 2012, ILL TOB AUSTR; Bayer R, 2010, NEW ENGL J MED, V362, P281, DOI 10.1056/NEJMp0909626; Bond L, 2009, AUSTRALAS MED J, V2, DOI 10.4066/AMJ.2009.43; Cairney P., 2020, UNDERSTANDING PUBLIC, V2nd; Carter SM, 2003, TOB CONTROL, V12, P71; Champion D, 2005, J EPIDEMIOL COMMUN H, V59, P679, DOI 10.1136/jech.2005.035915; Chapman S, 2003, TOB CONTROL, V12, P13; Charlesworth A, 2005, PEDIATRICS, V116, P1516, DOI 10.1542/peds.2005-0141; Cohen JE, 2001, TOB CONTROL, V10, P364, DOI 10.1136/tc.10.4.364; Daviter F, 2007, J EUR PUBLIC POLICY, V14, P654, DOI 10.1080/13501760701314474; Dearlove J, 2000, TOBACCO IND POLITICA; DiFranza J R, 1996, Tob Control, V5, P127, DOI 10.1136/tc.5.2.127; DiFranza JR, 2006, PEDIATRICS, V117, pE1237, DOI 10.1542/peds.2005-1817; Ennew C. T., 1993, MARKETING BLUEPRINT; Epps-Johnson T, 2009, STARS ALIGNED CORNFI; Eriksen M, 2012, TOBACCO ATLAS; Fooks GJ, 2013, TOBACCO CONTROL; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; Gilmore AB, 2006, BMJ-BRIT MED J, V332, P355, DOI 10.1136/bmj.332.7537.355; Glantz S, 2010, REPORTS STATE TOBACC; Goldberg ME, 2006, TOB CONTROL, V15, P54, DOI 10.1136/tc.2006.017947; Gruning T, 2008, GER POLIT, V17, P140, DOI 10.1080/09644000802075708; Hammond D, 2009, TOBACCO LABELLING PA; Hammond D, 2010, SALUD PUBLICA MEXICO, V52, pS226, DOI 10.1590/S0036-36342010000800018; Harris JK, 2010, TOB CONTROL, V19, P37, DOI 10.1136/tc.2009.032516; Hiilamo H, 2012, TOBACCO CONTROL; Hillman AJ, 1999, ACAD MANAGE REV, V24, P825, DOI 10.2307/259357; Hoek J, 2012, TOB CONTROL, V21, P497, DOI 10.1136/tc.2011.043687; Hurt RD, 2009, MAYO CLIN PROC, V84, P446, DOI 10.1016/S0025-6196(11)60563-6; Kennedy Allison, 2011, TOBACCO CONTROL FLOR; Kwan S, 2009, SOCIOL INQ, V79, P25, DOI 10.1111/j.1475-682X.2008.00271.x; Labonte R, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-14; Lambert A, 2004, TOB CONTROL, V13, P379, DOI 10.1136/tc.2004.008441; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Landman A, 2009, AM J PUBLIC HEALTH, V99, P45, DOI 10.2105/AJPH.2007.130740; Larsen L., 2008, SCI PUBL POLICY, V35, P757, DOI [10.3152/030234208X394697, DOI 10.3152/030234208X394697]; Lee C, 2001, TOBACCO IND SUCCESSF; Lee SH, 2012, CONSUM COMM NETWORK, P1, DOI 10.1109/CCNC.2012.6181052; Ling PM, 2010, AM J PUBLIC HEALTH, V100, P32, DOI 10.2105/AJPH.2008.144097; MacKenzie R, 2004, TOB CONTROL, V13, P112, DOI 10.1136/tc.2004.009381; Mackey TK, 2013, AM J PUBLIC HLTH, V103; Magzamen S, 2001, TOB CONTROL, V10, P154, DOI 10.1136/tc.10.2.154; Mamudu HM, 2008, AM J PUBLIC HEALTH, V98, P1630, DOI 10.2105/AJPH.2007.129478; McDaniel PA, 2005, TOBACCO CONTROL, V14; McDaniel PA, 2009, WOMEN HEALTH, V49, P441, DOI 10.1080/03630240903238800; Mekemson C, 2002, TOB CONTROL, V11, pI81, DOI 10.1136/tc.11.suppl_1.i81; Menashe CL, 1998, J HEALTH COMMUN, V3, P307, DOI 10.1080/108107398127139; Mitchell AD, 2010, ASIAN J WTO INT HEAL, V5, P405; Nakkash R, 2009, TOB CONTROL, V18, P310, DOI 10.1136/tc.2008.029405; NCI, 2008, ROL MED PROM RED TOB; Neuman M, 2002, LANCET, V359, P1323, DOI 10.1016/S0140-6736(02)08275-2; O'Sullivan B, 2000, TOB CONTROL, V9, P292, DOI 10.1136/tc.9.3.292; Outterson K, 2011, NEW ENGL J MED, V365, P2351, DOI 10.1056/NEJMp1113011; Pan American Health Organization, 2002, PROF PEOPL TOB IND A; Physicians for a Smoke-Free Canada, 2008, PLOT PLAIN PACK MULT; Pierce JP, 1998, JAMA-J AM MED ASSOC, V279, P511, DOI 10.1001/jama.279.7.511; Pucci LG, 1999, PREV MED, V29, P313, DOI 10.1006/pmed.1999.0554; Sargent JD, 2007, ARCH PEDIAT ADOL MED, V161, P849, DOI 10.1001/archpedi.161.9.849; Schooler C, 1996, AM J PUBLIC HEALTH, V86, P1216, DOI 10.2105/AJPH.86.9.1216; Sebrie EM, 2005, TOB CONTROL, V14, DOI 10.1136/tc.2005.011130; Sebrie EM, 2007, AM J PUBLIC HEALTH, V97, P1357, DOI 10.2105/AJPH.2006.094128; Shaffer Ellen, 2005, TOB CONTROL S2, V14, pii19, DOI DOI 10.1136/TC.2004.007930; Shirane R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001248; Slater SJ, 2007, ARCH PEDIAT ADOL MED, V161, P440, DOI 10.1001/archpedi.161.5.440; Smith KE, 2010, J EPIDEMIOL COMMUN H, V64, P478, DOI 10.1136/jech.2009.094300; Smith KE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000202; Smith KE, 2013, TOBACCO CONTROL, V22; Stanton C, 2009, TOBACCO CONTROL MAIN; Szilagyi T., 2004, Central European Journal of Public Health, V12, P190; Tannen Deborah, 1993, FRAMING DISCOURSE; Telegraph, 2012, TELEGRAPH; Titus-Ernstoff L, 2008, PEDIATRICS, V121, P15, DOI 10.1542/peds.2007-0051; Tobacco Tactics, 2012, LINDA BAULD; Tobacco Tactics, 2012, FOI U BATH; Tobacco Tactics, 2012, S CLARK; Tobacco Tactics, 2013, PLAIN PACK; Tsoukalas TH, 2003, SHIFTING TIDES MINNE; Tumwine J, 2011, INT J ENV RES PUB HE, V8, P4312, DOI 10.3390/ijerph8114312; Tung G, 2008, SWIMMING UPSTREAM TO; UCSF Library, 2012, TOB DOC BIBL; UCSF Library, 2010, LEG TOB DOC LIB MARK; Wackowski OA, 2011, SUBST USE MISUSE, V46, P882, DOI 10.3109/10826084.2011.570620; Wakefield M, 2005, J APPL SOC PSYCHOL, V35, P1894, DOI 10.1111/j.1559-1816.2005.tb02201.x; Wakefield M, 2003, HEALTH PROMOT INT, V18, P297, DOI 10.1093/heapro/dag413; Wakefield M, 2006, AM J PUBLIC HEALTH, V96, P2154, DOI 10.2105/AJPH.2005.083352; Washington MD, 2012, GOOD START OUT GATE; Weiss JW, 2006, NICOTINE TOB RES, V8, P455, DOI 10.1080/14622200600670454; Welle JR., 2004, TOBACCO CONTROL POLI; WHO, 2011, FACTSH TOB; WHO, 2011, GUID IMPL ART 5 3 WH; WHO, 2008, VOIC TRUTH; WHO, 2012, FCTC REP IMPL CONV D; Wise D, 2010, MASS COMMUN SOC, V13, P435, DOI 10.1080/15205430903296077; World Health Organization (WHO), 2005, WHO FRAM CONV TOB CO; [No title captured]	102	135	136	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87389	10.1371/journal.pone.0087389	http://dx.doi.org/10.1371/journal.pone.0087389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505286	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330829200045
J	Schaper, S; Louis, AA				Schaper, Steffen; Louis, Ard A.			The Arrival of the Frequent: How Bias in Genotype-Phenotype Maps Can Steer Populations to Local Optima	PLOS ONE			English	Article							RNA SECONDARY STRUCTURES; NEUTRAL EVOLUTION; EVOLVABILITY; ROBUSTNESS	Genotype-phenotype (GP) maps specify how the random mutations that change genotypes generate variation by altering phenotypes, which, in turn, can trigger selection. Many GP maps share the following general properties: 1) The total number of genotypes N-G is much larger than the number of selectable phenotypes; 2) Neutral exploration changes the variation that is accessible to the population; 3) The distribution of phenotype frequencies F-p = N-p/N-G, with N-p the number of genotypes mapping onto phenotype p, is highly biased: the majority of genotypes map to only a small minority of the phenotypes. Here we explore how these properties affect the evolutionary dynamics of haploid Wright-Fisher models that are coupled to a random GP map or to a more complex RNA sequence to secondary structure map. For both maps the probability of a mutation leading to a phenotype p scales to first order as F-p, although for the RNA map there are further correlations as well. By using mean-field theory, supported by computer simulations, we show that the discovery time T-p of a phenotype p similarly scales to first order as 1/F-p for a wide range of population sizes and mutation rates in both the monomorphic and polymorphic regimes. These differences in the rate at which variation arises can vary over many orders of magnitude. Phenotypic variation with a larger F-p is therefore be much more likely to arise than variation with a small F-p. We show, using the RNA model, that frequent phenotypes (with larger F-p) can fix in a population even when alternative, but less frequent, phenotypes with much higher fitness are potentially accessible. In other words, if the fittest never 'arrive' on the timescales of evolutionary change, then they can't fix. We call this highly non-ergodic effect the 'arrival of the frequent'.	[Schaper, Steffen; Louis, Ard A.] Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford, England	University of Oxford	Louis, AA (corresponding author), Univ Oxford, Rudolf Peierls Ctr Theoret Phys, Oxford, England.	ard.louis@physics.ox.ac.uk	louis, Ard a/E-6868-2010	louis, Ard a/0000-0002-8438-910X	Engineering and Physical Sciences Research Council (EPSRC) [EP/P504287/1]	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding for this research was received from the Engineering and Physical Sciences Research Council (EPSRC) under grant EP/P504287/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert SE, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026117; ALBERCH P, 1991, GENETICA, V84, P5, DOI 10.1007/BF00123979; [Anonymous], 1877, DIFFERENT FORMS FLOW; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Borenstein E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000202; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; De Vries H., 1904, SPECIES VARIETIES TH; England JL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218101; Ferrada E, 2012, BIOPHYS J, V102, P1916, DOI 10.1016/j.bpj.2012.01.047; Ferrada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014172; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huynen MA, 1996, J MOL EVOL, V43, P165; IWASA Y, 1988, J THEOR BIOL, V135, P265, DOI 10.1016/S0022-5193(88)80243-1; Jorg T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-464; Kimura M, 1985, NEUTRAL THEORY MOL E; Li H, 1996, SCIENCE, V273, P666, DOI 10.1126/science.273.5275.666; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Raman K, 2011, MOL BIOSYST, V7, P1081, DOI 10.1039/c0mb00165a; Reidys CH, 1997, ADV APPL MATH, V19, P360, DOI 10.1006/aama.1997.0553; Schaper S, 2013, THESIS U OXFORD; Schaper S, 2012, P ROY SOC B-BIOL SCI, V279, P1777, DOI 10.1098/rspb.2011.2183; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Yampolsky LY, 2001, EVOL DEV, V3, P73, DOI 10.1046/j.1525-142x.2001.003002073.x	30	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86635	10.1371/journal.pone.0086635	http://dx.doi.org/10.1371/journal.pone.0086635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505262	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200022
J	Thomson, CE; Gilbert, JDJ; Brooke, MD				Thomson, Caroline E.; Gilbert, James D. J.; Brooke, M. de L.			Cytochrome b Divergence between Avian Sister Species Is Linked to Generation Length and Body Mass	PLOS ONE			English	Article							METABOLIC-RATE; NUCLEOTIDE SUBSTITUTIONS; MOLECULAR EVOLUTION; MITOCHONDRIAL-DNA; MUTATION-RATE; SIZE; PHYLOGEOGRAPHY; TEMPERATURE; LONGEVITY; TIME	It is increasingly realised that the molecular clock does not tick at a constant rate. Rather, mitochondrial mutation rates are influenced by factors such as generation length and body mass. This has implications for the use of genetic data in species delimitation. It could be that speciation, as recognised by avian taxonomists, is associated with a certain minimum genetic distance between sister taxa, in which case we would predict no difference in the cytochrome b divergence of sister taxa according to the species' body size or generation time. Alternatively, if what taxonomists recognise as speciation has tended to be associated with the passage of a minimum amount of time since divergence, then there might be less genetic divergence between sister taxa with slower mutation rates, namely those that are heavier and/or with longer generation times. After excluding non-flying species, we analysed a database of over 600 avian sister species pairs, and found that species pairs with longer generation lengths (which tend to be the larger species) showed less cytochrome b divergence. This finding cautions against using any simple unitary criterion of genetic divergence to delimit species.	[Thomson, Caroline E.; Gilbert, James D. J.; Brooke, M. de L.] Univ Cambridge, Dept Zool, Cambridge, England; [Thomson, Caroline E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Gilbert, James D. J.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Cambridge; University of Oxford; University of Sydney	Brooke, MD (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	m.brooke@zoo.cam.ac.uk	Gilbert, James/A-8965-2010	Gilbert, James/0000-0001-7014-2803				Abbott CL, 2003, MOL ECOL, V12, P2747, DOI 10.1046/j.1365-294X.2003.01944.x; Aliabadian M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004119; AVISE JC, 1982, EVOL BIOL, V15, P151; Avise John C., 2004, P1; Bennett P. M., 2002, OX ECOL EV; Blackburn TM, 1999, ADV ECOL RES, V28, P181, DOI 10.1016/S0065-2504(08)60033-1; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Brooke M., 2004, ALBATROSSES PETRELS; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CRACRAFT J, 1992, CLADISTICS, V8, P1, DOI 10.1111/j.1096-0031.1992.tb00049.x; Dunning J.B., 2008, CRC HDB AVIAN BODY M, V2; Efe MA, 2009, MOL PHYLOGENET EVOL, V52, P263, DOI 10.1016/j.ympev.2009.03.030; Fox J, 2011, R COMMANDER PACKAGE; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Galtier N, 2009, BIOL LETTERS, V5, P413, DOI 10.1098/rsbl.2008.0662; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Helbig AJ, 2002, IBIS, V144, P518, DOI 10.1046/j.1474-919X.2002.00091.x; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2013, ECOL EVOL, V3, P1915, DOI 10.1002/ece3.597; Kolokotrones T, 2010, NATURE, V464, P753, DOI 10.1038/nature08920; LAIRD CD, 1969, NATURE, V224, P149, DOI 10.1038/224149a0; Lanfear R, 2007, P NATL ACAD SCI USA, V104, P15388, DOI 10.1073/pnas.0703359104; Lanfear R, 2010, P NATL ACAD SCI USA, V107, P20423, DOI 10.1073/pnas.1007888107; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Mayr E., 1942, P1; Mindell DP, 2005, NEORNITHES MODERN BI; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Orme D., 2009, CAIC COMP ANAL USING; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; R Core Team, 2021, R LANGUAGE ENV STAT; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Woolfit M, 2005, P ROY SOC B-BIOL SCI, V272, P2277, DOI 10.1098/rspb.2005.3217	48	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e85006	10.1371/journal.pone.0085006	http://dx.doi.org/10.1371/journal.pone.0085006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505250	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200010
J	Wu, X; Cao, MP; Shen, YY; Chu, KP; Tao, WB; Song, WT; Liu, LP; Wang, XH; Zheng, YF; Chen, SD; Zeng, QL; Xia, RH				Wu, Xia; Cao, Mei-Ping; Shen, Yun-Yun; Chu, Ke-Ping; Tao, Wu-Bin; Song, Wei-Tao; Liu, Li-Ping; Wang, Xiang-Hui; Zheng, Yu-Fang; Chen, Shu-De; Zeng, Qun-Li; Xia, Ruo-Hong			Weak Power Frequency Magnetic Field Acting Similarly to EGF Stimulation, Induces Acute Activations of the EGFR Sensitive Actin Cytoskeleton Motility in Human Amniotic Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CA2+ INFLUX; ELECTROMAGNETIC-FIELDS; BIOCHEMICAL-PROPERTIES; PROTEIN; FASCIN; KINASE; LINE; INHIBITOR; MIGRATION	In this article, we have examined the motility-related effects of weak power frequency magnetic fields (MFs) on the epidermal growth factor receptor (EGFR)-sensitive motility mechanism, including the F-actin cytoskeleton, growth of invasive protrusions and the levels of signal molecules in human amniotic epithelial (FL) cells. Without extracellular EGF stimulation, the field stimulated a large growth of new protrusions, especially filopodia and lamellipodia, an increased population of vinculin-associated focal adhesions. And, an obvious reduction of stress fiber content in cell centers was found, corresponding to larger cell surface areas and decreased efficiency of actin assembly of FL cells in vitro, which was associated with a decrease in overall F-actin content and special distributions. These effects were also associated with changes in protein content or distribution patterns of the EGFR downstream motility-related signaling molecules. All of these effects are similar to those following epidermal growth factor (EGF) stimulation of the cells and are time dependent. These results suggest that power frequency MF exposure acutely affects the migration/motility-related actin cytoskeleton reorganization that is regulated by the EGFR-cytoskeleton signaling pathway. Therefore, upon the MF exposure, cells are likely altered to be ready to transfer into a state of migration in response to the stimuli.	[Wu, Xia; Cao, Mei-Ping; Chu, Ke-Ping; Tao, Wu-Bin; Song, Wei-Tao; Wang, Xiang-Hui; Chen, Shu-De; Xia, Ruo-Hong] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China; [Shen, Yun-Yun; Zeng, Qun-Li] Zhejiang Univ, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Li-Ping; Zheng, Yu-Fang] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Wu, Xia; Xia, Ruo-Hong] E China Normal Univ, State Key Lab Precis Spect, Shanghai 200062, Peoples R China	East China Normal University; Zhejiang University; Fudan University; East China Normal University	Zeng, QL (corresponding author), Zhejiang Univ, Bioelectromagnet Lab, Hangzhou 310003, Zhejiang, Peoples R China.	zengql@zju.edu.cn; xirren@gmail.com	Zheng, Yufang/F-1091-2011; liu, li/HGC-0900-2022	Zheng, Yufang/0000-0002-0488-2624; Xia, Ruohong/0000-0002-4036-4007	973 program [2011CB503703]; Natural Science Foundation of China [30770509]	973 program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 program (No. 2011CB503703 to Ruohong Xia in Group 3, http://www.973.gov.cn/AreaAppl.aspx), and the Natural Science Foundation of China (No. 30770509 to Qunli Zeng, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Barbier E, 1996, BIOELECTROMAGNETICS, V17, P303, DOI 10.1002/(SICI)1521-186X(1996)17:4<303::AID-BEM6>3.0.CO;2-7; BARKER AT, 1984, LANCET, V1, P994; BAUMGARTEN LB, 1992, J BIOL CHEM, V267, P10524; Che Q, 2002, HYPERTENSION, V40, P700, DOI 10.1161/01.HYP.0000035524.10948.93; Chu K, 2007, CHIN J RADIOL HEALTH, V16, P259; Chu Ke-ping, 2007, Zhonghua Yufang Yixue Zazhi, V41, P391; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Fan LF, 2012, BIOCHEM SOC T, V40, P268, DOI 10.1042/BST20110625; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Hermle T, 2006, AM J PHYSIOL-CELL PH, V291, pC710, DOI 10.1152/ajpcell.00631.2005; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Ishikawa R, 1998, J BIOL CHEM, V273, P26991, DOI 10.1074/jbc.273.41.26991; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Jia CL, 2007, BIOELECTROMAGNETICS, V28, P197, DOI 10.1002/bem.20293; Komazaki S, 2007, J EXP ZOOL PART A, V307A, P156, DOI 10.1002/jez.a.359; Kroupova J, 2007, BIOELECTROCHEMISTRY, V70, P96, DOI 10.1016/j.bioelechem.2006.03.034; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; LINDSTROM E, 1993, J CELL PHYSIOL, V156, P395, DOI 10.1002/jcp.1041560223; Lisi A, 2000, BIOELECTROMAGNETICS, V21, P46, DOI 10.1002/(SICI)1521-186X(200001)21:1<46::AID-BEM7>3.0.CO;2-Z; Mace KA, 2005, J CELL SCI, V118, P2567, DOI 10.1242/jcs.02399; Mace KA, 2009, STEM CELLS, V27, P1654, DOI 10.1002/stem.90; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Man D, 1999, PLAST RECONSTR SURG, V104, P2261, DOI 10.1097/00006534-199912000-00051; Manni V, 2002, BIOELECTROMAGNETICS, V23, P298, DOI 10.1002/bem.10023; MARSTON SB, 1993, J BIOL CHEM, V268, P12317; Peiretti F, 1996, BLOOD, V87, P162; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Quittan M, 2000, ACTA MED AUST, V27, P61; Rieti S, 2004, J MICROSC-OXFORD, V213, P20, DOI 10.1111/j.1365-2818.2004.01279.x; RIJKEN PJ, 1991, J CELL SCI, V100, P491; Rosen LB, 1996, P NATL ACAD SCI USA, V93, P1113, DOI 10.1073/pnas.93.3.1113; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Sahin Umut, 2006, V327, P99; Song W, 2008, ACTA BIOCH BIOPH SIN, V40, P754, DOI 10.1111/j.1745-7270.2008.00447.x; Stevenson RP, 2012, J CELL SCI, V125, P1073, DOI 10.1242/jcs.093799; Sun Wen-jun, 2004, Zhonghua Yufang Yixue Zazhi, V38, P5; Suzuki T, 2002, CELL MICROBIOL, V4, P223, DOI 10.1046/j.1462-5822.2002.00185.x; Takahashi K, 2005, CELL BIOL INT, V29, P237, DOI 10.1016/j.cellbi.2004.12.009; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Toral C, 2007, CELL TISSUE RES, V327, P143, DOI 10.1007/s00441-006-0248-7; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Verdoni AM, 2008, PHYSIOL GENOMICS, V34, P9, DOI 10.1152/physiolgenomics.00285.2007; VOSTAL JG, 1993, BIOCHEM J, V294, P675, DOI 10.1042/bj2940675; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Yamashiro S, 1998, MOL BIOL CELL, V9, P993, DOI 10.1091/mbc.9.5.993; Yoneda M, 2000, J ENDOCRINOL, V166, P677, DOI 10.1677/joe.0.1660677; Zanet J, 2009, FLY, V3, P281, DOI 10.4161/fly.10315; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200	56	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87626	10.1371/journal.pone.0087626	http://dx.doi.org/10.1371/journal.pone.0087626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505297	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200056
J	Yang, BY; Fan, SJ; Zhi, XY; Li, YF; Liu, YY; Wang, D; He, M; Hou, YY; Zheng, QM; Sun, GF				Yang, Boyi; Fan, Shujun; Zhi, Xueyuan; Li, Yongfang; Liu, Yuyan; Wang, Da; He, Miao; Hou, Yongyong; Zheng, Quanmei; Sun, Guifan			Associations of MTHFR Gene Polymorphisms with Hypertension and Hypertension in Pregnancy: A Meta-Analysis from 114 Studies with 15411 Cases and 21970 Controls	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; FACTOR-V-LEIDEN; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; C677T POLYMORPHISM; RISK-FACTOR; BLOOD-PRESSURE; HOMOCYSTEINE LEVELS; SEVERE PREECLAMPSIA; INHERITED THROMBOPHILIAS	Background: Several epidemiological studies have investigated the associations of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms with hypertension (H) or hypertension in pregnancy (HIP). However, the results were controversial. We therefore performed a comprehensive meta-analysis to provide empirical evidences on the associations. Methodologies: The English and Chinese databases were systematically searched to identify relevant studies. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to evaluate the strength of the associations. Meta-regression, subgroup analysis, sensitivity analysis, cumulative meta-analysis and assessment of publication bias were performed in our study. Principal Findings: A total of 114 studies with 15411 cases and 21970 controls were included, 111 studies with 15094 cases and 21633 controls for the C677T polymorphism and 21 with 2533 cases and 2976 controls for the A1298C polymorphism. Overall, the C677T polymorphism was significantly associated with H and HIP (H & HIP: OR = 1.26, 95% CI = 1.17-1.34; H: OR = 1.36, 95% CI = 1.20-1.53; HIP: OR = 1.21, 95% CI = 1.08-1.32). Stratified analysis by ethnicity revealed a significant association among East Asians and Caucasians, but not among Latinos, Black Africans, and Indians and Sri Lankans. In the stratified analyses according to source of controls, genotyping method, sample size and study quality, significant associations were observed in all the subgroups, with the exception of population based subgroup in H studies and large sample size and "others'' genotyping method subgroups in HIP studies. For the A1298C polymorphism, no significant association was observed either in overall or subgroup analysis under all genetic models. Conclusions: This meta-analysis suggests that the MTHFR C677T rather than A1298C polymorphism may be associated with H & HIP, especially among East Asians and Caucasians.	[Yang, Boyi; Fan, Shujun; Zhi, Xueyuan; Li, Yongfang; Liu, Yuyan; Wang, Da; He, Miao; Zheng, Quanmei; Sun, Guifan] China Med Univ, Sch Publ Hlth, Environm & Noncommunicable Dis Res Ctr, Shenyang, Peoples R China; [Hou, Yongyong] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	China Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Sun, GF (corresponding author), China Med Univ, Sch Publ Hlth, Environm & Noncommunicable Dis Res Ctr, Shenyang, Peoples R China.	sungf@mail.cmu.edu.cn			National Natural Science Foundation of China (NSFC) [81072243]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by a grant ( No. 81072243) from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2011, J OBSTET GYNAECOL RE, V37, P1335, DOI 10.1111/j.1447-0756.2010.01523.x; Alaniz FV, 2013, PREG HYPER INT J WOM; Alfirevic Z, 2001, OBSTET GYNECOL, V97, P753, DOI 10.1016/S0029-7844(01)01190-5; Alghasham A, 2012, INT J HEALTH SCI-IJH, V6, P3, DOI 10.12816/0005968; Also-Rallo E, 2005, EUR J OBSTET GYN R B, V120, P45, DOI 10.1016/j.ejogrb.2004.08.008; Arj-Ong S, 2010, PEDIATR INT, V52, P527, DOI 10.1111/j.1442-200X.2010.03105.x; Bayramoglu A, 2015, CYTOTECHNOLOGY, V67, P115, DOI 10.1007/s10616-013-9665-0; Benes P, 2001, MOL GENET METAB, V73, P188, DOI 10.1006/mgme.2001.3188; Cai Y. M., 2009, CHIN J BIRTH HLTH HE, V17, P14, DOI [10.13404/j.cnki.cjbhh.2009.07.011.14, DOI 10.13404/J.CNKI.CJBHH.2009.07.011.14]; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Chikosi AB, 1999, BRIT J OBSTET GYNAEC, V106, P1219, DOI 10.1111/j.1471-0528.1999.tb08152.x; D'Elia AV, 2002, GYNECOL OBSTET INVES, V53, P84, DOI 10.1159/000052998; Dalmaz CA, 2006, BLOOD CELL MOL DIS, V37, P107, DOI 10.1016/j.bcmd.2006.07.005; Davalos IP, 2005, BLOOD CELL MOL DIS, V35, P66, DOI 10.1016/j.bcmd.2005.03.008; DE Maat MPM, 2004, J THROMB HAEMOST, V2, P1588, DOI 10.1111/j.1538-7836.2004.00861.x; Demir SC, 2006, SAUDI MED J, V27, P1161; Demirel Y, 2011, GENET TEST MOL BIOMA, V15, P785, DOI 10.1089/gtmb.2011.0044; Deng FM, 2007, THESIS SICHUAN U; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deveer R, 2013, FETAL PEDIATR PATHOL, V32, P213, DOI 10.3109/15513815.2012.721475; Ding YSh, 2008, CHIN J BIRTH HLTH HE, V16, P12; Dissanayake VHW, 2012, J OBSTET GYNAECOL RE, V38, P1168, DOI 10.1111/j.1447-0756.2012.01846.x; Dogan OO, 2011, J OBSTET GYNAECOL RE, V37, P527, DOI 10.1111/j.1447-0756.2010.01397.x; Driul L, 2005, INT J GYNECOL OBSTET, V88, P265, DOI 10.1016/j.ijgo.2004.12.013; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fakhrzadeh H, 2009, IRAN J DIABETES LIPI, V9, P37; Fan LP, 2007, THESIS NANCHANG U; Fowdar JY, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/190923; Fridman O, 2013, CLIN EXP HYPERTENS, V35, P159, DOI 10.3109/10641963.2012.690471; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Fu F, 2003, JIANGXI MED J, V38, P401; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Grandone E, 1999, THROMB HAEMOSTASIS, V81, P349; Heller T, 2006, THER DRUG MONIT, V28, P673, DOI 10.1097/01.ftd.0000246764.67129.2a; Hernandez-Diaz S, 2005, EPIDEMIOLOGY, V16, P628, DOI 10.1097/01.ede.0000172132.13513.e0; Heux S, 2004, HYPERTENS RES, V27, P663, DOI 10.1291/hypres.27.663; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu R.L., 2007, STROKE NERV DIS, V14, P13; Ibrahim ZM, 2012, MIDDLE EAST FERTIL S, V17, P105, DOI 10.1016/j.mefs.2011.09.005; Ilhan N, 2008, ARCH MED RES, V39, P125, DOI 10.1016/j.arcmed.2007.07.009; Jaakelainen E, 2006, HYPERTENS PREGNANCY, V25, P73, DOI 10.1080/10641950600745137; Jin Y., 2011, CHIN J GERIATR HEART, V13, P1081, DOI [10.3969/ j.issn.1009-0126.2011.12.008, DOI 10.3969/J.ISSN.1009-0126.2011.12.008]; Kahn SR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.023; Kaiser T, 2000, GYNECOL OBSTET INVES, V50, P100, DOI 10.1159/000010291; Kaur L, 2013, J THROMB THROMBOLYS, V35, P250, DOI 10.1007/s11239-012-0797-4; Kim YJ, 2001, AM J OBSTET GYNECOL, V184, P1211, DOI 10.1067/mob.2001.110411; Klai S, 2011, BLOOD COAGUL FIBRIN, V22, P374, DOI 10.1097/MBC.0b013e328344f80f; Kobashi G, 2000, AM J MED GENET, V93, P122, DOI 10.1002/1096-8628(20000717)93:2<122::AID-AJMG8>3.0.CO;2-Z; Kosmas IP, 2004, J HYPERTENS, V22, P1655, DOI 10.1097/00004872-200409000-00004; Kupferminc MJ, 2000, OBSTET GYNECOL, V96, P45, DOI 10.1016/S0029-7844(00)00861-9; Lachmeijer AMA, 2001, AM J OBSTET GYNECOL, V184, P394, DOI 10.1067/mob.2001.109393; Laivuori H, 2000, OBSTET GYNECOL, V96, P277, DOI 10.1016/S0029-7844(00)00896-6; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li K, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P76; Li LA, 2011, CLIN BIOCHEM, V44, P418, DOI 10.1016/j.clinbiochem.2010.12.018; Li XJ, 2009, J CAPITAL U MED SCI, V27, P497; Lin PT, 2008, INT J VITAM NUTR RES, V78, P33, DOI 10.1024/0300-9831.78.1.33; Liu H., 2011, TIANJIN MED J, V39, P1095, DOI [10.3969/j.issn.0253-9896.2011.12.003, DOI 10.3969/J.ISSN.0253-9896.2011.12.003]; Liu J. W., 2004, CHIN J GERIATR BRAIN, V6, P4, DOI [10.3969/j.issn.1009-0126.2004.01.002, DOI 10.3969/J.ISSN.1009-0126.2004.01.002]; Livingston JC, 2001, AM J OBSTET GYNECOL, V185, P153, DOI 10.1067/mob.2001.114691; [骆杰伟 LUO Jiewei], 2008, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V31, P351; Lwin H, 2006, CIRC J, V70, P83, DOI 10.1253/circj.70.83; Lykke JA, 2012, J THROMB HAEMOST, V10, P1320, DOI 10.1111/j.1538-7836.2012.04773.x; Ma J., 2011, CHIN J CARDIO RES, V9, P909, DOI [10.3969/j.issn.1672- 5301.2011.12.007, DOI 10.3969/J.ISSN.1672-5301.2011.12.007]; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007/s11010-007-9434-5; Coral-Vazquez RM, 2013, CLIN BIOCHEM, V46, P627, DOI 10.1016/j.clinbiochem.2012.12.016; Mello G, 2005, HYPERTENSION, V46, P1270, DOI 10.1161/01.HYP.0000188979.74172.4d; Mendilcioglu I, 2011, ARCH GYNECOL OBSTET, V284, P837, DOI 10.1007/s00404-010-1756-y; Mislanova C, 2011, REPRODUCTION, V142, P467, DOI 10.1530/REP-10-0484; Morrison ER, 2002, THROMB HAEMOSTASIS, V87, P779, DOI 10.1055/s-0037-1613083; Muetze S, 2008, ACTA OBSTET GYN SCAN, V87, P635, DOI 10.1080/00016340802112740; Murphy RP, 2000, ARTERIOSCL THROM VAS, V20, P266, DOI 10.1161/01.ATV.20.1.266; Nagy B, 2007, J HUM HYPERTENS, V21, P154, DOI 10.1038/sj.jhh.1002122; Nakata Y, 1998, AM J HYPERTENS, V11, P1019, DOI 10.1016/S0895-7061(98)00046-6; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Ng XW, 2009, J NUTRIGENET NUTRIGE, V2, P1, DOI 10.1159/000160079; Niu WQ, 2012, J HUM HYPERTENS, V26, P259, DOI 10.1038/jhh.2011.11; O'Shaughnessy KM, 1999, HYPERTENSION, V33, P1338, DOI 10.1161/01.HYP.33.6.1338; Padmanabhan S, 2012, TRENDS GENET, V28, P397, DOI 10.1016/j.tig.2012.04.001; Pegoraro RJ, 2004, ACTA OBSTET GYN SCAN, V83, P449, DOI 10.1111/j.0001-6349.2004.0355.x; Hui P, 2007, HYPERTENS RES, V30, P585, DOI 10.1291/hypres.30.585; Perez-Mutul J, 2004, ARCH MED RES, V35, P231, DOI 10.1016/j.arcmed.2004.02.004; Powers RW, 1999, J SOC GYNECOL INVEST, V6, P74, DOI 10.1016/S1071-5576(98)00052-5; Prasmusinto D, 2002, OBSTET GYNECOL, V99, P1085, DOI 10.1016/S0029-7844(02)01997-X; Procopciuc LM, 2010, GINECO RO, V6, P74; Qian XQ, 2007, EUR J HUM GENET, V15, P1239, DOI 10.1038/sj.ejhg.5201914; Rahimi Z, 2013, CLIN BIOCHEM, V46, P143, DOI 10.1016/j.clinbiochem.2012.10.020; Raijmakers MTM, 2001, EUR J OBSTET GYN R B, V95, P226, DOI 10.1016/S0301-2115(00)00497-8; Rajkovic A, 2000, MOL GENET METAB, V69, P33, DOI 10.1006/mgme.1999.2952; Rigo J, 2000, HYPERTENS PREGNANCY, V19, P163, DOI 10.1081/PRG-100100132; Rodriguez-Esparragon F, 2003, CLIN EXP HYPERTENS, V25, P209, DOI 10.1081/CEH-120020391; Rojas Julio C, 2010, Ginecol Obstet Mex, V78, P401; Ruano-Ravina A, 2008, GAC SANIT, V22, P609, DOI 10.1016/S0213-9111(08)75363-9; Said JM, 2012, ACTA OBSTET GYN SCAN, V91, P250, DOI 10.1111/j.1600-0412.2011.01293.x; Dusse LMS, 2007, EUR J OBSTET GYN R B, V134, P20, DOI 10.1016/j.ejogrb.2006.09.006; Saravani M, 2011, ZAHEDAN J RES MED SC, V7, P39; Sen U, 2010, PPAR RES, V2010, DOI 10.1155/2010/806538; [沈旭娜 SHEN Xuna], 2009, [实用妇产科杂志, Journal of Practical Obstetrics and Gynecology], V25, P236; Sohda S, 1997, J MED GENET, V34, P525, DOI 10.1136/jmg.34.6.525; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Stehouwer CDA, 2003, CLIN CHEM LAB MED, V41, P1408, DOI 10.1515/CCLM.2003.216; Stiefel P, 2009, MED CLIN-BARCELONA, V133, P657, DOI 10.1016/j.medcli.2009.03.042; Stonek F, 2007, OBSTET GYNECOL, V110, P363, DOI 10.1097/01.AOG.0000270122.13198.6f; Su N. J., 2011, PROG OBSTET GYNECOL, V20, P199, DOI [10.13283/j.cnki.xdfckjz, DOI 10.13283/J.CNKI.XDFCKJZ]; Tanira M, 2005, J HUM HYPERTENS, V19, P7, DOI 10.1038/sj.jhh.1001780; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tian G, 2005, CHIN J THROMB HEMOST, V11, P197; Trikalinos TA, 2008, ADV GENET, V60, P311, DOI 10.1016/S0065-2660(07)00413-0; Tylicki L, 2005, AM J HYPERTENS, V18, P1442, DOI 10.1016/j.amjhyper.2005.05.012; Ulukus M, 2006, J TURK-GER GYNECOL A, V7, P195; van der Put NMJ, 2000, EUR J OBSTET GYN R B, V92, P57, DOI 10.1016/S0301-2115(00)00426-7; van Guldener C, 2003, CURR HYPERTENS REP, V5, P26, DOI 10.1007/s11906-003-0007-z; Wang H., 2010, CHIN J MISDIAGN, V10, P3787; Wang Hai-yan, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P369; Wang L, 2002, TIANJIN MED J, V30, P579, DOI DOI 10.3969/J.ISSN.0253-9896.2002.10.001; Wang SM, 2008, CHIN J WOMAN CHILD H, V23, P552; Wang XM, 2013, ARCH MED RES, V44, P159, DOI 10.1016/j.arcmed.2013.01.011; Watanabe H, 2001, THROMB HAEMOSTASIS, V86, P1594; Wei S, 2001, CHINA J MOD MED, V11, P10; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams M A, 2004, J Matern Fetal Neonatal Med, V15, P337, DOI 10.1080/14767050410001680037; Xia XP, 2012, HYPERTENS RES, V35, P1129, DOI 10.1038/hr.2012.117; [邢绣荣 Xing Xiurong], 2007, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V32, P741; Yalinkaya A, 2006, ANN SAUDI MED, V26, P105, DOI 10.5144/0256-4947.2006.105; Yang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057917; Yang F, 2013, J XIAN JIAOTONG U ME; Yilmaz H, 2004, AUST NZ J OBSTET GYN, V44, P423, DOI 10.1111/j.1479-828X.2004.00283.x; Yin RX, 2012, AM J HYPERTENS, V25, P927, DOI 10.1038/ajh.2012.55; Yu W., 2010, J HENAN MED COL STAF, V22, P648, DOI [10.3969/j.issn.1008- 9276.2010.06.005, DOI 10.3969/J.ISSN.1008-9276.2010.06.005]; Zhan S, 2000, CHIN J EPIDEMIOL, V21, P194; Zhang XY, 2008, J PERINAT MED, V11, P245; Zhang XY, 2003, THESIS TIANJIN MED U; [张颖 Zhang Ying], 2012, [临床心血管病杂志, Journal of Clinical Cardiology], V28, P570; Zhang ZHZR, 2007, J BIRTH HLTH HERED, V15, P21; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061511; Zhong L, 2010, CHIN J HLTH LAB TECH, V20, P2128; Zhong SL, 2013, GENE, V527, P510, DOI 10.1016/j.gene.2013.06.054; Zhou CC, 2006, CANCER J, V12, P33, DOI 10.1097/00130404-200601000-00007; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048; Zusterzeel PLM, 2000, HYPERTENS PREGNANCY, V19, P299, DOI 10.1081/PRG-100101991; 姚蕊, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P1001; 曹正余, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P5118; 王素敏, 2006, [生殖与避孕, Reproduction and Contraception], V26, P378	147	53	56	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87497	10.1371/journal.pone.0087497	http://dx.doi.org/10.1371/journal.pone.0087497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505291	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200050
J	Nour, AMA; Azhar, E; Damanhouri, G; Bustin, SA				Nour, Afif M. Abdel; Azhar, Esam; Damanhouri, Ghazi; Bustin, Stephen A.			Five Years MIQE Guidelines: The Case of the Arabian Countries	PLOS ONE			English	Article							MINIMUM INFORMATION; PCR; PUBLICATION; NEED	The quantitative real time polymerase chain reaction (qPCR) has become a key molecular enabling technology with an immense range of research, clinical, forensic as well as diagnostic applications. Its relatively moderate instrumentation and reagent requirements have led to its adoption by numerous laboratories, including those located in the Arabian world, where qPCR, which targets DNA, and reverse transcription qPCR (RT-qPCR), which targets RNA, are widely used for region-specific biotechnology, agricultural and human genetic studies. However, it has become increasingly apparent that there are significant problems with both the quality of qPCR-based data as well as the transparency of reporting. This realisation led to the publication of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines in 2009 and their more widespread adoption in the last couple of years. An analysis of the performance of biomedical research in the Arabian world between 2001-2005 suggests that the Arabian world is producing fewer biomedical publications of lower quality than other Middle Eastern countries. Hence we have analysed specifically the quality of RT-qPCR-based peer-reviewed papers published since 2009 from Arabian researchers using a bespoke iOS/Android app developed by one of the authors. Our results show that compliance with 15 essential MIQE criteria was low (median of 40%, range 0-93%) and few details on RNA quality controls (22% compliance), assays design (12%), RT strategies (32%), amplification efficiencies (30%) and the normalisation process (3%). These data indicate that one of the reasons for the poor performance of Arabian world biomedical research may be the low standard of any supporting qPCR experiments and identify which aspects of qPCR experiments require significant improvements.	[Nour, Afif M. Abdel; Azhar, Esam] King Abdulaziz Univ, Special Infect Agents Unit Biosafety Level 3, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Azhar, Esam] King Abdulaziz Univ, Med Lab Technol Dept, Fac Appl Med Sci, Jeddah 21413, Saudi Arabia; [Damanhouri, Ghazi] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia; [Bustin, Stephen A.] Anglia Ruskin Univ, Postgrad Med Inst, Fac Hlth Social Care & Educ, Cambridge, England	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; Anglia Ruskin University	Nour, AMA (corresponding author), King Abdulaziz Univ, Special Infect Agents Unit Biosafety Level 3, King Fahd Med Res Ctr, Jeddah 21413, Saudi Arabia.	afif.abdelnour@gmail.com	Bustin, Stephen/HHT-0617-2022; Damanhouri, Ghazi/Q-7901-2019; Azhar, Esam/ABI-1044-2020	Bustin, Stephen/0000-0003-1870-6098; Azhar, Esam/0000-0002-1736-181X; Abdel Nour, Afif/0000-0002-4491-7692				Abdel Nour A, 2011, MIQE QPCR APP VERSIO; Benamer HTS, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-26; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dooms M, 2013, METHODS, V59, P147, DOI 10.1016/j.ymeth.2012.07.024; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jacob F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059180; Nolan T, 2006, ANAL BIOCHEM, V351, P308, DOI 10.1016/j.ab.2006.01.051; Stahlberg A, 2004, CLIN CHEM, V50, P509, DOI 10.1373/clinchem.2003.026161; UNESCO, 2010, UNESCO SCI REP; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; 2013, NATURE, V496, P398	18	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88266	10.1371/journal.pone.0088266	http://dx.doi.org/10.1371/journal.pone.0088266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505456	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300074
J	Wang, Q; Hu, J; Han, TX; Li, M; Zhao, HH; Chen, JW; Ye, LX; Zhou, YK				Wang, Qi; Hu, Jia; Han, Tian-xu; Li, Mei; Zhao, Huan-hu; Chen, Jian-wei; Ye, Lin-xiang; Zhou, Yi-kai			Application of BMD Approach to Identify Thresholds of Cadmium-Induced Renal Effect among 35 to 55 Year-Old Women in Two Cadmium Polluted Counties in China	PLOS ONE			English	Article								Background: Cadmium (Cd) is a heavy metal that can cause renal tubular dysfunction in humans. Women are among the high-risk group for Cd health effects. Determining the thresholds of Cd-induced renal effects is important. Thus, in this article, we aimed to identify the benchmark dose (BMD) and its low limit (BMDL) levels as the Cd thresholds for Chinese women. Methods: Epidemiologic investigation was performed in county A and county B to obtain data on Cd exposure and its renal effect on respondents. Levels of Cd (UCd), beta(2)-microglobulin (UB2M), and N-acetyl-beta-D-glucosaminidase (UNAG) were measured in morning urine samples. The BMD approach was mainly performed. Results: Results of the BMD approach were similar whether the method was conducted for the two sets of data (collected in CA and CB, respectively) separately or cooperatively. The BMD/BMDL values of UCd for all subjects were 1.07/0.44 and 2.12/0.53 mu g/g cr based on UB2M and UNAG, respectively, given a predetermined BMR of 0.05. Conclusions: The presented thresholds of Cd-induced renal effects (i.e., the BMDLs of UCd) are close to the counterpart values reported in Japan, Sweden and Belguim.	[Wang, Qi; Ye, Lin-xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Hu, Jia; Li, Mei; Chen, Jian-wei; Zhou, Yi-kai] Huazhong Univ Sci & Technol, MOE Key Lab Environm & Hlth, Inst Environm Med, Sch Publ Hlth, Wuhan 430074, Peoples R China; [Han, Tian-xu] Qiangyang Ctr Dis Control & Prevent, Chengdu, Peoples R China; [Zhao, Huan-hu] Minzu Univ China, Chinese Minor Tradit Med Ctr, Beijing, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Minzu University of China	Ye, LX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	yelx2004@163.com; zhouyk@mails.tjmu.edu.cn		Hu, Jia/0000-0001-5779-257X	Ministry of Environmental Protection of China [201109058]; National Natural Science Foundation of China [81102185]; Huazhong University of Science and Technology [2011QN202]	Ministry of Environmental Protection of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huazhong University of Science and Technology	The work has been funded by the programs of Ministry of Environmental Protection of China (201109058), National Natural Science Foundation of China (81102185), and Huazhong University of Science and Technology (2011QN202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.		0	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87817	10.1371/journal.pone.0087817	http://dx.doi.org/10.1371/journal.pone.0087817			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24505316	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800076
J	Xu, Q; Zhang, Y; Chen, Y; Tong, YY; Rong, GH; Huang, ZY; Zhao, RX; Zhao, WM; Wu, XS; Chang, GB; Chen, GH				Xu, Qi; Zhang, Yang; Chen, Yang; Tong, Yi-Yu; Rong, Guang-Hui; Huang, Zheng-Yang; Zhao, Rong-Xue; Zhao, Wen-Ming; Wu, Xin-sheng; Chang, Guo-Bin; Chen, Guo-Hong			Identification and Differential Expression of microRNAs in Ovaries of Laying and Broody Geese (Anser cygnoides) by Solexa Sequencing	PLOS ONE			English	Article							SMALL RNAS; MIRNAS; MIRBASE; TRANSCRIPTOME; INTEGRATION; ANNOTATION; CLONING; TESTIS	Background: Recent functional studies have demonstrated that the microRNAs (miRNAs) play critical roles in ovarian gonadal development, steroidogenesis, apoptosis, and ovulation in mammals. However, little is known about the involvement of miRNAs in the ovarian function of fowl. The goose (Anas cygnoides) is a commercially important food that is cultivated widely in China but the goose industry has been hampered by high broodiness and poor egg laying performance, which are influenced by ovarian function. Methodology/Principal Findings: In this study, the miRNA transcriptomes of ovaries from laying and broody geese were profiled using Solexa deep sequencing and bioinformatics was used to determine differential expression of the miRNAs. As a result, 11,350,396 and 9,890,887 clean reads were obtained in laying and broodiness goose, respectively, and 1,328 conserved known miRNAs and 22 novel potential miRNA candidates were identified. A total of 353 conserved microRNAs were significantly differentially expressed between laying and broody ovaries. Compared with miRNA expression in the laying ovary, 127 miRNAs were up-regulated and 126 miRNAs were down-regulated in the ovary of broody birds. A subset of the differentially expressed miRNAs (G-miR-320, G-miR-202, G-miR-146, and G-miR-143*) were validated using real-time quantitative PCR. In addition, 130,458 annotated mRNA transcripts were identified as putative target genes. Gene ontology annotation and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis suggested that the differentially expressed miRNAs are involved in ovarian function, including hormone secretion, reproduction processes and so on. Conclusions: The present study provides the first global miRNA transcriptome data in A. cygnoides and identifies novel and known miRNAs that are differentially expressed between the ovaries of laying and broody geese. These findings contribute to our understanding of the functional involvement of miRNAs in the broody period of goose.	[Xu, Qi; Zhang, Yang; Chen, Yang; Tong, Yi-Yu; Rong, Guang-Hui; Huang, Zheng-Yang; Zhao, Wen-Ming; Wu, Xin-sheng; Chang, Guo-Bin; Chen, Guo-Hong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China; [Zhao, Rong-Xue] Jiangsu High Qual Poultry Engn Technol Ctr, Changzhou, Peoples R China	Yangzhou University	Chang, GB (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China.	gbchang@yzu.edu.cn; ghchen@yzu.edu.cn	Huang, Zhengyang/J-6297-2013; XU, Qi/AID-2262-2022	Huang, Zhengyang/0000-0001-9197-6700; 	National Natural Science Foundation of China [31101704]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2011-137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work received financial support from the National Natural Science Foundation of China (31101704) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (2011-137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bannister SC, 2011, BIOL REPROD, V85, P22, DOI 10.1095/biolreprod.110.088476; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Carbon S, 2009, BIOINFORMATICS, V25, P288; Chen QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032860; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Donadeu FX, 2012, J ENDOCRINOL, V215, P323, DOI 10.1530/JOE-12-0252; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hossain MM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-443; Huang JM, 2011, INT J BIOL SCI, V7, P1016, DOI 10.7150/ijbs.7.1016; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kong FJ, 2011, THESIS HUAZHONG U SC; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li MT, 2011, INT J INNOV COMPUT I, V7, P1055; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McBride D, 2012, REPRODUCTION, V144, P221, DOI 10.1530/REP-12-0025; Miles JR, 2012, ANIM REPROD SCI, V130, P16, DOI 10.1016/j.anireprosci.2011.12.021; Mishima T, 2008, REPRODUCTION, V136, P811, DOI 10.1530/REP-08-0349; Otsuka M, 2008, J CLIN INVEST, V118, P1944, DOI 10.1172/JCI33680; Ro S, 2007, RNA, V13, P2366, DOI 10.1261/rna.754207; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sirotkin AV, 2009, J CELL PHYSIOL, V219, P415, DOI 10.1002/jcp.21689; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Tripurani SK, 2010, ANIM REPROD SCI, V120, P16, DOI 10.1016/j.anireprosci.2010.03.001; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Yao GD, 2011, THESIS U SCI TECHNOL; Yao J, 2011, BIOSCI BIOTECH BIOCH, V75, P54, DOI 10.1271/bbb.100530; Zhang L, 2013, GENE, V519, P77, DOI 10.1016/j.gene.2013.01.043; [张晓东 Zhang Xiaodong], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P146	43	22	28	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87920	10.1371/journal.pone.0087920	http://dx.doi.org/10.1371/journal.pone.0087920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505332	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300015
J	Zhang, JY; Wang, JHC				Zhang, Jianying; Wang, James H-C			Prostaglandin E-2 (PGE(2)) Exerts Biphasic Effects on Human Tendon Stem Cells	PLOS ONE			English	Article							DIFFERENTIATION; EXPRESSION; PROLIFERATION; BONE; MICRODIALYSIS; PLURIPOTENCY; PATHOGENESIS; ACTIVATION; RECEPTORS; INCREASES	Prostaglandin E-2 (PGE(2)) has been reported to exert different effects on tissues at low and high levels. In the present study, cell culture experiments were performed to determine the potential biphasic effects of PGE(2) on human tendon stem/ progenitor cells (hTSCs). After treatment with PGE(2), hTSC proliferation, stemness, and differentiation were analyzed. We found that high concentrations of PGE(2) (>1 ng/ml) decreased cell proliferation and induced non-tenocyte differentiation. However, at lower concentrations (<1 ng/ml), PGE(2) markedly enhanced hTSC proliferation. The expression levels of stem cell marker genes, specifically SSEA-4 and Stro-1, were more extensive in hTSCs treated with low concentrations of PGE(2) than in cells treated with high levels of PGE(2). Moreover, high levels of PGE(2) induced hTSCs to differentiate aberrantly into non-tenocytes, which was evident by the high levels of PPAR gamma, collagen type II, and osteocalcin expression in hTSCs treated with PGE(2) at concentrations >1 ng/ml. The findings of this study reveal that PGE(2) can exhibit biphasic effects on hTSCs, indicating that while high PGE(2) concentrations may be detrimental to tendons, low levels of PGE(2) may play a vital role in the maintenance of tendon homeostasis in vivo.	[Wang, James H-C] Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Bioengn, MechanoBiol Lab, Pittsburgh, PA USA; Univ Pittsburgh, Dept Mech Engn & Mat Sci, MechanoBiol Lab, Pittsburgh, PA USA; Univ Pittsburgh, Dept Phys Med & Rehabil, MechanoBiol Lab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15213 USA.	wanghc@pitt.edu			National Institutes of Health [AR061395, AR060920, AR049921]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049921, R21AR060920, R01AR061395] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health under award numbers AR061395, AR060920, and AR049921. No additional external funding received for this study. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; Arikawa T, 2004, J CELL PHYSIOL, V200, P400, DOI 10.1002/jcp.20031; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Ferry ST, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-2; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; Kleiveland CR, 2008, EXP CELL RES, V314, P1831, DOI 10.1016/j.yexcr.2008.02.004; Kohjima M, 2007, LIVER INT, V27, P1273, DOI 10.1111/j.1478-3231.2007.01560.x; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 2003, J PHYSIOL-LONDON, V551, P683, DOI 10.1113/jphysiol.2003.046094; Ling GQ, 2012, ONCOL LETT, V4, P1264, DOI 10.3892/ol.2012.916; Liou JY, 2007, STEM CELLS, V25, P1096, DOI 10.1634/stemcells.2006-0505; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Markworth JF, 2013, AM J PHYSL REGUL INT; Meknas K, 2012, SCAND J MED SCI SPOR, V22, P627, DOI 10.1111/j.1600-0838.2010.01287.x; Minear MA, 2011, HUM GENET, V129, P641, DOI 10.1007/s00439-011-0959-z; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Raisz LG, 1999, OSTEOARTHR CARTILAGE, V7, P419, DOI 10.1053/joca.1998.0230; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Tang LL, 2000, CIRC RES, V86, P663, DOI 10.1161/01.RES.86.6.663; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Yamato M, 2005, DIGESTION, V72, P109, DOI 10.1159/000088365; Yau L, 2003, MOL CELL ENDOCRINOL, V203, P77, DOI 10.1016/S0303-7207(03)00096-0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JY, 2012, J ORTHOP RES, V30, P47, DOI 10.1002/jor.21485; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962; Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11	38	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87706	10.1371/journal.pone.0087706	http://dx.doi.org/10.1371/journal.pone.0087706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504456	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000330631800063
J	Kloog, I; Nordio, F; Zanobetti, A; Coull, BA; Koutrakis, P; Schwartz, JD				Kloog, Itai; Nordio, Francesco; Zanobetti, Antonella; Coull, Brent A.; Koutrakis, Petros; Schwartz, Joel D.			Short Term Effects of Particle Exposure on Hospital Admissions in the Mid-Atlantic States: A Population Estimate	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; CARDIOVASCULAR-DISEASE; ULTRAFINE PARTICLES; FINE; DETROIT; STROKE; RISK	Background: Many studies report significant associations between PM2.5 (particulate matter <2.5 micrometers) and hospital admissions. These studies mostly rely on a limited number of monitors which introduces exposure error, and excludes rural and suburban populations from locations where monitors are not available, reducing generalizability and potentially creating selection bias. Methods: Using prediction models developed by our group, daily PM2.5 exposure was estimated across the Mid-Atlantic (Washington D. C., and the states of Delaware, Maryland, New Jersey, Pennsylvania, Virginia, New York and West Virginia). We then investigated the short-term effects of PM2.5 exposures on emergency hospital admissions of the elderly in the Mid-Atlantic region. We performed case-crossover analysis for each admission type, matching on day of the week, month and year and defined the hazard period as lag01 (a moving average of day of admission exposure and previous day exposure). Results: We observed associations between short-term exposure to PM2.5 and hospitalization for all outcomes examined. For example, for every 10-mu g/m(3) increase in short-term PM2.5 there was a 2.2% increase in respiratory diseases admissions (95% CI = 1.9 to 2.6), and a 0.78% increase in cardiovascular disease (CVD) admission rate (95% CI = 0.5 to 1.0). We found differences in risk for CVD admissions between people living in rural and urban areas. For every10-mu g/m(3) increase in PM2.5 exposure in the 'rural' group there was a 1.0% increase (95% CI = 0.6 to 1.5), while for the 'urban' group the increase was 0.7% (95% CI = 0.4 to 1.0). Conclusions: Our findings showed that PM2.5 exposure was associated with hospital admissions for all respiratory, cardio vascular disease, stroke, ischemic heart disease and chronic obstructive pulmonary disease admissions. In addition, we demonstrate that our AOD (Aerosol Optical Depth) based exposure models can be successfully applied to epidemiological studies investigating the health effects of short-term exposures to PM2.5.	[Kloog, Itai] Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel; [Kloog, Itai; Nordio, Francesco; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Exposure Epidemiol & Risk Program, Boston, MA 02115 USA; [Coull, Brent A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Ben Gurion University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Kloog, I (corresponding author), Ben Gurion Univ Negev, Dept Geog & Environm Dev, IL-84105 Beer Sheva, Israel.	ikloog@bgu.ac.il			Harvard Environmental Protection Agency (EPA) Center Grant USEPA [RD-83479801]; NIEHS [ES-000002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	Harvard Environmental Protection Agency (EPA) Center Grant USEPA; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the Harvard Environmental Protection Agency (EPA) Center Grant USEPA grant RD-83479801 and NIEHS ES-000002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames B N, 1988, IARC Sci Publ, P407; Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Belleudi V, 2010, EPIDEMIOLOGY, V21, P414, DOI 10.1097/EDE.0b013e3181d5c021; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Chudnovsky AA, 2013, ENVIRON POLLUT, V172, P131, DOI 10.1016/j.envpol.2012.08.016; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Ghio AJ, 1999, INHAL TOXICOL, V11, P293; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Kloog I, 2012, ENV SCI TECHNOL; Kloog I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034664; Kloog I, 2011, ATMOS ENVIRON, V45, P6267, DOI 10.1016/j.atmosenv.2011.08.066; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; NCDC, 2010, NAT CLIM DAT CTR DAT; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Schwartz J, 2005, AM J RESP CRIT CARE, V171, P627, DOI 10.1164/rccm.200407-933OC; Schwartz J, 1996, EPIDEMIOLOGY, V7, P20, DOI 10.1097/00001648-199601000-00005; SCHWARTZ J, 1995, AM J EPIDEMIOL, V142, P23, DOI 10.1093/oxfordjournals.aje.a117541; SCHWARTZ J, 1994, AM J RESP CRIT CARE, V150, P648, DOI 10.1164/ajrccm.150.3.8087333; Schwartz J, 1997, EPIDEMIOLOGY, V8, P371, DOI 10.1097/00001648-199707000-00004; Seinfeld J. H., 1998, ATMOSPHERIC CHEM PHY; SPENGLER JD, 1989, ENVIRON HEALTH PERSP, V79, P43; USCB, 2000, US CENS BUR 2000; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Zanobetti A, 2005, ENVIRON HEALTH PERSP, V113, P978, DOI 10.1289/ehp.7550; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P1071, DOI 10.2307/3434961; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382	31	65	71	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88578	10.1371/journal.pone.0088578	http://dx.doi.org/10.1371/journal.pone.0088578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516670	gold, Green Published, Green Submitted			2022-12-27	WOS:000330834400077
J	Lin, HN; O'Connor, JP				Lin, Hsuan-Ni; O'Connor, J. Patrick			Immunohistochemical Localization of Key Arachidonic Acid Metabolism Enzymes during Fracture Healing in Mice	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN G/H SYNTHASE-2; GROWTH-FACTOR-BETA; BONE-FORMATION; IN-VITRO; MOUSE MODEL; OSTEOARTHRITIC CHONDROCYTES; TRANSCRIPTIONAL INDUCTION; ENDOCHONDRAL OSSIFICATION; OSTEOCLAST PRECURSORS	This study investigated the localization of critical enzymes involved in arachidonic acid metabolism during the initial and regenerative phases of mouse femur fracture healing. Previous studies found that loss of cyclooxygenase-2 activity impairs fracture healing while loss of 5-lipoxygenase activity accelerates healing. These diametric results show that arachidonic acid metabolism has an essential function during fracture healing. To better understand the function of arachidonic acid metabolism during fracture healing, expression of cyclooxygenase-1 (COX-1), cyclooxygenase -2 (COX-2), 5-lipoxygenase (5-LO), and leukotriene A(4) hydrolase (LTA4H) was localized by immunohistochemistry in time-staged fracture callus specimens. All four enzymes were detected in leukocytes present in the bone marrow and attending inflammatory response that accompanied the fracture. In the tissues surrounding the fracture site, the proportion of leukocytes expressing COX-1, COX-2, or LTA4H decreased while those expressing 5-LO remained high at 4 and 7 days after fracture. This may indicate an inflammation resolution function for 5-LO during fracture healing. Only COX-1 was consistently detected in fracture callus osteoblasts during the later stages of healing (day 14 after fracture). In contrast, callus chondrocytes expressed all four enzymes, though 5-LO appeared to be preferentially expressed in newly differentiated chondrocytes. Most interestingly, osteoclasts consistently and strongly expressed COX-2. In addition to bone surfaces and the growth plate, COX-2 expressing osteoclasts were localized at the chondro-osseous junction of the fracture callus. These observations suggest that arachidonic acid mediated signaling from callus chondrocytes or from callus osteoclasts at the chondro-osseous junction regulate fracture healing.	[Lin, Hsuan-Ni; O'Connor, J. Patrick] Rutgers State Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07102 USA; [O'Connor, J. Patrick] Rutgers State Univ, Dept Biochem & Mol Biol, New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	O'Connor, JP (corresponding author), Rutgers State Univ, Grad Sch Biomed Sci, Dept Biochem & Mol Biol, Newark, NJ 07102 USA.	oconnojp@njms.rutgers.edu			National Institute of Dental & Craniofacial Research of the National Institutes of Health [R01DE019926]; Department of Defense [W81XWH-10-1-0944]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019926] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research of the National Institutes of Health; Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the National Institute of Dental & Craniofacial Research of the National Institutes of Health under award number R01DE019926 and by the Department of Defense Peer Reviewed Orthopaedic Research Program under award number W81XWH-10-1-0944 to JPOC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the United States Army, or the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat M, 1998, ARTHRITIS RHEUM, V41, P1645, DOI 10.1002/1529-0131(199809)41:9<1645::AID-ART16>3.0.CO;2-Z; Beam HA, 2002, J ORTHOPAED RES, V20, P1210, DOI 10.1016/S0736-0266(02)00066-9; Brochhausen C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1948; Brown HA, 2011, CHEM REV, V111, P5817, DOI 10.1021/cr200363s; CENTRELLA M, 1994, ENDOCRINOLOGY, V135, P1611, DOI 10.1210/en.135.4.1611; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Chikazu D, 2002, J BONE MINER RES, V17, P1430, DOI 10.1359/jbmr.2002.17.8.1430; CHYUN YS, 1984, PROSTAGLANDINS, V27, P97, DOI 10.1016/0090-6980(84)90223-5; Cottrell J, 2010, PHARMACEUTICALS, V3, P1668, DOI 10.3390/ph3051668; Cottrell JA, 2009, J BONE JOINT SURG AM, V91A, P2653, DOI 10.2106/JBJS.H.01844; Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182, DOI 10.1290/0510075.1; DOMINGUEZ JH, 1980, CALCIFIED TISSUE INT, V31, P29, DOI 10.1007/BF02407164; FEYEN JHM, 1985, PROSTAGLANDINS, V30, P827, DOI 10.1016/0090-6980(85)90011-5; Finkensieper A, 2010, CARDIOVASC RES, V86, P37, DOI 10.1093/cvr/cvp385; Forwood MR, 1998, ANAT REC, V252, P580, DOI 10.1002/(SICI)1097-0185(199812)252:4<580::AID-AR8>3.0.CO;2-S; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GENG Y, 1995, J IMMUNOL, V155, P796; Gerstenfeld LC, 2003, J ORTHOP RES, V21, P670, DOI 10.1016/S0736-0266(03)00003-2; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Han SY, 2005, BLOOD, V106, P1240, DOI 10.1182/blood-2004-12-4975; Ho ML, 1999, BIOCHEM PHARMACOL, V58, P983, DOI 10.1016/S0006-2952(99)00186-0; HULTH A, 1990, CLIN ORTHOP RELAT R, P289; Igarashi K, 2002, BIOCHEM PHARMACOL, V63, P523, DOI 10.1016/S0006-2952(01)00861-9; Iwaki A, 1997, J BONE MINER RES, V12, P96, DOI 10.1359/jbmr.1997.12.1.96; Janckila AJ, 2005, J LEUKOCYTE BIOL, V77, P209, DOI 10.1189/jlb.0504287; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Kajii T, 1999, ARCH ORAL BIOL, V44, P233, DOI 10.1016/S0003-9969(98)00120-4; Kaneki H, 1999, J CELL BIOCHEM, V73, P36, DOI 10.1002/(SICI)1097-4644(19990401)73:1<36::AID-JCB5>3.3.CO;2-6; KleinNulend J, 1997, J BONE MINER RES, V12, P45, DOI 10.1359/jbmr.1997.12.1.45; Koide M, 1999, BIOCHEM BIOPH RES CO, V259, P97, DOI 10.1006/bbrc.1999.0715; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; LEE SH, 1992, J BIOL CHEM, V267, P25934; Li L, 2006, CYTOKINE GROWTH F R, V17, P203, DOI 10.1016/j.cytogfr.2006.01.005; Li M, 2005, BONE, V37, P46, DOI 10.1016/j.bone.2005.03.016; Li M, 2003, J BONE MINER RES, V18, P2033, DOI 10.1359/jbmr.2003.18.11.2033; Li TF, 2004, EXP CELL RES, V300, P159, DOI 10.1016/j.yexcr.2004.06.019; Maciel FMB, 1997, J RHEUMATOL, V24, P2429; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; Manigrasso MB, 2008, CALCIFIED TISSUE INT, V82, P465, DOI 10.1007/s00223-008-9144-3; Manigrasso MB, 2010, ACTA ORTHOP, V81, P748, DOI 10.3109/17453674.2010.533931; Martel-Pelletier J, 2004, ARTHRITIS RHEUM-US, V50, P3925, DOI 10.1002/art.20632; MILLER SC, 1993, BONE, V14, P143, DOI 10.1016/8756-3282(93)90241-2; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Okada Y, 2000, J CLIN INVEST, V105, P823, DOI 10.1172/JCI8195; Onoe Y, 1996, J IMMUNOL, V156, P758; Paralkar VM, 2003, P NATL ACAD SCI USA, V100, P6736, DOI 10.1073/pnas.1037343100; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Pilbeam C, 1997, ENDOCRINOLOGY, V138, P4672, DOI 10.1210/en.138.11.4672; QUARLES LD, 1993, ENDOCRINOLOGY, V132, P1505, DOI 10.1210/en.132.4.1505; REN W, 1991, CALCIFIED TISSUE INT, V49, P197, DOI 10.1007/BF02556118; Sato T, 2011, ANN RHEUM DIS, V70, P221, DOI 10.1136/ard.2009.118620; SAVOSTINASLING I, 1975, ANAT RECORD, V183, P373, DOI 10.1002/ar.1091830303; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Simon AM, 2007, J BONE JOINT SURG AM, V89A, P500, DOI 10.2106/JBJS.F.00127; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Tai H, 1997, ENDOCRINOLOGY, V138, P2372, DOI 10.1210/en.138.6.2372; Talahalli R, 2010, INVEST OPHTH VIS SCI, V51, P1699, DOI 10.1167/iovs.09-3557; TAWARA T, 1991, INFLAMMATION, V15, P145, DOI 10.1007/BF00917509; Tay BKB, 1998, J ORTHOP RES, V16, P636, DOI 10.1002/jor.1100160518; Traianedes K, 1998, ENDOCRINOLOGY, V139, P3178, DOI 10.1210/en.139.7.3178; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; UEDA K, 1980, J PEDIATR-US, V97, P834, DOI 10.1016/S0022-3476(80)80282-4; Uusitalo H, 2000, CALCIFIED TISSUE INT, V67, P382, DOI 10.1007/s002230001152; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; Warden SJ, 2001, BIOCHEM BIOPH RES CO, V286, P443, DOI 10.1006/bbrc.2001.5412; Welting T J M, 2011, Eur Cell Mater, V22, P420; Welting TJ, 2011, EUR CELLS MATER, V22, P436; Xie C, 2008, BONE, V43, P1075, DOI 10.1016/j.bone.2008.08.109; Xu JQ, 1997, J CELL BIOCHEM, V64, P618, DOI 10.1002/(SICI)1097-4644(19970315)64:4<618::AID-JCB10>3.0.CO;2-8; Yoshida K, 2002, P NATL ACAD SCI USA, V99, P4580, DOI 10.1073/pnas.062053399; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681	79	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88423	10.1371/journal.pone.0088423	http://dx.doi.org/10.1371/journal.pone.0088423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516658	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400070
J	Geremek, M; Zietkiewicz, E; Bruinenberg, M; Franke, L; Pogorzelski, A; Wijmenga, C; Witt, M				Geremek, Maciej; Zietkiewicz, Ewa; Bruinenberg, Marcel; Franke, Lude; Pogorzelski, Andrzej; Wijmenga, Cisca; Witt, Michal			Ciliary Genes Are Down-Regulated in Bronchial Tissue of Primary Ciliary Dyskinesia Patients	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; DYNEIN ARMS; COMPLEX; OUTER; DEFECTS; INNER; RANDOMIZATION; EXOME; DNAH5	Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disease characterized by recurrent respiratory tract infections, sinusitis, bronchiectasis and male infertility. The pulmonary phenotype in PCD is caused by the impaired motility of cilia in the respiratory epithelium, due to ultrastructural defects of these organelles. We hypothesized that defects of multi-protein ciliary complexes should be reflected by gene expression changes in the respiratory epithelium. We have previously found that large group of genes functionally related to cilia share highly correlated expression pattern in PCD bronchial tissue. Here we performed an explorative analysis of differential gene expression in the bronchial tissue from six PCD patients and nine non-PCD controls, using Illumina HumanRef-12 Whole Genome BeadChips. We observed 1323 genes with at least 2-fold difference in the mean expression level between the two groups (t-test p-value <0.05). Annotation analysis showed that the genes down-regulated in PCD biopsies (602) were significantly enriched for terms related to cilia, whereas the up-regulated genes (721) were significantly enriched for terms related to cell cycle and mitosis. We assembled a list of human genes predicted to encode ciliary proteins, components of outer dynein arms, inner dynein arms, radial spokes, and intraflagellar transport proteins. A significant down-regulation of the expression of genes from all the four groups was observed in PCD, compared to non-PCD biopsies. Our data suggest that a coordinated down-regulation of the ciliome genes plays an important role in the molecular pathomechanism of PCD.	[Geremek, Maciej; Witt, Michal] Int Inst Mol & Cell Biol, Warsaw, Poland; [Geremek, Maciej; Bruinenberg, Marcel; Franke, Lude; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Geremek, Maciej; Bruinenberg, Marcel; Franke, Lude; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Geremek, Maciej; Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Grp, Utrecht, Netherlands; [Zietkiewicz, Ewa; Witt, Michal] Polish Acad Sci, Inst Human Genet, Dept Mol & Clin Genet, PL-60479 Poznan, Poland; [Pogorzelski, Andrzej] Inst TB & Lung Dis, Rabka, Poland	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences	Geremek, M (corresponding author), Int Inst Mol & Cell Biol, Warsaw, Poland.	macgerem@gmail.com	Wijmenga, Cisca/D-2173-2009; Franke, Lude/P-7036-2016; Wijmenga, Cisca/AAE-7719-2019; Zietkiewicz, Ewa/ABP-3539-2022	Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Zietkiewicz, Ewa/0000-0003-2437-5088; Geremek, Maciej/0000-0002-6484-8751; Witt, Michal/0000-0003-1729-4159	Ministry of Science and Higher Education, Poland [NN401 095537]; grant BESTCILIA [Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia (7FP)] [305404, HEALTH.2012.2.4.4-2]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); grant BESTCILIA [Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia (7FP)]	This work was covered in part by the grant NN401 095537 from the Ministry of Science and Higher Education, Poland and by the grant BESTCILIA [305404, Better Experimental Screening and Treatment for Primary Ciliary Dyskinesia (7FP, HEALTH.2012.2.4.4-2)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; CANCIANI M, 1988, PEDIATR PULM, V5, P210, DOI 10.1002/ppul.1950050406; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Geremek Maciej, 2004, Journal of Applied Genetics, V45, P347; Geremek M, 2011, HUM GENET, V129, P283, DOI 10.1007/s00439-010-0922-4; Hom EFY, 2011, CYTOSKELETON, V68, P555, DOI 10.1002/cm.20533; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072299; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Karadag B, 1999, EUR RESPIR J, V13, P1402, DOI 10.1034/j.1399-3003.1999.13f28.x; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Kott E, 2013, AM J HUM GENET, V93, P561, DOI 10.1016/j.ajhg.2013.07.013; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2014, J MED GENET, V51, P61, DOI 10.1136/jmedgenet-2013-101938; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pazour GJ, 2006, J MED GENET, V43, P62, DOI 10.1136/jmg.2005.033001; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; Satir P, 2008, HISTOCHEM CELL BIOL, V129, P687, DOI 10.1007/s00418-008-0416-9; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	44	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88216	10.1371/journal.pone.0088216	http://dx.doi.org/10.1371/journal.pone.0088216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516614	gold, Green Published, Green Submitted			2022-12-27	WOS:000330830700056
J	Manickam, M; Tulsawani, R				Manickam, Manimaran; Tulsawani, Rajkumar			Survival Response of Hippocampal Neurons under Low Oxygen Conditions Induced by Hippophae rhamnoides is Associated with JAK/STAT Signaling	PLOS ONE			English	Article							NF-KAPPA-B; MICROVASCULAR ENDOTHELIAL-CELLS; IN-VITRO; OXIDATIVE STRESS; ALTITUDE ILLNESS; HYPOXIA; PATHWAY; DEATH; STAT3; ANTIOXIDANT	Janus activated kinase/signal transducers and activators of transcription (JAK/STATs) pathway are associated with various neuronal functions including cell survival and inflammation. In the present study, it is hypothesized that protective action of aqueous extract of Hippophae rhamnoides in hippocampal neurons against hypoxia is mediated via JAK/STATs. Neuronal cells exposed to hypoxia (0.5% O-2) display higher reactive oxygen species with compromised antioxidant status compared to unexposed control cells. Further, these cells had elevated levels of pro-inflammatory cytokines; tumor necrosis factor a and interleukin 6 and nuclear factor kappa B. Moreover, the expression of JAK1 was found to be highly expressed with phosphorylation of STAT3 and STAT5. Cells treated with JAK1, STAT3 and STAT5 specific inhibitors resulted in more cell death compared to hypoxic cells. Treatment of cells with extract prevented oxidative stress and inflammatory response associated with hypoxia. The extract treated cells had more cell survival than hypoxic cells with induction of JAK1 and STAT5b. Cells treated with extract having suppressed JAK1 or STAT3 or STAT5 expression showed reduced cell viability than the cell treated with extract alone. Overall, the findings from these studies indicate that the aqueous extract of Hippophae rhamnoides treatment inhibited hypoxia induced oxidative stress by altering cellular JAK1, STAT3 and STAT5 levels thereby enhancing cellular survival response to hypoxia and provide a basis for possible use of aqueous extract of Hippophae rhamnoides in facilitating tolerance to hypoxia.	[Manickam, Manimaran; Tulsawani, Rajkumar] Def Res & Dev Org, Def Inst Physiol & Allied Sci, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Tulsawani, R (corresponding author), Def Res & Dev Org, Def Inst Physiol & Allied Sci, Delhi, India.	rktulsawani@yahoo.com	Tulsawani, Rajkumar/AAF-2017-2019		Defence Research and Development Organization, Ministry of Defence, Govt Of India, India; Indian Research and Medical Council (ICMR), Govt. Of India, India	Defence Research and Development Organization, Ministry of Defence, Govt Of India, India; Indian Research and Medical Council (ICMR), Govt. Of India, India	This work was supported by: 1. Defence Research and Development Organization, Ministry of Defence, Govt Of India, India. 2. Indian Research and Medical Council (ICMR), Govt. Of India, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Cooney RN, 2002, SHOCK, V17, P83, DOI 10.1097/00024382-200202000-00001; Dhingra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025009; Ebong S, 2004, INVEST OPHTH VIS SCI, V45, P872, DOI 10.1167/iovs.03-0311; Geetha S, 2002, J ETHNOPHARMACOL, V79, P373, DOI 10.1016/S0378-8741(01)00406-8; Gupta Asheesh, 2005, Int J Low Extrem Wounds, V4, P88; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Huang Y, 2013, ANAESTHESIA, V68, P31, DOI 10.1111/j.1365-2044.2012.07336.x; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Johnson RL, 2009, MOL BIOSYST, V5, P1039, DOI 10.1039/b902021g; Kallio H, 2002, J AGR FOOD CHEM, V50, P6136, DOI 10.1021/jf020421v; Kim Seulah, 2012, Immune Netw, V12, P181, DOI 10.4110/in.2012.12.5.181; KRASNEY JA, 1994, MED SCI SPORT EXER, V26, P195, DOI 10.1249/00005768-199402000-00010; Lemos VD, 2012, PSYCHOPHYSIOLOGY, V49, P1298, DOI 10.1111/j.1469-8986.2012.01411.x; Li B, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/128019; Liu Y, 2009, J BIOMED SCI, V5, P16; Logue SE, 2005, J MOL CELL CARDIOL, V38, P21, DOI 10.1016/j.yjmcc.2004.11.009; MAJNO G, 1995, AM J PATHOL, V146, P3; Miscia S, 2002, CELL GROWTH DIFFER, V13, P13; Morgan C, 2013, ANGIOGENESIS, V16, P493, DOI 10.1007/s10456-013-9341-1; MORIMOTO BH, 1990, NEURON, V5, P875, DOI 10.1016/0896-6273(90)90347-I; Nakasato M, 2006, BIOL REPROD, V75, P508, DOI 10.1095/biolreprod.105.047860; Naranjo-Suarez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030470; Narayanan S, 2005, MOL CELL BIOCHEM, V278, P9, DOI 10.1007/s11010-005-7636-2; Nicolas CS, 2013, LANDES BIOCIENCE, V2, P1; Nishimura Y, 2001, CELL DEATH DIFFER, V8, P850, DOI 10.1038/sj.cdd.4400877; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Raymond M, 2011, J NEUROSCI, V31, P17864, DOI 10.1523/JNEUROSCI.3179-11.2011; Saggu S, 2007, FOOD CHEM TOXICOL, V45, P609, DOI 10.1016/j.fct.2006.10.008; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021492; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sugar O, 1938, J NEUROPHYSIOL, V1, P558, DOI 10.1152/jn.1938.1.6.558; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; Tormo AJ, 2012, CYTOKINE, V60, P575, DOI 10.1016/j.cyto.2012.07.002; von Laue S, 2000, J ENDOCRINOL, V165, P301, DOI 10.1677/joe.0.1650301; Wang GS, 2005, CELL BIOL INT, V29, P598, DOI 10.1016/j.cellbi.2005.03.014; Wang G, 2008, INT J BIOCHEM CELL B, V40, P461, DOI 10.1016/j.biocel.2007.08.008; Yang CH, 2005, J BIOL CHEM, V280, P25849, DOI 10.1074/jbc.M413721200; Zhang Guang-You, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P450	52	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e87694	10.1371/journal.pone.0087694	http://dx.doi.org/10.1371/journal.pone.0087694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516559	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700027
J	Sarkar, A; Reinhold-Hurek, B				Sarkar, Abhijit; Reinhold-Hurek, Barbara			Transcriptional Profiling of Nitrogen Fixation and the Role of NifA in the Diazotrophic Endophyte Azoarcus sp Strain BH72	PLOS ONE			English	Article							PHENYLACETIC ACID; BRADYRHIZOBIUM-JAPONICUM; GENETIC-REGULATION; CATABOLIC PATHWAY; RHIZOBIUM-ETLI; VI SECRETION; EXPRESSION; COMPLEX; SYSTEM; RICE	Background: The model endophyte Azoarcus sp. strain BH72 is known to contribute fixed nitrogen to its host Kallar grass and also expresses nitrogenase genes endophytically in rice seedlings. Availability of nitrogen is a signal regulating the transcription of nitrogenase genes. Therefore, we analysed global transcription in response to differences in the nitrogen source. Methodology/Principal Findings: A DNA microarray, comprising 70-mer oligonucleotides representing 3989 open reading frames of the genome of strain BH72, was used for transcriptome studies. Transcription profiles of cells grown microaerobically on N-2 versus ammonium were compared. Expression of 7.2% of the genes was significantly up-regulated, and 5.8% down-regulated upon N-2 fixation, respectively. A parallel genome-wide prediction of sigma(54)-type promoter elements mapped to the upstream region of 38 sequences of which 36 were modulated under the N-2 response. In addition to modulation of genes related to N-2 fixation, the expressions of gene clusters that might be related to plant-microbe interaction and of several transcription factors were significantly enhanced. While comparing under N-2-fixation conditions the transcriptome of wild type with a nifLA(-) insertion mutant, NifA being the essential transcriptional activator for nif genes, 24.5% of the genome was found to be affected in expression. A genome-wide prediction of 29 NifA binding sequences matched to 25 of the target genes whose expression was differential during microarray analysis, some of which were putatively negatively regulated by NifA. For selected genes, differential expression was corroborated by real time RT-PCR studies. Conclusion/Significance: Our data suggest that life under conditions of nitrogen fixation is an important part of the lifestyle of strain BH72 in roots, as a wide range of genes far beyond the nif regulon is modulated. Moreover, the NifA regulon in strain BH72 appears to encompass a wider range of cellular functions beyond the regulation of nif genes.	[Sarkar, Abhijit; Reinhold-Hurek, Barbara] Univ Bremen, Dept Microbe Plant Interact, Fac Biol, D-28359 Bremen, Germany	University of Bremen	Reinhold-Hurek, B (corresponding author), Univ Bremen, Dept Microbe Plant Interact, Fac Biol, D-28359 Bremen, Germany.	breinhold@uni-bremen.de			DFG (Deutsche Forschungsgemeinschaft) [RE 756/14-1]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by a grant of the DFG (Deutsche Forschungsgemeinschaft) to B.R.-H. (RE 756/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Barrios H, 1999, NUCLEIC ACIDS RES, V27, P4305, DOI 10.1093/nar/27.22.4305; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bohm M, 2007, MOL PLANT MICROBE IN, V20, P526, DOI 10.1094/MPMI-20-5-0526; Brito B, 1997, P NATL ACAD SCI USA, V94, P6019, DOI 10.1073/pnas.94.12.6019; Bueno E, 2010, ENVIRON MICROBIOL, V12, P393, DOI 10.1111/j.1462-2920.2009.02076.x; Buschart A, 2012, MOL PLANT MICROBE IN, V25, P191, DOI 10.1094/MPMI-05-11-0138; Bush M, 2012, MICROBIOL MOL BIOL R, V76, P497, DOI 10.1128/MMBR.00006-12; Cases I, 2003, ENVIRON MICROBIOL, V5, P1281, DOI 10.1111/j.1462-2920.2003.00528.x; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Dixon R, 1998, ARCH MICROBIOL, V169, P371, DOI 10.1007/s002030050585; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Dombrecht B, 2005, MOL MICROBIOL, V55, P1207, DOI 10.1111/j.1365-2958.2005.04457.x; Dombrecht B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-12-research0076; Dorr J, 1998, MOL MICROBIOL, V30, P7, DOI 10.1046/j.1365-2958.1998.01010.x; Egener T, 2002, MICROBIOL-SGM, V148, P3203, DOI 10.1099/00221287-148-10-3203; Egener T, 2001, J BACTERIOL, V183, P3752, DOI 10.1128/JB.183.12.3752-3760.2001; Egener T, 1999, MOL PLANT MICROBE IN, V12, P813, DOI 10.1094/MPMI.1999.12.9.813; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hamilton TL, 2011, J BACTERIOL, V193, P4477, DOI 10.1128/JB.05099-11; Hauberg-Lotte L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030421; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; HUREK T, 1988, PLANT SOIL, V110, P339, DOI 10.1007/BF02226814; Hurek T, 2002, MOL PLANT MICROBE IN, V15, P233, DOI 10.1094/MPMI.2002.15.3.233; Hwang W, 2011, INFECT IMMUN, V79, P4068, DOI 10.1128/IAI.05351-11; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Krause A, 2011, MOL PLANT MICROBE IN, V24, P1325, DOI 10.1094/MPMI-05-11-0139; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Martin DE, 2000, MOL MICROBIOL, V38, P276, DOI 10.1046/j.1365-2958.2000.02095.x; Martinez-Argudo I, 2004, J BACTERIOL, V186, P601, DOI 10.1128/JB.186.3.601-610.2004; Martinez-Noel G, 2011, MOL MICROBIOL, V79, P1182, DOI 10.1111/j.1365-2958.2011.07540.x; MERRICK MJ, 1993, MOL MICROBIOL, V10, P903, DOI 10.1111/j.1365-2958.1993.tb00961.x; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Michiels J, 1998, J BACTERIOL, V180, P3620, DOI 10.1128/JB.180.14.3620-3628.1998; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; O' Leary ND, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-229; OW DW, 1983, P NATL ACAD SCI-BIOL, V80, P2524, DOI 10.1073/pnas.80.9.2524; Poggio S, 2006, J BIOL CHEM, V281, P27205, DOI 10.1074/jbc.M601735200; REINHOLD B, 1985, J BACTERIOL, V162, P190, DOI 10.1128/JB.162.1.190-195.1985; Reinhold-Hurek B, 1998, TRENDS MICROBIOL, V6, P139, DOI 10.1016/S0966-842X(98)01229-3; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; REINHOLDHUREK B, 1993, INT J SYST BACTERIOL, V43, P574, DOI 10.1099/00207713-43-3-574; Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001; Riordan JT, 2010, MICROBIOL-SGM, V156, P719, DOI 10.1099/mic.0.032631-0; Salazar E, 2010, APPL ENVIRON MICROB, V76, P4510, DOI 10.1128/AEM.02007-09; SANJUAN J, 1991, MOL PLANT MICROBE IN, V4, P365, DOI 10.1094/MPMI-4-365; Sarkar A, 2012, MOL MICROBIOL, V83, P408, DOI 10.1111/j.1365-2958.2011.07940.x; Sarma AD, 2006, PROTEOMICS, V6, P3008, DOI 10.1002/pmic.200500783; Shidore T, 2012, ENVIRON MICROBIOL, V14, P2775, DOI 10.1111/j.1462-2920.2012.02777.x; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Tian ZX, 2006, CHINESE SCI BULL, V51, P2079, DOI 10.1007/s11434-006-2092-2; Yan YL, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-405, 10.1186/1471-2164-11-11]; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705	61	30	32	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e86527	10.1371/journal.pone.0086527	http://dx.doi.org/10.1371/journal.pone.0086527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516534	Green Submitted, Green Published, gold			2022-12-27	WOS:000330830700009
J	Sorensen, CJ; Pedersen, OB; Petersen, MS; Sorensen, E; Kotze, S; Thorner, LW; Hjalgrim, H; Rigas, AS; Moller, B; Rostgaard, K; Riiskjaer, M; Ullum, H; Erikstrup, C				Sorensen, Cecilie J.; Pedersen, Ole B.; Petersen, Mikkel S.; Sorensen, Erik; Kotze, Sebastian; Thorner, Lise W.; Hjalgrim, Henrik; Rigas, Andreas S.; Moller, Bjarne; Rostgaard, Klaus; Riiskjaer, Mads; Ullum, Henrik; Erikstrup, Christian			Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; HORMONAL CONTRACEPTION; VENOUS THROMBOEMBOLISM; RISK; POPULATION; PLASMA; SERUM; CANCER; WOMEN	Background: C-reactive protein (CRP) is a well-established marker of inflammation. The level of CRP is affected by several lifestyle factors. A slightly increased CRP level, also known as low-grade inflammation (LGI), is associated with increased risk of several diseases, especially cardiovascular disease. The aim of this study was to identify predictors of increased CRP levels in healthy individuals. We therefore assessed CRP in a large cohort of blood donors. Methods: We measured plasma CRP levels in 15,684 participants from the Danish Blood Donor Study. CRP was measured by a commercial assay. Furthermore, all participants completed a standard questionnaire on smoking status, alcohol consumption, physical activity, diet, and various body measurements. Female participants also reported the use of contraception, childbirth, and menopausal status. The relationship between LGI (defined here as a plasma CRP level between 3 mg/L and 10 mg/L) and predictors was explored by multivariable logistic regression analysis. Results were presented as odds ratios (OR) with 95% confidence intervals (CI). Results: We found LGI in a total of 1,561 (10.0%) participants. LGI was more frequent in women using combined oral contraception (OC) (29.9%) than in men (6.1%) and women not using OC (7.9%). Among premenopausal women, OC was the strongest predictor of LGI (odds ratio = 8.98, p<0.001). Additionally, body mass index (BMI) and waist circumference were positively associated with LGI. Conclusion: High BMI and abdominal obesity strongly predicted LGI among healthy individuals. However, the most striking finding was the high prevalence of LGI among premenopausal women who used combined oral contraception. Although the significance of CRP as a marker of inflammation is well known, the role of CRP in pathogenesis is still uncertain. The impact of oral contraception on CRP levels should nevertheless be considered when CRP is used in risk assessment.	[Sorensen, Cecilie J.; Petersen, Mikkel S.; Kotze, Sebastian; Moller, Bjarne; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Pedersen, Ole B.] Naestved Sygehus, Dept Clin Immunol, Naestved, Denmark; [Sorensen, Erik; Thorner, Lise W.; Rigas, Andreas S.; Ullum, Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark; [Hjalgrim, Henrik; Rostgaard, Klaus] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Riiskjaer, Mads] Aarhus Univ Hosp, Dept Obstet & Gynaecol, DK-8000 Aarhus, Denmark	Aarhus University; Naestved Hospital; Rigshospitalet; University of Copenhagen; Statens Serum Institut; Aarhus University	Sorensen, CJ (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark.	ceciliejuulsorensen@gmail.com	Hjalgrim, Henrik/AAG-4973-2021; Pedersen, Ole Birger/W-8679-2019; Sørensen, Erik/A-1783-2016	Pedersen, Ole Birger/0000-0003-2312-5976; Ullum, Henrik/0000-0001-7306-9058; Rostgaard, Klaus/0000-0001-6220-9414; Erikstrup, Christian/0000-0001-6551-6647; Thorner, Lise Wegner/0000-0003-4391-4956; Riiskjaer, Mads/0000-0001-7804-8782	Danish Council for Independent Research - Medical Sciences; Danish Administrative Regions; Bloddonorernes Forskningsfond og Fonden til laegevidenskabens fremme	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Danish Administrative Regions; Bloddonorernes Forskningsfond og Fonden til laegevidenskabens fremme	This study was supported by grants from The Danish Council for Independent Research - Medical Sciences, The Danish Administrative Regions, Bloddonorernes Forskningsfond og Fonden til laegevidenskabens fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Atsma F, 2011, TRANSFUSION, V51, P412, DOI 10.1111/j.1537-2995.2010.02867.x; Buchbinder S, 2008, SCAND J CLIN LAB INV, V68, P140, DOI 10.1080/00365510701487727; Chenillot O, 2000, CLIN CHEM LAB MED, V38, P1003, DOI 10.1515/CCLM.2000.149; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dawood MY, 2006, OBSTET GYNECOL, V108, P428, DOI 10.1097/01.AOG.0000230214.26638.0c; Dreon DM, 2003, LIFE SCI, V73, P1245, DOI 10.1016/S0024-3205(03)00425-9; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Edgren G, 2007, TRANSFUSION, V47, P2017, DOI 10.1111/j.1537-2995.2007.01425.x; Fodevarestyrelsen, TIPS FISK; Grad E, 2013, BLOOD REV, V27, P23, DOI 10.1016/j.blre.2012.12.001; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Hung J, 2008, AM J CARDIOL, V101, P193, DOI 10.1016/j.amjcard.2007.07.061; Hutchinson WL, 2000, CLIN CHEM, V46, P934; Imhof A, 2003, CLIN CHEM, V49, P669, DOI 10.1373/49.4.669; Janssen EB, 2013, HUM REPROD UPDATE, V19, P570, DOI 10.1093/humupd/dmt016; Kaptoge S., 2012, NEW ENGL J MED, V367, P1310, DOI [10.1056/nejmoa1107477, DOI 10.1056/NEJMOA1107477]; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kluft C, 2002, VASC PHARMACOL, V39, P99, DOI 10.1016/S1537-1891(02)00293-8; Koch MB, 2012, SOCIAL ULIGHED SUNDH; Koninckx PR, 1998, HUM REPROD UPDATE, V4, P741, DOI 10.1093/humupd/4.5.741; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; Ledue TB, 2001, CLIN CHEM LAB MED, V39, P1171, DOI 10.1515/CCLM.2001.185; Lee J, 2009, RESP MED, V103, P1286, DOI 10.1016/j.rmed.2009.04.003; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Morin-Papunen L, 2008, AM J OBSTET GYNECOL, V199, DOI [10.1016/j.ajog.2008.04.013, DOI 10.1016/J.AJ0G.2008.04.013]; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Raitakari M, 2005, J INTERN MED, V258, P428, DOI 10.1111/j.1365-2796.2005.01563.x; Rhodes B, 2011, NAT REV RHEUMATOL, V7, P283, DOI 10.1038/nrrheum.2011.37; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Saadeddin Salam M, 2002, Med Sci Monit, V8, pRA5; Salobir B, 2006, BLOOD COAGUL FIBRIN, V17, P551, DOI 10.1097/01.mbc.0000245298.64644.0a; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Shulman LP, 2011, AM J OBSTET GYNECOL, V205, pS9, DOI 10.1016/j.ajog.2011.06.057; Skouby SO, 2010, EUR J CONTRACEP REPR, V15, pS42, DOI 10.3109/13625187.2010.533002; Soska V, 2011, SCAND J CLIN LAB INV, V71, P94, DOI 10.3109/00365513.2011.553240; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; van Rooijen M, 2006, J THROMB HAEMOST, V4, P77, DOI 10.1111/j.1538-7836.2005.01690.x; VILLEGAS R, 2010, NUTR METAB CARDIOVAS; Waist Circumference and Waist-Hip Ratio, 2008, WHO EXP CONS GEN 8 1; Wilson NM, 2012, ACTA OBSTET GYN SCAN, V91, P810, DOI 10.1111/j.1600-0412.2012.01416.x	46	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88196	10.1371/journal.pone.0088196	http://dx.doi.org/10.1371/journal.pone.0088196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516611	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700054
J	Asaba, A; Okabe, S; Nagasawa, M; Kato, M; Koshida, N; Osakada, T; Mogi, K; Kikusui, T				Asaba, Akari; Okabe, Shota; Nagasawa, Miho; Kato, Masahiro; Koshida, Nobuyoshi; Osakada, Takuya; Mogi, Kazutaka; Kikusui, Takefumi			Developmental Social Environment Imprints Female Preference for Male Song in Mice	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; MATING PREFERENCES; BEHAVIOR; ESTRUS	Background: Sexual imprinting is important for kin recognition and for promoting outbreeding, and has been a driving force for evolution; however, little is known about sexual imprinting by auditory cues in mammals. Male mice emit song-like ultrasonic vocalizations that possess strain-specific characteristics. Objectives: In this study, we asked whether female mice imprint and prefer specific characteristics in male songs. Methods and Findings: We used the two-choice test to determine the song preference of female C57BL/6 and BALB/c mice. By assessing the time engaged in searching behavior towards songs played back to females, we found that female mice displayed an innate preference for the songs of males from different strains. Moreover, this song preference was regulated by female reproductive status and by male sexual cues such as the pheromone ESP1. Finally, we revealed that this preference was reversed by cross-fostering and disappeared under fatherless conditions, indicating that the behavior was learned by exposure to the father's song. Conclusions: Our results suggest that female mice can discriminate among male song characteristics and prefer songs of mice from strains that are different from their parents, and that these preferences are based on their early social experiences. This is the first study in mammals to demonstrate that male songs contribute to kin recognition and mate choice by females, thus helping to avoid inbreeding and to facilitate offspring heterozygosity.	[Asaba, Akari; Okabe, Shota; Nagasawa, Miho; Mogi, Kazutaka; Kikusui, Takefumi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Kato, Masahiro] Kato Acoust Consulting Off, Yokohama, Kanagawa, Japan; [Koshida, Nobuyoshi] Tokyo Univ Agr & Technol, Div Elect & Informat Engn, Tokyo, Japan; [Osakada, Takuya] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Azabu University; Tokyo University of Agriculture & Technology; University of Tokyo	Kikusui, T (corresponding author), Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan.	kikusui@azabu-u.ac.jp	Osakada, Takuya/GLV-1245-2022	Mogi, Kazutaka/0000-0002-0689-9761; Okabe, Shota/0000-0003-3448-3584; Osakada, Takuya/0000-0003-3752-6594	Ministry of Education, Science, Sports and Culture of Japan [14760187, 16086204]; Azabu University; Grants-in-Aid for Scientific Research [13J08901, 26450433, 11J07094] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Azabu University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (T.K. 14760187 & 16086204) and partially supported by a research project grant awarded by the Azabu University (T.K. & K.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 1996, TRENDS ECOL EVOL, V11, P53, DOI 10.1016/0169-5347(96)81042-1; Baum MJ, 2002, HORM BEHAV, V41, P213, DOI 10.1006/hbeh.2001.1749; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; DEWSBURY DA, 1979, B PSYCHONOMIC SOC, V13, P320, DOI 10.3758/BF03336883; FALLS JB, 1982, ANIM BEHAV, V30, P997, DOI 10.1016/S0003-3472(82)80188-7; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Marler P., 2004, NATURES MUSIC SCI BI; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nowicki S, 2005, AUK, V122, P1, DOI 10.1642/0004-8038(2005)122[0001:SAMCIB]2.0.CO;2; NUNEZ AA, 1978, HORM BEHAV, V11, P264, DOI 10.1016/0018-506X(78)90030-2; NUNEZ AA, 1985, PHYSIOL BEHAV, V34, P901, DOI 10.1016/0031-9384(85)90011-3; Okabe S, 2013, BEHAV NEUROSCI, V127, P432, DOI 10.1037/a0032395; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Shinoda H, 1999, NATURE, V400, P853, DOI 10.1038/23664; Sugimoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022093; Tomihara K, 2009, PHYSIOL BEHAV, V96, P300, DOI 10.1016/j.physbeh.2008.10.014; Xiao K, 2004, HORM BEHAV, V46, P356, DOI 10.1016/j.yhbeh.2004.05.008; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; Yano S, 2012, J VET MED SCI, V74, P1311, DOI 10.1292/jvms.12-0067	25	42	42	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87186	10.1371/journal.pone.0087186	http://dx.doi.org/10.1371/journal.pone.0087186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505280	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200039
J	Bevelander, KE; Kaipainen, K; Swain, R; Dohle, S; Bongard, JC; Hines, PDH; Wansink, B				Bevelander, Kirsten E.; Kaipainen, Kirsikka; Swain, Robert; Dohle, Simone; Bongard, Josh C.; Hines, Paul D. H.; Wansink, Brian			Crowdsourcing Novel Childhood Predictors of Adult Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; ADOLESCENT OBESITY; HEALTH; PREVALENCE; OVERWEIGHT; CHILDREN; WEIGHT; CONSUMPTION; BEHAVIORS; PROGRAM	Effective and simple screening tools are needed to detect behaviors that are established early in life and have a significant influence on weight gain later in life. Crowdsourcing could be a novel and potentially useful tool to assess childhood predictors of adult obesity. This exploratory study examined whether crowdsourcing could generate well-documented predictors in obesity research and, moreover, whether new directions for future research could be uncovered. Participants were recruited through social media to a question-generation website, on which they answered questions and were able to pose new questions that they thought could predict obesity. During the two weeks of data collection, 532 participants (62% female; age = 26.5 +/- 6.7; BMI = 29.0 +/- 7.0) registered on the website and suggested a total of 56 unique questions. Nineteen of these questions correlated with body mass index (BMI) and covered several themes identified by prior research, such as parenting styles and healthy lifestyle. More importantly, participants were able to identify potential determinants that were related to a lower BMI, but have not been the subject of extensive research, such as parents packing their children's lunch to school or talking to them about nutrition. The findings indicate that crowdsourcing can reproduce already existing hypotheses and also generate ideas that are less well documented. The crowdsourced predictors discovered in this study emphasize the importance of family interventions to fight obesity. The questions generated by participants also suggest new ways to express known predictors.	[Bevelander, Kirsten E.] Univ Amsterdam, Dept Commun Sci, Amsterdam, Netherlands; [Kaipainen, Kirsikka] VTT Tech Res Ctr Finland, Tampere, Finland; [Swain, Robert; Bongard, Josh C.; Hines, Paul D. H.] Univ Vermont, Coll Engn & Math Sci, Burlington, VT USA; [Dohle, Simone] ETH, Inst Environm Decis, Zurich, Switzerland; [Wansink, Brian] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	University of Amsterdam; VTT Technical Research Center Finland; University of Vermont; ETH Zurich; Cornell University	Kaipainen, K (corresponding author), VTT Tech Res Ctr Finland, Tampere, Finland.	kirsikka.kaipainen@vtt.fi	Dohle, Simone/ABA-6304-2020; Bevelander, Kirsten E/E-7878-2012	Kaipainen, Kirsikka/0000-0002-7261-8868; , Kirsten/0000-0003-1011-7862; Dohle, Simone/0000-0003-1535-5464	Salwe Research Program for Mind and Body (Tekes - Finnish Funding Agency for Technology and Innovation) [1104/10]; NSF-PECASE [0953837]; DARPA [W911NF-1-11-0076, FA8650-11-1-7155]; endowed chair at Cornell University; NSF IGERT program at UVM [1144388]; Directorate For Engineering [1254549] Funding Source: National Science Foundation	Salwe Research Program for Mind and Body (Tekes - Finnish Funding Agency for Technology and Innovation); NSF-PECASE(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); endowed chair at Cornell University; NSF IGERT program at UVM; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	KK was supported in part by the Salwe Research Program for Mind and Body (Tekes - Finnish Funding Agency for Technology and Innovation Grant 1104/10). JCB was supported in part by NSF-PECASE 0953837 and DARPA grants W911NF-1-11-0076 and FA8650-11-1-7155. BW was supported by funds from his endowed chair at Cornell University. RS was supported by the NSF IGERT program at UVM: Grant #1144388. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschutz DJ, 2009, INT J EAT DISORDER, V42, P54, DOI 10.1002/eat.20569; Berge JM, 2010, J ADOLESCENT HEALTH, V46, P331, DOI 10.1016/j.jadohealth.2009.08.004; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Birch LL, 2000, AM J CLIN NUTR, V71, P1054; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Blaine B, 2008, J HEALTH PSYCHOL, V13, P1190, DOI 10.1177/1359105308095977; Bongard JC, 2012, CROWDSOURCING PREDIC, P1; Bonney R, 2009, BIOSCIENCE, V59, P977, DOI 10.1525/bio.2009.59.11.9; Bouchard C, 2007, INT J OBESITY, V31, P1337, DOI 10.1038/sj.ijo.0803610; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Branen L, 1999, J NUTR EDUC, V31, P304, DOI 10.1016/S0022-3182(99)70483-8; Brink PJ, 2007, J CHILD ADOL PSYCHOP, V12; Brisbois TD, 2012, OBES REV, V13, P347, DOI 10.1111/j.1467-789X.2011.00965.x; CDC, 2009, OV OB CAUS CONS; Chatzimilioudis G, 2012, IEEE INTERNET COMPUT, V16, P36, DOI 10.1109/MIC.2012.70; Danner FW, 2008, J PEDIATR PSYCHOL, V33, P1100, DOI 10.1093/jpepsy/jsn034; de Boer Victor, 2012, Knowledge Engineering and Knowledge Management. 18th International Conference, EKAW 2012. Proceedings, P16, DOI 10.1007/978-3-642-33876-2_3; Doan A, 2011, COMMUN ACM, V54, P86, DOI 10.1145/1924421.1924442; DONOVAN JE, 1993, J HEALTH SOC BEHAV, V34, P346, DOI 10.2307/2137372; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Faith MS, 2004, OBES RES, V12, P1711, DOI 10.1038/oby.2004.212; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fuller Johann, 2012, ADV INT MARKET, V23, P137, DOI DOI 10.1108/S1474-7979(2012)0000023010; Gleason PM, 2009, J AM DIET ASSOC, V109, pS118, DOI 10.1016/j.jada.2008.10.058; Grafova IB, 2008, PREV MED, V47, P304, DOI 10.1016/j.ypmed.2008.04.012; Gruber KJ, 2009, PREV CHRONIC DIS, V6; Hesketh K, 2004, INT J OBESITY, V28, P1233, DOI 10.1038/sj.ijo.0802624; Honaker J, 2011, J STAT SOFTW, V45, P1; Imai K, 2006, ZELIG EVERYONS STAT; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Kittur A., 2010, ACM MAGAZINE STUDENT, V17, P22, DOI DOI 10.1145/1869086.1869096; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; l'Allemand D, 2008, OBESITY, V16; Marshall SJ, 2008, INT J OBESITY, V28, P1238; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nicklas TA, 2004, J AM DIET ASSOC, V104, P753, DOI 10.1016/j.jada.2004.02.030; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Okasha M, 2003, J EPIDEMIOL COMMUN H, V57, P508, DOI 10.1136/jech.57.7.508; Parker A., 2012, P SIGCHI C HUMAN FAC, P99, DOI [10.1145/2207676.2207692, DOI 10.1145/2207676.2207692]; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Patrick H, 2005, APPETITE, V44, P243, DOI 10.1016/j.appet.2002.07.001; Pearce MJ, 2002, OBES RES, V10, P386, DOI 10.1038/oby.2002.53; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Poetz MK, 2012, J PROD INNOVAT MANAG, V29, P245, DOI 10.1111/j.1540-5885.2011.00893.x; Power C, 2000, P NUTR SOC, V59, P267, DOI 10.1017/S002966510000029X; Prestopnik N. R., 2012, P 2012 ICONFERENCE, P168, DOI DOI 10.1145/2132176.2132198; Puhl Rebecca M, 2003, Eat Behav, V4, P283, DOI 10.1016/S1471-0153(03)00024-2; Raddick M. Jordan, 2010, Astronomy Education Review, V9, DOI 10.3847/AER2009036; Shirk JL, 2012, ECOL SOC, V17, DOI 10.5751/ES-04705-170229; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sinha A, 2009, OBES SURG, V19, P113, DOI 10.1007/s11695-008-9650-4; Spence A, 2010, AUST EPIDEMIOLOGIST, V17, P17; Swan M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1988; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Viner RM, 2005, J PEDIATR-US, V147, P429, DOI 10.1016/j.jpeds.2005.05.005; Weitzman ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019256; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Young TK, 2000, J PEDIATR-US, V136, P365, DOI 10.1067/mpd.2000.103504; Zhong B, 2011, COMPUT HUM BEHAV, V27, P1265, DOI 10.1016/j.chb.2011.01.008	64	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87756	10.1371/journal.pone.0087756	http://dx.doi.org/10.1371/journal.pone.0087756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505310	Green Published, gold			2022-12-27	WOS:000330829200069
J	Heath, G; Childs, D; Docker, MF; McCauley, DW; Whyard, S				Heath, George; Childs, Darcy; Docker, Margaret F.; McCauley, David W.; Whyard, Steven			RNA Interference Technology to Control Pest Sea Lampreys - A Proof-of-Concept	PLOS ONE			English	Article							PETROMYZON-MARINUS CONTROL; DOUBLE-STRANDED-RNA; STERILE-MALE-RELEASE; MIGRATORY PHEROMONE; GENE; FISH; EVOLUTION; SUPERIOR; INSIGHTS; SKELETON	The parasitic sea lamprey (Petromyzon marinus) has caused extensive losses to commercial fish stocks of the upper Great Lakes of North America. Methods of controlling the sea lamprey include trapping, barriers to prevent migration, and use of a chemical lampricide (3-trifluoromethyl-4-nitrophenol) to kill the filter-feeding larvae. Concerns about the non-specificity of these methods have prompted continued development of species-specific methods to control lampreys outside their native range. In this study, we considered the utility of RNA interference to develop a sea lamprey-specific lampricide. Injection of six different short interfering, double-stranded RNAs (siRNAs) into lamprey embryos first confirmed that the siRNAs could reduce the targeted transcript levels by more than 50%. Two size classes of lamprey larvae were then fed the siRNAs complexed with liposomes, and three of the siRNAs (targeting elongation factor 1 alpha, calmodulin, and alpha-actinin) reduced transcript levels 2.5, 3.6, and 5.0-fold, respectively, within the lamprey midsections. This is not only the first demonstration of RNAi in lampreys, but it is also the first example of delivery of siRNAs to a non-mammalian vertebrate through feeding formulations. One of the siRNA treatments also caused increased mortality of the larvae following a single feeding of siRNAs, which suggests that prolonged or multiple feedings of siRNAs could be used to kill filter-feeding larvae within streams, following development of a slow-release formulation. The genes targeted in this study are highly conserved across many species, and only serve as a proof-of-concept demonstration that siRNAs can be used in lampreys. Given that RNA interference is a sequence-specific phenomenon, it should be possible to design siRNAs that selectively target gene sequences that are unique to sea lampreys, and thus develop a technology to control these pests without adversely affecting non-target species.	[Heath, George; Childs, Darcy; Docker, Margaret F.; Whyard, Steven] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [McCauley, David W.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Manitoba; University of Oklahoma System; University of Oklahoma - Norman	Whyard, S (corresponding author), Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada.	Steve.Whyard@umanitoba.ca		Whyard, Steve/0000-0002-9874-7780	Great Lakes Fishery Commission; Natural Sciences and Engineering Research Council (NSERC) of Canada	Great Lakes Fishery Commission; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Great Lakes Fishery Commission (www.glfc.org) and by Natural Sciences and Engineering Research Council (NSERC; www.nserc-crsng.gc.ca) of Canada grants to SW and MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bergstedt RA, 2007, J GREAT LAKES RES, V33, P48, DOI 10.3394/0380-1330(2007)33[48:RTSSAG]2.0.CO;2; Boogaard MA, 2003, J GREAT LAKES RES, V29, P529, DOI 10.1016/S0380-1330(03)70514-0; Boonanuntanasarn S, 2003, BIOCHEM BIOPH RES CO, V310, P1089, DOI 10.1016/j.bbrc.2003.09.127; Denli AM, 2003, TRENDS BIOCHEM SCI, V28, P196, DOI 10.1016/S0968-0004(03)00058-6; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fine JM, 2004, J CHEM ECOL, V30, P2091, DOI 10.1023/B:JOEC.0000048776.16091.b1; Gabel JA, 1985, GREAT LAKES FISH COM, V47, P1; Gruber Jens, 2005, RNA Biol, V2, P101, DOI 10.4161/rna.2.3.2060; HANSON LH, 1980, CAN J FISH AQUAT SCI, V37, P2108, DOI 10.1139/f80-252; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Huang LF, 2013, NAT PROTOC, V8, P2325, DOI 10.1038/nprot.2013.149; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jain K. K., 2008, Current Drug Delivery, V5, P27, DOI 10.2174/156720108783331023; Johnson DA, 1999, 62 GREAT LAK FISH CO, V62; Jones M.L., 2012, EVALUATING INTEGRATE; Kelly A, 2011, BRIEF FUNCT GENOMICS, V10, P189, DOI 10.1093/bfgp/elr014; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Krueger CC, 2007, J GREAT LAKES RES, V33, P1, DOI 10.3394/0380-1330(2007)33[1:SLRBBA]2.0.CO;2; Lakiza O, 2011, DEV BIOL, V359, P149, DOI 10.1016/j.ydbio.2011.08.012; Li W, 2007, J GREAT LAKES RES, V33, P70, DOI 10.3394/0380-1330(2007)33[70:RTGUOP]2.0.CO;2; Li WM, 2003, J GREAT LAKES RES, V29, P85, DOI 10.1016/S0380-1330(03)70479-1; Li YX, 2000, DEV BIOL, V217, P394, DOI 10.1006/dbio.1999.9540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Mangos S, 2001, MOL REPROD DEV, V59, P235, DOI 10.1002/mrd.1028; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin WM, 2009, DEV DYNAM, V238, P3126, DOI 10.1002/dvdy.22164; McCauley DW, 2006, NATURE, V441, P750, DOI 10.1038/nature04691; McDonald DG, 2007, J GREAT LAKES RES, V33, P20, DOI 10.3394/0380-1330(2007)33[20:RTGTUO]2.0.CO;2; Nikitina Natalya, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5123; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piavis G. W., 1961, Fishery Bulletin United States, V61, P111; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Raab RM, 2004, BIOTECHNOL BIOENG, V88, P121, DOI 10.1002/bit.20216; Sarathi M, 2008, MAR BIOTECHNOL, V10, P242, DOI 10.1007/s10126-007-9057-6; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; SCHULDT RJ, 1980, CAN J FISH AQUAT SCI, V37, P1872, DOI 10.1139/f80-229; Schyth BD, 2008, J FISH BIOL, V72, P1890, DOI 10.1111/j.1095-8649.2008.01819.x; Siefkes M.J., 2012, GREAT LAKES FISHERY, P651; Smith B.R., 1971, pUnpaginated; SMITH BR, 1980, CAN J FISH AQUAT SCI, V37, P1780, DOI 10.1139/f80-222; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sohail M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng038; Sorensen PW, 2007, J FISH BIOL, V71, P100, DOI 10.1111/j.1095-8649.2007.01681.x; Twohey MB, 2003, J GREAT LAKES RES, V29, P410, DOI 10.1016/S0380-1330(03)70504-8; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wagner CM, 2006, CAN J FISH AQUAT SCI, V63, P475, DOI [10.1139/f06-008, 10.1139/F06-008]; Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]; Yamanaka YJ, 2008, J BIOMAT SCI-POLYM E, V19, P1549, DOI 10.1163/156856208786440479; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao XF, 2008, FEBS J, V275, P2177, DOI 10.1111/j.1742-4658.2008.06371.x	57	23	25	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88387	10.1371/journal.pone.0088387	http://dx.doi.org/10.1371/journal.pone.0088387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505485	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200186
J	Heo, J; Oh, J; Subramanian, SV; Kim, Y; Kawachi, I				Heo, Jongho; Oh, Juhwan; Subramanian, S. V.; Kim, Yoon; Kawachi, Ichiro			Addictive Internet Use among Korean Adolescents: A National Survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; COLLEGE-STUDENTS; BEHAVIOR; SCHOOL; FAMILY; USAGE	Background: A psychological disorder called 'Internet addiction' has newly emerged along with a dramatic increase of worldwide Internet use. However, few studies have used population-level samples nor taken into account contextual factors on Internet addiction. Methods and Findings: We identified 57,857 middle and high school students (13-18 year olds) from a Korean nationally representative survey, which was surveyed in 2009. To identify associated factors with addictive Internet use, two-level multilevel regression models were fitted with individual-level responses (1st level) nested within schools (2nd level) to estimate associations of individual and school characteristics simultaneously. Gender differences of addictive Internet use were estimated with the regression model stratified by gender. Significant associations were found between addictive Internet use and school grade, parental education, alcohol use, tobacco use, and substance use. Female students in girls' schools were more likely to use Internet addictively than those in coeducational schools. Our results also revealed significant gender differences of addictive Internet use in its associated individual- and school-level factors. Conclusions: Our results suggest that multilevel risk factors along with gender differences should be considered to protect adolescents from addictive Internet use.	[Heo, Jongho] San Diego State Univ, Publ Hlth Joint Doctoral Program, La Jolla, CA USA; [Heo, Jongho] Univ Calif San Diego, La Jolla, CA 92093 USA; [Oh, Juhwan] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Kim, Yoon] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea	California State University System; San Diego State University; University of California System; University of California San Diego; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU)	Oh, J (corresponding author), Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea.	oh328@snu.ac.kr	Oh, Juhwan/O-6517-2019	Oh, Juhwan/0000-0003-0983-4872; Heo, Jongho/0000-0002-6405-3860				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2011, BBC NEWS ASIA PACIFI; Armstrong L, 2000, INT J HUM-COMPUT ST, V53, P537, DOI 10.1006/ijhc.2000.0400; Barnekow V., 2008, INEQUALITIES YOUNG P; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Brenner V, 1997, PSYCHOL REP, V80, P879, DOI 10.2466/pr0.1997.80.3.879; British Broadcasting Corporation (BBC), 2005, BBC NEWS; Caplan SE, 2002, COMPUT HUM BEHAV, V18, P553, DOI 10.1016/S0747-5632(02)00004-3; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; Chou C, 2000, COMPUT EDUC, V35, P65, DOI 10.1016/S0360-1315(00)00019-1; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; Davis RA, 2002, CYBERPSYCHOL BEHAV, V5, P331, DOI 10.1089/109493102760275581; Dong-il Kim, 2008, [Korea Journal of Counseling, 상담학연구], V9, P1703; Durkee T, 2012, ADDICTION, V107, P2210, DOI 10.1111/j.1360-0443.2012.03946.x; FAWZY FI, 1987, ADDICT BEHAV, V12, P79, DOI 10.1016/0306-4603(87)90013-X; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Garnefski N, 1996, J ADOLESCENCE, V19, P503, DOI 10.1006/jado.1996.0049; Greenfield D N, 1999, Cyberpsychol Behav, V2, P403, DOI 10.1089/cpb.1999.2.403; Griffiths M, 2000, CYBERPSYCHOL BEHAV, V3, P211, DOI 10.1089/109493100316067; Gross EF, 2004, J APPL DEV PSYCHOL, V25, P633, DOI 10.1016/j.appdev.2004.09.005; Ha JH, 2006, J CLIN PSYCHIAT, V67, P821, DOI 10.4088/JCP.v67n0517; Hawkins M., 2012, NBC NEWS; Hunter arnie, 2022, CNN; International Telecommunication Union, 2013, WORLD TEL ICT IND DA; Jones S., 2002, INTERNET GOES COLL S; Kaltiala-Heino R, 2004, ADDICT RES THEORY, V12, P89, DOI 10.1080/1606635031000098796; Kandell J.J., 1998, CYBERPSYCHOL BEHAV, V1, P11, DOI [10.1089/cpb.1998.1.11, DOI 10.1089/CPB.1998.1.11]; Kim H., 2007, INT C SOC AD; Kim K, 2006, INT J NURS STUD, V43, P185, DOI 10.1016/j.ijnurstu.2005.02.005; Ko CH, 2005, J NERV MENT DIS, V193, P273, DOI 10.1097/01.nmd.0000158373.85150.57; Ko CH, 2006, CAN J PSYCHIAT, V51, P887, DOI 10.1177/070674370605101404; Ko CH, 2009, ARCH PEDIAT ADOL MED, V163, P937, DOI 10.1001/archpediatrics.2009.159; Korea Statistical Information Service, 2013, STAT INT US; Kubey RW, 2001, J COMMUN, V51, P366, DOI 10.1111/j.1460-2466.2001.tb02885.x; Lavin M, 1999, Cyberpsychol Behav, V2, P425, DOI 10.1089/cpb.1999.2.425; Lin MP, 2008, CYBERPSYCHOL BEHAV, V11, P451, DOI 10.1089/cpb.2007.0121; Lin SSJ, 2002, COMPUT HUM BEHAV, V18, P411, DOI 10.1016/S0747-5632(01)00056-5; Mathy RM, 2003, PSYCHOTHERAPY, V40, P125, DOI 10.1037/0033-3204.40.1-2.125; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Nalwa K, 2003, CYBERPSYCHOL BEHAV, V6, P653, DOI 10.1089/109493103322725441; National Information Society Agency, 2011, INT ADD SURV 2010; Ng BD, 2005, CYBERPSYCHOL BEHAV, V8, P110, DOI 10.1089/cpb.2005.8.110; Rosenberg M, 1989, SOC ADOLESCENT SELF; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; SCHOLTE EM, 1992, J ABNORM CHILD PSYCH, V20, P247, DOI 10.1007/BF00916691; Shapira NA, 2003, DEPRESS ANXIETY, V17, P207, DOI 10.1002/da.10094; Soteriades ES, 2003, AM J PUBLIC HEALTH, V93, P1155, DOI 10.2105/AJPH.93.7.1155; Soule LC, 2003, J COMPUT INFORM SYST, V44, P64; Suler J., 2004, INT J APPL PSYCHOANA, V1, P359, DOI DOI 10.1002/APS.90; Tao R, 2010, ADDICTION, V105, P556, DOI 10.1111/j.1360-0443.2009.02828.x; Thatcher A., 2005, S AFRICAN J PSYCHOL, V35, P793, DOI [10.1177/008124630503500410, DOI 10.1177/008124630503500410]; The Korean National Information Society Agency, 2012, SURV INT ADD 2011; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]	56	70	73	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87819	10.1371/journal.pone.0087819	http://dx.doi.org/10.1371/journal.pone.0087819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505318	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200074
J	Ho, MM; Hu, XK; Karunakaran, S; Johnson, JD; Clee, SM				Ho, Maggie M.; Hu, Xiaoke; Karunakaran, Subashini; Johnson, James D.; Clee, Susanne M.			Altered Pancreatic Growth and Insulin Secretion in WSB/EiJ Mice	PLOS ONE			English	Article							BETA-CELL PROLIFERATION; DIET-INDUCED OBESITY; DIABETES SUSCEPTIBILITY; MOUSE; ARCHITECTURE; ISLETS; HYPERPLASIA; DYSFUNCTION; RESISTANCE; SORCS1	These data suggest that insulin secretion in WSB mice is blunted specifically in vivo, either due to a reduced insulin requirement and/or due to factors that are absent or destroyed in vitro. These studies also highlight the role of post-natal growth in determining adult beta-cell mass. Mice are important animal models for the study of metabolic physiology and the genetics of complex traits. Wild-derived inbred mouse strains, such as WSB/EiJ (WSB), are unrelated to the commonly studied mouse strains and are valuable tools to identify novel genes that modify disease risk. We have previously shown that in contrast to C57BL/6J (B6) mice, WSB mice fed a high fat diet do not develop hyperinsulinemia or insulin resistance, and had nearly undetectable insulin secretion in response to an intraperitoneal glucose challenge. As hyperinsulinemia may drive obesity and insulin resistance, we examined whether defects in beta-cell mass or function could contribute to the low insulin levels in WSB mice. In young WSB mice, beta-cell mass was similar to B6 mice. However, we found that adult WSB mice had reduced beta-cell mass due to reduced pancreatic weights. Pancreatic sizes were similar between the strains when normalized to body weight, suggesting their pancreatic size is appropriate to their body size in adults, but overall post-natal pancreatic growth was reduced in WSB mice compared to B6 mice. Islet architecture was normal in WSB mice. WSB mice had markedly increased insulin secretion from isolated islets in vitro. These data suggest that insulin secretion in WSB mice is blunted specifically in vivo, either due to a reduced insulin requirement and/or due to factors that are absent or destroyed in vitro. These studies suggest that WSB mice may provide novel insight into mechanisms regulating insulin secretion and also highlight the role of post-natal growth in determining adult beta-cell mass.	[Ho, Maggie M.; Hu, Xiaoke; Karunakaran, Subashini; Johnson, James D.; Clee, Susanne M.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Johnson, James D.] Univ British Columbia, Dept Surg, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Clee, SM (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	susanne.clee@ubc.ca	Clee, Susanne/AAC-4278-2020; Clee, Susanne/F-7312-2010	Clee, Susanne/0000-0001-7946-688X	Heart and Stroke Foundation of British Columbia and the Yukon [65465886-000026]; Canada Research Chairs program (Canada Research Chair in the Genetics of Obesity and Diabetes)	Heart and Stroke Foundation of British Columbia and the Yukon; Canada Research Chairs program (Canada Research Chair in the Genetics of Obesity and Diabetes)	These studies were supported by funding from the Heart and Stroke Foundation of British Columbia and the Yukon (#65465886-000026 to SMC; www.heartandstroke.bc.ca) and the Canada Research Chairs program (Canada Research Chair in the Genetics of Obesity and Diabetes (SMC); chairs.gc.ca). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2012, DIABETOLOGIA, V55, P3152, DOI 10.1007/s00125-012-2727-6; Auffret J, 2013, AM J PHYSL ENDOCRINO; Aylor DL, 2011, GENOME RES, V21, P1213, DOI 10.1101/gr.111310.110; Bhatnagar S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002323; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Dunmore SJ, 2013, J ENDOCRINOL, V216, pT37, DOI 10.1530/JOE-12-0278; Florez JC, 2008, DIABETOLOGIA, V51, P1100, DOI 10.1007/s00125-008-1025-9; Gonzalez A, 2013, ENDOCRINOLOGY, V154, P3515, DOI 10.1210/en.2013-1424; Goodarzi MO, 2007, DIABETES, V56, P1922, DOI 10.2337/db06-1677; Gunasekaran U, 2012, CELL CYCLE, V11, P2431, DOI 10.4161/cc.20545; Heiser PW, 2006, DEVELOPMENT, V133, P2023, DOI 10.1242/dev.02366; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Lee KTY, 2011, ENDOCRINOLOGY, V152, P3005, DOI 10.1210/en.2011-0060; Luciani DS, 2007, EUR J PHARMACOL, V576, P18, DOI 10.1016/j.ejphar.2007.07.055; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Osundiji MA, 2013, ENDOCRIN METAB CLIN, V42, P1, DOI 10.1016/j.ecl.2012.11.006; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Richards OC, 2010, ENDOCR REV, V31, P343, DOI 10.1210/er.2009-0035; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Rodriguez-Diaz R, 2013, ENDOCRIN METAB CLIN, V42, P39, DOI 10.1016/j.ecl.2012.11.001; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Sanger Institute, 2010, MOUS GEN PROJ; Scherneck S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000541; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Tamaki M, 2013, J CLIN INVEST; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Walthall K, 2005, BIRTH DEFECTS RES B, V74, P132, DOI 10.1002/bdrb.20040; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88352	10.1371/journal.pone.0088352	http://dx.doi.org/10.1371/journal.pone.0088352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505481	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200182
J	Hoppe, B; Kahl, T; Karasch, P; Wubet, T; Bauhus, J; Buscot, F; Kruger, D				Hoppe, Bjoern; Kahl, Tiemo; Karasch, Peter; Wubet, Tesfaye; Bauhus, Juergen; Buscot, Francois; Krueger, Dirk			Network Analysis Reveals Ecological Links between N-Fixing Bacteria and Wood-Decaying Fungi	PLOS ONE			English	Article							NITROGEN-FIXATION; COOCCURRENCE PATTERNS; PHYLOGENETIC ANALYSIS; NIFH GENE; DEBRIS; DIVERSITY; FORESTS; DECOMPOSITION; COMMUNITIES; PROTEIN	Nitrogen availability in dead wood is highly restricted and associations with N-fixing bacteria are thought to enable wood-decaying fungi to meet their nitrogen requirements for vegetative and generative growth. We assessed the diversity of nifH (dinitrogenase reductase) genes in dead wood of the common temperate tree species Fagus sylvatica and Picea abies from differently managed forest plots in Germany using molecular tools. By incorporating these genes into a large compilation of published nifH sequences and subsequent phylogenetic analyses of deduced proteins we verified the presence of diverse pools corresponding to functional nifH, almost all of which are new to science. The distribution of nifH genes strongly correlated with tree species and decay class, but not with forest management, while higher fungal fructification was correlated with decreasing nitrogen content of the dead wood and positively correlated with nifH diversity, especially during the intermediate stage of wood decay. Network analyses based on non-random species co-occurrence patterns revealed interactions among fungi and N-fixing bacteria in the dead wood and strongly indicate the occurrence of at least commensal relationships between these taxa.	[Hoppe, Bjoern; Wubet, Tesfaye; Buscot, Francois; Krueger, Dirk] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Hoppe, Bjoern; Kahl, Tiemo; Bauhus, Juergen] Univ Freiburg, Fac Environm & Nat Resources, Inst Silviculture, D-79106 Freiburg, Germany; [Karasch, Peter] Pilzteam Bayern, Hohenau, Germany; [Buscot, Francois] Univ Leipzig, Inst Biol 1, D-04109 Leipzig, Germany; [Wubet, Tesfaye; Buscot, Francois] German Ctr Integrat Biodivers Res iDiv, D-04109 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; Leipzig University	Hoppe, B (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	bjoern.hoppe@ufz.de; dirk.krueger@ufz.de	Bauhus, Jürgen/G-4449-2013; Buscot, Francois/A-4125-2016; Krüger, Dirk/C-3316-2012; Wubet, Tesfaye/C-6241-2012	Bauhus, Jürgen/0000-0002-9673-4986; Buscot, Francois/0000-0002-2364-0006; Krüger, Dirk/0000-0002-7305-5104; Wubet, Tesfaye/0000-0001-8572-4486; Hoppe, Bjorn/0000-0001-8689-4911	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" [BA 2821/9-2, BU941/17-1, KR3587/3-2]	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories"	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BA 2821/9-2, BU941/17-1, KR3587/3-2; www.DFG.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AHO PE, 1974, PHYTOPATHOLOGY, V64, P1413, DOI 10.1094/Phyto-64-1413; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; BODDY L, 1995, CAN J BOT, V73, pS1377, DOI 10.1139/b95-400; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brunner A, 2003, CAN J FOREST RES, V33, P1670, DOI 10.1139/X03-085; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Cornwell WK, 2009, GLOBAL CHANGE BIOL, V15, P2431, DOI 10.1111/j.1365-2486.2009.01916.x; COWLING EB, 1966, CAN J BOTANY, V44, P1539, DOI 10.1139/b66-167; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Diamond J.M., 1975, P342; Doyle J. J., 1987, PHYTOCHEM B, P11; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Fukasawa Y, 2009, J FOREST RES-JPN, V14, P20, DOI 10.1007/s10310-008-0098-0; Gaby JC, 2011, ENVIRON MICROBIOL, V13, P1790, DOI 10.1111/j.1462-2920.2011.02488.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Gotelli N. J., 2009, ECOSIM NULL MODELS S; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heilmann-Clausen J, 2003, BIODIVERS CONSERV, V12, P953, DOI 10.1023/A:1022825809503; Heilmann-Clausen J, 2001, MYCOL RES, V105, P575, DOI 10.1017/S0953756201003665; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; Hicks WT, 2003, FOREST ECOL MANAG, V176, P25, DOI 10.1016/S0378-1127(02)00229-3; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JURGENSEN MF, 1984, FOREST SCI, V30, P1038; Kahl T, 2012, ECOSCIENCE, V19, P364, DOI 10.2980/19-4-3501; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN MJ, 1978, MYCOLOGIA, V70, P1217, DOI 10.2307/3759320; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lassmann T, 2006, NUCLEIC ACIDS RES, V34, pW596, DOI 10.1093/nar/gkl191; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Lonsdale D, 2008, EUR J FOREST RES, V127, P1, DOI 10.1007/s10342-007-0182-6; Maddison WP, 2009, MESQUITE MODULAR SYS; MERRILL W, 1966, PHYTOPATHOLOGY, V56, P1083; Miller M.A., 2010, P GAT COMP ENV WORKS; Muller J, 2007, EUR J FOREST RES, V126, P513, DOI 10.1007/s10342-007-0173-7; Noy NF, 2009, NUCLEIC ACIDS RES, V37, pW170, DOI 10.1093/nar/gkp440; Poly F, 2001, RES MICROBIOL, V152, P95, DOI 10.1016/S0923-2508(00)01172-4; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; RAYNER ADM, 1988, ADV MICROB ECOL, V10, P115; Rondeux J, 2010, ENVIRON MONIT ASSESS, V164, P617, DOI 10.1007/s10661-009-0917-6; SEIDLER RJ, 1972, J GEN MICROBIOL, V73, P413, DOI 10.1099/00221287-73-2-413; Shaffer BT, 2000, MICROB ECOL, V39, P12, DOI 10.1007/s002489900183; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SILVESTER WB, 1982, CAN J FOREST RES, V12, P646, DOI 10.1139/x82-098; SPANO SD, 1982, PLANT SOIL, V68, P117, DOI 10.1007/BF02374731; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson TA, 2012, BOTANY, V90, P457, DOI [10.1139/b2012-011, 10.1139/B2012-011]; Ulrich W., 2008, PAIRS FORTRAN PROGRA; Ulrich W, 2006, OIKOS, V114, P338, DOI 10.1111/j.2006.0030-1299.14773.x; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; Volkenant K, 2007, BERICHTE FORSCHUNGSZ; Wang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00592-13; Wazny H., 1964, Holz als Roh- und Werkstoff, V22, P299, DOI 10.1007/BF02608323; Weisshaupt P, 2012, BAM DISSERTATIONSREI, V87; Whitaker RJ, 2009, CURR BIOL, V19, pR954, DOI 10.1016/j.cub.2009.09.035; Young JPW, 2005, GENOMES AND GENOMICS OF NITROGEN-FIXING ORGANISMS, P221; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zhang HB, 2008, INT BIODETER BIODEGR, V62, P471, DOI 10.1016/j.ibiod.2008.06.001; Zwickl DJ., 2006, THESIS	81	84	86	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88141	10.1371/journal.pone.0088141	http://dx.doi.org/10.1371/journal.pone.0088141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505405	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200123
J	Li, Y; Ehiri, J; Oren, E; Hu, DY; Luo, XN; Liu, Y; Li, DK; Wang, QY				Li, Ying; Ehiri, John; Oren, Eyal; Hu, Daiyu; Luo, Xingneng; Liu, Ying; Li, Daikun; Wang, Qingya			Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, China	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; ANTITUBERCULOSIS-DRUG-RESISTANCE; RISK-FACTORS; PULMONARY TUBERCULOSIS; EPIDEMIOLOGY; PREVALENCE; DELAYS; TIME	Multi-drug resistant tuberculosis (MDR-TB) represents a threat to health and development in countries with high TB burden. China's MDR-TB prevalence rate of 6.8% is the highest in the world. Interventions to remove barriers against effective TB control, and prevention of MDR-TB are urgently needed in the country. This paper reports a cross-sectional questionnaire survey of 513 pulmonary TB (PTB) patients, and qualitative interviews of 10 healthcare workers (HCWs), and 15 PTB patients. The objective was to assess barriers against effective control of PTB and prevention of MDR-TB by elucidating the perspectives of patients and healthcare providers. Results showed that more than half of the patients experienced patient delay of over 12.5 days. A similar proportion also experienced detection delay of over 30 days, and delay in initiating treatment of over 31 days. Consulting a non-TB health facility >= 3 times before seeking care at TB dispensary was a risk factor for both detection delay [AOR (95% CI): 1.89(1.07, 3.34) and delay in initiating treatment[AOR (95% CI): 1.88 (1.06, 3.36). Results revealed poor implementation of Directly Observed Therapy (DOT), whereby treatment of 34.3% patients was never monitored by HCWs. Only 31.8% patients had ever accessed TB health education before their TB diagnosis. Qualitative data consistently disclosed long patient delay, and indicated that patient's poor TB knowledge and socioeconomic barriers were primary reasons for patient delay. Seeking care and being treated at a non-TB hospital was an important reason for detection delay. Patient's long work hours and low income increased risk for treatment non-adherence. Evidence-based measures to improve TB health seeking behavior, reduce patient and detection delays, improve the quality of DOT, address financial and system barriers, and increase access to TB health promotion are urgently needed to address the burgeoning prevalence of MDR-TB in China.	[Li, Ying; Liu, Ying] Third Mil Med Univ, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China; [Ehiri, John] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Hlth Promot Sci, Tucson, AZ USA; [Oren, Eyal] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Hu, Daiyu; Wang, Qingya] Chongqing Inst TB Prevent & Treatment, Chongqing, Peoples R China; [Luo, Xingneng] Ctr Dis Control Shapingba Dist, Dept TB Control, Chongqing, Peoples R China; [Li, Daikun] Chongqing Med Univ, Univ Town Hosp, Dept Lab Med, Chongqing, Peoples R China	Army Medical University; University of Arizona; University of Arizona; Chongqing Medical University	Li, Y (corresponding author), Third Mil Med Univ, Dept Social Med & Hlth Serv Management, Chongqing, Peoples R China.	lilyliying2012@163.com	Oren, Eyal/AAD-5561-2019	Oren, Eyal/0000-0001-7817-3516	National Natural Science Foundation of China [81001297]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China (Award #81001297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; [Anonymous], 2011, RES METHODS ANTHR; Antunes ML, 2000, INT J TUBERC LUNG D, V4, P223; Bai Li-qiong, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P617; Barbara V, 1998, EPIDEMIOLOGY HLTH CA; Casal M, 2005, MICROB DRUG RESIST, V11, P62, DOI 10.1089/mdr.2005.11.62; Chien JY, 2013, J ANTIMICROB CHEMOTH, V68, P1910, DOI 10.1093/jac/dkt103; Department of Disease Control Department of Medical Administraton Chinese Center for Disease Control and Prevention, 2008, GUID IMPL NAT TUB CO; Department of Disease Control of Ministry of Health, 2008, GUID ENF CHIN TUB CO; Ejaz M, 2010, T ROY SOC TROP MED H, V104, P511, DOI 10.1016/j.trstmh.2010.03.005; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; He GX, 2011, EMERG INFECT DIS, V17, P1831, DOI 10.3201/eid1710.110546; He GX, 2005, INT J TUBERC LUNG D, V9, pS135; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Liu Ying, 2012, Modern Preventive Medicine, V39, P692; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; McLean Margot, 2003, GUID TUB CONTR NZ 20; Oren E, 2013, PUBLIC HEALTH REP, V128, P99, DOI 10.1177/003335491312800205; Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Ritchie J, 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.1186/1471-2288-13-117; Sanchez-Perez HJ, 2010, INT J TUBERC LUNG D, V14, P34; Shao Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-110; Skrahina A, 2013, B WORLD HEALTH ORGAN, V91, P36, DOI 10.2471/BLT.12.104588; Smith Joanna, 2011, Nurse Res, V18, P52; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Srivastava A, 2009, FRAMEWORK ANAL QUALI, DOI DOI 10.1002/JIA2.25572; Suarez-Garcia I, 2009, EUR J CLIN MICROBIOL, V28, P325, DOI 10.1007/s10096-008-0627-y; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Vadwai V, 2012, SCAND J INFECT DIS, V44, P48, DOI 10.3109/00365548.2011.611169; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang Y, 2011, REPORT 5 NATL SAMPLI; Ward DJ, 2013, J ADV NURS, V69, P2423, DOI 10.1111/jan.12127; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, 7 GLOB C HLTH PROM P; WHO, 2008, WHO REP 2008 GLOB TU; WHO, 2003, WHOCDSTB2003325; WHO, 1997, TREATM TUB GUID NAT, V2; World Health Organization, 1994, WHOTB94179; Zhao P, 2012, J INT MED RES, V40, P436, DOI 10.1177/147323001204000205; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhou ZeWen, 2013, Modern Preventive Medicine, V40, P201	46	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88330	10.1371/journal.pone.0088330	http://dx.doi.org/10.1371/journal.pone.0088330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505476	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200177
J	Muckenhuber, J; Burkert, N; Grossschadl, F; Freidl, W				Muckenhuber, Johanna; Burkert, Nathalie; Grossschaedl, Franziska; Freidl, Wolfgang			Income Inequality as a Moderator of the Relationship between Psychological Job Demands and Sickness Absence, in Particular in Men: An International Comparison of 23 Countries	PLOS ONE			English	Article							PSYCHOSOCIAL WORK FACTORS; HEALTH; DISTRESS	Objectives: The aim of this study was to investigate whether more sickness absence is reported in countries with higher income inequality than elsewhere, and whether the level of income inequality moderates the association between psychosocial job demands and sickness absence. Methods: Our analysis is based on the Fifth European Working Conditions Survey that compared 23 European countries. We performed multi-level regression analysis. On the macro-level of analysis we included the Gini-Index as measure of inequality. On the micro-level of analysis we followed the Karasek-Theorell model and included three scales for psychological job demands, physical job demands, and decision latitude in the model. The model was stratified by sex. Results: We found that, in countries with high income inequality, workers report significantly more sickness absence than workers in countries with low income inequality. In addition we found that the level of income inequality moderates the relationship between psychological job demands and sickness absence. High psychological job demands are significantly more strongly related to more days of sickness absence in countries with low income inequality than in countries with high income inequality. Conclusions: As the nature and causal pathways of cross-level interaction effects still cannot be fully explained, we argue that future research should aim to explore such causal pathways. In accordance with WHO recommendations we argue that inequalities should be reduced. In addition we state that, particularly in countries with low levels of income inequality, policies should aim to reduce psychological job demands.	[Muckenhuber, Johanna; Burkert, Nathalie; Grossschaedl, Franziska; Freidl, Wolfgang] Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria	Medical University of Graz	Muckenhuber, J (corresponding author), Med Univ Graz, Inst Social Med & Epidemiol, Graz, Austria.	johanna.muckenhuber@medunigraz.at		Grossschadl, Franziska/0000-0002-6726-0443				Aboa-Eboule C, 2011, PSYCHOSOM MED, V73, P448, DOI 10.1097/01.psy.0000399790.82499.d7; Aiken L. S., 1991, MULTIPLE REGRESSION; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P318, DOI 10.1136/jech.54.4.318; Carneiro IG, 2013, INT ARCH OCC ENV HEA, V86, P397, DOI 10.1007/s00420-012-0773-5; de Jonge J, 2010, INT J BEHAV MED, V17, P125, DOI 10.1007/s12529-010-9081-1; de Lange AH, 2002, SCAND J WORK ENV HEA, V28, P94, DOI 10.5271/sjweh.653; Diehl K, 2011, SOC SCI MED, V72, P1205, DOI 10.1016/j.socscimed.2011.02.013; Edme JL, 2011, REV EPIDEMIOL SANTE, V59, P295, DOI 10.1016/j.respe.2011.05.003; Eurofound, 2013, EUR METH; Eurofound, 2013, EWCS EUR DAT 2010 FI; Gravelle H, 2003, J EPIDEMIOL COMMUN H, V57, P125, DOI 10.1136/jech.57.2.125; Gravelle H, 2002, SOC SCI MED, V54, P577, DOI 10.1016/S0277-9536(01)00053-3; Hausser JA, 2010, WORK STRESS, V24, P1, DOI 10.1080/02678371003683747; Harenstam A, 2009, SCAND J WORK ENV HEA, V35, P127; Jen MH, 2009, SOC SCI MED, V68, P643, DOI 10.1016/j.socscimed.2008.11.026; Johansen K, 2009, SCAND J WORK ENV HEA, V35, P334, DOI 10.5271/sjweh.1346; Karasek R, 1990, HLTH WORK STRESS PRO; Karlsson M, 2010, SOC SCI MED, V70, P875, DOI 10.1016/j.socscimed.2009.10.056; Kennedy BP, 1996, BRIT MED J, V312, P1004, DOI 10.1136/bmj.312.7037.1004; Lopes CS, 2010, SOC PSYCH PSYCH EPID, V45, P345, DOI 10.1007/s00127-009-0066-9; Muckenhuber J, 2013, EUR J PUBLIC HLTH; Muntaner C, 1999, INT J HEALTH SERV, V29, P59, DOI 10.2190/G8QW-TT09-67PL-QTNC; Niedhammer I, 2012, OCCUP MED-OXFORD, V62, P196, DOI 10.1093/occmed/kqs020; Niedhammer I, 1998, SCAND J WORK ENV HEA, V24, P197, DOI 10.5271/sjweh.299; Niedhammer I, 2013, EUR J PUBLIC HEALTH, V23, P622, DOI 10.1093/eurpub/cks124; Semyonov M, 2013, SOC SCI MED; UNDP, 2013, INT HUM DEV IND; vanDoorslaer E, 1997, J HEALTH ECON, V16, P93, DOI 10.1016/S0167-6296(96)00532-2; WALDMANN RJ, 1992, Q J ECON, V107, P1283, DOI 10.2307/2118389; WHO Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Wildman J, 2001, HEALTH ECON, V10, P357, DOI 10.1002/hec.613; Wilkinson R, 2005, IMPACT INEQUALITY MA	32	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86845	10.1371/journal.pone.0086845	http://dx.doi.org/10.1371/journal.pone.0086845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505271	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200030
J	Roat, R; Rao, V; Doliba, NM; Matschinsky, FM; Tobias, JW; Garcia, E; Ahima, RS; Imai, Y				Roat, Regan; Rao, Vandana; Doliba, Nicolai M.; Matschinsky, Franz M.; Tobias, John W.; Garcia, Eden; Ahima, Rexford S.; Imai, Yumi			Alterations of Pancreatic Islet Structure, Metabolism and Gene Expression in Diet-Induced Obese C57BL/6J Mice	PLOS ONE			English	Article							HIGH-FAT DIET; BETA-CELL MASS; OXYGEN-REGULATED PROTEIN; INSULIN-RELEASE; EXTRACELLULAR-MATRIX; ANIMAL-MODELS; FAILURE; RESISTANCE; SECRETION; MOUSE	The reduction of functional beta cell mass is a key feature of type 2 diabetes. Here, we studied metabolic functions and islet gene expression profiles of C57BL/6J mice with naturally occurring nicotinamide nucleotide transhydrogenase (NNT) deletion mutation, a widely used model of diet-induced obesity and diabetes. On high fat diet (HF), the mice developed obesity and hyperinsulinemia, while blood glucose levels were only mildly elevated indicating a substantial capacity to compensate for insulin resistance. The basal serum insulin levels were elevated in HF mice, but insulin secretion in response to glucose load was significantly blunted. Hyperinsulinemia in HF fed mice was associated with an increase in islet mass and size along with higher BrdU incorporation to beta cells. The temporal profiles of glucose-stimulated insulin secretion (GSIS) of isolated islets were comparable in HF and normal chow fed mice. Islets isolated from HF fed mice had elevated basal oxygen consumption per islet but failed to increase oxygen consumption further in response to glucose or carbonyl cyanide-4-trifluoromethoxyphenylhydrazone (FCCP). To obtain an unbiased assessment of metabolic pathways in islets, we performed microarray analysis comparing gene expression in islets from HF to normal chow-fed mice. A few genes, for example, those genes involved in the protection against oxidative stress (hypoxia upregulated protein 1) and Pgc1 alpha were up-regulated in HF islets. In contrast, several genes in extracellular matrix and other pathways were suppressed in HF islets. These results indicate that islets from C57BL/6J mice with NNT deletion mutation develop structural, metabolic and gene expression features consistent with compensation and decompensation in response to HF diet.	[Roat, Regan; Rao, Vandana; Ahima, Rexford S.; Imai, Yumi] Univ Penn, Dept Med, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Doliba, Nicolai M.; Matschinsky, Franz M.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Perelman Sch Med, Penn Mol Profiling Facil, Bioinformat Grp, Philadelphia, PA 19104 USA; [Garcia, Eden; Imai, Yumi] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Dept Internal Med, Norfolk, VA 23501 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Eastern Virginia Medical School	Imai, Y (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA.	imaiy@evms.edu	Ahima, Rexford/W-1394-2019	Imai, Yumi/0000-0001-5046-4223	National Institutes of Health [K08-DK071536]; Institute for Diabetes Obesity and Metabolism at University of Pennsylvania pilot and feasibility Grant [P01-DK049210]; Diabetes Research Center Mouse Phenotyping and Islet Biology Cores [P30-DK19525]; Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525, R01DK090490, K08DK071536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Diabetes Obesity and Metabolism at University of Pennsylvania pilot and feasibility Grant; Diabetes Research Center Mouse Phenotyping and Islet Biology Cores; Penn Genome Frontiers Institute; Pennsylvania Department of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported in part by grants from National Institutes of Health (K08-DK071536 to YI), an Institute for Diabetes Obesity and Metabolism at University of Pennsylvania pilot and feasibility Grant (to YI), P01-DK049210 (to RSA), Diabetes Research Center Mouse Phenotyping and Islet Biology Cores (P30-DK19525), the Penn Genome Frontiers Institute, and a grant with the Pennsylvania Department of Health (to JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2005, J PROTEOME RES, V4, P931, DOI 10.1021/pr050024a; Ahren J, 2010, ISLETS, V2, P353, DOI 10.4161.islets.2.6.13619; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Boitard C, 2012, DIABETES OBES METAB, V14, DOI 10.1111/j.1463-1326.2012.01693.x; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Homo-Delarche F, 2006, DIABETES, V55, P1625, DOI 10.2337/db05-1526; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Ikeda J, 1997, BIOCHEM BIOPH RES CO, V230, P94, DOI 10.1006/bbrc.1996.5890; Ikegawa S, 2008, CURR MED CHEM, V15, P724, DOI 10.2174/092986708783885237; Imai Y, 2007, ENDOCRINOLOGY, V148, P5716, DOI 10.1210/en.2007-0404; Imai Y, 2008, PHYSIOL GENOMICS, V36, P43, DOI 10.1152/physiolgenomics.00050.2008; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Jensen LT, 1997, CARDIOVASC RES, V33, P535, DOI 10.1016/S0008-6363(96)00247-7; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Karasawa H, 2009, METABOLISM, V58, P296, DOI 10.1016/j.metabol.2008.09.028; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; Kobayashi T, 2005, PANCREAS, V30, P299, DOI 10.1097/01.mpa.0000163020.63478.fe; Kobayashi T, 2000, BIOCHEM BIOPH RES CO, V267, P831, DOI 10.1006/bbrc.1999.2052; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Liang Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE846, DOI 10.1152/ajpendo.1996.270.5.E846; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Masuyama T, 2004, BIOCHEM BIOPH RES CO, V314, P870, DOI 10.1016/j.bbrc.2003.12.180; McGill JB, 2012, CURR DIABETES REV, V8, P257, DOI 10.2174/157339912800840541; Ozawa K, 2005, DIABETES, V54, P657, DOI 10.2337/diabetes.54.3.657; Peyot ML, 2010, DIABETES, V59, P2178, DOI 10.2337/db09-1452; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Wang Y, 2011, J BIOL CHEM, V286, P11119, DOI 10.1074/jbc.M110.203323; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9	43	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86815	10.1371/journal.pone.0086815	http://dx.doi.org/10.1371/journal.pone.0086815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505268	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200027
J	Serduc, R; Bouchet, A; Pouyatos, B; Renaud, L; Brauer-Krisch, E; Le Duc, G; Laissue, JA; Bartzsch, S; Coquery, N; van de Looij, Y				Serduc, Raphael; Bouchet, Audrey; Pouyatos, Benoit; Renaud, Luc; Braeuer-Krisch, Elke; Le Duc, Geraldine; Laissue, Jean A.; Bartzsch, Stefan; Coquery, Nicolas; van de Looij, Yohan			Synchrotron X Ray Induced Axonal Transections in the Brain of Rats Assessed by High-Field Diffusion Tensor Imaging Tractography	PLOS ONE			English	Article							MICROBEAM RADIATION-THERAPY; MICROPLANAR BEAMS; INJURY; IRRADIATION; ANISOTROPY	Since approximately two thirds of epileptic patients are non-eligible for surgery, local axonal fiber transections might be of particular interest for them. Micrometer to millimeter wide synchrotron-generated X-ray beamlets produced by spatial fractionation of the main beam could generate such fiber disruptions non-invasively. The aim of this work was to optimize irradiation parameters for the induction of fiber transections in the rat brain white matter by exposure to such beamlets. For this purpose, we irradiated cortex and external capsule of normal rats in the antero-posterior direction with a 4 mmx4 mm array of 25 to 1000 mu m wide beamlets and entrance doses of 150 Gy to 500 Gy. Axonal fiber responses were assessed with diffusion tensor imaging and fiber tractography; myelin fibers were examined histopathologically. Our study suggests that high radiation doses (500 Gy) are required to interrupt axons and myelin sheaths. However, a radiation dose of 500 Gy delivered by wide minibeams (1000 mu m) induced macroscopic brain damage, depicted by a massive loss of matter in fiber tractography maps. With the same radiation dose, the damage induced by thinner microbeams (50 to 100 mu m) was limited to their paths. No macroscopic necrosis was observed in the irradiated target while overt transections of myelin were detected histopathologically. Diffusivity values were found to be significantly reduced. A radiation dose <= 500 Gy associated with a beamlet size of <50 mu m did not cause visible transections, neither on diffusion maps nor on sections stained for myelin. We conclude that a peak dose of 500 Gy combined with a microbeam width of 100 mu m optimally induced axonal transections in the white matter of the brain.	[Serduc, Raphael; Bouchet, Audrey; Pouyatos, Benoit; Coquery, Nicolas] INSERM, U836, Grenoble, France; [Serduc, Raphael; Bouchet, Audrey; Pouyatos, Benoit; Coquery, Nicolas] Univ Grenoble 1, Grenoble Inst Neurosci, UMR S836, Grenoble, France; [Bouchet, Audrey; Braeuer-Krisch, Elke; Le Duc, Geraldine] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Bouchet, Audrey; Laissue, Jean A.] Univ Bern, Bern, Switzerland; [Renaud, Luc] CNRS, CerCo, Toulouse, France; [Renaud, Luc] Univ Toulouse, UPS, Ctr Rech Cerveau & Cognit, Toulouse, France; [Bartzsch, Stefan] German Canc Res Ctr, Heidelberg, Germany; [van de Looij, Yohan] Hop Univ Geneve, Serv Dev & Croissance, Geneva, Switzerland; [van de Looij, Yohan] Ecole Polytech Fed Lausanne, Lab Imagerie Fonct & Metab, Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Synchrotron Radiation Facility (ESRF); University of Bern; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van de Looij, Y (corresponding author), Hop Univ Geneve, Serv Dev & Croissance, Geneva, Switzerland.	yohan.vandelooij@epfl.ch	coquery, nicolas/GQP-5662-2022; Audrey, Bouchet/AAR-5929-2021; coquery, nicolas/N-9206-2019; Serduc, Raphael/D-6398-2017; Brauer-Krisch, Elke/O-6026-2017	coquery, nicolas/0000-0002-4687-5924; Audrey, Bouchet/0000-0001-7228-8830; coquery, nicolas/0000-0002-4687-5924; Serduc, Raphael/0000-0003-3294-8544; van de Looij, Yohan/0000-0003-2830-5482; Bartzsch, Stefan/0000-0001-9550-9122; Brauer-Krisch, Elke/0000-0003-4587-1160	ANR EPIRAD	ANR EPIRAD(French National Research Agency (ANR))	Funded by ANR EPIRAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bouchet A, 2013, RADIOTHER ONCOL, V108, P143, DOI 10.1016/j.radonc.2013.05.013; Bouchet A, 2010, INT J RADIAT ONCOL, V78, P1503, DOI 10.1016/j.ijrobp.2010.06.021; Brauer-Krisch E, 2010, MUTAT RES-REV MUTAT, V704, P160, DOI 10.1016/j.mrrev.2009.12.003; Brauer-Krisch E, 2005, PHYS MED BIOL, V50, P3103, DOI 10.1088/0031-9155/50/13/009; BURGER PC, 1979, CANCER, V44, P1256, DOI 10.1002/1097-0142(197910)44:4<1256::AID-CNCR2820440415>3.0.CO;2-T; Dilmanian F A, 2003, Cardiovasc Radiat Med, V4, P139, DOI 10.1016/S1522-1865(03)00180-X; Dilmanian FA, 2007, EXP HEMATOL, V35, P69, DOI 10.1016/j.exphem.2007.01.014; Dilmanian FA, 2006, P NATL ACAD SCI USA, V103, P9709, DOI 10.1073/pnas.0603567103; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Gallyas F, 1979, Neurol Res, V1, P203; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Martinez-Rovira I, 2012, MED PHYS, V39, P119, DOI 10.1118/1.3665768; MORRELL F, 1969, ELECTROEN CLIN NEURO, V26, P120; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Pouyatos B, 2013, NEUROBIOL DIS, V51, P152, DOI 10.1016/j.nbd.2012.11.005; Romanelli P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053549; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; Serduc R, 2008, PHYS MED BIOL, V53, P3609, DOI 10.1088/0031-9155/53/13/015; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Serduc R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009028; Serduc R, 2009, PHYS MED BIOL, V54, P6711, DOI 10.1088/0031-9155/54/21/017; Siu A, 2012, ACTA NEUROCHIR, V154, P191, DOI 10.1007/s00701-011-1228-6; SLATKIN DN, 1992, MED PHYS, V19, P1395, DOI 10.1118/1.596771; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sun SW, 2003, MAGN RESON MED, V50, P743, DOI 10.1002/mrm.10605; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057534; Tian Y, 2008, J NEUROSURG, V109, P881, DOI 10.3171/JNS/2008/109/11/0881; van de Looij Y, 2012, PEDIATR RES, V72, P285, DOI 10.1038/pr.2012.72; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543	35	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88244	10.1371/journal.pone.0088244	http://dx.doi.org/10.1371/journal.pone.0088244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505446	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200150
J	Shi, YH; Guo, R; Wang, XK; Yuan, DD; Zhang, SH; Wang, J; Yan, XB; Wang, CZ				Shi, Yinghua; Guo, Rui; Wang, Xianke; Yuan, Dedi; Zhang, Senhao; Wang, Jie; Yan, Xuebing; Wang, Chengzhang			The Regulation of Alfalfa Saponin Extract on Key Genes Involved in Hepatic Cholesterol Metabolism in Hyperlipidemic Rats	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; HMG-COA REDUCTASE; BILE-ACID SYNTHESIS; MESSENGER-RNA; ACYL-COENZYME; RECEPTOR; PLASMA; DIET; ACYLTRANSFERASE	To investigate the cholesterol-lowering effects of alfalfa saponin extract (ASE) and its regulation mechanism on some key genes involved in cholesterol metabolism, 40 healthy 7 weeks old male Sprague Dawley (SD) rats were randomly divided into four groups with 10 rats in each group: control group, hyperlipidemic group, ASE treatment group, ASE prevention group. The body weight gain, relative liver weight and serum lipid 1evels of rats were determined. Total cholesterol (TC) and total bile acids (TBA) levels in liver and feces were also measured. Furthermore, the activity and mRNA expressions of Hmgcr, Acat2, Cyp7a1 and Ldlr were investigated. The results showed the following: (1) The abnormal serum lipid levels in hyperlipidemic rats were ameliorated by ASE administration (both ASE prevention group and treatment group) (P<0.05). (2) Both ASE administration to hyperlipidemic rats significantly reduced liver TC and increased liver TBA level (P<0.05). TC and TBA levels in feces of hyperlipidemic rats were remarkably elevated by both ASE administration (P<0.05). (3) mRNA expressions of Hmgcr and Acat2 in the liver of hyperlipidemic rats were remarkably down-regulated (P<0.05), as well as mRNA expressions of Cyp7a1 and Ldlr were dramatically up-regulated by both ASE administration (P<0.05). The activities of these enzymes also paralleled the observed changes in mRNA levels. (4) There was no significant difference between ASE treatment and ASE prevention group for most parameters evaluated. Our present study indicated that ASE had cholesterol-lowering effects. The possible mechanism could be attributed to (1) the down-regulation of Hmgcr and Acat2, as well as up-regulation of Cyp7a1 and Ldlr in the liver of hyperlipidemic rats, which was involved in cholesterol biosynthesis, uptake, and efflux pathway; (2) the increase in excretion of cholesterol. The findings in our study suggested ASE had great potential usefulness as a natural agent for treating hyperlipidemia.	[Shi, Yinghua; Guo, Rui; Wang, Xianke; Yuan, Dedi; Zhang, Senhao; Wang, Jie; Yan, Xuebing; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Shi, YH (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.	annysyh@126.com; wangchengzhang@263.net		Zhang, Senhao/0000-0002-9231-9750	Earmarked Fund for Modern Agro-industry Technology Research System [CARS-35]; "Twelfth Five-year'' National Science and Technology Support Program [2011BAD17B04]	Earmarked Fund for Modern Agro-industry Technology Research System; "Twelfth Five-year'' National Science and Technology Support Program	Financial support for this research was provided by the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-35), "Twelfth Five-year'' National Science and Technology Support Program (2011BAD17B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2005, ARTERIOSCL THROM VAS, V25, P2170, DOI 10.1161/01.ATV.0000181761.16341.2b; Alger HM, 2010, J BIOL CHEM, V285, P14267, DOI 10.1074/jbc.M110.118422; Arafa HMM, 2005, MED SCI MONITOR, V11, pBR228; Arsenault BJ, 2009, J AM COLL CARDIOL, V55, P35, DOI 10.1016/j.jacc.2009.07.057; BARNES D. K., 1995, AGRICULTURE, P205; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Cheeke P.R., 2000, J ANIM SCI, V77, P1, DOI DOI 10.2527/JAS2000.00218812007700ES0009X; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; Chiang MT, 1998, INT J VITAM NUTR RES, V68, P328; Choudhary MI, 2005, J ETHNOPHARMACOL, V98, P217, DOI 10.1016/j.jep.2005.01.013; Del Bas JM, 2005, FASEB J, V19, P479, DOI 10.1096/fj.04-3095fje; Durrington P, 2003, LANCET, V362, P717, DOI 10.1016/S0140-6736(03)14234-1; Gilardi F, 2007, PHARMACOL THERAPEUT, V116, P449, DOI 10.1016/j.pharmthera.2007.08.003; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Guo J, 2011, J ETHNOPHARMACOL, V135, P299, DOI 10.1016/j.jep.2011.03.012; Jurevics H, 2000, J LIPID RES, V41, P1048; Kawakami Y, 2004, J AGR FOOD CHEM, V52, P1764, DOI 10.1021/jf0345898; Kwok CY, 2010, J FUNCT FOODS, V2, P179, DOI 10.1016/j.jff.2010.04.006; Lee MK, 2003, BIOORGAN MED CHEM, V11, P393, DOI 10.1016/S0968-0896(02)00441-8; Lee RG, 2005, J LIPID RES, V46, P1205, DOI 10.1194/jlr.M500018-JLR200; Lee RG, 2004, CIRC RES, V95, P998, DOI 10.1161/01.RES.0000147558.15554.67; Li Q, 2009, PLANTA MED, V75, P1203, DOI 10.1055/s-0029-1185539; MALINOW MR, 1977, STEROIDS, V29, P105, DOI 10.1016/0039-128X(77)90113-1; MALINOW MR, 1979, AM J CLIN NUTR, V32, P1810, DOI 10.1093/ajcn/32.9.1810; MALINOW MR, 1977, AM J CLIN NUTR, V30, P2061, DOI 10.1093/ajcn/30.12.2061; Matsuyama H, 2005, BBA-MOL CELL BIOL L, V1734, P136, DOI 10.1016/j.bbalip.2005.03.006; MILGATE J, 1995, NUTR RES, V15, P1223, DOI 10.1016/0271-5317(95)00081-S; [倪鸿昌 Ni Hongchang], 2004, [中国药理学通报, Chinese Pharmacological Bulletin], V20, P703; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Rao A V, 2000, Drug Metabol Drug Interact, V17, P211; Reena MB, 2011, J NUTR, V141, P24, DOI 10.3945/jn.110.127027; Rudel LL, 2002, J BIOL CHEM, V277, P31401, DOI 10.1074/jbc.M204106200; RUDLING M, 1992, J LIPID RES, V33, P493; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Sen S, 1998, J AGR FOOD CHEM, V46, P131, DOI 10.1021/jf970389i; SPADY DK, 1985, P NATL ACAD SCI USA, V82, P4526, DOI 10.1073/pnas.82.13.4526; SPADY DK, 1983, P NATL ACAD SCI-BIOL, V80, P3499, DOI 10.1073/pnas.80.11.3499; STORY JA, 1984, AM J CLIN NUTR, V39, P917, DOI 10.1093/ajcn/39.6.917; TOPPING DL, 1980, AM J CLIN NUTR, V33, P783, DOI 10.1093/ajcn/33.4.783; Wang ChengZhang, 2011, Acta Prataculturae Sinica, V20, P210; Whitney EJ, 2005, ANN INTERN MED, V142, P95, DOI 10.7326/0003-4819-142-2-200501180-00008; Wu H., 2009, J GERIATR CARDIOL, V6, P119; Wu JH, 2013, J FUNCT FOODS, V5, P1159, DOI 10.1016/j.jff.2013.03.013; Yan LP, 2006, LIFE SCI, V79, P324, DOI 10.1016/j.lfs.2006.01.016; Yuan DD, 2013, ACTA PRATACULT SINIC, V22, P294; 王先科, 2012, [江苏农业科学, Jiangsu Agricultural Sciences], V40, P182; 郭姣, 2009, [中药材, Journal of Chinese Medicinal Materials], V32, P582	51	25	31	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88282	10.1371/journal.pone.0088282	http://dx.doi.org/10.1371/journal.pone.0088282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505463	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200165
J	Szipl, G; Boeckle, M; Werner, SAB; Kotrschal, K				Szipl, Georgine; Boeckle, Markus; Werner, Sinja A. B.; Kotrschal, Kurt			Mate Recognition and Expression of Affective State in Croop Calls of Northern Bald Ibis (Geronticus eremita)	PLOS ONE			English	Article							INDIVIDUAL RECOGNITION; VOCAL-TRACT; ADELIE PENGUINS; DISCRIMINATION; TESTOSTERONE; SIGNATURE; NEIGHBORS; BEHAVIOR; FEATURES; BABOONS	Northern Bald Ibis are socially monogamous and year-round colonial birds with a moderate repertoire of calls. Their 'croop', for example, is used during greeting of mates, but also during agonistic encounters, and provides an ideal case to study whether calls are revealing with respect to motivational states. We recorded croop calls in a semi-tame and free-roaming flock of Northern Bald Ibis in Austria, and analysed the vocal structure to identify parameters (e. g. call duration, fundamental frequency) potentially differing between social contexts, sexes and individuals. Additionally, we conducted playback experiments to test whether mated pairs would discriminate each other by their greeting croops. Acoustic features showed highly variable temporal and structural parameters. Almost all calls could be classified correctly and assigned to the different social contexts and sexes. Classification results of greeting croops were less clear for individuality. However, incubating individuals looked up more often and longer in response to playbacks of the greeting calls of their mate than to other colony members, indicating mate recognition. We show that acoustic parameters of agonistic and greeting croops contain features that may indicate the expression of affective states, and that greeting croops encode individual differences that are sufficient for individual recognition.	[Szipl, Georgine; Boeckle, Markus] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Szipl, Georgine; Boeckle, Markus; Werner, Sinja A. B.; Kotrschal, Kurt] Univ Vienna, Core Facil Konrad Lorenz Forsch Stelle Behav & Co, Grunau, Austria; [Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; University of Vienna; University of Vienna	Szipl, G (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	georgine.szipl@gmail.com	Boeckle, Markus/A-9968-2010	Boeckle, Markus/0000-0002-0738-2764	FWF START project: 'Raven Politics' [Y-366-B17]; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	FWF START project: 'Raven Politics'; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study received funding by FWF (www.fwf.ac.at) START project: 'Raven Politics' (Y-366-B17). The 'Verein der Forderer' and 'Herzog von Cumberland Stiftung' provided permanent support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers GJL, 2004, CURR BIOL, V14, P1592, DOI 10.1016/j.cub.2004.08.057; Boeckle M, 2012, CURR BIOL, V22, P801, DOI 10.1016/j.cub.2012.03.023; Boersma P., 2010, PRAAT DOING PHONETIC; Bonadonna F, 2007, J CHEM ECOL, V33, P1819, DOI 10.1007/s10886-007-9345-7; Bowden CGR, 2003, IBIS, V145, P419, DOI 10.1046/j.1474-919X.2003.00181.x; Bowden CGR, 2008, BIRD CONSERV INT, V18, pS74, DOI 10.1017/S0959270908000403; BRETAGNOLLE V, 1990, ETHOLOGY, V85, P313; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Clark JA, 2006, ANIM BEHAV, V72, P1141, DOI 10.1016/j.anbehav.2006.04.002; Clark JA, 2011, ZOO BIOL, V30, P1; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; COULSON JC, 1966, J ANIM ECOL, V35, P269, DOI 10.2307/2394; DAVIS LS, 1988, AUK, V105, P428, DOI 10.1093/auk/105.3.428; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Elliott A., 1992, HDB BIRDS WORLD ALIV; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Freeberg TM, 2008, J COMP PSYCHOL, V122, P312, DOI 10.1037/0735-7036.122.3.312; FUSANI L, 1994, BEHAVIOUR, V128, P301, DOI 10.1163/156853994X00307; GUHL A. M., 1953, CONDOR, V55, P287, DOI 10.2307/1365008; Hancock J., 1992, STORKS IBISES SPOONB; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; IUCN, 2013, IUCN RED LIST THREAT; Jouventin P, 2002, ANIM BEHAV, V64, P747, DOI 10.1006/anbe.2002.4002; Kotrschal K., 1999, 2 INT EEP STUDB ALP, P36; Lengagne T, 2001, BEHAVIOUR, V138, P1407, DOI 10.1163/156853901317367663; Lieberman P., 1988, SPEECH PHYSL SPEECH; Lovell SF, 2005, BEHAV ECOL SOCIOBIOL, V57, P623, DOI 10.1007/s00265-004-0884-4; Manser MB, 2010, HBK BEHAV NEUROSCI, V19, P477, DOI 10.1016/B978-0-12-374593-4.00043-7; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; PEGORARO K, 1995, J ORNITHOL, V136, P243, DOI 10.1007/BF01651291; Pegoraro K., 1992, ETHOLOGIE WALDRAPPS; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Poulin B, 2003, ORNIS FENNICA, V80, P11; R Core Team, 2021, R LANGUAGE ENV STAT; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; ROTELLA JJ, 1988, CONDOR, V90, P304, DOI 10.2307/1368558; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Searby A, 2004, ANIM BEHAV, V67, P615, DOI 10.1016/j.anbehav.2003.03.012; Serra G, 2009, J ORNITHOL, V150, P769, DOI 10.1007/s10336-009-0398-y; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Sorato E, 2006, GEN COMP ENDOCR, V146, P265, DOI 10.1016/j.ygcen.2005.11.020; SPEIRS EAH, 1991, ANIM BEHAV, V41, P937, DOI 10.1016/S0003-3472(05)80631-1; SUTHERS RA, 1994, J COMP PHYSIOL A, V175, P457; Tibbetts EA, 2007, TRENDS ECOL EVOL, V22, P529, DOI 10.1016/j.tree.2007.09.001; Vignal C, 2004, NATURE, V430, P448, DOI 10.1038/nature02645; WATANABE S, 1993, J ETHOL, V11, P67, DOI 10.1007/BF02350008; Wiley CJ, 2003, HORM BEHAV, V43, P554, DOI 10.1016/S0018-506X(03)00066-7; Wyman MT, 2008, ANIM BEHAV, V76, P1625, DOI 10.1016/j.anbehav.2008.05.032	53	7	7	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88265	10.1371/journal.pone.0088265	http://dx.doi.org/10.1371/journal.pone.0088265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505455	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200158
J	Wan, XJ; Meng, J; Dai, YN; Zhang, YN; Yan, S				Wan, Xiaojing; Meng, Jia; Dai, Yingnan; Zhang, Yina; Yan, Shuang			Visualization of Network Target Crosstalk Optimizes Drug Synergism in Myocardial Ischemia	PLOS ONE			English	Article							ANTICANCER ACTIVITY; IN-VITRO; CURCUMIN; COMBINATIONS; MECHANISMS; INFARCTION; INHIBITOR; TAMOXIFEN; INJURY	Numerous drugs and compounds have been validated as protecting against myocardial ischemia (MI), a leading cause of heart failure; however, synergistic possibilities among them have not been systematically explored. Thus, there appears to be significant room for optimization in the field of drug combination therapy for MI. Here, we propose an easy approach for the identification and optimization of MI-related synergistic drug combinations via visualization of the crosstalk between networks of drug targets corresponding to different drugs (each drug has a unique network of targets). As an example, in the present study, 28 target crosstalk networks (TCNs) of random pairwise combinations of 8 MI-related drugs (curcumin, capsaicin, celecoxib, raloxifene, silibinin, sulforaphane, tacrolimus, and tamoxifen) were established to illustrate the proposed method. The TCNs revealed a high likelihood of synergy between curcumin and the other drugs, which was confirmed by in vitro experiments. Further drug combination optimization showed a synergistic protective effect of curcumin, celecoxib, and sililinin in combination against H2O2-induced ischemic injury of cardiomyocytes at a relatively low concentration of 500 nM. This result is in agreement with the earlier finding of a denser and modular functional crosstalk between their networks of targets in the regulation of cell apoptosis. Our study offers a simple approach to rapidly search for and optimize potent synergistic drug combinations, which can be used for identifying better MI therapeutic strategies. Some new light was also shed on the characteristic features of drug synergy, suggesting that it is possible to apply this method to other complex human diseases.	[Wan, Xiaojing] Harbin Med Univ, Affiliated Hosp 4, Dept Geriatr, Harbin, Peoples R China; [Meng, Jia; Zhang, Yina] Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China; [Dai, Yingnan] Harbin Med Univ, Affiliated Hosp 4, Dept Cardiol, Harbin, Peoples R China; [Yan, Shuang] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhang, YN (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Geriatr, Harbin, Peoples R China.	yinazhlu@163.com; qingmei0724@163.com			Department of Education of Heilongjiang Province of China [11533042]; Department of Technology of Heilongjiang Province of China [D201020]	Department of Education of Heilongjiang Province of China; Department of Technology of Heilongjiang Province of China	This work is supported by a grant from Department of Education of Heilongjiang Province of China (No. 11533042) and the Department of Technology of Heilongjiang Province of China (No. D201020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai W, 2010, J CELL BIOCHEM, V110, P1111, DOI 10.1002/jcb.22623; Amit I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100195; Cho DC, 2012, ACTA NEUROCHIR, V154, P2215, DOI 10.1007/s00701-012-1516-9; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Choudhury D, 2013, BIOCHIMIE, V95, P1297, DOI 10.1016/j.biochi.2013.02.010; Chung MT, 2010, MENOPAUSE, V17, P127, DOI 10.1097/gme.0b013e3181b4c4ac; Cort A, 2012, MOL MED REP, V5, P1481, DOI 10.3892/mmr.2012.848; DALONZO AJ, 1995, EUR J PHARMACOL, V272, P269, DOI 10.1016/0014-2999(94)00653-O; Denke Margo A, 2004, J Am Osteopath Assoc, V104, pS17; Deters M, 2013, PHYTOMEDICINE, V20, P120, DOI 10.1016/j.phymed.2012.09.018; Du Q, 2013, ONCOL REP, V29, P1851, DOI 10.3892/or.2013.2310; Eghdamian B, 1998, DRUGS TODAY, V34, P943, DOI 10.1358/dot.1998.34.11.487479; Ek RO, 2008, MOL CELL BIOCHEM, V308, P227, DOI 10.1007/s11010-007-9633-0; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Hakkarainen KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033236; Higashikuni Y, 2012, HYPERTENS RES, V35, P62, DOI 10.1038/hr.2011.136; Hossain MM, 2012, NEUROCHEM INT, V61, P1102, DOI 10.1016/j.neuint.2012.08.002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Jiang M, 2013, MOLECULES, V18, P701, DOI 10.3390/molecules18010701; Krijnen PAJ, 2002, J CLIN PATHOL, V55, P801, DOI 10.1136/jcp.55.11.801; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Leung EL, 2013, BRIEF BIOINFORM, V14, P491, DOI 10.1093/bib/bbs043; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Ma YG, 2012, J CARDIOVASC TRANSL, V5, P848, DOI 10.1007/s12265-012-9398-z; Manikandan P, 2004, INT J BIOCHEM CELL B, V36, P1967, DOI 10.1016/j.biocel.2004.01.030; Mao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068949; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Misra MK, 2009, MED SCI MONITOR, V15, pRA209; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Mun SH, 2013, PHYTOMEDICINE, V20, P714, DOI 10.1016/j.phymed.2013.02.006; MYERBURG RJ, 1992, NEW ENGL J MED, V326, P1451, DOI 10.1056/NEJM199205283262202; Parasramka MA, 2012, J ONCOL, V2012, DOI 10.1155/2012/709739; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sleight P, 2003, AM J CARDIOL, V92, p4N, DOI 10.1016/S0002-9149(03)00962-7; Sohma Y, 2013, CURR PHARM DESIGN, V19, P3521, DOI 10.2174/13816128113199990320; Squadrito F, 2000, J MOL CELL CARDIOL, V32, P429, DOI 10.1006/jmcc.1999.1089; Sunagawa Y, 2011, CIRC J, V75, P2151, DOI 10.1253/circj.CJ-10-1072; Zhao M, 2012, CLIN EXP PHARMACOL P, V39, P233, DOI 10.1111/j.1440-1681.2011.05664.x; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	44	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88137	10.1371/journal.pone.0088137	http://dx.doi.org/10.1371/journal.pone.0088137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505402	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200122
J	Chen, J; Liu, J; Xu, WH; Xu, R; Hou, B; Cui, LY; Gao, S				Chen, Jie; Liu, Jia; Xu, Wei-Hai; Xu, Ren; Hou, Bo; Cui, Li-Ying; Gao, Shan			Impaired Dynamic Cerebral Autoregulation and Cerebrovascular Reactivity in Middle Cerebral Artery Stenosis	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER; CAROTID STENOSIS; INTRACRANIAL ATHEROSCLEROSIS; VASOMOTOR REACTIVITY; DISEASE; MATTER; STROKE; RISK; HEMODYNAMICS; OSCILLATIONS	Purpose: We sought to investigate the capacity of cerebral autoregulation and cerebrovascular reactivity (CVR) in patients with middle cerebral artery (MCA) stenosis. Methods: Twenty-one patients with MCA stenosis diagnosed by magnetic resonance angiography and 15 healthy controls were enrolled. Cerebral autoregulation was assessed by autoregulatory parameters (rate of recovery/phase/gain) derived from transfer function from spontaneous oscillations of cerebral blood flow velocity and blood pressure. CVR was tested by a rebreathing maneuver. Results: Rate of recovery, phase and CVR estimated from moderate MCA stenosis (rate of recovery = 17.76 +/- 8.21%/s, phase = 26.93 +/- 15.67 degrees, and CVR = 1.53 +/- 0.84%/mmHg, respectively) were significantly different (p < 0.05) from controls (rate of recovery = 39.62 +/- 27.99%/s, phase = 55.66 +/- 22.10 degrees, and CVR = 2.18 +/- 0.80%/mmHg, respectively). Rate of recovery (r = -0.698, p < 0.001), phase (r = -0.738, p < 0.001)) and CVR (r = -0.690, p < 0.001) were all significantly correlated with the degree of stenosis. Conclusion: Cerebral autoregulation and CVR were impaired in patients with >= 50% MCA stenosis. The measures of both hemodynamic properties were inversely correlated with the stenotic degree.	[Chen, Jie; Xu, Wei-Hai; Cui, Li-Ying; Gao, Shan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Chen, Jie; Xu, Wei-Hai; Cui, Li-Ying; Gao, Shan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Jia; Xu, Ren] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Hou, Bo] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China; [Hou, Bo] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, J (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	jia.liu@siat.ac.cn; dr.sgao@gmail.com	Xu, Ren/O-5479-2017; Xu, Wei-Hai/AAD-8932-2020		Chinese Academy of Medical Sciences; Peking Union Medical College [20121002039]; Natural Science Foundation of China [81000644]	Chinese Academy of Medical Sciences; Peking Union Medical College; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Innovation Fund of the Chinese Academy of Medical Sciences and Peking Union Medical College (No. 20121002039), (http:// graduate.pumc.edu.cn/). Dr Jia Liu's work was supported by the Natural Science Foundation of China (No. 81000644), (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Birns J, 2009, J NEUROL NEUROSUR PS, V80, P1093, DOI 10.1136/jnnp.2009.174607; Caplan LR, 2006, CEREBROVASC DIS, V21, P145, DOI 10.1159/000090791; Chen J, 2013, CNS NEUROSCI THER, V19, P638, DOI 10.1111/cns.12130; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; Gong XP, 2006, NEUROL RES, V28, P76, DOI 10.1179/016164106X91915; Haubrich C, 2003, STROKE, V34, P1881, DOI 10.1161/01.STR.0000080936.36601.34; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; King A, 2011, STROKE, V42, P1550, DOI 10.1161/STROKEAHA.110.609057; Kostoglou K, 2013, MED ENG PHY IN PRESS; Kozera GM, 2010, AM J HYPERTENS, V23, P1198, DOI 10.1038/ajh.2010.152; Lau AYL, 2012, CEREBROVASC DIS, V33, P517, DOI 10.1159/000337332; Lee JY, 2011, J NEUROL SCI, V301, P35, DOI 10.1016/j.jns.2010.11.008; Liu J, 2005, PHYSIOL MEAS, V26, P725, DOI 10.1088/0967-3334/26/5/012; Liu J, 2013, IEEE ENG MED BIO, P3929, DOI 10.1109/EMBC.2013.6610404; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Marmarelis VZ, 2013, ANN BIOMED ENG, V41, P1029, DOI 10.1007/s10439-012-0736-8; Marshall RS, 2003, STROKE, V34, P945, DOI 10.1161/01.STR.0000062351.66804.1C; MATSUSHITA K, 1994, HYPERTENSION, V23, P565, DOI 10.1161/01.HYP.23.5.565; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Peng TY, 2008, ANN BIOMED ENG, V36, P308, DOI 10.1007/s10439-007-9412-9; Reinhard M, 2004, STROKE, V35, P1381, DOI 10.1161/01.STR.0000127533.46914.31; Reinhard M, 2003, PHYSIOL MEAS, V24, P27, DOI 10.1088/0967-3334/24/1/303; Reinhard M, 2008, J NEUROL, V255, P1182, DOI 10.1007/s00415-008-0865-z; Scheltens P, 1998, EUR NEUROL, V39, P80, DOI 10.1159/000007921; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; van Lieshout JJ, 2003, J PHYSIOL-LONDON, V551, P402, DOI 10.1113/jphysiol.2003.050609; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Wong KS, 1996, STROKE, V27, P1084, DOI 10.1161/01.STR.27.6.1084; Wong LKS, 2006, INT J STROKE, V1, P158, DOI 10.1111/j.1747-4949.2006.00045.x; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	32	71	73	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88232	10.1371/journal.pone.0088232	http://dx.doi.org/10.1371/journal.pone.0088232			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6GD	24505442	Green Published, Green Submitted, gold			2022-12-27	WOS:000335516200001
J	Miller, JS; Barr, JL; Harper, LJ; Poole, RL; Gould, TJ; Unterwald, EM				Miller, Jonathan S.; Barr, Jeffrey L.; Harper, Lauren J.; Poole, Rachel L.; Gould, Thomas J.; Unterwald, Ellen M.			The GSK3 Signaling Pathway Is Activated by Cocaine and Is Critical for Cocaine Conditioned Reward in Mice	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; PROTEIN-KINASE-B; MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; EXTRACELLULAR DOPAMINE; INDUCED HYPERACTIVITY; NUCLEUS-ACCUMBENS; UPTAKE INHIBITION; PLACE PREFERENCE; NMDA RECEPTORS	The Akt - GSK3 signaling pathway has been recently implicated in psychostimulant-induced behavioral and cellular effects. Here, the ability of cocaine to regulate the activity of Akt and GSK3 was investigated by measuring the phosphorylation states of the two kinases. The anatomical specificity of the response was determined, as was the contributions of dopamine and NMDA receptors to the actions of cocaine. As GSK3 activity was found to be increased by cocaine, subsequent experiments investigated the importance of GSK3 activation in cocaine conditioned reward. Adult male CD-1 mice were injected with cocaine or saline, and levels of phosphorylated Akt and GSK3 alpha/beta were measured 30 minutes later. Acute administration of cocaine significantly decreased the phosphorylation of Akt-Thr308 (pAkt-Thr308) and GSK3 beta in the caudate putamen and nucleus accumbens core, without altering pAkt-Ser473 and pGSK3 alpha. To investigate the role of dopamine and NMDA receptors in the regulation of Akt and GSK3 by cocaine, specific receptor antagonists were administered prior to cocaine. Blockade of dopamine D2 receptors with eticlopride prevented the reduction of pAkt-Thr308 produced by cocaine, whereas antagonists at dopamine D1, dopamine D2 or glutamatergic NMDA receptors each blocked cocaine-induced reductions in pGSK3 beta. The potential importance of GSK3 activity in the rewarding actions of cocaine was determined using a cocaine conditioned place preference procedure. Administration of the selective GSK3 inhibitor, SB 216763, prior to cocaine conditioning sessions blocked the development of cocaine place preference. In contrast, SB 216763 did not alter the acquisition of a contextual fear conditioning response, demonstrating that SB 216763 did not globally inhibit contextual learning processes. The results of this study indicate that phosphorylation of GSK3 beta is reduced, hence GSK3 beta activity is increased following acute cocaine, an effect that is contingent upon both dopaminergic and glutamatergic receptors. Further, GSK3 activity is required for the development of cocaine conditioned reward.	[Miller, Jonathan S.; Barr, Jeffrey L.; Harper, Lauren J.; Unterwald, Ellen M.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; [Miller, Jonathan S.; Barr, Jeffrey L.; Harper, Lauren J.; Unterwald, Ellen M.] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Poole, Rachel L.; Gould, Thomas J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Unterwald, EM (corresponding author), Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	Ellen.Unterwald@temple.edu	Beentjes, Kevin/O-1238-2015; Miller, Jeremy/F-7592-2019; Beentjes, Kevin/AAA-6143-2021	Miller, Jeremy/0000-0001-8918-9775; Beentjes, Kevin/0000-0001-7669-3809	NIH [R01 DA009580, T32 DA007237, P30 DA013429]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA013429, T32DA007237, R01DA009580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funded by NIH grants to EMU: R01 DA009580, T32 DA007237, P30 DA013429. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; CERVO L, 1995, BRAIN RES, V673, P242, DOI 10.1016/0006-8993(94)01420-M; CHURCH WH, 1987, EUR J PHARMACOL, V139, P345, DOI 10.1016/0014-2999(87)90592-9; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis JA, 2006, PSYCHOPHARMACOLOGY, V184, P345, DOI 10.1007/s00213-005-0047-y; Del'Guidice T, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00058; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Enman NM, 2012, BEHAV BRAIN RES, V231, P217, DOI 10.1016/j.bbr.2012.03.027; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Fan GF, 2003, J BIOL CHEM, V278, P52432, DOI 10.1074/jbc.M310982200; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Ferreira TL, 2008, NEUROSCIENCE, V153, P84, DOI 10.1016/j.neuroscience.2008.02.013; Graham DL, 2007, PSYCHOPHARMACOLOGY, V191, P719, DOI 10.1007/s00213-006-0473-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; HEIKKILA RE, 1975, BIOCHEM PHARMACOL, V24, P847, DOI 10.1016/0006-2952(75)90152-5; Heusner CL, 2005, J NEUROSCI, V25, P6651, DOI 10.1523/JNEUROSCI.1474-05.2005; HURD YL, 1989, SYNAPSE, V3, P48, DOI 10.1002/syn.890030107; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; Kim HS, 1996, BRAIN RES BULL, V40, P201, DOI 10.1016/0361-9230(96)00006-8; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; la Cour CM, 2011, MOL PHARMACOL, V79, P91, DOI 10.1124/mol.110.065409; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Lesscher HM, 2012, REV NEUROSCI, V18, P1; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; McGinty JF, 2008, J NEUROCHEM, V104, P1440, DOI 10.1111/j.1471-4159.2008.05240.x; Mckee NL, 2005, NEUROSCIENCE, V133, P605, DOI 10.1016/j.neuroscience.2005.02.020; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; MOGHADDAM B, 1989, SYNAPSE, V4, P156, DOI 10.1002/syn.890040209; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Perrine SA, 2008, J NEUROCHEM, V107, P570, DOI 10.1111/j.1471-4159.2008.05632.x; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pohlack ST, 2012, BIOL PSYCHOL, V91, P74, DOI 10.1016/j.biopsycho.2012.04.004; Prinssen EPM, 2004, PSYCHOPHARMACOLOGY, V172, P409, DOI 10.1007/s00213-003-1691-8; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; SELF DW, 1992, BRAIN RES, V582, P349, DOI 10.1016/0006-8993(92)90155-3; Shi XD, 2007, J NEUROCHEM, V103, P706, DOI 10.1111/j.1471-4159.2007.04760.x; Shi XD, 2011, PSYCHOPHARMACOLOGY, V214, P653, DOI 10.1007/s00213-010-2068-4; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Uzbay IT, 2000, BEHAV BRAIN RES, V108, P57, DOI 10.1016/S0166-4328(99)00129-1; Wang HY, 1995, MOL PHARMACOL, V48, P988; Wei CJ, 2013, BIOL PSYCHIAT; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x	56	46	49	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88026	10.1371/journal.pone.0088026	http://dx.doi.org/10.1371/journal.pone.0088026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505362	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300039
J	Sakai, T; Watanabe, K; Ohashi, H; Sato, S; Inami, S; Shimada, N; Kitamoto, T				Sakai, Takaomi; Watanabe, Kazuki; Ohashi, Hirono; Sato, Shoma; Inami, Show; Shimada, Naoto; Kitamoto, Toshihiro			Insulin-Producing Cells Regulate the Sexual Receptivity through the Painless TRP Channel in Drosophila Virgin Females	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; NERVOUS-SYSTEM; NEURONS; MELANOGASTER; NOCICEPTION; EXPRESSION; FRUITLESS; ABLATION; RECEPTOR; HOMOLOG	In a variety of animal species, females hold a leading position in evaluating potential mating partners. The decision of virgin females to accept or reject a courting male is one of the most critical steps for mating success. In the fruitfly Drosophila melanogaster, however, the molecular and neuronal mechanisms underlying female receptivity are still poorly understood, particularly for virgin females. The Drosophila painless (pain) gene encodes a transient receptor potential (TRP) ion channel. We previously demonstrated that mutations in pain significantly enhance the sexual receptivity of virgin females and that pain expression in pain(GAL4) - positive neurons is necessary and sufficient for pain - mediated regulation of the virgin receptivity. Among the pain(GAL4) - positive neurons in the adult female brain, here we have found that insulin - producing cells (IPCs), a neuronal subset in the pars intercerebralis, are essential in virgin females for the regulation of sexual receptivity through Pain TRP channels. IPC - specific knockdown of pain expression or IPC ablation strongly enhanced female sexual receptivity as was observed in pain mutant females. When pain expression or neuronal activity was conditionally suppressed in adult IPCs, female sexual receptivity was similarly enhanced. Furthermore, both pain mutations and the conditional knockdown of pain expression in IPCs depressed female rejection behaviors toward courting males. Taken together, our results indicate that the Pain TRP channel in IPCs plays an important role in controlling the sexual receptivity of Drosophila virgin females by positively regulating female rejection behaviors during courtship.	[Sakai, Takaomi; Watanabe, Kazuki; Ohashi, Hirono; Sato, Shoma; Inami, Show; Shimada, Naoto] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Kitamoto, Toshihiro] Univ Iowa, Dept Anesthesia, Iowa City, IA 52242 USA; [Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA USA; [Kitamoto, Toshihiro] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA	Tokyo Metropolitan University; University of Iowa; University of Iowa; University of Iowa	Sakai, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan.	sakai-takaomi@tmu.ac.jp	Sakai, Takaomi/AAJ-1000-2020	Sakai, Takaomi/0000-0001-9613-3016; Kitamoto, Toshihiro/0000-0003-0863-8466	JSPS KAKENHI [23370035]; Sumitomo Foundation; NIH [R01MH062684, R01MH085081]; Grants-in-Aid for Scientific Research [25650116, 12J06931] Funding Source: KAKEN; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085081, R01MH062684] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Sumitomo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by JSPS KAKENHI Grant Number 23370035 (to TS), Sumitomo Foundation (to TS), and partly by NIH grants R01MH062684 and R01MH085081 (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; CONNOLLY K, 1973, BEHAVIOUR, V44, P142, DOI 10.1163/156853973X00364; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; Corl AB, 2005, NAT NEUROSCI, V8, P18, DOI 10.1038/nn1363; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hwang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030090; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nassel DR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00252; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Sakai T, 2006, J NEUROBIOL, V66, P821, DOI 10.1002/neu.20262; Sakai T, 2013, LEARN MEMORY, V20, P34, DOI 10.1101/lm.029041.112; Senatore S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001088; Sokabe T, 2008, J NEUROSCI, V28, P9929, DOI 10.1523/JNEUROSCI.2757-08.2008; Spieth HT, 1952, NAT HIST, V99, P3430; Stafford JW, 2012, J NEUROSCI, V32, P14767, DOI 10.1523/JNEUROSCI.1887-12.2012; Sun YS, 2009, P NATL ACAD SCI USA, V106, P13606, DOI 10.1073/pnas.0906377106; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Uchida K, 2011, ENDOCR J, V58, P1021, DOI 10.1507/endocrj.EJ11-0130; Wang KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025890; Wigby S, 2011, P ROY SOC B-BIOL SCI, V278, P424, DOI 10.1098/rspb.2010.1390; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Xu SY, 2006, GENES BRAIN BEHAV, V5, P602, DOI 10.1111/j.1601-183X.2006.00213.x; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0	42	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88175	10.1371/journal.pone.0088175	http://dx.doi.org/10.1371/journal.pone.0088175			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505416	Green Submitted, Green Published, gold			2022-12-27	WOS:000336971300064
J	Shushimita, S; de Bruijn, MJW; de Bruin, RWF; IJzermans, JNM; Hendriks, RW; Dor, FJMF				Shushimita, Shushimita; de Bruijn, Marjolein J. W.; de Bruin, Ron W. F.; IJzermans, Jan N. M.; Hendriks, Rudi W.; Dor, Frank J. M. F.			Dietary Restriction and Fasting Arrest B and T Cell Development and Increase Mature B and T Cell Numbers in Bone Marrow	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PROLONGS LIFE-SPAN; CALORIE RESTRICTION; INFLUENZA INFECTION; AGED MICE; PROTECTION; ORGANISMS; LONGEVITY; SURVIVAL; RETARDS	Dietary restriction (DR) delays ageing and extends life span. Both long-and short-term DR, as well as short-term fasting provide robust protection against many "neuronal and surgery related damaging phenomena" such as Parkinson's disease and ischemia-reperfusion injury. The exact mechanism behind this phenomenon has not yet been elucidated. Its anti-inflammatory actions prompted us to thoroughly investigate the consequences of DR and fasting on B and T cell compartments in primary and secondary lymphoid organs of male C57Bl/6 mice. In BM we found that DR and fasting cause a decrease in the total B cell population and arrest early B cell development, while increasing the number of recirculating mature B cells. In the fasting group, a significant reduction in peripheral B cell counts was observed in both spleen and mesenteric lymph nodes (mLN). Thymopoiesis was arrested significantly at double negative DN2 stage due to fasting, whereas DR resulted in a partial arrest of thymocyte development at the DN4 stage. Mature CD3(+) T cell populations were increased in BM and decreased in both spleen and mLN. Thus, DR arrests B cell development in the BM but increases the number of recirculating mature B cells. DR also arrests maturation of T cells in thymus, resulting in depletion of mature T cells from spleen and mLN while recruiting them to the BM. The functional relevance in relation to protection against organ damage needs to be determined.	[Shushimita, Shushimita; de Bruin, Ron W. F.; IJzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr, Erasmus MC, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands; [de Bruijn, Marjolein J. W.; Hendriks, Rudi W.] Univ Med Ctr, Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dor, FJMF (corresponding author), Univ Med Ctr, Erasmus MC, Div Transplant Surg, Dept Surg, Rotterdam, Netherlands.	f.dor@erasmusmc.nl			Erasmus MC fellowship grant	Erasmus MC fellowship grant	This study was supported by Erasmus MC fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Burne MJ, 2001, J CLIN INVEST, V108, P1283, DOI 10.1172/JCI200112080; Burne-Taney MJ, 2003, J IMMUNOL, V171, P3210, DOI 10.4049/jimmunol.171.6.3210; BUTCHER EC, 1982, J IMMUNOL, V129, P2698; Chen JC, 1998, J GERONTOL A-BIOL, V53, pB330, DOI 10.1093/gerona/53A.5.B330; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cox LS, 2009, AGING CELL, V8, P607, DOI 10.1111/j.1474-9726.2009.00509.x; EFFROS RB, 1991, J GERONTOL, V46, pB142, DOI 10.1093/geronj/46.4.B142; Eggenhofer E, 2013, J IMMUNOL, V191, P480, DOI 10.4049/jimmunol.1202975; FERNANDES G, 1992, J NUTR, V122, P716, DOI 10.1093/jn/122.suppl_3.716; Fontana L, 2006, JAMA-J AM MED ASSOC, V295, P1577, DOI 10.1001/jama.295.13.1577; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Fujita Y, 2012, CELL IMMUNOL, V273, P52, DOI 10.1016/j.cellimm.2011.11.007; Gardner EM, 2005, J GERONTOL A-BIOL, V60, P688, DOI 10.1093/gerona/60.6.688; GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Hochegger K, 2007, AM J PHYSIOL-RENAL, V293, pF741, DOI 10.1152/ajprenal.00486.2006; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Jiang JC, 2000, FASEB J, V14, P2135; Jolly CA, 2007, CURR OPIN LIPIDOL, V18, P53, DOI 10.1097/MOL.0b013e3280115416; Kemnitz JW, 2011, ILAR J, V52, P66, DOI 10.1093/ilar.52.1.66; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu YY, 2012, J IMMUNOL, V188, P2070, DOI 10.4049/jimmunol.1102835; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Pahlavani MA, 2000, FRONT BIOSCI-LANDMRK, V5, pD580, DOI 10.2741/Pahlavani; Payne AM, 2003, J APPL PHYSIOL, V95, P2554, DOI 10.1152/japplphysiol.00758.2003; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Ritz BW, 2008, J NUTR, V138, P2269, DOI 10.3945/jn.108.093633; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Tanaka M, 2011, J NEUROSCI, V31, P8373, DOI 10.1523/JNEUROSCI.6562-10.2011; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; van Ginhoven TM, 2010, TRANSPL INT, V23, P1171, DOI 10.1111/j.1432-2277.2010.01116.x; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821	41	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87772	10.1371/journal.pone.0087772	http://dx.doi.org/10.1371/journal.pone.0087772			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504160	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800070
J	Tang, Z; Zhou, T; Luo, YX; Xie, CC; Huo, D; Tao, LX; Pan, L; Sun, F; Zhu, HP; Yang, XH; Wang, W; Yan, AS; Li, X; Guo, XH				Tang, Zhe; Zhou, Tao; Luo, Yanxia; Xie, Changchun; Huo, Da; Tao, Lixin; Pan, Lei; Sun, Fei; Zhu, Huiping; Yang, Xinghua; Wang, Wei; Yan, Aoshuang; Li, Xia; Guo, Xiuhua			Risk Factors for Cerebrovascular Disease Mortality among the Elderly in Beijing: A Competing Risk Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; MEDITERRANEAN DIET; STROKE; POPULATION; MEN; DEATH; MODEL; LIFE	Objective: To examine the associations of combined lifestyle factors and physical conditions with cerebrovascular diseases (CBVD) mortality, after accounting for competing risk events, including death from cardiovascular diseases, cancers and other diseases. Methods: Data on 2010 subjects aged over 55 years were finally analyzed using competing risk models. All the subjects were interviewed by the Beijing Longitudinal Study of Aging (BLSA), in China, between 1 January 1992 and 30 August 2009. Results: Elderly females were at a lower risk of death from CBVD than elderly males (HR = 0.639, 95% CI = 0.457-0.895). Increasing age (HR = 1.543, 95% CI = 1.013-2.349), poor self-rated health (HR = 1.652, 95% CI = 1.198-2.277), hypertension (HR = 2.201, 95% CI = 1.524-3.178) and overweight (HR = 1.473, 95% CI = 1.013-2.142) or obesity (HR = 1.711, 95% CI = 1.1754-2.490) was associated with higher CBVD mortality risk. Normal cognition function (HR = 0.650, 95% CI = 0.434-0.973) and living in urban (HR = 0.456, 95% CI = 0.286-0.727) was associated with lower CBVD mortality risk. Gray's test also confirmed the cumulative incidence (CIF) of CBVD was lower in the 'married' group than those without spouse, and the mortality was lowest in the 'nutrition sufficient' group among the 'frequent consumption of meat group' and the 'medial type group' (P value<0.001). Conclusions: CBVD mortality was associated with gender, age, blood pressure, residence, BMI, cognitive function, nutrition and the result of self-rated health assessment in the elderly in Beijing, China.	[Tang, Zhe; Sun, Fei] Capital Med Univ, Xuan Wu Hosp, Beijing Geriatr Healthcare Ctr, Beijing, Peoples R China; [Zhou, Tao; Luo, Yanxia; Tao, Lixin; Pan, Lei; Zhu, Huiping; Yang, Xinghua; Yan, Aoshuang; Li, Xia; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Zhou, Tao; Luo, Yanxia; Tao, Lixin; Pan, Lei; Zhu, Huiping; Yang, Xinghua; Guo, Xiuhua] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Xie, Changchun] Univ Cincinnati, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Xie, Changchun] Univ Cincinnati, Ctr Clin & Translat Sci & Training, Cincinnati, OH USA; [Huo, Da] Beijing Ctr Dis Prevent & Control, Inst Infect Dis & Endem Dis Control, Beijing, Peoples R China; [Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Yan, Aoshuang] Beijing Municipal Sci & Technol Commiss, Beijing, Peoples R China; [Li, Xia] Natl Univ Ireland Univ Coll Cork, Cork, Ireland	Capital Medical University; Capital Medical University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Edith Cowan University; Beijing Municipal Science & Technology Commission; University College Cork	Yan, AS (corresponding author), Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China.	hnlg0771@hotmail.com; lixia_new@163.com; guoxiuh@ccmu.edu.cn	liu, li/HGC-0900-2022; TAO, Li/HIR-4254-2022	wang, wei/0000-0002-1430-1360	Beijing Natural Science Foundation [7131002]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period of China [2011BAI08B01]; Beijing Municipal Natural Science Foundation [7122016]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period of China; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by Beijing Natural Science Foundation (7131002); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period of China (2011BAI08B01); Beijing Municipal Natural Science Foundation (Serial Number: 7122016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz AN, 2011, ANN NEUROL, V70, P1006, DOI 10.1002/ana.22651; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Austin PC, 2012, PHARMACOEPIDEM DR S, V21, P714, DOI 10.1002/pds.3299; Bazzano LA, 2010, ANN NEUROL, V67, P11, DOI 10.1002/ana.21950; Beuscart JB, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-31; Beyersmann J, 2008, BIOSTATISTICS, V9, P765, DOI 10.1093/biostatistics/kxn009; Blackburn DJ, 2013, AGE AGEING, V42, P113, DOI 10.1093/ageing/afs116; Bruandet A, 2009, J NEUROL NEUROSUR PS, V80, P133, DOI 10.1136/jnnp.2007.137851; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P1, DOI 10.1016/j.atherosclerosis.2011.06.011; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flicker L, 2010, CLIN GERIATR MED, V26, P17, DOI 10.1016/j.cger.2009.12.005; Forsblom C, 2011, J AM SOC NEPHROL, V22, P537, DOI 10.1681/ASN.2010020194; Graham SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059480; Grool AM, 2012, J INTERN MED, V272, P277, DOI 10.1111/j.1365-2796.2012.02521.x; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Isozumi Kazuo, 2004, Keio J Med, V53, P7, DOI 10.2302/kjm.53.7; Jefferson AL, 2008, AM J GERIAT PSYCHIAT, V16, P375, DOI 10.1097/JGP.0b013e318162f197; Jiang Yong, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P293; Kurth T, 2005, CIRCULATION, V111, P1992, DOI 10.1161/01.CIR.0000161822.83163.B6; Latouche A, 2005, BIOMETRICAL J, V47, P807, DOI 10.1002/bimj.200410152; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Li XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029350, 10.1371/journal.pone.0051199]; Misirli G, 2012, AM J EPIDEMIOL, V176, P1185, DOI 10.1093/aje/kws205; Murray AD, 2013, DEPRESS ANXIETY, V30, P77, DOI 10.1002/da.22022; Nabi H, 2010, INT J EPIDEMIOL, V39, P1016, DOI 10.1093/ije/dyq050; Nicolaie MA, 2013, STAT MED, V32, P2031, DOI 10.1002/sim.5665; Novak M, 2013, EUR J EPIDEMIOL, V28, P697, DOI 10.1007/s10654-013-9833-8; Pintilie M, 2011, REV ESP CARDIOL, V64, P599, DOI [10.1016/j.recesp.2011.03.017, 10.1016/j.rec.2011.03.016]; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rohrmann S, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-63; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Scheike TH, 2013, LIFETIME DATA ANAL, V19, P19, DOI 10.1007/s10985-012-9229-1; Smallwood A, 2012, NEUROPATH APPL NEURO, V38, P337, DOI 10.1111/j.1365-2990.2011.01221.x; Tang Z, 1999, ARCH GERONTOL GERIAT, V29, P115, DOI 10.1016/S0167-4943(99)00026-6; Tian XB, 2011, J EPIDEMIOL, V21, P376, DOI 10.2188/jea.JE20110001; Wang W, 2012, J CAP MED U, V33, P218; World Health Organization, 2021, TOP 10 CAUS DEATH	38	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87884	10.1371/journal.pone.0087884	http://dx.doi.org/10.1371/journal.pone.0087884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504327	gold, Green Published, Green Submitted			2022-12-27	WOS:000336971300011
J	van Griensven, J; Phan, V; Thai, S; Koole, O; Lynen, L				van Griensven, Johan; Vichet Phan; Sopheak Thai; Koole, Olivier; Lynen, Lutgarde			Simplified Clinical Prediction Scores to Target Viral Load Testing in Adults with Suspected First Line Treatment Failure in Phnom Penh, Cambodia	PLOS ONE			English	Article							RESOURCE-CONSTRAINED SETTINGS; ANTIRETROVIRAL TREATMENT; LIMITED SETTINGS; ALGORITHM; SYSTEMS; MONITOR	Background: For settings with limited laboratory capacity, 2013 World Health Organization (WHO) guidelines recommend targeted HIV-1 viral load (VL) testing to identify virological failure. We previously developed and validated a clinical prediction score (CPS) for targeted VL testing, relying on clinical, adherence and laboratory data. While outperforming the WHO failure criteria, it required substantial calculation and review of all previous laboratory tests. In response, we developed four simplified, less error-prone and broadly applicable CPS versions that can be done 'on the spot'. Methodology/Principal: Findings From May 2010 to June 2011, we validated the original CPS in a non-governmental hospital in Phnom Penh, Cambodia applying the CPS to adults on first-line treatment >1 year. Virological failure was defined as a single VL >1000 copies/ml. The four CPSs included CPS1 with 'current CD4 count' instead of %-decline-from-peak CD4; CPS2 with hemoglobin measurements removed; CPS3 having 'decrease in CD4 count below baseline value' removed; CPS4 was purely clinical. Score development relied on the Spiegelhalter/Knill-Jones method. Variables independently associated with virological failure with a likelihood ratio >= 1.5 or <= 0.67 were retained. CPS performance was evaluated based on the area-under-the-ROC-curve (AUROC) and 95% confidence intervals (CI). The CPSs were validated in an independent dataset. A total of 1490 individuals (56.6% female, median age: 38 years (interquartile range (IQR 33-44)); median baseline CD4 count: 94 cells/mu L (IQR 28-205), median time on antiretroviral therapy 3.6 years (IQR 2.1-5.1)), were included. Forty-five 45 (3.0%) individuals had virological failure. CPS1 yielded an AUROC of 0.69 (95% CI: 0.62-0.75) in validation, CPS2 an AUROC of 0.68 (95% CI: 0.62-0.74), and CPS3, an AUROC of 0.67 (95% CI: 0.61-0.73). The purely clinical CPS4 performed poorly (AUROC-0.59; 95% CI: 0.53-0.65). Conclusions: Simplified CPSs retained acceptable accuracy as long as current CD4 count testing was included. Ease of field application and field accuracy remains to be defined.	[van Griensven, Johan; Vichet Phan; Sopheak Thai] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [van Griensven, Johan; Koole, Olivier; Lynen, Lutgarde] Inst Trop Med, B-2000 Antwerp, Belgium; [Koole, Olivier] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine	van Griensven, J (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	jvangriensven@itg.be	Lynen, Lutgarde/A-1212-2014; Lynen, Lutgarde/AAT-9180-2020	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895; Koole, Olivier/0000-0002-1122-5382	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine; Antwerp; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide; Inbev-Baillet Latour Fund	Belgian Directorate General of Development Cooperation; Institute of Tropical Medicine; Antwerp; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide; Inbev-Baillet Latour Fund	The HIV program was supported by the Belgian Directorate General of Development Cooperation through the framework agreement with the Institute of Tropical Medicine, Antwerp, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide. JvG is supported by the Inbev-Baillet Latour Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouyannis M, 2011, AIDS, V25, P1627, DOI 10.1097/QAD.0b013e328349a414; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Choun K, 2013, T ROY SOC TROP MED H, V107, P235, DOI 10.1093/trstmh/trt001; Colebunders R, 2006, LANCET INFECT DIS, V6, P53, DOI 10.1016/S1473-3099(05)70327-3; Gilks CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057580; Holmberg L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001491; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kumarasamy N, 2013, CURR OPIN HIV AIDS, V8, P586, DOI 10.1097/COH.0000000000000004; Labhardt ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047937; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Meya D, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-3; Phan V, 2013, J ACQUIR IMMUNE DEFI; Reid Steven D, 2013, Clin Epidemiol, V5, P387, DOI 10.2147/CLEP.S37069; Rutherford GW, 2013, PREDICTING TREATMENT; SEYMOUR DG, 1990, BRIT MED J, V300, P223, DOI 10.1136/bmj.300.6719.223; SPIEGELHALTER DJ, 1985, CLIN GASTROENTEROL, V14, P489; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2006, ANT THER HIV INF AD	24	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87879	10.1371/journal.pone.0087879	http://dx.doi.org/10.1371/journal.pone.0087879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24504463	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000336971300010
J	Xu, Q; Chen, Y; Zhao, WM; Huang, ZY; Zhang, Y; Li, X; Tong, YY; Chang, GB; Duan, XJ; Chen, GH				Xu, Qi; Chen, Yang; Zhao, Wen Ming; Huang, Zheng Yang; Zhang, Yang; Li, Xiu; Tong, Yi Yu; Chang, Guo Bing; Duan, Xiu Jun; Chen, Guo Hong			DNA Methylation and Regulation of the CD8A after Duck Hepatitis Virus Type 1 Infection	PLOS ONE			English	Article							CPG ISLAND; HEPATOCELLULAR-CARCINOMA; MOLECULAR ANALYSIS; GENE-EXPRESSION; T-CELLS; CD8-ALPHA; PROMOTER; HYPERMETHYLATION; IDENTIFICATION; CONTRIBUTE	Background: Cluster of differentiation 8 (CD8) is expressed in cytotoxic T cells, where it functions as a co-receptor for the T-cell receptor by binding to major histocompatibility complex class I (MHCI) proteins, which present peptides on the cell surface. CD8A is critical for cell-mediated immune defense and T-cell development. CD8A transcription is controlled by several cis-acting elements and trans-acting elements and is also regulated by DNA methylation. However, the epigenetic regulation of CD8A in the duck and its relationship with virus infection are still unclear. Results: We investigated the epigenetic transcriptional regulatory mechanisms, such as DNA methylation, for the expression of the CD8A and further evaluated the contribution of such epigenetic regulatory mechanisms to DHV-I infection in the duck. Real-time quantitative polymerase chain reaction (RT-qPCR) revealed the highest level of CD8A expression to be in the thymus, followed by the lungs, spleen, and liver, and the levels of CD8A expression were very low in the kidney, cerebrum, cerebellum, and muscle in the duck. RT-qPCR also demonstrated that the CD8A mRNA was down-regulated significantly in morbid ducklings treated with DHV-1 and up-regulated significantly in non-morbid ducklings in all the tissues tested. In addition, hypermethylation of CD8A was detected in the morbid ducklings, whereas relatively low methylation of CD8A was evident in the non-morbid ducklings. The CD8A mRNA level was negatively associated with the CpG methylation level of CD8A and global methylation status. Conclusions: We concluded that the mRNA level of the CD8A was negatively associated with the CpG methylation level of CD8A and global methylation status in the duck, suggesting that the hypermethylation of CD8A may be associated with DHV-1 infection. The first two CpG sites of the CD8A promoter region could be considered as epigenetic biomarkers for resistance breeding against duckling hepatitis disease in the duck.	[Xu, Qi; Chen, Yang; Zhao, Wen Ming; Huang, Zheng Yang; Zhang, Yang; Li, Xiu; Tong, Yi Yu; Chang, Guo Bing; Chen, Guo Hong] Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China; [Duan, Xiu Jun] Natl Waterfowl Germplasm Resource Pool, Taizhou, Peoples R China	Yangzhou University	Chang, GB (corresponding author), Yangzhou Univ, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Peoples R China.	gbchang@yzu.edu.cn; ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022; Huang, Zhengyang/J-6297-2013	Huang, Zhengyang/0000-0001-9197-6700	National Natural Science Foundation of China [31101704]; Priority Academic Program Development of Jiangsu Higher Education Institutions [2011-137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (31101704) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (2011-137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2006, EPIGENETICS, P45; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cui ZZ, 2007, ANIMAL IMMUNOLOGY, P81; Davidson GA, 1997, VET IMMUNOL IMMUNOP, V58, P363, DOI 10.1016/S0165-2427(97)00017-2; Duncan LG, 2009, VET IMMUNOL IMMUNOP, V129, P14, DOI 10.1016/j.vetimm.2008.12.003; Feik N, 2005, J IMMUNOL, V174, P1513, DOI 10.4049/jimmunol.174.3.1513; Fernandez-Roig S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-41; Fred D, 2011, AVIAN IMMUNOLOGY, P396; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; GAO MH, 1993, J IMMUNOL, V150, P4376; Gu CQ, 2012, POULTRY SCI, V91, P583, DOI 10.3382/ps.2011-01743; Hamerman JA, 1997, J IMMUNOL, V159, P1240; Hansen JD, 1998, IMMUNOL REV, V166, P199, DOI 10.1111/j.1600-065X.1998.tb01264.x; Jin X, 2008, RES VET SCI, V85, P595, DOI 10.1016/j.rvsc.2008.01.001; LANDRY DB, 1993, J EXP MED, V178, P941, DOI 10.1084/jem.178.3.941; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2011, BMC P, V4, P1753; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; Picchietti S, 2009, FISH SHELLFISH IMMUN, V27, P50, DOI 10.1016/j.fsi.2009.04.003; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Reaiche GY, 2008, THESIS U U ADELAIDE; Sonal P, 2008, FISH SHELLFISH IMMUN, V25, P570; Stephen T, 2012, THESIS U MELBOURNE; Suetake H, 2007, FISH SHELLFISH IMMUN, V23, P1107, DOI 10.1016/j.fsi.2007.05.005; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; TREGASKES CA, 1995, J IMMUNOL, V154, P4485; Ward A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-71; Wei Y, 2002, HEPATOLOGY, V36, P692, DOI 10.1053/jhep.2002.35342; Wu LM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-399; [徐琪 Xu Qi], 2012, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V43, P546; Xu SW, 2011, FISH SHELLFISH IMMUN, V30, P600, DOI 10.1016/j.fsi.2010.12.009; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang M, 2008, J VIROL METHODS, V153, P55, DOI 10.1016/j.jviromet.2008.06.012; Yu J, 2003, CELL RES, V13, P319, DOI 10.1038/sj.cr.7290177; Yu J, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-29; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; [岳华 YUE Hua], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P784; Zhong S, 2003, CLIN CANCER RES, V9, P3376; Zhong S, 2002, CLIN CANCER RES, V8, P1087; Zwollo P, 2005, J IMMUNOL, V174, P6608, DOI 10.4049/jimmunol.174.11.6608	42	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88023	10.1371/journal.pone.0088023	http://dx.doi.org/10.1371/journal.pone.0088023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505360	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300038
J	Broadbent, EN; Almeyda Zambrano, AM; Asner, GP; Soriano, M; Field, CB; de Souza, HR; Pena-Claros, M; Adams, RI; Dirzo, R; Giles, L				Broadbent, Eben N.; Almeyda Zambrano, Angelica M.; Asner, Gregory P.; Soriano, Marlene; Field, Christopher B.; de Souza, Harrison Ramos; Pena-Claros, Marielos; Adams, Rachel I.; Dirzo, Rodolfo; Giles, Larry			Integrating Stand and Soil Properties to Understand Foliar Nutrient Dynamics during Forest Succession Following Slash-and-Burn Agriculture in the Bolivian Amazon	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; N-15 NATURAL-ABUNDANCE; BELOW-GROUND CARBON; LAND-USE CHANGE; N-P RATIOS; SECONDARY FOREST; RAIN-FOREST; ORGANIC-MATTER; STABLE-ISOTOPES; WOOD DENSITY	Secondary forests cover large areas of the tropics and play an important role in the global carbon cycle. During secondary forest succession, simultaneous changes occur among stand structural attributes, soil properties, and species composition. Most studies classify tree species into categories based on their regeneration requirements. We use a high-resolution secondary forest chronosequence to assign trees to a continuous gradient in species successional status assigned according to their distribution across the chronosequence. Species successional status, not stand age or differences in stand structure or soil properties, was found to be the best predictor of leaf trait variation. Foliar delta C-13 had a significant positive relationship with species successional status, indicating changes in foliar physiology related to growth and competitive strategy, but was not correlated with stand age, whereas soil delta C-13 dynamics were largely constrained by plant species composition. Foliar delta N-15 had a significant negative correlation with both stand age and species successional status, - most likely resulting from a large initial biomass-burning enrichment in soil N-15 and C-13 and not closure of the nitrogen cycle. Foliar %C was neither correlated with stand age nor species successional status but was found to display significant phylogenetic signal. Results from this study are relevant to understanding the dynamics of tree species growth and competition during forest succession and highlight possibilities of, and potentially confounding signals affecting, the utility of leaf traits to understand community and species dynamics during secondary forest succession.	[Broadbent, Eben N.; Almeyda Zambrano, Angelica M.; Asner, Gregory P.; Field, Christopher B.; Giles, Larry] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Broadbent, Eben N.; Field, Christopher B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Broadbent, Eben N.; Almeyda Zambrano, Angelica M.] Harvard Univ, Kennedy Sch Govt, Sustainabil Sci Program, Cambridge, MA 02138 USA; [Almeyda Zambrano, Angelica M.] Stanford Univ, Dept Anthropol, Stanford, CA USA; [Soriano, Marlene; Pena-Claros, Marielos] Inst Boliviano Invest Forestal, Santa Cruz, Bolivia; [de Souza, Harrison Ramos] Univ Amazon Pando, Ctr Invest & Preservac Amazonia, Cobija, Bolivia; [Pena-Claros, Marielos] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Adams, Rachel I.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Carnegie Institution for Science; Stanford University; Harvard University; Stanford University; Wageningen University & Research; University of California System; University of California Berkeley	Broadbent, EN (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	eben@amazonico.org	Zambrano, Angelica Almeyda/Q-4758-2017; Asner, Gregory/G-9268-2013; Broadbent, Eben/H-2965-2013	Zambrano, Angelica Almeyda/0000-0001-5081-9936; Asner, Gregory/0000-0001-7893-6421; Adams, Rachel/0000-0003-4499-5743; Broadbent, Eben/0000-0002-4488-4237; Pena-Claros, Marielos/0000-0001-9134-6733	Carnegie Institution for Science, Stanford University; National Science Foundation (NSF) doctoral dissertation improvement grant; Global Change Education Program Graduate Research Education Fellowship (GCEP GREF) from the U.S. Department of Energy; Italy's Ministry for Environment, Land and Sea	Carnegie Institution for Science, Stanford University; National Science Foundation (NSF) doctoral dissertation improvement grant(National Science Foundation (NSF)); Global Change Education Program Graduate Research Education Fellowship (GCEP GREF) from the U.S. Department of Energy(United States Department of Energy (DOE)); Italy's Ministry for Environment, Land and Sea	This work was supported by the Carnegie Institution for Science, Stanford University, a National Science Foundation (NSF) doctoral dissertation improvement grant and a Global Change Education Program Graduate Research Education Fellowship (GCEP GREF) from the U.S. Department of Energy. This work was partially conducted while E. Broadbent was a doctoral fellow and A. Almeyda Zambrano was a Giorgio Ruffolo Fellow in the Sustainability Science Program at Harvard University. Support from Italy's Ministry for Environment, Land and Sea is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Agren GI, 1996, SOIL SCI SOC AM J, V60, P1121, DOI 10.2136/sssaj1996.03615995006000040023x; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; ANDREAE MO, 1988, J GEOPHYS RES-ATMOS, V93, P1509, DOI 10.1029/JD093iD02p01509; Aranibar JN, 2006, GLOBAL CHANGE BIOL, V12, P710, DOI 10.1111/j.1365-2486.2006.01121.x; Asner GP, 2012, ECOSYSTEMS, V15, P504, DOI 10.1007/s10021-012-9526-2; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; Awiti AO, 2008, AGR ECOSYST ENVIRON, V127, P265, DOI 10.1016/j.agee.2008.04.012; BALESDENT J, 1993, ECOLOGY, V74, P1713, DOI 10.2307/1939930; Barnes VB, 1998, FOREST ECOLOGY; BAZZAZ FA, 1980, ANNU REV ECOL SYST, V11, P287, DOI 10.1146/annurev.es.11.110180.001443; Beekma J, 1996, BASE AMBIENTAL DESAR; Bernoux M, 1998, GEODERMA, V82, P43, DOI 10.1016/S0016-7061(97)00096-7; Billings SA, 2006, OECOLOGIA, V148, P325, DOI 10.1007/s00442-006-0366-7; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blundell AG, 2004, ECOLOGY, V85, P704, DOI 10.1890/01-4101; Boeckx P, 2005, ISOT ENVIRON HEALT S, V41, P249, DOI 10.1080/10256010500230171; Bonal D, 2007, ANN FOREST SCI, V64, P169, DOI 10.1051/forest:2006101; BOUTTON T W, 1991, P173; BROWN S, 1990, PLANT SOIL, V124, P53, DOI 10.1007/BF00010931; BUDOWSKI G, 1965, TURRIALBA, V15, P40; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; CHAZDON RL, 1987, OECOLOGIA, V73, P222, DOI 10.1007/BF00377511; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chazdon RL, 2010, BIOTROPICA, V42, P31, DOI 10.1111/j.1744-7429.2009.00566.x; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Cochrane MA, 2011, S-P B ENVIRON SCI, P213; Compton JE, 2007, ECOSYSTEMS, V10, P1197, DOI 10.1007/s10021-007-9087-y; Davidson EA, 2007, NATURE, V449, P1000, DOI 10.1038/4491000a; Davidson EA, 2007, NATURE, V447, P995, DOI 10.1038/nature05900; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; DELWICHE CC, 1970, ENVIRON SCI TECHNOL, V4, P929, DOI 10.1021/es60046a004; DELWICHE CC, 1979, BOT GAZ, V140, pS65, DOI 10.1086/337037; Denslow JS, 2000, J VEG SCI, V11, P201, DOI 10.2307/3236800; Denslow JS, 1996, ECOL STU AN, V122, P127; Denslow JS, 1987, ANNU REV ECOL SYST, V30, P761; DESJARDINS T, 1994, GEODERMA, V61, P103, DOI 10.1016/0016-7061(94)90013-2; Domingues TF, 2005, EARTH INTERACT, V9; Ehleringer JR, 2000, ECOL APPL, V10, P412, DOI 10.1890/1051-0761(2000)010[0412:CIRIBC]2.0.CO;2; EHLERINGER JR, 1986, OECOLOGIA, V70, P520, DOI 10.1007/BF00379898; Elmore AJ, 2006, GLOBAL CHANGE BIOL, V12, P1761, DOI 10.1111/j.1365-2486.2006.01198.x; EWEL JJ, 1976, J ECOL, V64, P293, DOI 10.2307/2258696; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Fearnside PM, 1996, FOREST ECOL MANAG, V80, P35, DOI 10.1016/0378-1127(95)03648-2; FEIGL BJ, 1995, PLANT SOIL, V175, P21, DOI 10.1007/BF02413007; Feldpausch TR, 2004, ECOL APPL, V14, pS164; FINEGAN B, 1984, NATURE, V312, P109, DOI 10.1038/312109a0; Finegan B, 1996, TRENDS ECOL EVOL, V11, P793; Finkelstein DB, 2006, EARTH PLANET SC LETT, V250, P501, DOI 10.1016/j.epsl.2006.08.010; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GARTEN CT, 1992, INT J ENVIRON AN CH, V47, P33, DOI 10.1080/03067319208027017; Gehring C, 2005, J TROP ECOL, V21, P519, DOI 10.1017/S0266467405002543; Gilbert GS, 2007, ECOLOGY, V88, P539, DOI 10.1890/06-1671; Gomez-Pompa A, 1981, FOREST SUCCESSION CO, P246, DOI DOI 10.1007/978-1-4612-5950-3_16; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; GUEVARA S, 1986, VEGETATIO, V66, P77; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; HANDLEY LL, 1992, PLANT CELL ENVIRON, V15, P965, DOI 10.1111/j.1365-3040.1992.tb01650.x; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; He JS, 2010, J PLANT RES, V123, P551, DOI 10.1007/s10265-009-0294-9; He XH, 2009, J PLANT ECOL, V2, P107, DOI 10.1093/jpe/rtp015; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Herbert DA, 2003, BIOGEOCHEMISTRY, V65, P121, DOI 10.1023/A:1026020210887; Hobbie EA, 2003, NEW PHYTOL, V157, P115, DOI 10.1046/j.1469-8137.2003.00657.x; Hobbie EA, 2005, OECOLOGIA, V122, P273; Hobbie EA, 2009, BIOGEOCHEMISTRY, V95, P355, DOI 10.1007/s10533-009-9328-6; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Houlton BZ, 2006, P NATL ACAD SCI USA, V103, P8745, DOI 10.1073/pnas.0510185103; HUC R, 1994, OECOLOGIA, V99, P297, DOI 10.1007/BF00627742; HUSTON M, 1987, AM NAT, V130, P168, DOI 10.1086/284704; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; KELLER M, 1993, NATURE, V365, P244, DOI 10.1038/365244a0; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennard DK, 2002, J TROP ECOL, V18, P53, DOI 10.1017/S0266467402002031; Klumpp K, 2005, PLANT CELL ENVIRON, V28, P241, DOI 10.1111/j.1365-3040.2004.01268.x; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; Koerner W, 1999, OECOLOGIA, V121, P421, DOI 10.1007/s004420050947; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kull O, 1999, FUNCT ECOL, V13, P24, DOI 10.1046/j.1365-2435.1999.00292.x; Kuo S., 1996, SSSA BOOK SERIES, P869; Lawrence D, 2005, ECOLOGY, V86, P26, DOI 10.1890/03-0564; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Lopez-Ulloa M, 2005, SOIL SCI SOC AM J, V69, P1110, DOI 10.2136/sssaj2004.0353; Markewitz D, 2004, ECOL APPL, V14, pS177; MARTINELLI LA, 1992, OECOLOGIA, V90, P591, DOI 10.1007/BF01875455; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; MATSON P, 1990, OECOLOGIA, V85, P241, DOI 10.1007/BF00319408; Moran EF, 2000, FOREST ECOL MANAG, V139, P93, DOI 10.1016/S0378-1127(99)00337-0; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Niinemets U, 2007, PLANT CELL ENVIRON, V30, P1052, DOI 10.1111/j.1365-3040.2007.01683.x; Nogueira EM, 2007, FOREST ECOL MANAG, V248, P119, DOI 10.1016/j.foreco.2007.04.047; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Oliver C.D., 1990, FOREST STAND DYNAMIC; Ometto JPHB, 2006, BIOGEOCHEMISTRY, V79, P251, DOI 10.1007/s10533-006-9008-8; Ometto JPHB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001462; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Pardo LH, 2002, CAN J FOREST RES, V32, P1126, DOI [10.1139/x02-041, 10.1139/X02-041]; PARK R, 1960, GEOCHIM COSMOCHIM AC, V21, P110, DOI 10.1016/S0016-7037(60)80006-3; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Pena-Claros M, 2003, BIOTROPICA, V35, P450, DOI 10.1111/j.1744-7429.2003.tb00602.x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; PICCOLO MC, 1994, OECOLOGIA, V99, P112, DOI 10.1007/BF00317090; Piccolo MC, 1996, PLANT SOIL, V182, P249, DOI 10.1007/BF00029056; Pinard MA, 1999, FOREST ECOL MANAG, V113, P201, DOI 10.1016/S0378-1127(98)00426-5; Poorter L, 2004, PLANT BIOLOGY, V6, P746, DOI 10.1055/s-2004-821269; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; Powers JS, 2010, FUNCT ECOL, V24, P927, DOI 10.1111/j.1365-2435.2010.01701.x; PRACH K, 1993, OIKOS, V66, P343, DOI 10.2307/3544823; Pringle EG, 2011, BIOTROPICA, V43, P299, DOI 10.1111/j.1744-7429.2010.00697.x; QUAY P, 1989, J GEOPHYS RES-ATMOS, V94, P18327, DOI 10.1029/JD094iD15p18327; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; Quintero CE, 2003, COMMUN SOIL SCI PLAN, V34, P1435, DOI 10.1081/CSS-120020455; Rastetter EB, 2001, ECOSYSTEMS, V4, P369, DOI 10.1007/s10021-001-0018-z; REICH PB, 1995, FUNCT ECOL, V9, P65, DOI 10.2307/2390092; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; ROMANYA J, 1994, FOREST ECOL MANAG, V65, P89, DOI 10.1016/0378-1127(94)90161-9; Saldarriaga J, 1985, THESIS U TENNESSEE K; Schedlbauer JL, 2008, FOREST ECOL MANAG, V255, P1326, DOI 10.1016/j.foreco.2007.10.039; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; SCHULZE ED, 1994, OECOLOGIA, V100, P406, DOI 10.1007/BF00317862; SCHULZE ED, 1986, ANNU REV PLANT PHYS, V37, P247, DOI 10.1146/annurev.arplant.37.1.247; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Schwartz D., 1991, Cahiers ORSTOM, Serie Pedologie, V26, P327; Schweizer M, 1999, RAPID COMMUN MASS SP, V13, P1284, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1284::AID-RCM578>3.0.CO;2-0; Silver WL, 2000, ECOSYSTEMS, V3, P193, DOI 10.1007/s100210000019; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; SKJEMSTAD JO, 1990, AUST J SOIL RES, V28, P267, DOI 10.1071/SR9900267; SMITH BN, 1971, PLANT CELL PHYSIOL, V12, P451; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Tessier JT, 2003, J APPL ECOL, V40, P523, DOI 10.1046/j.1365-2664.2003.00820.x; Toledo M, 2006, BIOTROPICA, V38, P161, DOI 10.1111/j.1744-7429.2006.00120.x; Toledo M, 2011, J TROP ECOL, V27, P333, DOI 10.1017/S0266467411000034; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; van Breugel M, 2007, BIOTROPICA, V39, P610, DOI 10.1111/j.1744-7429.2007.00316.x; VELDKAMP E, 1994, SOIL BIOL BIOCHEM, V26, P153, DOI 10.1016/0038-0717(94)90158-9; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; VITOUSEK PM, 1995, ECOLOGY, V76, P712, DOI 10.2307/1939338; VITOUSEK PM, 1989, OECOLOGIA, V78, P383, DOI 10.1007/BF00379113; VITOUSEK PM, 1990, OECOLOGIA, V84, P362, DOI 10.1007/BF00329760; Wadsworth FH, 1997, AGR HDB USDA FOREST, V710; Wallander H, 2009, OECOLOGIA, V160, P87, DOI 10.1007/s00442-008-1270-0; Wang L, 2007, GEOPHYS RES LETT, V34, P1; WARING RH, 1994, TREE PHYSIOL, V14, P1203, DOI 10.1093/treephys/14.11.1203; Waring RH, 2007, FOREST ECOSYSTEMS AN, P149; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; WERNER P, 1984, BIOTROPICA, V16, P43, DOI 10.2307/2387893; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WONG SC, 1979, NATURE, V282, P424, DOI 10.1038/282424a0; World Agroforestry Center, 2010, WOOD DENS DAT; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P351, DOI 10.1046/j.1365-2435.2001.00522.x; Yakir D, 2000, OECOLOGIA, V123, P297, DOI 10.1007/s004420051016; Yan ER, 2006, PLANT SOIL, V289, P187, DOI 10.1007/s11104-006-9128-x; YONEYAMA T, 1993, PLANT SOIL, V153, P295, DOI 10.1007/BF00013003; Zarin DJ, 2005, FRONT ECOL ENVIRON, V3, P365, DOI 10.2307/3868585; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004	189	10	10	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e86042	10.1371/journal.pone.0086042	http://dx.doi.org/10.1371/journal.pone.0086042			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516525	Green Published, gold			2022-12-27	WOS:000330834400005
J	Wolf, DM; Lenburg, ME; Yau, C; Boudreau, A; van 't Veer, LJ				Wolf, Denise M.; Lenburg, Marc E.; Yau, Christina; Boudreau, Aaron; van 't Veer, Laura J.			Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; BIOLOGICAL PROCESSES; EXPRESSION PROFILES; TISSUE ARCHITECTURE; PROGNOSIS; IDENTIFICATION; PREDICTOR; DIMENSION; PATHWAYS; REVEALS	Co-expression modules are groups of genes with highly correlated expression patterns. In cancer, differences in module activity potentially represent the heterogeneity of phenotypes important in carcinogenesis, progression, or treatment response. To find gene expression modules active in breast cancer subpopulations, we assembled 72 breast cancer-related gene expression datasets containing similar to 5,700 samples altogether. Per dataset, we identified genes with bimodal expression and used mixture-model clustering to ultimately define 11 modules of genes that are consistently co-regulated across multiple datasets. Functionally, these modules reflected estrogen signaling, development/differentiation, immune signaling, histone modification, ERBB2 signaling, the extracellular matrix (ECM) and stroma, and cell proliferation. The Tcell/Bcell immune modules appeared tumor-extrinsic, with coherent expression in tumors but not cell lines; whereas most other modules, interferon and ECM included, appeared intrinsic. Only four of the eleven modules were represented in the PAM50 intrinsic subtype classifier and other well-established prognostic signatures; although the immune modules were highly correlated to previously published immune signatures. As expected, the proliferation module was highly associated with decreased recurrence-free survival (RFS). Interestingly, the immune modules appeared associated with RFS even after adjustment for receptor subtype and proliferation; and in a multivariate analysis, the combination of Tcell/Bcell immune module down-regulation and proliferation module upregulation strongly associated with decreased RFS. Immune modules are unusual in that their upregulation is associated with a good prognosis without chemotherapy and a good response to chemotherapy, suggesting the paradox of high immune patients who respond to chemotherapy but would do well without it. Other findings concern the ECM/stromal modules, which despite common themes were associated with different sites of metastasis, possibly relating to the "seed and soil" hypothesis of cancer dissemination. Overall, co-expression modules provide a high-level functional view of breast cancer that complements the "cancer hallmarks" and may form the basis for improved predictors and treatments.	[Wolf, Denise M.; Boudreau, Aaron; van 't Veer, Laura J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lenburg, Marc E.] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Yau, Christina] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Yau, Christina] Buck Inst Res Aging, Novato, CA USA	University of California System; University of California San Francisco; Boston University; University of California System; University of California San Francisco; Buck Institute for Research on Aging	Wolf, DM (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	Denise.Wolf@ucsf.edu	Lenburg, Marc/B-8027-2008	Lenburg, Marc/0000-0002-5760-4708	National Cancer Institute [P50CA58207]; NATIONAL CANCER INSTITUTE [P50CA058207] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the National Cancer Institute award P50CA58207-Bay Area Breast Specialized Program of Research Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2013, CLIN CANCER RES, V19, P28, DOI 10.1158/1078-0432.CCR-11-2701; [Anonymous], 2010, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bessarabova M, 2010, BMC GENOMICS, V11; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buness A, 2007, BIOINFORMATICS, V23, P2273, DOI 10.1093/bioinformatics/btm340; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dai MH, 2005, NUCLEIC ACIDS RES, V33; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fraley C, 2006, MCLUST VERSION 3 R N; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hu ZY, 2006, BMC GENOMICS    0427, V7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2013, STAT SIGNIFICANCE CL; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Liu Y, 2008, J AM STAT ASSOC, V103, P1281, DOI 10.1198/016214508000000454; Mentzen WI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-601; Nagalla S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r34; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Sabine VS, 2010, BREAST CANCER RES TR, V122, P419, DOI 10.1007/s10549-010-0928-6; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shi ZA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-74; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Sun SQ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1103; Sutherland RL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2878; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Therneau T, 2012, PACKAGE SURVIVAL ANA; Tutt A, 2008, BMC CANCER, V8; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang J, 2009, CANCER INFORM, V7, P199; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zhang J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002656; [No title captured]	53	64	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88309	10.1371/journal.pone.0088309	http://dx.doi.org/10.1371/journal.pone.0088309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516633	Green Submitted, gold, Green Published			2022-12-27	WOS:000330834400056
J	Chen, TP; Wang, HP; Zhang, ZQ; Li, Q; Yan, KL; Tao, QS; Ye, QL; Xiong, SD; Wang, YP; Zhai, ZM				Chen, Tianping; Wang, Huiping; Zhang, Zhiqiang; Li, Qing; Yan, Kaili; Tao, Qianshan; Ye, Qianling; Xiong, Shudao; Wang, Yiping; Zhai, Zhimin			A Novel Cellular Senescence Gene, SENEX, Is Involved in Peripheral Regulatory T Cells Accumulation in Aged Urinary Bladder Cancer	PLOS ONE			English	Article							LYMPHOCYTE SENESCENCE; IMMUNE-RESPONSES; DISEASE; INTERLEUKIN-2; HOMEOSTASIS; PROGRESSION; INHIBITION; ACTIVATION; EXPRESSION; SYSTEM	Regulatory T cells (Tregs) play an essential role in sustaining self-tolerance and immune homeostasis. Despite many studies on the correlation between Tregs accumulation and age, or malignancies, the related mechanism hasn't been well explored. To find out the mechanism of Tregs accumulation in aged urinary bladder cancer, we examined the novel cellular senesence gene SENEX and relevant apoptosis gene mRNA expression in sorted CD4+CD25(hi) Tregs from aged UBC donors, evaluated serum cytokine profiles related to tumor immunopathology, and further explored the relationship between SENEX expression, apoptosis gene expression and cytokine secretion. After having silenced down SENEX gene expression with RNA interference, we also evaluated the cellular apoptosis of Tregs sorted from aged UBC patients in response to H2O2-mediated stress. Our data indicated that upregulated SENEX mRNA expression in Tregs of aged UBC patients was correlated with proapoptotic gene expression and cytokine concentration. Silencing SENEX gene expression increased cellular apoptosis and pro-apoptotic gene expression of Tregs, in response to H2O2-mediated stress. Upregulated SENEX mRNA expression together with decreased pro-apoptotic gene expression and disturbances in cytokines synthesis may contribute to the Tregs proliferation and promote tumorigenesis and metastasis. Overall, upregulation of cellular senescence gene SENEX, was associated to regulatory T cells accumulation in aged urinary bladder cancer. Our study provides a new insight into understanding of peripheral Tregs accumulation in aged malignancies.	[Chen, Tianping; Wang, Huiping; Yan, Kaili; Tao, Qianshan; Ye, Qianling; Xiong, Shudao; Zhai, Zhimin] Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Peoples R China; [Chen, Tianping; Wang, Huiping; Xiong, Shudao; Zhai, Zhimin] Anhui Med Univ, Hosp 2, Hematol Res Ctr, Hefei, Peoples R China; [Zhang, Zhiqiang] Anhui Med Univ, Hosp 2, Dept Urol, Hefei, Peoples R China; [Li, Qing] Anhui Prov Hosp, Cent Lab, Hefei, Peoples R China; [Ye, Qianling; Wang, Yiping] Univ Sydney, Natl Inst Hlth, Sydney, NSW 2006, Australia; [Ye, Qianling; Wang, Yiping] Univ Sydney, WESTMEAD Transplants & Kidney Dis Res Ctr, Sydney, NSW 2006, Australia	Anhui Medical University; Anhui Medical University; Anhui Medical University; University of Sydney; University of Sydney	Zhai, ZM (corresponding author), Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Peoples R China.	zzm889@163.com	wang, hui/GRS-4730-2022; wang, yi/GVT-8516-2022; Wang, Yixuan/GZK-6559-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022		National Natural Science Foundation of China [81141104, 81272259]; Natural Science Foundation of Anhui Province [11010402168]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This study was supported by National Natural Science Foundation of China (Item No. 81141104, No. 81272259), and Natural Science Foundation of Anhui Province (Item No. 11010402168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Chougnet CA, 2011, J IMMUNOL, V186, P156, DOI 10.4049/jimmunol.1001505; Coleman PR, 2010, BLOOD, V116, P4016, DOI 10.1182/blood-2009-11-252700; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Erickson S, 1998, ONCOGENE, V17, P595, DOI 10.1038/sj.onc.1201965; Fahraeus R, 1996, CURR BIOL, V6, P84, DOI 10.1016/S0960-9822(02)00425-6; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Gregg R, 2005, CLIN EXP IMMUNOL, V140, P540, DOI 10.1111/j.1365-2249.2005.02798.x; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Li Q, 2010, LEUKEMIA RES, V34, P1158, DOI 10.1016/j.leukres.2010.03.017; Lin YC, 2013, INT J CANCER, V132, P1341, DOI 10.1002/ijc.27784; Mao XL, 2008, BLOOD, V112, P760, DOI 10.1182/blood-2008-02-142687; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; Sakaguchi S, 2007, EUR J IMMUNOL, V37, pS116, DOI 10.1002/eji.200737593; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sharma S, 2006, J IMMUNOL, V177, P8348, DOI 10.4049/jimmunol.177.12.8348; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Ye J, 2012, BLOOD, V120, P2021, DOI 10.1182/blood-2012-03-416040; Zhai ZM, 2007, TRANSPL INT, V20, P440, DOI 10.1111/j.1432-2277.2007.00462.x; Zhou J, 2009, INT J CANCER, V125, P1640, DOI 10.1002/ijc.24556	33	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87774	10.1371/journal.pone.0087774	http://dx.doi.org/10.1371/journal.pone.0087774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505313	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200072
J	Forster, A; Kerl, HU; Goerlitz, J; Wenz, H; Groden, C				Foerster, Alex; Kerl, Hans U.; Goerlitz, Johannes; Wenz, Holger; Groden, Christoph			Crossed Cerebellar Diaschisis in Acute Isolated Thalamic Infarction Detected by Dynamic Susceptibility Contrast Perfusion MRI	PLOS ONE			English	Article							BLOOD-FLOW; STROKE; HEMIATAXIA; TOMOGRAPHY; HEMORRHAGE; PET	Purpose: Crossed cerebellar diaschisis (CCD) is a state of neural depression caused by loss of connections to injured neural structures remote from the cerebellum usually evaluated by positron emission tomography. Recently it has been shown that dynamic susceptibility contrast perfusion weighted MRI (PWI) may also be feasible to detect the phenomenon. In this study we aimed to assess the frequency of CCD on PWI in patients with acute thalamic infarction. Methods: From a MRI report database we identified patients with acute isolated thalamic infarction. Contralateral cerebellar hypoperfusion was identified by inspection of time to peak (TTP) maps and evaluated quantitatively on TTP, mean transit time (MTT), cerebral blood flow and volume (CBF, CBV) maps. A competing cerebellar pathology or an underlying vascular pathology were excluded. Results: A total of 39 patients was included. Common symptoms were hemiparesis (53.8%), hemihypaesthesia (38.5%), dysarthria (30.8%), aphasia (17.9%), and ataxia (15.4%). In 9 patients (23.1%) PWI showed hypoperfusion in the contralateral cerebellar hemisphere. All of these had lesions in the territory of the tuberothalamic, paramedian, or inferolateral arteries. Dysarthria was observed more frequently in patients with CCD (6/9 vs. 6/30; OR 8.00; 95% CI 1.54-41.64, p = 0.01). In patients with CCD, the median ischemic lesion volume on DWI (0.91 cm(3), IQR 0.49-1.54 cm(3)) was larger compared to patients with unremarkable PWI (0.51 cm(3), IQR 0.32-0.74, p = 0.05). The most pronounced changes were found in CBF (0.94 +/- 0.11) and MTT (1.06 +/- 0.13) signal ratios, followed by TTP (1.05 +/- 0.02). Conclusions: Multimodal MRI demonstrates CCD in about 20% of acute isolated thalamic infarction patients. Lesion size seems to be a relevant factor in its pathophysiology.	[Foerster, Alex; Kerl, Hans U.; Goerlitz, Johannes; Wenz, Holger; Groden, Christoph] Heidelberg Univ, Univ Med Mannheim, Dept Neuroradiol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Forster, A (corresponding author), Heidelberg Univ, Univ Med Mannheim, Dept Neuroradiol, Mannheim, Germany.	alex.foerster@umm.de						ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Baron J C, 1981, Trans Am Neurol Assoc, V105, P459; BARON JC, 1986, BRAIN, V109, P1243, DOI 10.1093/brain/109.6.1243; BARON JC, 1992, J NEUROL NEUROSUR PS, V55, P935, DOI 10.1136/jnnp.55.10.935; BOGOUSSLAVSKY J, 1988, NEUROLOGY, V38, P837, DOI 10.1212/WNL.38.6.837; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; Caplan Lr, 2005, J Clin Neurol, V1, P14, DOI 10.3988/jcn.2005.1.1.14; DIPIERO V, 1990, STROKE, V21, P1365, DOI 10.1161/01.STR.21.9.1365; Engelborghs S, 2000, J NEUROL, V247, P476, DOI 10.1007/s004150070183; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Flint AC, 2006, STROKE, V37, pE1, DOI 10.1161/01.STR.0000195179.93268.e2; FUKUYAMA H, 1986, J NEUROL NEUROSUR PS, V49, P524, DOI 10.1136/jnnp.49.5.524; Glickstein M, 2008, CEREBELLUM, V7, P589, DOI 10.1007/s12311-008-0074-4; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Lim JS, 1998, J NUCL MED, V39, P2044; Lin DDM, 2009, AM J NEURORADIOL, V30, P710, DOI 10.3174/ajnr.A1435; Madai VI, 2011, J CEREBR BLOOD F MET, V31, P1493, DOI 10.1038/jcbfm.2011.15; MELO TP, 1992, J NEUROL NEUROSUR PS, V55, P581, DOI 10.1136/jnnp.55.7.581; MEYER JS, 1993, NEUROL RES, V15, P362; Neau JP, 1996, ANN NEUROL, V39, P779, DOI 10.1002/ana.410390614; O'Gorman RL, 2010, PEDIATR NEUROL, V42, P437, DOI 10.1016/j.pediatrneurol.2010.02.008; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Schmahmann JD, 2003, STROKE, V34, P2264, DOI 10.1161/01.STR.0000087786.38997.9E; SOLOMON DH, 1994, NEUROLOGY, V44, P810, DOI 10.1212/WNL.44.5.810; Takasawa M, 2002, AM J NEURORADIOL, V23, P189; Takasawa M, 2001, J NEUROIMAGING, V11, P438, DOI 10.1111/j.1552-6569.2001.tb00076.x; Tanaka A, 1996, J NEUROL SCI, V144, P191, DOI 10.1016/S0022-510X(96)00226-2; TANAKA M, 1992, J NEUROL NEUROSUR PS, V55, P121, DOI 10.1136/jnnp.55.2.121; von Monakow C, 1914, J AM MED ASS, VLXIII, P797; Voogd J, 2003, J CHEM NEUROANAT, V26, P243, DOI 10.1016/j.jchemneu.2003.07.005; Weimar C, 2007, NERVENARZT, V78, P957, DOI 10.1007/s00115-007-2268-2; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687; Yamada H, 1999, RADIOLOGY, V210, P558, DOI 10.1148/radiology.210.2.r99fe02558; YAMAUCHI H, 1992, STROKE, V23, P855, DOI 10.1161/01.STR.23.6.855	35	29	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88044	10.1371/journal.pone.0088044	http://dx.doi.org/10.1371/journal.pone.0088044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505372	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200106
J	Kondor, D; Posfai, M; Csabai, I; Vattay, G				Kondor, Daniel; Posfai, Marton; Csabai, Istvan; Vattay, Gabor			Do the Rich Get Richer? An Empirical Analysis of the Bitcoin Transaction Network	PLOS ONE			English	Article							HEAVY TAILS; WEALTH; DISTRIBUTIONS; EVOLUTION	The possibility to analyze everyday monetary transactions is limited by the scarcity of available data, as this kind of information is usually considered highly sensitive. Present econophysics models are usually employed on presumed random networks of interacting agents, and only some macroscopic properties (e.g. the resulting wealth distribution) are compared to real-world data. In this paper, we analyze Bitcoin, which is a novel digital currency system, where the complete list of transactions is publicly available. Using this dataset, we reconstruct the network of transactions and extract the time and amount of each payment. We analyze the structure of the transaction network by measuring network characteristics over time, such as the degree distribution, degree correlations and clustering. We find that linear preferential attachment drives the growth of the network. We also study the dynamics taking place on the transaction network, i.e. the flow of money. We measure temporal patterns and the wealth accumulation. Investigating the microscopic statistics of money movement, we find that sublinear preferential attachment governs the evolution of the wealth distribution. We report a scaling law between the degree and wealth associated to individual nodes.	[Kondor, Daniel; Posfai, Marton; Csabai, Istvan; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Posfai, Marton] Budapest Univ Technol & Econ, Dept Theoret Phys, Budapest, Hungary	Eotvos Lorand University; Budapest University of Technology & Economics	Kondor, D (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	kdani88@elte.hu	Csabai, Istvan/F-6045-2011; Vattay, Gabor/Q-4266-2019; Kondor, Daniel/AAD-9871-2019; Vattay, Gabor/G-9638-2017	Csabai, Istvan/0000-0001-9232-9898; Kondor, Daniel/0000-0003-3720-7462; Vattay, Gabor/0000-0002-0919-9429	European Union [FP7-ICT-255987-FOC-II]; European Social Fund through project FuturICT.hu [TAMOP-4.2.2.C-11/1/KONV-2012-0013]; OTKA [7779]; NAP [2005/KCKHA005]; Hungarian Government [EITKIC_12-1-2012-0001]; Research and Technology Innovation Fund; MAKOG Foundation	European Union(European Commission); European Social Fund through project FuturICT.hu; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NAP; Hungarian Government; Research and Technology Innovation Fund; MAKOG Foundation	This work has been supported by the European Union under grant agreement No. FP7-ICT-255987-FOC-II Project. The authors thank the partial support of the European Union and the European Social Fund through project FuturICT.hu (grant no.: TAMOP-4.2.2.C-11/1/KONV-2012-0013), the OTKA 7779 and the NAP 2005/KCKHA005 grants. EITKIC_12-1-2012-0001 project was partially supported by the Hungarian Government, managed by the National Development Agency, and financed by the Research and Technology Innovation Fund and the MAKOG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NATURE, V489, P507, DOI 10.1038/nature11486; Bargigli L, 2013, ECONOMICS-KIEL, V7, DOI 10.5018/economics-ejournal.ja.2013-17; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Caldarelli G., 2007, SCALE FREE NETWORKS; Caldarelli G, 2013, NAT PHYS, V9, P125, DOI 10.1038/nphys2580; Catanzaro M, 2013, NAT PHYS, V9, P121, DOI 10.1038/nphys2570; Christin N, 2012, ARXIV12077139; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cohen R., 2010, COMPLEX NETWORKS STR; DORFMAN R, 1979, REV ECON STAT, V61, P146, DOI 10.2307/1924845; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Garlaschelli D, 2005, PHYSICA A, V350, P491, DOI 10.1016/j.physa.2004.11.040; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Ispolatov S, 1998, EUR PHYS J B, V2, P267, DOI 10.1007/s100510050249; James King, MATTHEW, V13, P12; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Klass OS, 2007, EUR PHYS J B, V55, P143, DOI 10.1140/epjb/e2006-00396-1; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Kunegis J, 2013, ARXIV13036271; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Matray P, 2007, P ACM SIGMETRICS 200, DOI [10.1145/1269880.1269887, DOI 10.1145/1269880.1269887]; Menche J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046103; Mislove Alan E., 2009, THESIS; Nakamoto S., 2008, BITCOIN PEER TO PEER; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Ning D, 2007, CHINESE PHYS LETT, V24, P2434, DOI 10.1088/0256-307X/24/8/076; Palla G, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046115; Pastor-Satorras R, 2004, EVOLUTION STRUCTURE; Perc M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01720; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Reid F, 2011, ARXIV11074524; Ron D, 2012, IACR CRYPTOLOGY EPRI; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; SIMON HA, 1955, BIOMETRIKA, V42, P425; Tseng JJ, 2010, EUR PHYS J B, V73, P69, DOI 10.1140/epjb/e2009-00424-8; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703	49	153	155	0	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86197	10.1371/journal.pone.0086197	http://dx.doi.org/10.1371/journal.pone.0086197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505257	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200017
J	Ma, J; Ma, RM; Liu, XW; Bian, K; Wen, ZH; Li, XJ; Zhang, ZM; Hu, WD				Ma, Jin; Ma, Ru-Meng; Liu, Xi-Wen; Bian, Ka; Wen, Zhi-Hong; Li, Xiao-Jing; Zhang, Zuo-Ming; Hu, Wen-Dong			Workload Influence on Fatigue Related Psychological and Physiological Performance Changes of Aviators	PLOS ONE			English	Article								Objective: We evaluated a variety of non-invasive physiological technologies and a series of test approaches for examination of aviator performances under conditions of mental workload in order to provide a standard real-time test for physiological and psychological pilot fatigue assessments. Methods: Twenty-one male aviators were selected for a simulated flight in a hypobaric cabin with artificial altitude conditions of 2400 meter above sea level. The simulated flight lasted for 1.5 h, and was repeated for two times with an intervening 0.5 h rest period outside the hypobaric cabin. Subjective criteria (a fatigue assessment instrument [FAI]) and objective criteria (a standing-position balance test as well as a critical flicker fusion frequency (CFF) test) were used for fatigue evaluations. Results: No significant change was observed in the FAI scores before and after the simulated flight, indicating that there was no subjective fatigue feeling among the participants. However, significant differences were observed in the standing-position balance and CFF tests among the subjects, suggesting that psychophysiological indexes can reflect mental changes caused by workload to a certain extent. The CFF test was the simplest and clearly indicated the occurrence of workload influences on pilot performances after a simulated flight. Conclusions: Results showed that the CFF test was the easiest way to detect workload caused mental changes after a simulated flight in a hypobaric cabin and reflected the psychophysiological state of aviators. We suggest that this test might be used as an effective routine method for evaluating the workload influences on mental conditions of aviators.	[Ma, Jin; Wen, Zhi-Hong; Li, Xiao-Jing; Hu, Wen-Dong] Fourth Mil Med Univ 169, Fac Aerosp Med, Dept Aerosp Med Equipment, Xian, Peoples R China; [Zhang, Zuo-Ming] Fourth Mil Med Univ 169, Fac Aerosp Med, Dept Clin Aerosp Med, Xian, Peoples R China; [Ma, Ru-Meng] Fourth Mil Med Univ 1, Tangdu Hosp, Dept Expt Surg, Xian, Peoples R China; [Liu, Xi-Wen] Fourth Mil Med Univ 169, Sch Nursing, Dept Basic Nursing, Xian, Peoples R China; [Bian, Ka] Fourth Mil Med Univ 1, Tangdu Hosp, Dept Otolaryngol Head & Neck Surg, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhang, ZM (corresponding author), Fourth Mil Med Univ 169, Fac Aerosp Med, Dept Clin Aerosp Med, Xian, Peoples R China.	zhangzmBM@163.com; huwendongBM@163.com	Wen, Zhi-Hong/AAG-8034-2019; liu, xiwen/GSJ-3861-2022		National Natural Science Foundation of China [81202178, U1333101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China, No. 81202178 and No. U1333101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armentrout JJ, 2006, AVIAT SPACE ENVIR MD, V77, P963; Bolmont B, 2002, NEUROSCI LETT, V329, P96, DOI 10.1016/S0304-3940(02)00578-5; Coste O, 2009, J SLEEP RES, V18, P454, DOI 10.1111/j.1365-2869.2009.00744.x; FIFE TD, 1993, ANN NEUROL, V34, P694, DOI 10.1002/ana.410340512; Ge SQ, 1999, CHINESE J AEROSPACE, V10, P120; Luczak Anna, 1995, Int J Occup Saf Ergon, V1, P160, DOI 10.1080/10803548.1995.11076313; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; NORRE ME, 1987, ACTA OTO-LARYNGOL, V104, P50, DOI 10.3109/00016488709109046; Ott H, 1982, FLICKER TECHNIQUES P, P60; Sakellari V, 1997, ARCH PHYS MED REHAB, V78, P730, DOI 10.1016/S0003-9993(97)90081-2; SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N	11	19	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87121	10.1371/journal.pone.0087121	http://dx.doi.org/10.1371/journal.pone.0087121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505277	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200036
J	Middha, S; Baheti, S; Hart, SN; Kocher, JPA				Middha, Sumit; Baheti, Saurabh; Hart, Steven N.; Kocher, Jean-Pierre A.			From Days to Hours: Reporting Clinically Actionable Variants from Whole Genome Sequencing	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; READ ALIGNMENT	As the cost of whole genome sequencing (WGS) decreases, clinical laboratories will be looking at broadly adopting this technology to screen for variants of clinical significance. To fully leverage this technology in a clinical setting, results need to be reported quickly, as the turnaround rate could potentially impact patient care. The latest sequencers can sequence a whole human genome in about 24 hours. However, depending on the computing infrastructure available, the processing of data can take several days, with the majority of computing time devoted to aligning reads to genomics regions that are to date not clinically interpretable. In an attempt to accelerate the reporting of clinically actionable variants, we have investigated the utility of a multi-step alignment algorithm focused on aligning reads and calling variants in genomic regions of clinical relevance prior to processing the remaining reads on the whole genome. This iterative workflow significantly accelerates the reporting of clinically actionable variants with no loss of accuracy when compared to genotypes obtained with the OMNI SNP platform or to variants detected with a standard workflow that combines Novoalign and GATK.	[Middha, Sumit; Baheti, Saurabh; Hart, Steven N.; Kocher, Jean-Pierre A.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA	Mayo Clinic	Kocher, JPA (corresponding author), Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA.	kocher.jeanpierre@mayo.edu	Hart, Steven/AAI-4761-2021	Hart, Steven/0000-0001-7714-2734; Middha, Sumit/0000-0003-4135-6268	Center for Individualized Medecine at Mayo Clinic	Center for Individualized Medecine at Mayo Clinic	The funding was provided by the Center for Individualized Medecine at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Solomon BD, 2013, P NATL ACAD SCI USA, V110, P9851, DOI 10.1073/pnas.1302575110	9	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86803	10.1371/journal.pone.0086803	http://dx.doi.org/10.1371/journal.pone.0086803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505267	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200026
J	Yarrow, S; Razak, KA; Seitz, AR; Series, P				Yarrow, Stuart; Razak, Khaleel A.; Seitz, Aaron R.; Series, Peggy			Detecting and Quantifying Topography in Neural Maps	PLOS ONE			English	Article							SYSTEMATIC REPRESENTATION; FUNCTIONAL-ORGANIZATION; TOPOLOGY PRESERVATION; AUDITORY-CORTEX; CEREBRAL-CORTEX; VISUAL-CORTEX; REORGANIZATION; ARCHITECTURE; DEPENDENCE; COLUMNS	Topographic maps are an often-encountered feature in the brains of many species, yet there are no standard, objective procedures for quantifying topography. Topographic maps are typically identified and described subjectively, but in cases where the scale of the map is close to the resolution limit of the measurement technique, identifying the presence of a topographic map can be a challenging subjective task. In such cases, an objective topography detection test would be advantageous. To address these issues, we assessed seven measures (Pearson distance correlation, Spearman distance correlation, Zrehen's measure, topographic product, topological correlation, path length and wiring length) by quantifying topography in three classes of cortical map model: linear, orientation-like, and clusters. We found that all but one of these measures were effective at detecting statistically significant topography even in weakly-ordered maps, based on simulated noisy measurements of neuronal selectivity and sparse sampling of the maps. We demonstrate the practical applicability of these measures by using them to examine the arrangement of spatial cue selectivity in pallid bat A1. This analysis shows that significantly topographic arrangements of interaural intensity difference and azimuth selectivity exist at the scale of individual binaural clusters.	[Yarrow, Stuart; Series, Peggy] Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Razak, Khaleel A.; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of Edinburgh; University of California System; University of California Riverside	Yarrow, S (corresponding author), Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	stuart.yarrow@gmail.com		Series, Peggy/0000-0002-8580-7975	UK Engineering and Physical Sciences Research Council; UK Biotechnology and Biological Sciences Research Council; UK Medical Research Council [EP/F500385/1, BB/F529254/1]; Marie Curie Action [PIRSES-GA-2009-247543]; National Institutes of Health funding: National Institute on Deafness and Other Communication Disorders [R03 DC009882]; National Science Foundation [BCS-1057625]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009882] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [1057625] Funding Source: National Science Foundation	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Action(European Commission); National Institutes of Health funding: National Institute on Deafness and Other Communication Disorders; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was supported by the UK Engineering and Physical Sciences Research Council, UK Biotechnology and Biological Sciences Research Council and the UK Medical Research Council (grant numbers EP/F500385/1 and BB/F529254/1 for the University of Edinburgh School of Informatics Doctoral Training Centre in Neuroinformatics and Computational Neuroscience); additional support was provided by Marie Curie Action PIRSES-GA-2009-247543 to SY and PS for collaborative visits to the University of California, Riverside. The bat data was collected using National Institutes of Health funding: 'National Institute on Deafness and Other Communication Disorders Grant R03 DC009882' to KAR. ARS was supported by the National Science Foundation (grant number BCS-1057625). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez SA, 1998, B MATH BIOL, V60, P27, DOI 10.1006/bulm.1997.0002; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; BAUER HU, 1992, IEEE T NEURAL NETWOR, V3, P570, DOI 10.1109/72.143371; Bauer HU, 1999, NEURAL NETWORKS, V12, P659, DOI 10.1016/S0893-6080(99)00027-1; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; Benjamini Y, 2001, ANN STAT, V29, P1165; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; BEZDEK JC, 1995, PATTERN RECOGN, V28, P381, DOI 10.1016/0031-3203(94)00111-X; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Cohen YE, 1999, TRENDS NEUROSCI, V22, P128, DOI 10.1016/S0166-2236(98)01295-8; Doherty KAJ, 2006, ESANN2006 P EUR S AR; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Ferrier D, 1875, P ROY SOC LOND B BIO, V23, P409, DOI DOI 10.1098/RSPL.1874.0058; Goodhill GJ, 1997, NEURAL COMPUT, V9, P1291, DOI 10.1162/neco.1997.9.6.1291; Goodhill GJ, 1996, PROCEEDINGS OF THE 3RD JOINT SYMPOSIUM ON NEURAL COMPUTATION, VOL 6, P61; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Guo W, 2012, J NEUROSCI, V32, P9159, DOI 10.1523/JNEUROSCI.0065-12.2012; HALTON JH, 1964, COMMUN ACM, V7, P701, DOI 10.1145/355588.365104; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 2005, CURR BIOL, V15, pR205, DOI 10.1016/j.cub.2005.03.011; Kaschube M, 2003, EUR J NEUROSCI, V18, P3251, DOI 10.1111/j.1460-9568.2003.02979.x; Kaschube M, 2010, SCIENCE, V330, P1113, DOI 10.1126/science.1194869; Kaski S., 1996, Artificial Neural Networks - ICANN 96. 1996 International Conference Proceedings, P809; KRUGER J, 1981, EXP BRAIN RES, V41, P191; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Li Y, 2008, NATURE, V456, P952, DOI 10.1038/nature07417; Macke JH, 2011, NEUROIMAGE, V56, P570, DOI 10.1016/j.neuroimage.2010.04.272; Nauhaus I, 2008, NEURON, V57, P673, DOI 10.1016/j.neuron.2008.01.020; O'Donnell C, 2011, TRENDS NEUROSCI, V34, P51, DOI 10.1016/j.tins.2010.10.003; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Razak KA, 2000, NEUROREPORT, V11, P2919, DOI 10.1097/00001756-200009110-00018; Razak KA, 2002, J NEUROPHYSIOL, V87, P72, DOI 10.1152/jn.00226.2001; Razak KA, 2011, J NEUROSCI, V31, P13848, DOI 10.1523/JNEUROSCI.1937-11.2011; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Vidaurre D, 2007, IEEE T NEURAL NETWOR, V18, P1524, DOI 10.1109/TNN.2007.895820; Villmann T, 1997, IEEE T NEURAL NETWOR, V8, P256, DOI 10.1109/72.557663; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; Willshaw DJ, 2013, J NEUROSCI IN PRESS; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Yarrow S, 2012, NEURAL COMPUT, V24, P1740, DOI 10.1162/NECO_a_00292; Zheng WM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00065; Zrehen S, 1993, P INT C ART NEUR NET, P609	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87178	10.1371/journal.pone.0087178	http://dx.doi.org/10.1371/journal.pone.0087178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505279	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200038
J	Arnal, ME; Zhang, J; Messori, S; Bosi, P; Smidt, H; Lalles, JP				Arnal, Marie-Edith; Zhang, Jing; Messori, Stefano; Bosi, Paolo; Smidt, Hauke; Lalles, Jean-Paul			Early Changes in Microbial Colonization Selectively Modulate Intestinal Enzymes, but Not Inducible Heat Shock Proteins in Young Adult Swine	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; EPITHELIAL-CELLS; GUT MICROBIOTA; GASTROINTESTINAL-TRACT; GENE-EXPRESSION; MESSENGER-RNA; PIGLETS; GROWTH; DIET; RAT	Metabolic diseases and obesity are developing worldwide in a context of plethoric intake of high energy diets. The intestine may play a pivotal role due to diet-induced alterations in microbiota composition and increased permeability to bacterial lipopolysaccharide inducing metabolic inflammation. Early programming of metabolic disorders appearing in later life is also suspected, but data on the intestine are lacking. Therefore, we hypothesized that early disturbances in microbial colonization have short-and long-lasting consequences on selected intestinal components including key digestive enzymes and protective inducible heat shock proteins (HSP). The hypothesis was tested in swine offspring born to control mothers (n = 12) or mothers treated with the antibiotic amoxicillin around parturition (n = 11), and slaughtered serially at 14, 28 and 42 days of age to assess short-term effects. To evaluate long-term consequences, young adult offspring from the same litters were offered a normal or a fat-enriched diet for 4 weeks between 140 and 169 days of age and were then slaughtered. Amoxicillin treatment transiently modified both mother and offspring microbiota. This was associated with early but transient reduction in ileal alkaline phosphatase, HSP70 (but not HSP27) and crypt depth, suggesting a milder or delayed intestinal response to bacteria in offspring born to antibiotic-treated mothers. More importantly, we disclosed long-term consequences of this treatment on jejunal alkaline phosphatase (reduced) and jejunal and ileal dipeptidylpeptidase IV (increased and decreased, respectively) of offspring born to antibiotic-treated dams. Significant interactions between early antibiotic treatment and later diet were observed for jejunal alkaline phosphatase and sucrase. By contrast, inducible HSPs were not affected. In conclusion, our data suggest that early changes in bacterial colonization not only modulate intestinal architecture and function transiently, but also exert site-and sometimes diet-specific long-term effects on key components of intestinal homeostasis.	[Arnal, Marie-Edith; Lalles, Jean-Paul] French Natl Inst Res Agr INRA, Food & Digest Cent & Behav Adaptat Dept, St Gilles, France; [Zhang, Jing; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Messori, Stefano; Bosi, Paolo] Univ Bologna, Dept Agr & Food Sci, Reggio Emilia, Italy	INRAE; Wageningen University & Research; University of Bologna	Lalles, JP (corresponding author), French Natl Inst Res Agr INRA, Food & Digest Cent & Behav Adaptat Dept, St Gilles, France.	jean-paul.lalles@rennes.inra.fr	Messori, Stefano/G-2425-2016; Smidt, Hauke/D-7054-2014	Messori, Stefano/0000-0002-6988-7960; Smidt, Hauke/0000-0002-6138-5026; Lalles, Jean-Paul/0000-0003-2732-5350	European Union [227549]; INRA Human Nutrition Division; Region Bretagne, France; China Scholarship Council (CSC)	European Union(European Commission); INRA Human Nutrition Division; Region Bretagne, France(Region Bretagne); China Scholarship Council (CSC)(China Scholarship Council)	This work was financially supported by the European Union (contract No. 227549) through the Interplay project. The authors are solely responsible for the work described in this paper, and their opinions are not necessarily those of the European Union. MEA was the recipient of a PhD thesis grant from INRA Human Nutrition Division and the Region Bretagne, France which are acknowledged. JZ was supported by a PhD fellowship of the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Bosi P, 2011, J ANIM SCI, V89, P4043, DOI 10.2527/jas.2010-3311; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cao L, 2012, POULTRY SCI, V91, P3065, DOI 10.3382/ps.2012-02548; Caperna TJ, 2013, REPROD FERT DEVELOP, V25, P1126, DOI 10.1071/RD12103; CHANDRASENA G, 1992, CELL MOL BIOL, V38, P243; Chatelais L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019594; David JC, 2002, J NUTR, V132, P2551, DOI 10.1093/jn/132.9.2551; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; FLORES CA, 1988, J PEDIATR GASTR NUTR, V7, P914, DOI 10.1097/00005176-198811000-00021; GODA T, 1994, J NUTR, V124, P2233, DOI 10.1093/jn/124.11.2233; Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harada T, 2003, AM J PHYSIOL-GASTR L, V284, pG255, DOI 10.1152/ajpgi.00244.2002; Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0; Kisielinski K, 2002, CLIN EXP MED, V2, P131, DOI 10.1007/s102380200018; Kojima K, 2004, AM J PHYSIOL-GASTR L, V286, pG645, DOI 10.1152/ajpgi.00080.2003; Kozakova H, 2006, MICROBES INFECT, V8, P2629, DOI 10.1016/j.micinf.2006.07.008; Lalles JP, 2012, J ANIM SCI, V90, P421, DOI 10.2527/jas.53904; Lalles JP, 2012, J NUTR BIOCHEM, V23, P1490, DOI 10.1016/j.jnutbio.2011.10.001; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Lalles JP, 2013, NUTR REV IN PRESS; Le Floc'h N, 2008, J ANIM SCI, V86, P3473, DOI 10.2527/jas.2008-0999; Le Gall M, 2009, BRIT J NUTR, V102, P1285, DOI 10.1017/S0007114509990213; Lee DN, 2008, J ANIM PHYSIOL AN N, V92, P463, DOI 10.1111/j.1439-0396.2007.00735.x; Mani V, 2012, J ANIM SCI, V90, P1452, DOI 10.2527/jas.2011-4627; Mani V, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-6; Nutten S, 2007, CLIN VACCINE IMMUNOL, V14, P190, DOI 10.1128/CVI.00055-06; Perez Gutierrez O, 2010, THESIS WAGENINGEN U; Petersen YM, 2001, AM J PHYSIOL-REG I, V281, pR1986, DOI 10.1152/ajpregu.2001.281.6.R1986; Petrof Elaine O, 2004, Chin J Dig Dis, V5, P45, DOI 10.1111/j.1443-9573.2004.00154.x; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reinhold D, 2007, ANN NY ACAD SCI, V1110, P402, DOI 10.1196/annals.1423.042; Reyns T, 2009, J VET PHARMACOL THER, V32, P241, DOI 10.1111/j.1365-2885.2008.01033.x; Rocha CS, 2012, INFLAMM BOWEL DIS, V18, P657, DOI 10.1002/ibd.21834; Sauvant D, 2004, TABLES COMPOSITION N; Schumann A, 2005, PHYSIOL GENOMICS, V23, P235, DOI 10.1152/physiolgenomics.00057.2005; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Shirkey TW, 2006, EXP BIOL MED, V231, P1333, DOI 10.1177/153537020623100807; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Takada M, 2010, LIFE SCI, V86, P499, DOI 10.1016/j.lfs.2010.02.010; Tao Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1018, DOI 10.1152/ajpcell.00131.2005; Thanissery R, 2010, POULTRY SCI, V89, P2380, DOI 10.3382/ps.2010-00879; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861; Westerheide SD, 2012, CURR PROTEIN PEPT SC, V13, P86; Willing BP, 2009, J ANIM PHYSIOL AN N, V93, P586, DOI 10.1111/j.1439-0396.2008.00841.x; Wu X, 2013, FRONT BIOSCI-LANDMRK, V18, P356, DOI 10.2741/4106; Yang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00314; Zhang M, 2011, RES VET SCI, V90, P432, DOI 10.1016/j.rvsc.2010.06.028; Zhong X, 2011, J ANIM SCI, V89, P3634, DOI 10.2527/jas.2010-3751	56	40	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87967	10.1371/journal.pone.0087967	http://dx.doi.org/10.1371/journal.pone.0087967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24505340	Green Published, gold, Green Submitted			2022-12-27	WOS:000336971300026
J	Alqasim, A; Emes, R; Clark, G; Newcombe, J; La Ragione, R; McNally, A				Alqasim, Abdulaziz; Emes, Richard; Clark, Gemma; Newcombe, Jane; La Ragione, Roberto; McNally, Alan			Phenotypic Microarrays Suggest Escherichia coli ST131 Is Not a Metabolically Distinct Lineage of Extra-Intestinal Pathogenic E. coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; MOLECULAR EPIDEMIOLOGY; VIRULENCE FACTORS; GENOMIC ANALYSIS; CTX-M; NORTHWEST; STRAINS; PREVALENCE; EMERGENCE; CTX-M-15	Extraintestinal pathogenic E. coli (ExPEC) are the major aetiological agent of urinary tract infections (UTIs) in humans. The emergence of the CTX-M producing clone E. coli ST131 represents a major challenge to public health worldwide. A recent study on the metabolic potential of E. coli isolates demonstrated an association between the E. coli ST131 clone and enhanced utilisation of a panel of metabolic substrates. The studies presented here investigated the metabolic potential of ST131 and other major ExPEC ST isolates using 120 API test reagents and found that ST131 isolates demonstrated a lower metabolic activity for 5 of 120 biochemical tests in comparison to non-ST131 ExPEC isolates. Furthermore, comparative phenotypic microarray analysis showed a lack of specific metabolic profile for ST131 isolates countering the suggestion that these bacteria are metabolically fitter and therefore more successful human pathogens.	[Alqasim, Abdulaziz; Clark, Gemma; McNally, Alan] Nottingham Trent Univ, Pathogen Res Grp, Nottingham, England; [Emes, Richard] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Emes, Richard] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG7 2RD, England; [Newcombe, Jane] Univ Surrey, Dept Microbial & Cellular Sci, Guildford GU2 5XH, Surrey, England; [La Ragione, Roberto] Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Weybridge, Surrey, England; [La Ragione, Roberto] Univ Surrey, Sch Vet Med, Guildford GU2 5XH, Surrey, England	Nottingham Trent University; University of Nottingham; University of Nottingham; University of Surrey; Veterinary Laboratories Agency; University of Surrey	McNally, A (corresponding author), Nottingham Trent Univ, Pathogen Res Grp, Nottingham, England.	alan.mcnally@ntu.ac.uk	La Ragione, Roberto M/Q-9916-2017; La Ragione, Roberto M/F-7204-2010; Alqasim, Abdulaziz/M-3933-2019; Emes, Richard D/C-5341-2008	La Ragione, Roberto M/0000-0001-5861-613X; Emes, Richard D/0000-0001-6855-5481; McNally, Alan/0000-0002-3099-630X	King Saud University	King Saud University(King Saud University)	The work was supported by a studentship awarded to AA from King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram M, 2007, ANN CLIN MICROB ANTI, V6, P1; Alhashash F, 2013, EMERG INFECT DIS, V19, P1699, DOI 10.3201/eid1910.130309; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Clark G, 2012, J ANTIMICROB CHEMOTH, V67, P868, DOI 10.1093/jac/dkr585; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; COVESMITH A, 2007, TRENDS UROL GYNECOL, V12, P31, DOI DOI 10.1002/TRE.33; Croxall G, 2011, J ANTIMICROB CHEMOTH, V66, P2501, DOI 10.1093/jac/dkr349; Croxall G, 2011, J MED MICROBIOL, V60, P102, DOI 10.1099/jmm.0.020602-0; Durso LM, 2004, APPL ENVIRON MICROB, V70, P6466, DOI 10.1128/AEM.70.11.6466-6472.2004; Farajnia S, 2009, INT J INFECT DIS, V13, P140, DOI 10.1016/j.ijid.2008.04.014; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gibreel TM, 2012, J CLIN MICROBIOL, V50, P3202, DOI 10.1128/JCM.01423-12; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Le Bouguenec C, 2011, INT J MED MICROBIOL, V301, P1, DOI 10.1016/j.ijmm.2010.04.021; Leflon-Guibout V, 2008, J CLIN MICROBIOL, V46, P3900, DOI 10.1128/JCM.00734-08; Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; MCCORMICK A, 1995, MORBIDITY STAT GEN P; McNally A, 2013, CLIN MICROBIOL INFEC, V19, pE328, DOI 10.1111/1469-0691.12202; McNally A, 2013, GENOME BIOL EVOL, V5, P699, DOI 10.1093/gbe/evt038; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zhang LX, 2003, FRONT BIOSCI-LANDMRK, V8, pE235, DOI 10.2741/1007	39	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88374	10.1371/journal.pone.0088374	http://dx.doi.org/10.1371/journal.pone.0088374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516644	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400062
J	Ceunen, E; Zaman, J; Vlaeyen, JWS; Dankaerts, W; Van Diest, I				Ceunen, Erik; Zaman, Jonas; Vlaeyen, Johan W. S.; Dankaerts, Wim; Van Diest, Ilse			Effect of Seated Trunk Posture on Eye Blink Startle and Subjective Experience: Comparing Flexion, Neutral Upright Posture, and Extension of Spine	PLOS ONE			English	Article							FACIAL EXPRESSIONS; BODY POSTURES; EMOTION; EYEBLINK; MODULATION; RESPONSES; PRIDE	Postures are known to be able to affect emotion and motivation. Much less is known about whether (affective) modulation of eye blink startle occurs following specific postures. The objective of the current study was to explore this. Participants in the present study were requested to assume three different sitting postures: with the spine flexed (slouched), neutral upright, and extended. Each posture was assumed for four minutes, and was followed by the administration of brief self-report questionnaires before proceeding to the next posture. The same series of postures and measures were repeated prior to ending the experiment. Results indicate that, relative to the other postures, the extended sitting posture was associated with an increased startle, was more unpleasant, arousing, had smaller levels of dominance, induced more discomfort, and was perceived as more difficult. The upright and flexed sitting postures differed in the level of self-reported positive affect, but not in eye blink startle amplitudes.	[Ceunen, Erik; Zaman, Jonas; Vlaeyen, Johan W. S.; Van Diest, Ilse] KU Leuven Univ Leuven, Res Grp Hlth Psychol, Louvain, Belgium; [Vlaeyen, Johan W. S.] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Dankaerts, Wim] KU Leuven Univ Leuven, Res Grp Musculoskeletal Rehabil, Louvain, Belgium	KU Leuven; Maastricht University; KU Leuven	Van Diest, I (corresponding author), KU Leuven Univ Leuven, Res Grp Hlth Psychol, Louvain, Belgium.	Ilse.VanDiest@ppw.kuleuven.be	Zaman, Jonas/AAJ-1236-2021; Vlaeyen, Johan/P-9070-2019; Vlaeyen, Johan W.S./A-2555-2009	Zaman, Jonas/0000-0002-2218-3018; Vlaeyen, Johan/0000-0003-0437-6665; Van Diest, Ilse/0000-0002-0048-774X	Odyseuss grant "the Psychology of Pain and Disability Research Program"; Research Foundation Flanders (FWO Vlaanderen), Belgium	Odyseuss grant "the Psychology of Pain and Disability Research Program"; Research Foundation Flanders (FWO Vlaanderen), Belgium(FWO)	This study was supported by a grant from the Odyseuss grant "the Psychology of Pain and Disability Research Program" funded by the Research Foundation Flanders (FWO Vlaanderen), Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1996, MULTIPLE REGRESSION; Amodio DM, 2011, EMOTION, V11, P47, DOI 10.1037/a0021238; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brinol P, 2009, EUR J SOC PSYCHOL, V39, P1053, DOI 10.1002/ejsp.607; BROWN P, 1991, J NEUROL NEUROSUR PS, V54, P892, DOI 10.1136/jnnp.54.10.892; Ceunen E, 2013, INT J PSYCHOPHYSIOL, V88, P157, DOI 10.1016/j.ijpsycho.2013.03.013; Coulson M, 2004, J NONVERBAL BEHAV, V28, P117, DOI 10.1023/B:JONB.0000023655.25550.be; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; De Clercq A, 2006, BEHAV RES METHODS, V38, P504, DOI 10.3758/BF03192805; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; Deuter CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049866; DUCLOS SE, 1989, J PERS SOC PSYCHOL, V57, P100, DOI 10.1037/0022-3514.57.1.100; ENGELEN U, 2006, GEDRAG GEZONDHEID, P89; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Flack WF, 2006, COGNITION EMOTION, V20, P177, DOI 10.1080/02699930500359617; Gable PA, 2009, PSYCHOPHYSIOLOGY, V46, P487, DOI 10.1111/j.1469-8986.2009.00794.x; HONIG E, 1990, CLIN METHODS, P193; Landis C, 1939, STARTLE PATTERN; O'Sullivan PB, 2006, SPINE, V31, pE707, DOI 10.1097/01.brs.0000234735.98075.50; Oosterwijk S, 2009, EUR J SOC PSYCHOL, V39, P457, DOI 10.1002/ejsp.584; PAPPENS M, 2012, INT J PSYCHOPHYSIOLO; Pappens M, 2011, INT J PSYCHOPHYSIOL, V80, P161, DOI 10.1016/j.ijpsycho.2011.02.015; Pappens M, 2010, BIOL PSYCHOL, V84, P98, DOI 10.1016/j.biopsycho.2010.02.006; PEPER E, 2012, BIOFEEDBACK, V40, P125, DOI DOI 10.5298/1081-5937-40.3.01; Price TF, 2012, BIOL PSYCHOL, V90, P211, DOI 10.1016/j.biopsycho.2012.04.001; Price TF, 2012, MOTIV EMOTION, V36, P27, DOI 10.1007/s11031-011-9258-1; Price TF, 2011, PSYCHOPHYSIOLOGY, V48, P718, DOI 10.1111/j.1469-8986.2010.01127.x; RISKIND J H, 1982, Motivation and Emotion, V6, P273, DOI 10.1007/BF00992249; Schachinger H, 2009, PSYCHOPHYSIOLOGY, V46, pS17; Sikirov D, 2003, DIGEST DIS SCI, V48, P1201, DOI 10.1023/A:1024180319005; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Van Breukelen GJP, 2007, J INT NEUROPSYCH SOC, V13, P903, DOI 10.1017/S1355617707071147; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; WIELGOSZ J, 2012, PROTECTIVE BODY POST; Williams LA, 2009, PSYCHOL SCI, V20, P284, DOI 10.1111/j.1467-9280.2009.02292.x; World Medical Association, 2008, DECL HELS ETH PRINC; Yeomans JS, 2002, NEUROSCI BIOBEHAV R, V26, P1, DOI 10.1016/S0149-7634(01)00057-4	39	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88482	10.1371/journal.pone.0088482	http://dx.doi.org/10.1371/journal.pone.0088482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1CR	24516664	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400072
J	Regev-Yochay, G; Rahav, G; Riesenberg, K; Wiener-Well, Y; Strahilevitz, J; Stein, M; Glikman, D; Weber, G; Potasman, I; Dagan, R				Regev-Yochay, Gili; Rahav, Galia; Riesenberg, Klaris; Wiener-Well, Yonit; Strahilevitz, Jacob; Stein, Michal; Glikman, Daniel; Weber, Gabriel; Potasman, Israel; Dagan, Ron		IAIPD Study Grp	Initial Effects of the National PCV7 Childhood Immunization Program on Adult Invasive Pneumococcal Disease in Israel	PLOS ONE			English	Article							CONJUGATE VACCINE INTRODUCTION; STREPTOCOCCUS-PNEUMONIAE; CHANGING EPIDEMIOLOGY; SEROTYPES; CHILDREN; CANADA; TRENDS; IMPACT; CARRIAGE; PRE	Background: PCV7 was introduced as universal childhood vaccination in Israel in July 2009 and PCV13 in November 2010. Here we report data on adult invasive pneumococcal disease (IPD), two years post PCV7 implementation and before an expected effect of PCV13. Methods: An ongoing nationwide active-surveillance (all 27 laboratories performing blood cultures in Israel), providing all blood & CSF S. pneumoniae isolates from persons >18 y was initiated in July 2009. Capture-recapture method assured reporting of >95% cases. All isolates were serotyped in one central laboratory. IPD outcome and medical history were recorded in 90%. Second year post PCV implementation is compared to the first year. Results: During July 2009 to June 2011, 970 IPD cases were reported (annual incidence [/100,000] of 9.17 and 10.16 in the two consecutive years, respectively). Respective case fatality rates (CFRs) were 20% and 19.1%. Incidence of IPD and CFR increased with age and number of comorbidities. Incidence rate was significantly greater during the second winter, 7.79/100,000 vs. 6.14/100,000 in first winter, p = 0.004, with a non-significant decrease during summer months (3.02 to 2.48/100,000). The proportion of IPD cases due to PCV7-serotypes decreased from 27.5% to 13.1% (first to second year) (p<0.001). Yet, non-PCV13-strains increased from 32.7% to 40.2% (p = 0.017). The increase in non-PCV13-strains was highly significant in immunocompromised patients and to a lesser degree in non-immunocompromised at risk or in older patients (>64 y). Among younger/healthier patients serotype 5 was the major increasing serotype. Penicillin and ceftriaxone resistance decreased significantly in the second year. Conclusions: While overall annual incidence of IPD did not change, the indirect effect of PCV7 vaccination was evident by the significant decrease in PCV7 serotypes across all age groups. Increase in non-VT13 strains was significant in immunocompromised patients. A longer follow-up is required to appreciate the full effect of infant vaccination on annual IPD.	[Regev-Yochay, Gili; Rahav, Galia] Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel; [Riesenberg, Klaris] Soroka Univ, Med Ctr, Beer Sheva, Israel; [Wiener-Well, Yonit] Shaare Zedek Med Ctr, Infect Dis Unit, Jerusalem, Israel; [Strahilevitz, Jacob] Hadassah Hebrew Univ, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel; [Stein, Michal] Wolfson Med Ctr, Pediat Infect Dis Unit, Holon, Israel; [Glikman, Daniel] Western Galilee Hosp, Pediat Infect Dis Serv, Nahariyya, Israel; [Weber, Gabriel] Carmel Hosp, Infect Dis Unit, Haifa, Israel; [Potasman, Israel] Bnei Zion Med Ctr, Infect Dis Unit, Haifa, Israel; [Dagan, Ron] Soroka Univ, Med Ctr, Pediat Infect Dis Unit, Beer Sheva, Israel; [Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel	Chaim Sheba Medical Center; Ben Gurion University; Soroka Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Western Galilee Hospital; Clalit Health Services; Carmel Medical Center; Bnai Zion Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Regev-Yochay, G (corresponding author), Sheba Med Ctr, Infect Dis Unit, Ramat Gan, Israel.	gregev@hsph.harvard.edu	Goral, Aviva/K-8254-2016; RIESENBERG, KLARIS/F-1132-2012	Goral, Aviva/0000-0002-0784-0569; Glikman, Daniel/0000-0002-8006-5845; Regev-Yochay, Gili/0000-0001-7163-4607	Wyeth (Pfizer) [0887X1-4603]; Sheba Med Ctr; Soroka University Med Ctr	Wyeth (Pfizer)(WyethPfizer); Sheba Med Ctr; Soroka University Med Ctr	The study was supported in part by Wyeth (Pfizer), Grant No. 0887X1-4603. The commercial company had no role in designing the study, collecting the data, data analyses, interpretation of the data, writing the report or in the decision to submit the paper for publication. Other sources of support were internal organizational (Sheba Med Ctr & Soroka University Med Ctr). This does not alter our adherence to all PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Balicer RD, 2010, VACCINE, V28, P5591, DOI 10.1016/j.vaccine.2010.06.031; Ben-Shimol S, 2012, VACCINE, V30, P6600, DOI 10.1016/j.vaccine.2012.08.012; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Cadeddu C, 2012, J Prev Med Hyg, V53, P101; Chibuk TK, 2010, EUR J PEDIATR, V169, P1123, DOI 10.1007/s00431-010-1195-6; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; dos Santos SR, 2013, VACCINE, V31, P6150, DOI 10.1016/j.vaccine.2013.05.042; Fedson DS, 2013, HUM VACC IMMUNOTHER, V9, P1382, DOI 10.4161/hv.24692; Fleming-Dutra KE, 2013, J INFECT DIS, V207, P1135, DOI 10.1093/infdis/jit008; Gertz RE, 2010, J INFECT DIS, V201, P770, DOI 10.1086/650496; Hanage WP, 2007, J INFECT DIS, V195, P347, DOI 10.1086/510249; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Kellner JD, 2009, CLIN INFECT DIS, V49, P205, DOI 10.1086/599827; Kendall BA, 2011, VACCINE, V29, P9123, DOI 10.1016/j.vaccine.2011.10.009; Lee BE, 2010, INFECT CONT HOSP EP, V31, P535, DOI 10.1086/652159; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Liesenborghs L, 2013, VACCINE, V31, P1529, DOI 10.1016/j.vaccine.2012.11.103; Maraki S, 2010, EUR J CLIN MICROBIOL, V29, P1449, DOI 10.1007/s10096-010-1005-0; Melegaro A, 2004, EUR J EPIDEMIOL, V19, P353, DOI 10.1023/B:EJEP.0000024701.94769.98; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Regev-Yochay G, 2013, VACCINE, V31, P2387, DOI 10.1016/j.vaccine.2013.02.059; Rose M, 2009, EXPERT REV VACCINES, V8, P1351, DOI [10.1586/erv.09.78, 10.1586/ERV.09.78]; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Shrestha S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005982; Tyrrell GJ, 2012, EMERG INFECT DIS, V18, P733, DOI 10.3201/eid1805.110235; Tyrrell GJ, 2009, VACCINE, V27, P3553, DOI 10.1016/j.vaccine.2009.03.063; van Gils EJM, 2010, JAMA-J AM MED ASSOC, V304, P1099, DOI 10.1001/jama.2010.1290; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Weinberger DM, 2014, EUR RESPIR J, V43, P833, DOI 10.1183/09031936.00056813; Williams SR, 2011, MED J AUSTRALIA, V194, P116, DOI 10.5694/j.1326-5377.2011.tb04192.x	34	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88406	10.1371/journal.pone.0088406	http://dx.doi.org/10.1371/journal.pone.0088406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516649	Green Published, Green Submitted, gold			2022-12-27	WOS:000330834400065
J	Ackermann, MA; Shriver, M; Perry, NA; Hu, LYR; Kontrogianni-Konstantopoulos, A				Ackermann, Maegen A.; Shriver, Marey; Perry, Nicole A.; Hu, Li-Yen R.; Kontrogianni-Konstantopoulos, Aikaterini			Obscurins: Goliaths and Davids Take over Non-Muscle Tissues	PLOS ONE			English	Article							UNIDENTIFIED HUMAN GENES; PROTEINS IN-VITRO; EXCHANGE FACTOR DOMAIN; LIGHT-CHAIN KINASES; SMALL ANKYRIN 1; SARCOPLASMIC-RETICULUM; COMPLETE SEQUENCES; CDNA-CLONES; CODING SEQUENCES; SKELETAL-MUSCLE	Obscurins comprise a family of proteins originally identified in striated muscles, where they play essential roles in myofibrillogenesis, cytoskeletal organization, and Ca2+ homeostasis. They are encoded by the single OBSCN gene, and are composed of tandem adhesion domains and signaling motifs. To date, two giant obscurin isoforms have been described in detail that differ only at the extreme COOH-terminus; while obscurin-A (similar to 720 kDa) contains a non-modular COOH-terminus that harbors binding sites for the adaptor proteins ankyrins, obscurin-B (similar to 870 kDa) contains two COOH-terminal serine-threonine kinase domains preceded by adhesion motifs. Besides the two known giant obscurins, a thorough search of transcript databases suggests that complex alternative splicing of the obscurin transcript results in the generation of additional giant as well as small isoforms with molecular masses ranging between,50-970 kDa. These novel isoforms share common domains with the characterized isoforms, but also contain unique regions. Using a panel of highly specific antibodies directed against epitopes spanning the entire length of giant obscurins, we employed western blotting and immunohistochemistry to perform a systematic and comprehensive characterization of the expression profile of obscurins in muscle and non-muscle tissues. Our studies demonstrate for the first time that obscurins are not restricted to striated muscles, but are abundantly expressed in several tissues and organs including brain, skin, kidney, liver, spleen, and lung. While some obscurin isoforms are ubiquitously expressed, others are preferentially present in specific tissues and organs. Moreover, obscurins are present in select structures and cell types where they assume nuclear, cytosolic, and membrane distributions. Given the ubiquitous expression of some obscurins, along with the preferential expression of others, it becomes apparent that obscurins may play common and unique roles, respectively, in the regulation and maintenance of cell homeostasis in various tissues and organs throughout the body.	[Ackermann, Maegen A.; Shriver, Marey; Perry, Nicole A.; Hu, Li-Yen R.; Kontrogianni-Konstantopoulos, Aikaterini] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kontrogianni-Konstantopoulos, A (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	akons001@umaryland.edu		Shriver, Marey/0000-0002-1644-6408; Lieberman, Nicole/0000-0001-9334-8150	National Institutes of Health [R01 AR52768, K99 KHL116778A, 2T32AR7592-16]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592, R01AR052768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors' research has been supported by grants to A. K. K. from the National Institutes of Health (R01 AR52768), to M. A. A. from the National Institutes of Health (K99 KHL116778A), and to L.-Y.R.H. from the NIH training grant (2T32AR7592-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; ANDERSON JM, 1974, BIOCHEMISTRY-US, V13, P1195, DOI 10.1021/bi00703a602; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Borisov AB, 2006, HISTOCHEM CELL BIOL, V125, P227, DOI 10.1007/s00418-005-0069-x; Borisov AB, 2004, J HISTOCHEM CYTOCHEM, V52, P1117, DOI 10.1369/jhc.3A6183.2004; Borisov AB, 2003, BIOCHEM BIOPH RES CO, V310, P910, DOI 10.1016/j.bbrc.2003.09.035; Borisov AB, 2008, J CELL BIOCHEM, V103, P1621, DOI 10.1002/jcb.21551; Borisov AB, 2008, HISTOCHEM CELL BIOL, V129, P463, DOI 10.1007/s00418-008-0378-y; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Busby B, 2011, J MOL BIOL, V408, P321, DOI 10.1016/j.jmb.2011.01.053; Busby B, 2010, BIOCHEMISTRY-US, V49, P9948, DOI 10.1021/bi101165p; Carlsson L, 2008, HISTOCHEM CELL BIOL, V130, P91, DOI 10.1007/s00418-008-0413-z; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; DIJKSTRA CD, 1985, ADV EXP MED BIOL, V186, P409; Ford-Speelman DL, 2009, MOL BIOL CELL, V20, P3905, DOI 10.1091/mbc.E08-10-1029; Fukuzawa A, 2008, J CELL SCI, V121, P1841, DOI 10.1242/jcs.028019; Fukuzawa A, 2005, J MUSCLE RES CELL M, V26, P427, DOI 10.1007/s10974-005-9025-6; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Giacomello E, 2009, HISTOCHEM CELL BIOL, V131, P371, DOI 10.1007/s00418-008-0534-4; Hu L.-Y., 2013, FASEB J; Hu LYR, 2013, FASEB J, V27, P2001, DOI 10.1096/fj.12-221317; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2005, J MUSCLE RES CELL M, V26, P419, DOI 10.1007/s10974-005-9024-7; Kontrogianni-Konstantopoulos A, 2006, FASEB J, V20, P2102, DOI 10.1096/fj.06-5761com; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Lange S, 2012, MOL BIOL CELL, V23, P2490, DOI 10.1091/mbc.E12-01-0052; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nagase T, 2000, DNA RES, V7, P273; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nagase T, 2000, DNA RES, V7, P347, DOI 10.1093/dnares/7.6.347; Perry NA, 2013, IUBMB LIFE; Perry NA, 2012, FASEB J, V26, P2764, DOI 10.1096/fj.12-205419; Raeker MO, 2006, DEV DYNAM, V235, P2018, DOI 10.1002/dvdy.20812; Raeker MO, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/479135; Raeker MO, 2010, DEV BIOL, V337, P432, DOI 10.1016/j.ydbio.2009.11.018; Randazzo D, 2013, J CELL BIOL, V200, P523, DOI 10.1083/jcb.201205118; Russell MW, 2002, GENE, V282, P237, DOI 10.1016/S0378-1119(01)00795-8; Singh I, 2011, TXB HUMAN HISTOLOGY; Sutter SB, 2004, DEV GENES EVOL, V214, P352, DOI 10.1007/s00427-004-0413-5; Treuting P.M., 2012, COMP ANATOMY HISTOLO; Willis CD, 2012, MOL MEMBR BIOL, V29, P36, DOI 10.3109/09687688.2012.660709; Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110	52	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88162	10.1371/journal.pone.0088162	http://dx.doi.org/10.1371/journal.pone.0088162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516603	Green Published, gold			2022-12-27	WOS:000330830700050
J	Ke, K; Yuan, J; Morrissey, JH				Ke, Ke; Yuan, Jian; Morrissey, James H.			Tissue Factor Residues That Putatively Interact with Membrane Phospholipids	PLOS ONE			English	Article							FACTOR-FACTOR-VIIA; BLOOD-COAGULATION FACTOR; FACTOR-X; CRYSTAL-STRUCTURE; ACTIVE-SITE; SUBSTRATE RECOGNITION; ENERGY-TRANSFER; FACTOR REGION; GLA DOMAIN; ACTIVATION	Blood clotting is initiated by the two-subunit enzyme consisting of the plasma protease, factor VIIa (the catalytic subunit), bound to the integral membrane protein, tissue factor (the regulatory subunit). Molecular dynamics simulations have predicted that certain residues in the tissue factor ectodomain interact with phosphatidylserine headgroups to ensure optimal positioning of the tissue factor/factor VIIa complex relative to its membrane-bound protein substrates, factors IX and X. In this study, we individually mutated to alanine all the putative phosphatidylserine-interactive residues in the tissue factor ectodomain and measured their effects on tissue factor cofactor function (activation of factors IX and X by tissue factor/factor VIIa, and clotting of plasma). Some tissue factor mutants exhibited decreased activity in all three assays, with the most profound defects observed from mutations in or near the flexible loop from Lys159 to Gly164. The decreased activity of all of these tissue factor mutants could be partially or completely overcome by increasing the phosphatidylserine content of tissue factor-liposomes. Additionally, yeast surface display was used to screen a random library of tissue factor mutants for enhanced factor VIIa binding. Surprisingly, mutations at a single amino acid (Lys165) predominated, with the Lys165 -> Glu mutant exhibiting a 3-fold enhancement in factor VIIa binding affinity. Our studies reveal the functional contributions of residues in the C-terminal half of the tissue factor ectodomain that are implicated in interacting with phosphatidylserine headgroups to enhance tissue factor cofactor activity, possibly by allosterically modulating the conformation of the adjacent substrate-binding exosite region of tissue factor.	[Ke, Ke; Yuan, Jian; Morrissey, James H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Morrissey, JH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	jhmorris@illinois.edu	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569	National Heart, Lung and Blood Institute of the National Institutes of Health [R01 HL047014]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014, R01HL103999] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant R01 HL047014 from the National Heart, Lung and Blood Institute of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Carlsson K, 2003, EUR J BIOCHEM, V270, P2576, DOI 10.1046/j.1432-1033.2003.03625.x; FIORE MM, 1994, J BIOL CHEM, V269, P143; HARLOS K, 1994, NATURE, V370, P662, DOI 10.1038/370662a0; Huang QL, 1996, J BIOL CHEM, V271, P21752, DOI 10.1074/jbc.271.36.21752; KELLEY RF, 1995, BIOCHEMISTRY-US, V34, P10383, DOI 10.1021/bi00033a009; Kirchhofer D, 2000, BIOCHEMISTRY-US, V39, P7380, DOI 10.1021/bi000182+; Kirchhofer D, 2001, BIOCHEMISTRY-US, V40, P675, DOI 10.1021/bi002013v; Manithody C, 2007, BIOCHEMISTRY-US, V46, P3193, DOI 10.1021/bi6025193; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; McCallum CD, 1997, J BIOL CHEM, V272, P30160, DOI 10.1074/jbc.272.48.30160; Morrissey J. H., 2006, HEMOSTASIS THROMBOSI, P91; MORRISSEY JH, 1993, BLOOD, V81, P734; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; Morrissey JH, 1997, THROMB HAEMOSTASIS, V78, P112; Muller YA, 1996, J MOL BIOL, V256, P144, DOI 10.1006/jmbi.1996.0073; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; NEUENSCHWANDER PF, 1994, J BIOL CHEM, V269, P8007; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; REHEMTULLA A, 1992, BIOCHEM J, V282, P737, DOI 10.1042/bj2820737; REZAIE AR, 1992, PROTEIN EXPRES PURIF, V3, P453, DOI 10.1016/1046-5928(92)90062-2; ROY S, 1991, J BIOL CHEM, V266, P22063; RUF W, 1992, J BIOL CHEM, V267, P6375; RUF W, 1992, J BIOL CHEM, V267, P22206; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Starwalt SE, 2003, PROTEIN ENG, V16, P147, DOI 10.1093/proeng/gzg018; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Waters EK, 2006, BIOCHEMISTRY-US, V45, P3769, DOI 10.1021/bi052600m; Waters EK, 2006, J BIOL CHEM, V281, P26062, DOI 10.1074/jbc.M604915200; Zwaal RFA, 1998, BBA-REV BIOMEMBRANES, V1376, P433, DOI 10.1016/S0304-4157(98)00018-5	33	14	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88675	10.1371/journal.pone.0088675	http://dx.doi.org/10.1371/journal.pone.0088675			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516673	Green Published, Green Submitted, gold			2022-12-27	WOS:000330830700080
J	Manly, T; Fish, JE; Griffiths, S; Molenveld, M; Zhou, FZA; Davis, GJ				Manly, Tom; Fish, Jessica E.; Griffiths, Sarah; Molenveld, Meike; Zhou, Fanzhi A.; Davis, Greg J.			Unconscious Priming of Task-Switching Generalizes to an Untrained Task	PLOS ONE			English	Article							ACTIVATION; SETS	Evidence suggests that subliminal stimuli can influence ostensibly volitional, executive processes but it is unclear whether this is highly task-specific. To address this we used a set-switching task. Volunteers saw a word pair and reported either if both words had the same number of syllables or if both were concrete. Task selection was random and instructed by a hexagon/triangle preceding the words. A subliminally-presented square or diamond reliably preceded each of these consciously perceived instruction-shapes. Significant congruency effects were observed in a subsequent Test Phase in which primes no longer reliably predicted the task (and in which high/low tones now served as conscious instructions). The Generalization Phase required novel phonological (rhyme) or semantic (category) judgments. Remarkably, unconscious priming congruency effects carried over in those participants who had shown priming in the Test Phase, the degree correlating across the two conditions. In a final phase of the study, participants were asked to discriminate between the two originally presented prime shapes. Those participants whose discriminations were more accurate showed reduced priming relative to participants with less accurate discriminations. The results suggest that, rather than being highly task specific, priming can operate at the level of a generalizable process and that greater awareness of primes may lessen their impact on behavior.	[Manly, Tom; Fish, Jessica E.; Griffiths, Sarah; Molenveld, Meike] Med Res Council Cognit & Brain Sci Unit, Cambridge, England; [Fish, Jessica E.] Kings Coll London, Inst Psychiat, Dept Psychol, London WC2R 2LS, England; [Zhou, Fanzhi A.; Davis, Greg J.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of Cambridge	Manly, T (corresponding author), Med Res Council Cognit & Brain Sci Unit, Cambridge, England.	tom.manly@mrc-cbu.cam.ac.uk	Fish, Jessica/HGU-9515-2022	Fish, Jessica/0000-0002-9337-1489; Griffiths, Sarah Louise/0000-0002-0720-4511	Medical Research Council [MC-A060-5PQ20]; John Templeton Foundation; Medical Research Council [MC_U105559837] Funding Source: researchfish; MRC [MC_U105559837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); John Templeton Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council (MC-A060-5PQ20). GJD is supported by a John Templeton Foundation Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Huber DE, 2002, J EXP PSYCHOL LEARN, V28, P1120, DOI 10.1037//0278-7393.28.6.1120; Kinoshita S, 2010, Q J EXP PSYCHOL, V63, P194, DOI 10.1080/17470210902957174; Kunde W, 2003, COGNITION, V88, P223, DOI 10.1016/S0010-0277(03)00023-4; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Mattler U, 2005, PERCEPT PSYCHOPHYS, V67, P285, DOI 10.3758/BF03206492; Mattler U, 2003, PERCEPT PSYCHOPHYS, V65, P167, DOI 10.3758/BF03194793; Plaut DC, 2000, PSYCHOL REV, V107, P786, DOI 10.1037//0033-295X.107.4.786; Reuss H, 2011, CONSCIOUS COGN, V20, P556, DOI 10.1016/j.concog.2011.02.014; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Weibel S, 2013, CONSCIOUS COGN, V22, P517, DOI 10.1016/j.concog.2013.02.010; Yee E, 2012, PSYCHOL SCI, V23, P364, DOI 10.1177/0956797611430691; Zhou FA, 2012, ATTEN PERCEPT PSYCHO, V74, P105, DOI 10.3758/s13414-011-0221-8	15	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88416	10.1371/journal.pone.0088416	http://dx.doi.org/10.1371/journal.pone.0088416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1BH	24516655	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000330830700072
J	Djenontin, A; Pennetier, C; Zogo, B; Soukou, KB; Ole-Sangba, M; Akogbeto, M; Chandre, F; Yadav, R; Corbel, V				Djenontin, Armel; Pennetier, Cedric; Zogo, Barnabas; Soukou, Koffi Bhonna; Ole-Sangba, Marina; Akogbeto, Martin; Chandre, Fabrice; Yadav, Rajpal; Corbel, Vincent			Field Efficacy of Vectobac GR as a Mosquito Larvicide for the Control of Anopheline and Culicine Mosquitoes in Natural Habitats in Benin, West Africa	PLOS ONE			English	Article							MALARIA CONTROL; THURINGIENSIS-ISRAELENSIS; BACILLUS-SPHAERICUS; BURKINA-FASO; PREVENTION; TOXINS; NETS	Introduction: The efficacy of Vectobac GR (potency 200 ITU/mg), a new formulation of bacterial larvicide Bacillus thuringiensis var. israelensis Strain AM65-52, was evaluated against Anopheles gambiae and Culex quinquefasciatus in simulated field and natural habitats in Benin. Methods: In simulated field conditions, Vectobac GR formulation was tested at 3 dosages (0.6, 0.9, 1.2 g granules/m(2) against An. gambiae and 1, 1.5, 2 g granules/m(2) against Cx. quinquefasciatus) according to manufacturer's product label recommendations. The dosage giving optimum efficacy under simulated field conditions were evaluated in the field. The efficacy of Vectobac GR in terms of emergence inhibition in simulated field conditions and of reduction of larval and pupal densities in rice fields and urban cesspits was measured following WHO guidelines for testing and evaluation of mosquito larvicides. Results: Vectobac GR caused emergence inhibition of >= 80% until 21 [20-22] days for An. gambiae at 1.2 g/m(2) dose and 28 [27-29] days for Cx. quinquefasciatus at 2 g/m(2) in simulated field habitats. The efficacy of Vectobac GR in natural habitats was for 2 to 3 days against larvae and up to 10 days against pupae. Conclusions: Treatment with Vectobac GR caused complete control of immature mosquito within 2-3 days but did not show prolonged residual action. Larviciding can be an option for malaria and filariasis vector control particularly in managing pyrethroid-resistance in African malaria vectors. Since use of larvicides among several African countries is being emphasized through Economic Community of West Africa States, their epidemiological impact should be carefully investigated.	[Djenontin, Armel] Univ Abomey Calavi, Ctr Rech Entomol Cotonou, Fac Sci & Tech MIVEGEC IRD CNRS UM1 UM2 224 5290, Cotonou, Benin; [Pennetier, Cedric; Zogo, Barnabas; Soukou, Koffi Bhonna; Ole-Sangba, Marina] Ctr Rech Entomol Cotonou, MIVEGEC IRD CNRS UM1 UM2 224 5290, Cotonou, Benin; [Akogbeto, Martin] Univ Abomey Calavi, Ctr Rech Entomol Cotonou, Fac Sci & Tech, Cotonou, Benin; [Chandre, Fabrice] MIVEGEC IRD 224 CNRS 5290 UM1 UM2, Lab Lutte Insectes Nuisibles LIN, Montpellier, France; [Yadav, Rajpal] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Corbel, Vincent] Kasetsart Univ, Dept Entomol, MIVEGEC IRD CNRS UM1 UM2 224 5290, Ladyaow Chatuchak Bangko, Thailand	Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; Entomological Research Center of Cotonou (CREC); Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; World Health Organization	Djenontin, A (corresponding author), Univ Abomey Calavi, Ctr Rech Entomol Cotonou, Fac Sci & Tech MIVEGEC IRD CNRS UM1 UM2 224 5290, Cotonou, Benin.	armeldj@yahoo.fr; vincent.corbel@ird.fr	Chandre, Fabrice/Q-3429-2019; Pennetier, Cedric/K-2010-2016; Corbel, VIncent/G-9576-2016; Yadav, Rajpal Singh/AAX-4483-2020	Chandre, Fabrice/0000-0002-1994-9705; Yadav, Rajpal Singh/0000-0001-8264-1204; Pennetier, Cedric/0000-0002-3362-6371; corbel, vincent/0000-0003-0995-3257	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2008, Wkly Epidemiol Rec, V83, P177; Charles JF, 2000, MEM I OSWALDO CRUZ, V95, P201, DOI 10.1590/S0074-02762000000700034; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Economic Community of West African States (ECOWAS), 2011, ECOWAS TECHN M MAL V; Fillinger U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-353; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gimonneau G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-65; Haq S., 2004, Journal of Vector Borne Diseases, V41, P61; Kinde-Gazard D, 2012, MED MALADIES INFECT, V42, P114, DOI 10.1016/j.medmal.2012.01.010; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lagadic L, 2014, J APPL ECOL, V51, P102, DOI 10.1111/1365-2664.12165; Madliger M, 2011, ENVIRON SCI TECHNOL, V45, P4377, DOI 10.1021/es200022q; Majambere S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-76; Matthew TB, 2012, PLOS MED, V9; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Okumu FO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-208; PORTER AG, 1993, MICROBIOL REV, V57, P838, DOI 10.1128/MMBR.57.4.838-861.1993; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Skovmand O, 1999, J MED ENTOMOL, V36, P62, DOI 10.1093/jmedent/36.1.62; TOWNSON H, 2005, B WORLD HEALTH ORGAN, V83, P942; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2013, 2 WHO; WHO, 2011, WEEKLY EPIDEMIOLOGIC, P120; WHO, 2005, WHOCDSWHOPESGCDPP200	25	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87934	10.1371/journal.pone.0087934	http://dx.doi.org/10.1371/journal.pone.0087934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505334	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200086
J	Jiao, YJ; Legge, FS; Zeng, XY; Treutlein, HR; Zeng, J				Jiao, Yongjun; Legge, Fiona S.; Zeng, Xiaoyan; Treutlein, Herbert R.; Zeng, Jun			Antibody Recognition of Shiga Toxins (Stxs): Computational Identification of the Epitopes of Stx2 Subunit A to the Antibodies 11E10 and S2C4	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; MONOCLONAL-ANTIBODY; ESCHERICHIA-COLI; SHIGELLA-DYSENTERIAE; CRYSTAL-STRUCTURE; 3 REGIONS; DESIGN; NEUTRALIZES; INHIBITORS; BINDING	We have recently developed a new method to predict the epitopes of the antigens that are recognized by a specific antibody. In this work, we applied the method to identify the epitopes of the Shiga toxin (Stx2 subunit A) that were bound by two specific antibodies 11E10 and S2C4. The predicted epitopes of Stx2 binding to the antibody 11E10 resembles the recognition surface constructed by the regions of Stx2 identified experimentally. For the S2C4, our results indicate that the antibody recognizes the Stx2 at two different regions on the protein surface. The first region (residues 246-254: ARSVRAVNE) is similar to the recognition region of the 11E10, while the second region is formed by two epitopes. The second region is particularly significant because it includes the amino acid sequence region that is diverse between Stx2 and other Stx (residues 176-188: QREFRQALSETAPV). This new recognition region is believed to play an important role in the experimentally observed selectivity of S2C4 to the Stx2.	[Jiao, Yongjun; Zeng, Xiaoyan] Minist Hlth, Key Lab Enter Pathogen Microbiol, Jiangsu Prov Ctr Dis Prevent & Control, Inst Pathogen Microbiol, Nanjing, Jiangsu, Peoples R China; [Treutlein, Herbert R.; Zeng, Jun] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Legge, Fiona S.; Treutlein, Herbert R.; Zeng, Jun] Computist Bionanotech, Small Technol Clusters, Scoresby, Vic, Australia	Monash University	Treutlein, HR (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia.	Herbert.Treutlein@computistresearch.com; Jun.Zeng@computistresearch.com	Treutlein, Herbert Rudolf/AAC-7648-2021	Treutlein, Herbert Rudolf/0000-0001-5553-5553; Zeng, Jun/0000-0002-2736-1928	Jiangsu Province's Natural Science Foundation [BK2006242]; Outstanding Medical Academic Leader Program [RC2011082]; National Mega-Projects for Infectious Diseases from Ministry of Science and Technology [2011ZX10004-902, 2013ZX09102029]	Jiangsu Province's Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Outstanding Medical Academic Leader Program; National Mega-Projects for Infectious Diseases from Ministry of Science and Technology	This work was supported by grants from Jiangsu Province's Natural Science Foundation (BK2006242), Outstanding Medical Academic Leader Program (RC2011082), and National Mega-Projects for Infectious Diseases (2011ZX10004-902, 2013ZX09102029) from Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; CAFLISCH A, 1995, J MOL BIOL, V252, P672, DOI 10.1006/jmbi.1995.0528; Caflisch A, 1996, J COMPUT AID MOL DES, V10, P372, DOI 10.1007/BF00124471; CAFLISCH A, 1993, J MED CHEM, V36, P2142, DOI 10.1021/jm00067a013; DONOHUEROLFE A, 1989, MOL MICROBIOL, V3, P1231, DOI 10.1111/j.1365-2958.1989.tb00273.x; Dowling TC, 2005, ANTIMICROB AGENTS CH, V49, P1808, DOI 10.1128/AAC.49.5.1808-1812.2005; Edwards AC, 1998, ESCHERICHIA COLI O15; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; Franklin MC, 2011, STRUCTURE, V19, P1097, DOI 10.1016/j.str.2011.01.019; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; FURUTANI M, 1990, MICROBIOL IMMUNOL, V34, P387, DOI 10.1111/j.1348-0421.1990.tb01019.x; [郭喜玲 Guo Xiling], 2010, [医学分子生物学杂志, Journal of Medical Molecular Biology], V7, P382; Higuchi R., 1989, PCR TECHNOLOGY, P61; Housset D, 1997, EMBO J, V16, P4205, DOI 10.1093/emboj/16.14.4205; JACKSON MP, 1987, MICROB PATHOGENESIS, V2, P147, DOI 10.1016/0882-4010(87)90106-9; Jiao YJ, 2009, PROG BIOCHEM BIOPHYS, V36, P736, DOI 10.3724/SP.J.1206.2008.00415; Kimura T, 2002, HYBRIDOMA HYBRIDOM, V21, P161, DOI 10.1089/153685902760173872; KOZLOV YV, 1988, GENE, V67, P213, DOI 10.1016/0378-1119(88)90398-8; Ma Y, 2008, IMMUNOL LETT, V121, P110, DOI 10.1016/j.imlet.2008.09.008; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahalingam B, 2011, J IMMUNOL, V187, P6393, DOI 10.4049/jimmunol.1102394; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mukherjee J, 2002, INFECT IMMUN, V70, P612, DOI 10.1128/IAI.70.2.612-619.2002; Nakao H, 1999, INFECT IMMUN, V67, P5717, DOI 10.1128/IAI.67.11.5717-5722.1999; PERERA LP, 1988, J CLIN MICROBIOL, V26, P2127, DOI 10.1128/JCM.26.10.2127-2131.1988; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; SIMONSON T, 1994, J PHYS CHEM-US, V98, P4683, DOI 10.1021/j100068a033; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; Stinson JR, 2007, US Patent, Patent No. [US2007/0160607 A1, 20070160607]; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Zeng J, 1999, PROTEIN ENG, V12, P457, DOI 10.1093/protein/12.6.457; Zeng J, 2001, J COMPUT AID MOL DES, V15, P573, DOI 10.1023/A:1011145123635; Zeng J, 2001, PROTEIN ENG, V14, P39, DOI 10.1093/protein/14.1.39; Zeng J, 2000, COMB CHEM HIGH T SCR, V3, P355, DOI 10.2174/1386207003331490; Zhang WS, 2013, J COMPUT AID MOL DES, V27, P539, DOI 10.1007/s10822-013-9661-7; Zheng H, 2005, MICROBIOL IMMUNOL, V49, P1019, DOI 10.1111/j.1348-0421.2005.tb03698.x	39	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88191	10.1371/journal.pone.0088191	http://dx.doi.org/10.1371/journal.pone.0088191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24516609	gold, Green Published, Green Submitted			2022-12-27	WOS:000330829200132
J	Khanjani, S; Khanmohammadi, M; Zarnani, AH; Akhondi, MM; Ahani, A; Ghaempanah, Z; Naderi, MM; Eghtesad, S; Kazemnejad, S				Khanjani, Sayeh; Khanmohammadi, Manijeh; Zarnani, Amir-Hassan; Akhondi, Mohammad-Mehdi; Ahani, Ali; Ghaempanah, Zahra; Naderi, Mohammad Mehdi; Eghtesad, Saman; Kazemnejad, Somaieh			Comparative Evaluation of Differentiation Potential of Menstrual Blood- Versus Bone Marrow- Derived Stem Cells into Hepatocyte-Like Cells	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; HUMAN PLATELET RELEASATE; HEPATOGENIC DIFFERENTIATION; FUNCTIONAL HEPATOCYTES; EFFICIENT DIFFERENTIATION; MESENCHYMAL CELLS; LIVER DEVELOPMENT; PROGENITOR CELLS; STROMAL CELLS; TRANSPLANTATION	Menstrual blood has been introduced as an easily accessible and refreshing stem cell source with no ethical consideration. Although recent works have shown that menstrual blood stem cells (MenSCs) possess multi lineage differentiation capacity, their efficiency of hepatic differentiation in comparison to other stem cell resources has not been addressed so far. The aim of this study was to investigate hepatic differentiation capacity of MenSCs compared to bone marrow-derived stem cells (BMSCs) under protocols developed by different concentrations of hepatocyte growth factor (HGF) and oncostatin M (OSM) in combination with other components in serum supplemented or serum-free culture media. Such comparison was made after assessment of immunophenotye, trans-differentiation potential, immunogenicity and tumorigeicity of these cell types. The differential expression of mature hepatocyte markers such as albumin (ALB), cytokeratin 18 (CK-18), tyrosine aminotransferase and cholesterol 7 alpha-hydroxylase activities (CYP7A1) at both mRNA and protein levels in differentiating MenSCs was significantly higher in upper concentration of HGF and OSM (P1) compared to lower concentration of these factors (P2). Moreover, omission of serum during differentiation process (P3) caused typical improvement in functions assigned to hepatocytes in differentiated MenSCs. While up-regulation level of ALB and CYP7A1 was higher in differentiated MenSCs compared to driven BMSCs, expression level of CK-18, detected level of produced ALB and glycogen accumulation were lower or not significantly different. Therefore, based on the overall comparable hepatic differentiation ability of MenSCs with BMSCs, and also accessibility, refreshing nature and lack of ethical issues of MenSCs, these cells could be suggested as an apt and safe alternative to BMSCs for future stem cell therapy of chronic liver diseases.	[Khanjani, Sayeh; Khanmohammadi, Manijeh; Akhondi, Mohammad-Mehdi; Ahani, Ali; Ghaempanah, Zahra; Naderi, Mohammad Mehdi; Kazemnejad, Somaieh] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Zarnani, Amir-Hassan] ACECR, Avicenna Res Inst, Nanobiotechnol Res Ctr, Tehran, Iran; [Zarnani, Amir-Hassan] Iran Univ Med Sci, Immunol Res Ctr, Tehran, Iran; [Eghtesad, Saman] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Iran University of Medical Sciences; University System of Maryland; University of Maryland Baltimore	Kazemnejad, S (corresponding author), ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran.	s.kazemnejad@avicenna.ac.ir	Naderi, Mohammad Mehdi/AAA-1021-2020; Kazemnejad, Somaieh/AAD-7963-2019; Kazemnejad, Somaieh/O-6577-2018	Naderi, Mohammad Mehdi/0000-0002-7319-2424; Kazemnejad, Somaieh/0000-0003-1808-8357; Ahani, Ali/0000-0001-8109-1554; Akhondi, Mohammad mehdi/0000-0003-1707-3874	Iranian Stem Cell Network, a non-commercial organization	Iranian Stem Cell Network, a non-commercial organization	This research was supported by a research grant from the Iranian Stem Cell Network, a non-commercial organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Allameh A, 2012, CLIN BIOCHEM, V45, P385, DOI 10.1016/j.clinbiochem.2012.01.017; Allickson Julie G, 2011, Open Stem Cell J, V3, P4; Banas A, 2007, DEV DYNAM, V236, P3228, DOI 10.1002/dvdy.21330; Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712; Chivu M, 2009, TRANSL RES, V154, P122, DOI 10.1016/j.trsl.2009.05.007; Cui CH, 2007, MOL BIOL CELL, V18, P1586, DOI 10.1091/mbc.E06-09-0872; Darzi S, 2012, TISSUE ENG PT A, V18, P1720, DOI [10.1089/ten.tea.2011.0386, 10.1089/ten.TEA.2011.0386]; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Feldstein AE, 2009, HEPATOLOGY, V50, P1072, DOI 10.1002/hep.23050; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Grisham J. W., 1997, P233, DOI 10.1016/B978-012563455-7/50009-X; Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Henningson Jr CT, 2003, J ALLERGY CLIN IMMUN, V111, P5745; Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826; Ji R, 2012, BIOMATERIALS, V33, P8995, DOI 10.1016/j.biomaterials.2012.08.058; Kazemnejad S, 2008, VOX SANG, V95, P149, DOI 10.1111/j.1423-0410.2008.01075.x; Kazemnejad S, 2013, METHODS MOL BIOL, V1058, P149, DOI 10.1007/7651_2013_9; Kazemnejad S, 2009, J GASTROEN HEPATOL, V24, P278, DOI 10.1111/j.1440-1746.2008.05530.x; Khanjani S, 2013, J TIS ENG R IN PRESS; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; Lee HJ, 2012, DIFFERENTIATION, V84, P223, DOI 10.1016/j.diff.2012.05.007; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Li Y, 2013, STEM CELLS DEV, V22, P1147, DOI 10.1089/scd.2012.0428; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57; MOONEY DJ, 1995, J CELL SCI, V108, P2311; Musina RA, 2008, B EXP BIOL MED+, V145, P539, DOI 10.1007/s10517-008-0136-0; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004; Rodrigues MCO, 2012, NEUROSCI BIOBEHAV R, V36, P177, DOI 10.1016/j.neubiorev.2011.05.010; Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rodrigues DD, 2012, CELL TRANSPLANT, V21, P2215, DOI 10.3727/096368912X653048; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanberg PR, 2011, CELL TRANSPLANT, V20, P85, DOI 10.3727/096368910X532855; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Stock P, 2008, TRANSPL P, V40, P620, DOI 10.1016/j.transproceed.2008.01.058; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	49	47	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86075	10.1371/journal.pone.0086075	http://dx.doi.org/10.1371/journal.pone.0086075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505254	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200014
J	Kim, Y; Guntupalli, SR; Lee, SJ; Behbakht, K; Theodorescu, D; Lee, JK; Diamond, JR				Kim, Youngchul; Guntupalli, Saketh R.; Lee, Sun J.; Behbakht, Kian; Theodorescu, Dan; Lee, Jae K.; Diamond, Jennifer R.			Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; SIGNATURE	Aggressive tumors such as epithelial ovarian cancer (EOC) are highly heterogeneous in their therapeutic response, making it difficult to improve overall response by using drugs in unselected patients. The goal of this study was to retrospectively, but independently, examine whether biomarker-based personalized chemotherapy selection could improve survival of EOC patients. Using in vitro drug sensitivity and patient clinical outcome data, we have developed co-expression extrapolation (COXEN) biomarker models for predicting patient response to three standard chemotherapy drugs used to treat advanced EOC: paclitaxel, cyclophosphamide, and topotecan, for which sufficient patient data were available for our modeling and independent validation. Four different cohorts of 783 EOC patients were used in our study, including two cohorts of 499 patients for independent validation. The COXEN predictors for the three drugs independently showed high prediction both for patient short-term therapeutic response and long-term survival for recurrent EOC. We then examined the potential clinical benefit of the simultaneous use of the three drug predictors for a large diverse EOC cohort in a prospective manner, finding that the median overall survival was 21 months longer for recurrent EOC patients who were treated with the predicted most effective chemotherapies. Survival improvement was greater for platinum-sensitive patients if they were treated with the predicted most beneficial drugs. Following the FDA guidelines for diagnostic prediction analysis, our study has retrospectively, yet independently, showed a potential for biomarker-based personalized chemotherapy selection to significantly improve survival of patients in the heterogeneous EOC population when using standard chemotherapies.	[Kim, Youngchul; Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22903 USA; [Guntupalli, Saketh R.; Behbakht, Kian; Theodorescu, Dan; Diamond, Jennifer R.] Univ Colorado, Ctr Canc, Univ Colorado Denver, Aurora, CO USA; [Lee, Sun J.] Konkuk Univ, Sch Med, Seoul, South Korea	University of Virginia; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Konkuk University; Konkuk University Medical Center	Lee, JK (corresponding author), Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22903 USA.	jaeklee@virginia.edu; Jennifer.diamond@ucdenver.edu			UVA Experimental Therapeutics and Cancer center; NATIONAL CANCER INSTITUTE [K23CA172691, P30CA044579] Funding Source: NIH RePORTER	UVA Experimental Therapeutics and Cancer center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders, UVA Experimental Therapeutics and Cancer center, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provide a support purely for scientific cancer research.	Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Ferriss JS, 2012, PLOS ONE IN PRESS; Ferriss JS, PLOS ONE, V7; Helleman J, 2006, INT J CANCER, V118, P1963, DOI 10.1002/ijc.21599; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Moller KA, 2004, GYNECOL ONCOL, V94, P170, DOI 10.1016/j.ygyno.2004.03.040; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Spentzos D, 2005, J CLIN ONCOL, V23, P7911, DOI 10.1200/JCO.2005.02.9363; TCGA_Consortium, 2010, NATURE, V474, P609; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Williams PD, 2009, CANCER RES, V69, P8302, DOI 10.1158/0008-5472.CAN-09-0798; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Zhou XHJ, 2005, NAT BIOTECHNOL, V23, P238, DOI 10.1038/nbt1058	19	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86532	10.1371/journal.pone.0086532	http://dx.doi.org/10.1371/journal.pone.0086532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505259	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200019
J	Lee, CJ; Huang, YC; Yang, S; Tsao, KC; Chen, CJ; Hsieh, YC; Chiu, CH; Lin, TY				Lee, Chia-Jie; Huang, Yhu-Chering; Yang, Shuan; Tsao, Kuo-Chien; Chen, Chih-Jung; Hsieh, Yu-Chia; Chiu, Cheng-Hsun; Lin, Tzou-Yien			Clinical Features of Coxsackievirus A4, B3 and B4 Infections in Children	PLOS ONE			English	Article							RESPIRATORY VIRAL-INFECTIONS; ENTEROVIRUS INFECTIONS; TAIWAN; SURVEILLANCE; OUTPATIENTS; CHUNGNAM; KOREA	Background: Clinical features of coxsackievirus A4 (CA4), B3 (CB3) and B4 (CB4) infections in children have not been comprehensively described. Methods/Principal Findings: From January 2004 to June 2012, a total of 386 children with culture-proven CA4, CB3 and CB4 infections treated at Chang Gung Memorial Hospital, including 296 inpatients (CA4, 103; CB3, 131; CB4, 62) and 90 outpatients (CA4, 55; CB3, 14; CB4, 21), were included. From outpatients, only demographics were extracted and from inpatients, detailed clinical and laboratory data were collected retrospectively. The mean age was 32.1 +/- 30.2 months; male to female ratio was 1.3: 1. Children with CB3 infection were youngest (76.6% < 3 years of age), and had a highest hospitalization rate (90.3%) and a longest duration of hospitalization (mean +/- SD, 7.5 +/- 6.2 days). Herpangina (74.8%) was the most common presentation for children with CA4 infection, aseptic meningitis (26.7%) and young infant with fever (23.7%) for those with CB3 infection, and herpangina (32.3%) and tonsillitis/pharyngitis (27.4%) for children with CB4 infection. Almost all the inpatients had fever (97.6%). Twelve out of thirteen (92.3%) children with complications and ten of 11 children with long-term sequelae had CB3 infections. Two fatal cases were noted, one due to myocarditis with CA4 infection and CB3 were detected from the other case which had hepatic necrosis with coagulopathy. The remaining 285 children (96.3%) recovered uneventfully. Conclusion: CA4, CB3 and CB4 infections in children had different clinical disease spectrums and involved different age groups. Though rare, severe diseases may occur, particularly caused by CB3.	[Lee, Chia-Jie; Huang, Yhu-Chering; Chen, Chih-Jung; Hsieh, Yu-Chia; Chiu, Cheng-Hsun; Lin, Tzou-Yien] Chang Gung Mem Hosp Linkou, Dept Pediat, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Yang, Shuan; Tsao, Kuo-Chien; Chen, Chih-Jung; Hsieh, Yu-Chia; Chiu, Cheng-Hsun; Lin, Tzou-Yien] Chang Gung Univ Coll Med, Tao Yuan, Taiwan; [Yang, Shuan; Tsao, Kuo-Chien] Chang Gung Mem Hosp Linkou, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Huang, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 490112]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a grant from Chang Gung Memorial Hospital (CMRPG 490112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Baek K, 2009, J MICROBIOL BIOTECHN, V19, P1055, DOI 10.4014/jmb.0810.584; Chen Ju-Hsin, 2007, 4 TEPHINET SE AS W P; Cherry JD, 2009, TXB PEDIAT INFECT DI, P2110; Hohenthal U, 2008, THORAX, V63, P658; Hsu CH, 2011, J MICROBIOL IMMUNOL, V44, P265, DOI 10.1016/j.jmii.2011.01.029; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kiang D, 2009, J CLIN VIROL, V45, P334, DOI 10.1016/j.jcv.2009.05.035; Lin TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07; Lin TY, 2004, J CLIN VIROL, V30, P81, DOI 10.1016/j.jcv.2003.08.014; Lin TY, 2003, PEDIATR INFECT DIS J, V22, P889, DOI 10.1097/01.inf.0000091294.63706.f3; Lo SH, 2011, J MICROBIOL IMMUNOL, V44, P252, DOI 10.1016/j.jmii.2011.01.031; Muir P, 1998, CLIN MICROBIOL REV, V11, P202, DOI 10.1128/CMR.11.1.202; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Trallero G, 2010, J CLIN VIROL, V47, P170, DOI 10.1016/j.jcv.2009.11.013; Tsai HP, 2001, J CLIN MICROBIOL, V39, P111, DOI 10.1128/JCM.39.1.111-118.2001; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Yen FB, 2009, J MICROBIOL IMMUNOL, V42, P38	21	34	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87391	10.1371/journal.pone.0087391	http://dx.doi.org/10.1371/journal.pone.0087391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504149	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800031
J	Behradfar, E; Nygren, A; Vigmond, EJ				Behradfar, Elham; Nygren, Anders; Vigmond, Edward J.			The Role of Purkinje-Myocardial Coupling during Ventricular Arrhythmia: A Modeling Study	PLOS ONE			English	Article							CONDUCTION SYSTEM; DEFIBRILLATION SHOCKS; RABBIT; ACTIVATION; HEART; FIBRILLATION; MUSCLE; FIBERS; HETEROGENEITY; PROPAGATION	The Purkinje system is the fast conduction network of the heart which couples to the myocardium at discrete sites called Purkinje-Myocyte Junctions (PMJs). However, the distribution and number of PMJs remains elusive, as does whether a particular PMJ is functional. We hypothesized that the Purkinje system plays a role during reentry and that the number of functional PMJs affect reentry dynamics. We used a computer finite element model of rabbit ventricles in which we varied the number of PMJs. Sustained, complex reentry was induced by applying an electric shock and the role of the Purkinje system in maintaining the arrhythmia was assessed by analyzing phase singularities, frequency of activation, and bidirectional propagation at PMJs. For larger junctional resistances, increasing PMJ density increased the mean firing rate in the Purkinje system, the percentage of successful retrograde conduction at PMJs, and the incidence of wave break on the epicardium. However, the mean firing of the ventricles was not affected. Furthermore, increasing PMJ density above 13/cm(2) did not alter reentry dynamics. For lower junctional resistances, the trend was not as clear. We conclude that Purkinje system topology affects reentry dynamics and conditions which alter PMJ density can alter reentry dynamics.	[Behradfar, Elham; Nygren, Anders; Vigmond, Edward J.] Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada; [Vigmond, Edward J.] Univ Bordeaux 1, Inst LIRYC, Bordeaux, France; [Vigmond, Edward J.] Univ Bordeaux 1, Lab IMB, Bordeaux, France	University of Calgary; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Behradfar, E (corresponding author), Univ Calgary, Dept Elect & Comp Engn, Calgary, AB, Canada.	ebehradf@ucalgary.ca			National Institutes of Health [R01HL101196]; government of France through the Agence National de la Recherche [ANR-10-IAHU-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); government of France through the Agence National de la Recherche; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was in part supported by a grant from the National Institutes of Health, grant number R01HL101196. This work was also partly supported through the Investment of the Future grant, ANR-10-IAHU-04, from the government of France through the Agence National de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOUD S, 1991, CIRC RES, V68, P1751, DOI 10.1161/01.RES.68.6.1751; Ashihara T, 2005, EUROPACE, V7, pS155, DOI 10.1016/j.eupc.2005.03.020; Aslanidi OV, 2010, BIOPHYS J, V98, P2420, DOI 10.1016/j.bpj.2010.02.033; Atkinson A, 2011, J MOL CELL CARDIOL, V51, P689, DOI 10.1016/j.yjmcc.2011.05.020; Azarov JE, 2007, COMP BIOCHEM PHYS A, V146, P310, DOI 10.1016/j.cbpa.2006.10.036; Bishop MJ, 2012, J PHYSIOL-LONDON, V590, P4515, DOI 10.1113/jphysiol.2012.229062; Bishop MJ, 2011, BIOPHYS J, V101, P2871, DOI 10.1016/j.bpj.2011.10.052; Bordas R, 2011, PROG BIOPHYS MOL BIO, V107, P90, DOI 10.1016/j.pbiomolbio.2011.05.002; Boyle PM, 2013, HEART RHYTHM, V10, P1710, DOI 10.1016/j.hrthm.2013.08.010; Boyle PM, 2013, HEART RHYTHM, V10, P444, DOI 10.1016/j.hrthm.2012.11.021; Boyle PM, 2010, ANN BIOMED ENG, V38, P456, DOI 10.1007/s10439-009-9829-4; Cooper LL, 2012, AM J PHYSIOL-HEART C, V302, pH1625, DOI 10.1152/ajpheart.00960.2011; Deo M, 2010, AM J PHYSIOL-HEART C, V299, pH1002, DOI 10.1152/ajpheart.01237.2009; Deo M, 2009, HEART RHYTHM, V6, P1782, DOI 10.1016/j.hrthm.2009.08.023; Dosdall DJ, 2008, AM J PHYSIOL-HEART C, V295, pH883, DOI 10.1152/ajpheart.00466.2008; Huizar JF, 2007, AM J PHYSIOL-HEART C, V293, pH1617, DOI 10.1152/ajpheart.00130.2007; Ijiri T, 2008, J PHYSIOL SCI, V58, P481, DOI 10.2170/physiolsci.RP003208; JANSE MJ, 1995, J CARDIOVASC ELECTR, V6, P512, DOI 10.1111/j.1540-8167.1995.tb00424.x; KIENZLE MG, 1987, CIRCULATION, V76, P860, DOI 10.1161/01.CIR.76.4.860; KRASSOWSKA W, 1995, PACE, V18, P1644, DOI 10.1111/j.1540-8159.1995.tb06986.x; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; MENDEZ C, 1970, CIRC RES, V26, P135, DOI 10.1161/01.RES.26.2.135; Morley GE, 2005, P NATL ACAD SCI USA, V102, P4126, DOI 10.1073/pnas.0500881102; Panfilov AV, 2006, HEART RHYTHM, V3, P862, DOI 10.1016/j.hrthm.2005.12.022; Romero D, 2010, ANN BIOMED ENG, V38, P1388, DOI 10.1007/s10439-010-9926-4; Sebastian R, 2013, IEEE T MED IMAGING, V32, P45, DOI 10.1109/TMI.2012.2221474; Tabereaux PB, 2007, CIRCULATION, V116, P1113, DOI 10.1161/CIRCULATIONAHA.107.699264; TRANUMJENSEN J, 1991, CIRC RES, V69, P429, DOI 10.1161/01.RES.69.2.429; VASSALLADAMS PR, 1983, EUR HEART J, V4, P449, DOI 10.1093/oxfordjournals.eurheartj.a061501; Vigmond EJ, 2007, IEEE T BIO-MED ENG, V54, P389, DOI 10.1109/TBME.2006.888817; Vigmond EJ, 2003, J ELECTROCARDIOL, V36, P69, DOI 10.1016/j.jelectrocard.2003.09.017; Vigmond EJ, 2002, IEEE T BIO-MED ENG, V49, P1260, DOI 10.1109/TBME.2002.804597; Wiedmann RT, 1996, AM J PHYSIOL-HEART C, V271, pH1507, DOI 10.1152/ajpheart.1996.271.4.H1507	34	38	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e88000	10.1371/journal.pone.0088000	http://dx.doi.org/10.1371/journal.pone.0088000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516576	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400024
J	Powers, JF; Korgaonkar, PG; Fliedner, S; Giubellino, A; Pacak, K; Sahagian, GG; Tischler, AS				Powers, James F.; Korgaonkar, Parimal G.; Fliedner, Stephanie; Giubellino, Alessio; Pacak, Karel; Sahagian, G. Gary; Tischler, Arthur S.			Cytocidal Activities of Topoisomerase 1 Inhibitors and 5-Azacytidine against Pheochromocytoma/Paraganglioma Cells in Primary Human Tumor Cultures and Mouse Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; DNA METHYLATION; IN-VIVO; CAMPTOTHECIN; PROMOTER; NANOPARTICLES; PARAGANGLIOMA; APOPTOSIS; THERAPY; CANCER	There is currently no effective treatment for metastatic pheochromocytomas and paragangliomas. A deficiency in current chemotherapy regimens is that the metastases usually grow very slowly. Drugs that target dividing tumor cells have therefore had limited success. To improve treatment, new strategies and valid experimental models are required for preclinical testing. However, development of models has itself been hampered by the absence of human pheochromocytoma/paraganglioma cell lines for cultures or xenografts. Topoisomerase 1 (TOP1) inhibitors are drugs that interfere with mechanisms that maintain DNA integrity during transcription in both quiescent and dividing cells. We used primary cultures of representative human tumors to establish the cytotoxicity of camptothecin, a prototypical TOP1 inhibitor, against nondividing pheochromocytoma/paraganglioma cells, and then employed a mouse pheochromocytoma model (MPC) to show that efficacy of low concentrations of camptothecin and other TOP1 inhibitors is increased by intermittent coadministration of sub-toxic concentrations of 5-azacytidine, a DNA methylation inhibitor that modulates transcription. We then tested the same drugs against a clonal MPC derivative that expresses CMV reporter-driven luciferase and GFP, intended for in vivo drug testing. Unexpectedly, luciferase expression, bioluminescence and GFP expression were paradoxically increased by both camptothecin and SN38, the active metabolite of irinotecan, thereby masking cell death. Expression of chromogranin A, a marker for neuroendocrine secretory granules, was not increased, indicating that the drug effects on levels of luciferase and GFP are specific to the GFP-luciferase construct rather than generalized cellular responses. Our findings provide proof of principle for use of TOP1 inhibitors against pheochromocytoma/paraganglioma and suggest novel strategies for enhancing efficacy and reducing toxicity by optimizing the combination and timing of their use in conjunction with other drugs. The paradoxical effects of TOP1 inhibitors on luciferase and GFP dictate a need for caution in the use of CMV promoter-regulated constructs for cancer-related imaging studies.	[Powers, James F.; Tischler, Arthur S.] Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA; [Korgaonkar, Parimal G.] Tufts Univ, Sch Med, Small Anim Imaging Preclin Testing Facil, Boston, MA 02111 USA; [Fliedner, Stephanie; Giubellino, Alessio] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Fliedner, Stephanie] Univ Med Ctr Schleswig Holstein Lubeck, Dept Med 1, Lubeck, Germany	Tufts Medical Center; Tufts University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Powers, JF (corresponding author), Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA.	jpowers1@tuftsmedicalcenter.org	Fliedner, Stephanie MJ/D-3406-2012; Giubellino, Alessio/H-3432-2019	Giubellino, Alessio/0000-0002-5352-0662; Tischler, Arthur/0000-0002-9726-5739; Fliedner, Stephanie/0000-0001-5515-8196; Powers, James/0000-0001-8422-3938	Department of Defense [PR100171]; Pheo Para Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Pheo Para Alliance; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	JF Powers and AS Tischler were supported by grant PR100171 from the Department of Defense and by a grant from the Pheo Para Alliance (http://www.pheo-para-alliance.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLER P, 1992, CANCER RES, V52, P1245; Basili S, 2009, EXPERT OPIN THER PAT, V19, P555, DOI 10.1517/13543770902773437; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chen KJ, 2012, BIOMATERIALS, V33, P1162, DOI 10.1016/j.biomaterials.2011.10.044; DeLellis RA., 2004, TUMOURS ENDOCRINE OR; DOBNER PR, 1988, J BIOL CHEM, V263, P13983; Gary-Bobo M, 2012, INT J PHARMACEUT, V423, P509, DOI 10.1016/j.ijpharm.2011.11.045; Ghayee HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065624; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Giubellino A, 2012, CANCER LETT, V316, P46, DOI 10.1016/j.canlet.2011.10.019; Grassi G, 2003, CARCINOGENESIS, V24, P1625, DOI 10.1093/carcin/bgg118; Gu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3326; Ishiguro M, 2007, ANN SURG ONCOL, V14, P1752, DOI 10.1245/s10434-006-9285-4; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jonsson E, 1997, BRIT J CANCER, V76, P211, DOI 10.1038/bjc.1997.364; Kamensek U, 2011, MOL IMAGING BIOL, V13, P43, DOI 10.1007/s11307-010-0300-6; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kenmotsu Y, 2012, ANTICANCER RES, V32, P1453; Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092; Kiss NB, 2013, ENDOCR-RELAT CANCER, V20, P65, DOI 10.1530/ERC-12-0267; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Korpershoek E, 2012, ENDOCR PATHOL, V23, P43, DOI 10.1007/s12022-012-9194-y; LETEURTRE F, 1994, J BIOL CHEM, V269, P7893; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Mairs RJ, 2008, NUCL MED BIOL, V35, pS9, DOI 10.1016/j.nucmedbio.2008.04.008; Martiniova L, 2011, ENDOCR-RELAT CANCER, V18, P143, DOI 10.1677/ERC-10-0090; Martiniova L, 2009, CLIN EXP METASTAS, V26, P239, DOI 10.1007/s10585-009-9236-0; Milagre I, 2010, J ALZHEIMERS DIS, V22, P1209, DOI 10.3233/JAD-2010-100651; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Nolting S, 2012, ENDOCR PATHOL, V23, P21, DOI 10.1007/s12022-012-9199-6; Pacak K, 2007, NAT CLIN PRACT ENDOC, V3, P92, DOI 10.1038/ncpendmet0396; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Powers JF, 2009, HORM METAB RES, V41, P710, DOI 10.1055/s-0029-1224136; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Strong VE, 2008, SURGERY, V143, P759, DOI 10.1016/j.surg.2008.02.007; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tischler AS, 2008, ARCH PATHOL LAB MED, V132, P1272, DOI 10.1043/1543-2165(2008)132[1272:PAEPU]2.0.CO;2; TISCHLER AS, 1992, J HISTOCHEM CYTOCHEM, V40, P1043, DOI 10.1177/40.7.1351491; Tischler AS, 2004, HISTOL HISTOPATHOL, V19, P883, DOI 10.14670/HH-19.883; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Yamagata Y, 2012, EPIGENETICS-US, V7, P141, DOI 10.4161/epi.7.2.18906; Yew NS, 2002, MOL THER, V5, P731, DOI 10.1006/mthe.2002.0598; ZACCHETTI D, 1991, J BIOL CHEM, V266, P20152; Zhuang J, 2010, NEUROREPORT, V21, P282, DOI 10.1097/WNR.0b013e328336ee7e	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2014	9	2							e87807	10.1371/journal.pone.0087807	http://dx.doi.org/10.1371/journal.pone.0087807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1CR	24516563	Green Published, gold, Green Submitted			2022-12-27	WOS:000330834400018
J	Klimesova, J; Malikova, L; Rosenthal, J; Smilauer, P				Klimesova, Jitka; Malikova, Lenka; Rosenthal, Jonathan; Smilauer, Petr			Potential Bud Bank Responses to Apical Meristem Damage and Environmental Variables: Matching or Complementing Axillary Meristems?	PLOS ONE			English	Article							COMPENSATORY RESPONSES; MONOCARPIC HERBS; PLANT TOLERANCE; GROWTH; HERBIVORY; OVERCOMPENSATION; AVAILABILITY; OPTIMIZATION; CONTINUUM; DORMANCY	Soil nutrients, dormant axillary meristem availability, and competition can influence plant tolerance to damage. However, the role of potential bud banks (adventitious meristems initiated only after injury) is not known. Examining Central European field populations of 22 species of short-lived monocarpic herbs exposed to various sources of damage, we hypothesized that: (1) with increasing injury severity, the number of axillary branches would decrease, due to axillary meristem limitation, whereas the number of adventitious shoots (typically induced by severe injury) would increase; (2) favorable environmental conditions would allow intact plants to branch more, resulting in stronger axillary meristem limitation than in unfavorable conditions; and (3) consequently, adventitious sprouting would be better enabled in favorable than unfavorable conditions. We found strong support for the first hypothesis, only limited support for the second, and none for the third. Our results imply that whereas soil nutrients and competition marginally influence plant tolerance to damage, potential bud banks enable plants to overcome meristem limitation from severe damage, and therefore better tolerate it. All the significant effects were found in intraspecific comparisons, whereas interspecific differences were not found. Monocarpic plants with potential bud banks therefore represent a distinct strategy occupying a narrow environmental niche. The disturbance regime typical for this niche remains to be examined, as do the costs associated with the banks of adventitious and axillary reserve meristems.	[Klimesova, Jitka; Malikova, Lenka] Acad Sci Czech Republ, Inst Bot, Dept Funct Ecol, Trebon, Czech Republic; [Malikova, Lenka] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Rosenthal, Jonathan] SUNY Ulster, Dept Biol Sci, Stone Ridge, NY USA; [Smilauer, Petr] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; State University of New York (SUNY) System; University of South Bohemia Ceske Budejovice	Klimesova, J (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Funct Ecol, Trebon, Czech Republic.	klimesova@butbn.cas.cz	Klimešová, Jitka/ABC-6307-2020; Smilauer, Petr/D-7277-2016; Šmilauer, Petr/N-8313-2019; Malíková, Lenka/H-1609-2014; Klimesova, Jitka/A-1525-2009; thorhallsdottir, anna gudrun/B-6037-2011	Klimešová, Jitka/0000-0003-0123-3263; Smilauer, Petr/0000-0003-3065-5721; Šmilauer, Petr/0000-0003-3065-5721; thorhallsdottir, anna gudrun/0000-0001-7201-6931	Grant Agency of the Czech Republic [P504/12/P540, GA526/09/0963]; Institute of Botany, ASCR [RVO 67985939]; University of South Bohemia [GAJU 04-146/2013/P]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Botany, ASCR(Czech Academy of Sciences); University of South Bohemia	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant Agency of the Czech Republic (P504/12/P540, GA526/09/0963) http://www.gacr.cz/; Institute of Botany, ASCR (RVO 67985939) http://www.ibot.cas.cz/; University of South Bohemia (GAJU 04-146/2013/P) http://www.jcu.cz/.	AARSSEN LW, 1995, OIKOS, V74, P149, DOI 10.2307/3545684; Banta JA, 2010, OIKOS, V119, P359, DOI 10.1111/j.1600-0706.2009.17726.x; Bartuskova A, 2010, BOTANY, V88, P630, DOI 10.1139/B10-044; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bergelson J, 1996, AM NAT, V148, P744, DOI 10.1086/285952; Bonser SP, 2003, AM J BOT, V90, P404, DOI 10.3732/ajb.90.3.404; Desdevises Y, 2003, EVOLUTION, V57, P2647; Ellenberg H., 1991, SCRIPTA GEOBOTANICA, V18; Gruntman M, 2011, ANN BOT-LONDON, V108, P965, DOI 10.1093/aob/mcr204; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Huhta AP, 2003, PLANT ECOL, V166, P49, DOI 10.1023/A:1023278502972; Kerstetter RA, 1997, PLANT CELL, V9, P1001, DOI 10.1105/tpc.9.7.1001; Klimesova J, 2004, EVOL ECOL, V18, P669, DOI 10.1007/s10682-004-5149-1; Klimesova J, 2003, OIKOS, V103, P225, DOI 10.1034/j.1600-0706.2003.12725.x; Klimesova J, 2006, CLO PLA3 THE DATABAS; Klimesova J, 2007, PERSPECT PLANT ECOL, V8, P115, DOI 10.1016/j.ppees.2006.10.002; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Latzel V, 2011, BOTANY, V89, P313, DOI [10.1139/B11-018, 10.1139/b11-018]; Latzel V, 2009, BIOLOGIA, V64, P923, DOI 10.2478/s11756-009-0174-8; LEHTILA K, 1995, FUNCT ECOL, V9, P511, DOI 10.2307/2390017; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Malikova L, 2010, ANN BOT-LONDON, V105, P905, DOI 10.1093/aob/mcq069; Martinkova J, 2008, BASIC APPL ECOL, V9, P44, DOI 10.1016/j.baae.2006.12.001; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Nilsson P, 1996, AM NAT, V147, P269, DOI 10.1086/285849; Palacio S, 2007, ANN BOT-LONDON, V100, P865, DOI 10.1093/aob/mcm185; R Development Core Team, 2008, R LANG ENV STAT COMP; Rautio P, 2005, OIKOS, V111, P179, DOI 10.1111/j.0030-1299.2005.14045.x; Rodrigues RR, 2004, BRAZ ARCH BIOL TECHN, V47, P127, DOI 10.1590/S1516-89132004000100017; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; TUOMI J, 1994, ECOLOGY, V75, P1429, DOI 10.2307/1937466; van der Maarel E, 2007, J VEG SCI, V18, P767, DOI 10.1111/j.1654-1103.2007.tb02592.x; Vesk PA, 2004, OIKOS, V106, P200, DOI 10.1111/j.0030-1299.2004.13204.x; Vesk PA, 2004, J ECOL, V92, P310, DOI 10.1111/j.0022-0477.2004.00871.x; Wehsarg O, 1954, BIOL ACKERUNKRAUTER; Wise MJ, 2008, AM NAT, V172, P635, DOI 10.1086/591691; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x	40	14	14	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 6	2014	9	2							e88093	10.1371/journal.pone.0088093	http://dx.doi.org/10.1371/journal.pone.0088093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1BH	24516587	Green Published, gold, Green Submitted			2022-12-27	WOS:000330830700043
J	Burguet, J; Andrey, P				Burguet, Jasmine; Andrey, Philippe			Statistical Comparison of Spatial Point Patterns in Biological Imaging	PLOS ONE			English	Article							NUCLEUS LOCUS-CERULEUS; EFFERENT PROJECTIONS; AUTOMATIC DETECTION; ORGANIZATION; NEURONS; COERULEUS; RAT; REGISTRATION; POPULATIONS; VARIANCE	In biological systems, functions and spatial organizations are closely related. Spatial data in biology frequently consist of, or can be assimilated to, sets of points. An important goal in the quantitative analysis of such data is the evaluation and localization of differences in spatial distributions between groups. Because of experimental replications, achieving this goal requires comparing collections of point sets, a noticeably challenging issue for which no method has been proposed to date. We introduce a strategy to address this problem, based on the comparison of point intensities throughout space. Our method is based on a statistical test that determines whether local point intensities, estimated using replicated data, are significantly different or not. Repeating this test at different positions provides an intensity comparison map and reveals domains showing significant intensity differences. Simulated data were used to characterize and validate this approach. The method was then applied to two different neuroanatomical systems to evaluate its ability to reveal spatial differences in biological data sets. Applied to two distinct neuronal populations within the rat spinal cord, the method generated an objective representation of the spatial segregation established previously on a subjective visual basis. The method was also applied to analyze the spatial distribution of locus coeruleus neurons in control and mutant mice. The results objectively consolidated previous conclusions obtained from visual comparisons. Remarkably, they also provided new insights into the maturation of the locus coeruleus in mutant and control animals. Overall, the method introduced here is a new contribution to the quantitative analysis of biological organizations that provides meaningful spatial representations which are easy to understand and to interpret. Finally, because our approach is generic and punctual structures are widespread at the cellular and histological scales, it is potentially useful for a large spectrum of applications for the analysis of biological systems.	[Burguet, Jasmine; Andrey, Philippe] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Burguet, Jasmine; Andrey, Philippe] AgroParisTech, Inst Jean Pierre Bourgin, Versailles, France; [Burguet, Jasmine; Andrey, Philippe] INRA, UR1197, Jouy En Josas, France; [Burguet, Jasmine; Andrey, Philippe] NeuroSud Paris, IFR 144, Gif Sur Yvette, France; [Andrey, Philippe] Univ Paris 06, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Burguet, J (corresponding author), INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France.	Jasmine.Burguet@versailles.inra.fr	Andrey, Philippe/AAS-7228-2021					Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Andrey P, 2008, I S BIOMED IMAGING, P1183, DOI 10.1109/ISBI.2008.4541213; [Anonymous], 2012, NAT METHODS, V9, P627, DOI 10.1038/nmeth.2102; BADDELEY AJ, 1993, J R STAT SOC C-APPL, V42, P641; Banrezes B, 2002, NEUROSCIENCE, V115, P97, DOI 10.1016/S0306-4522(02)00405-0; Bell ML, 2004, BIOSTATISTICS, V5, P633, DOI 10.1093/biostatistics/kxh014; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEZIN L, 1994, J NEUROSCI, V14, P7486; BEZIN L, 1994, J NEUROSCI, V14, P7502; Bowman FD, 2007, NEUROIMAG CLIN N AM, V17, P441, DOI 10.1016/j.nic.2007.09.002; Burguet J, 2011, PATTERN RECOGN LETT, V32, P1894, DOI 10.1016/j.patrec.2011.07.008; Burguet J, 2009, J COMP NEUROL, V513, P483, DOI 10.1002/cne.21954; Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106; Diaz E, 2010, IEEE ACM T COMPUT BI, V7, P2, DOI 10.1109/TCBB.2008.30; Diggle P., 2003, STAT ANAL SPATIAL PO; DIGGLE PJ, 1991, J AM STAT ASSOC, V86, P618, DOI 10.2307/2290390; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Illian J., 2007, STAT ANAL MODELLING, DOI [10.1002/9780470725160, DOI 10.1002/9780470725160]; KELSALL JE, 1995, STAT MED, V14, P2335, DOI 10.1002/sim.4780142106; Kendall M, 1977, ADV THEORY STAT; Kopel H, 2009, J NEUROSCI METH, V182, P189, DOI 10.1016/j.jneumeth.2009.06.009; Landau S, 2004, BIOMETRICAL J, V46, P19, DOI 10.1002/bimj.200310010; Le Saux F, 2002, DEV BRAIN RES, V136, P197; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu WF, 2007, ADV DRUG DELIVER REV, V59, P1319, DOI 10.1016/j.addr.2007.08.011; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P307, DOI 10.1016/0306-4522(86)90156-9; LOUGHLIN SE, 1986, NEUROSCIENCE, V18, P291, DOI 10.1016/0306-4522(86)90155-7; Maschino E, 2006, COMPUT VIS IMAGE UND, V101, P16, DOI 10.1016/j.cviu.2005.06.004; MAURIN Y, 1986, BRAIN RES, V366, P379, DOI 10.1016/0006-8993(86)91323-5; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Myers G, 2012, NAT METHODS, V9, P659, DOI 10.1038/nmeth.2024; Myllymaki M, 2012, J MICROSC-OXFORD, V247, P228, DOI 10.1111/j.1365-2818.2012.03636.x; Nadasdy Z, 2001, ANAT EMBRYOL, V204, P303, DOI 10.1007/s004290100203; Odeh F, 2005, J NEUROSCI, V25, P5680, DOI 10.1523/JNEUROSCI.0558-05.2005; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Pawlas Z, 2011, KYBERNETIKA, V47, P880; Reed MG, 1997, J MICROSC-OXFORD, V186, P177, DOI 10.1046/j.1365-2818.1997.1710741.x; Schauer K, 2010, NAT METHODS, V7, P560, DOI [10.1038/NMETH.1462, 10.1038/nmeth.1462]; Schwarz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008974; Schwarz-Romond T, 2010, EMBO J, V29, P2675, DOI 10.1038/emboj.2010.185; Duong T, 2012, P NATL ACAD SCI USA, V109, P8382, DOI 10.1073/pnas.1117796109; Ullmann JFP, 2010, NEUROIMAGE, V51, P76, DOI 10.1016/j.neuroimage.2010.01.086; VIBERT JF, 1976, BRAIN RES, V114, P227, DOI 10.1016/0006-8993(76)90668-5; WATERHOUSE BD, 1983, J COMP NEUROL, V217, P418, DOI 10.1002/cne.902170406; Zaborszky L, 2005, NEUROSCIENCE, V136, P697, DOI 10.1016/j.neuroscience.2005.05.019	46	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87759	10.1371/journal.pone.0087759	http://dx.doi.org/10.1371/journal.pone.0087759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505311	Green Published, gold			2022-12-27	WOS:000330829200070
J	Deere, JD; Kauffman, RC; Cannavo, E; Higgins, J; Villalobos, A; Adamson, L; Schinazi, RF; Luciw, PA; North, TW				Deere, Jesse D.; Kauffman, Robert C.; Cannavo, Elda; Higgins, Joanne; Villalobos, Andradi; Adamson, Lourdes; Schinazi, Raymond F.; Luciw, Paul A.; North, Thomas W.			Analysis of Multiply Spliced Transcripts in Lymphoid Tissue Reservoirs of Rhesus Macaques Infected with RT-SHIV during HAART	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; TYPE-1 REVERSE-TRANSCRIPTASE; VIRAL MESSENGER-RNA; TRANSACTIVATOR GENE; HIV-1 INFECTION; HTLV-III; PRODUCTIVE INFECTION; ANTIVIRAL THERAPY	Highly active antiretroviral therapy (HAART) can reduce levels of human immunodeficiency virus type 1 (HIV-1) to undetectable levels in infected individuals, but the virus is not eradicated. The mechanisms of viral persistence during HAART are poorly defined, but some reservoirs have been identified, such as latently infected resting memory CD4(+) T cells. During latency, in addition to blocks at the initiation and elongation steps of viral transcription, there is a block in the export of viral RNA (vRNA), leading to the accumulation of multiply-spliced transcripts in the nucleus. Two of the genes encoded by the multiply-spliced transcripts are Tat and Rev, which are essential early in the viral replication cycle and might indicate the state of infection in a given population of cells. Here, the levels of multiply-spliced transcripts were compared to the levels of gag-containing RNA in tissue samples from RT-SHIV-infected rhesus macaques treated with HAART. Splice site sequence variation was identified during development of a TaqMan PCR assay. Multiply-spliced transcripts were detected in gastrointestinal and lymphatic tissues, but not the thymus. Levels of multiply-spliced transcripts were lower than levels of gag RNA, and both correlated with plasma virus loads. The ratio of multiply-spliced to gag RNA was greatest in the gastrointestinal samples from macaques with plasma virus loads <50 vRNA copies per mL at necropsy. Levels of gag RNA and multiply-spliced mRNA in tissues from RT-SHIV-infected macaques correlate with plasma virus load.	[Deere, Jesse D.; Kauffman, Robert C.; Cannavo, Elda; Higgins, Joanne; Villalobos, Andradi; Adamson, Lourdes; Luciw, Paul A.; North, Thomas W.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Schinazi, Raymond F.] Emory Univ, Vet Affairs Med Ctr, Sch Med, Ctr AIDS Res,Lab Biochem Pharmacol,Dept Pediat, Atlanta, GA USA; [Luciw, Paul A.] Univ Calif Davis, Sch Med, Dept Pathol, Davis, CA 95616 USA; [North, Thomas W.] Univ Calif Davis, Dept Vet Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of California System; University of California Davis; University of California System; University of California Davis	North, TW (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.	tnorth@emory.edu	Deere, Jesse Dee/ABH-7940-2020; Schinazi, Raymond F/B-6777-2017	Deere, Jesse/0000-0002-2539-0338	NIH [P01-AI058708, 1R01-RR-025996, 1RO1-MH10099, T32-AI60555]; Emory Centers for AIDS Research NIH [2P30-AI-050409]; Department of Veterans Affairs; California HIV/AIDS Research Program [D09-D-310]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058708, P30AI050409, T32AI060555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Centers for AIDS Research NIH; Department of Veterans Affairs(US Department of Veterans Affairs); California HIV/AIDS Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH program project grant P01-AI058708, NIH grant 1R01-RR-025996 (TWN and RFS) and 1RO1-MH10099 (RFS). It was also supported by the Emory Centers for AIDS Research NIH grant 2P30-AI-050409 and the Department of Veterans Affairs. J.D. Deere was supported in part by NIH training grant T32-AI60555. R.C. Kauffman was funded by the California HIV/AIDS Research Program grant D09-D-310. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; Ambrose Z, 2004, J VIROL, V78, P13553, DOI 10.1128/JVI.78.24.13553-13561.2004; Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; Baumgarth N, 2004, AM J PATHOL, V165, P707, DOI 10.1016/S0002-9440(10)63334-2; BEDNARIK DP, 1987, J VIROL, V61, P1253, DOI 10.1128/JVI.61.4.1253-1257.1987; Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deere JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011640; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FISHER AG, 1986, NATURE, V320, P367, DOI 10.1038/320367a0; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Gunthard HF, 1999, J VIROL, V73, P9404; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mok HP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-228; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; PARK IW, 1991, J VIROL, V65, P2987, DOI 10.1128/JVI.65.6.2987-2992.1991; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; Poles MA, 2006, JAIDS-J ACQ IMM DEF, V43, P65, DOI 10.1097/01.qai.0000230524.71717.14; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reinhart TA, 1996, VIROLOGY, V224, P338, DOI 10.1006/viro.1996.0539; Reinhart TA, 1997, NAT MED, V3, P218, DOI 10.1038/nm0297-218; SCHULZEFORSTER K, 1990, BIOCHEM BIOPH RES CO, V168, P141, DOI 10.1016/0006-291X(90)91685-L; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; UNGER RE, 1991, VIROLOGY, V182, P177, DOI 10.1016/0042-6822(91)90661-T; Van Rompay KKA, 2004, ANTIMICROB AGENTS CH, V48, P1469, DOI 10.1128/AAC.48.5.1469-1487.2004; VIGLIANTI GA, 1988, J VIROL, V62, P4523, DOI 10.1128/JVI.62.12.4523-4532.1988; VIGLIANTI GA, 1990, J VIROL, V64, P4207, DOI 10.1128/JVI.64.9.4207-4216.1990; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	67	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e87914	10.1371/journal.pone.0087914	http://dx.doi.org/10.1371/journal.pone.0087914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505331	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200085
J	Mananga, ES; El Fakhri, G; Schaefferkoetter, J; Bonab, AA; Ouyang, JS				Mananga, Eugene S.; El Fakhri, Georges; Schaefferkoetter, Joshua; Bonab, Ali A.; Ouyang, Jinsong			Myocardial Defect Detection Using PET-CT: Phantom Studies	PLOS ONE			English	Article							TIME-OF-FLIGHT; LESION DETECTION; HUMAN-OBSERVER; PERFUSION; SPECT; MODEL; VIABILITY; TRACER; RB-82; NOISE	It is expected that both noise and activity distribution can have impact on the detectability of a myocardial defect in a cardiac PET study. In this work, we performed phantom studies to investigate the detectability of a defect in the myocardium for different noise levels and activity distributions. We evaluated the performance of three reconstruction schemes: Filtered Back-Projection (FBP), Ordinary Poisson Ordered Subset Expectation Maximization (OP-OSEM), and Point Spread Function corrected OSEM (PSF-OSEM). We used the Channelized Hotelling Observer (CHO) for the task of myocardial defect detection. We found that the detectability of a myocardial defect is almost entirely dependent on the noise level and the contrast between the defect and its surroundings.	[Mananga, Eugene S.; El Fakhri, Georges; Bonab, Ali A.; Ouyang, Jinsong] Massachusetts Gen Hosp, Div Nucl Med & Mol Imaging, Ctr Adv Med Imaging Sci, Boston, MA 02114 USA; [Mananga, Eugene S.; El Fakhri, Georges; Bonab, Ali A.; Ouyang, Jinsong] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Schaefferkoetter, Joshua] A STAR NUS Clin Imaging & Res Ctr CIRC, Singapore, Singapore	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ouyang, JS (corresponding author), Massachusetts Gen Hosp, Div Nucl Med & Mol Imaging, Ctr Adv Med Imaging Sci, Boston, MA 02114 USA.	ouyang.jinsong@mgh.harvard.edu		Mananga, PH.D., M.Phil., M.SC., J.P.N.M., C.A.B., C.S.M., DEA, M.A., B.SC., Professor Dr. Eugene Stephane/0000-0002-0302-8231	National Institutes of Health (NIH) [R01-HL110241, T32-EB013180]; NATIONAL CANCER INSTITUTE [R01CA165221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB013180] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported in part by the National Institutes of Health (NIH) Grants R01-HL110241 and T32-EB013180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey CK, 2001, J OPT SOC AM A, V18, P473, DOI 10.1364/JOSAA.18.000473; BARRETT HH, 1993, P NATL ACAD SCI USA, V90, P9758, DOI 10.1073/pnas.90.21.9758; Chen M, 2001, IEEE T NUCL SCI, V48, P1428, DOI 10.1109/23.958373; Fukumoto D, 2012, SYNAPSE, V66, P909, DOI 10.1002/syn.21584; Gifford HC, 2000, J NUCL MED, V41, P514; Kadrmas DJ, 2009, J NUCL MED, V50, P1315, DOI 10.2967/jnumed.109.063016; Lin JW, 2001, J NUCL MED, V42, P201; Maddahi J, 2011, J NUCL MED, V52, P1490, DOI 10.2967/jnumed.111.092528; Matsunari I, 2001, J NUCL MED, V42, P1579; Nekolla SG, 2009, CIRCULATION, V119, P2333, DOI 10.1161/CIRCULATIONAHA.108.797761; Schelbert HR, 2002, SEMIN NUCL MED, V32, P60, DOI 10.1053/snuc.2002.29274; Surti S, 2009, PHYS MED BIOL, V54, P373, DOI 10.1088/0031-9155/54/2/013; Tang J, 2009, PHYS MED BIOL, V54, P3161, DOI 10.1088/0031-9155/54/10/013; Vallabhajosula S, 2011, SEMIN NUCL MED, V41, P246, DOI 10.1053/j.semnuclmed.2011.02.003; Wollenweber SD, 1999, IEEE T NUCL SCI, V46, P2098, DOI 10.1109/23.819288; YAO J, 1992, P SOC PHOTO-OPT INS, V1768, P161, DOI 10.1117/12.130899	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88200	10.1371/journal.pone.0088200	http://dx.doi.org/10.1371/journal.pone.0088200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505429	Green Published, gold, Green Submitted			2022-12-27	WOS:000330829200135
J	Saito, T; Psenicka, M; Goto, R; Adachi, S; Inoue, K; Arai, K; Yamaha, E				Saito, Taiju; Psenicka, Martin; Goto, Rie; Adachi, Shinji; Inoue, Kunio; Arai, Katsutoshi; Yamaha, Etsuro			The Origin and Migration of Primordial Germ Cells in Sturgeons	PLOS ONE			English	Article							MORPHOGENETIC MOVEMENTS; NUTRITIONAL ENDODERM; ACIPENSER-NACCARII; XENOPUS EMBRYOS; HOLOSTEAN FISH; MESSENGER-RNA; VASA RNA; PLASM; EVOLUTION; GENE	Primordial germ cells (PGCs) arise elsewhere in the embryo and migrate into developing gonadal ridges during embryonic development. In several model animals, formation and migration patterns of PGCs have been studied, and it is known that these patterns vary. Sturgeons (genus Acipenser) have great potential for comparative and evolutionary studies of development. Sturgeons belong to the super class Actinoptergii, and their developmental pattern is similar to that of amphibians, although their phylogenetic position is an out-group to teleost fishes. Here, we reveal an injection technique for sturgeon eggs allowing visualization of germplasm and PGCs. Using this technique, we demonstrate that the PGCs are generated at the vegetal pole of the egg and they migrate on the yolky cell mass toward the gonadal ridge. We also provide evidence showing that PGCs are specified by inheritance of maternally supplied germplasm. Furthermore, we demonstrate that the migratory mechanism is well-conserved between sturgeon and other remotely related teleosts, such as goldfish, by a single PGCs transplantation (SPT) assay. The mode of PGCs specification in sturgeon is similar to that of anurans, but the migration pattern resembles that of teleosts.	[Saito, Taiju; Goto, Rie; Yamaha, Etsuro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nanae Fresh Water Lab, Nanae, Japan; [Saito, Taiju; Arai, Katsutoshi] Hokkaido Univ, Fac Fisheries Sci, Lab Aquaculture Genet & Genom, Hakodate, Hokkaido, Japan; [Saito, Taiju; Psenicka, Martin] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Lab Reprod Physiol,Res Inst Fish Culture & Hydrob, Vodnany, Czech Republic; [Adachi, Shinji] Hokkaido Univ, Fac Fisheries Sci, Lab Aquaculture Biol, Hakodate, Hokkaido, Japan; [Inoue, Kunio] Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo 657, Japan	Hokkaido University; Hokkaido University; University of South Bohemia Ceske Budejovice; Hokkaido University; Kobe University	Saito, T (corresponding author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nanae Fresh Water Lab, Nanae, Japan.	tsaito@frov.jcu.cz	Pšenička, Martin/F-7929-2015; Saito, Taiju/A-3171-2013	Pšenička, Martin/0000-0002-3808-7856; Saito, Taiju/0000-0003-0029-2173	Japan Society for the Promotion of Science (JSPS) [21009325, 21658067, 24248033]; Bilateral Joint Research Project from JSPS [2013-2014FY]; Academy of Sciences of the Czech Republic (ASCR); Czech Science Foundation (GACR) [P502/13/26952S]; USB FFPW [CZ.1.07/2.3.00/20.0024]; CENAKVA [CZ.1.05/2.1.00/01.0024]; PROBRAIN (Promotion of Basic Research Activities for Innovative Biosciences); MEYS of the CR under the NPU I program [LO1205]; program Kontakt II [LH13246]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bilateral Joint Research Project from JSPS; Academy of Sciences of the Czech Republic (ASCR)(Czech Academy of Sciences); Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); USB FFPW; CENAKVA; PROBRAIN (Promotion of Basic Research Activities for Innovative Biosciences); MEYS of the CR under the NPU I program; program Kontakt II	This work was supported in part by the Grants-in-Aid from Japan Society for the Promotion of Science (JSPS) (No. 21009325, No. 21658067, and No. 24248033), the Bilateral Joint Research Project from JSPS (2013-2014FY) and Academy of Sciences of the Czech Republic (ASCR), program Kontakt II (No. LH13246), Czech Science Foundation (GACR) (No. P502/13/26952S), Strengthening of excellence scientific teams in USB FFPW CZ.1.07/2.3.00/20.0024, CENAKVA CZ.1.05/2.1.00/01.0024. This study was also supported by PROBRAIN (Promotion of Basic Research Activities for Innovative Biosciences). The results of the project LO1205 were obtained with a financial support from the MEYS of the CR under the NPU I program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarova RF, 2009, EVOL DEV, V11, P603, DOI 10.1111/j.1525-142X.2009.00366.x; BALLARD WW, 1986, J EXP ZOOL, V238, P337, DOI 10.1002/jez.1402380308; BALLARD WW, 1986, J EXP ZOOL, V238, P355, DOI 10.1002/jez.1402380309; BALLARD WW, 1980, J EXP ZOOL, V213, P69, DOI 10.1002/jez.1402130110; Berekelya LA, 2003, GENE EXPR PATTERNS, V3, P521, DOI 10.1016/S1567-133X(03)00055-3; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; BOLKER JA, 1993, J EXP ZOOL, V266, P132, DOI 10.1002/jez.1402660207; Bolker JA, 2004, FISH FISHERIES SERIE, V27, P134; BOLKER JA, 1994, AM ZOOL, V34, P313; BOLKER JA, 1993, J EXP ZOOL, V266, P116, DOI 10.1002/jez.1402660206; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Buchholz DR, 2007, DEV DYNAM, V236, P1259, DOI 10.1002/dvdy.21153; Cooper MS, 2007, J EXP ZOOL PART B, V308B, P591, DOI 10.1002/jez.b.21142; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Elinson RP, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-20; Elinson RP, 2009, J EXP ZOOL PART B, V312B, P526, DOI 10.1002/jez.b.21218; Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Extavour CGM, 2007, INTEGR COMP BIOL, V47, P770, DOI 10.1093/icb/icm027; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Ginsburg AS, 1991, ANIMAL SPECIES DEV S, V2, P16; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; Grande L., 1991, J VERTEBRATE PA S001, V1, P1, DOI DOI 10.1080/02724634.1991.10011424; Grandi G, 2007, J APPL ICHTHYOL, V23, P3, DOI 10.1111/j.1439-0426.2006.00819.x; Grandi G, 2008, J MORPHOL, V269, P1238, DOI 10.1002/jmor.10657; HEASMAN J, 1981, CELL, V27, P437, DOI 10.1016/0092-8674(81)90385-8; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Houston DW, 1998, DEVELOPMENT, V125, P171; Hudson C, 1998, MECH DEVELOP, V73, P159, DOI 10.1016/S0925-4773(98)00047-1; IKENISHI K, 1974, DEV BIOL, V36, P155, DOI 10.1016/0012-1606(74)90198-5; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Johnson AD, 2003, EVOL DEV, V5, P414, DOI 10.1046/j.1525-142X.2003.03048.x; Johnson AD, 2011, REPRODUCTION, V141, P291, DOI 10.1530/REP-10-0474; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kitauchi T, 2012, J APPL ICHTHYOL, V28, P998, DOI 10.1111/jai.12068; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Koprunner M, 2001, GENE DEV, V15, P2877; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; MacArthur H, 2000, MECH DEVELOP, V95, P291, DOI 10.1016/S0925-4773(00)00357-9; Maegawa S, 1999, MECH DEVELOP, V81, P223, DOI 10.1016/S0925-4773(98)00242-1; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; Mishima Y, 2011, DEVELOPMENT; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Miyake A, 2006, INT J DEV BIOL, V50, P619, DOI 10.1387/ijdb.062172am; Mizuno T, 1996, NATURE, V383, P131, DOI 10.1038/383131a0; Pelegri F, 1999, CURR BIOL, V9, P1431, DOI 10.1016/S0960-9822(00)80112-8; RESSOM RE, 1988, DEVELOPMENT, V103, P507; Robb DL, 1996, CELL, V87, P823, DOI 10.1016/S0092-8674(00)81990-X; Saito T, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024460, DOI 10.1371/J0URNAL.P0NE.0024460]; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; SAVAGE RM, 1993, DEV BIOL, V157, P371, DOI 10.1006/dbio.1993.1142; Sekizaki H, 2004, DEV DYNAM, V229, P367, DOI 10.1002/dvdy.10448; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; SUTASURJ.LA, 1974, ROUX ARCH DEV BIOL, V175, P199, DOI 10.1007/BF00582092; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Taguchi A, 2012, DEV GROWTH DIFFER, V54, P767, DOI 10.1111/dgd.12005; Takeuchi M, 2009, COLD SPRING HARBOR P, V2009, DOI [10.1101/pdb.emo117, DOI 10.1101/PDB.EM0117]; Takeuchi M, 2009, DEV BIOL, V332, P90, DOI 10.1016/j.ydbio.2009.05.543; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Theusch EV, 2006, DEV BIOL, V292, P129, DOI 10.1016/j.ydbio.2005.12.045; Venkatarama T, 2010, DEVELOPMENT, V137, P651, DOI 10.1242/dev.038554; Weidinger G, 1999, DEVELOPMENT, V126, P5295; WHITINGTON PM, 1975, J EMBRYOL EXP MORPH, V33, P57; Yamaha E, 1998, DEV GROWTH DIFFER, V40, P267; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zelazowska M, 2007, CELL TISSUE RES, V329, P137, DOI 10.1007/s00441-007-0403-9	70	57	61	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e86861	10.1371/journal.pone.0086861	http://dx.doi.org/10.1371/journal.pone.0086861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505272	Green Submitted, Green Published, gold			2022-12-27	WOS:000330829200031
J	Kashiyama, T; Oda, K; Ikeda, Y; Shiose, Y; Hirota, Y; Inaba, K; Makii, C; Kurikawa, R; Miyasaka, A; Koso, T; Fukuda, T; Tanikawa, M; Shoji, K; Sone, K; Arimoto, T; Wada-Hiraike, O; Kawana, K; Nakagawa, S; Matsuda, K; McCormick, F; Aburatani, H; Yano, T; Osuga, Y; Fujii, T				Kashiyama, Tomoko; Oda, Katsutoshi; Ikeda, Yuji; Shiose, Yoshinobu; Hirota, Yasuhide; Inaba, Kanako; Makii, Chinami; Kurikawa, Reiko; Miyasaka, Aki; Koso, Takahiro; Fukuda, Tomohiko; Tanikawa, Michihiro; Shoji, Keiko; Sone, Kenbun; Arimoto, Takahide; Wada-Hiraike, Osamu; Kawana, Kei; Nakagawa, Shunsuke; Matsuda, Koichi; McCormick, Frank; Aburatani, Hiroyuki; Yano, Tetsu; Osuga, Yutaka; Fujii, Tomoyuki			Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423	PLOS ONE			English	Article							P53-INDUCIBLE REGULATOR; HIGH-FREQUENCY; HUMAN CANCERS; P53; MUTATIONS; CARCINOMA; NVP-BEZ235; PATHWAY; PIK3CA; GROWTH	DS-7423, a novel, small-molecule dual inhibitor of phosphatidylinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), is currently in phase I clinical trials for solid tumors. Although DS-7423 potently inhibits PI3K alpha (IC50 = 15.6 nM) and mTOR (IC50 = 34.9 nM), it also inhibits other isoforms of class I PI3K (IC50 values: PI3K beta = 1,143 nM; PI3K gamma = 249 nM; PI3K delta = 262 nM). The PI3K/mTOR pathway is frequently activated in ovarian clear cell adenocarcinomas (OCCA) through various mutations that activate PI3K-AKT signaling. Here, we describe the anti-tumor effect of DS-7423 on a panel of nine OCCA cell lines. IC50 values for DS-7423 were <75 nM in all the lines, regardless of the mutational status of PIK3CA. In mouse xenograft models, DS-7423 suppressed the tumor growth of OCCA in a dose-dependent manner. Flow cytometry analysis revealed a decrease in S-phase cell populations in all the cell lines and an increase in sub-G1 cell populations following treatment with DS-7423 in six of the nine OCCA cell lines tested. DS-7423-mediated apoptosis was induced more effectively in the six cell lines without TP53 mutations than in the three cell lines with TP53 mutations. Concomitantly with the decreased phosphorylation level of MDM2 (mouse double minute 2 homolog), the level of phosphorylation of TP53 at Ser46 was increased by DS-7423 in the six cell lines with wild-type TP53, with induction of genes that mediate TP53-dependent apoptosis, including p53AIP1 and PUMA at 39 nM or higher doses. Our data suggest that the dual PI3K/mTOR inhibitor DS-7423 may constitute a promising molecular targeted therapy for OCCA, and that its antitumor effect might be partly obtained by induction of TP53-dependent apoptosis in TP53 wild-type OCCAs.	[Kashiyama, Tomoko; Oda, Katsutoshi; Ikeda, Yuji; Inaba, Kanako; Makii, Chinami; Kurikawa, Reiko; Miyasaka, Aki; Koso, Takahiro; Fukuda, Tomohiko; Tanikawa, Michihiro; Shoji, Keiko; Sone, Kenbun; Arimoto, Takahide; Wada-Hiraike, Osamu; Kawana, Kei; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Shiose, Yoshinobu; Hirota, Yasuhide] Daiichi Sankyo Co Ltd, Oncol Res Labs, Tokyo, Japan; [Nakagawa, Shunsuke] Teikyo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo 173, Japan; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genome, Tokyo, Japan; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Yano, Tetsu] Natl Ctr Global Hlth & Med, Dept Obstet & Gynecol, Tokyo, Japan	University of Tokyo; Daiichi Sankyo Company Limited; Teikyo University; University of Tokyo; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Tokyo; National Center for Global Health & Medicine - Japan	Oda, K (corresponding author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan.	katsutoshi-tky@umin.ac.jp	Fukuda, Tomohiko/AAX-6523-2021; Matsuda, Koichi/D-4597-2011	Wada-Hiraike, Osamu/0000-0002-3458-6711; Fukuda, Tomohiko/0000-0003-2711-3067; Matsuda, Koichi/0000-0001-7292-2686	Daiichi Sankyo Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan [19599005, 23592437]	Daiichi Sankyo Co. Ltd.(Daiichi Sankyo Company Limited); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Daiichi Sankyo Co. Ltd., The Grant-in-Aid for Scientific Research (C), Grant Number 19599005 and 23592437 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K Oda). This study was also performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan (to T Yano). Yoshinobu Shiose and Yasuhide Hirota, employees of Daiichi Sankyo Co. Ltd, contributed to the experiments (in vivo experiments) as listed in the "contributions'' of each author. The funders themselves had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglesio MS, 2011, GYNECOL ONCOL, V121, P407, DOI 10.1016/j.ygyno.2011.01.005; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Cao P, 2009, BRIT J CANCER, V100, P1267, DOI 10.1038/sj.bjc.6604995; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fujimura M, 2002, JPN J CANCER RES, V93, P1250, DOI 10.1111/j.1349-7006.2002.tb01231.x; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Ho ESC, 2001, GYNECOL ONCOL, V80, P189, DOI 10.1006/gyno.2000.6025; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Letai A, 2006, MOL CELL, V21, P728, DOI 10.1016/j.molcel.2006.03.005; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Matsuda K, 2002, CANCER RES, V62, P2883; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Minaguchi T, 2001, CLIN CANCER RES, V7, P2636; Munksgaard PS, 2012, GYNECOL ONCOL, V124, P164, DOI 10.1016/j.ygyno.2011.10.001; Nakagawa S, 1999, BRIT J CANCER, V79, P1139, DOI 10.1038/sj.bjc.6690181; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Rahmani M, 2009, BLOOD, V114, P4507, DOI 10.1182/blood-2008-09-177881; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Shoji K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037431; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Takano M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-53; Takano M, 2011, INT J CLIN ONCOL, V16, P605, DOI 10.1007/s10147-010-0177-z; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Yamamoto S, 2012, MODERN PATHOL, V25, P122, DOI 10.1038/modpathol.2011.143; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87220	10.1371/journal.pone.0087220	http://dx.doi.org/10.1371/journal.pone.0087220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504419	Green Published, Green Submitted, gold			2022-12-27	WOS:000330631800022
J	Li, J; Zhong, W; Wang, WW; Hu, SP; Yuan, JH; Zhang, B; Hu, TH; Song, G				Li, Juan; Zhong, Wei; Wang, Weiwei; Hu, Shaoping; Yuan, Jiahui; Zhang, Bing; Hu, Tianhui; Song, Gang			Ginsenoside Metabolite Compound K Promotes Recovery of Dextran Sulfate Sodium- Induced Colitis and Inhibits Inflammatory Responses by Suppressing NF-kappa B Activation	PLOS ONE			English	Article							INTESTINAL METABOLITE; ACCUMULATION; MECHANISMS; GROWTH; APOPTOSIS	Phytogenic compounds with anti-oxidant and anti-inflammatory properties, such as ginsenoside metabolite compound K (CK) or berberine (BBR), are currently discussed as promising complementary agents in the prevention and treatment of cancer and inflammation. The latest study showed that ginsenoside Rb1 and its metabolites could inhibit TNBS-induced colitis injury. However, the functional mechanisms of anti-inflammation effects of ginsenoside, particularly its metabolite CK are still not clear. Here, using dextran sulfate sodium (DSS)-induced colitis in mice, clinical parameters, intestinal integrity, pro-inflammatory cytokines production, and signaling pathways in colonic tissues were determined. In mild and sever colitis mice, CK and BBR (as a positive agent) alleviated colitis histopathology injury, ameliorated myeloperoxidase (MPO) activity, reduced pro-inflammatory cytokines production, such as, IL-6, IL-1 beta, TNF-alpha, and increased anti-inflammatory cytokine IL-10 production in both mice colon tissues and blood. Nevertheless, the results revealed that CK and BBR inhibited NF-kappa B p65 nuclear translocation, downregulated p-I kappa B alpha and upregulated I kappa B alpha, indicating that CK, as well as BBR, suppressed the activation of the NF-kappa B pathway in the progression of colitis with immunofluorescence, immunohistochemical and western blotting analysis. Furthermore, CK inhibited pro-inflammatory cytokines production in LPS-activated macrophages via down-regulation of NF-kappa B signaling pathway. Taken together, our results not only reveal that CK promotes the recovery of the progression of colitis and inhibits the inflammatory responses by suppressing NF-kappa B activation, but also suggest that CK downregulates intestinal inflammation through regulating the activation of macrophages and pro-inflammatory cytokines production.	[Li, Juan; Zhong, Wei; Wang, Weiwei; Hu, Shaoping; Yuan, Jiahui; Hu, Tianhui; Song, Gang] Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen, Peoples R China; [Zhang, Bing] Xiamen Univ, Coll Med, Dept Basic Med, Xiamen, Peoples R China	Xiamen University; Xiamen University	Hu, TH (corresponding author), Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen, Peoples R China.	thu@xmu.edu.cn; gangsongsd@xmu.edu.cn			National Natural Science Foundation of China [31071187, 81172284, 81272721]; Fundamental Research Funds for the Central Universities [2010121102]; Xiamen Municipal Science and Technology Innovation Fund Project [3502Z20114018]; Program for New Century Excellent Talents in Fujian Province University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Xiamen Municipal Science and Technology Innovation Fund Project; Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the grants from the National Natural Science Foundation of China (31071187, 81172284, 81272721), the Fundamental Research Funds for the Central Universities (2010121102), Xiamen Municipal Science and Technology Innovation Fund Project (3502Z20114018), and the Program for New Century Excellent Talents in Fujian Province University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAHAM C, 2009, NEW ENGL J MED, V361, P2066; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Araki A, 2013, CYTOKINE, V62, P262, DOI 10.1016/j.cyto.2013.03.006; Bae DS, 2012, BMB REP, V45, P108, DOI 10.5483/BMBRep.2012.45.2.108; Bedirli A, 2011, J SURG RES, V171, P355, DOI 10.1016/j.jss.2010.01.028; Blumberg RS, 2009, DIGEST DIS, V27, P455, DOI 10.1159/000235851; Choo MK, 2008, ONCOL REP, V19, P595; Clark M, 2007, GASTROENTEROLOGY, V133, P312, DOI 10.1053/j.gastro.2007.05.006; Fang Y, 2012, AM J PHYSIOL-GASTR L, V302, pG504; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hasegawa H, 1996, PLANTA MED, V62, P453, DOI 10.1055/s-2006-957938; Hasegawa H, 1997, ARCH PHARM RES, V20, P539, DOI 10.1007/BF02975208; Hu C, 2012, J CELL MOL MED, V16, P96, DOI 10.1111/j.1582-4934.2011.01278.x; Jiang Q, 2011, MOL CELL ENDOCRINOL, V331, P34, DOI 10.1016/j.mce.2010.07.023; Jo MJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/297427; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kalaiselvi P, 2013, FOOD CHEM TOXICOL, V56, P110, DOI 10.1016/j.fct.2013.01.042; Kim DY, 2009, J AGR FOOD CHEM, V57, P10573, DOI 10.1021/jf902700h; Kim DY, 2009, J AGR FOOD CHEM, V57, P1532, DOI 10.1021/jf802867b; Latella G, 2012, WORLD J GASTROENTERO, V18, P3790, DOI 10.3748/wjg.v18.i29.3790; Lee BH, 1998, PLANTA MED, V64, P500, DOI 10.1055/s-2006-957501; Lee ES, 2011, CHEM-BIOL INTERACT, V194, P13, DOI 10.1016/j.cbi.2011.08.008; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Ma BL, 2012, DRUG METAB DISPOS, V40, P381, DOI 10.1124/dmd.111.041152; MUELLER K, 2013, GASTROENTEROLOGY, V2013; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rieder F, 2012, J CROHNS COLITIS, V6, P373, DOI 10.1016/j.crohns.2011.11.009; Sann H, 2013, LIFE SCI, V92, P708, DOI 10.1016/j.lfs.2013.01.028; Schirbel A, 2010, J DIGEST DIS, V11, P266, DOI 10.1111/j.1751-2980.2010.00449.x; Song G, 2010, J AGR FOOD CHEM, V58, P12753, DOI 10.1021/jf103814f; Speca S, 2012, WORLD J GASTROENTERO, V18, P3635, DOI 10.3748/wjg.v18.i28.3635; Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200; Yan J, 2013, CELL, V152, P304, DOI 10.1016/j.cell.2012.12.021; Yang CS, 2008, J CELL MOL MED, V12, P1739, DOI 10.1111/j.1582-4934.2007.00181.x; YODA K, 2013, EUR J NUTR; Zhang ZY, 2013, INT J MOL SCI, V14, P2980, DOI 10.3390/ijms14022980; Zhou XX, 2012, J SURG RES, V173, pE47, DOI 10.1016/j.jss.2011.11.004	38	64	69	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87810	10.1371/journal.pone.0087810	http://dx.doi.org/10.1371/journal.pone.0087810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24504372	Green Submitted, gold, Green Published			2022-12-27	WOS:000330631800074
J	Song, Y; Liang, CL; Wang, W; Fang, J; Sun, NN; Jia, XD; Li, N				Song, Yan; Liang, Chunlai; Wang, Wei; Fang, Jin; Sun, Nana; Jia, Xudong; Li, Ning			Immunotoxicological Evaluation of Corn Genetically Modified with Bacillus thuringiensis Cry1Ah Gene by a 30-Day Feeding Study in BALB/c Mice	PLOS ONE			English	Article							IMMUNE-RESPONSE; TOXIN; MAIZE; L.	This study was to investigate the immunotoxicological potential of corn genetically modified (GM) with Bacillus thuringiensis (Bt) Cry1Ah gene in BALB/c mice. Female BALB/c mice were randomly assigned to one of the four groups: the negative control group, the parental corn group, the GM corn group and the positive control group with 10 mice per group. Mice in the GM corn group and the parental corn group were fed with diets containing 70% corresponding corn for 30 days. Mice in the negative control group and the positive control group were fed with AIN93G diet, administered with saline or 200 mg/kg of cyclophosphamide (CY) via intraperitoneal injection 24 h before the termination of the study, respectively. At the end of the study, the immunotoxicological effects of the GM corn were evaluated through immunopathology parameters including body and organ weights, hematology and clinical chemistry parameters, histological examination, peripheral blood lymphocytes phenotype; humoral immunity including antibody plaque-forming cell, serum immunoglobulin, cytokine and half hemolysis value; cellular immunity such as mitogen-induced splenocyte proliferation, cytotoxic T-lymphocyte reaction, delayed-type hypersensitivity reaction; non-specific immunity including phagocytic activities of phagocytes, natural killer cell activity. A single dose of cyclophosphamide (200 mg/kg bw) was found to have significant adverse effects on immunopathology, cellular immunity, and humoral immunity in mice. The corn genetically modified with Bt Cry1Ah gene is considered consistent with the parental corn in terms of immunopathology, humoral immunity, cellular immunity and non-specific immunity. No adverse immunotoxicological effects of GM corn with Bt Cry1Ah gene were found when feeding mice for 30 days.	[Song, Yan; Liang, Chunlai; Wang, Wei; Fang, Jin; Sun, Nana; Jia, Xudong; Li, Ning] China Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China		Li, N (corresponding author), China Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	lining_65@126.com			Special Fund for China Agro-scientific Research in the Public Interest [200903054-06]; China National GMO Cultivation Major Project of New Varieties [2008ZX08011-005, 2011ZX08011-005]	Special Fund for China Agro-scientific Research in the Public Interest; China National GMO Cultivation Major Project of New Varieties	The work was financially supported by Special Fund for China Agro-scientific Research in the Public Interest (200903054-06) and China National GMO Cultivation Major Project of New Varieties (2008ZX08011-005 and 2011ZX08011-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEGLE CC, 1992, CAN ENTOMOL, V124, P587, DOI 10.4039/Ent124587-4; Bernstein IL, 1999, ENVIRON HEALTH PERSP, V107, P575, DOI 10.2307/3434400; Bertoni G, 2005, VET RES COMMUN, V29, P13, DOI 10.1007/s11259-005-0004-6; Bin-Hafeez B, 2003, INT IMMUNOPHARMACOL, V3, P257, DOI 10.1016/S1567-5769(02)00292-8; CUNNINGHAM AJ, 1965, NATURE, V207, P1106, DOI 10.1038/2071106a0; European Commission, 1997, OFF J EUR COMMUN L, VL253, P1; FAO/WHO Codex Alimentarius Commission, 2001, EXPERT CONSULTATION, P1; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Harlander SK, 2002, J AM COLL NUTR, V21, p161S, DOI 10.1080/07315724.2002.10719260; Huang Qiong, 2007, Zhongguo Yaolixue Yu Dulixue Zazhi, V21, P140; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; LUSTER MI, 1988, FUND APPL TOXICOL, V10, P2, DOI 10.1016/0272-0590(88)90247-3; Marmiroli N, 2005, VET RES COMMUN, V29, P1, DOI 10.1007/s11259-005-0002-8; Mateo R, 2006, AM J TROP MED HYG, V75, P356, DOI 10.4269/ajtmh.2006.75.356; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Qi Lijuan, 2010, Wei Sheng Yan Jiu, V39, P313; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Seralinil GE, 2011, ENV SCI EUROPE; Sheng XL, 2007, WORLD J GASTROENTERO, V13, P5944, DOI 10.3748/wjg.v13.i44.5944; The Ministry of Health, 2003, TECHN STAND TEST ASS, P28; Thompson M A, 1995, Genet Eng (N Y), V17, P99; US EPA, 1998, IMMUNOTOXICITY, P1; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Yoon HS, 2010, J MICROBIOL BIOTECHN, V20, P438, DOI 10.4014/jmb.0905.05058; Yue TongQing, 2010, Journal of Agricultural Biotechnology, V18, P638; Zhu YZ, 2004, ARCH ANIM NUTR, V58, P295, DOI 10.1080/00039420412331273277	27	44	48	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2014	9	2							e78566	10.1371/journal.pone.0078566	http://dx.doi.org/10.1371/journal.pone.0078566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7CL	24520311	Green Published, Green Submitted, gold			2022-12-27	WOS:000331254600001
J	Liu, WY; Wu, SM; Xiong, Y; Li, TY; Wen, Z; Yan, MZ; Qin, K; Liu, YL; Wu, JG				Liu, Weiyong; Wu, Shimin; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo			Co-Circulation and Genomic Recombination of Coxsackievirus A16 and Enterovirus 71 during a Large Outbreak of Hand, Foot, and Mouth Disease in Central China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CLINICAL-FEATURES; ETIOLOGIC CHARACTERISTICS; INTRATYPIC RECOMBINATION; FREQUENT RECOMBINATION; PULMONARY-EDEMA; HONG-KONG; GROUP-A; INFECTION; TAIWAN	A total of 1844 patients with hand, foot, and mouth disease (HFMD), most of them were children of age 1-3-year-old, in Central China were hospitalized from 2011 to 2012. Among them, 422 were infected with coxsackievirus A16 (CVA16), 334 were infected with enterovirus 71 (EV71), 38 were co-infected with EV71 and CVA16, and 35 were infected with other enteroviruses. Molecular epidemiology analysis revealed that EV71 and CVA16 were detected year-round, but EV71 circulated mainly in July and CVA16 circulated predominantly in November, and incidence of HFMD was reduced in January and February and increased in March. Clinical data showed that hyperglycemia and neurologic complications were significantly higher in EV71-infected patients, while upper respiratory tract infection and C-reactive protein were significantly higher in CVA16-associated patients. 124 EV71 and 80 CVA16 strains were isolated, among them 56 and 68 EV71 strains were C4a and C4b, while 25 and 55 CVA16 strains were B1a and B1b, respectively. Similarity plots and bootscan analyses based on entire genomic sequences revealed that the three C4a sub-genotype EV71 strains were recombinant with C4b sub-genotype EV71 in 2B-2C region, and the three CVA16 strains were recombinant with EV71 in 2A-2B region. Thus, CVA16 and EV71 were the major causative agents in a large HFMD outbreak in Central China. HFMD incidence was high for children among household contact and was detected year-round, but outbreak was seasonal dependent. CVA16 B1b and EV71 C4b reemerged and caused a large epidemic in China after a quiet period of many years. Moreover, EV71 and CVA16 were co-circulated during the outbreak, which may have contributed to the genomic recombination between the pathogens. It should gain more attention as there may be an upward trend in co-circulation of the two pathogens globally and the new role recombination plays in the emergence of new enterovirus variants.	[Liu, Weiyong; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China; [Liu, Weiyong; Xiong, Ying; Li, Tongya; Wen, Zhou; Yan, Mingzhe; Qin, Kai; Liu, Yingle; Wu, Jianguo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Wu, Shimin] Wuhan Med Treatment Ctr, Dept Clin Lab, Wuhan, Peoples R China	Wuhan University; Wuhan University	Liu, YL (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	mvlwu@whu.edu.cn; jwu@whu.edu.cn		Wu, Jianguo/0000-0002-8326-2895	Major State Basic Research Development Program (973 Program) [2012CB518900]; National Natural Science Foundation of China [31230005, 812111146, 81171525]; National Mega Project on Major Infectious Disease Prevention [2012ZX10002006-003, 2012ZX10004-207]; National Mega Project on Major Drug Development [2011ZX09401-302]	Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Disease Prevention; National Mega Project on Major Drug Development	This work was supported by research grants from Major State Basic Research Development Program (973 Program) (No. 2012CB518900; http://www.973.gov.cn/Default_3.aspx), National Natural Science Foundation of China (Nos. 31230005, 812111146, and 81171525; http://www.nsfc.gov.cn/Portal0/default152.htm), the National Mega Project on Major Infectious Disease Prevention (2012ZX10002006-003 and 2012ZX10004-207; http://www.chinapop.gov.cn/zhuzhan/index.shtml), National Mega Project on Major Drug Development (No. 2011ZX09401-302; http://www.chinapop.gov.cn/zhuzhan/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; BLOMBERG J, 1974, LANCET, V2, P112; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Bracho MA, 2011, EMERG INFECT DIS, V17, P2223, DOI 10.3201/eid1712.110395; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen HL, 2008, VACCINE, V26, P2882, DOI 10.1016/j.vaccine.2008.03.041; Chen SP, 2010, J MICROBIOL IMMUNOL, V43, P99, DOI 10.1016/S1684-1182(10)60016-3; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Chua K B, 2007, Malays J Pathol, V29, P69; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Doraisingham S, 1987, Ann Acad Med Singap, V16, P243; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; GOLDBERG MF, 1963, J PEDIATR-US, V62, P762, DOI 10.1016/S0022-3476(63)80047-5; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Guan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044386; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Han JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/eid1802.111524; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; HIRST GK, 1962, COLD SPRING HARB SYM, V27, P303, DOI 10.1101/SQB.1962.027.001.028; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Ji BY, 2011, MOD PREVENTIVE MED, V13, P4226; Kapusinszky B, 2010, VIRUS GENES, V40, P163, DOI 10.1007/s11262-009-0440-4; Kim Kyung Hyo, 2010, Korean J Pediatr, V53, P616, DOI 10.3345/kjp.2010.53.5.616; Kliegman R, 2011, NELSON TXB PEDIAT, P242; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Ku ZQ, 2012, J VIROL METHODS, V186, P193, DOI 10.1016/j.jviromet.2012.06.025; Lan YC, 2011, SCAND J INFECT DIS, V43, P354, DOI 10.3109/00365548.2010.545995; LEDINKO N, 1963, VIROLOGY, V20, P107, DOI 10.1016/0042-6822(63)90145-4; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liang ZL, 2013, HUM VACCIN IMMUNOTHE, V9; Liu LJ, 2012, ARCH VIROL, V157, P2219, DOI 10.1007/s00705-012-1396-6; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Liu YD, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.25079, 10.4161/psb.23864, 10.1371/journal.pone.0065361]; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mandell GL, 2010, MANDELL DOUGLAS BENN, P172; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Ni HX, 2012, J CLIN VIROL, V54, P342, DOI 10.1016/j.jcv.2012.04.021; Oberste MS, 2004, J VIROL, V78, P855, DOI 10.1128/JVI.78.2.855-867.2004; Ong KC, 2010, J VIROL, V84, P661, DOI 10.1128/JVI.00999-09; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Pallansch M., 2007, FIELDS VIROL, P839; POYRY T, 1994, VIROLOGY, V202, P982, DOI 10.1006/viro.1994.1423; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Racaniello V. R., 2007, FIELDS VIROLOGY, P796; ROBINSON C R, 1958, Can Med Assoc J, V79, P615; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Shekhar K, 2005, Med J Malaysia, V60, P297; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; SICKLES GM, 1955, P SOC EXP BIOL MED, V90, P529, DOI 10.3181/00379727-90-22088; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Stanway G, 2005, VIRUS TAXONOMY, P757; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tian H, 2012, MED PRIN PRACT, V21, P355, DOI 10.1159/000334619; Urashima M, 2003, JPN J INFECT DIS, V56, P48; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang CY, 2004, PEDIATR INFECT DIS J, V23, P275, DOI 10.1097/01.inf.0000115950.63906.78; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wen HL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-115; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; WRIGHT HT, 1963, NEW ENGL J MED, V268, P1041, DOI 10.1056/NEJM196305092681904; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yang F, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-508; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yip CCY, 2011, J VIROL, V85, P12098, DOI 10.1128/JVI.05944-11; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zeng M, 2012, EPIDEMIOL INFECT, V140, P1122, DOI 10.1017/S0950268811001622; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou XB, 2013, HUM VACCIN IMMUNOTHE, V9; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005	119	113	136	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2014	9	4							e96051	10.1371/journal.pone.0096051	http://dx.doi.org/10.1371/journal.pone.0096051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW4HM	24776922	gold, Green Submitted, Green Published			2022-12-27	WOS:000346241800025
J	Liu, X; Zhang, JL; Gu, TY; Zhang, WM; Shen, QR; Yin, SX; Qiu, HZ				Liu, Xing; Zhang, Junlian; Gu, Tianyu; Zhang, Wenming; Shen, Qirong; Yin, Shixue; Qiu, Huizhen			Microbial Community Diversities and Taxa Abundances in Soils along a Seven-Year Gradient of Potato Monoculture Using High Throughput Pyrosequencing Approach	PLOS ONE			English	Article							CROPPING SYSTEMS; BACTERIAL COMMUNITIES; SOILBORNE DISEASES; TILLAGE; POPULATIONS; MANAGEMENT; CULTIVARS; DYNAMICS; ROTATION; PLANT	Background: Previous studies have focused on linking soil community structure, diversity, or specific taxa to disturbances. Relatively little attention has been directed to crop monoculture soils, particularly potato monoculture. Information about microbial community changes over time between monoculture and non-monoculture treatments is lacking. Furthermore, few studies have examined microbial communities in potato monoculture soils using a high throughput pyrosequencing approach. Methodology/Principal Findings: Soils along a seven-year gradient of potato monoculture were collected and microbial communities were characterized using high throughput pyrosequencing approach. Principal findings are as follows. First, diversity (H-Shannon) and richness (S-Chao1) indices of bacterial community, but not of fungal community, were linearly decreased over time and corresponded to a decline of soil sustainability represented by yield decline and disease incidence increase. Second, Fusarium, the only soilborne pathogen-associated fungal genus substantially detected, was linearly increased over time in abundance and was closely associated with yield decline. Third, Fusarium abundance was negatively correlated with soil organic matter (OM) and total nitrogen (TN) but positively with electrical conductivity (EC). Fourth, Fusarium was correlated in abundances with 6 bacterial taxa over time. Conclusions: Soil bacterial and fungal communities exhibited differential responses to the potato monoculture. The overall soil bacterial communities were shaped by potato monoculture. Fusarium was the only soilborne pathogen-associated genus associated with disease incidence increase and yield decline. The changes of soil OM, TN and EC were responsible for Fusarium enrichment, in addition to selections by the monoculture crop. Acidobacteria and Nitrospirae were linearly decreased over time in abundance, corresponding to the decrease of OM, suggesting their similar ecophysiologial trait. Correlations between abundance of Fusarium with several other bacterial taxa suggested their similar behaviors in responses to potato monoculture and/or soil variables, providing insights into the ecological behaviors of these taxa in the environment.	[Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Coll Resources & Environm Sci, Lanzhou, Gansu, Peoples R China; [Liu, Xing; Zhang, Wenming; Qiu, Huizhen] Gansu Agr Univ, Gansu Prov Key Lab Aridland Crop Sci, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Coll Agron, Lanzhou, Gansu, Peoples R China; [Zhang, Junlian] Gansu Agr Univ, Gansu Key Lab Crop Genet & Germplasm Enhancement, Lanzhou, Gansu, Peoples R China; [Gu, Tianyu; Yin, Shixue] Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China; [Shen, Qirong] Nanjing Agr Univ, Jiangsu Prov Key Lab Organ Solid Waste Utilizat, Nanjing, Jiangsu, Peoples R China	Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; Yangzhou University; Nanjing Agricultural University	Yin, SX (corresponding author), Yangzhou Univ, Coll Environm Sci & Engn, Yangzhou, Jaingsu Provinc, Peoples R China.	sxyin@yzu.edu.cn; hzqiu@gsau.edu.cn	Shen, Qirong/AAB-6531-2020; Liu, Xing/GPG-3245-2022	Liu, Xing/0000-0001-8578-3769; Liu, Xinting/0000-0002-2798-448X; zhang, wenming/0000-0001-6567-8099	Agricultural Ministry of China [201103004]; Natural Science Foundation of China [31360500]; National Nature Science Foundation of China [41071177]	Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Agricultural Ministry of China (201103004), the Natural Science Foundation of China (31360500) and the National Nature Science Foundation of China (41071177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Acosta-Martinez V., 2010, Diversity, V2, P910; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arroita M, 2013, J HAZARD MATER, V263, P139, DOI 10.1016/j.jhazmat.2013.06.049; Bernard E, 2012, APPL SOIL ECOL, V52, P29, DOI 10.1016/j.apsoil.2011.10.002; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cardenas E, 2010, APPL ENVIRON MICROB, V76, P6778, DOI 10.1128/AEM.01097-10; Ceja-Navarro JA, 2010, PLANT SOIL, V329, P127, DOI 10.1007/s11104-009-0140-9; Cook RJ, 2006, P NATL ACAD SCI USA, V103, P18389, DOI 10.1073/pnas.0605946103; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Xuan DT, 2012, BIOL FERT SOILS, V48, P217, DOI 10.1007/s00374-011-0618-5; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fiers M, 2012, AGRON SUSTAIN DEV, V32, P93, DOI 10.1007/s13593-011-0035-z; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; HOPKINS DL, 1992, PHYTOPATHOLOGY, V82, P290, DOI 10.1094/Phyto-82-290; HOPKINS DL, 1984, PLANT DIS, V68, P129, DOI 10.1094/PD-69-129; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Jeger MJ, 1996, POTATO RES, V39, P437, DOI 10.1007/BF02357949; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jumpponen A, 2010, MYCOLOGIA, V102, P1027, DOI 10.3852/09-316; Larkin RP, 2008, SOIL BIOL BIOCHEM, V40, P1341, DOI 10.1016/j.soilbio.2007.03.005; Larkin RP, 2011, PHYTOPATHOLOGY, V101, P58, DOI 10.1094/PHYTO-04-10-0100; Larkin RP, 2010, PLANT DIS, V94, P1491, DOI 10.1094/PDIS-03-10-0172; Larkin RP, 2006, PHYTOPATHOLOGY, V96, P68, DOI 10.1094/PHYTO-96-0068; Larkin RP, 2003, SOIL BIOL BIOCHEM, V35, P1451, DOI 10.1016/S0038-0717(03)00240-2; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LEACH SS, 1981, PHYTOPATHOLOGY, V71, P623, DOI 10.1094/Phyto-71-623; Lee J, 2011, BIODEGRADATION, V22, P687, DOI 10.1007/s10532-010-9429-x; Li CG, 2010, PLANT SOIL, V330, P423, DOI 10.1007/s11104-009-0216-6; Lu LH, 2013, SOIL BIOL BIOCHEM, V65, P186, DOI 10.1016/j.soilbio.2013.05.025; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luo J, 2010, SOIL SCI SOC AM J, V74, P2039, DOI 10.2136/sssaj2009.0437; McGuire KL, 2012, MICROB ECOL, V63, P804, DOI 10.1007/s00248-011-9973-x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Norris TB, 2002, APPL ENVIRON MICROB, V68, P6300, DOI 10.1128/AEM.68.12.6300-6309.2002; Silva MCPE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051554; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schramm A, 1999, APPL ENVIRON MICROB, V65, P3690; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; SHIPTON PJ, 1977, ANNU REV PHYTOPATHOL, V15, P387, DOI 10.1146/annurev.py.15.090177.002131; Silva MCPE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00077; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; van Bruggen AHC, 2006, EUR J PLANT PATHOL, V115, P105, DOI 10.1007/s10658-005-1250-8; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	52	95	113	7	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86610	10.1371/journal.pone.0086610	http://dx.doi.org/10.1371/journal.pone.0086610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24497959	Green Published, Green Submitted, gold			2022-12-27	WOS:000330617100022
J	Sun, ZK; He, X; Brancaccio, VF; Yuan, J; Riedel, CU				Sun, Zhongke; He, Xiang; Brancaccio, Vincenzo F.; Yuan, Jing; Riedel, Christian U.			Bifidobacteria Exhibit LuxS-Dependent Autoinducer 2 Activity and Biofilm Formation	PLOS ONE			English	Article							VIBRIO-HARVEYI; LISTERIA-MONOCYTOGENES; EXPRESSION PROFILES; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; GENOME SEQUENCE; LONGUM NCC2705; BACTERIA; LUMINESCENCE; METABOLISM	Autoinducer-2 (AI-2) molecules are one class of signalling molecules involved in gene regulation dependent on population density in a mechanism commonly referred to as quorum sensing (QS). AI-2 is produced by the methylthioadenosine/S-adenosyl-homocysteine nucleosidase LuxS. In the present study, we characterise the function of bifidobacterial LuxS proteins to address the question whether these economically important bacteria are able to perform QS communication. All publically available genome sequences of bifidobacteria harbour putative luxS genes. The deduced amino acid sequences are well conserved in the genus and show good homology to the LuxS protein of the prototypical AI-2 producer Vibrio harveyi. The luxS genes of three bifidobacterial strains were successfully expressed in AI-2-negative Escherichia coli DH5 alpha. Supernatants of these recombinant E. coli strains contained significant AI-2 activity. In initial experiments, we failed to detect AI-2 activity in supernatants of bifidobacteria grown in MRSc. High concentration of glucose as well as acidic pH had strong inhibitory effects on AI-2 activity. AI-2 activity could be detected when lower volumes of supernatants were used in the assay. Homologous overexpression of luxS in Bifidobacterium longum NCC2705 increased AI-2 levels in the supernatant. Furthermore, over-expression of luxS or supplementation with AI-2-containing supernatants enhanced biofilm formation of B. longum NCC2705. Collectively, these results suggest that bifidobacteria indeed harbour functional luxS genes that are involved in the production of AI-2-like molecules. To the best of our knowledge, this represents the first report on AI-2 activity produced by bifidobacteria. Self-produced AI-2 activity as well as AI-2-like molecules of other bacteria of the intestinal tract may have a regulatory function in biofilm formation and host colonization by bifidobacteria.	[Sun, Zhongke; Brancaccio, Vincenzo F.; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [He, Xiang; Yuan, Jing] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China	Ulm University; Academy of Military Medical Sciences - China	Yuan, J (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	yuanjing6216@163.com; christian.riedel@uni-ulm.de	Sun, Zhongke/AAF-5743-2020; Sun, Zhongke/R-2274-2019	Sun, Zhongke/0000-0002-9784-9769; Riedel, Christian U./0000-0001-7134-7085	German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]; German Academic Exchange Service	German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This study was partially funded by the German Academic Exchange Service/Federal Ministry of Education and Research (grant D/09/04778) to CUR. ZS was supported by a PhD fellowship of the German Academic Exchange Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Belval SC, 2006, APPL ENVIRON MICROB, V72, P2644, DOI 10.1128/AEM.72.4.2644-2650.2006; Brancaccio VF, 2013, BIOENGINEERED, V4, P197, DOI 10.4161/bioe.23381; DeKeersmaecker SCJ, 2003, MICROBIOL-SGM, V149, P1953, DOI 10.1099/mic.0.C0117-0; Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006; Hardie KR, 2003, MICROBIOL-SGM, V149, P715, DOI 10.1099/mic.0.25853-0; Klijn A, 2006, APPL ENVIRON MICROB, V72, P7401, DOI 10.1128/AEM.01611-06; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Leahy SC, 2005, J APPL MICROBIOL, V98, P1303, DOI 10.1111/j.1365-2672.2005.02600.x; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Mijakovic I, 2012, FEMS MICROBIOL REV, V36, P877, DOI 10.1111/j.1574-6976.2011.00314.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Riedel CU, 2009, MOL MICROBIOL, V71, P1177, DOI 10.1111/j.1365-2958.2008.06589.x; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela S, 2006, APPL ENVIRON MICROB, V72, P5653, DOI 10.1128/AEM.00048-06; SHENG Y, 1995, NUCLEIC ACIDS RES, V23, P1990, DOI 10.1093/nar/23.11.1990; Soufi B, 2012, CURR OPIN MICROBIOL, V15, P357, DOI 10.1016/j.mib.2012.05.003; Taga Michiko E, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01c01s00; Turovskiy Y, 2006, J MICROBIOL METH, V66, P497, DOI 10.1016/j.mimet.2006.02.001; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vilchez R, 2007, ANAL BIOANAL CHEM, V387, P489, DOI 10.1007/s00216-006-0824-4; Wilson CM, 2012, J BACTERIOL, V194, P1743, DOI 10.1128/JB.06318-11; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	36	55	66	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88260	10.1371/journal.pone.0088260	http://dx.doi.org/10.1371/journal.pone.0088260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24520369	Green Published, Green Submitted, gold			2022-12-27	WOS:000330829200156
J	Xie, YH; Chongsuvivatwong, V; Tang, ZZ; McNeil, EB; Tan, Y				Xie, Yi-hong; Chongsuvivatwong, Virasakdi; Tang, Zhenzhu; McNeil, Edward B.; Tan, Yi			Spatio-Temporal Clustering of Hand, Foot, and Mouth Disease at the County Level in Guangxi, China	PLOS ONE			English	Article							ENTEROVIRUS 71; OUTBREAK; EPIDEMIOLOGY; SURVEILLANCE; INFECTION	Background: Amid numerous outbreaks of hand, foot and mouth disease (HFMD) in Asia over the past decade, studies on spatio-temporal clustering are limited. Without this information the distribution of severe cases assumed to be sporadic. We analyzed surveillance data with onset dates between 1 May 2008 to 31 October 2013 with the aim to document the spatio-temporal clustering of HFMD cases and severe cases at the county level. Methods: Purely temporal and purely spatial descriptive analyses were done. These were followed by a space-time scan statistic for the whole study period and by year to detect the high risk clusters based on a discrete Poisson model. Results: The annual incidence rate of HFMD in Guangxi increased whereas the severe cases peaked in 2010 and 2012. EV71 and CoxA16 were alternating viruses. Both HFMD cases and severe cases had a seasonal peak in April to July. The spatio-temporal cluster of HFMD cases were mainly detected in the northeastern, central and southwestern regions, among which three clusters were observed in Nanning, Liuzhou, Guilin city and their neighbouring areas lasting from 1.2 to 2.5 years. The clusters of severe cases were less consistent in location and included around 40-70% of all severe cases in each year. Conclusions: Both HFMD cases and severe cases occur in spatio-temporal clusters. The continuous epidemic in Nanning, Liuzhou, Guilin cities and their neighbouring areas and the clusters of severe cases indicate the need for further intensive surveillance.	[Xie, Yi-hong; Tang, Zhenzhu; Tan, Yi] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Nanning, Guangxi, Peoples R China; [Xie, Yi-hong; Chongsuvivatwong, Virasakdi; McNeil, Edward B.] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand; [Xie, Yi-hong] Minist Publ Hlth, Bur Epidemiol, Int Field Epidemiol Training Program, Bangkok, Thailand	Prince of Songkla University; Ministry of Public Health - Thailand	Chongsuvivatwong, V (corresponding author), Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkla, Thailand.	cvirasak@gmail.com	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040				AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; [别芹芹 Bie Qinqin], 2010, 地球信息科学学报, V12, P380; BLOMBERG J, 1974, LANCET, V2, P112; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chen Jin, 2008, Int J Health Geogr, V7, P57, DOI 10.1186/1476-072X-7-57; Chinese Center for Disease Control and Prevention and the Office of the World Health Organization in China, 2008, REP HAND FOOT MOUTH; Deng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056943; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Infectious Disease Surveillance Centre (IDSC) National Institute of Infectious Diseases (NID) Japan, 2004, INFECT AGENTS SURVEI, V25, P224; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2011, SATSCAN TM USER GUID; Li LL, 2013, PRACTICAL PREVENTIVE, V20, P165; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063447, 10.1371/journal.pone.0076105]; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Ma JQ, 2006, DIS SURVEILL, V21, P600; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Ru Wei-Ping, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P448; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shekhar K, 2005, Med J Malaysia, V60, P297; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tango T, 2012, STAT MED, V31, P4207, DOI 10.1002/sim.5478; The Ministry of Health of China, 2010, HAND FOOT MON DIS DI; The Ministry of Health of China, 2008, HAND FOOT MON DIS PR; The Ministry of Health of China, 2009, HAND FOOT MOUTH DIS; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang Ying, 2010, Disease Surveillance, V25, P774; Western Pacific Region WHO, 2013, HAND FOOT MOUTH DIS; Xiao GeXin, 2012, Disease Surveillance, V27, P932; Yu SC, 2012, BIOMED ENVIRON SCI, V25, P645, DOI 10.3967/0895-3988.2012.06.006; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Q, 2011, BIOMED ENVIRON SCI, V24, P349, DOI 10.3967/0895-3988.2011.04.005; Zhu Qi, 2011, Modern Preventive Medicine, V38, P1824	46	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88065	10.1371/journal.pone.0088065	http://dx.doi.org/10.1371/journal.pone.0088065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA1AT	24505378	gold, Green Submitted, Green Published			2022-12-27	WOS:000330829200108
J	Zhang, XY; Zhang, T; Young, AA; Li, XS				Zhang, Xingyu; Zhang, Tao; Young, Alistair A.; Li, Xiaosong			Applications and Comparisons of Four Time Series Models in Epidemiological Surveillance Data	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; NEURAL-NETWORK; HYBRID ARIMA; PREDICTION; FORECAST; FEVER	Public health surveillance systems provide valuable data for reliable predication of future epidemic events. This paper describes a study that used nine types of infectious disease data collected through a national public health surveillance system in mainland China to evaluate and compare the performances of four time series methods, namely, two decomposition methods (regression and exponential smoothing), autoregressive integrated moving average (ARIMA) and support vector machine (SVM). The data obtained from 2005 to 2011 and in 2012 were used as modeling and forecasting samples, respectively. The performances were evaluated based on three metrics: mean absolute error (MAE), mean absolute percentage error (MAPE), and mean square error (MSE). The accuracy of the statistical models in forecasting future epidemic disease proved their effectiveness in epidemiological surveillance. Although the comparisons found that no single method is completely superior to the others, the present study indeed highlighted that the SVMs outperforms the ARIMA model and decomposition methods in most cases.	[Zhang, Xingyu; Zhang, Tao; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xingyu; Young, Alistair A.] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand	Sichuan University; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Med Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com		Zhang, Xingyu/0000-0001-8108-1997; Young, Alistair/0000-0001-5702-4220	National Special Foundation for Health Research of China [200802133]	National Special Foundation for Health Research of China	The entire study and the paper were financially supported by the National Special Foundation for Health Research of China (grant no. 200802133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowerman B. L., 1993, FORECASTING TIME SER; Chadwick D, 2006, J CLIN VIROL, V35, P147, DOI 10.1016/j.jcv.2005.06.002; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Christodoulos C, 2011, TECHNOL FORECAST SOC, V78, P163, DOI 10.1016/j.techfore.2010.08.007; Davision AC, 1997, BOOTSTRAP METHODS TH, P23; Farrington C, 2003, MONITORING HLTH POPU, V2003, P203; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Gonzalez-Parra G, 2009, COMMUN NONLINEAR SCI, V14, P3967, DOI 10.1016/j.cnsns.2009.02.023; Grahn T., 1995, J TIMES SERIES ANAL, V16, P509, DOI [DOI 10.1111/J.1467-9892.1995.TB00251.X, 10.1111/j.1467-9892.1995.tb00251.x]; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Hong WC, 2006, INT J ADV MANUF TECH, V28, P154, DOI 10.1007/s00170-004-2340-z; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu Q, 2011, BMC INFECT DIS, V11; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; MOGHRAM I, 1989, IEEE T POWER SYST, V4, P1484, DOI 10.1109/59.41700; Muller K.-R., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P999, DOI 10.1007/BFb0020283; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pai PF, 2005, INT J ADV MANUF TECH, V27, P205, DOI 10.1007/s00170-004-2139-y; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Spaeder MC, 2012, EPIDEMIOL INFECT, V140, P602, DOI 10.1017/S0950268811001026; Tay FEH, 2002, NEUROCOMPUTING, V48, P847, DOI 10.1016/S0925-2312(01)00676-2; Tay FEH, 2001, OMEGA-INT J MANAGE S, V29, P309, DOI 10.1016/S0305-0483(01)00026-3; Thiessen U, 2003, CHEMOMETR INTELL LAB, V69, P35, DOI 10.1016/S0169-7439(03)00111-4; Thomason M., 1999, J COMPUT FINANC, V7, P36; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wei W. W.-S., 1994, TIME SERIES ANAL; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang X-G, 2000, ACTA AUTOMATICA SIN, V26, P32; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	37	122	129	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2014	9	2							e88075	10.1371/journal.pone.0088075	http://dx.doi.org/10.1371/journal.pone.0088075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AA1AT	24505382	Green Submitted, gold, Green Published			2022-12-27	WOS:000330829200110
J	Xie, YJ; Stewart, SM; Lam, TH; Viswanath, K; Chan, SS				Xie, Yao Jie; Stewart, Sunita M.; Lam, Tai Hing; Viswanath, Kasisomayajula; Chan, Sophia S.			Television Viewing Time in Hong Kong Adult Population: Associations with Body Mass Index and Obesity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SCREEN-TIME; RISK; HEALTH; BEHAVIORS; MEDICINE; CHILDREN; LEISURE	Background: Obesity is increasing dramatically in the Asia-Pacific region particularly China. The population of Hong Kong was exposed to modernization far earlier than the rest of China, reflecting conditions that are likely to be replicated as other Chinese cities undergo rapid change. This study examined the relationship between television viewing and obesity in a Hong Kong sample. Information about the relationship between a key sedentary behavior, TV viewing, and obesity, and its moderation by demographic characteristics may identify sectors of the population at highest risk for excess weight. Methods: Data were from Hong Kong Family and Health Information Trends Survey (2009-2010), a population-based survey on the public's use of media for health information and family communication by telephone interviews with 3,016 Hong Kong adults (age >= 18 years). TV viewing time, body mass index (BMI), physical activity and other lifestyle variables were analyzed. Results: Viewing time was longer in women, increased with age but decreased with education level and vigorous physical activity (all P<0.01). Longer TV viewing time was significantly associated with higher BMI (Coefficients B = 0.17, 95% CI: 0.11, 0.24) after adjusting for age, gender, employment status, marital status, education level, smoking activity and vigorous physical activity. This association was stronger in women than men (Coefficients B: 0.19 versus 0.15) and strongest in those aged 18 to 34 years (Coefficients B = 0.35). Furthermore, an hour increase in daily TV viewing was associated with 10% greater odds of being obese. Conclusions: A significant socioeconomic gradient in television viewing time was observed. TV viewing time positively associated with BMI and obesity. The TV viewing - BMI associations were strongest in women and young adults, suggesting vulnerable groups to target for obesity prevention by decreasing TV viewing.	[Xie, Yao Jie; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Stewart, Sunita M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Ctr Community Based Res,Dept Soc & Behav Sci, Boston, MA 02115 USA; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Xie, Yao Jie/K-7001-2014	Xie, Yao Jie/0000-0001-9289-4985; McNeil, Edward Braddon/0000-0002-9492-1040	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society," which was funded by The Hong Kong Jockey Club Charities Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Banks E, 2011, PUBLIC HEALTH NUTR, V14, P34, DOI 10.1017/S1368980010000674; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Blass EM, 2006, PHYSIOL BEHAV, V88, P597, DOI 10.1016/j.physbeh.2006.05.035; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Boulos R, 2012, PHYSIOL BEHAV, V107, P146, DOI 10.1016/j.physbeh.2012.05.022; Brown PR, 2001, LEISURE SCI, V23, P131, DOI 10.1080/014904001316896837; Chang PC, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-193; Ching PLYH, 1996, AM J PUBLIC HEALTH, V86, P25, DOI 10.2105/AJPH.86.1.25; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Dunstan DW, 2007, DIABETES CARE, V30, P516, DOI 10.2337/dc06-1996; Dunstan DW, 2005, DIABETOLOGIA, V48, P2254, DOI 10.1007/s00125-005-1963-4; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; DURANT RH, 1994, PEDIATRICS, V94, P449; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FitzGerald SJ, 1997, MED SCI SPORT EXER, V29, P910, DOI 10.1097/00005768-199707000-00010; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Griffiths SM, 2010, ASIA-PAC J PUBLIC HE, V22, p110S, DOI 10.1177/1010539510373000; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Huang WY, 2013, J SCI MED SPORT, V16, P509, DOI 10.1016/j.jsams.2012.12.011; Inoue S, 2012, J EPIDEMIOL, V22, P50, DOI 10.2188/jea.JE20110054; King AC, 2008, ANN BEHAV MED, V35, P251, DOI 10.1007/s12160-008-9032-0; Lobstein T, 2005, OBES REV, V6, P203, DOI 10.1111/j.1467-789X.2005.00191.x; Mamun AA, 2012, PUBLIC HEALTH NUTR, V12, P1; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Nang EEK, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-70; Nelson DE, 2004, J HEALTH COMMUN, V9, P443, DOI 10.1080/10810730490504233; Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Scully M, 2009, PUBLIC HEALTH NUTR, V12, P105, DOI 10.1017/S1368980008002012; Teychenne M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-3; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Viswanath K SR, 2007, MACROSOCIAL DETERMIN, P275; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; World Health Organization, 2000, AS PAC PERSP RED OB; Xu F, 2008, PUBLIC HEALTH NUTR, V11, P891, DOI 10.1017/S1368980007001280; Zuzanna B, 2008, MCMASTER J COMMUNICA, V5	44	65	79	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2014	9	1							e85440	10.1371/journal.pone.0085440	http://dx.doi.org/10.1371/journal.pone.0085440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	291YG	24505378	gold, Green Submitted, Green Published			2022-12-27	WOS:000329868200050
J	Miao, HX; Sun, PG; Liu, WX; Xu, BY; Jin, ZQ				Miao, Hongxia; Sun, Peiguang; Liu, Weixin; Xu, Biyu; Jin, Zhiqiang			Identification of Genes Encoding Granule-Bound Starch Synthase Involved in Amylose Metabolism in Banana Fruit	PLOS ONE			English	Article							MOLECULAR-CLONING; POTATO; EXPRESSION; GELATINIZATION; BIOSYNTHESIS; EVOLUTION; ISOFORMS; CDNAS; FOOD	Granule-bound starch synthase (GBSS) is responsible for amylose synthesis, but the role of GBSS genes and their encoded proteins remains poorly understood in banana. In this study, amylose content and GBSS activity gradually increased during development of the banana fruit, and decreased during storage of the mature fruit. GBSS protein in banana starch granules was approximately 55.0 kDa. The protein was up-regulated expression during development while it was down-regulated expression during storage. Six genes, designated as MaGBSSI-1, MaGBSSI-2, MaGBSSI-3, MaGBSSI-4, MaGBSSII-1, and MaGBSSII-2, were cloned and characterized from banana fruit. Among the six genes, the expression pattern of MaGBSSI-3 was the most consistent with the changes in amylose content, GBSS enzyme activity, GBSS protein levels, and the quantity or size of starch granules in banana fruit. These results suggest that MaGBSSI-3 might regulate amylose metabolism by affecting the variation of GBSS levels and the quantity or size of starch granules in banana fruit during development or storage.	[Miao, Hongxia; Liu, Weixin; Xu, Biyu; Jin, Zhiqiang] China Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Hainan, Peoples R China; [Sun, Peiguang; Jin, Zhiqiang] China Acad Trop Agr Sci, Key Lab Genet Improvement Bananas, Haikou Expt Stn, Haikou, Hainan, Peoples R China; [Liu, Weixin] Hainan Univ, Dept Agr, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Hainan University	Xu, BY (corresponding author), China Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Trop Crop Biotechnol, Minist Agr, Haikou, Hainan, Peoples R China.	biyuxu@126.com; 18689846976@163.com		Wu, Jianguo/0000-0002-8326-2895	Ministry of Science and Technology of the People's Republic of China [2011AA10020605]; Modern Agro-industry Technology Research System [nycytx-33]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Modern Agro-industry Technology Research System	The work is financially supported by the Ministry of Science and Technology of the People's Republic of China (NO. 2011AA10020605) and the Modern Agro-industry Technology Research System (nycytx-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio-Saguilan A, 2013, CYTA-J FOOD, V11, P90, DOI 10.1080/19476337.2012.760653; Bansal A, 2012, PLANT CELL TISS ORG, V109, P247, DOI 10.1007/s11240-011-0090-9; Buleon A, 1997, PLANT PHYSIOL, V115, P949, DOI 10.1104/pp.115.3.949; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DRY I, 1992, PLANT J, V2, P193; Edwards A, 2002, PLANT CELL, V14, P1767, DOI 10.1105/tpc.002907; Jiang H, 2013, GENET MOL RES; Jobling S, 2004, CURR OPIN PLANT BIOL, V7, P210, DOI 10.1016/j.pbi.2003.12.001; Juansang J, 2012, FOOD CHEM, V131, P500, DOI 10.1016/j.foodchem.2011.09.013; Juarez-Garcia E, 2013, J SCI FOOD AGR, V93, P2660, DOI 10.1002/jsfa.6054; Kimura T, 2010, BIOSCI BIOTECH BIOCH, V74, P667, DOI 10.1271/bbb.90765; Ko YT, 2009, J AGR FOOD CHEM, V57, P4426, DOI 10.1021/jf900127u; Krishnan HB, 2013, J AGR FOOD CHEM, V61, P5404, DOI 10.1021/jf4014372; Liu J, 2013, FOOD CHEM, V141, P3103, DOI 10.1016/j.foodchem.2013.05.155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meenakshisundaram P., 2011, Crop Improvement, V38, P155; Nakamura T, 1998, PLANT PHYSIOL, V118, P451, DOI 10.1104/pp.118.2.451; Otani M, 2007, PLANT CELL REP, V26, P1801, DOI 10.1007/s00299-007-0396-6; Park YJ, 2009, BREEDING SCI, V59, P351, DOI 10.1270/jsbbs.59.351; SHURE M, 1983, CELL, V35, P225, DOI 10.1016/0092-8674(83)90225-8; SLACK PT, 1980, J I BREWING, V86, P74, DOI 10.1002/j.2050-0416.1980.tb03961.x; Stover RH, 1987, BANANAS, P192; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; Wang ZY, 2011, INFLAMM RES, V60, P525, DOI 10.1007/s00011-010-0298-x; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P6854, DOI 10.1021/es070627i; Xu BY, 2007, PLANTA, V226, P529, DOI 10.1007/s00425-007-0502-6; Yang J. H., 1992, Acta Agronomica Sinica, V18, P366; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zou W, 2012, CARBOHYD POLYM, V87, P1583, DOI 10.1016/j.carbpol.2011.09.060	30	113	136	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e88077	10.1371/journal.pone.0088077	http://dx.doi.org/10.1371/journal.pone.0088077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6GY	24776922	Green Published, Green Submitted, gold			2022-12-27	WOS:000336971300050
J	Chen, H; Luo, R; Gong, SZ; Matta, SG; Sharp, BM				Chen, Hao; Luo, Rui; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.			Protection Genes in Nucleus Accumbens Shell Affect Vulnerability to Nicotine Self-Administration across Isogenic Strains of Adolescent Rat	PLOS ONE			English	Article							CUE-INDUCED REINSTATEMENT; AFRICAN-AMERICAN SMOKERS; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMAS; CA2+ SENSOR VILIP-1; HIPPOCAMPAL-NEURONS; NEOSTRIATAL NEURONS; MOLECULAR-GENETICS; SMOKING-CESSATION; EUROPEAN-AMERICAN	Classical genetic studies show the heritability of cigarette smoking is 0.4-0.6, and that multiple genes confer susceptibility and resistance to smoking. Despite recent advances in identifying genes associated with smoking behaviors, the major source of this heritability and its impact on susceptibility and resistance are largely unknown. Operant self-administration (SA) of intravenous nicotine is an established model for smoking behavior. We recently confirmed that genetic factors exert strong control over nicotine intake in isogenic rat strains. Because the processing of afferent dopaminergic signals by nucleus accumbens shell (AcbS) is critical for acquisition and maintenance of motivated behaviors reinforced by nicotine, we hypothesized that differential basal gene expression in AcbS accounts for much of the strain-to-strain variation in nicotine SA. We therefore sequenced the transcriptome of AcbS samples obtained by laser capture microdissection from 10 isogenic adolescent rat strains and compared all RNA transcript levels with behavior. Weighted gene co-expression network analysis, a systems biology method, found 12 modules (i.e., unique sets of genes that covary across all samples) that correlated (p<0.05) with amount of self-administered nicotine; 9 of 12 correlated negatively, implying a protective role. PCR confirmed selected genes from these modules. Chilibot, a literature mining tool, identified 15 genes within 1 module that were nominally associated with cigarette smoking, thereby providing strong support for the analytical approach. This is the first report demonstrating that nicotine intake by adolescent rodents is associated with the expression of specific genes in AcbS of the mesolimbic system, which controls motivated behaviors. These findings provide new insights into genetic mechanisms that predispose or protect against tobacco addiction.	[Chen, Hao; Gong, Suzhen; Matta, Shannon G.; Sharp, Burt M.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA; [Luo, Rui] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, H (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA.	hchen@uthsc.edu; bsharp@uthsc.edu	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	NIH [RC2 DA 028962]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by NIH grant RC2 DA 028962. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anney RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-46; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Beuten J, 2007, AM J MED GENET B, V144B, P285, DOI 10.1002/ajmg.b.30399; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Brower VG, 2002, BRAIN RES, V930, P12, DOI 10.1016/S0006-8993(01)03375-3; Brunzell DH, 2010, NEUROPSYCHOPHARMACOL, V35, P665, DOI 10.1038/npp.2009.171; Buczek Y, 1999, PSYCHOPHARMACOLOGY, V144, P183, DOI 10.1007/s002130050992; Cadoni C, 2009, NEUROPHARMACOLOGY, V57, P496, DOI 10.1016/j.neuropharm.2009.07.033; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147; Chen H, 2007, NEUROPSYCHOPHARMACOL, V32, P700, DOI 10.1038/sj.npp.1301135; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044234; Chen H, 2011, NEUROPSYCHOPHARMACOL, V36, P2629, DOI 10.1038/npp.2011.149; Chen H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00098; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; Dao JM, 2011, NEUROPSYCHOPHARMACOL, V36, P1319, DOI 10.1038/npp.2011.8; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gold AB, 2012, NEUROPSYCHOPHARMACOL, V37, P1683, DOI 10.1038/npp.2012.13; Hafkamp HC, 2009, MODERN PATHOL, V22, P686, DOI 10.1038/modpathol.2009.23; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; Hamada M, 2004, J NEUROCHEM, V90, P1094, DOI 10.1111/j.1471-4159.2004.02574.x; Han SZ, 2010, BIOL PSYCHIAT, V67, P12, DOI 10.1016/j.biopsych.2009.08.028; Iancu OD, 2013, ALCOHOL CLIN EXP RES, V37, P1295, DOI 10.1111/acer.12100; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JOSEPH R, 1994, BIOCHEM BIOPH RES CO, V201, P1227, DOI 10.1006/bbrc.1994.1836; Kalomenidis L, 2001, LUNG, V179, P265, DOI 10.1007/s0040800000067; Kendler KS, 2012, NAT NEUROSCI, V15, P181, DOI 10.1038/nn.3018; Keskitalo-Vuokko K, 2012, NICOTINE TOB RES, V14, P153, DOI 10.1093/ntr/ntr153; Konu O, 2001, BRAIN RES, V909, P194, DOI 10.1016/S0006-8993(01)02685-3; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Le Foll B, 2012, INT J NEUROPSYCHOPH, V15, P1265, DOI 10.1017/S1461145711001398; Lecca D, 2006, PSYCHOPHARMACOLOGY, V184, P435, DOI 10.1007/s00213-005-0280-4; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liechti ME, 2007, J NEUROSCI, V27, P9077, DOI 10.1523/JNEUROSCI.1766-07.2007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu X, 2007, NEUROPSYCHOPHARMACOL, V32, P710, DOI 10.1038/sj.npp.1301129; Ma JZ, 2010, HUM GENET, V127, P503, DOI 10.1007/s00439-010-0787-6; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; O'Dell LE, 2007, J PHARMACOL EXP THER, V320, P180, DOI 10.1124/jpet.106.105270; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-63; Oyang EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024879; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Rose JE, 1997, PSYCHOPHARMACOLOGY, V130, P28, DOI 10.1007/s002130050209; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sasaki H, 2012, MOL MED REP, V5, P725, DOI 10.3892/mmr.2011.715; Sato N, 2010, PSYCHIAT GENET, V20, P135, DOI 10.1097/YPG.0b013e32833a21f9; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Sharp BM, 2011, GENES BRAIN BEHAV, V10, P778, DOI 10.1111/j.1601-183X.2011.00716.x; Shoaib M, 1997, PSYCHOPHARMACOLOGY, V129, P35, DOI 10.1007/s002130050159; Shoaib M, 1999, PSYCHOPHARMACOLOGY, V143, P318, DOI 10.1007/s002130050954; Slotkin TA, 2007, NEUROPSYCHOPHARMACOL, V32, P1082, DOI 10.1038/sj.npp.1301231; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Sullivan P F, 1999, Nicotine Tob Res, V1 Suppl 2, pS51; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Valentine JD, 1997, PSYCHOPHARMACOLOGY, V133, P300, DOI 10.1007/s002130050405; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wei JX, 2012, ADDICT BEHAV, V37, P622, DOI 10.1016/j.addbeh.2012.01.009; Winden KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020763; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young RJ, 2013, ORAL ONCOL, V49, P576, DOI 10.1016/j.oraloncology.2013.01.006; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	82	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2014	9	1							e86214	10.1371/journal.pone.0086214	http://dx.doi.org/10.1371/journal.pone.0086214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297VL	24465966	Green Published, Green Submitted, gold			2022-12-27	WOS:000330283100127
J	Chen, HX; Sun, SC; Norenburg, JL; Sundberg, P				Chen, Haixia; Sun, Shichun; Norenburg, Jon L.; Sundberg, Per			Mutation and Selection Cause Codon Usage and Bias in Mitochondrial Genomes of Ribbon Worms (Nemertea)	PLOS ONE			English	Article							AMINO-ACID USAGE; TRANSFER-RNAS; TRANSLATIONAL SELECTION; EFFECTIVE NUMBER; GENE-EXPRESSION; EVOLUTION; PATTERNS; FREQUENCIES; NUCLEOTIDE; ABUNDANCE	The phenomenon of codon usage bias is known to exist in many genomes and it is mainly determined by mutation and selection. To understand the patterns of codon usage in nemertean mitochondrial genomes, we use bioinformatic approaches to analyze the protein-coding sequences of eight nemertean species. Neutrality analysis did not find a significant correlation between GC12 and GC3. ENc-plot showed a few genes on or close to the expected curve, but the majority of points with low-ENc values are below it. ENc-plot suggested that mutational bias plays a major role in shaping codon usage. The Parity Rule 2 plot (PR2) analysis showed that GC and AT were not used proportionally and we propose that codons containing A or U at third position are used preferentially in nemertean species, regardless of whether corresponding tRNAs are encoded in the mitochondrial DNA. Context-dependent analysis indicated that the nucleotide at the second codon position slightly affects synonymous codon choices. These results suggested that mutational and selection forces are probably acting to codon usage bias in nemertean mitochondrial genomes.	[Chen, Haixia; Sundberg, Per] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Sun, Shichun] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Peoples R China; [Norenburg, Jon L.] Smithsonians Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC USA	University of Gothenburg; Ocean University of China; Smithsonian Institution; Smithsonian National Museum of Natural History	Chen, HX (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	chen_hai_xia@126.com; per.sundberg@bioenv.gu.se	Sharp, Burt/X-6200-2019; Chen, Hao/AAX-5849-2020; Norenburg, Jon L/K-3481-2015	Sharp, Burt/0000-0002-3765-8848; Chen, Hao/0000-0002-2680-6921; Norenburg, Jon L/0000-0001-7776-1527; Zhou, Tan/0000-0002-9193-5113; Yu, Rongjie/0000-0001-9285-5783	Swedish Research Council; National Natural Science Foundation of China [30970333]	Swedish Research Council(Swedish Research CouncilEuropean Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported (to PS) by the Swedish Research Council, and National Natural Science Foundation of China (to SCS, grant no. 30970333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; BULMER M, 1988, J EVOLUTION BIOL, V1, P15, DOI 10.1046/j.1420-9101.1988.1010015.x; Carullo M, 2008, J MOL EVOL, V66, P484, DOI 10.1007/s00239-008-9102-8; Chen HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-139; Chen HX, 2011, MOL BIOL REP, V38, P4509, DOI 10.1007/s11033-010-0582-4; Chen HX, 2009, GENE, V442, P8, DOI 10.1016/j.gene.2009.04.015; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Cutter AD, 2006, MOL BIOL EVOL, V23, P2303, DOI 10.1093/molbev/msl097; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Fuglsang A, 2008, GENE, V410, P82, DOI 10.1016/j.gene.2007.12.001; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Ingvarsson PK, 2007, MOL BIOL EVOL, V24, P836, DOI 10.1093/molbev/msl212; Ingvarsson PK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-307; Jia WL, 2008, MOL BIOL EVOL, V25, P339, DOI 10.1093/molbev/msm259; Kamatani T, 2007, BIOSYSTEMS, V90, P362, DOI 10.1016/j.biosystems.2006.09.039; Le Thanh Hoa, 2004, Korean Journal of Parasitology, V42, P159, DOI 10.3347/kjp.2004.42.4.159; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Mitreva M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r75; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Podsiadlowski L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-364; Powell JR, 1997, P NATL ACAD SCI USA, V94, P7784, DOI 10.1073/pnas.94.15.7784; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1993, BIOCHEM SOC T, V21, P835, DOI 10.1042/bst0210835; Shioiri C, 2001, J MOL EVOL, V53, P364, DOI 10.1007/s002390010226; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Subramanian S, 2008, GENETICS, V178, P2429, DOI 10.1534/genetics.107.086405; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Swire J, 2005, J MOL EVOL, V60, P128, DOI 10.1007/s00239-004-0077-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turbeville JM, 2007, MOL PHYLOGENET EVOL, V43, P1056, DOI 10.1016/j.ympev.2006.10.025; Vicario S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-226; Wang B, 2010, J INTEGR PLANT BIOL, V52, P1100, DOI 10.1111/j.1744-7909.2010.00998.x; Wang X, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-14; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Xia XH, 2005, GENE, V345, P13, DOI 10.1016/j.gene.2004.11.019; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016147	48	136	143	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2014	9	1							e85631	10.1371/journal.pone.0085631	http://dx.doi.org/10.1371/journal.pone.0085631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297DH	24465966	Green Submitted, Green Published, gold			2022-12-27	WOS:000330235100110
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
